Citrus Sinensis ID: 042763

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550----
Protein Sequence
AYHLSSSYSTETTTEKGSLSFTFSIFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDYCRLDLSLAKLSFSPGRKNLQKEVKEEPKTHDAGQNFHPREEKNYSGSLSTTKKVGIAATGLFVMSCALLCPCFYKKRKATAHTVLARDPNSMDSASSLDVNSGSEKVSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKSVKKG
Secondary Structure (PSIPRED)
cccccccccccccccccEEEEEEEEEEEccccccccccccHHHHHHHEEccccccccEEEEEEcccccEEEEEccccEEEEEEEcEEccccccccHHHHHHccccccccccccccEEcccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHEEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEcccccccccHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccccccccccccccccccccccEEEcEEccccccccHHHHHccccccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccc
Secondary Structure Prediction (SSPRO)
cccEccEEEEEEEccccEEEEEEEEEcccEcEEEEEcccccccccHHHHHHHHcccccEEEEEEEcccccEcccccccEEccEccEEccccccHHHHHHHHHcccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEcHHHHHHHHccccHHcccccccccEEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEEccHHHcEccccccccccHHHccHHHcccEcccccHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHcccHHHHccHcccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHHHccccccccc
Coil and Loop (DISEMBL)
ayhlsssystetttekgslsftfsiflpressldissnfapssFLLFLQFWGIFASGFAIqskvcgadhiaysnsnEVELFYINGnlvdkfsfcKVIQFHYAnhcifegysgsdycrldlslaklsfspgrknlqkevkeepkthdagqnfhpreeknysgslsttkkvgiAATGLFVMSCallcpcfykkrkatahtvlardpnsmdsassldvnsgsekvsgadkvppspmrvppspsrftmspklnrigSVHLNMSQVVKAtrnfspslrigeggfgTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGfvdkgnerliitefvpngtlrehldgqygktldfNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAkvadfgfarlgpmdsdrthistkvkgtvgyldpeymktyqlttksdvYSFGVLLLEIltgrrpvelkrppeervTLRWAFKrynegnlldmvdpsIKEVISMEILTKMFGLAIQcaapirndrpdmksVGEQLWAIRADslksvkkg
Flexible Loop (DISEMBL)
ayhlsssystetttekgslsFTFSIFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDYCRLDLSLAKLSFSPGRKNlqkevkeepkthdagqnfhpreeknysgslsTTKKVGIAATGLFVMSCALLCPCFYKKRKATAHTvlardpnsmdsassldvnsgsekvsgadkvppspmrvppspsrftmSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLlgfvdkgnerLIITefvpngtlrehLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFArlgpmdsdrthistkvkgtvgyldpEYMKTYQLTTKSDVYSFGVLLLEiltgrrpvelkrppeervtlrwafkrynegnlldmvdpSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWairadslksvkkg
Low Complexity Region (SEG)
AYHLsssystettteKGSLSFTFSIFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDYCRLDLSLAKLSFSPGRKNLQKEVKEEPKTHDAGQNFHPREEKNYSGSLSTTKKVGIAATGLFVMSCALLCPCFYKKRKATAHTVLARDPNSMDSASSLDVNSGSEKVSGADKvppspmrvppspsrFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKSVKKG
Disordered region (IsUnstruct)
******************LSFTFSIFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDYCRLDLSLAKL*****************************************KKVGIAATGLFVMSCALLCPCFYKKRKATAHTV*****************************************************SVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRN*********EQLWAI***********
Disordered Region (DISOPRED)
***************KGSLSFTFSIFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDYCR***************************************************VGIAATGLFVMSCALLCPCFY****************************************************************VHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAI***************SSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVEL*RPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR**********
Disordered Region (DISEMBL)
****************GSLSFTFSIFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDYCRLDLSLAKLSFSPGR****************GQNFHPRE*********TTKKVGIAATGLFVMSCALLCPCFYKKRKATAHTVLARDPNS******************************PSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKSVKKG
Disordered Region (DISPRO)
*YHLSSSYSTETTTEKGSLSFTFSIFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDYCRLDLSLAKLSFSPGRKNLQKE*************************LSTTKKVGIAATGLFVMSCALLCPCFYKKRKAT******************************************************RIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
AYHLSSSYSTETTTEKGSLSFTFSIFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDYCRLDLSLAKLSFSPGRKNLQKEVKEEPKTHDAGQNFHPREEKNYSGSLSTTKKVGIAATGLFVMSCALLCPCFYKKRKATAHTVLARDPNSMDSASSLDVNSGSEKVSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKSVKKG
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	554	2.2.26 [Sep-21-2011]
Q9ASQ5	510	Calmodulin-binding recept	yes	no	0.877	0.952	0.582	1e-160
Q8VZJ9	411	Calmodulin-binding recept	no	no	0.537	0.725	0.554	1e-96
Q9FIL7	470	Calmodulin-binding recept	no	no	0.590	0.695	0.527	3e-95
Q9LX66	830	Receptor-like protein kin	no	no	0.505	0.337	0.477	6e-65
Q9SA72	849	Probable receptor-like pr	no	no	0.637	0.415	0.393	9e-65
Q9FN92	829	Probable receptor-like pr	no	no	0.514	0.343	0.465	4e-64
Q9LK35	855	Receptor-like protein kin	no	no	0.521	0.338	0.442	3e-62
O80623	815	Probable receptor-like pr	no	no	0.507	0.344	0.442	6e-62
Q9T020	878	Probable receptor-like pr	no	no	0.512	0.323	0.437	6e-62
Q9FID8	873	Putative receptor-like pr	no	no	0.503	0.319	0.435	2e-61

>sp|Q9ASQ5|CRCK3_ARATH Calmodulin-binding receptor-like cytoplasmic kinase 3 OS=Arabidopsis thaliana GN=CRCK3 PE=2 SV=1

 Score =  567 bits (1460), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 296/508 (58%), Positives = 373/508 (73%), Gaps = 22/508 (4%)

Query: 44  FLLFLQFWGIFASGFAIQSKVCGADHIAYSNS-NEVELFYINGNLVDKFSFCKVIQFHYA 102
            L+ LQ     AS   + S VC +DH+ Y+    +  LF INGN V+K  FC+ ++FH A
Sbjct: 19  LLMLLQIKETSASTSFVSSSVCKSDHLTYTKPYQQGSLFTINGNPVEKLRFCEALRFHKA 78

Query: 103 NHCIFEGYSGSDYCRLDLSLAKLSFSPGRKNLQKEVKEEPKTHDAGQNFHPREEKNYSGS 162
           N CIFE     D+C +   L       GR+ L      E KT    +N  P+ E ++   
Sbjct: 79  NGCIFEDSFSDDFCTIHSLL-------GRRFL------EEKTVKDSKNSKPKTEYSHV-- 123

Query: 163 LSTTKKVGIAATGLFVMSCALLCPCFYKKRKATAHTVLARDPNSMDSASSLDVNSGSEKV 222
                KV IA +G  ++ CAL CPCF+K+RKA +H VL ++ NS+   SS +++  SEK+
Sbjct: 124 -----KVSIAGSGFLLLCCALCCPCFHKERKANSHEVLPKESNSVHQVSSFEMSPSSEKI 178

Query: 223 SGAD-KVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGT 281
             +  + PPSP RVP SPSR+ MSP+ +R+G ++L MSQ+  AT NF+ S +IGEGGFG 
Sbjct: 179 PQSPFRAPPSPSRVPQSPSRYAMSPRPSRLGPLNLTMSQINTATGNFADSHQIGEGGFGV 238

Query: 282 VYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII 341
           V+K  L+DG +VAIKRAKKE FENL+TEF SEV+LLSKI HRNLVKLLG+VDKG+ERLII
Sbjct: 239 VFKGVLDDGQVVAIKRAKKEHFENLRTEFKSEVDLLSKIGHRNLVKLLGYVDKGDERLII 298

Query: 342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL 401
           TE+V NGTLR+HLDG  G  L+FNQRLEI IDV HGLTYLH YAE+QIIHRD+KSSNILL
Sbjct: 299 TEYVRNGTLRDHLDGARGTKLNFNQRLEIVIDVCHGLTYLHSYAERQIIHRDIKSSNILL 358

Query: 402 TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLL 461
           T+SMRAKVADFGFAR GP DS++THI T+VKGTVGYLDPEYMKTY LT KSDVYSFG+LL
Sbjct: 359 TDSMRAKVADFGFARGGPTDSNQTHILTQVKGTVGYLDPEYMKTYHLTAKSDVYSFGILL 418

Query: 462 LEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQ 521
           +EILTGRRPVE KR P+ER+T+RWAF +YNEG + ++VDP+ +E +  +IL KMF LA Q
Sbjct: 419 VEILTGRRPVEAKRLPDERITVRWAFDKYNEGRVFELVDPNARERVDEKILRKMFSLAFQ 478

Query: 522 CAAPIRNDRPDMKSVGEQLWAIRADSLK 549
           CAAP + +RPDM++VG+QLWAIR+  L+
Sbjct: 479 CAAPTKKERPDMEAVGKQLWAIRSSYLR 506

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8VZJ9|CRCK2_ARATH Calmodulin-binding receptor-like cytoplasmic kinase 2 OS=Arabidopsis thaliana GN=CRCK2 PE=2 SV=1

 Score =  354 bits (908), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 168/303 (55%), Positives = 218/303 (71%), Gaps = 5/303 (1%)

Query: 249 NRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQ- 307
           N          ++  AT+NFSPS RIG+GGFGTVYK +L DG   A+KRAKK   ++ Q 
Sbjct: 100 NETEHTRFTFDEIYDATKNFSPSFRIGQGGFGTVYKVKLRDGKTFAVKRAKKSMHDDRQG 159

Query: 308 --TEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFN 365
              EF SE++ L+++ H +LVK  GFV   +E++++ E+V NGTLR+HLD + GKTLD  
Sbjct: 160 ADAEFMSEIQTLAQVTHLSLVKYYGFVVHNDEKILVVEYVANGTLRDHLDCKEGKTLDMA 219

Query: 366 QRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP-MDSDR 424
            RL+IA DVAH +TYLH+Y +  IIHRD+KSSNILLTE+ RAKVADFGFARL P  DS  
Sbjct: 220 TRLDIATDVAHAITYLHMYTQPPIIHRDIKSSNILLTENYRAKVADFGFARLAPDTDSGA 279

Query: 425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR 484
           TH+ST+VKGT GYLDPEY+ TYQLT KSDVYSFGVLL+E+LTGRRP+EL R  +ER+T+R
Sbjct: 280 THVSTQVKGTAGYLDPEYLTTYQLTEKSDVYSFGVLLVELLTGRRPIELSRGQKERITIR 339

Query: 485 WAFKRYNEGNLLDMVDPSIKEVISMEI-LTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI 543
           WA K++  G+ + ++DP +++  +  + L K+  +A QC AP R  RP MK   E LW I
Sbjct: 340 WAIKKFTSGDTISVLDPKLEQNSANNLALEKVLEMAFQCLAPHRRSRPSMKKCSEILWGI 399

Query: 544 RAD 546
           R D
Sbjct: 400 RKD 402

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIL7|CRCK1_ARATH Calmodulin-binding receptor-like cytoplasmic kinase 1 OS=Arabidopsis thaliana GN=CRCK1 PE=1 SV=1

 Score =  349 bits (896), Expect = 3e-95,   Method: Compositional matrix adjust.
 Identities = 175/332 (52%), Positives = 236/332 (71%), Gaps = 5/332 (1%)

Query: 217 SGSEKVSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGE 276
           S   KVSG  +   S  +   SP + + S K    G V  +  ++ +AT NFS   +IGE
Sbjct: 99  STERKVSGQYRFSGSRFQ---SPGKDSSSSKSWHQGPVIFSFGELQRATANFSSVHQIGE 155

Query: 277 GGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG 335
           GGFGTV+K +L+DG +VAIKRA+K  + ++   EF +E+  LSKI+H NLVKL GF++ G
Sbjct: 156 GGFGTVFKGKLDDGTIVAIKRARKNNYGKSWLLEFKNEIYTLSKIEHMNLVKLYGFLEHG 215

Query: 336 NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVK 395
           +E++I+ E+V NG LREHLDG  G  L+  +RLEIAIDVAH LTYLH Y +  IIHRD+K
Sbjct: 216 DEKVIVVEYVANGNLREHLDGLRGNRLEMAERLEIAIDVAHALTYLHTYTDSPIIHRDIK 275

Query: 396 SSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVY 455
           +SNIL+T  +RAKVADFGFARL   D   THIST+VKG+ GY+DP+Y++T+QLT KSDVY
Sbjct: 276 ASNILITNKLRAKVADFGFARLVSEDLGATHISTQVKGSAGYVDPDYLRTFQLTDKSDVY 335

Query: 456 SFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE-VISMEILTK 514
           SFGVLL+EILTGRRP+ELKRP ++R+T++WA +R  +   + ++DP +K    ++E+  K
Sbjct: 336 SFGVLLVEILTGRRPIELKRPRKDRLTVKWALRRLKDDEAVLIMDPFLKRNRAAIEVAEK 395

Query: 515 MFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD 546
           M  LA +C  P R  RP MK + E+LWAIR +
Sbjct: 396 MLRLASECVTPTRATRPAMKGIAEKLWAIRRE 427

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1

 Score =  249 bits (635), Expect = 6e-65,   Method: Compositional matrix adjust.
 Identities = 137/287 (47%), Positives = 179/287 (62%), Gaps = 7/287 (2%)

Query: 259 SQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLS 318
           + V  AT NF  S  IG GGFG VYK +L DG  VA+KR   +  + L  EF +E+E+LS
Sbjct: 476 AAVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKRGNPKSQQGL-AEFRTEIEMLS 534

Query: 319 KIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGL 378
           +  HR+LV L+G+ D+ NE ++I E++ NGT++ HL G    +L + QRLEI I  A GL
Sbjct: 535 QFRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGL 594

Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YLH    K +IHRDVKS+NILL E+  AKVADFG ++ GP + D+TH+ST VKG+ GYL
Sbjct: 595 HYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGP-ELDQTHVSTAVKGSFGYL 653

Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTL-RWAFKRYNEGNLLD 497
           DPEY +  QLT KSDVYSFGV+L E+L   RPV     P E V L  WA K   +G L  
Sbjct: 654 DPEYFRRQQLTDKSDVYSFGVVLFEVLCA-RPVIDPTLPREMVNLAEWAMKWQKKGQLDQ 712

Query: 498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR 544
           ++D S++  I  + L K      +C A    DRP M   G+ LW + 
Sbjct: 713 IIDQSLRGNIRPDSLRKFAETGEKCLADYGVDRPSM---GDVLWNLE 756

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1

 Score =  248 bits (633), Expect = 9e-65,   Method: Compositional matrix adjust.
 Identities = 147/374 (39%), Positives = 211/374 (56%), Gaps = 21/374 (5%)

Query: 170 GIAATGLFVMSCALLCPCFYKKRKATAHTVLARDPNSMDSASSLDVNSGSEKVSGADKVP 229
           GIA    FV    +L  C  KKR++ +       P        ++ ++ + K +G     
Sbjct: 438 GIAIIIFFVF-LGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVNNSTANAKATGGS--- 493

Query: 230 PSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLED 289
              +R+    +  TM  K          ++++  AT+NF   L IG GGFG VY+ +LED
Sbjct: 494 ---LRLNTLAAS-TMGRKFT--------LAEIRAATKNFDDGLAIGVGGFGKVYRGELED 541

Query: 290 GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGT 349
           G L+AIKRA     + L  EF +E+ +LS++ HR+LV L+GF D+ NE +++ E++ NGT
Sbjct: 542 GTLIAIKRATPHSQQGL-AEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGT 600

Query: 350 LREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKV 409
           LR HL G     L + QRLE  I  A GL YLH  +E+ IIHRDVK++NILL E+  AK+
Sbjct: 601 LRSHLFGSNLPPLSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKM 660

Query: 410 ADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRR 469
           +DFG ++ GP   D TH+ST VKG+ GYLDPEY +  QLT KSDVYSFGV+L E +  R 
Sbjct: 661 SDFGLSKAGP-SMDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARA 719

Query: 470 PVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRND 529
            +    P ++     WA     + NL  ++D +++   S E L K   +A +C A    +
Sbjct: 720 VINPTLPKDQINLAEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKN 779

Query: 530 RPDMKSVGEQLWAI 543
           RP M   GE LW++
Sbjct: 780 RPMM---GEVLWSL 790

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FN92|Y5597_ARATH Probable receptor-like protein kinase At5g59700 OS=Arabidopsis thaliana GN=At5g59700 PE=1 SV=1

 Score =  246 bits (627), Expect = 4e-64,   Method: Compositional matrix adjust.
 Identities = 136/292 (46%), Positives = 184/292 (63%), Gaps = 7/292 (2%)

Query: 253 SVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSS 312
           S  + +  V +AT +F  +  IG GGFG VYK +L DG  VA+KRA  +  + L  EF +
Sbjct: 467 SYRIPLVAVKEATNSFDENRAIGVGGFGKVYKGELHDGTKVAVKRANPKSQQGL-AEFRT 525

Query: 313 EVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI 372
           E+E+LS+  HR+LV L+G+ D+ NE +++ E++ NGTL+ HL G    +L + QRLEI I
Sbjct: 526 EIEMLSQFRHRHLVSLIGYCDENNEMILVYEYMENGTLKSHLYGSGLLSLSWKQRLEICI 585

Query: 373 DVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK 432
             A GL YLH    K +IHRDVKS+NILL E++ AKVADFG ++ GP + D+TH+ST VK
Sbjct: 586 GSARGLHYLHTGDAKPVIHRDVKSANILLDENLMAKVADFGLSKTGP-EIDQTHVSTAVK 644

Query: 433 GTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTL-RWAFKRYN 491
           G+ GYLDPEY +  QLT KSDVYSFGV++ E+L   RPV       E V L  WA K   
Sbjct: 645 GSFGYLDPEYFRRQQLTEKSDVYSFGVVMFEVLCA-RPVIDPTLTREMVNLAEWAMKWQK 703

Query: 492 EGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI 543
           +G L  ++DPS++  I  + L K      +C A    DRP M   G+ LW +
Sbjct: 704 KGQLEHIIDPSLRGKIRPDSLRKFGETGEKCLADYGVDRPSM---GDVLWNL 752

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1

 Score =  239 bits (611), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 132/298 (44%), Positives = 179/298 (60%), Gaps = 9/298 (3%)

Query: 251 IGSVHLN----MSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENL 306
           + S HL       +++ AT  F  S  +G GGFG VYK  LEDG  VA+KR      E  
Sbjct: 489 LASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRS-EQG 547

Query: 307 QTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQ 366
             EF +E+E+LSK+ HR+LV L+G+ D+ +E +++ E++ NG LR HL G     L + Q
Sbjct: 548 MAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQ 607

Query: 367 RLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH 426
           RLEI I  A GL YLH  A + IIHRDVK++NILL E++ AKVADFG ++ GP   D+TH
Sbjct: 608 RLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGP-SLDQTH 666

Query: 427 ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWA 486
           +ST VKG+ GYLDPEY +  QLT KSDVYSFGV+L+E+L  R  +    P E+     WA
Sbjct: 667 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWA 726

Query: 487 FKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR 544
                +G L  ++D ++   ++   L K    A +C A    DRP M   G+ LW + 
Sbjct: 727 MAWQKKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSM---GDVLWNLE 781

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O80623|Y2393_ARATH Probable receptor-like protein kinase At2g39360 OS=Arabidopsis thaliana GN=At2g39360 PE=1 SV=1

 Score =  239 bits (609), Expect = 6e-62,   Method: Compositional matrix adjust.
 Identities = 127/287 (44%), Positives = 184/287 (64%), Gaps = 6/287 (2%)

Query: 258 MSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELL 317
           ++ + +AT +F  SL IG GGFG VYK  L D   VA+KR   +  + L  EF +EVE+L
Sbjct: 477 LALIKEATDDFDESLVIGVGGFGKVYKGVLRDKTEVAVKRGAPQSRQGL-AEFKTEVEML 535

Query: 318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL-DGQYGKTLDFNQRLEIAIDVAH 376
           ++  HR+LV L+G+ D+ +E +I+ E++  GTL++HL D      L + QRLEI +  A 
Sbjct: 536 TQFRHRHLVSLIGYCDENSEMIIVYEYMEKGTLKDHLYDLDDKPRLSWRQRLEICVGAAR 595

Query: 377 GLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG 436
           GL YLH  + + IIHRDVKS+NILL ++  AKVADFG ++ GP D D+TH+ST VKG+ G
Sbjct: 596 GLHYLHTGSTRAIIHRDVKSANILLDDNFMAKVADFGLSKTGP-DLDQTHVSTAVKGSFG 654

Query: 437 YLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL 496
           YLDPEY+   QLT KSDVYSFGV++LE++ GR  ++   P E+   + WA K   +G L 
Sbjct: 655 YLDPEYLTRQQLTEKSDVYSFGVVMLEVVCGRPVIDPSLPREKVNLIEWAMKLVKKGKLE 714

Query: 497 DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI 543
           D++DP +   + +E + K   +  +C +    +RP M   G+ LW +
Sbjct: 715 DIIDPFLVGKVKLEEVKKYCEVTEKCLSQNGIERPAM---GDLLWNL 758

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1

 Score =  238 bits (608), Expect = 6e-62,   Method: Compositional matrix adjust.
 Identities = 127/290 (43%), Positives = 181/290 (62%), Gaps = 6/290 (2%)

Query: 255 HLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEV 314
           + ++S++ +AT+NF  S  IG GGFG VY   L+DG  VA+KR   +  + + TEF +E+
Sbjct: 513 YFSLSELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGI-TEFQTEI 571

Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LSK+ HR+LV L+G+ D+ +E +++ EF+ NG  R+HL G+    L + QRLEI I  
Sbjct: 572 QMLSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGS 631

Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT 434
           A GL YLH    + IIHRDVKS+NILL E++ AKVADFG ++   +   + H+ST VKG+
Sbjct: 632 ARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSK--DVAFGQNHVSTAVKGS 689

Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN 494
            GYLDPEY +  QLT KSDVYSFGV+LLE L  R  +  + P E+     WA +   +G 
Sbjct: 690 FGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGL 749

Query: 495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR 544
           L  ++DP +   I+ E + K    A +C      DRP M   G+ LW + 
Sbjct: 750 LEKIIDPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTM---GDVLWNLE 796

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FID8|Y5900_ARATH Putative receptor-like protein kinase At5g39000 OS=Arabidopsis thaliana GN=At5g39000 PE=3 SV=1

 Score =  237 bits (604), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 126/289 (43%), Positives = 184/289 (63%), Gaps = 10/289 (3%)

Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKAQLEDG-LLVAIKRAKKEQFENLQTEFSSEVELLS 318
           ++  AT +F   L IG GGFG+VYK Q++ G  LVA+KR +    +  + EF +E+E+LS
Sbjct: 510 EIKSATNDFEDKLIIGVGGFGSVYKGQIDGGATLVAVKRLEITSNQGAK-EFETELEMLS 568

Query: 319 KIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL---DGQYGKTLDFNQRLEIAIDVA 375
           K+ H +LV L+G+ D+ NE +++ E++P+GTL++HL   D      L + +RLEI I  A
Sbjct: 569 KLRHVHLVSLIGYCDEDNEMVLVYEYMPHGTLKDHLFRRDKTSDPPLSWKRRLEICIGAA 628

Query: 376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
            GL YLH  A+  IIHRD+K++NILL E+   KV+DFG +R+GP  + +TH+ST VKGT 
Sbjct: 629 RGLQYLHTGAKYTIIHRDIKTTNILLDENFVTKVSDFGLSRVGPTSASQTHVSTVVKGTF 688

Query: 436 GYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKR-PPEERVTLRWAFKRYNEGN 494
           GYLDPEY +   LT KSDVYSFGV+LLE+L   RP+ ++  PPE+   +RW    Y  G 
Sbjct: 689 GYLDPEYYRRQVLTEKSDVYSFGVVLLEVLCC-RPIRMQSVPPEQADLIRWVKSNYRRGT 747

Query: 495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI 543
           +  ++D  +   I+   L K   +A++C      +RP M  V   +WA+
Sbjct: 748 VDQIIDSDLSADITSTSLEKFCEIAVRCVQDRGMERPPMNDV---VWAL 793

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	554
296084520	509	unnamed protein product [Vitis vinifera]	0.907	0.988	0.689	0.0
224120516	496	predicted protein [Populus trichocarpa]	0.882	0.985	0.704	0.0
147804692	546	hypothetical protein VITISV_036164 [Viti	0.900	0.913	0.688	0.0
224144124	513	predicted protein [Populus trichocarpa]	0.909	0.982	0.707	0.0
359484743	502	PREDICTED: probable leucine-rich repeat	0.877	0.968	0.656	0.0
357478293	506	Receptor-like protein kinase [Medicago t	0.861	0.942	0.654	0.0
255579871	386	ATP binding protein, putative [Ricinus c	0.694	0.997	0.791	0.0
356562957	482	PREDICTED: probable leucine-rich repeat	0.839	0.964	0.625	0.0
351721966	480	calmodulin-binding receptor-like cytopla	0.833	0.962	0.624	1e-178
449465621	522	PREDICTED: calmodulin-binding receptor-l	0.920	0.977	0.614	1e-173

>gi|296084520|emb|CBI25541.3| unnamed protein product [Vitis vinifera]

 Score =  738 bits (1906), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 353/512 (68%), Positives = 424/512 (82%), Gaps = 9/512 (1%)

Query: 43  SFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYA 102
           S LL +Q   I AS   IQSKVCG DH+AY NS+  ELFYING++VDK  FCK ++ +YA
Sbjct: 7   SLLLLVQLPRILASDLGIQSKVCGTDHVAYLNSHGYELFYINGDVVDKDVFCKALKVYYA 66

Query: 103 NHCIFEGYSGSDYCRLDLSLAKLSFSPGRKNLQKEVKEEPKTHDAGQNFHPREEKNYSGS 162
           N+C+FEG+ GS+YC L+L L +L  + GRK L++ ++EE    +   N H RE K +  S
Sbjct: 67  NNCVFEGHPGSNYCGLNLPLVELPANAGRKFLRRLIQEESTIDNL--NNHERETK-HRKS 123

Query: 163 LSTTKKVGIAATGLFVMSCALLCPCFYKKRKATAHTVLARDPNSMDSASSLDVNSGSEKV 222
            S+ K + +A  G+ V+ C+LLCPCF  KRK T H VL+++P S DS SS +V      +
Sbjct: 124 ASSPKVIAMAVPGILVLCCSLLCPCFRAKRKETDHAVLSKEPISTDSISSFEV------I 177

Query: 223 SGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTV 282
           S  +KVP SP+RVPPSPSRF++SPK N+I SVHLNM+Q+ +AT NFSPSL+IGEGGFGTV
Sbjct: 178 SAPEKVPASPLRVPPSPSRFSISPKPNKIESVHLNMNQIARATNNFSPSLKIGEGGFGTV 237

Query: 283 YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT 342
           YKAQL+DG +VAIKRAKKE FENL+TEF SEVELL+KIDHRNLVKLLG+VDKGNERLIIT
Sbjct: 238 YKAQLQDGQVVAIKRAKKELFENLKTEFRSEVELLAKIDHRNLVKLLGYVDKGNERLIIT 297

Query: 343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT 402
           EFVPNGTLREHLDGQ GK LDFNQRLEI+IDVAH LTYLHLYAEKQIIHRDVKSSNILLT
Sbjct: 298 EFVPNGTLREHLDGQRGKILDFNQRLEISIDVAHALTYLHLYAEKQIIHRDVKSSNILLT 357

Query: 403 ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLL 462
           E  RAKVADFGFARLGP+D+++THISTKVKGTVGYLDPEYM+TYQLT KSDVYSFG+LL+
Sbjct: 358 EGFRAKVADFGFARLGPVDAEQTHISTKVKGTVGYLDPEYMRTYQLTPKSDVYSFGILLI 417

Query: 463 EILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQC 522
           EILTGRRPVEL++  +E+VTLRWAFK+YNEGN++++ DP ++EV+  EIL KMFGLAIQC
Sbjct: 418 EILTGRRPVELRKSTDEKVTLRWAFKKYNEGNVVELGDPLMEEVVDTEILNKMFGLAIQC 477

Query: 523 AAPIRNDRPDMKSVGEQLWAIRADSLKSVKKG 554
           AAPIR+DRPDMKSVGEQLW IR D ++SV++G
Sbjct: 478 AAPIRSDRPDMKSVGEQLWGIRMDYVRSVRRG 509

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224120516|ref|XP_002331067.1| predicted protein [Populus trichocarpa] gi|222872997|gb|EEF10128.1| predicted protein [Populus trichocarpa]

 Score =  734 bits (1896), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 360/511 (70%), Positives = 409/511 (80%), Gaps = 22/511 (4%)

Query: 44  FLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYAN 103
             L +QF  I ASGF IQSKVCG+DHIAYSN +  ELFYING L +K SFCK +     N
Sbjct: 8   IFLLMQFRIILASGFVIQSKVCGSDHIAYSNCHGHELFYINGELKEKESFCKALHSFDVN 67

Query: 104 HCIFEGYSGSDYCRLDLSLAKLSFSPGRKNLQKEVKEEPKTHDAGQNFHPREEKNYSGSL 163
            C FE Y G+D              P R  LQKEV+EE  +HD  Q+  P+E+     +L
Sbjct: 68  DCTFENYLGTDS----------PLKPERSLLQKEVREESPSHDLSQDT-PKEK-----TL 111

Query: 164 STTKKVGIAATGLFVMSCALLCPCFYKKRKATAHTVLARDPNSMDSASSLDVNSGSEKVS 223
           S   K GI A G+ VM C  LCPC YKK+KAT HTVL +DP S DS S  +VNS SEKV 
Sbjct: 112 SPPYKAGIGAAGVIVMCCTFLCPCLYKKKKATTHTVLEKDPKSTDSISPFNVNSASEKV- 170

Query: 224 GADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVY 283
                PPSP+RVPPSPSRF+ SPKL+R+GSVHLN+ QV +ATRNFSPSL+IGEGGFGTVY
Sbjct: 171 -----PPSPLRVPPSPSRFSQSPKLSRLGSVHLNLQQVARATRNFSPSLQIGEGGFGTVY 225

Query: 284 KAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE 343
           KA+L+DG +VAIKRAKKE F NL+TEFSSEVELL+KIDHRNLVKLLG+VDKGNERLIITE
Sbjct: 226 KAELDDGQVVAIKRAKKEHFANLRTEFSSEVELLAKIDHRNLVKLLGYVDKGNERLIITE 285

Query: 344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE 403
           +VPNGTLREHLD Q GK LDFNQRLEI+IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE
Sbjct: 286 YVPNGTLREHLDVQRGKILDFNQRLEISIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE 345

Query: 404 SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLE 463
           SMRAKVADFGFAR+GP+DSD+THISTKVKGTVGYLDPEYM+TYQLT KSDVYSFG+LLLE
Sbjct: 346 SMRAKVADFGFARMGPVDSDQTHISTKVKGTVGYLDPEYMRTYQLTPKSDVYSFGILLLE 405

Query: 464 ILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCA 523
           ILTGRRPVE ++P +ERVTLRW FK+YNEGN++DMVDP ++E +  E+L  MF LAIQCA
Sbjct: 406 ILTGRRPVEPRKPADERVTLRWVFKKYNEGNVVDMVDPLMEEKVDTEVLYSMFTLAIQCA 465

Query: 524 APIRNDRPDMKSVGEQLWAIRADSLKSVKKG 554
           APIR++RPDMK V E LW IRA+ LK VKKG
Sbjct: 466 APIRSERPDMKVVVEHLWGIRAEYLKGVKKG 496

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147804692|emb|CAN62615.1| hypothetical protein VITISV_036164 [Vitis vinifera]

 Score =  728 bits (1880), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 350/508 (68%), Positives = 416/508 (81%), Gaps = 9/508 (1%)

Query: 43  SFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYA 102
           S LL +Q     AS   IQSKVCG DH+AY NS+  ELFYING++VDK  FCK ++ +YA
Sbjct: 17  SLLLLVQLPRXLASDLGIQSKVCGTDHVAYLNSHGYELFYINGDVVDKDVFCKALKVYYA 76

Query: 103 NHCIFEGYSGSDYCRLDLSLAKLSFSPGRKNLQKEVKEEPKTHDAGQNFHPREEKNYSGS 162
           N+C+FEG+ GS+YC L+L L +L    GRK L++ ++EE    +   N H RE K +  S
Sbjct: 77  NNCVFEGHPGSNYCGLNLPLVELPAKAGRKILRRLIQEESTIDNL--NNHERETK-HRKS 133

Query: 163 LSTTKKVGIAATGLFVMSCALLCPCFYKKRKATAHTVLARDPNSMDSASSLDVNSGSEKV 222
            S+ K + +A  G+ V+ C+LLCPCF  KRK T H VL+++P S DS SS +V      +
Sbjct: 134 ASSPKVIAMAVPGILVLCCSLLCPCFRAKRKETDHAVLSKEPISTDSISSFEV------I 187

Query: 223 SGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTV 282
           S  +KVP SP+RVPPSPSRF++SPK N+I SVHLNM+Q+ +AT NFSPSL+IGEGGFGTV
Sbjct: 188 SAPEKVPASPLRVPPSPSRFSISPKPNKIESVHLNMNQIARATNNFSPSLKIGEGGFGTV 247

Query: 283 YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT 342
           YKAQL+DG +VAIKRAKKE FENL+TEF SEVELL+KIDHRNLVKLLG+VDKGNERLIIT
Sbjct: 248 YKAQLQDGQVVAIKRAKKELFENLKTEFRSEVELLAKIDHRNLVKLLGYVDKGNERLIIT 307

Query: 343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT 402
           EFVPNGTLREHLDGQ GK LDFNQRLEI+IDVAH LTYLHLYAEKQIIHRDVKSSNILLT
Sbjct: 308 EFVPNGTLREHLDGQRGKILDFNQRLEISIDVAHALTYLHLYAEKQIIHRDVKSSNILLT 367

Query: 403 ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLL 462
           E  RAKVADFGFARLGP+D ++THISTKVKGTVGYLDPEYM+TYQLT KSDVYSFG+LL+
Sbjct: 368 EGFRAKVADFGFARLGPVDXEQTHISTKVKGTVGYLDPEYMRTYQLTPKSDVYSFGILLI 427

Query: 463 EILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQC 522
           EILTGRRPVEL++  +E+VTLRWAFK+YNEGN +++ DP ++EV+  EIL KMFGLAIQC
Sbjct: 428 EILTGRRPVELRKSTDEKVTLRWAFKKYNEGNXVELGDPLMEEVVDTEILNKMFGLAIQC 487

Query: 523 AAPIRNDRPDMKSVGEQLWAIRADSLKS 550
           AAPIR+DRPDMKSVGEQLW IR D ++S
Sbjct: 488 AAPIRSDRPDMKSVGEQLWGIRMDYVRS 515

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224144124|ref|XP_002325194.1| predicted protein [Populus trichocarpa] gi|222866628|gb|EEF03759.1| predicted protein [Populus trichocarpa]

 Score =  711 bits (1834), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 363/513 (70%), Positives = 412/513 (80%), Gaps = 9/513 (1%)

Query: 44  FLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYAN 103
            LL +QF  I AS F+I SKVCG+DHIAYSN +  ELFYING L DK SFCK   F   N
Sbjct: 8   LLLLVQFPIILASRFSIHSKVCGSDHIAYSNFHGHELFYINGELKDKESFCKAFHFLDVN 67

Query: 104 HCIFEGYSGSDYCRLD--LSLAKLSFSPGRKNLQKEVKEEPKTHDAGQNFHPREEKNYSG 161
            CIFE Y GS    LD  LSLA       R  LQKE +EE  +H   Q+  P+E+K+   
Sbjct: 68  ACIFENYLGSSSSGLDPDLSLAGFPLKRERNLLQKEGREESTSHGPSQD-TPKEKKDDPA 126

Query: 162 SLSTTKKVGIAATGLFVMSCALLCPCFYKKRKATAHTVLARDPNSMDSASSLDVNSGSEK 221
           +LST  K G+A  G+ VM C  LCPC YKKRK   HTVL +DPNS+DS  S + N  SEK
Sbjct: 127 TLSTPYKAGLAVAGVVVMCCGFLCPCLYKKRKPATHTVLEKDPNSLDSVPSFNANPASEK 186

Query: 222 VSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGT 281
           V        +P RVPPSPSRF+ SPKL+R+GSVHLN+SQV +ATRNFSPSL+IGEGGFG 
Sbjct: 187 VLS------TPHRVPPSPSRFSPSPKLSRLGSVHLNLSQVARATRNFSPSLQIGEGGFGI 240

Query: 282 VYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII 341
           VYKAQL++G LVAIKRAKKE F NLQTEFSSEVELL+KIDHRNLVKLLG+VDKG+ERLII
Sbjct: 241 VYKAQLDNGQLVAIKRAKKEYFVNLQTEFSSEVELLAKIDHRNLVKLLGYVDKGDERLII 300

Query: 342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL 401
           TE+VPNGTLREHLD  +GK LDFNQRLEI+IDVAHGLTYLHLYAEKQIIHRDVKSSNILL
Sbjct: 301 TEYVPNGTLREHLDVLHGKILDFNQRLEISIDVAHGLTYLHLYAEKQIIHRDVKSSNILL 360

Query: 402 TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLL 461
           TESMRAKVADFGFAR+GP+DSD+THISTKVKGT+GYLDPEYMKTYQLT KSDVYSFG+LL
Sbjct: 361 TESMRAKVADFGFARMGPVDSDQTHISTKVKGTMGYLDPEYMKTYQLTPKSDVYSFGILL 420

Query: 462 LEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQ 521
           LEILTGRRPVE+K+P +ERVTLRW F++Y EGN++DM DP ++EV+  EIL+KMF LAIQ
Sbjct: 421 LEILTGRRPVEMKKPADERVTLRWVFRKYEEGNVVDMADPLMEEVVDAEILSKMFALAIQ 480

Query: 522 CAAPIRNDRPDMKSVGEQLWAIRADSLKSVKKG 554
           CAAPIR +RPDMK V EQLW IR+D LK VKKG
Sbjct: 481 CAAPIRTERPDMKVVVEQLWGIRSDYLKGVKKG 513

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484743|ref|XP_002263618.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At4g00330-like [Vitis vinifera]

 Score =  694 bits (1790), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 336/512 (65%), Positives = 407/512 (79%), Gaps = 26/512 (5%)

Query: 43  SFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYA 102
           S LL +Q   I AS   IQSKVCG DH+AY NS+  ELFYING++VDK  FCK ++ +YA
Sbjct: 17  SLLLLVQLPRILASDLGIQSKVCGTDHVAYLNSHGYELFYINGDVVDKDVFCKALKVYYA 76

Query: 103 NHCIFEGYSGSDYCRLDLSLAKLSFSPGRKNLQKEVKEEPKTHDAGQNFHPREEKNYSGS 162
           N+C+FEG+ GS+YC L+L L +L  + GRK L++ ++EE    +   N H RE K +  S
Sbjct: 77  NNCVFEGHPGSNYCGLNLPLVELPANAGRKFLRRLIQEESTIDNL--NNHERETK-HRKS 133

Query: 163 LSTTKKVGIAATGLFVMSCALLCPCFYKKRKATAHTVLARDPNSMDSASSLDVNSGSEKV 222
            S+ K + +A  G+ V+ C+LLCPCF  KRK T H VL+++P S DS SS +V      +
Sbjct: 134 ASSPKVIAMAVPGILVLCCSLLCPCFRAKRKETDHAVLSKEPISTDSISSFEV------I 187

Query: 223 SGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTV 282
           S  +KVP SP+RVPPSPSRF++SPK N+I SVHLNM+Q+ +AT NFSPSL+IGEGGFGTV
Sbjct: 188 SAPEKVPASPLRVPPSPSRFSISPKPNKIESVHLNMNQIARATNNFSPSLKIGEGGFGTV 247

Query: 283 YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT 342
           YKAQL+DG +VAIKRAKKE FENL+TEF SEVELL+KIDHRNLVKLLG+VDKGNERLIIT
Sbjct: 248 YKAQLQDGQVVAIKRAKKELFENLKTEFRSEVELLAKIDHRNLVKLLGYVDKGNERLIIT 307

Query: 343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT 402
           EFVPNGTLREHLDGQ GK LDFNQRLEI+IDVAH LTYLHLYA                 
Sbjct: 308 EFVPNGTLREHLDGQRGKILDFNQRLEISIDVAHALTYLHLYA----------------- 350

Query: 403 ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLL 462
           E  RAKVADFGFARLGP+D+++THISTKVKGTVGYLDPEYM+TYQLT KSDVYSFG+LL+
Sbjct: 351 EGFRAKVADFGFARLGPVDAEQTHISTKVKGTVGYLDPEYMRTYQLTPKSDVYSFGILLI 410

Query: 463 EILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQC 522
           EILTGRRPVEL++  +E+VTLRWAFK+YNEGN++++ DP ++EV+  EIL KMFGLAIQC
Sbjct: 411 EILTGRRPVELRKSTDEKVTLRWAFKKYNEGNVVELGDPLMEEVVDTEILNKMFGLAIQC 470

Query: 523 AAPIRNDRPDMKSVGEQLWAIRADSLKSVKKG 554
           AAPIR+DRPDMKSVGEQLW IR D ++SV++G
Sbjct: 471 AAPIRSDRPDMKSVGEQLWGIRMDYVRSVRRG 502

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357478293|ref|XP_003609432.1| Receptor-like protein kinase [Medicago truncatula] gi|355510487|gb|AES91629.1| Receptor-like protein kinase [Medicago truncatula]

 Score =  671 bits (1730), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/503 (65%), Positives = 403/503 (80%), Gaps = 26/503 (5%)

Query: 53  IFASGFAIQSKVCGADHIA--YSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGY 110
           IF S   +Q+K CG + +A  YS+  E ELFYINGN+V++  FCK +Q + AN C  + Y
Sbjct: 17  IFGSEVVLQTKGCGDNLVANSYSSHGE-ELFYINGNVVNRVDFCKALQLYIANGCDLKDY 75

Query: 111 SGSDYCRLDL--SLAKLSFSPGRKNLQKEVKEEPKTHDAGQNFHPREEKNYSGSLSTTKK 168
            GS+ C LDL  S   L  + GRK LQK++      +++     P++         ++ +
Sbjct: 76  FGSNNCVLDLNVSFVNLPSTAGRKLLQKDL-----NNNSTSQGDPKQ--------VSSSQ 122

Query: 169 VGIAATGLFVMSCALLCPCFY-KKRKATAHTVLARDPNSMDSASSLDVNSGSEKVSGADK 227
           VGI A G  ++ CA++CPCFY K+RKAT+H VL +DPNSM+  SS +        S +DK
Sbjct: 123 VGIFAGGALLVCCAVVCPCFYGKRRKATSHAVLEKDPNSMELGSSFEP-------SVSDK 175

Query: 228 VPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQL 287
           +P SP+RVPPSPSRF+MSPKL+R+ S+HLN+SQV KATRNFS +L+IGEGGFGTVYKA L
Sbjct: 176 IPASPLRVPPSPSRFSMSPKLSRLQSLHLNLSQVSKATRNFSETLQIGEGGFGTVYKAHL 235

Query: 288 EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPN 347
           +DGL+VA+KRAK+E FE+L+TEFSSEVELL+KIDHRNLVKLLG++DKGNER++ITEFV N
Sbjct: 236 DDGLVVAVKRAKREHFESLRTEFSSEVELLAKIDHRNLVKLLGYIDKGNERILITEFVAN 295

Query: 348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRA 407
           GTLREHLDG  GK LDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRA
Sbjct: 296 GTLREHLDGLRGKILDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRA 355

Query: 408 KVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG 467
           KVADFGFA+LGP+++D THISTKVKGTVGYLDPEYMKTY LT KSDVYSFG+LLLEILTG
Sbjct: 356 KVADFGFAKLGPVNNDHTHISTKVKGTVGYLDPEYMKTYHLTPKSDVYSFGILLLEILTG 415

Query: 468 RRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIR 527
           RRPVELK+  EERVTLRWAF++YNEG+++ ++DP ++E +  ++  KMF LA  CAAP+R
Sbjct: 416 RRPVELKKSAEERVTLRWAFRKYNEGSVVALLDPLMQEAVKTDVAVKMFDLAFNCAAPVR 475

Query: 528 NDRPDMKSVGEQLWAIRADSLKS 550
           +DRPDMK+VGEQLWAIRAD LKS
Sbjct: 476 SDRPDMKTVGEQLWAIRADYLKS 498

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255579871|ref|XP_002530772.1| ATP binding protein, putative [Ricinus communis] gi|223529688|gb|EEF31632.1| ATP binding protein, putative [Ricinus communis]

 Score =  652 bits (1683), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 311/393 (79%), Positives = 355/393 (90%), Gaps = 8/393 (2%)

Query: 162 SLSTTKKVGIAATGLFVMSCALLCPCFYKKRKATAHTVLARDPNSMDSASSLDVNSGSEK 221
           S ST K+VGI ATG+ V+SC LLCPCFY+KRKAT+H VLA+DP SMDS SS D NS SEK
Sbjct: 2   SFSTPKQVGIVATGIVVISCGLLCPCFYRKRKATSHDVLAKDPISMDSVSSFD-NSVSEK 60

Query: 222 VSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGT 281
           V      PPSP+RVPPSP +F+MSPKL+R+GS+HLN++QV +AT+NFS SL+IGEGGFGT
Sbjct: 61  V------PPSPLRVPPSP-KFSMSPKLSRVGSIHLNLNQVARATQNFSRSLQIGEGGFGT 113

Query: 282 VYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII 341
           VY+AQLEDG +VAIKRAKKE +E+L+TEFSSEVELL+KIDHRNLVKLLGFVDKGNERLII
Sbjct: 114 VYRAQLEDGQVVAIKRAKKENYESLRTEFSSEVELLAKIDHRNLVKLLGFVDKGNERLII 173

Query: 342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL 401
           TE+VPNGTLREHLDGQ GK LDFNQRLEIAIDVAH LTYLH Y+EKQIIHRDVKSSNILL
Sbjct: 174 TEYVPNGTLREHLDGQRGKILDFNQRLEIAIDVAHALTYLHTYSEKQIIHRDVKSSNILL 233

Query: 402 TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLL 461
           TESMRAKVADFGFA+LGP+D+D+THISTKVKGTVGYLDPEYM+TYQLT KSDVYSFG+LL
Sbjct: 234 TESMRAKVADFGFAKLGPVDADQTHISTKVKGTVGYLDPEYMRTYQLTPKSDVYSFGILL 293

Query: 462 LEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQ 521
           LE LTGRRPVELKRP +ERVTLRWAF++YNEG ++DMVDP ++E + +E+L KMF LAIQ
Sbjct: 294 LETLTGRRPVELKRPADERVTLRWAFRKYNEGTVVDMVDPLMEERVHVEVLVKMFALAIQ 353

Query: 522 CAAPIRNDRPDMKSVGEQLWAIRADSLKSVKKG 554
           CAAPIR+DRPDMK+VGEQLWAIRAD +KS K G
Sbjct: 354 CAAPIRSDRPDMKAVGEQLWAIRADYVKSPKHG 386

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356562957|ref|XP_003549734.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At4g00330-like [Glycine max]

 Score =  642 bits (1657), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 316/505 (62%), Positives = 388/505 (76%), Gaps = 40/505 (7%)

Query: 51  WGIFASGFAIQSKVCGADHIAYS-NSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG 109
           W +F S   +QS+ C +D +A+S +S+  +LFYINGN+V+K +FC+ +Q + A  C  + 
Sbjct: 15  WTVFGSEVVLQSRDCDSDWVAHSYSSHGQDLFYINGNVVNKVAFCEALQLYIAKGCDVKD 74

Query: 110 YSGSDYCRLDLSLAKLSFSPGRKNLQKEVKEEPKTHDAGQNFHPREEKNYSGSLSTTKKV 169
           Y GS  C +D S   L    GRK L+          D      PR + N   S    K V
Sbjct: 75  YFGSVKCVVDDSFVNLPLKAGRKLLK----------DLSNESTPRGDSNPVSS----KVV 120

Query: 170 GIAATGLFVMSCALLCPCFY-KKRKATAHTVLARDPNSMDSASSLDVNSGSEKVSGADKV 228
            I A G  ++ CA+LCPCFY K+RKAT+H VLA+DPNSMDS SS + ++        DK+
Sbjct: 121 VIGAGGALLVCCAVLCPCFYAKRRKATSHAVLAKDPNSMDSVSSFEASTN-------DKI 173

Query: 229 PPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLE 288
           P SP+RVPPSPSRF+MSPKL R+ S+HLN++QV +AT+NFS +L+IGEGGFGTVYKA+LE
Sbjct: 174 PASPLRVPPSPSRFSMSPKLTRLKSLHLNLNQVTRATQNFSETLQIGEGGFGTVYKAKLE 233

Query: 289 DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNG 348
           DG +VA+KRAKKE F++L+TEFSSE+ELL+KIDHRNLVKLLG++DKGNERL+ITEFVPNG
Sbjct: 234 DGRVVAVKRAKKEHFDSLRTEFSSEIELLAKIDHRNLVKLLGYIDKGNERLLITEFVPNG 293

Query: 349 TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAK 408
           TLREHLDG  GK LDFNQRLEIAIDVAHGLTYLHLYA                 ESMRAK
Sbjct: 294 TLREHLDGMRGKILDFNQRLEIAIDVAHGLTYLHLYA-----------------ESMRAK 336

Query: 409 VADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGR 468
           VADFGFARLGP+++D+THISTKVKGTVGYLDPEYMKTYQLT KSDVYSFG+LLLEI+TGR
Sbjct: 337 VADFGFARLGPVNTDQTHISTKVKGTVGYLDPEYMKTYQLTPKSDVYSFGILLLEIVTGR 396

Query: 469 RPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRN 528
           RPVELK+  EERVTLRWAF++YNEG+++++VDP ++E ++ ++L KMF LA QCAAPIR 
Sbjct: 397 RPVELKKTVEERVTLRWAFRKYNEGSVVELVDPLMEEAVNGDVLMKMFDLAFQCAAPIRT 456

Query: 529 DRPDMKSVGEQLWAIRADSLKSVKK 553
           DRPDMKSVGEQLWAIRAD LKS ++
Sbjct: 457 DRPDMKSVGEQLWAIRADYLKSARR 481

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351721966|ref|NP_001235180.1| calmodulin-binding receptor-like cytoplasmic kinase precursor [Glycine max] gi|223452436|gb|ACM89545.1| calmodulin-binding receptor-like cytoplasmic kinase [Glycine max]

 Score =  632 bits (1631), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 314/503 (62%), Positives = 387/503 (76%), Gaps = 41/503 (8%)

Query: 53  IFASGFAIQSKVCGADHIAYS-NSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYS 111
           IF S   +QSK CG+D +A+S +S+  +LFYINGN+V+K +FC+ ++ + A  C  + Y 
Sbjct: 17  IFGSEVVLQSKDCGSDWVAHSYSSHGQDLFYINGNVVNKVAFCEALKLYIAKGCDVKDYF 76

Query: 112 GSDYCRLDLSLAKLSFSPGRKNLQKEVKEEPKTHDAGQNFHPREEKNYSGSLSTTKKVGI 171
           GS  C +D S   L    GRK L K++  E            R+ K  S ++     V I
Sbjct: 77  GSVKCVMDDSFVTLPLKAGRK-LLKDLSSESTPQ--------RDSKPMSSNV-----VVI 122

Query: 172 AATGLFVMSCALLCPCFY-KKRKATAHTVLARDPNSMDSASSLDVNSGSEKVSGADKVPP 230
            A G  ++ CA+LCPCFY K+RKAT+H VL++DPNSMDS SS        + S  DK+P 
Sbjct: 123 GAGGALLVCCAVLCPCFYAKRRKATSHAVLSKDPNSMDSVSS--------EASVNDKIPA 174

Query: 231 SPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDG 290
           SP+RVPPSPSRF+MSPKL R+ S+HLN++QV +AT+NFS +L+IGEGGFGTVYKA+LEDG
Sbjct: 175 SPLRVPPSPSRFSMSPKLTRLQSLHLNLNQVTRATQNFSETLQIGEGGFGTVYKAKLEDG 234

Query: 291 LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTL 350
           L+VA+KRAKKE F++L+TEFSSE+ELL+KIDHRNLVKLLG++DKGNERL+ITEFVPNGTL
Sbjct: 235 LVVAVKRAKKEHFDSLRTEFSSEIELLAKIDHRNLVKLLGYIDKGNERLLITEFVPNGTL 294

Query: 351 REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVA 410
           REHLDG  GK LDFNQRLEIAIDVAHGLTYLHLYA                 ESMRAKVA
Sbjct: 295 REHLDGMRGKILDFNQRLEIAIDVAHGLTYLHLYA-----------------ESMRAKVA 337

Query: 411 DFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           DFGFARLGP+++D+THISTKVKGTVGYLDPEYMKTYQLT KSDVYSFG+LLLEI+T RRP
Sbjct: 338 DFGFARLGPVNTDQTHISTKVKGTVGYLDPEYMKTYQLTPKSDVYSFGILLLEIVTARRP 397

Query: 471 VELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDR 530
           VELK+   ERVTLRWAF++YNEG+++++VDP ++E ++ ++L KM  LA QCAAPIR DR
Sbjct: 398 VELKKTVAERVTLRWAFRKYNEGSVVELVDPLMEEAVNGDVLMKMLDLAFQCAAPIRTDR 457

Query: 531 PDMKSVGEQLWAIRADSLKSVKK 553
           PDMKSVGEQLWAIRAD LKS ++
Sbjct: 458 PDMKSVGEQLWAIRADYLKSARR 480

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449465621|ref|XP_004150526.1| PREDICTED: calmodulin-binding receptor-like cytoplasmic kinase 3-like [Cucumis sativus]

 Score =  614 bits (1584), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 321/522 (61%), Positives = 390/522 (74%), Gaps = 12/522 (2%)

Query: 33  LDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVE-LFYINGNLVDKF 91
           L +SS  A  + +L +Q  G+FAS F ++S     + I  S     E  +++NG  +DK 
Sbjct: 5   LVMSSIMASITAVLLVQSSGVFASEFMLESGGSRGNQIPCSLPKGCERCYFMNGIPMDKI 64

Query: 92  SFCKVIQFHYANHCIFEGYSGSDYCRLDLSLAKLSFSPGRKNLQKEVKEEPKTHDAGQNF 151
            FCK++QF     CIFE   GSD  R D S + +     RK L KE KEE      GQ +
Sbjct: 65  LFCKLLQFLRGYPCIFENSRGSDDGRWDSSFSGIRVKVSRK-LLKERKEEHVNLKDGQ-Y 122

Query: 152 HPREEKNYSGSLSTTKKVGIAATGLFVMSCALLCPCFYKKRKATAHTVLARDPNSMDSAS 211
            P+  K    S ST K +GIA TG FV+ C +LCPCFY+KR+ +    L  +  S+  AS
Sbjct: 123 LPQRAKEDPKSFSTPKNIGIAVTGTFVLCCGVLCPCFYRKRRRSVQK-LTEEQQSVHLAS 181

Query: 212 SLD-VNSGSEKVSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSP 270
           +++ +NS  EK+        SP+RVPPSP       KL R+GSVHLNMSQV KAT+ FS 
Sbjct: 182 TIEAMNSAHEKILA------SPLRVPPSPRYSPSP-KLKRLGSVHLNMSQVAKATQEFSS 234

Query: 271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +LRIGEGGFGTVYKAQL+DG +VAIKRAKKEQFEN +T+F SEVELLSKIDHR+LVKLLG
Sbjct: 235 ALRIGEGGFGTVYKAQLDDGQIVAIKRAKKEQFENSRTDFGSEVELLSKIDHRSLVKLLG 294

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           +VD GNER+IITE+V NGTLREHLDG +GK LDFNQRLEIAID+AHGLTYLHLYAEKQII
Sbjct: 295 YVDHGNERIIITEYVGNGTLREHLDGVHGKVLDFNQRLEIAIDIAHGLTYLHLYAEKQII 354

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRDVKS+NILLTE+MRAKVADFGFARLG + +++THIST+VKGTVGYLDPEYMKTYQLTT
Sbjct: 355 HRDVKSTNILLTETMRAKVADFGFARLGTLGTEQTHISTQVKGTVGYLDPEYMKTYQLTT 414

Query: 451 KSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISME 510
           KSDVYSFG+LL+EILTGRRP+E+KRPPEERVT+RWAF +Y+E  +L+ +DP ++E +  +
Sbjct: 415 KSDVYSFGILLVEILTGRRPLEVKRPPEERVTIRWAFNKYSEDKILETLDPLMEETVDAD 474

Query: 511 ILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKSVK 552
           I+ KMF LAI CAAP+R DRPDMK VGEQLWAIRAD +   K
Sbjct: 475 IVVKMFELAIHCAAPVRADRPDMKLVGEQLWAIRADYISQKK 516

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	554
TAIR|locus:2041735	510	CRCK3 "calmodulin-binding rece	0.725	0.788	0.614	6e-146
TAIR|locus:2126011	411	CRCK2 "calmodulin-binding rece	0.537	0.725	0.554	2.5e-88
TAIR|locus:2154563	470	CRCK1 "calmodulin-binding rece	0.532	0.627	0.555	9.9e-87
TAIR|locus:2174249	829	AT5G59700 [Arabidopsis thalian	0.510	0.341	0.468	4.8e-64
TAIR|locus:2075346	830	HERK1 "hercules receptor kinas	0.496	0.331	0.485	6.1e-64
TAIR|locus:2204564	849	HERK2 "hercules receptor kinas	0.507	0.330	0.454	7.1e-61
TAIR|locus:504954886	1113	AT5G56890 [Arabidopsis thalian	0.676	0.336	0.372	2.7e-60
TAIR|locus:2058636	834	AT2G23200 [Arabidopsis thalian	0.521	0.346	0.436	1.3e-59
TAIR|locus:2039717	815	AT2G39360 [Arabidopsis thalian	0.501	0.341	0.458	2.7e-59
TAIR|locus:2177202	873	AT5G39000 [Arabidopsis thalian	0.503	0.319	0.435	6.9e-59

TAIR|locus:2041735 CRCK3 "calmodulin-binding receptor-like cytoplasmic kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1284 (457.0 bits), Expect = 6.0e-146, Sum P(2) = 6.0e-146
 Identities = 252/410 (61%), Positives = 314/410 (76%)

Query:   141 EPKTHDAGQNFHPREEKNYSGSLSTTKKVGIAATGLFVMSCALLCPCFYKKRKATAHTVL 200
             E KT    +N  P+ E  YS       KV IA +G  ++ CAL CPCF+K+RKA +H VL
Sbjct:   104 EEKTVKDSKNSKPKTE--YSHV-----KVSIAGSGFLLLCCALCCPCFHKERKANSHEVL 156

Query:   201 ARDPNSMDSASSLDVNSGSEKVSGAD-KXXXXXXXXXXXXXXFTMSPKLNRIGSVHLNMS 259
              ++ NS+   SS +++  SEK+  +  +              + MSP+ +R+G ++L MS
Sbjct:   157 PKESNSVHQVSSFEMSPSSEKIPQSPFRAPPSPSRVPQSPSRYAMSPRPSRLGPLNLTMS 216

Query:   260 QVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSK 319
             Q+  AT NF+ S +IGEGGFG V+K  L+DG +VAIKRAKKE FENL+TEF SEV+LLSK
Sbjct:   217 QINTATGNFADSHQIGEGGFGVVFKGVLDDGQVVAIKRAKKEHFENLRTEFKSEVDLLSK 276

Query:   320 IDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLT 379
             I HRNLVKLLG+VDKG+ERLIITE+V NGTLR+HLDG  G  L+FNQRLEI IDV HGLT
Sbjct:   277 IGHRNLVKLLGYVDKGDERLIITEYVRNGTLRDHLDGARGTKLNFNQRLEIVIDVCHGLT 336

Query:   380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLD 439
             YLH YAE+QIIHRD+KSSNILLT+SMRAKVADFGFAR GP DS++THI T+VKGTVGYLD
Sbjct:   337 YLHSYAERQIIHRDIKSSNILLTDSMRAKVADFGFARGGPTDSNQTHILTQVKGTVGYLD 396

Query:   440 PEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV 499
             PEYMKTY LT KSDVYSFG+LL+EILTGRRPVE KR P+ER+T+RWAF +YNEG + ++V
Sbjct:   397 PEYMKTYHLTAKSDVYSFGILLVEILTGRRPVEAKRLPDERITVRWAFDKYNEGRVFELV 456

Query:   500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK 549
             DP+ +E +  +IL KMF LA QCAAP + +RPDM++VG+QLWAIR+  L+
Sbjct:   457 DPNARERVDEKILRKMFSLAFQCAAPTKKERPDMEAVGKQLWAIRSSYLR 506

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2126011 CRCK2 "calmodulin-binding receptor-like cytoplasmic kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 882 (315.5 bits), Expect = 2.5e-88, P = 2.5e-88
 Identities = 168/303 (55%), Positives = 218/303 (71%)

Query:   249 NRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQ- 307
             N          ++  AT+NFSPS RIG+GGFGTVYK +L DG   A+KRAKK   ++ Q 
Sbjct:   100 NETEHTRFTFDEIYDATKNFSPSFRIGQGGFGTVYKVKLRDGKTFAVKRAKKSMHDDRQG 159

Query:   308 --TEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFN 365
                EF SE++ L+++ H +LVK  GFV   +E++++ E+V NGTLR+HLD + GKTLD  
Sbjct:   160 ADAEFMSEIQTLAQVTHLSLVKYYGFVVHNDEKILVVEYVANGTLRDHLDCKEGKTLDMA 219

Query:   366 QRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP-MDSDR 424
              RL+IA DVAH +TYLH+Y +  IIHRD+KSSNILLTE+ RAKVADFGFARL P  DS  
Sbjct:   220 TRLDIATDVAHAITYLHMYTQPPIIHRDIKSSNILLTENYRAKVADFGFARLAPDTDSGA 279

Query:   425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR 484
             TH+ST+VKGT GYLDPEY+ TYQLT KSDVYSFGVLL+E+LTGRRP+EL R  +ER+T+R
Sbjct:   280 THVSTQVKGTAGYLDPEYLTTYQLTEKSDVYSFGVLLVELLTGRRPIELSRGQKERITIR 339

Query:   485 WAFKRYNEGNLLDMVDPSIKEVISMEI-LTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI 543
             WA K++  G+ + ++DP +++  +  + L K+  +A QC AP R  RP MK   E LW I
Sbjct:   340 WAIKKFTSGDTISVLDPKLEQNSANNLALEKVLEMAFQCLAPHRRSRPSMKKCSEILWGI 399

Query:   544 RAD 546
             R D
Sbjct:   400 RKD 402

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009555 "pollen development" evidence=IMP

TAIR|locus:2154563 CRCK1 "calmodulin-binding receptor-like cytoplasmic kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 867 (310.3 bits), Expect = 9.9e-87, P = 9.9e-87
 Identities = 165/297 (55%), Positives = 222/297 (74%)

Query:   252 GSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEF 310
             G V  +  ++ +AT NFS   +IGEGGFGTV+K +L+DG +VAIKRA+K  + ++   EF
Sbjct:   131 GPVIFSFGELQRATANFSSVHQIGEGGFGTVFKGKLDDGTIVAIKRARKNNYGKSWLLEF 190

Query:   311 SSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI 370
              +E+  LSKI+H NLVKL GF++ G+E++I+ E+V NG LREHLDG  G  L+  +RLEI
Sbjct:   191 KNEIYTLSKIEHMNLVKLYGFLEHGDEKVIVVEYVANGNLREHLDGLRGNRLEMAERLEI 250

Query:   371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
             AIDVAH LTYLH Y +  IIHRD+K+SNIL+T  +RAKVADFGFARL   D   THIST+
Sbjct:   251 AIDVAHALTYLHTYTDSPIIHRDIKASNILITNKLRAKVADFGFARLVSEDLGATHISTQ 310

Query:   431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY 490
             VKG+ GY+DP+Y++T+QLT KSDVYSFGVLL+EILTGRRP+ELKRP ++R+T++WA +R 
Sbjct:   311 VKGSAGYVDPDYLRTFQLTDKSDVYSFGVLLVEILTGRRPIELKRPRKDRLTVKWALRRL 370

Query:   491 NEGNLLDMVDPSIKEV-ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD 546
              +   + ++DP +K    ++E+  KM  LA +C  P R  RP MK + E+LWAIR +
Sbjct:   371 KDDEAVLIMDPFLKRNRAAIEVAEKMLRLASECVTPTRATRPAMKGIAEKLWAIRRE 427

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=IDA

GO:0005516 "calmodulin binding" evidence=IDA

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0042542 "response to hydrogen peroxide" evidence=IEP

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

TAIR|locus:2174249 AT5G59700 [Arabidopsis thaliana (taxid:3702)]

 Score = 629 (226.5 bits), Expect = 4.8e-64, Sum P(2) = 4.8e-64
 Identities = 136/290 (46%), Positives = 183/290 (63%)

Query:   253 SVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSS 312
             S  + +  V +AT +F  +  IG GGFG VYK +L DG  VA+KRA  +  + L  EF +
Sbjct:   467 SYRIPLVAVKEATNSFDENRAIGVGGFGKVYKGELHDGTKVAVKRANPKSQQGL-AEFRT 525

Query:   313 EVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI 372
             E+E+LS+  HR+LV L+G+ D+ NE +++ E++ NGTL+ HL G    +L + QRLEI I
Sbjct:   526 EIEMLSQFRHRHLVSLIGYCDENNEMILVYEYMENGTLKSHLYGSGLLSLSWKQRLEICI 585

Query:   373 DVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK 432
               A GL YLH    K +IHRDVKS+NILL E++ AKVADFG ++ GP + D+TH+ST VK
Sbjct:   586 GSARGLHYLHTGDAKPVIHRDVKSANILLDENLMAKVADFGLSKTGP-EIDQTHVSTAVK 644

Query:   433 GTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTL-RWAFKRYN 491
             G+ GYLDPEY +  QLT KSDVYSFGV++ E+L  R PV       E V L  WA K   
Sbjct:   645 GSFGYLDPEYFRRQQLTEKSDVYSFGVVMFEVLCAR-PVIDPTLTREMVNLAEWAMKWQK 703

Query:   492 EGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW 541
             +G L  ++DPS++  I  + L K      +C A    DRP M   G+ LW
Sbjct:   704 KGQLEHIIDPSLRGKIRPDSLRKFGETGEKCLADYGVDRPSM---GDVLW 750

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0007062 "sister chromatid cohesion" evidence=RCA

GO:0007131 "reciprocal meiotic recombination" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0033044 "regulation of chromosome organization" evidence=RCA

GO:0042138 "meiotic DNA double-strand break formation" evidence=RCA

GO:0045132 "meiotic chromosome segregation" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2075346 HERK1 "hercules receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 631 (227.2 bits), Expect = 6.1e-64, Sum P(2) = 6.1e-64
 Identities = 137/282 (48%), Positives = 177/282 (62%)

Query:   261 VVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI 320
             V  AT NF  S  IG GGFG VYK +L DG  VA+KR   +  + L  EF +E+E+LS+ 
Sbjct:   478 VKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKRGNPKSQQGL-AEFRTEIEMLSQF 536

Query:   321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
              HR+LV L+G+ D+ NE ++I E++ NGT++ HL G    +L + QRLEI I  A GL Y
Sbjct:   537 RHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGLHY 596

Query:   381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
             LH    K +IHRDVKS+NILL E+  AKVADFG ++ GP + D+TH+ST VKG+ GYLDP
Sbjct:   597 LHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGP-ELDQTHVSTAVKGSFGYLDP 655

Query:   441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTL-RWAFKRYNEGNLLDMV 499
             EY +  QLT KSDVYSFGV+L E+L  R PV     P E V L  WA K   +G L  ++
Sbjct:   656 EYFRRQQLTDKSDVYSFGVVLFEVLCAR-PVIDPTLPREMVNLAEWAMKWQKKGQLDQII 714

Query:   500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW 541
             D S++  I  + L K      +C A    DRP M   G+ LW
Sbjct:   715 DQSLRGNIRPDSLRKFAETGEKCLADYGVDRPSM---GDVLW 753

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0009791 "post-embryonic development" evidence=IGI

GO:0051510 "regulation of unidimensional cell growth" evidence=IGI;RCA

GO:0009741 "response to brassinosteroid stimulus" evidence=IGI

GO:0009826 "unidimensional cell growth" evidence=IGI

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2204564 HERK2 "hercules receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 623 (224.4 bits), Expect = 7.1e-61, P = 7.1e-61
 Identities = 130/286 (45%), Positives = 181/286 (63%)

Query:   258 MSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELL 317
             ++++  AT+NF   L IG GGFG VY+ +LEDG L+AIKRA     + L  EF +E+ +L
Sbjct:   510 LAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQQGL-AEFETEIVML 568

Query:   318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHG 377
             S++ HR+LV L+GF D+ NE +++ E++ NGTLR HL G     L + QRLE  I  A G
Sbjct:   569 SRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRLEACIGSARG 628

Query:   378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY 437
             L YLH  +E+ IIHRDVK++NILL E+  AK++DFG ++ GP   D TH+ST VKG+ GY
Sbjct:   629 LHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGP-SMDHTHVSTAVKGSFGY 687

Query:   438 LDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
             LDPEY +  QLT KSDVYSFGV+L E +  R  +    P ++     WA     + NL  
Sbjct:   688 LDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQKQRNLES 747

Query:   498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI 543
             ++D +++   S E L K   +A +C A    +RP M   GE LW++
Sbjct:   748 IIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMM---GEVLWSL 790

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IGI

GO:0009826 "unidimensional cell growth" evidence=IGI

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)]

 Score = 626 (225.4 bits), Expect = 2.7e-60, P = 2.7e-60
 Identities = 146/392 (37%), Positives = 214/392 (54%)

Query:   153 PREEKNYSGSLSTTKKVGIAATGLFVMSCALLCPCFYKKRKATAHTVLARDPNSMDSASS 212
             PR+++   GS++    V + +   F+  C ++      +R+     +  R P +  S  S
Sbjct:   619 PRKKELNGGSIA----VIVLSAAAFIGLCFVIVWFLVFRRQRDRRRLSKRTPLARPSLPS 674

Query:   213 LDVNSGSEKVSGADKXXXXXXXXXXXXXXFTMSPKLNRIGSVHLNMSQVVKATRNFSPSL 272
             L   SGS +     +              FT+S K           S+++KAT NF  S 
Sbjct:   675 LSKPSGSARSLTGSRFSSTSLSFESSIAPFTLSAKT-------FTASEIMKATNNFDESR 727

Query:   273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
              +GEGGFG VY+   +DG  VA+K  K++  +  + EF +EVE+LS++ HRNLV L+G  
Sbjct:   728 VLGEGGFGRVYEGVFDDGTKVAVKVLKRDDQQGSR-EFLAEVEMLSRLHHRNLVNLIGIC 786

Query:   333 DKGNERLIITEFVPNGTLREHLDG--QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +   R ++ E +PNG++  HL G  +    LD++ RL+IA+  A GL YLH  +  ++I
Sbjct:   787 IEDRNRSLVYELIPNGSVESHLHGIDKASSPLDWDARLKIALGAARGLAYLHEDSSPRVI 846

Query:   391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
             HRD KSSNILL      KV+DFG AR    D D  HIST+V GT GY+ PEY  T  L  
Sbjct:   847 HRDFKSSNILLENDFTPKVSDFGLARNALDDEDNRHISTRVMGTFGYVAPEYAMTGHLLV 906

Query:   451 KSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWA--FKRYNEGNLLDMVDPSIKEVIS 508
             KSDVYS+GV+LLE+LTGR+PV++ +PP +   + W   F    EG L  ++D S+   IS
Sbjct:   907 KSDVYSYGVVLLELLTGRKPVDMSQPPGQENLVSWTRPFLTSAEG-LAAIIDQSLGPEIS 965

Query:   509 MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
              + + K+  +A  C  P  + RP M  V + L
Sbjct:   966 FDSIAKVAAIASMCVQPEVSHRPFMGEVVQAL 997

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2058636 AT2G23200 [Arabidopsis thaliana (taxid:3702)]

 Score = 590 (212.7 bits), Expect = 1.3e-59, Sum P(2) = 1.3e-59
 Identities = 128/293 (43%), Positives = 183/293 (62%)

Query:   245 SPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFE 304
             SP  N    + +  + ++ AT NF   L IG+GGFG VYKA L DG   AIKR K    +
Sbjct:   465 SPLRNLHLGLTIPFTDILSATNNFDEQLLIGKGGFGYVYKAILPDGTKAAIKRGKTGSGQ 524

Query:   305 NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDF 364
              +  EF +E+++LS+I HR+LV L G+ ++ +E +++ EF+  GTL+EHL G    +L +
Sbjct:   525 GI-LEFQTEIQVLSRIRHRHLVSLTGYCEENSEMILVYEFMEKGTLKEHLYGSNLPSLTW 583

Query:   365 NQRLEIAIDVAHGLTYLHLY-AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
              QRLEI I  A GL YLH   +E  IIHRDVKS+NILL E   AKVADFG +++   + D
Sbjct:   584 KQRLEICIGAARGLDYLHSSGSEGAIIHRDVKSTNILLDEHNIAKVADFGLSKIH--NQD 641

Query:   424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTL 483
              ++IS  +KGT GYLDPEY++T++LT KSDVY+FGV+LLE+L  R  ++   P EE    
Sbjct:   642 ESNISINIKGTFGYLDPEYLQTHKLTEKSDVYAFGVVLLEVLFARPAIDPYLPHEEVNLS 701

Query:   484 RWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
              W     ++G + +++DPS+   I    L K   +A +C     ++RP M+ V
Sbjct:   702 EWVMFCKSKGTIDEILDPSLIGQIETNSLKKFMEIAEKCLKEYGDERPSMRDV 754

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2039717 AT2G39360 [Arabidopsis thaliana (taxid:3702)]

 Score = 608 (219.1 bits), Expect = 2.7e-59, P = 2.7e-59
 Identities = 131/286 (45%), Positives = 184/286 (64%)

Query:   258 MSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELL 317
             ++ + +AT +F  SL IG GGFG VYK  L D   VA+KR   +  + L  EF +EVE+L
Sbjct:   477 LALIKEATDDFDESLVIGVGGFGKVYKGVLRDKTEVAVKRGAPQSRQGL-AEFKTEVEML 535

Query:   318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL-DGQYGKTLDFNQRLEIAIDVAH 376
             ++  HR+LV L+G+ D+ +E +I+ E++  GTL++HL D      L + QRLEI +  A 
Sbjct:   536 TQFRHRHLVSLIGYCDENSEMIIVYEYMEKGTLKDHLYDLDDKPRLSWRQRLEICVGAAR 595

Query:   377 GLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG 436
             GL YLH  + + IIHRDVKS+NILL ++  AKVADFG ++ GP D D+TH+ST VKG+ G
Sbjct:   596 GLHYLHTGSTRAIIHRDVKSANILLDDNFMAKVADFGLSKTGP-DLDQTHVSTAVKGSFG 654

Query:   437 YLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTL-RWAFKRYNEGNL 495
             YLDPEY+   QLT KSDVYSFGV++LE++ GR PV     P E+V L  WA K   +G L
Sbjct:   655 YLDPEYLTRQQLTEKSDVYSFGVVMLEVVCGR-PVIDPSLPREKVNLIEWAMKLVKKGKL 713

Query:   496 LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW 541
              D++DP +   + +E + K   +  +C +    +RP M   G+ LW
Sbjct:   714 EDIIDPFLVGKVKLEEVKKYCEVTEKCLSQNGIERPAM---GDLLW 756

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2177202 AT5G39000 [Arabidopsis thaliana (taxid:3702)]

 Score = 606 (218.4 bits), Expect = 6.9e-59, P = 6.9e-59
 Identities = 126/289 (43%), Positives = 184/289 (63%)

Query:   260 QVVKATRNFSPSLRIGEGGFGTVYKAQLEDGL-LVAIKRAKKEQFENLQTEFSSEVELLS 318
             ++  AT +F   L IG GGFG+VYK Q++ G  LVA+KR +    +  + EF +E+E+LS
Sbjct:   510 EIKSATNDFEDKLIIGVGGFGSVYKGQIDGGATLVAVKRLEITSNQGAK-EFETELEMLS 568

Query:   319 KIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL---DGQYGKTLDFNQRLEIAIDVA 375
             K+ H +LV L+G+ D+ NE +++ E++P+GTL++HL   D      L + +RLEI I  A
Sbjct:   569 KLRHVHLVSLIGYCDEDNEMVLVYEYMPHGTLKDHLFRRDKTSDPPLSWKRRLEICIGAA 628

Query:   376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
              GL YLH  A+  IIHRD+K++NILL E+   KV+DFG +R+GP  + +TH+ST VKGT 
Sbjct:   629 RGLQYLHTGAKYTIIHRDIKTTNILLDENFVTKVSDFGLSRVGPTSASQTHVSTVVKGTF 688

Query:   436 GYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKR-PPEERVTLRWAFKRYNEGN 494
             GYLDPEY +   LT KSDVYSFGV+LLE+L  R P+ ++  PPE+   +RW    Y  G 
Sbjct:   689 GYLDPEYYRRQVLTEKSDVYSFGVVLLEVLCCR-PIRMQSVPPEQADLIRWVKSNYRRGT 747

Query:   495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI 543
             +  ++D  +   I+   L K   +A++C      +RP M  V   +WA+
Sbjct:   748 VDQIIDSDLSADITSTSLEKFCEIAVRCVQDRGMERPPMNDV---VWAL 793

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9ASQ5	CRCK3_ARATH	2, ., 7, ., 1, 1, ., 1	0.5826	0.8772	0.9529	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.10.2	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00006421001 SubName- Full=Chromosome chr11 scaffold_170, whole genome shotgun sequence; (519 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	554
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-56
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-55
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-55
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-53
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-50
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-45
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	9e-43
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-41
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-41
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-39
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-38
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-37
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-34
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-33
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-33
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-32
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-32
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-32
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-31
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-31
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-31
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-30
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-29
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-29
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-29
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-28
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-28
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-27
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-27
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-27
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-27
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-27
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-27
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-27
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-27
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-27
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-26
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-26
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-26
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-26
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-26
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-25
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-25
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-25
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-25
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-25
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-25
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-25
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-25
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-25
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-25
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-25
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-25
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-25
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-25
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-24
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-24
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-24
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-24
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-24
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-24
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-24
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-24
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-24
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-24
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-24
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-24
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-23
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-23
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-23
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-23
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	8e-23
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-22
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-22
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-22
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-22
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-22
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-22
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-21
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-21
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-21
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-20
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-20
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-20
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-20
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-20
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-20
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-19
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-19
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-19
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-19
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-19
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-19
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-19
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-18
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-18
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-18
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-18
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-17
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-17
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-17
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-16
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-16
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-16
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	8e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-16
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-15
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-14
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-14
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-14
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-13
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-13
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-12
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-12
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-10
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	9e-09
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	5e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.001
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.002
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  188 bits (480), Expect = 5e-56
 Identities = 84/272 (30%), Positives = 127/272 (46%), Gaps = 26/272 (9%)

Query: 274 IGEGGFGTVYKAQLED-----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +GEG FG VYK +L+       + VA+K  K++  E    EF  E  ++ K+DH N+VKL
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           LG   +     I+ E++  G L  +L  +    L  +  L  A+ +A G+ YL     K 
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE---SKN 122

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            IHRD+ + N L+ E++  K++DFG +R      D  +     K  + ++ PE +K  + 
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDL--YDDDYYRKRGGKLPIRWMAPESLKEGKF 180

Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS 508
           T+KSDV+SFGVLL EI T      L   P   ++     +    G  L        E+  
Sbjct: 181 TSKSDVWSFGVLLWEIFT------LGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYD 234

Query: 509 MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
                    L +QC A    DRP    + E L
Sbjct: 235 ---------LMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  186 bits (475), Expect = 3e-55
 Identities = 81/278 (29%), Positives = 128/278 (46%), Gaps = 30/278 (10%)

Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           +GEG FG VYK +L+        VA+K  K++  E  + +F  E  ++ K+ H N+V+LL
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 330 GFVDKGNERLIITEFVPNGTLREHL-------DGQYGKTLDFNQRLEIAIDVAHGLTYLH 382
           G   +     ++ E++  G L ++L             TL     L  AI +A G+ YL 
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122

Query: 383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEY 442
               K+ +HRD+ + N L+ E +  K++DFG +R    D D     T  K  + ++ PE 
Sbjct: 123 ---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY-DDDYYRKKTGGKLPIRWMAPES 178

Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS 502
           +K    T+KSDV+SFGVLL EI T      L   P   ++     +   +G  L    P 
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFT------LGATPYPGLSNEEVLEYLRKGYRLPK--PE 230

Query: 503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
                      +++ L + C      DRP    + E+L
Sbjct: 231 Y-------CPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  185 bits (472), Expect = 8e-55
 Identities = 86/272 (31%), Positives = 130/272 (47%), Gaps = 25/272 (9%)

Query: 274 IGEGGFGTVYKAQLEDG-----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +GEG FG VYK  L+       + VA+K  K++  E    EF  E  ++ K+DH N+VKL
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           LG   +    +I+ E++P G L ++L     K L  +  L  A+ +A G+ YL     K 
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            IHRD+ + N L+ E++  K++DFG +R      D  +     K  + ++ PE +K  + 
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDL--YDDDYYKVKGGKLPIRWMAPESLKEGKF 181

Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS 508
           T+KSDV+SFGVLL EI T      L   P   ++     +   +G  L        E+  
Sbjct: 182 TSKSDVWSFGVLLWEIFT------LGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYK 235

Query: 509 MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
                    L +QC A    DRP    + E L
Sbjct: 236 ---------LMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  181 bits (462), Expect = 2e-53
 Identities = 86/276 (31%), Positives = 133/276 (48%), Gaps = 33/276 (11%)

Query: 274 IGEGGFGTVYKAQL-----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +GEG FG VYK  L          VA+K  K+   E  + EF  E  ++ K+ H N+V+L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           LG   +G    I+TE++P G L + L  ++G+ L     L++A+ +A G+ YL     K 
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLE---SKN 122

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            +HRD+ + N L+TE++  K++DFG +R    + D        K  + ++ PE +K  + 
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDI-YEDDYYRKRGGGKLPIKWMAPESLKDGKF 181

Query: 449 TTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD---PSIK 504
           T+KSDV+SFGVLL EI T G +P       E         +   +G  L   +     + 
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------VLELLEDGYRLPRPENCPDELY 234

Query: 505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
           E++             QC A    DRP    + E L
Sbjct: 235 ELML------------QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  177 bits (452), Expect = 1e-52
 Identities = 73/194 (37%), Positives = 109/194 (56%), Gaps = 10/194 (5%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +GEGGFGTVY A+  + G  VAIK  KKE   +L  E   E+E+L K++H N+VKL G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
           +  N   ++ E+   G+L++ L  +    L  ++ L I + +  GL YLH      IIHR
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116

Query: 393 DVKSSNILLTE-SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ-LTT 450
           D+K  NILL   + + K+ADFG ++L   D     +   + GT  Y+ PE +      + 
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 451 KSDVYSFGVLLLEI 464
           KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  172 bits (439), Expect = 4e-50
 Identities = 67/198 (33%), Positives = 101/198 (51%), Gaps = 10/198 (5%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +GEG FG VY A+  + G LVAIK  KK++ +  +     E+++L K+ H N+V+L    
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
           +  ++  ++ E+   G L + L  +    L  ++       +   L YLH    K I+HR
Sbjct: 67  EDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYLH---SKGIVHR 121

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D+K  NILL E    K+ADFG AR      D     T   GT  Y+ PE +         
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQ----LDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV 177

Query: 453 DVYSFGVLLLEILTGRRP 470
           D++S GV+L E+LTG+ P
Sbjct: 178 DIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  159 bits (405), Expect = 3e-45
 Identities = 69/201 (34%), Positives = 104/201 (51%), Gaps = 11/201 (5%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           ++G G FGTVYKA+    G +VA+K  KK  +          E+ +L ++ H N+V+L+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
             +  +   ++ E+   G L ++L    G  L  ++  +IA+ +  GL YLH      II
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLH---SNGII 120

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL-T 449
           HRD+K  NILL E+   K+ADFG A+     S          GT  Y+ PE +       
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT---FVGTPWYMAPEVLLGGNGYG 177

Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            K DV+S GV+L E+LTG+ P
Sbjct: 178 PKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  153 bits (388), Expect = 9e-43
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 16/204 (7%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAK-KEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +G G FG+VY A  +D G L+A+K  +     E        E+ +LS + H N+V+  G 
Sbjct: 8   LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67

Query: 332 -VDK-GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI---AIDVAHGLTYLHLYAE 386
             D+  N   I  E+V  G+L   L  ++GK     + + I      +  GL YLH    
Sbjct: 68  ERDEEKNTLNIFLEYVSGGSLSSLLK-KFGK---LPEPV-IRKYTRQILEGLAYLH---S 119

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
             I+HRD+K +NIL+      K+ADFG A+    D +    +  V+GT  ++ PE ++  
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG-DIETGEGTGSVRGTPYWMAPEVIRGE 178

Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
           +    +D++S G  ++E+ TG+ P
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  148 bits (377), Expect = 3e-41
 Identities = 70/204 (34%), Positives = 105/204 (51%), Gaps = 10/204 (4%)

Query: 268 FSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
           F    +IG+GGFG VYKA     G  VAIK  K E  E  + +  +E+++L K  H N+V
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK-KEKIINEIQILKKCKHPNIV 60

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           K  G   K +E  I+ EF   G+L++ L     +TL  +Q   +  ++  GL YLH    
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYLH---S 116

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
             IIHRD+K++NILLT     K+ DFG +        R  +     GT  ++ PE +   
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV----GTPYWMAPEVINGK 172

Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
               K+D++S G+  +E+  G+ P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  147 bits (374), Expect = 7e-41
 Identities = 74/203 (36%), Positives = 113/203 (55%), Gaps = 18/203 (8%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-TEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VYK   LE G  VAIK+   E+ +         E++LL  + H N+VK +G 
Sbjct: 8   IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVA---HGLTYLHLYAEKQ 388
           ++  +   II E+  NG+LR+ +  ++G    F + L +A+ V     GL YLH   E+ 
Sbjct: 68  IETSDSLYIILEYAENGSLRQIIK-KFGP---FPESL-VAVYVYQVLQGLAYLH---EQG 119

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
           +IHRD+K++NIL T+    K+ADFG A +L  +  D       V GT  ++ PE ++   
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD----ASVVGTPYWMAPEVIEMSG 175

Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
            +T SD++S G  ++E+LTG  P
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  143 bits (363), Expect = 4e-39
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 12/202 (5%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFS-SEVELLSKIDHRNLVKLLG- 330
           IG+G FG VY  +   DG L  +K          + E + +EV++L K++H N++K    
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67

Query: 331 FVDKGNERLIITEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           F +KG    I+ E+   G L + +    + GK     Q L+  + +   L YLH    ++
Sbjct: 68  FEEKGK-LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRK 123

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           I+HRD+K  NI LT +   K+ DFG +++  + S      T V GT  YL PE  +    
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVV-GTPYYLSPELCQNKPY 180

Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
             KSD++S G +L E+ T + P
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  139 bits (352), Expect = 9e-38
 Identities = 74/200 (37%), Positives = 114/200 (57%), Gaps = 17/200 (8%)

Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           IG+G FG V       G  VA+K  K +        F +E  +++ + H NLV+LLG V 
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDDS--TAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           +GN   I+TE++  G+L ++L  +    +   Q+L  A+DV  G+ YL    EK  +HRD
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127

Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK--VKGTVGYLDPEYMKTYQLTTK 451
           + + N+L++E + AKV+DFG A+    ++ +   S K  VK T     PE ++  + +TK
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTA----PEALREKKFSTK 179

Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV+SFG+LL EI + GR P
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  139 bits (351), Expect = 3e-37
 Identities = 63/204 (30%), Positives = 110/204 (53%), Gaps = 11/204 (5%)

Query: 274 IGEGGFGTVYKAQLE-----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +GEG FG V   + +      G  VA+K       E  +++F  E+E+L  +DH N+VK 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 329 LGFVDK--GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            G  +K  G    +I E++P+G+LR++L     + ++  + L  +  +  G+ YL     
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLG---S 127

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           ++ IHRD+ + NIL+      K++DFG A++ P D D  ++    +  + +  PE ++T 
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187

Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
           + ++ SDV+SFGV L E+ T   P
Sbjct: 188 KFSSASDVWSFGVTLYELFTYGDP 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  131 bits (330), Expect = 1e-34
 Identities = 70/201 (34%), Positives = 107/201 (53%), Gaps = 8/201 (3%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           ++G G FG V++   ++ + VAIK  K +     Q +F  EV+ L ++ H++L+ L    
Sbjct: 13  KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK-QQDFQKEVQALKRLRHKHLISLFAVC 71

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
             G    IITE +  G+L   L    G+ L     +++A  VA G+ YL    E+  IHR
Sbjct: 72  SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHR 128

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D+ + NIL+ E +  KVADFG ARL     +  ++S+  K    +  PE       +TKS
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKS 185

Query: 453 DVYSFGVLLLEILT-GRRPVE 472
           DV+SFG+LL E+ T G+ P  
Sbjct: 186 DVWSFGILLYEMFTYGQVPYP 206

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  127 bits (320), Expect = 3e-33
 Identities = 69/201 (34%), Positives = 101/201 (50%), Gaps = 12/201 (5%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           ++G G FG V+         VA+K  K          F  E +++ K+ H  LV+L    
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS--PEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     I+TE++  G+L + L    GK L   Q +++A  +A G+ YL     +  IHR
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHR 127

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK--VKGTVGYLDPEYMKTYQLTT 450
           D+ + NIL+ E++  K+ADFG ARL   D        K  +K T     PE     + T 
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTA----PEAANYGRFTI 183

Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFG+LL EI+T GR P
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  127 bits (320), Expect = 4e-33
 Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 39/224 (17%)

Query: 274 IGEGGFGTVYKAQLEDGL------LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +GEG FG V+  +           LVA+K  K+    + + +F  E ELL+   H N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL------------DGQYGKTLDFNQRLEIAIDVA 375
             G   +G+  +++ E++ +G L + L                   L  +Q L+IA+ +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST----KV 431
            G+ YL   A +  +HRD+ + N L+   +  K+ DFG +R          + T    +V
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR---------DVYTTDYYRV 180

Query: 432 KGT----VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
            G     + ++ PE +   + TT+SDV+SFGV+L EI T G++P
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  125 bits (315), Expect = 1e-32
 Identities = 64/196 (32%), Positives = 107/196 (54%), Gaps = 7/196 (3%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +IG+G FG VYK  L+    VA+K  +     +L+ +F  E E+L + DH N+VKL+G  
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     I+ E VP G+L   L  +  + L   + L++++D A G+ YL     K  IHR
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLE---SKNCIHR 117

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT-VGYLDPEYMKTYQLTTK 451
           D+ + N L+ E+   K++DFG +R    +     +S  +K   + +  PE +   + T++
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175

Query: 452 SDVYSFGVLLLEILTG 467
           SDV+S+G+LL E  + 
Sbjct: 176 SDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  124 bits (313), Expect = 3e-32
 Identities = 68/200 (34%), Positives = 106/200 (53%), Gaps = 10/200 (5%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           ++G G FG V++    +   VA+K  K    +    +F +E +++ K+ H  L++L    
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD--PKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ-IIH 391
                  I+TE +  G+L E+L G  G+ L   Q +++A  VA G+ YL    E Q  IH
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL----EAQNYIH 126

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N+L+ E+   KVADFG AR+  +  D        K  + +  PE     + + K
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARV--IKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184

Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV+SFG+LL EI+T GR P
Sbjct: 185 SDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  124 bits (313), Expect = 5e-32
 Identities = 73/218 (33%), Positives = 111/218 (50%), Gaps = 25/218 (11%)

Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +GEG FG VYK +L           VAIK  K+     +Q EF  E EL+S + H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL--------------DGQYGKTLDFNQRLEIAID 373
           LLG   K     ++ E++ +G L E L              D     +LD +  L IAI 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
           +A G+ YL   +    +HRD+ + N L+ E +  K++DFG +R     +D   + +K   
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI-YSADYYRVQSKSLL 188

Query: 434 TVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
            V ++ PE +   + TT+SD++SFGV+L EI + G +P
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  123 bits (310), Expect = 9e-32
 Identities = 67/206 (32%), Positives = 116/206 (56%), Gaps = 18/206 (8%)

Query: 274 IGEGGFGTVYKAQL----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG V + +L    +  + VAIK  K    +  + +F +E  ++ + DH N+++L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 330 GFVDKGNERLIITEFVPNGT----LREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           G V K    +IITE++ NG+    LRE+ DG++       Q + +   +A G+ YL   +
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLREN-DGKFTVG----QLVGMLRGIASGMKYL---S 123

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
           E   +HRD+ + NIL+  ++  KV+DFG +R    DS+ T+ +   K  + +  PE +  
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATYTTKGGKIPIRWTAPEAIAY 182

Query: 446 YQLTTKSDVYSFGVLLLEILT-GRRP 470
            + T+ SDV+SFG+++ E+++ G RP
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  125 bits (314), Expect = 2e-31
 Identities = 84/294 (28%), Positives = 126/294 (42%), Gaps = 26/294 (8%)

Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKE--QFENLQTEFSSEVELLSKIDH-RNLVKLLG 330
           +GEG FG VY A+  D  LVA+K   K+          F  E+++L+ ++H  N+VKL  
Sbjct: 8   LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 331 FVDKGNERLIITEFVPNGTLREHLD-GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           F        ++ E+V  G+L + L        L  ++ L I   +   L YLH    K I
Sbjct: 66  FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGI 122

Query: 390 IHRDVKSSNILLTE-SMRAKVADFGFARLGPMDSDRTHI---STKVKGTVGYLDPEYMKT 445
           IHRD+K  NILL       K+ DFG A+L P     + I    +   GT GY+ PE +  
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182

Query: 446 YQL---TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS 502
             L   ++ SD++S G+ L E+LTG  P E ++                  +L   + PS
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242

Query: 503 IKEVIS---MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKSVKK 553
             E+IS    ++L K+        A    +R    S             +S   
Sbjct: 243 NPELISKAASDLLKKLL-------AKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289

Length = 384

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  121 bits (306), Expect = 2e-31
 Identities = 72/199 (36%), Positives = 111/199 (55%), Gaps = 15/199 (7%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
            IGEG FG V + +   G  VA+K  K +        F  E  +++K+ H+NLV+LLG +
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
              N   I+ E +  G L   L  +    +   Q L+ ++DVA G+ YL     K+++HR
Sbjct: 69  LH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHR 124

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D+ + NIL++E   AKV+DFG AR+G M  D + +  K      +  PE +K  + ++KS
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKS 178

Query: 453 DVYSFGVLLLEILT-GRRP 470
           DV+S+GVLL E+ + GR P
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  121 bits (304), Expect = 4e-31
 Identities = 70/207 (33%), Positives = 110/207 (53%), Gaps = 9/207 (4%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           ++G G FG V+         VAIK  K+         F +E  L+ ++ H  LV+L   V
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++ NG+L + L    G  L  N+ +++A  +A G+ ++     K  IHR
Sbjct: 71  TQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHR 126

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL++E++  K+ADFG ARL  ++ +        K  + +  PE +     T KS
Sbjct: 127 DLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184

Query: 453 DVYSFGVLLLEILT-GRRPVELKRPPE 478
           DV+SFG+LL EI+T GR P      PE
Sbjct: 185 DVWSFGILLTEIVTYGRIPYPGMTNPE 211

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  119 bits (300), Expect = 2e-30
 Identities = 68/203 (33%), Positives = 107/203 (52%), Gaps = 10/203 (4%)

Query: 273 RIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL-QTEFSSEVELLSKIDHRNLVKLL- 329
           +IG+G FG V+K  +  D  + A+K+    +     + E   E  +L+K+D   +++   
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F+DKG +  I+ E+  NG L + L  Q G+ L  +Q     I +  GL +LH    K+I
Sbjct: 67  SFLDKG-KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKI 122

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+KS N+ L      K+ D G A+L    SD T+ +  + GT  YL PE  +     
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKL---LSDNTNFANTIVGTPYYLSPELCEDKPYN 179

Query: 450 TKSDVYSFGVLLLEILTGRRPVE 472
            KSDV++ GV+L E  TG+ P +
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 2e-29
 Identities = 63/211 (29%), Positives = 112/211 (53%), Gaps = 12/211 (5%)

Query: 274 IGEGGFGTVYKAQ-LEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++E       E   E  +++ +DH ++V+L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           LG +   ++  +IT+ +P G L +++   +   +     L   + +A G++YL    EK+
Sbjct: 75  LG-ICLSSQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQIAKGMSYLE---EKR 129

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           ++HRD+ + N+L+      K+ DFG A+L  +D    H +   K  + ++  E +     
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH-AEGGKVPIKWMALESILHRIY 188

Query: 449 TTKSDVYSFGVLLLEILT-GRRPVELKRPPE 478
           T KSDV+S+GV + E++T G +P E     E
Sbjct: 189 THKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  116 bits (293), Expect = 3e-29
 Identities = 69/228 (30%), Positives = 107/228 (46%), Gaps = 32/228 (14%)

Query: 267 NFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKID-H 322
           +F     IGEG F TV  A+  E     AIK   K Q   E        E E+L++++ H
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61

Query: 323 RNLVKLLG-FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
             ++KL   F D+ N   ++ E+ PNG L +++  +   +LD       A ++   L YL
Sbjct: 62  PGIIKLYYTFQDEENLYFVL-EYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLALEYL 118

Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK--------- 432
           H    K IIHRD+K  NILL + M  K+ DFG A++  +D + +  S K           
Sbjct: 119 HS---KGIIHRDLKPENILLDKDMHIKITDFGTAKV--LDPNSSPESNKGDATNIDSQIE 173

Query: 433 ----------GTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
                     GT  Y+ PE +        SD+++ G ++ ++LTG+ P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  115 bits (290), Expect = 4e-29
 Identities = 69/197 (35%), Positives = 105/197 (53%), Gaps = 12/197 (6%)

Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + ++    L +A  ++  + YL    +K  IH
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK--VKGTVGYLDPEYMKTYQLT 449
           RD+ + N L+ E+   KVADFG +RL   D+   H   K  +K T     PE +   + +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKFS 183

Query: 450 TKSDVYSFGVLLLEILT 466
            KSDV++FGVLL EI T
Sbjct: 184 IKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  114 bits (286), Expect = 3e-28
 Identities = 83/216 (38%), Positives = 116/216 (53%), Gaps = 35/216 (16%)

Query: 274 IGEGGFGTVYKAQLE-DGLLV--AIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLL 329
           IGEG FG V +A ++ DGL +  AIK  K+   EN   +F+ E+E+L K+  H N++ LL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 330 GFVDKGNERLIITEFVPNGTLREHL--------DGQYGK------TLDFNQRLEIAIDVA 375
           G  +      I  E+ P G L + L        D  + K      TL   Q L+ A DVA
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
            G+ YL   +EKQ IHRD+ + N+L+ E++ +K+ADFG +R              VK T+
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---------GEEVYVKKTM 177

Query: 436 GYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILT 466
           G L   +M    L     TTKSDV+SFGVLL EI++
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  113 bits (284), Expect = 4e-28
 Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 12/200 (6%)

Query: 274 IGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G+G  G VYK +    G + A+K+   +  E  + +   E++ L   +   +VK  G  
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL--EIAIDVAHGLTYLHLYAEKQII 390
            K  E  I+ E++  G+L + L     K     + +   IA  +  GL YLH   ++ II
Sbjct: 69  YKEGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGLDYLH--TKRHII 122

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K SN+L+      K+ADFG +++  +++     +T V GTV Y+ PE ++    + 
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFV-GTVTYMSPERIQGESYSY 179

Query: 451 KSDVYSFGVLLLEILTGRRP 470
            +D++S G+ LLE   G+ P
Sbjct: 180 AADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  112 bits (282), Expect = 4e-28
 Identities = 71/223 (31%), Positives = 114/223 (51%), Gaps = 13/223 (5%)

Query: 271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
              IG G FG V+     +   VAIK  ++      + +F  E +++ K+ H  LV+L G
Sbjct: 9   VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHLYAEKQ 388
              + +   ++ EF+ +G L ++L  Q GK   F+Q   L + +DV  G+ YL       
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLE---SSN 120

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           +IHRD+ + N L+ E+   KV+DFG  R   +  D+   ST  K  V +  PE     + 
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRF--VLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178

Query: 449 TTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRY 490
           ++KSDV+SFGVL+ E+ + G+ P E +   E   T+   F+ Y
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY 221

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  111 bits (279), Expect = 1e-27
 Identities = 79/275 (28%), Positives = 141/275 (51%), Gaps = 28/275 (10%)

Query: 274 IGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG V++  L+      + VAIK  K    E  + +F SE  ++ +  H N+++L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G V K    +IITE++ NG L ++L    G+   + Q + +   +A G+ YL   ++   
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY-QLVGMLRGIAAGMKYL---SDMNY 128

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + NIL+  ++  KV+DFG +R+   D + T+ ++  K  + +  PE +   + T
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188

Query: 450 TKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS 508
           + SDV+SFG+++ E+++ G RP       E         K  N+G  L    P+      
Sbjct: 189 SASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDGFRL----PA-----P 232

Query: 509 MEILTKMFGLAIQCAAPIRNDRP---DMKSVGEQL 540
           M+  + ++ L +QC    R  RP   D+ ++ ++L
Sbjct: 233 MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  111 bits (278), Expect = 2e-27
 Identities = 73/215 (33%), Positives = 104/215 (48%), Gaps = 22/215 (10%)

Query: 274 IGEGGFGTVYKAQLEDGLL-------VAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
           +G G FG VY+    D L        VA+K  +K   +  + EF  E  L+S  +H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQ-----YGKTLDFNQRLEIAIDVAHGLTYL 381
           KLLG       + II E +  G L  +L            L   + L+I +DVA G  YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 382 HLYAEKQIIHRDVKSSNILLTESMRA-----KVADFGFARLGPMDSDRTHISTKVKGTVG 436
               +   IHRD+ + N L++E         K+ DFG AR     SD      +    V 
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYRKEGEGLLPVR 178

Query: 437 YLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
           ++ PE +   + TT+SDV+SFGVL+ EILT G++P
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 2e-27
 Identities = 80/216 (37%), Positives = 115/216 (53%), Gaps = 35/216 (16%)

Query: 274 IGEGGFGTVYKAQLE-DGLLV--AIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLVKLL 329
           IGEG FG V KA+++ DGL +  AIKR K+   ++   +F+ E+E+L K+ H  N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 330 GFVDKGNERLIITEFVPNGTLREHL--------DGQYGK------TLDFNQRLEIAIDVA 375
           G  +      +  E+ P+G L + L        D  +        TL   Q L  A DVA
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
            G+ YL   ++KQ IHRD+ + NIL+ E+  AK+ADFG +R              VK T+
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTM 170

Query: 436 GYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILT 466
           G L   +M    L     TT SDV+S+GVLL EI++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  110 bits (276), Expect = 2e-27
 Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 9/200 (4%)

Query: 272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L   
Sbjct: 12  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           V +     I+TE++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +H
Sbjct: 70  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 125

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T K
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV+SFG+LL E+ T GR P
Sbjct: 184 SDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 3e-27
 Identities = 68/200 (34%), Positives = 103/200 (51%), Gaps = 9/200 (4%)

Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           +G G FG V+  +    + VAIK  ++      + +F  E +++ K+ H NLV+L G   
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           K     I+TE++ NG L  +L  + GK L     L++  DV   + YL        IHRD
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125

Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           + + N L+ E    KV+DFG AR   +D   T  S   K  V +  PE     + ++KSD
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARY-VLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSD 183

Query: 454 VYSFGVLLLEILT-GRRPVE 472
           V+SFGVL+ E+ + G+ P E
Sbjct: 184 VWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  110 bits (276), Expect = 3e-27
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 9/203 (4%)

Query: 273 RIGEGGFGTVYKAQ----LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           ++G+G FG V + +        + VA+K  K ++  ++  +F  E  ++  +DH NL++L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
            G V   +  +++TE  P G+L + L          +   + A+ +A+G+ YL     K+
Sbjct: 62  YGVV-LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KR 117

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            IHRD+ + NILL    + K+ DFG  R  P + D   +   +K    +  PE ++T   
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177

Query: 449 TTKSDVYSFGVLLLEILT-GRRP 470
           +  SDV+ FGV L E+ T G  P
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  110 bits (275), Expect = 3e-27
 Identities = 64/194 (32%), Positives = 107/194 (55%), Gaps = 8/194 (4%)

Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           +G+G FG V+K  L+D   VA+K  K++  + L+ +F SE  +L + DH N+VKL+G   
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           +     I+ E VP G     L  +    L   Q ++ A+D A G+ YL     K  IHRD
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLES---KNCIHRD 118

Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT-VGYLDPEYMKTYQLTTKS 452
           + + N L+ E+   K++DFG +R    + D  + S+ +K   + +  PE +   + +++S
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 453 DVYSFGVLLLEILT 466
           DV+S+G+LL E  +
Sbjct: 176 DVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  110 bits (276), Expect = 4e-27
 Identities = 70/217 (32%), Positives = 115/217 (52%), Gaps = 25/217 (11%)

Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +GEG FG V+ A+       +D +LVA+K A KE  E+ + +F  E ELL+ + H+++V+
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVK-ALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 328 LLGFVDKGNERLIITEFVPNGT----LREH------LDGQYGKT---LDFNQRLEIAIDV 374
             G   +G   L++ E++ +G     LR H      L G        L   Q L IA  +
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT 434
           A G+ YL   A    +HRD+ + N L+ + +  K+ DFG +R     +D   +  +    
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-DIYSTDYYRVGGRTMLP 187

Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
           + ++ PE +   + TT+SD++SFGV+L EI T G++P
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  109 bits (273), Expect = 8e-27
 Identities = 64/199 (32%), Positives = 106/199 (53%), Gaps = 8/199 (4%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           ++G G FG V+     +   VA+K  K     ++Q  F  E  L+  + H  LV+L   V
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQA-FLEEANLMKTLQHDKLVRLYAVV 70

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            K     IITE++  G+L + L    G  +   + ++ +  +A G+ Y+     K  IHR
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 127

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++N+L++ES+  K+ADFG AR+  ++ +        K  + +  PE +     T KS
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185

Query: 453 DVYSFGVLLLEILT-GRRP 470
           DV+SFG+LL EI+T G+ P
Sbjct: 186 DVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  110 bits (275), Expect = 8e-27
 Identities = 79/216 (36%), Positives = 113/216 (52%), Gaps = 35/216 (16%)

Query: 274 IGEGGFGTVYKAQL-EDGLLV--AIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLL 329
           IGEG FG V KA++ +DGL +  AIKR K+   ++   +F+ E+E+L K+  H N++ LL
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 330 GFVDKGNERLIITEFVPNGTLREHLD--------------GQYGKTLDFNQRLEIAIDVA 375
           G  +      +  E+ P+G L + L                    TL   Q L  A DVA
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
            G+ YL   ++KQ IHRD+ + NIL+ E+  AK+ADFG +R              VK T+
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTM 182

Query: 436 GYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILT 466
           G L   +M    L     TT SDV+S+GVLL EI++
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 1e-26
 Identities = 67/212 (31%), Positives = 114/212 (53%), Gaps = 13/212 (6%)

Query: 273 RIGEGGFGTVYKA--QLEDG--LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
            +G G FG+V K    ++ G  + VA+K  K+E     + EF  E  +++++DH  +V+L
Sbjct: 2   ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           +G V KG   +++ E  P G L ++L  +  +    +   E+A  VA G+ YL     K 
Sbjct: 62  IG-VCKGEPLMLVMELAPLGPLLKYLK-KRREIPVSDL-KELAHQVAMGMAYLE---SKH 115

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            +HRD+ + N+LL    +AK++DFG +R LG   SD    +T  +  + +  PE +   +
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGA-GSDYYRATTAGRWPLKWYAPECINYGK 174

Query: 448 LTTKSDVYSFGVLLLEILT-GRRPVELKRPPE 478
            ++KSDV+S+GV L E  + G +P    +  E
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE 206

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  109 bits (273), Expect = 1e-26
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 13/200 (6%)

Query: 274 IGEGGFGTV----YKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +GEG FG V    Y    +  G +VA+K  K+E  +   + +  E+ +L  + H N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 329 LGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            G   +   +   +I E+VP G+LR++L       L+  Q L  A  +  G+ YLH    
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH---S 125

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           +  IHRD+ + N+LL      K+ DFG A+  P   +   +       V +   E +K  
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN 185

Query: 447 QLTTKSDVYSFGVLLLEILT 466
           + +  SDV+SFGV L E+LT
Sbjct: 186 KFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 2e-26
 Identities = 61/207 (29%), Positives = 104/207 (50%), Gaps = 18/207 (8%)

Query: 274 IGEGGFGTVYK---AQLEDG---LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G+G FG VY+     +  G     VAIK   +      + EF +E  ++ + +  ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQ--------YGKTLDFNQRLEIAIDVAHGLT 379
           LLG V  G   L++ E +  G L+ +L  +                + +++A ++A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLD 439
           YL   A K+ +HRD+ + N ++ E +  K+ DFG  R    ++D      K    V ++ 
Sbjct: 134 YL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMA 189

Query: 440 PEYMKTYQLTTKSDVYSFGVLLLEILT 466
           PE +K    TTKSDV+SFGV+L E+ T
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 2e-26
 Identities = 71/205 (34%), Positives = 104/205 (50%), Gaps = 21/205 (10%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLL- 329
           +G+G FG V   + +D G L A+K  KK++           +E  +LS+I+H  +VKL  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 330 GFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQ---RLEIAIDVAHGLTYLHLYA 385
            F  +  E+L ++ E+ P G L  HL  + G+   F++   R   A ++   L YLH   
Sbjct: 61  AFQTE--EKLYLVLEYAPGGELFSHLS-KEGR---FSEERARFYAA-EIVLALEYLH--- 110

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
              II+RD+K  NILL      K+ DFG A+    +  RT+  T   GT  YL PE +  
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN--TFC-GTPEYLAPEVLLG 167

Query: 446 YQLTTKSDVYSFGVLLLEILTGRRP 470
                  D +S GVLL E+LTG+ P
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  108 bits (272), Expect = 2e-26
 Identities = 75/220 (34%), Positives = 109/220 (49%), Gaps = 35/220 (15%)

Query: 273 RIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNL 325
            +GEG FG V KA+        +   VA+K  K +  E   ++  SE+E++  I  H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLD-----GQY---------GKTLDFNQRLEIA 371
           + LLG   +     ++ E+  +G LR+ L      G+Y          +TL     +  A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV 431
             VA G+ +L   A K+ IHRD+ + N+L+TE    K+ADFG AR      D  HI    
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR------DIHHIDYYR 189

Query: 432 KGTVGYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILT 466
           K T G L  ++M    L     T +SDV+SFGVLL EI T
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  108 bits (271), Expect = 3e-26
 Identities = 68/219 (31%), Positives = 113/219 (51%), Gaps = 30/219 (13%)

Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           IG+G FG V++A+       E   +VA+K  K+E   ++Q +F  E  L+++ DH N+VK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKT--------------------LDFNQR 367
           LLG    G    ++ E++  G L E L  +  +                     L   ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 368 LEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI 427
           L IA  VA G+ YL   +E++ +HRD+ + N L+ E+M  K+ADFG +R     +D    
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-NIYSADYYKA 188

Query: 428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           S      + ++ PE +   + TT+SDV+++GV+L EI +
Sbjct: 189 SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  107 bits (268), Expect = 5e-26
 Identities = 68/208 (32%), Positives = 108/208 (51%), Gaps = 21/208 (10%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           IG G FG VY A  L+ G L+A+K  R +    + ++ E + E+++L  + H NLVK  G
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIK-EIADEMKVLELLKHPNLVKYYG 66

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
                 +  I  E+   GTL E L  ++G+ LD +      + +  GL YLH      I+
Sbjct: 67  VEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYLH---SHGIV 121

Query: 391 HRDVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVG---YLDPEYMKTY 446
           HRD+K +NI L  +   K+ DFG A +L    ++ T +  +V+   G   Y+ PE + T 
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLK---NNTTTMGEEVQSLAGTPAYMAPE-VITG 177

Query: 447 QLTT----KSDVYSFGVLLLEILTGRRP 470
                    +D++S G ++LE+ TG+RP
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  106 bits (268), Expect = 8e-26
 Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 16/202 (7%)

Query: 273 RIGEGGFGTVYKA-QLEDGLLVAIKRAK--KEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           +IGEG  G VYKA     G  VAIK+ +  K+  E +  E    + ++    H N+V   
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINE----ILIMKDCKHPNIVDYY 81

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
                G+E  ++ E++  G+L + +  Q    ++  Q   +  +V  GL YLH    + +
Sbjct: 82  DSYLVGDELWVVMEYMDGGSLTDIIT-QNFVRMNEPQIAYVCREVLQGLEYLHS---QNV 137

Query: 390 IHRDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           IHRD+KS NILL++    K+ADFGF A+L    S R      V GT  ++ PE +K    
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR----NSVVGTPYWMAPEVIKRKDY 193

Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
             K D++S G++ +E+  G  P
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  106 bits (265), Expect = 1e-25
 Identities = 71/207 (34%), Positives = 113/207 (54%), Gaps = 17/207 (8%)

Query: 274 IGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG V + +L+      + VAIK  K    E  + +F SE  ++ + DH N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 330 GFVDKGNERLIITEFVPNGTLREHL---DGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           G V K    +IITEF+ NG L   L   DGQ+       Q + +   +A G+ YL   +E
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI----QLVGMLRGIAAGMKYL---SE 124

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHIST-KVKGTVGYLDPEYMK 444
              +HRD+ + NIL+  ++  KV+DFG +R L    SD T+ S+   K  + +  PE + 
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
             + T+ SDV+S+G+++ E+++ G RP
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  106 bits (266), Expect = 1e-25
 Identities = 67/215 (31%), Positives = 115/215 (53%), Gaps = 23/215 (10%)

Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +GEG FG V+ A+       +D +LVA+K   K+  +N + +F  E ELL+ + H ++VK
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVK-TLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL-----------DGQYGKTLDFNQRLEIAIDVAH 376
             G   +G+  +++ E++ +G L + L           +G     L  +Q L IA  +A 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 377 GLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG 436
           G+ YL   A +  +HRD+ + N L+ E++  K+ DFG +R     +D   +       + 
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR-DVYSTDYYRVGGHTMLPIR 187

Query: 437 YLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
           ++ PE +   + TT+SDV+S GV+L EI T G++P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  106 bits (266), Expect = 1e-25
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 31/216 (14%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIK--------RAKKEQFENLQTEFSSEVELLSKIDHR 323
            IG+G FGTV K +   DG ++  K          +K+Q         SEV +L ++ H 
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL-------VSEVNILRELKHP 59

Query: 324 NLVKLLG-FVDKGNERL-IITEFVPNGTL-----REHLDGQYGKTLDFNQRLEIAIDVAH 376
           N+V+     +D+ N+ L I+ E+   G L     +   + +Y   ++      I   +  
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY---IEEEFIWRILTQLLL 116

Query: 377 GLTYLH--LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT 434
            L   H        ++HRD+K +NI L  +   K+ DFG A++  +  D +   T V GT
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYV-GT 173

Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
             Y+ PE +       KSD++S G L+ E+     P
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  105 bits (264), Expect = 1e-25
 Identities = 70/201 (34%), Positives = 107/201 (53%), Gaps = 9/201 (4%)

Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           +G G FG V   +      VAIK  K+      + EF  E +++ K+ H  LV+L G   
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           K     I+TE++ NG L  +L  ++GK    +Q LE+  DV  G+ YL     KQ IHRD
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLR-EHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRD 125

Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           + + N L+ +    KV+DFG +R   +D + T  S   K  V +  PE +   + ++KSD
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRY-VLDDEYTS-SVGSKFPVRWSPPEVLLYSKFSSKSD 183

Query: 454 VYSFGVLLLEILT-GRRPVEL 473
           V++FGVL+ E+ + G+ P E 
Sbjct: 184 VWAFGVLMWEVYSLGKMPYER 204

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  105 bits (262), Expect = 2e-25
 Identities = 79/274 (28%), Positives = 128/274 (46%), Gaps = 35/274 (12%)

Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           IG+G FG V       G  VA+K  K +        F +E  +++++ H NLV+LLG + 
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 334 KGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
           +    L I+TE++  G+L ++L  +    L  +  L+ ++DV   + YL        +HR
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHR 126

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D+ + N+L++E   AKV+DFG  +      D   +  K      +  PE ++  + +TKS
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKS 180

Query: 453 DVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD---PSIKEVISM 509
           DV+SFG+LL EI +        R P  R+ L+    R  +G  +D  D   P + +V+  
Sbjct: 181 DVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMK- 233

Query: 510 EILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI 543
                      QC       RP    + EQL  I
Sbjct: 234 -----------QCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  104 bits (262), Expect = 2e-25
 Identities = 65/201 (32%), Positives = 100/201 (49%), Gaps = 17/201 (8%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAK-KEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +GEG +G+VYKA   E G +VAIK    +E  + +  E S    +L + D   +VK  G 
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEIS----ILKQCDSPYIVKYYGS 66

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             K  +  I+ E+   G++ + +     KTL   +   I      GL YLH     + IH
Sbjct: 67  YFKNTDLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHS---NKKIH 122

Query: 392 RDVKSSNILLTESMRAKVADFGFAR--LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           RD+K+ NILL E  +AK+ADFG +      M    T I     GT  ++ PE ++     
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-----GTPFWMAPEVIQEIGYN 177

Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            K+D++S G+  +E+  G+ P
Sbjct: 178 NKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 3e-25
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G+G FG VYKAQ  E GL  A K  + E  E L+ +F  E+++LS+  H N+V L    
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE-DFMVEIDILSECKHPNIVGLYEAY 71

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
              N+  I+ EF   G L   +  +  + L   Q   +   +   L +LH     ++IHR
Sbjct: 72  FYENKLWILIEFCDGGALDSIML-ELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHR 127

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM--KTYQLT- 449
           D+K+ NILLT     K+ADFG +        +    T + GT  ++ PE +  +T++   
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD--TFI-GTPYWMAPEVVACETFKDNP 184

Query: 450 --TKSDVYSFGVLLLEILTGRRP 470
              K+D++S G+ L+E+     P
Sbjct: 185 YDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  105 bits (263), Expect = 3e-25
 Identities = 69/218 (31%), Positives = 114/218 (52%), Gaps = 26/218 (11%)

Query: 274 IGEGGFGTVYKAQ------LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +GEG FG V+ A+       +D +LVA+K  K       + +F  E ELL+ + H ++VK
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVK 71

Query: 328 LLGFVDKGNERLIITEFVPNGTL----REH-------LDGQYGKT---LDFNQRLEIAID 373
             G    G+  +++ E++ +G L    R H       +DGQ  +    L  +Q L IA  
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
           +A G+ YL   A +  +HRD+ + N L+  ++  K+ DFG +R     +D   +      
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-DVYSTDYYRVGGHTML 187

Query: 434 TVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
            + ++ PE +   + TT+SDV+SFGV+L EI T G++P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  105 bits (262), Expect = 3e-25
 Identities = 76/290 (26%), Positives = 130/290 (44%), Gaps = 41/290 (14%)

Query: 274 IGEGGFGTVYKAQL-----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +GE  FG +YK  L     +   LVAIK  K         EF  E  L++++ H N+V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 329 LGFVDKGNERLIITEFVPNGTLREHL---------------DGQYGKTLDFNQRLEIAID 373
           LG V +     ++ E++  G L E L               DG    +LD    L IAI 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
           +A G+ YL   +    +H+D+ + NIL+ E +  K++D G +R     +D   +  K   
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR-EIYSADYYRVQPKSLL 188

Query: 434 TVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNE 492
            + ++ PE +   + ++ SD++SFGV+L EI + G +P                +  ++ 
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP----------------YYGFSN 232

Query: 493 GNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA 542
             +++MV        S +   +M+ L  +C     + RP  K +  +L +
Sbjct: 233 QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score =  105 bits (264), Expect = 4e-25
 Identities = 84/290 (28%), Positives = 130/290 (44%), Gaps = 42/290 (14%)

Query: 274 IGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRN 324
           +GEG FG V +A+         +  + VA+K  K    +    +  SE+EL+  I  H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD--------------FNQRLEI 370
           ++ LLG   +     +I E+   G LRE L  +     D              F   +  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
           A  VA G+ YL     ++ IHRD+ + N+L+TE    K+ADFG AR G  D D    ++ 
Sbjct: 140 AYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLAR-GVHDIDYYKKTSN 195

Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY 490
            +  V ++ PE +     T +SDV+SFG+L+ EI T      L   P   + +   FK  
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT------LGGSPYPGIPVEELFKLL 249

Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG+ +D   PS           +++ L  +C   +   RP  K + E L
Sbjct: 250 REGHRMDK--PS-------NCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  104 bits (263), Expect = 4e-25
 Identities = 68/213 (31%), Positives = 99/213 (46%), Gaps = 36/213 (16%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFS----SEVELLSKIDHRNLVK 327
           +IGEG +G VYKA+  + G LVA+K+ +    EN +  F      E++LL K+ H N+V+
Sbjct: 6   QIGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 328 LLGFV--DKGNERLIITEFVP---NGTLREHL----DGQYGKTLDFNQRLEIAIDVAHGL 378
           L   V         ++ E++     G L        + Q  K     Q LE       GL
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQI-KCY-MKQLLE-------GL 113

Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YLH      I+HRD+K SNIL+      K+ADFG AR  P     +   T    T+ Y 
Sbjct: 114 QYLH---SNGILHRDIKGSNILINNDGVLKLADFGLAR--PYTKRNSADYTNRVITLWYR 168

Query: 439 DPEYM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            PE +     Y    + D++S G +L E+  G+
Sbjct: 169 PPELLLGATRY--GPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  104 bits (261), Expect = 4e-25
 Identities = 65/206 (31%), Positives = 113/206 (54%), Gaps = 17/206 (8%)

Query: 274 IGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG V   +L+      + VAIK  K    E  + +F SE  ++ + DH N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 330 GFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           G V K    +I+TE++ NG+L    R+H DGQ+       Q + +   +A G+ YL   +
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKH-DGQFTVI----QLVGMLRGIASGMKYL---S 123

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
           +   +HRD+ + NIL+  ++  KV+DFG +R+   D +  + +   K  + +  PE +  
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 446 YQLTTKSDVYSFGVLLLEILT-GRRP 470
            + T+ SDV+S+G+++ E+++ G RP
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  104 bits (262), Expect = 4e-25
 Identities = 76/281 (27%), Positives = 141/281 (50%), Gaps = 18/281 (6%)

Query: 274 IGEGGFGTVYKAQ---LED--GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G+G FG+V   +   L+D  G +VA+K+ +    E+L+ +F  E+E+L  + H N+VK 
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR-DFEREIEILKSLQHDNIVKY 70

Query: 329 LGF---VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
            G      + N RL+  E++P G+LR++L     + LD  + L  A  +  G+ YL    
Sbjct: 71  KGVCYSAGRRNLRLV-MEYLPYGSLRDYLQKHRER-LDHRKLLLYASQICKGMEYL---G 125

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K+ +HRD+ + NIL+    R K+ DFG  ++ P D +   +    +  + +  PE +  
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185

Query: 446 YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG--NLLDMVDPSI 503
            + +  SDV+SFGV+L E+ T     +   PP E + +    K+      +L++++  + 
Sbjct: 186 SKFSVASDVWSFGVVLYELFTYSD--KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243

Query: 504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR 544
           +         +++ +  +C     + RP    +  Q+ AIR
Sbjct: 244 RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  104 bits (260), Expect = 4e-25
 Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 14/206 (6%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAK-KEQFENLQTEFSSEVELLSKIDHRNLVKLL-G 330
           +G+G +G+VYK + L D    A+K        +  + +  +E+ +L+ ++H N++     
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL--EIAIDVAHGLTYLHLYAEKQ 388
           F+D GN+  I+ E+ P G L + +  +  K     ++    I I +  GL  LH   E++
Sbjct: 68  FLD-GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQK 123

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           I+HRD+KS+NILL  +   K+ D G +++   +  +T I     GT  Y+ PE  K    
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYMAPEVWKGRPY 178

Query: 449 TTKSDVYSFGVLLLEILTGRRPVELK 474
           + KSD++S G LL E+ T   P E +
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEAR 204

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  103 bits (260), Expect = 4e-25
 Identities = 65/206 (31%), Positives = 95/206 (46%), Gaps = 14/206 (6%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFS--SEVELLSKIDHRNLVKL-L 329
           IG+G FG V   Q  D   + A+K   K++     +  +  +E  +L +++H  LV L  
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D+ N  L+  + +  G LR HL  Q  K  +   +  I  ++   L YLH    K I
Sbjct: 68  SFQDEENMYLV-VDLLLGGDLRYHL-SQKVKFSEEQVKFWIC-EIVLALEYLH---SKGI 121

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           IHRD+K  NILL E     + DF  A     D+    ++T   GT GY+ PE +     +
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDT----LTTSTSGTPGYMAPEVLCRQGYS 177

Query: 450 TKSDVYSFGVLLLEILTGRRPVELKR 475
              D +S GV   E L G+RP     
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHS 203

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  103 bits (259), Expect = 9e-25
 Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 18/213 (8%)

Query: 267 NFSPSLRIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI 320
           N      +G G FG V+ A+           LV +K  +K + ENLQ+EF  E+++  K+
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL-------DGQYGKTLDFNQRLEIAID 373
            H+N+V+LLG   +     +I E+   G L++ L       +      L   Q++ +   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
           +A G+ +L   +  + +HRD+ + N L++     KV+    ++   + +   +       
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALI 180

Query: 434 TVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
            + +L PE ++    +TKSDV+SFGVL+ E+ T
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 9e-25
 Identities = 70/199 (35%), Positives = 105/199 (52%), Gaps = 10/199 (5%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
            IG+G FG VYKA       +VAIK    E+ E+   +   E++ LS+     + K  G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             KG++  II E+   G+  + L  + GK LD      I  +V  GL YLH   E+  IH
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLL--KPGK-LDETYIAFILREVLLGLEYLH---EEGKIH 121

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+K++NILL+E    K+ADFG +  G + S  +  +T V GT  ++ PE +K      K
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEK 178

Query: 452 SDVYSFGVLLLEILTGRRP 470
           +D++S G+  +E+  G  P
Sbjct: 179 ADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  103 bits (259), Expect = 1e-24
 Identities = 94/296 (31%), Positives = 132/296 (44%), Gaps = 54/296 (18%)

Query: 274 IGEGGFGTVYKAQLEDGL---------LVAIKRAKKEQFENLQTEFSSEVELLSKI-DHR 323
           +GEG FG V  A+   GL          VA+K  K +  E   ++  SE+E++  I  H+
Sbjct: 26  LGEGCFGQVVMAE-AIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 84

Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ--------YGKT------LDFNQRLE 369
           N++ LLG   +     +I E+   G LRE+L  +        Y  T      L F   + 
Sbjct: 85  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
            A  VA G+ YL   A K+ IHRD+ + N+L+TE    K+ADFG AR      D  HI  
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 195

Query: 430 KVKGTVGYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR 484
             K T G L  ++M    L     T +SDV+SFGVLL EI T      L   P   V + 
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE 249

Query: 485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
             FK   EG+ +D       E         ++ +   C   + + RP  K + E L
Sbjct: 250 ELFKLLKEGHRMDKPSNCTNE---------LYMMMRDCWHAVPSQRPTFKQLVEDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  103 bits (258), Expect = 1e-24
 Identities = 60/202 (29%), Positives = 107/202 (52%), Gaps = 12/202 (5%)

Query: 274 IGEGGFGTVYKA----QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IGEG FG VY+        + + VA+K  K     +++ +F  E  ++ + DH ++VKL+
Sbjct: 14  IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G + + N   I+ E  P G LR +L      +LD    +  +  ++  L YL     K+ 
Sbjct: 74  GVITE-NPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLE---SKRF 128

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+L++     K+ DFG +R   ++ +  + ++K K  + ++ PE +   + T
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAPESINFRRFT 186

Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           + SDV+ FGV + EIL  G +P
Sbjct: 187 SASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 66/213 (30%), Positives = 110/213 (51%), Gaps = 26/213 (12%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTE---------FSSEVELLSKIDHR 323
           IG+G +G VY A  +  G ++A+K+ +       + +           SE+E L  +DH 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL--EIAIDVAHGLTYL 381
           N+V+ LGF        I  E+VP G++   L   YG+   F ++L       V  GL YL
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR-TYGR---FEEQLVRFFTEQVLEGLAYL 124

Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP--MDSDRTHISTKVKGTVGYLD 439
           H    K I+HRD+K+ N+L+      K++DFG ++      D+D+      ++G+V ++ 
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN---MSMQGSVFWMA 178

Query: 440 PEYMKTYQ--LTTKSDVYSFGVLLLEILTGRRP 470
           PE + +Y    + K D++S G ++LE+  GRRP
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  102 bits (258), Expect = 2e-24
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 25/206 (12%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS----EVELLSKIDHRNLVK 327
           ++GEG +G VYKA+  + G +VA+K+ + +  E       S    E+ LL ++ H N+VK
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE---GIPSTALREISLLKELKHPNIVK 62

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           LL  +    +  ++ E+     L+++LD +    L  N    I   +  GL Y H     
Sbjct: 63  LLDVIHTERKLYLVFEYCDM-DLKKYLD-KRPGPLSPNLIKSIMYQLLRGLAYCH---SH 117

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARL--GPMDSDRTHISTKVKGTVGYLDPEY--- 442
           +I+HRD+K  NIL+      K+ADFG AR    P+   RT+  T    T+ Y  PE    
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL---RTY--THEVVTLWYRAPEILLG 172

Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGR 468
            K Y  +T  D++S G +  E++TG+
Sbjct: 173 SKHY--STAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  101 bits (254), Expect = 3e-24
 Identities = 68/246 (27%), Positives = 120/246 (48%), Gaps = 17/246 (6%)

Query: 267 NFSPSLRIGEGGFG--TVYKAQLEDGLLVAIKRAK-KEQFENLQTEFSSEVELLSKIDHR 323
           ++ P   +G+G FG  T+Y+ + ED  LV  K        E  + +  +E+ +LS + H 
Sbjct: 1   HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59

Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
           N++         N  LI  E+   GTL + +  Q G+  +    L     +   ++Y+H 
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH- 118

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
             +  I+HRD+K+ NI LT++   K+ DFG +++  + S+ +   T V GT  Y+ PE  
Sbjct: 119 --KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVV-GTPYYMSPELC 173

Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI 503
           +  +   KSD+++ G +L E+LT +R  +   P    V +        +GN   +V    
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV-------QGNYTPVVSVYS 226

Query: 504 KEVISM 509
            E+IS+
Sbjct: 227 SELISL 232

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 3e-24
 Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 24/215 (11%)

Query: 274 IGEGGFGTVYKAQL--EDG--LLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKL 328
           +GEG FG+V + QL  +DG  L VA+K  K +     + E F SE   +   DH N++KL
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 329 LGFVDKGNER------LIITEFVPNGTLREHL----DGQYGKTLDFNQRLEIAIDVAHGL 378
           +G   + +        ++I  F+ +G L   L     G   + L     L+  +D+A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDR-THISTKVKGTVG 436
            YL   + +  IHRD+ + N +L E M   VADFG ++ +   D  R   I+   K  V 
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KMPVK 180

Query: 437 YLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
           ++  E +     T+KSDV++FGV + EI T G+ P
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  101 bits (253), Expect = 4e-24
 Identities = 66/200 (33%), Positives = 106/200 (53%), Gaps = 9/200 (4%)

Query: 272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +++G+G FG V+         VAIK  K      +   F  E +++ K+ H  LV L   
Sbjct: 12  VKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAV 69

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           V +     I+TEF+  G+L + L    GK L   Q +++A  +A G+ Y+        IH
Sbjct: 70  VSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIH 125

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD++++NIL+ +++  K+ADFG ARL  ++ +        K  + +  PE     + T K
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV+SFG+LL E++T GR P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  101 bits (252), Expect = 4e-24
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 9/202 (4%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFS-SEVELLSKIDHRNLVKLLGF 331
           IGEG FG +Y A+ + D     IK     +    + E S  EV LL+K+ H N+V     
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     I+ E+   G L + ++ Q G     +Q L   + ++ GL ++H   +++I+H
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILH 124

Query: 392 RDVKSSNILLTES-MRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           RD+KS NI L+++ M AK+ DFG AR     +D   ++    GT  YL PE  +      
Sbjct: 125 RDIKSQNIFLSKNGMVAKLGDFGIAR---QLNDSMELAYTCVGTPYYLSPEICQNRPYNN 181

Query: 451 KSDVYSFGVLLLEILTGRRPVE 472
           K+D++S G +L E+ T + P E
Sbjct: 182 KTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  101 bits (252), Expect = 5e-24
 Identities = 64/199 (32%), Positives = 102/199 (51%), Gaps = 9/199 (4%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           ++G G FG V+         VA+K  K          F  E +++ K+ H  LV+L   V
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     I+TE++  G+L + L    G+ L     +++A  VA G+ Y+        IHR
Sbjct: 71  SE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++S+NIL+ + +  K+ADFG ARL  ++ +        K  + +  PE     + T KS
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 453 DVYSFGVLLLEILT-GRRP 470
           DV+SFG+LL E++T GR P
Sbjct: 185 DVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score =  102 bits (255), Expect = 5e-24
 Identities = 83/290 (28%), Positives = 133/290 (45%), Gaps = 42/290 (14%)

Query: 274 IGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRN 324
           +GEG FG V  A+         ++ + VA+K  K +  E   ++  SE+E++  I  H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDG------QYG--------KTLDFNQRLEI 370
           ++ LLG   +     +I E+   G LRE+L        +Y         + + F   +  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
              VA G+ YL   A ++ IHRD+ + N+L+TE+   K+ADFG AR    + D    +T 
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DVNNIDYYKKTTN 198

Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY 490
            +  V ++ PE +     T +SDV+SFGVL+ EI T      L   P   + +   FK  
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 252

Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG+ +D       E         ++ +   C   I + RP  K + E L
Sbjct: 253 KEGHRMDKPANCTNE---------LYMMMRDCWHAIPSHRPTFKQLVEDL 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  100 bits (251), Expect = 7e-24
 Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 9/207 (4%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           ++G G FG V+ A       VA+K  K          F +E  ++  + H  LVKL   V
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAVV 70

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            K     IITEF+  G+L + L    G      + ++ +  +A G+ ++    ++  IHR
Sbjct: 71  TK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 126

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL++ S+  K+ADFG AR+  ++ +        K  + +  PE +     T KS
Sbjct: 127 DLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184

Query: 453 DVYSFGVLLLEILT-GRRPVELKRPPE 478
           DV+SFG+LL+EI+T GR P      PE
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPE 211

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  101 bits (252), Expect = 8e-24
 Identities = 65/200 (32%), Positives = 105/200 (52%), Gaps = 11/200 (5%)

Query: 274 IGEGGFGTV----YKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +GEG FG V    Y  + ++ G  VA+K  K E   N   +   E+E+L  + H N+VK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 329 LGFV--DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            G    D GN   +I EF+P+G+L+E+L     K ++  Q+L+ A+ +  G+ YL     
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYL---GS 127

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           +Q +HRD+ + N+L+    + K+ DFG  +    D +   +   +   V +  PE +   
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187

Query: 447 QLTTKSDVYSFGVLLLEILT 466
           +    SDV+SFGV L E+LT
Sbjct: 188 KFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  100 bits (251), Expect = 9e-24
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 19/217 (8%)

Query: 265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS----EVELLSK 319
             NF    +IG+G F  VYKA  L DG +VA+K  K + FE +  +       E++LL +
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALK--KVQIFEMMDAKARQDCLKEIDLLKQ 58

Query: 320 IDHRNLVKLL-GFVDKGNERLIITEFVPNGTLR---EHLDGQYGKTLDFNQRLEIAIDVA 375
           +DH N++K L  F++  NE  I+ E    G L    +H   Q  + +      +  + + 
Sbjct: 59  LDHPNVIKYLASFIEN-NELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTIWKYFVQLC 116

Query: 376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
             L ++H    K+I+HRD+K +N+ +T +   K+ D G  R     S  T   + V GT 
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLV-GTP 170

Query: 436 GYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVE 472
            Y+ PE +       KSD++S G LL E+   + P  
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  102 bits (255), Expect = 1e-23
 Identities = 73/254 (28%), Positives = 112/254 (44%), Gaps = 30/254 (11%)

Query: 232 PMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLR---IGEGGFGTVYKA-QL 287
           P+ +PP  S  + S       S          A ++ S   R   IG G  GTVYK    
Sbjct: 44  PLPLPPPSSSSSSS-------SSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHR 96

Query: 288 EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPN 347
             G L A+K       + ++ +   E+E+L  ++H N+VK     D   E  ++ EF+  
Sbjct: 97  PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156

Query: 348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRA 407
           G+L            D      +A  +  G+ YLH    + I+HRD+K SN+L+  +   
Sbjct: 157 GSLEGTHIADEQFLAD------VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNV 207

Query: 408 KVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT------YQLTTKSDVYSFGVLL 461
           K+ADFG +R+     D  + S    GT+ Y+ PE + T      Y      D++S GV +
Sbjct: 208 KIADFGVSRILAQTMDPCNSSV---GTIAYMSPERINTDLNHGAYD-GYAGDIWSLGVSI 263

Query: 462 LEILTGRRPVELKR 475
           LE   GR P  + R
Sbjct: 264 LEFYLGRFPFGVGR 277

Length = 353

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  100 bits (250), Expect = 1e-23
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 25/207 (12%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G G  G V K      G ++A+K  + E  E +Q +   E+++L K +   +V   G  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
               +  I  E++  G+L + L  +    +      +IA+ V  GLTYLH   + +IIHR
Sbjct: 69  YNNGDISICMEYMDGGSLDKILK-EVQGRIPERILGKIAVAVLKGLTYLH--EKHKIIHR 125

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV--------KGTVGYLDPEYMK 444
           DVK SNIL+    + K+ DFG             +S ++         GT  Y+ PE ++
Sbjct: 126 DVKPSNILVNSRGQIKLCDFG-------------VSGQLVNSLAKTFVGTSSYMAPERIQ 172

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRPV 471
               + KSD++S G+ L+E+ TGR P 
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 98.8 bits (246), Expect = 4e-23
 Identities = 59/209 (28%), Positives = 113/209 (54%), Gaps = 21/209 (10%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIK-----RAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G F + Y+A+ ++ G L+A+K     R    + E +      E+ L+++++H ++++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIA--IDVAHGLTYLHLYA 385
           +LG   + +   +  E++  G++  HL  +YG    F + + I     +  GL+YLH   
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGA---FKEAVIINYTEQLLRGLSYLH--- 120

Query: 386 EKQIIHRDVKSSNILLTES-MRAKVADFGFARLGPMDSDRT---HISTKVKGTVGYLDPE 441
           E QIIHRDVK +N+L+  +  R ++ADFG A    + +  T       ++ GT+ ++ PE
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAA--ARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 442 YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            ++  Q     DV+S G +++E+ T + P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score =  100 bits (249), Expect = 5e-23
 Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 42/290 (14%)

Query: 274 IGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRN 324
           +GEG FG V  A+            + VA+K  K +  +   ++  SE+E++  I  H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQY--------------GKTLDFNQRLEI 370
           ++ LLG   +     ++ E+   G LRE+L  +                + L F   +  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
           A  VA G+ YL   A ++ IHRD+ + N+L+TE    K+ADFG AR    + D    +T 
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR-DVHNIDYYKKTTN 195

Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY 490
            +  V ++ PE +     T +SDV+SFGVLL EI T      L   P   + +   FK  
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT------LGGSPYPGIPVEELFKLL 249

Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG+ +D       E         ++ +  +C   + + RP  K + E L
Sbjct: 250 KEGHRMDKPANCTHE---------LYMIMRECWHAVPSQRPTFKQLVEDL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 99.1 bits (247), Expect = 5e-23
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 19/204 (9%)

Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLV 326
           +G G FG V +A      + +  + VA+K  K     + +    SE++++S + +H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            LLG    G   L+ITE+   G L   L  +    L     L  +  VA G+ +L   A 
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---AS 159

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT----VGYLDPEY 442
           K  IHRD+ + N+LLT     K+ DFG AR   + +D  ++   VKG     V ++ PE 
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLAR--DIMNDSNYV---VKGNARLPVKWMAPES 214

Query: 443 MKTYQLTTKSDVYSFGVLLLEILT 466
           +     T +SDV+S+G+LL EI +
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 98.0 bits (244), Expect = 7e-23
 Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 29/215 (13%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRA------------KKEQFENLQTEFSSEVELLSKI 320
           IG G FG+VY       G L+A+K+             K+   + L      E+ LL ++
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALA----REIALLKEL 63

Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL--EIAIDVAHGL 378
            H N+V+ LG     +   I  E+VP G++   L+  YG    F + L       +  GL
Sbjct: 64  QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGA---FEETLVRNFVRQILKGL 119

Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK---VKGTV 435
            YLH    + IIHRD+K +NIL+      K++DFG ++    +S  T  +     ++G+V
Sbjct: 120 NYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 436 GYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            ++ PE +K    T K+D++S G L++E+LTG+ P
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 98.0 bits (244), Expect = 8e-23
 Identities = 81/270 (30%), Positives = 124/270 (45%), Gaps = 40/270 (14%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G+G +G VY A+ L   + +AIK   +     +Q     E+ L S + HRN+V+ LG  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHSYLKHRNIVQYLGSD 74

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI-AIDVAHGLTYLHLYAEKQIIH 391
            +     I  E VP G+L   L  ++G   D  Q +      +  GL YLH   + QI+H
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVH 131

Query: 392 RDVKSSNILL-TESMRAKVADFG----FARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           RD+K  N+L+ T S   K++DFG     A + P     T       GT+ Y+ PE +   
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-------GTLQYMAPEVIDKG 184

Query: 447 Q--LTTKSDVYSFGVLLLEILTGRRP-VELKRPPEE--RVTLRWAFKRYNEGNLLDMVDP 501
                  +D++S G  ++E+ TG+ P +EL  P     +V +   FK +          P
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM---FKIH----------P 231

Query: 502 SIKEVISMEILTKMFGLAIQCAAPIRNDRP 531
            I E +S E   K F L  +C  P  + R 
Sbjct: 232 EIPESLSAE--AKNFIL--RCFEPDPDKRA 257

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 96.8 bits (241), Expect = 1e-22
 Identities = 67/200 (33%), Positives = 104/200 (52%), Gaps = 9/200 (4%)

Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           +G G FG V+  +    + VAIK   +      + +F  E +++ K+ H  LV+L G   
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           +     I+TEF+ NG L  +L  + GK L  +  L +  DV  G+ YL        IHRD
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLE---RNSFIHRD 125

Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           + + N L++ +   KV+DFG  R   +D + T  S+  K  V +  PE     + ++KSD
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRY-VLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSD 183

Query: 454 VYSFGVLLLEILT-GRRPVE 472
           V+SFGVL+ E+ T G+ P E
Sbjct: 184 VWSFGVLMWEVFTEGKMPFE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 75/244 (30%), Positives = 114/244 (46%), Gaps = 14/244 (5%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IG G    VY A  L +   VAIKR   E+ +    E   EV+ +S+ +H N+VK     
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI---DVAHGLTYLHLYAEKQI 389
             G+E  ++  ++  G+L + +  +            IA    +V  GL YLH   +   
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK-VKGTVGYLDPEYMKTYQ- 447
           IHRD+K+ NILL E    K+ADFG +       DRT    K   GT  ++ PE M+    
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183

Query: 448 LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERV--TLRWAFKRYNEGNLLDMVDPSIKE 505
              K+D++SFG+  +E+ TG  P   K PP + +  TL+        G        S ++
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYS-KYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRK 242

Query: 506 VISM 509
           +IS+
Sbjct: 243 MISL 246

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 96.6 bits (240), Expect = 2e-22
 Identities = 68/241 (28%), Positives = 115/241 (47%), Gaps = 24/241 (9%)

Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G+G FG VY+       + E    VAIK   +      + EF +E  ++ + +  ++V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL-------DGQYGKTL-DFNQRLEIAIDVAHGLT 379
           LLG V +G   L+I E +  G L+ +L       +    +      + +++A ++A G+ 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLD 439
           YL+     + +HRD+ + N ++ E    K+ DFG  R    ++D      K    V ++ 
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVRWMS 189

Query: 440 PEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV 499
           PE +K    TT SDV+SFGV+L EI T      L   P + ++     +   EG LLD  
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGMSNEQVLRFVMEGGLLDKP 243

Query: 500 D 500
           D
Sbjct: 244 D 244

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 71/215 (33%), Positives = 104/215 (48%), Gaps = 25/215 (11%)

Query: 273 RIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG- 330
           R+GEG  G+V K +L   G++ A+K    +   +LQ +   E+E+        +VK  G 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67

Query: 331 FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQR------LEIAIDVAHGLTYLHL 383
           F+D+ +  + I  E+   G+L    D  Y K      R       +IA  V  GL+YLH 
Sbjct: 68  FLDESSSSIGIAMEYCEGGSL----DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH- 122

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
              ++IIHRD+K SNILLT   + K+ DFG +         T       GT  Y+ PE +
Sbjct: 123 --SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMAPERI 175

Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPE 478
           +    +  SDV+S G+ LLE+   R P     PPE
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNRFPF----PPE 206

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 96.2 bits (239), Expect = 3e-22
 Identities = 71/201 (35%), Positives = 106/201 (52%), Gaps = 18/201 (8%)

Query: 273 RIGEGGFGTVY-----KAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           R+G+G FGTVY     KA  E+ L V  +    E   N   + + E +LLSK+DH  +VK
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
                 + +   IITE+     L   L+     GKTL  NQ  E  I +  G+ Y+H   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--- 123

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARL--GPMDSDRTHISTKVKGTVGYLDPEYM 443
           +++I+HRD+K+ NI L  ++  K+ DFG +RL  G  D     ++T   GT  Y+ PE +
Sbjct: 124 QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD-----LATTFTGTPYYMSPEAL 177

Query: 444 KTYQLTTKSDVYSFGVLLLEI 464
           K     +KSD++S G +L E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 96.0 bits (239), Expect = 3e-22
 Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 12/200 (6%)

Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKK--EQFENLQ--TEFSSEVELLSKIDHRNLVKLL 329
           IG+G FG VY   L D     I  A K   +  +L+   +F  E  ++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 330 GF-VDKGNERLIITEFVPNGTLREHL-DGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           G  +      L++  ++ +G LR  +    +  T+     +   + VA G+ YL   A K
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYL---ASK 117

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + +HRD+ + N +L ES   KVADFG AR +   +    H  T  K  V ++  E ++T 
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 447 QLTTKSDVYSFGVLLLEILT 466
           + TTKSDV+SFGVLL E++T
Sbjct: 178 KFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 94.7 bits (235), Expect = 6e-22
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 10/197 (5%)

Query: 273 RIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           RIG G FG V+  +L  D   VA+K  ++    +L+ +F  E  +L +  H N+V+L+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     I+ E V  G     L  + G  L   + +++  + A G+ YL     K  IH
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLE---SKHCIH 117

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK--VKGTVGYLDPEYMKTYQLT 449
           RD+ + N L+TE    K++DFG +R    + D  + ST    +  V +  PE +   + +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174

Query: 450 TKSDVYSFGVLLLEILT 466
           ++SDV+SFG+LL E  +
Sbjct: 175 SESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 95.2 bits (237), Expect = 7e-22
 Identities = 84/287 (29%), Positives = 124/287 (43%), Gaps = 45/287 (15%)

Query: 274 IGEGGFGTVYKAQL--EDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G FG VY+      DG    L VA+K   +   E  +++F  E  ++SK +H+N+V+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKT-----LDFNQRLEIAIDVAHGLTYLH 382
           L+G   +   R I+ E +  G L+  L     +      L     L  A DVA G  YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 383 LYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMD---SDRTHISTKVKGTVG 436
              E   IHRD+ + N LLT       AK+ADFG AR    D   +       +    + 
Sbjct: 134 ---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAMLPIK 186

Query: 437 YLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPE--ERVTLRWAFKRYNEG 493
           ++ PE       T+K+DV+SFGVLL EI + G  P   +   E  E VT          G
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT---------GG 237

Query: 494 NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
             LD   P             ++ +   C      DRP+  ++ E++
Sbjct: 238 GRLD--PPK-------GCPGPVYRIMTDCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 95.5 bits (238), Expect = 8e-22
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 15/201 (7%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAK-KEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +IGEG +G VYKA+    G +VAIK+ K + + E +      E++LL +++H N++KLL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
                 +  ++ EF+ +  L + +     + L  +        +  GL + H      I+
Sbjct: 66  VFRHKGDLYLVFEFM-DTDLYKLIKD-RQRGLPESLIKSYLYQLLQGLAFCH---SHGIL 120

Query: 391 HRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTH-ISTKVKGTVGYLDPEYMKT-YQ 447
           HRD+K  N+L+      K+ADFG AR  G      TH + T+      Y  PE +     
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKG 175

Query: 448 LTTKSDVYSFGVLLLEILTGR 468
            +T  D++S G +  E+L+ R
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 94.6 bits (235), Expect = 9e-22
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 31/214 (14%)

Query: 274 IGEGGFGTVYKAQLEDGLLVAIKR---------AKKEQFENLQTEFSSEVELLSKIDHRN 324
           +G+G +GTVY      G L+A+K+         A ++++E LQ     EV+LL  + H N
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQ----EEVDLLKSLKHVN 63

Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI-----DVAHGLT 379
           +V+ LG     N   I  EFVP G++   L+        F    E         +  G+ 
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILN-------RFGPLPEPVFCKYTKQILDGVA 116

Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR---LGPMDSDRTHISTKVKGTVG 436
           YLH      ++HRD+K +N++L  +   K+ DFG AR      +    +++   + GT  
Sbjct: 117 YLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173

Query: 437 YLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           ++ PE +       KSD++S G  + E+ TG+ P
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 95.0 bits (236), Expect = 1e-21
 Identities = 63/211 (29%), Positives = 111/211 (52%), Gaps = 12/211 (5%)

Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTV+K   + +G    + VAIK  +         E +  +  +  +DH  +V+L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           LG    G    ++T+  P G+L +H+  Q+  +LD  + L   + +A G+ YL    E +
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLE---EHR 129

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           ++HR++ + NILL      ++ADFG A L   D D+ +  ++ K  + ++  E +   + 
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPD-DKKYFYSEHKTPIKWMALESILFGRY 188

Query: 449 TTKSDVYSFGVLLLEILT-GRRPVELKRPPE 478
           T +SDV+S+GV + E+++ G  P    RP E
Sbjct: 189 THQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 95.0 bits (236), Expect = 1e-21
 Identities = 78/296 (26%), Positives = 129/296 (43%), Gaps = 49/296 (16%)

Query: 274 IGEGGFGTVYKAQ------LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +GEG FG V KA             VA+K  K+    +   +  SE  LL +++H +++K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL-------------DGQYGKTLDFN--------- 365
           L G   +    L+I E+   G+LR  L             DG    +   N         
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 366 QRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT 425
             +  A  ++ G+ YL   AE +++HRD+ + N+L+ E  + K++DFG +R    + D  
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR-DVYEEDSY 183

Query: 426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLR 484
              +K +  V ++  E +  +  TT+SDV+SFGVLL EI+T G  P      PE      
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP-GIAPER----- 237

Query: 485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
             F     G  ++  +   +E         M+ L + C     + RP    + ++L
Sbjct: 238 -LFNLLKTGYRMERPENCSEE---------MYNLMLTCWKQEPDKRPTFADISKEL 283

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 18/206 (8%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEV-------ELLSKIDHRNL 325
           +G+G FG VY    ++ G  +A+K+     F+    E   EV       +LL  + H  +
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQV---PFDPDSPETKKEVNALECEIQLLKNLQHERI 66

Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           V+  G +       I  E++P G++++ L   YG  L      +    +  G+ YLH   
Sbjct: 67  VQYYGCLRDDETLSIFMEYMPGGSVKDQLK-AYG-ALTETVTRKYTRQILEGVEYLH--- 121

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
              I+HRD+K +NIL   +   K+ DFG + RL  + S  T + + V GT  ++ PE + 
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEVIS 180

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRP 470
                 K+DV+S G  ++E+LT + P
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 23/207 (11%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSS----EVELLSKIDHRNLVKL 328
           +G G FG+VY+   L+DG   A+K            E       E+ LLSK+ H N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           LG   + +   I  E VP G+L   L  +YG +            +  GL YLH   ++ 
Sbjct: 68  LGTEREEDNLYIFLELVPGGSL-AKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRN 122

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFAR----LGPMDSDRTHISTKVKGTVGYLDPEY-M 443
            +HRD+K +NIL+  +   K+ADFG A+         S         KG+  ++ PE   
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--------FKGSPYWMAPEVIA 174

Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +       +D++S G  +LE+ TG+ P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 93.0 bits (232), Expect = 5e-21
 Identities = 65/201 (32%), Positives = 93/201 (46%), Gaps = 16/201 (7%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQF-ENLQTE-FSSEVELLSKIDHRNLVKLLG 330
           +G G FG V   + +  G   A+K   K +  +  Q E   +E  +L  I H  LV L G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 331 -FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  L++ E+VP G L  HL  + G+          A  V   L YLH      I
Sbjct: 69  SFQDDSNLYLVM-EYVPGGELFSHLR-KSGR-FPEPVARFYAAQVVLALEYLH---SLDI 122

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           ++RD+K  N+LL      K+ DFGFA+       RT+    + GT  YL PE + +    
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAKRVK---GRTY---TLCGTPEYLAPEIILSKGYG 176

Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D ++ G+L+ E+L G  P
Sbjct: 177 KAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 92.6 bits (230), Expect = 5e-21
 Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 20/208 (9%)

Query: 273 RIGEGGFGTVYKAQL----EDGLLVAIKRAKKEQFENLQTEFS-SEVELLSKIDHRNLVK 327
           +IGEG FG   KA L    EDG    IK     +    + E S  EV +LS + H N+V+
Sbjct: 7   KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63

Query: 328 LL-GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
               F + GN   I+ ++   G L + ++ Q G     +Q L+  + +   L ++H   +
Sbjct: 64  YQESFEENGN-LYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---D 119

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARL--GPMDSDRTHISTKVKGTVGYLDPEYMK 444
           ++I+HRD+KS NI LT+    K+ DFG AR+    ++  RT I     GT  YL PE  +
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-----GTPYYLSPEICE 174

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRPVE 472
                 KSD+++ G +L E+ T +   E
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 73/280 (26%), Positives = 122/280 (43%), Gaps = 41/280 (14%)

Query: 274 IGEGGFGTVYKAQLEDG--LLVAIK-------------RAKKEQFENLQTEFSSEVELLS 318
           +G G FG VYK + ++    L+A+K             R + +   ++ +E +   E L 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 319 KIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQ-RL-EIAIDVAH 376
              H N+V+      + +   I+ + +    L EH +    K   F + R+  I + +  
Sbjct: 68  ---HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 377 GLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG 436
            L YLH   EK+I+HRD+  +NI+L E  +  + DFG A+            T V GT+ 
Sbjct: 125 ALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK----QKQPESKLTSVVGTIL 178

Query: 437 YLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL 496
           Y  PE +K      K+DV++FG +L ++ T      L+ P      L  A K      ++
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLATK------IV 226

Query: 497 DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
           + V   + E +  E +T +      C  P    RPD+  V
Sbjct: 227 EAVYEPLPEGMYSEDVTDVIT---SCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 67/206 (32%), Positives = 95/206 (46%), Gaps = 24/206 (11%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLL- 329
           +G GGFG V   +++      A+K  KK        Q    SE E+L + +H  +VKL  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 330 GFVDKGNERLIITEFVPNG----TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
            F DK    ++  E+   G     LR+   G + +      R  IA  V     YLH   
Sbjct: 61  TFKDKKYIYML-MEYCLGGELWTILRDR--GLFDEYT---ARFYIAC-VVLAFEYLH--- 110

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            + II+RD+K  N+LL  +   K+ DFGFA+ L      +T   T   GT  Y+ PE + 
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK--SGQKTW--TFC-GTPEYVAPEIIL 165

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRP 470
                   D +S G+LL E+LTGR P
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 32/212 (15%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAK---KEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           RIG G +G VYKA+ +  G LVAIK  K    + FE +Q     E+ +L +  H N+V  
Sbjct: 10  RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ----QEISMLKECRHPNIVAY 65

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI---DVAHGLTYLHLYA 385
            G   + ++  I+ E+   G+L++     Y  T      L+IA    +   GL YLH   
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQD----IYQVTRGPLSELQIAYVCRETLKGLAYLH--- 118

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVK---GTVGYLDPE 441
           E   IHRD+K +NILLTE    K+ADFG  A+L       T    K K   GT  ++ PE
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL-------TATIAKRKSFIGTPYWMAPE 171

Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGRRP 470
                +      K D+++ G+  +E+   + P
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 89.9 bits (223), Expect = 3e-20
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 10/207 (4%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +G G FG V+   +  D  LV IK+   EQ  ++ +    +E ++L  + H N+++    
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +    +I+ E+ P GTL E++  +    LD +  L   + +   L ++H    K I+H
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILH 124

Query: 392 RDVKSSNILLTE-SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           RD+K+ NILL +  M  K+ DFG +++    S ++   T V GT  Y+ PE  +      
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYT-VVGTPCYISPELCEGKPYNQ 180

Query: 451 KSDVYSFGVLLLEILTGRRPVELKRPP 477
           KSD+++ G +L E+ + +R  E    P
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLP 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 90.3 bits (224), Expect = 5e-20
 Identities = 64/209 (30%), Positives = 110/209 (52%), Gaps = 18/209 (8%)

Query: 267 NFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN 324
           NF    +IGEG +G VYKA+    G +VA+K+ + + + E + +    E+ LL +++H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + H +
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LG-PMDSDRTHISTKVKGTVGYLDPEY 442
              +++HRD+K  N+L+      K+ADFG AR  G P+   RT+    V  T+ Y  PE 
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVV--TLWYRAPEI 171

Query: 443 M---KTYQLTTKSDVYSFGVLLLEILTGR 468
           +   K Y  +T  D++S G +  E++T R
Sbjct: 172 LLGCKYY--STAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 89.9 bits (223), Expect = 6e-20
 Identities = 69/206 (33%), Positives = 99/206 (48%), Gaps = 31/206 (15%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG-- 330
           +G G  GTVYKA  L    ++A+K    +    LQ +  SE+E+L K D   ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 331 FVDKGNERLIITEFVPNGTLR------EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           FV+  N   I TEF+  G+L       EH+ G+            IA+ V  GLTYL   
Sbjct: 69  FVE--NRISICTEFMDGGSLDVYRKIPEHVLGR------------IAVAVVKGLTYLW-- 112

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
              +I+HRDVK SN+L+    + K+ DFG +           I+    GT  Y+ PE + 
Sbjct: 113 -SLKILHRDVKPSNMLVNTRGQVKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERIS 166

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRP 470
             Q    SDV+S G+  +E+  GR P
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 90.1 bits (224), Expect = 6e-20
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 10/199 (5%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKK-EQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            +GEG +G V K +    G +VAIK+ K+ E  E+++     EV++L ++ H N+V L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +     ++ E+V   TL E L+      L  +        +   + Y H      II
Sbjct: 68  AFRRKGRLYLVFEYVER-TLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCH---SHNII 122

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  NIL++ES   K+ DFGFAR          ++  V  T  Y  PE +       
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYV-ATRWYRAPELLVGDTNYG 180

Query: 451 KS-DVYSFGVLLLEILTGR 468
           K  DV++ G ++ E+L G 
Sbjct: 181 KPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 89.9 bits (224), Expect = 7e-20
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 41/216 (18%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ--TEFSS--EVELLSKIDHRNLVKL 328
           +GEG +  VYKA   E G +VAIK+ K  + +  +    F++  E++LL ++ H N++ L
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 329 LG-FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAH----------G 377
           L  F  K N  L+           E ++    K +       I +  A           G
Sbjct: 68  LDVFGHKSNINLVF----------EFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRG 114

Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY 437
           L YLH      I+HRD+K +N+L+      K+ADFG AR     S    ++ +V  T  Y
Sbjct: 115 LEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARS--FGSPNRKMTHQVV-TRWY 168

Query: 438 LDPEYM---KTYQLTTKSDVYSFGVLLLEILTGRRP 470
             PE +   + Y      D++S G +  E+L  R P
Sbjct: 169 RAPELLFGARHY--GVGVDMWSVGCIFAELLL-RVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 89.3 bits (221), Expect = 7e-20
 Identities = 67/204 (32%), Positives = 107/204 (52%), Gaps = 10/204 (4%)

Query: 268 FSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
           F+   RIG+G FG V+K        +VAIK    E+ E+   +   E+ +LS+ D   + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           K  G   KG +  II E++  G+    LD       D  Q   +  ++  GL YLH  +E
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSA---LDLLRAGPFDEFQIATMLKEILKGLDYLH--SE 120

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K+I HRD+K++N+LL+E    K+ADFG A  G +   +   +T V GT  ++ PE ++  
Sbjct: 121 KKI-HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176

Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
              +K+D++S G+  +E+  G  P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 89.7 bits (222), Expect = 8e-20
 Identities = 60/205 (29%), Positives = 111/205 (54%), Gaps = 12/205 (5%)

Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK   +        EF  E  +++ +DH +LV+L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           LG       +L+ T+ +P+G L +++  ++   +     L   + +A G+ YL    E++
Sbjct: 75  LGVCLSPTIQLV-TQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           ++HRD+ + N+L+      K+ DFG ARL   D ++ + +   K  + ++  E +   + 
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD-EKEYNADGGKMPIKWMALECIHYRKF 188

Query: 449 TTKSDVYSFGVLLLEILT-GRRPVE 472
           T +SDV+S+GV + E++T G +P +
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 89.2 bits (221), Expect = 8e-20
 Identities = 57/202 (28%), Positives = 105/202 (51%), Gaps = 11/202 (5%)

Query: 274 IGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           +G G FG + +  L+      L VAI   +    +  +  F +E   L + DH N+V+L 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G + +GN  +I+TE++ NG L   L    G+ L   Q + +   +A G+ YL   +E   
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYL---SEMGY 128

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +H+ + +  +L+   +  K++  GF RL    S+  + +   K  V +  PE ++ +  +
Sbjct: 129 VHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186

Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           + SDV+SFG+++ E+++ G RP
Sbjct: 187 SASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 88.8 bits (220), Expect = 1e-19
 Identities = 80/238 (33%), Positives = 120/238 (50%), Gaps = 38/238 (15%)

Query: 274 IGEGGFGTVYKAQL--EDGLL--VAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKL 328
           +G+G FG+V +AQL  EDG    VA+K  K + F +   E F  E   + + DH N++KL
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 329 LG--FVDKGNERL----IITEFVPNGTLREHL----DGQYGKTLDFNQRLEIAIDVAHGL 378
           +G     +   RL    +I  F+ +G L   L     G+   TL     +   ID+A G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGY 437
            YL   + K  IHRD+ + N +L E+M   VADFG ++ +   D  R   ++K+   V +
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP--VKW 181

Query: 438 LDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP---VE-------------LKRPPE 478
           L  E +     TT SDV++FGV + EI+T G+ P   VE             LK+PP+
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPD 239

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 19/206 (9%)

Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKE-----QFENLQTEFSSEVELLSKIDHRNLVKL 328
           +GEG FG   +A L   +    K A KE         ++     E  LL+K+ H N+V  
Sbjct: 8   VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIVAF 63

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
               +      I+ E+   G L + +  Q GK    +  L+  + +  G+ ++H   EK+
Sbjct: 64  KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKR 120

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARL--GPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           ++HRD+KS NI LT++ + K+ DFG ARL   P     T++     GT  Y+ PE  +  
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-----GTPYYVPPEIWENM 175

Query: 447 QLTTKSDVYSFGVLLLEILTGRRPVE 472
               KSD++S G +L E+ T + P +
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQ 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 79/278 (28%), Positives = 118/278 (42%), Gaps = 43/278 (15%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFS-------SEVELLSKIDHRNL 325
           +G+G +G V   +   DG    IK+       NL+            E +LLS++ H N+
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKL------NLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 326 VKLLGFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           V      +  +  L I+  F   G L   L  Q GK L  NQ +E  + +A  L YLH  
Sbjct: 62  VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH-- 119

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            EK I+HRD+K+ N+ LT +   KV D G AR+     D   +++ + GT  Y+ PE   
Sbjct: 120 -EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD---MASTLIGTPYYMSPELFS 175

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM---VDP 501
                 KSDV++ G  + E+ T +     K        +     R  EG L  M     P
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAK-------DMNSLVYRIIEGKLPPMPKDYSP 228

Query: 502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQ 539
            + E+I+           +    P    RP +KS+  Q
Sbjct: 229 ELGELIA----------TMLSKRP--EKRPSVKSILRQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 23/214 (10%)

Query: 274 IGEGGFGTVYKAQL--EDGLL-VAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLL 329
           +GEG FG+V + QL  +D +L VA+K  K       + E F SE   + + DH N+++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 330 GFVDKGNER------LIITEFVPNGTLREHLDGQYGKTLDFNQRL------EIAIDVAHG 377
           G   +  E       ++I  F+ +G L   L   Y +  D  Q L      +   D+A G
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFL--LYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY 437
           + YL   + K  IHRD+ + N +L E+M   VADFG ++    + D        K  V +
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK-KIYNGDYYRQGRIAKMPVKW 180

Query: 438 LDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
           +  E +     TTKSDV+SFGV + EI T G+ P
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 86.9 bits (215), Expect = 5e-19
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 22/209 (10%)

Query: 274 IGEGGFGTVYKAQLED------GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G+G FG VY+    D         VA+K   +      + EF +E  ++      ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL----------DGQYGKTLDFNQRLEIAIDVAHG 377
           LLG V KG   L++ E + +G L+ +L           G+   TL   + +++A ++A G
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 131

Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY 437
           + YL+    K+ +HRD+ + N ++      K+ DFG  R    ++D      K    V +
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVRW 187

Query: 438 LDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           + PE +K    TT SD++SFGV+L EI +
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 70/236 (29%), Positives = 114/236 (48%), Gaps = 35/236 (14%)

Query: 273 RIGEGGFGTVY------------KAQLEDG-----LLVAIKRAKKEQFENLQTEFSSEVE 315
           ++GEG FG V+            KA  E+      +LVA+K  + +  +N + +F  EV+
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 316 LLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL---------DGQYGKTLDFNQ 366
           +LS++   N+ +LLG         +I E++ NG L + L              K+L F+ 
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 367 RLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH 426
            L +A  +A G+ YL        +HRD+ + N L+ ++   K+ADFG +R     SD   
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR-NLYSSDYYR 187

Query: 427 ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVT 482
           +  +    + ++  E +   + TTKSDV++FGV L EILT  R       P E +T
Sbjct: 188 VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR-----EQPYEHLT 238

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 87.0 bits (215), Expect = 6e-19
 Identities = 64/199 (32%), Positives = 102/199 (51%), Gaps = 18/199 (9%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G+G FG VYKA+  E G L A K  + +  E L+ ++  E+E+L+  +H  +VKLLG  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYMVEIEILATCNHPYIVKLLGAF 78

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
               +  I+ EF P G + + +  +  + L   Q   I   +   L YLH     +IIHR
Sbjct: 79  YWDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHR 134

Query: 393 DVKSSNILLTESMRAKVADFGFA--RLGPMDSDRTHISTKVKGTVGYLDPEY-----MKT 445
           D+K+ N+LLT     K+ADFG +   +  +    + I     GT  ++ PE      MK 
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETMKD 189

Query: 446 YQLTTKSDVYSFGVLLLEI 464
                K+D++S G+ L+E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 86.9 bits (215), Expect = 7e-19
 Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 25/206 (12%)

Query: 273 RIGEGGFGTVYKA-QLEDGLLVAIKR------AKKEQFENLQTEFSSEVELLSKIDHRNL 325
           +IG+G  GTVY A  +  G  VAIK+       KKE   N       E+ ++ +  H N+
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-------EILVMRENKHPNI 78

Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           V  L     G+E  ++ E++  G+L    D      +D  Q   +  +    L +LH   
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQALEFLH--- 132

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
             Q+IHRD+KS NILL      K+ DFGF A++ P  S R   ST V GT  ++ PE + 
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMV-GTPYWMAPEVVT 188

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRP 470
                 K D++S G++ +E++ G  P
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 86.9 bits (215), Expect = 8e-19
 Identities = 61/227 (26%), Positives = 110/227 (48%), Gaps = 38/227 (16%)

Query: 273 RIGEGGFGTVYKAQLED-----------------GLLVAIKRAKKEQFENLQTEFSSEVE 315
           ++GEG FG V+  ++ +                  LLVA+K  + +  +N + +F  EV+
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 316 LLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQY----------------- 358
           +LS++   N+++LLG     +   +ITE++ NG L + L   +                 
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 359 GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG 418
              + ++  L +A+ +A G+ YL   +    +HRD+ + N L+ E++  K+ADFG +R  
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR-N 187

Query: 419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
               D   I  +    + ++  E +   + TT SDV++FGV L EIL
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 86.9 bits (216), Expect = 8e-19
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 45/217 (20%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEF--SS--EVELLSKIDHRNLVK 327
           RI EG +G VY+A+  + G +VA+K+ K    E  +  F  +S  E+ +L K+ H N+V 
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKLQHPNIVT 68

Query: 328 LLGFV--DKGNERLIITEFVPNG--TLREHLDGQYG----KTLDFNQRLEIAIDVAHGLT 379
           +   V     ++  ++ E+V +   +L E +   +     K L   Q L        G+ 
Sbjct: 69  VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL-MLQLLS-------GVA 120

Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-----LGPMDSDRTHISTKVKGT 434
           +LH   +  I+HRD+K+SN+LL      K+ DFG AR     L P         T++  T
Sbjct: 121 HLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--------TQLVVT 169

Query: 435 VGYLDPEYM---KTYQLTTKSDVYSFGVLLLEILTGR 468
           + Y  PE +   K Y  +T  D++S G +  E+LT +
Sbjct: 170 LWYRAPELLLGAKEY--STAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 86.3 bits (213), Expect = 9e-19
 Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 10/206 (4%)

Query: 266 RNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRN 324
             F+   RIG+G FG VYK        +VAIK    E+ E+   +   E+ +LS+ D   
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           + +  G   KG +  II E++  G+    LD      L+      I  ++  GL YLH  
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSA---LDLLKPGPLEETYIATILREILKGLDYLH-- 118

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
           +E++I HRD+K++N+LL+E    K+ADFG A  G +   +   +T V GT  ++ PE +K
Sbjct: 119 SERKI-HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFV-GTPFWMAPEVIK 174

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRP 470
                 K+D++S G+  +E+  G  P
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 64/273 (23%), Positives = 128/273 (46%), Gaps = 25/273 (9%)

Query: 272 LRIGEGGFGTVYKA--QLEDGLL-VAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           + +G G FG V K   ++    + VAIK  K E  ++++ E   E E++ ++D+  +V++
Sbjct: 1   VELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           +G  +     L++ E    G L + L G+    +  +  +E+   V+ G+ YL     K 
Sbjct: 61  IGVCEAEALMLVM-EMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLE---GKN 115

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            +HRD+ + N+LL     AK++DFG ++    D       +  K  + +  PE +   + 
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175

Query: 449 TTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI 507
           +++SDV+S+G+ + E  + G++P +  + PE                ++  ++   +   
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPE----------------VMSFIEQGKRLDC 219

Query: 508 SMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
             E   +M+ L   C      DRP+   V E++
Sbjct: 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERM 252

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 89.9 bits (223), Expect = 1e-18
 Identities = 63/190 (33%), Positives = 98/190 (51%), Gaps = 15/190 (7%)

Query: 293 VAIK--RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI-ITEFVPNGT 349
           VAIK  R    + E+ +  F  E  L +++ H N+V LL   +     L  + E+VP  T
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65

Query: 350 LREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES---MR 406
           LRE L       L   +   + + V   L   H    + I+HRD+K  NI+++++     
Sbjct: 66  LREVLAAD--GALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 407 AKVADFGFARLGP--MDSDRTHIS--TKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLL 462
           AKV DFG   L P   D+D   ++  T+V GT  Y  PE ++   +T  SD+Y++G++ L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180

Query: 463 EILTGRRPVE 472
           E LTG+R V+
Sbjct: 181 ECLTGQRVVQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 31/220 (14%)

Query: 273 RIGEGGFGTVYKAQLEDGL----------------LVAIKRAKKEQFENLQTEFSSEVEL 316
           ++GEG FG V+  + E GL                LVA+K  + +  +  + +F  E+++
Sbjct: 12  KLGEGQFGEVHLCEAE-GLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70

Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLD-----GQYGK-----TLDFNQ 366
           +S++ + N+++LLG     +   +ITE++ NG L + L        +       ++    
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 367 RLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH 426
            L +A+ +A G+ YL   A    +HRD+ + N L+      K+ADFG +R      D   
Sbjct: 131 LLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR-NLYSGDYYR 186

Query: 427 ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           I  +    + ++  E +   + TT SDV++FGV L E+ T
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 31/216 (14%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLG- 330
           IGEG +G VYKA   + G LVAIK       E+ + E   E  +L K  +H N+    G 
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDII--EDEEEEIKEEYNILRKYSNHPNIATFYGA 71

Query: 331 FVDKG-----NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE------IAIDVAHGLT 379
           F+ K      ++  ++ E    G++ + + G         +RL+      I  +   GL 
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTDLVKG----LRKKGKRLKEEWIAYILRETLRGLA 127

Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLD 439
           YLH   E ++IHRD+K  NILLT++   K+ DFG +    +DS     +T + GT  ++ 
Sbjct: 128 YLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFI-GTPYWMA 181

Query: 440 PE-----YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           PE              +SDV+S G+  +E+  G+ P
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 85.9 bits (212), Expect = 1e-18
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 10/204 (4%)

Query: 268 FSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
           F+   +IG+G FG V+K        +VAIK    E+ E+   +   E+ +LS+ D   + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           K  G   K  +  II E++  G+  + L+      LD  Q   I  ++  GL YLH  +E
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLH--SE 120

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K+I HRD+K++N+LL+E    K+ADFG A  G + +D         GT  ++ PE +K  
Sbjct: 121 KKI-HRDIKAANVLLSEHGEVKLADFGVA--GQL-TDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
              +K+D++S G+  +E+  G  P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 11/202 (5%)

Query: 274 IGEGGFGTVYKA--QLEDGL-LVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLL 329
           +G G FGTV K   +++     VA+K  K +     L+ E   E  ++ ++D+  +V+++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G  +     +++ E    G L + L  Q  K +      E+   V+ G+ YL    E   
Sbjct: 63  GICE-AESWMLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLE---ETNF 116

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+LL     AK++DFG ++    D +     T  K  V +  PE M  Y+ +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           +KSDV+SFGVL+ E  + G++P
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 69/212 (32%), Positives = 99/212 (46%), Gaps = 35/212 (16%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS--EVELLSKIDHRNLVKLL 329
           RIGEG +G VY+A+    G +VA+K+ + +  E      SS  E+ LL  + H N+V+L 
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 330 GFV--DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR-------LEIAIDVAHGLTY 380
             V     +   ++ E+       E         LD             + + +  GL Y
Sbjct: 73  EVVVGKHLDSIFLVMEYC------EQ---DLASLLDNMPTPFSESQVKCLMLQLLRGLQY 123

Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL-GPMDSDRTHISTKVKGTVGYLD 439
           LH   E  IIHRD+K SN+LLT+    K+ADFG AR  G      T    KV  T+ Y  
Sbjct: 124 LH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT---PKVV-TLWYRA 176

Query: 440 PEY---MKTYQLTTKSDVYSFGVLLLEILTGR 468
           PE      TY  TT  D+++ G +L E+L  +
Sbjct: 177 PELLLGCTTY--TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 20/203 (9%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG-F 331
           +G G  G+V K + +  G ++A K        +++ +   E++++ +     +V   G F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGK----TLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           +++ N   +  EF+  G     LD  Y K     ++   +  IA+ V  GLTYL  Y   
Sbjct: 73  LNENN-ICMCMEFMDCG----SLDRIYKKGGPIPVEILGK--IAVAVVEGLTYL--YNVH 123

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
           +I+HRD+K SNIL+    + K+ DFG +  G + +    I+    GT  Y+ PE ++  +
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVS--GELINS---IADTFVGTSTYMSPERIQGGK 178

Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
            T KSDV+S G+ ++E+  G+ P
Sbjct: 179 YTVKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 30/210 (14%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH---RNLVKLL 329
           IG G +G VY+   +  G +VA+K    +  ++  ++   EV LLS++      N+ K  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE------IAIDVAHGLTYLHL 383
           G   KG    II E+   G++R         TL     +       I  +V   L Y+H 
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVR---------TLMKAGPIAEKYISVIIREVLVALKYIH- 118

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
             +  +IHRD+K++NIL+T +   K+ DFG A L  ++ + +  ST V GT  ++ PE +
Sbjct: 119 --KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFV-GTPYWMAPEVI 173

Query: 444 ---KTYQLTTKSDVYSFGVLLLEILTGRRP 470
              K Y   TK+D++S G+ + E+ TG  P
Sbjct: 174 TEGKYYD--TKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 73/218 (33%), Positives = 112/218 (51%), Gaps = 35/218 (16%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IGEG +G VYKA+ +D G LVA+K+ + + + E        E+++L +++HRN+V L   
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74

Query: 332 V-----------DKGNERLIITEFVPN---GTLRE---HLDGQYGKTLDFNQRLEIAIDV 374
           V           DKG   L+  E++ +   G L     H    + K+    Q LE     
Sbjct: 75  VTDKQDALDFKKDKGAFYLVF-EYMDHDLMGLLESGLVHFSEDHIKSF-MKQLLE----- 127

Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT 434
             GL Y H   +K  +HRD+K SNILL    + K+ADFG ARL   +  R + + KV  T
Sbjct: 128 --GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY-TNKVI-T 180

Query: 435 VGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPV 471
           + Y  PE +   +    + DV+S G +L E+ T ++P+
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 63/231 (27%), Positives = 103/231 (44%), Gaps = 25/231 (10%)

Query: 256 LNMSQVVKATRNFSPS------LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQ--FENLQ 307
           +  S +       S        + I E    ++YK    +   V I+  KK     + L 
Sbjct: 4   ITRSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLI 62

Query: 308 TEFSSEVELLSKIDHRNLVKLLGF----VDKGNERLIITEFVPNGTLREHLDGQYGKTLD 363
               +E++ L +ID  N++K+ GF    VD      +I E+   G LRE LD    K L 
Sbjct: 63  DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD--KEKDLS 120

Query: 364 FNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           F  +L++AID   GL  L+ Y  K   ++++ S + L+TE+ + K+   G  ++      
Sbjct: 121 FKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKI------ 172

Query: 424 RTHISTKVKGTVGYLDPEYMKTY--QLTTKSDVYSFGVLLLEILTGRRPVE 472
            +    K    + Y   + +     + T K D+YS GV+L EI TG+ P E
Sbjct: 173 LSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223

Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 17/201 (8%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKR-AKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +IGEG +G V+K +  E G +VAIK+  + E    ++     E+ +L ++ H NLV L+ 
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 331 FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            V +   +L ++ E+  +  L E L+ +  + +  +   +I       + + H   +   
Sbjct: 68  -VFRRKRKLHLVFEYCDHTVLNE-LE-KNPRGVPEHLIKKIIWQTLQAVNFCH---KHNC 121

Query: 390 IHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRT-HISTKVKGTVGYLDPEYM-KTY 446
           IHRDVK  NIL+T+  + K+ DFGFAR L     D T +++T+      Y  PE +    
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPELLVGDT 176

Query: 447 QLTTKSDVYSFGVLLLEILTG 467
           Q     DV++ G +  E+LTG
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 84.7 bits (209), Expect = 6e-18
 Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 20/207 (9%)

Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 75  LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 126

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            E++++HRD+ + N+L+      K+ DFG A+L   D    H +   K  + ++  E + 
Sbjct: 127 -ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH-AEGGKVPIKWMALESIL 184

Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 83.9 bits (208), Expect = 6e-18
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 14/201 (6%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKR-AKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           RIGEG  G V+KA+  E G  VA+K+ A +     +  +   E++ L    H  +VKLL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
               G+  +++ E++P   L E L     + L   Q       +  G+ Y+H      I+
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSEVL-RDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIM 121

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM---KTYQ 447
           HRD+K +N+L++     K+ADFG AR      +   + +    T  Y  PE +   + Y 
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLAR--LFSEEEPRLYSHQVATRWYRAPELLYGARKY- 178

Query: 448 LTTKSDVYSFGVLLLEILTGR 468
                D+++ G +  E+L G 
Sbjct: 179 -DPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 87.2 bits (216), Expect = 7e-18
 Identities = 70/235 (29%), Positives = 111/235 (47%), Gaps = 22/235 (9%)

Query: 311 SSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI 370
           SSE+  + K+ H N+VKL+G         +I E++    L E L       L + +R +I
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKI 785

Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
           AI +A  L +LH      ++  ++    I++         D    RL           TK
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIII------DGKDEPHLRLSLPGL--LCTDTK 837

Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY 490
              +  Y+ PE  +T  +T KSD+Y FG++L+E+LTG+ P + +      + + WA  RY
Sbjct: 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI-VEWA--RY 894

Query: 491 NEGNL-LDM-VDPSIKEVISM---EILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
              +  LDM +DPSI+  +S+   EI+  M  LA+ C A     RP    V + L
Sbjct: 895 CYSDCHLDMWIDPSIRGDVSVNQNEIVEVM-NLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 17/202 (8%)

Query: 273 RIGEGGFGTVYKA-QLEDGLLVAIKRA--KKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           +IGEG  G V  A     G  VA+K+   +K+Q   L     +EV ++    H N+V++ 
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL---LFNEVVIMRDYQHPNIVEMY 82

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
                G+E  ++ EF+  G L    D      ++  Q   + + V   L++LH    + +
Sbjct: 83  SSYLVGDELWVVMEFLEGGALT---DIVTHTRMNEEQIATVCLAVLKALSFLH---AQGV 136

Query: 390 IHRDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           IHRD+KS +ILLT   R K++DFGF A++    S        + GT  ++ PE +     
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQV----SKEVPRRKSLVGTPYWMAPEVISRLPY 192

Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
            T+ D++S G++++E++ G  P
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 19/208 (9%)

Query: 274 IGEGGFGTVY---KAQLEDGLLVAIKRAKKE--QFENLQTEFSSEVELLSKIDHRNLVKL 328
           I +G +G V+   K    D  + AIK  KK     +N   +  +E ++LS+     +VKL
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 329 L-GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
              F  K N   ++ E++P G L   L+   G   +   R+ IA ++   L YLH     
Sbjct: 59  YYSFQGKKN-LYLVMEYLPGGDLASLLE-NVGSLDEDVARIYIA-EIVLALEYLHSNG-- 113

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMD-----SDRTHISTKVKGTVGYLDPEY 442
            IIHRD+K  NIL+  +   K+ DFG +++G +      +D      ++ GT  Y+ PE 
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +     +   D +S G +L E L G  P
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 60/202 (29%), Positives = 107/202 (52%), Gaps = 21/202 (10%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKR-AKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +GEG +G V K +  E G +VAIK+  + E  + ++     E+ +L ++ H NLV L+  
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     ++ EFV + T+ + L+ +Y   LD ++  +    +  G+ + H +    IIH
Sbjct: 69  FRRKKRLYLVFEFVDH-TVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCHSH---NIIH 123

Query: 392 RDVKSSNILLTESMRAKVADFGFARL--GPMDSDRTHISTK----VKGTVGYLDPEYMKT 445
           RD+K  NIL+++S   K+ DFGFAR    P +    +++T+     +  VG  D +Y + 
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG--DTKYGRA 181

Query: 446 YQLTTKSDVYSFGVLLLEILTG 467
                  D+++ G L+ E+LTG
Sbjct: 182 V------DIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 16/209 (7%)

Query: 272 LRIGEGGFGTVYKAQLED-GLLVAIKRA--KKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           ++IGEG  G V  A ++  G LVA+K+   +K+Q   L     +EV ++    H N+V++
Sbjct: 26  IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEM 82

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                 G+E  ++ EF+  G L    D      ++  Q   + + V   L+ LH    + 
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALT---DIVTHTRMNEEQIAAVCLAVLKALSVLH---AQG 136

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           +IHRD+KS +ILLT   R K++DFGF      +  R      + GT  ++ PE +     
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKSLVGTPYWMAPELISRLPY 193

Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP 477
             + D++S G++++E++ G  P     PP
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPY-FNEPP 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 75/249 (30%), Positives = 103/249 (41%), Gaps = 49/249 (19%)

Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ--TEFSSEVELLSKIDHRNLVKLL 329
           ++G+GG+G V+ A+ +D G +VA+KR KK     L       +E ++L+      LVKLL
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 330 -GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQ-RLEI-----AIDVAHGLTYLH 382
             F D     L + E+VP G  R  L+      L  +  R  +     A+D  H L Y  
Sbjct: 68  YAFQDDEYLYLAM-EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGY-- 122

Query: 383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEY 442
                  IHRD+K  N L+  S   K+ DFG +           I T     VG   P+Y
Sbjct: 123 -------IHRDLKPENFLIDASGHIKLTDFGLS---------KGIVTYANSVVG--SPDY 164

Query: 443 M-------KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEE-------RVTLRWAFK 488
           M       K Y  T   D +S G +L E L G  P     P E        + TL+    
Sbjct: 165 MAPEVLRGKGYDFTV--DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY 222

Query: 489 RYNEGNLLD 497
                NL D
Sbjct: 223 DDPRFNLSD 231

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 82.0 bits (202), Expect = 4e-17
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 16/209 (7%)

Query: 272 LRIGEGGFGTVYKA-QLEDGLLVAIKRA--KKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           ++IGEG  G V  A +   G  VA+K+   +K+Q   L     +EV ++    H N+V +
Sbjct: 28  IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL---LFNEVVIMRDYHHENVVDM 84

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                 G+E  ++ EF+  G L    D      ++  Q   + + V   L+YLH    + 
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALT---DIVTHTRMNEEQIATVCLSVLRALSYLH---NQG 138

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           +IHRD+KS +ILLT   R K++DFGF       S        + GT  ++ PE +     
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFC---AQVSKEVPKRKSLVGTPYWMAPEVISRLPY 195

Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP 477
            T+ D++S G++++E++ G  P     PP
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPY-FNEPP 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 81.6 bits (201), Expect = 4e-17
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 12/205 (5%)

Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + DG    + VAIK  ++        E   E  +++ +    + +L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           LG       +L+ T+ +P G L +++     + +     L   + +A G++YL    E +
Sbjct: 75  LGICLTSTVQLV-TQLMPYGCLLDYVRENKDR-IGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           ++HRD+ + N+L+      K+ DFG ARL  +D    H +   K  + ++  E +   + 
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH-ADGGKVPIKWMALESILHRRF 188

Query: 449 TTKSDVYSFGVLLLEILT-GRRPVE 472
           T +SDV+S+GV + E++T G +P +
Sbjct: 189 THQSDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 81.6 bits (201), Expect = 4e-17
 Identities = 65/197 (32%), Positives = 97/197 (49%), Gaps = 14/197 (7%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G+G FG VYKAQ  E G+L A K    +  E L+ ++  E+++L+  DH N+VKLL   
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDAF 71

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
              N   I+ EF   G + + +  +  + L   Q   +       L YLH   E +IIHR
Sbjct: 72  YYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHR 127

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM-----KTYQ 447
           D+K+ NIL T     K+ADFG +        R        GT  ++ PE +     K   
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 448 LTTKSDVYSFGVLLLEI 464
              K+DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 81.5 bits (201), Expect = 5e-17
 Identities = 58/220 (26%), Positives = 109/220 (49%), Gaps = 30/220 (13%)

Query: 273 RIGEGGFGTVYKAQLE-----------------DGLLVAIKRAKKEQFENLQTEFSSEVE 315
           ++GEG FG V+  + E                   +LVA+K  +++  +N + +F  E++
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 316 LLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGK---------TLDFNQ 366
           ++S++   N+++LL      +   +ITE++ NG L + L     +         T+ ++ 
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 367 RLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH 426
            + +A  +A G+ YL   +    +HRD+ + N L+ ++   K+ADFG +R      D   
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR-NLYSGDYYR 187

Query: 427 ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           I  +    + ++  E +   + TT SDV++FGV L EILT
Sbjct: 188 IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 81.3 bits (200), Expect = 6e-17
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 13/206 (6%)

Query: 273 RIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IG+G  GTVY A  +  G  VAIK+   +Q +  +    +E+ ++ +  + N+V  L  
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
              G+E  ++ E++  G+L    D      +D  Q   +  +    L +LH     Q+IH
Sbjct: 85  YLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQALDFLH---SNQVIH 138

Query: 392 RDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           RD+KS NILL      K+ DFGF A++ P  S R   ST V GT  ++ PE +       
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMV-GTPYWMAPEVVTRKAYGP 194

Query: 451 KSDVYSFGVLLLEILTGRRPVELKRP 476
           K D++S G++ +E++ G  P   + P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 7e-17
 Identities = 64/233 (27%), Positives = 101/233 (43%), Gaps = 69/233 (29%)

Query: 274 IGEGGFGTVYKAQL---EDGLLVAIK--RAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           IG G +G VYKA+    +DG   AIK  +  KEQ+  +      E+ LL ++ H N+V L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 329 LG-FVDKGNERL-------------IIT-------EFVPNGTLREHLDGQYGKTLDFNQR 367
           +  F++  ++ +             II          +P   +         K+L + Q 
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV---------KSLLW-QI 117

Query: 368 LEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT----ESMRAKVADFGFARL------ 417
           L       +G+ YLH      ++HRD+K +NIL+     E    K+ D G ARL      
Sbjct: 118 L-------NGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167

Query: 418 GPMDSDRTHISTKVKGTVGYLDPEYM---KTYQLTTKS-DVYSFGVLLLEILT 466
              D D       V  T+ Y  PE +   + Y   TK+ D+++ G +  E+LT
Sbjct: 168 PLADLD------PVVVTIWYRAPELLLGARHY---TKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 13/206 (6%)

Query: 273 RIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IG+G  GTVY A  +  G  VAI++   +Q +  +    +E+ ++ +  + N+V  L  
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
              G+E  ++ E++  G+L    D      +D  Q   +  +    L +LH     Q+IH
Sbjct: 86  YLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIH 139

Query: 392 RDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           RD+KS NILL      K+ DFGF A++ P  S R+ +     GT  ++ PE +       
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAYGP 195

Query: 451 KSDVYSFGVLLLEILTGRRPVELKRP 476
           K D++S G++ +E++ G  P   + P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENP 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 21/215 (9%)

Query: 268 FSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFEN-LQTEFSSEVELLSKI---DH 322
           + P   IG G +GTVYKA+    G  VA+K  + +  E+ L      EV LL ++   DH
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 323 RNLVKLLGF-----VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHG 377
            N+V+L+        D+  +  ++ E V +  LR +LD      L      ++      G
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120

Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIS-TKVKGTVG 436
           L +LH      I+HRD+K  NIL+T   + K+ADFG AR+         ++ T V  T+ 
Sbjct: 121 LDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIY-----SCQMALTPVVVTLW 172

Query: 437 YLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPV 471
           Y  PE +      T  D++S G +  E+   R+P+
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 20/208 (9%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEV-------ELLSKIDHRNL 325
           +G+G FG VY    ++ G  +A   AK+ QF+    E S EV       +LL  + H  +
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELA---AKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 326 VKLLGFV-DKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
           V+  G + D+  + L I  E++P G++++ L   YG   +   R +    +  G++YLH 
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA-YGALTESVTR-KYTRQILEGMSYLH- 123

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEY 442
                I+HRD+K +NIL   +   K+ DFG + RL  +    T I + V GT  ++ PE 
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPEV 180

Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +       K+DV+S G  ++E+LT + P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 79.1 bits (196), Expect = 2e-16
 Identities = 52/150 (34%), Positives = 83/150 (55%), Gaps = 14/150 (9%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS--EVELLSKI-DHRNLVKL 328
           ++G+G FG+VY A+  E G LVAIK+ KK +F + + E  +  EV+ L K+ +H N+VKL
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKK-KFYSWE-ECMNLREVKSLRKLNEHPNIVKL 63

Query: 329 LG-FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
              F +  +E   + E++  G L + +  + GK    +    I   +  GL ++H    K
Sbjct: 64  KEVFREN-DELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH----K 117

Query: 388 Q-IIHRDVKSSNILLTESMRAKVADFGFAR 416
               HRD+K  N+L++     K+ADFG AR
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 69/209 (33%), Positives = 102/209 (48%), Gaps = 24/209 (11%)

Query: 274 IGEGGFGTVYKAQL-EDGLLVAIKRAKK------EQFENLQTEFSSEVELLSKIDHRNLV 326
           +G+G FG V  A+L     L A+K  KK      +  E   TE    + L  K  H  L 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTE-KRVLALAGK--HPFLT 59

Query: 327 KLLG-FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +L   F  K  +RL  + E+V  G L  H+  + G+  D  +    A ++  GL +LH  
Sbjct: 60  QLHSCFQTK--DRLFFVMEYVNGGDLMFHIQ-RSGR-FDEPRARFYAAEIVLGLQFLH-- 113

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            E+ II+RD+K  N+LL      K+ADFG  + G +    T   +   GT  Y+ PE + 
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEIL- 168

Query: 445 TYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           +YQ    + D ++ GVLL E+L G+ P E
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 30/210 (14%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN----LQTEFSSEVELLSKIDHRNLVKL 328
           IGEG +G V  A     G+ VAIK  K   FE+     +T    E+++L +  H N++ +
Sbjct: 13  IGEGAYGMVCSATHKPTGVKVAIK--KISPFEHQTFCQRT--LREIKILRRFKHENIIGI 68

Query: 329 L-----GFVDKGNERLIITEFVPNGTLR----EHLDGQYGKTLDFNQRLEIAIDVAHGLT 379
           L        +  N+  I+ E +     +    +HL   + +   + Q L        GL 
Sbjct: 69  LDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY-QILR-------GLK 120

Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLD 439
           Y+H      ++HRD+K SN+LL  +   K+ DFG AR+   + D T   T+   T  Y  
Sbjct: 121 YIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 440 PEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
           PE M   +  TK+ D++S G +L E+L+ R
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 66/288 (22%), Positives = 123/288 (42%), Gaps = 41/288 (14%)

Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +GE  FG VYK  L      E    VAIK  K +    L+ EF  E  + S++ H N+V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL--------------DGQYGKTLDFNQRLEIAID 373
           LLG V K     +I  +  +  L E L              D     TL+    + I   
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
           +A G+ +L   +   ++H+D+ + N+L+ + +  K++D G  R     +D   +      
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR-EVYAADYYKLMGNSLL 188

Query: 434 TVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNE 492
            + ++ PE +   + +  SD++S+GV+L E+ + G +P                +  Y+ 
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP----------------YCGYSN 232

Query: 493 GNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            ++++M+          +    ++ L ++C     + RP  K +  +L
Sbjct: 233 QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 79.0 bits (194), Expect = 3e-16
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)

Query: 273 RIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTE-----FSSEVELLSKIDHRNLV 326
           +IG+G  GTV+ A  +  G  VAIK+       NLQ +       +E+ ++ ++ + N+V
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQI------NLQKQPKKELIINEILVMKELKNPNIV 79

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
             L     G+E  ++ E++  G+L    D      +D  Q   +  +    L +LH    
Sbjct: 80  NFLDSFLVGDELFVVMEYLAGGSLT---DVVTETCMDEAQIAAVCRECLQALEFLH---A 133

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            Q+IHRD+KS N+LL      K+ DFGF A++ P  S R   ST V GT  ++ PE +  
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR---STMV-GTPYWMAPEVVTR 189

Query: 446 YQLTTKSDVYSFGVLLLEILTGRRPVELKRP 476
                K D++S G++ +E++ G  P   + P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 19/205 (9%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQ-FENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +IGEG +G VYKA+    G +VA+K+ + E   E + +    E+ LL +++H N+V+LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            V   N+  ++ EF+ +  L++++D      LD          +  G+ Y H     +++
Sbjct: 66  VVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVL 121

Query: 391 HRDVKSSNILLTESMRAKVADFGFAR-LG-PMDSDRTHISTKVKGTVGYLDPEYM---KT 445
           HRD+K  N+L+      K+ADFG AR  G P+   RT+    V  T+ Y  PE +   + 
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGVPV---RTYTHEVV--TLWYRAPEILLGSRQ 176

Query: 446 YQLTTKSDVYSFGVLLLEILTGRRP 470
           Y  +T  D++S G +  E++  RRP
Sbjct: 177 Y--STPVDIWSIGCIFAEMVN-RRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 71/240 (29%), Positives = 107/240 (44%), Gaps = 51/240 (21%)

Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKR----AKKEQFENLQTEFSSEVELLS 318
             R++    ++GEG FG VYKA Q++ G +VA+K+     +K+ F    T    E+++L 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFP--ITALR-EIKILK 62

Query: 319 KIDHRNLVKLLGFV-----DKGNERLIITEFVP------NGTL---REHLDGQYGKTLDF 364
           K+ H N+V L+            +R  +    P      +G L      L     K    
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY-M 121

Query: 365 NQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL------- 417
            Q LE       G+ YLH   E  I+HRD+K++NIL+      K+ADFG AR        
Sbjct: 122 LQLLE-------GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171

Query: 418 ---GPMDSDRTHISTKVKGTVGYLDPEYM---KTYQLTTKSDVYSFGVLLLEILTGRRPV 471
              G     R + +  V  T  Y  PE +   + Y  TT  D++  G +  E+ T RRP+
Sbjct: 172 PKGGGGGGTRKYTNLVV--TRWYRPPELLLGERRY--TTAVDIWGIGCVFAEMFT-RRPI 226

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 15/216 (6%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSS--EVELLSKIDHRNLVKLLG 330
           +G+GGFG V   Q+   G + A K+ +K++ +  + E  +  E ++L K++ R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
             +  +   ++   +  G L+ H+        +  + +  A ++  GL  LH   +++I+
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIV 124

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           +RD+K  NILL +    +++D G A   P       I  +V GTVGY+ PE +K  + T 
Sbjct: 125 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRV-GTVGYMAPEVVKNERYTF 180

Query: 451 KSDVYSFGVLLLEILTGRRPVE-----LKRPPEERV 481
             D ++ G LL E++ G+ P +     +KR   ER+
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL 216

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 78.2 bits (192), Expect = 4e-16
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 20/208 (9%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEV-------ELLSKIDHRNL 325
           +G+G FG VY     D G  +A+K+    QF+    E S EV       +LL  + H  +
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQV---QFDPESPETSKEVNALECEIQLLKNLLHERI 66

Query: 326 VKLLGFVDKGNERL--IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
           V+  G +    ER   I  E +P G++++ L   YG  L  N   +    +  G++YLH 
Sbjct: 67  VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS-YG-ALTENVTRKYTRQILEGVSYLH- 123

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEY 442
                I+HRD+K +NIL       K+ DFG + RL  +    T + + V GT  ++ PE 
Sbjct: 124 --SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPEV 180

Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +       K+D++S G  ++E+LT + P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 13/210 (6%)

Query: 267 NFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFS--SEVELLSKIDHR 323
           NF    +IG G F  VY+A  L DG+ VA+K+ +     + +       E++LL +++H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLRE---HLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
           N++K      + NE  I+ E    G L     H   Q  + +      +  + +   L +
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-RLIPEKTVWKYFVQLCSALEH 121

Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
           +H    ++++HRD+K +N+ +T +   K+ D G   LG   S +T  +  + GT  Y+ P
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLG---LGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           E +       KSD++S G LL E+   + P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 78.7 bits (194), Expect = 5e-16
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 27/207 (13%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKR---AKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY A+ +    +VAIK+   + K+  E  Q +   EV  L ++ H N ++  
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ-DIIKEVRFLQQLRHPNTIEYK 81

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI---DVAHGLTYLHLYAE 386
           G   + +   ++ E+   G+  + L+  + K L   Q +EIA        GL YLH +  
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDILE-VHKKPL---QEVEIAAICHGALQGLAYLHSH-- 134

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEY---M 443
            + IHRD+K+ NILLTE    K+ADFG A L  +    + +     GT  ++ PE    M
Sbjct: 135 -ERIHRDIKAGNILLTEPGTVKLADFGSASL--VSPANSFV-----GTPYWMAPEVILAM 186

Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
              Q   K DV+S G+  +E L  R+P
Sbjct: 187 DEGQYDGKVDVWSLGITCIE-LAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 78.2 bits (192), Expect = 5e-16
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 25/213 (11%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH-RNLVKLLG- 330
           +G G +G VYK + ++ G L AIK       E  + E   E+ +L K  H RN+    G 
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 331 FVDKG-----NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           F+ K      ++  ++ EF   G++ + +    G TL       I  ++  GL++LH   
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 128

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM-- 443
           + ++IHRD+K  N+LLTE+   K+ DFG +    +D      +T + GT  ++ PE +  
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI-GTPYWMAPEVIAC 185

Query: 444 -----KTYQLTTKSDVYSFGVLLLEILTGRRPV 471
                 TY    KSD++S G+  +E+  G  P+
Sbjct: 186 DENPDATYDF--KSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 78.4 bits (193), Expect = 7e-16
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 12/203 (5%)

Query: 274 IGEGGFGTVYKAQL-EDGLLVAIKRAKKE---QFENLQTEFSSEVELLSKIDHRNLVKLL 329
           +G+G FG V  A+L E G L A+K  KK+   Q ++++   + +  L    +H  L +L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
                 +    + EFV  G L  H+  Q  +  D  +    A ++   L +LH   +K I
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLH---DKGI 117

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           I+RD+K  N+LL      K+ADFG  + G  +   T   +   GT  Y+ PE ++     
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT---STFCGTPDYIAPEILQEMLYG 174

Query: 450 TKSDVYSFGVLLLEILTGRRPVE 472
              D ++ GVLL E+L G  P E
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 77.5 bits (191), Expect = 8e-16
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 22/206 (10%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSS--EVELLSKIDHRNLVKL-L 329
           +G+GGFG V   Q++  G + A K+  K++ +  + E  +  E ++L K+  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F  K +  L++T  +  G L+ H+           + +  A  +  GL +LH   +++I
Sbjct: 61  AFETKDDLCLVMT-LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-----GTVGYLDPEYMK 444
           ++RD+K  N+LL +    +++D G A           +    K     GT GY+ PE ++
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA---------VELKGGKKIKGRAGTPGYMAPEVLQ 167

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRP 470
                   D ++ G  L E++ GR P
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 77.7 bits (191), Expect = 8e-16
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 25/213 (11%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH-RNLVKLLG- 330
           +G G +G VYK + ++ G L AIK    +  E+ + E   E+ +L K  H RN+    G 
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 331 FVDKG-----NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           F+ K      ++  ++ EF   G++ + +    G  L  +    I  ++  GL +LH + 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH- 140

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM-- 443
             ++IHRD+K  N+LLTE+   K+ DFG +    +D      +T + GT  ++ PE +  
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI-GTPYWMAPEVIAC 195

Query: 444 -----KTYQLTTKSDVYSFGVLLLEILTGRRPV 471
                 TY    +SD++S G+  +E+  G  P+
Sbjct: 196 DENPDATYDY--RSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 77.7 bits (191), Expect = 9e-16
 Identities = 71/286 (24%), Positives = 128/286 (44%), Gaps = 31/286 (10%)

Query: 266 RNFSPSLRIGEGGFGTVYKAQ-LEDG-LLVAIKRAK-KEQFENLQTEFSSEVELLSKID- 321
           + +     IGEG +G V+KA+ L++G   VA+KR + +   E +      EV +L  ++ 
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 322 --HRNLVKLLGF-----VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
             H N+V+L         D+  +  ++ E V +  L  +LD      +      ++   +
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL 119

Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT 434
             GL +LH +   +++HRD+K  NIL+T S + K+ADFG AR+           T V  T
Sbjct: 120 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALTSVVVT 172

Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN 494
           + Y  PE +      T  D++S G +  E+   R+P+       +++           G 
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQL-----------GK 220

Query: 495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
           +LD++    +E    ++         + A PI     D+  +G+ L
Sbjct: 221 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL 266

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 67/206 (32%), Positives = 92/206 (44%), Gaps = 21/206 (10%)

Query: 274 IGEGGFGTVYKAQL-EDGLLVAIKRAKKE------QFENLQTEFSSEVELLSKIDHRNLV 326
           +G G FG V  A+  + G L AIK  KK       + E+L  E     E  +   H  LV
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCE-KRIFETANSERHPFLV 65

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI--AIDVAHGLTYLHLY 384
            L       +    + E+   G L  H+      T  F++   +  A  V  GL YLH  
Sbjct: 66  NLFACFQTEDHVCFVMEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVVLGLQYLH-- 118

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            E +I++RD+K  N+LL      K+ADFG  + G    DRT  ST   GT  +L PE + 
Sbjct: 119 -ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FCGTPEFLAPEVLT 174

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRP 470
               T   D +  GVL+ E+L G  P
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 15/216 (6%)

Query: 272 LRIGEGGFGTVYKA-QLEDGLLVAIKRA--KKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           ++IGEG  G V  A +   G  VA+K    +K+Q   L     +EV ++    H+N+V++
Sbjct: 27  IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL---LFNEVVIMRDYQHQNVVEM 83

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                 G E  ++ EF+  G L + +       L+  Q   +   V   L YLH    + 
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLH---SQG 137

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           +IHRD+KS +ILLT   R K++DFGF      D  +      + GT  ++ PE +     
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKSLVGTPYWMAPEVISRTPY 194

Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR 484
            T+ D++S G++++E++ G  P     P +    LR
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 230

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 58/223 (26%), Positives = 108/223 (48%), Gaps = 15/223 (6%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSS--EVELLSKIDHRNLVKLLG 330
           +G+GGFG V   Q+   G + A KR +K++ +  + E  +  E ++L K++ + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
             +  +   ++   +  G L+ H+        +  + L  A ++  GL  LH    +  +
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTV 124

Query: 391 HRDVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +RD+K  NILL +    +++D G A ++   +S R  +     GTVGY+ PE +   + T
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-----GTVGYMAPEVLNNQRYT 179

Query: 450 TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE 492
              D +  G L+ E++ G+ P    R  +E+V      +R  E
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPF---RGRKEKVKREEVDRRVLE 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 69/233 (29%), Positives = 107/233 (45%), Gaps = 22/233 (9%)

Query: 253 SVHLNMSQVVKATRNFSPSLRIGEGGFGTVYK-AQLEDGLLVAIKRAKKEQFENLQTEFS 311
           S  L +  +   T  +     IG+G +G VYK    +DG L A+K    +   ++  E  
Sbjct: 9   SSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL--DPISDVDEEIE 66

Query: 312 SEVELLSKI-DHRNLVKLLGFVDK-----GNERLIITEFVPNGTLREHLDG--QYGKTLD 363
           +E  +L  + +H N+VK  G   K     G +  ++ E    G++ E + G    G+ LD
Sbjct: 67  AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126

Query: 364 FNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
                 I      GL +LH     +IIHRDVK +NILLT     K+ DFG +    + S 
Sbjct: 127 EAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTST 181

Query: 424 RTHISTKVKGTVGYLDPEYMKT-----YQLTTKSDVYSFGVLLLEILTGRRPV 471
           R   +T V GT  ++ PE +       Y    + DV+S G+  +E+  G  P+
Sbjct: 182 RLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 66/225 (29%), Positives = 108/225 (48%), Gaps = 16/225 (7%)

Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL 325
           +F     +G G  G V K Q +  GL++A K    E    ++ +   E+++L + +   +
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           V   G      E  I  E +  G+L + L  +  K +      +++I V  GL YL    
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLR--E 121

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM-DSDRTHISTKVKGTVGYLDPEYMK 444
           + QI+HRDVK SNIL+      K+ DFG +  G + DS    ++    GT  Y+ PE ++
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS----MANSFVGTRSYMSPERLQ 175

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
               + +SD++S G+ L+E+  GR P+    PP +   L   F R
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYPI----PPPDAKELEAIFGR 216

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 62/210 (29%), Positives = 114/210 (54%), Gaps = 20/210 (9%)

Query: 267 NFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL 325
           NF    ++GEG + TVYK +    G +VA+K    +  E   +    E+ L+ ++ H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
           V+L   +   N+ +++ E++ +  L++++D  G  G  LD N        +  G+ + H 
Sbjct: 61  VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRG-ALDPNTVKSFTYQLLKGIAFCH- 117

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LG-PMDSDRTHISTKVKGTVGYLDPE 441
             E +++HRD+K  N+L+ +    K+ADFG AR  G P+++     S +V  T+ Y  P+
Sbjct: 118 --ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT----FSNEVV-TLWYRAPD 170

Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   +TY  +T  D++S G ++ E++TGR
Sbjct: 171 VLLGSRTY--STSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 28/215 (13%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKK------EQFENLQTEFSSEVELLSKIDHRNLV 326
           I +G FG+VY A+    G   AIK  KK       Q  N++ E      ++ + +   + 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE---RAIMMIQGESPYVA 60

Query: 327 KLLGFVDKGNERLIITEFVPNG---TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
           KL       +   ++ E++  G   +L + L G     L  +   +   +V  G+  LH 
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG-----LPEDWAKQYIAEVVLGVEDLH- 114

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
             ++ IIHRD+K  N+L+ ++   K+ DFG +R G         + K  GT  YL PE +
Sbjct: 115 --QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG-------LENKKFVGTPDYLAPETI 165

Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPE 478
                   SD +S G ++ E L G  P   + P  
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 19/206 (9%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAK-KEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +IGEG +GTV+KA+  E   +VA+KR +  +  E + +    E+ LL ++ H+N+V+L  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            +    +  ++ E+  +  L+++ D   G  +D          +  GL + H      ++
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCH---SHNVL 121

Query: 391 HRDVKSSNILLTESMRAKVADFGFAR-LG-PMDSDRTHISTKVKGTVGYLDPEYM---KT 445
           HRD+K  N+L+ ++   K+ADFG AR  G P+       S +V  T+ Y  P+ +   K 
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRC----YSAEVV-TLWYRPPDVLFGAKL 176

Query: 446 YQLTTKSDVYSFGVLLLEILTGRRPV 471
           Y  +T  D++S G +  E+    RP+
Sbjct: 177 Y--STSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 25/216 (11%)

Query: 267 NFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL----QTEFSSEVELLSKID 321
           NF    +IG G F  VY+A  L D   VA+K  K + FE +    + +   E++LL +++
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALK--KVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL-------EIAIDV 374
           H N++K L    + NE  I+ E    G L + +     K     +RL       +  + +
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMI-----KYFKKQKRLIPERTVWKYFVQL 115

Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT 434
              + ++H    ++++HRD+K +N+ +T +   K+ D G   LG   S +T  +  + GT
Sbjct: 116 CSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLG---LGRFFSSKTTAAHSLVGT 169

Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
             Y+ PE +       KSD++S G LL E+   + P
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 45/126 (35%), Positives = 67/126 (53%), Gaps = 13/126 (10%)

Query: 369 EIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM-DSDRTHI 427
           +I+I V  GLTYL    + +I+HRDVK SNIL+      K+ DFG +  G + DS    +
Sbjct: 103 KISIAVLRGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS----M 154

Query: 428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF 487
           +    GT  Y+ PE ++    T +SD++S G+ L+E+  GR P+    PP +   L   F
Sbjct: 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI----PPPDAKELEAMF 210

Query: 488 KRYNEG 493
            R    
Sbjct: 211 GRPVSE 216

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 58/199 (29%), Positives = 104/199 (52%), Gaps = 12/199 (6%)

Query: 273 RIGEGGFGTVYK--AQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           ++GEG + TVYK  ++L D L VA+K  + E  E        EV LL  + H N+V L  
Sbjct: 13  KLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            +       ++ E++ +  L+++LD   G +++ +        +  GL Y H    ++++
Sbjct: 72  IIHTEKSLTLVFEYL-DKDLKQYLD-DCGNSINMHNVKLFLFQLLRGLNYCH---RRKVL 126

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE-YMKTYQLT 449
           HRD+K  N+L+ E    K+ADFG AR   + + +T+ +  V  T+ Y  P+  + +   +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSNEVV--TLWYRPPDILLGSTDYS 183

Query: 450 TKSDVYSFGVLLLEILTGR 468
           T+ D++  G +  E+ TGR
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 57/198 (28%), Positives = 103/198 (52%), Gaps = 10/198 (5%)

Query: 273 RIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++GEG + TV+K + +    LVA+K  + E  E        EV LL  + H N+V L   
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           +       ++ E++ +  L+++LD   G  +  +        +  GL+Y H   +++I+H
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYLD-NCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILH 126

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE-YMKTYQLTT 450
           RD+K  N+L+ E    K+ADFG AR   + + +T+ +  V  T+ Y  P+  + + + +T
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYSNEVV--TLWYRPPDVLLGSTEYST 183

Query: 451 KSDVYSFGVLLLEILTGR 468
             D++  G +L E+ TGR
Sbjct: 184 PIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 58/237 (24%), Positives = 92/237 (38%), Gaps = 54/237 (22%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS----EVELLSKIDHRNLVK 327
            IG G FG V+  +  + G + A+K  +K     ++    +    E ++L+  D   +VK
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM--IKRNQIAHVRAERDILADADSPWIVK 65

Query: 328 LL-GFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLD------FNQRLEIAIDVAHGLT 379
           L   F D+  E L ++ E++P G L   L  +            +   L +A+D  H L 
Sbjct: 66  LYYSFQDE--EHLYLVMEYMPGGDLMNLLI-RKD-VFPEETARFYIAELVLALDSVHKLG 121

Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA------------------------ 415
           +         IHRD+K  NIL+      K+ADFG                          
Sbjct: 122 F---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 416 --RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
                     R   +    GT  Y+ PE ++      + D +S GV+L E+L G  P
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 76.0 bits (187), Expect = 5e-15
 Identities = 65/201 (32%), Positives = 96/201 (47%), Gaps = 16/201 (7%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENL--QTEFSSEVELLSKIDHRNLVKLL- 329
           +G G FG V  A+ +  G   AIK  KK +   +      + E  +L ++ H  +V ++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D+ N    + EFV  G L  HL  + G+  +   +   A ++     YLH    K I
Sbjct: 86  SFQDE-NRVYFLLEFVVGGELFTHLR-KAGRFPNDVAKFYHA-ELVLAFEYLH---SKDI 139

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           I+RD+K  N+LL      KV DFGFA+  P   DRT     + GT  YL PE +++    
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDFGFAKKVP---DRTF---TLCGTPEYLAPEVIQSKGHG 193

Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D ++ GVLL E + G  P
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 30/226 (13%)

Query: 276 EGGFGTVYKAQLEDGLL-----VAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           EG FG ++   L D        V +K  K    E   T    E  LL  + H+N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 331 FVDKGNERLIITEFVPN-GTLREHL------DGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
              +  E   +     N G L+  L      +    + L   Q + +AI +A G++YLH 
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMD----SDRTHISTKVKGTVGYL 438
             ++ +IH+D+ + N ++ E ++ K+ D   +R L PMD     D  +   K      ++
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK------WM 186

Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP-VELKRPPEERVT 482
             E +   + ++ SDV+SFGVLL E++T G+ P VE+   P E   
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAA 230

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 74.5 bits (183), Expect = 7e-15
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)

Query: 274 IGEGGFGTVYKAQLEDGLLVA---IKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           IG G FG V   +   G+  A   +K  +     + Q  F  EV+   +++H N+++ LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR---LEIAIDVAHGLTYLHLYAEK 387
              +    L++ EF P G L+ +L    G      Q+     +A +VA GL +LH   + 
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG--YLDPEYM-- 443
             IH D+   N  LT  +  K+ D+G A L     D  +  TK    V   +L PE +  
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPED--YYITKDCHAVPLRWLAPELVEI 176

Query: 444 -----KTYQLTTKSDVYSFGVLLLEILT-GRRP 470
                     T KS+++S GV + E+ T   +P
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 74.7 bits (183), Expect = 9e-15
 Identities = 55/197 (27%), Positives = 103/197 (52%), Gaps = 10/197 (5%)

Query: 273 RIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++GEG + TVYK + + +G LVA+K  + ++ E        E  LL  + H N+V L   
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           +       ++ E+V +  L +++D   G     N +L     +  GL+Y+H   ++ I+H
Sbjct: 72  IHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKL-FLFQLLRGLSYIH---QRYILH 126

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE-YMKTYQLTT 450
           RD+K  N+L++++   K+ADFG AR   + S   H  +    T+ Y  P+  + + + +T
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPS---HTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 451 KSDVYSFGVLLLEILTG 467
             D++  G + +E++ G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 81/264 (30%), Positives = 124/264 (46%), Gaps = 47/264 (17%)

Query: 274 IGEGGFGTVY---KAQLED-GLLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHRNLV 326
           +G+G FG V+   K    D G L A+K  KK      + ++T+   E ++L++++H  +V
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM--ERDILAEVNHPFIV 61

Query: 327 KL-LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD----FNQRLEIAIDVAHGLTYL 381
           KL   F  +G   LI+ +F+  G L   L  +   T +    +   L +A+D  H L   
Sbjct: 62  KLHYAFQTEGKLYLIL-DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG-- 118

Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
                  II+RD+K  NILL E    K+ DFG ++   +D ++   S    GTV Y+ PE
Sbjct: 119 -------IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYS--FCGTVEYMAPE 168

Query: 442 YMKTYQLTTKSDVYSFGVLLLEILTGRRPVE---------------LKRP----PEERVT 482
            +     T  +D +SFGVL+ E+LTG  P +               L  P    PE +  
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 228

Query: 483 LRWAFKRYNEGNLLDMVDPSIKEV 506
           LR  FKR N  N L      ++E+
Sbjct: 229 LRALFKR-NPANRLGAGPDGVEEI 251

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 12/199 (6%)

Query: 273 RIGEGGFGTVYK--AQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           ++GEG + TV+K  ++L + L VA+K  + E  E        EV LL  + H N+V L  
Sbjct: 13  KLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            V       ++ E++ +  L++++D   G  +  +        +  GL Y H    ++++
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMD-DCGNIMSMHNVKIFLYQILRGLAYCH---RRKVL 126

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE-YMKTYQLT 449
           HRD+K  N+L+ E    K+ADFG AR   + + +T+ +  V  T+ Y  P+  + + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPT-KTYSNEVV--TLWYRPPDVLLGSSEYS 183

Query: 450 TKSDVYSFGVLLLEILTGR 468
           T+ D++  G +  E+ +GR
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 59/235 (25%), Positives = 109/235 (46%), Gaps = 26/235 (11%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSS--EVELLSKIDHRNLVKLLG 330
           +G+GGFG V   Q+   G + A K+ +K++ +  + E  +  E  +L K++ R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
             +  +   ++   +  G L+ H+        D  + +  A ++  GL  L     ++I+
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIV 124

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           +RD+K  NILL +    +++D G A   P   +   +  +V GTVGY+ PE +   + T 
Sbjct: 125 YRDLKPENILLDDRGHIRISDLGLAVQIP---EGETVRGRV-GTVGYMAPEVINNEKYTF 180

Query: 451 KSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE 505
             D +  G L+ E++ G+ P                F++  E    + VD  +KE
Sbjct: 181 SPDWWGLGCLIYEMIQGQSP----------------FRKRKERVKREEVDRRVKE 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 21/210 (10%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G G  G V+ A   D    VA+K+      ++++     E++++ ++DH N+VK+   +
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVYEVL 71

Query: 333 DKGNERL-----IITEFVPNGTLREHLDGQYGKTLDFNQRLE-----IAIDVAHGLTYLH 382
                 L      +TE      ++E+++      L+     E         +  GL Y+H
Sbjct: 72  GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIH 131

Query: 383 LYAEKQIIHRDVKSSNILL-TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG--YLD 439
                 ++HRD+K +N+ + TE +  K+ DFG AR+  +D   +H     +G V   Y  
Sbjct: 132 ---SANVLHRDLKPANVFINTEDLVLKIGDFGLARI--VDPHYSHKGYLSEGLVTKWYRS 186

Query: 440 PEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
           P  + +    TK+ D+++ G +  E+LTG+
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 68/220 (30%), Positives = 98/220 (44%), Gaps = 43/220 (19%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFEN-LQTEFSSEVELLSKID---HRNLVK 327
            IGEG +GTVYKA+ L  G  VA+K+ +    E  +      E+ LL +++   H N+V+
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65

Query: 328 LLG---FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL----------EIAIDV 374
           LL          E  +   F       EH+D Q     D    L          E   D+
Sbjct: 66  LLDVCHGPRTDRELKLTLVF-------EHVD-Q-----DLATYLSKCPKPGLPPETIKDL 112

Query: 375 AH----GLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
                 G+ +LH +    I+HRD+K  NIL+T   + K+ADFG AR+   +       T 
Sbjct: 113 MRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL----TS 165

Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           V  T+ Y  PE +      T  D++S G +  E L  RRP
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAE-LFRRRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 12/201 (5%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHRNLVKLL 329
           +G+G FG V+ A+L+      AIK  KK+     ++++     +  L    +H  L  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
                      + E++  G L  H+  Q     D  +    A ++  GL +LH    K I
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLH---SKGI 117

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           ++RD+K  NILL      K+ADFG  +   +   +T       GT  Y+ PE +   +  
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAPEILLGQKYN 174

Query: 450 TKSDVYSFGVLLLEILTGRRP 470
           T  D +SFGVLL E+L G+ P
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 18/215 (8%)

Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENL-QTE-FSSEVELLSKIDHR 323
           +      +G G FG V+  +        A+K     +   L Q +   +E  +L ++ H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHL--DGQYGKTLDFNQRLEIAIDVAHGLTYL 381
            +++L           ++ E+VP G L  +L   G++  +      L  A ++   L YL
Sbjct: 62  FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG----LFYASEIVCALEYL 117

Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H    K+I++RD+K  NILL +    K+ DFGFA+      DRT     + GT  YL PE
Sbjct: 118 H---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK---KLRDRTW---TLCGTPEYLAPE 168

Query: 442 YMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRP 476
            +++       D ++ G+L+ E+L G  P     P
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 69/208 (33%), Positives = 102/208 (49%), Gaps = 29/208 (13%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKR---AKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY A       +VA+K+   + K+  E  Q +   EV+ L ++ H N ++  
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQ-DIIKEVKFLQQLKHPNTIEYK 87

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI---DVAHGLTYLHLYAE 386
           G   K +   ++ E+   G+  + L+  + K L   Q +EIA        GL YLH +  
Sbjct: 88  GCYLKEHTAWLVMEYCL-GSASDLLE-VHKKPL---QEVEIAAITHGALQGLAYLHSHN- 141

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARL-GPMDSDRTHISTKVKGTVGYLDPEY--- 442
             +IHRD+K+ NILLTE  + K+ADFG A    P +S          GT  ++ PE    
Sbjct: 142 --MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS--------FVGTPYWMAPEVILA 191

Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           M   Q   K DV+S G+  +E L  R+P
Sbjct: 192 MDEGQYDGKVDVWSLGITCIE-LAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 72.2 bits (178), Expect = 4e-14
 Identities = 60/236 (25%), Positives = 98/236 (41%), Gaps = 29/236 (12%)

Query: 257 NMSQVVKATRNF------SPSLRIGEGGFGTVY--KAQLEDGLLVAIKRAKKEQFENLQT 308
           NM + +     F         L++ +G FG V   K +    L V  K  K + F  +  
Sbjct: 1   NMDKSLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQ-KIIKAKNFNAI-- 57

Query: 309 EFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL 368
           E    V  L K D+ N +KL   V      ++I +++ +G L + L  +    L   +  
Sbjct: 58  EPM--VHQLMK-DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSEAEVK 112

Query: 369 EIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHI 427
           +I   +   L  LH +    IIH D+K  N+L   +  R  + D+G  +           
Sbjct: 113 KIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK-------IIGT 162

Query: 428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTL 483
            +   GT+ Y  PE +K +      D ++ GVL  E+LTG+ P   K   +E + L
Sbjct: 163 PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP--FKEDEDEELDL 216

Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 20/208 (9%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEV-------ELLSKIDHRNL 325
           +G G FG VY     D G  +A+K+     F+    E S EV       +LL  + H  +
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVP---FDPDSQETSKEVNALECEIQLLKNLRHDRI 66

Query: 326 VKLLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
           V+  G +    E+   I  E++P G++++ L   YG  L  N        +  G++YLH 
Sbjct: 67  VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA-YG-ALTENVTRRYTRQILQGVSYLH- 123

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEY 442
                I+HRD+K +NIL   +   K+ DFG + R+  +    T I + V GT  ++ PE 
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEV 180

Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +       K+DV+S    ++E+LT + P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 72.8 bits (178), Expect = 5e-14
 Identities = 72/215 (33%), Positives = 105/215 (48%), Gaps = 31/215 (14%)

Query: 268 FSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKR---AKKEQFENLQTEFSSEVELLSKIDHR 323
           FS    IG G FG VY A+ + +  +VAIK+   + K+  E  Q +   EV  L K+ H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-DIIKEVRFLQKLRHP 75

Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHG----LT 379
           N ++  G   + +   ++ E+   G+  + L+  + K L   Q +EIA  V HG    L 
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLE-VHKKPL---QEVEIAA-VTHGALQGLA 129

Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL-GPMDSDRTHISTKVKGTVGYL 438
           YLH      +IHRDVK+ NILL+E    K+ DFG A +  P +           GT  ++
Sbjct: 130 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX--------FVGTPYWM 178

Query: 439 DPEY---MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            PE    M   Q   K DV+S G+  +E L  R+P
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 58/204 (28%), Positives = 107/204 (52%), Gaps = 14/204 (6%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +IGEG +G VYK +  + G +VA+K+ + E + E + +    E+ LL ++ H N+V L  
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 331 FVDKGNERLIITEFVPNGTLREHLDG-QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            + + +   +I EF+ +  L+++LD    G+ +D          +  G+ + H    +++
Sbjct: 67  VLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRV 122

Query: 390 IHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE-YMKTYQ 447
           +HRD+K  N+L+      K+ADFG AR  G      TH       T+ Y  PE  + + +
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV----TLWYRAPEVLLGSPR 178

Query: 448 LTTKSDVYSFGVLLLEILTGRRPV 471
            +T  D++S G +  E+ T ++P+
Sbjct: 179 YSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 72.4 bits (177), Expect = 6e-14
 Identities = 72/215 (33%), Positives = 109/215 (50%), Gaps = 31/215 (14%)

Query: 268 FSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKR---AKKEQFENLQTEFSSEVELLSKIDHR 323
           F+    IG G FG VY A+ +    +VAIK+   + K+  E  Q +   EV+ L +I H 
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ-DIIKEVKFLQRIKHP 85

Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHG----LT 379
           N ++  G   + +   ++ E+   G+  + L+  + K L   Q +EIA  + HG    L 
Sbjct: 86  NSIEYKGCYLREHTAWLVMEYCL-GSASDLLE-VHKKPL---QEVEIAA-ITHGALQGLA 139

Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL-GPMDSDRTHISTKVKGTVGYL 438
           YLH +    +IHRD+K+ NILLTE  + K+ADFG A +  P +S          GT  ++
Sbjct: 140 YLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS--------FVGTPYWM 188

Query: 439 DPEY---MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            PE    M   Q   K DV+S G+  +E L  R+P
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.4 bits (177), Expect = 7e-14
 Identities = 68/231 (29%), Positives = 114/231 (49%), Gaps = 18/231 (7%)

Query: 267 NFSPSLRIGEGGFGTVYK-AQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL 325
           +F     +G G  G V+K +    GL++A K    E    ++ +   E+++L + +   +
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL-EIAIDVAHGLTYLHLY 384
           V   G      E  I  E +  G+L + L  + G+  +  Q L +++I V  GLTYL   
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE--QILGKVSIAVIKGLTYLR-- 120

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM-DSDRTHISTKVKGTVGYLDPEYM 443
            + +I+HRDVK SNIL+      K+ DFG +  G + DS    ++    GT  Y+ PE +
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS----MANSFVGTRSYMSPERL 174

Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN 494
           +    + +SD++S G+ L+E+  GR P+    PP +   L   F    EG+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPI----PPPDAKELELMFGCPVEGD 221

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 73.4 bits (180), Expect = 8e-14
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 28/215 (13%)

Query: 274 IGEGGFGTV-YKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKL--- 328
           +G G  GTV    ++ DG   A+K    E   E  +    +EV  L   D  ++VK    
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99

Query: 329 LGFVDKGNERLI-----ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
               D  N   +     + ++   G LR+ +  +      F +  E  +     L  +H 
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREH-EAGLLFIQVLLAVHH 158

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG------- 436
              K +IHRD+KS+NILL  +   K+ DFGF++           +  V   VG       
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK---------MYAATVSDDVGRTFCGTP 209

Query: 437 -YLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            Y+ PE  +    + K+D++S GVLL E+LT +RP
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 71.8 bits (176), Expect = 9e-14
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 10/200 (5%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSS--EVELLSKIDHRNLVKLLG 330
           +G+GGFG V   Q+   G + A K+ +K++ +  + E  +  E ++L K++ R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
             +  +   ++   +  G L+ H+        D  + +  A ++  GL  LH    ++I+
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIV 124

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           +RD+K  NILL +    +++D G A   P   +   I  +V GTVGY+ PE +K  + T 
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVEIP---EGETIRGRV-GTVGYMAPEVVKNERYTF 180

Query: 451 KSDVYSFGVLLLEILTGRRP 470
             D +  G L+ E++ G+ P
Sbjct: 181 SPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 23/215 (10%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G+G +G+VYK      G+ +A+K  + E  E+   +   E+++L K     +V   G  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKT-LDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
                  +  E++  G+L +   G      +  +    I   V  GL +L    E  IIH
Sbjct: 69  FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK--EEHNIIH 126

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK------- 444
           RDVK +N+L+  + + K+ DFG +        +T+I     G   Y+ PE +K       
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQN 181

Query: 445 -TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPE 478
            TY  T +SDV+S G+ +LE+  GR P     PPE
Sbjct: 182 PTY--TVQSDVWSLGLSILEMALGRYPY----PPE 210

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 73.1 bits (179), Expect = 1e-13
 Identities = 52/180 (28%), Positives = 93/180 (51%), Gaps = 4/180 (2%)

Query: 312 SEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIA 371
           SE+  L+  DH  +VK        ++ L+I E+   G L + +  +  + L F Q  E+ 
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPF-QEYEVG 172

Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV 431
           +     +  L     ++++HRD+KS+NI L  +   K+ DFGF++    DS    +++  
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK-QYSDSVSLDVASSF 231

Query: 432 KGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN 491
            GT  YL PE  +  + + K+D++S GV+L E+LT  RP   K P +  +  +  + +Y+
Sbjct: 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP--FKGPSQREIMQQVLYGKYD 289

Length = 478

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 27/208 (12%)

Query: 273 RIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +IGEG +G VYKA+       +A+K+ + EQ  E + +    E+ LL ++ H N+V+L  
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIA----IDVAHGLTYLHLYAE 386
            V       ++ E++ +  L++H+D     + DF +   +       +  G+ Y H    
Sbjct: 69  VVHSEKRLYLVFEYL-DLDLKKHMD----SSPDFAKNPRLIKTYLYQILRGIAYCH---S 120

Query: 387 KQIIHRDVKSSNILLTESMRA-KVADFGFAR-LG-PMDSDRTHISTKVKGTVGYLDPEYM 443
            +++HRD+K  N+L+     A K+ADFG AR  G P+   RT     V  T+ Y  PE +
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV---RTFTHEVV--TLWYRAPEIL 175

Query: 444 ---KTYQLTTKSDVYSFGVLLLEILTGR 468
              + Y  +T  D++S G +  E++  +
Sbjct: 176 LGSRHY--STPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 51/146 (34%), Positives = 77/146 (52%), Gaps = 11/146 (7%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           RIG G +G VYKA+ +  G L AIK  K E  E+       E+ ++    H N+V   G 
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSNIVAYFGS 74

Query: 332 VDKGNERLIITEFVPNGTLRE--HLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
             + ++  I  EF   G+L++  H+ G     L  +Q   ++ +   GL YLH    K  
Sbjct: 75  YLRRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLH---SKGK 127

Query: 390 IHRDVKSSNILLTESMRAKVADFGFA 415
           +HRD+K +NILLT++   K+ADFG +
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 45/114 (39%), Positives = 63/114 (55%), Gaps = 13/114 (11%)

Query: 362 LDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD 421
           LD +  L  +  VA G+ +L   A K  IHRDV + N+LLT+   AK+ DFG AR    D
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265

Query: 422 SDRTHISTKVKGT----VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
           S+       VKG     V ++ PE +     T +SDV+S+G+LL EI + G+ P
Sbjct: 266 SNYV-----VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 16/212 (7%)

Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE---QFENLQTEFSSEVELLSKIDH 322
           +F+  + +G+G FG V  A+ +    L AIK  KK+   Q ++++     E  +L+  D 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMV-EKRVLALQDK 59

Query: 323 RNLVKLLGFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
              +  L    +  +RL  + E+V  G L  H+  Q GK  +  Q +  A +++ GL +L
Sbjct: 60  PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGKFKE-PQAVFYAAEISVGLFFL 117

Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H    + II+RD+K  N++L      K+ADFG  +   +D   T       GT  Y+ PE
Sbjct: 118 H---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC---GTPDYIAPE 171

Query: 442 YMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
            +  YQ   KS D +++GVLL E+L G+ P +
Sbjct: 172 II-AYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 12/201 (5%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHRNLVKLL 329
           +G+G FG V  A+L+  G   A+K  KK+     ++++     +  L    ++  L  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
                      + EF+  G L  H+  Q     D  +    A ++  GL +LH    K I
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHI--QDKGRFDLYRATFYAAEIVCGLQFLH---SKGI 117

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           I+RD+K  N++L      K+ADFG  +      +R   ++   GT  Y+ PE ++  + T
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR---ASTFCGTPDYIAPEILQGLKYT 174

Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D +SFGVLL E+L G+ P
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 63/223 (28%), Positives = 94/223 (42%), Gaps = 60/223 (26%)

Query: 274 IGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSS----EVELLSKIDHRNLVKL 328
           +G G +G V  A   + G  VAIK+     F++     +     E+ LL  +DH N++ L
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSA--IHAKRTYRELRLLKHMDHENVIGL 79

Query: 329 LGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFN-----QRLE------ 369
           L              F P  +L +        HL G      D N     Q+L       
Sbjct: 80  LDV------------FTPASSLEDFQDVYLVTHLMGA-----DLNNIVKCQKLSDDHIQF 122

Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +   +  GL Y+H      IIHRD+K SNI + E    K+ DFG AR         H   
Sbjct: 123 LVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR---------HTDD 170

Query: 430 KVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
           ++ G V    Y  PE M  +    ++ D++S G ++ E+LTG+
Sbjct: 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (171), Expect = 5e-13
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 13/201 (6%)

Query: 274 IGEGGFGTVYKAQLEDGLLV-AIKRAKKEQFENLQ--TEFSSEVELLSKIDHRNLVKL-L 329
           IG+G FG V + +  D   + A+K  +K    +    T   +E  +L++++   +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F       L++  F+  G L  HL  + G+      R   A ++   L  LH   +  +
Sbjct: 61  SFQSPEKLYLVLA-FINGGELFHHLQRE-GRFDLSRARFYTA-ELLCALENLH---KFNV 114

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           I+RD+K  NILL       + DFG  +L   D D+T+      GT  YL PE +  +  T
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---GTPEYLAPELLLGHGYT 171

Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D ++ GVLL E+LTG  P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 14/202 (6%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQ-FENLQTEFSSEVE---LLSKIDHRNLVKL 328
           +G+G FG V  A+L+      AIK  KK+   E+   E  + VE   L    +H  L  L
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVE-CTMVERRVLALAWEHPFLTHL 61

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                       + E++  G L  H+  Q     D  +    A ++  GL +LH   +K 
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICGLQFLH---KKG 116

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           II+RD+K  N+LL +    K+ADFG  +   M+ +    ++   GT  Y+ PE +K  + 
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKEN-MNGEGK--ASTFCGTPDYIAPEILKGQKY 173

Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
               D +SFGVLL E+L G+ P
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 25/210 (11%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGF 331
           IG G FGTV K      G ++A+KR +    E  Q     +++++ +  D   +VK  G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL------HLYA 385
           + +  +  I  E      +   LD  Y K +    +  I  ++   +         +L  
Sbjct: 72  LFREGDCWICMEL-----MDISLDKFY-KYVYEVLKSVIPEEILGKIAVATVKALNYLKE 125

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM-DSDRTHIS-TKVKGTVGYLDPEYM 443
           E +IIHRDVK SNILL  +   K+ DFG +  G + DS    I+ T+  G   Y+ PE +
Sbjct: 126 ELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDS----IAKTRDAGCRPYMAPERI 179

Query: 444 KTYQLT---TKSDVYSFGVLLLEILTGRRP 470
                     +SDV+S G+ L E+ TG+ P
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 7e-13
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 10/198 (5%)

Query: 273 RIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++GEG + TVYK + +  G LVA+K  + E  E        E  LL  + H N+V L   
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           +       ++ E++ +  L++++D   G  L  +        +  GL Y H   +++++H
Sbjct: 72  IHTKKTLTLVFEYL-DTDLKQYMD-DCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLH 126

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE-YMKTYQLTT 450
           RD+K  N+L++E    K+ADFG AR   + S +T+ +  V  T+ Y  P+  + + + +T
Sbjct: 127 RDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSNEVV--TLWYRPPDVLLGSTEYST 183

Query: 451 KSDVYSFGVLLLEILTGR 468
             D++  G +  E+ TGR
Sbjct: 184 SLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.8 bits (168), Expect = 7e-13
 Identities = 49/200 (24%), Positives = 97/200 (48%), Gaps = 10/200 (5%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSS--EVELLSKIDHRNLVKLLG 330
           +G+GGFG V   Q+++ G + A K+  K++ +    E  +  E E+L K++   +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
             +      ++   +  G L+ H+     + L+  + +  +  +  G+ +LH      I+
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           +RD+K  N+LL +    +++D G A    ++       T+  GT GY+ PE +K    + 
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLA----VELKDGKTITQRAGTNGYMAPEILKEEPYSY 173

Query: 451 KSDVYSFGVLLLEILTGRRP 470
             D ++ G  + E++ GR P
Sbjct: 174 PVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 68.6 bits (168), Expect = 9e-13
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 22/207 (10%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQ--FENLQTEFSSEVELLSKIDHRNLVKLLG 330
           IG G  G VYK + +  G ++A+K+ ++     EN +     +V L S  D   +VK  G
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH-DCPYIVKCYG 81

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ-I 389
           +    ++  I  E +   T  + L  +    +  +   ++ + +   L YL    EK  +
Sbjct: 82  YFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGV 136

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK----- 444
           IHRDVK SNILL  S   K+ DFG +  G +   +    T+  G   Y+ PE +      
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGIS--GRLVDSKAK--TRSAGCAAYMAPERIDPPDPN 192

Query: 445 -TYQLTTKSDVYSFGVLLLEILTGRRP 470
             Y +  ++DV+S G+ L+E+ TG+ P
Sbjct: 193 PKYDI--RADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 17/204 (8%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIK-----RAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           IG GGFG VY  +  D G + A+K     R K +Q E L       + L+S  D   +V 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           +       ++   I + +  G L  HL  Q+G   +   R   A ++  GL ++H    +
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFSEKEMRF-YATEIILGLEHMH---NR 116

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM-KTY 446
            +++RD+K +NILL E    +++D G A        + H S    GT GY+ PE + K  
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV---GTHGYMAPEVLQKGT 171

Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
              + +D +S G +L ++L G  P
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 68.7 bits (169), Expect = 1e-12
 Identities = 60/223 (26%), Positives = 88/223 (39%), Gaps = 54/223 (24%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSS---------EVELLSKIDHR 323
           IG G +G V  A     G  VAIK+        +   F           E++LL  + H 
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKK--------ISNVFDDLIDAKRILREIKLLRHLRHE 59

Query: 324 NLVKLLG-FVDKGNERL----IITEFVPNGTLREHLDGQYGKTLDFNQ--RLEIAIDVAH 376
           N++ LL        E      I+TE +                 D ++  +    +   H
Sbjct: 60  NIIGLLDILRPPSPEDFNDVYIVTELME---------------TDLHKVIKSPQPLTDDH 104

Query: 377 ----------GLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH 426
                     GL YLH      +IHRD+K SNIL+  +   K+ DFG AR    D D   
Sbjct: 105 IQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161

Query: 427 ISTKVKGTVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
             T+   T  Y  PE + +    TK+ D++S G +  E+LT +
Sbjct: 162 FLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 61/229 (26%), Positives = 102/229 (44%), Gaps = 48/229 (20%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS-------------EVELLSK 319
           +GEG +G V KA     G +VAIK+ K  +  N  T+                E++++++
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 320 IDHRNLVKLLG-FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE------IAI 372
           I H N++ L+  +V+     L++          + +     K +D   RL       I +
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVM----------DIMASDLKKVVDRKIRLTESQVKCILL 126

Query: 373 DVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR--LGPMDSD------- 423
            + +GL  LH +     +HRD+  +NI +      K+ADFG AR    P  SD       
Sbjct: 127 QILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183

Query: 424 ---RTHISTKVKGTVGYLDPE-YMKTYQLTTKSDVYSFGVLLLEILTGR 468
              R  +++KV  T+ Y  PE  M   +     D++S G +  E+LTG+
Sbjct: 184 MQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 50/149 (33%), Positives = 76/149 (51%), Gaps = 17/149 (11%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           R+G G +G VYKA+ L  G L A+K  K E  ++       E+ ++ +  H N+V   G 
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIVAYFGS 74

Query: 332 VDKGNERLIITEFVPNGTLRE--HLDGQYGKTLDFNQRLEIAI---DVAHGLTYLHLYAE 386
                +  I  E+   G+L++  H+ G   +       L+IA    +   GL YLH    
Sbjct: 75  YLSREKLWICMEYCGGGSLQDIYHVTGPLSE-------LQIAYVCRETLQGLAYLH---S 124

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFA 415
           K  +HRD+K +NILLT++   K+ADFG A
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 67/208 (32%), Positives = 101/208 (48%), Gaps = 22/208 (10%)

Query: 274 IGEGGFGTVYKAQLEDGL--LVAIKRAKKE---QFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G+G FG V  A+   G   L AIK  KK+   Q ++++     E  +L+       +  
Sbjct: 8   LGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMV-EKRVLALPGKPPFLTQ 65

Query: 329 LGFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEI--AIDVAHGLTYLHLYA 385
           L    +  +RL  + E+V  G L  H+  Q GK   F +   +  A ++A GL +LH   
Sbjct: 66  LHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGK---FKEPHAVFYAAEIAIGLFFLH--- 118

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K II+RD+K  N++L      K+ADFG  +        T       GT  Y+ PE +  
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---GTPDYIAPEII-A 174

Query: 446 YQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           YQ   KS D ++FGVLL E+L G+ P +
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 10/198 (5%)

Query: 273 RIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++GEG + TVYK     +G LVA+K    +  E +      E  LL  + H N+V L   
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           +        + E++ +  L +++    G    +N RL     +  GL Y+H    + I+H
Sbjct: 72  IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH---GQHILH 126

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE-YMKTYQLTT 450
           RD+K  N+L++     K+ADFG AR   + S +T+ S  V  T+ Y  P+  +     ++
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPS-QTYSSEVV--TLWYRPPDVLLGATDYSS 183

Query: 451 KSDVYSFGVLLLEILTGR 468
             D++  G + +E+L G+
Sbjct: 184 ALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 69.8 bits (170), Expect = 2e-12
 Identities = 68/278 (24%), Positives = 126/278 (45%), Gaps = 75/278 (26%)

Query: 252 GSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-------- 303
           G   LN  +V+K         +IG G FG V+           +K  + ++F        
Sbjct: 8   GESRLNEYEVIK---------KIGNGRFGEVF----------LVKHKRTQEFFCWKAISY 48

Query: 304 ----ENLQTEFSSEVELLSKIDHRNLVKLLG-FVDKGNERL-IITEFVPNGTLREHLDGQ 357
               E  +++   EV ++ ++ H+N+V+ +  F++K N++L I+ EF   G L  ++   
Sbjct: 49  RGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC 108

Query: 358 Y---GKTLDFNQRLEIAIDVAHGLTYLHLYAE----KQIIHRDVKSSNILLTESMR---- 406
           Y   GK ++ +  ++I   + H L Y H   +    ++++HRD+K  NI L+  +R    
Sbjct: 109 YKMFGK-IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167

Query: 407 -------------AKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM--KTYQLTTK 451
                        AK+ DFG ++   ++S    ++    GT  Y  PE +  +T     K
Sbjct: 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDK 223

Query: 452 SDVYSFGVLLLEILTGRRPV-----------ELKRPPE 478
           SD+++ G ++ E+ +G+ P            ELKR P+
Sbjct: 224 SDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPD 261

Length = 1021

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 62/226 (27%), Positives = 93/226 (41%), Gaps = 32/226 (14%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G  G V+  +L+  G L A+K   K++    N      +E E+L+ +DH  L  L  
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
                    ++ ++ P G L   L  Q GK L        A +V   L YLHL     I+
Sbjct: 69  SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIV 125

Query: 391 HRDVKSSNILLTESMRAKVADFGF--------------ARLGPMDSDRTHISTKVK---- 432
           +RD+K  NILL ES    ++DF                 R G   S    I ++      
Sbjct: 126 YRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEP 185

Query: 433 --------GTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
                   GT  Y+ PE +      +  D ++ G+LL E+L G  P
Sbjct: 186 SFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 43/141 (30%), Positives = 72/141 (51%), Gaps = 20/141 (14%)

Query: 354 LDGQYGKTLDFNQRL------EIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRA 407
           LD  Y K  D    +      +IA+ +   L YLH  ++  +IHRDVK SN+L+  + + 
Sbjct: 86  LDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQV 143

Query: 408 KVADFGFARLGPM-DSDRTHISTKVK-GTVGYLDPEY----MKTYQLTTKSDVYSFGVLL 461
           K+ DFG +  G + DS    ++  +  G   Y+ PE     +       KSDV+S G+ +
Sbjct: 144 KLCDFGIS--GYLVDS----VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197

Query: 462 LEILTGRRPVELKRPPEERVT 482
           +E+ TGR P +  + P +++ 
Sbjct: 198 IELATGRFPYDSWKTPFQQLK 218

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGF 331
           IG+G +G V+K    ++G   A+K    +   ++  E  +E  +L  + DH N+VK  G 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 332 -----VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI--DVAHGLTYLHLY 384
                V  G++  ++ E    G++ + + G   +     + +   I  +   GL +LH  
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH-- 141

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
              + IHRDVK +NILLT     K+ DFG +    + S R   +T V GT  ++ PE + 
Sbjct: 142 -VNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSV-GTPFWMAPEVIA 197

Query: 445 TYQ-----LTTKSDVYSFGVLLLEILTGRRPVELKRP 476
             Q        + DV+S G+  +E+  G  P+    P
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 66.9 bits (163), Expect = 5e-12
 Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 32/185 (17%)

Query: 297 RAKKEQFE-------NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGT 349
           RAK+E F          +  F + VE  S++D R        ++ G   ++ + F P+ +
Sbjct: 104 RAKREFFSPYREKSPKQRGRFRAMVEQ-SRVDRR--------IEAGQASVLFSRFQPSTS 154

Query: 350 LR----EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM 405
                 +  D  +   L     +  +  VA G+ +L   A ++ IHRD+ + NILL+E+ 
Sbjct: 155 GSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENN 211

Query: 406 RAKVADFGFARLGPMDSDRTHISTKVKGT----VGYLDPEYMKTYQLTTKSDVYSFGVLL 461
             K+ DFG AR    D D        KG+    + ++ PE +     TT+SDV+SFGVLL
Sbjct: 212 VVKICDFGLARDIYKDPDYVR-----KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLL 266

Query: 462 LEILT 466
            EI +
Sbjct: 267 WEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.1 bits (161), Expect = 5e-12
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 17/204 (8%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIK-----RAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           IG GGFG VY  +  D G + A+K     R K +Q E L       + L+S  D   +V 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           +       ++   I + +  G L  HL  Q+G   +   R   A ++  GL ++H    +
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEAEMRF-YAAEIILGLEHMH---NR 116

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM-KTY 446
            +++RD+K +NILL E    +++D G A        + H S    GT GY+ PE + K  
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV---GTHGYMAPEVLQKGV 171

Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
              + +D +S G +L ++L G  P
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 67.2 bits (164), Expect = 6e-12
 Identities = 44/115 (38%), Positives = 60/115 (52%), Gaps = 13/115 (11%)

Query: 361 TLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM 420
            LD    L  +  VA G+++L   A K  IHRD+ + NILLT     K+ DFG AR    
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266

Query: 421 DSDRTHISTKVKGT----VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
           DS+       VKG     V ++ PE +     T +SDV+S+G+LL EI + G  P
Sbjct: 267 DSNYV-----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 66.8 bits (163), Expect = 6e-12
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 18/207 (8%)

Query: 274 IGEGGFGTVYKAQLEDGLLV-AIKRAKKEQFEN------LQTEFSSEVELLSKIDHRNLV 326
           IG G +  V   +L+    + A+K  KKE   +      +QTE     E  S  +H  LV
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTE-KHVFETAS--NHPFLV 59

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            L       +    + EFV  G L  H+  Q  + L        + +++  L +LH   E
Sbjct: 60  GLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLH---E 114

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + II+RD+K  N+LL      K+ D+G  + G    D T   +   GT  Y+ PE ++  
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRGE 171

Query: 447 QLTTKSDVYSFGVLLLEILTGRRPVEL 473
                 D ++ GVL+ E++ GR P ++
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 66.2 bits (161), Expect = 9e-12
 Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 49/224 (21%)

Query: 266 RNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVELLSKIDH 322
           +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ LL  + H
Sbjct: 20  QNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKH 75

Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRLE----- 369
            N++ LL              F P  +L E        HL G     +   Q+L      
Sbjct: 76  ENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 123

Query: 370 -IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIS 428
            +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR         H  
Sbjct: 124 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---------HTD 171

Query: 429 TKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
            ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 172 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 66.2 bits (161), Expect = 9e-12
 Identities = 62/201 (30%), Positives = 89/201 (44%), Gaps = 12/201 (5%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVE---LLSKIDHRNLVKLL 329
           IG+G FG V  A+ + DG   A+K  +K+   N + +     E   LL  + H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
                  +   + +FV  G L  HL  Q  ++    +    A ++A  L YLH      I
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLH---SINI 117

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           ++RD+K  NILL       + DFG  + G   SD T   T   GT  YL PE ++     
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRKQPYD 174

Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D +  G +L E+L G  P
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 33/223 (14%)

Query: 258 MSQVVKATRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFEN--LQTEFSSEV 314
              V + T  +     +G G FG V  A+    G  VAIK+  K  F    L      E+
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKP-FSTPVLAKRTYREL 60

Query: 315 ELLSKIDHRNLVKLLG-FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE---- 369
           +LL  + H N++ L   F+    +   +TE          L G     L  ++ LE    
Sbjct: 61  KLLKHLRHENIISLSDIFISPLEDIYFVTE----------LLGTDLHRLLTSRPLEKQFI 110

Query: 370 --IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT-H 426
                 +  GL Y+H      ++HRD+K SNIL+ E+   K+ DFG AR    D   T +
Sbjct: 111 QYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR--IQDPQMTGY 165

Query: 427 ISTKVKGTVGYLDPEYMKTYQ-LTTKSDVYSFGVLLLEILTGR 468
           +ST+      Y  PE M T+Q    + D++S G +  E+L G+
Sbjct: 166 VSTRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 32/222 (14%)

Query: 265 TRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSS--EVELLSKID 321
              + P   IG G +G V  A   E    VAIK+     F+N      +  E++LL  +D
Sbjct: 4   DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN-AFDNRIDAKRTLREIKLLRHLD 62

Query: 322 HRNLVKLLGFV-----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE------I 370
           H N++ +   +     +  N+  I+ E          +D    + +  +Q L        
Sbjct: 63  HENVIAIKDIMPPPHREAFNDVYIVYEL---------MDTDLHQIIRSSQTLSDDHCQYF 113

Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
              +  GL Y+H      ++HRD+K SN+LL  +   K+ DFG AR     S++    T+
Sbjct: 114 LYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT---SEKGDFMTE 167

Query: 431 VKGTVGYLDPE-YMKTYQLTTKSDVYSFGVLLLEILTGRRPV 471
              T  Y  PE  +   + TT  DV+S G +  E+L GR+P+
Sbjct: 168 YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 65.6 bits (160), Expect = 4e-11
 Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 44/231 (19%)

Query: 274 IGEGGFGTVYKAQLED---GLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKL 328
           IG+GG G VY A   D      VA+K+ +++  EN  L+  F  E ++ + + H  +V +
Sbjct: 10  IGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 329 LGFVDKGNERLIITEFVPNGTLR--------------EHLDGQYGKTLDFNQRLEIAIDV 374
                 G+       ++   TL+              E  +            L I   +
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF-----LSIFHKI 122

Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD----------- 423
              + Y+H    K ++HRD+K  NILL       + D+G A    ++ +           
Sbjct: 123 CATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179

Query: 424 ----RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
                  I  K+ GT  Y+ PE +     +  +D+Y+ GV+L ++LT   P
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 4/93 (4%)

Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
           VA G+ +L   A ++ IHRD+ + NILL+E+   K+ DFG AR    D D        + 
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGDARL 237

Query: 434 TVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
            + ++ PE +     TT+SDV+SFGVLL EI +
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 12/203 (5%)

Query: 274 IGEGGFGTVYKAQLEDGLLV-AIKRAKKE---QFENLQTEFSSEVELLSKIDHRNLVKLL 329
           +G+G FG V  A+L+    V AIK  KK+   Q +++    + +  L     H  L  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
                 +    + E+V  G L   +  Q  +  D  +    A +V   L +LH +    +
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTLALMFLHRHG---V 117

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           I+RD+K  NILL      K+ADFG  + G ++   T   T   GT  Y+ PE ++  +  
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQELEYG 174

Query: 450 TKSDVYSFGVLLLEILTGRRPVE 472
              D ++ GVL+ E++ G+ P E
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 18/207 (8%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFEN------LQTEFSSEVELLSKIDHRNLV 326
           IG G +  V   +L+    + A+K  KKE   +      +QTE     E  S  +H  LV
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTE-KHVFEQAS--NHPFLV 59

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            L       +    + E+V  G L  H+  Q  + L        + +++  L YLH   E
Sbjct: 60  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---E 114

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + II+RD+K  N+LL      K+ D+G  + G    D T   +   GT  Y+ PE ++  
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGE 171

Query: 447 QLTTKSDVYSFGVLLLEILTGRRPVEL 473
                 D ++ GVL+ E++ GR P ++
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 19/206 (9%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVE--LLSKIDHRNLVKL-L 329
           +G+GGFG V   Q+   G L A K+  K++ +  +    + VE  +L+K+  R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI--AIDVAHGLTYLHLYAEK 387
            F  K +  L++T  +  G LR H+     +   F +         +  GL +LH   ++
Sbjct: 61  AFQTKTDLCLVMT-IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QR 116

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK---GTVGYLDPEYMK 444
           +II+RD+K  N+LL      +++D G A       +     +K K   GT G++ PE ++
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLA------VELKDGQSKTKGYAGTPGFMAPELLQ 170

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRP 470
             +     D ++ GV L E++  R P
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 63.1 bits (154), Expect = 6e-11
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 29/206 (14%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFSSEVELLSKI-DHRNLVKLL 329
           +IGEG F  V KAQ  + G   AIK  KK  F++L Q     E++ L ++  H N+++L+
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCMKK-HFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 330 GFV-DKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
             + D+   RL ++ E + +  L E + G+  + L   +       +   L ++H     
Sbjct: 65  EVLFDRKTGRLALVFELM-DMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMH---RN 119

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFAR----LGPMDSDRTHISTKVKGTVGYLDPEYM 443
            I HRD+K  NIL+ +    K+ADFG  R      P      +IST+      Y  PE +
Sbjct: 120 GIFHRDIKPENILI-KDDILKLADFGSCRGIYSKPPYTE---YISTR-----WYRAPECL 170

Query: 444 KT---YQLTTKSDVYSFGVLLLEILT 466
            T   Y    K D+++ G +  EIL+
Sbjct: 171 LTDGYY--GPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 63.0 bits (153), Expect = 6e-11
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 28/216 (12%)

Query: 274 IGEGGFGTVYKAQLEDGL---LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           IG G FG V   ++  G     V +K  +       Q +F  E +    + H NL++ LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGK---TLDFNQRLEIAIDVAHGLTYLHLYAEK 387
              +    L++ EF P G L+ +L         T D      +A ++A GL +LH   + 
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMD-----SDRTHISTKVKGTVGYLDPEY 442
             IH D+   N LLT  +  K+ D+G +     +      D+  +  +      ++ PE 
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR------WIAPEL 173

Query: 443 MKTYQ-------LTTKSDVYSFGVLLLEILT-GRRP 470
           +            T +S+V+S GV + E+   G +P
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 63.7 bits (155), Expect = 6e-11
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 27/214 (12%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQT--EFSSEVELLSKIDHRNLVKLL- 329
           +G G FG V    +   G + A+K  KK      +T   F  E ++LS  +   + +L  
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68

Query: 330 GFVDKGNERLIITEFVPNGTLREHL---DGQYGKTLD--FNQRLEIAIDVAHGLTYLHLY 384
            F DK N  L++ E+ P G L   L   + Q+ + +   +   L +AI   H + Y    
Sbjct: 69  AFQDKDNLYLVM-EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY---- 123

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
                +HRD+K  N+L+  +   K+ADFG A    + +++   S    GT  Y+ PE + 
Sbjct: 124 -----VHRDIKPENVLIDRTGHIKLADFGSA--ARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 445 TYQLTTKS------DVYSFGVLLLEILTGRRPVE 472
           T     K       D +S GV+  E++ GR P  
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 20/214 (9%)

Query: 267 NFSPSLRIGEGGFGTVYKAQLEDG-LLVAIKRAKKE---QFENLQTEFSSEVELLSKIDH 322
           +F+  + +G+G FG V  A+ +    L AIK  KK+   Q ++++     +  L      
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI--AIDVAHGLTY 380
             L +L       +    + E+V  G L   +  Q G+   F +   +  A ++A GL +
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGR---FKEPHAVFYAAEIAIGLFF 116

Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV-KGTVGYLD 439
           LH    K II+RD+K  N++L      K+ADFG  +    D     ++TK   GT  Y+ 
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFCGTPDYIA 169

Query: 440 PEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           PE +  YQ   KS D ++FGVLL E+L G+ P E
Sbjct: 170 PEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 63.5 bits (154), Expect = 7e-11
 Identities = 68/266 (25%), Positives = 103/266 (38%), Gaps = 77/266 (28%)

Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLV 326
           +G G FG V +A      +      VA+K  K+    +      SE+++L  I H  N+V
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 327 KLLGFVDK-GNERLIITE-----------------FVP----NGTLREHLDGQYGKTLDF 364
            LLG   K G   ++I E                 FVP    +   R+   G    + D 
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134

Query: 365 NQRLE--------------------------------------------IAIDVAHGLTY 380
            +RL+                                             +  VA G+ +
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194

Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
           L   A ++ IHRD+ + NILL+E+   K+ DFG AR    D D        +  + ++ P
Sbjct: 195 L---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGDARLPLKWMAP 250

Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILT 466
           E +     T +SDV+SFGVLL EI +
Sbjct: 251 ETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 41/137 (29%), Positives = 68/137 (49%), Gaps = 12/137 (8%)

Query: 339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSN 398
            ++ E+V  G L  H+  Q  + L        A ++   L +LH   E+ II+RD+K  N
Sbjct: 72  FLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDN 126

Query: 399 ILLTESMRAKVADFGFAR--LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYS 456
           +LL      K+ D+G  +  LGP D+  T       GT  Y+ PE ++  +     D ++
Sbjct: 127 VLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-----GTPNYIAPEILRGEEYGFSVDWWA 181

Query: 457 FGVLLLEILTGRRPVEL 473
            GVL+ E++ GR P ++
Sbjct: 182 LGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 41/157 (26%), Positives = 75/157 (47%), Gaps = 17/157 (10%)

Query: 313 EVELLSKIDHRNLVKLLG-FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIA 371
           E  LL  ++H +++++    V      +++  +  +  L  +L  +    L  +Q L I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY--SSDLYTYLTKRSRP-LPIDQALIIE 163

Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL---GPMDSDRTHIS 428
             +  GL YLH    ++IIHRDVK+ NI + +  +  + D G A+     P         
Sbjct: 164 KQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF------- 213

Query: 429 TKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
             + GTV    PE +   +  +K+D++S G++L E+L
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 44/224 (19%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFS----SEVELLSKIDHRNLVK 327
           +IG+G FG V+KA+  +   +VA+K+      EN +  F      E+++L  + H N+V 
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVL---MENEKEGFPITALREIKILQLLKHENVVN 75

Query: 328 LL---------GFVDKGNERLIITEFVPNGTLREH-LDG--QYGKTLDFNQRLEIAIDVA 375
           L+             KG+  L+  EF       EH L G     K + F    EI   + 
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVF-EFC------EHDLAGLLSN-KNVKFTLS-EIKKVMK 126

Query: 376 H---GLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR--LGPMDSDRTHISTK 430
               GL Y+H     +I+HRD+K++NIL+T+    K+ADFG AR      +S     + +
Sbjct: 127 MLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183

Query: 431 VKGTVGYLDPEYM---KTYQLTTKSDVYSFGVLLLEILTGRRPV 471
           V  T+ Y  PE +   + Y      D++  G ++ E+ T R P+
Sbjct: 184 VV-TLWYRPPELLLGERDY--GPPIDMWGAGCIMAEMWT-RSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 58/239 (24%), Positives = 101/239 (42%), Gaps = 42/239 (17%)

Query: 309 EFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL 368
            F     L+S++ H++LVKL G V   +E +++ E+V  G L   L  +    +  + +L
Sbjct: 47  AFFETASLMSQLSHKHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHRE-KNNVSLHWKL 104

Query: 369 EIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE-------SMRAKVADFGFAR-LGPM 420
           ++A  +A  L YL    +K+++H +V   NIL+             K++D G    +   
Sbjct: 105 DVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161

Query: 421 DSDRTHISTKVKGTVGYLDPEYMKTYQ--LTTKSDVYSFGVLLLEILT-GRRPVELKRPP 477
           +     I         ++ PE ++  Q  LT  +D +SFG  LLEI + G  P+      
Sbjct: 162 EERVERIP--------WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS 213

Query: 478 EERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
           E+        + Y + + L M  P   E+           L  QC       RP  +++
Sbjct: 214 EKE-------RFYQDQHRLPM--PDCAEL---------ANLINQCWTYDPTKRPSFRAI 254

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 61/202 (30%), Positives = 91/202 (45%), Gaps = 14/202 (6%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF--ENLQTEFSSEVE-LLSKIDHRNLVKLL 329
           IG+G FG V  A+   DG   A+K  +K+    +  Q    +E   LL  + H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 330 GFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
            +  +  ++L  + ++V  G L  HL  Q  ++    +    A ++A  L YLH      
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLH---SLN 116

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           II+RD+K  NILL       + DFG  + G   S  T   +   GT  YL PE ++    
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT---STFCGTPEYLAPEVLRKQPY 173

Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
               D +  G +L E+L G  P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 30/216 (13%)

Query: 268 FSPSLRIGEGGFGTVYK-AQLEDGLLVAIKRAKKEQFENLQT--EFSSEVELLSKIDHRN 324
             P   IG G FG V+      DG  VA+K+     F+NL +      E+++L    H N
Sbjct: 2   VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPN-VFQNLVSCKRVFRELKMLCFFKHDN 60

Query: 325 LVKLLGFVDKGN-----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE------IAID 373
           ++  L  +   +     E  ++TE          +     K +   Q L           
Sbjct: 61  VLSALDILQPPHIDPFEEIYVVTEL---------MQSDLHKIIVSPQPLSSDHVKVFLYQ 111

Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
           +  GL YLH      I+HRD+K  N+L+  +   K+ DFG AR+   D +  H++ +V  
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-ESKHMTQEVV- 166

Query: 434 TVGYLDPE-YMKTYQLTTKSDVYSFGVLLLEILTGR 468
           T  Y  PE  M +   T+  D++S G +  E+L  R
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 47/175 (26%), Positives = 78/175 (44%), Gaps = 11/175 (6%)

Query: 312 SEVELLSKIDHRNLVKLL-GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI 370
            E+++L  I HR ++ L+  +  K    +++ ++  +  L  ++D      L   Q + I
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD--LFTYVDRS--GPLPLEQAITI 190

Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHIST 429
              +   L YLH    + IIHRDVK+ NI L E   A + DFG A +L       T    
Sbjct: 191 QRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD--AHPDTPQCY 245

Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR 484
              GT+    PE +       K+D++S G++L E+      +  K+       LR
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLR 300

Length = 392

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 72/249 (28%), Positives = 106/249 (42%), Gaps = 71/249 (28%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKK-EQFENLQTE-FSSEVELLSKIDHRNLVKLL- 329
           IG G FG V   Q +D G + A+K+ +K E  E  Q     +E ++L++ D+  +VKL  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYY 68

Query: 330 GFVDKGNERLIITEFVPNG----------TLREHLDGQY-GKTLDFNQRLEIAIDVAHGL 378
            F D+    LI+ E++P G          T  E     Y  +T+       +AID  H L
Sbjct: 69  SFQDENYLYLIM-EYLPGGDMMTLLMKKDTFTEEETRFYIAETI-------LAIDSIHKL 120

Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFG------------FARL--------- 417
            Y         IHRD+K  N+LL      K++DFG            F R+         
Sbjct: 121 GY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171

Query: 418 -----GPMDSDRTHISTKVK---------GTVGYLDPE-YMKT-YQLTTKSDVYSFGVLL 461
                 PM S R   + K           GT  Y+ PE +++T Y    + D +S GV++
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY--NKECDWWSLGVIM 229

Query: 462 LEILTGRRP 470
            E+L G  P
Sbjct: 230 YEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 24/210 (11%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN-LVKLL 329
           +IGEG +G VYKA+    G LVA+K+ + E   E +      E+ LL  +     +V+LL
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 330 GFV----DKGNERL-IITEFVPNGTLREHLDGQYGKT---LDFNQRLEIAIDVAHGLTYL 381
                    G   L ++ E++ +  L++ +D         L           +  G+ + 
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126

Query: 382 HLYAEKQIIHRDVKSSNILLTES-MRAKVADFGFARLG--PMDSDRTHISTKVKGTVGYL 438
           H +    ++HRD+K  N+L+ +     K+AD G  R    P+ S  TH       T+ Y 
Sbjct: 127 HKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS-YTHEIV----TLWYR 178

Query: 439 DPE-YMKTYQLTTKSDVYSFGVLLLEILTG 467
            PE  + +   +T  D++S G +  E+   
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 61.0 bits (148), Expect = 4e-10
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 15/204 (7%)

Query: 274 IGEGGFGTVYKAQLEDGL----LVAIKRAKKEQFENLQTEFS---SEVELLSKIDHRNLV 326
           +G+GG+G V++ +   G     + A+K  KK      Q + +   +E  +L  + H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            L+     G +  +I E++  G L  HL+ + G  ++      ++ +++  L +LH   +
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHLERE-GIFMEDTACFYLS-EISLALEHLH---Q 118

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + II+RD+K  NILL      K+ DFG  +    +   TH      GT+ Y+ PE +   
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAPEILMRS 175

Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
                 D +S G L+ ++LTG  P
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 61.2 bits (149), Expect = 4e-10
 Identities = 57/229 (24%), Positives = 92/229 (40%), Gaps = 47/229 (20%)

Query: 267 NFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSS--EVELLSKIDHR 323
            + P   IG G +G V  A     G  VAIK+     F+       +  E+++L    H 
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPH-AFDVPTLAKRTLRELKILRHFKHD 64

Query: 324 NLVKLLG-FVDKGNE----------------RLIITEFVPNGTLREHLDGQYGKTLDFNQ 366
           N++ +       G +                 +I +    +  L E     +       Q
Sbjct: 65  NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHS----DQPLTEEHIRYF-----LYQ 115

Query: 367 RLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS---D 423
            L        GL Y+H      +IHRD+K SN+L+ E    ++ DFG AR   + S   +
Sbjct: 116 LLR-------GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARG--LSSSPTE 163

Query: 424 RTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPV 471
             +  T+   T  Y  PE + +  + TT  D++S G +  E+L GRR +
Sbjct: 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 61.6 bits (149), Expect = 4e-10
 Identities = 39/109 (35%), Positives = 60/109 (55%), Gaps = 12/109 (11%)

Query: 362 LDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD 421
           L +   +  +  VA+G+ +L   A K  +HRD+ + N+L+ E    K+ DFG AR   + 
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR--DIM 290

Query: 422 SDRTHISTKVKGT----VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
            D  +IS   KG+    + ++ PE +     TT SDV+SFG+LL EI T
Sbjct: 291 RDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 41/126 (32%), Positives = 61/126 (48%), Gaps = 14/126 (11%)

Query: 346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM 405
            +  ++  L     + L     L     VA G+ +L   A K  +HRD+ + N+LL +  
Sbjct: 218 NDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGK 274

Query: 406 RAKVADFGFARLGPMDSDRTHISTKV-KGT----VGYLDPEYMKTYQLTTKSDVYSFGVL 460
             K+ DFG AR      D  H S  V KG+    V ++ PE +     TT SDV+S+G+L
Sbjct: 275 IVKICDFGLAR------DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGIL 328

Query: 461 LLEILT 466
           L EI +
Sbjct: 329 LWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAK-KEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +GEG +G V K +  E   +VAIK+ K  E+ E ++     E+++L  +   N+V+L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 332 VDKGNERLIITEFVPNGTLR---EHLDGQY-GKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
             +  +  ++ E+V    L    E  +G    K   +  +L  AI   H         + 
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH---------KN 119

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            I+HRD+K  N+L++ +   K+ DFGFAR     S+  +  T+   T  Y  PE +    
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY--TEYVATRWYRSPELLLGAP 177

Query: 448 LTTKSDVYSFGVLLLEILTGR 468
                D++S G +L E+  G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 60.3 bits (147), Expect = 7e-10
 Identities = 69/214 (32%), Positives = 103/214 (48%), Gaps = 35/214 (16%)

Query: 273 RIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL---QTEFSSEVELLSKI-DHRNLVK 327
           ++G+G +G V+KA       +VA+K+   + F N    Q  F  E+  L ++ DH N+VK
Sbjct: 14  KLGKGAYGIVWKAIDRRTKEVVALKKIF-DAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQ--RLEIAIDVAHG-LTYLHLY 384
           LL  +   N++ I   F       E+++       D +   R  I  DV    + Y  L 
Sbjct: 72  LLNVIKAENDKDIYLVF-------EYMET------DLHAVIRANILEDVHKRYIMYQLLK 118

Query: 385 AEKQI-----IHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTH-ISTKVKGTVGY 437
           A K I     IHRD+K SNILL    R K+ADFG AR L  ++ +  + + T    T  Y
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178

Query: 438 LDPEYM---KTYQLTTKSDVYSFGVLLLEILTGR 468
             PE +     Y  T   D++S G +L E+L G+
Sbjct: 179 RAPEILLGSTRY--TKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 26/208 (12%)

Query: 272 LRIGEGGFGTV-YKAQLEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLL 329
            ++G G +GTV        G  VAIK+  +  Q E        E+ LL  + H N++ LL
Sbjct: 21  KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80

Query: 330 GF------VDKGNERLIITEFVPN--GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
                   +D+ ++  ++  F+    G L +H      + L  ++   +   +  GL Y+
Sbjct: 81  DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYI 134

Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H      IIHRD+K  N+ + E    K+ DFG AR    DS+ T        T  Y  PE
Sbjct: 135 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVV----TRWYRAPE 185

Query: 442 YMKTYQLTTKS-DVYSFGVLLLEILTGR 468
            +  +   T++ D++S G ++ E+LTG+
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 41/217 (18%)

Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE----------------FSSEVELL 317
           +G+G F  ++K          I+R   +  E  +TE                F     ++
Sbjct: 3   LGQGTFTKIFKG---------IRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMM 53

Query: 318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHG 377
           S++ H++LV   G    G+E +++ E+V  G+L  +L  +    ++ + +LE+A  +A  
Sbjct: 54  SQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAWA 112

Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT--- 434
           L +L    +K + H +V + N+LL      K  +  F +L    SD   IS  V      
Sbjct: 113 LHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL----SD-PGISITVLPKEIL 164

Query: 435 ---VGYLDPEYMKTYQ-LTTKSDVYSFGVLLLEILTG 467
              + ++ PE ++  Q L+  +D +SFG  L EI +G
Sbjct: 165 LERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 10/99 (10%)

Query: 377 GLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR---LGPMDSDRTHISTKVKG 433
           GL Y+H      ++HRD+K  N+L+      K+ DFG AR     P ++    ++  V  
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA-GFMTEYV-A 171

Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPV 471
           T  Y  PE M ++Q  TK+ DV+S G +L E+L GR+PV
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 21/210 (10%)

Query: 274 IGEGGFGTVYKAQLEDGLL--VAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLL 329
           +G G FG V  A  ++     VAIKR +K +   +       SE ++L+ I+H   V L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL--EIAIDVAHGLTYLHLYAEK 387
           G     +   ++ EFV        + G++   L  N+R   ++    A  +  +  Y + 
Sbjct: 98  GSFKDESYLYLVLEFV--------IGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 388 -QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
             I++RD+K  N+LL +    K+ DFGFA++  +D+ RT+    + GT  Y+ PE +   
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--VDT-RTY---TLCGTPEYIAPEILLNV 203

Query: 447 QLTTKSDVYSFGVLLLEILTGRRPVELKRP 476
                +D ++ G+ + EIL G  P     P
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPPFYANEP 233

Length = 340

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 20/205 (9%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIK-------RAKKEQFENLQTEFSSEVELLSKIDHRNL 325
           IG+G FG V  A+ + DG   A+K         KKEQ  ++  E +    LL  + H  L
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQ-NHIMAERNV---LLKNLKHPFL 58

Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           V L        +   + ++V  G L  HL  Q  +     +    A +VA  + YLH   
Sbjct: 59  VGLHYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAEVASAIGYLH--- 113

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
              II+RD+K  NILL       + DFG  + G ++ + T  ++   GT  YL PE ++ 
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG-VEPEET--TSTFCGTPEYLAPEVLRK 170

Query: 446 YQLTTKSDVYSFGVLLLEILTGRRP 470
                  D +  G +L E+L G  P
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 33/213 (15%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRN-------- 324
           IG+G FG VY+ + +D   + A+K   K+       E  ++ E+   I  RN        
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKK-------EIVAKKEVAHTIGERNILVRTLLD 53

Query: 325 ----LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
               +V L       ++  ++T+++  G L  HL  + G+  +   +  IA ++   L +
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE-GRFSEDRAKFYIA-ELVLALEH 111

Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
           LH   +  I++RD+K  NILL  +    + DFG ++    D+  T+      GT  YL P
Sbjct: 112 LH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAP 165

Query: 441 EYM---KTYQLTTKSDVYSFGVLLLEILTGRRP 470
           E +   K Y  T   D +S GVL+ E+  G  P
Sbjct: 166 EVLLDEKGY--TKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 70/253 (27%), Positives = 104/253 (41%), Gaps = 51/253 (20%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKK-EQFENLQ-TEFSSEVELLSKIDHRNLVKLL- 329
           IG G FG V   Q +D G + A+K  +K +  E  Q     +E ++L + D   +VK+  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQ----RLEIAIDVAHGLTYLHLYA 385
            F DK N  LI+ EF+P G +   L  +   + +  Q       +AID  H L +     
Sbjct: 69  SFQDKRNLYLIM-EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF----- 122

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFG------------FAR-----------LGPMDS 422
               IHRD+K  N+LL      K++DFG            F R              M+S
Sbjct: 123 ----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 423 ---------DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVEL 473
                    +R  ++    GT  Y+ PE           D +S GV++ E+L G  P   
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238

Query: 474 KRPPEE-RVTLRW 485
           + P E  R  + W
Sbjct: 239 ETPQETYRKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 56.8 bits (137), Expect = 7e-09
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 22/207 (10%)

Query: 274 IGEGGFGTVYKAQLEDGLLVA---IKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           IG G FG V  +++     VA   +K  K       Q EF  + +    + H N+++ LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI---AIDVAHGLTYLHLYAEK 387
              +    L++ E+   G L+ +L  +     + +Q L +   A ++A G+T++H   + 
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN-SQLLLLQRMACEIAAGVTHMH---KH 118

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG--YLDPEYMKT 445
             +H D+   N  LT  +  KV D+G   +GP      +I T+    V   +L PE +  
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYG---IGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175

Query: 446 YQ-------LTTKSDVYSFGVLLLEIL 465
           +         T  S+V++ GV L E+ 
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 57.4 bits (138), Expect = 8e-09
 Identities = 70/253 (27%), Positives = 104/253 (41%), Gaps = 51/253 (20%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKK-EQFENLQT-EFSSEVELLSKIDHRNLVKLL- 329
           IG G FG V   Q +D G + A+K  +K +  E  Q     +E ++L + D   +VK+  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQ----RLEIAIDVAHGLTYLHLYA 385
            F DK N  LI+ EF+P G +   L  +   T +  Q       +AID  H L +     
Sbjct: 69  SFQDKLNLYLIM-EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF----- 122

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFG------------FAR-----------LGPMDS 422
               IHRD+K  N+LL      K++DFG            F R              M+S
Sbjct: 123 ----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 423 ---------DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVEL 473
                    +R  ++    GT  Y+ PE           D +S GV++ E+L G  P   
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238

Query: 474 KRPPEE-RVTLRW 485
           + P E  +  + W
Sbjct: 239 ETPQETYKKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.0 bits (138), Expect = 8e-09
 Identities = 53/218 (24%), Positives = 89/218 (40%), Gaps = 45/218 (20%)

Query: 277 GGFGTVYKAQLEDGLLVAIKR-----AKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG- 330
                + K +     LVA+K+       KE  + LQ     E+    ++ H N++  +  
Sbjct: 13  LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQ----QEIITSRQLQHPNILPYVTS 67

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI-----DVAHGLTYLHLYA 385
           F+   +E  +++  +  G+  + L   + + L      E+AI     DV + L Y+H   
Sbjct: 68  FIVD-SELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALDYIH--- 118

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS---------DRTHISTKVKGTVG 436
            K  IHR VK+S+ILL+   +  ++  G      M           D    S K    + 
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKN---LP 173

Query: 437 YLDPEYMKTYQ----LTTKSDVYSFGVLLLEILTGRRP 470
           +L PE +   Q       KSD+YS G+   E+  G  P
Sbjct: 174 WLSPEVL--QQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 41/134 (30%), Positives = 64/134 (47%), Gaps = 11/134 (8%)

Query: 340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNI 399
           +I ++V  G L  HL  Q     +   R+ IA ++   L +LH   +  II+RD+K  NI
Sbjct: 82  LILDYVNGGELFTHL-YQREHFTESEVRVYIA-EIVLALDHLH---QLGIIYRDIKLENI 136

Query: 400 LLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS--DVYS 456
           LL       + DFG ++     + +R +      GT+ Y+ PE ++          D +S
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPEVIRGGSGGHDKAVDWWS 193

Query: 457 FGVLLLEILTGRRP 470
            GVL  E+LTG  P
Sbjct: 194 LGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 64/265 (24%), Positives = 109/265 (41%), Gaps = 63/265 (23%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQ--FENLQTEFSSEVELLSKIDHRNLVKLL- 329
           +G G FG V  A+  D   L A+K  +K+     N      +E ++L++ D+  +V+L  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 330 GFVDKGNERLIITEFVPNGTLREHL--DGQYGKTLD--FNQRLEIAIDVAHGLTYLHLYA 385
            F DK N   ++ +++P G +   L   G + + L   +   L  A++  H + +     
Sbjct: 69  SFQDKDNLYFVM-DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF----- 122

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFA------------------------------ 415
               IHRD+K  NIL+      K+ DFG                                
Sbjct: 123 ----IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 416 ---------RLGPMD--SDRTH---ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLL 461
                    RL P++  + R H   ++  + GT  Y+ PE +     T   D +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238

Query: 462 LEILTGRRPVELKRPPEERV-TLRW 485
            E+L G+ P   + P E ++  + W
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 17/203 (8%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKE----QFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G+G FG V   + +  G   A+K  KKE    + E   T   S V  L    H  L  L
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRV--LQNTRHPFLTAL 60

Query: 329 LGFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
             +  + ++RL  + E+   G L  HL  +   + D   R   A ++   L YLH     
Sbjct: 61  -KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGA-EIVSALGYLH---SC 114

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            +++RD+K  N++L +    K+ DFG  + G  D           GT  YL PE ++   
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLEDND 171

Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
                D +  GV++ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 19/202 (9%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLG- 330
           +G G +G+V  A     G  VAIK+  +  Q E        E+ LL  + H N++ LL  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F    +       ++    ++  L    G  L  ++   +   +  GL Y+H      II
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH---SAGII 139

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV---GYLDPEYMKTYQ 447
           HRD+K  N+ + E    K+ DFG AR         H   ++ G V    Y  PE +  + 
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLAR---------HADAEMTGYVVTRWYRAPEVILNWM 190

Query: 448 LTTKS-DVYSFGVLLLEILTGR 468
              ++ D++S G ++ E+LTG+
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 19/206 (9%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ--TEFSSEVELLSKIDHRNLVKLLG 330
           IG+G +G V  A     G  VAIK+   + FE++   T    E++LL  + H ++V++  
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE------IAIDVAHGLTYLHLY 384
            +   + R    EF     + E ++    + +  N  L           +   L Y+H  
Sbjct: 67  IMLPPSRR----EFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH-- 120

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
               + HRD+K  NIL     + K+ DFG AR+   D+      T    T  Y  PE   
Sbjct: 121 -TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179

Query: 445 TY--QLTTKSDVYSFGVLLLEILTGR 468
           ++  + T   D++S G +  E+LTG+
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 55.5 bits (133), Expect = 3e-08
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 11/200 (5%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K  KKE    ++      +E  +L    H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
                +    + E+V  G L  HL  +  +    ++      ++   L YLH     +I+
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLH---SGKIV 117

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           +RD+K  N++L +    K+ DFG  + G  D+          GT  YL PE ++      
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC---GTPEYLAPEVLEDNDYGR 174

Query: 451 KSDVYSFGVLLLEILTGRRP 470
             D +  GV++ E++ GR P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 55.5 bits (133), Expect = 3e-08
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 24/210 (11%)

Query: 274 IGEGGFGTVYKAQLEDGLLV-AIKRAKK-EQFENLQTE-FSSEVELLSKIDHRNLVKL-L 329
           IG G FG V   +L++   V A+K   K E  +  +T  F  E ++L   D++ +  L  
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68

Query: 330 GFVDKGNERLIITEFVPNG--TLREHLDGQYGKTLD--FNQRLEIAIDVAHGLTYLHLYA 385
            F D+ N  L++  +V     TL    + +  + +   +   + IAID  H L Y     
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY----- 123

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
               +HRD+K  NIL+  +   ++ADFG + L  M+ D T  S+   GT  Y+ PE ++ 
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFG-SCLKLME-DGTVQSSVAVGTPDYISPEILQA 177

Query: 446 YQ-----LTTKSDVYSFGVLLLEILTGRRP 470
            +        + D +S GV + E+L G  P
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 37/114 (32%), Positives = 54/114 (47%), Gaps = 16/114 (14%)

Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM-----------DSD-RT 425
           L YLH Y    I+HRD+K  N+L+T     K+ DFG +++G M           + D R 
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEE 479
            +  +V GT  Y+ PE +         D ++ G++L E L G  P      PEE
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF-FGDTPEE 223

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 37/106 (34%), Positives = 52/106 (49%), Gaps = 17/106 (16%)

Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD-RTHIS 428
           +A+D  H + +         IHRDVK  N+LL +S   K+ADFG      MD++      
Sbjct: 153 LALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCM--KMDANGMVRCD 201

Query: 429 TKVKGTVGYLDPEYMKTY----QLTTKSDVYSFGVLLLEILTGRRP 470
           T V GT  Y+ PE +K+         + D +S GV L E+L G  P
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 61/246 (24%), Positives = 106/246 (43%), Gaps = 50/246 (20%)

Query: 310 FSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE 369
           F     L+S++ H +L  + G   +G+E +++ EFV +G L   L  + G+ +    ++ 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGR-VPVAWKIT 121

Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +A  +A  L+YL    +K ++H +V + NILL             ARLG  +     I  
Sbjct: 122 VAQQLASALSYLE---DKNLVHGNVCAKNILL-------------ARLGLAEGTSPFIKL 165

Query: 430 KVKGT-------------VGYLDPEYMKTY-QLTTKSDVYSFGVLLLEI-LTGRRPVELK 474
              G              + ++ PE +     L+T +D +SFG  LLEI   G  P++ +
Sbjct: 166 SDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225

Query: 475 RPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMK 534
            P E+        +R+ E     + +PS KE+ +         L  QC       RP  +
Sbjct: 226 TPSEK--------ERFYEKK-HRLPEPSCKELAT---------LISQCLTYEPTQRPSFR 267

Query: 535 SVGEQL 540
           ++   L
Sbjct: 268 TILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 54.3 bits (130), Expect = 6e-08
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 10/200 (5%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K  KKE    ++      +E  +L    H  L  L  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
                +    + E+   G L  HL  +  +    ++      ++   L YLH  +EK ++
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLH--SEKNVV 118

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           +RD+K  N++L +    K+ DFG  + G  D           GT  YL PE ++      
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---GTPEYLAPEVLEDNDYGR 175

Query: 451 KSDVYSFGVLLLEILTGRRP 470
             D +  GV++ E++ GR P
Sbjct: 176 AVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 54.3 bits (130), Expect = 6e-08
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 16/207 (7%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG-F 331
           ++G G +G VYKA+ +DG        K+ +   +      E+ LL ++ H N++ L   F
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 332 VDKGNERL-IITEFVPNG---TLREHLDGQYGKT---LDFNQRLEIAIDVAHGLTYLHLY 384
           +   + ++ ++ ++  +     ++ H   +  K    L       +   +  G+ YLH  
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-- 125

Query: 385 AEKQIIHRDVKSSNILLT----ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
               ++HRD+K +NIL+     E  R K+AD GFARL             V  T  Y  P
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 441 EYMKTYQLTTKS-DVYSFGVLLLEILT 466
           E +   +  TK+ D+++ G +  E+LT
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.9 bits (129), Expect = 8e-08
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 16/207 (7%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG-F 331
           ++G G +G VYKA+ +DG        K+ +   +      E+ LL ++ H N++ L   F
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 332 VDKGNERL-IITEFVPNG---TLREHLDGQYGKT---LDFNQRLEIAIDVAHGLTYLHLY 384
           +   + ++ ++ ++  +     ++ H   +  K    L  +    +   +  G+ YLH  
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH-- 125

Query: 385 AEKQIIHRDVKSSNILLT----ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
               ++HRD+K +NIL+     E  R K+AD GFARL             V  T  Y  P
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 441 EYMKTYQLTTKS-DVYSFGVLLLEILT 466
           E +   +  TK+ D+++ G +  E+LT
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 50.9 bits (122), Expect = 1e-07
 Identities = 31/149 (20%), Positives = 55/149 (36%), Gaps = 15/149 (10%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV--KLLG 330
            +  G    VY    +D   V     K         +   EV +L  +  + L   K+L 
Sbjct: 5   LLKGGLTNRVYLLGTKDEDYVL----KINPSREKGADREREVAILQLLARKGLPVPKVLA 60

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
             +      ++ E++   TL E         +   ++ +IA  +A  L  LH      + 
Sbjct: 61  SGESDGWSYLLMEWIEGETLDE---------VSEEEKEDIAEQLAELLAKLHQLPLLVLC 111

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGP 419
           H D+   NIL+ +     + D+ +A  GP
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 34/209 (16%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSS---EVELLSKIDHRNLVKLL 329
           IG G  G V  A     G+ VA+K+  +  F+N QT       E+ LL  ++H+N++ LL
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQN-QTHAKRAYRELVLLKCVNHKNIISLL 86

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQY-GKTLDFNQRLEIAIDVAHG-LTYL------ 381
                         F P  +L E  D     + +D N    I +++ H  ++YL      
Sbjct: 87  NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC 134

Query: 382 ---HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
              HL++   IIHRD+K SNI++      K+ DFG AR    +     + T    T  Y 
Sbjct: 135 GIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN----FMMTPYVVTRYYR 189

Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILTG 467
            PE +         D++S G ++ E++ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.2 bits (127), Expect = 2e-07
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 41/222 (18%)

Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A L+    VAIK+  +  F+N QT       E+
Sbjct: 15  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRP-FQN-QTHAKRAYREL 67

Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQY-GKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  +L E  D     + +D N    I ++
Sbjct: 68  VLMKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQME 115

Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 170

Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
            + + T    T  Y  PE +         D++S G ++ E++
Sbjct: 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 28/212 (13%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKK-EQFENLQTE-FSSEVELLSKIDHRNLVKL-L 329
           IG G FG V   ++++ G + A+K   K E  +  +T  F  E ++L   D R +  L  
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHY 68

Query: 330 GFVDKGNERLIITEFVPNGTL------REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
            F D+ N  L++  +V    L       + L     +   +   + +AID  H L Y   
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF--YLAEMVLAIDSVHQLGY--- 123

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
                 +HRD+K  N+LL ++   ++ADFG      + +D T  S    GT  Y+ PE +
Sbjct: 124 ------VHRDIKPDNVLLDKNGHIRLADFGSCL--RLLADGTVQSNVAVGTPDYISPEIL 175

Query: 444 KTYQ-----LTTKSDVYSFGVLLLEILTGRRP 470
           +  +        + D +S GV + E+L G  P
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 49/230 (21%)

Query: 260 QVVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENL--QTEFSSEV 314
           +V +  +N +P   +G G +G+V   Y  +L     VA+K+  +  F++L        E+
Sbjct: 12  EVPERYQNLTP---VGSGAYGSVCSAYDTRLRQK--VAVKKLSRP-FQSLIHARRTYREL 65

Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTL---DFN-----Q 366
            LL  + H N++ LL              F P  ++    +      L   D N     Q
Sbjct: 66  RLLKHMKHENVIGLLDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQ 113

Query: 367 RLE------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM 420
           +L       +   +  GL Y+H      IIHRD+K SN+ + E    ++ DFG AR    
Sbjct: 114 KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QA 168

Query: 421 DSDRT-HISTKVKGTVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
           D + T +++T+      Y  PE M  +    ++ D++S G ++ E+L G+
Sbjct: 169 DDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 52.4 bits (125), Expect = 3e-07
 Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 41/225 (18%)

Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A LE    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRP-FQN-QTHAKRAYREL 74

Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  +L E  D     + +D N    I ++
Sbjct: 75  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 122

Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 177

Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGR 468
            + + T    T  Y  PE +         D++S G ++ E++ G 
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 12/201 (5%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTE---FSSEVELLSKIDHRNLVKLL 329
           IG+G FG V  A+ + +    A+K  +K+     + E    S    LL  + H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
                 ++   + +++  G L  HL  +    L+   R   A ++A  L YLH      I
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERC-FLEPRARF-YAAEIASALGYLH---SLNI 117

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           ++RD+K  NILL       + DFG  +    + +    ++   GT  YL PE +      
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174

Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D +  G +L E+L G  P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 35/214 (16%)

Query: 274 IGEGGFGTVYKAQLEDGLLV-AIKRAKKEQFENLQTE----FSSEVELLSKIDHRNLVKL 328
           IG G FG V   + +    V A+K   K  FE ++      F  E ++++  +   +V+L
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLSK--FEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDG-----QYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                      ++ E++P G L   +       ++ K   +   + +A+D  H +     
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF--YTAEVVLALDAIHSMG---- 162

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT---HISTKVKGTVGYLDP 440
                +IHRDVK  N+LL +    K+ADFG      M  D T      T V GT  Y+ P
Sbjct: 163 -----LIHRDVKPDNMLLDKHGHLKLADFGTC----MKMDETGMVRCDTAV-GTPDYISP 212

Query: 441 EYMKTY----QLTTKSDVYSFGVLLLEILTGRRP 470
           E +K+         + D +S GV L E+L G  P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.5 bits (123), Expect = 5e-07
 Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 13/201 (6%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K  +KE    ++      +E  +L    H  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-K 61

Query: 331 FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           +  + ++RL  + E+   G L  HL  +   T +   R   A ++   L YLH    + +
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGA-EIVSALEYLH---SRDV 116

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           ++RD+K  N++L +    K+ DFG  + G  D           GT  YL PE ++     
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAPEVLEDNDYG 173

Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D +  GV++ E++ GR P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)

Query: 267 NFSPSLRIGEGGFGTVY---KAQLED-GLLVAIKRAKKE---QFENLQTEFSSEVELLSK 319
           NF     +G G +G V+   K    D G L A+K  KK    Q         +E ++L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 320 IDHRNLVKLLGFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI-DVAHG 377
           I     +  L +  + + +L +I +++  G L  HL  +        Q ++I   ++   
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLA 117

Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY 437
           L +LH      II+RD+K  NILL  +    + DFG ++      D    +    GT+ Y
Sbjct: 118 LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK--EFHEDEVERAYSFCGTIEY 172

Query: 438 LDPEYMKTYQL--TTKSDVYSFGVLLLEILTGRRP 470
           + P+ ++          D +S GVL+ E+LTG  P
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 50.7 bits (121), Expect = 8e-07
 Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 24/214 (11%)

Query: 274 IGEGGFGTVY---KAQLED-GLLVAIKRAKKE---QFENLQTEFSSEVELLSKIDHRNLV 326
           +G G +G V+   K    D G L A+K  +K    Q         +E  +L  +     +
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 327 KLLGFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI---DVAHGLTYLH 382
             L +  +   +L +I ++V  G +  HL   Y +  D     E+     ++   L +LH
Sbjct: 68  VTLHYAFQTEAKLHLILDYVSGGEMFTHL---YQR--DNFSEDEVRFYSGEIILALEHLH 122

Query: 383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
                 I++RD+K  NILL       + DFG ++     + +RT+      GT+ Y+ PE
Sbjct: 123 KLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---SFCGTIEYMAPE 176

Query: 442 YMKTYQLTTKS-DVYSFGVLLLEILTGRRPVELK 474
            ++      K+ D +S G+L+ E+LTG  P  L+
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 40/214 (18%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A  ++    VAIK+  ++ Q++N       E+ ++  ++H N++ L  +
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN------RELLIMKNLNHINIIFLKDY 127

Query: 332 VD----KGNERLI----ITEFVPNGTLREHLDGQYGKTLDFNQRLEI------AIDVAHG 377
                 K NE+ I    + EF+P  T+ +++   Y +    N  L +      +  +   
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMK-HYARN---NHALPLFLVKLYSYQLCRA 182

Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRA-KVADFGFAR--LGPMDSDRTHISTKVKGT 434
           L Y+H    K I HRD+K  N+L+  +    K+ DFG A+  L    S  ++I ++    
Sbjct: 183 LAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS-VSYICSRF--- 235

Query: 435 VGYLDPEYM-KTYQLTTKSDVYSFGVLLLEILTG 467
             Y  PE M      TT  D++S G ++ E++ G
Sbjct: 236 --YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 29/211 (13%)

Query: 274 IGEGGFGTVYKAQLEDGLLV-AIKRAKKEQFENLQTE----FSSEVELLSKIDHRNLVKL 328
           IG G FG V   + +    V A+K   K  FE ++      F  E ++++  +   +V+L
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLLSK--FEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLD-----GQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                      ++ E++P G L   +       ++ +   +   + +A+D  H + +   
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF--YTAEVVLALDAIHSMGF--- 163

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
                 IHRDVK  N+LL +S   K+ADFG      M+ +         GT  Y+ PE +
Sbjct: 164 ------IHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGMVRCDTAVGTPDYISPEVL 215

Query: 444 KTY----QLTTKSDVYSFGVLLLEILTGRRP 470
           K+         + D +S GV L E+L G  P
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 62/265 (23%), Positives = 107/265 (40%), Gaps = 63/265 (23%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLL- 329
           +G G FG V  A +++   L A+K  +K+     N      +E ++L++ D+  +VKL  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 330 GFVDKGNERLIITEFVPNGTLREHL--DGQYGKTLD--FNQRLEIAIDVAHGLTYLHLYA 385
            F DK N   ++ +++P G +   L     + + L   +   L +AI+  H + +     
Sbjct: 69  SFQDKDNLYFVM-DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF----- 122

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFA---------------------RLGPMD--- 421
               IHRD+K  NIL+      K+ DFG                        + P D   
Sbjct: 123 ----IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 422 -----------------SDRTH---ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLL 461
                            + + H   ++  + GT  Y+ PE +     T   D +S GV+L
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238

Query: 462 LEILTGRRPVELKRPPEERV-TLRW 485
            E+L G+ P     P E ++  + W
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 64/253 (25%), Positives = 98/253 (38%), Gaps = 58/253 (22%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLL- 329
           IG G FG V   +  D   L A+K  +K      N      +E ++L++ D+  +VKL  
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68

Query: 330 GFVDKGNERLIITEFVPNGTLREHL--DGQYGKTLD--FNQRLEIAIDVAHGLTYLHLYA 385
            F DK N   ++ +++P G +   L   G + + L   +   L  AI+  H + +     
Sbjct: 69  SFQDKDNLYFVM-DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF----- 122

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGF------------------------------- 414
               IHRD+K  NIL+      K+ DFG                                
Sbjct: 123 ----IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 415 ----ARLGPMDSDRTHISTKVK-----GTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
                RL P++  R     +       GT  Y+ PE +     T   D +S GV+L E+L
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238

Query: 466 TGRRPVELKRPPE 478
            G+ P     P E
Sbjct: 239 VGQPPFLADTPAE 251

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 54/174 (31%), Positives = 78/174 (44%), Gaps = 37/174 (21%)

Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLL---VAIKRAKKEQFENLQTEFSS---E 313
            V+K  +N  P   IG G  G V  A   D +    VAIK+  +  F+N  T       E
Sbjct: 13  TVLKRYQNLKP---IGSGAQGIVCAA--YDTVTGQNVAIKKLSRP-FQN-VTHAKRAYRE 65

Query: 314 VELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTL-DFNQRLEIAI 372
           + L+  ++H+N++ LL              F P  +L E  D      L D N    I +
Sbjct: 66  LVLMKLVNHKNIIGLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQM 113

Query: 373 DVAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR 416
           D+ H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR
Sbjct: 114 DLDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 16/106 (15%)

Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +AI   H L Y         +HRD+K  N+LL  +   ++ADFG      M+ D T  S+
Sbjct: 113 LAIHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCL--KMNQDGTVQSS 161

Query: 430 KVKGTVGYLDPEYMKTYQ-----LTTKSDVYSFGVLLLEILTGRRP 470
              GT  Y+ PE ++  +        + D +S GV + E+L G  P
Sbjct: 162 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.3 bits (115), Expect = 6e-06
 Identities = 44/156 (28%), Positives = 68/156 (43%), Gaps = 16/156 (10%)

Query: 267 NFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKR-AKKEQFENLQ-TEFSSEVELLSKIDHR 323
           +F     IG+G FG V   Q  + G + A+K   K E F+  Q     +E ++L++ D  
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61

Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQ----RLEIAIDVAHGLT 379
            +V L           +I EF+P G L   L      + D  +       +AI+  H L 
Sbjct: 62  WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG 121

Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA 415
           +         IHRD+K  NIL+      K++DFG +
Sbjct: 122 F---------IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 47.7 bits (113), Expect = 9e-06
 Identities = 31/101 (30%), Positives = 46/101 (45%), Gaps = 5/101 (4%)

Query: 368 LEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI 427
           L I   V   + YLH   E +IIHRD+K+ NI +       + DFG A   P+D +    
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKY 240

Query: 428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGR 468
                GT+    PE +         D++S G++L E+ T  
Sbjct: 241 YGWA-GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 12/149 (8%)

Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           I  G FG VY  + + +  L A+K  KK     +N+  +  +E + L+      +V L  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 331 FVDKGNERLIITEFVPNGTLRE--HLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
            +   N   ++ E++  G ++   H+ G +    D    ++   +VA  L YLH +    
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYF----DEEMAVKYISEVALALDYLHRHG--- 124

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARL 417
           IIHRD+K  N+L++     K+ DFG +++
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 29/207 (14%)

Query: 281 TVYKAQ-LEDGLLVAIK-----RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDK 334
           +VY A+    G LV ++        +E  + LQ    +EV L     H N++        
Sbjct: 15  SVYLARHTPTGTLVTVRITDLENCTEEHLKALQ----NEVVLSHFFRHPNIMTSWTVFTT 70

Query: 335 GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDV 394
           G+   +I+ F+  G+    L   + + +       I      GL YLH   +   IHR++
Sbjct: 71  GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNI 127

Query: 395 KSSNILLTESMRAKVADFGFARLGPMDS---------DRTHISTKVKGTVGYLDPEYMKT 445
           K+S+IL++      V+  G + L  +           D    ST V   + +L PE ++ 
Sbjct: 128 KASHILISGD--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELLRQ 182

Query: 446 --YQLTTKSDVYSFGVLLLEILTGRRP 470
             Y    KSD+YS G+   E+ TGR P
Sbjct: 183 DLYGYNVKSDIYSVGITACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 38/127 (29%), Positives = 58/127 (45%), Gaps = 9/127 (7%)

Query: 274 IGEGGFGTVYKAQL-----EDGLL-VAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLV 326
           +G G FG V +A       ED +L VA+K  K     + +    SE+++LS +  H+N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            LLG    G   L+ITE+   G L   L  +    L  N  + +         Y ++  E
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFL--NFVMALPEISETSSDYKNITLE 163

Query: 387 KQIIHRD 393
           K+ I  D
Sbjct: 164 KKYIRSD 170

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 35/149 (23%), Positives = 59/149 (39%), Gaps = 11/149 (7%)

Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
           N+V L  ++   +   ++ +    G L  H+        +  +R    + VA  L  LH 
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA--LDALH- 102

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
              + I+ RD+  +NILL +    ++  F          D   +         Y  PE  
Sbjct: 103 --REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEVG 154

Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRPVE 472
              + T   D +S G +L E+LTG+  VE
Sbjct: 155 GISEETEACDWWSLGAILFELLTGKTLVE 183

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 19/201 (9%)

Query: 310 FSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE 369
           F     ++ ++ H+++V L G   +  E +++ EFV  G L   +  +    L    + +
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFK 109

Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFG-FARLGPMDSDRTHIS 428
           +A  +A  L+YL    +K ++H +V + NILL         + G F +L       T +S
Sbjct: 110 VAKQLASALSYLE---DKDLVHGNVCTKNILLARE--GIDGECGPFIKLSDPGIPITVLS 164

Query: 429 TKVK-GTVGYLDPEYMK-TYQLTTKSDVYSFGVLLLEI-LTGRRPVELKRPPEERVTLRW 485
            +     + ++ PE ++ +  L+  +D +SFG  L EI   G  P++ K   E+      
Sbjct: 165 RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------ 218

Query: 486 AFKRYNEGNLLDMVDPSIKEV 506
             +R+ EG  + +V PS KE+
Sbjct: 219 --ERFYEGQCM-LVTPSCKEL 236

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 42.8 bits (100), Expect = 4e-04
 Identities = 38/163 (23%), Positives = 71/163 (43%), Gaps = 7/163 (4%)

Query: 306 LQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDG--QYGKTLD 363
              +  +E+  L +++H N++K+   +       +IT+           D    +     
Sbjct: 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPL 265

Query: 364 FNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
             Q   I   +   + Y+H   +K++IHRD+K  NI L    +  + DFG A   P + +
Sbjct: 266 LKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAM--PFEKE 320

Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           R        GTV    PE +        +D++S G++LL++L+
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 49/198 (24%), Positives = 77/198 (38%), Gaps = 38/198 (19%)

Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLV 326
           +G G FG V +A        +  + VA+K  K     + +    SE++++S +  H N+V
Sbjct: 45  LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            LLG   KG    IITE+            +YG  +D+  R        +  T+L  Y +
Sbjct: 105 NLLGACTKGGPIYIITEYC-----------RYGDLVDYLHR--------NKHTFLQYYLD 145

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV-----KGTVGYLDPE 441
           K      + S         ++ V+    +  G MD  +   +  V     KGTV Y D E
Sbjct: 146 KNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIE 205

Query: 442 ---YMKTYQLTTKSDVYS 456
              Y   Y       + S
Sbjct: 206 SSNYESPYD----QYLPS 219

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 14/157 (8%)

Query: 311 SSEVELLSKIDHRNLVKLLGF-VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE 369
             E  LL ++ H  ++ LL   V  G   L++ ++     L  +L G   + L   Q   
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY--RSDLYTYL-GARLRPLGLAQVTA 264

Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFG---FARLGPMDSDRTH 426
           +A  +   + Y+H    + IIHRD+K+ N+L+       + DFG   FAR     S  T 
Sbjct: 265 VARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR----GSWSTP 317

Query: 427 ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLE 463
               + GTV    PE +     T   D++S G+++ E
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 40/218 (18%)

Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE-FSSEVEL---------------L 317
           IG GGFG VY+ Q        I      + ENL+ E    E  +               +
Sbjct: 20  IGCGGFGCVYETQCASDH--CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI 77

Query: 318 SKIDHRNLVKLLG---FVDKGNE---RLIITEFVPNGTLREHLDGQYGKTLDFNQRL--E 369
             IDH  + K  G   F  K      R I+ E      L E+    + +    N++L   
Sbjct: 78  HNIDHLGIPKYYGCGSF--KRCRMYYRFILLE-----KLVENTKEIFKRIKCKNKKLIKN 130

Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           I  D+   L Y+H +    I H D+K  NI++  + R  + D+G A    +       S 
Sbjct: 131 IMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187

Query: 430 KVK----GTVGYLDPEYMKTYQLTTKSDVYSFGVLLLE 463
           + K    GT+ Y   +      +T + D+ S G  +L+
Sbjct: 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 22/194 (11%)

Query: 290 GLLVAIKRAKKEQFENLQTEF-SSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNG 348
           G  V ++R   E   N    F   E+ +    +H N+V         NE  ++T F+  G
Sbjct: 25  GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84

Query: 349 TLREHLDGQYGKTLDFNQRLEIA---IDVAHGLTYLHLYAEKQIIHRDVKSSNILLT--- 402
           + ++ +   +   +D    L IA     V   L Y+H       +HR VK+S+IL++   
Sbjct: 85  SAKDLICTHF---MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDG 138

Query: 403 ----ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT--YQLTTKSDVYS 456
                 +R+ ++     +   +  D    S KV   + +L PE ++        KSD+YS
Sbjct: 139 KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKV---LPWLSPEVLQQNLQGYDAKSDIYS 195

Query: 457 FGVLLLEILTGRRP 470
            G+   E+  G  P
Sbjct: 196 VGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	554
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.98
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.82
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.82
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.81
PRK10345	210	hypothetical protein; Provisional	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
smart00090	237	RIO RIO-like kinase.	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.76
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.65
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.6
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.51
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.39
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.38
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.36
KOG1243	690	consensus Protein kinase [General function predict	99.31
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.28
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.25
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.24
KOG3087	229	consensus Serine/threonine protein kinase [General	99.2
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.2
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.11
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.06
COG4248	637	Uncharacterized protein with protein kinase and he	99.02
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.97
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.96
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.81
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.68
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.67
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.63
PRK09902	216	hypothetical protein; Provisional	98.63
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.48
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.39
PLN03150	623	hypothetical protein; Provisional	98.35
PF01636	239	APH: Phosphotransferase enzyme family This family	98.35
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.31
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.26
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.26
PLN02876	822	acyl-CoA dehydrogenase	98.22
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.18
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.06
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.05
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.0
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.96
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.94
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.85
PRK10593	297	hypothetical protein; Provisional	97.8
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.79
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.7
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.7
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.63
PRK05231	319	homoserine kinase; Provisional	97.49
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	97.46
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.42
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.26
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.25
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.24
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.06
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.02
PLN03150	623	hypothetical protein; Provisional	96.85
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.77
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.73
PLN02236	344	choline kinase	96.63
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.58
PLN02756	418	S-methyl-5-thioribose kinase	96.54
KOG2270	520	consensus Serine/threonine protein kinase involved	96.53
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.4
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	96.12
PRK12396	409	5-methylribose kinase; Reviewed	96.08
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.02
COG2334	331	Putative homoserine kinase type II (protein kinase	95.93
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.9
PRK11768	325	serine/threonine protein kinase; Provisional	95.84
PRK06148	1013	hypothetical protein; Provisional	95.82
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.58
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.42

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-54  Score=443.36  Aligned_cols=291  Identities=48%  Similarity=0.773  Sum_probs=255.3

Q ss_pred             cccccChHHHHHhhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeE
Q 042763          252 GSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF  331 (554)
Q Consensus       252 ~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~  331 (554)
                      ....+++.++..+|++|...+.||+|+||.||+|...+|..||||++....... ..+|.+|++++.+++|||+|+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            445688999999999999999999999999999999999999999887765432 4569999999999999999999999


Q ss_pred             EEcCC-ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEE
Q 042763          332 VDKGN-ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVA  410 (554)
Q Consensus       332 ~~~~~-~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~  410 (554)
                      |.+++ +.+||||||++|+|.++|+......++|.+|++||.++|+||+|||..+...|+||||||+|||+|+++.+||+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99988 49999999999999999988654388999999999999999999998777789999999999999999999999


Q ss_pred             eecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhh
Q 042763          411 DFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY  490 (554)
Q Consensus       411 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  490 (554)
                      |||+|+..+..  .....+...||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+...+......+.|+....
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999765431  1111111179999999999999999999999999999999999999998766555556788998888


Q ss_pred             ccCCccccCChhhh-hhccH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          491 NEGNLLDMVDPSIK-EVISM-EILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       491 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      .++.+.+++|+.+. ..+.. +...++..++.+|++.+|++||+|.||+++|..+..
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            88899999999987 44554 678889999999999999999999999999966543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-49  Score=393.00  Aligned_cols=257  Identities=25%  Similarity=0.401  Sum_probs=212.4

Q ss_pred             hcCCCcceeeeccCceEEEEE-EEcCCcEEEEEEcchhhhhh------HHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN------LQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a-~~~~g~~vAvK~~~~~~~~~------~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  337 (554)
                      .+.|...+.||+|+||.|-+| +.++|+.||||++.+.....      ....+.+|+++|++|+|||||+++++|+..+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            356778889999999999999 45579999999998775432      22346799999999999999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC---CcEEEEeecC
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES---MRAKVADFGF  414 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~---~~vkl~DfGl  414 (554)
                      .|+||||++||+|.+++-.+  +.+.+.....++.|++.|+.|||   +.||+||||||+|||+..+   ..+||+|||+
T Consensus       251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence            99999999999999999766  56778888899999999999999   9999999999999999766   7899999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCChh-hHHHHHHHHHhh
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ---LTTKSDVYSFGVLLLEILTGRRPVELKRPPE-ERVTLRWAFKRY  490 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~ksDVwSlGvil~elltg~~P~~~~~~~~-~~~~~~~~~~~~  490 (554)
                      |++..    ......+.||||.|.|||++.+..   +..+.||||+||+||-+|+|.+||.....+. ....+.      
T Consensus       326 AK~~g----~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~------  395 (475)
T KOG0615|consen  326 AKVSG----EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL------  395 (475)
T ss_pred             hhccc----cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh------
Confidence            99743    445566789999999999998764   3458899999999999999999998655443 222221      


Q ss_pred             ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                       .+.+.  .-|.    ...++.++..++|.+||..||++|||+.|+++|.|--
T Consensus       396 -~G~y~--f~p~----~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~  441 (475)
T KOG0615|consen  396 -KGRYA--FGPL----QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK  441 (475)
T ss_pred             -cCccc--ccCh----hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence             11111  0111    2345677889999999999999999999999999954

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-48  Score=403.46  Aligned_cols=252  Identities=27%  Similarity=0.462  Sum_probs=220.3

Q ss_pred             cCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .+|...+.||+|||+.||.++. ..|+.||+|++.+...  ....+.+.+||++.++|+|||||+++++|++.+..|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6788899999999999999977 7899999999988654  345678999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      |+|++++|..+++.+  +.+++.+++.++.||+.||.|||   +++|+|||||..|+|++++++|||+|||+|.....+.
T Consensus        98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            999999999999844  79999999999999999999999   9999999999999999999999999999999864332


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                         ....+.||||.|.|||++.....+..+||||+|||||-||.|++||+.....+....+...       +.       
T Consensus       173 ---Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-------~Y-------  235 (592)
T KOG0575|consen  173 ---ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-------EY-------  235 (592)
T ss_pred             ---cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-------Cc-------
Confidence               3345689999999999999999999999999999999999999999976554444333321       11       


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                         ..+..+.....+||.++|+.||.+|||+.+|+.+-+-
T Consensus       236 ---~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  236 ---SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             ---ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence               1233455678899999999999999999999998765

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-48  Score=383.50  Aligned_cols=257  Identities=27%  Similarity=0.382  Sum_probs=216.5

Q ss_pred             CCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC-ceEEEEEeC
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN-ERLIITEFV  345 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-~~~lv~E~~  345 (554)
                      .+..+.||+|..|+|||+.++ +++.+|+|++........++++.+|++++++.+||+||.+||.|..++ +..++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            344668999999999999776 689999999966665667789999999999999999999999999888 599999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ++|+|++++...  +.+++...-+++.+|++||.|||.  +++||||||||+|||++..|.|||||||.++.....    
T Consensus       161 DgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----  232 (364)
T KOG0581|consen  161 DGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----  232 (364)
T ss_pred             CCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence            999999999765  678999999999999999999993  499999999999999999999999999999874322    


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--hhhHHHHHHHHHhhccCCccccCChhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRP--PEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                       ....++||..|||||.+.+..|+.++||||||++++|+.+|+.||....+  ......+.++...         ..|. 
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~---------ppP~-  301 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE---------PPPR-  301 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC---------CCCC-
Confidence             45667899999999999999999999999999999999999999987522  1222222322110         1111 


Q ss_pred             hhhccH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          504 KEVISM-EILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       504 ~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                         .+. .++.++..++..||+.||.+||++.|+++|.|-.+.+
T Consensus       302 ---lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  302 ---LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             ---CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence               222 3667799999999999999999999999999876543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-48  Score=394.73  Aligned_cols=258  Identities=34%  Similarity=0.509  Sum_probs=213.8

Q ss_pred             ceeeeccCceEEEEEEEcCCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC-ceEEEEEeCCCC
Q 042763          271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN-ERLIITEFVPNG  348 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-~~~lv~E~~~~g  348 (554)
                      .+.||+|+||+||+|.+.+...||||++...... ...++|.+|+.+|.+++|||||+++|+|.++. ..++|||||++|
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G  125 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG  125 (362)
T ss_pred             hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence            4459999999999999985444999999876532 22678999999999999999999999999887 799999999999


Q ss_pred             CHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCC-eEeCCCCCCCeEECCCC-cEEEEeecCcccCCCCCCCcc
Q 042763          349 TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ-IIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTH  426 (554)
Q Consensus       349 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~~~~~~~~~  426 (554)
                      +|.++++......+++..++.|+.|||+||+|||   +.+ ||||||||+|||++.++ ++||+|||+++......   .
T Consensus       126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~---~  199 (362)
T KOG0192|consen  126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK---T  199 (362)
T ss_pred             cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc---c
Confidence            9999998855578999999999999999999999   777 99999999999999998 99999999998632211   2


Q ss_pred             ccccccCCCCCcChhccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          427 ISTKVKGTVGYLDPEYMK--TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       427 ~~~~~~gt~~y~aPE~l~--~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      ..+...||+.|||||++.  ...|+.|+||||||++||||+||+.||........   ...+......        +   
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~---~~~v~~~~~R--------p---  265 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV---ASAVVVGGLR--------P---  265 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHhcCCC--------C---
Confidence            333467999999999999  56899999999999999999999999997665211   1111111111        1   


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK  549 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~  549 (554)
                       .++..+...+..++.+||+.||+.||++.+|+..|..+......
T Consensus       266 -~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  266 -PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             -CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence             12333667789999999999999999999999999998876543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-48  Score=381.48  Aligned_cols=208  Identities=32%  Similarity=0.536  Sum_probs=187.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhh-hhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQ-FENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ..+|...++||+|+||+||+|+++ ++..||||.+.+.. ..+.++.+..|+++|+.++|||||++++++..++..++||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            357888888999999999999775 58999999998875 3556677899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC------CcEEEEeecCcc
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES------MRAKVADFGFAR  416 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~------~~vkl~DfGla~  416 (554)
                      |||.||||.+|++.+  +.+++..+..++.|||.||++||   +++||||||||+|||++..      -.+||+|||+|+
T Consensus        89 EyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            999999999999876  58999999999999999999999   9999999999999999865      568999999999


Q ss_pred             cCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHH
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERV  481 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~  481 (554)
                      ...    ......+.+|+|.|||||++...+|+.|+|+||+|+++|||++|+.||......+...
T Consensus       164 ~L~----~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~  224 (429)
T KOG0595|consen  164 FLQ----PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL  224 (429)
T ss_pred             hCC----chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence            754    4455667899999999999999999999999999999999999999999776655433

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7e-47  Score=442.00  Aligned_cols=262  Identities=26%  Similarity=0.435  Sum_probs=211.0

Q ss_pred             cCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ..|...+.||+|+||.||+|.. .+|..||||++.....     ....|++.+++++||||+++++++.+++..++||||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            4577788999999999999976 4789999998865431     123468899999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++|+|.++++     .++|.++.+++.|+++||+|||..++.+|+||||||+||+++.++..++. ||.......    
T Consensus       765 ~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----  834 (968)
T PLN00113        765 IEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----  834 (968)
T ss_pred             CCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence            99999999995     37899999999999999999997667799999999999999999988876 665543211    


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                         .....+|+.|||||++.+..++.++|||||||++|||+||+.||..... .......|.............+|+.+.
T Consensus       835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcccc
Confidence               1223588999999999999999999999999999999999999964322 222344555444444444445565543


Q ss_pred             hh--ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          505 EV--ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       505 ~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      ..  ...+...++.+++.+||+.+|++||+|+||++.|+++...
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            22  2345566789999999999999999999999999988653

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-48  Score=393.75  Aligned_cols=255  Identities=31%  Similarity=0.487  Sum_probs=220.3

Q ss_pred             cceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCC
Q 042763          270 PSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGT  349 (554)
Q Consensus       270 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~  349 (554)
                      ..+.||+|.||.||.|.+.....||+|.++.....  .++|.+|+++|++|+|+|||+++|+|..++..+||||||+.|+
T Consensus       210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~--~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs  287 (468)
T KOG0197|consen  210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS--PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS  287 (468)
T ss_pred             HHHHhcCCccceEEEEEEcCCCcccceEEeccccC--hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence            35689999999999999997779999999886432  3689999999999999999999999999889999999999999


Q ss_pred             HHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccc
Q 042763          350 LREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST  429 (554)
Q Consensus       350 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~  429 (554)
                      |.+||+...+..+...+.+.++.|||+|++||+   ++++|||||.++||||+++..+||+|||+|+..  ..+......
T Consensus       288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~--~d~~Y~~~~  362 (468)
T KOG0197|consen  288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI--GDDEYTASE  362 (468)
T ss_pred             HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc--CCCceeecC
Confidence            999999877789999999999999999999999   999999999999999999999999999999943  233333444


Q ss_pred             cccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhcc
Q 042763          430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS  508 (554)
Q Consensus       430 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  508 (554)
                      ...-+..|.|||.+....++.|||||||||+||||+| |+.||......+....+....+.                ..+
T Consensus       363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl----------------p~P  426 (468)
T KOG0197|consen  363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL----------------PRP  426 (468)
T ss_pred             CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC----------------CCC
Confidence            4456788999999999999999999999999999999 99999887765554443322111                134


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          509 MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       509 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                      ..|+..+++||..||+.+|++|||++.+...+.++....
T Consensus       427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            457788999999999999999999999999998887643

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.2e-46  Score=402.56  Aligned_cols=260  Identities=31%  Similarity=0.488  Sum_probs=221.2

Q ss_pred             CCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      +....+.||+|+||+||+|+..      +...||||.++.....+.+.+|++|+++++.++|||||+|+|+|.+++.+++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            3445668999999999999654      3468999999998877788999999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhccc------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEE
Q 042763          341 ITEFVPNGTLREHLDGQY------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAK  408 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vk  408 (554)
                      |+|||..|||.+||..+.            ..+++..+.+.||.|||.|++||-   ++.+|||||..+|+||.++..||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEE
Confidence            999999999999996432            123888999999999999999999   99999999999999999999999


Q ss_pred             EEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHH
Q 042763          409 VADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAF  487 (554)
Q Consensus       409 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~  487 (554)
                      |+|||++|-... .+.........-+.+||+||.+..++|+++||||||||+|||+++ |+.||.+-...+...      
T Consensus       644 IsDfGLsRdiYs-sDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe------  716 (774)
T KOG1026|consen  644 ISDFGLSRDIYS-SDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE------  716 (774)
T ss_pred             ecccccchhhhh-hhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH------
Confidence            999999986432 333333434456789999999999999999999999999999999 999998876654433      


Q ss_pred             HhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          488 KRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                       .+..+++.+         .+..++.++++||..||+.+|.+||+++||-..|.+....
T Consensus       717 -~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  717 -CIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             -HHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence             333333332         4567888999999999999999999999999998776543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-47  Score=360.48  Aligned_cols=256  Identities=26%  Similarity=0.395  Sum_probs=208.3

Q ss_pred             cCCCcceeeeccCceEEEEE-EEcCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeee-EEEcCCc-eEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLG-FVDKGNE-RLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a-~~~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~-~~~~~~~-~~lv  341 (554)
                      .+|++.++||+|.||+||++ ...+|..||.|.+.-... .+..++...|+.+|++|+|||||++++ .+.++++ ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            34667789999999999999 456899999998875544 345577899999999999999999998 5666666 8999


Q ss_pred             EEeCCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhc-cCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          342 TEFVPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLY-AEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ||||..|||...++..  ..+.+++..+|+++.|++.||..+|.. ...-|+||||||.||+++.+|.|||+|||+++++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999998642  346899999999999999999999931 1234999999999999999999999999999985


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      .   .........+|||.||+||.+.+.+|+.||||||+||++|||+.-++||.++.-.+       ...++..++... 
T Consensus       179 ~---s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-------L~~KI~qgd~~~-  247 (375)
T KOG0591|consen  179 S---SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-------LCKKIEQGDYPP-  247 (375)
T ss_pred             c---chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-------HHHHHHcCCCCC-
Confidence            3   23344556789999999999999999999999999999999999999999763211       122233332221 


Q ss_pred             CChhhhhhcc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          499 VDPSIKEVIS-MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       499 ~d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                              ++ ..++.++.+||..|+.+||+.||+.-.+++.+
T Consensus       248 --------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  248 --------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             --------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence                    22 45677899999999999999999975555544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-46  Score=368.41  Aligned_cols=261  Identities=25%  Similarity=0.340  Sum_probs=217.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .++|++.++||+|+||+||.++.+ +++.+|+|++++....  +..+....|..+|.+++||+||+++-.|.+++.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            468999999999999999999655 5899999999887653  3467789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      +||+.||.|..+|++.  ..+++..+..++..|+.||.|||   +++||||||||+|||+|++|+++|+|||+++..   
T Consensus       104 ld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~---  175 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKED---  175 (357)
T ss_pred             EeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhc---
Confidence            9999999999999865  68999999999999999999999   999999999999999999999999999999863   


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                      .........++||+.|||||++.+.+|+..+|+||||+++|||++|.+||...+.......+..       +.+      
T Consensus       176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~-------~k~------  242 (357)
T KOG0598|consen  176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK-------GKL------  242 (357)
T ss_pred             ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc-------CcC------
Confidence            2233344558999999999999999999999999999999999999999998765443332221       110      


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHHHHHhhhhhhh
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRP----DMKSVGEQLWAIRADSLK  549 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~~l~~i~~~~~~  549 (554)
                         ...+.-......+++...|..||++|.    .+.+|-+|..--.-+|.+
T Consensus       243 ---~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~  291 (357)
T KOG0598|consen  243 ---PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK  291 (357)
T ss_pred             ---CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence               001222445678999999999999995    677776665444444433

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-45  Score=369.39  Aligned_cols=257  Identities=24%  Similarity=0.326  Sum_probs=216.3

Q ss_pred             HHhhcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCc
Q 042763          262 VKATRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNE  337 (554)
Q Consensus       262 ~~~~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~  337 (554)
                      .+...+|...+.||+|+|++|++|+. .++++||||++.+...  ++....+.+|-+.|.+| .||.|++|+..|.++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            45568899999999999999999955 4699999999988765  23345678899999999 89999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      +|+|+||+++|+|.++|++.  ..+++..++.++.+|+.||+|||   ++|||||||||+|||+|.+|++||+|||.|+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999999876  68999999999999999999999   99999999999999999999999999999998


Q ss_pred             CCCCCCC-------c-cc--cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 042763          418 GPMDSDR-------T-HI--STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF  487 (554)
Q Consensus       418 ~~~~~~~-------~-~~--~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~  487 (554)
                      +......       . ..  ...++||..|++||++.....+..+|+|+||||||+|+.|++||.+.++--....+.   
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~---  300 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ---  300 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH---
Confidence            6432211       0 11  134789999999999999999999999999999999999999998765432221111   


Q ss_pred             HhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          488 KRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                          .-          ...++...+....+|+.+.|..||.+|++..||-+|.
T Consensus       301 ----~l----------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  301 ----AL----------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             ----Hh----------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence                11          1113444556788999999999999999999998884

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.3e-45  Score=348.95  Aligned_cols=266  Identities=22%  Similarity=0.312  Sum_probs=213.2

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .|+...++|+|+||+||+++.+ +|+.||||++.....+ ...+-.++|+++|++|+|+|+|.|+.+|.....+++|+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            4667778999999999999876 4999999999776543 3345578999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      |+. ++.+-+... ...++...+.+++.|++.|+.|+|   +++++||||||+||||+.+|.+||||||+|+....   .
T Consensus        83 ~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~---p  154 (396)
T KOG0593|consen   83 CDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA---P  154 (396)
T ss_pred             cch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC---C
Confidence            966 444444433 457889999999999999999999   99999999999999999999999999999997532   4


Q ss_pred             ccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhc---------cCC
Q 042763          425 THISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN---------EGN  494 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~---------~~~  494 (554)
                      ....+.++.|.+|+|||.+.+ .+|+...||||+||++.||++|.+.|.+.+..+....+.......-         ++-
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            455667789999999999988 6899999999999999999999999998877666555543322111         111


Q ss_pred             cc-----ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          495 LL-----DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       495 ~~-----~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                      +.     +.-++..-+..-+....-+.+++..||+.||.+|++-+|++.|-
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~  285 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP  285 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence            11     11111111111224455789999999999999999999999874

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=369.72  Aligned_cols=266  Identities=22%  Similarity=0.315  Sum_probs=219.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCC-ceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGN-ERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~-~~~lv  341 (554)
                      -++|...++||.|+||.||+|+. .+|..||||++++......+-.=++|+..|++|+ ||||++|.+++.+.+ .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            46788899999999999999965 4689999999988764433333479999999998 999999999998887 99999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||| ..+|.++++.+ ++.+++..+..|+.||++||+|+|   .+|+.|||+||+|||+.....+||+|||+||...  
T Consensus        89 fE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~--  161 (538)
T KOG0661|consen   89 FEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVR--  161 (538)
T ss_pred             HHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccc--
Confidence            9999 68999999987 789999999999999999999999   9999999999999999999999999999999643  


Q ss_pred             CCCccccccccCCCCCcChhccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc----
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMK-TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL----  496 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~----  496 (554)
                        .....+.++.|.+|+|||++. .+.|+.+.||||+|||++|+.+-++.|.+.+..++...+-.+........+.    
T Consensus       162 --SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  162 --SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             --cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence              233455678899999999875 4579999999999999999999999999887766655554433322222211    


Q ss_pred             ----------ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          497 ----------DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       497 ----------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                                ....-.+....+. +..+..+++.+|+++||.+|||+.|.+++.
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence                      1122233333333 677899999999999999999999999985

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-44  Score=366.51  Aligned_cols=265  Identities=25%  Similarity=0.379  Sum_probs=220.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      ....+.++||+|.||.|.+++...+..||||.++.......+.+|.+|+++|.+|+||||++++|+|..++.+++|+|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            45667889999999999999998889999999999988888899999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ++|+|..|+.++..........++|+.||+.|++||.   +.++|||||.++|+|++.++++||+|||++|-+.. .+..
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys-g~yy  693 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS-GDYY  693 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCccccccccc-CCce
Confidence            9999999999886555667777889999999999999   89999999999999999999999999999996533 3444


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT--GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      +...+.+-+.+|||||.+..++++.++|||+||+++||+++  ...||........   ++........+.... +-   
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~-~l---  766 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQV-VL---  766 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCcce-ec---
Confidence            55556677899999999999999999999999999999977  7888875433222   222212222211111 11   


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                        .-+.-++..+++++.+||+.+-++||+++++..+|.+.
T Consensus       767 --~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  767 --SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             --cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence              12334677899999999999999999999999998764

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-44  Score=358.81  Aligned_cols=262  Identities=27%  Similarity=0.424  Sum_probs=210.1

Q ss_pred             cCCCcceeeeccCceEEEEEEEcC-CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC--ceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN--ERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--~~~lv~  342 (554)
                      .+|...+.||+|+||+||++...+ |...|||.+....... .+.+.+|+.+|.+++|||||+.+|......  .++++|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            446667789999999999997654 8999999887764322 567899999999999999999999854444  689999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC-CCcEEEEeecCcccCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE-SMRAKVADFGFARLGPMD  421 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~~~~~~  421 (554)
                      ||+++|+|.+++.+..+ .+++..++.++.||++||+|||   +++++||||||+|||++. ++.+||+|||+++.....
T Consensus        96 Ey~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             eccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999999999998755 7999999999999999999999   999999999999999999 799999999999864432


Q ss_pred             CCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      ...........||+.|||||++..+ ....++|||||||++.||+||+.||...     .....+.+....+...     
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~-----  241 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL-----  241 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC-----
Confidence            2223334457799999999999863 3345999999999999999999999853     1111122222222111     


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      |    .++..++.+..+++..|++.+|++|||+.++++|.+-....
T Consensus       242 P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  242 P----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             C----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            1    23444666788999999999999999999999998876544

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=366.66  Aligned_cols=256  Identities=24%  Similarity=0.411  Sum_probs=215.3

Q ss_pred             hhcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh----hhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCc
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF----ENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNE  337 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~----~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~  337 (554)
                      ..++|...+.||+|+||+|++|.. .+|..||+|++.+...    ....+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            456888999999999999999954 4689999998776522    134566779999999998 9999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC-CcEEEEeecCcc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES-MRAKVADFGFAR  416 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkl~DfGla~  416 (554)
                      .++||||+.+|+|.+++...  ..+.+.++..++.|++.|++|||   +++|+||||||+|||++.+ +++||+|||++.
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             EEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            99999999999999999873  67888999999999999999999   9999999999999999999 999999999998


Q ss_pred             cCCCCCCCccccccccCCCCCcChhccccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ-LT-TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s-~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      ...   .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..........       ...+.
T Consensus       170 ~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-------i~~~~  239 (370)
T KOG0583|consen  170 ISP---GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-------IRKGE  239 (370)
T ss_pred             ccC---CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-------HhcCC
Confidence            743   2334556789999999999999977 86 789999999999999999999997443322211       11111


Q ss_pred             ccccCChhhhhhccHHH-HHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          495 LLDMVDPSIKEVISMEI-LTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       495 ~~~~~d~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      +.          ++... ..++..++.+|+..+|.+|+++.+|+++.|--.
T Consensus       240 ~~----------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  240 FK----------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             cc----------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            10          22223 567899999999999999999999999988765

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-43  Score=349.15  Aligned_cols=268  Identities=25%  Similarity=0.316  Sum_probs=219.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .+.|+...+||.|..++||+|.. +.++.||||++.-.........+.+|+..|+.++||||++.+..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            46788889999999999999954 46899999999888777667899999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      ||.+|++.+++...+...+++..+..|++++++||.|||   .+|-||||||+.||||+.+|.|||+|||.+........
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            999999999999988889999999999999999999999   99999999999999999999999999998876544333


Q ss_pred             Ccccc-ccccCCCCCcChhcccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          424 RTHIS-TKVKGTVGYLDPEYMKT--YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       424 ~~~~~-~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      ..... ..+.||++|||||++..  ..|+.|+||||||++..||.+|..||...-+-...  +........ .......+
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~tLqn~pp-~~~t~~~~  258 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLTLQNDPP-TLLTSGLD  258 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHHhcCCCC-CcccccCC
Confidence            33333 56789999999999644  47999999999999999999999999865432211  111000000 00011111


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ..    -.......+.+++..||+.||++|||+++++.+-+-
T Consensus       259 ~d----~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FF  296 (516)
T KOG0582|consen  259 KD----EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFF  296 (516)
T ss_pred             hH----HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHH
Confidence            11    122344578999999999999999999999988543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=335.81  Aligned_cols=257  Identities=25%  Similarity=0.366  Sum_probs=216.5

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|+..+.||.|+||+|.+++.+ +|..+|+|++++...-  +..+...+|..+|+.+.||+++++.+.+.+.+..++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            56788899999999999999765 5899999999887653  34577899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||++||.|..++++.  .++++..++.+|.||+.||+|||   +.+|++|||||+|||+|.+|.+||+|||+|+...   
T Consensus       124 eyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~---  195 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS---  195 (355)
T ss_pred             eccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence            999999999999765  68999999999999999999999   9999999999999999999999999999998632   


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                         ....+.||||.|+|||++...+|+.++|.|||||++|||+.|.+||....+...       ..++-++++.      
T Consensus       196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i-------Y~KI~~~~v~------  259 (355)
T KOG0616|consen  196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI-------YEKILEGKVK------  259 (355)
T ss_pred             ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH-------HHHHHhCccc------
Confidence               124568999999999999999999999999999999999999999998766322       2222222221      


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCC-----CCHHHHHHHHHHhhhhhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDR-----PDMKSVGEQLWAIRADSLKS  550 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~R-----Ps~~evl~~l~~i~~~~~~~  550 (554)
                          ++......+.+|+...|+.|-.+|     +-..+|..|.|--.-+|.+-
T Consensus       260 ----fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i  308 (355)
T KOG0616|consen  260 ----FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAI  308 (355)
T ss_pred             ----CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHH
Confidence                334445667889999999999888     45556777766555555443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.1e-43  Score=360.95  Aligned_cols=263  Identities=29%  Similarity=0.430  Sum_probs=207.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEE------cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcC-C
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKG-N  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~-~  336 (554)
                      .++|.+.++||+|+||.||+|..      .++..||||+++..........+.+|+.++.++ +||||+++++++... +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46788999999999999999964      235689999997654444456789999999999 899999999988764 4


Q ss_pred             ceEEEEEeCCCCCHHHHHhccc----------------------------------------------------------
Q 042763          337 ERLIITEFVPNGTLREHLDGQY----------------------------------------------------------  358 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------------  358 (554)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            5789999999999999997532                                                          


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCC
Q 042763          359 --GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG  436 (554)
Q Consensus       359 --~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~  436 (554)
                        ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....... ........+++.
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~~  241 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLPLK  241 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCCCCCcc
Confidence              124778889999999999999999   89999999999999999999999999999986432211 111223346788


Q ss_pred             CcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHH
Q 042763          437 YLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKM  515 (554)
Q Consensus       437 y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  515 (554)
                      |+|||++.+..++.++|||||||++|||++ |..||......+...      .....+....         .+..++..+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~l  306 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC------QRLKDGTRMR---------APENATPEI  306 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH------HHHhcCCCCC---------CCCCCCHHH
Confidence            999999998899999999999999999997 999998654432211      1111111100         112234568


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          516 FGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       516 ~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      .+++.+||+.||++|||+.||++.|+++..+
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            8999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-44  Score=364.43  Aligned_cols=253  Identities=25%  Similarity=0.401  Sum_probs=213.5

Q ss_pred             cCCCcceeeeccCceEEEEEE-EcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ..|....+||+|+.|.||.|. ..+++.||||++...... ..+-+.+|+.+|+..+|+|||++++.|..++++++||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            467777889999999999994 456899999999876532 346689999999999999999999999888999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      |++|+|.|.+...   .+++.++..|+.++++||+|||   .++|+|||||.+|||++.+|.+||+|||+|..+....  
T Consensus       352 m~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--  423 (550)
T KOG0578|consen  352 MEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--  423 (550)
T ss_pred             cCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccccc--
Confidence            9999999999765   5999999999999999999999   9999999999999999999999999999998743222  


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                       ......+|||.|||||+.....|++|.||||||++++||+-|.+||-...+......+.-            ...|.++
T Consensus       424 -~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~------------ng~P~lk  490 (550)
T KOG0578|consen  424 -SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------------NGTPKLK  490 (550)
T ss_pred             -CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh------------cCCCCcC
Confidence             244566899999999999999999999999999999999999999987555433222211            1112221


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                        ....++..+.+++.+||+.|+++||++.|+|+|..-
T Consensus       491 --~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl  526 (550)
T KOG0578|consen  491 --NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL  526 (550)
T ss_pred             --CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence              234566778999999999999999999999998644

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=362.72  Aligned_cols=262  Identities=29%  Similarity=0.482  Sum_probs=211.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .+.+.....||+|.||+||+|.+.+  .||||++..... +...+.|++|+.++++-+|.||+-+.|||..+.. .||..
T Consensus       391 ~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq  467 (678)
T KOG0193|consen  391 PEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ  467 (678)
T ss_pred             HHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence            3445567789999999999999873  489999977654 3456889999999999999999999999998777 99999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      +|+|-+|+.+++... ..++..+.+.||.||++|+.|||   .++|||||||..||++.+++.|||+|||++...... .
T Consensus       468 wCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w-~  542 (678)
T KOG0193|consen  468 WCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW-S  542 (678)
T ss_pred             hccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeee-c
Confidence            999999999998764 57899999999999999999999   999999999999999999999999999999763222 1


Q ss_pred             CccccccccCCCCCcChhccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTY---QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~---~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      .........|...|||||+++.+   +|++.+||||||+++|||+||..||. ....+.   +-|.   +..+.    +.
T Consensus       543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dq---Iifm---VGrG~----l~  611 (678)
T KOG0193|consen  543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQ---IIFM---VGRGY----LM  611 (678)
T ss_pred             cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhh---eEEE---ecccc----cC
Confidence            22222334588899999999754   68999999999999999999999998 333222   1111   11111    11


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      +.+.. ....+++.|.+|+..||..+|++||.+.+|+..|.++...
T Consensus       612 pd~s~-~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  612 PDLSK-IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             ccchh-hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            11111 2235678899999999999999999999999988887764

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3e-42  Score=347.30  Aligned_cols=258  Identities=23%  Similarity=0.346  Sum_probs=209.3

Q ss_pred             CCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .|+..+.||+|+||+||+|.. .+|+.||+|.+......  .....+.+|+.++++++|+||+++++++.+++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367788999999999999965 46899999998765432  223467899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++|+|.+++.......+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++......  
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--  155 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--  155 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--
Confidence            999999998887654457899999999999999999999   899999999999999999999999999999864321  


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..   ......         
T Consensus       156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~~~~~---------  221 (285)
T cd05631         156 --ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR---RVKEDQ---------  221 (285)
T ss_pred             --CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH---Hhhccc---------
Confidence              112344689999999999999999999999999999999999999987554322211111   111100         


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHHhh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPD-----MKSVGEQLWAIR  544 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~i~  544 (554)
                       ..+.......+.+++.+||+.||++||+     +.+++++.|--.
T Consensus       222 -~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~  266 (285)
T cd05631         222 -EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN  266 (285)
T ss_pred             -ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence             0122234567889999999999999997     899999876443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=372.62  Aligned_cols=261  Identities=27%  Similarity=0.453  Sum_probs=226.3

Q ss_pred             CCCcceeeeccCceEEEEEEEcC----CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLED----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ...+.++||.|.||.||+|+++-    ...||||.++....++.+.+|+.|..||.+++||||++|.|+.......+||.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            44567789999999999997762    35799999999988888999999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      |||++|+|+.||+.+.+ .+.+.+.+-++.+||.|+.||-   +.++|||||..+|||++.+..+|++|||++|....+.
T Consensus       710 EyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            99999999999998764 4899999999999999999999   8999999999999999999999999999999876555


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                      ........-.-+.+|.|||.+..++++.+|||||||++|||.++ |.+||......+....++..+              
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy--------------  851 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY--------------  851 (996)
T ss_pred             CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc--------------
Confidence            33332223334678999999999999999999999999999998 999999877655444333211              


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                        +---+++++..|++|+..||+.|..+||.+.+|+..|.++-.+.
T Consensus       852 --RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  852 --RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             --CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence              11145688999999999999999999999999999999887654

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.6e-42  Score=324.65  Aligned_cols=267  Identities=23%  Similarity=0.325  Sum_probs=213.4

Q ss_pred             cCCCcceeeeccCceEEEEEE-EcCCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .+|...++||+|.||.||+|+ ..+|+.||||+++..... .......+||+.|+.++|+||+.++++|.+.+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            467778899999999999995 457999999999876543 334568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      || ..||...++.+ ...+...++..++.++++||+|||   .+.|+||||||.|+|++.+|.+||+|||+|+.+.... 
T Consensus        82 fm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~-  155 (318)
T KOG0659|consen   82 FM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN-  155 (318)
T ss_pred             ec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCC-
Confidence            99 57999988765 467888999999999999999999   9999999999999999999999999999999865332 


Q ss_pred             CccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc---C
Q 042763          424 RTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM---V  499 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  499 (554)
                        ...+..+.|.+|+|||.+.| +.|+...||||.|||+.||+.|.+-|.+.+.-++...+-.+.....+..+.++   .
T Consensus       156 --~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  156 --RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             --cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence              22233378999999998876 57999999999999999999999888877655544433333322222222211   1


Q ss_pred             C---------hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          500 D---------PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       500 d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      |         +.+.. +-..+..+..+++..|+..||.+|+++.|.+++-+
T Consensus       234 dY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y  283 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPY  283 (318)
T ss_pred             cHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence            1         11111 11234566799999999999999999999998854

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-43  Score=352.39  Aligned_cols=268  Identities=25%  Similarity=0.347  Sum_probs=212.2

Q ss_pred             hcCCCcceeeeccCceEEEEEE-EcCCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcC--CceEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKG--NERLI  340 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~l  340 (554)
                      .+.|+.+++||+|+||.||+|+ ..+|+.||+|+++....+ ....-..+||.+|++|+||||++|.+...+.  ..+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            4567788899999999999994 567999999999876532 3345577999999999999999999998765  68899


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      |+|||+ -||..++.. .+-.+++.++..++.|++.||+|+|   .++|+|||||.+|||||.+|.+||+|||||+++..
T Consensus       196 VFeYMd-hDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  196 VFEYMD-HDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             EEeccc-chhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            999995 588888754 2457999999999999999999999   99999999999999999999999999999997543


Q ss_pred             CCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc-
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM-  498 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  498 (554)
                        ......+..+-|.+|+|||++.+. .|+.+.|+||.||||.||++|++.|.+....+....+........+. .+.. 
T Consensus       271 --~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~-~W~~~  347 (560)
T KOG0600|consen  271 --SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED-YWPVS  347 (560)
T ss_pred             --CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh-ccccc
Confidence              333336667789999999998875 79999999999999999999999999877655544333222111111 1110 


Q ss_pred             -------------CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          499 -------------VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       499 -------------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                                   ....+.+. -...+...++|+..+|..||.+|.|+.++++.-+
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~sey  402 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEY  402 (560)
T ss_pred             cCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCcc
Confidence                         01122222 1123456789999999999999999999987644

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.9e-42  Score=350.97  Aligned_cols=264  Identities=22%  Similarity=0.297  Sum_probs=217.9

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      ..++|+..+.||+|+||.||+|+.+ +|..+|+|++++...  ....+.++.|-.+|...++|+||+|+-.|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            3578999999999999999999665 599999999998765  3455788999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||||++|||+..+|...  ..+++..+..++.+++.|++.||   ..|+|||||||+|+|||..|++||+||||+.-...
T Consensus       219 iMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            99999999999999766  68999999999999999999999   99999999999999999999999999999853211


Q ss_pred             ---------------------CCCCcc----c-------------------cccccCCCCCcChhccccCCCCchhhHHH
Q 042763          421 ---------------------DSDRTH----I-------------------STKVKGTVGYLDPEYMKTYQLTTKSDVYS  456 (554)
Q Consensus       421 ---------------------~~~~~~----~-------------------~~~~~gt~~y~aPE~l~~~~~s~ksDVwS  456 (554)
                                           ..+...    .                   ....+|||.|||||++.+..|+...|+||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence                                 000000    0                   01246999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCC---H
Q 042763          457 FGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPD---M  533 (554)
Q Consensus       457 lGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~  533 (554)
                      ||||+||||.|.+||....+.+....+......+..+.             ..++..+..+||.+|+. ||++|--   +
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-------------~~~~s~eA~DLI~rll~-d~~~RLG~~G~  439 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-------------EVDLSDEAKDLITRLLC-DPENRLGSKGA  439 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-------------cCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence            99999999999999999888777665543332222211             11233678899999999 9999975   8


Q ss_pred             HHHHHHHHHhhhh
Q 042763          534 KSVGEQLWAIRAD  546 (554)
Q Consensus       534 ~evl~~l~~i~~~  546 (554)
                      .||-+|.|--.-+
T Consensus       440 ~EIK~HPfF~~v~  452 (550)
T KOG0605|consen  440 EEIKKHPFFKGVD  452 (550)
T ss_pred             HHHhcCCccccCC
Confidence            8888876644333

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=9.5e-43  Score=354.18  Aligned_cols=249  Identities=29%  Similarity=0.398  Sum_probs=212.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+... ++....+.+|++++++++||||+.++++|++..++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46777888999999999999766 588999999977653 4456779999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      ||.| +|..++...  ..++++.+..++.+++.||.|||   +.+|+|||+||+|||++.+|.+|+||||+|+..   ..
T Consensus        82 ~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m---~~  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAM---ST  152 (808)
T ss_pred             hhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhc---cc
Confidence            9955 999999765  68999999999999999999999   999999999999999999999999999999963   33


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      ...+.+.+.|||.|||||+..+.+|+..+|+||+||++|||++|++||...+..    .+   .+.+...       +- 
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~----~L---v~~I~~d-------~v-  217 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT----QL---VKSILKD-------PV-  217 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH----HH---HHHHhcC-------CC-
Confidence            556677788999999999999999999999999999999999999999743221    11   1111111       10 


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                        ..+......+.+++...|+.||.+|.+..+++.|.
T Consensus       218 --~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp  252 (808)
T KOG0597|consen  218 --KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP  252 (808)
T ss_pred             --CCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence              02336677899999999999999999999999985

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.3e-41  Score=345.61  Aligned_cols=263  Identities=26%  Similarity=0.403  Sum_probs=204.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEcC-----------------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceee
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLED-----------------GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL  328 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~-----------------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l  328 (554)
                      ++|...++||+|+||.||+|...+                 +..||+|.+..........++.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578888999999999999997532                 347999998775545556789999999999999999999


Q ss_pred             eeEEEcCCceEEEEEeCCCCCHHHHHhccc-----------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEe
Q 042763          329 LGFVDKGNERLIITEFVPNGTLREHLDGQY-----------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH  391 (554)
Q Consensus       329 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH  391 (554)
                      ++++.+.+..++||||+++|+|.+++....                 ...+++.+++.++.||+.||.|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999986431                 124678889999999999999999   899999


Q ss_pred             CCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh--CCC
Q 042763          392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT--GRR  469 (554)
Q Consensus       392 ~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt--g~~  469 (554)
                      |||||+|||++.++.+||+|||+++...... .........++..|+|||++.+..++.++||||||+++|||++  +..
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGD-YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCc-eeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999997542211 1122233456789999999988899999999999999999987  566


Q ss_pred             CCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          470 PVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       470 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ||..........   ........... ...     ...+..++..+.+++.+||+.+|++|||+.+|.+.|.
T Consensus       241 p~~~~~~~~~~~---~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQVIE---NAGEFFRDQGR-QVY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHHHHH---HHHHHhhhccc-ccc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            776544322211   11111111000 000     0011234567899999999999999999999988875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-42  Score=360.56  Aligned_cols=254  Identities=24%  Similarity=0.337  Sum_probs=215.5

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      -|+..+.||.|+.|.|-+|++. +|+.+|||++.+...  +.....+.+||-+|+.+.|||++++++++++..++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            3566778999999999999654 799999999977632  2334568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++|.|.+++-.+  +++++.++.+++.||+.|+.|+|   ..+|+||||||+|+|+|..+.+||+|||+|..    ..
T Consensus        93 yv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsL----e~  163 (786)
T KOG0588|consen   93 YVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASL----EV  163 (786)
T ss_pred             ecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeec----cc
Confidence            99999999999776  68999999999999999999999   89999999999999999999999999999986    23


Q ss_pred             CccccccccCCCCCcChhccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLT-TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s-~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                      ......+.||.|.|.+||++.+.+|. .++||||+|||||.||||+.||++++....       ..++..+.+.      
T Consensus       164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~L-------LlKV~~G~f~------  230 (786)
T KOG0588|consen  164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVL-------LLKVQRGVFE------  230 (786)
T ss_pred             CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHH-------HHHHHcCccc------
Confidence            33445667899999999999999885 789999999999999999999995432221       2222232221      


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                          .+..++.+..+|+++|+..||++|-|++||++|.|-....
T Consensus       231 ----MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  231 ----MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             ----CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence                3345667789999999999999999999999999866543

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2e-41  Score=348.86  Aligned_cols=270  Identities=26%  Similarity=0.375  Sum_probs=210.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|+..+.||+|+||.||++... +|..||+|.+.........+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            467899999999999999999766 5889999998765444455779999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK-QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||   +. +|+||||||+|||++.++.+||+|||+++..... 
T Consensus        84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            99999999999764  46889999999999999999999   54 6999999999999999999999999998754221 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc------
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL------  496 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~------  496 (554)
                          ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+.............      
T Consensus       158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence                1233468999999999999899999999999999999999999997554322111110000000000000      


Q ss_pred             ---------------------ccCChhh----hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          497 ---------------------DMVDPSI----KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       497 ---------------------~~~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                                           +..+...    ..........++.+++.+||+.||++|||+.+++++.|--+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~  306 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR  306 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence                                 0000000    00001124567899999999999999999999999988543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-42  Score=320.75  Aligned_cols=255  Identities=28%  Similarity=0.449  Sum_probs=221.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .++|++.+.||+|-||.||.|+.+ ++-.||+|++.+.+..  ....++.+|+++-+.|+||||++++++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            467899999999999999999665 5789999999887653  3456799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      +||..+|.+...|.+.....+++.....+..|+|.||.|+|   .++|+||||||+|+|++..+.+||+|||.+-..+  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999999999887889999999999999999999999   9999999999999999999999999999997633  


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                         .......+||..|++||...+..++.+.|+|++|++.||++.|.+||+.....+....+...          +..  
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~----------~~~--  240 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV----------DLK--  240 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc----------ccc--
Confidence               23345678999999999999999999999999999999999999999976644433332221          111  


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                           ++..++....++|.+|+..+|.+|.+..|+++|.|-..
T Consensus       241 -----~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  241 -----FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             -----CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence                 23345567889999999999999999999999999654

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-42  Score=352.21  Aligned_cols=258  Identities=24%  Similarity=0.371  Sum_probs=210.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|++.++||+|+||.||+|... +++.||||++......  .....+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999776 5899999999876432  33467889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++...  ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....  
T Consensus        81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999999999654  46889999999999999999999   89999999999999999999999999999975322  


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                          ......||+.|+|||++.+..++.++|||||||++|||++|..||......+....+..........   ...++ 
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~---~~~~~-  225 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRP---VYDDP-  225 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCC---CCCcc-
Confidence                2234569999999999999899999999999999999999999998765433322221110000000   00000 


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                           ...+...+.+++.+||+.+|++||++.+++++.|--
T Consensus       226 -----~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~  261 (333)
T cd05600         226 -----RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK  261 (333)
T ss_pred             -----ccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence                 123456788999999999999999999999997643

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.2e-42  Score=345.05  Aligned_cols=268  Identities=23%  Similarity=0.331  Sum_probs=206.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|...++||+|+||+||+|... ++..||+|+++..........+.+|+.++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56888999999999999999765 68999999987654333445678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      ++ ++|.+++... ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......  
T Consensus        85 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--  157 (288)
T cd07871          85 LD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--  157 (288)
T ss_pred             CC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence            96 5999988654 345789999999999999999999   8999999999999999999999999999997532211  


Q ss_pred             ccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC---------C
Q 042763          425 THISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG---------N  494 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---------~  494 (554)
                       .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+..........         .
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence             11233468999999998865 568999999999999999999999998765544333222111100000         0


Q ss_pred             ccccCChhhh----hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          495 LLDMVDPSIK----EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       495 ~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ......+...    .........++.+++.+||+.||.+|||++|+++|.|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~  287 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY  287 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence            0001111000    0001123456789999999999999999999998865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-42  Score=346.29  Aligned_cols=255  Identities=24%  Similarity=0.314  Sum_probs=209.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|+..++||+|+||+||+|... +|+.||+|++......  ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888899999999999999765 6899999998764322  23456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++...  ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence            999999999999765  46889999999999999999999   899999999999999999999999999999764221 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.       ....       
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~-------~~~~-------  215 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL-------AGKL-------  215 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCc-------
Confidence                 123468999999999999899999999999999999999999998654332211111       1110       


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHHhhhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPD-----MKSVGEQLWAIRADSL  548 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~i~~~~~  548 (554)
                         .++......+.+++.+||+.||.+||+     +.++++|.|--.-++.
T Consensus       216 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         216 ---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             ---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence               011223456789999999999999995     9999999886544443

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=358.81  Aligned_cols=244  Identities=25%  Similarity=0.349  Sum_probs=210.2

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~  339 (554)
                      ..++|...++||+|.||+|+++..+ +++.+|||++++...  ++..+..+.|..++... +||.++++++.|.+.+++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            4478999999999999999999876 588999999998764  44567788898888877 5999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +||||+.|||+..+.+   ...+++..+..++..|+.||+|||   +++|||||||.+|||+|.+|.+||+|||+++.. 
T Consensus       446 fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~-  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG-  518 (694)
T ss_pred             EEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccccccccc-
Confidence            9999999999544443   357999999999999999999999   999999999999999999999999999999863 


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                        ........+++|||.|||||++.+..|+.+.|+|||||+|||||.|..||.+.+.++....+..       .+     
T Consensus       519 --m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~-------d~-----  584 (694)
T KOG0694|consen  519 --MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN-------DE-----  584 (694)
T ss_pred             --CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-------CC-----
Confidence              3344466789999999999999999999999999999999999999999998776654433321       11     


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCH
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDM  533 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  533 (554)
                           -.++..++.+...++.++|..+|++|.-+
T Consensus       585 -----~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 -----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                 11556677888999999999999999987

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-42  Score=341.19  Aligned_cols=251  Identities=22%  Similarity=0.398  Sum_probs=215.6

Q ss_pred             hcCCCcceeeeccCceEEEEEE-EcCCcEEEEEEcchhhhhh--HHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~~~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ..+|++.+.||+|.||.|-+|. ...|+.||||.+++...++  ..-.+.+||++|+.|+||||+.++.+|+..+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            3578888899999999999994 4679999999998887643  334688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||..+|.|+||+.++  ..+++.++..++.||..|+.|+|   .++++|||||.+|||+|+++++||+|||++..+.  
T Consensus       132 MEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~--  204 (668)
T KOG0611|consen  132 MEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA--  204 (668)
T ss_pred             EEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc--
Confidence            9999999999999876  68999999999999999999999   9999999999999999999999999999998743  


Q ss_pred             CCCccccccccCCCCCcChhccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQL-TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                        ......++||+|-|.+||+.++.+| .+..|-|||||+||-|+.|..||++.+.......+       ..+.+     
T Consensus       205 --~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI-------s~GaY-----  270 (668)
T KOG0611|consen  205 --DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI-------SRGAY-----  270 (668)
T ss_pred             --cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh-------hcccc-----
Confidence              2234567899999999999999988 47899999999999999999999986543322222       11211     


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                            ..++.+....-||++||-.+|++|.|+.+|..|.|-
T Consensus       271 ------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  271 ------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             ------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence                  122334556789999999999999999999999983

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=348.84  Aligned_cols=251  Identities=29%  Similarity=0.394  Sum_probs=213.8

Q ss_pred             cCCCcceeeeccCceEEEEEE-EcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ..|.....||+|.||.||+|. ...++.||+|++.....+...+++.+|+.++.+++++||.++++.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            446666789999999999995 4568999999999988888788999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      |.+|++.+.+...  ..+++.++..++.+++.||.|||   ..+.+|||||+.|||+..+|.+|++|||.+-....... 
T Consensus        93 ~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-  166 (467)
T ss_pred             hcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh-
Confidence            9999999999754  45588888899999999999999   89999999999999999999999999999977543322 


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                        ...+++|||.|||||++....|+.|+||||||++.+||.+|.+|+....+-....            .+.+...|.+.
T Consensus       167 --rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------------lIpk~~PP~L~  232 (467)
T KOG0201|consen  167 --RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------------LIPKSAPPRLD  232 (467)
T ss_pred             --ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------------eccCCCCCccc
Confidence              2256889999999999998899999999999999999999999998655521100            11122233333


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                          ......+.+++..||+.||+.||++.++++|-
T Consensus       233 ----~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~  264 (467)
T KOG0201|consen  233 ----GDFSPPFKEFVEACLDKNPEFRPSAKELLKHK  264 (467)
T ss_pred             ----cccCHHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence                35566799999999999999999999999873

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.6e-41  Score=338.49  Aligned_cols=249  Identities=26%  Similarity=0.362  Sum_probs=201.6

Q ss_pred             ceeeeccCceEEEEEEEcCCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc----CCceEEEEEe
Q 042763          271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK----GNERLIITEF  344 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~~lv~E~  344 (554)
                      ...||+|++|.||+|.. +|+.||||+++....  ....+.+.+|+.+|++++||||++++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            35799999999999988 589999999976532  2234678899999999999999999999866    3467899999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++|+|.+++...  ..+++...+.++.|++.||.|||.  ..+++||||||+|||+++++.+||+|||+++.....   
T Consensus       104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---  176 (283)
T PHA02988        104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---  176 (283)
T ss_pred             CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence            9999999999765  578899999999999999999992  248889999999999999999999999999864221   


Q ss_pred             ccccccccCCCCCcChhcccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          425 THISTKVKGTVGYLDPEYMKT--YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                         .....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......+...   ........        +.
T Consensus       177 ---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~---~i~~~~~~--------~~  242 (283)
T PHA02988        177 ---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD---LIINKNNS--------LK  242 (283)
T ss_pred             ---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH---HHHhcCCC--------CC
Confidence               123458899999999976  689999999999999999999999998654332211   11110000        00


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                          .+..++..+.+++.+||+.||++|||+.||++.|..++.
T Consensus       243 ----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        243 ----LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             ----CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                122345678999999999999999999999999988764

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.5e-41  Score=340.40  Aligned_cols=269  Identities=20%  Similarity=0.261  Sum_probs=207.3

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ++|++.+.||+|+||+||+|... +++.||+|++..... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888999999999999999776 588999999875432 2334678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |++++.+..+...  ...+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  154 (287)
T cd07848          81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-  154 (287)
T ss_pred             cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-
Confidence            9988766655432  356899999999999999999999   8999999999999999999999999999998643221 


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHh---------hccCC
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR---------YNEGN  494 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~---------~~~~~  494 (554)
                       ........|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+......         .....
T Consensus       155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 -NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             -cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence             11223456899999999999888999999999999999999999999875543332222211100         00000


Q ss_pred             ccccCCh------hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          495 LLDMVDP------SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       495 ~~~~~d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ......+      ..........+..+.+++.+||+.||++|||++|+++|.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~  286 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA  286 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence            0000000      0111111234567999999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.5e-41  Score=349.30  Aligned_cols=255  Identities=26%  Similarity=0.402  Sum_probs=201.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .+|+..++||+|+||+||+|... +|+.||||++...........+.+|++++++++|+||+++++++..++..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45666788999999999999765 68999999987655445567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++|+|.+..      ...+..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......  
T Consensus       154 ~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--  222 (353)
T PLN00034        154 MDGGSLEGTH------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--  222 (353)
T ss_pred             CCCCcccccc------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--
Confidence            9999986532      3567778899999999999999   8999999999999999999999999999998643221  


Q ss_pred             ccccccccCCCCCcChhcccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          425 THISTKVKGTVGYLDPEYMKT-----YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                       .......||..|+|||++..     ...+.++|||||||++|||++|+.||......+......... ....       
T Consensus       223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~-------  293 (353)
T PLN00034        223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQP-------  293 (353)
T ss_pred             -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCC-------
Confidence             11233569999999998743     234568999999999999999999998443322111111110 0000       


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                       +    .....+...+.+++.+||+.||++||++.|+++|.|-.+.
T Consensus       294 -~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        294 -P----EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             -C----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence             0    0122345678999999999999999999999999886665

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=351.82  Aligned_cols=258  Identities=26%  Similarity=0.419  Sum_probs=211.9

Q ss_pred             ccccccChHHHHHhhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeee
Q 042763          251 IGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG  330 (554)
Q Consensus       251 ~~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~  330 (554)
                      ...+...+++|..       .+-||.|+.|.||+|+++ ++.||||+++.-+        ..+|+-|++|+||||+.+.|
T Consensus       116 ~e~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkG  179 (904)
T KOG4721|consen  116 EELWEIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKG  179 (904)
T ss_pred             hhhccCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEee
Confidence            3445555665543       446999999999999998 7889999776432        35778999999999999999


Q ss_pred             EEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEE
Q 042763          331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVA  410 (554)
Q Consensus       331 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~  410 (554)
                      +|.....++||||||..|-|...|+..  ..+.....+.|..+||.|+.|||   .+.|||||||.-||||+.+..|||+
T Consensus       180 VCtqsPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIs  254 (904)
T KOG4721|consen  180 VCTQSPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKIS  254 (904)
T ss_pred             eecCCceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEec
Confidence            999999999999999999999999765  57788888999999999999999   8999999999999999999999999


Q ss_pred             eecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhh
Q 042763          411 DFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY  490 (554)
Q Consensus       411 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  490 (554)
                      |||.++....   . .....++||..|||||++++.+.+.|+|||||||||||||||..||..-+..    .+-|.    
T Consensus       255 DFGTS~e~~~---~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwG----  322 (904)
T KOG4721|consen  255 DFGTSKELSD---K-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWG----  322 (904)
T ss_pred             cccchHhhhh---h-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEe----
Confidence            9999985321   1 2233578999999999999999999999999999999999999999753321    11121    


Q ss_pred             ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                             .-...+.-..+..+++-+.-|+.+||+-.|.+||++++|+.||.-...+-+
T Consensus       323 -------VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell  373 (904)
T KOG4721|consen  323 -------VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL  373 (904)
T ss_pred             -------ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence                   111222223455677888999999999999999999999999876655544

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-41  Score=349.71  Aligned_cols=269  Identities=21%  Similarity=0.272  Sum_probs=202.0

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC-----CceE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG-----NERL  339 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~~~  339 (554)
                      +|+..++||+|+||.||+|... +|..||||++..... ......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999754 689999999875322 22335688999999999999999999987543     2479


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +||||| +++|.+++...  ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            999999 57999988654  46899999999999999999999   8999999999999999999999999999998643


Q ss_pred             CCCCCccccccccCCCCCcChhcccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH--------Hh
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKT--YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF--------KR  489 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~--------~~  489 (554)
                      .............||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+....        ..
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            22222222234579999999999876  578999999999999999999999997654322211111000        00


Q ss_pred             hccCCc-------cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          490 YNEGNL-------LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       490 ~~~~~~-------~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ......       ............ ......+.+++.+||+.||++||++.|++++.|-
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f  293 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYF  293 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchh
Confidence            000000       000000000000 1123567899999999999999999999999775

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.6e-42  Score=350.77  Aligned_cols=247  Identities=22%  Similarity=0.299  Sum_probs=202.5

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNG  348 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g  348 (554)
                      +.||+|+||.||+|... +|+.||+|+++....  ......+.+|++++++++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999764 689999999986542  233456789999999999999999999999999999999999999


Q ss_pred             CHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcccc
Q 042763          349 TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIS  428 (554)
Q Consensus       349 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~  428 (554)
                      +|.+++...  ..+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....   ....
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~---~~~~  152 (323)
T cd05571          81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD---GATM  152 (323)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC---CCcc
Confidence            999998754  57899999999999999999999   899999999999999999999999999998752211   1122


Q ss_pred             ccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhcc
Q 042763          429 TKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS  508 (554)
Q Consensus       429 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  508 (554)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ...    .....          .++
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~~----~~~~~----------~~p  215 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---ELI----LMEEI----------RFP  215 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH---HHH----HcCCC----------CCC
Confidence            3456999999999999999999999999999999999999999764432211   111    11100          012


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHh
Q 042763          509 MEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAI  543 (554)
Q Consensus       509 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i  543 (554)
                      ......+.+++.+||+.||++||     ++.++++|.|--
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~  255 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFA  255 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcC
Confidence            23455688999999999999999     899999987643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.5e-41  Score=341.70  Aligned_cols=268  Identities=22%  Similarity=0.353  Sum_probs=205.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|+..++||+|+||+||+|... +++.||||++...........+.+|+.++++++||||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999775 6899999998765433334567889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+ .++|.+++... ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....  
T Consensus        84 ~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--  156 (303)
T cd07869          84 YV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--  156 (303)
T ss_pred             CC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--
Confidence            99 57888888654 346888999999999999999999   899999999999999999999999999998753211  


Q ss_pred             CccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC--------
Q 042763          424 RTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN--------  494 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--------  494 (554)
                       ........+|+.|+|||++.+ ..++.++|||||||++|||++|..||........  .+...........        
T Consensus       157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         157 -SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             -CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchh
Confidence             112233468999999998865 4588999999999999999999999986543221  1111111111000        


Q ss_pred             ---------ccccCChhhhhhcc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          495 ---------LLDMVDPSIKEVIS-MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       495 ---------~~~~~d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                               ........+..... ......+.+++.+||+.||++|||+.|+++|.|-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f  291 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF  291 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccc
Confidence                     00000011111000 0123567899999999999999999999998763

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4e-41  Score=335.44  Aligned_cols=256  Identities=24%  Similarity=0.411  Sum_probs=207.2

Q ss_pred             cCCCcceeeeccCceEEEEEEEc----CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ++|++.+.||+|+||.||+|.+.    .+..||+|.++..........+.+|+.++++++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            56888899999999999999653    36789999998765445557799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++|+|.+++... ...+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+|++|||.+......
T Consensus        85 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          85 TEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            9999999999999764 246899999999999999999999   899999999999999999999999999987642211


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                        .........++..|+|||.+.+..++.++|||||||++|||++ |..||......+..   ...    ......    
T Consensus       161 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~---~~~----~~~~~~----  227 (266)
T cd05064         161 --AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI---KAV----EDGFRL----  227 (266)
T ss_pred             --chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH---HHH----HCCCCC----
Confidence              1111112345678999999999999999999999999999875 99999865433221   111    111000    


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      +     .+..++..+.+++.+||+.+|++||++.+|.+.|.++
T Consensus       228 ~-----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 P-----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             C-----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            0     1223456789999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.1e-41  Score=340.23  Aligned_cols=267  Identities=24%  Similarity=0.336  Sum_probs=202.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEc--CCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhC---CCCCceeeeeEEE-----c
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE--DGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKI---DHRNLVKLLGFVD-----K  334 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~-----~  334 (554)
                      ++|+..+.||+|+||+||+|...  +|..||+|+++..... .....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999763  4788999988754322 2234566777777766   6999999999885     3


Q ss_pred             CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecC
Q 042763          335 GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGF  414 (554)
Q Consensus       335 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl  414 (554)
                      ....++||||++ ++|.+++.......+++.+++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999995 79999998765567899999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      ++.....    .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+...........
T Consensus       157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         157 ARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             eEeccCC----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            9864322    223345689999999999888999999999999999999999999987654333222211110000000


Q ss_pred             ccc-------cCC----hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          495 LLD-------MVD----PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       495 ~~~-------~~d----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ...       ...    ..+.. ...+....+.+++.+||+.||++|||+.|++++.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~  289 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  289 (290)
T ss_pred             chhhhcccchhccCCCCCCHHH-HccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence            000       000    00111 11234556789999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2e-41  Score=354.70  Aligned_cols=259  Identities=30%  Similarity=0.426  Sum_probs=205.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEE------cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~  337 (554)
                      .++|+..++||+|+||.||+|..      .++..||||+++........+.+.+|+.+++.+ +||||+++++++..++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            34688889999999999999963      236689999997654444456789999999999 89999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHhccc-----------------------------------------------------------
Q 042763          338 RLIITEFVPNGTLREHLDGQY-----------------------------------------------------------  358 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~-----------------------------------------------------------  358 (554)
                      .++|||||++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986432                                                           


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          359 --------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       359 --------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                                    ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124788889999999999999999   899999999999999999999999999999864322211


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                       .......++..|+|||.+.+..++.++||||||+++|||++ |..||.........  .....    .+. . ..    
T Consensus       271 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~--~~~~~----~~~-~-~~----  337 (375)
T cd05104         271 -VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF--YKMIK----EGY-R-ML----  337 (375)
T ss_pred             -cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH--HHHHH----hCc-c-CC----
Confidence             11222345678999999999999999999999999999998 88898764432221  11111    110 0 00    


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                         .+...+.++.+++.+||+.||++||++.||++.|++
T Consensus       338 ---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         338 ---SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence               011224568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-42  Score=378.49  Aligned_cols=264  Identities=34%  Similarity=0.483  Sum_probs=219.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEcC--Cc----EEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLED--GL----LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~--g~----~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      .+.+..+.||+|.||.||.|...+  |.    .||||.+++........+|++|..+|++++|||||+++|++.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            344556789999999999997653  43    499999998877777899999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhccc-----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecC
Q 042763          340 IITEFVPNGTLREHLDGQY-----GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGF  414 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl  414 (554)
                      |++|||++|||..||++.+     ...+...+.+.++.+||+|+.||+   ++++|||||..+|+|+++...|||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999998653     357889999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccC
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEG  493 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~  493 (554)
                      |+.... .+.........-...|||||.+..+.++.|+|||||||+|||++| |..||...+..+....+.      ..+
T Consensus       849 ArDiy~-~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~------~gg  921 (1025)
T KOG1095|consen  849 ARDIYD-KDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL------EGG  921 (1025)
T ss_pred             hHhhhh-chheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH------hCC
Confidence            994322 222222222234578999999999999999999999999999999 999998766544322111      111


Q ss_pred             CccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 042763          494 NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK  549 (554)
Q Consensus       494 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~  549 (554)
                      ++          ..+..|+..+++||.+||+.+|++||++..|++++.+|.+....
T Consensus       922 RL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~  967 (1025)
T KOG1095|consen  922 RL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG  967 (1025)
T ss_pred             cc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence            11          13556888999999999999999999999999999888776543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.8e-42  Score=350.85  Aligned_cols=251  Identities=26%  Similarity=0.343  Sum_probs=207.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .+|...+.||+|+||.||+|... +++.||+|++.....  ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888899999999999999775 589999999976543  233467889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            999999999999764  56889999999999999999999   899999999999999999999999999999864321 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........       .....+...      
T Consensus       172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------~~i~~~~~~------  233 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY-------EKILAGRLK------  233 (329)
T ss_pred             -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH-------HHHhcCCcC------
Confidence                 12346999999999999999999999999999999999999999764432211       111111110      


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHHhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPD-----MKSVGEQLWAIR  544 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~i~  544 (554)
                          .+..+...+.+++.+||+.||++||+     +.+++.|.|--.
T Consensus       234 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        234 ----FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence                11123346789999999999999997     799999977543

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.8e-41  Score=352.44  Aligned_cols=260  Identities=29%  Similarity=0.443  Sum_probs=206.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~  337 (554)
                      .++|+..+.||+|+||.||+|...      ++..||||+++........+.+.+|+++++.+ +||||+++++++..++.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            357888999999999999998642      24589999997654444456789999999999 89999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHhccc-----------------------------------------------------------
Q 042763          338 RLIITEFVPNGTLREHLDGQY-----------------------------------------------------------  358 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~-----------------------------------------------------------  358 (554)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999986421                                                           


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccc
Q 042763          359 ---------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST  429 (554)
Q Consensus       359 ---------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~  429 (554)
                               ...+++.++++++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++....... .....
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-~~~~~  272 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YVVKG  272 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-eeecc
Confidence                     124778889999999999999999   89999999999999999999999999999976432211 11122


Q ss_pred             cccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhcc
Q 042763          430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS  508 (554)
Q Consensus       430 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  508 (554)
                      ...+++.|||||++.+..++.++|||||||++|||++ |+.||............      .... . ...       .+
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~------~~~~-~-~~~-------~~  337 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM------VKRG-Y-QMS-------RP  337 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH------HHcc-c-Ccc-------CC
Confidence            2335678999999998899999999999999999997 99999764432211111      0000 0 000       01


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          509 MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       509 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      ...+..+.+++.+||+.||++||++.+|++.|.++
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11245688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=9.2e-41  Score=335.38  Aligned_cols=258  Identities=32%  Similarity=0.489  Sum_probs=209.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEcC------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLED------GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      ++|+..+.||+|+||.||+|....      ...||+|.+...........+.+|+.++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467788899999999999997643      25799999876654555677999999999999999999999999989999


Q ss_pred             EEEEeCCCCCHHHHHhcccC--------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC
Q 042763          340 IITEFVPNGTLREHLDGQYG--------------KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM  405 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~  405 (554)
                      ++|||+++++|.+++.....              ..+++.+++.++.|++.||.|||   +.+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            99999999999999975421              45788999999999999999999   89999999999999999999


Q ss_pred             cEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHH
Q 042763          406 RAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLR  484 (554)
Q Consensus       406 ~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~  484 (554)
                      .+||+|||+++..... ..........+++.|+|||.+.+..++.++|||||||++|||++ |..||......+...   
T Consensus       162 ~~~L~dfg~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~---  237 (283)
T cd05048         162 TVKISDFGLSRDIYSA-DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE---  237 (283)
T ss_pred             cEEECCCcceeecccc-ccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---
Confidence            9999999999754221 11122233456889999999988899999999999999999998 999998655432211   


Q ss_pred             HHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       485 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      .    .......         ..+..++..+.+++.+||+.+|.+||++.||+++|..+
T Consensus       238 ~----i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         238 M----IRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             H----HHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            1    1111111         12234567799999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=336.11  Aligned_cols=262  Identities=24%  Similarity=0.342  Sum_probs=211.5

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      +|+..++||+|+||+||++... +++.||+|++......  .....+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778889999999999999764 6899999998765432  223457889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++|+|.+++.......+++..+..++.|++.||+|||   +.+++||||||+||++++++.++|+|||+++...... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999999887654557899999999999999999999   8999999999999999999999999999998643211 


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                         ......|++.|+|||++.+..++.++||||||+++|||++|+.||...........+...   .....         
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~---~~~~~---------  221 (285)
T cd05605         157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR---VKEDQ---------  221 (285)
T ss_pred             ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH---hhhcc---------
Confidence               112346899999999999889999999999999999999999999865433222111111   11100         


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHhhhhhh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAIRADSL  548 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i~~~~~  548 (554)
                       ..++...+..+.+++.+||+.||.+||     ++.+++++.|-...++-
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05605         222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK  270 (285)
T ss_pred             -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence             012233456688999999999999999     89999998776554443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.4e-41  Score=345.95  Aligned_cols=251  Identities=22%  Similarity=0.308  Sum_probs=203.8

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNG  348 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g  348 (554)
                      +.||+|+||.||++... +|..||+|+++....  ......+.+|++++++++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36999999999999764 689999999976532  223456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcccc
Q 042763          349 TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIS  428 (554)
Q Consensus       349 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~  428 (554)
                      +|..++...  ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....   ....
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~---~~~~  152 (323)
T cd05595          81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATM  152 (323)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC---CCcc
Confidence            999988654  47899999999999999999999   899999999999999999999999999998753211   1122


Q ss_pred             ccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhcc
Q 042763          429 TKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS  508 (554)
Q Consensus       429 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  508 (554)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.............     .....            ++
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~-----~~~~~------------~p  215 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-----MEEIR------------FP  215 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh-----cCCCC------------CC
Confidence            34569999999999999899999999999999999999999997654322211110     00000            12


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHhhhhh
Q 042763          509 MEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAIRADS  547 (554)
Q Consensus       509 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i~~~~  547 (554)
                      ..+...+.+++.+||+.||++||     ++.+++++.|-...++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            23345678999999999999998     8999999876554443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-41  Score=344.19  Aligned_cols=245  Identities=24%  Similarity=0.317  Sum_probs=200.5

Q ss_pred             eeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCH
Q 042763          274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTL  350 (554)
Q Consensus       274 LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L  350 (554)
                      ||+|+||+||+|... +++.||+|++.....  ......+.+|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999765 588999999976532  23346688999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcccccc
Q 042763          351 REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK  430 (554)
Q Consensus       351 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~  430 (554)
                      .+++...  ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....   ......
T Consensus        81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~---~~~~~~  152 (312)
T cd05585          81 FHHLQRE--GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD---DDKTNT  152 (312)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC---CCcccc
Confidence            9999754  46899999999999999999999   899999999999999999999999999999753221   122334


Q ss_pred             ccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHH
Q 042763          431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISME  510 (554)
Q Consensus       431 ~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  510 (554)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.........       ........          .++..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~-------~~~~~~~~----------~~~~~  215 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY-------RKILQEPL----------RFPDG  215 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH-------HHHHcCCC----------CCCCc
Confidence            57999999999999999999999999999999999999999864432211       11111110          01223


Q ss_pred             HHHHHHHHHHHccCCCCCCCC---CHHHHHHHHHHh
Q 042763          511 ILTKMFGLAIQCAAPIRNDRP---DMKSVGEQLWAI  543 (554)
Q Consensus       511 ~~~~l~~li~~cl~~dP~~RP---s~~evl~~l~~i  543 (554)
                      ....+.+++.+||+.||++||   ++.|++.|.|--
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~  251 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFS  251 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcC
Confidence            445688999999999999997   578998886643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=352.67  Aligned_cols=261  Identities=30%  Similarity=0.472  Sum_probs=211.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEcC--C--cE-EEEEEcch--hhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCce
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLED--G--LL-VAIKRAKK--EQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~--g--~~-vAvK~~~~--~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  338 (554)
                      ++....++||+|+||.||+|.+..  +  .. ||||..+.  ........+|.+|.++|++++|||||+++|++.....+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            334445799999999999997653  2  23 89998885  23355678999999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ++|||+|.||+|.++|++.. ..++..+++.++.+.|.||+|||   +++++||||-.+|+|++.++.+||+|||+++..
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            99999999999999998763 36999999999999999999999   999999999999999999999999999999863


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                      .   ..........-+..|+|||.+....|+.++|||||||++||+++ |..||.+....+....+..      .+ ...
T Consensus       313 ~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~------~~-~r~  382 (474)
T KOG0194|consen  313 S---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK------NG-YRM  382 (474)
T ss_pred             c---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh------cC-ccC
Confidence            2   11111112246789999999999999999999999999999999 8999987665433222211      00 000


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                              ..+...+..+..++.+||..+|++||+|.++.+.+..+.....
T Consensus       383 --------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  383 --------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             --------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                    0122345567888899999999999999999999998876644

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.3e-41  Score=336.43  Aligned_cols=270  Identities=26%  Similarity=0.385  Sum_probs=206.1

Q ss_pred             CCcceeeeccCceEEEEEEE-----cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC--CceEE
Q 042763          268 FSPSLRIGEGGFGTVYKAQL-----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG--NERLI  340 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~l  340 (554)
                      |+..+.||+|+||+||++..     .++..||+|.++..........+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            47888999999999988643     357899999987654334456788999999999999999999988653  35789


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      +|||+++++|.+++...   .+++.+++.++.|++.||+|||   +++++||||||+|||++.++.+||+|||+++....
T Consensus        86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            99999999999999764   5899999999999999999999   89999999999999999999999999999986543


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      ............++..|+|||.+.+..++.++||||||+++|||++|..|+........ ..............+.+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhh
Confidence            22222222233456779999999888899999999999999999999999865432110 00100000000001111111


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      .......+..++..+.+++.+||+.+|++|||+++|++.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            11111122334567999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.7e-41  Score=346.42  Aligned_cols=248  Identities=23%  Similarity=0.308  Sum_probs=202.8

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNG  348 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g  348 (554)
                      +.||+|+||.||++... +|+.||+|++.....  ......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999764 689999999976532  233467889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcccc
Q 042763          349 TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIS  428 (554)
Q Consensus       349 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~  428 (554)
                      +|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....   ....
T Consensus        81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---~~~~  152 (328)
T cd05593          81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---AATM  152 (328)
T ss_pred             CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc---cccc
Confidence            999988654  57899999999999999999999   899999999999999999999999999998753211   1122


Q ss_pred             ccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhcc
Q 042763          429 TKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS  508 (554)
Q Consensus       429 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  508 (554)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........       ......          .++
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~-------~~~~~~----------~~p  215 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-------ILMEDI----------KFP  215 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH-------hccCCc----------cCC
Confidence            345799999999999998999999999999999999999999976543221111       110000          012


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHhh
Q 042763          509 MEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAIR  544 (554)
Q Consensus       509 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i~  544 (554)
                      ......+.+++.+||+.||++||     ++.|++++.|-..
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            23445688999999999999997     8999999876543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.1e-40  Score=341.56  Aligned_cols=266  Identities=25%  Similarity=0.381  Sum_probs=207.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|+..++||+|+||.||++... ++..+|+|.+...........+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468899999999999999999776 5888999988765434445678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||.  ..+++||||||+|||++.++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            99999999999754  468889999999999999999992  247999999999999999999999999998754221  


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc-----
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM-----  498 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  498 (554)
                         ......|+..|+|||++.+..++.++|||||||++|||++|+.||...........    ............     
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  230 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM----FGCPVEGDPAESETSPR  230 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHH----hcCcccCCccccccCcc
Confidence               12234689999999999988899999999999999999999999976443221111    000000000000     


Q ss_pred             ----------CChh--------------hhh----hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          499 ----------VDPS--------------IKE----VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       499 ----------~d~~--------------l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                                ..+.              ...    ........++.+++.+||+.||++|||+.|++++.|--
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~  303 (333)
T cd06650         231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK  303 (333)
T ss_pred             cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHh
Confidence                      0000              000    00001235688999999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1e-40  Score=331.04  Aligned_cols=256  Identities=27%  Similarity=0.446  Sum_probs=209.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .++|+..++||+|+||.||+|...++..||+|.+.....  ..+.+.+|+.++++++|+||+++++++..++..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            357888899999999999999888888999998875432  246789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++.......+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||+++......  
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--  157 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE--  157 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCc--
Confidence            99999999998766677899999999999999999999   8999999999999999999999999999998643221  


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.........   ....    ....    .+. 
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~----~~~~----~~~-  225 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM---SALQ----RGYR----MPR-  225 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH---HHHH----cCCC----CCC-
Confidence            111222346778999999988889999999999999999998 99999754432211   1111    1100    010 


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                          ...++..+.+++.+||+.+|++||++.++.+.|+++
T Consensus       226 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         226 ----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                112345688999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.5e-41  Score=347.39  Aligned_cols=251  Identities=25%  Similarity=0.320  Sum_probs=206.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEcC--CcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLED--GLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~--g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ++|...+.||+|+||.||+|...+  +..||+|++.....  ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            568889999999999999997543  36899999876532  23346788999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       110 ~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            9999999999999765  56899999999999999999999   899999999999999999999999999999864221


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                            .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........       ......  .   
T Consensus       185 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~-------i~~~~~--~---  246 (340)
T PTZ00426        185 ------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK-------ILEGII--Y---  246 (340)
T ss_pred             ------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH-------HhcCCC--C---
Confidence                  1245699999999999998899999999999999999999999986543221111       111110  0   


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHhh
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAIR  544 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i~  544 (554)
                           ++......+.+++.+||+.+|++|+     +++++++|.|--.
T Consensus       247 -----~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        247 -----FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             -----CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence                 1122334578999999999999995     9999999977543

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.9e-40  Score=354.91  Aligned_cols=270  Identities=19%  Similarity=0.278  Sum_probs=200.5

Q ss_pred             HHHhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCC------CCceeeeeEEE
Q 042763          261 VVKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH------RNLVKLLGFVD  333 (554)
Q Consensus       261 l~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~H------pnIv~l~~~~~  333 (554)
                      +....++|++.++||+|+||+||+|... .++.||||+++...  ....++..|+++++.++|      ++++++++++.
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            3345688999999999999999999664 58899999986532  223455667777777654      45888999887


Q ss_pred             cC-CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCeEeCCCCCCCeEECCCC------
Q 042763          334 KG-NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE-KQIIHRDVKSSNILLTESM------  405 (554)
Q Consensus       334 ~~-~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-~~ivH~Dlkp~NILl~~~~------  405 (554)
                      .+ ...++|||++ +++|.+++...  ..+++.++..++.||+.||+|||   . .+|+||||||+|||++.++      
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccc
Confidence            64 4678999988 78999988754  57899999999999999999999   6 5999999999999998765      


Q ss_pred             ----------cEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 042763          406 ----------RAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKR  475 (554)
Q Consensus       406 ----------~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~  475 (554)
                                .+||+|||.+....      .......||+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDER------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             cccccCCCCceEEECCCCccccCc------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                      49999999876421      12334679999999999999999999999999999999999999998765


Q ss_pred             ChhhHHHHHHHHHhhc------------------cCCccccCChhh-hhh------ccHHHHHHHHHHHHHccCCCCCCC
Q 042763          476 PPEERVTLRWAFKRYN------------------EGNLLDMVDPSI-KEV------ISMEILTKMFGLAIQCAAPIRNDR  530 (554)
Q Consensus       476 ~~~~~~~~~~~~~~~~------------------~~~~~~~~d~~l-~~~------~~~~~~~~l~~li~~cl~~dP~~R  530 (554)
                      ..+....+........                  ...+....++.. ...      ........+.+|+.+||+.||++|
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            4433322221110000                  000000111110 000      000113457899999999999999


Q ss_pred             CCHHHHHHHHHHhh
Q 042763          531 PDMKSVGEQLWAIR  544 (554)
Q Consensus       531 Ps~~evl~~l~~i~  544 (554)
                      ||++|+++|.|-.+
T Consensus       430 ~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        430 LNARQMTTHPYVLK  443 (467)
T ss_pred             CCHHHHhcCccccc
Confidence            99999999988643

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-40  Score=343.37  Aligned_cols=255  Identities=22%  Similarity=0.317  Sum_probs=203.4

Q ss_pred             CCCcceeeeccCceEEEEEEEc----CCcEEEEEEcchhhh---hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCce
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~  338 (554)
                      +|++.++||+|+||+||+++..    +++.||+|++.+...   ....+.+..|+.+++++ +||||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4778899999999999998653    578999999976432   22345678899999999 599999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ++||||+++|+|.+++..+  ..+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            9999999999999999754  46899999999999999999999   899999999999999999999999999999754


Q ss_pred             CCCCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                      .....  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+..   ....     
T Consensus       156 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~---~~~~-----  225 (332)
T cd05614         156 LSEEK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR---RILK-----  225 (332)
T ss_pred             cccCC--CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH---HHhc-----
Confidence            22211  122345799999999999865 478999999999999999999999975433222211111   1111     


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLW  541 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~  541 (554)
                       .++.    ++......+.+++.+||+.||++||     ++.+++++.|
T Consensus       226 -~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  269 (332)
T cd05614         226 -CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF  269 (332)
T ss_pred             -CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence             0111    1122345678999999999999999     8889999876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-41  Score=345.52  Aligned_cols=256  Identities=23%  Similarity=0.384  Sum_probs=220.0

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc-eEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE-RLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~-~~lv~  342 (554)
                      ++|...+++|+|+||.++.++++ +++.+|+|.+.-... +..++...+|+.++++++|||||.+.+.|..++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56788889999999999999655 578999998876543 3445578999999999999999999999988888 89999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      +||+||++.+.+.++.+..++++.++.|+.|++.|++|||   ++.|+|||||+.||+++.++.|||.|||+|+......
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999999988889999999999999999999999   9999999999999999999999999999999854322


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                         .....+.||+.||.||++.+.+|+.|+|||||||++|||++-+++|...+.......+...           ..   
T Consensus       161 ---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~-----------~~---  223 (426)
T KOG0589|consen  161 ---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG-----------LY---  223 (426)
T ss_pred             ---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc-----------cC---
Confidence               2445678999999999999999999999999999999999999999987765443322111           01   


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                        ...+..+...+..++..|++.+|+.||++.+++.+..-.
T Consensus       224 --~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  224 --SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             --CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence              124556678899999999999999999999999985443

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-40  Score=346.31  Aligned_cols=261  Identities=20%  Similarity=0.229  Sum_probs=201.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ..+|+..++||+|+||.||+|... +++.||+|....       ..+.+|++++++++||||+++++++..+...++|||
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            357999999999999999999654 689999996532       346789999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      ++ .++|..++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....  
T Consensus       164 ~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~--  235 (391)
T PHA03212        164 RY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI--  235 (391)
T ss_pred             cC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc--
Confidence            99 57899888654  46889999999999999999999   899999999999999999999999999999753211  


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChh----hHHHHHHHHHhhccC--Ccc-
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPE----ERVTLRWAFKRYNEG--NLL-  496 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~----~~~~~~~~~~~~~~~--~~~-  496 (554)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......    ....+..........  ... 
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence            1112234579999999999999899999999999999999999998875432110    011111111111000  000 


Q ss_pred             --------------------ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          497 --------------------DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       497 --------------------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                                          ....+...  .....+..+.+++.+||+.||++|||+.|++++.|-
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f  379 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWT--NLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF  379 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHH--HHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence                                00000000  011345678999999999999999999999998874

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-41  Score=348.23  Aligned_cols=258  Identities=23%  Similarity=0.337  Sum_probs=209.3

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|.+.+.||+|+||+||+|... +|+.||||++......  .....+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999765 6899999999865432  34467889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++++|.+++...  ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999999765  57899999999999999999999   8999999999999999999999999999997643222


Q ss_pred             --------------------------CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 042763          423 --------------------------DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRP  476 (554)
Q Consensus       423 --------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~  476 (554)
                                                ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                      001122345699999999999999999999999999999999999999987653


Q ss_pred             hhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHH
Q 042763          477 PEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPD-MKSVGEQLWA  542 (554)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~l~~  542 (554)
                      ......+..    ... ..   ..+.     ...++..+.+++.+|++ +|.+||+ +.+++++.|-
T Consensus       236 ~~~~~~i~~----~~~-~~---~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~  288 (350)
T cd05573         236 QETYNKIIN----WKE-SL---RFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF  288 (350)
T ss_pred             HHHHHHHhc----cCC-cc---cCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence            322211110    000 00   0000     01135668899999998 9999999 9999998764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-41  Score=330.18  Aligned_cols=270  Identities=23%  Similarity=0.281  Sum_probs=212.4

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc-----C
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK-----G  335 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~  335 (554)
                      .....|...+.||+|+||.|+.|.. .+|+.||||++..... ....++..+|+++|++++|+||+.+.+.+..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            3456677778899999999999955 4799999999874332 3345778899999999999999999998754     4


Q ss_pred             CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCc
Q 042763          336 NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA  415 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla  415 (554)
                      +..|+|+|+| ..||...++.+  +.++...+..++.|+++||.|+|   +.+|+||||||+|+|++.+..+||+|||+|
T Consensus        99 ~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccce
Confidence            5789999999 78999999765  45999999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      +..... ......+..+.|.+|.|||++.. ..|+.+.||||.|||+.||++|++-|.+.+.......+........+..
T Consensus       173 R~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  173 RYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            986443 33344566789999999998754 5799999999999999999999999998776555444333222211111


Q ss_pred             ccccCChhh---------------hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          495 LLDMVDPSI---------------KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       495 ~~~~~d~~l---------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                      +..+-.+..               ...++ .......+|+.+||..||.+|+|++|.++|.
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hP  311 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHP  311 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence            111111111               11111 3335678999999999999999999999885

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.2e-41  Score=333.60  Aligned_cols=251  Identities=35%  Similarity=0.554  Sum_probs=197.4

Q ss_pred             cceeeeccCceEEEEEEEc-----CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          270 PSLRIGEGGFGTVYKAQLE-----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       270 ~~~~LG~G~fG~Vy~a~~~-----~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ..+.||.|.||.||+|.+.     .+..|+||.+.........+.+.+|++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3568999999999999877     25789999997654444568899999999999999999999999988889999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++|+|.+++.......+++.+++.|+.||+.||.|||   +++++|+||+++||+++.++.+||+|||++...... ..
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~-~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK-SK  158 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS-SS
T ss_pred             cccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc-cc
Confidence            99999999998876678999999999999999999999   889999999999999999999999999999875211 12


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      ............|+|||.+....++.++||||||+++|||++ |+.||......+.   ....    .......      
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~---~~~~----~~~~~~~------  225 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI---IEKL----KQGQRLP------  225 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH---HHHH----HTTEETT------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccc----cccccce------
Confidence            222333457788999999999889999999999999999999 7888876532221   1111    1111100      


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                         .+..++..+.+++.+||+.+|++||++.+|++.|
T Consensus       226 ---~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 ---IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence               1223456688999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-40  Score=328.37  Aligned_cols=258  Identities=28%  Similarity=0.460  Sum_probs=209.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC----CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      .++|+..+.||+|+||+||+|.+..    ...||||.++.........++.+|+.++++++||||+++++++..++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3568889999999999999997642    458999998766555556788999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      +|||+++++|.+++.... ..+++.+++.++.|++.||+|||   +++|+||||||+||++++++.++|+|||+++....
T Consensus        83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          83 ITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999997643 36899999999999999999999   89999999999999999999999999999987541


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      .. .........+++.|+|||.+.+..++.++||||||+++|||++ |..||.........   ...    .....    
T Consensus       159 ~~-~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~---~~~----~~~~~----  226 (266)
T cd05033         159 SE-ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI---KAV----EDGYR----  226 (266)
T ss_pred             cc-cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH---HHH----HcCCC----
Confidence            11 1111222345678999999998899999999999999999998 99999754332211   111    11000    


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      .+     .+..++..+.+++.+||+.+|++||++.||+++|.++
T Consensus       227 ~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         227 LP-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            00     1123345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.7e-40  Score=327.25  Aligned_cols=251  Identities=28%  Similarity=0.436  Sum_probs=203.5

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      .+|+..+.||+|+||.||+++..++..+|+|.+.....  ....+.+|++++++++||||+++++++..++..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            45777889999999999999988888999998875432  2357889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ++|+|.+++.... ..+++..++.++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~--~  155 (256)
T cd05114          82 ENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--Y  155 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc--e
Confidence            9999999997543 35889999999999999999999   8999999999999999999999999999987642211  1


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+...   ..    ....  ....+.  
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~---~i----~~~~--~~~~~~--  224 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE---MI----SRGF--RLYRPK--  224 (256)
T ss_pred             eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HH----HCCC--CCCCCC--
Confidence            11122345678999999998889999999999999999999 899997654332221   11    1110  001111  


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                           .....+.+++.+||+.+|++||++.++++.|
T Consensus       225 -----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         225 -----LASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             -----CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                 1234689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.6e-40  Score=348.68  Aligned_cols=258  Identities=22%  Similarity=0.340  Sum_probs=202.5

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .|...+.||+|+||+||+|... +++.||||++.....  ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999654 588999999976542  2344678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++|+|.+++...  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            99999999999764  46889999999999999999999   89999999999999999999999999999764211000


Q ss_pred             --------------------------------------------CccccccccCCCCCcChhccccCCCCchhhHHHHHH
Q 042763          424 --------------------------------------------RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGV  459 (554)
Q Consensus       424 --------------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGv  459 (554)
                                                                  .........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                        000112356999999999999989999999999999


Q ss_pred             HHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHH--ccCCCCCCCCCHHHHH
Q 042763          460 LLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQ--CAAPIRNDRPDMKSVG  537 (554)
Q Consensus       460 il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~evl  537 (554)
                      ++|||++|+.||......+....+..     ..... . ..      ....+...+.+++.+  |+..+|..||++.+++
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~-----~~~~~-~-~~------~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l  303 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVIN-----WENTL-H-IP------PQVKLSPEAVDLITKLCCSAEERLGRNGADDIK  303 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHc-----ccccc-C-CC------CCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence            99999999999987554332211110     00000 0 00      001223456777776  5566677799999999


Q ss_pred             HHHHH
Q 042763          538 EQLWA  542 (554)
Q Consensus       538 ~~l~~  542 (554)
                      .|.|-
T Consensus       304 ~hp~f  308 (381)
T cd05626         304 AHPFF  308 (381)
T ss_pred             cCccc
Confidence            99764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.5e-40  Score=342.13  Aligned_cols=254  Identities=23%  Similarity=0.358  Sum_probs=201.7

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      +.||+|+||.||+|... +++.||+|++++....  .....+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999765 5889999999875432  2345688899999998 799999999999999999999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |+|.+++...  ..+++..++.++.|++.||+|||   +++++||||||+|||++.++.+||+|||+++.....   ...
T Consensus        81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~~  152 (329)
T cd05588          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP---GDT  152 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccC---CCc
Confidence            9999988654  57899999999999999999999   899999999999999999999999999998742111   112


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChh--hHHHHHHHHHhhccCCccccCChhhhh
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPE--ERVTLRWAFKRYNEGNLLDMVDPSIKE  505 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~  505 (554)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+  ......+...........         
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------  223 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR---------  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC---------
Confidence            234579999999999999999999999999999999999999997432211  111111111111111110         


Q ss_pred             hccHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHHHHh
Q 042763          506 VISMEILTKMFGLAIQCAAPIRNDRPD------MKSVGEQLWAI  543 (554)
Q Consensus       506 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~l~~i  543 (554)
                       .+..+...+.+++.+||+.||++||+      +.++++|.|--
T Consensus       224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~  266 (329)
T cd05588         224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR  266 (329)
T ss_pred             -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence             12223456889999999999999997      78999886653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-40  Score=326.79  Aligned_cols=258  Identities=26%  Similarity=0.339  Sum_probs=216.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC-CcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .++|+..+.||.|.-|+||+++.++ +..+|+|++.+....  +...+...|-+||+.++||.++.||+.++.+...++|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3566778899999999999998875 589999999988654  3345678899999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      ||||+||+|....+++.++.+++..++.++..++.||+|||   ..|||+|||||+||||.++|++.|+||.++......
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999999999999999999999999999999999999   899999999999999999999999999998643110


Q ss_pred             --------------------------------CCC---------------------ccccccccCCCCCcChhccccCCC
Q 042763          422 --------------------------------SDR---------------------THISTKVKGTVGYLDPEYMKTYQL  448 (554)
Q Consensus       422 --------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~l~~~~~  448 (554)
                                                      ...                     ...+..++||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            000                     011123569999999999999999


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCC
Q 042763          449 TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRN  528 (554)
Q Consensus       449 s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~  528 (554)
                      +.++|+|+|||++||||.|..||.+....+....+...     +          +.-...+..+..+.+||++.|..||+
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----~----------l~Fp~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----P----------LKFPEEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----C----------CcCCCCCcchhHHHHHHHHHhccChh
Confidence            99999999999999999999999988776554332211     1          10001124567789999999999999


Q ss_pred             CCCC----HHHHHHHH
Q 042763          529 DRPD----MKSVGEQL  540 (554)
Q Consensus       529 ~RPs----~~evl~~l  540 (554)
                      +|--    +.||-+|.
T Consensus       378 kRlg~~rGA~eIK~Hp  393 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKRHP  393 (459)
T ss_pred             hhhccccchHHhhcCc
Confidence            9999    88888774

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-41  Score=348.13  Aligned_cols=258  Identities=22%  Similarity=0.354  Sum_probs=205.5

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|+..+.||+|+||+||+|... +|+.||||++.....  ......+.+|+++++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888999999999999999765 589999999976532  233456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++...  ..+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            999999999999764  46899999999999999999999   8999999999999999999999999999987532111


Q ss_pred             CCc-----------------------------------cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhC
Q 042763          423 DRT-----------------------------------HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG  467 (554)
Q Consensus       423 ~~~-----------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg  467 (554)
                      ...                                   ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            000                                   011124699999999999999999999999999999999999


Q ss_pred             CCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHHH
Q 042763          468 RRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPD---MKSVGEQLWA  542 (554)
Q Consensus       468 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~l~~  542 (554)
                      ..||...........+.    ... ... ..  +.     .......+.+++.+|+. +|.+|++   +.|++++.|-
T Consensus       236 ~~Pf~~~~~~~~~~~i~----~~~-~~~-~~--~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~  299 (364)
T cd05599         236 YPPFCSDNPQETYRKII----NWK-ETL-QF--PD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF  299 (364)
T ss_pred             CCCCCCCCHHHHHHHHH----cCC-Ccc-CC--CC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCc
Confidence            99998655332211110    000 000 00  00     00234567888999997 8999998   9999998764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=358.72  Aligned_cols=264  Identities=23%  Similarity=0.340  Sum_probs=212.7

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcCC-cEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeE-EE----c--
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLEDG-LLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGF-VD----K--  334 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~g-~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~-~~----~--  334 (554)
                      ...+.++.+.|.+|||+.||+|....+ ..||+|++-.. .+...+.+.+||++|++|+ |+|||.+++. ..    .  
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            456677888999999999999987765 99999998776 3566788999999999997 9999999993 21    1  


Q ss_pred             CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecC
Q 042763          335 GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGF  414 (554)
Q Consensus       335 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl  414 (554)
                      .-+.+|+||||++|.|-|+|..+....|++.++++|+.++++|+++||.. ..+|||||||-+||||+.++..||||||.
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            23678999999999999999987777799999999999999999999943 67799999999999999999999999999


Q ss_pred             cccCCCCCCCccc------cccccCCCCCcChhcc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH
Q 042763          415 ARLGPMDSDRTHI------STKVKGTVGYLDPEYM---KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRW  485 (554)
Q Consensus       415 a~~~~~~~~~~~~------~~~~~gt~~y~aPE~l---~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~  485 (554)
                      +.-.-........      .-...-|+.|+|||.+   ++..+++|+|||||||+||-|+....||+.....-       
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-------  265 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-------  265 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-------
Confidence            8642111111100      1123469999999976   56789999999999999999999999998653211       


Q ss_pred             HHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          486 AFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                                  ++.....---.+.+...|.+||+.||++||++||++.+|++.+.+++....
T Consensus       266 ------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  266 ------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             ------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence                        111111100114678899999999999999999999999999999886543

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.4e-40  Score=341.41  Aligned_cols=248  Identities=25%  Similarity=0.352  Sum_probs=199.6

Q ss_pred             CCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHH---HhCCCCCceeeeeEEEcCCceEEE
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELL---SKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l---~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      |.+.+.||+|+||.||+|... +|+.||||+++....  ....+.+.+|+.++   ++++||||+++++++.+++..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            566789999999999999765 589999999986542  22335566776665   466899999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++++|..++..   ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.... 
T Consensus        81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~-  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG-  153 (324)
T ss_pred             EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC-
Confidence            999999999988864   36899999999999999999999   89999999999999999999999999999874321 


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                        .........|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+.       ....      
T Consensus       154 --~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~-------~~~~------  218 (324)
T cd05589         154 --FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV-------NDEV------  218 (324)
T ss_pred             --CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCC------
Confidence              1122234579999999999999899999999999999999999999998654332211111       1100      


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLW  541 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~  541 (554)
                          ..+..+...+.+++.+||+.||.+||     ++.+++++.|
T Consensus       219 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~  259 (324)
T cd05589         219 ----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF  259 (324)
T ss_pred             ----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCC
Confidence                01223345678999999999999999     6888888764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.9e-40  Score=326.21  Aligned_cols=255  Identities=29%  Similarity=0.423  Sum_probs=207.1

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .+|...++||+|+||.||+|... .++.||+|++....  ....++.+|++++++++||||+++++++..++..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            45777889999999999999765 58899999987543  2346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++.......+++..++.++.|++.||+|||   +++++||||||+||++++++.+||+|||++.......  
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~--  158 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--  158 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccce--
Confidence            99999999997765567899999999999999999999   8999999999999999999999999999997643211  


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+       ....     .+  
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-------~~~~-----~~--  224 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKGY-----RM--  224 (263)
T ss_pred             eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HCCC-----CC--
Confidence            111112234678999999998899999999999999999998 99998765432221111       1100     00  


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                        ..+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       225 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 --ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence              01122446789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-40  Score=327.28  Aligned_cols=255  Identities=29%  Similarity=0.451  Sum_probs=208.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .++|+..+.||+|+||.||+|...+++.||+|.++....  ..+++.+|++++++++||||+++++++...+..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            456888899999999999999887788999999876532  246788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++....+..+++.++..++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++......  
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--  157 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI--  157 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc--
Confidence            99999999998765567899999999999999999999   8999999999999999999999999999998654211  


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      .........+..|+|||++.+..++.++||||||+++|||++ |+.||..........   ..    ......       
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~~----~~~~~~-------  223 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ---QV----DQGYRM-------  223 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HH----HcCCCC-------
Confidence            111111223467999999998899999999999999999999 999997544322111   11    110000       


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                        ..+..++..+.+++.+||+.+|++||++.++.+.|++
T Consensus       224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence              0112344678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.1e-40  Score=342.72  Aligned_cols=259  Identities=23%  Similarity=0.354  Sum_probs=201.2

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|+..+.||+|+||+||+|... +++.||+|+++....  ......+.+|+.++.+++||||+++++.+.++...++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999665 589999999976542  223456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++...  ..+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            999999999999764  57899999999999999999999   8999999999999999999999999999987532110


Q ss_pred             CC--------------------------------ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 042763          423 DR--------------------------------THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP  470 (554)
Q Consensus       423 ~~--------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P  470 (554)
                      ..                                .......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            00                                0011235799999999999999999999999999999999999999


Q ss_pred             CCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccC--CCCCCCCCHHHHHHHHHH
Q 042763          471 VELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAA--PIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       471 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~~l~~  542 (554)
                      |......+....+..    . ....  .+.+.      ......+.+++.+++.  .++..||++.||++|.|-
T Consensus       236 f~~~~~~~~~~~i~~----~-~~~~--~~p~~------~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f  296 (363)
T cd05628         236 FCSETPQETYKKVMN----W-KETL--IFPPE------VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFF  296 (363)
T ss_pred             CCCCCHHHHHHHHHc----C-cCcc--cCCCc------CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCC
Confidence            986554332211110    0 0000  01110      0123445666766443  234467999999999553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.9e-40  Score=340.36  Aligned_cols=247  Identities=23%  Similarity=0.357  Sum_probs=201.0

Q ss_pred             eeeeccCceEEEEEEE----cCCcEEEEEEcchhhh---hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          272 LRIGEGGFGTVYKAQL----EDGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~----~~g~~vAvK~~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++||+|+||.||++..    .+++.||+|+++....   ......+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999965    3578999999976532   12234678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++...  ..+.+..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....   
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  153 (323)
T cd05584          82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE---  153 (323)
T ss_pred             CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC---
Confidence            9999999999754  46788899999999999999999   899999999999999999999999999998743211   


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||..........   .    ......         
T Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~---~----~~~~~~---------  217 (323)
T cd05584         154 GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID---K----ILKGKL---------  217 (323)
T ss_pred             CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH---H----HHcCCC---------
Confidence            112234569999999999998889999999999999999999999998654322111   1    111110         


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHh
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAI  543 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i  543 (554)
                       .++......+.+++.+||+.+|++||     ++.+++++.|--
T Consensus       218 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~  260 (323)
T cd05584         218 -NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR  260 (323)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcC
Confidence             01222345678999999999999999     899999987643

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5e-40  Score=346.12  Aligned_cols=262  Identities=25%  Similarity=0.364  Sum_probs=208.5

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCC
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGN  336 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~  336 (554)
                      ..++|.+.++||+|+||.||+|...      .+..||||++.........+.+.+|+++++++. ||||+++++++.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3567888999999999999999753      235799999976554455578999999999996 999999999999999


Q ss_pred             ceEEEEEeCCCCCHHHHHhccc----------------------------------------------------------
Q 042763          337 ERLIITEFVPNGTLREHLDGQY----------------------------------------------------------  358 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------------  358 (554)
                      ..++|||||++|+|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999999986431                                                          


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC
Q 042763          359 ------------------------------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT  402 (554)
Q Consensus       359 ------------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~  402 (554)
                                                          ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence                                                124778888999999999999999   89999999999999999


Q ss_pred             CCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHH
Q 042763          403 ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERV  481 (554)
Q Consensus       403 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~  481 (554)
                      .++.+||+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |..||..........
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSN-YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             CCCEEEEEeCCcceecccccc-ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            999999999999986432211 111223346788999999998899999999999999999997 999987643322211


Q ss_pred             HHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          482 TLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                        .    ........         ..+..++..+.+++.+||+.+|++||++.+|.+.|.++.
T Consensus       351 --~----~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         351 --N----KIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             --H----HHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence              1    11111000         012234567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.1e-40  Score=330.21  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=201.4

Q ss_pred             eeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCH
Q 042763          274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTL  350 (554)
Q Consensus       274 LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L  350 (554)
                      ||+|+||+||++... +|+.||+|++......  ...+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999765 6899999998765432  2235678899999999999999999999999999999999999999


Q ss_pred             HHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcccc
Q 042763          351 REHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIS  428 (554)
Q Consensus       351 ~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~  428 (554)
                      .+++...  ....+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++.......   ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~---~~~  154 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SKT  154 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---ccc
Confidence            9887542  2356899999999999999999999   8999999999999999999999999999997543221   112


Q ss_pred             ccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhcc
Q 042763          429 TKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS  508 (554)
Q Consensus       429 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  508 (554)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||.............   ........          .++
T Consensus       155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~---~~~~~~~~----------~~~  221 (280)
T cd05608         155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK---QRILNDSV----------TYP  221 (280)
T ss_pred             cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH---HhhcccCC----------CCc
Confidence            33568999999999999999999999999999999999999998654322111111   11111000          122


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHh
Q 042763          509 MEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAI  543 (554)
Q Consensus       509 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i  543 (554)
                      ..++..+.+++.+||+.||++||     +++++++|.|--
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~  261 (280)
T cd05608         222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFR  261 (280)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhh
Confidence            23456788999999999999999     889999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.8e-40  Score=339.27  Aligned_cols=253  Identities=25%  Similarity=0.334  Sum_probs=203.0

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCC-CceeeeeEEEcCCceEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHR-NLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~Hp-nIv~l~~~~~~~~~~~lv~  342 (554)
                      +|+..+.||+|+||.||+|... +++.||||++.....  ....+.+..|++++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999765 478999999976532  23346688899999999765 5888999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            999999999999654  46889999999999999999999   8999999999999999999999999999987422111


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                         .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...   ..    .....       
T Consensus       156 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~---~i----~~~~~-------  218 (324)
T cd05587         156 ---KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ---SI----MEHNV-------  218 (324)
T ss_pred             ---CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH---HH----HcCCC-------
Confidence               12234569999999999999999999999999999999999999998654322211   11    11100       


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHHhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDM-----KSVGEQLWAIR  544 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~l~~i~  544 (554)
                         .++......+.+++.+||+.+|++||+.     .++.++.|--+
T Consensus       219 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         219 ---SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence               0112234567899999999999999986     78888765433

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.2e-41  Score=343.76  Aligned_cols=247  Identities=22%  Similarity=0.306  Sum_probs=200.7

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNG  348 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g  348 (554)
                      +.||+|+||.||++... +|+.||+|++.....  ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999754 689999999986542  223456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          349 TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE-KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       349 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      +|.+++...  ..+++.++..++.||+.||+|||   + .+|+||||||+|||++.++.+||+|||+++......   ..
T Consensus        81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~---~~  152 (325)
T cd05594          81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---AT  152 (325)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC---cc
Confidence            999988654  47899999999999999999999   6 799999999999999999999999999987532111   11


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhc
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI  507 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  507 (554)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+       .....      .    +
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i-------~~~~~------~----~  215 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------LMEEI------R----F  215 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH-------hcCCC------C----C
Confidence            23356999999999999989999999999999999999999999765432221111       00000      0    1


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHh
Q 042763          508 SMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAI  543 (554)
Q Consensus       508 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i  543 (554)
                      +......+.+++.+||+.||++|+     ++.++++|.|--
T Consensus       216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~  256 (325)
T cd05594         216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA  256 (325)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcC
Confidence            122345678999999999999996     999999987643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.7e-40  Score=335.88  Aligned_cols=269  Identities=21%  Similarity=0.325  Sum_probs=206.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|...++||+|+||+||+|... +++.||+|+++..........+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999765 57899999987654443445678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      ++ ++|.+++... ...+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......  
T Consensus        86 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  158 (309)
T cd07872          86 LD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--  158 (309)
T ss_pred             CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence            96 5888888654 345789999999999999999999   8999999999999999999999999999997532211  


Q ss_pred             ccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc-----
Q 042763          425 THISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM-----  498 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  498 (554)
                       .......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||......+....+...............     
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence             11223457899999998865 46899999999999999999999999876554433322221111000000000     


Q ss_pred             ---------CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          499 ---------VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       499 ---------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                               ....... ....+...+.+++.+||+.||++|||+.|++++.|--
T Consensus       238 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  290 (309)
T cd07872         238 FKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR  290 (309)
T ss_pred             hhhhhcCccCCCchhh-hccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence                     0000000 1112345678999999999999999999999987753

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.5e-40  Score=326.98  Aligned_cols=257  Identities=32%  Similarity=0.507  Sum_probs=211.5

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ...+|+..++||+|+||.||+|...++..+|+|.+..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            3456888889999999999999888899999999876543 234578899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++++|.+++....+..+++.+++.++.|++.||+|||   +++++|+||||+||+++.++.+||+|||++....... 
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-  158 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-  158 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence            999999999998766677899999999999999999999   8999999999999999999999999999997643221 


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                        .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+..   .........          
T Consensus       159 --~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~---~~~~~~~~~----------  223 (261)
T cd05148         159 --YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY---DQITAGYRM----------  223 (261)
T ss_pred             --ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH---HHHHhCCcC----------
Confidence              11123346778999999988899999999999999999998 89999765432221   111110000          


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                         ..+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 ---PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence               01223445688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.9e-40  Score=336.89  Aligned_cols=262  Identities=24%  Similarity=0.405  Sum_probs=207.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCc----EEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGL----LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      ..+|+..+.||+|+||+||+|.+. +|.    .||+|+++........+++.+|+.+++.++||||++++|++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            356889999999999999999754 333    48999987654445567899999999999999999999999764 568


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +++||+++|+|.+++.... ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        85 ~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          85 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccccc
Confidence            9999999999999997652 45788999999999999999999   8999999999999999999999999999998653


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.    ....   ......  
T Consensus       161 ~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~----~~~~---~~~~~~--  230 (316)
T cd05108         161 ADEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSIL---EKGERL--  230 (316)
T ss_pred             CCCcc-eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHH---hCCCCC--
Confidence            22211 11122335678999999999999999999999999999998 9999975432211    1111   111000  


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                      .       .+..+...+.+++.+||+.+|++||++.+++..+.++..+..
T Consensus       231 ~-------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~  273 (316)
T cd05108         231 P-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  273 (316)
T ss_pred             C-------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence            0       011233467899999999999999999999999998877653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=334.12  Aligned_cols=265  Identities=28%  Similarity=0.364  Sum_probs=210.1

Q ss_pred             HHHHhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhh-------------HHHHHHHHHHHHHhCCCCCc
Q 042763          260 QVVKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFEN-------------LQTEFSSEVELLSKIDHRNL  325 (554)
Q Consensus       260 ~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~-------------~~~~~~~Ei~~l~~l~HpnI  325 (554)
                      +-.+.-++|++.+.||+|.||.|-+|... +++.||||++.+.....             ..+.+.+||.+|++++||||
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV  170 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV  170 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence            33445688999999999999999999654 69999999997664321             12578899999999999999


Q ss_pred             eeeeeEEEcC--CceEEEEEeCCCCCHHHHHhcccCCC-CCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC
Q 042763          326 VKLLGFVDKG--NERLIITEFVPNGTLREHLDGQYGKT-LDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT  402 (554)
Q Consensus       326 v~l~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~  402 (554)
                      |+|+.+..+.  +..|||+|||..|.+...=   ..+. +.+.++++++.+++.||+|||   .++|+||||||+|+|++
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~  244 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLS  244 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEc
Confidence            9999998765  5789999999988875332   2234 899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEEeecCcccCCCCC--CCccccccccCCCCCcChhccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 042763          403 ESMRAKVADFGFARLGPMDS--DRTHISTKVKGTVGYLDPEYMKTYQ----LTTKSDVYSFGVLLLEILTGRRPVELKRP  476 (554)
Q Consensus       403 ~~~~vkl~DfGla~~~~~~~--~~~~~~~~~~gt~~y~aPE~l~~~~----~s~ksDVwSlGvil~elltg~~P~~~~~~  476 (554)
                      ++|.|||+|||.+...+...  +.........|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||.+...
T Consensus       245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~  324 (576)
T KOG0585|consen  245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE  324 (576)
T ss_pred             CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence            99999999999998654332  1222233478999999999887632    45789999999999999999999986443


Q ss_pred             hhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          477 PEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      -+.       +.++.+..+.        -...+++...+.+||.++|+.||++|-+..+|..|+|--+.
T Consensus       325 ~~l-------~~KIvn~pL~--------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  325 LEL-------FDKIVNDPLE--------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHH-------HHHHhcCccc--------CCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            322       2222222111        11122456678999999999999999999999999997765

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-40  Score=329.38  Aligned_cols=268  Identities=27%  Similarity=0.374  Sum_probs=200.1

Q ss_pred             ceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHh--CCCCCceeeeeEEEcCC----ceEEEEEe
Q 042763          271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSK--IDHRNLVKLLGFVDKGN----ERLIITEF  344 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~~~~~~~~----~~~lv~E~  344 (554)
                      ...||+|.||.||||.+. ++.||||++....    .+.|.+|-++++.  |+|+||++++++-..+.    +++||+||
T Consensus       215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f  289 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF  289 (534)
T ss_pred             HHHhhcCccceeehhhcc-CceeEEEecCHHH----HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence            346899999999999987 5999999998764    3567778787775  58999999999876555    88999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhc------cCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY------AEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      .+.|+|.+||..+   .++|.+..+|+..+++||+|||+.      ...+|+|||||++|||+..|++..|+|||+|..+
T Consensus       290 h~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  290 HPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             ccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            9999999999877   899999999999999999999963      2467999999999999999999999999999887


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCC-CC-----chhhHHHHHHHHHHHHhCCCCCCCCCChhhHHH-HHH------
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQ-LT-----TKSDVYSFGVLLLEILTGRRPVELKRPPEERVT-LRW------  485 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s-----~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~-~~~------  485 (554)
                      ......... ...+||.+|||||++.+.- +.     .+.||||+|.|||||++.-.-+..... .+... .+.      
T Consensus       367 ~p~~~~~d~-~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~v-p~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  367 EPGKPQGDT-HGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPV-PEYQLPFEAEVGNHP  444 (534)
T ss_pred             cCCCCCcch-hhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCC-CcccCchhHHhcCCC
Confidence            644333322 2368999999999997642 22     368999999999999986544432111 00000 000      


Q ss_pred             HHHhhccCCccccCChhhhh-hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          486 AFKRYNEGNLLDMVDPSIKE-VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       486 ~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                      ..+...+-.+.+...|.+.+ +.....++.+.+.+..||..||+-|.|+.=|.+.++++..-+.
T Consensus       445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            00000000011111222211 1122446678999999999999999999999999998876543

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.8e-40  Score=330.23  Aligned_cols=256  Identities=28%  Similarity=0.471  Sum_probs=207.5

Q ss_pred             cCCCcceeeeccCceEEEEEEEcC------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLED------GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      ++|.+.+.||+|+||.||+|...+      +..||||.++........+.+.+|++++++++||||+++++++..+...+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457778899999999999997643      47899999876654445678999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhccc------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcE
Q 042763          340 IITEFVPNGTLREHLDGQY------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRA  407 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v  407 (554)
                      +||||+++++|.+++....            ...+++.++..++.|++.||+|||   +++++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            9999999999999997542            235788999999999999999999   8999999999999999999999


Q ss_pred             EEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHH
Q 042763          408 KVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWA  486 (554)
Q Consensus       408 kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~  486 (554)
                      ||+|||+++...... .........+++.|+|||++.+..++.++||||||+++|||++ |..||......+..   ...
T Consensus       162 kl~d~g~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~---~~~  237 (280)
T cd05049         162 KIGDFGMSRDVYTTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI---ECI  237 (280)
T ss_pred             EECCcccceecccCc-ceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHH
Confidence            999999997532221 1112233446788999999999999999999999999999998 99999765443221   111


Q ss_pred             HHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          487 FKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .    .+....         .+...+..+.+++.+||+.+|++||++.||++.|.
T Consensus       238 ~----~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 T----QGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             H----cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            1    111110         11234466899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.8e-40  Score=350.34  Aligned_cols=265  Identities=21%  Similarity=0.262  Sum_probs=200.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC--------
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG--------  335 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--------  335 (554)
                      .++|...++||+|+||+||+|... +++.||||++....     ....+|+.++++++||||+++++++...        
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            467999999999999999999764 58899999886532     2345799999999999999999876432        


Q ss_pred             CceEEEEEeCCCCCHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC-cEEEEee
Q 042763          336 NERLIITEFVPNGTLREHLDG--QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADF  412 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~Df  412 (554)
                      ...++||||++ ++|.+++..  .....+++..++.++.||+.||+|||   +++|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            24578999996 578777753  23457899999999999999999999   89999999999999999664 7999999


Q ss_pred             cCcccCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhh-
Q 042763          413 GFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY-  490 (554)
Q Consensus       413 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~-  490 (554)
                      |+|+......    ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+....+....+....... 
T Consensus       216 Gla~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~  291 (440)
T PTZ00036        216 GSAKNLLAGQ----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT  291 (440)
T ss_pred             ccchhccCCC----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9998643211    1223468999999998865 469999999999999999999999998765543332222111000 


Q ss_pred             -----------ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          491 -----------NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       491 -----------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                                 ....+.......+...++...+.++.+++.+||+.||.+|||+.|+++|.|-
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f  354 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF  354 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence                       0000111111222223333445678999999999999999999999999873

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-40  Score=347.55  Aligned_cols=258  Identities=22%  Similarity=0.321  Sum_probs=202.6

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|...++||+|+||+||++... +++.||||++.....  ......+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888999999999999999654 689999999876532  233467889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            999999999999754  56889999999999999999999   8999999999999999999999999999996321100


Q ss_pred             CC----------c----------------------------------cccccccCCCCCcChhccccCCCCchhhHHHHH
Q 042763          423 DR----------T----------------------------------HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFG  458 (554)
Q Consensus       423 ~~----------~----------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlG  458 (554)
                      ..          .                                  .......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            00          0                                  000124699999999999998999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCC---CCCHHH
Q 042763          459 VLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRND---RPDMKS  535 (554)
Q Consensus       459 vil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~---RPs~~e  535 (554)
                      |++|||++|..||......+....+.   . .. .. ...  +.     ...+...+.+++.+|++ +|.+   ||++.|
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~---~-~~-~~-~~~--p~-----~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKII---N-WR-ET-LYF--PD-----DIHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHH---c-cC-Cc-cCC--CC-----CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            99999999999998655432211111   0 00 00 000  00     01233567889999997 6665   469999


Q ss_pred             HHHHHHH
Q 042763          536 VGEQLWA  542 (554)
Q Consensus       536 vl~~l~~  542 (554)
                      ++.+.|-
T Consensus       302 ~l~hp~~  308 (377)
T cd05629         302 IKSHPFF  308 (377)
T ss_pred             HhcCCCc
Confidence            9999764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.4e-40  Score=348.61  Aligned_cols=259  Identities=22%  Similarity=0.336  Sum_probs=203.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .+|++.++||+|+||+||+|+.. +++.||||++.....  ......+.+|++++++++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36888999999999999999765 589999999876532  223466889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++...  ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|.......
T Consensus        81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999999999764  46888999999999999999999   8999999999999999999999999999975321000


Q ss_pred             C----------------------------------------CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHH
Q 042763          423 D----------------------------------------RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLL  462 (554)
Q Consensus       423 ~----------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~  462 (554)
                      .                                        .........||+.|||||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence            0                                        000112356999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 042763          463 EILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRP---DMKSVGEQ  539 (554)
Q Consensus       463 elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~~  539 (554)
                      ||++|+.||......+....+..    ... .. .  .+     ....+...+.+++.+|+ .+|.+|+   ++.|+++|
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~~----~~~-~~-~--~~-----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVIN----WET-TL-H--IP-----SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHhc----cCc-cc-c--CC-----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999999987654332221110    000 00 0  00     01123345677777766 4999999   99999999


Q ss_pred             HHHh
Q 042763          540 LWAI  543 (554)
Q Consensus       540 l~~i  543 (554)
                      .|--
T Consensus       302 ~~~~  305 (376)
T cd05598         302 PFFK  305 (376)
T ss_pred             CCcC
Confidence            7743

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.8e-40  Score=340.13  Aligned_cols=262  Identities=29%  Similarity=0.428  Sum_probs=206.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEc-CC
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDK-GN  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~-~~  336 (554)
                      .++|++.+.||+|+||.||+|...      +++.||+|+++........+.+.+|++++.++ +|+||+++++++.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357889999999999999999532      35789999987544334446788999999999 89999999998764 45


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccC---------------------------------------------------------
Q 042763          337 ERLIITEFVPNGTLREHLDGQYG---------------------------------------------------------  359 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~---------------------------------------------------------  359 (554)
                      ..+++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999999864321                                                         


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCC
Q 042763          360 --KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY  437 (554)
Q Consensus       360 --~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y  437 (554)
                        ..+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++........ .......++..|
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~~y  241 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPLKW  241 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCccc
Confidence              26789999999999999999999   899999999999999999999999999999864322111 112233467789


Q ss_pred             cChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHH
Q 042763          438 LDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMF  516 (554)
Q Consensus       438 ~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  516 (554)
                      +|||++.+..++.++|||||||++|||++ |..||......+...  .    ....... ..        .+......+.
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~--~----~~~~~~~-~~--------~~~~~~~~~~  306 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC--R----RLKEGTR-MR--------APEYATPEIY  306 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHH--H----HHhccCC-CC--------CCccCCHHHH
Confidence            99999999999999999999999999998 999997644332211  1    1111100 00        1122345689


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          517 GLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       517 ~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      +++.+||+.+|++||++.||+++|.++..
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.1e-40  Score=328.67  Aligned_cols=258  Identities=28%  Similarity=0.425  Sum_probs=204.7

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE  337 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  337 (554)
                      ..++|+..+.||+|+||.||+|...      .+..||+|++..........++.+|+.+++.++||||+++++++..+..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999998653      2567999998654433345678999999999999999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHhccc--------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEE
Q 042763          338 RLIITEFVPNGTLREHLDGQY--------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKV  409 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl  409 (554)
                      .++||||+++++|.+++....        ...+++..++.++.|++.||+|||   +.+++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999996532        124578889999999999999999   899999999999999999999999


Q ss_pred             EeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHH
Q 042763          410 ADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFK  488 (554)
Q Consensus       410 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~  488 (554)
                      +|||+++....... ........+++.|+|||++.+..++.++||||||+++|||++ |..||.........   ...  
T Consensus       161 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~---~~~--  234 (277)
T cd05062         161 GDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL---RFV--  234 (277)
T ss_pred             CCCCCccccCCcce-eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHH--
Confidence            99999875432211 111122345788999999998899999999999999999999 78898765432211   111  


Q ss_pred             hhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          489 RYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       489 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                        .......         .+..++..+.+++.+||+.+|++||++.|++++++
T Consensus       235 --~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         235 --MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             --HcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence              1111111         11223456899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.5e-40  Score=336.57  Aligned_cols=246  Identities=25%  Similarity=0.344  Sum_probs=196.0

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      +.||+|+||.||+|... +++.||+|+++....  ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999765 578999999986532  22334556677777654 899999999999999999999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |+|.+++...  ..+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......   ..
T Consensus        81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~  152 (316)
T cd05592          81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GK  152 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---Cc
Confidence            9999998754  46899999999999999999999   8999999999999999999999999999997532211   22


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhc
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI  507 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  507 (554)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........       .....      +    .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~-------i~~~~------~----~~  215 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS-------ILNDR------P----HF  215 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHcCC------C----CC
Confidence            3345799999999999998999999999999999999999999986543221111       11100      0    01


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHHH
Q 042763          508 SMEILTKMFGLAIQCAAPIRNDRPDMK-SVGEQLWA  542 (554)
Q Consensus       508 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~l~~  542 (554)
                      +..+...+.+++.+||+.+|++||++. +++++.|-
T Consensus       216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~  251 (316)
T cd05592         216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF  251 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCccc
Confidence            222345678999999999999999875 67666553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.4e-40  Score=336.03  Aligned_cols=245  Identities=26%  Similarity=0.399  Sum_probs=197.0

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      +.||+|+||+||+|... +++.||||+++....  +.....+..|..++..+ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999765 478999999987532  23345566788888764 899999999999999999999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |+|.+++...  ..+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....   ...
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~  152 (316)
T cd05619          81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG---DAK  152 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC---CCc
Confidence            9999999754  46889999999999999999999   899999999999999999999999999998742211   112


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhc
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI  507 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  507 (554)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.     ...        +.    +
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~-----~~~--------~~----~  215 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR-----MDN--------PC----Y  215 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hCC--------CC----C
Confidence            234569999999999999899999999999999999999999998654322211111     000        00    1


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHH
Q 042763          508 SMEILTKMFGLAIQCAAPIRNDRPDMK-SVGEQLW  541 (554)
Q Consensus       508 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~l~  541 (554)
                      +......+.+++.+||+.+|++||++. ++.++.|
T Consensus       216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~  250 (316)
T cd05619         216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQHPF  250 (316)
T ss_pred             CccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcc
Confidence            112345678999999999999999997 7777654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.8e-41  Score=315.74  Aligned_cols=258  Identities=24%  Similarity=0.362  Sum_probs=211.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh-------hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcC
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF-------ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKG  335 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~-------~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~  335 (554)
                      -..|.+.+.||+|..++|-++.. ++|..+|+|++.....       ....++-.+|+.+|+++ .||+|+++.++|+.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            45678888999999999999854 4689999998864322       23456677899999998 699999999999999


Q ss_pred             CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCc
Q 042763          336 NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA  415 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla  415 (554)
                      ...++|+|.|+.|.|.|+|...  ..+++++..+|+.|+..|++|||   .++||||||||+|||++++.++||+|||++
T Consensus        96 sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecccee
Confidence            9999999999999999999876  68999999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHh
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMK------TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR  489 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~  489 (554)
                      ...+.    .......||||+|+|||.+.      ...|+...|+||+||+||-|+.|.+||.....-..   +    ..
T Consensus       171 ~~l~~----GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM---L----R~  239 (411)
T KOG0599|consen  171 CQLEP----GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM---L----RM  239 (411)
T ss_pred             eccCC----chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH---H----HH
Confidence            87543    33455679999999999884      34699999999999999999999999975332111   1    11


Q ss_pred             hccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          490 YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      ..++.+. +-.|.     -.++.....+||.+||+.||++|-|++|+++|.|-+.
T Consensus       240 ImeGkyq-F~spe-----Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  240 IMEGKYQ-FRSPE-----WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             HHhcccc-cCCcc-----hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            2222211 11111     1345667899999999999999999999999998754

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.1e-40  Score=337.75  Aligned_cols=246  Identities=25%  Similarity=0.370  Sum_probs=197.5

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      ++||+|+||.||+|... +|+.||+|+++....  ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999775 588999999987542  23345567788888764 899999999999999999999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |+|.+++...  ..+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....   ....
T Consensus        81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~  152 (316)
T cd05620          81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF---GDNR  152 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc---CCCc
Confidence            9999998754  46889999999999999999999   89999999999999999999999999999874211   1112


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhc
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI  507 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  507 (554)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.     ...        +.    .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~-----~~~--------~~----~  215 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR-----VDT--------PH----Y  215 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hCC--------CC----C
Confidence            334579999999999999999999999999999999999999998654322111110     000        00    1


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCH-HHHHHHHHH
Q 042763          508 SMEILTKMFGLAIQCAAPIRNDRPDM-KSVGEQLWA  542 (554)
Q Consensus       508 ~~~~~~~l~~li~~cl~~dP~~RPs~-~evl~~l~~  542 (554)
                      +..+..++.+++.+||+.||++||++ .++++|.|-
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f  251 (316)
T cd05620         216 PRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFF  251 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCc
Confidence            11234567899999999999999998 477767554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=9.6e-40  Score=341.77  Aligned_cols=265  Identities=23%  Similarity=0.312  Sum_probs=203.8

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC-----ceE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN-----ERL  339 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----~~~  339 (554)
                      +|++.++||+|+||+||++... +|+.||||++..... ......+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999764 689999999865422 223457889999999999999999999998776     789


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +||||+. ++|.+++...  ..+++..+..++.||+.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999995 6888888543  57899999999999999999999   8999999999999999999999999999998643


Q ss_pred             CCCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccc-
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD-  497 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-  497 (554)
                      ...  ........+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+...   .......+ 
T Consensus       155 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~g~~~~~~~  229 (372)
T cd07853         155 PDE--SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDL---LGTPSLEAM  229 (372)
T ss_pred             cCc--cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH---cCCCCHHHH
Confidence            221  1122334688999999998774 5899999999999999999999999876544332222111   00000000 


Q ss_pred             ---------------cCChhhhh--hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          498 ---------------MVDPSIKE--VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       498 ---------------~~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                                     ...+....  .........+.+++.+||+.||++|||+.|++++.|-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  291 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL  291 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhh
Confidence                           00000000  0112234568899999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.4e-40  Score=338.55  Aligned_cols=253  Identities=23%  Similarity=0.369  Sum_probs=199.9

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      +.||+|+||+||+|... +++.||+|++++...  ......+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999765 588999999987532  22345678899988877 899999999999999999999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |+|..++...  ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....   ...
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~---~~~  152 (329)
T cd05618          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP---GDT  152 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC---CCc
Confidence            9999988654  57899999999999999999999   899999999999999999999999999998753211   112


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChh--hHHHHHHHHHhhccCCccccCChhhhh
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPE--ERVTLRWAFKRYNEGNLLDMVDPSIKE  505 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~  505 (554)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ......+..........          
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------  222 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence            234579999999999999999999999999999999999999996322111  11111122222111111          


Q ss_pred             hccHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHHHH
Q 042763          506 VISMEILTKMFGLAIQCAAPIRNDRPD------MKSVGEQLWA  542 (554)
Q Consensus       506 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~l~~  542 (554)
                      .++......+.+++.+||+.||++||+      +.++++|.|-
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f  265 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  265 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCC
Confidence            022233456789999999999999998      6788888654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.1e-40  Score=337.47  Aligned_cols=246  Identities=25%  Similarity=0.369  Sum_probs=199.9

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      +.||+|+||+||+|..+ +++.||||++.+...  ....+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999765 588999999976532  23345677888888876 699999999999999999999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |+|.+++...  ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....   ...
T Consensus        81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~---~~~  152 (320)
T cd05590          81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN---GKT  152 (320)
T ss_pred             chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC---CCc
Confidence            9999998754  56899999999999999999999   899999999999999999999999999998753211   122


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhc
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI  507 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  507 (554)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ..    ......   .       .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~---~~----i~~~~~---~-------~  215 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF---EA----ILNDEV---V-------Y  215 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH---HH----HhcCCC---C-------C
Confidence            23456999999999999989999999999999999999999999865432221   11    111110   0       1


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHHH
Q 042763          508 SMEILTKMFGLAIQCAAPIRNDRPDM------KSVGEQLWA  542 (554)
Q Consensus       508 ~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~l~~  542 (554)
                      +......+.+++.+||+.||++||++      .+++.|.|-
T Consensus       216 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f  256 (320)
T cd05590         216 PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF  256 (320)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCc
Confidence            12234567899999999999999998      888888664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.5e-39  Score=321.94  Aligned_cols=260  Identities=23%  Similarity=0.365  Sum_probs=209.2

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|++.++||+|+||.||+|... +++.||||.+.....  ......+.+|++++++++||||+++++++.+.+..+++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57888999999999999999764 689999998764321  333467889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          343 EFVPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       343 E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||+++++|.+++...  ....+++.+++.++.|++.||+|||   +++++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            999999999988642  2345788999999999999999999   89999999999999999999999999999886432


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      ..   .......+++.|+|||.+.+..++.++||||||+++|||++|+.||........ ....    ........    
T Consensus       159 ~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~~----~~~~~~~~----  226 (267)
T cd08228         159 KT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SLCQ----KIEQCDYP----  226 (267)
T ss_pred             hh---HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HHHH----HHhcCCCC----
Confidence            11   112234588899999999988899999999999999999999999975433211 1111    11111110    


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      +.    ........+.+++.+||+.+|++||++.+|++.+++++
T Consensus       227 ~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         227 PL----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             CC----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            00    11234567899999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.1e-40  Score=352.60  Aligned_cols=253  Identities=23%  Similarity=0.277  Sum_probs=203.5

Q ss_pred             CCCcceeeeccCceEEEEEEEc-C-CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-D-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~-g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .|...+.||+|+||.||+|... + +..||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            3778889999999999999654 4 6788888775443 23345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          345 VPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       345 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      +++|+|.+++...  ....+++.++..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            9999999988643  2346889999999999999999999   8999999999999999999999999999998643221


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                       ........+||+.|+|||++.+..++.++|||||||++|||++|+.||......+..   ...    ..+...    + 
T Consensus       224 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~---~~~----~~~~~~----~-  290 (478)
T PTZ00267        224 -SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM---QQV----LYGKYD----P-  290 (478)
T ss_pred             -ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH----HhCCCC----C-
Confidence             112234567999999999999999999999999999999999999999764432211   111    011110    0 


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                          .+..+...+.+++.+||+.+|++||++.+++.+.
T Consensus       291 ----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~  324 (478)
T PTZ00267        291 ----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTE  324 (478)
T ss_pred             ----CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCH
Confidence                1122345689999999999999999999998763

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-39  Score=328.77  Aligned_cols=258  Identities=24%  Similarity=0.362  Sum_probs=207.9

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .|+..+.||+|+||.||++... +++.||+|.+......  .....+.+|+.++++++|+|++++++.+.+++..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3667789999999999999665 6899999998765432  223457789999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++++|.+++.......+++.+++.++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            999999999997655557899999999999999999999   8999999999999999999999999999987533211 


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                         ......|+..|+|||++.+..++.++||||||+++|||++|+.||....................            
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~------------  221 (285)
T cd05630         157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ------------  221 (285)
T ss_pred             ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh------------
Confidence               11234689999999999998999999999999999999999999986443221111111111000            


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHHhh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPD-----MKSVGEQLWAIR  544 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~i~  544 (554)
                       ..........+.+++.+||+.||++|||     +.|+++|.|--+
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         222 -EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             -hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence             0112233456789999999999999999     999999887544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.5e-40  Score=337.31  Aligned_cols=246  Identities=23%  Similarity=0.352  Sum_probs=200.4

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      ++||+|+||.||+|... +++.||+|++.....  ....+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999765 478999999976542  23345677889998876 799999999999999999999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |+|.+++...  ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.....   ...
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~---~~~  152 (321)
T cd05591          81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN---GVT  152 (321)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccC---Ccc
Confidence            9999998654  46889999999999999999999   899999999999999999999999999998753211   112


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhc
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI  507 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  507 (554)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ...    .....   .       .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~---~~i----~~~~~---~-------~  215 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF---ESI----LHDDV---L-------Y  215 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH---HHH----HcCCC---C-------C
Confidence            23456999999999999989999999999999999999999999865533221   111    11110   0       1


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHHHHH
Q 042763          508 SMEILTKMFGLAIQCAAPIRNDRP-------DMKSVGEQLWA  542 (554)
Q Consensus       508 ~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~l~~  542 (554)
                      +......+.+++.+||+.||++||       ++.+++++.|-
T Consensus       216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~  257 (321)
T cd05591         216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF  257 (321)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence            112345678999999999999999       89999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.3e-39  Score=319.80  Aligned_cols=253  Identities=28%  Similarity=0.405  Sum_probs=208.2

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +|...+.||+|+||.||+|... +++.|++|.+..... .....++.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999765 589999998875432 33456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++.......+++.+++.++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++......  
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--  155 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--  155 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence            99999999998765678899999999999999999999   8999999999999999999999999999988643221  


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                       .......|++.|+|||++.+..++.++||||||+++|||++|+.||........   ....    ......     .  
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~----~~~~~~-----~--  220 (256)
T cd08529         156 -NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---ILKI----IRGVFP-----P--  220 (256)
T ss_pred             -chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----HcCCCC-----C--
Confidence             122334688999999999998999999999999999999999999976542211   1111    111110     0  


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                        ....+...+.+++.+||+.+|++||++.+++++.|
T Consensus       221 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  255 (256)
T cd08529         221 --VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPS  255 (256)
T ss_pred             --CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCC
Confidence              11234567899999999999999999999998743

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.3e-40  Score=337.06  Aligned_cols=250  Identities=25%  Similarity=0.341  Sum_probs=201.7

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      +|...+.||+|+||+||+|... +++.||+|++.+...  ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999765 578999999986542  22334567788888877 5899999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++...  ..+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-  154 (323)
T cd05616          81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-  154 (323)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-
Confidence            999999999998654  46889999999999999999999   899999999999999999999999999999753211 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                        ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ....    ....       
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~---~~i~----~~~~-------  218 (323)
T cd05616         155 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---QSIM----EHNV-------  218 (323)
T ss_pred             --CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH---HHHH----hCCC-------
Confidence              11223457999999999999999999999999999999999999999865432221   1111    1110       


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHH
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDM-----KSVGEQLW  541 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~l~  541 (554)
                         .++......+.+++.+||+.+|++|++.     .++.++.|
T Consensus       219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~  259 (323)
T cd05616         219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF  259 (323)
T ss_pred             ---CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCC
Confidence               0122344568899999999999999984     77877644

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.5e-39  Score=323.91  Aligned_cols=258  Identities=29%  Similarity=0.477  Sum_probs=206.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CC---cEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DG---LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g---~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ++|+..+.||+|+||.||+|... ++   ..+|+|.++........+.+.+|++++++++||||+++.+++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46778889999999999999764 23   379999987654444457789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++++|.+++.... ..+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          85 TEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999997542 46899999999999999999999   899999999999999999999999999999764322


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      ............+..|+|||++.+..++.++||||||+++|||++ |+.||......+...   ..    ....    ..
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~---~i----~~~~----~~  229 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMK---AI----NDGF----RL  229 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH---HH----hcCC----CC
Confidence            221111112223567999999998889999999999999999998 999997654322111   11    1110    00


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      +     ...+++..+.+++.+||+.+|++||++.+|++.|.++
T Consensus       230 ~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         230 P-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0     1113446689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.8e-40  Score=346.04  Aligned_cols=257  Identities=22%  Similarity=0.341  Sum_probs=201.6

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      +|+..++||+|+||+||+|... +++.||+|++.....  ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999764 588999999976542  2345678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      ||++|+|.+++...  ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            99999999999754  46888999999999999999999   89999999999999999999999999999753211000


Q ss_pred             --------------------------------------------CccccccccCCCCCcChhccccCCCCchhhHHHHHH
Q 042763          424 --------------------------------------------RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGV  459 (554)
Q Consensus       424 --------------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGv  459 (554)
                                                                  .........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                        000112346999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCC---HHHH
Q 042763          460 LLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPD---MKSV  536 (554)
Q Consensus       460 il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev  536 (554)
                      ++|||++|+.||....+.+....+.   . .. ... .  .+     ........+.+++.+|+ .+|++|++   +.|+
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~---~-~~-~~~-~--~p-----~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei  302 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQMKVI---N-WQ-TSL-H--IP-----PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI  302 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHH---c-cC-CCc-C--CC-----CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence            9999999999998755432221111   0 00 000 0  00     01122345667777765 49999997   9999


Q ss_pred             HHHHHH
Q 042763          537 GEQLWA  542 (554)
Q Consensus       537 l~~l~~  542 (554)
                      ++|.|-
T Consensus       303 ~~hp~f  308 (382)
T cd05625         303 KAHPFF  308 (382)
T ss_pred             hcCCCc
Confidence            988664

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.3e-40  Score=329.62  Aligned_cols=266  Identities=25%  Similarity=0.441  Sum_probs=202.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-----CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEc--CCce
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDK--GNER  338 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-----~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~  338 (554)
                      .+|++.+.||+|+||+||++..+     ++..||+|++.... ....+.+.+|++++++++||||+++++++..  ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            46888899999999999999642     57899999987654 3334678999999999999999999998743  3467


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ++||||+++++|.+++... ...+++..++.++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++..
T Consensus        83 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            8999999999999999754 245899999999999999999999   899999999999999999999999999999875


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ..............++..|+|||.+.+..++.++||||||+++|||++|..|+......  .  .    ...........
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~--~----~~~~~~~~~~~  230 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--F--M----RMMGNDKQGQM  230 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--h--h----hhccccccccc
Confidence            43322211122223455699999999888999999999999999999988776432210  0  0    00000000000


Q ss_pred             CChhh--------hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          499 VDPSI--------KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       499 ~d~~l--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      ....+        .......++..+.+++.+||+.+|++|||+.||++.|.+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            00000        00011234567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.8e-40  Score=341.39  Aligned_cols=257  Identities=21%  Similarity=0.297  Sum_probs=206.5

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|...+.||+|+||+||+|... +|+.||+|+++....  ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999765 689999999987643  234466889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            999999999999764 246899999999999999999999   8999999999999999999999999999998643221


Q ss_pred             CCccccccccCCCCCcChhccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc
Q 042763          423 DRTHISTKVKGTVGYLDPEYMK------TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL  496 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~------~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  496 (554)
                        ........||+.|+|||++.      ...++.++|||||||++|||++|+.||...........+.      ......
T Consensus       157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~------~~~~~~  228 (330)
T cd05601         157 --MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM------NFQRFL  228 (330)
T ss_pred             --ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH------cCCCcc
Confidence              11223346899999999986      4567899999999999999999999998655433221111      001111


Q ss_pred             ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          497 DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       497 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ...       ........+.+++..|++ +|.+||++.+++.|.|-
T Consensus       229 ~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~  266 (330)
T cd05601         229 KFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF  266 (330)
T ss_pred             CCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCc
Confidence            100       011234567889999998 99999999999998763

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-40  Score=338.85  Aligned_cols=254  Identities=22%  Similarity=0.340  Sum_probs=215.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC-CcEEEEEEcchhhhhh--HHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFEN--LQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~--~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~l  340 (554)
                      ...|+..+.||+|.||.||++..+. |+.+|+|.+.+.....  ..+.+.+|+++|+++. |||||.++++|++.+..++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            4567778899999999999997764 9999999998876533  3478999999999998 9999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC----CcEEEEeecCcc
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES----MRAKVADFGFAR  416 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~----~~vkl~DfGla~  416 (554)
                      |||+|.||.|.+.+...   .+++..+..++.|++.++.|||   +.+|+||||||+|+|+...    +.+|++|||++.
T Consensus       114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            99999999999999876   3899999999999999999999   8999999999999999643    579999999998


Q ss_pred             cCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL  496 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  496 (554)
                      ....    .......+||+.|+|||++....|+..+||||+|+++|.|++|..||...........+..       +.+ 
T Consensus       188 ~~~~----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~-------~~~-  255 (382)
T KOG0032|consen  188 FIKP----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR-------GDF-  255 (382)
T ss_pred             EccC----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc-------CCC-
Confidence            7433    3345567899999999999999999999999999999999999999998775544332221       111 


Q ss_pred             ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          497 DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       497 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                           ......-+.+...+.+++..|+..||.+|+|+.++++|.|
T Consensus       256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence                 1111122345677899999999999999999999999998

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=321.88  Aligned_cols=256  Identities=21%  Similarity=0.351  Sum_probs=206.3

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh----hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF----ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      ++|...+.||+|++|.||+|... +++.||+|.+.....    ......+.+|++++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            56888999999999999999654 689999998864322    1223568899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||||+++++|.+++...  ..+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||+++....
T Consensus        82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            99999999999999764  46888999999999999999999   89999999999999999999999999999976432


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      ............++..|+|||.+.+..++.++||||||+++|||++|+.||..........   ...   ....     .
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~---~~~~-----~  225 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF---KIA---TQPT-----N  225 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH---HHh---ccCC-----C
Confidence            2111111133457889999999999889999999999999999999999997543322211   110   0000     0


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      +    ..+......+.+++.+||+.+|++||++.+++++.|
T Consensus       226 ~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         226 P----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF  262 (263)
T ss_pred             C----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence            0    122234456889999999999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.4e-39  Score=324.72  Aligned_cols=245  Identities=22%  Similarity=0.350  Sum_probs=195.3

Q ss_pred             eeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCH
Q 042763          274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTL  350 (554)
Q Consensus       274 LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L  350 (554)
                      ||+|+||+||++..+ +|+.||+|++......  .....+..|++++++++||||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999765 5899999998764332  2234566799999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcccccc
Q 042763          351 REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK  430 (554)
Q Consensus       351 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~  430 (554)
                      .+++.......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++......    .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~----~~~~~  153 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG----KTITQ  153 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC----ceeec
Confidence            99987665567899999999999999999999   899999999999999999999999999998764321    12233


Q ss_pred             ccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHH
Q 042763          431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISME  510 (554)
Q Consensus       431 ~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  510 (554)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.||...........+..   .......    ..     ....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~----~~-----~~~~  221 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR---RTLEDEV----KF-----EHQN  221 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH---Hhhcccc----cc-----cccc
Confidence            4689999999999988899999999999999999999999975433221111111   1111110    00     0112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHH
Q 042763          511 ILTKMFGLAIQCAAPIRNDRPDMKSVG  537 (554)
Q Consensus       511 ~~~~l~~li~~cl~~dP~~RPs~~evl  537 (554)
                      +...+.+++.+||+.||++||+++|++
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~  248 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKN  248 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccch
Confidence            345689999999999999999995544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.8e-39  Score=326.35  Aligned_cols=257  Identities=29%  Similarity=0.457  Sum_probs=204.8

Q ss_pred             cCCCcceeeeccCceEEEEEEE-----cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQL-----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      .+|+..++||+|+||+||+|..     .++..||+|.+...........+.+|++++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577788999999999999974     24678999999765444445678999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhccc---------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC
Q 042763          341 ITEFVPNGTLREHLDGQY---------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM  405 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~  405 (554)
                      ||||+++++|.+++....               ...+++.+.+.++.|++.||+|||   +++++||||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999985332               135788899999999999999999   89999999999999999999


Q ss_pred             cEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHH
Q 042763          406 RAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLR  484 (554)
Q Consensus       406 ~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~  484 (554)
                      .+||+|||+++...... .........++..|+|||++.+..++.++||||||+++|||++ |..||........   ..
T Consensus       162 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~---~~  237 (283)
T cd05090         162 HVKISDLGLSREIYSAD-YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV---IE  237 (283)
T ss_pred             cEEeccccccccccCCc-ceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HH
Confidence            99999999997643221 1112233446778999999988889999999999999999999 9999875433211   11


Q ss_pred             HHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       485 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ..    .......         .+..++..+.+++.+||+.+|++||++.+|.+++..
T Consensus       238 ~~----~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 MV----RKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HH----HcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11    1111110         112234568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.8e-40  Score=343.54  Aligned_cols=260  Identities=21%  Similarity=0.295  Sum_probs=205.1

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      ...++|+..++||+|+||.||++... +++.||+|++.+...  ......+.+|+.+++.++||||+++++++.+++..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999775 588999999876432  223456789999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +||||+++|+|.+++...   .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++....
T Consensus       120 lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            999999999999999654   5788999999999999999999   8999999999999999999999999999998642


Q ss_pred             CCCCCccccccccCCCCCcChhccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTY----QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      ..  .........||+.|+|||++.+.    .++.++|||||||++|||++|+.||...........+   ...  ....
T Consensus       194 ~~--~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i---~~~--~~~~  266 (370)
T cd05621         194 ET--GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI---MDH--KNSL  266 (370)
T ss_pred             cC--CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHH---HhC--Cccc
Confidence            21  11122345799999999998764    3789999999999999999999999865533221111   100  0000


Q ss_pred             cccCChhhhhhccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHHHh
Q 042763          496 LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRND--RPDMKSVGEQLWAI  543 (554)
Q Consensus       496 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~~i  543 (554)
                       ..  +     ........+.+++..|++.++.+  ||++.|+++|.|--
T Consensus       267 -~~--p-----~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~  308 (370)
T cd05621         267 -NF--P-----EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK  308 (370)
T ss_pred             -CC--C-----CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence             00  0     01123456788899999755544  89999999998753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.1e-40  Score=345.17  Aligned_cols=259  Identities=22%  Similarity=0.286  Sum_probs=206.4

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      ..++|+..++||+|+||+||+|... +++.||+|++.....  ......+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4568999999999999999999765 588999999976432  1223457889999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||||+++|+|.+++...   .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999998654   5788889999999999999999   89999999999999999999999999999976422


Q ss_pred             CCCCccccccccCCCCCcChhccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTY----QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL  496 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  496 (554)
                      .  .........||+.|+|||++.+.    .++.++|||||||++|||++|+.||...........+.      ....-.
T Consensus       195 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~------~~~~~~  266 (370)
T cd05596         195 N--GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM------DHKNSL  266 (370)
T ss_pred             C--CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHH------cCCCcC
Confidence            1  11122345699999999998653    47899999999999999999999998755432211111      000000


Q ss_pred             ccCChhhhhhccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHHHh
Q 042763          497 DMVDPSIKEVISMEILTKMFGLAIQCAAPIRND--RPDMKSVGEQLWAI  543 (554)
Q Consensus       497 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~~i  543 (554)
                      .  .+     ....++..+.+++.+||+.+|.+  ||++.++++|.|--
T Consensus       267 ~--~~-----~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~  308 (370)
T cd05596         267 T--FP-----DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK  308 (370)
T ss_pred             C--CC-----CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccC
Confidence            0  00     01123567889999999999988  99999999997643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.2e-40  Score=335.86  Aligned_cols=249  Identities=24%  Similarity=0.339  Sum_probs=201.5

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      +.||+|+||+||+|... +++.||||++++...  ......+..|+++++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999765 578999999986542  23345677899999888 699999999999999999999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |+|.+++...  ..+++.++..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++......   ..
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~  152 (318)
T cd05570          81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VT  152 (318)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC---Cc
Confidence            9999998754  47899999999999999999999   8999999999999999999999999999987422111   11


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhc
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI  507 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  507 (554)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||.........   ..    ......          ..
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~---~~----i~~~~~----------~~  215 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF---QS----ILEDEV----------RY  215 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH---HH----HHcCCC----------CC
Confidence            23346899999999999999999999999999999999999999765432111   11    111110          01


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHHhhh
Q 042763          508 SMEILTKMFGLAIQCAAPIRNDRPDM-----KSVGEQLWAIRA  545 (554)
Q Consensus       508 ~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~l~~i~~  545 (554)
                      +......+.+++.+||+.||++||++     .+++++.|--..
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            22234568899999999999999999     999988765443

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.7e-40  Score=336.10  Aligned_cols=252  Identities=23%  Similarity=0.344  Sum_probs=199.9

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      +.||+|+||+||+|... +++.||+|+++.....  ...+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999765 5789999999875432  3345688999999888 699999999999999999999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |+|..++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....   ...
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~---~~~  152 (327)
T cd05617          81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP---GDT  152 (327)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC---CCc
Confidence            9999988654  47899999999999999999999   899999999999999999999999999998742211   112


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhc
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI  507 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  507 (554)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.............+..........          ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~  222 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RI  222 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CC
Confidence            23457999999999999999999999999999999999999999753322211111122221111110          01


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHHH
Q 042763          508 SMEILTKMFGLAIQCAAPIRNDRPD------MKSVGEQLW  541 (554)
Q Consensus       508 ~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~l~  541 (554)
                      +......+.+++.+||+.||++||+      +.++.+|.|
T Consensus       223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~  262 (327)
T cd05617         223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTF  262 (327)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCC
Confidence            2223456789999999999999998      568887754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=340.83  Aligned_cols=257  Identities=29%  Similarity=0.415  Sum_probs=217.6

Q ss_pred             CCCcceeeeccCceEEEEEEEcC-CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      +.....+||-|.||.||.|.|+. ...||||.++....  ..++|+.|..+|+.++|||+|+|+|+|..+...|||.|||
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            34456789999999999998875 67899999988754  3689999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ..|+|.+||++.....++.-..+++|.||+.|++||.   .+++|||||..+|+|+.++..||++|||++++...+....
T Consensus       346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA  422 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA  422 (1157)
T ss_pred             cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence            9999999999877777888888999999999999999   9999999999999999999999999999999865443332


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      +  ......+.|.|||-+....++.|+|||+|||+|||+.| |..||.+.+.......++..+                +
T Consensus       423 H--AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy----------------R  484 (1157)
T KOG4278|consen  423 H--AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY----------------R  484 (1157)
T ss_pred             c--cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc----------------c
Confidence            2  33346788999999999999999999999999999999 999998755433322222211                1


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      -..+..|+.++++||++||+++|.+||+++|+-+.++.+-.+
T Consensus       485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence            113456788999999999999999999999999999876543

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2e-39  Score=322.56  Aligned_cols=255  Identities=30%  Similarity=0.459  Sum_probs=205.8

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ..+|.+.++||+|+||+||+|...++..||+|+++....  ..+.+.+|++++++++||||+++++++.+ ...++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            356888999999999999999887777899999976432  23578999999999999999999998754 567999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++|+|.+++.......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||.++....... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-  157 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  157 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence            99999999998765567899999999999999999999   89999999999999999999999999999976432211 


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                       .......++..|+|||.+.+..++.++||||||+++|||+| |..||......+.....       ......       
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~-------~~~~~~-------  222 (262)
T cd05071         158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------ERGYRM-------  222 (262)
T ss_pred             -ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-------hcCCCC-------
Confidence             11122346778999999988899999999999999999999 88888755432221111       010000       


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                        ....+++..+.+++.+|++.+|++||++.++++.|++.
T Consensus       223 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence              01234556788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.6e-40  Score=353.46  Aligned_cols=259  Identities=26%  Similarity=0.359  Sum_probs=207.2

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC----
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN----  336 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----  336 (554)
                      ...++|.+.+.||+|+||+||+|.. .+|+.||||++..... ......+.+|+..+..++|+||++++..+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3457899999999999999999965 4689999999876533 333466889999999999999999988765432    


Q ss_pred             ----ceEEEEEeCCCCCHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEE
Q 042763          337 ----ERLIITEFVPNGTLREHLDGQY--GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVA  410 (554)
Q Consensus       337 ----~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~  410 (554)
                          ..++||||+++|+|.+++..+.  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence                3679999999999999997532  357889999999999999999999   8999999999999999999999999


Q ss_pred             eecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhh
Q 042763          411 DFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY  490 (554)
Q Consensus       411 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  490 (554)
                      |||+++...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||......+...       ..
T Consensus       186 DFGls~~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~-------~~  257 (496)
T PTZ00283        186 DFGFSKMYAATV-SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH-------KT  257 (496)
T ss_pred             ecccCeeccccc-cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-------HH
Confidence            999998643221 1122334579999999999999999999999999999999999999997654322111       11


Q ss_pred             ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ..+..    ++     .+..++..+.+++.+||+.+|.+||++.+++++.+
T Consensus       258 ~~~~~----~~-----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~  299 (496)
T PTZ00283        258 LAGRY----DP-----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPI  299 (496)
T ss_pred             hcCCC----CC-----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHH
Confidence            11111    00     12234567899999999999999999999998754

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.3e-39  Score=320.13  Aligned_cols=250  Identities=26%  Similarity=0.498  Sum_probs=199.1

Q ss_pred             eeeccCceEEEEEEEc---CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCC
Q 042763          273 RIGEGGFGTVYKAQLE---DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGT  349 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~  349 (554)
                      .||+|+||.||+|.+.   ++..||+|++.........+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999654   3567999999766544555779999999999999999999998864 57899999999999


Q ss_pred             HHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccc
Q 042763          350 LREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST  429 (554)
Q Consensus       350 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~  429 (554)
                      |.+++... ...+++.++++++.|++.||+|||   +++++||||||+|||++.++.+||+|||+++.............
T Consensus        81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99998753 346899999999999999999999   89999999999999999999999999999975432222111122


Q ss_pred             cccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhcc
Q 042763          430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS  508 (554)
Q Consensus       430 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  508 (554)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |..||......+...   ..    ..+...         ..+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~----~~~~~~---------~~~  220 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS---FI----EQGKRL---------DCP  220 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH---HH----HCCCCC---------CCC
Confidence            2234678999999988889999999999999999996 999998654332211   11    111000         012


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          509 MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       509 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      ..++..+.+++.+||+.+|++||++.+|.+.|.++
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            23456788999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9e-40  Score=329.04  Aligned_cols=267  Identities=26%  Similarity=0.331  Sum_probs=200.7

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhC---CCCCceeeeeEEEc-----CC
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKI---DHRNLVKLLGFVDK-----GN  336 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~-----~~  336 (554)
                      +|++.+.||+|+||+||+|... +|+.||+|.++..... .....+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999765 6899999988754322 1223456677777665   79999999998754     34


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ..+++|||++ ++|.+++.......+++.++..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            5799999996 68999987765567899999999999999999999   8999999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL  496 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  496 (554)
                      .....    .......||+.|+|||++.+..++.++|||||||++|||++|++||......+....+.............
T Consensus       157 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         157 IYSCQ----MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             cccCc----ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            64321    11233468999999999998899999999999999999999999997655433222211111000000000


Q ss_pred             c-------cCC---hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          497 D-------MVD---PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       497 ~-------~~d---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .       ...   +........++...+.+++.+||+.||++|||+.|++.+.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~  287 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF  287 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            0       000   00001112234567899999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-40  Score=338.91  Aligned_cols=245  Identities=26%  Similarity=0.348  Sum_probs=198.8

Q ss_pred             eeeeccCceEEEEEEE----cCCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCC
Q 042763          272 LRIGEGGFGTVYKAQL----EDGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVP  346 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~----~~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  346 (554)
                      +.||+|+||.||++..    .+|+.||+|++...... .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999864    35889999999865432 233457789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcc
Q 042763          347 NGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH  426 (554)
Q Consensus       347 ~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~  426 (554)
                      +|+|.+++...  ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....   ..
T Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~---~~  153 (318)
T cd05582          82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH---EK  153 (318)
T ss_pred             CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC---CC
Confidence            99999999654  46899999999999999999999   899999999999999999999999999998753221   11


Q ss_pred             ccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhh
Q 042763          427 ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEV  506 (554)
Q Consensus       427 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  506 (554)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........   ...    .....          .
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~~i----~~~~~----------~  216 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM---TMI----LKAKL----------G  216 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH---HHH----HcCCC----------C
Confidence            223457999999999999888999999999999999999999999865432211   111    11110          0


Q ss_pred             ccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHH
Q 042763          507 ISMEILTKMFGLAIQCAAPIRNDRPD-----MKSVGEQLW  541 (554)
Q Consensus       507 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~  541 (554)
                      .+......+.+++.+||+.||++||+     +.+++.+.|
T Consensus       217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~  256 (318)
T cd05582         217 MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF  256 (318)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCC
Confidence            12233456789999999999999999     566776654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.5e-39  Score=321.50  Aligned_cols=251  Identities=25%  Similarity=0.360  Sum_probs=206.3

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      +|+..++||+|+||.||++... ++..+|+|.++........+.+.+|+.++++++||||+++++.+..++..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778889999999999999765 688999998865443444567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ++++|.+++.......+++..++.++.|++.||.|||   +++++|+||||+||++++++.++++|||+++.....   .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~---~  154 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---G  154 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccc---c
Confidence            9999999997665667899999999999999999999   899999999999999999999999999999764321   1


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE  505 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  505 (554)
                      .......|++.|+|||++.+..++.++||||||+++|+|++|..||..........       .........        
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~~--------  219 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL-------KVCQGSYKP--------  219 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH-------HHhcCCCCC--------
Confidence            12234568899999999998889999999999999999999999998644322111       111111110        


Q ss_pred             hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042763          506 VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQ  539 (554)
Q Consensus       506 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  539 (554)
                       .+......+.+++.+||+.||++||++.+|+..
T Consensus       220 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 -LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             112234568899999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2e-39  Score=325.11  Aligned_cols=257  Identities=30%  Similarity=0.421  Sum_probs=204.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED------GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  338 (554)
                      .++|...+.||+|+||.||+|...+      +..||+|.+...........+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678889999999999999997653      5789999887654444456799999999999999999999999988899


Q ss_pred             EEEEEeCCCCCHHHHHhcccC-----CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC---cEEEE
Q 042763          339 LIITEFVPNGTLREHLDGQYG-----KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM---RAKVA  410 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~---~vkl~  410 (554)
                      ++||||+++++|.+++.....     ..+++.+++.++.||+.||+|||   +++++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence            999999999999999976532     25889999999999999999999   88999999999999998755   59999


Q ss_pred             eecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHh
Q 042763          411 DFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKR  489 (554)
Q Consensus       411 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~  489 (554)
                      |||+++....... .........+..|+|||++.+..++.++|||||||++|||++ |..||......+....   ..  
T Consensus       162 dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~---~~--  235 (277)
T cd05036         162 DFGMARDIYRASY-YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF---VT--  235 (277)
T ss_pred             cCccccccCCccc-eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HH--
Confidence            9999986422111 111112234568999999998899999999999999999997 9999986544322111   10  


Q ss_pred             hccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          490 YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                       .... .         ..+..++..+.+++.+||+.+|++||++.+|+++|.
T Consensus       236 -~~~~-~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 -GGGR-L---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -cCCc-C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence             0000 0         012233467889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.9e-39  Score=323.35  Aligned_cols=258  Identities=28%  Similarity=0.463  Sum_probs=206.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEc----CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .+|++.+.||+|+||.||+|...    .+..+|+|.++........+.+.+|+.++++++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56788899999999999999753    23479999987654444557899999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++++|.+++.... ..+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.++|+|||+++.....
T Consensus        84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999997653 46899999999999999999999   899999999999999999999999999999865332


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      ...........++..|+|||.+.+..++.++||||||+++||+++ |..||......+..   ....    ...  ..  
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~---~~~~----~~~--~~--  228 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI---KAIE----EGY--RL--  228 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH---HHHh----CCC--cC--
Confidence            211111112234568999999998899999999999999999887 99999765433221   1111    110  00  


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      +     ....++..+.+++.+|++.+|++||+|.++++.|.++
T Consensus       229 ~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 P-----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             C-----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            0     1122345688999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.7e-39  Score=320.64  Aligned_cols=248  Identities=27%  Similarity=0.440  Sum_probs=198.0

Q ss_pred             eeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCHH
Q 042763          273 RIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLR  351 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~  351 (554)
                      .||+|+||.||+|... +++.||+|.+...........+.+|++++++++||||+++++++......++||||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            6899999999999764 689999998875544445577999999999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccc
Q 042763          352 EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV  431 (554)
Q Consensus       352 ~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~  431 (554)
                      +++... ...+++.+++.++.|++.||+|||   +++++||||||+||+++.++.+||+|||++....... ........
T Consensus        82 ~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~  156 (252)
T cd05084          82 TFLRTE-GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV-YASTGGMK  156 (252)
T ss_pred             HHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccccccc-ccccCCCC
Confidence            999754 346889999999999999999999   8999999999999999999999999999987532111 00001111


Q ss_pred             cCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHH
Q 042763          432 KGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISME  510 (554)
Q Consensus       432 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  510 (554)
                      ..+..|+|||.+.+..++.++||||||+++|||++ |..||..........    ........            ..+..
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~----~~~~~~~~------------~~~~~  220 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE----AIEQGVRL------------PCPEL  220 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH----HHHcCCCC------------CCccc
Confidence            23457999999998889999999999999999998 888886543322111    11110000            01223


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          511 ILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       511 ~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ++..+.+++.+||+.+|++||++.+|++.|.
T Consensus       221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            3457889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.8e-39  Score=321.99  Aligned_cols=254  Identities=30%  Similarity=0.484  Sum_probs=207.3

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .++|+..++||+|+||.||+|..++++.||+|.+......  ...+.+|+.++++++||||+++++++. .+..+++|||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            3578889999999999999999888999999998765432  357889999999999999999999874 4678999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++....+..+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--  156 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE--  156 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC--
Confidence            99999999998766667899999999999999999999   8999999999999999999999999999997643211  


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+       .......      
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~~~~------  223 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-------ERGYRMP------  223 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-------HcCCCCC------
Confidence            111223346778999999998889999999999999999999 99999865433221111       0100000      


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                         .....+..+.+++.+||+.+|++||+++++.+.|++
T Consensus       224 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 ---RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence               111234568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.3e-39  Score=326.66  Aligned_cols=261  Identities=28%  Similarity=0.476  Sum_probs=209.1

Q ss_pred             cCCCcceeeeccCceEEEEEEE------cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      ++|.+.+.||+|+||+||++..      .++..+|+|.+.... ......+.+|++++++++||||+++++++..++..+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            5678888999999999999964      235678999887643 334567899999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhccc-----------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEE
Q 042763          340 IITEFVPNGTLREHLDGQY-----------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAK  408 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vk  408 (554)
                      +||||+++++|.+++....           ...+++.+++.++.|++.||+|||   +++++||||||+|||+++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence            9999999999999997532           135899999999999999999999   89999999999999999999999


Q ss_pred             EEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHH
Q 042763          409 VADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAF  487 (554)
Q Consensus       409 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~  487 (554)
                      |+|||+++...... .........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+..   ..  
T Consensus       161 l~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~---~~--  234 (288)
T cd05093         161 IGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI---EC--  234 (288)
T ss_pred             eccCCccccccCCc-eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH--
Confidence            99999997543221 1112223446788999999998899999999999999999998 99998765432211   11  


Q ss_pred             HhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          488 KRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                        ...+....         .+...+..+.+++.+||+.+|.+|||+.+|.+.|+++....
T Consensus       235 --i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         235 --ITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             --HHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence              11111111         01123346899999999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.7e-39  Score=318.54  Aligned_cols=261  Identities=26%  Similarity=0.391  Sum_probs=210.5

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++....  ....+.+.+|++++++++|+|++++++++..++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999776 789999998864322  233567899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          343 EFVPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       343 E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||+++++|.+++...  ....+++.+++.++.+++.||.|||   +.+++||||+|+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999998642  2346889999999999999999999   89999999999999999999999999999876432


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      ..   .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........ .    .......+...    
T Consensus       159 ~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~----~~~~~~~~~~~----  226 (267)
T cd08224         159 KT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-S----LCKKIEKCDYP----  226 (267)
T ss_pred             CC---cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH-H----HHhhhhcCCCC----
Confidence            21   112234588899999999988899999999999999999999999975432111 0    11111111111    


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      +.    ........+.+++.+||..+|++||++.+|++.+.++++
T Consensus       227 ~~----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~  267 (267)
T cd08224         227 PL----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA  267 (267)
T ss_pred             CC----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence            10    111345578899999999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.4e-39  Score=325.08  Aligned_cols=255  Identities=23%  Similarity=0.353  Sum_probs=206.0

Q ss_pred             CCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      |+..+.||+|+||+||+|... +++.||+|.+......  .....+.+|++++++++|+||+++.+++..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999664 6899999998765432  2235578899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++.......+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            99999999987654557999999999999999999999   8999999999999999999999999999997543211  


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                        ......|+..|+|||.+.+..++.++||||||+++|||++|..||...........+..   ......  .       
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~---~~~~~~--~-------  222 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR---RVLETE--E-------  222 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH---hhhccc--c-------
Confidence              12234689999999999988999999999999999999999999986544322222111   111110  0       


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHH
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPD-----MKSVGEQLWA  542 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~  542 (554)
                       .+.......+.+++..||+.+|++||+     +.+++.+.|-
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~  264 (285)
T cd05632         223 -VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF  264 (285)
T ss_pred             -ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhh
Confidence             012233456789999999999999999     7888887543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2e-39  Score=321.36  Aligned_cols=251  Identities=30%  Similarity=0.440  Sum_probs=202.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      ++|...+.||+|+||+||+|+..++..+|+|.+.....  ..+++.+|+.++++++||||+++++++...+..+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            45777889999999999999887777899998875432  2357899999999999999999999999888999999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~--~  155 (256)
T cd05113          82 SNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--Y  155 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc--e
Confidence            9999999997643 36899999999999999999999   8999999999999999999999999999987643221  1


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||..........   ..    ......    .   
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~---~~----~~~~~~----~---  221 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE---KV----SQGLRL----Y---  221 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH---HH----hcCCCC----C---
Confidence            11122345678999999988889999999999999999999 999987544322111   11    110000    0   


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                        .+......+.+++.+||+.+|++||++.+|++.+
T Consensus       222 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         222 --RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             --CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence              0111245789999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.4e-40  Score=316.87  Aligned_cols=267  Identities=24%  Similarity=0.301  Sum_probs=211.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhh-HHHHHHHHHHHHHhCCCCCceeeeeEEE--cCCceEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFEN-LQTEFSSEVELLSKIDHRNLVKLLGFVD--KGNERLI  340 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~--~~~~~~l  340 (554)
                      .++|+..++|++|+||.||+|+.+ +++.||+|+++...... .--.-++||.+|.+.+|||||.+-.+..  +-+..|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            356778889999999999999654 68999999998765321 2234679999999999999999988764  4457899


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      |||||+ -||...++... .++...++.-+..|+++|++|||   .+.|+|||||++|+|++..|.+||+|||+||.+..
T Consensus       155 VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  155 VMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             eHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999995 59999998663 67889999999999999999999   99999999999999999999999999999997543


Q ss_pred             CCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC--Cccc
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG--NLLD  497 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~  497 (554)
                         .....+..+-|.+|+|||.+.+. .|+++.|+||+|||+.||+++++-|.+.+..++...   ++.....+  .++.
T Consensus       230 ---p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~---If~llGtPte~iwp  303 (419)
T KOG0663|consen  230 ---PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK---IFKLLGTPSEAIWP  303 (419)
T ss_pred             ---CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH---HHHHhCCCccccCC
Confidence               33445677889999999998875 699999999999999999999999998876555443   33333222  2221


Q ss_pred             cCC---------------hhhhhhccHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          498 MVD---------------PSIKEVISME-ILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       498 ~~d---------------~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      -++               ..++..+... ..+.-++|+...+..||.+|-|+.|.+++-|-
T Consensus       304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F  364 (419)
T KOG0663|consen  304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYF  364 (419)
T ss_pred             CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccc
Confidence            111               1111112211 33566899999999999999999999988653

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=321.72  Aligned_cols=251  Identities=30%  Similarity=0.436  Sum_probs=202.1

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      .+|+..+.||+|+||.||+|..+++..+|+|.+.....  ....+.+|++++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            35777889999999999999887777899999865432  2356888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ++++|.+++..+. ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~--~  155 (256)
T cd05059          82 ANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--Y  155 (256)
T ss_pred             CCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc--c
Confidence            9999999997543 36899999999999999999999   8999999999999999999999999999997643211  1


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....   .    ....     ...  
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---~----~~~~-----~~~--  221 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES---V----SAGY-----RLY--  221 (256)
T ss_pred             cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH---H----HcCC-----cCC--
Confidence            11112224567999999998899999999999999999999 8999976543322111   1    1100     000  


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                        .+..++..+.+++.+||+.+|++||++.|+++.|
T Consensus       222 --~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         222 --RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence              1112455789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.7e-39  Score=328.09  Aligned_cols=262  Identities=31%  Similarity=0.445  Sum_probs=209.4

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEEcC------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcC
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQLED------GLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKG  335 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~  335 (554)
                      ...++|+..+.||+|+||.||++...+      ...+|+|.+..........++.+|++++.++ +||||+++++++..+
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            344678888999999999999997642      3689999987654444456788999999999 799999999999999


Q ss_pred             CceEEEEEeCCCCCHHHHHhcc--------------cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE
Q 042763          336 NERLIITEFVPNGTLREHLDGQ--------------YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL  401 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl  401 (554)
                      +..+++|||+++|+|.+++...              ....+++..++.++.|++.||+|||   +++|+||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence            9999999999999999999653              2356889999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhH
Q 042763          402 TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEER  480 (554)
Q Consensus       402 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~  480 (554)
                      +.++.+||+|||+++...... .........++..|+|||.+.+..++.++|||||||++|||++ |..||......+..
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  244 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHID-YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  244 (293)
T ss_pred             cCCCeEEeCcccccccccccc-ceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence            999999999999998643221 1111122335678999999988899999999999999999998 99998755433221


Q ss_pred             HHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          481 VTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      ...       .......         .+..+...+.+++.+||+.+|++|||+.|+++.|.++.
T Consensus       245 ~~~-------~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 KLL-------KEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHH-------HcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            111       1111000         11233456889999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.4e-39  Score=329.00  Aligned_cols=259  Identities=28%  Similarity=0.410  Sum_probs=208.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCce
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~  338 (554)
                      ++|...+.||+|+||.||++...      .+..||||+++........+.+.+|+++++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            56888999999999999999641      35689999987654444456799999999999 799999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      +++|||+++|+|.+++.......+++.++..++.|++.||+|||   +++++|+||||+|||++.++.++++|||+++..
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            99999999999999998655455899999999999999999999   899999999999999999999999999999864


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                      ..... ........++..|+|||.+.+..++.++||||||+++|||++ |..||......+....  ..    ..+. . 
T Consensus       192 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~--~~----~~~~-~-  262 (302)
T cd05055         192 MNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK--LI----KEGY-R-  262 (302)
T ss_pred             cCCCc-eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH--HH----HcCC-c-
Confidence            33221 111222346788999999998899999999999999999998 9999876544322111  11    0000 0 


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                         ..    .+......+.+++.+||+.+|++||++.||++.|.++
T Consensus       263 ---~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 ---MA----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ---CC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence               00    1112245689999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.1e-39  Score=329.98  Aligned_cols=262  Identities=32%  Similarity=0.435  Sum_probs=207.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEc--------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCC
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE--------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGN  336 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~  336 (554)
                      ++|.+.+.||+|+||.||++...        ++..+|+|.+..........++.+|+++++++ +||||+++++++..++
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            56888999999999999999642        23579999998654344456788999999999 7999999999999999


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccC--------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC
Q 042763          337 ERLIITEFVPNGTLREHLDGQYG--------------KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT  402 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~  402 (554)
                      ..++||||+++|+|.+++..+..              ..+++.+++.++.|++.||+|||   +.+++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence            99999999999999999976421              35789999999999999999999   89999999999999999


Q ss_pred             CCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHH
Q 042763          403 ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERV  481 (554)
Q Consensus       403 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~  481 (554)
                      .++.+||+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+...
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~  253 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  253 (307)
T ss_pred             CCCcEEECCCcccccccccch-hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            999999999999875432111 111112234578999999998889999999999999999998 888886543221111


Q ss_pred             HHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          482 TLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                      .       .......+         .+......+.+++.+||..+|++||++.+|++.|+++....
T Consensus       254 ~-------~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         254 L-------LKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             H-------HHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            1       11111000         11233467889999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-39  Score=326.96  Aligned_cols=263  Identities=25%  Similarity=0.401  Sum_probs=204.1

Q ss_pred             cCCCcceeeeccCceEEEEEEEcC---------------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeee
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLED---------------GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG  330 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~---------------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~  330 (554)
                      ++|++.++||+|+||.||++...+               ...||+|.++..........+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578888999999999999986532               23589999876544445567999999999999999999999


Q ss_pred             EEEcCCceEEEEEeCCCCCHHHHHhccc----------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeE
Q 042763          331 FVDKGNERLIITEFVPNGTLREHLDGQY----------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNIL  400 (554)
Q Consensus       331 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIL  400 (554)
                      ++...+..++||||+++++|.+++....          ...+++..++.++.|++.||+|||   +.+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            9999999999999999999999986432          124688899999999999999999   899999999999999


Q ss_pred             ECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCChh
Q 042763          401 LTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT--GRRPVELKRPPE  478 (554)
Q Consensus       401 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt--g~~P~~~~~~~~  478 (554)
                      ++.++.+||+|||+++...... .........++..|+|||.+.+..++.++||||||+++|||++  |..||.......
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGD-YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EcCCCcEEecccccccccccCc-ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            9999999999999997543221 1112223345778999999988889999999999999999998  667777554332


Q ss_pred             hHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          479 ERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ........+..........         .+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLS---------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHhhhhccccccCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            2221111111000000000         11123457899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.3e-39  Score=330.51  Aligned_cols=270  Identities=22%  Similarity=0.330  Sum_probs=206.6

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|...++||+|+||.||+|... +++.||+|.+...........+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888999999999999999765 58899999987554333345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      ++ ++|.+++... ...+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++.......  
T Consensus        86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--  158 (301)
T cd07873          86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--  158 (301)
T ss_pred             cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence            96 6999988654 346789999999999999999999   8999999999999999999999999999997532211  


Q ss_pred             ccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC---
Q 042763          425 THISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD---  500 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d---  500 (554)
                       .......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+.....................+   
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence             112233578899999988653 578999999999999999999999987654333222211111100100000000   


Q ss_pred             ------hhhh----hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          501 ------PSIK----EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       501 ------~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                            +...    ......+...+.+++.+||+.||.+|||+.|++++.|-.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~  290 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH  290 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence                  0000    001123455688999999999999999999999988753

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.7e-39  Score=319.42  Aligned_cols=248  Identities=27%  Similarity=0.478  Sum_probs=197.5

Q ss_pred             eeeccCceEEEEEEEc---CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCC
Q 042763          273 RIGEGGFGTVYKAQLE---DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNG  348 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g  348 (554)
                      +||+|+||.||+|.++   ++..+|+|+++.... ....+++.+|+.++++++||||+++++++. ++..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999643   578999999875432 234567899999999999999999999885 45678999999999


Q ss_pred             CHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcccc
Q 042763          349 TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIS  428 (554)
Q Consensus       349 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~  428 (554)
                      +|.+++...  ..+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++............
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            999999754  46899999999999999999999   8999999999999999999999999999998643322211112


Q ss_pred             ccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhc
Q 042763          429 TKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI  507 (554)
Q Consensus       429 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  507 (554)
                      ....++..|+|||.+....++.++||||||+++|||++ |..||......+..   ..    ........         .
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~----i~~~~~~~---------~  219 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT---QM----IESGERME---------C  219 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HHCCCCCC---------C
Confidence            22334678999999988889999999999999999998 99999764432211   11    11111111         1


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          508 SMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       508 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      +..++..+.+++.+||+.||++||++.+|.+.|.+
T Consensus       220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            22344568899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.4e-39  Score=324.80  Aligned_cols=259  Identities=28%  Similarity=0.421  Sum_probs=205.6

Q ss_pred             CCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      +|+..+.||+|+||.||+|...      ....+|+|.+...........+.+|+.+++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677889999999999999653      2357899988765444445678999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhccc----------------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCC
Q 042763          341 ITEFVPNGTLREHLDGQY----------------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSN  398 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N  398 (554)
                      +|||+.+++|.+++....                      ...+++.+++.++.|++.||+|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999986421                      135788999999999999999999   8999999999999


Q ss_pred             eEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCh
Q 042763          399 ILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPP  477 (554)
Q Consensus       399 ILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~  477 (554)
                      ||+++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||....+.
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999754322211 11223345778999999988889999999999999999998 99999765432


Q ss_pred             hhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          478 EERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      ....   .    ......     ..    .+..+...+.+++.+||+.+|++||++.|+++.|+++-.
T Consensus       237 ~~~~---~----~~~~~~-----~~----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         237 RLFN---L----LKTGYR-----ME----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHHH---H----HhCCCC-----CC----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            2111   1    111100     00    112234568899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.7e-39  Score=337.22  Aligned_cols=268  Identities=21%  Similarity=0.242  Sum_probs=206.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc---CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE---DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ..+|.+.++||+|+||.||++...   .+..||+|.+...      ....+|++++++++||||+++++++......+++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            457999999999999999999653   3578999988654      2346899999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      ||++ .++|.+++...  ..+++.+++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       165 ~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        165 MPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             ehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9999 57899988433  57899999999999999999999   899999999999999999999999999999754322


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc--cc-
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL--DM-  498 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-  498 (554)
                      . .........||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.............  .. 
T Consensus       239 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        239 P-DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             c-ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            1 1122234579999999999999899999999999999999999999998765433222222222211110000  00 


Q ss_pred             --------------CCh--hhhh-hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          499 --------------VDP--SIKE-VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       499 --------------~d~--~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                                    ..+  .... .........+.+++.+||..||++||++.|++.+.|-.+.
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                          000  0000 0001123467889999999999999999999999887553

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.2e-40  Score=337.11  Aligned_cols=245  Identities=26%  Similarity=0.354  Sum_probs=195.6

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHH-HHHhCCCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVE-LLSKIDHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      +.||+|+||+||+|... +|+.||+|++......  ....++..|.. +++.++||||+++++++.+++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999765 6899999999765432  22344555555 56789999999999999999999999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |+|.+++...  ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....   ....
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~---~~~~  152 (323)
T cd05575          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE---HSKT  152 (323)
T ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc---CCCc
Confidence            9999998754  57889999999999999999999   89999999999999999999999999999875321   1122


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhc
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI  507 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  507 (554)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....       ......      .    .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-------i~~~~~------~----~  215 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDN-------ILNKPL------R----L  215 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHH-------HHcCCC------C----C
Confidence            3345699999999999999999999999999999999999999986543221111       111110      0    1


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHHH
Q 042763          508 SMEILTKMFGLAIQCAAPIRNDRPDM----KSVGEQLW  541 (554)
Q Consensus       508 ~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~l~  541 (554)
                      .......+.+++.+||+.||++||++    .+++++.|
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~  253 (323)
T cd05575         216 KPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVF  253 (323)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCC
Confidence            12234568899999999999999998    57777654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.6e-39  Score=325.98  Aligned_cols=264  Identities=27%  Similarity=0.423  Sum_probs=207.3

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC-----------------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCcee
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED-----------------GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK  327 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~-----------------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~  327 (554)
                      ..+|++.++||+|+||.||+|...+                 +..||+|++.........+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578889999999999999986542                 25689999886654455678999999999999999999


Q ss_pred             eeeEEEcCCceEEEEEeCCCCCHHHHHhccc---------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCC
Q 042763          328 LLGFVDKGNERLIITEFVPNGTLREHLDGQY---------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSN  398 (554)
Q Consensus       328 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N  398 (554)
                      +++++..++..+++|||+++++|.+++....         ...+++..++.++.|++.||+|||   +.+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999997643         126899999999999999999999   8999999999999


Q ss_pred             eEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCC
Q 042763          399 ILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT--GRRPVELKRP  476 (554)
Q Consensus       399 ILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt--g~~P~~~~~~  476 (554)
                      |+++.++.++|+|||+++..... ..........+++.|+|||.+.+..++.++||||||+++|||++  |..||.....
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSS-DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             eeecCCCceEEccccceeecccC-cceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            99999999999999999754322 11122234456789999999988889999999999999999998  7778765433


Q ss_pred             hhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          477 PEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ...   +................+      .+..++.++.+++.+||+.+|++||++.||++.|.
T Consensus       240 ~~~---~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 QQV---IENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHH---HHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            221   122111111111100000      11223467899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.9e-39  Score=321.02  Aligned_cols=256  Identities=32%  Similarity=0.505  Sum_probs=205.1

Q ss_pred             CCcceeeeccCceEEEEEEEcC-CcEEEEEEcchhhhhhHH-HHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          268 FSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-TEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~-~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      |+..+.||+|+||+||++.... ++.||+|++......... ....+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            4567899999999999997764 678999999877554332 34466999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ++++|.+++...  ..+++.+++.++.|+++||.+||   +.+++|+||||+||+++.++.++|+|||.+...   ....
T Consensus        81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~---~~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL---SENN  152 (260)
T ss_dssp             TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEES---TSTT
T ss_pred             cccccccccccc--ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc---cccc
Confidence            999999999833  57899999999999999999999   889999999999999999999999999999753   1122


Q ss_pred             cccccccCCCCCcChhccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          426 HISTKVKGTVGYLDPEYMK-TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      .......++..|+|||++. +..++.++||||||+++|+|++|..||......................        .. 
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~-  223 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS--------SS-  223 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH--------HT-
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc--------cc-
Confidence            2334556899999999998 7889999999999999999999999998663222222222111100000        00 


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                       .........+.+++.+||+.||++||++.+++++.|
T Consensus       224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~  259 (260)
T PF00069_consen  224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPW  259 (260)
T ss_dssp             -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred             -cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence             000011267899999999999999999999998866

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.3e-39  Score=325.10  Aligned_cols=259  Identities=28%  Similarity=0.486  Sum_probs=208.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      ++|...+.||+|+||.||+|...      ++..+++|.+..... .....+.+|++++++++||||+++++++..++..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            45777889999999999999642      356789998875542 33457889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhccc--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC
Q 042763          340 IITEFVPNGTLREHLDGQY--------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM  405 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~  405 (554)
                      +||||+++++|.+++....              ...+++..++.++.||+.||+|||   +++++||||||+|||++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCC
Confidence            9999999999999997542              234789999999999999999999   89999999999999999999


Q ss_pred             cEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHH
Q 042763          406 RAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLR  484 (554)
Q Consensus       406 ~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~  484 (554)
                      .++|+|||+++...... .........++..|+|||.+.+..++.++||||||+++|||+| |+.||......+..   .
T Consensus       161 ~~~l~dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~  236 (291)
T cd05094         161 LVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI---E  236 (291)
T ss_pred             cEEECCCCcccccCCCc-eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H
Confidence            99999999997543221 1122233456788999999999899999999999999999999 99998765443211   1


Q ss_pred             HHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       485 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      .    ...+....         .....+..+.+++.+||+.+|++||++.+|++.+.++..
T Consensus       237 ~----~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         237 C----ITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             H----HhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            1    11111111         111234568899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.8e-39  Score=328.44  Aligned_cols=269  Identities=25%  Similarity=0.356  Sum_probs=207.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|+..++||+|+||.||++... ++..+|+|.+...........+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999765 58889999887553344456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE-KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      +++++|.+++...  ..+++..+..++.|++.||.|||   + .+++||||||+|||++.++.+||+|||++......  
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  153 (308)
T cd06615          81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  153 (308)
T ss_pred             cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence            9999999999765  56889999999999999999999   5 58999999999999999999999999998753221  


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc------cc
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL------LD  497 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------~~  497 (554)
                         ......+++.|+|||.+.+..++.++||||||+++|||++|+.||........................      ..
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence               123356889999999998888999999999999999999999999754422111111000000000000      00


Q ss_pred             cCCh-------hhh--------hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          498 MVDP-------SIK--------EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       498 ~~d~-------~l~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      .-++       ...        ..........+.+++.+||+.+|++||++.+|+++.|-.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence            0000       000        0000113456899999999999999999999999998655

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.3e-40  Score=328.68  Aligned_cols=265  Identities=27%  Similarity=0.428  Sum_probs=206.1

Q ss_pred             cCCCcceeeeccCceEEEEEEE-----cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC--Cce
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQL-----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG--NER  338 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~  338 (554)
                      +.|+..++||+|+||.||++..     .++..||+|.++..........+.+|++++++++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578889999999999999964     357899999987654444556799999999999999999999998765  567


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ++||||+++++|.+++.... ..+++.+++.++.|++.||+|||   +++++||||||+||+++.++.++|+|||+++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            99999999999999996542 36899999999999999999999   899999999999999999999999999999865


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCh--------hhHHHHHHHHHhh
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP--------EERVTLRWAFKRY  490 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~--------~~~~~~~~~~~~~  490 (554)
                      ..............++..|+|||.+.+..++.++||||||+++|||++++.|.......        .............
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            43322222223445777899999998888999999999999999999988765322110        0000000111111


Q ss_pred             ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      ......         .....++..+.+++.+||+.+|++||++.++++.++++
T Consensus       240 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         240 EEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            111100         01123456789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6e-39  Score=324.87  Aligned_cols=263  Identities=25%  Similarity=0.410  Sum_probs=204.6

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-----------------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceee
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-----------------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL  328 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-----------------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l  328 (554)
                      ++|+..++||+|+||.||++...                 ++..||+|++..........++.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56888999999999999998532                 2457899999765444556789999999999999999999


Q ss_pred             eeEEEcCCceEEEEEeCCCCCHHHHHhcccC---------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCe
Q 042763          329 LGFVDKGNERLIITEFVPNGTLREHLDGQYG---------KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNI  399 (554)
Q Consensus       329 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI  399 (554)
                      ++++..++..+++|||+++++|.+++.....         ..+++.+++.++.|++.||+|||   +.+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            9999999999999999999999999975421         24678899999999999999999   89999999999999


Q ss_pred             EECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCh
Q 042763          400 LLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT--GRRPVELKRPP  477 (554)
Q Consensus       400 Ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt--g~~P~~~~~~~  477 (554)
                      |++.++.++|+|||+++....... ........+++.|++||...+..++.++|||||||++|||++  |..||......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcc-eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            999999999999999975432211 111222345678999999888889999999999999999998  77888754433


Q ss_pred             hhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          478 EERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      +........+.   .... ....+     .+..++..+.+++.+||+.||++||++.+|.+.|.
T Consensus       241 ~~~~~~~~~~~---~~~~-~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QVIENTGEFFR---DQGR-QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHHHHHh---hccc-cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            32221111111   1000 00001     11223467889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.9e-39  Score=325.92  Aligned_cols=256  Identities=24%  Similarity=0.398  Sum_probs=203.7

Q ss_pred             CCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      +|...++||+|+||.||+|...      ++..||+|+++........+.+.+|+.++..++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            3566778999999999999753      2578999999865444445678999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhccc--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc
Q 042763          341 ITEFVPNGTLREHLDGQY--------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR  406 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~  406 (554)
                      ++||+++++|.+++....              ...+++..++.++.|++.||+|||   +++++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence            999999999999985321              235788889999999999999999   899999999999999999999


Q ss_pred             EEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHH
Q 042763          407 AKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRW  485 (554)
Q Consensus       407 vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~  485 (554)
                      +||+|||+++...... .........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.   ...
T Consensus       163 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~~  238 (283)
T cd05091         163 VKISDLGLFREVYAAD-YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---IEM  238 (283)
T ss_pred             eEecccccccccccch-heeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH
Confidence            9999999987643221 1111223346789999999988889999999999999999998 8888875433221   111


Q ss_pred             HHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          486 AFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                          .......         ..+.+++..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       239 ----i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         239 ----IRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ----HHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                1111111         1223455668899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.7e-39  Score=325.92  Aligned_cols=261  Identities=33%  Similarity=0.441  Sum_probs=206.2

Q ss_pred             cCCCcceeeeccCceEEEEEEEcC-C--cEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLED-G--LLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~-g--~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|.++........+.+.+|+++++++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468888899999999999997653 3  347888887543344456789999999999 799999999999999999999


Q ss_pred             EEeCCCCCHHHHHhccc--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcE
Q 042763          342 TEFVPNGTLREHLDGQY--------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRA  407 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v  407 (554)
                      |||+++++|.+++....              ...+++.+++.++.|++.||+|||   +++++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999996532              135788999999999999999999   8999999999999999999999


Q ss_pred             EEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHH
Q 042763          408 KVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWA  486 (554)
Q Consensus       408 kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~  486 (554)
                      ||+|||++.....    .........+..|+|||.+.+..++.++|||||||++|||++ |..||..........   . 
T Consensus       159 kl~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~---~-  230 (297)
T cd05089         159 KIADFGLSRGEEV----YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE---K-  230 (297)
T ss_pred             EECCcCCCccccc----eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---H-
Confidence            9999999864211    111111223557999999998889999999999999999998 999997654332111   1 


Q ss_pred             HHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 042763          487 FKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK  549 (554)
Q Consensus       487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~  549 (554)
                         ...+.     ..    ..+..++..+.+++.+||+.+|.+||++.++++.|.++......
T Consensus       231 ---~~~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         231 ---LPQGY-----RM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             ---HhcCC-----CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence               11100     00    01122445688999999999999999999999999888775543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.2e-39  Score=331.23  Aligned_cols=264  Identities=22%  Similarity=0.288  Sum_probs=191.9

Q ss_pred             ceeeeccCceEEEEEEEc---CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEc--CCceEEEEEeC
Q 042763          271 SLRIGEGGFGTVYKAQLE---DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDK--GNERLIITEFV  345 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~lv~E~~  345 (554)
                      .++||+|+||+||+|...   +++.||+|.+.....   ...+.+|++++++++||||+++++++..  +...+++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            457999999999999764   467899998875432   2457789999999999999999998854  45678999999


Q ss_pred             CCCCHHHHHhccc-------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE----CCCCcEEEEeecC
Q 042763          346 PNGTLREHLDGQY-------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL----TESMRAKVADFGF  414 (554)
Q Consensus       346 ~~g~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl----~~~~~vkl~DfGl  414 (554)
                       +++|.+++....       ...+++..+..++.||+.||+|||   +++|+||||||+|||+    +.++.+||+|||+
T Consensus        83 -~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 -EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             -CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence             568888875321       235888999999999999999999   8999999999999999    4667899999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhh------HHHHHHHH
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEE------RVTLRWAF  487 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~------~~~~~~~~  487 (554)
                      ++................||+.|+|||++.+ ..++.++||||+||++|||++|++||........      ...+....
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            9865433222222344678999999999876 4589999999999999999999999975432110      11111111


Q ss_pred             HhhccCC---------------ccccCCh------hhhh---hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          488 KRYNEGN---------------LLDMVDP------SIKE---VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       488 ~~~~~~~---------------~~~~~d~------~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .......               .......      .+..   .........+.+++.+||+.||++|||++|+++|.|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~  316 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  316 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            1100000               0000000      0000   000011235789999999999999999999998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.7e-39  Score=322.33  Aligned_cols=260  Identities=27%  Similarity=0.430  Sum_probs=204.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCc----EEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGL----LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      .+|+..+.||+|+||+||+|.+. ++.    .+++|.+..........++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46777889999999999999764 344    4788887654333444678889999999999999999998764 55788


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ++||+++|+|.+++... ...+++..++.++.||+.||+|||   +++++||||||+|||+++++.+||+|||+++....
T Consensus        86 i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            99999999999999754 246899999999999999999999   89999999999999999999999999999986432


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      .. .........++..|+|||.+.+..++.++||||||+++|||++ |..||...........    .   ..+...  .
T Consensus       162 ~~-~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~----~---~~~~~~--~  231 (279)
T cd05111         162 DD-KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL----L---EKGERL--A  231 (279)
T ss_pred             CC-cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----H---HCCCcC--C
Confidence            21 1122234457788999999998899999999999999999998 9999976543321111    1   111100  0


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                      .+.       .+...+.+++.+||..+|++|||+.|+++.+..+..+.
T Consensus       232 ~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         232 QPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             CCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence            111       12345788999999999999999999999998877654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.4e-39  Score=323.67  Aligned_cols=263  Identities=24%  Similarity=0.354  Sum_probs=210.4

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcC-----CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEc-CCc
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLED-----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDK-GNE  337 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~-----g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~  337 (554)
                      ..++|...+.||+|+||.||+|...+     +..|++|++.........+.+.+|+.++++++||||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35678888999999999999998765     688999998765444556778999999999999999999998765 567


Q ss_pred             eEEEEEeCCCCCHHHHHhcccC------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEe
Q 042763          338 RLIITEFVPNGTLREHLDGQYG------KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVAD  411 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~D  411 (554)
                      .++++||+++++|.+++.....      ..+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence            8999999999999999975432      46889999999999999999999   89999999999999999999999999


Q ss_pred             ecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhh
Q 042763          412 FGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRY  490 (554)
Q Consensus       412 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  490 (554)
                      ||+++...... .........++..|+|||.+.+..++.++||||||+++||+++ |+.||....+.+.   ..+..   
T Consensus       161 ~g~~~~~~~~~-~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~---  233 (280)
T cd05043         161 NALSRDLFPMD-YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM---AAYLK---  233 (280)
T ss_pred             CCCcccccCCc-eEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH---HHHHH---
Confidence            99997543211 1111223346778999999998889999999999999999999 9999976543221   11111   


Q ss_pred             ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      .....      .    ....++..+.+++.+||+.+|++|||+.++++.|.++...
T Consensus       234 ~~~~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         234 DGYRL------A----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             cCCCC------C----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            01000      0    0112345688999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-39  Score=318.54  Aligned_cols=251  Identities=27%  Similarity=0.465  Sum_probs=200.5

Q ss_pred             eeeeccCceEEEEEEEcC----CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLED----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      ++||+|+||.||+|....    +..+|+|.+.........+++.+|++++++++||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            369999999999996532    26899999987655445678999999999999999999999876 4578999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      ++|.+++...  ..+++..++.++.|++.||+|||   ..+++|+||||+|||++.++.+||+|||+++...........
T Consensus        80 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            9999999765  37899999999999999999999   889999999999999999999999999999865332222111


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhh
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEV  506 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  506 (554)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+.   ..+...    ....         .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~~~~~~----~~~~---------~  218 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---IAMLES----GERL---------P  218 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHHc----CCcC---------C
Confidence            122224568999999998899999999999999999998 9999976543221   111111    1000         0


Q ss_pred             ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          507 ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       507 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      .+..++..+.+++.+||+.+|++||++.+|++.|.++-
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            12234467889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=313.38  Aligned_cols=264  Identities=21%  Similarity=0.307  Sum_probs=213.1

Q ss_pred             hcCCCcceeeeccCceEEEEE-EEcCCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a-~~~~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++.|++.+.||+|.|+.||++ ...+|+.+|+|++...... ...+++.+|+.+.+.|+||||++|++.+......|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            456777778999999999999 4557999999988766542 34578999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC---CCCcEEEEeecCcccCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGP  419 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~---~~~~vkl~DfGla~~~~  419 (554)
                      |+|.|++|..-+-.+  ..+++..+-..+.||+.+|.|+|   .++|||||+||+|+|+.   ...-+||+|||+|....
T Consensus        90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999999998766444  34667777789999999999999   99999999999999995   34569999999998654


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                          .........|||.|||||++...+|+..+|||+.||+||-|+.|.+||.+.+.......+......         +
T Consensus       165 ----~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd---------~  231 (355)
T KOG0033|consen  165 ----DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD---------Y  231 (355)
T ss_pred             ----CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC---------C
Confidence                223344568999999999999999999999999999999999999999975544333222211111         1


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKS  550 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~~  550 (554)
                      ++.    .-..+.....+|+++||..||.+|-|+.|.+.|.|--..+..++
T Consensus       232 ~~~----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As  278 (355)
T KOG0033|consen  232 PSP----EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVAS  278 (355)
T ss_pred             CCc----ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHH
Confidence            111    11234456789999999999999999999999999776666554

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.6e-39  Score=319.12  Aligned_cols=253  Identities=29%  Similarity=0.450  Sum_probs=204.6

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      ++|++.++||+|+||.||+|...++..+|+|.+......  .+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            467888999999999999998888888999998765432  357899999999999999999999885 45689999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ++++|.+++.......+++.+++.++.|++.||+|||   +.+++||||||+||++++++.++|+|||++........  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~--  157 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY--  157 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc--
Confidence            9999999998765567899999999999999999999   88999999999999999999999999999976432211  


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+.   .....    ....     .   
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~~----~~~~-----~---  222 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV---LEQVE----RGYR-----M---  222 (260)
T ss_pred             ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHH----cCCC-----C---
Confidence            11122235678999999988889999999999999999999 8899975443221   11111    0000     0   


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                       ..+...+..+.+++.+||+.+|++|||+.++.+.|++
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 -PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             0122334568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-40  Score=305.44  Aligned_cols=268  Identities=24%  Similarity=0.343  Sum_probs=210.8

Q ss_pred             HHHhhcCCCcceeeeccCceEEEEEE-EcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC----
Q 042763          261 VVKATRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG----  335 (554)
Q Consensus       261 l~~~~~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~----  335 (554)
                      +....++|.+.+.||+|||+-||+++ ..+++.||+|++.-.. .+..+..++|++..++++|||+++++++...+    
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            34456899999999999999999996 5578999999998765 34467889999999999999999999886433    


Q ss_pred             -CceEEEEEeCCCCCHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEee
Q 042763          336 -NERLIITEFVPNGTLREHLDGQY--GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADF  412 (554)
Q Consensus       336 -~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df  412 (554)
                       .+.|++++|...|+|.+.+....  +..+++.++++|+.+|++||++||.. ..+++||||||.|||+.+.+.++|.||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence             34899999999999999987543  45799999999999999999999932 234999999999999999999999999


Q ss_pred             cCcccCCCCCCCccc------cccccCCCCCcChhccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHH
Q 042763          413 GFARLGPMDSDRTHI------STKVKGTVGYLDPEYMK---TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTL  483 (554)
Q Consensus       413 Gla~~~~~~~~~~~~------~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~  483 (554)
                      |.++..+........      ......|..|+|||.+.   +...++++|||||||+||+|+.|..||+..-.       
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-------  246 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-------  246 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-------
Confidence            999865432222111      11234789999999885   44678999999999999999999999973211       


Q ss_pred             HHHHHhhccCCcc-ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          484 RWAFKRYNEGNLL-DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       484 ~~~~~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                             ..+.+. ....+.+.-.-...++..+.+++.+|++.||.+||++.+++.++.++.
T Consensus       247 -------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 -------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             -------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                   111111 111222221122236788999999999999999999999999988763

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.7e-39  Score=339.67  Aligned_cols=262  Identities=22%  Similarity=0.280  Sum_probs=206.0

Q ss_pred             HHHHhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC
Q 042763          260 QVVKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN  336 (554)
Q Consensus       260 ~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  336 (554)
                      ++....++|+..+.||+|+||.||+|... +++.||+|++.....  ......+.+|+.+++.++||||+++++++.+++
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            44445689999999999999999999766 588999999875432  223355788999999999999999999999999


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ..++||||+++|+|.+++...   .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            999999999999999999654   5788899999999999999999   8999999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccCCCCCcChhccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhcc
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKTY----QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE  492 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  492 (554)
                      .....  .........||+.|+|||++.+.    .++.++|||||||++|||++|+.||...........+   .   ..
T Consensus       191 ~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i---~---~~  262 (371)
T cd05622         191 KMNKE--GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI---M---NH  262 (371)
T ss_pred             EcCcC--CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH---H---cC
Confidence            64321  11122345799999999998754    3789999999999999999999999865432221111   0   11


Q ss_pred             CCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHHH
Q 042763          493 GNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRND--RPDMKSVGEQLWA  542 (554)
Q Consensus       493 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~~  542 (554)
                      .......       ....+...+.+++.+|+..++.+  ||++.++++|.|-
T Consensus       263 ~~~~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~  307 (371)
T cd05622         263 KNSLTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  307 (371)
T ss_pred             CCcccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence            0000100       01234556788999999844443  8899999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=6.1e-39  Score=318.40  Aligned_cols=253  Identities=29%  Similarity=0.443  Sum_probs=204.3

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      ++|....+||+|+||.||+|...++..+|+|.+....  ...+.+.+|++++++++|||++++++++. .+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            4577888999999999999988777789999886543  23457889999999999999999999875 45679999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ++++|.+++.......+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||+++.......  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~--  157 (260)
T cd05069          83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY--  157 (260)
T ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc--
Confidence            9999999998765566899999999999999999999   88999999999999999999999999999976432211  


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+.   ..+.....   .      .   
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~~---~------~---  222 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQVERGY---R------M---  222 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCC---C------C---
Confidence            11122346678999999998889999999999999999999 8999976443221   11111100   0      0   


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                       ..+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             0122345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-39  Score=319.10  Aligned_cols=255  Identities=30%  Similarity=0.466  Sum_probs=208.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .++|.+.++||+|+||.||+|..++++.||||.+.....  ...++.+|+.++++++||||+++++++......++||||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            467888999999999999999888788999999876533  235789999999999999999999999998999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++.......+++.++..++.|++.||.|||   +++++|+||||+||+++.++.+||+|||+++.....  .
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~--~  157 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD--E  157 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccch--h
Confidence            99999999998776667899999999999999999999   889999999999999999999999999998764321  1


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |+.||........   ..........           
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~~~~~~~-----------  223 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQVERGYRM-----------  223 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCCC-----------
Confidence            111122235678999999998889999999999999999999 9999975443221   1111111100           


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                        ..+...+..+.+++.+|++.+|++||++.++.+.|++
T Consensus       224 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 --PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              0111224568999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.1e-39  Score=327.39  Aligned_cols=260  Identities=33%  Similarity=0.465  Sum_probs=205.1

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCc--EEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGL--LVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~--~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ++|+..+.||+|+||.||+|... ++.  .+|+|.+...........+.+|++++.++ +||||+++++++.+++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            56788889999999999999764 454  46788776543344456788999999999 899999999999999999999


Q ss_pred             EEeCCCCCHHHHHhccc--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcE
Q 042763          342 TEFVPNGTLREHLDGQY--------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRA  407 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v  407 (554)
                      |||+++++|.+++....              ...+++.+++.++.|++.||+|||   +++++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence            99999999999997542              235789999999999999999999   8999999999999999999999


Q ss_pred             EEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHH
Q 042763          408 KVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWA  486 (554)
Q Consensus       408 kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~  486 (554)
                      ||+|||+++....    ........++..|+|||.+.+..++.++||||||+++|||+| |..||......+...   . 
T Consensus       164 kl~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~---~-  235 (303)
T cd05088         164 KIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE---K-  235 (303)
T ss_pred             EeCccccCcccch----hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH---H-
Confidence            9999999863211    111112234668999999988889999999999999999998 999997544322111   1 


Q ss_pred             HHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          487 FKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                         ........         .+...+..+.+++.+||+.+|++||++.+++++++++.....
T Consensus       236 ---~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         236 ---LPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             ---HhcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence               11100000         111234567899999999999999999999999988765543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.3e-39  Score=337.22  Aligned_cols=267  Identities=20%  Similarity=0.262  Sum_probs=201.3

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC------
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN------  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------  336 (554)
                      .++|+..+.||+|+||.||++... +|..||||++..... ......+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            478999999999999999999764 589999999865432 233467889999999999999999999986443      


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ..++||||++ ++|.+.+..    .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus       100 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876         100 DVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             eeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence            4699999995 567776643    4788899999999999999999   8999999999999999999999999999997


Q ss_pred             cCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH----------
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWA----------  486 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~----------  486 (554)
                      ....    ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+........          
T Consensus       172 ~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         172 TACT----NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             cccc----CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence            5321    11223456899999999999999999999999999999999999999865432221111000          


Q ss_pred             -----HHhh--ccCCc-----cccCChhh---hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          487 -----FKRY--NEGNL-----LDMVDPSI---KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       487 -----~~~~--~~~~~-----~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                           ...+  .....     .+....-.   ...........+.+++.+||+.||++|||+.|+++|.|-.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  319 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT  319 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence                 0000  00000     00000000   0000111235688999999999999999999999998753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.6e-39  Score=316.28  Aligned_cols=247  Identities=28%  Similarity=0.468  Sum_probs=200.8

Q ss_pred             eeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCHHH
Q 042763          273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE  352 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~  352 (554)
                      +||+|+||.||+|...++..+|+|.+...........+.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   81 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS   81 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence            68999999999998888899999998765544445678999999999999999999999999999999999999999999


Q ss_pred             HHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcccccccc
Q 042763          353 HLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK  432 (554)
Q Consensus       353 ~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~  432 (554)
                      ++.... ..+++.+++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||++.......  ........
T Consensus        82 ~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~  155 (250)
T cd05085          82 FLRKKK-DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI--YSSSGLKQ  155 (250)
T ss_pred             HHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccc--cccCCCCC
Confidence            987542 45789999999999999999999   8999999999999999999999999999987532211  11111223


Q ss_pred             CCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHH
Q 042763          433 GTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEI  511 (554)
Q Consensus       433 gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  511 (554)
                      ++..|+|||++.+..++.++||||||+++|||++ |..||...........   .    .......         .+..+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~---~----~~~~~~~---------~~~~~  219 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ---V----EKGYRMS---------CPQKC  219 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH---H----HcCCCCC---------CCCCC
Confidence            4678999999998889999999999999999998 9999976543322111   1    1110000         11224


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          512 LTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       512 ~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      +..+.+++.+||+.+|++||++.|+++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            467899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.9e-39  Score=322.11  Aligned_cols=256  Identities=27%  Similarity=0.365  Sum_probs=202.7

Q ss_pred             cCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|+..++||+|+||.||+|.. .+++.||+|++..........++.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577788999999999999965 468899999987654344456799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|..+.      .+++..+..++.|++.||+|||   +.+|+|+||||+|||++.++.++|+|||++......   
T Consensus        81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---  148 (279)
T cd06619          81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---  148 (279)
T ss_pred             CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence            9999997652      4678889999999999999999   899999999999999999999999999999753221   


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                        ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.......................     .+.+ 
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-  220 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL-  220 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC-
Confidence              12235689999999999988999999999999999999999999975332211110000011111100     0000 


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                        ........+.+++.+||+.+|++||++.|++++.|-.
T Consensus       221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~  257 (279)
T cd06619         221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV  257 (279)
T ss_pred             --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence              1112345688999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7.9e-39  Score=318.37  Aligned_cols=260  Identities=24%  Similarity=0.384  Sum_probs=208.7

Q ss_pred             cCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|+..+.||+|+||.||+|.. .++..+|||.+.....  .....++.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677788999999999999975 4789999998765332  233467889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          343 EFVPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       343 E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||+++++|.+++...  ....+++.+++.++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999998642  2346899999999999999999999   89999999999999999999999999999876432


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      ..   .......++..|+|||.+.+..++.++||||||+++|||++|..||........ ...    .......     .
T Consensus       159 ~~---~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~----~~~~~~~-----~  225 (267)
T cd08229         159 KT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLC----KKIEQCD-----Y  225 (267)
T ss_pred             CC---cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHh----hhhhcCC-----C
Confidence            21   112234688999999999988899999999999999999999999975433211 111    1111111     0


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      +..   ........+.+++.+||+.+|++||||.+|++.+.++.
T Consensus       226 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         226 PPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             CCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            100   11234567899999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5e-39  Score=326.73  Aligned_cols=262  Identities=30%  Similarity=0.445  Sum_probs=208.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc--------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcC
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE--------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKG  335 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~  335 (554)
                      ..+|.+.+.||+|+||.||+|...        ++..||+|.+..........++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            456778889999999999999641        24579999987654344457789999999999 899999999999999


Q ss_pred             CceEEEEEeCCCCCHHHHHhccc--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE
Q 042763          336 NERLIITEFVPNGTLREHLDGQY--------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL  401 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl  401 (554)
                      ...+++|||+++|+|.+++....              ...+++.+++.++.||+.||+|||   +++++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999997642              135788899999999999999999   8999999999999999


Q ss_pred             CCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhH
Q 042763          402 TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEER  480 (554)
Q Consensus       402 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~  480 (554)
                      +.++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||......+..
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  249 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  249 (304)
T ss_pred             cCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence            99999999999999864322111 11222346678999999988889999999999999999998 78888654322211


Q ss_pred             HHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          481 VTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      .       .........         .+..++..+.+++.+||+.+|++||++.||++.|.++..-
T Consensus       250 ~-------~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         250 K-------LLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             H-------HHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            1       111111000         1123456788999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2e-39  Score=318.01  Aligned_cols=265  Identities=25%  Similarity=0.337  Sum_probs=209.0

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCC-ceeeeeEEEcCC------
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRN-LVKLLGFVDKGN------  336 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~~~~~~~~------  336 (554)
                      ..|...++||+|+||+||+|+.. +|+.||+|+++-... +.......+|+.++++|+|+| |++|++++.+.+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34556678999999999999654 689999999987653 223355689999999999999 999999998777      


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccC--CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecC
Q 042763          337 ERLIITEFVPNGTLREHLDGQYG--KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGF  414 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl  414 (554)
                      ..++|+||+ .-+|..++.....  ..++...+..++.||+.||+|||   +++|+||||||+||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence            788999999 6799999987643  35777889999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG  493 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  493 (554)
                      |+....   .....+..++|.+|.|||++.+. .|+...||||+|||+.||++++.-|.+....+   .+..++.....+
T Consensus       167 Ara~~i---p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~---ql~~If~~lGtP  240 (323)
T KOG0594|consen  167 ARAFSI---PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID---QLFRIFRLLGTP  240 (323)
T ss_pred             HHHhcC---CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH---HHHHHHHHcCCC
Confidence            996432   22335566799999999999876 79999999999999999999999998877633   344445444332


Q ss_pred             C---ccccC---Chh--hhhhc-c-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          494 N---LLDMV---DPS--IKEVI-S-------MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       494 ~---~~~~~---d~~--l~~~~-~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                      .   +....   +-.  ..... +       +.......+++.+|++.+|.+|.|++..++|.
T Consensus       241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~  303 (323)
T KOG0594|consen  241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHP  303 (323)
T ss_pred             CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence            1   11111   110  00000 0       11113678999999999999999999999983

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.4e-39  Score=333.62  Aligned_cols=245  Identities=24%  Similarity=0.330  Sum_probs=194.3

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHH-HHHhCCCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVE-LLSKIDHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      ++||+|+||.||+|... +|+.||+|++.+...  ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999765 588999999876543  222344555554 67889999999999999999999999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      ++|..++...  ..+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....   ....
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~---~~~~  152 (321)
T cd05603          81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE---PEET  152 (321)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC---CCCc
Confidence            9999888654  56888999999999999999999   89999999999999999999999999999875221   1122


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhc
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI  507 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  507 (554)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....   ..    ......          ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~----i~~~~~----------~~  215 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY---DN----ILHKPL----------QL  215 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH---HH----HhcCCC----------CC
Confidence            33456999999999999989999999999999999999999999865432211   11    111110          01


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHHH
Q 042763          508 SMEILTKMFGLAIQCAAPIRNDRPDM----KSVGEQLW  541 (554)
Q Consensus       508 ~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~l~  541 (554)
                      +......+.+++.+||+.+|.+||++    .|++++.|
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~  253 (321)
T cd05603         216 PGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVF  253 (321)
T ss_pred             CCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCC
Confidence            22234568899999999999999975    46666654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.1e-39  Score=335.76  Aligned_cols=267  Identities=19%  Similarity=0.250  Sum_probs=202.1

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC------
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG------  335 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------  335 (554)
                      ..++|...+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999654 588999999875432 23346678999999999999999999988543      


Q ss_pred             CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCc
Q 042763          336 NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA  415 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla  415 (554)
                      ...++||||++ ++|.+++..    .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          95 QDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             ceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence            34699999995 577777653    4788999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH--------
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF--------  487 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~--------  487 (554)
                      +....    ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.........        
T Consensus       167 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         167 RTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             ccCCC----ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            85322    122234568999999999999899999999999999999999999998655332211111000        


Q ss_pred             -------Hhh--ccCCccccCChhh--------hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          488 -------KRY--NEGNLLDMVDPSI--------KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       488 -------~~~--~~~~~~~~~d~~l--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                             ..+  ..........+..        ...........+.+++.+||+.||++|||+.|++++.|-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~  314 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI  314 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence                   000  0000000000000        000111234568899999999999999999999999764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.2e-39  Score=331.29  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=200.2

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      +|...+.||+|+||+||+|... +|+.||+|++.....  ....+.+..|..+++.+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677889999999999999765 689999999986532  233456778899998885 577888999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++...  ..+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-  154 (323)
T cd05615          81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-  154 (323)
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC-
Confidence            999999999998654  46899999999999999999999   899999999999999999999999999998753221 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                        ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ....    ....       
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~---~~i~----~~~~-------  218 (323)
T cd05615         155 --GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF---QSIM----EHNV-------  218 (323)
T ss_pred             --CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH---HHHH----hCCC-------
Confidence              11223456999999999999989999999999999999999999999865432211   1111    1110       


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHH
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDM-----KSVGEQLW  541 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~l~  541 (554)
                         .++......+.+++.+||+.+|.+|++.     .++.+|.|
T Consensus       219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~  259 (323)
T cd05615         219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAF  259 (323)
T ss_pred             ---CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcc
Confidence               0122234567899999999999999984     66766643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.6e-39  Score=322.82  Aligned_cols=256  Identities=25%  Similarity=0.391  Sum_probs=203.3

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcC-----
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKG-----  335 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~-----  335 (554)
                      .+++.|+..+.||+|+||+||+|... +++.||+|++....  .....+.+|+.+++++ +||||+++++++...     
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            35667888889999999999999765 58899999986543  2245788999999998 799999999998653     


Q ss_pred             -CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecC
Q 042763          336 -NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGF  414 (554)
Q Consensus       336 -~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl  414 (554)
                       ...+++|||+++++|.+++.......+++..+..++.|++.||+|||   +++|+|+||||+||++++++.++|+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence             45789999999999999998765567899999999999999999999   88999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHh
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMK-----TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR  489 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~  489 (554)
                      +.......   .......|++.|+|||++.     +..++.++|||||||++|||++|+.||............      
T Consensus       158 ~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~------  228 (272)
T cd06637         158 SAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------  228 (272)
T ss_pred             ceeccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH------
Confidence            87542211   1223456899999999986     345888999999999999999999999754332211110      


Q ss_pred             hccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          490 YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                       ........        ....++..+.+++.+||+.+|.+|||+.+++++.|
T Consensus       229 -~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  271 (272)
T cd06637         229 -PRNPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF  271 (272)
T ss_pred             -hcCCCCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence             00000001        11123456889999999999999999999998865

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.5e-39  Score=322.67  Aligned_cols=267  Identities=22%  Similarity=0.326  Sum_probs=203.1

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +|+..+.||+|+||.||+|... ++..||+|+++.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4777889999999999999765 689999998865432 22345788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          345 VPNGTLREHLDGQY-GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       345 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      ++ ++|.+++.... ...+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  154 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--  154 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--
Confidence            96 78999886543 257899999999999999999999   899999999999999999999999999999754321  


Q ss_pred             CccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc-------
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL-------  495 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-------  495 (554)
                       ........+++.|+|||++.+. .++.++||||||+++|||+||+.||....................+...       
T Consensus       155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         155 -VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             -cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence             1122233578899999988654 5789999999999999999999999865443222211111100000000       


Q ss_pred             ------cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          496 ------LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       496 ------~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                            .......... ....+..++.+++.+||+.||++|||+.+|+++.|
T Consensus       234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~  284 (285)
T cd07861         234 DYKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY  284 (285)
T ss_pred             HHHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence                  0000000000 01124566789999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-39  Score=321.77  Aligned_cols=257  Identities=27%  Similarity=0.431  Sum_probs=206.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED------GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  338 (554)
                      .++|...+.||+|+||.||+|...+      +..||+|.+...........+.+|+.+++.++||||+++++++..+...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3578888999999999999997642      4689999987654444456788999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHhccc--------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEE
Q 042763          339 LIITEFVPNGTLREHLDGQY--------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVA  410 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~  410 (554)
                      ++||||+++|+|.+++....        ...+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999996532        224688899999999999999999   8999999999999999999999999


Q ss_pred             eecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHh
Q 042763          411 DFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKR  489 (554)
Q Consensus       411 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~  489 (554)
                      |||+++...... .........++..|+|||.+.+..++.++||||||+++|||++ |..||......+..   ....  
T Consensus       162 dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~~~--  235 (277)
T cd05032         162 DFGMTRDIYETD-YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL---KFVI--  235 (277)
T ss_pred             CcccchhhccCc-ccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH---HHHh--
Confidence            999987543221 1112233456789999999988889999999999999999998 99999765433221   1111  


Q ss_pred             hccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          490 YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                        ......         .+..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus       236 --~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 --DGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             --cCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence              111111         11123567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.1e-39  Score=323.53  Aligned_cols=266  Identities=25%  Similarity=0.391  Sum_probs=208.1

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE  337 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  337 (554)
                      ..++|++.++||+|+||.||+|..+      .+..||+|.+...........+.+|+.++++++||||+++++++.+++.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578899999999999999999643      2458999988755433344568899999999999999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHhccc--------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEE
Q 042763          338 RLIITEFVPNGTLREHLDGQY--------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKV  409 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl  409 (554)
                      .++||||+++|+|.+++....        .....+..+..++.|++.||.|||   +++|+||||||+||+++.++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999997532        124467788899999999999999   899999999999999999999999


Q ss_pred             EeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHH
Q 042763          410 ADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFK  488 (554)
Q Consensus       410 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~  488 (554)
                      +|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||......+.   ....  
T Consensus       161 ~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~---~~~~--  234 (288)
T cd05061         161 GDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV---LKFV--  234 (288)
T ss_pred             CcCCcccccccccc-ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH--
Confidence            99999985432211 111222345678999999998889999999999999999999 7888875443221   1111  


Q ss_pred             hhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 042763          489 RYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK  549 (554)
Q Consensus       489 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~  549 (554)
                        .......         .+...+..+.+++.+||+.+|++|||+.++++.+.+....+.+
T Consensus       235 --~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  284 (288)
T cd05061         235 --MDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP  284 (288)
T ss_pred             --HcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence              1111111         1112345789999999999999999999999998876554443

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-39  Score=316.46  Aligned_cols=251  Identities=32%  Similarity=0.519  Sum_probs=207.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .++|+..+.||+|+||.||+|... |+.||+|.++....  ..+++.+|+.++++++|+||+++++++...+..++||||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            457888899999999999999876 78899999976643  456789999999999999999999999988999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++.......+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||.++......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--  156 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--  156 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence            99999999998765557899999999999999999999   8999999999999999999999999999998642111  


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                          .....+..|+|||.+.+..++.++||||||+++|||++ |..||......+...   ..    .......      
T Consensus       157 ----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---~~----~~~~~~~------  219 (256)
T cd05039         157 ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---HV----EKGYRME------  219 (256)
T ss_pred             ----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HH----hcCCCCC------
Confidence                12235668999999988889999999999999999997 999987543222111   11    1110000      


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                         .+...+..+.+++.+||+.+|++||++.+++++|.++
T Consensus       220 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         220 ---APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ---CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence               1122346788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7.5e-39  Score=318.38  Aligned_cols=256  Identities=25%  Similarity=0.417  Sum_probs=205.3

Q ss_pred             CCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-----hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-----ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      +|...+.||+|+||+||+|...+|+.+|+|.+.....     ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4677889999999999999887899999998864321     22335688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++++|.+++...  ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            9999999999999754  46789999999999999999999   889999999999999999999999999998754211


Q ss_pred             C---CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          422 S---DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       422 ~---~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      .   ..........|+..|+|||.+.+..++.++||||||+++|||++|..||.............     .....    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~----  226 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-----AHRGL----  226 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh-----hccCC----
Confidence            1   11112233568999999999999889999999999999999999999997544322211110     00000    


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                       .+.    .+..+...+.+++.+||+.+|++||++.+++.+.|
T Consensus       227 -~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~  264 (265)
T cd06631         227 -MPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF  264 (265)
T ss_pred             -CCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence             011    12234456789999999999999999999998754

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1e-38  Score=320.20  Aligned_cols=261  Identities=24%  Similarity=0.404  Sum_probs=207.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCc----EEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGL----LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      .++|+..++||+|+||+||+|.+. +|+    .||+|++..........++.+|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            457888899999999999999753 444    4899998765545556788999999999999999999999875 4578


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +++||+++|+|.+++... ...+++.+++.++.|++.||+|||   +++++||||||+|||+++++.+||+|||+++...
T Consensus        85 l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            999999999999999754 246899999999999999999999   8999999999999999999999999999998653


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ..... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.........   .+. .   ...... 
T Consensus       161 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~-~---~~~~~~-  231 (279)
T cd05109         161 IDETE-YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP---DLL-E---KGERLP-  231 (279)
T ss_pred             cccce-eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHH-H---CCCcCC-
Confidence            22111 11122345678999999998899999999999999999998 99998754332211   111 1   111000 


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                              .+..++..+.+++.+||+.||++||++.++++.+.++..++
T Consensus       232 --------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         232 --------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             --------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                    11223456889999999999999999999999998887765

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-38  Score=330.23  Aligned_cols=263  Identities=30%  Similarity=0.429  Sum_probs=204.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEE------cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEc-CC
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDK-GN  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~-~~  336 (554)
                      .++|+..+.||+|+||+||+|..      .+++.||||+++..........+.+|+.++.++ +||||+++++++.. +.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35788999999999999999963      347899999997654444456788999999999 68999999998765 45


Q ss_pred             ceEEEEEeCCCCCHHHHHhccc----------------------------------------------------------
Q 042763          337 ERLIITEFVPNGTLREHLDGQY----------------------------------------------------------  358 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------------  358 (554)
                      ..+++|||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999986432                                                          


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccc
Q 042763          359 -------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV  431 (554)
Q Consensus       359 -------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~  431 (554)
                             ...+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....... .......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~  241 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDA  241 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-hhhcCCC
Confidence                   123678888999999999999999   89999999999999999999999999999976432211 1111223


Q ss_pred             cCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHH
Q 042763          432 KGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISME  510 (554)
Q Consensus       432 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  510 (554)
                      .++..|+|||.+.+..++.++||||||+++|||++ |..||...........      ....+....         .+..
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~------~~~~~~~~~---------~~~~  306 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR------RLKEGTRMR---------APDY  306 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH------HHhccCCCC---------CCCC
Confidence            45678999999988899999999999999999997 9999876443222111      111111000         0111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          511 ILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       511 ~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      ....+.+++.+||+.+|++||++.||+++|..+-+.
T Consensus       307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            234578999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.9e-39  Score=316.56  Aligned_cols=251  Identities=29%  Similarity=0.515  Sum_probs=202.9

Q ss_pred             eeeeccCceEEEEEEEcC--C--cEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLED--G--LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~~--g--~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      ++||+|++|.||+|.+.+  +  ..||+|.+.........+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999997643  3  36999999877654556789999999999999999999999988 889999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      ++|.+++.......+++..++.++.|++.||+|||   +++++|+||||+||+++.++.+||+|||+++...........
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999998754356899999999999999999999   899999999999999999999999999999875433222222


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhh
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEV  506 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  506 (554)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.   ......   ......         
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~---~~~~~~---------  221 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKIDK---EGERLE---------  221 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHh---cCCcCC---------
Confidence            223457889999999998899999999999999999999 9999975433221   111111   000000         


Q ss_pred             ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          507 ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       507 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11223467889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.1e-39  Score=336.45  Aligned_cols=260  Identities=28%  Similarity=0.403  Sum_probs=205.5

Q ss_pred             cCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCce
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNER  338 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~  338 (554)
                      ++|.+.++||+|+||.||+|.+.      .+..||+|+++........+.+.+|+++|.++. ||||+++++++...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            45677889999999999999753      246899999976544444557889999999997 99999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHhcccC-----------------------------------------------------------
Q 042763          339 LIITEFVPNGTLREHLDGQYG-----------------------------------------------------------  359 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~-----------------------------------------------------------  359 (554)
                      ++||||+++|+|.++++....                                                           
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            999999999999999965321                                                           


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC
Q 042763          360 -------------------------------------KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT  402 (554)
Q Consensus       360 -------------------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~  402 (554)
                                                           ..+++.+++.++.|++.||+|||   +.+++||||||+|||++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEe
Confidence                                                 23567788899999999999999   89999999999999999


Q ss_pred             CCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHH
Q 042763          403 ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERV  481 (554)
Q Consensus       403 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~  481 (554)
                      +++.+||+|||+++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+...
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~  352 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY  352 (401)
T ss_pred             CCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence            9999999999999864322111 11223357889999999998889999999999999999998 889987543322211


Q ss_pred             HHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          482 TLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      ..      ...+.  ..       ..+..+...+.+++.+||+.+|++||++++|++.|+++-
T Consensus       353 ~~------~~~~~--~~-------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         353 NA------IKRGY--RM-------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HH------HHcCC--CC-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            10      11110  00       011223467899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-38  Score=318.33  Aligned_cols=255  Identities=29%  Similarity=0.403  Sum_probs=197.8

Q ss_pred             CcceeeeccCceEEEEEEEcC-Cc--EEEEEEcchhh-hhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC------Cce
Q 042763          269 SPSLRIGEGGFGTVYKAQLED-GL--LVAIKRAKKEQ-FENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG------NER  338 (554)
Q Consensus       269 ~~~~~LG~G~fG~Vy~a~~~~-g~--~vAvK~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------~~~  338 (554)
                      .+.++||+|+||.||+|...+ +.  .||+|.++... .....+.+.+|+++++.++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456789999999999997754 32  68999886542 223356788999999999999999999987432      246


Q ss_pred             EEEEEeCCCCCHHHHHhcc----cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecC
Q 042763          339 LIITEFVPNGTLREHLDGQ----YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGF  414 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl  414 (554)
                      +++|||+++|+|.+++...    ....+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999988432    2345889999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccC
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEG  493 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~  493 (554)
                      ++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||........   ..    ....+
T Consensus       159 ~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~----~~~~~  230 (272)
T cd05075         159 SKKIYNGDY-YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI---YD----YLRQG  230 (272)
T ss_pred             ccccCcccc-eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----HHHcC
Confidence            986432211 111222346778999999999899999999999999999999 8889875433211   11    11111


Q ss_pred             CccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          494 NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       494 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      ....         ....++..+.+++.+||+.+|++|||+.+|++.|.++
T Consensus       231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         231 NRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1110         1112345688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.7e-39  Score=338.41  Aligned_cols=258  Identities=23%  Similarity=0.360  Sum_probs=203.6

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|+..+.||+|+||+||+|... +++.||+|+++....  ......+.+|+.++.+++||||+++++.+.+++..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999765 589999999976432  233467889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            999999999999754  46899999999999999999999   8999999999999999999999999999987532110


Q ss_pred             C--------------------------------CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 042763          423 D--------------------------------RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP  470 (554)
Q Consensus       423 ~--------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P  470 (554)
                      .                                ........+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            0                                00011235699999999999999999999999999999999999999


Q ss_pred             CCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHHHHH
Q 042763          471 VELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRP---DMKSVGEQLWA  542 (554)
Q Consensus       471 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~~l~~  542 (554)
                      |....+......+..    . ....  ...+.      ......+.+++.+|+. +|.+|+   ++.|+++|.|-
T Consensus       236 f~~~~~~~~~~~i~~----~-~~~~--~~p~~------~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f  296 (360)
T cd05627         236 FCSETPQETYRKVMN----W-KETL--VFPPE------VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFF  296 (360)
T ss_pred             CCCCCHHHHHHHHHc----C-CCce--ecCCC------CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCC
Confidence            987654332221110    0 0000  00110      0133457778888764 999998   48999999763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.9e-39  Score=321.65  Aligned_cols=256  Identities=24%  Similarity=0.328  Sum_probs=203.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|++.++||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            35788999999999999999976 4688999999875432 233567899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++++|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++...... 
T Consensus        87 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06646          87 YCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-  160 (267)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence            99999999998654  46899999999999999999999   8999999999999999999999999999998643211 


Q ss_pred             CccccccccCCCCCcChhccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          424 RTHISTKVKGTVGYLDPEYMK---TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                        .......|++.|+|||.+.   ...++.++||||||+++|||++|+.||....+.....       ......   ...
T Consensus       161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~---~~~  228 (267)
T cd06646         161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSN---FQP  228 (267)
T ss_pred             --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCC---CCC
Confidence              1122346889999999884   3457889999999999999999999986443221110       000000   001


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      +...  .....+..+.+++.+||+.+|++||++++|++++|
T Consensus       229 ~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         229 PKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             CCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            1111  01123467889999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=315.25  Aligned_cols=250  Identities=32%  Similarity=0.496  Sum_probs=205.4

Q ss_pred             eeeeccCceEEEEEEEcC----CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLED----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      +.||+|+||.||+|....    +..||+|.+.........+.+.+|+++++.++|+||+++++++..+...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            368999999999997653    7899999998765444467899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccc-------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          348 GTLREHLDGQY-------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       348 g~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ++|.+++....       ...+++.+++.++.|++.||+|||   +++++||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999997652       367899999999999999999999   89999999999999999999999999999987543


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ... ........+++.|+|||.+....++.++||||||+++|||++ |..||.........   ..    .......   
T Consensus       158 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~----~~~~~~~---  226 (262)
T cd00192         158 DDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL---EY----LRKGYRL---  226 (262)
T ss_pred             ccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH---HH----HHcCCCC---
Confidence            321 122334557889999999988889999999999999999999 69999876332211   11    1111100   


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                            ..+..++..+.+++.+||+.+|++||++.+++++|+
T Consensus       227 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 ------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  012233567899999999999999999999998863

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.4e-38  Score=325.16  Aligned_cols=262  Identities=30%  Similarity=0.447  Sum_probs=207.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc--------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcC
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE--------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKG  335 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~  335 (554)
                      .++|.+.++||+|+||.||+|...        ....+|+|.++.........++.+|+++++++ +||||+++++++..+
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            357788899999999999999642        24579999987654444456788999999999 699999999999998


Q ss_pred             CceEEEEEeCCCCCHHHHHhccc--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE
Q 042763          336 NERLIITEFVPNGTLREHLDGQY--------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL  401 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl  401 (554)
                      +..+++|||+++|+|.+++....              ...+++.++..++.|++.||.|||   +++++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence            99999999999999999997542              235889999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhH
Q 042763          402 TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEER  480 (554)
Q Consensus       402 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~  480 (554)
                      +.++.+||+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||......+..
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDY-YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             cCCCcEEEcccccccccccccc-ccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999986432111 111112234567999999998889999999999999999999 88998754332211


Q ss_pred             HHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          481 VTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      .       ....+...+         .+..++..+.+++.+||+.+|++||++.++++.|+++...
T Consensus       247 ~-------~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         247 K-------LLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             H-------HHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            1       111111111         1123345688999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-38  Score=315.40  Aligned_cols=253  Identities=28%  Similarity=0.382  Sum_probs=205.4

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc-CCceEEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK-GNERLIITE  343 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~lv~E  343 (554)
                      +|+..+.||+|++|.||++... +++.||+|++..... ....+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778899999999999999765 578999999875433 2344678899999999999999999998764 445789999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++++|.+++.......+++.+++.++.|++.||++||   +.+++||||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            999999999998765667899999999999999999999   8999999999999999999999999999998643221 


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                        .......+++.|+|||++.+..++.++||||||+++|+|++|+.||...........       ...+...       
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~-------~~~~~~~-------  220 (257)
T cd08223         157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR-------IIEGKLP-------  220 (257)
T ss_pred             --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------HHhcCCC-------
Confidence              122345688999999999998999999999999999999999999975442211110       1111110       


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                        ..+......+.+++.+||+.+|++||++.+++++.|
T Consensus       221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  256 (257)
T cd08223         221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY  256 (257)
T ss_pred             --CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence              012234567899999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.5e-39  Score=318.85  Aligned_cols=257  Identities=29%  Similarity=0.480  Sum_probs=204.7

Q ss_pred             CCCcceeeeccCceEEEEEEEcC-C---cEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLED-G---LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~~-g---~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      +|+..+.||+|+||.||+|.... +   ..||||.+..........++..|+.++++++||||+++++++.++...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46778899999999999997653 3   3699999876544445678999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++++|.+++... ...+++.+++.++.|++.||+|||   +++++|+||||+||+++.++.+||+|||++.......
T Consensus        85 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          85 EFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             ecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            999999999999754 346899999999999999999999   8999999999999999999999999999987643322


Q ss_pred             CCcccccccc--CCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          423 DRTHISTKVK--GTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       423 ~~~~~~~~~~--gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ..........  .+..|+|||.+.+..++.++||||||+++|||++ |..||......+.   ..+...   ....    
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i~~---~~~~----  230 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAIEQ---DYRL----  230 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHHHc---CCcC----
Confidence            1111111111  2457999999999899999999999999999987 9999976543321   112110   0000    


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                       +     .+.+++..+.+++.+||+.+|++||++.+|+..|.++
T Consensus       231 -~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         231 -P-----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -C-----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             0     1123445688999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-39  Score=334.67  Aligned_cols=245  Identities=26%  Similarity=0.359  Sum_probs=194.6

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHH-HHHhCCCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVE-LLSKIDHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      +.||+|+||+||+|... +|+.||+|++.....  ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36999999999999764 689999999976532  223345556655 46779999999999999999999999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |+|..++...  ..+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....   ....
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~---~~~~  152 (325)
T cd05604          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA---QSDT  152 (325)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC---CCCC
Confidence            9999988654  57899999999999999999999   89999999999999999999999999999875321   1112


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhc
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI  507 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  507 (554)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||......+....       ......  .        .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~-------~~~~~~--~--------~  215 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN-------ILHKPL--V--------L  215 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHH-------HHcCCc--c--------C
Confidence            2345699999999999999999999999999999999999999986543322111       111110  0        1


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHH----HHHHHHH
Q 042763          508 SMEILTKMFGLAIQCAAPIRNDRPDMK----SVGEQLW  541 (554)
Q Consensus       508 ~~~~~~~l~~li~~cl~~dP~~RPs~~----evl~~l~  541 (554)
                      .+.....+.+++.+|++.+|++||+++    +++++.|
T Consensus       216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~  253 (325)
T cd05604         216 RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPF  253 (325)
T ss_pred             CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCC
Confidence            112345678999999999999999875    6666543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.2e-39  Score=332.82  Aligned_cols=245  Identities=24%  Similarity=0.330  Sum_probs=193.6

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHH-HHHhCCCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVE-LLSKIDHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      +.||+|+||+||+|... +++.||+|++......  .....+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999765 5788999999765432  22234444444 56788999999999999999999999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |+|.+++...  ..+.+..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....   ....
T Consensus        81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~---~~~~  152 (325)
T cd05602          81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE---HNGT  152 (325)
T ss_pred             CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCccccc---CCCC
Confidence            9999999754  46788889999999999999999   89999999999999999999999999999975321   1112


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhc
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI  507 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  507 (554)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..   ....    ....          ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~----~~~~----------~~  215 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY---DNIL----NKPL----------QL  215 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH---HHHH----hCCc----------CC
Confidence            33457999999999999999999999999999999999999999865433221   1111    1000          01


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHH----HHHHHHH
Q 042763          508 SMEILTKMFGLAIQCAAPIRNDRPDMK----SVGEQLW  541 (554)
Q Consensus       508 ~~~~~~~l~~li~~cl~~dP~~RPs~~----evl~~l~  541 (554)
                      ...+...+.+++.+||+.+|.+||++.    ++.++.|
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~  253 (325)
T cd05602         216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIF  253 (325)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcc
Confidence            123445688999999999999999877    5555443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=317.93  Aligned_cols=256  Identities=30%  Similarity=0.441  Sum_probs=201.6

Q ss_pred             CCcceeeeccCceEEEEEEEcC----CcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc-----
Q 042763          268 FSPSLRIGEGGFGTVYKAQLED----GLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE-----  337 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~-----  337 (554)
                      |.+.+.||+|+||.||+|....    +..||+|+++.... ......+.+|++.++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567789999999999997642    36899999875432 2334678999999999999999999998866554     


Q ss_pred             -eEEEEEeCCCCCHHHHHhccc----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEee
Q 042763          338 -RLIITEFVPNGTLREHLDGQY----GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADF  412 (554)
Q Consensus       338 -~~lv~E~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df  412 (554)
                       .+++|||+++|+|..++....    ...+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             699999999999999985432    246889999999999999999999   899999999999999999999999999


Q ss_pred             cCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhc
Q 042763          413 GFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYN  491 (554)
Q Consensus       413 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  491 (554)
                      |+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+.   ..+.    .
T Consensus       158 g~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~---~~~~----~  229 (273)
T cd05035         158 GLSKKIYSGDYY-RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI---YDYL----R  229 (273)
T ss_pred             cceeeccccccc-cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----H
Confidence            999864322211 11222335678999999988889999999999999999999 8888875443221   1111    1


Q ss_pred             cCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          492 EGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       492 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      .+....         .+..+...+.+++.+||+.||++||++.||++.|.++
T Consensus       230 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 HGNRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             cCCCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111110         1223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=9.2e-39  Score=316.23  Aligned_cols=249  Identities=29%  Similarity=0.455  Sum_probs=202.2

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEE-EcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV-DKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-~~~~~~~lv~E~  344 (554)
                      ++|...+.||+|+||.||++... |..||+|.++...   ..+.+.+|+.++++++|+|++++++++ ..++..+++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            46888899999999999999776 7889999886543   245788999999999999999999976 455678999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++.......+++..++.++.|++.||+|||   +++++||||||+||++++++.+||+|||+++.....   
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---  155 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  155 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc---
Confidence            99999999998765556899999999999999999999   899999999999999999999999999998753221   


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                         .....++..|+|||++.+..++.++||||||+++|||++ |+.||........   ....    .....     +  
T Consensus       156 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~----~~~~~-----~--  218 (256)
T cd05082         156 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRV----EKGYK-----M--  218 (256)
T ss_pred             ---CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----hcCCC-----C--
Confidence               112335678999999998889999999999999999998 9999875433221   1111    11100     0  


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                        .....++..+.+++.+||+.+|++|||+.++++.|.++
T Consensus       219 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 --DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence              01123456688999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.5e-39  Score=322.63  Aligned_cols=257  Identities=31%  Similarity=0.486  Sum_probs=205.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  338 (554)
                      .++|+..+.||+|+||.||+|...      ++..||+|++..........++.+|+.++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467888999999999999999753      46789999987654445557799999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHhccc--------------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCC
Q 042763          339 LIITEFVPNGTLREHLDGQY--------------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSN  398 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N  398 (554)
                      +++|||+++|+|.+++....                    ...+++.+++.++.|++.||+|||   +++++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999996432                    124678889999999999999999   8999999999999


Q ss_pred             eEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCh
Q 042763          399 ILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPP  477 (554)
Q Consensus       399 ILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~  477 (554)
                      |+++.++.++|+|||+++....... .........+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADY-YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             eEecCCCceEECccccceecccCcc-ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999875422211 111122235677999999998899999999999999999998 88888754432


Q ss_pred             hhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          478 EERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      +.   ..    ....+....         .+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       240 ~~---~~----~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         240 EV---IY----YVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HH---HH----HHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            21   11    111111111         11223467899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.1e-38  Score=327.77  Aligned_cols=267  Identities=20%  Similarity=0.254  Sum_probs=200.1

Q ss_pred             ceeeecc--CceEEEEEEE-cCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCC
Q 042763          271 SLRIGEG--GFGTVYKAQL-EDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVP  346 (554)
Q Consensus       271 ~~~LG~G--~fG~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  346 (554)
                      .++||+|  +||+||++.. .+|+.||+|+++.... ....+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4579999  7899999965 4689999999976543 2334567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc-
Q 042763          347 NGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT-  425 (554)
Q Consensus       347 ~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~-  425 (554)
                      +|+|.+++..+....+++..++.++.|++.||+|||   +++|+||||||+|||++.++.++++||+.+.......... 
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            999999997665567899999999999999999999   8999999999999999999999999998654321111110 


Q ss_pred             ---cccccccCCCCCcChhcccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhc---------
Q 042763          426 ---HISTKVKGTVGYLDPEYMKT--YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN---------  491 (554)
Q Consensus       426 ---~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~---------  491 (554)
                         .......++..|+|||++.+  ..++.++|||||||++|||++|+.||.........  .........         
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCccccccccchh
Confidence               01122346778999999976  46899999999999999999999999754322111  000000000         


Q ss_pred             -------------cCCcccc-----CCh----hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          492 -------------EGNLLDM-----VDP----SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       492 -------------~~~~~~~-----~d~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                                   +....+.     ..+    .............+.+++.+||+.||++|||+.|++++.|-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f  310 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  310 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence                         0000000     000    00001122345678999999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.7e-39  Score=333.91  Aligned_cols=267  Identities=20%  Similarity=0.249  Sum_probs=201.7

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC------
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG------  335 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------  335 (554)
                      ..++|...+.||+|+||.||+|... .++.||||++..... ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3478999999999999999999654 588999999875432 23345678999999999999999999987543      


Q ss_pred             CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCc
Q 042763          336 NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA  415 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla  415 (554)
                      ...++||||++ ++|.+++..    .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            35699999995 578777753    4788899999999999999999   899999999999999999999999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH-------
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFK-------  488 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~-------  488 (554)
                      +....    ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.....       
T Consensus       174 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         174 RTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             cccCC----CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            85322    1122345689999999999999999999999999999999999999986554332221110000       


Q ss_pred             --------hh--ccCCccccC----Chhh----hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          489 --------RY--NEGNLLDMV----DPSI----KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       489 --------~~--~~~~~~~~~----d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                              .+  .........    .+..    ...........+.+++.+||+.||++|||+.|+++|.|-
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~  321 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  321 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence                    00  000000000    0000    000011123567899999999999999999999999764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.9e-39  Score=326.82  Aligned_cols=264  Identities=22%  Similarity=0.288  Sum_probs=191.6

Q ss_pred             ceeeeccCceEEEEEEEc---CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEc--CCceEEEEEeC
Q 042763          271 SLRIGEGGFGTVYKAQLE---DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDK--GNERLIITEFV  345 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~lv~E~~  345 (554)
                      ..+||+|+||+||+|...   ++..||+|.+.....   ...+.+|++++++++||||+++++++..  +...++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            357999999999999765   357899998875432   2457789999999999999999998843  45679999999


Q ss_pred             CCCCHHHHHhcc-------cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE----CCCCcEEEEeecC
Q 042763          346 PNGTLREHLDGQ-------YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL----TESMRAKVADFGF  414 (554)
Q Consensus       346 ~~g~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl----~~~~~vkl~DfGl  414 (554)
                      + ++|.+++...       ....+++..++.++.|++.||.|||   +.+|+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            5 6888877532       1235788899999999999999999   8999999999999999    5677999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhh------HHHHHHHH
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEE------RVTLRWAF  487 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~------~~~~~~~~  487 (554)
                      ++................||+.|+|||++.+ ..++.++|||||||++|||+||+.||........      ...+....
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            9865433222222334568999999999876 4589999999999999999999999975432110      01111111


Q ss_pred             HhhccCC------------cccc---------CChhhhh---hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          488 KRYNEGN------------LLDM---------VDPSIKE---VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       488 ~~~~~~~------------~~~~---------~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .......            ....         ....+..   .........+.+++.+||+.||.+|||+.|++++.|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~  316 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY  316 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence            1100000            0000         0000000   000112345788999999999999999999998865

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-39  Score=329.95  Aligned_cols=259  Identities=21%  Similarity=0.293  Sum_probs=201.1

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|++.+.||+|+||+||++... +++.||+|++.+...  ....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999765 589999999976432  223456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++... ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999999999653 346889999999999999999999   8999999999999999999999999999987533211


Q ss_pred             CCccccccccCCCCCcChhcccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKT-----YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                        ........||+.|+|||++..     ..++.++|||||||++|||++|+.||......+....+      ........
T Consensus       157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i------~~~~~~~~  228 (331)
T cd05597         157 --TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------MNHKEHFQ  228 (331)
T ss_pred             --CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH------HcCCCccc
Confidence              112223469999999999863     45788999999999999999999999865433221111      00000000


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCC--CCCCCHHHHHHHHHH
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIR--NDRPDMKSVGEQLWA  542 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP--~~RPs~~evl~~l~~  542 (554)
                       +.+.     ...++..+.+++.+|+..++  ..||++.+++++.|-
T Consensus       229 -~~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~  269 (331)
T cd05597         229 -FPPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF  269 (331)
T ss_pred             -CCCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence             0010     11234567788888775544  448999999999774

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.4e-38  Score=317.54  Aligned_cols=259  Identities=27%  Similarity=0.448  Sum_probs=207.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEcC----CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLED----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ++|...++||+|+||.||+|...+    ...||||...........+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788899999999999997643    246899988765434455689999999999999999999999875 567899


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++++|.+++... ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          85 MELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            9999999999999754 236899999999999999999999   899999999999999999999999999999764322


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                        .........++..|+|||.+....++.++||||||+++|||++ |..||......+...   +.    .......   
T Consensus       161 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~---~~----~~~~~~~---  228 (270)
T cd05056         161 --SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG---RI----ENGERLP---  228 (270)
T ss_pred             --cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HH----HcCCcCC---
Confidence              1111222335568999999988889999999999999999996 999997655432211   11    1110000   


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                            .+..++..+.+++.+|+..+|++|||+.++++.|.+++.+.
T Consensus       229 ------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         229 ------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             ------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                  12234567889999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-39  Score=332.69  Aligned_cols=268  Identities=21%  Similarity=0.288  Sum_probs=202.7

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcC-----
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKG-----  335 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----  335 (554)
                      ...++|...+.||+|+||+||+|.. .+++.||||++...... .....+.+|++++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            4467899999999999999999965 46889999998764322 2345677999999999999999999887533     


Q ss_pred             -CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecC
Q 042763          336 -NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGF  414 (554)
Q Consensus       336 -~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl  414 (554)
                       ...++++|++ +++|.+++..   ..+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcc
Confidence             4568999998 8899988864   36899999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHh----
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR----  489 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~----  489 (554)
                      ++.....      .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......    
T Consensus       165 ~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07878         165 ARQADDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE  238 (343)
T ss_pred             ceecCCC------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9864221      233468999999999876 56899999999999999999999999765433221111110000    


Q ss_pred             ----hccC-------CccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          490 ----YNEG-------NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       490 ----~~~~-------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                          ....       .+.......+.... ......+.+++.+||+.||++|||+.|+++|.|-..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~  303 (343)
T cd07878         239 VLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ  303 (343)
T ss_pred             HHHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence                0000       00000000000000 012234789999999999999999999999987654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.6e-38  Score=315.45  Aligned_cols=254  Identities=28%  Similarity=0.466  Sum_probs=206.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .++|...++||+|+||.||++...++..+|+|.+....  .....+.+|++++++++|+||+++++++.+ ...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            35788899999999999999988778889999887543  234678899999999999999999999887 778999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++.......+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--  156 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--  156 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC--
Confidence            99999999998765667899999999999999999999   8999999999999999999999999999997643221  


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      ........++..|+|||++....++.++||||||+++|+|++ |+.||..........   +.    .......      
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~---~~----~~~~~~~------  223 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR---AL----ERGYRMP------  223 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH---HH----hCCCCCC------
Confidence            111222345678999999998889999999999999999999 999997654322211   11    1110000      


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                         .....+..+.+++.+||+.+|++||++.++.+.|.+
T Consensus       224 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 ---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               112334568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.1e-38  Score=323.19  Aligned_cols=257  Identities=23%  Similarity=0.362  Sum_probs=208.3

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ..+|+..+.||+|+||.||+|... +++.||+|.+....... .+.+.+|+.+++.++||||+++++.+..+...++|||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            357888999999999999999754 68899999887654332 4678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++++|.+++...   .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        98 ~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-  170 (296)
T cd06654          98 YLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (296)
T ss_pred             ccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence            99999999998653   5789999999999999999999   8999999999999999999999999999987532211 


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                        .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.....  ..    ..... ...     
T Consensus       171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~--~~----~~~~~-~~~-----  236 (296)
T cd06654         171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--LI----ATNGT-PEL-----  236 (296)
T ss_pred             --cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH--HH----hcCCC-CCC-----
Confidence              11223468899999999998889999999999999999999999997654322111  11    00000 000     


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                        ..+......+.+++.+||..+|++||++.+|+++.|-...
T Consensus       237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             --CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence              0122344568899999999999999999999998775544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.1e-38  Score=320.24  Aligned_cols=255  Identities=28%  Similarity=0.483  Sum_probs=203.0

Q ss_pred             cCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      +++...++||+|+||.||++...      ++..+|+|.+.... ......+.+|+++++.++|+||+++++++..++..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            46677889999999999999632      35689999887543 344568999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcccC-------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc
Q 042763          340 IITEFVPNGTLREHLDGQYG-------------KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR  406 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~  406 (554)
                      ++|||+++++|.+++.....             ..+++..++.++.|++.||+|||   +.+++||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence            99999999999999975421             35789999999999999999999   899999999999999999999


Q ss_pred             EEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHH
Q 042763          407 AKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRW  485 (554)
Q Consensus       407 vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~  485 (554)
                      +||+|||+++...... .........+++.|+|||.+.+..++.++|||||||++|||++ |..||......+...... 
T Consensus       161 ~kL~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-  238 (280)
T cd05092         161 VKIGDFGMSRDIYSTD-YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-  238 (280)
T ss_pred             EEECCCCceeEcCCCc-eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH-
Confidence            9999999987543211 1111223345788999999999899999999999999999998 999987544332211110 


Q ss_pred             HHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          486 AFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                            .+....         .+..++..+.+++.+||+.||++||++.+|.+.|.
T Consensus       239 ------~~~~~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         239 ------QGRELE---------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ------cCccCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                  000000         11123456889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.8e-38  Score=314.83  Aligned_cols=254  Identities=27%  Similarity=0.406  Sum_probs=195.1

Q ss_pred             eeeeccCceEEEEEEEc----CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEE-cCCceEEEEEeCC
Q 042763          272 LRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD-KGNERLIITEFVP  346 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-~~~~~~lv~E~~~  346 (554)
                      +.||+|+||.||+|...    ++..||+|++.........+.+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36899999999999753    246799998865433334567889999999999999999999775 4556799999999


Q ss_pred             CCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc-
Q 042763          347 NGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT-  425 (554)
Q Consensus       347 ~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~-  425 (554)
                      +|+|.+++.... ....+..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++......... 
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999997542 34677888899999999999999   8999999999999999999999999999997543211111 


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG-RRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      .......++..|+|||.+.+..++.++||||||+++|||++| ..||......+   ......    .+..     +.  
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~~----~~~~-----~~--  222 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYLL----QGRR-----LL--  222 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHh----cCCC-----CC--
Confidence            111233467789999999888999999999999999999995 55565433221   111111    1000     00  


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                        .+...+..+.+++.+||+.+|++||++.+|++.+.++..
T Consensus       223 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         223 --QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             --CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence              011234568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.3e-39  Score=337.13  Aligned_cols=265  Identities=23%  Similarity=0.308  Sum_probs=210.5

Q ss_pred             CCCcceeeeccCceEEEEE-EEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-C-----CCceeeeeEEEcCCceE
Q 042763          267 NFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-H-----RNLVKLLGFVDKGNERL  339 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a-~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-H-----pnIv~l~~~~~~~~~~~  339 (554)
                      +|.+.+.||+|+||.|-+| +..+++.||||+++...  ....+-..|+.+|..|+ |     -|+|+++++|...++.|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            7899999999999999999 45579999999998764  34456778999999996 4     37999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC--CcEEEEeecCccc
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES--MRAKVADFGFARL  417 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~--~~vkl~DfGla~~  417 (554)
                      ||+|.+ ..+|.++++.+....++...++.++.||+.||.+||   +.+|||+||||+|||+.+-  ..|||+|||.|.+
T Consensus       265 iVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            999999 789999999988889999999999999999999999   9999999999999999753  4699999999986


Q ss_pred             CCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHh--------
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR--------  489 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~--------  489 (554)
                      ...   .   .....-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.+..+....+......        
T Consensus       341 ~~q---~---vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  341 ESQ---R---VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             cCC---c---ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            321   1   11456788999999999999999999999999999999999988877655444333322110        


Q ss_pred             ------hccC--Ccc------c--------------------cCCh----hhhhhccHHHHHHHHHHHHHccCCCCCCCC
Q 042763          490 ------YNEG--NLL------D--------------------MVDP----SIKEVISMEILTKMFGLAIQCAAPIRNDRP  531 (554)
Q Consensus       490 ------~~~~--~~~------~--------------------~~d~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RP  531 (554)
                            +.+.  ...      +                    ..-|    .+...........+.+++.+||.+||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence                  0000  000      0                    0000    000011112235689999999999999999


Q ss_pred             CHHHHHHHHHHh
Q 042763          532 DMKSVGEQLWAI  543 (554)
Q Consensus       532 s~~evl~~l~~i  543 (554)
                      |+.|.++|.|--
T Consensus       495 tp~qal~Hpfl~  506 (586)
T KOG0667|consen  495 TPAQALNHPFLT  506 (586)
T ss_pred             CHHHHhcCcccc
Confidence            999999998754

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-38  Score=331.48  Aligned_cols=263  Identities=20%  Similarity=0.258  Sum_probs=197.1

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ...+|.+.+.||+|+||.||+|... ++..||+|+....       ....|+.++++++||||+++++++..+...++||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            3467999999999999999999775 4788999975443       2346899999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+ .++|.+++... ...+++.+++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++..... 
T Consensus       137 e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  210 (357)
T PHA03209        137 PHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-  210 (357)
T ss_pred             Ecc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence            999 57899988653 357899999999999999999999   899999999999999999999999999999752211 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhH-------HHHHHHHHhhc--cC
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEER-------VTLRWAFKRYN--EG  493 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~-------~~~~~~~~~~~--~~  493 (554)
                         .......||+.|+|||++.+..++.++|||||||++|||+++..|+....+....       ..+........  ..
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  287 (357)
T PHA03209        211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE  287 (357)
T ss_pred             ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence               1123456999999999999999999999999999999999965554322211100       01111111100  00


Q ss_pred             CccccCChhh-h-----------------hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          494 NLLDMVDPSI-K-----------------EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       494 ~~~~~~d~~l-~-----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .+.......+ .                 ..........+.+++.+||+.||++|||+.|+++|.|-
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f  354 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF  354 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence            0000000000 0                 00001223456679999999999999999999999773

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-38  Score=314.50  Aligned_cols=252  Identities=27%  Similarity=0.414  Sum_probs=206.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEcC-CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|+..++||+|+||.||+|...+ +..+|+|.+.....   .+++.+|++++++++||||+++++++..+...++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            578888999999999999998764 78999999876532   56899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++... ...+++..++.++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||++.......  
T Consensus        80 ~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--  153 (256)
T cd06612          80 CGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--  153 (256)
T ss_pred             CCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--
Confidence            9999999998653 357899999999999999999999   8899999999999999999999999999988643221  


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                       .......++..|+|||++.+..++.++||||||+++|+|++|+.||............       ...     ..+...
T Consensus       154 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-------~~~-----~~~~~~  220 (256)
T cd06612         154 -AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-------PNK-----PPPTLS  220 (256)
T ss_pred             -cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------ccC-----CCCCCC
Confidence             1223345888999999999989999999999999999999999999864432211100       000     000000


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                        .+..+...+.+++.+||+.+|++|||+.||+++.|
T Consensus       221 --~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~  255 (256)
T cd06612         221 --DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF  255 (256)
T ss_pred             --chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence              12234467899999999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-38  Score=315.95  Aligned_cols=249  Identities=34%  Similarity=0.485  Sum_probs=197.0

Q ss_pred             eeeccCceEEEEEEEcC-Cc--EEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEEEeCCCC
Q 042763          273 RIGEGGFGTVYKAQLED-GL--LVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEFVPNG  348 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~-g~--~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~g  348 (554)
                      .||+|+||.||+|...+ +.  .+|+|.+.........+.+.+|++++.++ +||||+++++++...+..+++|||+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            58999999999997753 43  56888887544344456789999999999 7999999999999999999999999999


Q ss_pred             CHHHHHhccc--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecC
Q 042763          349 TLREHLDGQY--------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGF  414 (554)
Q Consensus       349 ~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl  414 (554)
                      +|.+++....              ...+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999997542              124789999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccC
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEG  493 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~  493 (554)
                      +.....    .........+..|+|||++....++.++||||||+++|||++ |..||......+...   .    ....
T Consensus       159 ~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~---~----~~~~  227 (270)
T cd05047         159 SRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE---K----LPQG  227 (270)
T ss_pred             ccccch----hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH---H----HhCC
Confidence            863211    111112234567999999988889999999999999999997 999997543322111   1    1111


Q ss_pred             CccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          494 NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       494 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      ...+         ........+.+++.+||+.+|.+|||+.+++..|.++-
T Consensus       228 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         228 YRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            0000         11123456889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-38  Score=318.52  Aligned_cols=266  Identities=27%  Similarity=0.468  Sum_probs=207.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-----CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEc--CCce
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDK--GNER  338 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-----~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~  338 (554)
                      ++|...+.||+|+||.||+|...     ++..+|||++.........+.+.+|+++++.++||||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777789999999999999753     3689999999866544345789999999999999999999999877  5678


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      +++|||+++++|.+++.... ..+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++...
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            99999999999999997653 35899999999999999999999   899999999999999999999999999999875


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhH--------HHHHHHHHhh
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEER--------VTLRWAFKRY  490 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~--------~~~~~~~~~~  490 (554)
                      ..............++..|+|||.+.+..++.++||||||+++|||++|..|+.........        ..........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            42222222222234566799999998888999999999999999999999998653321100        0000000001


Q ss_pred             ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      ....         ....+..++..+.+++.+||+.+|++||+|.||+++|.+|+
T Consensus       240 ~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         240 KEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             HcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            1100         00011233467899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.7e-38  Score=315.03  Aligned_cols=258  Identities=24%  Similarity=0.403  Sum_probs=202.8

Q ss_pred             HHhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          262 VKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       262 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      ..+++++.....||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.++++++|+||+++++++..++..++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            345666777779999999999999754 578899998876542 334678999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCC--CHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC-CCcEEEEeecCccc
Q 042763          341 ITEFVPNGTLREHLDGQYGKTL--DFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE-SMRAKVADFGFARL  417 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~~  417 (554)
                      |+||+++++|.+++.... ..+  ++..+..++.|++.||+|||   +.+|+||||||+||+++. ++.++|+|||++..
T Consensus        83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            999999999999997642 234  78888899999999999999   899999999999999976 67999999999875


Q ss_pred             CCCCCCCccccccccCCCCCcChhccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKTY--QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      .....   .......|++.|+|||++.+.  .++.++||||||+++|+|++|+.||..........   +.......   
T Consensus       159 ~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~~~~~---  229 (268)
T cd06624         159 LAGIN---PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVGMFKI---  229 (268)
T ss_pred             cccCC---CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhhhhcc---
Confidence            42211   112234588999999998664  37899999999999999999999997543222111   11000000   


Q ss_pred             cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          496 LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       496 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                          .+    .++......+.+++.+||+.+|++|||+.|++++.|
T Consensus       230 ----~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  267 (268)
T cd06624         230 ----HP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF  267 (268)
T ss_pred             ----CC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence                01    122334566889999999999999999999998865

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.2e-38  Score=319.19  Aligned_cols=251  Identities=27%  Similarity=0.380  Sum_probs=205.1

Q ss_pred             CCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCC
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVP  346 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  346 (554)
                      |+..+.||+|+||.||+|... ++..||+|.+.........+.+.+|++++++++||||+++++++..++..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            555668999999999999654 5889999998755444455689999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcc
Q 042763          347 NGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH  426 (554)
Q Consensus       347 ~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~  426 (554)
                      +++|.+++..   ..+++..+..++.|++.|+.|||   +++++|+||+|+||++++++.++|+|||++......   ..
T Consensus        86 ~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~---~~  156 (277)
T cd06642          86 GGSALDLLKP---GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QI  156 (277)
T ss_pred             CCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCc---ch
Confidence            9999999864   36889999999999999999999   899999999999999999999999999998764321   11


Q ss_pred             ccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhh
Q 042763          427 ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEV  506 (554)
Q Consensus       427 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  506 (554)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....+....   ..    ....     ..+.    
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~----~~~~-----~~~~----  220 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FL----IPKN-----SPPT----  220 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hh----hhcC-----CCCC----
Confidence            222345888999999999988999999999999999999999998754332111   00    0000     0111    


Q ss_pred             ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          507 ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       507 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      .....+..+.+++.+||+.+|++||++.+|+.+.|-.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  257 (277)
T cd06642         221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT  257 (277)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence            1223456688999999999999999999999988754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.2e-38  Score=313.19  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=207.8

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +|+..+.||+|+||.||.++.. +++.+++|.+..... .....++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5788899999999999999654 588999998765432 33446788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++.......+++.++..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            99999999998765567899999999999999999999   88999999999999999999999999999986433221 


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                        ......+++.|+|||.+.+..++.++||||||+++|||++|..||......+....+       ..+....       
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~-------~~~~~~~-------  220 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI-------VQGNYTP-------  220 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HcCCCCC-------
Confidence              223456899999999998888999999999999999999999999764433221111       1111111       


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                        ........+.+++.+||+.+|++||++.+++++++
T Consensus       221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~  255 (256)
T cd08221         221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL  255 (256)
T ss_pred             --CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence              11234566889999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.5e-38  Score=314.45  Aligned_cols=252  Identities=25%  Similarity=0.373  Sum_probs=191.8

Q ss_pred             eeeccCceEEEEEEEcC---CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCC
Q 042763          273 RIGEGGFGTVYKAQLED---GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGT  349 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~---g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~  349 (554)
                      +||+|+||+||+|...+   ...+|+|.+...........+.+|+++++.++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999996543   457889987655444455678899999999999999999999999999999999999999


Q ss_pred             HHHHHhcccC---CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcc
Q 042763          350 LREHLDGQYG---KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH  426 (554)
Q Consensus       350 L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~  426 (554)
                      |.+++.....   ...++...+.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~  157 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED-YYI  157 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccch-hee
Confidence            9999976532   23567888899999999999999   8999999999999999999999999999986532211 111


Q ss_pred             ccccccCCCCCcChhcccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          427 ISTKVKGTVGYLDPEYMKT-------YQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       427 ~~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ......+++.|+|||++..       ..++.++||||||+++|||++ |..||......+.   .....   .+ .....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~~~~---~~-~~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---LKQVV---RE-QDIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HHHHh---hc-cCccC
Confidence            1223346778999998743       356889999999999999999 7888875433221   11111   11 11111


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                      ..+.    ........+.+++..|| .||++||++++|++.+
T Consensus       231 ~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         231 PKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            1222    12234455677888888 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-38  Score=319.61  Aligned_cols=262  Identities=23%  Similarity=0.326  Sum_probs=209.6

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|+..++||+|+||+||++... +|+.||+|++.........+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56777889999999999999765 58899999887654445567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++...  ..+++..+..++.+++.||.|||.  ..+++||||||+||+++.++.++|+|||++.......  
T Consensus        85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--  158 (284)
T cd06620          85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--  158 (284)
T ss_pred             CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence            9999999998764  468999999999999999999993  3689999999999999999999999999986532111  


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhH-----HHHHHHHHhhccCCccccC
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEER-----VTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  499 (554)
                         .....|+..|+|||++.+..++.++|||||||++|+|++|..||......++.     ....+....... .     
T Consensus       159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----  229 (284)
T cd06620         159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-P-----  229 (284)
T ss_pred             ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-c-----
Confidence               12346899999999998888999999999999999999999999865432110     011111111100 0     


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      .+.   ....+.+..+.+++.+||+.||++||++.|++++.|-++.
T Consensus       230 ~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         230 PPR---LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             CCC---CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            000   0111245678999999999999999999999999877664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.5e-38  Score=315.26  Aligned_cols=256  Identities=26%  Similarity=0.378  Sum_probs=210.6

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ..|+..++||+|+||.||+|... ++..||+|.+...........+.+|+.++++++||||+++++++.+++..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            34667788999999999999765 58899999987655445567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++...   .+++.++..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.......  
T Consensus        84 ~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06640          84 LGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--
Confidence            9999999998653   6888999999999999999999   8999999999999999999999999999997643211  


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                       .......++..|+|||.+.+..++.++||||||+++|||++|..||....+.......       ...     ..    
T Consensus       156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------~~~-----~~----  218 (277)
T cd06640         156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------PKN-----NP----  218 (277)
T ss_pred             -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-------hcC-----CC----
Confidence             1122345788999999998888999999999999999999999999765432211110       000     00    


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      ......++..+.+++.+||+.+|++||++.+++.+.|-.+..
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence            113345667789999999999999999999999998765543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-37  Score=331.99  Aligned_cols=265  Identities=18%  Similarity=0.198  Sum_probs=199.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ..+|.+.+.||+|+||.||+|... .++.||||....       ..+.+|++++++++|+||+++++++..++..++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            457999999999999999999765 478999996432       245689999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      ++ .++|.+++... ...+++.+++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++...... 
T Consensus       241 ~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~-  314 (461)
T PHA03211        241 KY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW-  314 (461)
T ss_pred             cc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc-
Confidence            99 57999988654 246899999999999999999999   8999999999999999999999999999998643221 


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCh-----hhHHHHHHHHHh-hccCCccc
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP-----EERVTLRWAFKR-YNEGNLLD  497 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~  497 (554)
                      .........||+.|+|||++.+..++.++|||||||++|||++|..|+......     ............ .....+..
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            111223457999999999999999999999999999999999988665322111     001111111000 00000000


Q ss_pred             cCChhhhhh-----------------cc--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          498 MVDPSIKEV-----------------IS--MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       498 ~~d~~l~~~-----------------~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .....+...                 ..  ......+.+|+.+||+.||++|||+.|++++.|-
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f  458 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF  458 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence            000000000                 00  0122467899999999999999999999998763

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.9e-38  Score=317.90  Aligned_cols=260  Identities=25%  Similarity=0.391  Sum_probs=206.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|+..+.||+|+||.||++... +|..||+|.+...........+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35778889999999999999776 68999999887543334456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          345 VPNGTLREHLDGQY-GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       345 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      +++++|..++.... ...+++..+..++.|++.||.|||.  +.+++||||||+||+++.++.+||+|||++......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            99999999987532 2368999999999999999999992  359999999999999999999999999998754221  


Q ss_pred             CccccccccCCCCCcChhccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTY------QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~------~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                         ......+++.|+|||.+.+.      .++.++|||||||++|||++|+.||...........+..    ......  
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~~~~--  227 (286)
T cd06622         157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA----IVDGDP--  227 (286)
T ss_pred             ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH----HhhcCC--
Confidence               12234588899999998543      358899999999999999999999975433222111111    111100  


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                         +    ..+..+...+.+++.+||+.+|++||++.+++++.|-...
T Consensus       228 ---~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         228 ---P----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             ---C----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence               0    1223355678899999999999999999999999875443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.8e-38  Score=352.17  Aligned_cols=262  Identities=23%  Similarity=0.342  Sum_probs=204.3

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|+..++||+|+||.||+|... +|+.||+|++.....  +...+++.+|++++++++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57888999999999999999765 589999999875432  234567999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhccc---------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeec
Q 042763          343 EFVPNGTLREHLDGQY---------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFG  413 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfG  413 (554)
                      ||+++|+|.+++....         ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999986421         234567788999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCCCCCC---------------ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChh
Q 042763          414 FARLGPMDSDR---------------THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPE  478 (554)
Q Consensus       414 la~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~  478 (554)
                      +++........               ........||+.|||||++.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            99864211100               011123569999999999999999999999999999999999999997633221


Q ss_pred             hHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHhh
Q 042763          479 ERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRP-DMKSVGEQLWAIR  544 (554)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~l~~i~  544 (554)
                      ..    .. ...        .++... ....+++..+.+++.+|++.||++|| ++.++.+.+....
T Consensus       239 i~----~~-~~i--------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        239 IS----YR-DVI--------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             hh----hh-hhc--------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            10    00 000        000000 00123455688999999999999996 5666766666553

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.9e-38  Score=317.37  Aligned_cols=268  Identities=23%  Similarity=0.335  Sum_probs=205.5

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ++|+..+.||+|+||.||+|... +|+.||+|++..... ....+.+.+|++++++++|||++++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999776 589999998865432 2234567899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |++++.|..++...  ..+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            99998888876543  46899999999999999999999   89999999999999999999999999999986432211


Q ss_pred             CccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhh--------ccCC
Q 042763          424 RTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY--------NEGN  494 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~--------~~~~  494 (554)
                         ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+............        ....
T Consensus       156 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         156 ---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             ---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence               1223457889999999876 468899999999999999999999998765443322222111100        0000


Q ss_pred             c-cccCChhhhh-----hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          495 L-LDMVDPSIKE-----VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       495 ~-~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      . .....+....     .........+.+++.+||+.+|++||++.|++.+.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~  285 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY  285 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence            0 0000010000     001123567899999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.9e-38  Score=313.66  Aligned_cols=253  Identities=26%  Similarity=0.407  Sum_probs=206.9

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +|+..++||+|+||.||++... +|+.||+|++..... .....++.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4778899999999999999654 689999999875432 23346789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++.......+++.+++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--  155 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--  155 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence            99999999997665556889999999999999999999   8999999999999999999999999999997643211  


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                       .......|++.|+|||++.+..++.++||||||+++++|++|+.||......+.....       ..+....       
T Consensus       156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~-------~~~~~~~-------  220 (256)
T cd08218         156 -ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI-------IRGSYPP-------  220 (256)
T ss_pred             -hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH-------hcCCCCC-------
Confidence             1122345888999999999888999999999999999999999999754432211111       1111100       


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                        .+......+.+++.+||+.+|++||++.+|+++.|
T Consensus       221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~  255 (256)
T cd08218         221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF  255 (256)
T ss_pred             --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence              12234566899999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.5e-38  Score=314.20  Aligned_cols=261  Identities=27%  Similarity=0.386  Sum_probs=210.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|+..+.||.|+||+||+|... ++..+|+|++...........+.+|+++++.++|+||+++++.+..++..++||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999754 58899999987654444567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          345 VPNGTLREHLDGQYG-KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      +++++|.+++..... ..+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999976533 56899999999999999999999   89999999999999999999999999999876543322


Q ss_pred             Cc-cccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          424 RT-HISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       424 ~~-~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                      .. .......|+..|+|||.+... .++.++|+||||+++|||++|+.||...........  ..    ..      ..+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~--~~----~~------~~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML--TL----QN------DPP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH--Hh----cC------CCC
Confidence            21 122345689999999998876 789999999999999999999999976543221111  00    00      001


Q ss_pred             hhhhhc-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          502 SIKEVI-SMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       502 ~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ...... ....+..+.+++.+||+.+|++||++.+|+++.|
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~  266 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF  266 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence            111000 1234567899999999999999999999998754

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-38  Score=321.39  Aligned_cols=256  Identities=23%  Similarity=0.358  Sum_probs=208.8

Q ss_pred             cCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .+|+..+.||.|+||+||+|.. .+|+.||+|.+..... ...+.+.+|+++++.++||||+++++++..++..++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            4688999999999999999965 4689999998875443 2346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++...   .+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......  
T Consensus        98 ~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--  169 (296)
T cd06655          98 LAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--  169 (296)
T ss_pred             cCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccc--
Confidence            9999999998654   5899999999999999999999   8999999999999999999999999999987543221  


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                       .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...........   ... ......   .     
T Consensus       170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~---~~~-~~~~~~---~-----  236 (296)
T cd06655         170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IAT-NGTPEL---Q-----  236 (296)
T ss_pred             -ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh-cCCccc---C-----
Confidence             112234688999999999988899999999999999999999999987654332211   110 000000   0     


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                        .+..+...+.+++.+||..+|++||++.+|+.+-|--..
T Consensus       237 --~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         237 --NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             --CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence              112234568899999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-38  Score=316.59  Aligned_cols=256  Identities=29%  Similarity=0.388  Sum_probs=209.2

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|+..+.||.|+||.||+|... +++.||+|.+...........+.+|+++++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36778889999999999999765 58999999987654344456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++...   .+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+++......  
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--  152 (274)
T cd06609          81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--  152 (274)
T ss_pred             eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence            9999999999754   7899999999999999999999   8999999999999999999999999999998654321  


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                       .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||....+......   .    ...     ..+.+.
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~---~----~~~-----~~~~~~  219 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL---I----PKN-----NPPSLE  219 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH---h----hhc-----CCCCCc
Confidence             122334688899999999988899999999999999999999999976543221110   0    000     011111


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      .   ..++..+.+++.+||..+|++||++++++++.|-.+.
T Consensus       220 ~---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         220 G---NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             c---cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence            0   0144568899999999999999999999998776543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.2e-38  Score=312.75  Aligned_cols=253  Identities=24%  Similarity=0.359  Sum_probs=193.3

Q ss_pred             eeeccCceEEEEEEEcC---CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCC
Q 042763          273 RIGEGGFGTVYKAQLED---GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGT  349 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~---g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~  349 (554)
                      .||+|+||.||+|...+   +..+|+|.++..........+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            58999999999997643   467999988765444444578899999999999999999999999899999999999999


Q ss_pred             HHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcc
Q 042763          350 LREHLDGQY---GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH  426 (554)
Q Consensus       350 L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~  426 (554)
                      |.+++....   ....++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++...... ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~-~~~  157 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED-YYV  157 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcc-eee
Confidence            999997542   224567788899999999999999   8999999999999999999999999999997532211 111


Q ss_pred             ccccccCCCCCcChhccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          427 ISTKVKGTVGYLDPEYMKTY-------QLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       427 ~~~~~~gt~~y~aPE~l~~~-------~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ......++..|+|||++.+.       .++.++||||||+++|||++ |..||......+...   ...   . ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~~---~-~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YTV---R-EQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HHh---h-cccCCC
Confidence            22334578899999988642       35789999999999999996 999997654332211   110   0 111111


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .++.+..    .....+.+++.+|+ .+|++|||+.||+..|.
T Consensus       231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            2222211    12345778999999 58999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.4e-38  Score=320.05  Aligned_cols=262  Identities=23%  Similarity=0.365  Sum_probs=204.7

Q ss_pred             hHHHHHhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEE--
Q 042763          258 MSQVVKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVD--  333 (554)
Q Consensus       258 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~--  333 (554)
                      ++.+....++|+..+.||+|+||.||+|... +++.+|+|++....  .....+.+|+.+++++ +||||+++++++.  
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            3455667889999999999999999999664 58899999876532  2235678899999999 6999999999873  


Q ss_pred             ---cCCceEEEEEeCCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEE
Q 042763          334 ---KGNERLIITEFVPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAK  408 (554)
Q Consensus       334 ---~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vk  408 (554)
                         .++..++||||+++++|.+++...  ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEE
Confidence               345689999999999999988642  2346888999999999999999999   89999999999999999999999


Q ss_pred             EEeecCcccCCCCCCCccccccccCCCCCcChhcccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHH
Q 042763          409 VADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-----YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTL  483 (554)
Q Consensus       409 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~  483 (554)
                      |+|||+++......   .......|++.|+|||++..     ..++.++|||||||++|||++|+.||........... 
T Consensus       165 l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~-  240 (286)
T cd06638         165 LVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-  240 (286)
T ss_pred             EccCCceeecccCC---CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-
Confidence            99999987643211   11223468999999998853     4578999999999999999999999976543221110 


Q ss_pred             HHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          484 RWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       484 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                            ..........++       ......+.+++.+||+.+|++||++.||++++|
T Consensus       241 ------~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         241 ------IPRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             ------ccccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence                  000000011111       112346889999999999999999999999876

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.8e-39  Score=317.88  Aligned_cols=255  Identities=25%  Similarity=0.356  Sum_probs=202.1

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|...++||+|+||.||+|... +++.||+|.++.... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            46777889999999999999664 588999999875532 2235678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++...  ..+++.+++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++......   
T Consensus        88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~---  159 (267)
T cd06645          88 CGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT---  159 (267)
T ss_pred             cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc---
Confidence            9999999998654  47899999999999999999999   889999999999999999999999999998754221   


Q ss_pred             ccccccccCCCCCcChhccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          425 THISTKVKGTVGYLDPEYMK---TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                      ........|++.|+|||.+.   ...++.++|||||||++|||++|..||....+........      . ....   .+
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~------~-~~~~---~~  229 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT------K-SNFQ---PP  229 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh------c-cCCC---CC
Confidence            11123346899999999874   4568899999999999999999999987544322211110      0 0000   01


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ....  ...++..+.+++.+||+.+|++||++.+|+++.|
T Consensus       230 ~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         230 KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            1110  0123346889999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.3e-38  Score=325.19  Aligned_cols=262  Identities=30%  Similarity=0.443  Sum_probs=207.6

Q ss_pred             cCCCcceeeeccCceEEEEEEEc--------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCC
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE--------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGN  336 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~  336 (554)
                      .+|.+.+.||+|+||.||+|...        .+..||+|.+..........++.+|+++++++ +||||+++++++..++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888899999999999999642        12468999887654444457889999999999 7999999999999999


Q ss_pred             ceEEEEEeCCCCCHHHHHhccc--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC
Q 042763          337 ERLIITEFVPNGTLREHLDGQY--------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT  402 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~  402 (554)
                      ..+++|||+++|+|.+++..+.              ...+++.+++.++.|++.||+|||   +++++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999997532              235788999999999999999999   89999999999999999


Q ss_pred             CCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHH
Q 042763          403 ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERV  481 (554)
Q Consensus       403 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~  481 (554)
                      .++.+||+|||+++...... .........++..|+|||++.+..++.++||||||+++|||++ |..||......+...
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  247 (334)
T cd05100         169 EDNVMKIADFGLARDVHNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  247 (334)
T ss_pred             CCCcEEECCcccceeccccc-ccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            99999999999997543211 1111122234567999999999899999999999999999998 888887543222111


Q ss_pred             HHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          482 TLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                             ........+         .+..+...+.+++.+||+.+|++||++.|+++.|+++....
T Consensus       248 -------~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         248 -------LLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             -------HHHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence                   111111111         11233456889999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-38  Score=318.91  Aligned_cols=266  Identities=22%  Similarity=0.340  Sum_probs=202.0

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|+..+.||+|++|.||+|..+ +++.||+|.+...........+.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999765 68999999987654333334577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      ++ ++|.+++.... ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++......  
T Consensus        85 ~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--  157 (291)
T cd07844          85 LD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--  157 (291)
T ss_pred             CC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence            96 59999887543 36889999999999999999999   8999999999999999999999999999987532111  


Q ss_pred             ccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhcc--CCc------
Q 042763          425 THISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE--GNL------  495 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~------  495 (554)
                       .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......+...  ........  ...      
T Consensus       158 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLH--KIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             -ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH--HHHHhcCCCChhhhhhhhh
Confidence             11122346889999998865 4589999999999999999999999976542222111  11111000  000      


Q ss_pred             ---------cccCChhhhhhcc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          496 ---------LDMVDPSIKEVIS-MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       496 ---------~~~~d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                               .......+..... ......+.+++.+||+.+|++||++.|++++.|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~  290 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY  290 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence                     0000111111110 011256789999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=319.49  Aligned_cols=264  Identities=25%  Similarity=0.366  Sum_probs=209.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|++.+.||+|+||.||++... ++..+|+|++.... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            356888889999999999999765 58899999987553 2334678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++++|.+++... ...+++.+++.++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||++......  
T Consensus        83 ~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--  156 (280)
T cd06611          83 FCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--  156 (280)
T ss_pred             ccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence            99999999998754 346899999999999999999999   899999999999999999999999999998753221  


Q ss_pred             CccccccccCCCCCcChhccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          424 RTHISTKVKGTVGYLDPEYMK-----TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                       ........+++.|+|||.+.     ...++.++||||||+++|||++|+.||............       .....   
T Consensus       157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~---  225 (280)
T cd06611         157 -LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI-------LKSEP---  225 (280)
T ss_pred             -ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH-------hcCCC---
Confidence             11223346899999999875     345778999999999999999999999765432221111       11000   


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhhh
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKS  550 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~~  550 (554)
                        +.+.  .+..+...+.+++.+||+.+|++||++.+|+++.|-......+.
T Consensus       226 --~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  273 (280)
T cd06611         226 --PTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKA  273 (280)
T ss_pred             --CCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccchhHH
Confidence              0000  11223456889999999999999999999999988655444333

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-39  Score=318.42  Aligned_cols=267  Identities=23%  Similarity=0.320  Sum_probs=204.0

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC-----ceEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN-----ERLI  340 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----~~~l  340 (554)
                      .|...+++|.|+||.||+|... +++.||||+.-.+..     .-.+|+++|++++|||||+|.-+|....     ...+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            4566788999999999999765 478999998866532     2347899999999999999998874332     3468


Q ss_pred             EEEeCCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC-CcEEEEeecCccc
Q 042763          341 ITEFVPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES-MRAKVADFGFARL  417 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkl~DfGla~~  417 (554)
                      |||||+ .+|.++++..  .+..++...+.-+..||.+||.|||   +.+|+||||||+|+|+|.+ |.+||||||.|+.
T Consensus       100 VleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            999995 5899888742  2457888888999999999999999   8999999999999999976 9999999999998


Q ss_pred             CCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC---
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG---  493 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---  493 (554)
                      .....    .......|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.+..+....+-.+.......   
T Consensus       176 L~~~e----pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  176 LVKGE----PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             eccCC----CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            54322    2233457889999998876 479999999999999999999999999876655544433332211111   


Q ss_pred             ----CccccCChhh-----hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHhhhh
Q 042763          494 ----NLLDMVDPSI-----KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQ--LWAIRAD  546 (554)
Q Consensus       494 ----~~~~~~d~~l-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--l~~i~~~  546 (554)
                          ...+...+.+     .+........+..+++.++|+.+|.+|.++.|++.|  +.++|..
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                1111111222     122334456788999999999999999999999987  3555544

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.6e-38  Score=317.74  Aligned_cols=254  Identities=26%  Similarity=0.370  Sum_probs=202.0

Q ss_pred             CCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCC
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVP  346 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  346 (554)
                      |++.++||+|+||.||+|... ++..+++|.+.... ....+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            566778999999999999766 47888999886543 2335678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcc
Q 042763          347 NGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH  426 (554)
Q Consensus       347 ~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~  426 (554)
                      +++|..++... ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......   ..
T Consensus        86 ~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~---~~  158 (282)
T cd06643          86 GGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---IQ  158 (282)
T ss_pred             CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc---cc
Confidence            99999987653 246899999999999999999999   899999999999999999999999999998753221   11


Q ss_pred             ccccccCCCCCcChhccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          427 ISTKVKGTVGYLDPEYMK-----TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       427 ~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                      ......+++.|+|||++.     +..++.++|||||||++|||++|+.||..........  ...  .....   ...  
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~~~--~~~~~---~~~--  229 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL--KIA--KSEPP---TLA--  229 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHH--HHh--hcCCC---CCC--
Confidence            223346899999999884     3457889999999999999999999997644322111  110  00000   000  


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                           .+..+...+.+++.+||+.+|++||++.+++++.|-.
T Consensus       230 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  266 (282)
T cd06643         230 -----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT  266 (282)
T ss_pred             -----CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEe
Confidence                 1122345789999999999999999999999987744

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.4e-38  Score=327.83  Aligned_cols=259  Identities=20%  Similarity=0.259  Sum_probs=200.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|...++||+|+||+||++... +++.||+|++.+...  ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999776 478899999875432  223345888999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++... ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++...... 
T Consensus        81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-  155 (332)
T ss_pred             eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccC-
Confidence            999999999999753 246889999999999999999999   899999999999999999999999999998753221 


Q ss_pred             CCccccccccCCCCCcChhccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          423 DRTHISTKVKGTVGYLDPEYMK-----TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                       .........||+.|+|||++.     ...++.++|||||||++|||++|+.||......+....+.      .......
T Consensus       156 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~------~~~~~~~  228 (332)
T cd05623         156 -GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------NHKERFQ  228 (332)
T ss_pred             -CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh------CCCcccc
Confidence             112223356999999999986     3468899999999999999999999998654333221111      1000000


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCC--CCCCCHHHHHHHHHH
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIR--NDRPDMKSVGEQLWA  542 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP--~~RPs~~evl~~l~~  542 (554)
                       ....     ...+...+.+++.+|+..++  ..||++.|+++|.|-
T Consensus       229 -~p~~-----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f  269 (332)
T cd05623         229 -FPAQ-----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF  269 (332)
T ss_pred             -CCCc-----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCc
Confidence             0000     11234567788888885544  447899999999653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-38  Score=321.26  Aligned_cols=259  Identities=25%  Similarity=0.333  Sum_probs=209.5

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|+..+.||+|+||+||+|... +++.||+|.+......  ...+.+..|++++++++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999776 4899999998765433  24467889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+.+++|.+++.......+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999998766678999999999999999999999   8999999999999999999999999999987543211


Q ss_pred             CCc--------------------------cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 042763          423 DRT--------------------------HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRP  476 (554)
Q Consensus       423 ~~~--------------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~  476 (554)
                      ...                          .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            100                          011134588999999999988899999999999999999999999976554


Q ss_pred             hhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCC----HHHHHHHHHH
Q 042763          477 PEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPD----MKSVGEQLWA  542 (554)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~~l~~  542 (554)
                      .......       ......   .+     .....+..+.+++.+||+.+|++||+    +.|++.+.|-
T Consensus       238 ~~~~~~~-------~~~~~~---~~-----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~  292 (316)
T cd05574         238 DETFSNI-------LKKEVT---FP-----GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF  292 (316)
T ss_pred             HHHHHHH-------hcCCcc---CC-----CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence            3221111       010000   00     01114567899999999999999999    8999888664

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=309.67  Aligned_cols=270  Identities=22%  Similarity=0.337  Sum_probs=225.4

Q ss_pred             ChHHHHHhhcCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeee
Q 042763          257 NMSQVVKATRNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG  330 (554)
Q Consensus       257 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~  330 (554)
                      ...++.....+++....+-+|.||.||.|.+.      +.+.|-||.++....+-....++.|.-++..+.|||+.++.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            34566666778888889999999999999544      346678888887776667788999999999999999999999


Q ss_pred             EEEc-CCceEEEEEeCCCCCHHHHHhc------ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC
Q 042763          331 FVDK-GNERLIITEFVPNGTLREHLDG------QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE  403 (554)
Q Consensus       331 ~~~~-~~~~~lv~E~~~~g~L~~~l~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~  403 (554)
                      ++.+ ....++++.++.-|+|..|+..      .+.+.+...+.+.++.|++.|++|||   +++|||.||..+|++|++
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehh
Confidence            9855 4567899999999999999972      23456778888999999999999999   999999999999999999


Q ss_pred             CCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 042763          404 SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVT  482 (554)
Q Consensus       404 ~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~  482 (554)
                      ..+|||+|=.++|-. ...+..........+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+....
T Consensus       432 ~LqVkltDsaLSRDL-FP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y  510 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDL-FPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY  510 (563)
T ss_pred             heeEEeccchhcccc-CcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence            999999999999854 34566666666778889999999999999999999999999999999 9999987766554333


Q ss_pred             HHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          483 LRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       483 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      +....              ++  ..+..++++++.++.-||+..|++||+++|+..-|.+.+..
T Consensus       511 lkdGy--------------Rl--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q  558 (563)
T KOG1024|consen  511 LKDGY--------------RL--AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ  558 (563)
T ss_pred             Hhccc--------------ee--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence            22111              11  13456889999999999999999999999999988877654

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=328.40  Aligned_cols=267  Identities=23%  Similarity=0.337  Sum_probs=201.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC-----Cce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG-----NER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~~  338 (554)
                      +++|++.++||+|+||.||+|... +|+.||+|++...........+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999654 68999999987543334456788999999999999999999987544     357


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ++++||++ ++|.+++..+   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            99999995 5888887543   6899999999999999999999   899999999999999999999999999999764


Q ss_pred             CCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC---C
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG---N  494 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~  494 (554)
                      ..............|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||..........   .........   .
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~---~~~~~~~~~~~~~  233 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN---LILGVLGTPSQED  233 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCCHHH
Confidence            332222222234568999999998754 568999999999999999999999997644322111   111111100   0


Q ss_pred             ccccCChhhh--------------hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          495 LLDMVDPSIK--------------EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       495 ~~~~~d~~l~--------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .....+....              ..........+.+++.+||+.+|++||++.|++++.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~  294 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY  294 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence            0000000000              0001123466899999999999999999999999854

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-39  Score=328.62  Aligned_cols=257  Identities=28%  Similarity=0.447  Sum_probs=214.3

Q ss_pred             CCCcceeeeccCceEEEEEEEcC---C--cEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLED---G--LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~~---g--~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .....++||+|.||.||+|.+.+   |  -.||||.-+.+...+..+.|+.|..+|++++||||++|+|+|.+ ...++|
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence            34455679999999999996542   3  46899998886665567889999999999999999999999986 578999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      ||.++.|.|+.|++.+ ...++......++.||..||.|||   +...|||||..+|||+...--|||+|||++|....+
T Consensus       469 mEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  469 MELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             EecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            9999999999999865 356888899999999999999999   999999999999999999999999999999986543


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      ...  ..+...-+..|||||.++.+.++.++|||.|||.+||++. |..||.+-...+....       ...+       
T Consensus       545 ~yY--kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-------iEnG-------  608 (974)
T KOG4257|consen  545 AYY--KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-------IENG-------  608 (974)
T ss_pred             chh--hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-------ecCC-------
Confidence            322  2334456778999999999999999999999999999988 9999987544332111       1111       


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                        -+-..++.|+..++.|+.+||+.+|.+||++.|+...|.+|..+
T Consensus       609 --eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  609 --ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             --CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence              11125667888999999999999999999999999999998874

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-38  Score=315.82  Aligned_cols=262  Identities=26%  Similarity=0.424  Sum_probs=208.6

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCc----EEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGL----LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      .+|+..+.||+|+||+||+|... +|.    .+|+|............++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56778889999999999999764 233    6899988776555556789999999999999999999999987 78899


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999999999999997653 35899999999999999999999   89999999999999999999999999999986542


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ..... ......++..|+|||.+....++.++||||||+++|||++ |+.||......+...   .    .......  .
T Consensus       162 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~----~~~~~~~--~  231 (279)
T cd05057         162 DEKEY-HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD---L----LEKGERL--P  231 (279)
T ss_pred             cccce-ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH---H----HhCCCCC--C
Confidence            22111 1112234678999999988889999999999999999999 999998654322111   1    1111100  0


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK  549 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~  549 (554)
                             .+..+...+.+++.+||..+|.+||++.++++.+.++..++.+
T Consensus       232 -------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~  274 (279)
T cd05057         232 -------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQR  274 (279)
T ss_pred             -------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcc
Confidence                   0111234578999999999999999999999999998766543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.8e-38  Score=318.64  Aligned_cols=262  Identities=24%  Similarity=0.394  Sum_probs=206.8

Q ss_pred             ChHHHHHhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEc
Q 042763          257 NMSQVVKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDK  334 (554)
Q Consensus       257 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~  334 (554)
                      ++.++....+.|+..+.||+|+||.||+|... +++.+|+|++....  ....++..|+.+++++ +||||+++++++..
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            34455556788999999999999999999764 58899999886543  2335688899999998 69999999999843


Q ss_pred             ------CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEE
Q 042763          335 ------GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAK  408 (554)
Q Consensus       335 ------~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vk  408 (554)
                            ++..+++|||+++|+|.+++.......+++..++.++.|++.||.|||   +.+++|+||+|+||++++++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence                  457799999999999999998765567888899999999999999999   89999999999999999999999


Q ss_pred             EEeecCcccCCCCCCCccccccccCCCCCcChhccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHH
Q 042763          409 VADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK-----TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTL  483 (554)
Q Consensus       409 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~  483 (554)
                      |+|||++.......   .......|++.|+|||.+.     +..++.++|||||||++|||++|..||....+.......
T Consensus       162 l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~  238 (282)
T cd06636         162 LVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI  238 (282)
T ss_pred             EeeCcchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence            99999987532111   1123356899999999885     346888999999999999999999999754432221111


Q ss_pred             HHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          484 RWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       484 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .       ..     ..+.   .....++..+.+++.+||+.||.+||++.||+++.|
T Consensus       239 ~-------~~-----~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~  281 (282)
T cd06636         239 P-------RN-----PPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF  281 (282)
T ss_pred             h-------hC-----CCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence            0       00     0000   011234567899999999999999999999998765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.2e-38  Score=311.93  Aligned_cols=254  Identities=27%  Similarity=0.441  Sum_probs=203.7

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--------hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--------ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE  337 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--------~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  337 (554)
                      +|.....||+|+||.||+|... +++.||+|.+.....        ....+.+.+|++++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4667789999999999999654 588999998764321        1233578899999999999999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .+++|||+++++|.+++...  ..+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||+++.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            99999999999999999764  56889999999999999999999   89999999999999999999999999999986


Q ss_pred             CCCCCCCc---cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          418 GPMDSDRT---HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       418 ~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      ........   .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.........   ...    ..  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~----~~--  226 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI---FKI----GE--  226 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH---HHH----hc--
Confidence            54221111   1112345889999999999888999999999999999999999999864332211   110    00  


Q ss_pred             ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       495 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                         ...+.    .+......+.+++.+||+.+|++||++.||+++.|
T Consensus       227 ---~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  266 (267)
T cd06628         227 ---NASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF  266 (267)
T ss_pred             ---cCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence               01111    12234567889999999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.4e-38  Score=327.59  Aligned_cols=259  Identities=20%  Similarity=0.271  Sum_probs=201.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|...+.||+|+||+||+++.. +++.||+|++.+...  ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999765 578999999876432  223355788999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++... ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999999753 246889999999999999999999   8999999999999999999999999999997643221


Q ss_pred             CCccccccccCCCCCcChhcccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKT-----YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                        ........||+.|+|||++.+     ..++.++||||||+++|||++|+.||......+....+.   .  ..... .
T Consensus       157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~---~--~~~~~-~  228 (331)
T cd05624         157 --TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---N--HEERF-Q  228 (331)
T ss_pred             --ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHH---c--CCCcc-c
Confidence              112233569999999999875     467899999999999999999999998654332211110   0  00000 0


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHHH
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRND--RPDMKSVGEQLWA  542 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~~  542 (554)
                       +.+..     .+++..+.+++.+|+..++++  |+++.++++|.|-
T Consensus       229 -~p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f  269 (331)
T cd05624         229 -FPSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF  269 (331)
T ss_pred             -CCCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCc
Confidence             01111     123456788899988865544  5789999988653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.7e-38  Score=311.97  Aligned_cols=255  Identities=23%  Similarity=0.366  Sum_probs=199.3

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh----hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc--CCce
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF----ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK--GNER  338 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~  338 (554)
                      .+|...+.||+|+||.||+|... ++..||+|++.....    ......+.+|+.++++++||||+++++++.+  +...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46888899999999999999664 589999998864321    2334568899999999999999999998865  3567


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      +++|||+++++|.+++...  ..+++...+.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            8999999999999999754  45889999999999999999999   899999999999999999999999999998754


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ..............++..|+|||.+.+..++.++||||||+++|||++|+.||..........      ......     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~------~~~~~~-----  225 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF------KIATQP-----  225 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH------HHhcCC-----
Confidence            321111111223458899999999998889999999999999999999999997543322211      110000     


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ..+.    .+......+.+++ +||..+|++||+++||++|.|
T Consensus       226 ~~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~  263 (266)
T cd06651         226 TNPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLRHPF  263 (266)
T ss_pred             CCCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcc
Confidence            0111    1222334455666 788899999999999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.2e-38  Score=318.45  Aligned_cols=268  Identities=24%  Similarity=0.345  Sum_probs=205.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ++|+..++||+|+||.||+|... +++.||+|++...... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36788899999999999999876 5899999988654332 234678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++++|.++....  ..+++.+++.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-  154 (286)
T cd07846          81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  154 (286)
T ss_pred             cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence            99998888876543  45899999999999999999999   8899999999999999999999999999987643221 


Q ss_pred             CccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC---------
Q 042763          424 RTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG---------  493 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---------  493 (554)
                        .......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+..........         
T Consensus       155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence              12233457889999998875 357889999999999999999999997655433222222211111000         


Q ss_pred             -----CccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          494 -----NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       494 -----~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                           ...+.............++..+.+++.+||+.+|++||++.+++++.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  285 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF  285 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence                 000000000000011234567899999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.4e-38  Score=317.93  Aligned_cols=265  Identities=21%  Similarity=0.325  Sum_probs=200.9

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +|+..+.||+|+||.||+|... +|+.||+|+++..... .....+.+|++++++++||||+++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778889999999999999765 6899999998754322 2235678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      ++ ++|.+++... ...+++..++.++.||++||.|||   +++++||||||+||+++.++.+||+|||+++......  
T Consensus        81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--  153 (284)
T cd07839          81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--  153 (284)
T ss_pred             CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence            95 6888887653 346899999999999999999999   8999999999999999999999999999997542211  


Q ss_pred             ccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC----------
Q 042763          425 THISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG----------  493 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~----------  493 (554)
                       .......+++.|+|||.+.+. .++.++|||||||++|||+||..|+.........  +..........          
T Consensus       154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH--HHHHHHHhCCCChHHhHHhhh
Confidence             112234578899999988764 4789999999999999999999987543332221  11111111000          


Q ss_pred             ----CccccCChhh-hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          494 ----NLLDMVDPSI-KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       494 ----~~~~~~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                          .......... ...........+.+++.+||+.||.+|||+.+++++.|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~  283 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY  283 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence                0000000000 01111234567889999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5e-38  Score=317.35  Aligned_cols=255  Identities=26%  Similarity=0.373  Sum_probs=203.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +.|++.++||+|+||.||+|... ++..||+|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            56888999999999999999775 48899999987653 33456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|..++... ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......   
T Consensus        91 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---  163 (292)
T cd06644          91 CPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT---  163 (292)
T ss_pred             CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc---
Confidence            9999998887643 246899999999999999999999   899999999999999999999999999998753211   


Q ss_pred             ccccccccCCCCCcChhccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          425 THISTKVKGTVGYLDPEYMK-----TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ........+++.|+|||++.     ...++.++|||||||++|||++|..||.........  ..     ......    
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~~-----~~~~~~----  232 (292)
T cd06644         164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LK-----IAKSEP----  232 (292)
T ss_pred             ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH--HH-----HhcCCC----
Confidence            11123345888999999884     345788999999999999999999999764432111  11     111000    


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                       +..  ..+..+...+.+++.+||+.+|++||++.+++++.|-
T Consensus       233 -~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  272 (292)
T cd06644         233 -PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV  272 (292)
T ss_pred             -ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence             000  0122344568899999999999999999999998764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-39  Score=330.79  Aligned_cols=246  Identities=22%  Similarity=0.304  Sum_probs=193.8

Q ss_pred             eeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhC---CCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKI---DHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       274 LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      ||+|+||+||+|... +++.||||++......  .....+..|..++.+.   +||||+++++++.+++..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999765 5899999999765332  2223455677777665   699999999999999999999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |+|.+++...  ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....   ...
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~---~~~  152 (330)
T cd05586          81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD---NKT  152 (330)
T ss_pred             ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC---CCC
Confidence            9999998754  57899999999999999999999   899999999999999999999999999998753221   112


Q ss_pred             cccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhh
Q 042763          428 STKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEV  506 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  506 (554)
                      .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........       ...+.. ...       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~-------i~~~~~-~~~-------  217 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN-------IAFGKV-RFP-------  217 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHH-------HHcCCC-CCC-------
Confidence            2345799999999998754 589999999999999999999999976543221111       111110 000       


Q ss_pred             ccHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHHHHHh
Q 042763          507 ISMEILTKMFGLAIQCAAPIRNDRP----DMKSVGEQLWAI  543 (554)
Q Consensus       507 ~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~~l~~i  543 (554)
                       .......+.+++.+||+.||++||    ++.++++|.|-.
T Consensus       218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~  257 (330)
T cd05586         218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA  257 (330)
T ss_pred             -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcccc
Confidence             012345678999999999999998    688998887643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.5e-38  Score=320.68  Aligned_cols=256  Identities=24%  Similarity=0.369  Sum_probs=207.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ..+|...+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            36889999999999999999975 46899999998754432 34668899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++++|.+++.+.   .+++.++..++.|++.||.|||   +.+++||||||+|||++.++.++|+|||++....... 
T Consensus        97 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-  169 (297)
T cd06656          97 YLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  169 (297)
T ss_pred             ccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-
Confidence            99999999998653   5788999999999999999999   8999999999999999999999999999987543221 


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                        .......+++.|+|||.+.+..++.++||||||+++|+|++|..||....+......   .   ...+      .+..
T Consensus       170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---~---~~~~------~~~~  235 (297)
T cd06656         170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---I---ATNG------TPEL  235 (297)
T ss_pred             --cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee---e---ccCC------CCCC
Confidence              112234688999999999988899999999999999999999999976443221110   0   0000      0000


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                        ..+......+.+++.+||+.+|++||++.+|+++.|--+
T Consensus       236 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (297)
T cd06656         236 --QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL  274 (297)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence              011234456789999999999999999999999877543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-38  Score=308.54  Aligned_cols=249  Identities=30%  Similarity=0.480  Sum_probs=200.9

Q ss_pred             eeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCHH
Q 042763          272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLR  351 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~  351 (554)
                      ++||+|+||.||++...+++.||+|.+...........+.+|++++++++||||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            36999999999999877799999999876654445578999999999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccc
Q 042763          352 EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV  431 (554)
Q Consensus       352 ~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~  431 (554)
                      +++... ...+++..++.++.+++.||+|||   +++++||||||+||+++.++.+||+|||++....... ........
T Consensus        81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~  155 (251)
T cd05041          81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI-YTVSDGLK  155 (251)
T ss_pred             HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCc-ceeccccC
Confidence            999654 236789999999999999999999   8999999999999999999999999999997532111 11111122


Q ss_pred             cCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHH
Q 042763          432 KGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISME  510 (554)
Q Consensus       432 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  510 (554)
                      .++..|+|||.+.+..++.++||||||+++|||++ |..||...........+.       ...  ..       ..+..
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-------~~~--~~-------~~~~~  219 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-------SGY--RM-------PAPQL  219 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-------cCC--CC-------CCCcc
Confidence            34567999999988889999999999999999999 888887654332221111       000  00       01123


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          511 ILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       511 ~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .+..+.+++.+||+.+|++||++.||++.|.
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            3457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.6e-38  Score=318.11  Aligned_cols=263  Identities=25%  Similarity=0.377  Sum_probs=206.3

Q ss_pred             ChHHHHHhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEc
Q 042763          257 NMSQVVKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDK  334 (554)
Q Consensus       257 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~  334 (554)
                      .+.++..+.++|...+.||+|+||.||++... +++.+|+|++....  .....+.+|+.+++++ +|||++++++++..
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            33456667889999999999999999999764 68899999986542  2245678899999999 89999999999865


Q ss_pred             C-----CceEEEEEeCCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcE
Q 042763          335 G-----NERLIITEFVPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRA  407 (554)
Q Consensus       335 ~-----~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v  407 (554)
                      .     +..++||||+++++|.++++..  ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence            3     3579999999999999988642  2457899999999999999999999   8999999999999999999999


Q ss_pred             EEEeecCcccCCCCCCCccccccccCCCCCcChhccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHH
Q 042763          408 KVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY-----QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVT  482 (554)
Q Consensus       408 kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~  482 (554)
                      ||+|||++.......   .......|+..|+|||.+...     .++.++|||||||++|||++|+.||...........
T Consensus       168 kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~  244 (291)
T cd06639         168 KLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK  244 (291)
T ss_pred             EEeecccchhccccc---ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH
Confidence            999999987643211   112234588999999988643     368899999999999999999999976543222111


Q ss_pred             HHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          483 LRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       483 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                             ..........+       .......+.+++.+||+.+|++||++.|++++.|
T Consensus       245 -------~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~  289 (291)
T cd06639         245 -------IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF  289 (291)
T ss_pred             -------HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence                   01111111111       1223456899999999999999999999998865

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.3e-38  Score=314.30  Aligned_cols=249  Identities=33%  Similarity=0.484  Sum_probs=198.0

Q ss_pred             eeeccCceEEEEEEEcC-------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          273 RIGEGGFGTVYKAQLED-------GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~-------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      .||+|+||.||+|...+       +..+|+|.+...........+.+|+++++.++||||+++++++...+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            58999999999997642       25799998866543344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccc-----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC-----cEEEEeecCc
Q 042763          346 PNGTLREHLDGQY-----GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM-----RAKVADFGFA  415 (554)
Q Consensus       346 ~~g~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-----~vkl~DfGla  415 (554)
                      ++++|.+++....     ...+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++     .++++|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999997532     234788999999999999999999   89999999999999999887     8999999998


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      +...... .........++..|+|||++.+..++.++||||||+++|||++ |+.||......+.   ....    ....
T Consensus       159 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~~----~~~~  230 (269)
T cd05044         159 RDIYKSD-YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQHV----TAGG  230 (269)
T ss_pred             ccccccc-ccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHHH----hcCC
Confidence            7543221 1111222345788999999999899999999999999999998 9999975433221   1111    1110


Q ss_pred             ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       495 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ..         ......+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            00         012234567889999999999999999999998875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.4e-38  Score=314.00  Aligned_cols=238  Identities=24%  Similarity=0.416  Sum_probs=188.4

Q ss_pred             eeeccCceEEEEEEEcC-------------------------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCcee
Q 042763          273 RIGEGGFGTVYKAQLED-------------------------GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK  327 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~-------------------------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~  327 (554)
                      +||+|+||.||+|....                         ...||+|++..... ....++.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence            59999999999986421                         13589998876543 34467889999999999999999


Q ss_pred             eeeEEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC--
Q 042763          328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM--  405 (554)
Q Consensus       328 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~--  405 (554)
                      +++++.++...++||||+++|+|..++... ...+++..++.++.|+++||+|||   +++|+||||||+|||++..+  
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcc
Confidence            999999999999999999999999998653 346889999999999999999999   89999999999999997654  


Q ss_pred             -----cEEEEeecCcccCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCChh
Q 042763          406 -----RAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEIL-TGRRPVELKRPPE  478 (554)
Q Consensus       406 -----~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~ell-tg~~P~~~~~~~~  478 (554)
                           .+|++|||++......       ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cCccceeeecCCccccccccc-------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                 3899999988642211       12347788999998865 56899999999999999995 6999997654432


Q ss_pred             hHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          479 ERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                      ....    ....  ..            .+......+.+++.+||+.+|++||++.+|++.|
T Consensus       230 ~~~~----~~~~--~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         230 KERF----YEKK--HR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHH----HHhc--cC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            2111    1100  00            0111224588999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-38  Score=309.45  Aligned_cols=255  Identities=26%  Similarity=0.357  Sum_probs=206.1

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|+..+.||+|+||.||+|... +++.+|+|.+...... ..+.+.+|++++++++||||+++++++..++..+++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            57888899999999999999765 5788999998765433 456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++... ...+++.++..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++......   
T Consensus        82 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~---  154 (262)
T cd06613          82 CGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT---  154 (262)
T ss_pred             CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhh---
Confidence            9999999998754 246889999999999999999999   899999999999999999999999999998754321   


Q ss_pred             ccccccccCCCCCcChhccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          425 THISTKVKGTVGYLDPEYMKTY---QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~---~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                      ........++..|+|||.+.+.   .++.++||||||+++|||++|+.||.............  .....        .+
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--~~~~~--------~~  224 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--KSNFP--------PP  224 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccCC--------Cc
Confidence            1122334688899999999776   78999999999999999999999998655332221111  00000        01


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                      .+.  .....+..+.+++.+||+.+|++||++.+|+.+-
T Consensus       225 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~  261 (262)
T cd06613         225 KLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP  261 (262)
T ss_pred             ccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence            110  1223456789999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.3e-38  Score=311.38  Aligned_cols=259  Identities=27%  Similarity=0.405  Sum_probs=208.5

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      +|+..+.||+|+||.||++... +++.+|+|++..........++.+|++++++++||||+++++++..++..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5777789999999999999776 589999999877654455677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE-KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      ++++|.+++.... ..+++..+..++.|++.||+|||   + .+++|+||||+||+++.++.++|+|||.+.......  
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--  155 (265)
T cd06605          82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--  155 (265)
T ss_pred             CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH--
Confidence            9999999997643 57889999999999999999999   7 999999999999999999999999999987532111  


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                         .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......... ... ........     .+.+ 
T Consensus       156 ---~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~-~~~~~~~~-----~~~~-  224 (265)
T cd06605         156 ---AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-FEL-LQYIVNEP-----PPRL-  224 (265)
T ss_pred             ---hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH-HHH-HHHHhcCC-----CCCC-
Confidence               112568899999999999899999999999999999999999997543211110 111 11111110     0000 


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                        ........+.+++.+||..+|++||++.+++.+.|-.+
T Consensus       225 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         225 --PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             --ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence              01114566899999999999999999999999988643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.4e-38  Score=310.63  Aligned_cols=255  Identities=22%  Similarity=0.329  Sum_probs=200.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhh----hhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC--Cce
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQ----FENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG--NER  338 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~  338 (554)
                      .+|...+.||+|+||.||+|... +|..||+|.+....    .....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57888999999999999999765 58999999875322    122346788999999999999999999988663  457


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      +++|||+++++|.+++...  ..+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            8999999999999998754  45788999999999999999999   899999999999999999999999999998754


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ..............++..|+|||.+.+..++.++||||||+++|||++|+.||.........   ...   ....     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~---~~~~-----  225 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI---FKI---ATQP-----  225 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH---HHH---hcCC-----
Confidence            32111111123346889999999998888999999999999999999999999754322211   111   0000     


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ..+    ..+......+.+++.+|+. +|++||++++|+++.|
T Consensus       226 ~~~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~  263 (265)
T cd06652         226 TNP----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF  263 (265)
T ss_pred             CCC----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence            011    1233445667888999985 9999999999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.8e-38  Score=310.16  Aligned_cols=251  Identities=29%  Similarity=0.477  Sum_probs=202.0

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      .+|+..+.||+|+||.||++...++..+|+|.+......  ...+.+|++++++++|||++++++++......++||||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            457778899999999999998877889999988754332  356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ++++|.+++.... ..+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  155 (256)
T cd05112          82 EHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ--Y  155 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc--c
Confidence            9999999987543 35789999999999999999999   8999999999999999999999999999987543211  1


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||.........   ...    ...  .....+.  
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---~~~----~~~--~~~~~~~--  224 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV---ETI----NAG--FRLYKPR--  224 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH---HHH----hCC--CCCCCCC--
Confidence            11122335678999999998889999999999999999998 99999754432211   111    110  0111111  


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                           ..+..+.+++.+||+.+|++||++.+++++|
T Consensus       225 -----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         225 -----LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -----CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                 1235688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.4e-38  Score=314.41  Aligned_cols=264  Identities=23%  Similarity=0.346  Sum_probs=206.1

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +|+..+.||+|+||.||+|... +|..||+|++..... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778889999999999999764 689999999876543 33456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      + +++|.+++.... ..+++.+++.++.||+.||+|||   +.+++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-  154 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence            9 999999987543 56899999999999999999999   89999999999999999999999999999986533221 


Q ss_pred             ccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC---------
Q 042763          425 THISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN---------  494 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---------  494 (554)
                       .......++..|+|||.+.+. .++.++||||||+++|||++|.+||.........   .+.........         
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHHHhhccC
Confidence             122334689999999988654 4689999999999999999998888654432221   11111111100         


Q ss_pred             ---ccccC----Ch-hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          495 ---LLDMV----DP-SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       495 ---~~~~~----d~-~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                         .....    .+ .+.. ...+....+.+++.+||+.+|++||++++++.|.|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~  284 (286)
T cd07832         231 LPDYNKITFPESKPIPLEE-IFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY  284 (286)
T ss_pred             cchhhcccCCCCCcchHHH-hCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence               00000    00 1111 11234578899999999999999999999999865

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.4e-38  Score=311.00  Aligned_cols=238  Identities=23%  Similarity=0.394  Sum_probs=188.6

Q ss_pred             eeeccCceEEEEEEEcC-------------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          273 RIGEGGFGTVYKAQLED-------------GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~-------------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      .||+|+||.||+|...+             ...||+|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            58999999999997532             2358899877654 334567889999999999999999999999989999


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc-------EEEEee
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR-------AKVADF  412 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~-------vkl~Df  412 (554)
                      +||||+++++|..++..+ ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.       ++++||
T Consensus        81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            999999999999988654 246899999999999999999999   899999999999999987664       899999


Q ss_pred             cCcccCCCCCCCccccccccCCCCCcChhccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCChhhHHHHHHHHHhh
Q 042763          413 GFARLGPMDSDRTHISTKVKGTVGYLDPEYMK-TYQLTTKSDVYSFGVLLLEIL-TGRRPVELKRPPEERVTLRWAFKRY  490 (554)
Q Consensus       413 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvil~ell-tg~~P~~~~~~~~~~~~~~~~~~~~  490 (554)
                      |++.....       .....++..|+|||.+. +..++.++||||||+++|||+ +|..||......+..    ..    
T Consensus       157 g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~----~~----  221 (262)
T cd05077         157 GIPITVLS-------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE----RF----  221 (262)
T ss_pred             CCCccccC-------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH----HH----
Confidence            99865321       12235788999999886 467899999999999999998 588887654322111    00    


Q ss_pred             ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                      ..... ...         ......+.+++.+||+.||++||++.+|++.+
T Consensus       222 ~~~~~-~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         222 YEGQC-MLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HhcCc-cCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            01100 011         11234678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.1e-37  Score=317.12  Aligned_cols=266  Identities=21%  Similarity=0.297  Sum_probs=208.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|+..+.||+|+||.||++... +++.||+|.+.....  ......+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888899999999999999765 478999999876543  233457889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++++|.+++...  ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++......
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            999999999999765  46899999999999999999999   8999999999999999999999999999987421111


Q ss_pred             CC------------ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhh
Q 042763          423 DR------------THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY  490 (554)
Q Consensus       423 ~~------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  490 (554)
                      ..            ........++..|+|||.+.+..++.++||||||+++|||++|..||......+...       ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~-------~~  228 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG-------QV  228 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HH
Confidence            00            011122457889999999988889999999999999999999999997544322111       11


Q ss_pred             ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHHHhhhhhhhh
Q 042763          491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPD---MKSVGEQLWAIRADSLKS  550 (554)
Q Consensus       491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~l~~i~~~~~~~  550 (554)
                      .....   ..+..    ....+..+.+++.+||+.+|++||+   +.+++++.|-....+...
T Consensus       229 ~~~~~---~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~  284 (305)
T cd05609         229 ISDDI---EWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGL  284 (305)
T ss_pred             Hhccc---CCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHH
Confidence            10000   01110    1123456889999999999999998   688888877655444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.9e-38  Score=313.16  Aligned_cols=256  Identities=27%  Similarity=0.437  Sum_probs=204.5

Q ss_pred             cCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      ++|+....||+|+||.||+|..+      +.+.|++|.+..........++.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888889999999999999754      246799998876554445678999999999999999999999999989999


Q ss_pred             EEEEeCCCCCHHHHHhcccC-------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEee
Q 042763          340 IITEFVPNGTLREHLDGQYG-------KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADF  412 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df  412 (554)
                      +||||+++|+|.+++.....       ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999976542       25899999999999999999999   899999999999999999999999999


Q ss_pred             cCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhc
Q 042763          413 GFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYN  491 (554)
Q Consensus       413 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  491 (554)
                      |+++.....  .........++..|+|||.+.+..++.++||||||+++|+|++ |..||........   +..    ..
T Consensus       162 ~~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~~~----~~  232 (275)
T cd05046         162 SLSKDVYNS--EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---LNR----LQ  232 (275)
T ss_pred             ccccccCcc--cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---HHH----HH
Confidence            998753211  1112223346778999999988888999999999999999999 8888864332211   111    11


Q ss_pred             cCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          492 EGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       492 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .......        ....++..+.+++.+||+.+|++||++.|++.+++
T Consensus       233 ~~~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         233 AGKLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             cCCcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1111100        11123456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.8e-37  Score=307.47  Aligned_cols=256  Identities=26%  Similarity=0.410  Sum_probs=211.2

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|+..+.||+|++|.||+|... +++.||||++...........+.+|++.+.+++|+||+++++++..++..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36788899999999999999776 48999999987765434467899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE-KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      +++++|.+++...  ..+++..++.++.|+++||+|||   + .+++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999999999765  57899999999999999999999   8 9999999999999999999999999999986432221


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      .   .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.............+..    ....     +. 
T Consensus       156 ~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~-----~~-  222 (264)
T cd06623         156 Q---CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPP-----PS-  222 (264)
T ss_pred             c---ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCC-----CC-
Confidence            1   123458899999999999899999999999999999999999998665322222222211    1110     00 


Q ss_pred             hhhccHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          504 KEVISME-ILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       504 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                         .... ++..+.+++.+||+.+|++||++.+++++.|-
T Consensus       223 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~  259 (264)
T cd06623         223 ---LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFI  259 (264)
T ss_pred             ---CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHH
Confidence               1222 45678999999999999999999999998664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=6.3e-38  Score=314.96  Aligned_cols=267  Identities=24%  Similarity=0.352  Sum_probs=203.8

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +|+..+.||+|+||.||+|... +|+.||||++..... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778889999999999999765 689999998875432 22335788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +. ++|.+++.......+++..++.++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||++.......  
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--  154 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  154 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence            95 78999997765667899999999999999999999   8999999999999999999999999999987543211  


Q ss_pred             ccccccccCCCCCcChhccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhcc-----------
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQ-LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE-----------  492 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-----------  492 (554)
                       .......+++.|+|||.+.+.. ++.++||||||+++|||+||+.||.....................           
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence             1122334688999999887644 688999999999999999999999765433222111110000000           


Q ss_pred             --CCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          493 --GNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       493 --~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                        .............. .......+.+++.+||+.||++||++++++.+.|
T Consensus       234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~  283 (284)
T cd07860         234 YKPSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF  283 (284)
T ss_pred             HHhhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence              00000001111111 1123456789999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=320.02  Aligned_cols=251  Identities=21%  Similarity=0.343  Sum_probs=213.8

Q ss_pred             cCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhH-HHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENL-QTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .-|...+.||+|.|+.|-+|++ -+|..||||++.+.+.+.. ...+.+|+..|+.++|||||+||.+..+...+|+|+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            3466677899999999999954 3799999999998776543 3568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE-CCCCcEEEEeecCcccCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL-TESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl-~~~~~vkl~DfGla~~~~~~~  422 (554)
                      .-++|+|.+|+.++ ...+.+..+.+++.||+.|+.|+|   ...+|||||||+||.+ ..-|-|||+|||++..+.   
T Consensus        98 LGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~---  170 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ---  170 (864)
T ss_pred             ecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCC---
Confidence            99999999999876 357899999999999999999999   8999999999999866 567899999999997542   


Q ss_pred             CCccccccccCCCCCcChhccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLT-TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s-~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                       .....+..||+..|-|||++.+..|+ ++.||||||||||-|+.|+.||+.....+....+.       .+.       
T Consensus       171 -PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm-------DCK-------  235 (864)
T KOG4717|consen  171 -PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM-------DCK-------  235 (864)
T ss_pred             -CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh-------ccc-------
Confidence             33445678999999999999998886 68999999999999999999999766554432221       111       


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                         .-++.....++.+||..||..||.+|.+.+||...-|
T Consensus       236 ---YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W  272 (864)
T KOG4717|consen  236 ---YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW  272 (864)
T ss_pred             ---ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence               1256677888999999999999999999999998877

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-38  Score=314.57  Aligned_cols=269  Identities=22%  Similarity=0.309  Sum_probs=208.1

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ++|+..++||+|+||.||+|... +++.||+|+++.... ....+.+.+|++++++++|+||+++++++..++..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999766 588999998876432 2334678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |++++.+..+....  ..+++.++..++.|++.||+|||   ..+++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            99887776655433  45899999999999999999999   88999999999999999999999999999886443221


Q ss_pred             CccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhcc---------C
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE---------G  493 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---------~  493 (554)
                        .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+..............         .
T Consensus       156 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         156 --SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             --ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence              122335678899999999887 8899999999999999999999999865443322222211111000         0


Q ss_pred             -----CccccCCh-hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          494 -----NLLDMVDP-SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       494 -----~~~~~~d~-~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                           ...+..++ .....++..++..+.+++.+||+.+|++||++++++.+-|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  287 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY  287 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence                 00011111 1111222334678999999999999999999999988754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-37  Score=307.86  Aligned_cols=252  Identities=34%  Similarity=0.527  Sum_probs=203.1

Q ss_pred             CCcceeeeccCceEEEEEEEcC-----CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          268 FSPSLRIGEGGFGTVYKAQLED-----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~~-----g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      |++.+.||+|+||.||++...+     +..||+|++...........+..|+++++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3456789999999999997753     38899999977654445678999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++++|.+++.......+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||+++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            9999999999998654333899999999999999999999   8999999999999999999999999999998654321


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                      ..  ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........   .....    ......    
T Consensus       158 ~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~~----~~~~~~----  224 (258)
T smart00219      158 YY--KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LEYLK----KGYRLP----  224 (258)
T ss_pred             cc--ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHh----cCCCCC----
Confidence            11  1112337789999999988889999999999999999998 7888876333221   11111    111100    


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                           .....+..+.+++.+|++.+|++|||+.++++.|
T Consensus       225 -----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 -----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                 1112456788999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.1e-38  Score=318.25  Aligned_cols=262  Identities=25%  Similarity=0.421  Sum_probs=205.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCc----EEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGL----LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      ..+|+..+.||+|+||.||+|... +|.    .||+|.+..........++.+|+.++++++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356778889999999999999653 444    57899887654444455789999999999999999999998754 567


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +++||+++|+|.+++... ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++...
T Consensus        85 ~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccccccc
Confidence            999999999999998754 235789999999999999999999   8999999999999999999999999999998643


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.........   .+..    ....  .
T Consensus       161 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~---~~~~----~~~~--~  230 (303)
T cd05110         161 GDEKE-YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP---DLLE----KGER--L  230 (303)
T ss_pred             Ccccc-cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHH----CCCC--C
Confidence            22211 11222345778999999998899999999999999999998 99999754322211   1111    1000  0


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                      .       ....+...+.+++.+||..+|++||++.++++.++++..+..
T Consensus       231 ~-------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         231 P-------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             C-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence            0       011123467899999999999999999999999999876654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.3e-38  Score=309.54  Aligned_cols=251  Identities=26%  Similarity=0.408  Sum_probs=205.1

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +|+..+.||+|+||.||++... +++.+|+|++..... ......+.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4778889999999999999664 688999999876532 23456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC-CcEEEEeecCcccCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES-MRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkl~DfGla~~~~~~~~  423 (554)
                      +++++|.+++.......+++..+..++.|++.||+|||   +++++|+||+|+||+++.+ +.+||+|||++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999998765667899999999999999999999   8999999999999999865 468999999998643221 


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                         ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..........   ...    ......      
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~---~~~----~~~~~~------  220 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL---KIM----SGTFAP------  220 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH---HHH----hcCCCC------
Confidence               1223468899999999998889999999999999999999999997654432211   111    011001      


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                         .+......+.+++.+||+.+|++|||+.|++++.
T Consensus       221 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p  254 (256)
T cd08220         221 ---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP  254 (256)
T ss_pred             ---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCC
Confidence               1112445688999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-37  Score=309.54  Aligned_cols=258  Identities=22%  Similarity=0.425  Sum_probs=205.4

Q ss_pred             CCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh-----hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF-----ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      +|+..+.||+|+||.||++.. .+++.||+|++.....     ....+.+.+|++++++++|+||+++++++.+++..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477788999999999999965 5689999998865331     1234678999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC-cEEEEeecCcccCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGP  419 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~~  419 (554)
                      ||||+++++|.+++...  ..+++..++.++.|++.||+|||   +++++|+||+|+||+++.++ .+||+|||.+....
T Consensus        81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99999999999999754  46889999999999999999999   89999999999999998776 59999999987654


Q ss_pred             CCCCC-ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          420 MDSDR-THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       420 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ..... ........++..|+|||.+.+..++.++||||||+++|+|++|..||.....................      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  229 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA------  229 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC------
Confidence            32111 11122346889999999998888999999999999999999999999754432222111111100000      


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                        +    ..+......+.+++.+||+.+|++||++.+++.+.|
T Consensus       230 --~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~  266 (268)
T cd06630         230 --P----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPV  266 (268)
T ss_pred             --C----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence              0    123345567889999999999999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-38  Score=313.39  Aligned_cols=257  Identities=29%  Similarity=0.419  Sum_probs=204.3

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCC----
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGN----  336 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~----  336 (554)
                      ...++|+..+.||+|+||.||+|... +++.+++|++.....  ..+.+.+|+++++++ +|+||+++++++....    
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            34678999999999999999999775 578999999876542  246789999999999 6999999999996644    


Q ss_pred             --ceEEEEEeCCCCCHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEee
Q 042763          337 --ERLIITEFVPNGTLREHLDGQY--GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADF  412 (554)
Q Consensus       337 --~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df  412 (554)
                        ..++||||+++++|.+++....  ...+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCC
Confidence              4799999999999999987543  457899999999999999999999   899999999999999999999999999


Q ss_pred             cCcccCCCCCCCccccccccCCCCCcChhcccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 042763          413 GFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-----YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF  487 (554)
Q Consensus       413 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~  487 (554)
                      |++......   ........|+..|+|||.+..     ..++.++||||||+++|+|++|+.||...........   . 
T Consensus       158 ~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~-  230 (275)
T cd06608         158 GVSAQLDST---LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK---I-  230 (275)
T ss_pred             ccceecccc---hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH---h-
Confidence            998754321   112233458899999998753     3477899999999999999999999975433221111   0 


Q ss_pred             HhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          488 KRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                         .....     +.+.  ........+.+++.+||..||++|||+.+++++.|
T Consensus       231 ---~~~~~-----~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~  274 (275)
T cd06608         231 ---PRNPP-----PTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF  274 (275)
T ss_pred             ---hccCC-----CCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence               01000     0110  11235567899999999999999999999998765

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-37  Score=308.11  Aligned_cols=237  Identities=25%  Similarity=0.426  Sum_probs=189.8

Q ss_pred             eeeeccCceEEEEEEEcC-C----------cEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          272 LRIGEGGFGTVYKAQLED-G----------LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~~-g----------~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      +.||+|+||.||+|...+ +          ..+++|.+......  ...+.+|+.++++++||||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            368999999999997764 3          25788877655322  5778999999999999999999999988 77899


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC-------cEEEEeec
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM-------RAKVADFG  413 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-------~vkl~DfG  413 (554)
                      ||||+++|+|.+++.... ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++       .+||+|||
T Consensus        78 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          78 VEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999999997653 26889999999999999999999   89999999999999999888       79999999


Q ss_pred             CcccCCCCCCCccccccccCCCCCcChhccccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhh
Q 042763          414 FARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY--QLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRY  490 (554)
Q Consensus       414 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  490 (554)
                      ++.....       .....++..|+|||++.+.  .++.++||||||+++|||++ |..||..........   +. .  
T Consensus       154 ~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~-~--  220 (259)
T cd05037         154 IPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FY-Q--  220 (259)
T ss_pred             ccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HH-h--
Confidence            9975322       1223467789999999876  78999999999999999999 577776554221111   10 0  


Q ss_pred             ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                       ......  .         .....+.+++.+||+.+|++||++.+|++.|
T Consensus       221 -~~~~~~--~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         221 -DQHRLP--M---------PDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             -cCCCCC--C---------CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence             000000  0         0115788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=312.98  Aligned_cols=250  Identities=27%  Similarity=0.399  Sum_probs=210.4

Q ss_pred             CCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          267 NFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      -|.+..+||+|+||.||+|.+ ..|+.+|||.+....   ..+++..|+.+|++.+.|++|+++|.|.....+++|||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            366778999999999999955 469999999887653   3578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      .-|++.+.++.+ .+++.+.++..++...++||+|||   ...-+|||||..|||++.+|..||+|||.|-.+.   +..
T Consensus       111 GAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT---DTM  183 (502)
T KOG0574|consen  111 GAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT---DTM  183 (502)
T ss_pred             CCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhh---hhH
Confidence            999999999765 578999999999999999999999   6778999999999999999999999999997643   233


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE  505 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  505 (554)
                      .....+.|||.|||||++..-.|+.++||||||++..||.-|++||....+-....       ...     ....|..+ 
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-------MIP-----T~PPPTF~-  250 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-------MIP-----TKPPPTFK-  250 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-------ecc-----CCCCCCCC-
Confidence            33456789999999999999999999999999999999999999998544321110       000     11112211 


Q ss_pred             hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          506 VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       506 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                       .+.+.+..+-+++++||-..|++|-|+.++++|.
T Consensus       251 -KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  251 -KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             -ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence             3456678899999999999999999999999984

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-37  Score=311.15  Aligned_cols=258  Identities=26%  Similarity=0.455  Sum_probs=202.8

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh---------hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF---------ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN  336 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---------~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  336 (554)
                      +|...+.||+|+||.||+|... +|+.||+|.++....         ....+.+.+|+.++++++|||++++++++..++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667789999999999999654 689999998754211         112356888999999999999999999999999


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||   +++++||||+|+||+++.++.++|+|||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            999999999999999999765  57889999999999999999999   8999999999999999999999999999997


Q ss_pred             cCCCCCCCccccccccCCCCCcChhccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ--LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      ...... .........|+..|+|||.+....  ++.++||||||+++|||++|..||.........      .... ...
T Consensus       157 ~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~-~~~  228 (272)
T cd06629         157 KSDDIY-DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM------FKLG-NKR  228 (272)
T ss_pred             cccccc-cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH------HHhh-ccc
Confidence            643211 111223456889999999987654  889999999999999999999999643322111      1111 111


Q ss_pred             ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       495 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .....+..    ....++..+.+++.+||+.+|++||++.+|+++.|
T Consensus       229 ~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  271 (272)
T cd06629         229 SAPPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQHPF  271 (272)
T ss_pred             cCCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence            11111111    22234567899999999999999999999998865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.2e-38  Score=318.31  Aligned_cols=252  Identities=25%  Similarity=0.407  Sum_probs=201.8

Q ss_pred             CCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCC
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVP  346 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  346 (554)
                      |.....||+|+||.||++... ++..||||.+.... ....+.+.+|+.++++++||||+++++.+..++..++||||++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            333457999999999999764 58899999886543 2335678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcc
Q 042763          347 NGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH  426 (554)
Q Consensus       347 ~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~  426 (554)
                      +++|.+++...   .+++.++..++.||+.||+|||   +++++||||||+||+++.++.++|+|||++.......   .
T Consensus       103 ~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~---~  173 (292)
T cd06658         103 GGALTDIVTHT---RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV---P  173 (292)
T ss_pred             CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc---c
Confidence            99999988543   5889999999999999999999   8899999999999999999999999999987543221   1


Q ss_pred             ccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhh
Q 042763          427 ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEV  506 (554)
Q Consensus       427 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  506 (554)
                      ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.............    ...        .+...  
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~----~~~--------~~~~~--  239 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR----DNL--------PPRVK--  239 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hcC--------CCccc--
Confidence            1223468899999999988889999999999999999999999998654322211111    000        11100  


Q ss_pred             ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          507 ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       507 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      ........+.+++.+||+.+|++|||+.+++++.|-.
T Consensus       240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~  276 (292)
T cd06658         240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK  276 (292)
T ss_pred             cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhh
Confidence            0112344678899999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.4e-38  Score=349.22  Aligned_cols=259  Identities=20%  Similarity=0.336  Sum_probs=200.6

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc--CCceE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK--GNERL  339 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~  339 (554)
                      ..++|.+.++||+|+||+||+|... ++..||+|.+..... ......+..|+.++++|+||||++++++|..  ....+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3468999999999999999999765 578899998875432 2345678999999999999999999998854  35689


Q ss_pred             EEEEeCCCCCHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHhhhcc----CCCeEeCCCCCCCeEECC----------
Q 042763          340 IITEFVPNGTLREHLDGQY--GKTLDFNQRLEIAIDVAHGLTYLHLYA----EKQIIHRDVKSSNILLTE----------  403 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~----~~~ivH~Dlkp~NILl~~----------  403 (554)
                      +||||+++|+|.++|....  ...+++..++.|+.||+.||.|||...    ..+|+||||||+|||++.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999999999999997532  346899999999999999999999421    146999999999999964          


Q ss_pred             -------CCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhcccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 042763          404 -------SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT--YQLTTKSDVYSFGVLLLEILTGRRPVELK  474 (554)
Q Consensus       404 -------~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvil~elltg~~P~~~~  474 (554)
                             .+.+||+|||+++.....    .......||+.|+|||++.+  ..++.++|||||||+||||++|+.||...
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~----s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIE----SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccCCCCceEEccCCcccccccc----ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                   335899999999764321    12234569999999999854  45899999999999999999999999754


Q ss_pred             CChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          475 RPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       475 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .......  .    .......     .     .....+..+.+||.+||+.+|.+||++.|++.+.|-
T Consensus       247 ~~~~qli--~----~lk~~p~-----l-----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i  298 (1021)
T PTZ00266        247 NNFSQLI--S----ELKRGPD-----L-----PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQII  298 (1021)
T ss_pred             CcHHHHH--H----HHhcCCC-----C-----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence            4322211  1    1111100     0     001234568899999999999999999999976553

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.4e-37  Score=308.60  Aligned_cols=253  Identities=21%  Similarity=0.322  Sum_probs=191.1

Q ss_pred             eeeccCceEEEEEEEcCC---cEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCC
Q 042763          273 RIGEGGFGTVYKAQLEDG---LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGT  349 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~g---~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~  349 (554)
                      +||+|+||+||+|...++   ..+++|.+.........+.+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999965433   35667776655434456789999999999999999999999999999999999999999


Q ss_pred             HHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          350 LREHLDGQY--GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       350 L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |.+++....  ....++..++.++.||+.||+|||   +.+++||||||+|||++.++.+||+|||++...... .....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~  157 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIET  157 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcc-hhhhc
Confidence            999997642  234667778899999999999999   899999999999999999999999999998642211 11112


Q ss_pred             cccccCCCCCcChhcccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          428 STKVKGTVGYLDPEYMKT-------YQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      .....++..|+|||++..       ..++.++||||||+++|||++ |..||......+..   ....    ........
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~---~~~~----~~~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL---NHVI----KDQQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHH----hhcccccC
Confidence            234568899999998753       245789999999999999997 56787654332211   1111    11112223


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ++.+..    .....+.+++..|| .+|++||++.+|++.|.
T Consensus       231 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            333222    23356788999999 57999999999988763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.3e-37  Score=310.73  Aligned_cols=262  Identities=27%  Similarity=0.374  Sum_probs=206.0

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC--CceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG--NERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~lv~  342 (554)
                      ++|...++||.|++|.||++... +++.+|+|.+...........+.+|++++++++||||+++++++...  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999775 58899999987654444567799999999999999999999988543  4679999


Q ss_pred             EeCCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          343 EFVPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       343 E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||+++++|.+++...  ....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999987642  2346788999999999999999999   89999999999999999999999999999875322


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCh--hhHHHHHHHHHhhccCCcccc
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP--EERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ..     .....++..|+|||.+.+..++.++||||||+++|+|++|..||......  .......+... ...   ...
T Consensus       158 ~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~---~~~  228 (287)
T cd06621         158 SL-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPN---PEL  228 (287)
T ss_pred             cc-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCc---hhh
Confidence            11     12345788999999999889999999999999999999999999865321  11111222111 000   000


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                       .....  ........+.+++.+||+.+|++|||+.||+++.|-
T Consensus       229 -~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~  269 (287)
T cd06621         229 -KDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI  269 (287)
T ss_pred             -ccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence             00000  011235678999999999999999999999998875

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.3e-37  Score=313.99  Aligned_cols=270  Identities=23%  Similarity=0.309  Sum_probs=202.4

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++.+|...+.||+|+||.||+|... +|..||+|++...........+.+|+++++.++|+||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578899999999999999999654 688999999876543333456788999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+. ++|.+++.... ..+.+.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++......
T Consensus        83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9995 78888775432 45788889999999999999999   8899999999999999999999999999987532211


Q ss_pred             CCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC--------
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG--------  493 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--------  493 (554)
                         .......+++.|+|||.+.+. .++.++||||||+++|||++|..||.......+...-.|........        
T Consensus       158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         158 ---QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             ---CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence               112233578999999998764 57899999999999999999999998655432221111110000000        


Q ss_pred             --Ccc-c----cCChhhhhhc-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          494 --NLL-D----MVDPSIKEVI-SMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       494 --~~~-~----~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                        ... .    .....+.... .......+.+++.+|++.||++|||+.|++.+.|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~  290 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY  290 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence              000 0    0000000000 0011356789999999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-39  Score=331.48  Aligned_cols=254  Identities=24%  Similarity=0.413  Sum_probs=213.6

Q ss_pred             ceeeeccCceEEEEEEEc--CC--cEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCC
Q 042763          271 SLRIGEGGFGTVYKAQLE--DG--LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVP  346 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~--~g--~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  346 (554)
                      .++||+|.||.|++|.|.  +|  ..||||.++.........+|++|+.+|.+|+|||+++|||+..+ ....+|||.++
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap  193 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP  193 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence            457999999999999775  34  46899999887765567899999999999999999999999987 77889999999


Q ss_pred             CCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcc
Q 042763          347 NGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH  426 (554)
Q Consensus       347 ~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~  426 (554)
                      .|+|.+.|++.....+-......++.|||.|+.||.   .+++|||||..+|+|+-..-.|||+|||+.+-++...+...
T Consensus       194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv  270 (1039)
T KOG0199|consen  194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV  270 (1039)
T ss_pred             cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence            999999999855667888888899999999999999   99999999999999999999999999999998876666655


Q ss_pred             ccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhh
Q 042763          427 ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE  505 (554)
Q Consensus       427 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  505 (554)
                      +.....-...|.|||.++...++.++|||+|||++|||+| |..||.+........                .+|..-+-
T Consensus       271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~----------------~iD~~erL  334 (1039)
T KOG0199|consen  271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK----------------NIDAGERL  334 (1039)
T ss_pred             ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH----------------hccccccC
Confidence            5555566778999999999999999999999999999999 899998755432211                11111111


Q ss_pred             hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          506 VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       506 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      .-+..|++++++++.+||..+|++|||+..|.+.+-..+
T Consensus       335 pRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            134568889999999999999999999999986654433

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.4e-38  Score=309.38  Aligned_cols=246  Identities=32%  Similarity=0.531  Sum_probs=199.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      ++|.+.+.||+|+||.||++.. +++.||+|.++...   ..+.+.+|+.++++++|||++++++++..+ ..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            4578888999999999999975 47889999886542   235788999999999999999999998764 579999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ++++|.+++.......+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......    
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            9999999998765557899999999999999999999   899999999999999999999999999998753211    


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                        ......+..|+|||.+.+..++.++||||||+++|||++ |+.||......+.....       .....   .+    
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~~---~~----  217 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-------EKGYR---ME----  217 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-------hCCCC---CC----
Confidence              112234568999999988899999999999999999998 99999765443221111       11100   00    


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                        ....++..+.+++.+||+.+|++||++.+|++.+.
T Consensus       218 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         218 --PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             --CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence              11223456789999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.6e-37  Score=309.69  Aligned_cols=253  Identities=28%  Similarity=0.396  Sum_probs=206.0

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      -|+..++||+|+||.||+|... ++..||+|.+...........+.+|+.++++++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3667788999999999999654 688999998876544445567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ++++|.+++...   .+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++......   .
T Consensus        85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~---~  155 (277)
T cd06641          85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---Q  155 (277)
T ss_pred             CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccc---h
Confidence            999999998643   6889999999999999999999   899999999999999999999999999998754321   1


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE  505 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  505 (554)
                      .......++..|+|||.+.+..++.++||||||+++|+|++|..||.........   ..    ......     +.   
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~----~~~~~~-----~~---  220 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL---FL----IPKNNP-----PT---  220 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH---HH----HhcCCC-----CC---
Confidence            1122345888999999998888999999999999999999999999754322111   11    111100     11   


Q ss_pred             hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          506 VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       506 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                       ....++..+.+++.+||+.+|++||++.+++++.|-.+
T Consensus       221 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~  258 (277)
T cd06641         221 -LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR  258 (277)
T ss_pred             -CCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence             12234456889999999999999999999999866544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.7e-37  Score=314.15  Aligned_cols=267  Identities=24%  Similarity=0.296  Sum_probs=204.4

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh----hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE----NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      +|+..+.||+|+||.||+|... +|+.||||+++.....    .....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999765 6899999998765432    2335577899999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+ +++|.+++.... ..+++..++.++.||++||.|||   +++++|+||||+||+++.++.++|+|||+++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 999999997653 36899999999999999999999   899999999999999999999999999999864332


Q ss_pred             CCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC------C
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG------N  494 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~------~  494 (554)
                      .   .......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||......+...............      .
T Consensus       156 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         156 N---RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             C---ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence            1   11222346788999998854 467899999999999999999988887655432221111100000000      0


Q ss_pred             cccc------CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          495 LLDM------VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       495 ~~~~------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ....      ....... ........+.+++.+||+.+|++|||+.|++++-|-
T Consensus       233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~  285 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF  285 (298)
T ss_pred             ccccccccccCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccc
Confidence            0000      0011111 112345678999999999999999999999998663

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.1e-37  Score=310.99  Aligned_cols=267  Identities=22%  Similarity=0.339  Sum_probs=205.4

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      +|+..++||+|++|.||+|... +|..||||+++..........+.+|++++++++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999875 589999999876543333456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          346 PNGTLREHLDGQY-GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       346 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      + ++|.+++.... ...+++.++..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||+++.....   
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~---  153 (284)
T cd07836          81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---  153 (284)
T ss_pred             C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC---
Confidence            7 58998886543 246899999999999999999999   889999999999999999999999999999753221   


Q ss_pred             ccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhcc---------CC
Q 042763          425 THISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE---------GN  494 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---------~~  494 (554)
                      ........++..|++||.+.+. .++.++||||||+++|+|++|+.||......+.............+         ..
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence            1112234578899999988654 5789999999999999999999999876654332222111100000         00


Q ss_pred             c----cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          495 L----LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       495 ~----~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .    ....+... ....+.....+.+++.+|++.+|++||++.+++++.|
T Consensus       234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~  283 (284)
T cd07836         234 YKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW  283 (284)
T ss_pred             hcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence            0    00001111 1112234567899999999999999999999998754

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-37  Score=335.92  Aligned_cols=271  Identities=19%  Similarity=0.212  Sum_probs=192.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC--CcEEEEE--------------Ecchh--hhhhHHHHHHHHHHHHHhCCCCCce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED--GLLVAIK--------------RAKKE--QFENLQTEFSSEVELLSKIDHRNLV  326 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~--g~~vAvK--------------~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv  326 (554)
                      ..+|++.++||+|+||+||++..+.  +..+++|              .+.+.  ........+.+|+.+|++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4689999999999999999986542  2222222              11111  0122345688999999999999999


Q ss_pred             eeeeEEEcCCceEEEEEeCCCCCHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC
Q 042763          327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQY---GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE  403 (554)
Q Consensus       327 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~  403 (554)
                      ++++++..++..++|+|++ .++|.+++....   .......++..++.||+.||+|||   +++|+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence            9999999999999999999 578888775432   122345677889999999999999   899999999999999999


Q ss_pred             CCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHH
Q 042763          404 SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTL  483 (554)
Q Consensus       404 ~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~  483 (554)
                      ++.+||+|||+++.....  .........||+.|+|||++.+..++.++|||||||++|||++|..++...........+
T Consensus       303 ~~~vkL~DFGla~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKE--REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCEEEEeCCCceecCcc--cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            999999999999864322  112223457999999999999999999999999999999999988654332221111111


Q ss_pred             HHHHHhhccCCccccCCh------------------hhhhhc-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          484 RWAFKRYNEGNLLDMVDP------------------SIKEVI-SMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       484 ~~~~~~~~~~~~~~~~d~------------------~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .......... ..+..++                  .+...+ ......++.+++.+||+.||++|||+.|++++.|-
T Consensus       381 ~~~~~~~~~~-~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        381 LKIIDSLSVC-DEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHhcccC-hhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            1111111000 0000000                  000000 00123457788999999999999999999999874

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=315.69  Aligned_cols=271  Identities=21%  Similarity=0.290  Sum_probs=202.2

Q ss_pred             CCCcceeeeccCceEEEEEEEc---CCcEEEEEEcchhh--hhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC--CceE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE---DGLLVAIKRAKKEQ--FENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG--NERL  339 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~  339 (554)
                      +|...++||+|+||.||+|...   ++..||+|.+....  .....+.+.+|+.++++++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4777889999999999999765   47899999987642  122345678899999999999999999999887  7899


Q ss_pred             EEEEeCCCCCHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC----CCcEEEEee
Q 042763          340 IITEFVPNGTLREHLDGQY---GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE----SMRAKVADF  412 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~----~~~vkl~Df  412 (554)
                      +||||++ ++|.+++....   ...+++..++.++.|++.||+|||   +.+++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            9999996 57777775332   236889999999999999999999   899999999999999999    999999999


Q ss_pred             cCcccCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChh------hHHHHHH
Q 042763          413 GFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPE------ERVTLRW  485 (554)
Q Consensus       413 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~------~~~~~~~  485 (554)
                      |+++................+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.......      ....+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            999865433222222334568899999998866 458999999999999999999999998654332      0111111


Q ss_pred             HHHhhccC------------Ccc---------ccCChhhhhhccH--HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          486 AFKRYNEG------------NLL---------DMVDPSIKEVISM--EILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       486 ~~~~~~~~------------~~~---------~~~d~~l~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ........            ...         ......+......  .....+.+++.+||+.||++|||+.|++++.|
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            11111000            000         0000111111111  23456899999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.8e-37  Score=306.36  Aligned_cols=251  Identities=25%  Similarity=0.392  Sum_probs=203.2

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh----hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF----ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      +|+..+.||+|+||+||+|... ++..|++|.+.....    ....+.+.+|++++++++|+||+++++++..+...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4667788999999999999776 789999998865432    23446789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++++|.+++...  ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            9999999999999754  46889999999999999999999   899999999999999999999999999998764322


Q ss_pred             CCCccccccccCCCCCcChhccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQ-LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      .    ......+++.|+|||.+.... ++.++|+||||+++|+|++|+.||..........  ..  .  ......    
T Consensus       156 ~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~--~~--~--~~~~~~----  221 (258)
T cd06632         156 S----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF--KI--G--RSKELP----  221 (258)
T ss_pred             c----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH--HH--H--hcccCC----
Confidence            1    223456889999999987766 8999999999999999999999997644211111  11  0  000000    


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                           ..+..+...+.+++.+||+.+|++||++.+++.+.|
T Consensus       222 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  257 (258)
T cd06632         222 -----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF  257 (258)
T ss_pred             -----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence                 012223456788999999999999999999998753

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.9e-37  Score=311.10  Aligned_cols=259  Identities=24%  Similarity=0.375  Sum_probs=200.6

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHH-HHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVEL-LSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~-l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ++|++.+.||+|+||.||+|... +|+.||+|+++..........+..|+.. ++.++||||+++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888899999999999999765 6999999998765433334456666665 566789999999999999999999999


Q ss_pred             eCCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          344 FVPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYAEK-QIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       344 ~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      |++ |+|.+++...  ....+++..++.++.|++.||+|||   ++ +++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            995 7888887653  2346899999999999999999999   66 999999999999999999999999999976422


Q ss_pred             CCCCccccccccCCCCCcChhcccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKT----YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL  496 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~----~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  496 (554)
                      .    .......++..|+|||.+.+    ..++.++|+||||+++|||++|+.||........  .+.....   . .  
T Consensus       157 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~---~-~--  224 (283)
T cd06617         157 S----VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ--QLKQVVE---E-P--  224 (283)
T ss_pred             c----cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH--HHHHHHh---c-C--
Confidence            1    11223458889999998864    4578899999999999999999999964332111  1111110   0 0  


Q ss_pred             ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          497 DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       497 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                         .+..   ....++..+.+++.+||+.+|++||++.+|+++.|-.+..
T Consensus       225 ---~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         225 ---SPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             ---CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence               0000   0112446689999999999999999999999987765543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.6e-37  Score=310.91  Aligned_cols=251  Identities=25%  Similarity=0.345  Sum_probs=207.3

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|+..+.||+|+||.||++... +++.||+|++.....  ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36788899999999999999765 589999999876543  233467889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            999999999999765  57899999999999999999999   899999999999999999999999999999864322 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                           .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||........   ....    .....      .
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~----~~~~~------~  216 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI---YEKI----LEGKV------R  216 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----hcCCc------c
Confidence                 2344689999999999888899999999999999999999999976542211   1111    11110      0


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAIR  544 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i~  544 (554)
                          ++......+.+++.+||+.+|.+||     +++|++++.|--.
T Consensus       217 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~  259 (290)
T cd05580         217 ----FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG  259 (290)
T ss_pred             ----CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence                1122345688999999999999999     9999998877433

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.5e-37  Score=311.37  Aligned_cols=269  Identities=22%  Similarity=0.312  Sum_probs=203.6

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ++|+..+.||+|++|+||+|... +|+.||+|.+..... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999765 689999998865432 2334568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC-CCcEEEEeecCcccCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE-SMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~~~~~~~  422 (554)
                      |++ ++|.+++.......+++..+..++.||+.||+|||   +++++||||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            995 68888887654455688888999999999999999   899999999999999985 5679999999997543211


Q ss_pred             CCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc-----
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL-----  496 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-----  496 (554)
                         .......+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||......+.............+....     
T Consensus       158 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        158 ---RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             ---cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence               11223457889999998866 457899999999999999999999998655433322211110000000000     


Q ss_pred             -c-------cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          497 -D-------MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       497 -~-------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                       +       ....... .........+.+++.+|++.+|++||++.+++++.|-
T Consensus       235 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~  287 (294)
T PLN00009        235 PDYKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF  287 (294)
T ss_pred             hhhhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchH
Confidence             0       0000100 1112345668999999999999999999999998764

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.9e-37  Score=313.16  Aligned_cols=268  Identities=22%  Similarity=0.293  Sum_probs=204.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcC--CceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKG--NERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~lv  341 (554)
                      ++|+..+.||+|+||.||+|... +++.+|+|.++..... .....+.+|++++++++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888889999999999999776 5889999998754332 2234577899999999999999999998777  889999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||++ ++|.+++.... ..+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++.....
T Consensus        85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            99996 59999887643 36899999999999999999999   889999999999999999999999999999864332


Q ss_pred             CCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH--------h---
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFK--------R---  489 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~--------~---  489 (554)
                      .   .......+++.|+|||.+.+. .++.++||||||+++|||++|..||...........+.....        .   
T Consensus       160 ~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         160 L---KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             c---cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            1   112234578899999988764 468999999999999999999999986654333222111000        0   


Q ss_pred             ---hccCCccccCChhhhhhccHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          490 ---YNEGNLLDMVDPSIKEVISME-ILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       490 ---~~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                         .............+...++.. ....+.+++.+||+.+|++|||+.|++.+-|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~  292 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY  292 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence               000011111111222222222 3567889999999999999999999998754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=312.46  Aligned_cols=266  Identities=23%  Similarity=0.347  Sum_probs=202.9

Q ss_pred             CCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      |+..++||+|++|.||+|... +|..||+|++...... .....+.+|++++++++|||++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            566789999999999999764 6999999998755322 23356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                       +++|.+++.......+++..++.++.|++.||+|||   +++++||||+|+||+++.++.++|+|||+++......   
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---  153 (283)
T cd07835          81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV---  153 (283)
T ss_pred             -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc---
Confidence             579999997765457899999999999999999999   8899999999999999999999999999997542211   


Q ss_pred             cccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC-----------
Q 042763          426 HISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG-----------  493 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-----------  493 (554)
                      .......+++.|+|||++.+. .++.++||||||+++|+|++|+.||....................+.           
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            111223468899999988654 57899999999999999999999998655432222111100000000           


Q ss_pred             --CccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          494 --NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       494 --~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                        ............ ........+.+++.+||+.+|++||++.|++++.|
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~  282 (283)
T cd07835         234 KPTFPKWARQDLSK-VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY  282 (283)
T ss_pred             hhhcccccccchhh-hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence              000000011111 11233467889999999999999999999998755

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.8e-38  Score=316.43  Aligned_cols=254  Identities=25%  Similarity=0.401  Sum_probs=203.9

Q ss_pred             CCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCC
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVP  346 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  346 (554)
                      |....+||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..+++|||++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            334557999999999999764 689999999865432 334668899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcc
Q 042763          347 NGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH  426 (554)
Q Consensus       347 ~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~  426 (554)
                      +++|..++..   ..+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......   .
T Consensus       102 ~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~---~  172 (297)
T cd06659         102 GGALTDIVSQ---TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV---P  172 (297)
T ss_pred             CCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc---c
Confidence            9999998754   36889999999999999999999   8999999999999999999999999999987543221   1


Q ss_pred             ccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhh
Q 042763          427 ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEV  506 (554)
Q Consensus       427 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  506 (554)
                      ......|+..|+|||++.+..++.++||||||+++|||++|+.||......+....+.       ....     +...  
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-------~~~~-----~~~~--  238 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-------DSPP-----PKLK--  238 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------ccCC-----CCcc--
Confidence            1233568999999999998889999999999999999999999998654332211111       0000     0000  


Q ss_pred             ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          507 ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       507 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      ........+.+++.+||+.+|++||++.+++++.|-...
T Consensus       239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         239 NAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence            011233457899999999999999999999998876654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.1e-37  Score=305.84  Aligned_cols=254  Identities=25%  Similarity=0.398  Sum_probs=201.2

Q ss_pred             CCCcceeeeccCceEEEEEEEcC--CcEEEEEEcchhh---------hhhHHHHHHHHHHHHHh-CCCCCceeeeeEEEc
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLED--GLLVAIKRAKKEQ---------FENLQTEFSSEVELLSK-IDHRNLVKLLGFVDK  334 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~~--g~~vAvK~~~~~~---------~~~~~~~~~~Ei~~l~~-l~HpnIv~l~~~~~~  334 (554)
                      +|+..+.||+|+||.||+|....  ++.+|+|.+....         ......++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999998764  6889999875321         12234567788888875 799999999999999


Q ss_pred             CCceEEEEEeCCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEee
Q 042763          335 GNERLIITEFVPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADF  412 (554)
Q Consensus       335 ~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df  412 (554)
                      ++..+++|||+++++|.+++...  ....+++..++.++.|++.||.|||.  ..+++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999988542  23568899999999999999999992  368999999999999999999999999


Q ss_pred             cCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhcc
Q 042763          413 GFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE  492 (554)
Q Consensus       413 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  492 (554)
                      |++.......    ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...........       ..+
T Consensus       159 g~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~-------~~~  227 (269)
T cd08528         159 GLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK-------IVE  227 (269)
T ss_pred             cceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH-------Hhh
Confidence            9998643221    22345688999999999988899999999999999999999999975443221111       111


Q ss_pred             CCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          493 GNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       493 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ....    +.    ........+.+++.+||+.||++||++.||.+++.
T Consensus       228 ~~~~----~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         228 AVYE----PL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ccCC----cC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1111    10    01123456889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.7e-37  Score=313.97  Aligned_cols=261  Identities=24%  Similarity=0.359  Sum_probs=210.0

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|...+.||+|+||.||++... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            67888999999999999999654 68899999986543 22346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++...   .+++.++..++.|++.||.|||   +++++|+||||+||+++.++.++|+|||++.......  
T Consensus        98 ~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--  169 (293)
T cd06647          98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  169 (293)
T ss_pred             CCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--
Confidence            9999999999754   5789999999999999999999   8999999999999999999999999999887543221  


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                       .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.............    ......          
T Consensus       170 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~----~~~~~~----------  234 (293)
T cd06647         170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----TNGTPE----------  234 (293)
T ss_pred             -cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh----cCCCCC----------
Confidence             11223458889999999988889999999999999999999999997654322211000    000000          


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhhh
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKS  550 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~~  550 (554)
                      ..........+.+++.+||+.+|++||++.+++.|.|--....+.+
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~  280 (293)
T cd06647         235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSS  280 (293)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccccc
Confidence            0011223456889999999999999999999999987766554444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3e-37  Score=311.80  Aligned_cols=268  Identities=20%  Similarity=0.276  Sum_probs=201.1

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCc-----
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNE-----  337 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~-----  337 (554)
                      ++|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+.+++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999765 6899999988654322 23356888999999995 6999999999877665     


Q ss_pred             eEEEEEeCCCCCHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC-CCcEEEEeec
Q 042763          338 RLIITEFVPNGTLREHLDGQY---GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE-SMRAKVADFG  413 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfG  413 (554)
                      .++||||++ ++|.+++....   ...+++..++.++.||+.||+|||   +++++||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            799999997 48998886543   246899999999999999999999   899999999999999998 8999999999


Q ss_pred             CcccCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhcc
Q 042763          414 FARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE  492 (554)
Q Consensus       414 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  492 (554)
                      +++......   .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.........
T Consensus       157 ~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  233 (295)
T cd07837         157 LGRAFSIPV---KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE  233 (295)
T ss_pred             cceecCCCc---cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            987542211   11222356889999998865 45799999999999999999999999865543332211111000000


Q ss_pred             CCccc------------cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          493 GNLLD------------MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       493 ~~~~~------------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .....            .....+.. ..+.....+.+++.+||+.+|.+||++.|++.+.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~  293 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY  293 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence            00000            00001111 11234567899999999999999999999998765

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.6e-37  Score=304.20  Aligned_cols=257  Identities=27%  Similarity=0.437  Sum_probs=205.0

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +|...+.||+|+||.||+|... +++.||+|.++..... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778889999999999999764 6889999998765432 3567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++...  ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            9999999999764  45789999999999999999999   899999999999999999999999999999875433222


Q ss_pred             ccc-cccccCCCCCcChhccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          425 THI-STKVKGTVGYLDPEYMKTYQ---LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       425 ~~~-~~~~~gt~~y~aPE~l~~~~---~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      ... .....+++.|+|||++.+..   ++.++||||||+++|||++|+.||........   ..+....   ..     .
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~---~~~~~~~---~~-----~  224 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---IMFHVGA---GH-----K  224 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH---HHHHHhc---CC-----C
Confidence            111 12346889999999998766   88999999999999999999999975432211   1111000   00     0


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      +.+..  ...+...+.+++.+||+.+|++||++.+++.+.|
T Consensus       225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~  263 (264)
T cd06626         225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF  263 (264)
T ss_pred             CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence            00000  1123456789999999999999999999988754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.1e-37  Score=303.45  Aligned_cols=255  Identities=23%  Similarity=0.354  Sum_probs=204.2

Q ss_pred             CCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc--CCceEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK--GNERLIIT  342 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~lv~  342 (554)
                      +|+..+.||.|+||.||++.. .++..||+|++..... ....+.+.+|++++++++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477788999999999999965 4688999998865432 3334678899999999999999999998753  45678999


Q ss_pred             EeCCCCCHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHhhhcc--CCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          343 EFVPNGTLREHLDGQY--GKTLDFNQRLEIAIDVAHGLTYLHLYA--EKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ||+++++|.+++....  ...+++.+++.++.|++.||.|||..+  +.+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            9999999999996532  357899999999999999999999543  678999999999999999999999999999865


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ....   .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......   ....    .......  
T Consensus       161 ~~~~---~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~~~~~--  228 (265)
T cd08217         161 GHDS---SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASK----IKEGKFR--  228 (265)
T ss_pred             cCCc---ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHH----HhcCCCC--
Confidence            4322   11223468999999999998889999999999999999999999998654221   1111    1111110  


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                             ..+......+.+++.+||+.+|++||++.+|+++.
T Consensus       229 -------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~  263 (265)
T cd08217         229 -------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP  263 (265)
T ss_pred             -------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCC
Confidence                   12234456789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-38  Score=294.10  Aligned_cols=257  Identities=21%  Similarity=0.362  Sum_probs=203.6

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ++.+.+..||.|+.|+||++..+ +|...|||.+.+.......++++..+.++.+-+ .|+||+.+|||..+...++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            34455667999999999999776 589999999988776666677888888777664 8999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      .| ...+..++... ..++++.-+-++...++.||.||..  .++|+|||+||+|||+|+.|.+|+||||.+-..-    
T Consensus       172 lM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv----  243 (391)
T KOG0983|consen  172 LM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV----  243 (391)
T ss_pred             HH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceee----
Confidence            98 44555555443 3567888888899999999999985  7899999999999999999999999999997632    


Q ss_pred             CccccccccCCCCCcChhcccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          424 RTHISTKVKGTVGYLDPEYMKT---YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      .....++..|.+.|||||.+.-   ..|+.++||||||++++||.||+.||...+.+-+  .+..+..  .       ..
T Consensus       244 dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~ltkvln--~-------eP  312 (391)
T KOG0983|consen  244 DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VLTKVLN--E-------EP  312 (391)
T ss_pred             cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HHHHHHh--c-------CC
Confidence            3344556679999999999864   4689999999999999999999999997654322  2222211  1       11


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      |.+.+  ....+..+.+++..||+.|+.+||...++++|..-.
T Consensus       313 P~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~  353 (391)
T KOG0983|consen  313 PLLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIK  353 (391)
T ss_pred             CCCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCccee
Confidence            22221  122567799999999999999999999999985433

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-37  Score=304.07  Aligned_cols=269  Identities=25%  Similarity=0.350  Sum_probs=206.3

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHh--CCCCCceeeeeEEEcC----Cce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSK--IDHRNLVKLLGFVDKG----NER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~~~~~~~----~~~  338 (554)
                      .++....+.||+|.||.||+|+++ |+.||||++....    ++.+.+|.++++.  |+|+||+.+++.=..+    .++
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-CCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            356677889999999999999999 8999999997654    3567788888875  5999999999875433    367


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhc-----cCCCeEeCCCCCCCeEECCCCcEEEEeec
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY-----AEKQIIHRDVKSSNILLTESMRAKVADFG  413 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dlkp~NILl~~~~~vkl~DfG  413 (554)
                      +||.+|.++|+|.|||...   +++.+..++++..+|.||++||..     ....|.|||||+.|||+..++...|+|+|
T Consensus       285 wLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            9999999999999999875   899999999999999999999952     35679999999999999999999999999


Q ss_pred             CcccCCCCCCC-ccccccccCCCCCcChhccccCC----C--CchhhHHHHHHHHHHHHhC----------CCCCCCCCC
Q 042763          414 FARLGPMDSDR-THISTKVKGTVGYLDPEYMKTYQ----L--TTKSDVYSFGVLLLEILTG----------RRPVELKRP  476 (554)
Q Consensus       414 la~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~----~--s~ksDVwSlGvil~elltg----------~~P~~~~~~  476 (554)
                      +|-......+. .......+||.+|||||++...-    +  -..+||||||+++||+...          +.||..-.+
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            99765444322 22334568999999999997632    1  1368999999999999753          456654332


Q ss_pred             hhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          477 PEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      .+...  +...+.+-..++...++.+   +...+....+.++|+.||..+|.-|-|+-.|-+.+.++-..
T Consensus       442 ~DPs~--eeMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  442 SDPSF--EEMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             CCCCH--HHHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            22111  1111111122222222222   23457788999999999999999999999999999888754

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.3e-37  Score=313.38  Aligned_cols=260  Identities=25%  Similarity=0.340  Sum_probs=200.2

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEEEEEe
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +|...++||+|+||.||++... +++.||+|.+...........+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4455678999999999999765 589999999876544445567899999999996 99999999999999999999999


Q ss_pred             CCCCCHHHHH---hcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          345 VPNGTLREHL---DGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       345 ~~~g~L~~~l---~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      +. +++.++.   .......+++..+..++.|++.||+|||+  ..+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            85 5665543   33334578999999999999999999992  359999999999999999999999999999754321


Q ss_pred             CCCccccccccCCCCCcChhccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTY---QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      .    ......|++.|+|||.+.+.   .++.++||||||+++|||++|+.||......     ..... ......    
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~-~~~~~~----  227 (288)
T cd06616         162 I----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQLT-QVVKGD----  227 (288)
T ss_pred             C----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-----HHHHh-hhcCCC----
Confidence            1    11233588999999998775   6899999999999999999999999754311     11111 111100    


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                       .+.+.......++..+.+++.+||+.+|++|||+.+|+.+.|--+
T Consensus       228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence             111111111235567899999999999999999999999977533

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-37  Score=308.15  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=203.6

Q ss_pred             CCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC---CCCceeeeeEEEcCCceEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID---HRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+..........++.+|++++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            466778899999999999976 4689999999876544444567889999999996   999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++++|.+++...   .+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            999999999998653   6889999999999999999999   8999999999999999999999999999998654322


Q ss_pred             CCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                         .......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||..........       .....     ..+
T Consensus       156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~~~~~-----~~~  220 (277)
T cd06917         156 ---SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LIPKS-----KPP  220 (277)
T ss_pred             ---cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------ccccC-----CCC
Confidence               11233468899999998865 457899999999999999999999997543322111       00000     011


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .+.   .......+.+++.+||+.+|++||++.+++.+.|-
T Consensus       221 ~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~  258 (277)
T cd06917         221 RLE---DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWI  258 (277)
T ss_pred             CCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence            111   11144568899999999999999999999998765

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.2e-38  Score=309.68  Aligned_cols=238  Identities=23%  Similarity=0.412  Sum_probs=187.8

Q ss_pred             eeeccCceEEEEEEEcC--------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          273 RIGEGGFGTVYKAQLED--------GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~--------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .||+|+||.||+|....        ...+|+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            58999999999996542        2348888876543 33456788999999999999999999999998999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc--------EEEEeecCcc
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR--------AKVADFGFAR  416 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~--------vkl~DfGla~  416 (554)
                      +++|+|.+++.... ..+++..++.++.||+.||+|||   +++|+||||||+||+++.++.        ++++|||++.
T Consensus        81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            99999999997653 36889999999999999999999   899999999999999987765        6999999886


Q ss_pred             cCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCC-CCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGR-RPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      ....       .....+++.|+|||++.+ ..++.++||||||+++|||++|. .|+.......... .   ..  ....
T Consensus       157 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~---~~--~~~~  223 (258)
T cd05078         157 TVLP-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-F---YE--DRHQ  223 (258)
T ss_pred             ccCC-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-H---HH--cccc
Confidence            4321       123457889999999976 45899999999999999999985 5554333221111 0   00  0000


Q ss_pred             ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       495 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                                  .+.....++.+++.+||+.+|++|||++++++.|
T Consensus       224 ------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         224 ------------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             ------------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                        1112235688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.4e-37  Score=307.53  Aligned_cols=263  Identities=22%  Similarity=0.268  Sum_probs=198.7

Q ss_pred             CCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcC--CceEEEEE
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKG--NERLIITE  343 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~--~~~~lv~E  343 (554)
                      |+..++||+|+||.||+|... +++.||+|+++............+|+.++.++. |||++++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            566788999999999999764 689999999876533323334567899999885 99999999999887  88999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |++ ++|.+++.... ..+++.+++.++.|++.||+|||   +.+++||||+|+||+++. +.+||+|||+++...... 
T Consensus        81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-  153 (282)
T cd07831          81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-  153 (282)
T ss_pred             cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC-
Confidence            996 68888886542 46899999999999999999999   899999999999999999 999999999997643221 


Q ss_pred             CccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH--------HhhccCC
Q 042763          424 RTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF--------KRYNEGN  494 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~--------~~~~~~~  494 (554)
                         ......++..|+|||.+.. ..++.++|||||||++|||++|..||......+.........        .......
T Consensus       154 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         154 ---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             ---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence               1123457889999997644 457889999999999999999999998755433222111100        0000000


Q ss_pred             ccccC-----ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          495 LLDMV-----DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       495 ~~~~~-----d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .....     ...+.. .....+..+.+++.+||+.+|++||++.+++++.|
T Consensus       231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~  281 (282)
T cd07831         231 HMNYNFPSKKGTGLRK-LLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY  281 (282)
T ss_pred             cccccCcccccccHHH-HcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence            00000     001111 11245678999999999999999999999998865

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.6e-37  Score=307.49  Aligned_cols=251  Identities=25%  Similarity=0.321  Sum_probs=206.1

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      +|+..+.||+|+||.||+|... +++.||+|.+......  ...+.+.+|++++++++||||+++++++..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999765 5899999999765432  345678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++++|.+++...  ..+++.++..++.|+++||.|||   +.+++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999999999765  57899999999999999999999   8999999999999999999999999999987643221 


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                         ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||............    .....  ..       
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~--~~-------  218 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQET--AD-------  218 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhcc--cc-------
Confidence               223355888999999999888999999999999999999999999876543111111    11110  00       


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCH--HHHHHHH
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDM--KSVGEQL  540 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~~l  540 (554)
                       ...+...+..+.+++.+||+.+|.+||++  +|++++.
T Consensus       219 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~  256 (258)
T cd05578         219 -VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHP  256 (258)
T ss_pred             -ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCC
Confidence             01222344678899999999999999999  7777654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-37  Score=307.94  Aligned_cols=267  Identities=25%  Similarity=0.319  Sum_probs=204.5

Q ss_pred             CCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhh-hhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC--CceEEEEE
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQ-FENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG--NERLIITE  343 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~lv~E  343 (554)
                      |+..++||+|+||.||+|... +++.+|+|++.... .......+.+|++++++++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            566789999999999999776 48899999998653 223345788999999999999999999999887  78999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |++ ++|.+++.... ..+++.+++.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            996 58988886542 47899999999999999999999   88999999999999999999999999999986433221


Q ss_pred             CccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc------
Q 042763          424 RTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL------  496 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~------  496 (554)
                        .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.............      
T Consensus       156 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         156 --ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             --ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence              11223456888999997765 457899999999999999999999998766443332222111100000000      


Q ss_pred             --------ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          497 --------DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       497 --------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                              ......+.+.....++..+.+++.+||+.+|++||++++++++.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~  286 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY  286 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence                    001111112222223667899999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.1e-37  Score=306.01  Aligned_cols=253  Identities=28%  Similarity=0.428  Sum_probs=204.9

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +|+..+.||+|+||.||+|... +|..+|+|.+...... ...+.+.+|++++++++|+||+++++.+..+...++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778889999999999999765 5889999998765322 2345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC-cEEEEeecCcccCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSD  423 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~~~~~~  423 (554)
                      +++++|.+++.......+++..++.++.|++.||.|||   +.+++|+||||+||++++++ .+||+|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-  156 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence            99999999998765556899999999999999999999   89999999999999999885 46999999987643221 


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                        .......|++.|+|||.+.+..++.++||||||+++|||++|..||.........   .   ... ......      
T Consensus       157 --~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~---~~~-~~~~~~------  221 (257)
T cd08225         157 --ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV---L---KIC-QGYFAP------  221 (257)
T ss_pred             --ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH---H---HHh-cccCCC------
Confidence              1222345889999999998888999999999999999999999999754332211   1   111 111110      


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                         ........+.+++.+||+.+|++|||+.+++.+.|
T Consensus       222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~  256 (257)
T cd08225         222 ---ISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPF  256 (257)
T ss_pred             ---CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence               11223456889999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.9e-37  Score=308.47  Aligned_cols=259  Identities=25%  Similarity=0.400  Sum_probs=210.9

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ..+.|+..+.||+|+||.||+|... ++..|++|++.....  ..+.+.+|++++++++|+|++++++++..+...++++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            4567888889999999999999776 688999999876543  3567889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++++|.+++.... ..+++.+++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            9999999999998753 47899999999999999999999   8999999999999999999999999999987543211


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                         .......++..|++||.+.+..++.++||||||+++|+|++|+.||....+.......  .     ........   
T Consensus       171 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~--~-----~~~~~~~~---  237 (286)
T cd06614         171 ---SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI--T-----TKGIPPLK---  237 (286)
T ss_pred             ---hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H-----hcCCCCCc---
Confidence               1122345788999999998888999999999999999999999999755433221111  0     00000000   


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                          ....+...+.+++.+||+.+|.+||++.+|+++.|-.+.
T Consensus       238 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         238 ----NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             ----chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence                111244668899999999999999999999998876653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.6e-37  Score=299.83  Aligned_cols=252  Identities=29%  Similarity=0.440  Sum_probs=206.3

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      +|...+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+|++++++++..+...++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            3677889999999999999775 688999999977643 34568899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ++++|.+++.... ..+++..+..++.|++.||.|||   ..+++||||+|+||++++++.++|+|||.+........  
T Consensus        80 ~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          80 SGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            9999999987653 57899999999999999999999   89999999999999999999999999999876432221  


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE  505 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  505 (554)
                        .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.............    .   ........     
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~---~~~~~~~~-----  219 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA----T---NGPPGLRN-----  219 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH----h---cCCCCcCc-----
Confidence              234568899999999988889999999999999999999999997654322211111    0   00001100     


Q ss_pred             hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          506 VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       506 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                        ...+...+.+++.+||+.||++|||+.+++++.|
T Consensus       220 --~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         220 --PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             --ccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence              1112456899999999999999999999998754

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.6e-37  Score=306.11  Aligned_cols=257  Identities=32%  Similarity=0.455  Sum_probs=199.0

Q ss_pred             CCcceeeeccCceEEEEEEEc----CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC------
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN------  336 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------  336 (554)
                      |...+.||+|+||.||+|...    +++.||||++..... ....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456778999999999999653    368999999876432 233567889999999999999999999885432      


Q ss_pred             ceEEEEEeCCCCCHHHHHhccc----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEee
Q 042763          337 ERLIITEFVPNGTLREHLDGQY----GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADF  412 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df  412 (554)
                      ..++++||+++|+|.+++....    ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999998875322    225788899999999999999999   899999999999999999999999999


Q ss_pred             cCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhc
Q 042763          413 GFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYN  491 (554)
Q Consensus       413 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  491 (554)
                      |+++...... .........+++.|++||.+.+..++.++||||||+++|||++ |+.||......+.   ..+..    
T Consensus       158 g~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~~~----  229 (273)
T cd05074         158 GLSKKIYSGD-YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNYLI----  229 (273)
T ss_pred             cccccccCCc-ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHHHH----
Confidence            9998643221 1111223345678999999998889999999999999999999 8888875433211   11111    


Q ss_pred             cCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          492 EGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       492 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      ......         .....+..+.+++.+||+.+|++||++.|+++.|.++.
T Consensus       230 ~~~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~  273 (273)
T cd05074         230 KGNRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW  273 (273)
T ss_pred             cCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            110000         11234457899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.1e-37  Score=318.29  Aligned_cols=268  Identities=20%  Similarity=0.261  Sum_probs=202.8

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC------
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG------  335 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------  335 (554)
                      ..++|+..+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999764 689999999865321 22345677899999999999999999988543      


Q ss_pred             CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCc
Q 042763          336 NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA  415 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla  415 (554)
                      ...++||||+ .++|.+.+...    ++..++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~-~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEecc-CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            3569999999 46888887543    788999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH--------
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF--------  487 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~--------  487 (554)
                      +.....    .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+....        
T Consensus       166 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         166 RTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             eeCCCC----CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            864321    11233458899999999999999999999999999999999999997654322211110000        


Q ss_pred             -------Hhhcc--C-----CccccCCh----hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          488 -------KRYNE--G-----NLLDMVDP----SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       488 -------~~~~~--~-----~~~~~~d~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                             .....  .     .+.+....    .............+.+++.+||+.||++|||+.|++++.|--
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~  315 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN  315 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence                   00000  0     00000000    000000113456688999999999999999999999998743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.2e-37  Score=313.28  Aligned_cols=269  Identities=26%  Similarity=0.310  Sum_probs=203.3

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcC--CceEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKG--NERLI  340 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~l  340 (554)
                      .++|+..++||+|+||.||+|... +|+.||+|+++..... .....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467889999999999999999765 5899999998754322 2233567899999999999999999998654  46799


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||||++ ++|.+++... ...+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        86 v~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            999995 5898888754 256899999999999999999999   89999999999999999999999999999986432


Q ss_pred             CCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccc--
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD--  497 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--  497 (554)
                      ..   .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....... ......  
T Consensus       161 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~-~~~~~~~~  236 (309)
T cd07845         161 PA---KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP-NESIWPGF  236 (309)
T ss_pred             cc---CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC-Chhhchhh
Confidence            21   11222346788999998865 468999999999999999999999998665443322222111000 000000  


Q ss_pred             -------cC--C----hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          498 -------MV--D----PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       498 -------~~--d----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                             ..  .    ...... .......+.+++.+||+.||++|||+.+++.+.|-.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~  294 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK  294 (309)
T ss_pred             hcccccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence                   00  0    000000 011355678999999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.9e-37  Score=312.08  Aligned_cols=272  Identities=21%  Similarity=0.293  Sum_probs=201.3

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC------
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN------  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------  336 (554)
                      -++|+..++||+|+||.||+|... +++.||||.+..... ......+.+|++++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457889999999999999999765 589999998865432 222345678999999999999999999986654      


Q ss_pred             --ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecC
Q 042763          337 --ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGF  414 (554)
Q Consensus       337 --~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl  414 (554)
                        ..++||||+. ++|.+++... ...+++.+++.++.|++.||+|||   +++++|+||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence              3499999995 6888887654 246899999999999999999999   88999999999999999999999999999


Q ss_pred             cccCCCCCCC-ccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhcc
Q 042763          415 ARLGPMDSDR-THISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE  492 (554)
Q Consensus       415 a~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  492 (554)
                      +......... ........++..|+|||.+.+. .++.++||||||+++|||++|..||...........+.........
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9764322211 1112234578899999988664 4789999999999999999999999876554333333222211111


Q ss_pred             CCcccc--------------CChhhhhhc-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          493 GNLLDM--------------VDPSIKEVI-SMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       493 ~~~~~~--------------~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ......              ......... .......+.+++.+||+.||++|||+.|++++.|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~  309 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF  309 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence            000000              000000000 0011245679999999999999999999998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.4e-37  Score=306.42  Aligned_cols=254  Identities=22%  Similarity=0.313  Sum_probs=202.9

Q ss_pred             eeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCH
Q 042763          274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTL  350 (554)
Q Consensus       274 LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L  350 (554)
                      ||+|+||+||+|... +|+.||+|.+.....  ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999654 689999999876432  22344567899999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcccccc
Q 042763          351 REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK  430 (554)
Q Consensus       351 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~  430 (554)
                      .+++.......+++.+++.++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||.+......    .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~  153 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG----KKIKG  153 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC----Ccccc
Confidence            99998765557899999999999999999999   899999999999999999999999999998764321    11223


Q ss_pred             ccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHH
Q 042763          431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISME  510 (554)
Q Consensus       431 ~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  510 (554)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+..   .....      ..    ..+..
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~------~~----~~~~~  220 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR---RTLEM------AV----EYPDK  220 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---ccccc------cc----cCCcc
Confidence            4578899999999888899999999999999999999999976544222111111   00000      00    01222


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHhhhhh
Q 042763          511 ILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAIRADS  547 (554)
Q Consensus       511 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i~~~~  547 (554)
                      ....+.+++.+||+.+|++||     ++.+++.+.|-.+-++
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~  262 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW  262 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence            355688999999999999999     8888998877655444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-38  Score=325.35  Aligned_cols=246  Identities=28%  Similarity=0.459  Sum_probs=202.2

Q ss_pred             eeeccCceEEEEEEEcC-CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCHH
Q 042763          273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLR  351 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~  351 (554)
                      +||+|.||+||-|+..+ ....|||.+..... ...+-+..||.+.++|+|.|||+++|.+.+++..-|.||-++||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            59999999999997654 56789999876643 33456889999999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCC--CHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC-CCCcEEEEeecCcccCCCCCCCcccc
Q 042763          352 EHLDGQYGKTL--DFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT-ESMRAKVADFGFARLGPMDSDRTHIS  428 (554)
Q Consensus       352 ~~l~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~-~~~~vkl~DfGla~~~~~~~~~~~~~  428 (554)
                      +++..+-+ ++  .+.+.-.+.+||++||.|||   ++.|||||||-+||||+ -.|.+||+|||-++...   .-....
T Consensus       661 sLLrskWG-PlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA---ginP~T  733 (1226)
T KOG4279|consen  661 SLLRSKWG-PLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA---GINPCT  733 (1226)
T ss_pred             HHHHhccC-CCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhc---cCCccc
Confidence            99986643 34  56777789999999999999   99999999999999996 57899999999998642   233344


Q ss_pred             ccccCCCCCcChhccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhh
Q 042763          429 TKVKGTVGYLDPEYMKTY--QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEV  506 (554)
Q Consensus       429 ~~~~gt~~y~aPE~l~~~--~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  506 (554)
                      .++.||..|||||++..+  .|+.++|||||||++.||.||++||.....+.....      ++.--+.    -    ..
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF------kVGmyKv----H----P~  799 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF------KVGMYKV----H----PP  799 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh------hhcceec----C----CC
Confidence            567899999999999765  699999999999999999999999986555432211      1110011    1    12


Q ss_pred             ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          507 ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       507 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                      ++.+...+...+|.+|..+||.+||++.++++..
T Consensus       800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~Dp  833 (1226)
T KOG4279|consen  800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDP  833 (1226)
T ss_pred             CcHHHHHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence            5667788899999999999999999999998764

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=6.9e-37  Score=308.26  Aligned_cols=254  Identities=23%  Similarity=0.387  Sum_probs=203.7

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      .|...++||+|++|.||++... +++.+|+|++..... ...+.+.+|+.+++.++||||+++++++..++..++++||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            3455678999999999999754 688999998865432 23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ++++|.+++..   ..+++.++..++.|++.||+|||   +++++||||+|+||+++.++.++|+|||++.......   
T Consensus        99 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~---  169 (285)
T cd06648          99 EGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV---  169 (285)
T ss_pred             CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC---
Confidence            99999999876   36889999999999999999999   8999999999999999999999999999887543221   


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE  505 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  505 (554)
                      .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....+........       ...     .+... 
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~-------~~~-----~~~~~-  236 (285)
T cd06648         170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR-------DNL-----PPKLK-  236 (285)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH-------hcC-----CCCCc-
Confidence            11223458899999999998889999999999999999999999997644322211111       100     00100 


Q ss_pred             hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          506 VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       506 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                       ....+...+.+++.+||+.+|++||++.+++++.|--.
T Consensus       237 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  274 (285)
T cd06648         237 -NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK  274 (285)
T ss_pred             -ccccCCHHHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence             01123457899999999999999999999998876433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-36  Score=302.05  Aligned_cols=247  Identities=26%  Similarity=0.318  Sum_probs=201.4

Q ss_pred             eeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCH
Q 042763          274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTL  350 (554)
Q Consensus       274 LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L  350 (554)
                      ||.|+||.||+|... +++.||+|++......  ...+.+.+|+.++++++||||+++++++.++...+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999775 4889999998765432  3456799999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcccccc
Q 042763          351 REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK  430 (554)
Q Consensus       351 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~  430 (554)
                      .+++.+.  ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||+++......    ....
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~  151 (262)
T cd05572          81 WTILRDR--GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWT  151 (262)
T ss_pred             HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----cccc
Confidence            9999765  45889999999999999999999   8999999999999999999999999999998643221    2223


Q ss_pred             ccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHH
Q 042763          431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISME  510 (554)
Q Consensus       431 ~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  510 (554)
                      ..+++.|++||.+.+..++.++|+||||+++|+|++|..||........ ......   ......         ...+..
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~---~~~~~~---------~~~~~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EIYNDI---LKGNGK---------LEFPNY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HHHHHH---hccCCC---------CCCCcc
Confidence            4688999999999888899999999999999999999999986553111 111111   100000         001222


Q ss_pred             HHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHH
Q 042763          511 ILTKMFGLAIQCAAPIRNDRPD-----MKSVGEQLWA  542 (554)
Q Consensus       511 ~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~  542 (554)
                      ....+.+++.+||+.+|++||+     ++|++++.|-
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~  255 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF  255 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhh
Confidence            3567899999999999999999     8999998773

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.1e-36  Score=312.98  Aligned_cols=266  Identities=21%  Similarity=0.292  Sum_probs=199.4

Q ss_pred             eeecc--CceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCC
Q 042763          273 RIGEG--GFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNG  348 (554)
Q Consensus       273 ~LG~G--~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g  348 (554)
                      .||+|  +||+||++... +|+.||+|++..... ....+.+.+|+.+++.++||||+++++++..++..++||||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  99999999764 699999999875432 233467889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcc--
Q 042763          349 TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH--  426 (554)
Q Consensus       349 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~--  426 (554)
                      +|.+++.......+++..+..++.|++.||+|||   +.+++||||||+|||++.++.++++||+.+...........  
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            9999998765567899999999999999999999   89999999999999999999999999986543211111110  


Q ss_pred             --ccccccCCCCCcChhccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhh------------
Q 042763          427 --ISTKVKGTVGYLDPEYMKTY--QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY------------  490 (554)
Q Consensus       427 --~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~------------  490 (554)
                        ......++..|+|||++.+.  .++.++|||||||++|||++|+.||...........  ......            
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ--KLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHH--HhcCCCCCCccccccchh
Confidence              01112356679999999763  578999999999999999999999976543221110  000000            


Q ss_pred             ---------------ccCCc-----cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          491 ---------------NEGNL-----LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       491 ---------------~~~~~-----~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                                     .+...     ....+..+...........+.+++.+||+.||++|||+.|++++.|--
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~  312 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK  312 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence                           00000     001111111112234567889999999999999999999999998743

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.5e-37  Score=307.08  Aligned_cols=250  Identities=23%  Similarity=0.322  Sum_probs=193.7

Q ss_pred             eeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHH---hCCCCCceeeeeEEEcCCceEEEEEeCC
Q 042763          273 RIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLS---KIDHRNLVKLLGFVDKGNERLIITEFVP  346 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~---~l~HpnIv~l~~~~~~~~~~~lv~E~~~  346 (554)
                      .||+|+||.||++... +++.+|+|.+.+....  .....+.+|..+++   ..+||||+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            3899999999999764 5899999988764322  11223444544433   3479999999999999999999999999


Q ss_pred             CCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcc
Q 042763          347 NGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH  426 (554)
Q Consensus       347 ~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~  426 (554)
                      +++|.+++..+  ..+++..+..++.|++.||+|||   +.+++||||||+|||++.++.++|+|||++......     
T Consensus        81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-----  150 (279)
T cd05633          81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----  150 (279)
T ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-----
Confidence            99999998754  46899999999999999999999   899999999999999999999999999998753211     


Q ss_pred             ccccccCCCCCcChhccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhh
Q 042763          427 ISTKVKGTVGYLDPEYMK-TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE  505 (554)
Q Consensus       427 ~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  505 (554)
                      ......|++.|+|||.+. +..++.++|||||||++|||++|..||.......... ....   ...      ...    
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~---~~~------~~~----  216 (279)
T cd05633         151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRM---TLT------VNV----  216 (279)
T ss_pred             CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHH---hhc------CCc----
Confidence            112346899999999886 4568999999999999999999999997544322111 1111   000      001    


Q ss_pred             hccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHhhhh
Q 042763          506 VISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAIRAD  546 (554)
Q Consensus       506 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i~~~  546 (554)
                      ..+......+.+++.+||+.||++||     +++|+++|.|--.-+
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            12233456788999999999999999     699999997765433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=325.74  Aligned_cols=256  Identities=27%  Similarity=0.398  Sum_probs=207.0

Q ss_pred             cCCCcceeeeccCceEEEEEEEcC-CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +.|.++..||.|+||.||+|..++ +...|.|++.... ....+++.-||++|+..+||+||+|++.|..++.++++.||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            346667789999999999997765 4445678776654 44567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      |.||-++..+-.- +..+.+.++..++.|++.||.|||   +++|+|||||..|||++.+|.++|+|||.+...   ...
T Consensus       111 C~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn---~~t  183 (1187)
T KOG0579|consen  111 CGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN---KST  183 (1187)
T ss_pred             cCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccc---hhH
Confidence            9999998887653 568999999999999999999999   999999999999999999999999999998642   223


Q ss_pred             ccccccccCCCCCcChhcc-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          425 THISTKVKGTVGYLDPEYM-----KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l-----~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ......+.|||+|||||+.     ...+|+.++||||||++|.||..+.+|-..-++-  +..+.-  .+...+.   ++
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--RVllKi--aKSePPT---Ll  256 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKI--AKSEPPT---LL  256 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--HHHHHH--hhcCCCc---cc
Confidence            3344567899999999976     3568999999999999999999999997644331  111111  1111111   11


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                             .+......+.+++.+||..||+.||++.++++|.|--
T Consensus       257 -------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  257 -------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             -------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence                   2334567789999999999999999999999997743

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-37  Score=306.31  Aligned_cols=265  Identities=23%  Similarity=0.288  Sum_probs=205.7

Q ss_pred             CCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      |...+.||+|++|.||+|... +++.+++|++...... .....+.+|++++++++|+||+++++++..++..++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456778999999999999765 6899999998765432 33467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      + ++|.+++.... ..+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||.+.......   
T Consensus        81 ~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~---  152 (283)
T cd05118          81 D-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV---  152 (283)
T ss_pred             C-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence            6 58888887643 57899999999999999999999   8999999999999999999999999999997654322   


Q ss_pred             cccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc--------
Q 042763          426 HISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL--------  496 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--------  496 (554)
                      .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+..................        
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence            122234578899999998776 78999999999999999999999997665433322221110000000000        


Q ss_pred             ------ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          497 ------DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       497 ------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                            ...+... .........++.+++.+||+.||++||++.+++.+.|
T Consensus       233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~  282 (283)
T cd05118         233 YKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY  282 (283)
T ss_pred             hhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence                  0000111 1122345678999999999999999999999998765

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.3e-36  Score=309.40  Aligned_cols=254  Identities=27%  Similarity=0.389  Sum_probs=203.2

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ..|...++||+|+||+||+|... +|+.||+|++.....  .....++.+|+++++.++||||+++++++..++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            55888899999999999999765 589999998864322  233457889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||++ |++.+++... ...+++.++..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++...... 
T Consensus        95 e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          95 EYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            9995 6787777543 246899999999999999999999   899999999999999999999999999998753211 


Q ss_pred             CCccccccccCCCCCcChhccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          423 DRTHISTKVKGTVGYLDPEYMK---TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                            ....+++.|+|||++.   ...++.++||||||+++|||++|+.||.............      .. ..    
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~------~~-~~----  231 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------QN-DS----  231 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh------cC-CC----
Confidence                  2345788999999874   4568899999999999999999999997654322211110      00 00    


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                       +.   .........+.+++.+||+.+|++||++.+|+.+.|-.+..
T Consensus       232 -~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         232 -PT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             -CC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence             00   01123456789999999999999999999999998865543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-37  Score=306.03  Aligned_cols=265  Identities=24%  Similarity=0.336  Sum_probs=203.2

Q ss_pred             CCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEEEEEeC
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      |++.+.||+|+||+||+|... +++.||||++.............+|+..+++++ ||||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566789999999999999876 478999999876543222334567999999999 999999999999999999999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                       +|+|.+++.......+++.+++.++.|++.+|.|||   +++++|+||+|+||+++.++.++|+|||++.......   
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---  153 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---  153 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence             889999998765567899999999999999999999   8999999999999999999999999999997543211   


Q ss_pred             cccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhh----------ccCC
Q 042763          426 HISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY----------NEGN  494 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~----------~~~~  494 (554)
                       ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+............          ....
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence             1223457889999998754 457899999999999999999999997665443322211110000          0000


Q ss_pred             cc----ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          495 LL----DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       495 ~~----~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ..    ......+....+ .....+.+++.+||+.+|++||++.|++.+.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~  282 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPY  282 (283)
T ss_pred             ccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence            00    000111111111 12467899999999999999999999998754

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-37  Score=316.44  Aligned_cols=268  Identities=23%  Similarity=0.294  Sum_probs=206.3

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC-----ceE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN-----ERL  339 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----~~~  339 (554)
                      +|...+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5778889999999999999775 489999998876532 233467889999999999999999999987765     789


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      ++|||++ ++|.+++...  ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.++|+|||++....
T Consensus        81 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999996 6899988654  47899999999999999999999   8999999999999999999999999999998754


Q ss_pred             CCCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc---
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL---  495 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---  495 (554)
                      .............+++.|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+............   
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            332111122334578899999999887 7899999999999999999999999876543322222111100000000   


Q ss_pred             -----cccC-------ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          496 -----LDMV-------DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       496 -----~~~~-------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                           ...+       ...... ........+.+++.+||+.+|++||++.+++++.|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  291 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSK-LFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY  291 (330)
T ss_pred             cccchhhHHhhcccCCcchhHH-hcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence                 0000       000000 11224567899999999999999999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.6e-37  Score=317.47  Aligned_cols=272  Identities=20%  Similarity=0.273  Sum_probs=205.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc----CCce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK----GNER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~  338 (554)
                      .++|+..+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478899999999999999999655 589999999876432 2234567889999999999999999998753    3467


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ++||||+. ++|.+++...  ..+++..++.++.||+.||+|||   +++++||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            99999994 7999998654  46899999999999999999999   899999999999999999999999999999764


Q ss_pred             CCCCCC-ccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHh-------
Q 042763          419 PMDSDR-THISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR-------  489 (554)
Q Consensus       419 ~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~-------  489 (554)
                      ...... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+......       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            322211 111233468899999998865 46899999999999999999999999765543222111110000       


Q ss_pred             -hccCCccc-------cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          490 -YNEGNLLD-------MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       490 -~~~~~~~~-------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                       ........       ..+.... ......+..+.+++.+||+.+|++||++.+++.+.|--
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~  298 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWS-KIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA  298 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHH-HHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence             00000000       0000000 01123457789999999999999999999999998764

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.5e-36  Score=309.72  Aligned_cols=264  Identities=18%  Similarity=0.240  Sum_probs=197.8

Q ss_pred             eeeccCceEEEEEEEcCCcEEEEEEcchhh-hhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCHH
Q 042763          273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQ-FENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLR  351 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~  351 (554)
                      .+|.|+++.||++.. +++.||||++.... .....+.+.+|+++++.++||||+++++++.+.+..+++|||+++++|.
T Consensus         9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   87 (314)
T cd08216           9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE   87 (314)
T ss_pred             hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence            345555555555544 58999999987652 2344567999999999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC----ccc
Q 042763          352 EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR----THI  427 (554)
Q Consensus       352 ~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~----~~~  427 (554)
                      +++.......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||.+.........    ...
T Consensus        88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~  164 (314)
T cd08216          88 DLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF  164 (314)
T ss_pred             HHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence            9998766667899999999999999999999   899999999999999999999999999988654322111    111


Q ss_pred             cccccCCCCCcChhcccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhc-----------cCC
Q 042763          428 STKVKGTVGYLDPEYMKT--YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN-----------EGN  494 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~-----------~~~  494 (554)
                      .....++..|+|||++..  ..++.++||||||+++|||++|+.||.........  .........           ...
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
T cd08216         165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCLLDKSTYPLYEDS  242 (314)
T ss_pred             cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCccccccCchhhhcCC
Confidence            223457788999999876  35889999999999999999999999864432211  111100000           000


Q ss_pred             ccc----cCCh----hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          495 LLD----MVDP----SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       495 ~~~----~~d~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ...    ..++    .............+.+++.+||+.||++|||+.+++++.|-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~  298 (314)
T cd08216         243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF  298 (314)
T ss_pred             cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence            000    0011    01111223345678999999999999999999999999774

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-37  Score=313.30  Aligned_cols=257  Identities=22%  Similarity=0.319  Sum_probs=202.0

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEE
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~l  340 (554)
                      ...+.|++.++||+||.+.||++...+.+.||+|++..... ......|.+|+++|.+|+ |.+|++|++|-..++.+|+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            35677999999999999999999988888888887765543 445678999999999995 9999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||||- ..||..+|+.+......| .+..+..|++.|+.++|   .++|||.||||.|+|+-. |.+||+|||.|.....
T Consensus       438 vmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             Eeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            99965 789999998775555555 77788999999999999   999999999999999865 6899999999987665


Q ss_pred             CCCCccccccccCCCCCcChhccccC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHh
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTY-----------QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR  489 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~  489 (554)
                      +. ........+||+.||+||.+...           ++++++||||||||||+|+.|+.||..-.     .  .|+.  
T Consensus       512 DT-TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n--~~aK--  581 (677)
T KOG0596|consen  512 DT-TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----N--QIAK--  581 (677)
T ss_pred             cc-cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----H--HHHH--
Confidence            43 33344556899999999988432           36689999999999999999999997311     1  1111  


Q ss_pred             hccCCccccCChhhhhhccHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          490 YNEGNLLDMVDPSIKEVISME-ILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       490 ~~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                           +..+.||.-.-.++.- ....+.+++..||++||.+||+..|++++.
T Consensus       582 -----l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp  628 (677)
T KOG0596|consen  582 -----LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP  628 (677)
T ss_pred             -----HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence                 1112222111111110 011289999999999999999999999874

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=303.58  Aligned_cols=265  Identities=25%  Similarity=0.323  Sum_probs=201.9

Q ss_pred             CCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhC---CCCCceeeeeEEEcCCc-----
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKI---DHRNLVKLLGFVDKGNE-----  337 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~~~~-----  337 (554)
                      |++.+.||+|+||.||+|... +++.||+|+++..... .....+.+|+.+++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999876 4899999998754322 2234567788877766   59999999999987776     


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .+++|||+. ++|.+++.......+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999995 58999987654456899999999999999999999   88999999999999999999999999999976


Q ss_pred             CCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC---
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN---  494 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---  494 (554)
                      .....    ......++..|+|||.+.+..++.++||||||+++|||++|..||......+....+...........   
T Consensus       157 ~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         157 YSFEM----ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ccCCc----ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            43221    11233578899999999988899999999999999999999999986554332222111100000000   


Q ss_pred             --------ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          495 --------LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       495 --------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                              ......... .....+....+.+++.+||+.||++||++.+++.+-|
T Consensus       233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~  286 (287)
T cd07838         233 NVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY  286 (287)
T ss_pred             Ccccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence                    000001111 1112244567889999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.9e-37  Score=316.33  Aligned_cols=268  Identities=22%  Similarity=0.278  Sum_probs=202.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC-----Cc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG-----NE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~  337 (554)
                      .++|...+.||+|+||+||+|... +++.||||.+..... ......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457889999999999999999654 689999998875321 22235677899999999999999999987644     34


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .++||||+ +++|.+++...  ..+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            79999999 47899988654  56899999999999999999999   89999999999999999999999999999986


Q ss_pred             CCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL  496 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  496 (554)
                      .....   .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||.........................
T Consensus       158 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         158 TSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             cCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            43221   22233457889999998765 468999999999999999999999997654322221111110000000000


Q ss_pred             c---------------cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          497 D---------------MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       497 ~---------------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .               ..++.... ....+...+.+++.+||+.+|++|||+.+++++.|-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~  294 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL  294 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence            0               00111111 112355678999999999999999999999999553

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.9e-36  Score=296.01  Aligned_cols=255  Identities=25%  Similarity=0.375  Sum_probs=208.0

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC--CceEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG--NERLIIT  342 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~lv~  342 (554)
                      +|...+.||+|++|.||+|... +++.|++|++..... ....+.+.+|++++++++||||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999776 689999999876543 23457789999999999999999999999888  8899999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++++|.+++...  ..+++.+++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            999999999999765  38899999999999999999999   8999999999999999999999999999998754332


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                      .. .......++..|+|||.+.+..++.++||||||+++|+|++|..||........   ..+  ........       
T Consensus       156 ~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~--~~~~~~~~-------  222 (260)
T cd06606         156 TG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA---ALY--KIGSSGEP-------  222 (260)
T ss_pred             cc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHH--hccccCCC-------
Confidence            11 112335688999999999988899999999999999999999999986552111   111  11100000       


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                        ...+......+.+++.+|++.+|++||++.+++.+.|
T Consensus       223 --~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~  259 (260)
T cd06606         223 --PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPF  259 (260)
T ss_pred             --cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence              1122334577899999999999999999999998765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.2e-36  Score=308.29  Aligned_cols=270  Identities=25%  Similarity=0.338  Sum_probs=203.2

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC-----
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN-----  336 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----  336 (554)
                      ..++|++.++||+|+||.||+|... +|+.||+|+++.... +.....+.+|++++++++||||+++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4578889999999999999999775 588999999875432 223356788999999999999999999987654     


Q ss_pred             -----ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEe
Q 042763          337 -----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVAD  411 (554)
Q Consensus       337 -----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~D  411 (554)
                           ..++|+||+++ ++.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+||++++++.+||+|
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence                 78999999965 777777654 346899999999999999999999   89999999999999999999999999


Q ss_pred             ecCcccCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhh
Q 042763          412 FGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY  490 (554)
Q Consensus       412 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  490 (554)
                      ||++........  .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.......
T Consensus       160 fg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         160 FGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             ccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            999986433221  11122346788999998865 357899999999999999999999998655433322222211111


Q ss_pred             ccCCcccc--------CC------hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          491 NEGNLLDM--------VD------PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       491 ~~~~~~~~--------~d------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ........        .+      ....... ...+..+.+++.+||+.+|++||++.+++.+.|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  301 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW  301 (302)
T ss_pred             Chhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            11000000        00      0111111 123567899999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=308.81  Aligned_cols=250  Identities=24%  Similarity=0.352  Sum_probs=207.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .+.|..-++||+|+||.||-++.+ +|+.||.|++.+....  +.....++|-.+|.+++.+.||.+--.|++.+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356888999999999999999655 6999999999877653  3345678999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |..|.||||.-+|.......+++..++.++.+|+.||++||   +..||+|||||+|||+|+.|+++|+|+|+|..++..
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999998887789999999999999999999999   999999999999999999999999999999864322


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                          ......+||.+|||||++.+..|+...|.|||||++|||+.|+.||...........+..   +..+.        
T Consensus       341 ----~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr---r~~~~--------  405 (591)
T KOG0986|consen  341 ----KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR---RTLED--------  405 (591)
T ss_pred             ----CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH---HHhcc--------
Confidence                222334799999999999999999999999999999999999999986554433222211   11110        


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHH
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMK  534 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  534 (554)
                        ...++...+.+..++....|+.||++|.-.+
T Consensus       406 --~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  406 --PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             --hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence              1124445566778888899999999997544

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-36  Score=299.87  Aligned_cols=254  Identities=22%  Similarity=0.317  Sum_probs=200.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhh----hhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC--Cce
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQ----FENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG--NER  338 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~  338 (554)
                      .+|...+.||+|+||.||+|... ++..||+|.+....    .......+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888999999999999999764 58999999875321    123346788999999999999999999998664  457


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ++++||+++++|.+++...  ..+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            8999999999999998754  45789999999999999999999   899999999999999999999999999999864


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ..............++..|+|||.+.+..++.++||||||+++|+|++|+.||.........   ....   ...     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~---~~~-----  225 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI---FKIA---TQP-----  225 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH---HHHH---cCC-----
Confidence            32111111122356889999999999888999999999999999999999999754332211   1111   000     


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                          .....+......+.+++.+||+ +|.+||++.+++.|.
T Consensus       226 ----~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         226 ----TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             ----CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence                0011333455678999999999 579999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.3e-36  Score=297.78  Aligned_cols=253  Identities=27%  Similarity=0.450  Sum_probs=207.8

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +|...+.||+|+||.||++... ++..||+|++..... ......+.+|+++++.++|||++++++.+..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777889999999999999765 588999999876543 23456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          345 VPNGTLREHLDGQY--GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       345 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      +++++|.+++....  ...+++.++..++.+++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999997654  467899999999999999999999   8899999999999999999999999999997643322


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                         .......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||..........       .........     
T Consensus       158 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~~-----  222 (258)
T cd08215         158 ---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL-------KILKGQYPP-----  222 (258)
T ss_pred             ---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH-------HHhcCCCCC-----
Confidence               12233468899999999998889999999999999999999999997654322111       111111111     


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                          .+......+.+++.+||..+|++||++.+++++.|
T Consensus       223 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  257 (258)
T cd08215         223 ----IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPF  257 (258)
T ss_pred             ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence                11133456889999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-38  Score=319.73  Aligned_cols=252  Identities=27%  Similarity=0.385  Sum_probs=206.0

Q ss_pred             CCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .|.-.+.||.|+||.||.|.. .+.+.||||++.-...  ...-.+++.|+..|++++|||++.+-|+|-.+...++|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            456677899999999999954 5688999999865432  2223679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      || -|+-.|++.-. .+++.+.++..|+.+.+.||+|||   +.+.||||||..|||+++.|.|||+|||.|.+.     
T Consensus       107 YC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~-----  176 (948)
T KOG0577|consen  107 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIM-----  176 (948)
T ss_pred             HH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhc-----
Confidence            99 78888888654 368899999999999999999999   999999999999999999999999999998753     


Q ss_pred             CccccccccCCCCCcChhccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          424 RTHISTKVKGTVGYLDPEYMK---TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                        .....++|||.|||||++.   .+.|+-|+||||||++..||.-.++|+...+.-.....+            ...-.
T Consensus       177 --~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI------------AQNes  242 (948)
T KOG0577|consen  177 --APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------------AQNES  242 (948)
T ss_pred             --CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH------------HhcCC
Confidence              1234578999999999874   568999999999999999999999997654322211111            11112


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      |.+.   .++....+.+++..||+.-|++|||..+++.|..-.|.
T Consensus       243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~  284 (948)
T KOG0577|consen  243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE  284 (948)
T ss_pred             CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence            2222   45677889999999999999999999999998654443

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.8e-36  Score=305.08  Aligned_cols=250  Identities=24%  Similarity=0.408  Sum_probs=200.6

Q ss_pred             ceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCC
Q 042763          271 SLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGT  349 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~  349 (554)
                      ..+||+|+||.||++... +|+.||||++.... ......+.+|+.++++++|+||+++++++..++..++||||+++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            347999999999999764 68999999886443 2345678999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccc
Q 042763          350 LREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST  429 (554)
Q Consensus       350 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~  429 (554)
                      |.+++...   .+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||++.......   ....
T Consensus       104 L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~---~~~~  174 (292)
T cd06657         104 LTDIVTHT---RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---PRRK  174 (292)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc---cccc
Confidence            99987543   5789999999999999999999   8899999999999999999999999999987543221   1122


Q ss_pred             cccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccH
Q 042763          430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISM  509 (554)
Q Consensus       430 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  509 (554)
                      ...|++.|+|||.+.+..++.++||||||+++|||++|..||..............   ..         .+....  ..
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~---~~---------~~~~~~--~~  240 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NL---------PPKLKN--LH  240 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---hC---------CcccCC--cc
Confidence            34588999999999888899999999999999999999999986543322211111   00         011000  01


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          510 EILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       510 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      .+...+.+++.+||+.+|.+||++.+++++-|-.+
T Consensus       241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~  275 (292)
T cd06657         241 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK  275 (292)
T ss_pred             cCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhc
Confidence            23445788999999999999999999999877443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-36  Score=313.94  Aligned_cols=270  Identities=24%  Similarity=0.320  Sum_probs=202.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcC--CceE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKG--NERL  339 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~--~~~~  339 (554)
                      .++|+..+.||+|+||.||+|... +|+.+|+|++..... ......+.+|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            467888889999999999999765 588999998854321 22335677899999999 999999999998643  3679


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +||||++ ++|..++...   .+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++...
T Consensus        86 lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            9999996 6999988654   6789999999999999999999   8999999999999999999999999999998653


Q ss_pred             CCCCC--ccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC---
Q 042763          420 MDSDR--THISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG---  493 (554)
Q Consensus       420 ~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---  493 (554)
                      .....  ........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+..........   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            32211  112233568999999998755 467899999999999999999999997655443322221111100000   


Q ss_pred             --------CccccC----ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          494 --------NLLDMV----DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       494 --------~~~~~~----d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                              ...+..    ....... ...+...+.+++.+||+.+|++|||+.+++++.|-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~  298 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDEL-LPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV  298 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhh-ccCCCHHHHHHHHHhccCCcccccCHHHHhhChhh
Confidence                    000000    0001111 11245678999999999999999999999998543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.5e-36  Score=305.41  Aligned_cols=253  Identities=27%  Similarity=0.397  Sum_probs=201.2

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .|...+.||+|+||.||++... ++..||+|++.....  ......+.+|++++++++|||++++++++.+++..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3677889999999999999764 588999998864322  2334578899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+. |+|.+++... ...+++.++..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||++.....   
T Consensus       106 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---  177 (317)
T cd06635         106 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---  177 (317)
T ss_pred             CCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence            995 6888877543 346899999999999999999999   89999999999999999999999999999875321   


Q ss_pred             CccccccccCCCCCcChhccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          424 RTHISTKVKGTVGYLDPEYMK---TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                          .....|++.|+|||.+.   ...++.++|||||||++|||++|+.||.............      .... ..   
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~------~~~~-~~---  243 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------QNES-PT---  243 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH------hccC-CC---
Confidence                12345888999999873   4568899999999999999999999987643222211111      0000 00   


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                           .........+.+++.+||+.+|++||++.+|++++|.+...
T Consensus       244 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         244 -----LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             -----CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence                 01123445688999999999999999999999998765543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4e-36  Score=304.18  Aligned_cols=258  Identities=23%  Similarity=0.366  Sum_probs=200.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC-CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .++|+..+.||+|+||.||+|...+ ++.||||.++.........++..|+.++.+.. ||||+++++++.++...+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3567888999999999999998764 89999999976544444556777888777775 999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE-KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      ||+ .+++.+++... ...+++..+..++.|++.||+|||   + .+++||||+|+||+++.++.+||+|||++......
T Consensus        94 e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          94 ELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             ecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            998 45777776553 247899999999999999999999   5 59999999999999999999999999998754321


Q ss_pred             CCCccccccccCCCCCcChhccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQ----LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~----~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                      .    ......++..|+|||.+.+..    ++.++||||||+++|||++|+.||.......  ..+....   ... ...
T Consensus       169 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~---~~~-~~~  238 (296)
T cd06618         169 K----AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVLTKIL---QEE-PPS  238 (296)
T ss_pred             C----cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HHHHHHh---cCC-CCC
Confidence            1    112335788999999987553    7889999999999999999999997532211  1111111   110 000


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      . ..      ...+...+.+++.+||+.+|++||++.+++++.|-.+
T Consensus       239 ~-~~------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  278 (296)
T cd06618         239 L-PP------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR  278 (296)
T ss_pred             C-CC------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence            0 00      0023456899999999999999999999999988554

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.2e-36  Score=311.02  Aligned_cols=269  Identities=22%  Similarity=0.303  Sum_probs=203.7

Q ss_pred             HHHHHhhcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC-
Q 042763          259 SQVVKATRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG-  335 (554)
Q Consensus       259 ~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-  335 (554)
                      .++...+++|...+.||+|+||.||+|.. .+|+.||+|++..... ....+.+.+|++++++++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            45666789999999999999999999965 4689999999875432 22345678899999999999999999987543 


Q ss_pred             -----CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEE
Q 042763          336 -----NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVA  410 (554)
Q Consensus       336 -----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~  410 (554)
                           ...+++++++ +++|.+++...   .+++..++.++.|+++||+|||   +.+++||||||+||+++.++.+||+
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEe
Confidence                 3467888887 88999888643   5899999999999999999999   8999999999999999999999999


Q ss_pred             eecCcccCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHh
Q 042763          411 DFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR  489 (554)
Q Consensus       411 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~  489 (554)
                      |||+++....      ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+......
T Consensus       163 dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (345)
T cd07877         163 DFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  236 (345)
T ss_pred             cccccccccc------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999875321      1223467899999998866 56889999999999999999999999765433222111111000


Q ss_pred             hccCCccc-cCCh---------------hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          490 YNEGNLLD-MVDP---------------SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       490 ~~~~~~~~-~~d~---------------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      . ...... ..+.               ..... .......+.+++.+|++.||++||++.+++.+.|-
T Consensus       237 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f  303 (345)
T cd07877         237 P-GAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF  303 (345)
T ss_pred             C-CHHHHhhcccHhHHHHHHHhcccCCcchhhh-cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhh
Confidence            0 000000 0000               00000 00124567899999999999999999999999874

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.2e-35  Score=296.37  Aligned_cols=252  Identities=22%  Similarity=0.305  Sum_probs=196.1

Q ss_pred             HHHHHhhcCCCcceee--eccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEc
Q 042763          259 SQVVKATRNFSPSLRI--GEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDK  334 (554)
Q Consensus       259 ~~l~~~~~~f~~~~~L--G~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~  334 (554)
                      .+.....++|.+.+.+  |+|+||.||++..+ ++..+|+|.+........      |+.....+ +||||+++++++..
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI------EPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh------hHHHHHHhhcCCCEEEEEEEEec
Confidence            3444455677777766  99999999999764 588999999876532211      22222222 79999999999999


Q ss_pred             CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC-cEEEEeec
Q 042763          335 GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFG  413 (554)
Q Consensus       335 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfG  413 (554)
                      ++..++||||+++++|.+++...  ..+++.+++.++.|+++||.|||   +.+++||||||+||+++.++ .++|+|||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            99999999999999999999765  37899999999999999999999   88999999999999999998 99999999


Q ss_pred             CcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC
Q 042763          414 FARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG  493 (554)
Q Consensus       414 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  493 (554)
                      +++.....       ....++..|+|||++.+..++.++||||||+++|||++|+.||....... .....+... . ..
T Consensus       156 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-~-~~  225 (267)
T PHA03390        156 LCKIIGTP-------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKR-Q-QK  225 (267)
T ss_pred             cceecCCC-------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHh-h-cc
Confidence            98754321       12358899999999999899999999999999999999999998543321 111111111 1 00


Q ss_pred             CccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHH
Q 042763          494 NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPD-MKSVGEQLW  541 (554)
Q Consensus       494 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~l~  541 (554)
                      .. .         ........+.+++.+||+.+|.+||+ +.|++++-|
T Consensus       226 ~~-~---------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~  264 (267)
T PHA03390        226 KL-P---------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF  264 (267)
T ss_pred             cC-C---------cccccCHHHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence            00 0         11134566899999999999999996 699998866

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-37  Score=324.42  Aligned_cols=256  Identities=26%  Similarity=0.415  Sum_probs=213.5

Q ss_pred             CcceeeeccCceEEEEEEE-cCC----cEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          269 SPSLRIGEGGFGTVYKAQL-EDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       269 ~~~~~LG~G~fG~Vy~a~~-~~g----~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ...++||+|+||+||+|.+ ..|    .+||+|++......+...++++|+-+|.+|+|||+++|+|+|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3456899999999999955 333    4789999988776666789999999999999999999999998755 889999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      ||+.|+|.+|++.++ ..+.....+.|..|||+||.|||   .+.+|||||-.+|||+..-..+||+|||+++....+..
T Consensus       778 ~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             hcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999998764 56788899999999999999999   99999999999999999999999999999998665444


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                      +... ....-.+.|||-|.+....|+.++|||||||++||++| |..|+++....+.-..++...              +
T Consensus       854 ey~~-~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge--------------R  918 (1177)
T KOG1025|consen  854 EYSA-PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE--------------R  918 (1177)
T ss_pred             cccc-cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc--------------c
Confidence            3322 22345678999999999999999999999999999999 999998776554433322110              0


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      +  ..++-+..+++.++.+||-.|+..||+++++...+.+.-.+
T Consensus       919 L--sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  919 L--SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             C--CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            1  13456778899999999999999999999999988776543

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.2e-36  Score=301.20  Aligned_cols=254  Identities=26%  Similarity=0.357  Sum_probs=206.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ++|...+.||+|+||.||+|... +|+.||+|++.....  ......+.+|++++++++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888899999999999999765 689999999876432  233467889999999998 99999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++++|.+++...  ..+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++++|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            9999999999999765  47999999999999999999999   899999999999999999999999999998764332


Q ss_pred             CCC-----------------ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHH
Q 042763          422 SDR-----------------THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR  484 (554)
Q Consensus       422 ~~~-----------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~  484 (554)
                      ...                 ........++..|+|||.+....++.++||||||+++++|++|..||........   ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~  232 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---FQ  232 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---HH
Confidence            211                 0122234578999999999888899999999999999999999999986542211   11


Q ss_pred             HHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHHH
Q 042763          485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDM----KSVGEQLW  541 (554)
Q Consensus       485 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~l~  541 (554)
                      ...    ...          ...+...+..+.+++.+||+.+|++||++    ++++++.|
T Consensus       233 ~~~----~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~  279 (280)
T cd05581         233 KIL----KLE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF  279 (280)
T ss_pred             HHH----hcC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence            111    000          01222335668999999999999999999    88887754

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-36  Score=296.12  Aligned_cols=248  Identities=23%  Similarity=0.304  Sum_probs=193.4

Q ss_pred             eeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHH-HhCCCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELL-SKIDHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l-~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      +.||+|+||.||+|... +|+.||+|++.....  ......+..|..++ ...+|+|++++++++..++..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999764 589999999875432  12223445555544 455899999999999999999999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      ++|.+++...  ..+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||+++....       
T Consensus        82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-------  149 (260)
T cd05611          82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-------  149 (260)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence            9999999754  46889999999999999999999   89999999999999999999999999999875322       


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhc
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI  507 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  507 (554)
                      .....+++.|+|||.+.+..++.++||||||+++|||++|..||............       ......  ....    .
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~--~~~~----~  216 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI-------LSRRIN--WPEE----V  216 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HhcccC--CCCc----c
Confidence            22345888999999998888999999999999999999999999765432211111       111000  0000    1


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHHhh
Q 042763          508 SMEILTKMFGLAIQCAAPIRNDRPDM---KSVGEQLWAIR  544 (554)
Q Consensus       508 ~~~~~~~l~~li~~cl~~dP~~RPs~---~evl~~l~~i~  544 (554)
                      ...++..+.+++.+||+.+|++||++   .|++.+.|-..
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~  256 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS  256 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence            11345678999999999999999955   67777766543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-36  Score=314.98  Aligned_cols=256  Identities=24%  Similarity=0.370  Sum_probs=215.4

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhh-HHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFEN-LQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ....|.+..+||+|.|++|.+|.+. ++..||||.+++..... ....+.+|+++|..|+|||||+++.+.+....+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3567889999999999999999654 69999999998876542 335588999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+.+|.+.+++.++  ..+.+..+..++.|+.+|++|||   ++.|+|||||++|||++.++.+||+|||++.++.  
T Consensus       134 ~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--  206 (596)
T ss_pred             EEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec--
Confidence            9999999999999876  45666889999999999999999   9999999999999999999999999999998753  


Q ss_pred             CCCccccccccCCCCCcChhccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQL-TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                        ........+|++.|.|||++.+..| .++.|+||+|+++|-|+.|..||++....+....+.       .+       
T Consensus       207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl-------~g-------  270 (596)
T KOG0586|consen  207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL-------RG-------  270 (596)
T ss_pred             --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe-------ee-------
Confidence              3345567789999999999999876 479999999999999999999999765443221111       00       


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                       .  -.++.-...++.+++++++-.+|.+|+++.++.++-|.-..
T Consensus       271 -k--~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~  312 (596)
T KOG0586|consen  271 -K--YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL  312 (596)
T ss_pred             -e--ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence             0  01233345567899999999999999999999999886443

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=7.9e-36  Score=294.34  Aligned_cols=250  Identities=26%  Similarity=0.407  Sum_probs=205.0

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +|+..++||+|+||.||++... +++.+|+|++..... .....++.+|++++++++|+||+++++++..+...++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778889999999999999654 688999999876432 23346778999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          345 VPNGTLREHLDGQY--GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       345 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      +++++|.+++....  ...+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999986632  356889999999999999999999   899999999999999999999999999999875432 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                          ......+++.|++||.+.+..++.++|+||||+++|||++|+.||..........       .........     
T Consensus       157 ----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~~-----  220 (256)
T cd08530         157 ----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY-------KVQRGKYPP-----  220 (256)
T ss_pred             ----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHhcCCCCC-----
Confidence                2223458889999999999889999999999999999999999997654322111       111111111     


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                          ........+.+++.+|++.+|++||++.+++++.
T Consensus       221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p  254 (256)
T cd08530         221 ----IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP  254 (256)
T ss_pred             ----CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence                1224456689999999999999999999998763

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=8.6e-36  Score=300.63  Aligned_cols=261  Identities=22%  Similarity=0.322  Sum_probs=203.5

Q ss_pred             CCCcceeeeccCceEEEEEEE----cCCcEEEEEEcchhhh---hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCce
Q 042763          267 NFSPSLRIGEGGFGTVYKAQL----EDGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~~~~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~  338 (554)
                      +|+..+.||+|+||.||+|..    .+|..||+|++.....   ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467788999999999999975    3688999999876432   12346688999999999 599999999999998999


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.|||   +.+++||||+|+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            9999999999999999764  46888999999999999999999   899999999999999999999999999999764


Q ss_pred             CCCCCCccccccccCCCCCcChhccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTY--QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL  496 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  496 (554)
                      ....  ........|+..|+|||.+...  .++.++||||||+++|+|++|..||...........+...  ....    
T Consensus       156 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~----  227 (290)
T cd05613         156 HEDE--VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR--ILKS----  227 (290)
T ss_pred             cccc--ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH--hhcc----
Confidence            3211  1112234688999999998753  4788999999999999999999999753322111111111  0000    


Q ss_pred             ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHhhhhh
Q 042763          497 DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAIRADS  547 (554)
Q Consensus       497 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i~~~~  547 (554)
                         .+.    .+..+...+.+++.+||+.+|++||     ++.+++.+.|--+.++
T Consensus       228 ---~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         228 ---EPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             ---CCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence               000    1222445678999999999999997     8999999865544443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.2e-36  Score=298.23  Aligned_cols=248  Identities=26%  Similarity=0.418  Sum_probs=198.8

Q ss_pred             eeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCH
Q 042763          274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTL  350 (554)
Q Consensus       274 LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L  350 (554)
                      ||+|+||.||++... +|+.+|+|++.....  ....+.+.+|++++++++||||+++++.+..+...+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999876 489999999876543  23456789999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC-----c
Q 042763          351 REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR-----T  425 (554)
Q Consensus       351 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~-----~  425 (554)
                      .+++...  ..+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.........     .
T Consensus        81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENV--GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            9999765  37899999999999999999999   899999999999999999999999999998764322111     1


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE  505 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  505 (554)
                      .......++..|+|||.+.+..++.++||||||+++|||++|..||......+....       ...+...   .+.   
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~---~~~---  222 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN-------ILNGKIE---WPE---  222 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HhcCCcC---CCc---
Confidence            122345578899999999888899999999999999999999999976543222111       1111100   000   


Q ss_pred             hccHHHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHH
Q 042763          506 VISMEILTKMFGLAIQCAAPIRNDRPDM---KSVGEQLW  541 (554)
Q Consensus       506 ~~~~~~~~~l~~li~~cl~~dP~~RPs~---~evl~~l~  541 (554)
                        .......+.+++.+||+.+|.+|||+   .+++.+.|
T Consensus       223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~  259 (265)
T cd05579         223 --DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF  259 (265)
T ss_pred             --cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence              00125678899999999999999999   77766654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.5e-36  Score=313.99  Aligned_cols=269  Identities=19%  Similarity=0.259  Sum_probs=199.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC--------
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG--------  335 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--------  335 (554)
                      ..+|...+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++...        
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            468899999999999999999664 589999998866543 3346688999999999999999999876543        


Q ss_pred             ------CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC-CCCcEE
Q 042763          336 ------NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT-ESMRAK  408 (554)
Q Consensus       336 ------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~-~~~~vk  408 (554)
                            ...++||||++ ++|.+++...   .+++..++.++.||+.||.|||   +.+++||||||+||+++ +++.+|
T Consensus        83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          83 GSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEE
Confidence                  35789999996 6998888643   6889999999999999999999   89999999999999997 456789


Q ss_pred             EEeecCcccCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 042763          409 VADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF  487 (554)
Q Consensus       409 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~  487 (554)
                      |+|||+++................++..|+|||.+.. ..++.++|||||||++|||++|+.||................
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999999764322111111223457889999997654 568899999999999999999999998665433322221110


Q ss_pred             HhhccCCcc--------------ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          488 KRYNEGNLL--------------DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       488 ~~~~~~~~~--------------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .........              ......... ........+.+++.+||+.||++|||+.|++.+.|-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~  303 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM  303 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence            000000000              000000000 111234568899999999999999999999988664

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3e-36  Score=306.43  Aligned_cols=271  Identities=24%  Similarity=0.309  Sum_probs=200.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC------
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN------  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------  336 (554)
                      .++|+..++||+|+||.||+|... +++.+|+|++...... .....+.+|++++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999765 5889999988654322 22345778999999999999999999874433      


Q ss_pred             --ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecC
Q 042763          337 --ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGF  414 (554)
Q Consensus       337 --~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl  414 (554)
                        ..++||||+. ++|...+... ...+++.++..++.|+++||+|||   +.+++|+||||+||+++.++.++|+|||+
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence              4699999995 5777777643 347899999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCCCCCc--------cccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH
Q 042763          415 ARLGPMDSDRT--------HISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRW  485 (554)
Q Consensus       415 a~~~~~~~~~~--------~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~  485 (554)
                      ++.........        ...+...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            97643222111        11123457889999998765 3589999999999999999999999986554433222211


Q ss_pred             HHHhhccC--------------CccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          486 AFKRYNEG--------------NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       486 ~~~~~~~~--------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ......+.              .......+.+.... ......+.+++.+||+.+|++|||+.|++.+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~  310 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY  310 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence            11100000              00001111111111 122356889999999999999999999998764

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.5e-35  Score=300.01  Aligned_cols=259  Identities=20%  Similarity=0.238  Sum_probs=186.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC----CcEEEEEEcchhhhhhH----------HHHHHHHHHHHHhCCCCCceeeee
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED----GLLVAIKRAKKEQFENL----------QTEFSSEVELLSKIDHRNLVKLLG  330 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~~~~----------~~~~~~Ei~~l~~l~HpnIv~l~~  330 (554)
                      .++|.+.++||+|+||+||+|...+    +..+|+|+.........          ......+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3679999999999999999997654    34566665432211100          011223344556678999999998


Q ss_pred             EEEcCC----ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc
Q 042763          331 FVDKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR  406 (554)
Q Consensus       331 ~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~  406 (554)
                      ++....    ..++++|++ ..++.+.+...  ...++..++.++.|++.||+|||   +++|+||||||+|||++.++.
T Consensus        91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCc
Confidence            765443    346788877 45677766543  34578888999999999999999   899999999999999999999


Q ss_pred             EEEEeecCcccCCCCCCCc----cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHH-
Q 042763          407 AKVADFGFARLGPMDSDRT----HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERV-  481 (554)
Q Consensus       407 vkl~DfGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~-  481 (554)
                      ++|+|||+|+.........    .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... 
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            9999999998653221111    11123469999999999999999999999999999999999999998763322211 


Q ss_pred             HHHH-HHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          482 TLRW-AFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       482 ~~~~-~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                      .... .......+..           ....++..+.+++..|++.+|++||++.++.+.+
T Consensus       245 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        245 AAKCDFIKRLHEGKI-----------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HhHHHHHHHhhhhhh-----------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1111 1111111111           0112346789999999999999999999998865

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6.5e-36  Score=308.13  Aligned_cols=270  Identities=23%  Similarity=0.291  Sum_probs=201.8

Q ss_pred             cCCCc-ceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhh-------------HHHHHHHHHHHHHhCCCCCceeeee
Q 042763          266 RNFSP-SLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFEN-------------LQTEFSSEVELLSKIDHRNLVKLLG  330 (554)
Q Consensus       266 ~~f~~-~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~-------------~~~~~~~Ei~~l~~l~HpnIv~l~~  330 (554)
                      ++|.. .+.||+|+||+||+|... +++.||||+++......             ....+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            44543 467999999999999755 68999999886543221             1124778999999999999999999


Q ss_pred             EEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEE
Q 042763          331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVA  410 (554)
Q Consensus       331 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~  410 (554)
                      ++..++..++||||+. |+|.+++...  ..+++.....++.|++.||+|||   +.+++|+||+|+||+++.++.++|+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEEC
Confidence            9999999999999995 7999998654  46899999999999999999999   8999999999999999999999999


Q ss_pred             eecCcccCCCCC-----------CCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChh
Q 042763          411 DFGFARLGPMDS-----------DRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPE  478 (554)
Q Consensus       411 DfGla~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~  478 (554)
                      |||+++......           ..........+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999997643111           001111223468899999998764 47899999999999999999999998665433


Q ss_pred             hHHHHHHHHHhhccCCccc------------cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          479 ERVTLRWAFKRYNEGNLLD------------MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~------------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ....+...........+.+            ...+..... .......+.+++.+||+.+|++||++.|++.+.|-
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~  316 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF  316 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence            2221111111111100000            001111111 11235678899999999999999999999998775

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1e-35  Score=298.57  Aligned_cols=250  Identities=23%  Similarity=0.310  Sum_probs=193.5

Q ss_pred             eeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHH---HHHHhCCCCCceeeeeEEEcCCceEEEEEeCC
Q 042763          273 RIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEV---ELLSKIDHRNLVKLLGFVDKGNERLIITEFVP  346 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei---~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  346 (554)
                      .||+|+||.||+|... +++.||+|.+......  .....+..|.   ..++...||||+++++++..++..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            3899999999999664 5889999988764322  1112233443   34445689999999999999999999999999


Q ss_pred             CCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcc
Q 042763          347 NGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH  426 (554)
Q Consensus       347 ~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~  426 (554)
                      +++|.+++...  ..+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......     
T Consensus        81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-----  150 (278)
T cd05606          81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----  150 (278)
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-----
Confidence            99999998654  57899999999999999999999   899999999999999999999999999998753211     


Q ss_pred             ccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhh
Q 042763          427 ISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE  505 (554)
Q Consensus       427 ~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  505 (554)
                      ......|+..|+|||.+.+. .++.++||||+|+++|||++|+.||........... ...   ...      .+..   
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~~~---~~~------~~~~---  217 (278)
T cd05606         151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRM---TLT------MAVE---  217 (278)
T ss_pred             CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-HHH---hhc------cCCC---
Confidence            11234689999999998754 689999999999999999999999986533221111 110   000      0011   


Q ss_pred             hccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHhhhh
Q 042763          506 VISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAIRAD  546 (554)
Q Consensus       506 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i~~~  546 (554)
                       .+...+..+.+++.+|+..+|.+||     ++.+++++.|-...+
T Consensus       218 -~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         218 -LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             -CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence             1122346788999999999999999     999999987765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-37  Score=293.68  Aligned_cols=263  Identities=22%  Similarity=0.302  Sum_probs=215.2

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|...++||+|.||.|.+++.+ +|+.+|+|++++.-.  .+....-+.|-.+|+..+||.+..|--.|...+.+++||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            57888889999999999999655 699999999988754  233455678899999999999999988899999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+.||.|.-+|...  +.+++...+.+...|+.||.|||   +++||+||||.+|.|+|.+|++||+|||+++.   ..
T Consensus       248 eyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE---~I  319 (516)
T KOG0690|consen  248 EYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKE---EI  319 (516)
T ss_pred             EEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchh---cc
Confidence            999999999998764  67899999999999999999999   89999999999999999999999999999985   23


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                      ........+||||.|+|||++....|+.+.|.|.+||++|||+.|+.||...+.......+...       .        
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-------d--------  384 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-------D--------  384 (516)
T ss_pred             cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-------h--------
Confidence            3344456789999999999999999999999999999999999999999876554332222111       0        


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHhhhhhhhhhcc
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAIRADSLKSVKK  553 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i~~~~~~~~~~  553 (554)
                      +  .++..+..+...|+.-.|..||.+|.     .++||.++-.-.--+|-+-.+|
T Consensus       385 ~--kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~K  438 (516)
T KOG0690|consen  385 L--KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRK  438 (516)
T ss_pred             c--cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHh
Confidence            0  13334455677888899999999996     4788887755554455444433

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-37  Score=308.47  Aligned_cols=250  Identities=25%  Similarity=0.361  Sum_probs=206.3

Q ss_pred             ceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCC
Q 042763          271 SLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNG  348 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g  348 (554)
                      .+.||.|.||+||-|.+ ++|+.||||++.+..+. +....+++|+.+|.+++||.||.+...|++.+..++|||-+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            45799999999999955 47999999999887663 44577899999999999999999999999999999999999 77


Q ss_pred             CHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC---CcEEEEeecCcccCCCCCCCc
Q 042763          349 TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES---MRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       349 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~---~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ++.+.+-......+++.....+..||+.||.|||   -++|+|.||||+|||+...   ..+||||||+||+.+..    
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk----  720 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK----  720 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchh----
Confidence            7777776555568899999999999999999999   8999999999999999654   46999999999986532    


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE  505 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  505 (554)
                      .....++|||.|+|||+++.+.|+..-|+||.|||+|--++|..||..+..-.  +.++.+..+         ..+... 
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNAaFM---------yPp~PW-  788 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNAAFM---------YPPNPW-  788 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhhccccc---------cCCCch-
Confidence            23445789999999999999999999999999999999999999998544322  222222211         222222 


Q ss_pred             hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          506 VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       506 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                         .++.....++|...|+..-++|-|..+-+.|.|--
T Consensus       789 ---~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq  823 (888)
T KOG4236|consen  789 ---SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQ  823 (888)
T ss_pred             ---hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhh
Confidence               23445578899999999999999999999998843

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.1e-36  Score=307.67  Aligned_cols=270  Identities=24%  Similarity=0.293  Sum_probs=203.6

Q ss_pred             HHHHhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc-CC
Q 042763          260 QVVKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK-GN  336 (554)
Q Consensus       260 ~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~  336 (554)
                      ++...+++|+..+.||+|+||.||+|... +++.||+|++..... ....+.+.+|++++++++||||+++++++.. +.
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            34456789999999999999999999655 689999998765322 2334678899999999999999999998865 56


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ..+++|||+ +++|.+++...   .+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++.
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            789999999 67899888643   5788888899999999999999   8999999999999999999999999999987


Q ss_pred             cCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH--------
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF--------  487 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~--------  487 (554)
                      ....      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+....        
T Consensus       157 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  230 (328)
T cd07856         157 IQDP------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI  230 (328)
T ss_pred             ccCC------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            5321      1123457889999998766 568999999999999999999999997654322211111100        


Q ss_pred             HhhccCCccccC------ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          488 KRYNEGNLLDMV------DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       488 ~~~~~~~~~~~~------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .........+..      .+.........+...+.+++.+||+.+|++||++.+++.+.|-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~  291 (328)
T cd07856         231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL  291 (328)
T ss_pred             HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence            000000000000      0000000011234678999999999999999999999998665

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-36  Score=310.52  Aligned_cols=261  Identities=21%  Similarity=0.306  Sum_probs=196.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC------
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN------  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------  336 (554)
                      ..+|...+.||+|+||.||+|... +|+.||||++..... +.....+.+|++++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            378999999999999999999764 689999999875422 223456889999999999999999999986543      


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ..++|+||+. .+|..++.    ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            4589999995 57776652    35889999999999999999999   8999999999999999999999999999987


Q ss_pred             cCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      .....      .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..... ......
T Consensus       166 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~  238 (342)
T cd07879         166 HADAE------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG-VPGPEF  238 (342)
T ss_pred             CCCCC------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCCHHH
Confidence            53211      123457889999999876 4689999999999999999999999987554332222111100 000000


Q ss_pred             ccc----------------CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          496 LDM----------------VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       496 ~~~----------------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .+.                ....+.. ..+.....+.+++.+||+.||++||++.+++.+.|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~  299 (342)
T cd07879         239 VQKLEDKAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY  299 (342)
T ss_pred             HHHhcccchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence            000                0000000 00123456889999999999999999999998843

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-35  Score=290.79  Aligned_cols=250  Identities=30%  Similarity=0.443  Sum_probs=204.3

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +|+..+.||+|++|.||++... +++.|++|.+...... ...+.+.+|++++++++|||++++++++.+++..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4777889999999999999765 5789999998766431 3456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++...  ..+++..++.++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (254)
T cd06627          81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-  154 (254)
T ss_pred             CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence            9999999999765  57899999999999999999999   89999999999999999999999999999986433221 


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                        ......++..|+|||.+.+..++.++|||+||+++|+|++|+.||........    .+........        .  
T Consensus       155 --~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~--------~--  218 (254)
T cd06627         155 --DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----LFRIVQDDHP--------P--  218 (254)
T ss_pred             --cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHhccCCC--------C--
Confidence              12334688999999999888889999999999999999999999975442111    1111111110        0  


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                        .+......+.+++.+||..+|++||++.+++.+-
T Consensus       219 --~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~  252 (254)
T cd06627         219 --LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHP  252 (254)
T ss_pred             --CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCC
Confidence              1122345678999999999999999999998753

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-36  Score=298.68  Aligned_cols=265  Identities=24%  Similarity=0.352  Sum_probs=203.6

Q ss_pred             CCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      |+..+.||+|+||.||+|... +++.||+|++..... +...+.+..|++++++++|+|++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            455678999999999999776 489999999876542 233467788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      + ++|.+++.... ..+++.+++.++.|++.||+|||   +.+++||||+|+||++++++.++|+|||+++.......  
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  153 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--  153 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence            6 69999997653 46899999999999999999999   88999999999999999999999999999976432211  


Q ss_pred             cccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhc-------------
Q 042763          426 HISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN-------------  491 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~-------------  491 (554)
                       ......++..|+|||.+.+. .++.++||||||+++|||++|..||......+....+........             
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence             12233467889999998776 789999999999999999999999976554332222111100000             


Q ss_pred             cCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          492 EGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       492 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ................ +.....+.+++.+||+.+|++||++.+++.+.|
T Consensus       233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~  281 (282)
T cd07829         233 KPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY  281 (282)
T ss_pred             cccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence            0000000011111111 123567899999999999999999999998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-36  Score=314.39  Aligned_cols=248  Identities=27%  Similarity=0.406  Sum_probs=195.2

Q ss_pred             CcceeeeccCceEEEEEEE-cCCcEEEEEEc---chhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc--eEEEE
Q 042763          269 SPSLRIGEGGFGTVYKAQL-EDGLLVAIKRA---KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE--RLIIT  342 (554)
Q Consensus       269 ~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~---~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~--~~lv~  342 (554)
                      ....+||+|+|-+||+|-+ .+|..||--.+   +........++|..|+.+|+.|+||||++++.++.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            3445799999999999944 45888874322   222334445789999999999999999999999977655  78899


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC-CCcEEEEeecCcccCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE-SMRAKVADFGFARLGPMD  421 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~~~~~~  421 (554)
                      |.|..|+|+.|+++.  +.++.+.+..|+.||++||.|||.. ..+|+|||||-+||+|+. .|.|||+|+|+|......
T Consensus       123 EL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            999999999999877  6788899999999999999999964 679999999999999975 689999999999874322


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                      .     ...+.|||.|||||... ..|+...||||||+.|+||.|+.+||..-..+-.  .++.+........+...-||
T Consensus       200 ~-----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ--IYKKV~SGiKP~sl~kV~dP  271 (632)
T KOG0584|consen  200 H-----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ--IYKKVTSGIKPAALSKVKDP  271 (632)
T ss_pred             c-----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH--HHHHHHcCCCHHHhhccCCH
Confidence            1     22367999999999988 5899999999999999999999999975444322  12222221222222222222


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                                  ++.++|.+|+.. .++|||+.|++.+.
T Consensus       272 ------------evr~fIekCl~~-~~~R~sa~eLL~d~  297 (632)
T KOG0584|consen  272 ------------EVREFIEKCLAT-KSERLSAKELLKDP  297 (632)
T ss_pred             ------------HHHHHHHHHhcC-chhccCHHHHhhCh
Confidence                        367889999999 99999999999874

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-35  Score=307.85  Aligned_cols=266  Identities=21%  Similarity=0.298  Sum_probs=201.5

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC----
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN----  336 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----  336 (554)
                      ...++|+..+.||+|+||.||+|.. .+|..||||++..... ......+.+|++++++++||||+++++++..+.    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            3567899999999999999999965 4689999998864322 233456889999999999999999999986543    


Q ss_pred             --ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecC
Q 042763          337 --ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGF  414 (554)
Q Consensus       337 --~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl  414 (554)
                        ..++||||+ +++|.+++..   ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence              358999999 7899988864   36899999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH------
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF------  487 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~------  487 (554)
                      +......      .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||................      
T Consensus       165 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07880         165 ARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE  238 (343)
T ss_pred             ccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            9753221      123357889999998876 458899999999999999999999998654322211110000      


Q ss_pred             --HhhccCC-------ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          488 --KRYNEGN-------LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       488 --~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                        .......       +.......+.. ....+...+.+++.+|++.||++|||+.+++.+.|-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~  301 (343)
T cd07880         239 FVQKLQSEDAKNYVKKLPRFRKKDFRS-LLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF  301 (343)
T ss_pred             HHHhhcchhHHHHHHhccccCcchHHH-hccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccH
Confidence              0000000       00000001111 112334568899999999999999999999987654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.3e-35  Score=296.05  Aligned_cols=255  Identities=22%  Similarity=0.317  Sum_probs=197.1

Q ss_pred             CCCcceeeeccCceEEEEEEEc----CCcEEEEEEcchhhh---hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCce
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~  338 (554)
                      +|+..+.||+|+||.||++...    +++.||||+++....   ....+.+.+|++++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4677889999999999998642    578899999875432   22345688999999999 599999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            9999999999999998754  46889999999999999999999   899999999999999999999999999998764


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQ--LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL  496 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  496 (554)
                      ....  ........|+..|+|||.+.+..  .+.++||||||+++|||++|..||.............   ......   
T Consensus       156 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~---~~~~~~---  227 (288)
T cd05583         156 LAEE--EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS---RRILKS---  227 (288)
T ss_pred             cccc--ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHH---HHHHcc---
Confidence            3221  11122345889999999987654  7889999999999999999999996433211111111   111000   


Q ss_pred             ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHH---HHHHH
Q 042763          497 DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV---GEQLW  541 (554)
Q Consensus       497 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev---l~~l~  541 (554)
                         .+.    .+......+.+++.+||+.+|++|||+.++   +++.|
T Consensus       228 ---~~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~  268 (288)
T cd05583         228 ---KPP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF  268 (288)
T ss_pred             ---CCC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence               000    112234567899999999999999996655   55543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.9e-35  Score=298.91  Aligned_cols=248  Identities=27%  Similarity=0.383  Sum_probs=197.4

Q ss_pred             CCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      |...++||+|+||+||+|... +|..||+|++.....  ......+.+|++++++++|||++++++++.++...++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            556678999999999999764 588999999865432  23335688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +. |++.+++... ...+++.+++.++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++.....    
T Consensus       103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            94 6888877643 346899999999999999999999   88999999999999999999999999999864211    


Q ss_pred             ccccccccCCCCCcChhccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          425 THISTKVKGTVGYLDPEYMK---TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                         .....|+..|+|||.+.   ...++.++||||||+++|||++|..||.............      .. .....   
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~------~~-~~~~~---  240 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------QN-DSPTL---  240 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH------hc-CCCCC---
Confidence               12346889999999884   4568899999999999999999999997654322221111      00 00000   


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                           ........+.+++.+||+.+|++||++.+++.+.|-
T Consensus       241 -----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~  276 (313)
T cd06633         241 -----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFV  276 (313)
T ss_pred             -----CccccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence                 111233468899999999999999999999988554

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.9e-36  Score=309.65  Aligned_cols=265  Identities=23%  Similarity=0.297  Sum_probs=201.8

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc----
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE----  337 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~----  337 (554)
                      ..++|...+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++++++|||++++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999775 588999998865321 2234567789999999999999999998766554    


Q ss_pred             --eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCc
Q 042763          338 --RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA  415 (554)
Q Consensus       338 --~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla  415 (554)
                        .++|+||+ +++|.+++..   ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence              89999999 7799999875   36899999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH------
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFK------  488 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~------  488 (554)
                      ......      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.....      
T Consensus       166 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         166 RHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             cccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            764221      223457889999998865 3678999999999999999999999976544322211111000      


Q ss_pred             --hhccCCcc-------ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          489 --RYNEGNLL-------DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       489 --~~~~~~~~-------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                        +.......       ....+..... .......+.+++.+||+.+|++|||+.||+++.|-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~  301 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL  301 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCc
Confidence              00000000       0000000000 01235678999999999999999999999988654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=326.31  Aligned_cols=263  Identities=31%  Similarity=0.435  Sum_probs=211.6

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc--------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEc
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE--------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDK  334 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~  334 (554)
                      ..++..+.+.||+|.||.|++|...        ....||||.++........+.+..|+++|+.+ +|+||+.++|+|.+
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3344455668999999999999643        14579999998877677778899999999998 69999999999999


Q ss_pred             CCceEEEEEeCCCCCHHHHHhccc------------C--CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeE
Q 042763          335 GNERLIITEFVPNGTLREHLDGQY------------G--KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNIL  400 (554)
Q Consensus       335 ~~~~~lv~E~~~~g~L~~~l~~~~------------~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIL  400 (554)
                      .+..++|+||++.|+|.+|++..+            .  ..+...+.+.++.|||.|++||+   +.+++||||..+|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEE
Confidence            999999999999999999998764            0  13888999999999999999999   899999999999999


Q ss_pred             ECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhh
Q 042763          401 LTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEE  479 (554)
Q Consensus       401 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~  479 (554)
                      ++++..+||+|||+|+................-...|||||.+....|+.|+||||||++||||+| |..||.+.....+
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~  530 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE  530 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence            999999999999999864333222211111113456999999999999999999999999999999 8899976332222


Q ss_pred             HHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          480 RVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      .  ..+    .+++.-.         ..+..+..++++++..||+.+|++||++.++.+.+..+-
T Consensus       531 l--~~~----l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  531 L--LEF----LKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             H--HHH----HhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            1  222    2222211         134456778999999999999999999999999998853

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.1e-35  Score=300.85  Aligned_cols=253  Identities=26%  Similarity=0.387  Sum_probs=200.5

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhh--hhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQ--FENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      +.|+..+.||+|+||.||+|... ++..+|+|.+....  ......++.+|+++++.++|+|++++++++..+...++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34666788999999999999765 57899999886432  2233456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+. |++.+++... ...+++.++..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++.....  
T Consensus        95 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--  167 (308)
T cd06634          95 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (308)
T ss_pred             EccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence            9995 6888877543 245889999999999999999999   89999999999999999999999999999875321  


Q ss_pred             CCccccccccCCCCCcChhccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          423 DRTHISTKVKGTVGYLDPEYMK---TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                           .....+++.|+|||.+.   ...++.++|||||||++|||++|..||.............       ....    
T Consensus       168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-------~~~~----  231 (308)
T cd06634         168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------QNES----  231 (308)
T ss_pred             -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh-------hcCC----
Confidence                 12345888999999874   3467889999999999999999999987543222111110       0000    


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                       +.   .........+.+++.+||+.+|++||++.+++.+.|.+..
T Consensus       232 -~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         232 -PA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             -CC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence             00   0112344668899999999999999999999999886654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.9e-35  Score=304.40  Aligned_cols=269  Identities=22%  Similarity=0.265  Sum_probs=197.8

Q ss_pred             CCCcceeeeccCceEEEEEEEc-C--CcEEEEEEcchhhh-hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEc----CCc
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-D--GLLVAIKRAKKEQF-ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDK----GNE  337 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~--g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~----~~~  337 (554)
                      +|...+.||+|+||.||++... .  +..||+|++..... ....+.+.+|+++++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4777889999999999999765 3  77899998875322 22345678899999999 59999999987533    245


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .++++||+. ++|.+++...  ..+++.+++.++.||+.||+|||   +.+++||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            688999984 7999998654  57899999999999999999999   89999999999999999999999999999976


Q ss_pred             CCCCCCC-ccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          418 GPMDSDR-THISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       418 ~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      ....... ........|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........................
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            4322111 111233568999999998765 46899999999999999999999999865432221111111000000000


Q ss_pred             cccCC---------------hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          496 LDMVD---------------PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       496 ~~~~d---------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .....               ..+.. ........+.+++.+||+.+|++|||+.+++.+.|-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~  295 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL  295 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence            00000               00000 111124578899999999999999999999998774

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.4e-36  Score=329.07  Aligned_cols=258  Identities=25%  Similarity=0.369  Sum_probs=194.2

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC------
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG------  335 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------  335 (554)
                      +-..+|++...||+||||.||+++.+ ||+.||||++...........+.+|+.++++|+|||||+++..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34567888889999999999999876 89999999998776566667899999999999999999987521000      


Q ss_pred             --------------------------------------------------------------------------------
Q 042763          336 --------------------------------------------------------------------------------  335 (554)
Q Consensus       336 --------------------------------------------------------------------------------  335 (554)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhh
Q 042763          336 ---------------------------------NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLH  382 (554)
Q Consensus       336 ---------------------------------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH  382 (554)
                                                       ..+||-||||+...+.++++.+.... .....|+++.+|+.||.|+|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence                                             12468899999888888887652111 47788999999999999999


Q ss_pred             hccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC---------------CCCCCccccccccCCCCCcChhccccCC
Q 042763          383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP---------------MDSDRTHISTKVKGTVGYLDPEYMKTYQ  447 (554)
Q Consensus       383 ~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~---------------~~~~~~~~~~~~~gt~~y~aPE~l~~~~  447 (554)
                         +.+||||||||.||+++++..|||+|||+|+...               .........+..+||.-|+|||++.+..
T Consensus       715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence               8999999999999999999999999999998611               0011112345567999999999997654


Q ss_pred             ---CCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccC
Q 042763          448 ---LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAA  524 (554)
Q Consensus       448 ---~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~  524 (554)
                         |+.|+|+||||+|++||+.   ||...   .++..+-   ...+.+.+..-     .. +..+....-..+|.+|++
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts---MERa~iL---~~LR~g~iP~~-----~~-f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTS---MERASIL---TNLRKGSIPEP-----AD-FFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCch---HHHHHHH---HhcccCCCCCC-----cc-cccccchHHHHHHHHHhc
Confidence               9999999999999999985   45421   2222211   11223332221     00 111222234689999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 042763          525 PIRNDRPDMKSVGEQ  539 (554)
Q Consensus       525 ~dP~~RPs~~evl~~  539 (554)
                      .||.+|||+.|++..
T Consensus       857 hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  857 HDPSKRPTATELLNS  871 (1351)
T ss_pred             CCCccCCCHHHHhhc
Confidence            999999999999865

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.7e-35  Score=293.29  Aligned_cols=252  Identities=29%  Similarity=0.378  Sum_probs=197.2

Q ss_pred             CCCcceeeeccCceEEEEEEEcC-CcEEEEEEcchhhh----hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQF----ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      +|.+.++||+|+||.||++.... +..+++|.++....    ......+..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788899999999999996653 44455555543221    12234577899999999999999999999988999999


Q ss_pred             EEeCCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          342 TEFVPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      |||+++++|.+++...  ....+++.+++.++.|++.||.|||   +.+++|+||+|+||+++. +.++|+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988642  3457899999999999999999999   899999999999999975 569999999987643


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ...   .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.........   ..    ...+.     
T Consensus       157 ~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~---~~----~~~~~-----  221 (260)
T cd08222         157 GSC---DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV---LR----IVEGP-----  221 (260)
T ss_pred             CCc---ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH---HH----HHcCC-----
Confidence            221   2223456889999999998888999999999999999999999999753322111   11    11111     


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .+.    .+..+...+.+++.+||+.+|++||++.|++++.|
T Consensus       222 ~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  259 (260)
T cd08222         222 TPS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF  259 (260)
T ss_pred             CCC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence            111    22345567899999999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-36  Score=312.94  Aligned_cols=273  Identities=27%  Similarity=0.384  Sum_probs=210.7

Q ss_pred             CCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC------CceEE
Q 042763          268 FSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG------NERLI  340 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------~~~~l  340 (554)
                      |...+.||+|+||.||+|+. .+|+.||||.++........+...+|+++|++|+|||||+++++-++.      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            34455799999999999984 579999999998877666778899999999999999999999876543      35689


Q ss_pred             EEEeCCCCCHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC--CCC--cEEEEeecCc
Q 042763          341 ITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT--ESM--RAKVADFGFA  415 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~--~~~--~vkl~DfGla  415 (554)
                      |||||.+|+|+..|+.- +...+++.+.+.++.++..||.|||   +++|+||||||.||++-  .+|  ..||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            99999999999999753 3458999999999999999999999   99999999999999984  333  4799999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      +-...+    .....+.||+.|++||.... +.|+...|.|||||++|+..||..||.....+.....+.|....-....
T Consensus       172 rel~d~----s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  172 RELDDN----SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             ccCCCC----CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            965433    25566789999999999984 7899999999999999999999999987655543333444332222211


Q ss_pred             ccccCChhhh------------hhccHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHHHhhhhh
Q 042763          495 LLDMVDPSIK------------EVISMEILTKMFGLAIQCAAPIRNDRP--DMKSVGEQLWAIRADS  547 (554)
Q Consensus       495 ~~~~~d~~l~------------~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~l~~i~~~~  547 (554)
                      +.-..++...            ..........+-..+..+|..+|++|-  ...+....+..|....
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence            1111111110            011223445667777788899999999  7777777777766543

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=7.4e-35  Score=325.46  Aligned_cols=146  Identities=27%  Similarity=0.447  Sum_probs=131.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|.+.++||+|+||+||+|... +++.||||+++....  ......+.+|+.+++.++||||+++++++...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999766 689999999876432  233467889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ||+++++|.+++...  ..+++..++.++.||+.||+|||   .++|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999654  46788999999999999999999   8899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-37  Score=337.98  Aligned_cols=255  Identities=25%  Similarity=0.335  Sum_probs=203.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      +-+|+...+||.|.||.||.|.. .+|...|+|-++-... ......+.+|+.++..|+|||+|+.+|+-.+.+..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            45778888999999999999954 5699999997765433 334467889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      |||++|+|.+.+...  ...++.....+..|++.|++|||   +++||||||||+||+++.+|.+|++|||.|.......
T Consensus      1314 EyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            999999999999643  45677777788999999999999   9999999999999999999999999999998754332


Q ss_pred             -CCccccccccCCCCCcChhccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          423 -DRTHISTKVKGTVGYLDPEYMKTY---QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       423 -~~~~~~~~~~gt~~y~aPE~l~~~---~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                       +-........||+.|||||++.+.   +...++||||||||+.||+||++||...+..   ..+.+.......+.    
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy~V~~gh~Pq---- 1461 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMYHVAAGHKPQ---- 1461 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHHHhHHhccCCCC----
Confidence             111222346799999999999763   4567899999999999999999999754332   11222111112211    


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQ  539 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  539 (554)
                              ++......-.+++.+||+.||.+|.++.|++++
T Consensus      1462 --------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 --------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             --------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                    333455666889999999999999999988876

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-35  Score=287.57  Aligned_cols=243  Identities=27%  Similarity=0.349  Sum_probs=198.1

Q ss_pred             eeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCH
Q 042763          274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTL  350 (554)
Q Consensus       274 LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L  350 (554)
                      ||+|+||.||++... +++.+|+|++......  .....+..|++++++++||||+++++.+..+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999765 4899999998776432  2446789999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcccccc
Q 042763          351 REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK  430 (554)
Q Consensus       351 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~  430 (554)
                      .+++...  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~  152 (250)
T cd05123          81 FSHLSKE--GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SRTNT  152 (250)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC---CcccC
Confidence            9999765  36899999999999999999999   8999999999999999999999999999987643221   12234


Q ss_pred             ccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHH
Q 042763          431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISME  510 (554)
Q Consensus       431 ~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  510 (554)
                      ..++..|+|||...+...+.++|+||||+++|+|++|..||........   ....    .....          ..+..
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~~~----~~~~~----------~~~~~  215 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI---YEKI----LKDPL----------RFPEF  215 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH----hcCCC----------CCCCC
Confidence            5688899999999888899999999999999999999999975443111   1111    11100          01122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCH---HHHHHHHH
Q 042763          511 ILTKMFGLAIQCAAPIRNDRPDM---KSVGEQLW  541 (554)
Q Consensus       511 ~~~~l~~li~~cl~~dP~~RPs~---~evl~~l~  541 (554)
                      .+..+.+++.+||..||++||++   .+++++.|
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~  249 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF  249 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCC
Confidence            24667899999999999999999   67766543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-35  Score=280.29  Aligned_cols=272  Identities=24%  Similarity=0.373  Sum_probs=212.0

Q ss_pred             ChHHHHHhhcCCCcceeeeccCceEEEEE-EEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEc
Q 042763          257 NMSQVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDK  334 (554)
Q Consensus       257 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~a-~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~  334 (554)
                      .++++.+.+     .+.||+|+|+.|-.+ ...+|.+||||++.+.. ...+.++.+|++++.+.+ |+||++|+++|++
T Consensus        74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd  147 (463)
T KOG0607|consen   74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFED  147 (463)
T ss_pred             hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence            456766666     346999999999998 45689999999998874 445678999999999985 9999999999999


Q ss_pred             CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc---EEEEe
Q 042763          335 GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR---AKVAD  411 (554)
Q Consensus       335 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~---vkl~D  411 (554)
                      +...|+|||-|.||.|..+++++  +-+++.++-++.++|+.||.+||   .++|.|||+||+|||-.....   |||||
T Consensus       148 d~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCD  222 (463)
T KOG0607|consen  148 DTRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICD  222 (463)
T ss_pred             cceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeec
Confidence            99999999999999999999876  67999999999999999999999   999999999999999876543   89999


Q ss_pred             ecCcccCCCCCCCccc----cccccCCCCCcChhccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCh-----
Q 042763          412 FGFARLGPMDSDRTHI----STKVKGTVGYLDPEYMK-----TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP-----  477 (554)
Q Consensus       412 fGla~~~~~~~~~~~~----~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~-----  477 (554)
                      |.+..-.....+-...    ....+|+..|||||+..     ...|+.+.|.||||||||-||.|.+||.+.-..     
T Consensus       223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd  302 (463)
T KOG0607|consen  223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD  302 (463)
T ss_pred             cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence            9987543222222211    22356899999999763     236899999999999999999999999764321     


Q ss_pred             --hh-HHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          478 --EE-RVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       478 --~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                        +. ..--...+..+.++.+. +.|...     ..++....+++...+-.++.+|.++.+++.+.|-=+.
T Consensus       303 rGe~Cr~CQ~~LFesIQEGkYe-FPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~  367 (463)
T KOG0607|consen  303 RGEVCRVCQNKLFESIQEGKYE-FPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC  367 (463)
T ss_pred             CCCccHHHHHHHHHHHhccCCc-CChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence              11 11112234444444332 111111     2456677889999999999999999999998885443

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=282.30  Aligned_cols=258  Identities=22%  Similarity=0.290  Sum_probs=203.5

Q ss_pred             hcCCCcc-eeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEc----CCc
Q 042763          265 TRNFSPS-LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDK----GNE  337 (554)
Q Consensus       265 ~~~f~~~-~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~----~~~  337 (554)
                      +++|.+. .+||-|-.|.|..+..+ +|+.+|+|++...      ...++|+++.-.. .|||||+++++|++    ...
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            4566554 46999999999999554 6899999998765      2456788876655 69999999998854    346


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC---CCcEEEEeecC
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE---SMRAKVADFGF  414 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~DfGl  414 (554)
                      +.+|||.|+||.|...++.+....+++.++-.|+.||..|+.|||   +.+|.||||||+|+|.+.   +..+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence            789999999999999999988889999999999999999999999   999999999999999974   55799999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      |+...    ........+.||.|.|||++...+|+...|+||+||++|-||.|.+||........   ..-...++..+.
T Consensus       211 AK~t~----~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk~rI~~gq  283 (400)
T KOG0604|consen  211 AKETQ----EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKRRIRTGQ  283 (400)
T ss_pred             ccccC----CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHHhHhhccC
Confidence            98632    23334456789999999999999999999999999999999999999975332100   000111222222


Q ss_pred             ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       495 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      + ++.++..     ..+++...++|+.+|..+|++|.|+.|++.+.|--.
T Consensus       284 y-~FP~pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~  327 (400)
T KOG0604|consen  284 Y-EFPEPEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ  327 (400)
T ss_pred             c-cCCChhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence            1 1111211     245677899999999999999999999999988544

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.1e-35  Score=283.86  Aligned_cols=274  Identities=23%  Similarity=0.276  Sum_probs=209.9

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcC-----CcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEc-CC
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLED-----GLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDK-GN  336 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~-----g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~  336 (554)
                      ....|+.+..||+|.||.||+|...+     .+.+|+|+++..+.. .......+|+.+++.++|||++.|..++.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            34578889999999999999995432     237899988766332 223567799999999999999999998866 77


Q ss_pred             ceEEEEEeCCCCCHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC----CcEEE
Q 042763          337 ERLIITEFVPNGTLREHLDGQY---GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES----MRAKV  409 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~----~~vkl  409 (554)
                      ..++++||.+ -||...++-++   .+.++...+..|+.||+.|+.|||   ++-|+||||||.|||+..+    |.|||
T Consensus       102 ~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence            8899999996 48888876433   356888889999999999999999   9999999999999999887    99999


Q ss_pred             EeecCcccCCCCCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCC------hhhHHH
Q 042763          410 ADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRP------PEERVT  482 (554)
Q Consensus       410 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~------~~~~~~  482 (554)
                      +|||++|++...-........++-|.+|+|||.+.+. .|+++.||||.|||+.||+|.++-|.+...      +-....
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            9999999977665555566678899999999998774 699999999999999999999998875432      222334


Q ss_pred             HHHHHHhhccCCccccCC----hhh----h----hhccH----H-------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042763          483 LRWAFKRYNEGNLLDMVD----PSI----K----EVISM----E-------ILTKMFGLAIQCAAPIRNDRPDMKSVGEQ  539 (554)
Q Consensus       483 ~~~~~~~~~~~~~~~~~d----~~l----~----~~~~~----~-------~~~~l~~li~~cl~~dP~~RPs~~evl~~  539 (554)
                      +..++.....+...+..+    |..    .    ..+..    .       -....++|+..+|+.||-+|-|+++.+++
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            445555443332211110    000    0    00000    0       01236899999999999999999999988


Q ss_pred             HH
Q 042763          540 LW  541 (554)
Q Consensus       540 l~  541 (554)
                      .-
T Consensus       338 ~y  339 (438)
T KOG0666|consen  338 PY  339 (438)
T ss_pred             cc
Confidence            54

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-36  Score=293.18  Aligned_cols=263  Identities=24%  Similarity=0.313  Sum_probs=209.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEcC-CcEEEEEEcchhhh--hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQF--ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .+|....+||+|+||.|.+|+.++ .+.+|||++++.-.  ++..+--..|-++|+.. +-|.+++++.+|.+-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            467888899999999999997764 67899999987643  22234445677788766 578999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+.||+|-.+++.-  ..+.++.++.+|..||-||-+||   +++|++||||.+|||++.+|++||+|||+++.-   
T Consensus       429 MEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn---  500 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN---  500 (683)
T ss_pred             EEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccc---
Confidence            9999999999999765  57889999999999999999999   999999999999999999999999999999852   


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                      ........+++|||.|+|||++...+|+..+|+|||||+||||+.|++||++.+..+....+...       .+      
T Consensus       501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-------nv------  567 (683)
T KOG0696|consen  501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-------NV------  567 (683)
T ss_pred             ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-------cC------
Confidence            22333345689999999999999999999999999999999999999999987765544333211       11      


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHHhhhhhhhhhcc
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDM-----KSVGEQLWAIRADSLKSVKK  553 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~l~~i~~~~~~~~~~  553 (554)
                          .++...+.+...+....+...|.+|.-.     ++|.+|..-=+-+|.+..+|
T Consensus       568 ----syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~  620 (683)
T KOG0696|consen  568 ----SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERR  620 (683)
T ss_pred             ----cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhc
Confidence                1445566677888888888999998643     34444443333444444433

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=288.32  Aligned_cols=266  Identities=22%  Similarity=0.310  Sum_probs=210.2

Q ss_pred             hcCCCcceeeeccCceEEEEEE-EcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC--CCC----ceeeeeEEEcCCc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID--HRN----LVKLLGFVDKGNE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~--Hpn----Iv~l~~~~~~~~~  337 (554)
                      +++|.+..++|+|.||.|-.+- ...+..||||+++.-  .+..+..+-|++++.++.  -|+    +|++.+||+..++
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            6889999999999999999994 445789999999865  456778889999999993  233    7888899999999


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC--------------
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE--------------  403 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~--------------  403 (554)
                      .++|+|.+ |-++.+++..+...+++..+++.++.|+++++++||   +.+++|-||||+|||+..              
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999998 779999999988889999999999999999999999   999999999999999842              


Q ss_pred             ------CCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCh
Q 042763          404 ------SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP  477 (554)
Q Consensus       404 ------~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~  477 (554)
                            +..++|+|||.|++..    ..  ...++.|..|.|||++.+.+++.+.||||+||||+||.||...|+..+..
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~----e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDH----EH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             eeccCCCcceEEEecCCcceec----cC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                  3458999999998622    11  24567899999999999999999999999999999999999999877654


Q ss_pred             hhHHHHHHHHH-------------hh-ccCCc--------------cccCChhhhh-hccHHHHHHHHHHHHHccCCCCC
Q 042763          478 EERVTLRWAFK-------------RY-NEGNL--------------LDMVDPSIKE-VISMEILTKMFGLAIQCAAPIRN  528 (554)
Q Consensus       478 ~~~~~~~~~~~-------------~~-~~~~~--------------~~~~d~~l~~-~~~~~~~~~l~~li~~cl~~dP~  528 (554)
                      +....++.+..             ++ ..+.+              .+...|.-.. ........+|.+|+..||..||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            43322221111             00 00100              0001111111 11233456799999999999999


Q ss_pred             CCCCHHHHHHHHHH
Q 042763          529 DRPDMKSVGEQLWA  542 (554)
Q Consensus       529 ~RPs~~evl~~l~~  542 (554)
                      +|+|++|++.|.+-
T Consensus       396 ~RiTl~EAL~HpFF  409 (415)
T KOG0671|consen  396 RRITLREALSHPFF  409 (415)
T ss_pred             ccccHHHHhcCHHh
Confidence            99999999998764

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=285.16  Aligned_cols=252  Identities=28%  Similarity=0.335  Sum_probs=197.1

Q ss_pred             ceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEEEeCCCC
Q 042763          271 SLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEFVPNG  348 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~g  348 (554)
                      ...||.|+||+|+|..++ .|+..|||+++....+..+++++.|.+...+- +.||||+++|.+..++..++.||.| ..
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence            446999999999999655 69999999999887777778899998866554 7999999999999999999999999 66


Q ss_pred             CHHHHHhc---ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          349 TLREHLDG---QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       349 ~L~~~l~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      +|+.+.+.   .....+++.-.-.|....+.||.||..  ...|+|||+||+|||++..|.+||||||.+-.+.    ..
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv----~S  221 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV----DS  221 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH----HH
Confidence            77665432   223567888888899999999999985  7899999999999999999999999999987532    23


Q ss_pred             cccccccCCCCCcChhcccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          426 HISTKVKGTVGYLDPEYMKT--YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      ...+.-.|...|||||.+..  ..|+.+|||||||++|||+.||+.|+..-+..  ...+..+    ..+..     |.+
T Consensus       222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv--feql~~V----v~gdp-----p~l  290 (361)
T KOG1006|consen  222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV--FEQLCQV----VIGDP-----PIL  290 (361)
T ss_pred             HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH--HHHHHHH----HcCCC-----Cee
Confidence            33445579999999999853  35999999999999999999999999854331  1111111    11111     111


Q ss_pred             hh-hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          504 KE-VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       504 ~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                      .. .-..+....|...+.-|+..|.++||...++.++.
T Consensus       291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~  328 (361)
T KOG1006|consen  291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP  328 (361)
T ss_pred             cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence            11 11134567799999999999999999999998763

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=300.40  Aligned_cols=244  Identities=25%  Similarity=0.335  Sum_probs=199.4

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .+..|.....+|.|+|+.|-.+... +++..+||++.+..     .+-.+|+.++... +||||+++.+.+.++.+.++|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            3567777778999999999999554 68899999998763     2334566666555 799999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE-CCCCcEEEEeecCcccCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL-TESMRAKVADFGFARLGPM  420 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl-~~~~~vkl~DfGla~~~~~  420 (554)
                      ||.+.++-+.+.+..+   .....++..|+.+|+.|+.|||   ++++|||||||+|||+ +..++++|+|||.++..+.
T Consensus       395 ~e~l~g~ell~ri~~~---~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSK---PEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             ehhccccHHHHHHHhc---chhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            9999999888887655   2223777789999999999999   8999999999999999 6899999999999986543


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      .      ....+-|..|.|||++....|++++||||||++||+||+|+.||.......+      ...+...+..     
T Consensus       469 ~------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e------i~~~i~~~~~-----  531 (612)
T KOG0603|consen  469 S------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE------IHTRIQMPKF-----  531 (612)
T ss_pred             h------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH------HHHhhcCCcc-----
Confidence            3      2234578899999999999999999999999999999999999986544311      1222222221     


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                             ...++....+|+.+||+.||.+||+|.++..+.|.
T Consensus       532 -------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  532 -------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             -------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                   13455678899999999999999999999999987

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3e-34  Score=281.06  Aligned_cols=226  Identities=19%  Similarity=0.172  Sum_probs=180.2

Q ss_pred             cCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCHHHHHh
Q 042763          277 GGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLD  355 (554)
Q Consensus       277 G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~  355 (554)
                      |.||.||++... +++.||+|+++...      .+.+|...+....||||+++++++.+.+..+++|||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            899999999654 68999999997653      23344455556679999999999999999999999999999999987


Q ss_pred             cccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCC
Q 042763          356 GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV  435 (554)
Q Consensus       356 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~  435 (554)
                      ..  ..+++..+..++.|++.||+|||   +++++||||||+||+++.++.++++|||.+......      .....++.
T Consensus        78 ~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~~  146 (237)
T cd05576          78 KF--LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------CDGEAVEN  146 (237)
T ss_pred             Hh--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc------cccCCcCc
Confidence            65  45899999999999999999999   899999999999999999999999999987653221      12234677


Q ss_pred             CCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHH
Q 042763          436 GYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKM  515 (554)
Q Consensus       436 ~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  515 (554)
                      .|+|||.+.+..++.++||||+|+++|||++|..|+.......            ...     ...    ..+..+...+
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~-----~~~----~~~~~~~~~~  205 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH-----TTL----NIPEWVSEEA  205 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc-----ccc----CCcccCCHHH
Confidence            8999999988889999999999999999999998875321100            000     000    0222344568


Q ss_pred             HHHHHHccCCCCCCCCCH-----HHHHHHH
Q 042763          516 FGLAIQCAAPIRNDRPDM-----KSVGEQL  540 (554)
Q Consensus       516 ~~li~~cl~~dP~~RPs~-----~evl~~l  540 (554)
                      .+++.+|++.||++||++     .+++.|.
T Consensus       206 ~~li~~~l~~dp~~R~~~~~~~~~~~~~h~  235 (237)
T cd05576         206 RSLLQQLLQFNPTERLGAGVAGVEDIKSHP  235 (237)
T ss_pred             HHHHHHHccCCHHHhcCCCccchHHHHcCC
Confidence            899999999999999996     6666553

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-35  Score=318.06  Aligned_cols=268  Identities=22%  Similarity=0.256  Sum_probs=215.7

Q ss_pred             HHHHHhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcC
Q 042763          259 SQVVKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKG  335 (554)
Q Consensus       259 ~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  335 (554)
                      .++.-..++|.+.++||+|+||.|..++++ +++.||+|++.+-..-  ....-|..|-.+|..-+.+-|++++-.|.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            345556789999999999999999999776 5889999999874332  1234578888999988899999999999999


Q ss_pred             CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCc
Q 042763          336 NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA  415 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla  415 (554)
                      .++|+|||||+||||..++.+..  .+++.-+..++..|+.||.-||   +.|+|||||||+|||+|..|++||+|||.+
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhH
Confidence            99999999999999999998762  7999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhcccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhh
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKT-----YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY  490 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  490 (554)
                      -...  .+....+...+|||.|.+||++..     +.|++..|+||+||++|||+.|..||...+..+....+...    
T Consensus       223 lkm~--~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h----  296 (1317)
T KOG0612|consen  223 LKMD--ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH----  296 (1317)
T ss_pred             HhcC--CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch----
Confidence            7643  344455666789999999999852     56899999999999999999999999865544443332211    


Q ss_pred             ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHHHhhhhh
Q 042763          491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPD---MKSVGEQLWAIRADS  547 (554)
Q Consensus       491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~l~~i~~~~  547 (554)
                        .....+.+       ..+++....+||.+.+. +|+.|..   +.++-.|.+---.+|
T Consensus       297 --k~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W  346 (1317)
T KOG0612|consen  297 --KESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW  346 (1317)
T ss_pred             --hhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence              11111110       12355667888887776 6788888   999999887666666

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-35  Score=294.32  Aligned_cols=260  Identities=22%  Similarity=0.283  Sum_probs=220.0

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCc-EEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGL-LVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~-~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .+++.+..||-|+||.|-++...... .+|+|.+++...  .+.++.+..|-.+|...+.|.||+++-.|.+....|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45556667999999999999776433 489999988765  345677899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      |-|-||.|...|.++  ..++...+..++..+++|++|||   +++||+|||||+|.+++.+|-+||.|||+|+..... 
T Consensus       500 EaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-  573 (732)
T ss_pred             HhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence            999999999999876  67899999999999999999999   999999999999999999999999999999975433 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                         ....+++|||.|+|||++.++..+.++|.||||+++|||++|.+||.+.++-.....+......+            
T Consensus       574 ---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------------  638 (732)
T KOG0614|consen  574 ---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------------  638 (732)
T ss_pred             ---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh------------
Confidence               34557899999999999999999999999999999999999999999888766555443322211            


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHHhhhhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPD-----MKSVGEQLWAIRADSLK  549 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~i~~~~~~  549 (554)
                         .++..+.....+|+++....+|.+|.-     +.+|-.|-|-.--+|..
T Consensus       639 ---~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg  687 (732)
T KOG0614|consen  639 ---EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEG  687 (732)
T ss_pred             ---hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence               134455667788999999999999987     78888888876655543

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3e-34  Score=254.34  Aligned_cols=266  Identities=21%  Similarity=0.305  Sum_probs=205.4

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhh-HHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFEN-LQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +|...++||+|.||+||+|+.. +++.||+|+++-...+. .....++|+-+++.++|+|||++++....+..+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            3555678999999999999655 58899999988765432 345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      | ..+|..|...- +..++...+..++.|+++||.++|   ++++.|||+||+|.||+.+|.+|++|||+++.+...   
T Consensus        83 c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip---  154 (292)
T KOG0662|consen   83 C-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP---  154 (292)
T ss_pred             h-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc---
Confidence            9 67898888765 356888999999999999999999   999999999999999999999999999999975432   


Q ss_pred             ccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCcc---ccC
Q 042763          425 THISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLL---DMV  499 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  499 (554)
                      ..-....+-|.+|.+|.++-+. -|++..|+||-||++.|+.. |++.|.+.+..+....+.|......+..+.   .+.
T Consensus       155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence            2223344679999999998775 48999999999999999998 666666666555544444444333333322   122


Q ss_pred             Chhhhhhcc---------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          500 DPSIKEVIS---------MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       500 d~~l~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                      |-.....++         +.....=.+++...+.-+|.+|-++++.+++.
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp  284 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP  284 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence            211111111         12222336788888888999999999998764

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-34  Score=302.70  Aligned_cols=261  Identities=25%  Similarity=0.377  Sum_probs=214.6

Q ss_pred             hHHHHHhhcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEE--
Q 042763          258 MSQVVKATRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVD--  333 (554)
Q Consensus       258 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~--  333 (554)
                      ++.+...+..|++.+.||.|.+|.||+++. ++|+..|+|++.....  ..+++..|.++++.+ .|||++.++|++.  
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            344445567789999999999999999954 4689999999887643  346788899999988 6999999999983  


Q ss_pred             ---cCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEE
Q 042763          334 ---KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVA  410 (554)
Q Consensus       334 ---~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~  410 (554)
                         .+++++||||||.+|+..|++++-.+..+.|..+..|+..++.|+.+||   ...++|||||-.|||++.++.|||+
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEe
Confidence               4678999999999999999999877889999999999999999999999   9999999999999999999999999


Q ss_pred             eecCcccCCCCCCCccccccccCCCCCcChhcccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH
Q 042763          411 DFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-----YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRW  485 (554)
Q Consensus       411 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~  485 (554)
                      |||.+.....   .........|||.|||||++.-     ..|+..+|+||||++..||--|.+|+....+-..      
T Consensus       166 DFGvSaQlds---T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra------  236 (953)
T KOG0587|consen  166 DFGVSAQLDS---TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA------  236 (953)
T ss_pred             eeeeeeeeec---ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh------
Confidence            9999986422   2233445679999999999853     3577899999999999999999999876554321      


Q ss_pred             HHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          486 AFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                      .+...+      ...|.+.  -+....+++.++|..||..|-++||++.++++|.
T Consensus       237 LF~IpR------NPPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp  283 (953)
T KOG0587|consen  237 LFLIPR------NPPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP  283 (953)
T ss_pred             hccCCC------CCCcccc--chhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence            121111      1222222  3455678899999999999999999999999874

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=8.6e-33  Score=268.97  Aligned_cols=242  Identities=29%  Similarity=0.383  Sum_probs=195.4

Q ss_pred             CceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCHHHHHhc
Q 042763          278 GFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDG  356 (554)
Q Consensus       278 ~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~  356 (554)
                      +||.||+|... +|+.+|+|++.........+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999876 48999999998765433357899999999999999999999999998999999999999999999976


Q ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCC
Q 042763          357 QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG  436 (554)
Q Consensus       357 ~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~  436 (554)
                      ..  .+++..++.++.+++.++.|||   ..+++|+||+|+||+++.++.++|+|||.+.......    ......++..
T Consensus        81 ~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~  151 (244)
T smart00220       81 RG--RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTPE  151 (244)
T ss_pred             cc--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCcC
Confidence            53  3889999999999999999999   8899999999999999999999999999998644321    2234568889


Q ss_pred             CcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHH
Q 042763          437 YLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMF  516 (554)
Q Consensus       437 y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  516 (554)
                      |++||.+.+..++.++|||+||+++|+|++|..||........  ......    ......    .   .....+...+.
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~--~~~~~~----~~~~~~----~---~~~~~~~~~~~  218 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE--LFKKIG----KPKPPF----P---PPEWKISPEAK  218 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHh----ccCCCC----c---cccccCCHHHH
Confidence            9999999988899999999999999999999999976322211  111111    110000    0   00000446789


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          517 GLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       517 ~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      +++.+|+..+|++||++.+++++.|
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~~~~  243 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQHPF  243 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhhCCC
Confidence            9999999999999999999998643

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-34  Score=267.63  Aligned_cols=272  Identities=21%  Similarity=0.301  Sum_probs=202.5

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhh-hhhHHHHHHHHHHHHHhCCCCCceeeeeEEEc--------C
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQ-FENLQTEFSSEVELLSKIDHRNLVKLLGFVDK--------G  335 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--------~  335 (554)
                      ..|....+||+|.||.||+|+.+ +|+.||+|++.... .+..-...++|+++|..|+|+|++.++..|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34555668999999999999765 47888988654422 23334567899999999999999999987732        2


Q ss_pred             CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCc
Q 042763          336 NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA  415 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla  415 (554)
                      ...|+|+.+|+ -+|..++... ...++..++.+++.++..||.|+|   ...|+|||+|++|+||+.+|.+||+|||++
T Consensus        97 ~t~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   97 ATFYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ceeeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence            34799999995 5888888644 357899999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCCC-CCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC
Q 042763          416 RLGPMD-SDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG  493 (554)
Q Consensus       416 ~~~~~~-~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  493 (554)
                      +.+... .......+..+-|.+|++||.+.+ +.|+++.|||.-||++.||+|+.+-+++.........+......... 
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk-  250 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK-  250 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc-
Confidence            764322 112222445567999999998876 47999999999999999999999999877655444444332222221 


Q ss_pred             CccccCCh-hhhhhc------------cHHHH------HHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          494 NLLDMVDP-SIKEVI------------SMEIL------TKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       494 ~~~~~~d~-~l~~~~------------~~~~~------~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      .++..+|. .+...+            -.+..      +..++|+.+++..||.+|+++.+++.|.|--
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~  319 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW  319 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence            22222221 110000            01111      2568999999999999999999999886643

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-33  Score=253.04  Aligned_cols=205  Identities=26%  Similarity=0.395  Sum_probs=171.8

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .+....+..||+|++|.|-+.++. +|...|+|+++..-..+.+.+.++|+.+..+- .+|.+|.++|.+......++.|
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            344455667999999999988654 69999999998776666677888999877665 7999999999999999999999


Q ss_pred             EeCCCCCHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          343 EFVPNGTLREHLDG--QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       343 E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      |.| ..+|..|-.+  ..+..+++...-+|+..+++||.|||+  ...++|||+||+|||++.+|+||+||||.+-.+..
T Consensus       125 E~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  125 ELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             HHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            999 6788877654  235678899999999999999999995  78999999999999999999999999999976432


Q ss_pred             CCCCccccccccCCCCCcChhcccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKT----YQLTTKSDVYSFGVLLLEILTGRRPVELKRP  476 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~----~~~s~ksDVwSlGvil~elltg~~P~~~~~~  476 (554)
                          ....+.-.|...|||||.+..    ..|+.|+||||||+++.||.+++.||.....
T Consensus       202 ----SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  202 ----SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             ----hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence                222233468889999998853    4799999999999999999999999986544

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-33  Score=269.05  Aligned_cols=250  Identities=23%  Similarity=0.353  Sum_probs=200.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhh--HHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~--~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~l  340 (554)
                      .++|...++||+|+|++|..++++ +.+.||+|++++.-...  ...=++.|..+..+- +||.+|-++.+|.++..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            468999999999999999999765 57899999998764422  122345677777665 79999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      |.||++||+|--+++.+  +.++++.++.+...|..||.|||   +++|++||||.+|||+|..|++||+|+|+++..  
T Consensus       329 vieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~--  401 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--  401 (593)
T ss_pred             EEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcC--
Confidence            99999999999888766  68999999999999999999999   999999999999999999999999999999853  


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChh-hHHHHHHHHHhhccCCccccC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPE-ERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  499 (554)
                       -.......+++|||.|.|||++++..|....|+|+|||+++||+.|+.||+.-.... +...-.+.+..+-+..+.   
T Consensus       402 -l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir---  477 (593)
T KOG0695|consen  402 -LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR---  477 (593)
T ss_pred             -CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc---
Confidence             233344567899999999999999999999999999999999999999997432211 111112223322222221   


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCC
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPD  532 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs  532 (554)
                             ++...+-+...++...|+.||.+|.-
T Consensus       478 -------iprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  478 -------IPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             -------ccceeehhhHHHHHHhhcCCcHHhcC
Confidence                   33334455677888999999998854

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.2e-32  Score=300.66  Aligned_cols=266  Identities=20%  Similarity=0.217  Sum_probs=172.6

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-C----CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeE------E
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-D----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF------V  332 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~----g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~------~  332 (554)
                      ..++|+..++||+|+||.||+|... +    +..||||++......   +.+..|  .+.+..+.++..+...      .
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            4578999999999999999999765 4    689999987643211   111111  1222222222222211      2


Q ss_pred             EcCCceEEEEEeCCCCCHHHHHhcccCC------------------CCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCC
Q 042763          333 DKGNERLIITEFVPNGTLREHLDGQYGK------------------TLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDV  394 (554)
Q Consensus       333 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~------------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl  394 (554)
                      ..+...++||||+++++|.+++......                  ......+..++.||+.||+|||   +++|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcC
Confidence            4567889999999999999998654210                  1122345679999999999999   899999999


Q ss_pred             CCCCeEECC-CCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccC----------------------CCCch
Q 042763          395 KSSNILLTE-SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY----------------------QLTTK  451 (554)
Q Consensus       395 kp~NILl~~-~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~s~k  451 (554)
                      ||+|||++. ++.+||+|||+|+.....  .........+++.|||||.+...                      .++.+
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~--~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVG--INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccc--cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            999999986 689999999999754322  12223456789999999965322                      24456


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC--CccccCC----hhhhhhcc--HHHHHHHHHHHHHcc
Q 042763          452 SDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG--NLLDMVD----PSIKEVIS--MEILTKMFGLAIQCA  523 (554)
Q Consensus       452 sDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d----~~l~~~~~--~~~~~~l~~li~~cl  523 (554)
                      +|||||||+||||+++..|+...     ..............  .+.....    +.+...+.  ........+|+.+||
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~-----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL  434 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSN-----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM  434 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchH-----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence            79999999999999977664321     11111000000000  0000000    11000000  001123568999999


Q ss_pred             CCCCCCCCCHHHHHHHHHHhh
Q 042763          524 APIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       524 ~~dP~~RPs~~evl~~l~~i~  544 (554)
                      +.||++|||+.|+++|.|--.
T Consensus       435 ~~dP~kR~ta~e~L~Hpff~~  455 (566)
T PLN03225        435 RFKGRQRISAKAALAHPYFDR  455 (566)
T ss_pred             cCCcccCCCHHHHhCCcCcCC
Confidence            999999999999999987543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.9e-32  Score=290.09  Aligned_cols=267  Identities=22%  Similarity=0.259  Sum_probs=184.4

Q ss_pred             hhcCCCcceeeeccCceEEEEEEE-----------------cCCcEEEEEEcchhhhhh-------------HHHHHHHH
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQL-----------------EDGLLVAIKRAKKEQFEN-------------LQTEFSSE  313 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~-----------------~~g~~vAvK~~~~~~~~~-------------~~~~~~~E  313 (554)
                      ..++|++.++||+|+||+||+|..                 .+++.||||++.......             ..+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            457899999999999999999953                 235689999986432111             11223457


Q ss_pred             HHHHHhCCCCCc-----eeeeeEEEc--------CCceEEEEEeCCCCCHHHHHhcccC---------------------
Q 042763          314 VELLSKIDHRNL-----VKLLGFVDK--------GNERLIITEFVPNGTLREHLDGQYG---------------------  359 (554)
Q Consensus       314 i~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~~---------------------  359 (554)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.++++...+                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            778888876654     677777643        3567999999999999999874321                     


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCc
Q 042763          360 -KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL  438 (554)
Q Consensus       360 -~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~  438 (554)
                       ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......  ........+++.|+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~--~~~~~~g~~tp~Y~  377 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI--NFNPLYGMLDPRYS  377 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC--ccCccccCCCccee
Confidence             13467788899999999999999   8899999999999999999999999999997532211  11111233588999


Q ss_pred             ChhccccCC----------------------CCchhhHHHHHHHHHHHHhCCC-CCCCCCChhh-HH---HHHHHHHhhc
Q 042763          439 DPEYMKTYQ----------------------LTTKSDVYSFGVLLLEILTGRR-PVELKRPPEE-RV---TLRWAFKRYN  491 (554)
Q Consensus       439 aPE~l~~~~----------------------~s~ksDVwSlGvil~elltg~~-P~~~~~~~~~-~~---~~~~~~~~~~  491 (554)
                      |||.+....                      ...+.||||+||+++||++|.. |+........ ..   .....+....
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~  457 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK  457 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence            999875422                      1234799999999999999875 6653211110 00   0001111111


Q ss_pred             cCCccccCChhhhhhccHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHHHHHh
Q 042763          492 EGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIR---NDRPDMKSVGEQLWAI  543 (554)
Q Consensus       492 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~l~~i  543 (554)
                      ....    +-.    ..........+++.+||..+|   .+|+|+.|+++|.|-.
T Consensus       458 ~~~~----~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        458 GQKY----DFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             ccCC----Ccc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            1111    100    112234567889999998765   7899999999998753

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-33  Score=278.19  Aligned_cols=260  Identities=25%  Similarity=0.405  Sum_probs=200.7

Q ss_pred             cCCCcceeeeccCceEEEEE-EEcCCcEEEEEEcchhhh------hhHHHHHHHHHHHHHhCCCCCceeeeeEEE-cCCc
Q 042763          266 RNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF------ENLQTEFSSEVELLSKIDHRNLVKLLGFVD-KGNE  337 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a-~~~~g~~vAvK~~~~~~~------~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-~~~~  337 (554)
                      ++|-....||+|||+.||+| ++...+.||||+......      ++..+...+|..+.+.|+||.||++++|+. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            35666778999999999999 556688999998654322      334456778999999999999999999985 4456


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC---CCCcEEEEeecC
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGF  414 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~---~~~~vkl~DfGl  414 (554)
                      .+-|+|||+|.+|+-||+.+  +.+++.+++.|+.||+.||.||... ..+|+|-||||.|||+-   ..|.+||+|||+
T Consensus       543 FCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             ceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            78999999999999999876  6899999999999999999999854 78899999999999994   568899999999


Q ss_pred             cccCCCCCCCc----cccccccCCCCCcChhcccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH
Q 042763          415 ARLGPMDSDRT----HISTKVKGTVGYLDPEYMKT----YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWA  486 (554)
Q Consensus       415 a~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~----~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~  486 (554)
                      +++...+....    .......||.+|++||.+.-    .+++.|.||||+|||+|+.+.|+.||.......+  .+...
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--ILqeN  697 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--ILQEN  697 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HHhhh
Confidence            99876554432    23345679999999997743    2578899999999999999999999975443221  22211


Q ss_pred             HHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042763          487 FKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQ  539 (554)
Q Consensus       487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  539 (554)
                      . .....   +.--|     ..+-+......+|++||+...++|-...++..+
T Consensus       698 T-IlkAt---EVqFP-----~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  698 T-ILKAT---EVQFP-----PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             c-hhcce---eccCC-----CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            0 00000   00000     112344567889999999999999988887654

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-32  Score=281.43  Aligned_cols=210  Identities=24%  Similarity=0.395  Sum_probs=179.5

Q ss_pred             CCCcceeeeccCceEEEEEE-EcCCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      -|..++.||-|+||.|.++. .++...||.|.+++...  .+....++.|-.||+.-+++-||+|+-.|.+.+.+|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            46677889999999999994 44577899999988764  3445678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |++|||+-.+|-+.  ..+.+..++.++..+..|+++.|   ..|+|||||||+|||||.+|++||+||||+.-+....+
T Consensus       710 YIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             ccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccc
Confidence            99999999998765  67889999999999999999999   99999999999999999999999999999863211100


Q ss_pred             C--------c-------------------------------cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHH
Q 042763          424 R--------T-------------------------------HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEI  464 (554)
Q Consensus       424 ~--------~-------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~el  464 (554)
                      .        .                               ......+||+.|+|||++....|+...|+||.|||||||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence            0        0                               000124699999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCChhhHH
Q 042763          465 LTGRRPVELKRPPEERV  481 (554)
Q Consensus       465 ltg~~P~~~~~~~~~~~  481 (554)
                      +.|+.||....+.+...
T Consensus       865 ~~g~~pf~~~tp~~tq~  881 (1034)
T KOG0608|consen  865 LVGQPPFLADTPGETQY  881 (1034)
T ss_pred             hhCCCCccCCCCCccee
Confidence            99999999888776544

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.98  E-value=3.7e-32  Score=288.85  Aligned_cols=247  Identities=26%  Similarity=0.385  Sum_probs=193.6

Q ss_pred             CCcceeeeccCceE-EEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEEEeC
Q 042763          268 FSPSLRIGEGGFGT-VYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       268 f~~~~~LG~G~fG~-Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      |...+.+|.|+-|+ ||+|... |+.||||++-....    .-..+||..|+.- +|||||++++.-.+.+..||..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~----~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF----DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH----HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            44455689999887 6899887 88999998876542    3567899999987 5999999999989999999999999


Q ss_pred             CCCCHHHHHhcc-c-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC---C--CcEEEEeecCcccC
Q 042763          346 PNGTLREHLDGQ-Y-GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE---S--MRAKVADFGFARLG  418 (554)
Q Consensus       346 ~~g~L~~~l~~~-~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~--~~vkl~DfGla~~~  418 (554)
                       ..+|.+++... . .........+.+..|++.||++||   +.+||||||||.||||+.   +  ..++|+|||+++..
T Consensus       586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence             78999999874 1 111112455788999999999999   899999999999999975   3  57899999999988


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                      ..+...........||-+|+|||++....-+.++|||||||++|+.++ |.+||......+...       ...+..+..
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI-------l~~~~~L~~  734 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI-------LTGNYTLVH  734 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh-------hcCccceee
Confidence            766655555667789999999999999888889999999999999998 599998543221111       011111111


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQ  539 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  539 (554)
                      + .+      ..++  ...+||.+|++++|..||++.+|+.|
T Consensus       735 L-~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  735 L-EP------LPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             e-cc------CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            1 11      0111  57899999999999999999999987

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-30  Score=260.71  Aligned_cols=132  Identities=29%  Similarity=0.409  Sum_probs=116.6

Q ss_pred             hcCCCcceeeeccCceEEEEE-EEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-----CC---CceeeeeEEE--
Q 042763          265 TRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-----HR---NLVKLLGFVD--  333 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a-~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-----Hp---nIv~l~~~~~--  333 (554)
                      ..+|...++||.|.|++||+| +..+.+.||+|+.+...  ...+....||++|++++     |+   .||+|++.|.  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            368889999999999999999 55568899999998763  45577889999999983     33   5999999985  


Q ss_pred             --cCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE
Q 042763          334 --KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL  401 (554)
Q Consensus       334 --~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl  401 (554)
                        .+.+.+||+|++ |.+|..+|.....+.++...+.+|+.||+.||.|||.  ..+|+|-||||+|||+
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence              456889999999 8899999998878899999999999999999999996  7799999999999998

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.6e-29  Score=239.52  Aligned_cols=212  Identities=37%  Similarity=0.606  Sum_probs=184.6

Q ss_pred             eeccCceEEEEEEEcC-CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCHHH
Q 042763          274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE  352 (554)
Q Consensus       274 LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~  352 (554)
                      ||+|.+|.||++...+ ++.+++|++.........+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998764 899999999876543245679999999999999999999999999899999999999999999


Q ss_pred             HHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC-CCcEEEEeecCcccCCCCCCCccccccc
Q 042763          353 HLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE-SMRAKVADFGFARLGPMDSDRTHISTKV  431 (554)
Q Consensus       353 ~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~~~~~~~~~~~~~~~~  431 (554)
                      ++.... ..+++..++.++.++++++++||   +.+++|+||+|.||+++. ++.++|+|||.+........   .....
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~  153 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTI  153 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhhcc
Confidence            987542 46889999999999999999999   889999999999999999 89999999999986433221   22334


Q ss_pred             cCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHH
Q 042763          432 KGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISME  510 (554)
Q Consensus       432 ~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  510 (554)
                      .+...|++||.+... .++.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            578899999999887 788999999999999999                                              


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          511 ILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       511 ~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                        ..+.+++..|++.+|++||++.++++++
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence              4578899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=2.5e-30  Score=237.53  Aligned_cols=260  Identities=18%  Similarity=0.299  Sum_probs=196.9

Q ss_pred             hhcCCCcceeeeccCceEEEEEE-EcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCC--ceE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGN--ERL  339 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~--~~~  339 (554)
                      ..++|++.+++|+|.++.||.|. ..+.+.++||++++-.    .+.+.+|+.+|..|. ||||+.|++...++.  ...
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            35789999999999999999995 4568899999998865    357889999999997 999999999987654  457


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC-CcEEEEeecCcccC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES-MRAKVADFGFARLG  418 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkl~DfGla~~~  418 (554)
                      +|+||+.+.+...+.     .+++..++...+.+++.||.|+|   +.||+|||+||.|++||.. -.++|+|+|+|.++
T Consensus       112 LiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             hHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhc
Confidence            999999888877665     36778889999999999999999   9999999999999999965 46999999999985


Q ss_pred             CCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-ChhhHHHHHHHHHhhccCCc-
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKR-PPEERVTLRWAFKRYNEGNL-  495 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~-~~~~~~~~~~~~~~~~~~~~-  495 (554)
                      ....+.    ...+.+..|..||.+.. ..|+..-|+|||||++..|+..+.||-... ..+....+..+   .....+ 
T Consensus       184 Hp~~eY----nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV---LGt~el~  256 (338)
T KOG0668|consen  184 HPGKEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV---LGTDELY  256 (338)
T ss_pred             CCCcee----eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH---hChHHHH
Confidence            432222    22346678899998865 458889999999999999999999986433 33322222111   111000 


Q ss_pred             ------cccCChhhhh------------hccHH----HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          496 ------LDMVDPSIKE------------VISME----ILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       496 ------~~~~d~~l~~------------~~~~~----~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                            .-.+||....            ++..+    ...+..+++...|..|-++|||++|.+.|.+-
T Consensus       257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF  325 (338)
T KOG0668|consen  257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF  325 (338)
T ss_pred             HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence                  0012222211            11111    12567899999999999999999999998643

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-31  Score=249.56  Aligned_cols=263  Identities=22%  Similarity=0.307  Sum_probs=195.6

Q ss_pred             CCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcC-----CceEE
Q 042763          268 FSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKG-----NERLI  340 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~~~l  340 (554)
                      .++.+.||-|+||.||.+.. ++|+.||+|++..-... ...+.+.+|+++|.-++|.|++..++...-.     .+.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            34566899999999999955 47999999988654321 1236788999999999999999988876433     35678


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      +.|.| ..+|...+-.  ...++.+.+.-+..||++||.|||   +.+|+||||||.|.|++.+..+||||||+++.-. 
T Consensus       135 ~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee-  207 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD-  207 (449)
T ss_pred             HHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc-
Confidence            88988 6688877743  357888888889999999999999   9999999999999999999999999999999732 


Q ss_pred             CCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccc--
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD--  497 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--  497 (554)
                       .+.....+..+-|..|.|||++.+. .|+.+.||||.||++.||+..+..|+..++......+..   .........  
T Consensus       208 -~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd---LLGTPs~EaMr  283 (449)
T KOG0664|consen  208 -QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID---LLGTPSQEAMK  283 (449)
T ss_pred             -hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH---HhCCCcHHHHH
Confidence             2333334555678999999999874 699999999999999999999999987776554433321   111111110  


Q ss_pred             ---------cC-----Chhhhhhc----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          498 ---------MV-----DPSIKEVI----SMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       498 ---------~~-----d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                               ++     .|.....+    +...-.....+..+++.+||++|-+..+.+.++.
T Consensus       284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence                     00     01110000    0111224567778999999999999999887653

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=3e-30  Score=263.88  Aligned_cols=200  Identities=27%  Similarity=0.416  Sum_probs=172.2

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHH-----HHHHHHHHHHHhCC---CCCceeeeeE
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQ-----TEFSSEVELLSKID---HRNLVKLLGF  331 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~-----~~~~~Ei~~l~~l~---HpnIv~l~~~  331 (554)
                      +...+|...+.+|+|+||.|++|.++ +...|+||.+.+...  +.+.     -.+-.||++|..|+   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            34457889999999999999999766 467899999887653  2222     23557999999997   9999999999


Q ss_pred             EEcCCceEEEEEeC-CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEE
Q 042763          332 VDKGNERLIITEFV-PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVA  410 (554)
Q Consensus       332 ~~~~~~~~lv~E~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~  410 (554)
                      |++++..|++||-. ++.+|.+++..+  +.+++.++..|+.|++.|+++||   +.+|||||||-+||.++.+|-+||+
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEe
Confidence            99999999999965 566999999766  68999999999999999999999   9999999999999999999999999


Q ss_pred             eecCcccCCCCCCCccccccccCCCCCcChhccccCCC-CchhhHHHHHHHHHHHHhCCCCCC
Q 042763          411 DFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL-TTKSDVYSFGVLLLEILTGRRPVE  472 (554)
Q Consensus       411 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvil~elltg~~P~~  472 (554)
                      |||.|....     ......+.||..|.|||++.+.+| ...-|||++|++||-++....||.
T Consensus       713 dfgsaa~~k-----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTK-----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhc-----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999997632     223445789999999999999877 567899999999999999999875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=7.7e-28  Score=231.97  Aligned_cols=200  Identities=36%  Similarity=0.537  Sum_probs=172.2

Q ss_pred             CCcceeeeccCceEEEEEEEcC-CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCC
Q 042763          268 FSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVP  346 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  346 (554)
                      |...+.||+|++|+||++...+ ++.+|+|.+.........+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567789999999999998765 889999999876433245788999999999999999999999999899999999999


Q ss_pred             CCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcc
Q 042763          347 NGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH  426 (554)
Q Consensus       347 ~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~  426 (554)
                      +++|.+++..... .+++..++.++.+++.++.+||   +.+++|+||+|+||+++.++.++|+|||.+........  .
T Consensus        81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~--~  154 (225)
T smart00221       81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA--A  154 (225)
T ss_pred             CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc--c
Confidence            9999999976532 1789999999999999999999   88999999999999999999999999999987543320  1


Q ss_pred             ccccccCCCCCcChhcc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 042763          427 ISTKVKGTVGYLDPEYM-KTYQLTTKSDVYSFGVLLLEILTGRRPVEL  473 (554)
Q Consensus       427 ~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwSlGvil~elltg~~P~~~  473 (554)
                      ......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22334578899999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=243.34  Aligned_cols=262  Identities=22%  Similarity=0.251  Sum_probs=193.5

Q ss_pred             cCCCcceeeeccCceEEEEE-EEcCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc------CCc
Q 042763          266 RNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK------GNE  337 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a-~~~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~------~~~  337 (554)
                      .+|.-.+.+|.|.- .|.-| +.-.++.||+|++..... ....+...+|..++..++|+||++++.++.-      -.+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45556667888887 55555 333588999998765421 1223567789999999999999999998843      346


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .|+||||| ..+|...+..    .++-.....|+.|++.|++|||   +.+|+||||||+||++..++.+||.|||+|+.
T Consensus        96 ~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence            69999999 7899998873    4677888899999999999999   99999999999999999999999999999985


Q ss_pred             CCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH----------
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF----------  487 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~----------  487 (554)
                      .    ......+..+.|..|.|||++.+..|.+.+||||+||++.||++|+.-|.+.+.-+....+....          
T Consensus       168 e----~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  168 E----DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             c----CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            2    22245667789999999999999899999999999999999999999998654333222111100          


Q ss_pred             --------Hh----hccCCccccCChhh-hhh--ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          488 --------KR----YNEGNLLDMVDPSI-KEV--ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       488 --------~~----~~~~~~~~~~d~~l-~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                              .+    +......+.+...+ ...  .+.--...+.+++.+||-.+|++|-++++++.|.
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP  311 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP  311 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence                    00    00000111110000 000  0011234568899999999999999999999884

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=2.5e-29  Score=254.19  Aligned_cols=266  Identities=21%  Similarity=0.240  Sum_probs=203.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC------CCCceeeeeEEEcCCc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKID------HRNLVKLLGFVDKGNE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~------HpnIv~l~~~~~~~~~  337 (554)
                      ..+|.+....|+|-|++|.+|... -|..||||+++.+..  ..+.=+.|+++|++|+      --|+++|+-.|...++
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            467777788899999999999654 488999999988743  3455678999999995      2479999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC-cEEEEeecCc
Q 042763          338 RLIITEFVPNGTLREHLDGQY-GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFA  415 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla  415 (554)
                      +|||+|-+ ..+|.+.|++.. ...+....+..++.|+..||..|.   ..+|+|.||||+|||+++.. .+||||||.|
T Consensus       509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccc
Confidence            99999988 789999997642 346788899999999999999999   89999999999999999764 5899999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH-----hh
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFK-----RY  490 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~-----~~  490 (554)
                      .......     .+.+.-+..|.|||++.|.+|+...|+||.||+||||.||+..|.+...............     .+
T Consensus       585 ~~~~ene-----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml  659 (752)
T KOG0670|consen  585 SFASENE-----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML  659 (752)
T ss_pred             ccccccc-----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence            7643222     2233355679999999999999999999999999999999999987655433222211111     01


Q ss_pred             ccCC---------------------------ccccCCh------hhhhh--cc---HHHHHHHHHHHHHccCCCCCCCCC
Q 042763          491 NEGN---------------------------LLDMVDP------SIKEV--IS---MEILTKMFGLAIQCAAPIRNDRPD  532 (554)
Q Consensus       491 ~~~~---------------------------~~~~~d~------~l~~~--~~---~~~~~~l~~li~~cl~~dP~~RPs  532 (554)
                      ..+.                           ++..+.|      .+...  ++   +.....|.+|+..|+..||++|-|
T Consensus       660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit  739 (752)
T KOG0670|consen  660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT  739 (752)
T ss_pred             hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence            1100                           0111111      11110  12   345668899999999999999999


Q ss_pred             HHHHHHHHH
Q 042763          533 MKSVGEQLW  541 (554)
Q Consensus       533 ~~evl~~l~  541 (554)
                      ..+.+.|..
T Consensus       740 ~nqAL~HpF  748 (752)
T KOG0670|consen  740 VNQALKHPF  748 (752)
T ss_pred             HHHHhcCCc
Confidence            999998753

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=4.7e-29  Score=259.07  Aligned_cols=254  Identities=23%  Similarity=0.351  Sum_probs=202.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|+....+|.|.+|.|||++. ..++..|||+++-...+. ..-+.+|+-+++..+||||+.++|.+...+..+++||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            35788888999999999999965 468999999998765433 4567889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      ||.+|+|.+.-+.-  .++++.++..+++..++||+|||   +.+-+|||||-.|||+++.|.+|++|||.+..+..   
T Consensus        93 ycgggslQdiy~~T--gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita---  164 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA---  164 (829)
T ss_pred             ecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh---
Confidence            99999999876543  68899999999999999999999   89999999999999999999999999999865322   


Q ss_pred             CccccccccCCCCCcChhcc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          424 RTHISTKVKGTVGYLDPEYM---KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l---~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      .-.....+.||+.|||||+.   +.+.|..++|||++|++..|+---++|.....+-......  ....+.        .
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm--TkS~~q--------p  234 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM--TKSGFQ--------P  234 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh--hccCCC--------C
Confidence            22233456799999999976   4568999999999999999998888876543321111100  000011        1


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQ  539 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  539 (554)
                      +.+++  .......+.++++.|+-.+|.+||+++.+++|
T Consensus       235 p~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  235 PTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             CcccC--CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence            12221  12345568999999999999999999998875

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=6.2e-28  Score=240.30  Aligned_cols=269  Identities=23%  Similarity=0.314  Sum_probs=198.1

Q ss_pred             HHHhhcCCCcceeeeccCceEEEEEEEc----CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcC
Q 042763          261 VVKATRNFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKG  335 (554)
Q Consensus       261 l~~~~~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~  335 (554)
                      +....+.|..+++||+|.|++||++...    ..+.||+|.+......   ..+.+|+++|..+ .+.||+++.+++..+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            3334567889999999999999999443    4688999998776543   4688999999999 499999999999999


Q ss_pred             CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC-CCCcEEEEeecC
Q 042763          336 NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT-ESMRAKVADFGF  414 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~-~~~~vkl~DfGl  414 (554)
                      +...+|+||+++.+..++..     .++..++..++..++.||.++|   .+|||||||||+|+|.+ ..+.-.|+|||+
T Consensus       108 d~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             CeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechh
Confidence            99999999999999999885     4678999999999999999999   99999999999999997 467889999999


Q ss_pred             cccCCCCC-----------------------------------------CCccccccccCCCCCcChhccccC-CCCchh
Q 042763          415 ARLGPMDS-----------------------------------------DRTHISTKVKGTVGYLDPEYMKTY-QLTTKS  452 (554)
Q Consensus       415 a~~~~~~~-----------------------------------------~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ks  452 (554)
                      |.......                                         ..........||++|.|||++... ..++++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            97210000                                         000001123599999999998764 578999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCChhhH-HHHH---------HHHHhhccCCccc--c-------------CC-hh----
Q 042763          453 DVYSFGVLLLEILTGRRPVELKRPPEER-VTLR---------WAFKRYNEGNLLD--M-------------VD-PS----  502 (554)
Q Consensus       453 DVwSlGvil~elltg~~P~~~~~~~~~~-~~~~---------~~~~~~~~~~~~~--~-------------~d-~~----  502 (554)
                      ||||.|||++-++++++||-....+-+. ..+.         ..........+++  .             ++ ..    
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            9999999999999999999654322111 1010         0000000000111  0             00 00    


Q ss_pred             ----hh-hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042763          503 ----IK-EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL  540 (554)
Q Consensus       503 ----l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l  540 (554)
                          .. +......+..+++++.+|+..||.+|-|+++.+.|.
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp  382 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP  382 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence                00 000111234789999999999999999999999874

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=8.7e-28  Score=225.99  Aligned_cols=254  Identities=20%  Similarity=0.369  Sum_probs=187.3

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC-CcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeE-EEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGF-VDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~-~~~~~~~~lv  341 (554)
                      .+.|.+.+.||+|.||.+-+++++. .+.+|+|-+.....  ...+|.+|...--.| .|.||+.-++. |...+..+++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            4678888999999999999998774 67889998877643  347888888766666 58999988765 6777788899


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC--CCCcEEEEeecCcccCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT--ESMRAKVADFGFARLGP  419 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~--~~~~vkl~DfGla~~~~  419 (554)
                      +||++.|+|..-+...   .+.+....+++.|++.|+.|+|   ++++||||||.+||||-  +..+|||||||+.+...
T Consensus       101 qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             eccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            9999999999887653   6778888899999999999999   99999999999999993  34589999999997633


Q ss_pred             CCCCCccccccccCCCCCcChhccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTY-----QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      ..-      ....-+..|-+||.....     ...+.+|||.||+++|.+|||..||+.....+..   .|.+..+..+.
T Consensus       175 ~tV------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~---Y~~~~~w~~rk  245 (378)
T KOG1345|consen  175 TTV------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP---YWEWEQWLKRK  245 (378)
T ss_pred             cee------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch---HHHHHHHhccc
Confidence            211      112245578999977532     3577899999999999999999999954433221   22233332222


Q ss_pred             ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       495 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ...  -|..-    .....++.++.++-+.++|++|=-..++..+..
T Consensus       246 ~~~--~P~~F----~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  246 NPA--LPKKF----NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             Ccc--Cchhh----cccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence            111  11111    123345678888999999999955555544443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1.3e-27  Score=273.23  Aligned_cols=202  Identities=21%  Similarity=0.246  Sum_probs=142.4

Q ss_pred             hCCC-CCceeeeeEE-------EcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeE
Q 042763          319 KIDH-RNLVKLLGFV-------DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII  390 (554)
Q Consensus       319 ~l~H-pnIv~l~~~~-------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv  390 (554)
                      .++| +||+++++++       .+....++++||+ +++|.+++... ...+++.+++.++.||++||+|||   +++|+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH---SQGIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            3445 5778888877       2334567788988 77999999753 356899999999999999999999   89999


Q ss_pred             eCCCCCCCeEECCCCc-------------------EEEEeecCcccCCCCCCC-------------ccccccccCCCCCc
Q 042763          391 HRDVKSSNILLTESMR-------------------AKVADFGFARLGPMDSDR-------------THISTKVKGTVGYL  438 (554)
Q Consensus       391 H~Dlkp~NILl~~~~~-------------------vkl~DfGla~~~~~~~~~-------------~~~~~~~~gt~~y~  438 (554)
                      ||||||+|||++..+.                   +|++|||+++........             ........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999965444                   555555555431100000             00011235889999


Q ss_pred             ChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHH
Q 042763          439 DPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGL  518 (554)
Q Consensus       439 aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  518 (554)
                      |||++.+..|+.++|||||||+||||++|..|+.....     ........        ..++..     .........+
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~~--------~~~~~~-----~~~~~~~~~~  244 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRHR--------VLPPQI-----LLNWPKEASF  244 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHHh--------hcChhh-----hhcCHHHHHH
Confidence            99999999999999999999999999999888653211     11110000        011111     0112335678


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          519 AIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       519 i~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      +.+||+++|.+||+|.||+++.|-.
T Consensus       245 ~~~~L~~~P~~Rps~~eil~h~~~~  269 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQSEFIN  269 (793)
T ss_pred             HHHhCCCChhhCcChHHHhhchhhh
Confidence            8899999999999999999988743

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=3.1e-26  Score=213.51  Aligned_cols=172  Identities=22%  Similarity=0.277  Sum_probs=130.8

Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |+|.+++..+ +..+++.+++.++.|++.||+|||   +.+      ||+|||++.++.+|+  ||+++.....      
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc------
Confidence            7899999754 356999999999999999999999   555      999999999999999  9999864321      


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhc
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI  507 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  507 (554)
                        ...||+.|||||++.+..++.++|||||||++|||+||+.||.........  +...........      +... ..
T Consensus        63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~------~~~~-~~  131 (176)
T smart00750       63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI--LEILLNGMPADD------PRDR-SN  131 (176)
T ss_pred             --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH--HHHHHHHhccCC------cccc-cc
Confidence              125889999999999999999999999999999999999999754332211  111111111110      0000 01


Q ss_pred             cHHHHH--HHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          508 SMEILT--KMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       508 ~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                      ......  .+.+++.+||+.+|++||++.|++++++.+..+..
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~~  174 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAETL  174 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHHh
Confidence            112222  68999999999999999999999999999876543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=8.2e-25  Score=224.23  Aligned_cols=264  Identities=23%  Similarity=0.271  Sum_probs=200.7

Q ss_pred             CCCcceeeeccCceEEEEEEEcCC--cEEEEEEcchhhhhhHHHHHHHHHHHHHhCCC----CCceeeeeEE-EcCCceE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLEDG--LLVAIKRAKKEQFENLQTEFSSEVELLSKIDH----RNLVKLLGFV-DKGNERL  339 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~~g--~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~H----pnIv~l~~~~-~~~~~~~  339 (554)
                      +|.+.++||+|+||.||++...+.  ..+|+|........... .+..|+.++..+..    +++..+++.. ..+...+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            899999999999999999976543  47888877665332222 67788899988863    5899999988 5778889


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC-----CcEEEEeecC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES-----MRAKVADFGF  414 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-----~~vkl~DfGl  414 (554)
                      +||+.+ |.+|.++......+.++..+++.|+.|++.+|++||   +.+++||||||+|+++...     ..+.|.|||+
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            999988 999999887665678999999999999999999999   9999999999999999865     4699999999


Q ss_pred             cccCC--CCCCC---cc-c-cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 042763          415 ARLGP--MDSDR---TH-I-STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF  487 (554)
Q Consensus       415 a~~~~--~~~~~---~~-~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~  487 (554)
                      ++...  .....   .. . .....||..|.+++...+...+.+.|+||++.++.||+.|..||................
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            98322  22211   11 1 223559999999999999999999999999999999999999997655443322222221


Q ss_pred             HhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          488 KRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                      .......            .....+..+..+...+-..+..++|....+...++++..+.
T Consensus       254 ~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  254 RKLLTDR------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             hhhcccc------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            1111110            11112234555555555689999999999999987776553

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=6.8e-25  Score=225.21  Aligned_cols=168  Identities=18%  Similarity=0.162  Sum_probs=130.4

Q ss_pred             HHhhcCCCcceeeeccCceEEEEEEEc--CCcEEEEEEcchhh----hhhHHHHHHHHHHHHHhCCCCCcee-eeeEEEc
Q 042763          262 VKATRNFSPSLRIGEGGFGTVYKAQLE--DGLLVAIKRAKKEQ----FENLQTEFSSEVELLSKIDHRNLVK-LLGFVDK  334 (554)
Q Consensus       262 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~~~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~-l~~~~~~  334 (554)
                      .....+|...+.||+|+||+||+|...  +++.||||++....    .....+.+.+|+++|++++|+|+++ ++++   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            344577999999999999999999764  57888999865331    1233567999999999999999985 4432   


Q ss_pred             CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCC-CCCCeEECCCCcEEEEeec
Q 042763          335 GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDV-KSSNILLTESMRAKVADFG  413 (554)
Q Consensus       335 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~NILl~~~~~vkl~DfG  413 (554)
                       +..++||||+++++|... ..     ..   ...++.|+++||.|||   +++|+|||| ||+|||++.++.+||+|||
T Consensus        91 -~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             -CCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence             467999999999999632 11     11   1467889999999999   899999999 9999999999999999999


Q ss_pred             CcccCCCCCCCccc-----cccccCCCCCcChhcccc
Q 042763          414 FARLGPMDSDRTHI-----STKVKGTVGYLDPEYMKT  445 (554)
Q Consensus       414 la~~~~~~~~~~~~-----~~~~~gt~~y~aPE~l~~  445 (554)
                      +|+...........     .+...+++.|+|||.+..
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99876443322221     135668899999998854

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=6.8e-24  Score=205.05  Aligned_cols=265  Identities=18%  Similarity=0.283  Sum_probs=206.2

Q ss_pred             hcCCCcceeeeccCceEEEEEE-EcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      +-+|.+.++||+|.||..+.|+ +-++++||||.-.....   ..++..|....+.| ..++|...+-+..++-+-.||+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            4578899999999999999995 45799999997655432   24677788888888 5789999998888888889999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC-----CcEEEEeecCccc
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES-----MRAKVADFGFARL  417 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-----~~vkl~DfGla~~  417 (554)
                      |.+ |-+|.|+++ -+++.++.++++.+|.|++.-++|+|   ++.+|.|||||+|+||..-     ..+.|+|||+|+.
T Consensus       104 dLL-GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  104 DLL-GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhh-CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            999 889998875 44678999999999999999999999   9999999999999999743     3589999999998


Q ss_pred             CCCCCCCcccc----ccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC
Q 042763          418 GPMDSDRTHIS----TKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG  493 (554)
Q Consensus       418 ~~~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  493 (554)
                      +.......+..    ....||.+||+-....++..+...|+-|||-+++.+|.|..||++-..+......+.+-+..+..
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            76554443332    23569999999999999999999999999999999999999999877665443333332222111


Q ss_pred             CccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          494 NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       494 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      .+         +.+....+.++..-+.-.-+.+-.+-|...-+...+.++-+.
T Consensus       259 ~i---------~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr  302 (449)
T KOG1165|consen  259 PI---------EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR  302 (449)
T ss_pred             CH---------HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence            11         112223455666666666667778889988887777666543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=1.1e-22  Score=204.97  Aligned_cols=262  Identities=30%  Similarity=0.428  Sum_probs=200.7

Q ss_pred             CCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhh--HHHHHHHHHHHHHhCCCC-CceeeeeEEEcCCceEEEEEe
Q 042763          268 FSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHR-NLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~--~~~~~~~Ei~~l~~l~Hp-nIv~l~~~~~~~~~~~lv~E~  344 (554)
                      |.....||.|+||.||++...  ..+++|.+.......  ....+.+|+.+++.+.|+ +++++.+.+......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566778999999999999876  788999998776543  467899999999999988 799999999777778999999


Q ss_pred             CCCCCHHHHHhcccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC-cEEEEeecCcccCCCCC
Q 042763          345 VPNGTLREHLDGQYG-KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDS  422 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~~~~~  422 (554)
                      +.++++.+++..... ..+.......++.|++.++.|+|   ..+++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977765422 26888999999999999999999   88999999999999999988 79999999998543322


Q ss_pred             CCcc---ccccccCCCCCcChhcccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCh-hhHHHHHHHHHhhccCCc
Q 042763          423 DRTH---ISTKVKGTVGYLDPEYMKT---YQLTTKSDVYSFGVLLLEILTGRRPVELKRPP-EERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       423 ~~~~---~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvil~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~  495 (554)
                      ....   ......|+..|+|||.+.+   ..++...|+|++|++++++++|..||...... ............... ..
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~  235 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL  235 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence            2221   3456679999999999987   57889999999999999999999997765531 011111111111111 00


Q ss_pred             cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042763          496 LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQ  539 (554)
Q Consensus       496 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  539 (554)
                      .......    ........+.+++..|+..+|..|.++.+....
T Consensus       236 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         236 ASPLSPS----NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccCcc----ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0000000    002223567889999999999999999988776

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=6.1e-24  Score=197.07  Aligned_cols=263  Identities=17%  Similarity=0.272  Sum_probs=204.5

Q ss_pred             hcCCCcceeeeccCceEEEEEE-EcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCC-CCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH-RNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~~lv~  342 (554)
                      ...|..+++||.|+||.+|.|. ..+|+.||||+-.....   ...+..|..+.+.|++ ..|..+..|..+.+.-.+||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            4678999999999999999994 56799999998765432   2467789999999974 67888888888889999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC---CCcEEEEeecCcccCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE---SMRAKVADFGFARLGP  419 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~DfGla~~~~  419 (554)
                      +.. |.+|.+++.- ..+.++..+++-++.|++.-++|+|   .++.+||||||+|+|..-   ...+.++|||+|+.+.
T Consensus        91 dLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             ecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            998 8999998763 3467899999999999999999999   899999999999999963   4568999999999865


Q ss_pred             CCCCCccc----cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          420 MDSDRTHI----STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       420 ~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      ......+.    .....||.+|.+-....+...+...|+-|+|.+|..+..|..||++..........+.+.++.....+
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i  245 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI  245 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence            44333332    34567999999999888888899999999999999999999999987766554444443332222111


Q ss_pred             cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          496 LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       496 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                               +.+-...+.++.-.+.-|-..--++-|...-+-+.+.-+.
T Consensus       246 ---------e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf  285 (341)
T KOG1163|consen  246 ---------EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF  285 (341)
T ss_pred             ---------HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence                     1122233455666777777777778888777766555443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=5.4e-25  Score=240.18  Aligned_cols=259  Identities=21%  Similarity=0.283  Sum_probs=194.6

Q ss_pred             CcceeeeccCceEEEEEEEc-CCcEEEEEEcc----hhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          269 SPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAK----KEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       269 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~----~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ...+.+|.|++|.|+.+... ..+.++.|..+    .... .+....+..|+.+-..++|||++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            35668999999988877443 34444444332    2211 222233667888888899999988887777666666669


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      |||+. ||..++...  ..+...++-.+++|++.|++|+|   ..+|.|||+|++|++++.+|.+||+|||.+..+....
T Consensus       401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            99998 999998764  46788889999999999999999   9999999999999999999999999999998755443


Q ss_pred             CC-ccccccccCCCCCcChhccccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          423 DR-THISTKVKGTVGYLDPEYMKTYQLTT-KSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       423 ~~-~~~~~~~~gt~~y~aPE~l~~~~~s~-ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      +. ......++|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||......+...       ............
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~~~~~~~  547 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYSDQRNIF  547 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhccccccccc
Confidence            32 24566788999999999999999876 5899999999999999999998765544322       000000001111


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .. ...+...++.....++.+||+++|.+|-|+.+|++.-|
T Consensus       548 ~~-~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W  587 (601)
T KOG0590|consen  548 EG-PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW  587 (601)
T ss_pred             cC-hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence            11 11233455667899999999999999999999988766

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=9.7e-25  Score=205.38  Aligned_cols=247  Identities=21%  Similarity=0.346  Sum_probs=195.9

Q ss_pred             ceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCC
Q 042763          271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGT  349 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~  349 (554)
                      ..+|.+...|..|+|++. |..+++|++..... ....++|..|.-.|+-+.||||+.++|.|..+....++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            347899999999999998 55567787766543 3344678899999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEE--eecCcccCCCCCCCccc
Q 042763          350 LREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVA--DFGFARLGPMDSDRTHI  427 (554)
Q Consensus       350 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~--DfGla~~~~~~~~~~~~  427 (554)
                      |...+++..+-..+-.++++++.++++|++|||+. +.-|.---|.+..|+||++.+.+|.  |--++..          
T Consensus       274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq----------  342 (448)
T KOG0195|consen  274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----------  342 (448)
T ss_pred             HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee----------
Confidence            99999998877889999999999999999999964 3334445688999999999887774  3222211          


Q ss_pred             cccccCCCCCcChhccccCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          428 STKVKGTVGYLDPEYMKTYQLT---TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s---~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      .....-.|.||+||.+...+-+   .++|+|||++++|||.|...||..-.+-+....+               .-..++
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---------------aleglr  407 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---------------ALEGLR  407 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---------------hhcccc
Confidence            1112246889999999876543   5789999999999999999999876554332211               112233


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      -.+++.+...+..|+.-|++.||.+||.+..|+-.|++++
T Consensus       408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            3466777888999999999999999999999999888764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=6.9e-22  Score=189.37  Aligned_cols=171  Identities=11%  Similarity=0.126  Sum_probs=133.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhh--HHH------HHHHHHHHHHhCCCCCceeeeeEEEcC-
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFEN--LQT------EFSSEVELLSKIDHRNLVKLLGFVDKG-  335 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~--~~~------~~~~Ei~~l~~l~HpnIv~l~~~~~~~-  335 (554)
                      .++|...+.||.|+||.||+++. ++..+|||.+.+.....  ...      .+.+|+..+.++.|++|..+.+++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            57899999999999999999866 47789999997654322  112      267999999999999999999886532 


Q ss_pred             -------CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEE
Q 042763          336 -------NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAK  408 (554)
Q Consensus       336 -------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vk  408 (554)
                             +..+++|||++|.+|.++..      ++.    ....+++.+|..+|   ..+++|||+||+||+++.++ ++
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence                   35789999999999988742      222    34569999999999   99999999999999999998 99


Q ss_pred             EEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHH
Q 042763          409 VADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL  465 (554)
Q Consensus       409 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ell  465 (554)
                      |+|||.........   . .           ..+.....|+.++|+|+||+++..+.
T Consensus       175 liDfg~~~~~~e~~---a-~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRK---A-K-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchh---h-H-----------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999887532111   0 0           11344556778999999999987664

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=1.5e-21  Score=184.26  Aligned_cols=139  Identities=17%  Similarity=0.183  Sum_probs=108.5

Q ss_pred             ceeeeccCceEEEEEEEcCCcEEEEEEcchhhhh--h-----------------------HHHHHHHHHHHHHhCCCCCc
Q 042763          271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFE--N-----------------------LQTEFSSEVELLSKIDHRNL  325 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~--~-----------------------~~~~~~~Ei~~l~~l~HpnI  325 (554)
                      ...||+|+||.||+|...+|+.||||+++.....  .                       .......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3479999999999998878999999999764211  0                       01123459999999988776


Q ss_pred             eeeeeEEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHh-hhccCCCeEeCCCCCCCeEECCC
Q 042763          326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL-HLYAEKQIIHRDVKSSNILLTES  404 (554)
Q Consensus       326 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~ivH~Dlkp~NILl~~~  404 (554)
                      .....+..  ...++||||++++++.......  ..++..++..++.|++.+|.++ |   +.+|+||||||+|||++ +
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-C
Confidence            44333322  2338999999888776553222  4688999999999999999999 6   78999999999999998 4


Q ss_pred             CcEEEEeecCccc
Q 042763          405 MRAKVADFGFARL  417 (554)
Q Consensus       405 ~~vkl~DfGla~~  417 (554)
                      +.++|+|||+|..
T Consensus       154 ~~v~LiDFG~a~~  166 (190)
T cd05147         154 GKLYIIDVSQSVE  166 (190)
T ss_pred             CcEEEEEcccccc
Confidence            7899999999975

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=1.4e-20  Score=176.78  Aligned_cols=190  Identities=15%  Similarity=0.112  Sum_probs=142.7

Q ss_pred             cceeeeccCceEEEEEEEcCCcEEEEEEcchhhhh---hHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEEEEEeC
Q 042763          270 PSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFE---NLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       270 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~---~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      +...|++|+||+||.+.. ++..++.+.+.....-   -....+.+|+++|++|+ |+++++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            456799999999998876 5778887777655431   11235889999999995 5889999886    4569999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCC-CCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDV-KSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +|.+|...+..         ....++.|++.+|.++|   +.+|+|||| ||+|||++.++.++|+|||++.........
T Consensus        81 ~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         81 AGAAMYQRPPR---------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             cCccHHhhhhh---------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            99998654321         12357889999999999   999999999 799999999999999999999864322210


Q ss_pred             cc--c--------cccccCCCCCcChhccccC-CCC-chhhHHHHHHHHHHHHhCCCCCCCCCC
Q 042763          425 TH--I--------STKVKGTVGYLDPEYMKTY-QLT-TKSDVYSFGVLLLEILTGRRPVELKRP  476 (554)
Q Consensus       425 ~~--~--------~~~~~gt~~y~aPE~l~~~-~~s-~ksDVwSlGvil~elltg~~P~~~~~~  476 (554)
                      ..  .        ......++.|++|+...-. ..+ ...+.++-|..+|.++|++.+...+..
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            00  0        1122378899999855432 233 567899999999999999998765443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.85  E-value=1.7e-22  Score=220.53  Aligned_cols=251  Identities=20%  Similarity=0.265  Sum_probs=182.4

Q ss_pred             CCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHH---HHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFS---SEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~---~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ++...+.||.+.|=+|.+|+++.|. |+||++-+....-..+.|.   .|++ ...++|||.+++.-+-..+...|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5666778999999999999988887 8899887665332223333   3344 556699999999888777778899999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |. .-+|+|.+.-+  ..+..-+...|+.|++.||.-+|   ..+|+|||||.+||||+.-.-+.|+||.--+-..-..+
T Consensus       102 yv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  102 YV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            99 56899998655  56777888899999999999999   99999999999999999999999999987654322222


Q ss_pred             Cccc----cccccCCCCCcChhccccC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHH
Q 042763          424 RTHI----STKVKGTVGYLDPEYMKTY----------Q-LTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAF  487 (554)
Q Consensus       424 ~~~~----~~~~~gt~~y~aPE~l~~~----------~-~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~  487 (554)
                      ....    ..+...-.+|.|||.+...          . .+++.||||+||+++||++ |++||...      ..+.   
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~a---  246 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLA---  246 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHh---
Confidence            2211    1122234579999977431          1 5678999999999999999 78888621      1111   


Q ss_pred             HhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          488 KRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                        ++.+. .......+... +.   ..+.+++..|++.||++|-++++.++.-.
T Consensus       247 --Yr~~~-~~~~e~~Le~I-ed---~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  247 --YRSGN-ADDPEQLLEKI-ED---VSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             --HhccC-ccCHHHHHHhC-cC---ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence              11111 11111111111 11   25788999999999999999999988743

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=2.2e-20  Score=176.68  Aligned_cols=139  Identities=19%  Similarity=0.199  Sum_probs=110.4

Q ss_pred             ceeeeccCceEEEEEEEcCCcEEEEEEcchhhhh------------------------h-HHHHHHHHHHHHHhCCCCCc
Q 042763          271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFE------------------------N-LQTEFSSEVELLSKIDHRNL  325 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~------------------------~-~~~~~~~Ei~~l~~l~HpnI  325 (554)
                      ...||+|+||.||+|...+|+.||||+++.....                        . ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4579999999999998778999999998764210                        0 01234678999999999987


Q ss_pred             eeeeeEEEcCCceEEEEEeCCCCCHHHH-HhcccCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCeEeCCCCCCCeEECC
Q 042763          326 VKLLGFVDKGNERLIITEFVPNGTLREH-LDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE-KQIIHRDVKSSNILLTE  403 (554)
Q Consensus       326 v~l~~~~~~~~~~~lv~E~~~~g~L~~~-l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-~~ivH~Dlkp~NILl~~  403 (554)
                      .....+...  ..++||||++++++... +..   ..++..+...++.|++.++.++|   . .+|+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-
Confidence            554444332  34899999988755443 332   35678889999999999999999   6 8999999999999999 


Q ss_pred             CCcEEEEeecCcccC
Q 042763          404 SMRAKVADFGFARLG  418 (554)
Q Consensus       404 ~~~vkl~DfGla~~~  418 (554)
                      ++.++|+|||++...
T Consensus       153 ~~~~~liDFG~a~~~  167 (190)
T cd05145         153 DGKPYIIDVSQAVEL  167 (190)
T ss_pred             CCCEEEEEcccceec
Confidence            889999999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=2.6e-20  Score=194.93  Aligned_cols=218  Identities=29%  Similarity=0.470  Sum_probs=165.6

Q ss_pred             HHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCe-EeCCCC
Q 042763          317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI-IHRDVK  395 (554)
Q Consensus       317 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i-vH~Dlk  395 (554)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+... ...+++.....+..+|+.||+|||   ..+| .|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeec
Confidence            45689999999999999999999999999999999999763 357889999999999999999999   4444 999999


Q ss_pred             CCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCC-------CCchhhHHHHHHHHHHHHhCC
Q 042763          396 SSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ-------LTTKSDVYSFGVLLLEILTGR  468 (554)
Q Consensus       396 p~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-------~s~ksDVwSlGvil~elltg~  468 (554)
                      +.|++++..+.+||+|||+....... ..........-..-|.|||.++...       .+.+.||||||++++|+++.+
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~-~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEET-AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             cccceeeeeEEEEechhhhccccccc-ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999998875421 1111111122345699999997641       467799999999999999999


Q ss_pred             CCCCCCCChhhH-HHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          469 RPVELKRPPEER-VTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       469 ~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      .||......... ..+.+...     .......|.+....  +....+..++.+||..+|++||++.+|-..+..+...
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             CccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            999864433322 12222211     11122333332211  4444789999999999999999999999988877663

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.8e-21  Score=203.45  Aligned_cols=225  Identities=26%  Similarity=0.313  Sum_probs=177.2

Q ss_pred             eeccCceEEEEEEE----cCCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          274 IGEGGFGTVYKAQL----EDGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       274 LG~G~fG~Vy~a~~----~~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      +|+|.||.|+++..    +.|..+|.|+.++.... ........|-.++...+ ||.+++++-.+..+...+++++|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            79999999998732    34778999988766432 11224556778888887 99999999999999999999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |+|...+...  ..+.+.....+...++-+++++|   ..+++|||+|++||+++.+|++++.|||+++..-...     
T Consensus        82 g~lft~l~~~--~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-----  151 (612)
T KOG0603|consen   82 GDLFTRLSKE--VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-----  151 (612)
T ss_pred             chhhhccccC--CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh-----
Confidence            9999888654  45666667777888999999999   8999999999999999999999999999998632211     


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhc
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI  507 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  507 (554)
                        ..+||..|||||+++  .....+|.||||++++||+||..||..    +....+..                 .+-..
T Consensus       152 --~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~-----------------~~~~~  206 (612)
T KOG0603|consen  152 --IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK-----------------AELEM  206 (612)
T ss_pred             --hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh-----------------hccCC
Confidence              128999999999998  578899999999999999999999986    11111110                 01113


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCH
Q 042763          508 SMEILTKMFGLAIQCAAPIRNDRPDM  533 (554)
Q Consensus       508 ~~~~~~~l~~li~~cl~~dP~~RPs~  533 (554)
                      +.+......+++.++...+|.+|--.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            44556667778888888888888765

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.82  E-value=1.7e-19  Score=178.00  Aligned_cols=233  Identities=19%  Similarity=0.261  Sum_probs=148.9

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhh--hhhHHHHHHHHHHHHHhCCC----------CCceeeeeE--
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQ--FENLQTEFSSEVELLSKIDH----------RNLVKLLGF--  331 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~~Ei~~l~~l~H----------pnIv~l~~~--  331 (554)
                      .+.....||.|+++.||.+++. +|+.+|||+.....  .....+.+++|.-....+.+          -.++-.++.  
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4455678999999999999776 58999999774432  23345667776655555432          112211221  


Q ss_pred             -------EEcCC--------ceEEEEEeCCCCCHHHHHhc---ccC--CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEe
Q 042763          332 -------VDKGN--------ERLIITEFVPNGTLREHLDG---QYG--KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH  391 (554)
Q Consensus       332 -------~~~~~--------~~~lv~E~~~~g~L~~~l~~---~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH  391 (554)
                             +....        ..+++|+-+ .+||.+++..   ...  ..+....++.+..|+++.+++||   ..+++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence                   11111        236788877 7899887642   211  12334455677799999999999   899999


Q ss_pred             CCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhcccc--------CCCCchhhHHHHHHHHHH
Q 042763          392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT--------YQLTTKSDVYSFGVLLLE  463 (554)
Q Consensus       392 ~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~ksDVwSlGvil~e  463 (554)
                      +||+|+|++++.+|.++|+||+.......    .. . ....+..|.+||....        -.++.+.|.|+||+++|.
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~----~~-~-~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~  242 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT----RY-R-CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS  242 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTE----EE-E-GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCc----ee-e-ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence            99999999999999999999998765221    11 1 1335578999997643        247889999999999999


Q ss_pred             HHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCC
Q 042763          464 ILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDR  530 (554)
Q Consensus       464 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R  530 (554)
                      |++|..||....+......                    .-..+. +.++.+..||..+|+.+|++|
T Consensus       243 lWC~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  243 LWCGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999986543211100                    112244 778889999999999999998

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=2e-19  Score=200.46  Aligned_cols=258  Identities=21%  Similarity=0.249  Sum_probs=188.6

Q ss_pred             HHHhhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC---CCCceeeeeEEEcCCc
Q 042763          261 VVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID---HRNLVKLLGFVDKGNE  337 (554)
Q Consensus       261 l~~~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~  337 (554)
                      +......|.+.+.||+|+||+||+|...+|+.||+|+-++.....    |.--.+++.+|+   -+.|..+...+.-.+.
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            344567788899999999999999988889999999987765321    222224555555   2345555555666778


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC-------CCcEEEE
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE-------SMRAKVA  410 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~-------~~~vkl~  410 (554)
                      .++|+||.+.|+|.++++  ..+.+++.-+..+..|+++.++.||   ..+|||+||||+|+||..       ...++|+
T Consensus       769 S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             ceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEE
Confidence            899999999999999998  4478999999999999999999999   999999999999999952       3459999


Q ss_pred             eecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhh
Q 042763          411 DFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY  490 (554)
Q Consensus       411 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  490 (554)
                      |||.+--.....+. ......++|-.+--+|...|+.++..+|.|.|+.+++-||.|++-             +     .
T Consensus       844 DfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-------------q-----~  904 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-------------E-----V  904 (974)
T ss_pred             ecccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-------------H-----h
Confidence            99998543222222 223445788899999999999999999999999999999999852             0     1


Q ss_pred             ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhhh
Q 042763          491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKS  550 (554)
Q Consensus       491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~~  550 (554)
                      ..+..+ .++..+.+....+.   +.+++..+|++|-..=|...++...++.+..+....
T Consensus       905 ~~g~~~-~~~~~~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~~  960 (974)
T KOG1166|consen  905 KNGSSW-MVKTNFPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFTG  960 (974)
T ss_pred             cCCcce-eccccchhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHHH
Confidence            111111 22222222233333   344555566677677788888888887776665543

>PRK10345 hypothetical protein; Provisional

Probab=99.80  E-value=5.4e-19  Score=168.71  Aligned_cols=136  Identities=21%  Similarity=0.270  Sum_probs=104.7

Q ss_pred             CcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-----CCCCceeeeeEEEcCC---ceE-
Q 042763          269 SPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-----DHRNLVKLLGFVDKGN---ERL-  339 (554)
Q Consensus       269 ~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~l~~~~~~~~---~~~-  339 (554)
                      .....||+|+||.||. .-.++. .+||++..... ...+.+.+|+.+++.+     +||||++++|+++++.   ..+ 
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcC-eEEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            3456899999999996 323344 47998876432 2346789999999999     5799999999998864   333 


Q ss_pred             EEEEe--CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHH-HHhhhccCCCeEeCCCCCCCeEECC----CCcEEEEee
Q 042763          340 IITEF--VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGL-TYLHLYAEKQIIHRDVKSSNILLTE----SMRAKVADF  412 (554)
Q Consensus       340 lv~E~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~ivH~Dlkp~NILl~~----~~~vkl~Df  412 (554)
                      +|+||  +.+++|.+++...   .+++.  ..++.|++.++ +|||   +++|+||||||+|||++.    ++.++|+||
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            78999  5579999999653   34444  35677888777 9999   999999999999999974    347999995


Q ss_pred             cCc
Q 042763          413 GFA  415 (554)
Q Consensus       413 Gla  415 (554)
                      +-+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            433

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=2.5e-18  Score=165.19  Aligned_cols=135  Identities=19%  Similarity=0.360  Sum_probs=114.0

Q ss_pred             eeeeccCceEEEEEEEcCCcEEEEEEcchhhh-------hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-------ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-------~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +.||+|++|.||+|.. +|..+++|+......       ......+.+|++++..++|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4799999999999987 577899997654321       11234578899999999999988877777777888999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      ++|++|.+++...     .. ++..++.+++.+|.++|   ..+++|||++|+|||++ ++.++|+|||+++.
T Consensus        81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998653     12 78899999999999999   89999999999999999 78999999999874

>smart00090 RIO RIO-like kinase

Probab=99.76  E-value=3.1e-18  Score=167.29  Aligned_cols=148  Identities=16%  Similarity=0.173  Sum_probs=114.8

Q ss_pred             HHHHhhcCCCcceeeeccCceEEEEEE--EcCCcEEEEEEcchhhhh-----------------------hHHHHHHHHH
Q 042763          260 QVVKATRNFSPSLRIGEGGFGTVYKAQ--LEDGLLVAIKRAKKEQFE-----------------------NLQTEFSSEV  314 (554)
Q Consensus       260 ~l~~~~~~f~~~~~LG~G~fG~Vy~a~--~~~g~~vAvK~~~~~~~~-----------------------~~~~~~~~Ei  314 (554)
                      .+......|.+.+.||+|+||.||+|.  ..+|+.||+|+++.....                       .....+.+|+
T Consensus        22 ~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~  101 (237)
T smart00090       22 SLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEF  101 (237)
T ss_pred             HHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence            344445568889999999999999997  567999999988754210                       0123467899


Q ss_pred             HHHHhCCCCC--ceeeeeEEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCC-eEe
Q 042763          315 ELLSKIDHRN--LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ-IIH  391 (554)
Q Consensus       315 ~~l~~l~Hpn--Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-ivH  391 (554)
                      +.+.++.+.+  +.+++++    ...++||||+++++|..+....  ..+...+...++.|++.++.+||   ..+ ++|
T Consensus       102 ~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH  172 (237)
T smart00090      102 RNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLY---KEGELVH  172 (237)
T ss_pred             HHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHH---hcCCEEe
Confidence            9999997533  3444443    2358999999988887665322  24556667899999999999999   888 999


Q ss_pred             CCCCCCCeEECCCCcEEEEeecCccc
Q 042763          392 RDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       392 ~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      |||||+||+++ ++.++|+|||.+..
T Consensus       173 ~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      173 GDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             CCCChhhEEEE-CCCEEEEEChhhhc
Confidence            99999999999 88999999999875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.76  E-value=5.8e-19  Score=193.14  Aligned_cols=211  Identities=24%  Similarity=0.312  Sum_probs=146.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC-CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ..+|..++.|-.|++|.||.++++. .+.+|+|+-+..       .+.+.  ++.....|.+|                 
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-------lilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-------LILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc-------hhhhc--cccccCCccee-----------------
Confidence            4678889999999999999997764 677888433322       11111  23333344444                 


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                          ||-...++..  +.++..        ++.+++|||   +.+|+|||+||+|.+|+.-|++|++|||+++.......
T Consensus       136 ----gDc~tllk~~--g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ----GDCATLLKNI--GPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ----chhhhhcccC--CCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence                4555555432  233322        278899999   89999999999999999999999999999986322111


Q ss_pred             C------------ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhc
Q 042763          424 R------------THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN  491 (554)
Q Consensus       424 ~------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~  491 (554)
                      .            ......++|||.|.|||++..+.|...+|+|++|+|+||++-|..||.++.+.+....+......+.
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp  278 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  278 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence            0            1112346899999999999999999999999999999999999999998876554333221111111


Q ss_pred             cCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCC
Q 042763          492 EGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPD  532 (554)
Q Consensus       492 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs  532 (554)
                      ++              ......+..+++.+.|+.+|..|--
T Consensus       279 E~--------------dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  279 EE--------------DEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             cc--------------CcCCCHHHHHHHHHHHHhChHhhcc
Confidence            11              1122345678888888889988854

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=3.2e-18  Score=169.34  Aligned_cols=194  Identities=22%  Similarity=0.274  Sum_probs=136.9

Q ss_pred             CCCCceeeeeEEEc---------------------------CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHH
Q 042763          321 DHRNLVKLLGFVDK---------------------------GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAID  373 (554)
Q Consensus       321 ~HpnIv~l~~~~~~---------------------------~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~q  373 (554)
                      +|||||++.++|.+                           +..+|+||.-. ..+|+.++..+   ..+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence            59999999887632                           23568999877 56999998765   4566677789999


Q ss_pred             HHHHHHHhhhccCCCeEeCCCCCCCeEE--CCCC--cEEEEeecCcccCCCCC---CCccccccccCCCCCcChhccccC
Q 042763          374 VAHGLTYLHLYAEKQIIHRDVKSSNILL--TESM--RAKVADFGFARLGPMDS---DRTHISTKVKGTVGYLDPEYMKTY  446 (554)
Q Consensus       374 i~~~L~~LH~~~~~~ivH~Dlkp~NILl--~~~~--~vkl~DfGla~~~~~~~---~~~~~~~~~~gt~~y~aPE~l~~~  446 (554)
                      +++|+.|||   .++|.|||+|++|||+  ++|+  .+.|+|||++--.....   .........-|...-||||+....
T Consensus       350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            999999999   9999999999999998  3443  47899999985421100   011111223478889999998653


Q ss_pred             C------CCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHH
Q 042763          447 Q------LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAI  520 (554)
Q Consensus       447 ~------~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~  520 (554)
                      +      .-.|+|.|+.|.+.||+++...||.....-.    +.  ...+.+..+     |.    .+..++..+.+++.
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~----L~--~r~Yqe~qL-----Pa----lp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML----LD--TRTYQESQL-----PA----LPSRVPPVARQLVF  491 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe----ec--hhhhhhhhC-----CC----CcccCChHHHHHHH
Confidence            2      1258999999999999999999998632210    00  011222221     11    22334456789999


Q ss_pred             HccCCCCCCCCCHHHH
Q 042763          521 QCAAPIRNDRPDMKSV  536 (554)
Q Consensus       521 ~cl~~dP~~RPs~~ev  536 (554)
                      ..|+.||++||+..-.
T Consensus       492 ~lL~r~pskRvsp~iA  507 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIA  507 (598)
T ss_pred             HHhcCCccccCCccHH
Confidence            9999999999997543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=7.4e-18  Score=160.49  Aligned_cols=144  Identities=20%  Similarity=0.165  Sum_probs=113.3

Q ss_pred             HHHHHhhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh--h-------------------hHHHHHHHHHHHH
Q 042763          259 SQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF--E-------------------NLQTEFSSEVELL  317 (554)
Q Consensus       259 ~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~--~-------------------~~~~~~~~Ei~~l  317 (554)
                      .++......|...+.||+|+||.||++..++|+.||||+++....  .                   ........|+.++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            455555556888899999999999999888899999998654320  0                   0112367889999


Q ss_pred             HhCCCCC--ceeeeeEEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCC
Q 042763          318 SKIDHRN--LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVK  395 (554)
Q Consensus       318 ~~l~Hpn--Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk  395 (554)
                      ..+.|++  ++..++    ....++||||+++++|......        .....++.+++.++.++|   ..+++|||||
T Consensus        88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~  152 (198)
T cd05144          88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY---KHGIIHGDLS  152 (198)
T ss_pred             HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH---HCCCCcCCCC
Confidence            9998774  444443    2455899999999998765421        345678899999999999   8999999999


Q ss_pred             CCCeEECCCCcEEEEeecCccc
Q 042763          396 SSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       396 p~NILl~~~~~vkl~DfGla~~  417 (554)
                      |+||++++++.++|+|||++..
T Consensus       153 p~Nill~~~~~~~liDfg~~~~  174 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVS  174 (198)
T ss_pred             cccEEEcCCCcEEEEECCcccc
Confidence            9999999999999999999964

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=6.2e-19  Score=181.30  Aligned_cols=180  Identities=26%  Similarity=0.405  Sum_probs=134.0

Q ss_pred             ceEEEEEeCCCCCHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCc
Q 042763          337 ERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA  415 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla  415 (554)
                      ..++.|++|+..+|.+|+..+ .....++...+.++.|++.|++|      ++.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999744 35577888999999999999999      68999999999999999999999999998


Q ss_pred             ccCCCCC---CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhc
Q 042763          416 RLGPMDS---DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYN  491 (554)
Q Consensus       416 ~~~~~~~---~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  491 (554)
                      .......   ......+...||..||+||.+.+..|+.|+||||||++|+||+. =.-+++.          ..+....+
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~r  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDIR  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhhh
Confidence            7643332   11223445679999999999999999999999999999999997 2222110          01111122


Q ss_pred             cCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          492 EGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       492 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .+.    ++|.....++     +=+.++.+++.+.|.+||++.++..+.+
T Consensus       474 ~g~----ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~~~~~~  514 (516)
T KOG1033|consen  474 DGI----IPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEVALHEF  514 (516)
T ss_pred             cCC----CChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHHhhhhh
Confidence            221    2222222222     2257888999999999997766655543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=9.8e-18  Score=159.55  Aligned_cols=131  Identities=20%  Similarity=0.362  Sum_probs=107.3

Q ss_pred             eeeccCceEEEEEEEcCCcEEEEEEcchhhh-------hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-------ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-------~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      .||+|+||.||+|.. +|..+++|+......       ......+.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999985 478899998654321       112356789999999999887665555555666779999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      ++++|.+++....  .       .++.+++.+|.+||   +.+++|||++|+||+++ ++.++++|||+++.
T Consensus        80 ~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN--D-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH--H-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999875431  0       78999999999999   89999999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=1.8e-17  Score=181.32  Aligned_cols=138  Identities=22%  Similarity=0.330  Sum_probs=112.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEc-chh-h---h--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRA-KKE-Q---F--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~-~~~-~---~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  337 (554)
                      ...|...++||+|+||+||+|.+.+.. +++|+. .+. .   .  ....+.+.+|++++++++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            345567789999999999999876443 444432 211 1   0  1123568899999999999999988888777778


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .++||||+++++|.+++.          ....++.+++++|.+||   +.+++||||||+|||+ .++.++|+|||+++.
T Consensus       411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            899999999999999885          34678999999999999   8999999999999999 678999999999975

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=6.5e-16  Score=138.88  Aligned_cols=135  Identities=20%  Similarity=0.222  Sum_probs=114.1

Q ss_pred             cceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCC--CCceeeeeEEEcCCceEEEEEeCCC
Q 042763          270 PSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH--RNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       270 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      +.+.||+|.++.||++...+ ..+++|.......   ...+.+|+..++.++|  .++++++++...++..+++|||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            35679999999999998764 7899998866532   4578899999999976  5899999998888889999999988


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      +.+..+         +......++.+++.+++++|.....+++|+|++|+||++++++.++++|||.++.
T Consensus        78 ~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            777544         4556677899999999999954346799999999999999999999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.65  E-value=6.2e-16  Score=145.56  Aligned_cols=135  Identities=21%  Similarity=0.240  Sum_probs=97.7

Q ss_pred             ceeeeccCceEEEEEEEcCCcEEEEEEcchhhhh--hHHHH---------------------HHHHHHHHHhCCCCC--c
Q 042763          271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFE--NLQTE---------------------FSSEVELLSKIDHRN--L  325 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~--~~~~~---------------------~~~Ei~~l~~l~Hpn--I  325 (554)
                      .+.||+|+||+||+|...+|+.||||++......  .....                     ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4579999999999998888999999988754221  11111                     135666666664433  4


Q ss_pred             eeeeeEEEcCCceEEEEEeCCCCCHHHH-HhcccCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCeEeCCCCCCCeEECC
Q 042763          326 VKLLGFVDKGNERLIITEFVPNGTLREH-LDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE-KQIIHRDVKSSNILLTE  403 (554)
Q Consensus       326 v~l~~~~~~~~~~~lv~E~~~~g~L~~~-l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-~~ivH~Dlkp~NILl~~  403 (554)
                      .+.+++    ...++||||++++.+... +...   .. ..++..++.+++.++.++|   . .+|+||||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~-~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RL-LEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh---hh-cccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-
Confidence            444443    245899999998544321 1111   01 1667889999999999999   7 9999999999999999 


Q ss_pred             CCcEEEEeecCccc
Q 042763          404 SMRAKVADFGFARL  417 (554)
Q Consensus       404 ~~~vkl~DfGla~~  417 (554)
                      ++.++++|||.+..
T Consensus       150 ~~~~~liDfg~a~~  163 (187)
T cd05119         150 DGKVYIIDVPQAVE  163 (187)
T ss_pred             CCcEEEEECccccc
Confidence            89999999999974

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=3.2e-15  Score=146.27  Aligned_cols=135  Identities=19%  Similarity=0.217  Sum_probs=105.4

Q ss_pred             eeee-ccCceEEEEEEEcCCcEEEEEEcchhhh------------hhHHHHHHHHHHHHHhCCCCCc--eeeeeEEEcCC
Q 042763          272 LRIG-EGGFGTVYKAQLEDGLLVAIKRAKKEQF------------ENLQTEFSSEVELLSKIDHRNL--VKLLGFVDKGN  336 (554)
Q Consensus       272 ~~LG-~G~fG~Vy~a~~~~g~~vAvK~~~~~~~------------~~~~~~~~~Ei~~l~~l~HpnI--v~l~~~~~~~~  336 (554)
                      ..|| .|+.|+||++... +..++||++.....            ......+.+|++++.+|+|++|  +..+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4688 8999999999876 67889998754211            0123567889999999998875  66777643322


Q ss_pred             -c---eEEEEEeCCC-CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEe
Q 042763          337 -E---RLIITEFVPN-GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVAD  411 (554)
Q Consensus       337 -~---~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~D  411 (554)
                       .   .++||||+++ .+|.+++...   .++..    .+.+++.+|.+||   +.+|+||||||+|||++.++.++|+|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence             2   2599999997 6999888643   34433    3578999999999   99999999999999999999999999


Q ss_pred             ecCccc
Q 042763          412 FGFARL  417 (554)
Q Consensus       412 fGla~~  417 (554)
                      ||.++.
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            999875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.60  E-value=6.2e-17  Score=177.07  Aligned_cols=263  Identities=22%  Similarity=0.302  Sum_probs=196.7

Q ss_pred             CCcceeeeccCceEEEEEEEc--CCcEEEEEEcchhh-hhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEEEEE
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE--DGLLVAIKRAKKEQ-FENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~~~~~~-~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      |...+.||+|+|+.|-.....  ....+|+|.+.... .....+....|..+-..+. |+|++.+++...+.+..+++++
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~  101 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS  101 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence            444556999999999988553  24566777665443 2333455666777777776 9999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC-cEEEEeecCcccCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDS  422 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~~~~~  422 (554)
                      |..++++.+.+........+....-..+.|+..++.|+|.  ..++.|+||||+|.+++..+ ..+++|||+|..+....
T Consensus       102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~  179 (601)
T KOG0590|consen  102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN  179 (601)
T ss_pred             cccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence            9999999988832222256667777899999999999995  67899999999999999999 99999999998876533


Q ss_pred             CCccccccccC-CCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          423 DRTHISTKVKG-TVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       423 ~~~~~~~~~~g-t~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      .........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.......... ..|...+   .....   
T Consensus       180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~~~---~~~~~---  252 (601)
T KOG0590|consen  180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKSNK---GRFTQ---  252 (601)
T ss_pred             CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeecccc---ccccc---
Confidence            44444555678 9999999999885 45678999999999999999999998765543211 1111111   00000   


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                           ...........+++..++..+|..|.+.+++...-|-..
T Consensus       253 -----~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  253 -----LPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             -----CccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                 011223345677888999999999999999988777665

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.51  E-value=9.7e-14  Score=147.42  Aligned_cols=140  Identities=20%  Similarity=0.241  Sum_probs=99.2

Q ss_pred             eeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHH---------------------------------------HHHHH
Q 042763          272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQ---------------------------------------TEFSS  312 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~---------------------------------------~~~~~  312 (554)
                      +.||.|++|.||+|++++|+.||||+.++...+...                                       -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            579999999999999999999999998654211100                                       12445


Q ss_pred             HHHHHHhC----CCCCceeeeeEE-EcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHH-HHHHhhhccC
Q 042763          313 EVELLSKI----DHRNLVKLLGFV-DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAH-GLTYLHLYAE  386 (554)
Q Consensus       313 Ei~~l~~l----~HpnIv~l~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~-~L~~LH~~~~  386 (554)
                      |...+.++    +|.+-+.+-.++ ......++||||++|++|.++...... ..   ....++.+++. .+..+|   .
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~---~  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVL---R  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHH---h
Confidence            55555554    232223322222 233457999999999999887653211 11   23456666666 467888   8


Q ss_pred             CCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          387 KQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       387 ~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      .+++|+|+||.||+++.++.++++|||++...
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            89999999999999999999999999999764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=3e-13  Score=131.67  Aligned_cols=209  Identities=22%  Similarity=0.286  Sum_probs=142.4

Q ss_pred             HHHHhCCCCCceeeeeEEEcC-----CceEEEEEeCCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCC
Q 042763          315 ELLSKIDHRNLVKLLGFVDKG-----NERLIITEFVPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYAEK  387 (554)
Q Consensus       315 ~~l~~l~HpnIv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~  387 (554)
                      .-+-.+.|.|||+++.|+.+.     .+..++.|||..|++..+|++.  ..+.+....-.+|+.||+.||.|||.+ +.
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            344456799999999998543     3468999999999999999753  345677777789999999999999976 78


Q ss_pred             CeEeCCCCCCCeEECCCCcEEEEeecCcccCCC-CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh
Q 042763          388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPM-DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT  466 (554)
Q Consensus       388 ~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~-~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt  466 (554)
                      .|+|+++..+-|++..+|-+|+.----....+. ............+-++|-+||.=.....+.++|||+||....||.-
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            999999999999999999888853211111000 0001111112346789999997776677889999999999999988


Q ss_pred             CCCCCCC-CCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          467 GRRPVEL-KRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       467 g~~P~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      +..-... .+.......+..+        +...-++            .-..++..|++..|+.||+|++++.|+-.+.
T Consensus       278 lEiq~tnseS~~~~ee~ia~~--------i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANV--------IIGLENG------------LQRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             heeccCCCcceeehhhhhhhh--------eeeccCc------------cccCcCcccccCCCCCCcchhhhhcCceeee
Confidence            7653221 1111100000000        0000011            1135667999999999999999998865443

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.39  E-value=6.5e-13  Score=142.90  Aligned_cols=142  Identities=17%  Similarity=0.192  Sum_probs=92.0

Q ss_pred             cCCCcceeeeccCceEEEEEEEcC-CcEEEEEEcchhhhh---------------------------------hHHHH--
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFE---------------------------------NLQTE--  309 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~---------------------------------~~~~~--  309 (554)
                      ..|+. +.||.|++|.||+|++++ |+.||||+.++.-.+                                 ...+.  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 689999999999999987 999999999755211                                 11112  


Q ss_pred             ----HHHHHHHHHhCC----CCCceeeeeEE-EcCCceEEEEEeCCCCCHHHHH--hcccC--CCCCHHHHHHHHHHHHH
Q 042763          310 ----FSSEVELLSKID----HRNLVKLLGFV-DKGNERLIITEFVPNGTLREHL--DGQYG--KTLDFNQRLEIAIDVAH  376 (554)
Q Consensus       310 ----~~~Ei~~l~~l~----HpnIv~l~~~~-~~~~~~~lv~E~~~~g~L~~~l--~~~~~--~~l~~~~~~~i~~qi~~  376 (554)
                          +.+|...+.+++    +.+.+.+-.++ +.....++||||++|+.+.++.  .....  +.+....+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence                333444444432    33333332332 2235678999999999998753  22100  012222222333333  


Q ss_pred             HHHHhhhccCCCeEeCCCCCCCeEECCCC----cEEEEeecCcccC
Q 042763          377 GLTYLHLYAEKQIIHRDVKSSNILLTESM----RAKVADFGFARLG  418 (554)
Q Consensus       377 ~L~~LH~~~~~~ivH~Dlkp~NILl~~~~----~vkl~DfGla~~~  418 (554)
                           +   ..+++|+|+||.||+++.++    .++++|||++...
T Consensus       277 -----f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        277 -----F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             -----H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence                 3   57999999999999999988    9999999999764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=4.9e-13  Score=140.56  Aligned_cols=252  Identities=22%  Similarity=0.240  Sum_probs=180.5

Q ss_pred             cCCCcceeeec--cCceEEEEEEE---cCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCce
Q 042763          266 RNFSPSLRIGE--GGFGTVYKAQL---EDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       266 ~~f~~~~~LG~--G~fG~Vy~a~~---~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~  338 (554)
                      ..|.....+|.  |.+|.||.+..   .++..+|+|+-+.... ......=.+|+....++ .|+|.++.+..++..+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34566677999  99999999865   4688999997433221 11122334566666666 499999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHH----HHHHhhhccCCCeEeCCCCCCCeEECCC-CcEEEEeec
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAH----GLTYLHLYAEKQIIHRDVKSSNILLTES-MRAKVADFG  413 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkl~DfG  413 (554)
                      ++-+|+| +.+|..+.... ...++....+....+..+    ||.++|   ..+++|-|+||.||++..+ ...+++|||
T Consensus       194 fiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcc
Confidence            9999999 68888887654 234777888888888888    999999   9999999999999999999 889999999


Q ss_pred             CcccCCCCCCCc--cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhc
Q 042763          414 FARLGPMDSDRT--HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN  491 (554)
Q Consensus       414 la~~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~  491 (554)
                      +...........  .......|...|++||...+ -++.++|||++|.+..+-.++..+.......      .|.  ..+
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~--~~r  339 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS------SWS--QLR  339 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC------Ccc--ccc
Confidence            987654332111  11122357778999998877 6788999999999999999887765433110      011  000


Q ss_pred             cCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042763          492 EGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQ  539 (554)
Q Consensus       492 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  539 (554)
                      ...        +...+-.....++..++.+|++.+|..|++.+.+..+
T Consensus       340 ~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  340 QGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            000        0000111122344558889999999999998887654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.36  E-value=3e-12  Score=118.27  Aligned_cols=128  Identities=20%  Similarity=0.193  Sum_probs=96.1

Q ss_pred             ceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCce-eeeeEEEcCCceEEEEEeCCCCC
Q 042763          271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV-KLLGFVDKGNERLIITEFVPNGT  349 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~~~~~~~~~~~lv~E~~~~g~  349 (554)
                      ++.|+.|.++.||+++.. +..|++|.......  ....+..|+.+++.+.+.+++ +++.+..  ...++||||+++.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            456899999999999876 77899998765431  123467888999988655544 4554432  34589999999988


Q ss_pred             HHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCC-----eEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          350 LREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ-----IIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       350 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-----ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      +....          .....++.+++++|+.||   ..+     ++|+|++|.||+++ ++.++++|||.+..
T Consensus        78 l~~~~----------~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          78 LLTED----------FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccccc----------ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            76430          111345678999999999   555     59999999999999 67899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.31  E-value=5.5e-11  Score=126.40  Aligned_cols=167  Identities=17%  Similarity=0.221  Sum_probs=126.7

Q ss_pred             EEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHH
Q 042763          286 QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFN  365 (554)
Q Consensus       286 ~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~  365 (554)
                      +..++.+|.|...+.... ...+...+-++.|+.++||||+++++.++..+..|+|+|-+  -.|..++++.     ...
T Consensus        33 ~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l-----~~~  104 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL-----GKE  104 (690)
T ss_pred             eeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh-----HHH
Confidence            334577788877766543 33455778889999999999999999999999999999988  4677777654     355


Q ss_pred             HHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhcccc
Q 042763          366 QRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT  445 (554)
Q Consensus       366 ~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~  445 (554)
                      .....+.||+.||.|||+  +.+++|++|.-+.|+++..|+.||++|.++........   ......---.|..|+.+..
T Consensus       105 ~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCc
Confidence            666788999999999985  78999999999999999999999999998864322111   0011111224666765543


Q ss_pred             CCCCchhhHHHHHHHHHHHHhC
Q 042763          446 YQLTTKSDVYSFGVLLLEILTG  467 (554)
Q Consensus       446 ~~~s~ksDVwSlGvil~elltg  467 (554)
                      ..  -..|.|.||++++|++.|
T Consensus       180 s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 SE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cc--cchhhhhHHHHHHHHhCc
Confidence            22  346999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.28  E-value=2.5e-12  Score=135.32  Aligned_cols=251  Identities=22%  Similarity=0.245  Sum_probs=181.0

Q ss_pred             hhcCCCcceeeeccCceEEEEEEE--cCCcEEEEEEcchhhhhhHH-HHHHHHHHHHHhC-CCCCceeeeeEEEcCCceE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQL--EDGLLVAIKRAKKEQFENLQ-TEFSSEVELLSKI-DHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~--~~g~~vAvK~~~~~~~~~~~-~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~  339 (554)
                      ...+|..+..||.|.|+.|++...  .++..|++|.+......... ..-..|+.+...+ .|.++++....+...+..+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            346788999999999999999854  36889999987665432222 2234666666666 5889999888887778888


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC-CcEEEEeecCcccC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES-MRAKVADFGFARLG  418 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkl~DfGla~~~  418 (554)
                      +-.|||+++++...+.  ....+++..++++..|++.++.++|   ++.++|+|+||+||++..+ +.-++.|||+....
T Consensus       343 ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             CchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccc
Confidence            9999999999877662  2246788889999999999999999   9999999999999999886 78899999988632


Q ss_pred             CCCCCCccccccccCCCCCc--ChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc
Q 042763          419 PMDSDRTHISTKVKGTVGYL--DPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL  496 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~--aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  496 (554)
                      .....      .....-+++  +++......+..+.|+++||..+.|.+++..--.....        |.  ....+.. 
T Consensus       418 ~~~~~------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~--~i~~~~~-  480 (524)
T KOG0601|consen  418 AFSSG------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SL--TIRSGDT-  480 (524)
T ss_pred             ceecc------cccccccccccchhhccccccccccccccccccccccccCcccCccccc--------ce--eeecccc-
Confidence            21111      111233344  55566667788999999999999999998754321110        10  0111111 


Q ss_pred             ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          497 DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       497 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                          +.    .+ .....+..+...+..+++..||.+.++..+....++
T Consensus       481 ----p~----~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  481 ----PN----LP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             ----cC----CC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence                00    11 122556778889999999999999999887766554

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.25  E-value=5.7e-11  Score=114.51  Aligned_cols=143  Identities=20%  Similarity=0.269  Sum_probs=110.5

Q ss_pred             eeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCC--CCceeeeeEEEcC---CceEEEEEeCC
Q 042763          272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH--RNLVKLLGFVDKG---NERLIITEFVP  346 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~---~~~~lv~E~~~  346 (554)
                      +.|+.|..+.||+++..+|..+++|.............+..|+++++.+.+  .++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            468999999999998877789999988664322234578899999999975  3457777776553   25689999999


Q ss_pred             CCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhcc-----------------------------------------
Q 042763          347 NGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA-----------------------------------------  385 (554)
Q Consensus       347 ~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----------------------------------------  385 (554)
                      +.++.+.+..   ..++..+...++.+++++|..||...                                         
T Consensus        84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            9888776532   24667777788888888888888421                                         


Q ss_pred             ------------CCCeEeCCCCCCCeEECC--CCcEEEEeecCccc
Q 042763          386 ------------EKQIIHRDVKSSNILLTE--SMRAKVADFGFARL  417 (554)
Q Consensus       386 ------------~~~ivH~Dlkp~NILl~~--~~~vkl~DfGla~~  417 (554)
                                  ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        245799999999999998  66789999998875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.24  E-value=1e-10  Score=110.05  Aligned_cols=135  Identities=16%  Similarity=0.150  Sum_probs=97.6

Q ss_pred             eeeeccCceEEEEEEEcC-------CcEEEEEEcchhhh---------------------hhHHHHHH----HHHHHHHh
Q 042763          272 LRIGEGGFGTVYKAQLED-------GLLVAIKRAKKEQF---------------------ENLQTEFS----SEVELLSK  319 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~~-------g~~vAvK~~~~~~~---------------------~~~~~~~~----~Ei~~l~~  319 (554)
                      ..||.|--+.||.|...+       +..+|||+.+....                     ......+.    +|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            368999999999996543       47899997653210                     01122333    79999998


Q ss_pred             CCC--CCceeeeeEEEcCCceEEEEEeCCCCCHHH-HHhcccCCCCCHHHHHHHHHHHHHHHHHh-hhccCCCeEeCCCC
Q 042763          320 IDH--RNLVKLLGFVDKGNERLIITEFVPNGTLRE-HLDGQYGKTLDFNQRLEIAIDVAHGLTYL-HLYAEKQIIHRDVK  395 (554)
Q Consensus       320 l~H--pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~ivH~Dlk  395 (554)
                      +..  -++..++++    ...++||||+.+..+.. .+..   ..++..+...+..+++.+|..+ |   ..+++|+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            853  456666654    46689999997654422 2221   1344556677889999999999 7   8899999999


Q ss_pred             CCCeEECCCCcEEEEeecCccc
Q 042763          396 SSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       396 p~NILl~~~~~vkl~DfGla~~  417 (554)
                      +.|||++ ++.+.|+|||.+-.
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~  173 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVE  173 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCcee
Confidence            9999997 46899999998864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.20  E-value=3.7e-10  Score=102.37  Aligned_cols=144  Identities=21%  Similarity=0.257  Sum_probs=107.8

Q ss_pred             cceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-----h--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          270 PSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-----E--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       270 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-----~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ....|-+|+-+.|+++.+. |+...||.-.....     +  -...+.++|++.+.++.--.|.-..=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4557899999999999987 77777774332221     1  12356788999999987555554444566666778999


Q ss_pred             EeCCC-CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC---cEEEEeecCccc
Q 042763          343 EFVPN-GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM---RAKVADFGFARL  417 (554)
Q Consensus       343 E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~---~vkl~DfGla~~  417 (554)
                      ||+++ -++.+++...............++..|-+.+.-||   ..+|+|+||..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99965 38888887664444333344688999999999999   99999999999999997654   358999999875

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.20  E-value=2.1e-10  Score=104.47  Aligned_cols=131  Identities=21%  Similarity=0.376  Sum_probs=100.9

Q ss_pred             eeeccCceEEEEEEEcCCcEEEEEEcchhhh-----h--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-----E--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-----~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      .+++|+-+.+|.+.+. |..+++|.-.++..     +  -..+.-.+|..++++++--.|....=+..+.+...|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            5789999999999876 44466664322221     1  12245678999999987656655555666778889999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      +|-.|.+.+...         ...++..+-.-+.-||   ..+|+|+||.++||++..+. +.++|||++.+
T Consensus        82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999888654         2456677777788899   99999999999999998775 99999999975

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.11  E-value=1.1e-11  Score=136.93  Aligned_cols=250  Identities=19%  Similarity=0.191  Sum_probs=166.5

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      +.|.+.+-+-+|.++.++.+.-. .|...+.|+......  ....+....+-.++-..++|-+++..--+......++++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            34444556778888888877443 344455554433221  111223333334444445666665554445566789999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC-
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD-  421 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~-  421 (554)
                      +|..+++|...++.-  ...+.+-.......+.++++|||   ...+.|+|++|.|.|+..++..+++|||.......- 
T Consensus       884 ~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             HHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccccccccc
Confidence            999999999988754  24455555566777889999999   777999999999999999999999999843321100 


Q ss_pred             ----C-----------------------CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 042763          422 ----S-----------------------DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELK  474 (554)
Q Consensus       422 ----~-----------------------~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~  474 (554)
                          .                       +.........||+.|.+||.+.+......+|+|++|++++|.++|..||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                0                       0001122356999999999999999999999999999999999999999876


Q ss_pred             CChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHH
Q 042763          475 RPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMK  534 (554)
Q Consensus       475 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  534 (554)
                      .+....       +......   .-.+.    .+.+......+++...+..+|.+|-.|.
T Consensus      1039 tpq~~f-------~ni~~~~---~~~p~----g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIF-------ENILNRD---IPWPE----GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             chhhhh-------hccccCC---CCCCC----CccccChhhhhhhhhhhccCchhccCcc
Confidence            553321       1111111   11111    2223344567778888888999988776

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.06  E-value=3.1e-09  Score=105.38  Aligned_cols=141  Identities=17%  Similarity=0.152  Sum_probs=101.9

Q ss_pred             eeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHH----------HHHHHHHHHHHhCCCCC--ceeeeeEEEc-----C
Q 042763          273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQ----------TEFSSEVELLSKIDHRN--LVKLLGFVDK-----G  335 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~----------~~~~~Ei~~l~~l~Hpn--Iv~l~~~~~~-----~  335 (554)
                      .+-+-....|.++.. +|+.|.||+..........          ..+.+|...+.+|...+  .+.++++.+.     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            344444445677766 4788999977544322111          14778999888885433  3344556543     2


Q ss_pred             CceEEEEEeCCCC-CHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC-------CCcE
Q 042763          336 NERLIITEFVPNG-TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE-------SMRA  407 (554)
Q Consensus       336 ~~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~-------~~~v  407 (554)
                      ...++|+|++++. +|.+++........+......++.+++..+.-||   ..+|+|+|++++|||++.       ++.+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceE
Confidence            3568999999876 8999986432334566777889999999999999   999999999999999975       4689


Q ss_pred             EEEeecCccc
Q 042763          408 KVADFGFARL  417 (554)
Q Consensus       408 kl~DfGla~~  417 (554)
                      .++||+.++.
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998864

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.02  E-value=1.6e-08  Score=102.29  Aligned_cols=263  Identities=18%  Similarity=0.226  Sum_probs=162.4

Q ss_pred             cceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeE------EEcCCc-eEEE
Q 042763          270 PSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGF------VDKGNE-RLII  341 (554)
Q Consensus       270 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~------~~~~~~-~~lv  341 (554)
                      ..+.||+|+-+.+|-...-.+ . +.|+........ ..   +.++.|... .||-+-.-+.+      .-++.. .-++
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d-~-VAKIYh~Pppa~-~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRD-Q-VAKIYHAPPPAA-QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecchhhc-h-hheeecCCCchH-HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            355799999999996532212 2 346554432211 11   122344443 56644331211      112222 5677


Q ss_pred             EEeCCCC-CHHHHHhc----ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          342 TEFVPNG-TLREHLDG----QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       342 ~E~~~~g-~L~~~l~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      |..+.+. -+..+...    +......|...++.+..++.+.+-||   ..|-+-+|+.++|+|+.+++.|.|.|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEccccee
Confidence            8877654 23333321    22346789999999999999999999   8999999999999999999999999866544


Q ss_pred             cCCCCCCCccccccccCCCCCcChhccc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCCC-------ChhhHHHH
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMK-----TYQLTTKSDVYSFGVLLLEILTG-RRPVELKR-------PPEERVTL  483 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvil~elltg-~~P~~~~~-------~~~~~~~~  483 (554)
                      +.    .........+|.+.|.+||...     +..-+...|.|.||+++++++.| ++||.+..       +.+.....
T Consensus       166 i~----~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         166 IN----ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             ec----cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            31    2223334557899999999765     33456789999999999999986 99997532       11111100


Q ss_pred             -HHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHHHHHhhhhhhh
Q 042763          484 -RWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAP--IRNDRPDMKSVGEQLWAIRADSLK  549 (554)
Q Consensus       484 -~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~l~~i~~~~~~  549 (554)
                       .++......   . -..+.....--.-.+..+..+..+|...  ++.-|||++-++..|..++++.-+
T Consensus       242 g~f~ya~~~~---~-g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         242 GRFAYASDQR---R-GLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             ceeeechhcc---C-CCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence             000000000   0 0011111111112334567777888864  467999999999999999887544

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.97  E-value=6e-09  Score=97.62  Aligned_cols=125  Identities=23%  Similarity=0.292  Sum_probs=83.7

Q ss_pred             EEEEEEEcCCcEEEEEEcchhhh-------------------------hhHHHHHHHHHHHHHhCCCC--CceeeeeEEE
Q 042763          281 TVYKAQLEDGLLVAIKRAKKEQF-------------------------ENLQTEFSSEVELLSKIDHR--NLVKLLGFVD  333 (554)
Q Consensus       281 ~Vy~a~~~~g~~vAvK~~~~~~~-------------------------~~~~~~~~~Ei~~l~~l~Hp--nIv~l~~~~~  333 (554)
                      .||.|...+|..+|||+.+....                         ........+|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999988899999997653210                         01224467899999999765  466666552 


Q ss_pred             cCCceEEEEEeCC--CCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHH-hhhccCCCeEeCCCCCCCeEECCCCcEEEE
Q 042763          334 KGNERLIITEFVP--NGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY-LHLYAEKQIIHRDVKSSNILLTESMRAKVA  410 (554)
Q Consensus       334 ~~~~~~lv~E~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~  410 (554)
                         ..++||||++  +..+..+....    ++..+...++.+++..+.. +|   ..+|+|+||.+.|||++++ .+.|+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEE
Confidence               4479999998  55554443322    2244556778888885555 57   8999999999999999988 99999


Q ss_pred             eecCccc
Q 042763          411 DFGFARL  417 (554)
Q Consensus       411 DfGla~~  417 (554)
                      |||.+..
T Consensus       149 Df~qav~  155 (188)
T PF01163_consen  149 DFGQAVD  155 (188)
T ss_dssp             -GTTEEE
T ss_pred             ecCccee
Confidence            9998864

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.96  E-value=2.8e-08  Score=103.01  Aligned_cols=169  Identities=21%  Similarity=0.246  Sum_probs=125.5

Q ss_pred             CceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEE----cCCceEEEEEeCCC-CCHH
Q 042763          278 GFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD----KGNERLIITEFVPN-GTLR  351 (554)
Q Consensus       278 ~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~----~~~~~~lv~E~~~~-g~L~  351 (554)
                      --.+.|++.. .||..|++|++.-..... ....-.-++.++++.|+|+|++..++.    .+..+++||+|.++ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            4567899954 479999999993332111 112234468899999999999998875    34467899999876 4676


Q ss_pred             HHHhcc-------------cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          352 EHLDGQ-------------YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       352 ~~l~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ++-...             .+...++...|.++.|+..||.++|   +.|+.-+-|.+.+||++.+.+++|..+|.....
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeee
Confidence            654211             1235678999999999999999999   899999999999999999999999999987764


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP  470 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P  470 (554)
                      ..+..                 |-+   .--.+-|.=.||.+++.|.||..-
T Consensus       444 ~~d~~-----------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  444 QEDPT-----------------EPL---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             cCCCC-----------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence            33220                 001   112457999999999999999653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.81  E-value=2.6e-08  Score=96.17  Aligned_cols=144  Identities=24%  Similarity=0.227  Sum_probs=103.3

Q ss_pred             HHHHHhhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh---------------------hhHHHHHHHHHHHH
Q 042763          259 SQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF---------------------ENLQTEFSSEVELL  317 (554)
Q Consensus       259 ~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~---------------------~~~~~~~~~Ei~~l  317 (554)
                      ..+.....-..+..+||.|--+.||.|..++|.++|||.-+....                     .-.+....+|.+.|
T Consensus        84 ~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L  163 (304)
T COG0478          84 HALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEAL  163 (304)
T ss_pred             HHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHH
Confidence            334333333456678999999999999999999999996542211                     00123466899999


Q ss_pred             HhCCCC--CceeeeeEEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCC
Q 042763          318 SKIDHR--NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVK  395 (554)
Q Consensus       318 ~~l~Hp--nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk  395 (554)
                      .+|.-.  .+...+++    +...+||||+++-.|...-       ++....-.++..|+.-+.-+-   ..|+||+|+.
T Consensus       164 ~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~---~~GiVHGDlS  229 (304)
T COG0478         164 QRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY---RRGIVHGDLS  229 (304)
T ss_pred             HHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH---HcCccccCCc
Confidence            999654  67777665    5668999999886664432       123344455555555555555   6799999999


Q ss_pred             CCCeEECCCCcEEEEeecCcc
Q 042763          396 SSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       396 p~NILl~~~~~vkl~DfGla~  416 (554)
                      +-||+++++|.+.++||-.+.
T Consensus       230 efNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         230 EFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             hheEEEecCCCEEEEeCcccc
Confidence            999999999999999998765

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.68  E-value=4.3e-09  Score=112.64  Aligned_cols=154  Identities=19%  Similarity=0.256  Sum_probs=107.2

Q ss_pred             HHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC------CccccccccCCCCCcChhccc
Q 042763          371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD------RTHISTKVKGTVGYLDPEYMK  444 (554)
Q Consensus       371 ~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~------~~~~~~~~~gt~~y~aPE~l~  444 (554)
                      +.+++.|+.|+|.  +.++||++|.|++|.++.++..||+.|+++........      ......-..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3455699999994  78999999999999999999999999998865432111      111111223566799999999


Q ss_pred             cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHcc
Q 042763          445 TYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCA  523 (554)
Q Consensus       445 ~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl  523 (554)
                      +...+.++|+||+|+++|-+.. |+.-+..........     ..        ...+..-...+...++.++.+=+.+++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-----~~--------~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-----FS--------RNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhh-----hh--------hcccccccccccccCcHHHHHHHHHHh
Confidence            9888999999999999999994 555444333222111     11        111111111133456677888888999


Q ss_pred             CCCCCCCCCHHHHHHH
Q 042763          524 APIRNDRPDMKSVGEQ  539 (554)
Q Consensus       524 ~~dP~~RPs~~evl~~  539 (554)
                      ..++.-||++.++...
T Consensus       250 ~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLSI  265 (700)
T ss_pred             cCCcccCcchhhhhcc
Confidence            9999999988877543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.67  E-value=1.9e-07  Score=89.32  Aligned_cols=123  Identities=24%  Similarity=0.273  Sum_probs=91.1

Q ss_pred             CcEEEEEEcchhhhh------hHHHHHHHHHHHHHhCCCC--CceeeeeEEEcCC----ceEEEEEeCCCC-CHHHHHhc
Q 042763          290 GLLVAIKRAKKEQFE------NLQTEFSSEVELLSKIDHR--NLVKLLGFVDKGN----ERLIITEFVPNG-TLREHLDG  356 (554)
Q Consensus       290 g~~vAvK~~~~~~~~------~~~~~~~~Ei~~l~~l~Hp--nIv~l~~~~~~~~----~~~lv~E~~~~g-~L~~~l~~  356 (554)
                      ++.+.+|.....-..      -......+|...+..|..-  .....+++.+...    ..++|+|++++. +|.+++..
T Consensus        32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~  111 (206)
T PF06293_consen   32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ  111 (206)
T ss_pred             ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence            556666654322111      1234577888888877533  3455666665422    348999999874 89999876


Q ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC---cEEEEeecCccc
Q 042763          357 QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM---RAKVADFGFARL  417 (554)
Q Consensus       357 ~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~---~vkl~DfGla~~  417 (554)
                      ..  ..+......++.+++..+.-||   ..+|+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       112 ~~--~~~~~~~~~ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  112 WE--QLDPSQRRELLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             hc--ccchhhHHHHHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            42  2566677889999999999999   99999999999999999887   899999998875

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.63  E-value=2.2e-07  Score=99.76  Aligned_cols=141  Identities=18%  Similarity=0.223  Sum_probs=92.1

Q ss_pred             eeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHH---------------------------------------HHHHH
Q 042763          272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQ---------------------------------------TEFSS  312 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~---------------------------------------~~~~~  312 (554)
                      ..|+.++-|.||+|++++|+.||||+.++.-.+...                                       -++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            468999999999999999999999998755221100                                       11334


Q ss_pred             HHHHHHhCC-----CCCceeeeeEEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCC
Q 042763          313 EVELLSKID-----HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK  387 (554)
Q Consensus       313 Ei~~l~~l~-----HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~  387 (554)
                      |..-+.+++     .+++.--.=|++......++|||++|..+.+...-+. ...+.+.......++.  +..+-   ..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~---~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLL---RD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHH---hc
Confidence            444444442     2333222223344467789999999999988853222 2444333332222221  11121   45


Q ss_pred             CeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          388 QIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       388 ~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      +++|.|.+|.||+++.+|.+.+.|||+....
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecC
Confidence            9999999999999999999999999998754

>PRK09902 hypothetical protein; Provisional

Probab=98.63  E-value=4.4e-07  Score=85.78  Aligned_cols=139  Identities=16%  Similarity=0.172  Sum_probs=104.1

Q ss_pred             eeccCceEEEEEEEcCCcEEEEEEcchhhh-----hhHHHHHHHHHHHHHhCCCCC--ceeeeeEEE---cC--CceEEE
Q 042763          274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-----ENLQTEFSSEVELLSKIDHRN--LVKLLGFVD---KG--NERLII  341 (554)
Q Consensus       274 LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-----~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~~~---~~--~~~~lv  341 (554)
                      -|+||-+-|++.... |..+-+|+-...-.     ......|.+|+..+.+|..-+  +.+.. ++.   .+  ...+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            478999999998876 55788897642111     223567999999999885322  44444 332   11  235899


Q ss_pred             EEeCCC-CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc--EEEEeecCccc
Q 042763          342 TEFVPN-GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR--AKVADFGFARL  417 (554)
Q Consensus       342 ~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~--vkl~DfGla~~  417 (554)
                      +|-+++ -+|.+++....-...+..+...+..+++..+.-||   ..++.|+|+-+.||+++.++.  ++++||--++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997753 58999987654445677778899999999999999   999999999999999986667  99999987764

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.48  E-value=2.3e-06  Score=83.04  Aligned_cols=139  Identities=17%  Similarity=0.174  Sum_probs=85.6

Q ss_pred             eeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCC--ceeeeeEEEcCCceEEEEEeCCCCC
Q 042763          272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRN--LVKLLGFVDKGNERLIITEFVPNGT  349 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~~~~~~~~~lv~E~~~~g~  349 (554)
                      ..||+|..+.||+..   |..+++|......   ......+|.++++.+..-+  +.+.+++...++...+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTHK---TGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEec---CCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            468999999999842   4567888876533   1245688999999886433  4677788777777889999998863


Q ss_pred             -HHHHH---------------------hcccCCCCCHHHHHH-HHH----------HHHH-HHHHhhh-ccCCCeEeCCC
Q 042763          350 -LREHL---------------------DGQYGKTLDFNQRLE-IAI----------DVAH-GLTYLHL-YAEKQIIHRDV  394 (554)
Q Consensus       350 -L~~~l---------------------~~~~~~~l~~~~~~~-i~~----------qi~~-~L~~LH~-~~~~~ivH~Dl  394 (554)
                       +...+                     +.-............ +..          .+.. ...+|.. .....++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             21111                     110000111111110 000          0000 1122221 11345789999


Q ss_pred             CCCCeEECCCCcEEEEeecCccc
Q 042763          395 KSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       395 kp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .|.||++++++ +.++||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999988 99999998864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.39  E-value=3e-06  Score=80.45  Aligned_cols=137  Identities=16%  Similarity=0.218  Sum_probs=92.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHH---------HHHHHHHHHHhCCC---CCceeeeeEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQT---------EFSSEVELLSKIDH---RNLVKLLGFV  332 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~---------~~~~Ei~~l~~l~H---pnIv~l~~~~  332 (554)
                      ..+|...+.+-.....-|.+.+.. |..+++|..+..... .++         ...+++..+.+++.   -....++.+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            467777778877777778777765 788999987765422 111         12344444444432   2233322222


Q ss_pred             -----EcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcE
Q 042763          333 -----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRA  407 (554)
Q Consensus       333 -----~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v  407 (554)
                           .-....+++|||++|..|.++..      ++.    .++..+.+++.-||   ..|++|+|..|.|++++.++ +
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-E
Confidence                 12234578999999988876642      221    35566778899999   89999999999999998654 9


Q ss_pred             EEEeecCccc
Q 042763          408 KVADFGFARL  417 (554)
Q Consensus       408 kl~DfGla~~  417 (554)
                      +++||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PLN03150 hypothetical protein; Provisional

Probab=98.35  E-value=3.3e-07  Score=102.07  Aligned_cols=84  Identities=10%  Similarity=0.019  Sum_probs=42.3

Q ss_pred             EEeeecCCCcccccCCchhHHHHHHHhhhh--hhccc---ee--eccccCCCceeeccCCcceeEEEcCccccchhhhhh
Q 042763           24 SIFLPRESSLDISSNFAPSSFLLFLQFWGI--FASGF---AI--QSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKV   96 (554)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~---~~--~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~   96 (554)
                      .+..++|++|+|+|.+.+.+..+.- |...  ....+   .+  -.....+..|+|++|+      ++|.+|+.++.|++
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~-L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~------lsg~iP~~l~~L~~  491 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS------FNGSIPESLGQLTS  491 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCC-CCEEECCCCcccCcCChHHhCCCCCCEEECCCCC------CCCCCchHHhcCCC
Confidence            3667789999999888764332211 0000  00000   00  0122334555555555      55555555555555


Q ss_pred             hhhhhccCceeecccCCC
Q 042763           97 IQFHYANHCIFEGYSGSD  114 (554)
Q Consensus        97 l~~l~~~~n~~~g~~~~~  114 (554)
                      |+.|++++|+++|.+|..
T Consensus       492 L~~L~Ls~N~l~g~iP~~  509 (623)
T PLN03150        492 LRILNLNGNSLSGRVPAA  509 (623)
T ss_pred             CCEEECcCCcccccCChH
Confidence            555555555555555543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.35  E-value=4.2e-06  Score=80.89  Aligned_cols=143  Identities=17%  Similarity=0.195  Sum_probs=85.0

Q ss_pred             ceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCC--CceeeeeEEE---cCCceEEEEEeC
Q 042763          271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR--NLVKLLGFVD---KGNERLIITEFV  345 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hp--nIv~l~~~~~---~~~~~~lv~E~~  345 (554)
                      ++.|+.|..+.||++...+ ..+++|.....   .....+.+|..+++.+...  .+.+++.+..   .....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            4579999999999999887 58999987665   2345677888888888533  3556666442   223468999999


Q ss_pred             CCCCHHH----------------HH---hcc--cCCCCCHHH---------HHHH------------HHHHHH-HHHHhh
Q 042763          346 PNGTLRE----------------HL---DGQ--YGKTLDFNQ---------RLEI------------AIDVAH-GLTYLH  382 (554)
Q Consensus       346 ~~g~L~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~qi~~-~L~~LH  382 (554)
                      ++..+..                .+   +..  .........         ....            ...+.+ .++.++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9888877                11   111  001111100         0000            111222 233333


Q ss_pred             hc----cCCCeEeCCCCCCCeEEC-CCCcEEEEeecCccc
Q 042763          383 LY----AEKQIIHRDVKSSNILLT-ESMRAKVADFGFARL  417 (554)
Q Consensus       383 ~~----~~~~ivH~Dlkp~NILl~-~~~~vkl~DfGla~~  417 (554)
                      ..    ....++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            21    256799999999999999 666678999998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.31  E-value=6.2e-06  Score=79.21  Aligned_cols=150  Identities=21%  Similarity=0.235  Sum_probs=96.7

Q ss_pred             hHHHHHhhcCCCccee---eeccCceEEEEEEEcCCcEEEEEEcchhhhh--h--------------------HHHH-HH
Q 042763          258 MSQVVKATRNFSPSLR---IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFE--N--------------------LQTE-FS  311 (554)
Q Consensus       258 ~~~l~~~~~~f~~~~~---LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~--~--------------------~~~~-~~  311 (554)
                      .+.+....++..+...   |..|--+.||+|...++..+|||+.+.....  .                    .... ..
T Consensus        37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~  116 (268)
T COG1718          37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR  116 (268)
T ss_pred             HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence            3444444445444444   5678888899998888999999988654321  0                    0000 22


Q ss_pred             HHHHHHHhCC--CCCceeeeeEEEcCCceEEEEEeCCCCCH-HHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCC
Q 042763          312 SEVELLSKID--HRNLVKLLGFVDKGNERLIITEFVPNGTL-REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ  388 (554)
Q Consensus       312 ~Ei~~l~~l~--HpnIv~l~~~~~~~~~~~lv~E~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~  388 (554)
                      .|..-|.++.  +-.+.+-+++.    .-.+||||+...-. .-.|..   ..+...+...+..++++.+.-|-.  ..+
T Consensus       117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~--~a~  187 (268)
T COG1718         117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYK--EAG  187 (268)
T ss_pred             HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHH--hcC
Confidence            4666666653  33344445443    34799999954311 001111   122333677788888888888772  489


Q ss_pred             eEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          389 IIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       389 ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      +||+||..-|||+. ++.+.|+|||-|..
T Consensus       188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         188 LVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             cccccchhhheEEE-CCeEEEEECccccc
Confidence            99999999999999 88999999998864

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.26  E-value=5.8e-06  Score=88.70  Aligned_cols=137  Identities=17%  Similarity=0.233  Sum_probs=88.3

Q ss_pred             eeeeccCceEEEEEEEcCCcEEEEEEcchhhhhh------------------------------HHH------HHHHHHH
Q 042763          272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFEN------------------------------LQT------EFSSEVE  315 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~------------------------------~~~------~~~~Ei~  315 (554)
                      +.||.-+.|.||+|++++|+.||||+-++.-.+.                              ..+      +|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            3689999999999999999999999876542111                              011      1333433


Q ss_pred             HHHh----CCCCC------ceeeeeEEEcCCceEEEEEeCCCCCHHHH--HhcccCCCCCHHHHHHHHHHHHHHHHHhhh
Q 042763          316 LLSK----IDHRN------LVKLLGFVDKGNERLIITEFVPNGTLREH--LDGQYGKTLDFNQRLEIAIDVAHGLTYLHL  383 (554)
Q Consensus       316 ~l~~----l~Hpn------Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~--l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~  383 (554)
                      -..+    +.|-+      |.+++-.  ......|+||||+|..+.|.  +.+.   .++...+..-+.+...-+-+   
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~~qIf---  318 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYLEQIF---  318 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHHHHHH---
Confidence            3322    23444      3333332  23467899999999877664  3332   45554444333332222222   


Q ss_pred             ccCCCeEeCCCCCCCeEECC----CCcEEEEeecCcccC
Q 042763          384 YAEKQIIHRDVKSSNILLTE----SMRAKVADFGFARLG  418 (554)
Q Consensus       384 ~~~~~ivH~Dlkp~NILl~~----~~~vkl~DfGla~~~  418 (554)
                        ..|.+|.|-+|.||+++.    ++.+.+-|||+....
T Consensus       319 --~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  319 --KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             --hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence              458999999999999984    678999999998753

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.26  E-value=1.3e-05  Score=78.81  Aligned_cols=139  Identities=18%  Similarity=0.191  Sum_probs=85.2

Q ss_pred             eeccCc-eEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEEEEEeCCCCCHH
Q 042763          274 IGEGGF-GTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLIITEFVPNGTLR  351 (554)
Q Consensus       274 LG~G~f-G~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~  351 (554)
                      |-.|.. ..||+.... +..++||+.....    ...+.+|+++++.+. +--+.+++++...++..++|||+++|.++.
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            444555 889999765 4678888876543    235667888888873 444667788777666789999999988776


Q ss_pred             HHHh-------------------cccCC--CCC--HHHHHHHHH--------------------HHHHHHHHhhh----c
Q 042763          352 EHLD-------------------GQYGK--TLD--FNQRLEIAI--------------------DVAHGLTYLHL----Y  384 (554)
Q Consensus       352 ~~l~-------------------~~~~~--~l~--~~~~~~i~~--------------------qi~~~L~~LH~----~  384 (554)
                      ....                   .....  .+.  .........                    .+...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            4321                   00000  100  000000000                    01111122210    0


Q ss_pred             cCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       385 ~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      ....++|+|+.|.|||++++..+.|+||+.+..
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            134589999999999999988789999998864

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.22  E-value=1.3e-05  Score=92.33  Aligned_cols=79  Identities=11%  Similarity=0.263  Sum_probs=58.3

Q ss_pred             ceeeeccCceEEEEEEEcCC---cEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCc--eeeeeEEEcC---CceEEE
Q 042763          271 SLRIGEGGFGTVYKAQLEDG---LLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNL--VKLLGFVDKG---NERLII  341 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g---~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnI--v~l~~~~~~~---~~~~lv  341 (554)
                      .+.++.|.+..+|+.+..++   ..+++|+............+.+|+++|+.+. |.++  .+++.++.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56789999999999877654   4678887654432222346889999999995 6664  7788887664   457899


Q ss_pred             EEeCCCCC
Q 042763          342 TEFVPNGT  349 (554)
Q Consensus       342 ~E~~~~g~  349 (554)
                      |||+++..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998754

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.18  E-value=3.6e-05  Score=72.77  Aligned_cols=135  Identities=21%  Similarity=0.292  Sum_probs=93.1

Q ss_pred             ceeeeccCceEEEEEEEcCCcEEEEEEcchhh---------------hhhHHHHHHHHHHHHHhCC------CCCceeee
Q 042763          271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQ---------------FENLQTEFSSEVELLSKID------HRNLVKLL  329 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~---------------~~~~~~~~~~Ei~~l~~l~------HpnIv~l~  329 (554)
                      ...||+|+.=.||.  +++.....||+.....               ......+..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            44699999999995  4445567888887665               0112345666666666555      78899999


Q ss_pred             eEEEcCCceEEEEEeCCCC------CHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC
Q 042763          330 GFVDKGNERLIITEFVPNG------TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE  403 (554)
Q Consensus       330 ~~~~~~~~~~lv~E~~~~g------~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~  403 (554)
                      |+.+++...-+|+|.+.+.      +|.+++...   .++. ...+.+.   +-.+||-   +.+|+.+|++|.||++..
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~---~f~~~l~---~~~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALD---EFKRYLL---DHHIVIRDLNPHNIVVQR  153 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHH---HHHHHHH---HcCCeecCCCcccEEEEe
Confidence            9999999999999986432      578888543   3444 3333333   3345565   778999999999999964


Q ss_pred             C---C-cEEEEe-ecCccc
Q 042763          404 S---M-RAKVAD-FGFARL  417 (554)
Q Consensus       404 ~---~-~vkl~D-fGla~~  417 (554)
                      .   . .+.|+| ||....
T Consensus       154 ~~~~~~~lvlIDG~G~~~~  172 (199)
T PF10707_consen  154 RDSGEFRLVLIDGLGEKEL  172 (199)
T ss_pred             cCCCceEEEEEeCCCCccc
Confidence            3   2 577887 565443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.06  E-value=7.3e-07  Score=94.81  Aligned_cols=181  Identities=21%  Similarity=0.188  Sum_probs=128.4

Q ss_pred             eeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCC-ceeeeeEEEcCCceEEEEEeCCCC-CH
Q 042763          273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRN-LVKLLGFVDKGNERLIITEFVPNG-TL  350 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~~~~~~~~~~~lv~E~~~~g-~L  350 (554)
                      -+++|+.++++|.+-...+....+.+...      ....-++++|.+++||| .+..++-++.+...+++++++..+ +.
T Consensus       249 ~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~  322 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS  322 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence            36889999999886443333445554432      34556889999999999 666666677777889999999777 22


Q ss_pred             HHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCcccccc
Q 042763          351 REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK  430 (554)
Q Consensus       351 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~  430 (554)
                      ..-.... ...+...+...+...-+++++++|   +..=+|+|    ||+..+ +..+..||+....+....    ....
T Consensus       323 ~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~----~~~t  389 (829)
T KOG0576|consen  323 ALEMTVS-EIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM----KPRT  389 (829)
T ss_pred             cccCChh-hHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc----cccc
Confidence            2111100 012233344456666778899999   55568888    777665 689999999887543322    3445


Q ss_pred             ccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 042763          431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVE  472 (554)
Q Consensus       431 ~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~  472 (554)
                      ..+|+.|+|||+.....+..+-|+|++|+-..+|--|.+|-.
T Consensus       390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            679999999999999999999999999988778877777653

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.05  E-value=1.8e-05  Score=74.39  Aligned_cols=101  Identities=24%  Similarity=0.243  Sum_probs=81.3

Q ss_pred             HHHHHHHHhCCC-CCceeeeeEEEcCCceEEEEEeCCCCCHHHH---HhcccCCCCCHHHHHHHHHHHHHHHHHhhhccC
Q 042763          311 SSEVELLSKIDH-RNLVKLLGFVDKGNERLIITEFVPNGTLREH---LDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE  386 (554)
Q Consensus       311 ~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~---l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~  386 (554)
                      ..|.-+++.+++ +++++++|+|-.    +++.||...+++...   +...  ...+|..+.+||.++++.+++|++...
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            457788888876 699999999943    688999987755421   1111  246899999999999999999996555


Q ss_pred             CCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          387 KQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       387 ~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      ..+.-.|++++|+-+++++++|++|...+-.
T Consensus        81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             CcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            6689999999999999999999999987754

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.00  E-value=0.00013  Score=68.62  Aligned_cols=126  Identities=25%  Similarity=0.414  Sum_probs=89.1

Q ss_pred             cCCCcceeeeccCc-eEEEEEEEcCCcEEEEEEcch---hhh-------h----------hHHHHHHHHHHHHHhCC---
Q 042763          266 RNFSPSLRIGEGGF-GTVYKAQLEDGLLVAIKRAKK---EQF-------E----------NLQTEFSSEVELLSKID---  321 (554)
Q Consensus       266 ~~f~~~~~LG~G~f-G~Vy~a~~~~g~~vAvK~~~~---~~~-------~----------~~~~~~~~Ei~~l~~l~---  321 (554)
                      .+++..+.||.|.- |.||+++.. |+.||+|..+.   ...       .          ....-|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            66777889999999 999999987 78999999221   110       0          11234778888888775   


Q ss_pred             CCCc--eeeeeEEEcC------------------CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHh
Q 042763          322 HRNL--VKLLGFVDKG------------------NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL  381 (554)
Q Consensus       322 HpnI--v~l~~~~~~~------------------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L  381 (554)
                      +.++  |+.+||..-.                  ....||.||++...           .+.    ..-+.+|.+-|..+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~  180 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKIL  180 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHH
Confidence            4456  8999987221                  12256777775433           112    23345667778889


Q ss_pred             hhccCCCeEeCCCCCCCeEECCCCcEEEEeecCc
Q 042763          382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA  415 (554)
Q Consensus       382 H~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla  415 (554)
                      |   ..+|+-+|+++.|..     .-||+|||.+
T Consensus       181 ~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 H---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             H---HCCeeeccCcccccc-----CCEEEecccC
Confidence            9   899999999999986     4589999865

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.96  E-value=4.4e-05  Score=69.59  Aligned_cols=128  Identities=19%  Similarity=0.246  Sum_probs=89.7

Q ss_pred             cceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCce-eeeeEEEcCCceEEEEEeCCCC
Q 042763          270 PSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV-KLLGFVDKGNERLIITEFVPNG  348 (554)
Q Consensus       270 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~~~~~~~~~~~lv~E~~~~g  348 (554)
                      ..+.||+|.+|.||++.+. |..+|+|+-+.+.   .+..+..|+++|..+.--++. +++.|.    +.++.|||+.|-
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~   97 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence            3557999999999999998 5689999877654   346788999999998766654 455543    234569999888


Q ss_pred             CHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCC-CCCeEECCCCcEEEEeecCccc
Q 042763          349 TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVK-SSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       349 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk-p~NILl~~~~~vkl~DfGla~~  417 (554)
                      .|.++....     +-.+..    .++..---|-   ..+|-|+.|. |...++..++.+.|+||.-|++
T Consensus        98 ~L~~~~~~~-----~rk~l~----~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGG-----DRKHLL----RVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcc-----cHHHHH----HHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            888776432     222222    3333333333   6789999987 5555555555999999998874

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.94  E-value=8.4e-05  Score=72.57  Aligned_cols=74  Identities=11%  Similarity=0.151  Sum_probs=46.0

Q ss_pred             ceeeeccCce-EEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCC---CceeeeeEEEcC---CceEEEEE
Q 042763          271 SLRIGEGGFG-TVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR---NLVKLLGFVDKG---NERLIITE  343 (554)
Q Consensus       271 ~~~LG~G~fG-~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hp---nIv~l~~~~~~~---~~~~lv~E  343 (554)
                      ++.|+.|+.. .||+..    ..+++|......   ....+.+|.+++..+...   -+.+.++.....   ...+++|+
T Consensus         2 ~~~~~~gG~~n~vy~~~----~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~   74 (235)
T cd05155           2 IEPVDSGGTDNATFRLG----DDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR   74 (235)
T ss_pred             ceeccCCCcccceEEcC----CceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence            3457777766 499762    347778755422   234788899999887532   244444443322   23478999


Q ss_pred             eCCCCCHH
Q 042763          344 FVPNGTLR  351 (554)
Q Consensus       344 ~~~~g~L~  351 (554)
                      +++|.++.
T Consensus        75 ~i~G~~l~   82 (235)
T cd05155          75 WLEGETAT   82 (235)
T ss_pred             eecCCCCC
Confidence            99887764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.85  E-value=0.00018  Score=70.12  Aligned_cols=141  Identities=16%  Similarity=0.168  Sum_probs=82.2

Q ss_pred             ceeeeccCceEEEEEEEcC--CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCC-ceeeeeEEEcCCceEEEEEeCCC
Q 042763          271 SLRIGEGGFGTVYKAQLED--GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRN-LVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~--g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      .+.|..|-...+|+....+  +..|++|+...... . .....+|+.+++.+...+ .+++++...    ..++|||++|
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G   76 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-L-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPG   76 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-c-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCC
Confidence            3568889999999998764  67888997764321 1 123347888888885433 344444432    2479999988


Q ss_pred             CCHHHH-------H----------hcccC---------CCCC-HHHHHHHHH----------------------HHHHHH
Q 042763          348 GTLREH-------L----------DGQYG---------KTLD-FNQRLEIAI----------------------DVAHGL  378 (554)
Q Consensus       348 g~L~~~-------l----------~~~~~---------~~l~-~~~~~~i~~----------------------qi~~~L  378 (554)
                      .++...       +          +....         .... +..+..+..                      .+...+
T Consensus        77 ~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  156 (235)
T cd05157          77 RTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEI  156 (235)
T ss_pred             CcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHH
Confidence            765321       1          11000         0111 112111111                      111111


Q ss_pred             HHh----hhc-cCCCeEeCCCCCCCeEECC-CCcEEEEeecCccc
Q 042763          379 TYL----HLY-AEKQIIHRDVKSSNILLTE-SMRAKVADFGFARL  417 (554)
Q Consensus       379 ~~L----H~~-~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~~  417 (554)
                      ..|    -.. ....++|+|+.+.|||++. ++.+.++||..|..
T Consensus       157 ~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         157 SWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            111    100 1346999999999999998 57899999998864

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.80  E-value=0.00037  Score=70.62  Aligned_cols=78  Identities=13%  Similarity=0.077  Sum_probs=56.8

Q ss_pred             CcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCC---CCceeeeeEEEc---CCceEEEE
Q 042763          269 SPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH---RNLVKLLGFVDK---GNERLIIT  342 (554)
Q Consensus       269 ~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~H---pnIv~l~~~~~~---~~~~~lv~  342 (554)
                      ...+.||.|..+.||+....+++ +++|..+...   ....+..|.+.|+.|.-   -.+.++++++..   .+..++||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGN-PMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCC-EEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            33557999999999999776564 6667643311   12578899999998853   357888887754   36689999


Q ss_pred             EeCCCCCH
Q 042763          343 EFVPNGTL  350 (554)
Q Consensus       343 E~~~~g~L  350 (554)
                      |++++.++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99988754

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.79  E-value=9.7e-05  Score=84.06  Aligned_cols=198  Identities=18%  Similarity=0.200  Sum_probs=136.1

Q ss_pred             HHHHHHHHHHhCCCCCceeeeeEEEcCCce----EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 042763          309 EFSSEVELLSKIDHRNLVKLLGFVDKGNER----LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY  384 (554)
Q Consensus       309 ~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~----~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~  384 (554)
                      ....|.+.+.+..|+|++.++.|..+....    .+..|+|...++...+...  ...+....+.+..++..||.|+|  
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h--  303 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLH--  303 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHH--
Confidence            344577788888999999999987554333    3456788888888888654  56788888999999999999999  


Q ss_pred             cCCCeEeCCCCCC---CeEECCCCcEEEE--eecCcccCCCCCCCccccccccCCCCCcChhccccCCCCc--hhhHHHH
Q 042763          385 AEKQIIHRDVKSS---NILLTESMRAKVA--DFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT--KSDVYSF  457 (554)
Q Consensus       385 ~~~~ivH~Dlkp~---NILl~~~~~vkl~--DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~--ksDVwSl  457 (554)
                       +....|.-+..+   +--.+.++.+.+.  ||+.++..+.....    ....-+..|.+||......++.  ..|+|.+
T Consensus       304 -~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  304 -SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             -HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc----hhhcCccccccccccccccchhhhhhHHHHH
Confidence             555555554444   4445566777777  89888764432211    1122455688888877655544  4799999


Q ss_pred             HHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 042763          458 GVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVG  537 (554)
Q Consensus       458 Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  537 (554)
                      |.....+..|..+-........                          ..+......+.+....|+..++++|+++.+++
T Consensus       379 gll~~~~~~~~~i~~~~~~~~~--------------------------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll  432 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSAVPVS--------------------------LLDVLSTSELLDALPKCLDEDSEERLSALELL  432 (1351)
T ss_pred             HHHHhhhhhcCcccccccchhh--------------------------hhccccchhhhhhhhhhcchhhhhccchhhhh
Confidence            9999999998876432111100                          01111111456777899999999999999999


Q ss_pred             HHHH
Q 042763          538 EQLW  541 (554)
Q Consensus       538 ~~l~  541 (554)
                      .+..
T Consensus       433 ~~~f  436 (1351)
T KOG1035|consen  433 THPF  436 (1351)
T ss_pred             hchh
Confidence            8753

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.70  E-value=0.0011  Score=69.42  Aligned_cols=77  Identities=17%  Similarity=0.207  Sum_probs=54.2

Q ss_pred             ceeeeccCceEEEEEEEcCC-cEEEEEEcchh------hhhhHHHHHHHHHHHHHhCC---CCCceeeeeEEEcCCceEE
Q 042763          271 SLRIGEGGFGTVYKAQLEDG-LLVAIKRAKKE------QFENLQTEFSSEVELLSKID---HRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g-~~vAvK~~~~~------~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~l  340 (554)
                      .+.||.|.+..||++...+| +.|+||...+.      ...-..+....|.+.|+.+.   -.++++++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            34689999999999988877 58999985422      11123456777888888763   2456777766  3355789


Q ss_pred             EEEeCCCCC
Q 042763          341 ITEFVPNGT  349 (554)
Q Consensus       341 v~E~~~~g~  349 (554)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998644

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.70  E-value=0.00022  Score=72.13  Aligned_cols=142  Identities=20%  Similarity=0.199  Sum_probs=85.1

Q ss_pred             ceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCC--ceeeeeE------EEcCCceEEEE
Q 042763          271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRN--LVKLLGF------VDKGNERLIIT  342 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~------~~~~~~~~lv~  342 (554)
                      .+.|..|....+|+....+ ..+++|+.....    ...+..|++++..+.+.+  +.+++..      ...++..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKVS----AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCCC----hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            5567888889999987654 468889876521    245667788888774332  4444331      23345668999


Q ss_pred             EeCCCCCHHH----HH----------hcc---cC------CCCCHHHHH----------HHHHHHHHHHHHhhh----cc
Q 042763          343 EFVPNGTLRE----HL----------DGQ---YG------KTLDFNQRL----------EIAIDVAHGLTYLHL----YA  385 (554)
Q Consensus       343 E~~~~g~L~~----~l----------~~~---~~------~~l~~~~~~----------~i~~qi~~~L~~LH~----~~  385 (554)
                      +|++|..+..    .+          +..   ..      ....|....          .....+..++.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9998876532    10          100   00      001111110          011122333444431    11


Q ss_pred             CCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          386 EKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       386 ~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      ..+++|+|+.|.||++++++.+.|+||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            35799999999999999987788999998864

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.63  E-value=0.00028  Score=69.81  Aligned_cols=137  Identities=15%  Similarity=0.219  Sum_probs=78.1

Q ss_pred             eeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCc-eeeeeEEEcCCceEEEEEeCCCCCHHH
Q 042763          274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL-VKLLGFVDKGNERLIITEFVPNGTLRE  352 (554)
Q Consensus       274 LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lv~E~~~~g~L~~  352 (554)
                      +..|-.+.+|+... ++..+++|...... ....-...+|.++++.+...++ .+++....    -++||||++|..+..
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~-~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVC-KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCccc-ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            56688889999874 46778888765432 1111134678888888864333 33444332    368999998866532


Q ss_pred             H-----------------Hhccc--CCCCCHHHHH-HHHHHH---------HHHHHHhhhc-----cCCCeEeCCCCCCC
Q 042763          353 H-----------------LDGQY--GKTLDFNQRL-EIAIDV---------AHGLTYLHLY-----AEKQIIHRDVKSSN  398 (554)
Q Consensus       353 ~-----------------l~~~~--~~~l~~~~~~-~i~~qi---------~~~L~~LH~~-----~~~~ivH~Dlkp~N  398 (554)
                      .                 ++...  ...++..... .+..++         ...+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11111  1122222111 111111         1111111110     12358999999999


Q ss_pred             eEECCCCcEEEEeecCccc
Q 042763          399 ILLTESMRAKVADFGFARL  417 (554)
Q Consensus       399 ILl~~~~~vkl~DfGla~~  417 (554)
                      |++++++ +.++||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.49  E-value=0.0018  Score=66.20  Aligned_cols=142  Identities=17%  Similarity=0.176  Sum_probs=77.3

Q ss_pred             ceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCC--ceeeee------EEEcCCceEEEE
Q 042763          271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRN--LVKLLG------FVDKGNERLIIT  342 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~------~~~~~~~~~lv~  342 (554)
                      .+.|+.|....+|+.+..+| .+++|+.....    .+.+..|+.++..|...+  +.+.+.      +....+..++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~----~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~  101 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLT----AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV  101 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccCC----hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence            34577788889999987666 68889875211    123344555555553211  223332      122345678999


Q ss_pred             EeCCCCCHH-----------HHH---hccc---C------CCC-CHHHHHH------------HH-HHHHHHHHHhhhc-
Q 042763          343 EFVPNGTLR-----------EHL---DGQY---G------KTL-DFNQRLE------------IA-IDVAHGLTYLHLY-  384 (554)
Q Consensus       343 E~~~~g~L~-----------~~l---~~~~---~------~~l-~~~~~~~------------i~-~qi~~~L~~LH~~-  384 (554)
                      ||++|..+.           ..+   +...   .      ..+ .|.+...            .. ..+...++.+... 
T Consensus       102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  181 (319)
T PRK05231        102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA  181 (319)
T ss_pred             EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence            999886431           111   1100   0      011 1111111            11 1111122222210 


Q ss_pred             ---cCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          385 ---AEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       385 ---~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                         ...+++|+|+.|.||+++.+...-|+||+.+..
T Consensus       182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence               245899999999999999776568999998864

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=97.46  E-value=0.00013  Score=86.08  Aligned_cols=67  Identities=12%  Similarity=0.076  Sum_probs=45.4

Q ss_pred             EEeeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhcc
Q 042763           24 SIFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYAN  103 (554)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~  103 (554)
                      +...+++|+|+|.|.+...+.-+.                  ...+|++++|+      ++|.+|..|+.+++|+.|+++
T Consensus       500 ~L~~L~Ls~N~l~~~~p~~~~~l~------------------~L~~L~Ls~N~------l~~~~p~~~~~l~~L~~L~Ls  555 (968)
T PLN00113        500 ELMQLKLSENKLSGEIPDELSSCK------------------KLVSLDLSHNQ------LSGQIPASFSEMPVLSQLDLS  555 (968)
T ss_pred             ccCEEECcCCcceeeCChHHcCcc------------------CCCEEECCCCc------ccccCChhHhCcccCCEEECC
Confidence            345577888888887654332211                  14677777777      777777777777777777777


Q ss_pred             CceeecccCCC
Q 042763          104 HCIFEGYSGSD  114 (554)
Q Consensus       104 ~n~~~g~~~~~  114 (554)
                      +|+++|.+|..
T Consensus       556 ~N~l~~~~p~~  566 (968)
T PLN00113        556 QNQLSGEIPKN  566 (968)
T ss_pred             CCcccccCChh
Confidence            77777777743

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.42  E-value=0.00089  Score=67.90  Aligned_cols=141  Identities=26%  Similarity=0.311  Sum_probs=83.3

Q ss_pred             ceeeeccCceEEEEEEEcC-------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCc-eeeeeEEEcCCceEEEE
Q 042763          271 SLRIGEGGFGTVYKAQLED-------GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL-VKLLGFVDKGNERLIIT  342 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~-------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lv~  342 (554)
                      ++.|..|-...+|+....+       ++.+++|+..... . ...+..+|.+++..+...++ .++++++..    .+|+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~   76 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-E-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE   76 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-c-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence            3457778888999997665       4788999866542 1 12345678888888753333 345555432    3589


Q ss_pred             EeCCCCCHHHHH-----------------hcccCC-------CCC--HHHHHH--------------------------H
Q 042763          343 EFVPNGTLREHL-----------------DGQYGK-------TLD--FNQRLE--------------------------I  370 (554)
Q Consensus       343 E~~~~g~L~~~l-----------------~~~~~~-------~l~--~~~~~~--------------------------i  370 (554)
                      ||++|..+....                 +.....       ..+  +.....                          +
T Consensus        77 e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (302)
T cd05156          77 EFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLF  156 (302)
T ss_pred             heeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHH
Confidence            999887664310                 111000       000  101100                          1


Q ss_pred             HHHHHHHHHHhhh------ccCCCeEeCCCCCCCeEECCC----CcEEEEeecCccc
Q 042763          371 AIDVAHGLTYLHL------YAEKQIIHRDVKSSNILLTES----MRAKVADFGFARL  417 (554)
Q Consensus       371 ~~qi~~~L~~LH~------~~~~~ivH~Dlkp~NILl~~~----~~vkl~DfGla~~  417 (554)
                      ...+...+..+-.      .....++|+|+.+.|||++++    +.++++||..|..
T Consensus       157 ~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         157 LEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            1122222333321      124578999999999999985    8899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.26  E-value=8.9e-05  Score=86.08  Aligned_cols=176  Identities=14%  Similarity=0.050  Sum_probs=122.5

Q ss_pred             EEEEEcchhhhhh----HHHHHHHHHHHHHhCCCCCceeeeeEE--EcCCceEEEEEeCCCCCHHHHHhcccCC--CCCH
Q 042763          293 VAIKRAKKEQFEN----LQTEFSSEVELLSKIDHRNLVKLLGFV--DKGNERLIITEFVPNGTLREHLDGQYGK--TLDF  364 (554)
Q Consensus       293 vAvK~~~~~~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~~~~--~~~~~~~lv~E~~~~g~L~~~l~~~~~~--~l~~  364 (554)
                      +.+|+.+.-..+.    ..+....|...++...|+++.....-.  .+..+.+..++|+..|++.+.+-+...+  .++.
T Consensus      1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred             eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence            3455554443322    234455666777778899888765544  2344668999999999999988654322  2333


Q ss_pred             HHHHHHHHHHHHHHHHhhhc--cCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhc
Q 042763          365 NQRLEIAIDVAHGLTYLHLY--AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEY  442 (554)
Q Consensus       365 ~~~~~i~~qi~~~L~~LH~~--~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~  442 (554)
                      .-+.....+...+..-+|..  ...-.+|+++|+-|.+|..+..+|+.++|+.++..   ..........+++.|++|++
T Consensus      1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn---p~~sf~Gl~l~sp~~v~qli 1411 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN---PVLSFFGLELCSPIYVLQLI 1411 (2724)
T ss_pred             chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccC---chHhhhhhhhCCHHHHHHHH
Confidence            33333333435555555532  23458999999999999999999999999998422   12222334567889999999


Q ss_pred             cccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 042763          443 MKTYQLTTKSDVYSFGVLLLEILTGRRPV  471 (554)
Q Consensus       443 l~~~~~s~ksDVwSlGvil~elltg~~P~  471 (554)
                      .+.-.++.++|+|..|+-+|++..|..+|
T Consensus      1412 ~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1412 KNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            99989999999999999999998887765

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.25  E-value=0.0056  Score=62.31  Aligned_cols=143  Identities=17%  Similarity=0.196  Sum_probs=82.6

Q ss_pred             ceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCC--ceeeeeE------EEcCCceEEEE
Q 042763          271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRN--LVKLLGF------VDKGNERLIIT  342 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~------~~~~~~~~lv~  342 (554)
                      .+.++.|....+|+.+..+| .+++|+......   ..++..|++++..|...+  +.+++..      ....+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            45577787889999876655 577887654321   234456677777764222  3344331      12245678999


Q ss_pred             EeCCCCCHHH-----------H---Hhcc---cCCC-------CCHHHHH------------HHHHHHHHHHHHhhh---
Q 042763          343 EFVPNGTLRE-----------H---LDGQ---YGKT-------LDFNQRL------------EIAIDVAHGLTYLHL---  383 (554)
Q Consensus       343 E~~~~g~L~~-----------~---l~~~---~~~~-------l~~~~~~------------~i~~qi~~~L~~LH~---  383 (554)
                      ||++|..+..           .   ++..   ....       -.|....            .....+...++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            9998754321           0   1110   0000       0111100            011123334555532   


Q ss_pred             -ccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          384 -YAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       384 -~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                       ....+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence             1247899999999999999988778999998864

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.24  E-value=0.00046  Score=68.77  Aligned_cols=135  Identities=20%  Similarity=0.200  Sum_probs=92.9

Q ss_pred             CCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh--hh---------------H----HHHHHHHHHHHHhCC-CCC
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF--EN---------------L----QTEFSSEVELLSKID-HRN  324 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~--~~---------------~----~~~~~~Ei~~l~~l~-Hpn  324 (554)
                      -+...++||-|--+-||.+...+|.+.++|..+....  ..               |    +-...+|...|+.|. |..
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            4567889999999999999988899999995432211  00               1    122456888888884 332


Q ss_pred             -ceeeeeEEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC
Q 042763          325 -LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE  403 (554)
Q Consensus       325 -Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~  403 (554)
                       +.+.+++    +..++|||++.+..|...-+     ..+.+++   ...+..-+--|-   .+|+||+|..--||++++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-----v~d~~~l---y~~lm~~Iv~la---~~GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH-----VEDPPTL---YDDLMGLIVRLA---NHGLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeee-----cCChHHH---HHHHHHHHHHHH---HcCceecccchheeEEec
Confidence             3344443    56689999998888765432     1223333   333333344454   789999999999999999


Q ss_pred             CCcEEEEeecCcc
Q 042763          404 SMRAKVADFGFAR  416 (554)
Q Consensus       404 ~~~vkl~DfGla~  416 (554)
                      ++.++++||--.-
T Consensus       238 d~~i~vIDFPQmv  250 (465)
T KOG2268|consen  238 DDKIVVIDFPQMV  250 (465)
T ss_pred             CCCEEEeechHhh
Confidence            9999999997654

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.06  E-value=0.00062  Score=71.58  Aligned_cols=164  Identities=21%  Similarity=0.278  Sum_probs=92.0

Q ss_pred             HHHHHHHHHHhCCCCCceeeeeEEEcC-CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCC
Q 042763          309 EFSSEVELLSKIDHRNLVKLLGFVDKG-NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK  387 (554)
Q Consensus       309 ~~~~Ei~~l~~l~HpnIv~l~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~  387 (554)
                      .++-...+++.+.|+|+...+++-... ....+|||++ +.+|.+.+..+.   +.      .+...+.           
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~------~~s~~~~-----------   86 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LK------DESLLAH-----------   86 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cc------hhhhccc-----------
Confidence            455666889999999999999886543 3468899999 789999986552   11      1111111           


Q ss_pred             CeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhC
Q 042763          388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG  467 (554)
Q Consensus       388 ~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg  467 (554)
                      ++.|-     |       ..+++| -++...                     |     ....+|+|||++|.++.|+.-|
T Consensus        87 ~~~~~-----~-------~~~~td-~~~t~~---------------------~-----~~~~pKsdVwsl~~i~~el~L~  127 (725)
T KOG1093|consen   87 GVLHL-----N-------IIYITD-HFLTKY---------------------P-----SPIGPKSDVWSLGFIILELYLG  127 (725)
T ss_pred             cccee-----h-------hhhccc-cccccC---------------------C-----CCCCcchhhhhHHHHHHHHHHh
Confidence            22221     1       223333 111100                     0     0112599999999999999999


Q ss_pred             CCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 042763          468 RRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVG  537 (554)
Q Consensus       468 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  537 (554)
                      ..-+......+....+...   +....  +..--.....+.-++...+.++...|+-..|..||...+..
T Consensus       128 ~~l~~~~~~s~~l~~i~k~---~~~d~--~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  128 ISLEAELTESEYLEILLKY---YTDDQ--ELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS  192 (725)
T ss_pred             hHHHHHHHHHHHHHHHHHh---ccCch--hHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence            8765533222211111111   11000  00000111123335567788999999999998888655543

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.02  E-value=0.008  Score=60.19  Aligned_cols=31  Identities=26%  Similarity=0.519  Sum_probs=26.2

Q ss_pred             CCeEeCCCCCCCeEECCCCc-EEEEeecCccc
Q 042763          387 KQIIHRDVKSSNILLTESMR-AKVADFGFARL  417 (554)
Q Consensus       387 ~~ivH~Dlkp~NILl~~~~~-vkl~DfGla~~  417 (554)
                      ..++|+|+++.|||+++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 46999999875

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN03150 hypothetical protein; Provisional

Probab=96.85  E-value=0.00052  Score=76.75  Aligned_cols=45  Identities=16%  Similarity=0.155  Sum_probs=40.3

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCCCcc
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDYC  116 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~~~~  116 (554)
                      .+.+|+|++|+      ++|.+|+.++.|++|+.|++++|+++|.+|...+
T Consensus       443 ~L~~L~Ls~N~------l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~  487 (623)
T PLN03150        443 HLQSINLSGNS------IRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG  487 (623)
T ss_pred             CCCEEECCCCc------ccCcCChHHhCCCCCCEEECCCCCCCCCCchHHh
Confidence            46789999999      9999999999999999999999999999985543

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.77  E-value=0.013  Score=60.22  Aligned_cols=80  Identities=15%  Similarity=0.231  Sum_probs=50.6

Q ss_pred             eeeccCceEEEEEEEcCC-cEEEEEEcchh------hhhhHHHHHHHHHHHHHhCC--CCC-ceeeeeEEEcCCceEEEE
Q 042763          273 RIGEGGFGTVYKAQLEDG-LLVAIKRAKKE------QFENLQTEFSSEVELLSKID--HRN-LVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~g-~~vAvK~~~~~------~~~~~~~~~~~Ei~~l~~l~--Hpn-Iv~l~~~~~~~~~~~lv~  342 (554)
                      .||.|...-||++..++| +.|+||...+-      ...-..++...|.+.|+...  -|. +.+++.+  ++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            479999999999987754 68999965422      12223345567778877653  343 4445433  445567999


Q ss_pred             EeCCCC-CHHHHH
Q 042763          343 EFVPNG-TLREHL  354 (554)
Q Consensus       343 E~~~~g-~L~~~l  354 (554)
                      |+++.. .|++.|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            998543 343444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.73  E-value=0.016  Score=58.69  Aligned_cols=138  Identities=14%  Similarity=0.224  Sum_probs=79.8

Q ss_pred             ceeeeccCceEEEEEEEcCCcEEEEEEcch-hhhhhHHHHHHHHHHHHHhCCC--CCceeeeeEEEcCC--ceEEEEEeC
Q 042763          271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKK-EQFENLQTEFSSEVELLSKIDH--RNLVKLLGFVDKGN--ERLIITEFV  345 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~-~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~--~~~lv~E~~  345 (554)
                      .+.+-.|.--.+|..... ++.+++. ... ...........+|..+++.+.-  .-+...+++|.++.  ..+.||+|+
T Consensus        30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            333433433344544433 7778888 332 2222334566788888887742  22445566776655  669999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHH-HHHHHHHH---------------------------------------------
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIA-IDVAHGLT---------------------------------------------  379 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~-~qi~~~L~---------------------------------------------  379 (554)
                      +|..+.+.+...     ...  .+++ ..++..|.                                             
T Consensus       108 eGe~~~~~~~~~-----~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         108 EGEVVWSALPPE-----SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             cceeccCcCCcc-----cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            874332222110     000  0111 13333333                                             


Q ss_pred             -----Hhhhc-----cCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          380 -----YLHLY-----AEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       380 -----~LH~~-----~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                           +|+..     ....++|+|+++.|++++.+..+-+.||+++..
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                 33321     123599999999999999999999999999986

>PLN02236 choline kinase

Probab=96.63  E-value=0.016  Score=59.92  Aligned_cols=140  Identities=18%  Similarity=0.273  Sum_probs=81.0

Q ss_pred             eeeeccCceEEEEEEEcC-----CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCce-eeeeEEEcCCceEEEEEeC
Q 042763          272 LRIGEGGFGTVYKAQLED-----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV-KLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~~-----g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~~~~~~~~~~~lv~E~~  345 (554)
                      ..|-.|-.-.+|++...+     ++.|++|+..... +... .-.+|..+++.+..-++. ++++.+..+    .|+||+
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-Ceee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            346568888999987542     3678899876543 2211 225788888888544433 455655332    579999


Q ss_pred             CCCCHHHH-----------------Hhccc--C-C-CCCHHHHHHHHHHH-----------------HHHHHHhhh----
Q 042763          346 PNGTLREH-----------------LDGQY--G-K-TLDFNQRLEIAIDV-----------------AHGLTYLHL----  383 (554)
Q Consensus       346 ~~g~L~~~-----------------l~~~~--~-~-~l~~~~~~~i~~qi-----------------~~~L~~LH~----  383 (554)
                      ++.++...                 ++...  . . ...+.+..++..++                 ...+..|..    
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            77665321                 01110  0 0 11123332332211                 111222211    


Q ss_pred             -ccCCCeEeCCCCCCCeEECC-CCcEEEEeecCccc
Q 042763          384 -YAEKQIIHRDVKSSNILLTE-SMRAKVADFGFARL  417 (554)
Q Consensus       384 -~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~~  417 (554)
                       .....++|+|+++.|||+++ ++.+.++||..+..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             11346899999999999986 47899999998864

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.58  E-value=0.022  Score=57.84  Aligned_cols=31  Identities=29%  Similarity=0.484  Sum_probs=26.8

Q ss_pred             CCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          386 EKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       386 ~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      ..+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            467999999999999988 6789999997753

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.54  E-value=0.035  Score=58.20  Aligned_cols=81  Identities=19%  Similarity=0.134  Sum_probs=52.6

Q ss_pred             ceeeeccCceEEEEEEEcCCcEEEEEEcchhhh------hhHHHHHHHHHHHHHhCC---CCCceeeeeEEEcCCceEEE
Q 042763          271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF------ENLQTEFSSEVELLSKID---HRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~------~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .+.||.|....||+.... +..++||.-.....      .....+-..|.+.|+.+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            457899999999998865 45688997652111      112233445566666553   247888888877  456789


Q ss_pred             EEeCCC--CCHHHHH
Q 042763          342 TEFVPN--GTLREHL  354 (554)
Q Consensus       342 ~E~~~~--g~L~~~l  354 (554)
                      |||+++  ..+.+-+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999976  2444443

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.53  E-value=0.02  Score=58.42  Aligned_cols=136  Identities=19%  Similarity=0.229  Sum_probs=89.8

Q ss_pred             eeeccCceEEEEEEEcCCcEEEEEEcchhhh---------------------hhHHHH----HHHHHHHHHhCCCCCcee
Q 042763          273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF---------------------ENLQTE----FSSEVELLSKIDHRNLVK  327 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~---------------------~~~~~~----~~~Ei~~l~~l~HpnIv~  327 (554)
                      .|..|--+.||.|...+|..+|||+.+..-.                     .+.++.    ...|+.-|.+|+...|.-
T Consensus       151 CiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~  230 (520)
T KOG2270|consen  151 CISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC  230 (520)
T ss_pred             ccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            5788999999999999999999998653210                     001111    235667777765444321


Q ss_pred             eeeEEEcCCceEEEEEeCCCCCHHH-HHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc
Q 042763          328 LLGFVDKGNERLIITEFVPNGTLRE-HLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR  406 (554)
Q Consensus       328 l~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~  406 (554)
                      .--...  ....|||+|+....... .|+   ...++...+..+-.|++.-+.-|..  ...+||.||.--|+|+- +|.
T Consensus       231 PePIlL--k~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyh-dG~  302 (520)
T KOG2270|consen  231 PEPILL--KNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYH-DGK  302 (520)
T ss_pred             CCceee--ecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEE-CCE
Confidence            111111  23479999994322111 111   1256666778888888888888874  67899999999999985 568


Q ss_pred             EEEEeecCcc
Q 042763          407 AKVADFGFAR  416 (554)
Q Consensus       407 vkl~DfGla~  416 (554)
                      +.|+|-+-+-
T Consensus       303 lyiIDVSQSV  312 (520)
T KOG2270|consen  303 LYIIDVSQSV  312 (520)
T ss_pred             EEEEEccccc
Confidence            9999998774

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.40  E-value=0.041  Score=56.04  Aligned_cols=32  Identities=19%  Similarity=0.293  Sum_probs=29.1

Q ss_pred             CCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          386 EKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       386 ~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      ..+++|+|+.+.|||++.++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45799999999999999999999999998874

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=96.12  E-value=0.0022  Score=44.86  Aligned_cols=37  Identities=14%  Similarity=0.141  Sum_probs=32.1

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ...+|++++|+      ++ ++|+.+..|++|+.|++++|+++.
T Consensus         2 ~L~~L~l~~N~------i~-~l~~~l~~l~~L~~L~l~~N~i~~   38 (44)
T PF12799_consen    2 NLEELDLSNNQ------IT-DLPPELSNLPNLETLNLSNNPISD   38 (44)
T ss_dssp             T-SEEEETSSS-------S-SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred             cceEEEccCCC------Cc-ccCchHhCCCCCCEEEecCCCCCC
Confidence            35789999999      99 799889999999999999999883

...

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.08  E-value=0.019  Score=59.91  Aligned_cols=82  Identities=21%  Similarity=0.294  Sum_probs=52.2

Q ss_pred             ceeeeccCceEEEEEEEcC-CcEEEEEEcchh-----hhhhHHHHHHHHHHHHHhCC--CCC-ceeeeeEEEcCCceEEE
Q 042763          271 SLRIGEGGFGTVYKAQLED-GLLVAIKRAKKE-----QFENLQTEFSSEVELLSKID--HRN-LVKLLGFVDKGNERLII  341 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~-----~~~~~~~~~~~Ei~~l~~l~--Hpn-Iv~l~~~~~~~~~~~lv  341 (554)
                      .+.||-|.-.-||++...+ ++.|+||...+-     .+.-..++...|.+.|+...  -|. +++++.+  ++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4578999999999998753 567999964321     22233456677888888763  343 4555543  34556789


Q ss_pred             EEeCCCC-CHHHHH
Q 042763          342 TEFVPNG-TLREHL  354 (554)
Q Consensus       342 ~E~~~~g-~L~~~l  354 (554)
                      ||+++.. .|++.|
T Consensus       112 MEdL~~~~ilR~~L  125 (409)
T PRK12396        112 MEDLSDHTILRTAL  125 (409)
T ss_pred             HHhCcccHHHHHHH
Confidence            9998543 344443

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.02  E-value=0.039  Score=55.49  Aligned_cols=75  Identities=17%  Similarity=0.323  Sum_probs=48.6

Q ss_pred             CcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC---CCCceeeeeEEEcCCceEEEEEeC
Q 042763          269 SPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID---HRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       269 ~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      +..+.|+.|....+|+.+ .+++.+.||+-....    ...|..|.+-|+.|.   --.+.+.+++....+..++||||+
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSESG----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGG----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecChhh----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            345568999999999988 557889999887332    246778888888773   345778899888777889999999


Q ss_pred             CCC
Q 042763          346 PNG  348 (554)
Q Consensus       346 ~~g  348 (554)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.93  E-value=0.069  Score=54.70  Aligned_cols=140  Identities=22%  Similarity=0.337  Sum_probs=83.4

Q ss_pred             eeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCC------ceeeeeE----EEcCCceEEEE
Q 042763          273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRN------LVKLLGF----VDKGNERLIIT  342 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn------Iv~l~~~----~~~~~~~~lv~  342 (554)
                      .|.+ .-..||+....+|.. ++|+.... ..  ..++.-|.+.|..|.-.+      +..+-|-    ...+...+-++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~--~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG-WT--RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC-CC--HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            3555 667899998887776 89988876 22  345667778887773211      2222221    22223678899


Q ss_pred             EeCCCCCHHH-H----H--------------hccc------CCCCCHHH----H---------HHHHHHHHHHHHHhhhc
Q 042763          343 EFVPNGTLRE-H----L--------------DGQY------GKTLDFNQ----R---------LEIAIDVAHGLTYLHLY  384 (554)
Q Consensus       343 E~~~~g~L~~-~----l--------------~~~~------~~~l~~~~----~---------~~i~~qi~~~L~~LH~~  384 (554)
                      +|++|..+.. .    +              ++..      .....|..    .         .....++...+..+...
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9998887772 1    1              0000      01122320    0         11233344444444421


Q ss_pred             -----cCCC--eEeCCCCCCCeEECCCCc-EEEEeecCccc
Q 042763          385 -----AEKQ--IIHRDVKSSNILLTESMR-AKVADFGFARL  417 (554)
Q Consensus       385 -----~~~~--ivH~Dlkp~NILl~~~~~-vkl~DfGla~~  417 (554)
                           ...+  +||+|+.|.||+++.+.. +-++||+-+..
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence                 1223  999999999999999885 89999998864

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.90  E-value=0.055  Score=55.67  Aligned_cols=140  Identities=19%  Similarity=0.269  Sum_probs=78.4

Q ss_pred             eeeeccCceEEEEEEEcC----CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCc-eeeeeEEEcCCceEEEEEeCC
Q 042763          272 LRIGEGGFGTVYKAQLED----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL-VKLLGFVDKGNERLIITEFVP  346 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lv~E~~~  346 (554)
                      +.|..|-...+|+....+    +..|++|+..... +. .-.-.+|..+++.+..-++ .++++++.. +   +|.+|++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~   93 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-DY-VIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFIN   93 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc-Ce-EechHHHHHHHHHHHhcCCCCceeEEeCC-c---Eeehhhc
Confidence            346668888899986543    2378888776542 11 1123568888888865444 355655532 2   5899987


Q ss_pred             CCCHHH-------HH----------hccc--C-C-CCCHHHHHHHHHHH----------------------HHHHHHhhh
Q 042763          347 NGTLRE-------HL----------DGQY--G-K-TLDFNQRLEIAIDV----------------------AHGLTYLHL  383 (554)
Q Consensus       347 ~g~L~~-------~l----------~~~~--~-~-~l~~~~~~~i~~qi----------------------~~~L~~LH~  383 (554)
                      +..|..       .+          +...  . . .--+..+.++..++                      ..-+..+..
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            665421       01          1110  0 0 11122222222221                      111222211


Q ss_pred             c-----cCCCeEeCCCCCCCeEECC-CCcEEEEeecCccc
Q 042763          384 Y-----AEKQIIHRDVKSSNILLTE-SMRAKVADFGFARL  417 (554)
Q Consensus       384 ~-----~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~~  417 (554)
                      .     ...-++|+|+.+.|||+++ ++.++++||..|..
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1     1224799999999999975 57899999998864

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.84  E-value=0.37  Score=49.46  Aligned_cols=72  Identities=18%  Similarity=0.172  Sum_probs=45.5

Q ss_pred             ccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCC--ceeee---e--EEEcCCceEEEEEeCCCC
Q 042763          276 EGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRN--LVKLL---G--FVDKGNERLIITEFVPNG  348 (554)
Q Consensus       276 ~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~---~--~~~~~~~~~lv~E~~~~g  348 (554)
                      .+.-..||+....+|..+++|+.+....  ...++..|++.+..|....  ++...   |  ....++..+.++++++|.
T Consensus        35 ~s~eN~vy~v~~~~~~~~vlKv~r~~~~--~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~  112 (325)
T PRK11768         35 NSYENRVYQFGDEDGRRVVAKFYRPERW--SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR  112 (325)
T ss_pred             ccccceEEEEecCCCCEEEEEEcCcccC--CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence            4566789999888888899998864431  2345667777777663211  22211   2  223345678899999775


Q ss_pred             C
Q 042763          349 T  349 (554)
Q Consensus       349 ~  349 (554)
                      .
T Consensus       113 ~  113 (325)
T PRK11768        113 A  113 (325)
T ss_pred             C
Confidence            4

>PRK06148 hypothetical protein; Provisional

Probab=95.82  E-value=0.11  Score=61.63  Aligned_cols=141  Identities=21%  Similarity=0.271  Sum_probs=79.4

Q ss_pred             eeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-------CCCCceeee-e----EEEc-CC--
Q 042763          272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-------DHRNLVKLL-G----FVDK-GN--  336 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-------~HpnIv~l~-~----~~~~-~~--  336 (554)
                      +.|+ |..-.+|+.+..+|..+++|+.......   .....|.+.|..|       .-|.+++-. |    .... ++  
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~---~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~  106 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR---VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEP  106 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccch---hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCce
Confidence            4464 4568899998888889999999865322   2333444555544       233333322 1    1111 22  


Q ss_pred             ceEEEEEeCCCCCHHHHH-----------------h----ccc----CCCCCHHH-----------------HHHHHHHH
Q 042763          337 ERLIITEFVPNGTLREHL-----------------D----GQY----GKTLDFNQ-----------------RLEIAIDV  374 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l-----------------~----~~~----~~~l~~~~-----------------~~~i~~qi  374 (554)
                      ..+.+++|++|..+.+..                 +    ...    ...+.|..                 ...++.++
T Consensus       107 ~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~  186 (1013)
T PRK06148        107 RLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERF  186 (1013)
T ss_pred             EEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHH
Confidence            356789999987776511                 0    000    01122211                 11222222


Q ss_pred             HHHHH-----HhhhccCCCeEeCCCCCCCeEECCCC--cEE-EEeecCccc
Q 042763          375 AHGLT-----YLHLYAEKQIIHRDVKSSNILLTESM--RAK-VADFGFARL  417 (554)
Q Consensus       375 ~~~L~-----~LH~~~~~~ivH~Dlkp~NILl~~~~--~vk-l~DfGla~~  417 (554)
                      ....+     .+.. ...++||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       187 ~~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        187 LARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            22221     1211 256799999999999999875  555 999998864

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.58  E-value=0.1  Score=49.98  Aligned_cols=77  Identities=16%  Similarity=0.304  Sum_probs=54.6

Q ss_pred             cceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC---CCCCceeeeeEEEcCCceEEEEEeCC
Q 042763          270 PSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI---DHRNLVKLLGFVDKGNERLIITEFVP  346 (554)
Q Consensus       270 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~~~~~~lv~E~~~  346 (554)
                      ..+.+.-|.--..|.... +...+.||+-....    ...|..|+.-|..|   +--.+.+.+.+....++.|+||||++
T Consensus        20 er~~v~gG~inea~~v~d-g~~~~FvK~n~~~~----~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~   94 (286)
T COG3001          20 EREEVSGGDINEAWRLRD-GTDPFFVKCNQREQ----LSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP   94 (286)
T ss_pred             cccccCCccccceeEeec-CCcceEEEecchhh----HHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence            344566566666666553 35678888765442    35677787776666   34567888899899999999999999


Q ss_pred             CCCHH
Q 042763          347 NGTLR  351 (554)
Q Consensus       347 ~g~L~  351 (554)
                      -+.+.
T Consensus        95 ~~~~d   99 (286)
T COG3001          95 TGPLD   99 (286)
T ss_pred             CCCCC
Confidence            87665

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.42  E-value=0.046  Score=52.25  Aligned_cols=31  Identities=29%  Similarity=0.497  Sum_probs=22.3

Q ss_pred             CCeEeCCCCCCCeEE-CCCCcEEEEeecCccc
Q 042763          387 KQIIHRDVKSSNILL-TESMRAKVADFGFARL  417 (554)
Q Consensus       387 ~~ivH~Dlkp~NILl-~~~~~vkl~DfGla~~  417 (554)
                      ..++|+|+.+.|||+ +.++.++++||..|..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            458999999999999 8899999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	554
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-52
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-52
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-50
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-48
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-39
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-36
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-26
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-26
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-26
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-25
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-25
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-25
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-25
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		9e-25
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-25
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-24
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-24
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-24
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-24
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-24
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-24
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-24
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-24
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-24
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-24
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-24
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-23
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-23
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-23
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-23
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-23
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-23
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-23
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-23
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-23
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-23
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-23
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-23
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-23
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-23
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-23
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-23
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-23
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-23
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-23
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-23
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-23
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-23
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-23
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-23
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-23
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-23
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-23
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-23
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-23
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-23
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-23
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-23
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-23
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-23
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-23
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-23
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-23
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-23
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-23
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-23
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-23
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-23
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-23
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-23
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-23
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-23
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-23
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-23
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-23
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-23
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-23
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-22
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-22
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-22
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-22
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-22
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-22
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-22
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-22
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-22
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-22
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-22
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-22
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-22
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-22
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-22
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-22
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-22
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-22
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-22
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-22
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-22
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-22
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-22
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-22
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-22
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-22
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-22
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-22
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-22
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-22
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-22
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-22
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-22
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-22
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-22
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-22
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-22
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-22
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-22
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-22
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-22
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-22
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-22
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-22
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-22
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-22
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-22
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-22
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-22
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-22
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-22
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-22
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-22
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-22
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-22
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-22
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-22
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-22
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-22
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-22
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-22
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-21
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-21
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-21
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-21
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-21
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-21
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-21
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-21
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-21
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-21
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-21
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-21
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-21
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-21
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-21
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-21
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-21
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-21
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-21
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-21
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-21
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-21
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-21
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-21
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-21
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-21
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-21
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-21
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-21
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-21
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-21
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-21
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-21
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-21
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-21
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-21
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-21
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-21
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-21
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-21
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-21
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-21
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-21
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		7e-21
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-21
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-21
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-21
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-21
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-21
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-21
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-21
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-21
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		9e-21
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-20
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-20
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-20
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-20
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-20
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-20
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-20
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-20
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-20
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-20
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-20
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-20
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-20
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-20
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-20
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-20
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-20
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-20
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-20
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-20
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-19
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-19
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-19
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-19
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-19
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-19
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-19
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-19
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-19
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-19
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-19
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-19
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-19
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-19
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-19
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-19
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-19
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-19
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-19
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-19
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-19
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-19
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-19
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-19
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-19
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-19
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-19
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-19
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-19
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-19
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-19
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-19
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-19
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-19
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-19
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-19
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-19
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-19
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-19
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-19
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-19
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-19
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-19
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-19
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-19
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-19
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-19
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		9e-19
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-18
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-18
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-18
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-18
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-18
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-18
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-18
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-18
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-18
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-18
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-18
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-18
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-18
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-18
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-18
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-18
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-18
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-18
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-18
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-18
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-18
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-18
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-18
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-18
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-18
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-18
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-18
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-18
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-18
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-17
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-17
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-17
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-17
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-17
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-17
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-17
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-17
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-17
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-17
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-17
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-17
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-17
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-17
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-17
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-17
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-17
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-17
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		9e-17
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-16
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-16
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-16
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-16
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-16
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-16
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-15
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-15
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-15
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-15
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-15
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-15
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-15
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-15
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-15
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-14
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		9e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-13
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-13
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		9e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-10
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-10
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		9e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		9e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		9e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		9e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		9e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-08
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		9e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		9e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		9e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		9e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		9e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-06
3soa_A	444	Full-Length Human Camkii Length = 444		1e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-06

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  204 bits (519), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 126/284 (44%), Positives = 169/284 (59%), Gaps = 12/284 (4%)
Query: 263 KATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH 322
           +AT NF     IG G FG VYK  L DG  VA+KR   E  + ++    +E+E LS   H
Sbjct: 36  EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF-ETEIETLSFCRH 94
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD--FNQRLEIAIDVAHGLTY 380
            +LV L+GF D+ NE ++I +++ NG L+ HL G    T+   + QRLEI I  A GL Y
Sbjct: 95  PHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHY 154
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
           LH  A   IIHRDVKS NILL E+   K+ DFG ++ G  + D+TH+   VKGT+GY+DP
Sbjct: 155 LHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG-TELDQTHLXXVVKGTLGYIDP 210
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTL-RWAFKRYNEGNLLDMV 499
           EY    +LT KSDVYSFGV+L E+L  R  + ++  P E V L  WA + +N G L  +V
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPREMVNLAEWAVESHNNGQLEQIV 269
Query: 500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI 543
           DP++ + I  E L K    A++C A    DRP M   G+ LW +
Sbjct: 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM---GDVLWKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  201 bits (512), Expect = 7e-52,   Method: Compositional matrix adjust.
 Identities = 125/284 (44%), Positives = 168/284 (59%), Gaps = 12/284 (4%)
Query: 263 KATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH 322
           +AT NF     IG G FG VYK  L DG  VA+KR   E  + ++    +E+E LS   H
Sbjct: 36  EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF-ETEIETLSFCRH 94
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD--FNQRLEIAIDVAHGLTY 380
            +LV L+GF D+ NE ++I +++ NG L+ HL G    T+   + QRLEI I  A GL Y
Sbjct: 95  PHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHY 154
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
           LH  A   IIHRDVKS NILL E+   K+ DFG ++ G  +  +TH+   VKGT+GY+DP
Sbjct: 155 LHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG-TELGQTHLXXVVKGTLGYIDP 210
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTL-RWAFKRYNEGNLLDMV 499
           EY    +LT KSDVYSFGV+L E+L  R  + ++  P E V L  WA + +N G L  +V
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPREMVNLAEWAVESHNNGQLEQIV 269
Query: 500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI 543
           DP++ + I  E L K    A++C A    DRP M   G+ LW +
Sbjct: 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM---GDVLWKL 310

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  194 bits (493), Expect = 9e-50,   Method: Compositional matrix adjust.
 Identities = 110/286 (38%), Positives = 171/286 (59%), Gaps = 10/286 (3%)
Query: 257 NMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVEL 316
           ++ ++  A+ NFS    +G GGFG VYK +L DG LVA+KR K+E+ +  + +F +EVE+
Sbjct: 29  SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEM 88
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGT----LREHLDGQYGKTLDFNQRLEIAI 372
           +S   HRNL++L GF     ERL++  ++ NG+    LRE  + Q    LD+ +R  IA+
Sbjct: 89  ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ--PPLDWPKRQRIAL 146
Query: 373 DVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK 432
             A GL YLH + + +IIHRDVK++NILL E   A V DFG A+L  MD    H+   V+
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL--MDYKDXHVXXAVR 204
Query: 433 GTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKR--PPEERVTLRWAFKRY 490
           GT+G++ PEY+ T + + K+DV+ +GV+LLE++TG+R  +L R    ++ + L W     
Sbjct: 205 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 264
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
            E  L  +VD  ++     E + ++  +A+ C      +RP M  V
Sbjct: 265 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 310

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  190 bits (483), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 108/286 (37%), Positives = 169/286 (59%), Gaps = 10/286 (3%)
Query: 257 NMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVEL 316
           ++ ++  A+ NF     +G GGFG VYK +L DG LVA+KR K+E+ +  + +F +EVE+
Sbjct: 21  SLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGT----LREHLDGQYGKTLDFNQRLEIAI 372
           +S   HRNL++L GF     ERL++  ++ NG+    LRE  + Q    LD+ +R  IA+
Sbjct: 81  ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ--PPLDWPKRQRIAL 138
Query: 373 DVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK 432
             A GL YLH + + +IIHRDVK++NILL E   A V DFG A+L  MD    H+   V+
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL--MDYKDXHVXXAVR 196
Query: 433 GTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKR--PPEERVTLRWAFKRY 490
           G +G++ PEY+ T + + K+DV+ +GV+LLE++TG+R  +L R    ++ + L W     
Sbjct: 197 GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
            E  L  +VD  ++     E + ++  +A+ C      +RP M  V
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  162 bits (409), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 98/276 (35%), Positives = 158/276 (57%), Gaps = 10/276 (3%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           ++GEGGFG VYK  + +  +   K A       E L+ +F  E+++++K  H NLV+LLG
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGK-TLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           F   G++  ++  ++PNG+L + L    G   L ++ R +IA   A+G+ +LH   E   
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHH 154
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           IHRD+KS+NILL E+  AK++DFG AR     + +T + +++ GT  Y+ PE ++  ++T
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFA-QTVMXSRIVGTTAYMAPEALRG-EIT 212
Query: 450 TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISM 509
            KSD+YSFGV+LLEI+TG   V+  R P + +          E  + D +D  + +  S 
Sbjct: 213 PKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDEEKTIEDYIDKKMNDADST 271
Query: 510 EILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA 545
            +   M+ +A QC    +N RPD+K V + L  + A
Sbjct: 272 SV-EAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  161 bits (407), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 98/276 (35%), Positives = 157/276 (56%), Gaps = 10/276 (3%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           ++GEGGFG VYK  + +  +   K A       E L+ +F  E+++++K  H NLV+LLG
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGK-TLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           F   G++  ++  ++PNG+L + L    G   L ++ R +IA   A+G+ +LH   E   
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHH 154
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           IHRD+KS+NILL E+  AK++DFG AR     + +T +  ++ GT  Y+ PE ++  ++T
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFA-QTVMXXRIVGTTAYMAPEALRG-EIT 212
Query: 450 TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISM 509
            KSD+YSFGV+LLEI+TG   V+  R P + +          E  + D +D  + +  S 
Sbjct: 213 PKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDEEKTIEDYIDKKMNDADST 271
Query: 510 EILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA 545
            +   M+ +A QC    +N RPD+K V + L  + A
Sbjct: 272 SV-EAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  159 bits (403), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 97/276 (35%), Positives = 155/276 (56%), Gaps = 10/276 (3%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           ++GEGGFG VYK  + +  +   K A       E L+ +F  E+++++K  H NLV+LLG
Sbjct: 32  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGK-TLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           F   G++  ++  ++PNG+L + L    G   L ++ R +IA   A+G+ +LH   E   
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHH 148
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           IHRD+KS+NILL E+  AK++DFG AR     +    +  ++ GT  Y+ PE ++  ++T
Sbjct: 149 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV-MXXRIVGTTAYMAPEALRG-EIT 206
Query: 450 TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISM 509
            KSD+YSFGV+LLEI+TG   V+  R P + +          E  + D +D  + +  S 
Sbjct: 207 PKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDEEKTIEDYIDKKMNDADST 265
Query: 510 EILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA 545
            +   M+ +A QC    +N RPD+K V + L  + A
Sbjct: 266 SV-EAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 300

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 97/276 (35%), Positives = 148/276 (53%), Gaps = 10/276 (3%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           + GEGGFG VYK  + +  +   K A       E L+ +F  E+++ +K  H NLV+LLG
Sbjct: 29  KXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGK-TLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           F   G++  ++  + PNG+L + L    G   L ++ R +IA   A+G+ +LH   E   
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLH---ENHH 145
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           IHRD+KS+NILL E+  AK++DFG AR     +     S ++ GT  Y  PE ++  ++T
Sbjct: 146 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXS-RIVGTTAYXAPEALRG-EIT 203
Query: 450 TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISM 509
            KSD+YSFGV+LLEI+TG   V+  R P + +          E  + D +D    +  S 
Sbjct: 204 PKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDEEKTIEDYIDKKXNDADST 262
Query: 510 EILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA 545
            +    + +A QC    +N RPD+K V + L    A
Sbjct: 263 SV-EAXYSVASQCLHEKKNKRPDIKKVQQLLQEXTA 297

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 111/200 (55%), Gaps = 7/200 (3%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQT-EFSSEVELLSKIDHRNLVKLLGF 331
           +IG G FGTV++A+   G  VA+K   ++ F   +  EF  EV ++ ++ H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGK-TLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           V +     I+TE++  G+L   L     +  LD  +RL +A DVA G+ YLH      I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+KS N+L+ +    KV DFG +RL    +     S    GT  ++ PE ++      
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRL---KASXFLXSKXAAGTPEWMAPEVLRDEPSNE 218
Query: 451 KSDVYSFGVLLLEILTGRRP 470
           KSDVYSFGV+L E+ T ++P
Sbjct: 219 KSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 74/201 (36%), Positives = 114/201 (56%), Gaps = 9/201 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQT-EFSSEVELLSKIDHRNLVKLLGF 331
           +IG G FGTV++A+   G  VA+K   ++ F   +  EF  EV ++ ++ H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGK-TLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           V +     I+TE++  G+L   L     +  LD  +RL +A DVA G+ YLH      I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK-VKGTVGYLDPEYMKTYQLT 449
           HR++KS N+L+ +    KV DFG +RL       T +S+K   GT  ++ PE ++     
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL----KASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            KSDVYSFGV+L E+ T ++P
Sbjct: 218 EKSDVYSFGVILWELATLQQP 238

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/306 (29%), Positives = 152/306 (49%), Gaps = 37/306 (12%)
Query: 261 VVKATRNFSPSLR-----IGEGGFGTVYKAQLEDG-----LLVAIKRAKKEQFENLQTEF 310
           V+K T    PS       IG G FG VYK  L+       + VAIK  K    E  + +F
Sbjct: 34  VLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF 93
Query: 311 SSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI 370
             E  ++ +  H N+++L G + K    +IITE++ NG L + L  + G+     Q + +
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGM 152
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
              +A G+ YL   A    +HRD+ + NIL+  ++  KV+DFG +R+   D + T+ ++ 
Sbjct: 153 LRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 209
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKR 489
            K  + +  PE +   + T+ SDV+SFG+++ E++T G RP              W    
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY-------------WELSN 256
Query: 490 YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRP---DMKSVGEQLWAIRA- 545
           +    ++  ++   +    M+  + ++ L +QC    R  RP   D+ S+ ++L  IRA 
Sbjct: 257 H---EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL--IRAP 311
Query: 546 DSLKSV 551
           DSLK++
Sbjct: 312 DSLKTL 317

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  116 bits (290), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 110/203 (54%), Gaps = 10/203 (4%)
Query: 271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           S RIG G FGTVYK +    + V I +      E  Q  F +EV +L K  H N++  +G
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQA-FRNEVAVLRKTRHVNILLFMG 99
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           ++ K N   I+T++    +L +HL  Q  K   F Q ++IA   A G+ YLH    K II
Sbjct: 100 YMTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMF-QLIDIARQTAQGMDYLH---AKNII 154
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ--- 447
           HRD+KS+NI L E +  K+ DFG A +    S    +     G+V ++ PE ++      
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT-GSVLWMAPEVIRMQDNNP 213
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
            + +SDVYS+G++L E++TG  P
Sbjct: 214 FSFQSDVYSYGIVLYELMTGELP 236

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G FG V+         VA+K  K+         F +E  L+ ++ H+ LV+L   V
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++ NG+L + L    G  L  N+ L++A  +A G+ ++    E+  IHR
Sbjct: 80  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 135
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL+++++  K+ADFG ARL  ++ +        K  + +  PE +     T KS
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 193
Query: 453 DVYSFGVLLLEILT-GRRPVELKRPPE 478
           DV+SFG+LL EI+T GR P      PE
Sbjct: 194 DVWSFGILLTEIVTHGRIPYPGMTNPE 220

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G FG V+         VA+K  K+         F +E  L+ ++ H+ LV+L   V
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++ NG+L + L    G  L  N+ L++A  +A G+ ++    E+  IHR
Sbjct: 79  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 134
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL+++++  K+ADFG ARL  ++ +        K  + +  PE +     T KS
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 192
Query: 453 DVYSFGVLLLEILT-GRRPVELKRPPE 478
           DV+SFG+LL EI+T GR P      PE
Sbjct: 193 DVWSFGILLTEIVTHGRIPYPGMTNPE 219

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 110/199 (55%), Gaps = 9/199 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G FG V+         VA+K  K+         F +E  L+ ++ H+ LV+L   V
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++ NG+L + L    G  L  N+ L++A  +A G+ ++    E+  IHR
Sbjct: 86  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 141
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL+++++  K+ADFG ARL  ++ +        K  + +  PE +     T KS
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 199
Query: 453 DVYSFGVLLLEILT-GRRP 470
           DV+SFG+LL EI+T GR P
Sbjct: 200 DVWSFGILLTEIVTHGRIP 218

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G FG V+         VA+K  K+         F +E  L+ ++ H+ LV+L   V
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++ NG+L + L    G  L  N+ L++A  +A G+ ++    E+  IHR
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL+++++  K+ADFG ARL  ++ +        K  + +  PE +     T KS
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 453 DVYSFGVLLLEILT-GRRPVELKRPPE 478
           DV+SFG+LL EI+T GR P      PE
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 110/199 (55%), Gaps = 9/199 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G FG V+         VA+K  K+         F +E  L+ ++ H+ LV+L   V
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++ NG+L + L    G  L  N+ L++A  +A G+ ++    E+  IHR
Sbjct: 87  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 142
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL+++++  K+ADFG ARL  ++ +        K  + +  PE +     T KS
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 200
Query: 453 DVYSFGVLLLEILT-GRRP 470
           DV+SFG+LL EI+T GR P
Sbjct: 201 DVWSFGILLTEIVTHGRIP 219

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G FG V+         VA+K  K+         F +E  L+ ++ H+ LV+L   V
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++ NG+L + L    G  L  N+ L++A  +A G+ ++    E+  IHR
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL+++++  K+ADFG ARL  ++ +        K  + +  PE +     T KS
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 453 DVYSFGVLLLEILT-GRRPVELKRPPE 478
           DV+SFG+LL EI+T GR P      PE
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 110/199 (55%), Gaps = 9/199 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G FG V+         VA+K  K+         F +E  L+ ++ H+ LV+L   V
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++ NG+L + L    G  L  N+ L++A  +A G+ ++    E+  IHR
Sbjct: 84  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 139
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL+++++  K+ADFG ARL  ++ +        K  + +  PE +     T KS
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 453 DVYSFGVLLLEILT-GRRP 470
           DV+SFG+LL EI+T GR P
Sbjct: 198 DVWSFGILLTEIVTHGRIP 216

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G FG V+         VA+K  K+         F +E  L+ ++ H+ LV+L   V
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++ NG+L + L    G  L  N+ L++A  +A G+ ++    E+  IHR
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL+++++  K+ADFG ARL  ++ +        K  + +  PE +     T KS
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 453 DVYSFGVLLLEILT-GRRPVELKRPPE 478
           DV+SFG+LL EI+T GR P      PE
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G FG V+         VA+K  K+         F +E  L+ ++ H+ LV+L   V
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++ NG+L + L    G  L  N+ L++A  +A G+ ++    E+  IHR
Sbjct: 88  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 143
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL+++++  K+ADFG ARL  ++ +        K  + +  PE +     T KS
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 201
Query: 453 DVYSFGVLLLEILT-GRRPVELKRPPE 478
           DV+SFG+LL EI+T GR P      PE
Sbjct: 202 DVWSFGILLTEIVTHGRIPYPGMTNPE 228

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G FG V+         VA+K  K+         F +E  L+ ++ H+ LV+L   V
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++ NG+L + L    G  L  N+ L++A  +A G+ ++    E+  IHR
Sbjct: 73  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 128
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL+++++  K+ADFG ARL  ++ +        K  + +  PE +     T KS
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 453 DVYSFGVLLLEILT-GRRPVELKRPPE 478
           DV+SFG+LL EI+T GR P      PE
Sbjct: 187 DVWSFGILLTEIVTHGRIPYPGMTNPE 213

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G FG V+         VA+K  K+         F +E  L+ ++ H+ LV+L   V
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++ NG+L + L    G  L  N+ L++A  +A G+ ++    E+  IHR
Sbjct: 83  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 138
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL+++++  K+ADFG ARL  ++ +        K  + +  PE +     T KS
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 196
Query: 453 DVYSFGVLLLEILT-GRRPVELKRPPE 478
           DV+SFG+LL EI+T GR P      PE
Sbjct: 197 DVWSFGILLTEIVTHGRIPYPGMTNPE 223

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G FG V+         VA+K  K+         F +E  L+ ++ H+ LV+L   V
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++ NG+L + L    G  L  N+ L++A  +A G+ ++    E+  IHR
Sbjct: 84  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 139
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL+++++  K+ADFG ARL  ++ +        K  + +  PE +     T KS
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 453 DVYSFGVLLLEILT-GRRPVELKRPPE 478
           DV+SFG+LL EI+T GR P      PE
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPE 224

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G FG V+         VA+K  K+         F +E  L+ ++ H+ LV+L   V
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++ NG+L + L    G  L  N+ L++A  +A G+ ++    E+  IHR
Sbjct: 74  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 129
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           +++++NIL+++++  K+ADFG ARL  ++ +        K  + +  PE +     T KS
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 453 DVYSFGVLLLEILT-GRRPVELKRPPE 478
           DV+SFG+LL EI+T GR P      PE
Sbjct: 188 DVWSFGILLTEIVTHGRIPYPGMTNPE 214

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 113/216 (52%), Gaps = 35/216 (16%)
Query: 274 IGEGGFGTVYKAQLE-DGLLV--AIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLVKLL 329
           IGEG FG V KA+++ DGL +  AIKR K+   ++   +F+ E+E+L K+ H  N++ LL
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 330 GFVDKGNERLIITEFVPNGTLREHLD--------------GQYGKTLDFNQRLEIAIDVA 375
           G  +      +  E+ P+G L + L                    TL   Q L  A DVA
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
            G+ YL   ++KQ IHRD+ + NIL+ E+  AK+ADFG +R              VK T+
Sbjct: 143 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTM 190
Query: 436 GYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILT 466
           G L   +M    L     TT SDV+S+GVLL EI++
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  108 bits (271), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 113/216 (52%), Gaps = 35/216 (16%)
Query: 274 IGEGGFGTVYKAQLE-DGLLV--AIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLVKLL 329
           IGEG FG V KA+++ DGL +  AIKR K+   ++   +F+ E+E+L K+ H  N++ LL
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 330 GFVDKGNERLIITEFVPNGTLREHLD--------------GQYGKTLDFNQRLEIAIDVA 375
           G  +      +  E+ P+G L + L                    TL   Q L  A DVA
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
            G+ YL   ++KQ IHRD+ + NIL+ E+  AK+ADFG +R              VK T+
Sbjct: 153 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTM 200
Query: 436 GYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILT 466
           G L   +M    L     TT SDV+S+GVLL EI++
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            +++G+G FG V+         VAIK  K          F  E +++ KI H  LV+L  
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKIRHEKLVQLYA 80
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            V +     I+TE++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +
Sbjct: 81  VVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFG+LL E+ T GR P
Sbjct: 195 KSDVWSFGILLTELTTKGRVP 215

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 136/279 (48%), Gaps = 33/279 (11%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH 322
           N S    +G G FG V   +L+      + VAIK  K    E  + +F  E  ++ + DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGL 378
            N+++L G V K    +I+TE++ NG+L    R+H D Q+       Q + +   +A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVI----QLVGMLRGIASGM 160
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YL   ++   +HRD+ + NIL+  ++  KV+DFG AR+   D +  + +   K  + + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWT 217
Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
            PE +   + T+ SDV+S+G++L E+++ G RP                +   +  +++ 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQDVIK 261
Query: 498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
            VD   +    M+    ++ L + C    RN+RP  + +
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 110/201 (54%), Gaps = 10/201 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           RIG G FGTVYK +    + V +        + LQ  F +EV +L K  H N++  +G+ 
Sbjct: 19  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYS 77
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            K  +  I+T++    +L  HL     K  +  + ++IA   A G+ YLH    K IIHR
Sbjct: 78  TK-PQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLH---AKSIIHR 132
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK---TYQLT 449
           D+KS+NI L E    K+ DFG A +    S  +H   ++ G++ ++ PE ++   +   +
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYS 191
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            +SDVY+FG++L E++TG+ P
Sbjct: 192 FQSDVYAFGIVLYELMTGQLP 212

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L  
Sbjct: 13  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYA 70
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            V +     I+TE++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +
Sbjct: 71  VVSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 126
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T 
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARL--IEDNEXTARQGAKFPIKWTAPEAALYGRFTI 184
Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFG+LL E+ T GR P
Sbjct: 185 KSDVWSFGILLTELTTKGRVP 205

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 110/207 (53%), Gaps = 9/207 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G  G V+         VA+K  K+         F +E  L+ ++ H+ LV+L   V
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++ NG+L + L    G  L  N+ L++A  +A G+ ++    E+  IHR
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL+++++  K+ADFG ARL  ++          K  + +  PE +     T KS
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARL--IEDAEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 453 DVYSFGVLLLEILT-GRRPVELKRPPE 478
           DV+SFG+LL EI+T GR P      PE
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L  
Sbjct: 12  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYA 69
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            V +     I+TE++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +
Sbjct: 70  VVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 125
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T 
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTI 183
Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFG+LL E+ T GR P
Sbjct: 184 KSDVWSFGILLTELTTKGRVP 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L  
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            V +     I+TE++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +
Sbjct: 81  VVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFG+LL E+ T GR P
Sbjct: 195 KSDVWSFGILLTELTTKGRVP 215

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 136/279 (48%), Gaps = 33/279 (11%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH 322
           N S    +G G FG V   +L+      + VAIK  K    E  + +F  E  ++ + DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGL 378
            N+++L G V K    +I+TE++ NG+L    R+H D Q+       Q + +   +A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVI----QLVGMLRGIASGM 160
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YL   ++   +HRD+ + NIL+  ++  KV+DFG +R+   D +  + +   K  + + 
Sbjct: 161 KYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
            PE +   + T+ SDV+S+G++L E+++ G RP                +   +  +++ 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQDVIK 261
Query: 498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
            VD   +    M+    ++ L + C    RN+RP  + +
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L  
Sbjct: 14  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYA 71
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            V +     I+TE++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +
Sbjct: 72  VVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 127
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T 
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFG+LL E+ T GR P
Sbjct: 186 KSDVWSFGILLTELTTKGRVP 206

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L   
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           V +     I+TE++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +H
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 386
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T K
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV+SFG+LL E+ T GR P
Sbjct: 445 SDVWSFGILLTELTTKGRVP 464

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 136/279 (48%), Gaps = 33/279 (11%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH 322
           N S    +G G FG V   +L+      + VAIK  K    E  + +F  E  ++ + DH
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGL 378
            N+++L G V K    +I+TE++ NG+L    R+H D Q+       Q + +   +A G+
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVI----QLVGMLRGIASGM 131
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YL   ++   +HRD+ + NIL+  ++  KV+DFG +R+   D +  + +   K  + + 
Sbjct: 132 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
            PE +   + T+ SDV+S+G++L E+++ G RP                +   +  +++ 
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQDVIK 232
Query: 498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
            VD   +    M+    ++ L + C    RN+RP  + +
Sbjct: 233 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 271

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/216 (36%), Positives = 113/216 (52%), Gaps = 35/216 (16%)
Query: 274 IGEGGFGTVYKAQLE-DGLLV--AIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLVKLL 329
           IGEG FG V KA+++ DGL +  AIKR K+   ++   +F+ E+E+L K+ H  N++ LL
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 330 GFVDKGNERLIITEFVPNGTLREHLD--------------GQYGKTLDFNQRLEIAIDVA 375
           G  +      +  E+ P+G L + L                    TL   Q L  A DVA
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
            G+ YL   ++KQ IHR++ + NIL+ E+  AK+ADFG +R              VK T+
Sbjct: 150 RGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTM 197
Query: 436 GYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILT 466
           G L   +M    L     TT SDV+S+GVLL EI++
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L  
Sbjct: 16  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYA 73
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            V +     I+TE++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +
Sbjct: 74  VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 129
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T 
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTI 187
Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFG+LL E+ T GR P
Sbjct: 188 KSDVWSFGILLTELTTKGRVP 208

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 109/201 (54%), Gaps = 11/201 (5%)
Query: 272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLLG 330
           +++G+G FG V+         VAIK  K     N+  E F  E +++ K+ H  LV+L  
Sbjct: 191 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPG---NMSPEAFLQEAQVMKKLRHEKLVQLYA 247
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            V +     I+TE++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +
Sbjct: 248 VVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 303
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD++++NIL+ E++  KVADFG  RL  ++ +        K  + +  PE     + T 
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTI 361
Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFG+LL E+ T GR P
Sbjct: 362 KSDVWSFGILLTELTTKGRVP 382

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 136/279 (48%), Gaps = 33/279 (11%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH 322
           N S    +G G FG V   +L+      + VAIK  K    E  + +F  E  ++ + DH
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGL 378
            N+++L G V K    +I+TE++ NG+L    R+H D Q+       Q + +   +A G+
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVI----QLVGMLRGIASGM 148
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YL   ++   +HRD+ + NIL+  ++  KV+DFG +R+   D +  + +   K  + + 
Sbjct: 149 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 205
Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
            PE +   + T+ SDV+S+G++L E+++ G RP                +   +  +++ 
Sbjct: 206 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQDVIK 249
Query: 498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
            VD   +    M+    ++ L + C    RN+RP  + +
Sbjct: 250 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 288

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 136/279 (48%), Gaps = 33/279 (11%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH 322
           N S    +G G FG V   +L+      + VAIK  K    E  + +F  E  ++ + DH
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGL 378
            N+++L G V K    +I+TE++ NG+L    R+H D Q+       Q + +   +A G+
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVI----QLVGMLRGIASGM 158
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YL   ++   +HRD+ + NIL+  ++  KV+DFG +R+   D +  + +   K  + + 
Sbjct: 159 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 215
Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
            PE +   + T+ SDV+S+G++L E+++ G RP                +   +  +++ 
Sbjct: 216 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQDVIK 259
Query: 498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
            VD   +    M+    ++ L + C    RN+RP  + +
Sbjct: 260 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 298

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 136/279 (48%), Gaps = 33/279 (11%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH 322
           N S    +G G FG V   +L+      + VAIK  K    E  + +F  E  ++ + DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGL 378
            N+++L G V K    +I+TE++ NG+L    R+H D Q+       Q + +   +A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVI----QLVGMLRGIASGM 160
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YL   ++   +HRD+ + NIL+  ++  KV+DFG +R+   D +  + +   K  + + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
            PE +   + T+ SDV+S+G++L E+++ G RP                +   +  +++ 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQDVIK 261
Query: 498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
            VD   +    M+    ++ L + C    RN+RP  + +
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           V +     I+TE++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +H
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T K
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV+SFG+LL E+ T GR P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 136/279 (48%), Gaps = 33/279 (11%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH 322
           N S    +G G FG V   +L+      + VAIK  K    E  + +F  E  ++ + DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGL 378
            N+++L G V K    +I+TE++ NG+L    R+H D Q+       Q + +   +A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVI----QLVGMLRGIASGM 160
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YL   ++   +HRD+ + NIL+  ++  KV+DFG +R+   D +  + +   K  + + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
            PE +   + T+ SDV+S+G++L E+++ G RP                +   +  +++ 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQDVIK 261
Query: 498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
            VD   +    M+    ++ L + C    RN+RP  + +
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 136/279 (48%), Gaps = 33/279 (11%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH 322
           N S    +G G FG V   +L+      + VAIK  K    E  + +F  E  ++ + DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGL 378
            N+++L G V K    +I+TE++ NG+L    R+H D Q+       Q + +   +A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVI----QLVGMLRGIASGM 160
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YL   ++   +HRD+ + NIL+  ++  KV+DFG +R+   D +  + +   K  + + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
            PE +   + T+ SDV+S+G++L E+++ G RP                +   +  +++ 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQDVIK 261
Query: 498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
            VD   +    M+    ++ L + C    RN+RP  + +
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 136/279 (48%), Gaps = 33/279 (11%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH 322
           N S    +G G FG V   +L+      + VAIK  K    E  + +F  E  ++ + DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGL 378
            N+++L G V K    +I+TE++ NG+L    R+H D Q+       Q + +   +A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVI----QLVGMLRGIASGM 160
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YL   ++   +HRD+ + NIL+  ++  KV+DFG +R+   D +  + +   K  + + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
            PE +   + T+ SDV+S+G++L E+++ G RP                +   +  +++ 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQDVIK 261
Query: 498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
            VD   +    M+    ++ L + C    RN+RP  + +
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           V +     I+TE++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +H
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T K
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV+SFG+LL E+ T GR P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 9/201 (4%)
Query: 271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L  
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            V +     I+TE++  G L + L G+ GK L   Q +++A  +A G+ Y+        +
Sbjct: 81  VVSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFG+LL E+ T GR P
Sbjct: 195 KSDVWSFGILLTELTTKGRVP 215

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 135/279 (48%), Gaps = 33/279 (11%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH 322
           N S    +G G FG V   +L+      + VAIK  K    E  + +F  E  ++ + DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGL 378
            N+++L G V K    +I+TE++ NG+L    R+H D Q+       Q + +   +A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVI----QLVGMLRGIASGM 160
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YL   ++   +HRD+ + NIL+  ++  KV+DFG  R+   D +  + +   K  + + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
            PE +   + T+ SDV+S+G++L E+++ G RP                +   +  +++ 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQDVIK 261
Query: 498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
            VD   +    M+    ++ L + C    RN+RP  + +
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 110/201 (54%), Gaps = 10/201 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           RIG G FGTVYK +    + V +        + LQ  F +EV +L K  H N++  +G+ 
Sbjct: 17  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYS 75
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            K  +  I+T++    +L  HL     K  +  + ++IA   A G+ YLH    K IIHR
Sbjct: 76  TK-PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSIIHR 130
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ---LT 449
           D+KS+NI L E +  K+ DFG A +    S  +H   ++ G++ ++ PE ++       +
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYS 189
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            +SDVY+FG++L E++TG+ P
Sbjct: 190 FQSDVYAFGIVLYELMTGQLP 210

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 110/201 (54%), Gaps = 10/201 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           RIG G FGTVYK +    + V +        + LQ  F +EV +L K  H N++  +G+ 
Sbjct: 20  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYS 78
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            K  +  I+T++    +L  HL     K  +  + ++IA   A G+ YLH    K IIHR
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSIIHR 133
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ---LT 449
           D+KS+NI L E +  K+ DFG A +    S  +H   ++ G++ ++ PE ++       +
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            +SDVY+FG++L E++TG+ P
Sbjct: 193 FQSDVYAFGIVLYELMTGQLP 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 110/201 (54%), Gaps = 10/201 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           RIG G FGTVYK +    + V +        + LQ  F +EV +L K  H N++  +G+ 
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYS 73
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            K  +  I+T++    +L  HL     K  +  + ++IA   A G+ YLH    K IIHR
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ---LT 449
           D+KS+NI L E +  K+ DFG A +    S  +H   ++ G++ ++ PE ++       +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            +SDVY+FG++L E++TG+ P
Sbjct: 188 FQSDVYAFGIVLYELMTGQLP 208

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 107/210 (50%), Gaps = 24/210 (11%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EVELLSKIDHRNLVKLLG 330
           IG GGFG VY+A    G  VA+K A+ +  E++     +   E +L + + H N++ L G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              K     ++ EF   G L   L G   K +  +  +  A+ +A G+ YLH  A   II
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 391 HRDVKSSNILLTESMR--------AKVADFGFARLGPMDSDRTHISTKVK--GTVGYLDP 440
           HRD+KSSNIL+ + +          K+ DFG AR         H +TK+   G   ++ P
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAR-------EWHRTTKMSAAGAYAWMAP 183
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           E ++    +  SDV+S+GVLL E+LTG  P
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 106/200 (53%), Gaps = 9/200 (4%)
Query: 272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L   
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           V +     I+TE++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +H
Sbjct: 82  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ ++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T K
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV+SFG+LL E+ T GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 110/201 (54%), Gaps = 10/201 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           RIG G FGTVYK +    + V +        + LQ  F +EV +L K  H N++  +G+ 
Sbjct: 20  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYS 78
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            K  +  I+T++    +L  HL     K  +  + ++IA   A G+ YLH    K IIHR
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSIIHR 133
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ---LT 449
           D+KS+NI L E +  K+ DFG A +    S  +H   ++ G++ ++ PE ++       +
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            +SDVY+FG++L E++TG+ P
Sbjct: 193 FQSDVYAFGIVLYELMTGQLP 213

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 109/201 (54%), Gaps = 10/201 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           RIG G FGTVYK +    + V +        + LQ  F +EV +L K  H N++  +G+ 
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYS 89
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            K  +  I+T++    +L  HL     K  +  + ++IA   A G+ YLH    K IIHR
Sbjct: 90  TK-PQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK---TYQLT 449
           D+KS+NI L E    K+ DFG A      S  +H   ++ G++ ++ PE ++   +   +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            +SDVY+FG++L E++TG+ P
Sbjct: 204 FQSDVYAFGIVLYELMTGQLP 224

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 128/264 (48%), Gaps = 45/264 (17%)
Query: 266 RNFSPSLRIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSK 319
           R+      +GEG FG V+ A+       +D +LVA+K A KE  E+ + +F  E ELL+ 
Sbjct: 18  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK-ALKEASESARQDFQREAELLTM 76
Query: 320 IDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL--DGQYGK-----------TLDFNQ 366
           + H+++V+  G   +G   L++ E++ +G L   L   G   K            L   Q
Sbjct: 77  LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 136
Query: 367 RLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH 426
            L +A  VA G+ YL   A    +HRD+ + N L+ + +  K+ DFG +R     +D   
Sbjct: 137 LLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-DIYSTDYYR 192
Query: 427 ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPV-------------- 471
           +  +    + ++ PE +   + TT+SDV+SFGV+L EI T G++P               
Sbjct: 193 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 252
Query: 472 --ELKR----PPEERVTLRWAFKR 489
             EL+R    PPE    +R  ++R
Sbjct: 253 GRELERPRACPPEVYAIMRGCWQR 276

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 128/264 (48%), Gaps = 45/264 (17%)
Query: 266 RNFSPSLRIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSK 319
           R+      +GEG FG V+ A+       +D +LVA+K A KE  E+ + +F  E ELL+ 
Sbjct: 12  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK-ALKEASESARQDFQREAELLTM 70
Query: 320 IDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL--DGQYGK-----------TLDFNQ 366
           + H+++V+  G   +G   L++ E++ +G L   L   G   K            L   Q
Sbjct: 71  LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 130
Query: 367 RLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH 426
            L +A  VA G+ YL   A    +HRD+ + N L+ + +  K+ DFG +R     +D   
Sbjct: 131 LLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-DIYSTDYYR 186
Query: 427 ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPV-------------- 471
           +  +    + ++ PE +   + TT+SDV+SFGV+L EI T G++P               
Sbjct: 187 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 246
Query: 472 --ELKR----PPEERVTLRWAFKR 489
             EL+R    PPE    +R  ++R
Sbjct: 247 GRELERPRACPPEVYAIMRGCWQR 270

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 128/264 (48%), Gaps = 45/264 (17%)
Query: 266 RNFSPSLRIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSK 319
           R+      +GEG FG V+ A+       +D +LVA+K A KE  E+ + +F  E ELL+ 
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK-ALKEASESARQDFQREAELLTM 99
Query: 320 IDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL--DGQYGK-----------TLDFNQ 366
           + H+++V+  G   +G   L++ E++ +G L   L   G   K            L   Q
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 367 RLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH 426
            L +A  VA G+ YL   A    +HRD+ + N L+ + +  K+ DFG +R     +D   
Sbjct: 160 LLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-DIYSTDYYR 215
Query: 427 ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPV-------------- 471
           +  +    + ++ PE +   + TT+SDV+SFGV+L EI T G++P               
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275
Query: 472 --ELKR----PPEERVTLRWAFKR 489
             EL+R    PPE    +R  ++R
Sbjct: 276 GRELERPRACPPEVYAIMRGCWQR 299

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 115/215 (53%), Gaps = 23/215 (10%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +GEG FG V+ A+       +D +LVA+K   K+  +N + +F  E ELL+ + H ++VK
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVK-TLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL-----------DGQYGKTLDFNQRLEIAIDVAH 376
             G   +G+  +++ E++ +G L + L           +G     L  +Q L IA  +A 
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 377 GLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG 436
           G+ YL   A +  +HRD+ + N L+ E++  K+ DFG +R     +D   +       + 
Sbjct: 140 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR-DVYSTDYYRVGGHTMLPIR 195
Query: 437 YLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
           ++ PE +   + TT+SDV+S GV+L EI T G++P
Sbjct: 196 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L  
Sbjct: 20  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYA 77
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            V +     I+TE++  G+L + L G+ GK L   Q ++++  +A G+ Y+        +
Sbjct: 78  VVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T 
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARL--IEDNEWTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFG+LL E+ T GR P
Sbjct: 192 KSDVWSFGILLTELTTKGRVP 212

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 110/201 (54%), Gaps = 10/201 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           RIG G FGTVYK +    + V +        + LQ  F +EV +L K  H N++  +G+ 
Sbjct: 42  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYS 100
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            K  +  I+T++    +L  HL     K  +  + ++IA   A G+ YLH    K IIHR
Sbjct: 101 TK-PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSIIHR 155
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ---LT 449
           D+KS+NI L E +  K+ DFG A +    S  +H   ++ G++ ++ PE ++       +
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYS 214
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            +SDVY+FG++L E++TG+ P
Sbjct: 215 FQSDVYAFGIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 110/201 (54%), Gaps = 10/201 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           RIG G FGTVYK +    + V +        + LQ  F +EV +L K  H N++  +G+ 
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYS 101
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            K  +  I+T++    +L  HL     K  +  + ++IA   A G+ YLH    K IIHR
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSIIHR 156
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ---LT 449
           D+KS+NI L E +  K+ DFG A +    S  +H   ++ G++ ++ PE ++       +
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYS 215
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            +SDVY+FG++L E++TG+ P
Sbjct: 216 FQSDVYAFGIVLYELMTGQLP 236

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 135/279 (48%), Gaps = 33/279 (11%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH 322
           N S    +G G FG V   +L+      + VAIK  K    E  + +F  E  ++ + DH
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGL 378
            N+++L G V K    +I+TE + NG+L    R+H D Q+       Q + +   +A G+
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH-DAQFTVI----QLVGMLRGIASGM 131
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YL   ++   +HRD+ + NIL+  ++  KV+DFG +R+   D +  + +   K  + + 
Sbjct: 132 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
            PE +   + T+ SDV+S+G++L E+++ G RP                +   +  +++ 
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQDVIK 232
Query: 498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
            VD   +    M+    ++ L + C    RN+RP  + +
Sbjct: 233 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 271

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 9/201 (4%)
Query: 271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L  
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            V +     I+ E++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +
Sbjct: 81  VVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARL--IEDNEXTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFG+LL E+ T GR P
Sbjct: 195 KSDVWSFGILLTELTTKGRVP 215

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 109/201 (54%), Gaps = 10/201 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           RIG G FGTVYK +    + V +        + LQ  F +EV +L K  H N++  +G+ 
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGY- 72
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
               +  I+T++    +L  HL     K  +  + ++IA   A G+ YLH    K IIHR
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ---LT 449
           D+KS+NI L E +  K+ DFG A +    S  +H   ++ G++ ++ PE ++       +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            +SDVY+FG++L E++TG+ P
Sbjct: 188 FQSDVYAFGIVLYELMTGQLP 208

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 9/201 (4%)
Query: 271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L  
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            V +     I+ E++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +
Sbjct: 81  VVSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFG+LL E+ T GR P
Sbjct: 195 KSDVWSFGILLTELTTKGRVP 215

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L  
Sbjct: 20  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYA 77
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            V +     I+TE++  G+L + L G+ GK L   Q ++++  +A G+ Y+        +
Sbjct: 78  VVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T 
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFG+LL E+ T GR P
Sbjct: 192 KSDVWSFGILLTELTTKGRVP 212

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 131/268 (48%), Gaps = 33/268 (12%)
Query: 274 IGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG V    L+      + VAIK  K    E  + +F SE  ++ + DH N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 330 GFVDKGNERLIITEFVPNGTLREHL---DGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           G V K    +IITEF+ NG+L   L   DGQ+       Q + +   +A G+ YL   A+
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI----QLVGMLRGIAAGMKYL---AD 153
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD-SDRTHIST-KVKGTVGYLDPEYMK 444
              +HRD+ + NIL+  ++  KV+DFG +R    D SD T+ S    K  + +  PE ++
Sbjct: 154 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 213
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI 503
             + T+ SDV+S+G+++ E+++ G RP                +      ++++ ++   
Sbjct: 214 YRKFTSASDVWSYGIVMWEVMSYGERP----------------YWDMTNQDVINAIEQDY 257
Query: 504 KEVISMEILTKMFGLAIQCAAPIRNDRP 531
           +    M+  + +  L + C    RN RP
Sbjct: 258 RLPPPMDCPSALHQLMLDCWQKDRNHRP 285

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 134/296 (45%), Gaps = 54/296 (18%)
Query: 274 IGEGGFGTVYKAQLEDGL---------LVAIKRAKKEQFENLQTEFSSEVELLSKI-DHR 323
           +GEG FG V  A+   GL          VA+K  K +  E   ++  SE+E++  I  H+
Sbjct: 36  LGEGAFGQVVLAE-AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFN--------------QRLE 369
           N++ LLG   +     +I E+   G LRE+L  +    L+F+                + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVS 154
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
            A  VA G+ YL   A K+ IHRD+ + N+L+TE    K+ADFG AR      D  HI  
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDX 205
Query: 430 KVKGTVGYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR 484
             K T G L  ++M    L     T +SDV+SFGVLL EI T      L   P   V + 
Sbjct: 206 XKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE 259
Query: 485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
             FK   EG+ +D   PS           +++ +   C   + + RP  K + E L
Sbjct: 260 ELFKLLKEGHRMD--KPS-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 135/279 (48%), Gaps = 33/279 (11%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH 322
           N S    +G G FG V   +L+      + VAIK  K    E  + +F  E  ++ + DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGL 378
            N+++L G V K    +I+TE + NG+L    R+H D Q+       Q + +   +A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH-DAQFTVI----QLVGMLRGIASGM 160
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YL   ++   +HRD+ + NIL+  ++  KV+DFG +R+   D +  + +   K  + + 
Sbjct: 161 KYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
            PE +   + T+ SDV+S+G++L E+++ G RP                +   +  +++ 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQDVIK 261
Query: 498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
            VD   +    M+    ++ L + C    RN+RP  + +
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 125/250 (50%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 124
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +S    GT+ YL P
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAP-SSRRTTLS----GTLDYLPP 176
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 229
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 230 VTEGARDLIS 239

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 135/279 (48%), Gaps = 33/279 (11%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH 322
           N S    +G G FG V   +L+      + VAIK  K    E  + +F  E  ++ + DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGL 378
            N+++L G V K    +I+TE + NG+L    R+H D Q+       Q + +   +A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH-DAQFTVI----QLVGMLRGIASGM 160
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YL   ++   +HRD+ + NIL+  ++  KV+DFG +R+   D +  + +   K  + + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
            PE +   + T+ SDV+S+G++L E+++ G RP                +   +  +++ 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQDVIK 261
Query: 498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
            VD   +    M+    ++ L + C    RN+RP  + +
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 9/201 (4%)
Query: 271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L  
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            V +     I+ E++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +
Sbjct: 81  VVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFG+LL E+ T GR P
Sbjct: 195 KSDVWSFGILLTELTTKGRVP 215

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 111/201 (55%), Gaps = 12/201 (5%)
Query: 273 RIGEGGFGTVYKAQ---LED--GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   +   L+D  G +VA+K+ +    E+L+ +F  E+E+L  + H N+VK
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVK 78
Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G       R   +I EF+P G+LRE+L  ++ + +D  + L+    +  G+ YL    
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQ-KHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K+ IHRD+ + NIL+    R K+ DFG  ++ P D +   +    +  + +  PE +  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 446 YQLTTKSDVYSFGVLLLEILT 466
            + +  SDV+SFGV+L E+ T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 108/201 (53%), Gaps = 10/201 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           RIG G FGTVYK +    + V +        + LQ  F +EV +L K  H N++  +G+ 
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGY- 88
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
               +  I+T++    +L  HL     K  +  + ++IA   A G+ YLH    K IIHR
Sbjct: 89  STAPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK---TYQLT 449
           D+KS+NI L E    K+ DFG A      S  +H   ++ G++ ++ PE ++   +   +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            +SDVY+FG++L E++TG+ P
Sbjct: 204 FQSDVYAFGIVLYELMTGQLP 224

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 9/201 (4%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           +G G FG V   + +    VA+K  K+      + EF  E + + K+ H  LVK  G   
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           K     I+TE++ NG L  +L   +GK L+ +Q LE+  DV  G+ +L      Q IHRD
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRD 129
Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           + + N L+   +  KV+DFG  R    D   + + TK    V +  PE    ++ ++KSD
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF--PVKWSAPEVFHYFKYSSKSD 187
Query: 454 VYSFGVLLLEILT-GRRPVEL 473
           V++FG+L+ E+ + G+ P +L
Sbjct: 188 VWAFGILMWEVFSLGKMPYDL 208

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 123/240 (51%), Gaps = 26/240 (10%)
Query: 252 GSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFEN 305
           G++H  +       R+      +GEG FG V+ A+       +D +LVA+K A K+    
Sbjct: 1   GAMHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK-ALKDPTLA 59
Query: 306 LQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGT----LREH-------L 354
            + +F  E ELL+ + H ++VK  G    G+  +++ E++ +G     LR H       +
Sbjct: 60  ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119
Query: 355 DGQYGKT---LDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVAD 411
           DGQ  +    L  +Q L IA  +A G+ YL   A +  +HRD+ + N L+  ++  K+ D
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGD 176
Query: 412 FGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
           FG +R     +D   +       + ++ PE +   + TT+SDV+SFGV+L EI T G++P
Sbjct: 177 FGMSR-DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 114/226 (50%), Gaps = 33/226 (14%)
Query: 274 IGEGGFGTVYKAQ------LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           IGEG FG V++A+       E   +VA+K  K+E   ++Q +F  E  L+++ D+ N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKT----------------------LDFN 365
           LLG    G    ++ E++  G L E L      T                      L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 366 QRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT 425
           ++L IA  VA G+ YL   +E++ +HRD+ + N L+ E+M  K+ADFG +R     +D  
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-NIYSADYY 230
Query: 426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
                    + ++ PE +   + TT+SDV+++GV+L EI + G +P
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 9/201 (4%)
Query: 271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L  
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            V +     I+ E++  G L + L G+ GK L   Q +++A  +A G+ Y+        +
Sbjct: 81  VVSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFG+LL E+ T GR P
Sbjct: 195 KSDVWSFGILLTELTTKGRVP 215

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 138/291 (47%), Gaps = 35/291 (12%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 123
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL P
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTELC----GTLDYLPP 175
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 228
Query: 499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK 549
           V    +++IS  +                + RP ++ V E  W I A+S K
Sbjct: 229 VTEGARDLISRLLKHNP------------SQRPMLREVLEHPW-ITANSSK 266

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 113/206 (54%), Gaps = 17/206 (8%)
Query: 274 IGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG V   +L+      + VAIK  K    E  + +F  E  ++ + DH N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 330 GFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           G V +G   +I+ EF+ NG L    R+H DGQ+       Q + +   +A G+ YL   A
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKH-DGQFTVI----QLVGMLRGIAAGMRYL---A 162
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
           +   +HRD+ + NIL+  ++  KV+DFG +R+   D +  + +T  K  V +  PE ++ 
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 446 YQLTTKSDVYSFGVLLLEILT-GRRP 470
            + T+ SDV+S+G+++ E+++ G RP
Sbjct: 223 RKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 109/201 (54%), Gaps = 10/201 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           RIG G FGTVYK +    + V +        + LQ  F +EV +L K  H N++  +G+ 
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYS 73
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            K  +  I+T++    +L  HL     K  +  + ++IA   A G+ YLH    K IIHR
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ---LT 449
           D+KS+NI L E +  K+ DFG A      S  +H   ++ G++ ++ PE ++       +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            +SDVY+FG++L E++TG+ P
Sbjct: 188 FQSDVYAFGIVLYELMTGQLP 208

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 106/200 (53%), Gaps = 9/200 (4%)
Query: 272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           V +     I+ E++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +H
Sbjct: 248 VSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T K
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV+SFG+LL E+ T GR P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 138/291 (47%), Gaps = 35/291 (12%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 128
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL P
Sbjct: 129 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLC----GTLDYLPP 180
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 233
Query: 499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK 549
           V    +++IS  +                + RP ++ V E  W I A+S K
Sbjct: 234 VTEGARDLISRLLKHNP------------SQRPXLREVLEHPW-ITANSSK 271

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 123
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL P
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC----GTLDYLPP 175
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 228
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 229 VTEGARDLIS 238

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 128
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL P
Sbjct: 129 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC----GTLDYLPP 180
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 233
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 234 VTEGARDLIS 243

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 109/201 (54%), Gaps = 10/201 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           RIG G FGTVYK +    + V +        + LQ  F +EV +L K  H N++  +G+ 
Sbjct: 35  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYS 93
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            K  +  I+T++    +L  HL     K  +  + ++IA   A G+ YLH    K IIHR
Sbjct: 94  TK-PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSIIHR 148
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ---LT 449
           D+KS+NI L E +  K+ DFG A      S  +H   ++ G++ ++ PE ++       +
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYS 207
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            +SDVY+FG++L E++TG+ P
Sbjct: 208 FQSDVYAFGIVLYELMTGQLP 228

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 124
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL P
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC----GTLDYLPP 176
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 229
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 230 VTEGARDLIS 239

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 274 IGEGGFGTV----YKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +GEG FG V    Y  + ++ G  VA+K  K E   N   +   E+E+L  + H N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 329 LGFV--DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            G    D GN   +I EF+P+G+L+E+L     K ++  Q+L+ A+ +  G+ YL     
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYL---GS 132
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           +Q +HRD+ + N+L+    + K+ DFG  +    D +   +       V +  PE +   
Sbjct: 133 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 192
Query: 447 QLTTKSDVYSFGVLLLEILT 466
           +    SDV+SFGV L E+LT
Sbjct: 193 KFYIASDVWSFGVTLHELLT 212

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 126
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL P
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLC----GTLDYLPP 178
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 231
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 232 VTEGARDLIS 241

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 128
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL P
Sbjct: 129 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLC----GTLDYLPP 180
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 233
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 234 VTEGARDLIS 243

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 123
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL P
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC----GTLDYLPP 175
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 228
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 229 VTEGARDLIS 238

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 106/199 (53%), Gaps = 8/199 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G FG V+     +   VA+K  K     ++Q  F  E  L+  + H  LV+L   V
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQA-FLEEANLMKTLQHDKLVRLYAVV 77
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++  G+L + L    G  +   + ++ +  +A G+ Y+     K  IHR
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 134
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++N+L++ES+  K+ADFG AR+  ++ +        K  + +  PE +     T KS
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 192
Query: 453 DVYSFGVLLLEILT-GRRP 470
           DV+SFG+LL EI+T G+ P
Sbjct: 193 DVWSFGILLYEIVTYGKIP 211

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 138/291 (47%), Gaps = 35/291 (12%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 123
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL P
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLC----GTLDYLPP 175
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 228
Query: 499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK 549
           V    +++IS  +                + RP ++ V E  W I A+S K
Sbjct: 229 VTEGARDLISRLLKHNP------------SQRPMLREVLEHPW-ITANSSK 266

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 274 IGEGGFGTV----YKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +GEG FG V    Y  + ++ G  VA+K  K E   N   +   E+E+L  + H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 329 LGFV--DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            G    D GN   +I EF+P+G+L+E+L     K ++  Q+L+ A+ +  G+ YL     
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYL---GS 144
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           +Q +HRD+ + N+L+    + K+ DFG  +    D +   +       V +  PE +   
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 204
Query: 447 QLTTKSDVYSFGVLLLEILT 466
           +    SDV+SFGV L E+LT
Sbjct: 205 KFYIASDVWSFGVTLHELLT 224

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 109/201 (54%), Gaps = 10/201 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           RIG G FGTVYK +    + V +        + LQ  F +EV +L K  H N++  +G+ 
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYS 101
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            K  +  I+T++    +L  HL     K  +  + ++IA   A G+ YLH    K IIHR
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSIIHR 156
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ---LT 449
           D+KS+NI L E +  K+ DFG A      S  +H   ++ G++ ++ PE ++       +
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYS 215
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            +SDVY+FG++L E++TG+ P
Sbjct: 216 FQSDVYAFGIVLYELMTGQLP 236

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 123
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL P
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTXLC----GTLDYLPP 175
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 228
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 229 VTEGARDLIS 238

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 127
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL P
Sbjct: 128 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLC----GTLDYLPP 179
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 232
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 233 VTEGARDLIS 242

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 94/301 (31%), Positives = 136/301 (45%), Gaps = 54/301 (17%)
Query: 274 IGEGGFGTVYKAQLEDGL---------LVAIKRAKKEQFENLQTEFSSEVELLSKI-DHR 323
           +GEG FG V  A+   GL          VA+K  K +  E   ++  SE+E++  I  H+
Sbjct: 77  LGEGAFGQVVLAE-AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--------------LE 369
           N++ LLG   +     +I E+   G LRE+L  +    L+++                + 
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
            A  VA G+ YL   A K+ IHRD+ + N+L+TE    K+ADFG AR      D  HI  
Sbjct: 196 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 246
Query: 430 KVKGTVGYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR 484
             K T G L  ++M    L     T +SDV+SFGVLL EI T      L   P   V + 
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE 300
Query: 485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR 544
             FK   EG+ +D   PS           +++ +   C   + + RP  K + E L  I 
Sbjct: 301 ELFKLLKEGHRMD--KPS-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351
Query: 545 A 545
           A
Sbjct: 352 A 352

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 134/296 (45%), Gaps = 54/296 (18%)
Query: 274 IGEGGFGTVYKAQLEDGL---------LVAIKRAKKEQFENLQTEFSSEVELLSKI-DHR 323
           +GEG FG V  A+   GL          VA+K  K +  E   ++  SE+E++  I  H+
Sbjct: 25  LGEGAFGQVVLAE-AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 83
Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--------------LE 369
           N++ LLG   +     +I E+   G LRE+L  +    L+++                + 
Sbjct: 84  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 143
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
            A  VA G+ YL   A K+ IHRD+ + N+L+TE    K+ADFG AR      D  HI  
Sbjct: 144 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 194
Query: 430 KVKGTVGYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR 484
             K T G L  ++M    L     T +SDV+SFGVLL EI T      L   P   V + 
Sbjct: 195 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE 248
Query: 485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
             FK   EG+ +D   PS           +++ +   C   + + RP  K + E L
Sbjct: 249 ELFKLLKEGHRMD--KPS-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 295

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 134/296 (45%), Gaps = 54/296 (18%)
Query: 274 IGEGGFGTVYKAQLEDGL---------LVAIKRAKKEQFENLQTEFSSEVELLSKI-DHR 323
           +GEG FG V  A+   GL          VA+K  K +  E   ++  SE+E++  I  H+
Sbjct: 29  LGEGAFGQVVLAE-AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 87
Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--------------LE 369
           N++ LLG   +     +I E+   G LRE+L  +    L+++                + 
Sbjct: 88  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 147
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
            A  VA G+ YL   A K+ IHRD+ + N+L+TE    K+ADFG AR      D  HI  
Sbjct: 148 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 198
Query: 430 KVKGTVGYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR 484
             K T G L  ++M    L     T +SDV+SFGVLL EI T      L   P   V + 
Sbjct: 199 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE 252
Query: 485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
             FK   EG+ +D   PS           +++ +   C   + + RP  K + E L
Sbjct: 253 ELFKLLKEGHRMD--KPS-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 299

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 134/296 (45%), Gaps = 54/296 (18%)
Query: 274 IGEGGFGTVYKAQLEDGL---------LVAIKRAKKEQFENLQTEFSSEVELLSKI-DHR 323
           +GEG FG V  A+   GL          VA+K  K +  E   ++  SE+E++  I  H+
Sbjct: 36  LGEGAFGQVVLAE-AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--------------LE 369
           N++ LLG   +     +I E+   G LRE+L  +    L+++                + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
            A  VA G+ YL   A K+ IHRD+ + N+L+TE    K+ADFG AR      D  HI  
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 205
Query: 430 KVKGTVGYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR 484
             K T G L  ++M    L     T +SDV+SFGVLL EI T      L   P   V + 
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE 259
Query: 485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
             FK   EG+ +D   PS           +++ +   C   + + RP  K + E L
Sbjct: 260 ELFKLLKEGHRMD--KPS-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 140
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL P
Sbjct: 141 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLC----GTLDYLPP 192
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 245
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 246 VTEGARDLIS 255

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 138/291 (47%), Gaps = 35/291 (12%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 149
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL P
Sbjct: 150 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLC----GTLDYLPP 201
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 254
Query: 499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK 549
           V    +++IS  +                + RP ++ V E  W I A+S K
Sbjct: 255 VTEGARDLISRLLKHNP------------SQRPMLREVLEHPW-ITANSSK 292

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 134/296 (45%), Gaps = 54/296 (18%)
Query: 274 IGEGGFGTVYKAQLEDGL---------LVAIKRAKKEQFENLQTEFSSEVELLSKI-DHR 323
           +GEG FG V  A+   GL          VA+K  K +  E   ++  SE+E++  I  H+
Sbjct: 36  LGEGAFGQVVLAE-AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--------------LE 369
           N++ LLG   +     +I E+   G LRE+L  +    L+++                + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
            A  VA G+ YL   A K+ IHRD+ + N+L+TE    K+ADFG AR      D  HI  
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 205
Query: 430 KVKGTVGYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR 484
             K T G L  ++M    L     T +SDV+SFGVLL EI T      L   P   V + 
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE 259
Query: 485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
             FK   EG+ +D   PS           +++ +   C   + + RP  K + E L
Sbjct: 260 ELFKLLKEGHRMD--KPS-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P G + + L  Q     D  +      ++A+ L+Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYITELANALSY 128
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL P
Sbjct: 129 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLC----GTLDYLPP 180
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 233
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 234 VTEGARDLIS 243

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 134/296 (45%), Gaps = 54/296 (18%)
Query: 274 IGEGGFGTVYKAQLEDGL---------LVAIKRAKKEQFENLQTEFSSEVELLSKI-DHR 323
           +GEG FG V  A+   GL          VA+K  K +  E   ++  SE+E++  I  H+
Sbjct: 28  LGEGAFGQVVLAE-AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 86
Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--------------LE 369
           N++ LLG   +     +I E+   G LRE+L  +    L+++                + 
Sbjct: 87  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 146
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
            A  VA G+ YL   A K+ IHRD+ + N+L+TE    K+ADFG AR      D  HI  
Sbjct: 147 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 197
Query: 430 KVKGTVGYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR 484
             K T G L  ++M    L     T +SDV+SFGVLL EI T      L   P   V + 
Sbjct: 198 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE 251
Query: 485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
             FK   EG+ +D   PS           +++ +   C   + + RP  K + E L
Sbjct: 252 ELFKLLKEGHRMD--KPS-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 298

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 116/217 (53%), Gaps = 14/217 (6%)
Query: 257 NMSQVVKATRNFSPSLRIGEGGFGTVYKAQ---LED--GLLVAIKRAKKEQFENLQTEFS 311
           NM+Q  +    F   L  G+G FG+V   +   L+D  G +VA+K+ +    E+L+ +F 
Sbjct: 21  NMTQFEERHLKFLQQL--GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFE 77
Query: 312 SEVELLSKIDHRNLVKLLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLE 369
            E+E+L  + H N+VK  G       R   +I E++P G+LR++L  ++ + +D  + L+
Sbjct: 78  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQ 136
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
               +  G+ YL     K+ IHRD+ + NIL+    R K+ DFG  ++ P D +   +  
Sbjct: 137 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 193
Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
             +  + +  PE +   + +  SDV+SFGV+L E+ T
Sbjct: 194 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 133/296 (44%), Gaps = 54/296 (18%)
Query: 274 IGEGGFGTVYKAQLEDGL---------LVAIKRAKKEQFENLQTEFSSEVELLSKI-DHR 323
           +GEG FG V  A+   GL          VA+K  K +  E   ++  SE+E++  I  H+
Sbjct: 36  LGEGAFGQVVLAE-AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDF--------------NQRLE 369
           N++ LLG   +     +I E+   G LRE+L  +    L++                 + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 154
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
            A  VA G+ YL   A K+ IHRD+ + N+L+TE    K+ADFG AR      D  HI  
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 205
Query: 430 KVKGTVGYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR 484
             K T G L  ++M    L     T +SDV+SFGVLL EI T      L   P   V + 
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE 259
Query: 485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
             FK   EG+ +D   PS           +++ +   C   + + RP  K + E L
Sbjct: 260 ELFKLLKEGHRMD--KPS-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 133/296 (44%), Gaps = 54/296 (18%)
Query: 274 IGEGGFGTVYKAQLEDGL---------LVAIKRAKKEQFENLQTEFSSEVELLSKI-DHR 323
           +GEG FG V  A+   GL          VA+K  K +  E   ++  SE+E++  I  H+
Sbjct: 21  LGEGAFGQVVLAE-AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDF--------------NQRLE 369
           N++ LLG   +     +I E+   G LRE+L  +    L++                 + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 139
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
            A  VA G+ YL   A K+ IHRD+ + N+L+TE    K+ADFG AR      D  HI  
Sbjct: 140 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 190
Query: 430 KVKGTVGYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR 484
             K T G L  ++M    L     T +SDV+SFGVLL EI T      L   P   V + 
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE 244
Query: 485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
             FK   EG+ +D   PS           +++ +   C   + + RP  K + E L
Sbjct: 245 ELFKLLKEGHRMD--KPS-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 122
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL P
Sbjct: 123 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLC----GTLDYLPP 174
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 227
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 228 VTEGARDLIS 237

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 126
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL P
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLC----GTLDYLPP 178
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 231
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 232 VTEGARDLIS 241

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 110/201 (54%), Gaps = 12/201 (5%)
Query: 273 RIGEGGFGTVYKAQ---LED--GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   +   L+D  G +VA+K+ +    E+L+ +F  E+E+L  + H N+VK
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVK 78
Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G       R   +I E++P G+LR++L   + + +D  + L+    +  G+ YL    
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQA-HAERIDHIKLLQYTSQICKGMEYL---G 134
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K+ IHRD+ + NIL+    R K+ DFG  ++ P D +   +    +  + +  PE +  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 446 YQLTTKSDVYSFGVLLLEILT 466
            + +  SDV+SFGV+L E+ T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 116/217 (53%), Gaps = 14/217 (6%)
Query: 257 NMSQVVKATRNFSPSLRIGEGGFGTVYKAQ---LED--GLLVAIKRAKKEQFENLQTEFS 311
           NM+Q  +    F   L  G+G FG+V   +   L+D  G +VA+K+ +    E+L+ +F 
Sbjct: 21  NMTQFEERHLKFLQQL--GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFE 77
Query: 312 SEVELLSKIDHRNLVKLLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLE 369
            E+E+L  + H N+VK  G       R   +I E++P G+LR++L  ++ + +D  + L+
Sbjct: 78  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQ 136
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
               +  G+ YL     K+ IHRD+ + NIL+    R K+ DFG  ++ P D +   +  
Sbjct: 137 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 193
Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
             +  + +  PE +   + +  SDV+SFGV+L E+ T
Sbjct: 194 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 106/199 (53%), Gaps = 8/199 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           ++G G FG V+     +   VA+K  K     ++Q  F  E  L+  + H  LV+L   V
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQA-FLEEANLMKTLQHDKLVRLYAVV 76
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            K     IITEF+  G+L + L    G  +   + ++ +  +A G+ Y+     K  IHR
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 133
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++N+L++ES+  K+ADFG AR+  ++ +        K  + +  PE +     T KS
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 191
Query: 453 DVYSFGVLLLEILT-GRRP 470
           +V+SFG+LL EI+T G+ P
Sbjct: 192 NVWSFGILLYEIVTYGKIP 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 111/201 (55%), Gaps = 12/201 (5%)
Query: 273 RIGEGGFGTVYKAQ---LED--GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   +   L+D  G +VA+K+ +    E+L+ +F  E+E+L  + H N+VK
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVK 79
Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G       R   +I E++P G+LR++L  ++ + +D  + L+    +  G+ YL    
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYL---G 135
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K+ IHRD+ + NIL+    R K+ DFG  ++ P D +   +    +  + +  PE +  
Sbjct: 136 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 446 YQLTTKSDVYSFGVLLLEILT 466
            + +  SDV+SFGV+L E+ T
Sbjct: 196 SKFSVASDVWSFGVVLYELFT 216

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 111/201 (55%), Gaps = 12/201 (5%)
Query: 273 RIGEGGFGTVYKAQ---LED--GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   +   L+D  G +VA+K+ +    E+L+ +F  E+E+L  + H N+VK
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVK 106
Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G       R   +I E++P G+LR++L  ++ + +D  + L+    +  G+ YL    
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYL---G 162
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K+ IHRD+ + NIL+    R K+ DFG  ++ P D +   +    +  + +  PE +  
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 222
Query: 446 YQLTTKSDVYSFGVLLLEILT 466
            + +  SDV+SFGV+L E+ T
Sbjct: 223 SKFSVASDVWSFGVVLYELFT 243

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 120
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL P
Sbjct: 121 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLC----GTLDYLPP 172
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 225
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 226 VTEGARDLIS 235

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 111/201 (55%), Gaps = 12/201 (5%)
Query: 273 RIGEGGFGTVYKAQ---LED--GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   +   L+D  G +VA+K+ +    E+L+ +F  E+E+L  + H N+VK
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVK 82
Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G       R   +I E++P G+LR++L  ++ + +D  + L+    +  G+ YL    
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYL---G 138
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K+ IHRD+ + NIL+    R K+ DFG  ++ P D +   +    +  + +  PE +  
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 446 YQLTTKSDVYSFGVLLLEILT 466
            + +  SDV+SFGV+L E+ T
Sbjct: 199 SKFSVASDVWSFGVVLYELFT 219

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 111/201 (55%), Gaps = 12/201 (5%)
Query: 273 RIGEGGFGTVYKAQ---LED--GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   +   L+D  G +VA+K+ +    E+L+ +F  E+E+L  + H N+VK
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVK 80
Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G       R   +I E++P G+LR++L  ++ + +D  + L+    +  G+ YL    
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYL---G 136
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K+ IHRD+ + NIL+    R K+ DFG  ++ P D +   +    +  + +  PE +  
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 446 YQLTTKSDVYSFGVLLLEILT 466
            + +  SDV+SFGV+L E+ T
Sbjct: 197 SKFSVASDVWSFGVVLYELFT 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 111/201 (55%), Gaps = 12/201 (5%)
Query: 273 RIGEGGFGTVYKAQ---LED--GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   +   L+D  G +VA+K+ +    E+L+ +F  E+E+L  + H N+VK
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVK 75
Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G       R   +I E++P G+LR++L  ++ + +D  + L+    +  G+ YL    
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K+ IHRD+ + NIL+    R K+ DFG  ++ P D +   +    +  + +  PE +  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 446 YQLTTKSDVYSFGVLLLEILT 466
            + +  SDV+SFGV+L E+ T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 111/201 (55%), Gaps = 12/201 (5%)
Query: 273 RIGEGGFGTVYKAQ---LED--GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   +   L+D  G +VA+K+ +    E+L+ +F  E+E+L  + H N+VK
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVK 74
Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G       R   +I E++P G+LR++L  ++ + +D  + L+    +  G+ YL    
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYL---G 130
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K+ IHRD+ + NIL+    R K+ DFG  ++ P D +   +    +  + +  PE +  
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 446 YQLTTKSDVYSFGVLLLEILT 466
            + +  SDV+SFGV+L E+ T
Sbjct: 191 SKFSVASDVWSFGVVLYELFT 211

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 111/201 (55%), Gaps = 12/201 (5%)
Query: 273 RIGEGGFGTVYKAQ---LED--GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   +   L+D  G +VA+K+ +    E+L+ +F  E+E+L  + H N+VK
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVK 75
Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G       R   +I E++P G+LR++L  ++ + +D  + L+    +  G+ YL    
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K+ IHRD+ + NIL+    R K+ DFG  ++ P D +   +    +  + +  PE +  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 446 YQLTTKSDVYSFGVLLLEILT 466
            + +  SDV+SFGV+L E+ T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 111/201 (55%), Gaps = 12/201 (5%)
Query: 273 RIGEGGFGTVYKAQ---LED--GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   +   L+D  G +VA+K+ +    E+L+ +F  E+E+L  + H N+VK
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVK 81
Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G       R   +I E++P G+LR++L  ++ + +D  + L+    +  G+ YL    
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYL---G 137
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K+ IHRD+ + NIL+    R K+ DFG  ++ P D +   +    +  + +  PE +  
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 446 YQLTTKSDVYSFGVLLLEILT 466
            + +  SDV+SFGV+L E+ T
Sbjct: 198 SKFSVASDVWSFGVVLYELFT 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 111/201 (55%), Gaps = 12/201 (5%)
Query: 273 RIGEGGFGTVYKAQ---LED--GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   +   L+D  G +VA+K+ +    E+L+ +F  E+E+L  + H N+VK
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVK 78
Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G       R   +I E++P G+LR++L  ++ + +D  + L+    +  G+ YL    
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K+ IHRD+ + NIL+    R K+ DFG  ++ P D +   +    +  + +  PE +  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 446 YQLTTKSDVYSFGVLLLEILT 466
            + +  SDV+SFGV+L E+ T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 111/201 (55%), Gaps = 12/201 (5%)
Query: 273 RIGEGGFGTVYKAQ---LED--GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   +   L+D  G +VA+K+ +    E+L+ +F  E+E+L  + H N+VK
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVK 73
Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G       R   +I E++P G+LR++L  ++ + +D  + L+    +  G+ YL    
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYL---G 129
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K+ IHRD+ + NIL+    R K+ DFG  ++ P D +   +    +  + +  PE +  
Sbjct: 130 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 189
Query: 446 YQLTTKSDVYSFGVLLLEILT 466
            + +  SDV+SFGV+L E+ T
Sbjct: 190 SKFSVASDVWSFGVVLYELFT 210

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 126
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S R  +     GT+ YL P
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRAALC----GTLDYLPP 178
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 231
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 232 VTEGARDLIS 241

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 130/268 (48%), Gaps = 33/268 (12%)
Query: 274 IGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG V    L+      + VAIK  K    E  + +F SE  ++ + DH N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 330 GFVDKGNERLIITEFVPNGTLREHL---DGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           G V K    +IITEF+ NG+L   L   DGQ+       Q + +   +A G+ YL   A+
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI----QLVGMLRGIAAGMKYL---AD 127
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD-SDRTHIST-KVKGTVGYLDPEYMK 444
              +HR + + NIL+  ++  KV+DFG +R    D SD T+ S    K  + +  PE ++
Sbjct: 128 MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI 503
             + T+ SDV+S+G+++ E+++ G RP                +      ++++ ++   
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMSYGERP----------------YWDMTNQDVINAIEQDY 231
Query: 504 KEVISMEILTKMFGLAIQCAAPIRNDRP 531
           +    M+  + +  L + C    RN RP
Sbjct: 232 RLPPPMDCPSALHQLMLDCWQKDRNHRP 259

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 122/250 (48%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 124
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P     T     + GT+ YL P
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT-----LCGTLDYLPP 176
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 229
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 230 VTEGARDLIS 239

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + ++    L +A  ++  + YL    +K  IH
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLAYNKFSIK 197
Query: 452 SDVYSFGVLLLEILT 466
           SDV++FGVLL EI T
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 138/291 (47%), Gaps = 35/291 (12%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 125
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+A+FG++   P  S RT +     GT+ YL P
Sbjct: 126 CH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP-SSRRTTLC----GTLDYLPP 177
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 230
Query: 499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK 549
           V    +++IS  +                + RP ++ V E  W I A+S K
Sbjct: 231 VTEGARDLISRLLKHNP------------SQRPMLREVLEHPW-ITANSSK 268

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 103/195 (52%), Gaps = 8/195 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G FG VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + +     L +A  ++  + YL    +K  IH
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 132
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLAYNKFSIK 190
Query: 452 SDVYSFGVLLLEILT 466
           SDV++FGVLL EI T
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 125
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S R  +     GT+ YL P
Sbjct: 126 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRXXLC----GTLDYLPP 177
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 230
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 231 VTEGARDLIS 240

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 111/206 (53%), Gaps = 17/206 (8%)
Query: 274 IGEGGFGTVYKAQL----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G  G V   +L    +  + VAIK  K    E  + +F SE  ++ + DH N+++L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 330 GFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           G V +G   +I+TE++ NG+L    R H DGQ+       Q + +   V  G+ YL   +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQF----TIMQLVGMLRGVGAGMRYL---S 168
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
           +   +HRD+ + N+L+  ++  KV+DFG +R+   D D  + +T  K  + +  PE +  
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 446 YQLTTKSDVYSFGVLLLEILT-GRRP 470
              ++ SDV+SFGV++ E+L  G RP
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 126
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+A+FG++   P  S RT +     GT+ YL P
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP-SSRRTTLC----GTLDYLPP 178
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 231
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 232 VTEGARDLIS 241

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 123
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S R  +     GT+ YL P
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRAALC----GTLDYLPP 175
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 228
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 229 VTEGARDLIS 238

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 123
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S R  +     GT+ YL P
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRXXLC----GTLDYLPP 175
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 228
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 229 VTEGARDLIS 238

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 9/200 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + ++    L +A  ++  + YL    +K  IH
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNKFSIK 197
Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV++FGVLL EI T G  P
Sbjct: 198 SDVWAFGVLLWEIATYGMSP 217

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 9/200 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + ++    L +A  ++  + YL    +K  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV++FGVLL EI T G  P
Sbjct: 193 SDVWAFGVLLWEIATYGMSP 212

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 126
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S R  +     GT+ YL P
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRXXLC----GTLDYLPP 178
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 231
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 232 VTEGARDLIS 241

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 107/200 (53%), Gaps = 11/200 (5%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLLGF 331
           ++G G FG V+ A       VA+K  K     ++  E F +E  ++  + H  LVKL   
Sbjct: 22  KLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           V K     IITEF+  G+L + L    G      + ++ +  +A G+ ++    ++  IH
Sbjct: 79  VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIH 134
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD++++NIL++ S+  K+ADFG AR+  ++ +        K  + +  PE +     T K
Sbjct: 135 RDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV+SFG+LL+EI+T GR P
Sbjct: 193 SDVWSFGILLMEIVTYGRIP 212

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 274 IGEGGFGTVYKAQL-----EDGLL-VAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLV 326
           +G G FG V +A       ED +L VA+K  K     + +    SE++++S +  H N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 327 KLLGFVDKGNERLIITEFVPNGTL--------REHLDGQYGKTLDFNQRLEIAIDVAHGL 378
            LLG    G   L+ITE+   G L           LD + G+ L+    L  +  VA G+
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            +L   A K  IHRDV + N+LLT    AK+ DFG AR   M+     +    +  V ++
Sbjct: 166 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIVKGNARLPVKWM 221
Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT 466
            PE +     T +SDV+S+G+LL EI +
Sbjct: 222 APESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + ++    L +A  ++  + YL    +K  IH
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 138
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 196
Query: 452 SDVYSFGVLLLEILT 466
           SDV++FGVLL EI T
Sbjct: 197 SDVWAFGVLLWEIAT 211

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 149
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S R  +     GT+ YL P
Sbjct: 150 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRDDLC----GTLDYLPP 201
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 254
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 255 VTEGARDLIS 264

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 9/200 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + ++    L +A  ++  + YL    +K  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV++FGVLL EI T G  P
Sbjct: 193 SDVWAFGVLLWEIATYGMSP 212

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLEDG-LLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A+ ++   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 123
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S R  +     GT+ YL P
Sbjct: 124 CH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRAALC----GTLDYLPP 175
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQDTYKRISRVEFTFPDF 228
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 229 VTEGARDLIS 238

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLLGF 331
           ++G G FG V+ A       VA+K  K     ++  E F +E  ++  + H  LVKL   
Sbjct: 189 KLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           V K     IITEF+  G+L + L    G      + ++ +  +A G+ ++    ++  IH
Sbjct: 246 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIH 301
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD++++NIL++ S+  K+ADFG AR+G             K  + +  PE +     T K
Sbjct: 302 RDLRAANILVSASLVCKIADFGLARVG------------AKFPIKWTAPEAINFGSFTIK 349
Query: 452 SDVYSFGVLLLEILT-GRRPVELKRPPE 478
           SDV+SFG+LL+EI+T GR P      PE
Sbjct: 350 SDVWSFGILLMEIVTYGRIPYPGMSNPE 377

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P G + + L  Q     D  +      ++A+ L+Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYITELANALSY 128
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S R      + GT+ YL P
Sbjct: 129 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSR---RXXLXGTLDYLPP 180
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 233
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 234 VTEGARDLIS 243

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 111/201 (55%), Gaps = 12/201 (5%)
Query: 273 RIGEGGFGTVYKAQ---LED--GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   +   L+D  G +VA+K+ +    E+L+ +F  E+E+L  + H N+VK
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVK 75
Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G       R   +I E++P G+LR++L  ++ + +D  + L+    +  G+ YL    
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K+ IHRD+ + NIL+    R K+ DFG  ++ P D +   +    +  + +  PE +  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 446 YQLTTKSDVYSFGVLLLEILT 466
            + +  SDV+SFGV+L E+ T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKI 320
           A  +F     +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H N+++L G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 126
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
            H    K++IHRD+K  N+LL  +   K+ADFG++   P  S R  +     GT+ YL P
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRDDLC----GTLDYLPP 178
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDM 498
           E ++      K D++S GVL  E L G       +PP E  T +  +KR +  E    D 
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISRVEFTFPDF 231
Query: 499 VDPSIKEVIS 508
           V    +++IS
Sbjct: 232 VTEGARDLIS 241

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 9/200 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + ++    L +A  ++  + YL    +K  IH
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 194
Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV++FGVLL EI T G  P
Sbjct: 195 SDVWAFGVLLWEIATYGMSP 214

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 9/200 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + ++    L +A  ++  + YL    +K  IH
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 194
Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV++FGVLL EI T G  P
Sbjct: 195 SDVWAFGVLLWEIATYGMSP 214

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 9/200 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + ++    L +A  ++  + YL    +K  IH
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 197
Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV++FGVLL EI T G  P
Sbjct: 198 SDVWAFGVLLWEIATYGMSP 217

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 274 IGEGGFGTVYKAQL-----EDGLL-VAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLV 326
           +G G FG V +A       ED +L VA+K  K     + +    SE++++S +  H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 327 KLLGFVDKGNERLIITEFVPNGTL--------REHLDGQYGKTLDFNQRLEIAIDVAHGL 378
            LLG    G   L+ITE+   G L           LD + G+ L+    L  +  VA G+
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            +L   A K  IHRDV + N+LLT    AK+ DFG AR   M+     +    +  V ++
Sbjct: 174 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIVKGNARLPVKWM 229
Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT 466
            PE +     T +SDV+S+G+LL EI +
Sbjct: 230 APESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 110/206 (53%), Gaps = 17/206 (8%)
Query: 274 IGEGGFGTVYKAQL----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G  G V   +L    +  + VAIK  K    E  + +F SE  ++ + DH N+++L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 330 GFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           G V +G   +I+TE++ NG+L    R H DGQ+       Q + +   V  G+ YL   +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQF----TIMQLVGMLRGVGAGMRYL---S 168
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
           +   +HRD+ + N+L+  ++  KV+DFG +R+   D D    +T  K  + +  PE +  
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAF 228
Query: 446 YQLTTKSDVYSFGVLLLEILT-GRRP 470
              ++ SDV+SFGV++ E+L  G RP
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 9/200 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + ++    L +A  ++  + YL    +K  IH
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 147
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 205
Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV++FGVLL EI T G  P
Sbjct: 206 SDVWAFGVLLWEIATYGMSP 225

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 132/275 (48%), Gaps = 31/275 (11%)
Query: 274 IGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG V   +L+      L VAIK  K    E  + +F  E  ++ + DH N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 330 GFVDKGNERLIITEFVPNGTLREHL---DGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           G V K    +I+TE++ NG+L   L   DGQ+       Q + +   ++ G+ YL   ++
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVI----QLVGMLRGISAGMKYL---SD 142
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
              +HRD+ + NIL+  ++  KV+DFG +R+   D +  + +   K  + +  PE +   
Sbjct: 143 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 447 QLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE 505
           + T+ SDV+S+G+++ E+++ G RP          +T +   K   EG  L    PS   
Sbjct: 203 KFTSASDVWSYGIVMWEVVSYGERPY-------WEMTNQDVIKAVEEGYRL----PS--- 248
Query: 506 VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
              M+    ++ L + C    RN RP    +   L
Sbjct: 249 --PMDCPAALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 109/208 (52%), Gaps = 11/208 (5%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLLGF 331
           ++G G FG V+ A       VA+K  K     ++  E F +E  ++  + H  LVKL   
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           V K     IITEF+  G+L + L    G      + ++ +  +A G+ ++    ++  IH
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIH 307
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD++++NIL++ S+  K+ADFG AR+  ++ +        K  + +  PE +     T K
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 452 SDVYSFGVLLLEILT-GRRPVELKRPPE 478
           SDV+SFG+LL+EI+T GR P      PE
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSNPE 393

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 103/195 (52%), Gaps = 8/195 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + +     L +A  ++  + YL    +K  IH
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 197
Query: 452 SDVYSFGVLLLEILT 466
           SDV++FGVLL EI T
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G FG V+         VAIK  K          F  E +++ K+ H  LV+L   V
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMS--PESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     I+TE++  G+L + L    G+ L     +++A  VA G+ Y+        IHR
Sbjct: 74  SE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 129
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++S+NIL+   +  K+ADFG ARL  ++ +        K  + +  PE     + T KS
Sbjct: 130 DLRSANILVGNGLICKIADFGLARL--IEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 453 DVYSFGVLLLEILT-GRRP 470
           DV+SFG+LL E++T GR P
Sbjct: 188 DVWSFGILLTELVTKGRVP 206

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 105/200 (52%), Gaps = 9/200 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + +     L +A  ++  + YL    +K  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV++FGVLL EI T G  P
Sbjct: 193 SDVWAFGVLLWEIATYGMSP 212

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 126/276 (45%), Gaps = 25/276 (9%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           IG G FG V+     +   VAIK  ++      + +F  E E++ K+ H  LV+L G   
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           +     ++ EF+ +G L ++L  Q G        L + +DV  G+ YL    E  +IHRD
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EASVIHRD 128
Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           + + N L+ E+   KV+DFG  R   +  D+   ST  K  V +  PE     + ++KSD
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 454 VYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEIL 512
           V+SFGVL+ E+ + G+ P E +   E    +   F+ Y          P +         
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---------PRLAS------- 230
Query: 513 TKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL 548
           T ++ +   C      DRP    +  QL AI A  L
Sbjct: 231 THVYQIMNHCWKERPEDRPAFSRLLRQLAAIAASGL 266

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 103/195 (52%), Gaps = 8/195 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + ++    L +A  ++  + YL    +K  IH
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 135
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL  M  D        K  + +  PE +   + + K
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK 193
Query: 452 SDVYSFGVLLLEILT 466
           SDV++FGVLL EI T
Sbjct: 194 SDVWAFGVLLWEIAT 208

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 113/215 (52%), Gaps = 26/215 (12%)
Query: 273 RIGEGGFGTVYKAQL-EDGLLVAIK-------RAKKEQFENLQTEFSSEVELLSKIDHRN 324
           +IG+GGFG V+K +L +D  +VAIK         + E  E  Q EF  EV ++S ++H N
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ-EFQREVFIMSNLNHPN 84
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKL G +   N   ++ EFVP G L   L  +    + ++ +L + +D+A G+ Y+   
Sbjct: 85  IVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQ-N 140
Query: 385 AEKQIIHRDVKSSNILL-----TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLD 439
               I+HRD++S NI L        + AKVADFG ++         H  + + G   ++ 
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVSGLLGNFQWMA 194
Query: 440 PEYMKTYQ--LTTKSDVYSFGVLLLEILTGRRPVE 472
           PE +   +   T K+D YSF ++L  ILTG  P +
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 103/195 (52%), Gaps = 8/195 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + ++    L +A  ++  + YL    +K  IH
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL  M  D        K  + +  PE +   + + K
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK 194
Query: 452 SDVYSFGVLLLEILT 466
           SDV++FGVLL EI T
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 103/195 (52%), Gaps = 8/195 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + +     L +A  ++  + YL    +K  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 452 SDVYSFGVLLLEILT 466
           SDV++FGVLL EI T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 111/201 (55%), Gaps = 12/201 (5%)
Query: 273 RIGEGGFGTVYKAQ---LED--GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   +   L+D  G +VA+K+ +    E+L+ +F  E+E+L  + H N+VK
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVK 76
Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G       R   +I E++P G+LR++L  ++ + +D  + L+    +  G+ YL    
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYL---G 132
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K+ IHR++ + NIL+    R K+ DFG  ++ P D +   +    +  + +  PE +  
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 446 YQLTTKSDVYSFGVLLLEILT 466
            + +  SDV+SFGV+L E+ T
Sbjct: 193 SKFSVASDVWSFGVVLYELFT 213

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 120/240 (50%), Gaps = 22/240 (9%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S + H N+++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           +        +I E+ P GT+   L  Q     D  +      ++A+ L+Y H    K++I
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYITELANALSYCH---SKRVI 134
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL  +   K+ADFG++   P  S RT +     GT+ YL PE ++      
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSVHAP-SSRRTTLC----GTLDYLPPEMIEGRMHDE 189
Query: 451 KSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDMVDPSIKEVIS 508
           K D++S GVL  E L G        PP E  T +  ++R +  E    D V    +++IS
Sbjct: 190 KVDLWSLGVLCYEFLVG-------MPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLIS 242

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 111/207 (53%), Gaps = 17/207 (8%)
Query: 274 IGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG V + +L+        VAIK  K    E  + EF SE  ++ + +H N+++L 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 330 GFVDKGNERLIITEFVPNGTLREHL---DGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           G V      +I+TEF+ NG L   L   DGQ+       Q + +   +A G+ YL   AE
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI----QLVGMLRGIASGMRYL---AE 134
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHIST-KVKGTVGYLDPEYMK 444
              +HRD+ + NIL+  ++  KV+DFG +R L    SD T+ S+   K  + +  PE + 
Sbjct: 135 MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIA 194
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
             + T+ SD +S+G+++ E+++ G RP
Sbjct: 195 FRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 103/195 (52%), Gaps = 8/195 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + +     L +A  ++  + YL    +K  IH
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 132
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKF--PIKWTAPESLAYNKFSIK 190
Query: 452 SDVYSFGVLLLEILT 466
           SDV++FGVLL EI T
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 103/195 (52%), Gaps = 8/195 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     II EF+  G L ++L     + ++    L +A  ++  + YL    +K  IH
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 135
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLAYNKFSIK 193
Query: 452 SDVYSFGVLLLEILT 466
           SDV++FGVLL EI T
Sbjct: 194 SDVWAFGVLLWEIAT 208

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/238 (30%), Positives = 120/238 (50%), Gaps = 23/238 (9%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG-FV 332
           IG+G FG V       G  VA+K  K +        F +E  +++++ H NLV+LLG  V
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
           ++     I+TE++  G+L ++L  +    L  +  L+ ++DV   + YL        +HR
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 141
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D+ + N+L++E   AKV+DFG  +      D   +  K      +  PE ++  + +TKS
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKS 195
Query: 453 DVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD---PSIKEVI 507
           DV+SFG+LL EI +        R P  R+ L+    R  +G  +D  D   P++ EV+
Sbjct: 196 DVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 247

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 105/200 (52%), Gaps = 9/200 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     II EF+  G L ++L     + ++    L +A  ++  + YL    +K  IH
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 197
Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV++FGVLL EI T G  P
Sbjct: 198 SDVWAFGVLLWEIATYGMSP 217

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 114/225 (50%), Gaps = 10/225 (4%)
Query: 245 SPKLNR--IGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKE 301
           +PK N+  I  V  N  +      + +   ++G G +G VY+   +   L VA+K  K++
Sbjct: 197 APKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED 256
Query: 302 QFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKT 361
             E    EF  E  ++ +I H NLV+LLG   +     IITEF+  G L ++L     + 
Sbjct: 257 TME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 314
Query: 362 LDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD 421
           +     L +A  ++  + YL    +K  IHR++ + N L+ E+   KVADFG +RL   D
Sbjct: 315 VSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371
Query: 422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           +   H   K    + +  PE +   + + KSDV++FGVLL EI T
Sbjct: 372 TYTAHAGAKFP--IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 266 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + ++    L +A  ++  + YL    +K  IH
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 380
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           R++ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 438
Query: 452 SDVYSFGVLLLEILT 466
           SDV++FGVLL EI T
Sbjct: 439 SDVWAFGVLLWEIAT 453

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 72/238 (30%), Positives = 119/238 (50%), Gaps = 23/238 (9%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG-FV 332
           IG+G FG V       G  VA+K  K +        F +E  +++++ H NLV+LLG  V
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
           ++     I+TE++  G+L ++L  +    L  +  L+ ++DV   + YL        +HR
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 132
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D+ + N+L++E   AKV+DFG  +      D   +  K      +  PE ++    +TKS
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREAAFSTKS 186
Query: 453 DVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD---PSIKEVI 507
           DV+SFG+LL EI +        R P  R+ L+    R  +G  +D  D   P++ EV+
Sbjct: 187 DVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 238

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 134/295 (45%), Gaps = 52/295 (17%)
Query: 274 IGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRN 324
           +GEG FG V  A+         ++ + VA+K  K +  E   ++  SE+E++  I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD--------------FNQRLEI 370
           ++ LLG   +     +I E+   G LRE+L  +    ++              F   +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
              +A G+ YL   A ++ IHRD+ + N+L+TE+   K+ADFG AR      D  +I   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDXX 213
Query: 431 VKGTVGYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRW 485
            K T G L  ++M    L     T +SDV+SFGVL+ EI T      L   P   + +  
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEE 267
Query: 486 AFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            FK   EG+ +D   P+           +++ +   C   + + RP  K + E L
Sbjct: 268 LFKLLKEGHRMD--KPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 134/295 (45%), Gaps = 52/295 (17%)
Query: 274 IGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRN 324
           +GEG FG V  A+         ++ + VA+K  K +  E   ++  SE+E++  I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD--------------FNQRLEI 370
           ++ LLG   +     +I E+   G LRE+L  +    ++              F   +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
              +A G+ YL   A ++ IHRD+ + N+L+TE+   K+ADFG AR      D  +I   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDXX 213
Query: 431 VKGTVGYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRW 485
            K T G L  ++M    L     T +SDV+SFGVL+ EI T      L   P   + +  
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEE 267
Query: 486 AFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            FK   EG+ +D   P+           +++ +   C   + + RP  K + E L
Sbjct: 268 LFKLLKEGHRMD--KPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 8/195 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     II EF+  G L ++L     + +     L +A  ++  + YL    +K  IH
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 132
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLAYNKFSIK 190
Query: 452 SDVYSFGVLLLEILT 466
           SDV++FGVLL EI T
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 72/238 (30%), Positives = 120/238 (50%), Gaps = 23/238 (9%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG-FV 332
           IG+G FG V       G  VA+K  K +        F +E  +++++ H NLV+LLG  V
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
           ++     I+TE++  G+L ++L  +    L  +  L+ ++DV   + YL        +HR
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 126
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D+ + N+L++E   AKV+DFG  +      D   +  K      +  PE ++  + +TKS
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKS 180
Query: 453 DVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD---PSIKEVI 507
           DV+SFG+LL EI +        R P  R+ L+    R  +G  +D  D   P++ EV+
Sbjct: 181 DVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 232

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 130/279 (46%), Gaps = 35/279 (12%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG-FV 332
           IG+G FG V       G  VA+K  K +        F +E  +++++ H NLV+LLG  V
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
           ++     I+TE++  G+L ++L  +    L  +  L+ ++DV   + YL        +HR
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 313
Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D+ + N+L++E   AKV+DFG  +      D   +  K      +  PE ++  + +TKS
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKS 367
Query: 453 DVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD---PSIKEVISM 509
           DV+SFG+LL EI +        R P  R+ L+    R  +G  +D  D   P++ +V+  
Sbjct: 368 DVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMK- 420
Query: 510 EILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL 548
                       C       RP    + EQL  IR   L
Sbjct: 421 -----------NCWHLDAATRPTFLQLREQLEHIRTHEL 448

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 113/215 (52%), Gaps = 26/215 (12%)
Query: 273 RIGEGGFGTVYKAQL-EDGLLVAIK-------RAKKEQFENLQTEFSSEVELLSKIDHRN 324
           +IG+GGFG V+K +L +D  +VAIK         + E  E  Q EF  EV ++S ++H N
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ-EFQREVFIMSNLNHPN 84
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKL G +   N   ++ EFVP G L   L  +    + ++ +L + +D+A G+ Y+   
Sbjct: 85  IVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQ-N 140
Query: 385 AEKQIIHRDVKSSNILL-----TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLD 439
               I+HRD++S NI L        + AKVADFG ++         H  + + G   ++ 
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ------QSVHSVSGLLGNFQWMA 194
Query: 440 PEYMKTYQ--LTTKSDVYSFGVLLLEILTGRRPVE 472
           PE +   +   T K+D YSF ++L  ILTG  P +
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 110/207 (53%), Gaps = 17/207 (8%)
Query: 274 IGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG V + +L+        VAIK  K    E  + EF SE  ++ + +H N+++L 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 330 GFVDKGNERLIITEFVPNGTLREHL---DGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           G V      +I+TEF+ NG L   L   DGQ+       Q + +   +A G+ YL   AE
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI----QLVGMLRGIASGMRYL---AE 136
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHIST-KVKGTVGYLDPEYMK 444
              +HRD+ + NIL+  ++  KV+DFG +R L    SD T  S+   K  + +  PE + 
Sbjct: 137 MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIA 196
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
             + T+ SD +S+G+++ E+++ G RP
Sbjct: 197 FRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 127/263 (48%), Gaps = 25/263 (9%)
Query: 274 IGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG V   +L+      + VAIK  K    +  + +F SE  ++ + DH N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G V K    +IITE++ NG+L   L    G+     Q + +   +  G+ YL   ++   
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGR-FTVIQLVGMLRGIGSGMKYL---SDMSY 131
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + NIL+  ++  KV+DFG +R+   D +  + +   K  + +  PE +   + T
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 191
Query: 450 TKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS 508
           + SDV+S+G+++ E+++ G RP                +   +  +++  ++   +    
Sbjct: 192 SASDVWSYGIVMWEVMSYGERP----------------YWDMSNQDVIKAIEEGYRLPPP 235
Query: 509 MEILTKMFGLAIQCAAPIRNDRP 531
           M+    +  L + C    R+DRP
Sbjct: 236 MDCPIALHQLMLDCWQKERSDRP 258

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 104/200 (52%), Gaps = 9/200 (4%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           IG G FG V+     +   VAIK  ++      + +F  E E++ K+ H  LV+L G   
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           +     ++TEF+ +G L ++L  Q G        L + +DV  G+ YL    E  +IHRD
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EACVIHRD 129
Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           + + N L+ E+   KV+DFG  R   +  D+   ST  K  V +  PE     + ++KSD
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 454 VYSFGVLLLEILT-GRRPVE 472
           V+SFGVL+ E+ + G+ P E
Sbjct: 188 VWSFGVLMWEVFSEGKIPYE 207

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 127/263 (48%), Gaps = 25/263 (9%)
Query: 274 IGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG V   +L+      + VAIK  K    +  + +F SE  ++ + DH N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G V K    +IITE++ NG+L   L    G+     Q + +   +  G+ YL   ++   
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGR-FTVIQLVGMLRGIGSGMKYL---SDMSY 137
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + NIL+  ++  KV+DFG +R+   D +  + +   K  + +  PE +   + T
Sbjct: 138 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 197
Query: 450 TKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS 508
           + SDV+S+G+++ E+++ G RP                +   +  +++  ++   +    
Sbjct: 198 SASDVWSYGIVMWEVMSYGERP----------------YWDMSNQDVIKAIEEGYRLPPP 241
Query: 509 MEILTKMFGLAIQCAAPIRNDRP 531
           M+    +  L + C    R+DRP
Sbjct: 242 MDCPIALHQLMLDCWQKERSDRP 264

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 127/263 (48%), Gaps = 25/263 (9%)
Query: 274 IGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG V   +L+      + VAIK  K    +  + +F SE  ++ + DH N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G V K    +IITE++ NG+L   L    G+     Q + +   +  G+ YL   ++   
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDGR-FTVIQLVGMLRGIGSGMKYL---SDMSA 152
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + NIL+  ++  KV+DFG +R+   D +  + +   K  + +  PE +   + T
Sbjct: 153 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 212
Query: 450 TKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS 508
           + SDV+S+G+++ E+++ G RP                +   +  +++  ++   +    
Sbjct: 213 SASDVWSYGIVMWEVMSYGERP----------------YWDMSNQDVIKAIEEGYRLPPP 256
Query: 509 MEILTKMFGLAIQCAAPIRNDRP 531
           M+    +  L + C    R+DRP
Sbjct: 257 MDCPIALHQLMLDCWQKERSDRP 279

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRN 324
           +GEG FG V  A+         ++ + VA+K  K +  E   ++  SE+E++  I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD--------------FNQRLEI 370
           ++ LLG   +     +I E+   G LRE+L  +    ++              F   +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
              +A G+ YL   A ++ IHRD+ + N+L+TE+   K+ADFG AR    + D    +T 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYKKTTN 218
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY 490
            +  V ++ PE +     T +SDV+SFGVL+ EI T      L   P   + +   FK  
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 272
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG+ +D   P+           +++ +   C   + + RP  K + E L
Sbjct: 273 KEGHRMD--KPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRN 324
           +GEG FG V  A+         ++ + VA+K  K +  E   ++  SE+E++  I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD--------------FNQRLEI 370
           ++ LLG   +     +I E+   G LRE+L  +    ++              F   +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
              +A G+ YL   A ++ IHRD+ + N+L+TE+   K+ADFG AR    + D    +T 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYKNTTN 218
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY 490
            +  V ++ PE +     T +SDV+SFGVL+ EI T      L   P   + +   FK  
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 272
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG+ +D   P+           +++ +   C   + + RP  K + E L
Sbjct: 273 KEGHRMD--KPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRN 324
           +GEG FG V  A+         ++ + VA+K  K +  E   ++  SE+E++  I  H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD--------------FNQRLEI 370
           ++ LLG   +     +I E+   G LRE+L  +    ++              F   +  
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
              +A G+ YL   A ++ IHRD+ + N+L+TE+   K+ADFG AR    + D    +T 
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYKKTTN 207
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY 490
            +  V ++ PE +     T +SDV+SFGVL+ EI T      L   P   + +   FK  
Sbjct: 208 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 261
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG+ +D   P+           +++ +   C   + + RP  K + E L
Sbjct: 262 KEGHRMD--KPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 302

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 103/200 (51%), Gaps = 9/200 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY    +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
                   I+TE++P G L ++L     + +     L +A  ++  + YL    +K  IH
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIH 153
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +     + K
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNTFSIK 211
Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV++FGVLL EI T G  P
Sbjct: 212 SDVWAFGVLLWEIATYGMSP 231

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRN 324
           +GEG FG V  A+         ++ + VA+K  K +  E   ++  SE+E++  I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD--------------FNQRLEI 370
           ++ LLG   +     +I E+   G LRE+L  +    ++              F   +  
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
              +A G+ YL   A ++ IHRD+ + N+L+TE+   K+ADFG AR    + D    +T 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYKKTTN 218
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY 490
            +  V ++ PE +     T +SDV+SFGVL+ EI T      L   P   + +   FK  
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 272
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG+ +D   P+           +++ +   C   + + RP  K + E L
Sbjct: 273 KEGHRMD--KPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRN 324
           +GEG FG V  A+         ++ + VA+K  K +  E   ++  SE+E++  I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD--------------FNQRLEI 370
           ++ LLG   +     +I E+   G LRE+L  +    ++              F   +  
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
              +A G+ YL   A ++ IHRD+ + N+L+TE+   K+ADFG AR    + D    +T 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYKKTTN 218
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY 490
            +  V ++ PE +     T +SDV+SFGVL+ EI T      L   P   + +   FK  
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 272
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG+ +D   P+           +++ +   C   + + RP  K + E L
Sbjct: 273 KEGHRMD--KPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 9/200 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     II EF+  G L ++L     + +     L +A  ++  + YL    +K  IH
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV++FGVLL EI T G  P
Sbjct: 193 SDVWAFGVLLWEIATYGMSP 212

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 118/240 (49%), Gaps = 22/240 (9%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG VY A + +   ++A+K   K Q E   ++ +   EVE+ S + H N+++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           +        +I E+ P GT+   L  Q     D  +      ++A+ L+Y H    K++I
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYITELANALSYCH---SKRVI 134
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL  +   K+ADFG++   P     T     + GT+ YL PE ++      
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT-----LCGTLDYLPPEMIEGRMHDE 189
Query: 451 KSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN--EGNLLDMVDPSIKEVIS 508
           K D++S GVL  E L G        PP E  T +  ++R +  E    D V    +++IS
Sbjct: 190 KVDLWSLGVLCYEFLVG-------MPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLIS 242

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRN 324
           +GEG FG V  A+         ++ + VA+K  K +  E   ++  SE+E++  I  H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD--------------FNQRLEI 370
           ++ LLG   +     +I E+   G LRE+L  +    ++              F   +  
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
              +A G+ YL   A ++ IHRD+ + N+L+TE+   K+ADFG AR    + D    +T 
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLAR-DINNIDYYKKTTN 205
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY 490
            +  V ++ PE +     T +SDV+SFGVL+ EI T      L   P   + +   FK  
Sbjct: 206 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 259
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG+ +D   P+           +++ +   C   + + RP  K + E L
Sbjct: 260 KEGHRMD--KPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 300

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRN 324
           +GEG FG V  A+         ++ + VA+K  K +  E   ++  SE+E++  I  H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD--------------FNQRLEI 370
           ++ LLG   +     +I E+   G LRE+L  +    ++              F   +  
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
              +A G+ YL   A ++ IHRD+ + N+L+TE+   K+ADFG AR    + D    +T 
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYKKTTN 210
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY 490
            +  V ++ PE +     T +SDV+SFGVL+ EI T      L   P   + +   FK  
Sbjct: 211 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 264
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG+ +D   P+           +++ +   C   + + RP  K + E L
Sbjct: 265 KEGHRMD--KPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 305

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 105/221 (47%), Gaps = 32/221 (14%)
Query: 274 IGEGGFGTVYKAQL-----EDGLL-VAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLV 326
           +G G FG V +A       ED +L VA+K  K     + +    SE++++S +  H N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 327 KLLGFVDKGNERLIITEFVPNGTL---------------------REHLDGQYGKTLDFN 365
            LLG    G   L+ITE+   G L                      E LD + G+ L+  
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 366 QRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT 425
             L  +  VA G+ +L   A K  IHRDV + N+LLT    AK+ DFG AR   M+    
Sbjct: 159 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNY 214
Query: 426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
            +    +  V ++ PE +     T +SDV+S+G+LL EI +
Sbjct: 215 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 8/195 (4%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     II EF+  G L ++L     + +     L +A  ++  + YL    +K  IH
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL   D+   H   K    + +  PE +   + + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 452 SDVYSFGVLLLEILT 466
           SDV++FGVLL EI T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRN 324
           +GEG FG V  A+         ++ + VA+K  K +  E   ++  SE+E++  I  H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD--------------FNQRLEI 370
           ++ LLG   +     +I E+   G LRE+L  +    ++              F   +  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
              +A G+ YL   A ++ IHRD+ + N+L+TE+   K+ADFG AR    + D    +T 
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYKKTTN 264
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY 490
            +  V ++ PE +     T +SDV+SFGVL+ EI T      L   P   + +   FK  
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 318
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG+ +D   P+           +++ +   C   + + RP  K + E L
Sbjct: 319 KEGHRMD--KPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 112/215 (52%), Gaps = 26/215 (12%)
Query: 273 RIGEGGFGTVYKAQL-EDGLLVAIK-------RAKKEQFENLQTEFSSEVELLSKIDHRN 324
           +IG+GGFG V+K +L +D  +VAIK         + E  E  Q EF  EV ++S ++H N
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ-EFQREVFIMSNLNHPN 84
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKL G +   N   ++ EFVP G L   L  +    + ++ +L + +D+A G+ Y+   
Sbjct: 85  IVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQ-N 140
Query: 385 AEKQIIHRDVKSSNILL-----TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLD 439
               I+HRD++S NI L        + AKVADF  ++         H  + + G   ++ 
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ------QSVHSVSGLLGNFQWMA 194
Query: 440 PEYMKTYQ--LTTKSDVYSFGVLLLEILTGRRPVE 472
           PE +   +   T K+D YSF ++L  ILTG  P +
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 134/290 (46%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRN 324
           +GEG FG V  A+         ++ + VA+K  K +  E   ++  SE+E++  I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD--------------FNQRLEI 370
           ++ LLG   +     +I E+   G LRE+L  +    ++              F   +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
              +A G+ YL   A ++ IHRD+ + N+L+TE+   ++ADFG AR    + D    +T 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLAR-DINNIDYYKKTTN 218
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY 490
            +  V ++ PE +     T +SDV+SFGVL+ EI T      L   P   + +   FK  
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 272
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG+ +D   P+           +++ +   C   + + RP  K + E L
Sbjct: 273 KEGHRMD--KPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           +G G FG V   +      VAIK  K+      + EF  E +++  + H  LV+L G   
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           K     IITE++ NG L  +L  +        Q LE+  DV   + YL     KQ +HRD
Sbjct: 90  KQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 145
Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           + + N L+ +    KV+DFG +R    D + + + +K    V +  PE +   + ++KSD
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKF--PVRWSPPEVLMYSKFSSKSD 203
Query: 454 VYSFGVLLLEILT-GRRPVE 472
           +++FGVL+ EI + G+ P E
Sbjct: 204 IWAFGVLMWEIYSLGKMPYE 223

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 109/218 (50%), Gaps = 9/218 (4%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           IG G FG V+     +   VAIK  K+      + +F  E E++ K+ H  LV+L G   
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS--EDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           +     ++ EF+ +G L ++L  Q G        L + +DV  G+ YL    E  +IHRD
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EACVIHRD 148
Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           + + N L+ E+   KV+DFG  R   +  D+   ST  K  V +  PE     + ++KSD
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 454 VYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRY 490
           V+SFGVL+ E+ + G+ P E +   E    +   F+ Y
Sbjct: 207 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY 244

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 107/209 (51%), Gaps = 29/209 (13%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IG GGFG V+KA+   DG    IKR K   + N + E   EV+ L+K+DH N+V   G  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVK---YNNEKAE--REVKALAKLDHVNIVHYNGCW 73
Query: 333 D----------KGNER------LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAH 376
           D          K + R       I  EF   GTL + ++ + G+ LD    LE+   +  
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133
Query: 377 GLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG 436
           G+ Y+H    K++I+RD+K SNI L ++ + K+ DFG       D  R     + KGT+ 
Sbjct: 134 GVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR----XRSKGTLR 186
Query: 437 YLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
           Y+ PE + +     + D+Y+ G++L E+L
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 105/209 (50%), Gaps = 27/209 (12%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G+G FG   K    E G ++ +K   +   E  Q  F  EV+++  ++H N++K +G +
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 333 DKGNERLIITEFVPNGTLR---EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            K      ITE++  GTLR   + +D QY     ++QR+  A D+A G+ YLH      I
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQY----PWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIS-------------TKVKGTVG 436
           IHRD+ S N L+ E+    VADFG ARL  M  ++T                  V G   
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARL--MVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 437 YLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
           ++ PE +       K DV+SFG++L EI+
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 109/218 (50%), Gaps = 9/218 (4%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           IG G FG V+     +   VAIK  ++      + +F  E E++ K+ H  LV+L G   
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           +     ++ EF+ +G L ++L  Q G        L + +DV  G+ YL    E  +IHRD
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EACVIHRD 128
Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           + + N L+ E+   KV+DFG  R   +  D+   ST  K  V +  PE     + ++KSD
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 454 VYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRY 490
           V+SFGVL+ E+ + G+ P E +   E    +   F+ Y
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY 224

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 133/290 (45%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRN 324
           +GEG FG V  A+         ++ + VA+K  K +  E   ++  SE+E++  I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD--------------FNQRLEI 370
           ++ LLG   +     +I  +   G LRE+L  +    ++              F   +  
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
              +A G+ YL   A ++ IHRD+ + N+L+TE+   K+ADFG AR    + D    +T 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYKKTTN 218
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY 490
            +  V ++ PE +     T +SDV+SFGVL+ EI T      L   P   + +   FK  
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 272
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG+ +D   P+           +++ +   C   + + RP  K + E L
Sbjct: 273 KEGHRMD--KPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 103/200 (51%), Gaps = 9/200 (4%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           IG G FG V+     +   VAIK  ++      + +F  E E++ K+ H  LV+L G   
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           +     ++ EF+ +G L ++L  Q G        L + +DV  G+ YL    E  +IHRD
Sbjct: 76  EQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EACVIHRD 131
Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           + + N L+ E+   KV+DFG  R   +  D+   ST  K  V +  PE     + ++KSD
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 189
Query: 454 VYSFGVLLLEILT-GRRPVE 472
           V+SFGVL+ E+ + G+ P E
Sbjct: 190 VWSFGVLMWEVFSEGKIPYE 209

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 109/218 (50%), Gaps = 9/218 (4%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           IG G FG V+     +   VAIK  ++      + +F  E E++ K+ H  LV+L G   
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           +     ++ EF+ +G L ++L  Q G        L + +DV  G+ YL    E  +IHRD
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EACVIHRD 126
Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           + + N L+ E+   KV+DFG  R   +  D+   ST  K  V +  PE     + ++KSD
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 454 VYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRY 490
           V+SFGVL+ E+ + G+ P E +   E    +   F+ Y
Sbjct: 185 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY 222

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 133/290 (45%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRN 324
           +GEG FG V  A+         ++ + VA+K  K +  E   ++  SE+E++  I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD--------------FNQRLEI 370
           ++ LLG   +     +I  +   G LRE+L  +    ++              F   +  
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
              +A G+ YL   A ++ IHRD+ + N+L+TE+   K+ADFG AR    + D    +T 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYKKTTN 218
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY 490
            +  V ++ PE +     T +SDV+SFGVL+ EI T      L   P   + +   FK  
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 272
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG+ +D   P+           +++ +   C   + + RP  K + E L
Sbjct: 273 KEGHRMD--KPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           +G G FG V   +      VAIK  K+      + EF  E +++  + H  LV+L G   
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           K     IITE++ NG L  +L  +        Q LE+  DV   + YL     KQ +HRD
Sbjct: 90  KQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 145
Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           + + N L+ +    KV+DFG +R   +D + T  S   K  V +  PE +   + ++KSD
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 454 VYSFGVLLLEILT-GRRPVE 472
           +++FGVL+ EI + G+ P E
Sbjct: 204 IWAFGVLMWEIYSLGKMPYE 223

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 108/222 (48%), Gaps = 42/222 (18%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IG GGFG V+KA+   DG    I+R K   + N + E   EV+ L+K+DH N+V   G  
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVK---YNNEKAE--REVKALAKLDHVNIVHYNGCW 74
Query: 333 D-----------------------KGNER------LIITEFVPNGTLREHLDGQYGKTLD 363
           D                       K + R       I  EF   GTL + ++ + G+ LD
Sbjct: 75  DGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 134
Query: 364 FNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
               LE+   +  G+ Y+H    K++IHRD+K SNI L ++ + K+ DFG       D  
Sbjct: 135 KVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 191
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
           R    T+ KGT+ Y+ PE + +     + D+Y+ G++L E+L
Sbjct: 192 R----TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           +G G FG V   +      VAIK  K+      + EF  E +++  + H  LV+L G   
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           K     IITE++ NG L  +L  +        Q LE+  DV   + YL     KQ +HRD
Sbjct: 75  KQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 130
Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           + + N L+ +    KV+DFG +R   +D + T  S   K  V +  PE +   + ++KSD
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 454 VYSFGVLLLEILT-GRRPVE 472
           +++FGVL+ EI + G+ P E
Sbjct: 189 IWAFGVLMWEIYSLGKMPYE 208

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           +G G FG V   +      VAIK  K+      + EF  E +++  + H  LV+L G   
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           K     IITE++ NG L  +L  +        Q LE+  DV   + YL     KQ +HRD
Sbjct: 74  KQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 129
Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           + + N L+ +    KV+DFG +R   +D + T  S   K  V +  PE +   + ++KSD
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKSD 187
Query: 454 VYSFGVLLLEILT-GRRPVE 472
           +++FGVL+ EI + G+ P E
Sbjct: 188 IWAFGVLMWEIYSLGKMPYE 207

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           +G G FG V   +      VAIK  K+      + EF  E +++  + H  LV+L G   
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           K     IITE++ NG L  +L  +        Q LE+  DV   + YL     KQ +HRD
Sbjct: 70  KQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 125
Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           + + N L+ +    KV+DFG +R   +D + T  S   K  V +  PE +   + ++KSD
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKSD 183
Query: 454 VYSFGVLLLEILT-GRRPVE 472
           +++FGVL+ EI + G+ P E
Sbjct: 184 IWAFGVLMWEIYSLGKMPYE 203

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           +G G FG V   +      VAIK  K+      + EF  E +++  + H  LV+L G   
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           K     IITE++ NG L  +L  +        Q LE+  DV   + YL     KQ +HRD
Sbjct: 81  KQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 136
Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           + + N L+ +    KV+DFG +R   +D + T  S   K  V +  PE +   + ++KSD
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKSD 194
Query: 454 VYSFGVLLLEILT-GRRPVE 472
           +++FGVL+ EI + G+ P E
Sbjct: 195 IWAFGVLMWEIYSLGKMPYE 214

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 108/202 (53%), Gaps = 14/202 (6%)
Query: 273 RIGEGGFGTVYKAQLED-----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   + +      G LVA+K+ +    +  Q +F  E+++L  +    +VK
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVK 72
Query: 328 LLGFVDKGNER---LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
             G V  G  R    ++ E++P+G LR+ L  ++   LD ++ L  +  +  G+ YL   
Sbjct: 73  YRG-VSYGPGRPELRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYL--- 127
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
             ++ +HRD+ + NIL+      K+ADFG A+L P+D D   +    +  + +  PE + 
Sbjct: 128 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLS 187
Query: 445 TYQLTTKSDVYSFGVLLLEILT 466
               + +SDV+SFGV+L E+ T
Sbjct: 188 DNIFSRQSDVWSFGVVLYELFT 209

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 108/201 (53%), Gaps = 12/201 (5%)
Query: 273 RIGEGGFGTVYKAQLED-----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   + +      G LVA+K+ +     + Q +F  E+++L  +    +VK
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVK 75
Query: 328 LLGF-VDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G     G + L ++ E++P+G LR+ L  ++   LD ++ L  +  +  G+ YL    
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYL---G 131
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            ++ +HRD+ + NIL+      K+ADFG A+L P+D D   +    +  + +  PE +  
Sbjct: 132 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 191
Query: 446 YQLTTKSDVYSFGVLLLEILT 466
              + +SDV+SFGV+L E+ T
Sbjct: 192 NIFSRQSDVWSFGVVLYELFT 212

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 274 IGEGGFGTV----YKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +GEG FG V    Y    +  G +VA+K  K +     ++ +  E+++L  + H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 329 LGFV-DKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            G   D G   L ++ E+VP G+LR++L      ++   Q L  A  +  G+ YLH    
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH---A 152
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           +  IHRD+ + N+LL      K+ DFG A+  P   +   +       V +  PE +K Y
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEY 212
Query: 447 QLTTKSDVYSFGVLLLEILT 466
           +    SDV+SFGV L E+LT
Sbjct: 213 KFYYASDVWSFGVTLYELLT 232

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 108/201 (53%), Gaps = 12/201 (5%)
Query: 273 RIGEGGFGTVYKAQLED-----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   + +      G LVA+K+ +     + Q +F  E+++L  +    +VK
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVK 76
Query: 328 LLGF-VDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G     G + L ++ E++P+G LR+ L  ++   LD ++ L  +  +  G+ YL    
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYL---G 132
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            ++ +HRD+ + NIL+      K+ADFG A+L P+D D   +    +  + +  PE +  
Sbjct: 133 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 192
Query: 446 YQLTTKSDVYSFGVLLLEILT 466
              + +SDV+SFGV+L E+ T
Sbjct: 193 NIFSRQSDVWSFGVVLYELFT 213

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 119/267 (44%), Gaps = 29/267 (10%)
Query: 273 RIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQT--EFSSEVELLSKIDHRNLV 326
           ++G+G FG V + + +      + VA+K  K +     +   +F  EV  +  +DHRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           +L G V     +++ TE  P G+L + L    G  L        A+ VA G+ YL     
Sbjct: 85  RLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLE---S 139
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K+ IHRD+ + N+LL      K+ DFG  R  P + D   +    K    +  PE +KT 
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 447 QLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE 505
             +  SD + FGV L E+ T G+ P                +   N   +L  +D   + 
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP----------------WIGLNGSQILHKIDKEGER 243
Query: 506 VISMEILTK-MFGLAIQCAAPIRNDRP 531
           +   E   + ++ + +QC A    DRP
Sbjct: 244 LPRPEDCPQDIYNVMVQCWAHKPEDRP 270

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 108/201 (53%), Gaps = 12/201 (5%)
Query: 273 RIGEGGFGTVYKAQLED-----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   + +      G LVA+K+ +     + Q +F  E+++L  +    +VK
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVK 88
Query: 328 LLGF-VDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G     G + L ++ E++P+G LR+ L  ++   LD ++ L  +  +  G+ YL    
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYL---G 144
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            ++ +HRD+ + NIL+      K+ADFG A+L P+D D   +    +  + +  PE +  
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 446 YQLTTKSDVYSFGVLLLEILT 466
              + +SDV+SFGV+L E+ T
Sbjct: 205 NIFSRQSDVWSFGVVLYELFT 225

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           +G G FG V   +      VAIK  K+      + EF  E +++  + H  LV+L G   
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           K     IITE++ NG L  +L  +        Q LE+  DV   + YL     KQ +HRD
Sbjct: 75  KQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 130
Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           + + N L+ +    KV+DFG +R   +D + T  S   K  V +  PE +   + ++KSD
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTS-SRGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 454 VYSFGVLLLEILT-GRRPVE 472
           +++FGVL+ EI + G+ P E
Sbjct: 189 IWAFGVLMWEIYSLGKMPYE 208

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 274 IGEGGFGTVYKAQLED-----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +GEG FG V     +      G +VA+K  K +     ++ +  E+++L  + H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 329 LGFV-DKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            G   D+G + L ++ E+VP G+LR++L      ++   Q L  A  +  G+ YLH    
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH---S 135
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           +  IHR++ + N+LL      K+ DFG A+  P   +   +       V +  PE +K Y
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 447 QLTTKSDVYSFGVLLLEILT 466
           +    SDV+SFGV L E+LT
Sbjct: 196 KFYYASDVWSFGVTLYELLT 215

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 119/267 (44%), Gaps = 29/267 (10%)
Query: 273 RIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQT--EFSSEVELLSKIDHRNLV 326
           ++G+G FG V + + +      + VA+K  K +     +   +F  EV  +  +DHRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           +L G V     +++ TE  P G+L + L    G  L        A+ VA G+ YL     
Sbjct: 75  RLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLE---S 129
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K+ IHRD+ + N+LL      K+ DFG  R  P + D   +    K    +  PE +KT 
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 447 QLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE 505
             +  SD + FGV L E+ T G+ P                +   N   +L  +D   + 
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP----------------WIGLNGSQILHKIDKEGER 233
Query: 506 VISMEILTK-MFGLAIQCAAPIRNDRP 531
           +   E   + ++ + +QC A    DRP
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRP 260

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 119/267 (44%), Gaps = 29/267 (10%)
Query: 273 RIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQT--EFSSEVELLSKIDHRNLV 326
           ++G+G FG V + + +      + VA+K  K +     +   +F  EV  +  +DHRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           +L G V     +++ TE  P G+L + L    G  L        A+ VA G+ YL     
Sbjct: 79  RLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLE---S 133
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K+ IHRD+ + N+LL      K+ DFG  R  P + D   +    K    +  PE +KT 
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 447 QLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE 505
             +  SD + FGV L E+ T G+ P                +   N   +L  +D   + 
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP----------------WIGLNGSQILHKIDKEGER 237
Query: 506 VISMEILTK-MFGLAIQCAAPIRNDRP 531
           +   E   + ++ + +QC A    DRP
Sbjct: 238 LPRPEDCPQDIYNVMVQCWAHKPEDRP 264

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 126/267 (47%), Gaps = 32/267 (11%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           +G G FG V KA+      VAIK+ + E   + +  F  E+  LS+++H N+VKL G   
Sbjct: 17  VGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL 72
Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDF---NQRLEIAIDVAHGLTYLHLYAEKQII 390
             N   ++ E+   G+L   L G   + L +      +   +  + G+ YLH    K +I
Sbjct: 73  --NPVCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 391 HRDVKSSNILLTESMRA-KVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           HRD+K  N+LL       K+ DFG A        +TH+ T  KG+  ++ PE  +    +
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHM-TNNKGSAAWMAPEVFEGSNYS 182
Query: 450 TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISM 509
            K DV+S+G++L E++T R+P +    P  R+   WA        L+  +   I+ +++ 
Sbjct: 183 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAVHNGTRPPLIKNLPKPIESLMT- 239
Query: 510 EILTKMFGLAIQCAAPIRNDRPDMKSV 536
                      +C +   + RP M+ +
Sbjct: 240 -----------RCWSKDPSQRPSMEEI 255

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 119/267 (44%), Gaps = 29/267 (10%)
Query: 273 RIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQT--EFSSEVELLSKIDHRNLV 326
           ++G+G FG V + + +      + VA+K  K +     +   +F  EV  +  +DHRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           +L G V     +++ TE  P G+L + L    G  L        A+ VA G+ YL     
Sbjct: 79  RLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLE---S 133
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K+ IHRD+ + N+LL      K+ DFG  R  P + D   +    K    +  PE +KT 
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 447 QLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE 505
             +  SD + FGV L E+ T G+ P                +   N   +L  +D   + 
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP----------------WIGLNGSQILHKIDKEGER 237
Query: 506 VISMEILTK-MFGLAIQCAAPIRNDRP 531
           +   E   + ++ + +QC A    DRP
Sbjct: 238 LPRPEDCPQDIYNVMVQCWAHKPEDRP 264

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 274 IGEGGFGTVYKAQLED-----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +GEG FG V     +      G +VA+K  K +     ++ +  E+++L  + H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 329 LGFV-DKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            G   D+G + L ++ E+VP G+LR++L      ++   Q L  A  +  G+ YLH    
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH---A 135
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           +  IHR++ + N+LL      K+ DFG A+  P   +   +       V +  PE +K Y
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 447 QLTTKSDVYSFGVLLLEILT 466
           +    SDV+SFGV L E+LT
Sbjct: 196 KFYYASDVWSFGVTLYELLT 215

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 119/267 (44%), Gaps = 29/267 (10%)
Query: 273 RIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQT--EFSSEVELLSKIDHRNLV 326
           ++G+G FG V + + +      + VA+K  K +     +   +F  EV  +  +DHRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           +L G V     +++ TE  P G+L + L    G  L        A+ VA G+ YL     
Sbjct: 85  RLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLE---S 139
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K+ IHRD+ + N+LL      K+ DFG  R  P + D   +    K    +  PE +KT 
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 447 QLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE 505
             +  SD + FGV L E+ T G+ P                +   N   +L  +D   + 
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP----------------WIGLNGSQILHKIDKEGER 243
Query: 506 VISMEILTK-MFGLAIQCAAPIRNDRP 531
           +   E   + ++ + +QC A    DRP
Sbjct: 244 LPRPEDCPQDIYNVMVQCWAHKPEDRP 270

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 126/267 (47%), Gaps = 32/267 (11%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           +G G FG V KA+      VAIK+ + E   + +  F  E+  LS+++H N+VKL G   
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDF---NQRLEIAIDVAHGLTYLHLYAEKQII 390
             N   ++ E+   G+L   L G   + L +      +   +  + G+ YLH    K +I
Sbjct: 72  --NPVCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 391 HRDVKSSNILLTESMRA-KVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           HRD+K  N+LL       K+ DFG A        +TH+ T  KG+  ++ PE  +    +
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHM-TNNKGSAAWMAPEVFEGSNYS 181
Query: 450 TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISM 509
            K DV+S+G++L E++T R+P +    P  R+   WA        L+  +   I+ +++ 
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAVHNGTRPPLIKNLPKPIESLMT- 238
Query: 510 EILTKMFGLAIQCAAPIRNDRPDMKSV 536
                      +C +   + RP M+ +
Sbjct: 239 -----------RCWSKDPSQRPSMEEI 254

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 119/267 (44%), Gaps = 29/267 (10%)
Query: 273 RIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQT--EFSSEVELLSKIDHRNLV 326
           ++G+G FG V + + +      + VA+K  K +     +   +F  EV  +  +DHRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           +L G V     +++ TE  P G+L + L    G  L        A+ VA G+ YL     
Sbjct: 75  RLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLE---S 129
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K+ IHRD+ + N+LL      K+ DFG  R  P + D   +    K    +  PE +KT 
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 447 QLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE 505
             +  SD + FGV L E+ T G+ P                +   N   +L  +D   + 
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP----------------WIGLNGSQILHKIDKEGER 233
Query: 506 VISMEILTK-MFGLAIQCAAPIRNDRP 531
           +   E   + ++ + +QC A    DRP
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRP 260

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 119/267 (44%), Gaps = 29/267 (10%)
Query: 273 RIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQT--EFSSEVELLSKIDHRNLV 326
           ++G+G FG V + + +      + VA+K  K +     +   +F  EV  +  +DHRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           +L G V     +++ TE  P G+L + L    G  L        A+ VA G+ YL     
Sbjct: 75  RLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLE---S 129
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K+ IHRD+ + N+LL      K+ DFG  R  P + D   +    K    +  PE +KT 
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 447 QLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE 505
             +  SD + FGV L E+ T G+ P                +   N   +L  +D   + 
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP----------------WIGLNGSQILHKIDKEGER 233
Query: 506 VISMEILTK-MFGLAIQCAAPIRNDRP 531
           +   E   + ++ + +QC A    DRP
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRP 260

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 120/251 (47%), Gaps = 24/251 (9%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELL 317
           A    + S  +G+G FG VY+       + E    VAIK   +      + EF +E  ++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL-----DGQYGKTL---DFNQRLE 369
            + +  ++V+LLG V +G   L+I E +  G L+ +L     + +    L     ++ ++
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +A ++A G+ YL+     + +HRD+ + N ++ E    K+ DFG  R    ++D      
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIXETDXXRKGG 192
Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           K    V ++ PE +K    TT SDV+SFGV+L EI T      L   P + ++     + 
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNEQVLRF 246
Query: 490 YNEGNLLDMVD 500
             EG LLD  D
Sbjct: 247 VMEGGLLDKPD 257

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 120/251 (47%), Gaps = 24/251 (9%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELL 317
           A    + S  +G+G FG VY+       + E    VAIK   +      + EF +E  ++
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL-----DGQYGKTL---DFNQRLE 369
            + +  ++V+LLG V +G   L+I E +  G L+ +L     + +    L     ++ ++
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +A ++A G+ YL+     + +HRD+ + N ++ E    K+ DFG  R    ++D      
Sbjct: 128 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIXETDXXRKGG 183
Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           K    V ++ PE +K    TT SDV+SFGV+L EI T      L   P + ++     + 
Sbjct: 184 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNEQVLRF 237
Query: 490 YNEGNLLDMVD 500
             EG LLD  D
Sbjct: 238 VMEGGLLDKPD 248

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 121/239 (50%), Gaps = 25/239 (10%)
Query: 252 GSVHLNMS----QVVKATRN--FSPSLRI-------GEGGFGTVYKAQLEDG----LLVA 294
           G+VH+++S    ++V+A ++    PS  I       G G FG VY   L D     +  A
Sbjct: 3   GTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 62
Query: 295 IKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG-NERLIITEFVPNGTLREH 353
           +K   +       ++F +E  ++    H N++ LLG   +     L++  ++ +G LR  
Sbjct: 63  VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 122
Query: 354 LDGQ-YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADF 412
           +  + +  T+     +   + VA G+ +L   A K+ +HRD+ + N +L E    KVADF
Sbjct: 123 IRNETHNPTV--KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADF 177
Query: 413 GFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           G AR +   + D  H  T  K  V ++  E ++T + TTKSDV+SFGVLL E++T   P
Sbjct: 178 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 274 IGEGGFGTVYKAQL-----EDGLL-VAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLV 326
           +G G FG V +A       ED +L VA+K  K     + +    SE++++S +  H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHL---------DGQYG---KTLDFNQRLEIAIDV 374
            LLG    G   L+ITE+   G L   L         D  +     TL     L  +  V
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT 434
           A G+ +L   A K  IHRDV + N+LLT    AK+ DFG AR   M+     +    +  
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIVKGNARLP 229
Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           V ++ PE +     T +SDV+S+G+LL EI +
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           R+G GGFG V +   +D G  VAIK+ ++E     +  +  E++++ K++H N+V     
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 332 VD------KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHL 383
            D        +  L+  E+   G LR++L+ Q+       +     +  D++  L YLH 
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDISSALRYLH- 139
Query: 384 YAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
             E +IIHRD+K  NI+L    + +  K+ D G+A+    + D+  + T+  GT+ YL P
Sbjct: 140 --ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK----ELDQGELCTEFVGTLQYLAP 193
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           E ++  + T   D +SFG L  E +TG RP
Sbjct: 194 ELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           R+G GGFG V +   +D G  VAIK+ ++E     +  +  E++++ K++H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 332 VD------KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHL 383
            D        +  L+  E+   G LR++L+ Q+       +     +  D++  L YLH 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDISSALRYLH- 138
Query: 384 YAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
             E +IIHRD+K  NI+L    + +  K+ D G+A+    + D+  + T+  GT+ YL P
Sbjct: 139 --ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK----ELDQGELCTEFVGTLQYLAP 192
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           E ++  + T   D +SFG L  E +TG RP
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 120/239 (50%), Gaps = 25/239 (10%)
Query: 252 GSVHLNMS----QVVKATRN--FSPSLRI-------GEGGFGTVYKAQLEDG----LLVA 294
           GSVH+++S    ++V+A ++    PS  I       G G FG VY   L D     +  A
Sbjct: 1   GSVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 60
Query: 295 IKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG-NERLIITEFVPNGTLREH 353
           +K   +       ++F +E  ++    H N++ LLG   +     L++  ++ +G LR  
Sbjct: 61  VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 120
Query: 354 LDGQ-YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADF 412
           +  + +  T+     +   + VA G+ YL   A K+ +HRD+ + N +L E    KVADF
Sbjct: 121 IRNETHNPTV--KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADF 175
Query: 413 GFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           G AR +   +    H  T  K  V ++  E ++T + TTKSDV+SFGVLL E++T   P
Sbjct: 176 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 118/251 (47%), Gaps = 24/251 (9%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELL 317
           A    + S  +G+G FG VY+       + E    VAIK   +      + EF +E  ++
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL--------DGQYGKTLDFNQRLE 369
            + +  ++V+LLG V +G   L+I E +  G L+ +L        +         ++ ++
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +A ++A G+ YL+     + +HRD+ + N ++ E    K+ DFG  R    ++D      
Sbjct: 133 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGG 188
Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           K    V ++ PE +K    TT SDV+SFGV+L EI T      L   P + ++     + 
Sbjct: 189 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNEQVLRF 242
Query: 490 YNEGNLLDMVD 500
             EG LLD  D
Sbjct: 243 VMEGGLLDKPD 253

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 120/251 (47%), Gaps = 24/251 (9%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELL 317
           A    + S  +G+G FG VY+       + E    VAIK   +      + EF +E  ++
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL-----DGQYGKTL---DFNQRLE 369
            + +  ++V+LLG V +G   L+I E +  G L+ +L     + +    L     ++ ++
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 133
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +A ++A G+ YL+     + +HRD+ + N ++ E    K+ DFG  R    ++D      
Sbjct: 134 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGG 189
Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           K    V ++ PE +K    TT SDV+SFGV+L EI T      L   P + ++     + 
Sbjct: 190 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNEQVLRF 243
Query: 490 YNEGNLLDMVD 500
             EG LLD  D
Sbjct: 244 VMEGGLLDKPD 254

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 120/251 (47%), Gaps = 24/251 (9%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELL 317
           A    + S  +G+G FG VY+       + E    VAIK   +      + EF +E  ++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL-----DGQYGKTL---DFNQRLE 369
            + +  ++V+LLG V +G   L+I E +  G L+ +L     + +    L     ++ ++
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +A ++A G+ YL+     + +HRD+ + N ++ E    K+ DFG  R    ++D      
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGG 192
Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           K    V ++ PE +K    TT SDV+SFGV+L EI T      L   P + ++     + 
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNEQVLRF 246
Query: 490 YNEGNLLDMVD 500
             EG LLD  D
Sbjct: 247 VMEGGLLDKPD 257

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 120/251 (47%), Gaps = 24/251 (9%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELL 317
           A    + S  +G+G FG VY+       + E    VAIK   +      + EF +E  ++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL-----DGQYGKTL---DFNQRLE 369
            + +  ++V+LLG V +G   L+I E +  G L+ +L     + +    L     ++ ++
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +A ++A G+ YL+     + +HRD+ + N ++ E    K+ DFG  R    ++D      
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGG 191
Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           K    V ++ PE +K    TT SDV+SFGV+L EI T      L   P + ++     + 
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNEQVLRF 245
Query: 490 YNEGNLLDMVD 500
             EG LLD  D
Sbjct: 246 VMEGGLLDKPD 256

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 118/251 (47%), Gaps = 24/251 (9%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELL 317
           A    + S  +G+G FG VY+       + E    VAIK   +      + EF +E  ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL--------DGQYGKTLDFNQRLE 369
            + +  ++V+LLG V +G   L+I E +  G L+ +L        +         ++ ++
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +A ++A G+ YL+     + +HRD+ + N ++ E    K+ DFG  R    ++D      
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGG 198
Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           K    V ++ PE +K    TT SDV+SFGV+L EI T      L   P + ++     + 
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNEQVLRF 252
Query: 490 YNEGNLLDMVD 500
             EG LLD  D
Sbjct: 253 VMEGGLLDKPD 263

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 120/251 (47%), Gaps = 24/251 (9%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELL 317
           A    + S  +G+G FG VY+       + E    VAIK   +      + EF +E  ++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL-----DGQYGKTL---DFNQRLE 369
            + +  ++V+LLG V +G   L+I E +  G L+ +L     + +    L     ++ ++
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +A ++A G+ YL+     + +HRD+ + N ++ E    K+ DFG  R    ++D      
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGG 185
Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           K    V ++ PE +K    TT SDV+SFGV+L EI T      L   P + ++     + 
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNEQVLRF 239
Query: 490 YNEGNLLDMVD 500
             EG LLD  D
Sbjct: 240 VMEGGLLDKPD 250

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 120/251 (47%), Gaps = 24/251 (9%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELL 317
           A    + S  +G+G FG VY+       + E    VAIK   +      + EF +E  ++
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL-----DGQYGKTL---DFNQRLE 369
            + +  ++V+LLG V +G   L+I E +  G L+ +L     + +    L     ++ ++
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 164
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +A ++A G+ YL+     + +HRD+ + N ++ E    K+ DFG  R    ++D      
Sbjct: 165 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGG 220
Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           K    V ++ PE +K    TT SDV+SFGV+L EI T      L   P + ++     + 
Sbjct: 221 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNEQVLRF 274
Query: 490 YNEGNLLDMVD 500
             EG LLD  D
Sbjct: 275 VMEGGLLDKPD 285

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 274 IGEGGFGTVYKAQL-----EDGLL-VAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLV 326
           +G G FG V +A       ED +L VA+K  K     + +    SE++++S +  H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--------------LEIAI 372
            LLG    G   L+ITE+   G L   L  +    L+++                L  + 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 373 DVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK 432
            VA G+ +L   A K  IHRDV + N+LLT    AK+ DFG AR   M+     +    +
Sbjct: 174 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIVKGNAR 229
Query: 433 GTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
             V ++ PE +     T +SDV+S+G+LL EI +
Sbjct: 230 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 10/197 (5%)
Query: 273 RIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IG G FG V+  +L  D  LVA+K  ++    +L+ +F  E  +L +  H N+V+L+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     I+ E V  G     L  + G  L     L++  D A G+ YL     K  IH
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE---SKCCIH 236
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK--VKGTVGYLDPEYMKTYQLT 449
           RD+ + N L+TE    K++DFG +R    ++D  + ++    +  V +  PE +   + +
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSR---EEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 450 TKSDVYSFGVLLLEILT 466
           ++SDV+SFG+LL E  +
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 120/251 (47%), Gaps = 24/251 (9%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELL 317
           A    + S  +G+G FG VY+       + E    VAIK   +      + EF +E  ++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL-----DGQYGKTL---DFNQRLE 369
            + +  ++V+LLG V +G   L+I E +  G L+ +L     + +    L     ++ ++
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +A ++A G+ YL+     + +HRD+ + N ++ E    K+ DFG  R    ++D      
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGG 191
Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           K    V ++ PE +K    TT SDV+SFGV+L EI T      L   P + ++     + 
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNEQVLRF 245
Query: 490 YNEGNLLDMVD 500
             EG LLD  D
Sbjct: 246 VMEGGLLDKPD 256

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 12/204 (5%)
Query: 274 IGEGGFGTV----YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IGEG FG V    Y +     L VAIK  K    ++++ +F  E   + + DH ++VKL+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G + + N   II E    G LR  L  +   +LD    +  A  ++  L YL     K+ 
Sbjct: 83  GVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRF 137
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+L++ +   K+ DFG +R   M+    + ++K K  + ++ PE +   + T
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 450 TKSDVYSFGVLLLEILT-GRRPVE 472
           + SDV+ FGV + EIL  G +P +
Sbjct: 196 SASDVWMFGVCMWEILMHGVKPFQ 219

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 118/251 (47%), Gaps = 24/251 (9%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELL 317
           A    + S  +G+G FG VY+       + E    VAIK   +      + EF +E  ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL--------DGQYGKTLDFNQRLE 369
            + +  ++V+LLG V +G   L+I E +  G L+ +L        +         ++ ++
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 142
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +A ++A G+ YL+     + +HRD+ + N ++ E    K+ DFG  R    ++D      
Sbjct: 143 MAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGG 198
Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           K    V ++ PE +K    TT SDV+SFGV+L EI T      L   P + ++     + 
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNEQVLRF 252
Query: 490 YNEGNLLDMVD 500
             EG LLD  D
Sbjct: 253 VMEGGLLDKPD 263

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 12/204 (5%)
Query: 274 IGEGGFGTV----YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IGEG FG V    Y +     L VAIK  K    ++++ +F  E   + + DH ++VKL+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G + + N   II E    G LR  L  +   +LD    +  A  ++  L YL     K+ 
Sbjct: 106 GVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRF 160
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+L++ +   K+ DFG +R   M+    + ++K K  + ++ PE +   + T
Sbjct: 161 VHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 450 TKSDVYSFGVLLLEILT-GRRPVE 472
           + SDV+ FGV + EIL  G +P +
Sbjct: 219 SASDVWMFGVCMWEILMHGVKPFQ 242

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 12/204 (5%)
Query: 274 IGEGGFGTV----YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IGEG FG V    Y +     L VAIK  K    ++++ +F  E   + + DH ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G + + N   II E    G LR  L  +   +LD    +  A  ++  L YL     K+ 
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRF 132
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+L++ +   K+ DFG +R   M+    + ++K K  + ++ PE +   + T
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 450 TKSDVYSFGVLLLEILT-GRRPVE 472
           + SDV+ FGV + EIL  G +P +
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 10/203 (4%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY   L D     +  A+K   +       ++F +E  ++    H N++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 330 GFVDKG-NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           G   +     L++  ++ +G LR  +  +          +   + VA G+ +L   A K+
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL---ASKK 212
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            +HRD+ + N +L E    KVADFG AR +   + D  H  T  K  V ++  E ++T +
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 272
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
            TTKSDV+SFGVLL E++T   P
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAP 295

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 12/204 (5%)
Query: 274 IGEGGFGTV----YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IGEG FG V    Y +     L VAIK  K    ++++ +F  E   + + DH ++VKL+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G + + N   II E    G LR  L  +   +LD    +  A  ++  L YL     K+ 
Sbjct: 80  GVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRF 134
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+L++ +   K+ DFG +R   M+    + ++K K  + ++ PE +   + T
Sbjct: 135 VHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 450 TKSDVYSFGVLLLEILT-GRRPVE 472
           + SDV+ FGV + EIL  G +P +
Sbjct: 193 SASDVWMFGVCMWEILMHGVKPFQ 216

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY   L D     +  A+K   +       ++F +E  ++    H N++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 330 GFVDKG-NERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           G   +     L++  ++ +G LR  +  + +  T+     +   + VA G+ +L   A K
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 157
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + +HRD+ + N +L E    KVADFG AR +   + D  H  T  K  V ++  E ++T 
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 217
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
           + TTKSDV+SFGVLL E++T   P
Sbjct: 218 KFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 12/204 (5%)
Query: 274 IGEGGFGTV----YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IGEG FG V    Y +     L VAIK  K    ++++ +F  E   + + DH ++VKL+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G + + N   II E    G LR  L  +   +LD    +  A  ++  L YL     K+ 
Sbjct: 75  GVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRF 129
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+L++ +   K+ DFG +R   M+    + ++K K  + ++ PE +   + T
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 450 TKSDVYSFGVLLLEILT-GRRPVE 472
           + SDV+ FGV + EIL  G +P +
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQ 211

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY   L D     +  A+K   +       ++F +E  ++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 330 GFVDKG-NERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           G   +     L++  ++ +G LR  +  + +  T+     +   + VA G+ +L   A K
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 150
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + +HRD+ + N +L E    KVADFG AR +   + D  H  T  K  V ++  E ++T 
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 210
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
           + TTKSDV+SFGVLL E++T   P
Sbjct: 211 KFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 12/204 (5%)
Query: 274 IGEGGFGTV----YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IGEG FG V    Y +     L VAIK  K    ++++ +F  E   + + DH ++VKL+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G + + N   II E    G LR  L  +   +LD    +  A  ++  L YL     K+ 
Sbjct: 81  GVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRF 135
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+L++ +   K+ DFG +R   M+    + ++K K  + ++ PE +   + T
Sbjct: 136 VHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 450 TKSDVYSFGVLLLEILT-GRRPVE 472
           + SDV+ FGV + EIL  G +P +
Sbjct: 194 SASDVWMFGVCMWEILMHGVKPFQ 217

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY   L D     +  A+K   +       ++F +E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 330 GFVDKG-NERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           G   +     L++  ++ +G LR  +  + +  T+     +   + VA G+ +L   A K
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 152
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + +HRD+ + N +L E    KVADFG AR +   + D  H  T  K  V ++  E ++T 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
           + TTKSDV+SFGVLL E++T   P
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 274 IGEGGFGTVYKAQLED-----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +GEG FG V     +      G +VA+K  K+     L++ +  E+E+L  + H ++VK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 329 LGFVDKGNERLI--ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            G  +   E+ +  + E+VP G+LR++L       +   Q L  A  +  G+ YLH    
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH---CVGLAQLLLFAQQICEGMAYLH---A 130
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           +  IHR + + N+LL      K+ DFG A+  P   +   +       V +  PE +K  
Sbjct: 131 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 190
Query: 447 QLTTKSDVYSFGVLLLEILT 466
           +    SDV+SFGV L E+LT
Sbjct: 191 KFYYASDVWSFGVTLYELLT 210

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY   L D     +  A+K   +       ++F +E  ++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 330 GFVDKG-NERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           G   +     L++  ++ +G LR  +  + +  T+     +   + VA G+ +L   A K
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 153
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + +HRD+ + N +L E    KVADFG AR +   + D  H  T  K  V ++  E ++T 
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
           + TTKSDV+SFGVLL E++T   P
Sbjct: 214 KFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 10/203 (4%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY   L D     +  A+K   +       ++F +E  ++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 330 GFVDKG-NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           G   +     L++  ++ +G LR  +  +          +   + VA G+ +L   A K+
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL---ASKK 154
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            +HRD+ + N +L E    KVADFG AR +   + D  H  T  K  V ++  E ++T +
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQK 214
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
            TTKSDV+SFGVLL E++T   P
Sbjct: 215 FTTKSDVWSFGVLLWELMTRGAP 237

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 12/204 (5%)
Query: 274 IGEGGFGTV----YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IGEG FG V    Y +     + VAIK  K    ++++ +F  E   + + DH ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G + + N   II E    G LR  L  +   +LD    +  A  ++  L YL     K+ 
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRF 132
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+L++ +   K+ DFG +R   M+    + ++K K  + ++ PE +   + T
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 450 TKSDVYSFGVLLLEILT-GRRPVE 472
           + SDV+ FGV + EIL  G +P +
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 274 IGEGGFGTVYKAQLED-----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +GEG FG V     +      G +VA+K  K+     L++ +  E+E+L  + H ++VK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 329 LGFVDKGNERLI--ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            G  +   E+ +  + E+VP G+LR++L       +   Q L  A  +  G+ YLH    
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH---CVGLAQLLLFAQQICEGMAYLH---A 129
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           +  IHR + + N+LL      K+ DFG A+  P   +   +       V +  PE +K  
Sbjct: 130 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 189
Query: 447 QLTTKSDVYSFGVLLLEILT 466
           +    SDV+SFGV L E+LT
Sbjct: 190 KFYYASDVWSFGVTLYELLT 209

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 14/205 (6%)
Query: 274 IGEGGFGTV----YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IGEG FG V    Y +     + VAIK  K    ++++ +F  E   + + DH ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGK-TLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           G + + N   II E    G LR  L  Q  K +LD    +  A  ++  L YL     K+
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE---SKR 131
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            +HRD+ + N+L++ +   K+ DFG +R   M+    + ++K K  + ++ PE +   + 
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 449 TTKSDVYSFGVLLLEILT-GRRPVE 472
           T+ SDV+ FGV + EIL  G +P +
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 273 RIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IG G FG V+  +L  D  LVA+K  ++    +L+ +F  E  +L +  H N+V+L+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     I+ E V  G     L  + G  L     L++  D A G+ YL     K  IH
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE---SKCCIH 236
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK--VKGTVGYLDPEYMKTYQLT 449
           RD+ + N L+TE    K++DFG +R    ++D    ++    +  V +  PE +   + +
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSR---EEADGVXAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 450 TKSDVYSFGVLLLEILT 466
           ++SDV+SFG+LL E  +
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY   L D     +  A+K   +       ++F +E  ++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 330 GFVDKGN-ERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           G   +     L++  ++ +G LR  +  + +  T+     +   + VA G+ YL   A K
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 151
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + +HRD+ + N +L E    KVADFG AR +   +    H  T  K  V ++  E ++T 
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQ 211
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
           + TTKSDV+SFGVLL E++T   P
Sbjct: 212 KFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 274 IGEGGFGTVYKAQL-----EDGLL-VAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLV 326
           +G G FG V +A       ED +L VA+K  K     + +    SE++++S +  H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHL---------DGQYG---KTLDFNQRLEIAIDV 374
            LLG    G   L+ITE+   G L   L         D  +     T      L  +  V
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT 434
           A G+ +L   A K  IHRDV + N+LLT    AK+ DFG AR   M+     +    +  
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIVKGNARLP 229
Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           V ++ PE +     T +SDV+S+G+LL EI +
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 110/203 (54%), Gaps = 12/203 (5%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK   +        EF  E  +++ +DH +LV+L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           LG       +L+ T+ +P+G L E++  ++   +     L   + +A G+ YL    E++
Sbjct: 106 LGVCLSPTIQLV-TQLMPHGCLLEYVH-EHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 160
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           ++HRD+ + N+L+      K+ DFG ARL   D ++ + +   K  + ++  E +   + 
Sbjct: 161 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD-EKEYNADGGKMPIKWMALECIHYRKF 219
Query: 449 TTKSDVYSFGVLLLEILT-GRRP 470
           T +SDV+S+GV + E++T G +P
Sbjct: 220 THQSDVWSYGVTIWELMTFGGKP 242

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 274 IGEGGFGTVYKAQLEDGL------LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G+G FG VY+    D +       VA+K   +      + EF +E  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL----------DGQYGKTLDFNQRLEIAIDVAHG 377
           LLG V KG   L++ E + +G L+ +L           G+   TL   + +++A ++A G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 142
Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY 437
           + YL+    K+ +HRD+ + N ++      K+ DFG  R    ++D      K    V +
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIXETDXXRKGGKGLLPVRW 198
Query: 438 LDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
           + PE +K    TT SD++SFGV+L EI +      L   P + ++     K   +G  LD
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQGLSNEQVLKFVMDGGYLD 252
Query: 498 MVD 500
             D
Sbjct: 253 QPD 255

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 274 IGEGGFGTVYKAQLEDGL------LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G+G FG VY+    D +       VA+K   +      + EF +E  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL----------DGQYGKTLDFNQRLEIAIDVAHG 377
           LLG V KG   L++ E + +G L+ +L           G+   TL   + +++A ++A G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 142
Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY 437
           + YL+    K+ +HRD+ + N ++      K+ DFG  R    ++D      K    V +
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIXETDXXRKGGKGLLPVRW 198
Query: 438 LDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
           + PE +K    TT SD++SFGV+L EI +      L   P + ++     K   +G  LD
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQGLSNEQVLKFVMDGGYLD 252
Query: 498 MVD 500
             D
Sbjct: 253 QPD 255

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 119/251 (47%), Gaps = 24/251 (9%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELL 317
           A    + S  +G+G FG VY+       + E    VAIK   +      + EF +E  ++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL-----DGQYGKTL---DFNQRLE 369
            + +  ++V+LLG V +G   L+I E +  G L+ +L     + +    L     ++ ++
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +A ++A G+ YL+     + +HRD+ + N  + E    K+ DFG  R    ++D      
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTR-DIYETDYYRKGG 185
Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           K    V ++ PE +K    TT SDV+SFGV+L EI T      L   P + ++     + 
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNEQVLRF 239
Query: 490 YNEGNLLDMVD 500
             EG LLD  D
Sbjct: 240 VMEGGLLDKPD 250

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 274 IGEGGFGTVYKAQLEDGL------LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G+G FG VY+    D +       VA+K   +      + EF +E  ++      ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL----------DGQYGKTLDFNQRLEIAIDVAHG 377
           LLG V KG   L++ E + +G L+ +L           G+   TL   + +++A ++A G
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 139
Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY 437
           + YL+    K+ +HRD+ + N ++      K+ DFG  R    ++D      K    V +
Sbjct: 140 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIXETDXXRKGGKGLLPVRW 195
Query: 438 LDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
           + PE +K    TT SD++SFGV+L EI +      L   P + ++     K   +G  LD
Sbjct: 196 MAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQGLSNEQVLKFVMDGGYLD 249
Query: 498 MVD 500
             D
Sbjct: 250 QPD 252

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 110/203 (54%), Gaps = 12/203 (5%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK   +        EF  E  +++ +DH +LV+L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           LG       +L+ T+ +P+G L E++  ++   +     L   + +A G+ YL    E++
Sbjct: 83  LGVCLSPTIQLV-TQLMPHGCLLEYVH-EHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 137
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           ++HRD+ + N+L+      K+ DFG ARL   D ++ + +   K  + ++  E +   + 
Sbjct: 138 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD-EKEYNADGGKMPIKWMALECIHYRKF 196
Query: 449 TTKSDVYSFGVLLLEILT-GRRP 470
           T +SDV+S+GV + E++T G +P
Sbjct: 197 THQSDVWSYGVTIWELMTFGGKP 219

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 14/205 (6%)
Query: 274 IGEGGFGTV----YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IGEG FG V    Y +     + VAIK  K    ++++ +F  E   + + DH ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGK-TLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           G + + N   II E    G LR  L  Q  K +LD    +  A  ++  L YL     K+
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE---SKR 131
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            +HRD+ + N+L++ +   K+ DFG +R   M+      ++K K  + ++ PE +   + 
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 449 TTKSDVYSFGVLLLEILT-GRRPVE 472
           T+ SDV+ FGV + EIL  G +P +
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G FG VY+ Q+         L VA+K   +   E  + +F  E  ++SK++H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGK-----TLDFNQRLEIAIDVAHGLTYLH 382
            +G   +   R I+ E +  G L+  L     +     +L     L +A D+A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 383 LYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKG-----T 434
              E   IHRD+ + N LLT       AK+ DFG AR      D    S   KG      
Sbjct: 173 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKGGCAMLP 223
Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           V ++ PE       T+K+D +SFGVLL EI +
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY   L D     +  A+K   +       ++F +E  ++    H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 330 GFVDKG-NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           G   +     L++  ++ +G LR  +  +          +   + VA G+ YL   A K+
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---ASKK 172
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            +HRD+ + N +L E    KVADFG AR +   +    H  T  K  V ++  E ++T +
Sbjct: 173 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 232
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
            TTKSDV+SFGVLL E++T   P
Sbjct: 233 FTTKSDVWSFGVLLWELMTRGAP 255

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY   L D     +  A+K   +       ++F +E  ++    H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 330 GFVDKG-NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           G   +     L++  ++ +G LR  +  +          +   + VA G+ YL   A K+
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---ASKK 145
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            +HRD+ + N +L E    KVADFG AR +   +    H  T  K  V ++  E ++T +
Sbjct: 146 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 205
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
            TTKSDV+SFGVLL E++T   P
Sbjct: 206 FTTKSDVWSFGVLLWELMTRGAP 228

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY   L D     +  A+K   +       ++F +E  ++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 330 GFVDKGN-ERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           G   +     L++  ++ +G LR  +  + +  T+     +   + VA G+ YL   A K
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 147
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + +HRD+ + N +L E    KVADFG AR +   +    H  T  K  V ++  E ++T 
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
           + TTKSDV+SFGVLL E++T   P
Sbjct: 208 KFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY   L D     +  A+K   +       ++F +E  ++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 330 GFVDKGN-ERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           G   +     L++  ++ +G LR  +  + +  T+     +   + VA G+ YL   A K
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 151
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + +HRD+ + N +L E    KVADFG AR +   +    H  T  K  V ++  E ++T 
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 211
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
           + TTKSDV+SFGVLL E++T   P
Sbjct: 212 KFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY   L D     +  A+K   +       ++F +E  ++    H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 330 GFVDKG-NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           G   +     L++  ++ +G LR  +  +          +   + VA G+ YL   A K+
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---ASKK 171
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            +HRD+ + N +L E    KVADFG AR +   +    H  T  K  V ++  E ++T +
Sbjct: 172 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 231
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
            TTKSDV+SFGVLL E++T   P
Sbjct: 232 FTTKSDVWSFGVLLWELMTRGAP 254

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G FG VY+ Q+         L VA+K   +   E  + +F  E  ++SK +H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGK-----TLDFNQRLEIAIDVAHGLTYLH 382
            +G   +   R I+ E +  G L+  L     +     +L     L +A D+A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 383 LYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKG-----T 434
              E   IHRD+ + N LLT       AK+ DFG AR      D    S   KG      
Sbjct: 158 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKGGCAMLP 208
Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           V ++ PE       T+K+D +SFGVLL EI +
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 132/284 (46%), Gaps = 27/284 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G F  VY+A+ +  GL VAIK   K+      +     +EV++  ++ H ++++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           + +  N   ++ E   NG +  +L  +  K    N+       +  G+ YLH +    I+
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHG---IL 134
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+  SN+LLT +M  K+ADFG A    M  ++ +    + GT  Y+ PE         
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY---TLCGTPNYISPEIATRSAHGL 191
Query: 451 KSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISME 510
           +SDV+S G +   +L G       RPP +  T++      N  N + + D  +   +S+E
Sbjct: 192 ESDVWSLGCMFYTLLIG-------RPPFDTDTVK------NTLNKVVLADYEMPSFLSIE 238
Query: 511 ILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKSVKKG 554
               +  L  +  A    DR  + SV +  +  R  S KS  +G
Sbjct: 239 AKDLIHQLLRRNPA----DRLSLSSVLDHPFMSRNSSTKSKDEG 278

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY   L D     +  A+K   +       ++F +E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 330 GFVDKGN-ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           G   +     L++  ++ +G LR  +  +          +   + VA G+ YL   A K+
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---ASKK 153
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            +HRD+ + N +L E    KVADFG AR +   +    H  T  K  V ++  E ++T +
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 213
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
            TTKSDV+SFGVLL E++T   P
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY   L D     +  A+K   +       ++F +E  ++    H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 330 GFVDKG-NERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           G   +     L++  ++ +G LR  +  + +  T+     +   + VA G+ YL   A K
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 149
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + +HRD+ + N +L E    KVADFG AR +   +    H  T  K  V ++  E ++T 
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 209
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
           + TTKSDV+SFGVLL E++T   P
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY   L D     +  A+K   +       ++F +E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 330 GFVDKGN-ERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           G   +     L++  ++ +G LR  +  + +  T+     +   + VA G+ YL   A K
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 152
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + +HRD+ + N +L E    KVADFG AR +   +    H  T  K  V ++  E ++T 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
           + TTKSDV+SFGVLL E++T   P
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G FG VY+ Q+         L VA+K   +   E  + +F  E  ++SK++H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGK-----TLDFNQRLEIAIDVAHGLTYLH 382
            +G   +   R I+ E +  G L+  L     +     +L     L +A D+A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 383 LYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKG-----T 434
              E   IHRD+ + N LLT       AK+ DFG AR      D    S   KG      
Sbjct: 159 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKGGCAMLP 209
Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           V ++ PE       T+K+D +SFGVLL EI +
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G FG VY+ Q+         L VA+K   +   E  + +F  E  ++SK +H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGK-----TLDFNQRLEIAIDVAHGLTYLH 382
            +G   +   R I+ E +  G L+  L     +     +L     L +A D+A G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 383 LYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKG-----T 434
              E   IHRD+ + N LLT       AK+ DFG AR      D    S   KG      
Sbjct: 173 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKGGCAMLP 223
Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           V ++ PE       T+K+D +SFGVLL EI +
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G FG VY+ Q+         L VA+K   +   E  + +F  E  ++SK +H+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGK-----TLDFNQRLEIAIDVAHGLTYLH 382
            +G   +   R I+ E +  G L+  L     +     +L     L +A D+A G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 383 LYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKG-----T 434
              E   IHRD+ + N LLT       AK+ DFG AR      D    S   KG      
Sbjct: 150 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKGGCAMLP 200
Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           V ++ PE       T+K+D +SFGVLL EI +
Sbjct: 201 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 274 IGEGGFGTVYKAQLEDGL------LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G+G FG VY+    D +       VA+K   +      + EF +E  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL----------DGQYGKTLDFNQRLEIAIDVAHG 377
           LLG V KG   L++ E + +G L+ +L           G+   TL   + +++A ++A G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 142
Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY 437
           + YL+    K+ +HRD+ + N ++      K+ DFG  R    ++D      K    V +
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVRW 198
Query: 438 LDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
           + PE +K    TT SD++SFGV+L EI +      L   P + ++     K   +G  LD
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQGLSNEQVLKFVMDGGYLD 252
Query: 498 MVD 500
             D
Sbjct: 253 QPD 255

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G FG VY+ Q+         L VA+K   +   E  + +F  E  ++SK +H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGK-----TLDFNQRLEIAIDVAHGLTYLH 382
            +G   +   R I+ E +  G L+  L     +     +L     L +A D+A G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 383 LYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKG-----T 434
              E   IHRD+ + N LLT       AK+ DFG AR      D    S   KG      
Sbjct: 158 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKGGCAMLP 208
Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           V ++ PE       T+K+D +SFGVLL EI +
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 274 IGEGGFGTVYKAQLEDGL------LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G+G FG VY+    D +       VA+K   +      + EF +E  ++      ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL----------DGQYGKTLDFNQRLEIAIDVAHG 377
           LLG V KG   L++ E + +G L+ +L           G+   TL   + +++A ++A G
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 141
Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY 437
           + YL+    K+ +HRD+ + N ++      K+ DFG  R    ++D      K    V +
Sbjct: 142 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVRW 197
Query: 438 LDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
           + PE +K    TT SD++SFGV+L EI +      L   P + ++     K   +G  LD
Sbjct: 198 MAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQGLSNEQVLKFVMDGGYLD 251
Query: 498 MVD 500
             D
Sbjct: 252 QPD 254

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG VY A + +   +VA+K   K Q E   ++ +   E+E+ + + H N+++L  
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           +        +I E+ P G L + L  Q   T D  +   I  ++A  L Y H    K++I
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKEL--QKSCTFDEQRTATIMEELADALMYCH---GKKVI 145
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL      K+ADFG++   P    +T     + GT+ YL PE ++      
Sbjct: 146 HRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKT-----MCGTLDYLPPEMIEGRMHNE 200
Query: 451 KSDVYSFGVLLLEILTGRRPVE 472
           K D++  GVL  E+L G  P E
Sbjct: 201 KVDLWCIGVLCYELLVGNPPFE 222

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G FG VY+ Q+         L VA+K   +   E  + +F  E  ++SK +H+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGK-----TLDFNQRLEIAIDVAHGLTYLH 382
            +G   +   R I+ E +  G L+  L     +     +L     L +A D+A G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 383 LYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKG-----T 434
              E   IHRD+ + N LLT       AK+ DFG AR      D    S   KG      
Sbjct: 175 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKGGCAMLP 225
Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           V ++ PE       T+K+D +SFGVLL EI +
Sbjct: 226 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G FG VY+ Q+         L VA+K   +   E  + +F  E  ++SK +H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGK-----TLDFNQRLEIAIDVAHGLTYLH 382
            +G   +   R I+ E +  G L+  L     +     +L     L +A D+A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 383 LYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKG-----T 434
              E   IHRD+ + N LLT       AK+ DFG AR      D    S   KG      
Sbjct: 173 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKGGCAMLP 223
Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           V ++ PE       T+K+D +SFGVLL EI +
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 14/205 (6%)
Query: 274 IGEGGFGTV----YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IGEG FG V    Y +     + VAIK  K    ++++ +F  E   + + DH ++VKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGK-TLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           G + + N   II E    G LR  L  Q  K +LD    +  A  ++  L YL     K+
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE---SKR 511
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            +HRD+ + N+L++ +   K+ DFG +R   M+    + ++K K  + ++ PE +   + 
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 449 TTKSDVYSFGVLLLEILT-GRRPVE 472
           T+ SDV+ FGV + EIL  G +P +
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQ 594

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G FG VY+ Q+         L VA+K   +   E  + +F  E  ++SK +H+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGK-----TLDFNQRLEIAIDVAHGLTYLH 382
            +G   +   R I+ E +  G L+  L     +     +L     L +A D+A G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 383 LYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKG-----T 434
              E   IHRD+ + N LLT       AK+ DFG AR      D    S   KG      
Sbjct: 165 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKGGCAMLP 215
Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           V ++ PE       T+K+D +SFGVLL EI +
Sbjct: 216 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 105/199 (52%), Gaps = 11/199 (5%)
Query: 273 RIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++GEG +G+VYKA   E G +VAIK+   E   +LQ E   E+ ++ + D  ++VK  G 
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQ-EIIKEISIMQQCDSPHVVKYYGS 92
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             K  +  I+ E+   G++ + +  +  KTL  ++   I      GL YLH   +   IH
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRK---IH 148
Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+K+ NILL     AK+ADFG A  G + +D       V GT  ++ PE ++       
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVA--GQL-TDXMAKRNXVIGTPFWMAPEVIQEIGYNCV 205
Query: 452 SDVYSFGVLLLEILTGRRP 470
           +D++S G+  +E+  G+ P
Sbjct: 206 ADIWSLGITAIEMAEGKPP 224

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G FG VY+ Q+         L VA+K   +   E  + +F  E  ++SK +H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGK-----TLDFNQRLEIAIDVAHGLTYLH 382
            +G   +   R I+ E +  G L+  L     +     +L     L +A D+A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 383 LYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKG-----T 434
              E   IHRD+ + N LLT       AK+ DFG AR      D    S   KG      
Sbjct: 159 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKGGCAMLP 209
Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           V ++ PE       T+K+D +SFGVLL EI +
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 14/205 (6%)
Query: 274 IGEGGFGTV----YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IGEG FG V    Y +     + VAIK  K    ++++ +F  E   + + DH ++VKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGK-TLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           G + + N   II E    G LR  L  Q  K +LD    +  A  ++  L YL     K+
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE---SKR 511
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            +HRD+ + N+L++ +   K+ DFG +R   M+    + ++K K  + ++ PE +   + 
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 449 TTKSDVYSFGVLLLEILT-GRRPVE 472
           T+ SDV+ FGV + EIL  G +P +
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQ 594

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G FG VY+ Q+         L VA+K   +   E  + +F  E  ++SK +H+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGK-----TLDFNQRLEIAIDVAHGLTYLH 382
            +G   +   R I+ E +  G L+  L     +     +L     L +A D+A G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 383 LYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKG-----T 434
              E   IHRD+ + N LLT       AK+ DFG AR      D    S   KG      
Sbjct: 185 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKGGCAMLP 235
Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           V ++ PE       T+K+D +SFGVLL EI +
Sbjct: 236 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 115/248 (46%), Gaps = 38/248 (15%)
Query: 274 IGEGGFGTVYKAQLEDGL------LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G+G FG VY+    D +       VA+K   +      + EF +E  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL----------DGQYGKTLDFNQRLEIAIDVAHG 377
           LLG V KG   L++ E + +G L+ +L           G+   TL   + +++A ++A G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 142
Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG- 436
           + YL+    K+ +HRD+ + N ++      K+ DFG  R      D    +   KG  G 
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR------DIYETAYYRKGGKGL 193
Query: 437 ----YLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE 492
               ++ PE +K    TT SD++SFGV+L EI +      L   P + ++     K   +
Sbjct: 194 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQGLSNEQVLKFVMD 247
Query: 493 GNLLDMVD 500
           G  LD  D
Sbjct: 248 GGYLDQPD 255

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 8/202 (3%)
Query: 273 RIGEGGFG-TVYKAQLEDGLLVAIKRAKKEQFENLQTEFSS-EVELLSKIDHRNLVKLLG 330
           +IGEG FG  +     EDG    IK     +  + + E S  EV +L+ + H N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
             ++     I+ ++   G L + ++ Q G     +Q L+  + +   L ++H   +++I+
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+KS NI LT+    ++ DFG AR+  ++S    ++    GT  YL PE  +      
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARV--LNST-VELARACIGTPYYLSPEICENKPYNN 204
Query: 451 KSDVYSFGVLLLEILTGRRPVE 472
           KSD+++ G +L E+ T +   E
Sbjct: 205 KSDIWALGCVLYELCTLKHAFE 226

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 274 IGEGGFGTVYKAQLEDGL------LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G+G FG VY+    D +       VA+K   +      + EF +E  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL----------DGQYGKTLDFNQRLEIAIDVAHG 377
           LLG V KG   L++ E + +G L+ +L           G+   TL   + +++A ++A G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 142
Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY 437
           + YL+    K+ +HR++ + N ++      K+ DFG  R    ++D      K    V +
Sbjct: 143 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVRW 198
Query: 438 LDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
           + PE +K    TT SD++SFGV+L EI +      L   P + ++     K   +G  LD
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQGLSNEQVLKFVMDGGYLD 252
Query: 498 MVD 500
             D
Sbjct: 253 QPD 255

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 274 IGEGGFGTVYKAQLEDGL------LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G+G FG VY+    D +       VA+K   +      + EF +E  ++      ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL----------DGQYGKTLDFNQRLEIAIDVAHG 377
           LLG V KG   L++ E + +G L+ +L           G+   TL   + +++A ++A G
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 143
Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY 437
           + YL+    K+ +HR++ + N ++      K+ DFG  R    ++D      K    V +
Sbjct: 144 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVRW 199
Query: 438 LDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD 497
           + PE +K    TT SD++SFGV+L EI +      L   P + ++     K   +G  LD
Sbjct: 200 MAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQGLSNEQVLKFVMDGGYLD 253
Query: 498 MVD 500
             D
Sbjct: 254 QPD 256

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG VY A + ++  ++A+K   K Q E   ++ +   E+E+ S + H N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           +        ++ EF P G L + L  ++G+  D  +      ++A  L Y H   E+++I
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQ-KHGR-FDEQRSATFMEELADALHYCH---ERKVI 136
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+L+      K+ADFG++   P    R      + GT+ YL PE ++      
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRX-----MCGTLDYLPPEMIEGKTHDE 191
Query: 451 KSDVYSFGVLLLEILTGRRPVE 472
           K D++  GVL  E L G  P +
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG VY A + ++  ++A+K   K Q E   ++ +   E+E+ S + H N++++  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           +        ++ EF P G L + L  ++G+  D  +      ++A  L Y H   E+++I
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQ-KHGR-FDEQRSATFMEELADALHYCH---ERKVI 137
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+L+      K+ADFG++   P    R      + GT+ YL PE ++      
Sbjct: 138 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRX-----MCGTLDYLPPEMIEGKTHDE 192
Query: 451 KSDVYSFGVLLLEILTGRRPVE 472
           K D++  GVL  E L G  P +
Sbjct: 193 KVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G FG VY+ Q+         L VA+K   +   E  + +F  E  ++SK +H+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGK-----TLDFNQRLEIAIDVAHGLTYLH 382
            +G   +   R I+ E +  G L+  L     +     +L     L +A D+A G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 383 LYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKG-----T 434
              E   IHRD+ + N LLT       AK+ DFG AR      D        KG      
Sbjct: 176 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRAGYYRKGGCAMLP 226
Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           V ++ PE       T+K+D +SFGVLL EI +
Sbjct: 227 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G FG VY+ Q+         L VA+K   +   E  + +F  E  ++SK +H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGK-----TLDFNQRLEIAIDVAHGLTYLH 382
            +G   +   R I+ E +  G L+  L     +     +L     L +A D+A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 383 LYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKG-----T 434
              E   IHRD+ + N LLT       AK+ DFG AR      D        KG      
Sbjct: 199 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRAGYYRKGGCAMLP 249
Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           V ++ PE       T+K+D +SFGVLL EI +
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 130/301 (43%), Gaps = 59/301 (19%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +GEG FG V KA             VA+K  K+    +   +  SE  +L +++H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 328 LLGFVDKGNERLIITEFVPNGTLR----------------------EHLDGQYGKTLDFN 365
           L G   +    L+I E+   G+LR                        LD    + L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 366 QRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT 425
             +  A  ++ G+ YL   AE +++HRD+ + NIL+ E  + K++DFG +R      D  
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR------DVY 201
Query: 426 HISTKVKGTVGYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILT-GRRPVELKRPPEE 479
              + VK + G +  ++M    L     TT+SDV+SFGVLL EI+T G  P     PPE 
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP-GIPPER 260
Query: 480 RVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQ 539
                  F     G+ ++  D   +E         M+ L +QC     + RP    + + 
Sbjct: 261 ------LFNLLKTGHRMERPDNCSEE---------MYRLMLQCWKQEPDKRPVFADISKD 305
Query: 540 L 540
           L
Sbjct: 306 L 306

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G FG VY+ Q+         L VA+K   +   E  + +F  E  ++SK +H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGK-----TLDFNQRLEIAIDVAHGLTYLH 382
            +G   +   R I+ E +  G L+  L     +     +L     L +A D+A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 383 LYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKG-----T 434
              E   IHRD+ + N LLT       AK+ DFG A+      D    S   KG      
Sbjct: 159 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ------DIYRASYYRKGGCAMLP 209
Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           V ++ PE       T+K+D +SFGVLL EI +
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 129/301 (42%), Gaps = 59/301 (19%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +GEG FG V KA             VA+K  K+    +   +  SE  +L +++H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 328 LLGFVDKGNERLIITEFVPNGTLR----------------------EHLDGQYGKTLDFN 365
           L G   +    L+I E+   G+LR                        LD    + L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 366 QRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT 425
             +  A  ++ G+ YL   AE  ++HRD+ + NIL+ E  + K++DFG +R      D  
Sbjct: 151 DLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSR------DVY 201
Query: 426 HISTKVKGTVGYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILT-GRRPVELKRPPEE 479
              + VK + G +  ++M    L     TT+SDV+SFGVLL EI+T G  P     PPE 
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP-GIPPER 260
Query: 480 RVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQ 539
                  F     G+ ++  D   +E         M+ L +QC     + RP    + + 
Sbjct: 261 ------LFNLLKTGHRMERPDNCSEE---------MYRLMLQCWKQEPDKRPVFADISKD 305
Query: 540 L 540
           L
Sbjct: 306 L 306

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 130/301 (43%), Gaps = 59/301 (19%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +GEG FG V KA             VA+K  K+    +   +  SE  +L +++H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 328 LLGFVDKGNERLIITEFVPNGTLR----------------------EHLDGQYGKTLDFN 365
           L G   +    L+I E+   G+LR                        LD    + L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 366 QRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT 425
             +  A  ++ G+ YL   AE +++HRD+ + NIL+ E  + K++DFG +R      D  
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR------DVY 201
Query: 426 HISTKVKGTVGYLDPEYMKTYQL-----TTKSDVYSFGVLLLEILT-GRRPVELKRPPEE 479
              + VK + G +  ++M    L     TT+SDV+SFGVLL EI+T G  P     PPE 
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP-GIPPER 260
Query: 480 RVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQ 539
                  F     G+ ++  D   +E         M+ L +QC     + RP    + + 
Sbjct: 261 ------LFNLLKTGHRMERPDNCSEE---------MYRLMLQCWKQEPDKRPVFADISKD 305
Query: 540 L 540
           L
Sbjct: 306 L 306

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 121/273 (44%), Gaps = 34/273 (12%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL- 329
           +G GG   V+ A+ L D   VA+K  RA   +  +    F  E +  + ++H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 330 ---GFVDKGNERLIITEFVPNGTLRE--HLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
                   G    I+ E+V   TLR+  H +G     +   + +E+  D    L + H  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSH-- 133
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +  IIHRDVK +NIL++ +   KV DFG AR      +    +  V GT  YL PE  +
Sbjct: 134 -QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQAR 192
Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK 504
              +  +SDVYS G +L E+LTG  P     P      +  A++   E    D + PS +
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVRE----DPIPPSAR 242
Query: 505 --------EVISMEILTKMFGLAIQCAAPIRND 529
                   + + ++ L K      Q AA +R D
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 274 IGEGGFGTVYKA----QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG+G FG VY      Q ++ +  AIK   +         F  E  L+  ++H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR-------LEIAIDVAHGLTYLH 382
           G        ++  E +P+  L     G   + +   QR       +   + VA G+ YL 
Sbjct: 89  GI-------MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL- 140
Query: 383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK----VKGTVGYL 438
             AE++ +HRD+ + N +L ES   KVADFG AR      DR + S +     +  V + 
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLAR---DILDREYYSVQQHRHARLPVKWT 195
Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
             E ++TY+ TTKSDV+SFGVLL E+LT   P
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYKA--QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLL 329
           +G G FGTV K   Q++  +     +  K +  +  L+ E  +E  ++ ++D+  +V+++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G  +     +++ E    G L ++L  Q  + +     +E+   V+ G+ YL    E   
Sbjct: 79  GICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 132
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+LL     AK++DFG ++    D +     T  K  V +  PE +  Y+ +
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           +KSDV+SFGVL+ E  + G++P
Sbjct: 193 SKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYKA--QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLL 329
           +G G FGTV K   Q++  +     +  K +  +  L+ E  +E  ++ ++D+  +V+++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G  +     +++ E    G L ++L  Q  + +     +E+   V+ G+ YL    E   
Sbjct: 75  GICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 128
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+LL     AK++DFG ++    D +     T  K  V +  PE +  Y+ +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           +KSDV+SFGVL+ E  + G++P
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYKA--QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLL 329
           +G G FGTV K   Q++  +     +  K +  +  L+ E  +E  ++ ++D+  +V+++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G  +     +++ E    G L ++L  Q  + +     +E+   V+ G+ YL    E   
Sbjct: 79  GICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 132
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+LL     AK++DFG ++    D +     T  K  V +  PE +  Y+ +
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           +KSDV+SFGVL+ E  + G++P
Sbjct: 193 SKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYKA--QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLL 329
           +G G FGTV K   Q++  +     +  K +  +  L+ E  +E  ++ ++D+  +V+++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G  +     +++ E    G L ++L  Q  + +     +E+   V+ G+ YL    E   
Sbjct: 93  GICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 146
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+LL     AK++DFG ++    D +     T  K  V +  PE +  Y+ +
Sbjct: 147 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 206
Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           +KSDV+SFGVL+ E  + G++P
Sbjct: 207 SKSDVWSFGVLMWEAFSYGQKP 228

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYKA--QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLL 329
           +G G FGTV K   Q++  +     +  K +  +  L+ E  +E  ++ ++D+  +V+++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G  +     +++ E    G L ++L  Q  + +     +E+   V+ G+ YL    E   
Sbjct: 95  GICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 148
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+LL     AK++DFG ++    D +     T  K  V +  PE +  Y+ +
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           +KSDV+SFGVL+ E  + G++P
Sbjct: 209 SKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYKA--QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLL 329
           +G G FGTV K   Q++  +     +  K +  +  L+ E  +E  ++ ++D+  +V+++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G  +     +++ E    G L ++L  Q  + +     +E+   V+ G+ YL    E   
Sbjct: 95  GICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 148
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+LL     AK++DFG ++    D +     T  K  V +  PE +  Y+ +
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           +KSDV+SFGVL+ E  + G++P
Sbjct: 209 SKSDVWSFGVLMWEAFSYGQKP 230

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYKA--QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLL 329
           +G G FGTV K   Q++  +     +  K +  +  L+ E  +E  ++ ++D+  +V+++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G  +     +++ E    G L ++L  Q  + +     +E+   V+ G+ YL    E   
Sbjct: 73  GICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 126
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+LL     AK++DFG ++    D +     T  K  V +  PE +  Y+ +
Sbjct: 127 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 186
Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           +KSDV+SFGVL+ E  + G++P
Sbjct: 187 SKSDVWSFGVLMWEAFSYGQKP 208

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYKA--QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLL 329
           +G G FGTV K   Q++  +     +  K +  +  L+ E  +E  ++ ++D+  +V+++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G  +     +++ E    G L ++L  Q  + +     +E+   V+ G+ YL    E   
Sbjct: 85  GICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 138
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+LL     AK++DFG ++    D +     T  K  V +  PE +  Y+ +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           +KSDV+SFGVL+ E  + G++P
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 121/273 (44%), Gaps = 34/273 (12%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL- 329
           +G GG   V+ A+ L D   VA+K  RA   +  +    F  E +  + ++H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 330 ---GFVDKGNERLIITEFVPNGTLRE--HLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
                   G    I+ E+V   TLR+  H +G     +   + +E+  D    L + H  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSH-- 133
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +  IIHRDVK +NI+++ +   KV DFG AR      +    +  V GT  YL PE  +
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK 504
              +  +SDVYS G +L E+LTG  P     P      +  A++   E    D + PS +
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVRE----DPIPPSAR 242
Query: 505 --------EVISMEILTKMFGLAIQCAAPIRND 529
                   + + ++ L K      Q AA +R D
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL- 329
           +G GG   V+ A+ L D   VA+K  RA   +  +    F  E +  + ++H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 330 ---GFVDKGNERLIITEFVPNGTLRE--HLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
                   G    I+ E+V   TLR+  H +G     +   + +E+  D    L + H  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSH-- 133
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +  IIHRDVK +NI+++ +   KV DFG AR      +    +  V GT  YL PE  +
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRP 470
              +  +SDVYS G +L E+LTG  P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 12/202 (5%)
Query: 274 IGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           +GEG FG VY+        + + VA+K  KK+   + + +F SE  ++  +DH ++VKL+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G +++     II E  P G L  +L+ +   +L     +  ++ +   + YL        
Sbjct: 92  GIIEE-EPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLE---SINC 146
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+   NIL+      K+ DFG +R   ++ +  + ++  +  + ++ PE +   + T
Sbjct: 147 VHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKASVTRLPIKWMSPESINFRRFT 204
Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           T SDV+ F V + EIL+ G++P
Sbjct: 205 TASDVWMFAVCMWEILSFGKQP 226

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYKA--QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLL 329
           +G G FGTV K   Q++  +     +  K +  +  L+ E  +E  ++ ++D+  +V+++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G  +     +++ E    G L ++L  Q  + +     +E+   V+ G+ YL    E   
Sbjct: 437 GICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 490
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+LL     AK++DFG ++    D +     T  K  V +  PE +  Y+ +
Sbjct: 491 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 550
Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           +KSDV+SFGVL+ E  + G++P
Sbjct: 551 SKSDVWSFGVLMWEAFSYGQKP 572

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYKA--QLEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLL 329
           +G G FGTV K   Q++  +     +  K +  +  L+ E  +E  ++ ++D+  +V+++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G  +     +++ E    G L ++L  Q  + +     +E+   V+ G+ YL    E   
Sbjct: 438 GICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 491
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+ + N+LL     AK++DFG ++    D +     T  K  V +  PE +  Y+ +
Sbjct: 492 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 551
Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           +KSDV+SFGVL+ E  + G++P
Sbjct: 552 SKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 12/202 (5%)
Query: 274 IGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           +GEG FG VY+        + + VA+K  KK+   + + +F SE  ++  +DH ++VKL+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G +++     II E  P G L  +L+ +   +L     +  ++ +   + YL        
Sbjct: 80  GIIEE-EPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLE---SINC 134
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+   NIL+      K+ DFG +R   ++ +  + ++  +  + ++ PE +   + T
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           T SDV+ F V + EIL+ G++P
Sbjct: 193 TASDVWMFAVCMWEILSFGKQP 214

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 12/202 (5%)
Query: 274 IGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           +GEG FG VY+        + + VA+K  KK+   + + +F SE  ++  +DH ++VKL+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G +++     II E  P G L  +L+ +   +L     +  ++ +   + YL        
Sbjct: 76  GIIEE-EPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLE---SINC 130
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+   NIL+      K+ DFG +R   ++ +  + ++  +  + ++ PE +   + T
Sbjct: 131 VHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           T SDV+ F V + EIL+ G++P
Sbjct: 189 TASDVWMFAVCMWEILSFGKQP 210

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 119/273 (43%), Gaps = 34/273 (12%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G GG   V+ A+   L   + V + RA   +  +    F  E +  + ++H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 331 F----VDKGNERLIITEFVPNGTLRE--HLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
                   G    I+ E+V   TLR+  H +G     +   + +E+  D    L + H  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSH-- 133
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +  IIHRDVK +NI+++ +   KV DFG AR      +    +  V GT  YL PE  +
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK 504
              +  +SDVYS G +L E+LTG  P     P      +  A++   E    D + PS +
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVRE----DPIPPSAR 242
Query: 505 --------EVISMEILTKMFGLAIQCAAPIRND 529
                   + + ++ L K      Q AA +R D
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 119/273 (43%), Gaps = 34/273 (12%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL- 329
           +G GG   V+ A+   L   + V + RA   +  +    F  E +  + ++H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 330 ---GFVDKGNERLIITEFVPNGTLRE--HLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
                   G    I+ E+V   TLR+  H +G     +   + +E+  D    L + H  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSH-- 133
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +  IIHRDVK +NI+++ +   KV DFG AR      +    +  V GT  YL PE  +
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK 504
              +  +SDVYS G +L E+LTG  P     P      +  A++   E    D + PS +
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVRE----DPIPPSAR 242
Query: 505 --------EVISMEILTKMFGLAIQCAAPIRND 529
                   + + ++ L K      Q AA +R D
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 120/254 (47%), Gaps = 38/254 (14%)
Query: 258 MSQVVKATRNFSPSLRIGEGGFGTVYKAQL--EDG--LLVAIKRAKKEQFENLQTE-FSS 312
           +  V+   + F+    +G+G FG+V +AQL  EDG  + VA+K  K +   +   E F  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 313 EVELLSKIDHRNLVKLLGFVDKGNER------LIITEFVPNGTLREHL----DGQYGKTL 362
           E   + + DH ++ KL+G   +   +      ++I  F+ +G L   L     G+    L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 363 DFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMD 421
                +   +D+A G+ YL   + +  IHRD+ + N +L E M   VADFG +R +   D
Sbjct: 135 PLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPV--------- 471
             R   ++K+   V +L  E +     T  SDV++FGV + EI+T G+ P          
Sbjct: 192 YYRQGCASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 472 -------ELKRPPE 478
                   LK+PPE
Sbjct: 250 NYLIGGNRLKQPPE 263

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTV+K   + +G    + V IK  + +         +  +  +  +DH ++V+L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           LG    G+   ++T+++P G+L +H+  Q+   L     L   + +A G+ YL    E  
Sbjct: 81  LGLC-PGSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLE---EHG 135
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           ++HR++ + N+LL    + +VADFG A L P D D+  + ++ K  + ++  E +   + 
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-DKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 449 TTKSDVYSFGVLLLEILT 466
           T +SDV+S+GV + E++T
Sbjct: 195 THQSDVWSYGVTVWELMT 212

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 12/203 (5%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + DG    + VAIK  ++        E   E  +++ +    + +L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           LG       +L+ T+ +P G L +H+    G+ L     L   + +A G++YL    + +
Sbjct: 85  LGICLTSTVQLV-TQLMPYGCLLDHVRENRGR-LGSQDLLNWCMQIAKGMSYLE---DVR 139
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           ++HRD+ + N+L+      K+ DFG ARL  +D    H +   K  + ++  E +   + 
Sbjct: 140 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH-ADGGKVPIKWMALESILRRRF 198
Query: 449 TTKSDVYSFGVLLLEILT-GRRP 470
           T +SDV+S+GV + E++T G +P
Sbjct: 199 THQSDVWSYGVTVWELMTFGAKP 221

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTV+K   + +G    + V IK  + +         +  +  +  +DH ++V+L
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           LG    G+   ++T+++P G+L +H+  Q+   L     L   + +A G+ YL    E  
Sbjct: 99  LGLC-PGSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLE---EHG 153
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           ++HR++ + N+LL    + +VADFG A L P D D+  + ++ K  + ++  E +   + 
Sbjct: 154 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-DKQLLYSEAKTPIKWMALESIHFGKY 212
Query: 449 TTKSDVYSFGVLLLEILT 466
           T +SDV+S+GV + E++T
Sbjct: 213 THQSDVWSYGVTVWELMT 230

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 273 RIGEGGFGTVYKAQLEDGLL---VAIKR---AKKEQFENLQTEFSSEVELLSKIDHRNLV 326
           ++G GG  TVY A  ED +L   VAIK      +E+ E L+  F  EV   S++ H+N+V
Sbjct: 18  KLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLK-RFEREVHNSSQLSHQNIV 74
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            ++   ++ +   ++ E++   TL E+++      L  +  +     +  G+ + H   +
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAH---D 129
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
            +I+HRD+K  NIL+  +   K+ DFG A+   +       +  V GTV Y  PE  K  
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
                +D+YS G++L E+L G  P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 108/204 (52%), Gaps = 10/204 (4%)
Query: 268 FSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
           F+   RIG+G FG V+K        +VAIK    E+ E+   +   E+ +LS+ D   + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           K  G   KG++  II E++  G+    LD       D  Q   +  ++  GL YLH  +E
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGS---ALDLLRAGPFDEFQIATMLKEILKGLDYLH--SE 139
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K+I HRD+K++N+LL+E    K+ADFG A  G +   +   +T V GT  ++ PE ++  
Sbjct: 140 KKI-HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFV-GTPFWMAPEVIQQS 195
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
              +K+D++S G+  +E+  G  P
Sbjct: 196 AYDSKADIWSLGITAIELAKGEPP 219

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 119/273 (43%), Gaps = 34/273 (12%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL- 329
           +G GG   V+ A+   L   + V + RA   +  +    F  E +  + ++H  +V +  
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 96
Query: 330 ---GFVDKGNERLIITEFVPNGTLRE--HLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
                   G    I+ E+V   TLR+  H +G     +   + +E+  D    L + H  
Sbjct: 97  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSH-- 150
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +  IIHRDVK +NI+++ +   KV DFG AR      +    +  V GT  YL PE  +
Sbjct: 151 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 209
Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK 504
              +  +SDVYS G +L E+LTG  P     P      +  A++   E    D + PS +
Sbjct: 210 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVRE----DPIPPSAR 259
Query: 505 --------EVISMEILTKMFGLAIQCAAPIRND 529
                   + + ++ L K      Q AA +R D
Sbjct: 260 HEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 292

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 133/274 (48%), Gaps = 27/274 (9%)
Query: 272 LRIGEGGFGTVYKA---QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           + +G G FG+V +      +  + VAIK  K+   +    E   E +++ ++D+  +V+L
Sbjct: 16  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           +G V +    +++ E    G L + L G+  + +  +   E+   V+ G+ YL    EK 
Sbjct: 76  IG-VCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE---EKN 130
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            +HRD+ + N+LL     AK++DFG ++ LG  DS  T  S   K  + +  PE +   +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-KWPLKWYAPECINFRK 189
Query: 448 LTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEV 506
            +++SDV+S+GV + E L+ G++P +  + PE                ++  ++   +  
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----------------VMAFIEQGKRME 233
Query: 507 ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
              E   +++ L   C      DRPD  +V +++
Sbjct: 234 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 18/225 (8%)
Query: 257 NMSQVVKATRNFSPSL------RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEF 310
           +M Q    TR+ +P         +G+G FG VYKAQ ++  ++A  +    + E    ++
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 311 SSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI 370
             E+++L+  DH N+VKLL      N   I+ EF   G + + +  +  + L  +Q   +
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVV 140
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
                  L YLH   + +IIHRD+K+ NIL T     K+ADFG +        R      
Sbjct: 141 CKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR---RDS 194
Query: 431 VKGTVGYLDPEYM-----KTYQLTTKSDVYSFGVLLLEILTGRRP 470
             GT  ++ PE +     K      K+DV+S G+ L+E+     P
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 18/225 (8%)
Query: 257 NMSQVVKATRNFSPSL------RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEF 310
           +M Q    TR+ +P         +G+G FG VYKAQ ++  ++A  +    + E    ++
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 311 SSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI 370
             E+++L+  DH N+VKLL      N   I+ EF   G + + +  +  + L  +Q   +
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVV 140
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
                  L YLH   + +IIHRD+K+ NIL T     K+ADFG +        R      
Sbjct: 141 CKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR---RDX 194
Query: 431 VKGTVGYLDPEYM-----KTYQLTTKSDVYSFGVLLLEILTGRRP 470
             GT  ++ PE +     K      K+DV+S G+ L+E+     P
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 18/225 (8%)
Query: 257 NMSQVVKATRNFSPSL------RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEF 310
           +M Q    TR+ +P         +G+G FG VYKAQ ++  ++A  +    + E    ++
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 311 SSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI 370
             E+++L+  DH N+VKLL      N   I+ EF   G + + +  +  + L  +Q   +
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVV 140
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
                  L YLH   + +IIHRD+K+ NIL T     K+ADFG +        R      
Sbjct: 141 CKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDS 194
Query: 431 VKGTVGYLDPEYM-----KTYQLTTKSDVYSFGVLLLEILTGRRP 470
             GT  ++ PE +     K      K+DV+S G+ L+E+     P
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 273 RIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IG+G  GTVY A  +  G  VAI++   +Q +  +    +E+ ++ +  + N+V  L  
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
              G+E  ++ E++  G+L    D      +D  Q   +  +    L +LH     Q+IH
Sbjct: 86  YLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIH 139
Query: 392 RDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           RD+KS NILL      K+ DFGF A++ P  S R+ +     GT  ++ PE +       
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV----GTPYWMAPEVVTRKAYGP 195
Query: 451 KSDVYSFGVLLLEILTGRRP 470
           K D++S G++ +E++ G  P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 8/201 (3%)
Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
            +G+G FG VYKA+  E G L A K  + +  E L+ ++  E+E+L+  DH  +VKLLG 
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIVKLLGA 76
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
                +  I+ EF P G + + +  +  + L   Q   +   +   L +LH    K+IIH
Sbjct: 77  YYHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIH 132
Query: 392 RDVKSSNILLTESMRAKVADFGFA--RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           RD+K+ N+L+T     ++ADFG +   L  +    + I T        +  E MK     
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 192
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            K+D++S G+ L+E+     P
Sbjct: 193 YKADIWSLGITLIEMAQIEPP 213

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 8/200 (4%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G+G FG VYKA+  E G L A K  + +  E L+ ++  E+E+L+  DH  +VKLLG  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIVKLLGAY 85
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
               +  I+ EF P G + + +  +  + L   Q   +   +   L +LH    K+IIHR
Sbjct: 86  YHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHR 141
Query: 393 DVKSSNILLTESMRAKVADFGFA--RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           D+K+ N+L+T     ++ADFG +   L  +    + I T        +  E MK      
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDY 201
Query: 451 KSDVYSFGVLLLEILTGRRP 470
           K+D++S G+ L+E+     P
Sbjct: 202 KADIWSLGITLIEMAQIEPP 221

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 273 RIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IG+G  GTVY A  +  G  VAI++   +Q +  +    +E+ ++ +  + N+V  L  
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
              G+E  ++ E++  G+L    D      +D  Q   +  +    L +LH     Q+IH
Sbjct: 86  YLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIH 139
Query: 392 RDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           RD+KS NILL      K+ DFGF A++ P  S R   ST V GT  ++ PE +       
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMV-GTPYWMAPEVVTRKAYGP 195
Query: 451 KSDVYSFGVLLLEILTGRRP 470
           K D++S G++ +E++ G  P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 122/290 (42%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLV 326
           +G G FG V +A      +      VA+K  K+    +      SE+++L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 327 KLLGFVDK-GNERLIITEFVPNGTLREHLDGQ--------------YGKTLDFNQRLEIA 371
            LLG   K G   ++ITEF   G L  +L  +              Y   L     +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV 431
             VA G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR    D D        
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR-KGDA 201
Query: 432 KGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF-KRY 490
           +  + ++ PE +     T +SDV+SFGVLL EI +      L   P   V +   F +R 
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCRRL 255
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG  +   D +  E         M+   + C     + RP    + E L
Sbjct: 256 KEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 109/206 (52%), Gaps = 21/206 (10%)
Query: 273 RIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G + TVYK      G+ VA+K  K +  E   +    E+ L+ ++ H N+V+L   
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 332 VDKGNERLIITEFVPNGTLREHLD----GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           +   N+  ++ EF+ N  L++++D    G   + L+ N        +  GL + H   E 
Sbjct: 72  IHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---EN 127
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFAR-LG-PMDSDRTHISTKVKGTVGYLDPEYM-- 443
           +I+HRD+K  N+L+ +  + K+ DFG AR  G P+++  + +      T+ Y  P+ +  
Sbjct: 128 KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-----TLWYRAPDVLMG 182
Query: 444 -KTYQLTTKSDVYSFGVLLLEILTGR 468
            +TY  +T  D++S G +L E++TG+
Sbjct: 183 SRTY--STSIDIWSCGCILAEMITGK 206

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IG+G  GTVY A  +  G  VAI++   +Q +  +    +E+ ++ +  + N+V  L  
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
              G+E  ++ E++  G+L    D      +D  Q   +  +    L +LH     Q+IH
Sbjct: 86  YLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIH 139
Query: 392 RDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           RD+KS NILL      K+ DFGF A++ P  S R+ +     GT  ++ PE +       
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV----GTPYWMAPEVVTRKAYGP 195
Query: 451 KSDVYSFGVLLLEILTGRRP 470
           K D++S G++ +E++ G  P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 107/204 (52%), Gaps = 10/204 (4%)
Query: 268 FSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
           F+   +IG+G FG V+K        +VAIK    E+ E+   +   E+ +LS+ D   + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           K  G   K  +  II E++  G+    LD      LD  Q   I  ++  GL YLH  +E
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILREILKGLDYLH--SE 123
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K+I HRD+K++N+LL+E    K+ADFG A  G +   +   +T V GT  ++ PE +K  
Sbjct: 124 KKI-HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFV-GTPFWMAPEVIKQS 179
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
              +K+D++S G+  +E+  G  P
Sbjct: 180 AYDSKADIWSLGITAIELARGEPP 203

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IG+G  GTVY A  +  G  VAI++   +Q +  +    +E+ ++ +  + N+V  L  
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
              G+E  ++ E++  G+L    D      +D  Q   +  +    L +LH     Q+IH
Sbjct: 87  YLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIH 140
Query: 392 RDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           RD+KS NILL      K+ DFGF A++ P  S R+ +     GT  ++ PE +       
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV----GTPYWMAPEVVTRKAYGP 196
Query: 451 KSDVYSFGVLLLEILTGRRP 470
           K D++S G++ +E++ G  P
Sbjct: 197 KVDIWSLGIMAIEMIEGEPP 216

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 108/204 (52%), Gaps = 10/204 (4%)
Query: 268 FSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
           F+   +IG+G FG V+K        +VAIK    E+ E+   +   E+ +LS+ D   + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           K  G   K  +  II E++  G+  + L+      LD  Q   I  ++  GL YLH  +E
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLH--SE 143
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K+I HRD+K++N+LL+E    K+ADFG A  G +   +   +T V GT  ++ PE +K  
Sbjct: 144 KKI-HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFV-GTPFWMAPEVIKQS 199
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
              +K+D++S G+  +E+  G  P
Sbjct: 200 AYDSKADIWSLGITAIELARGEPP 223

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G FG V+  +    GL   IK   K++ +    +  +E+E+L  +DH N++K+   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQY--GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            +  +   I+ E    G L E +      GK L      E+   + + L Y H    + +
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHV 145
Query: 390 IHRDVKSSNILLTES---MRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           +H+D+K  NIL  ++      K+ DFG A L   D      ST   GT  Y+ PE  K  
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH----STNAAGTALYMAPEVFKR- 200
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
            +T K D++S GV++  +LTG  P
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 122/290 (42%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLV 326
           +G G FG V +A      +      VA+K  K+    +      SE+++L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 327 KLLGFVDK-GNERLIITEFVPNGTLREHLDGQ--------------YGKTLDFNQRLEIA 371
            LLG   K G   ++ITEF   G L  +L  +              Y   L     +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV 431
             VA G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR    D D        
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDA 201
Query: 432 KGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRY 490
           +  + ++ PE +     T +SDV+SFGVLL EI + G  P    +  EE        +R 
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRL 255
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG  +   D +  E         M+   + C     + RP    + E L
Sbjct: 256 KEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 122/290 (42%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLV 326
           +G G FG V +A      +      VA+K  K+    +      SE+++L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 327 KLLGFVDK-GNERLIITEFVPNGTLREHLDGQ--------------YGKTLDFNQRLEIA 371
            LLG   K G   ++ITEF   G L  +L  +              Y   L     +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV 431
             VA G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR    D D        
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDA 201
Query: 432 KGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRY 490
           +  + ++ PE +     T +SDV+SFGVLL EI + G  P    +  EE        +R 
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRL 255
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG  +   D +  E         M+   + C     + RP    + E L
Sbjct: 256 KEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 80  LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAEGMNYLE-- 131
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 132 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 189
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 190 HRIYTHQSDVWSYGVTVWELMTFGSKP 216

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 86  LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 137
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 138 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 195
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 86  LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 137
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 138 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 195
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 83  LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 134
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 192
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 85  LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 136
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 194
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 77  LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 128
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 129 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 186
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKP 213

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 86  LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 137
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 138 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 195
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 89  LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 140
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 141 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 198
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 199 HRIYTHQSDVWSYGVTVWELMTFGSKP 225

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 83  LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 134
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 192
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 90  LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 141
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 142 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 199
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 93  LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 144
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 145 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 202
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 203 HRIYTHQSDVWSYGVTVWELMTFGSKP 229

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 134/276 (48%), Gaps = 27/276 (9%)
Query: 272 LRIGEGGFGTVYKA---QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           + +G G FG+V +      +  + VAIK  K+   +    E   E +++ ++D+  +V+L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           +G V +    +++ E    G L + L G+  + +  +   E+   V+ G+ YL    EK 
Sbjct: 402 IG-VCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE---EKN 456
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            +HR++ + N+LL     AK++DFG ++ LG  DS  T  S   K  + +  PE +   +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-KWPLKWYAPECINFRK 515
Query: 448 LTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEV 506
            +++SDV+S+GV + E L+ G++P +  + PE                ++  ++   +  
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----------------VMAFIEQGKRME 559
Query: 507 ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA 542
              E   +++ L   C      DRPD  +V +++ A
Sbjct: 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 272 LRIGEGGFGTVYKAQLED-GLLVAIKRA--KKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           ++IGEG  G V  A +   G LVA+K+   +K+Q   L     +EV ++    H N+V++
Sbjct: 37  IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEM 93
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                 G+E  ++ EF+  G L    D      ++  Q   + + V   L+ LH    + 
Sbjct: 94  YNSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQG 147
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           +IHRD+KS +ILLT   R K++DFGF      +  R      + GT  ++ PE +     
Sbjct: 148 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVGTPYWMAPELISRLPY 204
Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
             + D++S G++++E++ G  P
Sbjct: 205 GPEVDIWSLGIMVIEMVDGEPP 226

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 272 LRIGEGGFGTVYKAQLED-GLLVAIKRA--KKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           ++IGEG  G V  A +   G LVA+K+   +K+Q   L     +EV ++    H N+V++
Sbjct: 35  IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEM 91
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                 G+E  ++ EF+  G L    D      ++  Q   + + V   L+ LH    + 
Sbjct: 92  YNSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQG 145
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           +IHRD+KS +ILLT   R K++DFGF      +  R      + GT  ++ PE +     
Sbjct: 146 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVGTPYWMAPELISRLPY 202
Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
             + D++S G++++E++ G  P
Sbjct: 203 GPEVDIWSLGIMVIEMVDGEPP 224

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 108 LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 159
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 160 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 217
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 218 HRIYTHQSDVWSYGVTVWELMTFGSKP 244

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 83  LGICLTSTVQLI-TQLMPFGXLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 134
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 192
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 272 LRIGEGGFGTVYKAQLED-GLLVAIKRA--KKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           ++IGEG  G V  A +   G LVA+K+   +K+Q   L     +EV ++    H N+V++
Sbjct: 30  IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEM 86
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                 G+E  ++ EF+  G L    D      ++  Q   + + V   L+ LH    + 
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALT---DIVTHTRMNEEQIAAVCLAVLQALSVLH---AQG 140
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           +IHRD+KS +ILLT   R K++DFGF      +  R      + GT  ++ PE +     
Sbjct: 141 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVGTPYWMAPELISRLPY 197
Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
             + D++S G++++E++ G  P
Sbjct: 198 GPEVDIWSLGIMVIEMVDGEPP 219

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 272 LRIGEGGFGTVYKAQLED-GLLVAIKRA--KKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           ++IGEG  G V  A +   G LVA+K+   +K+Q   L     +EV ++    H N+V++
Sbjct: 26  IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEM 82
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                 G+E  ++ EF+  G L    D      ++  Q   + + V   L+ LH    + 
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALT---DIVTHTRMNEEQIAAVCLAVLQALSVLH---AQG 136
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           +IHRD+KS +ILLT   R K++DFGF      +  R      + GT  ++ PE +     
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVGTPYWMAPELISRLPY 193
Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
             + D++S G++++E++ G  P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPP 215

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 272 LRIGEGGFGTVYKAQLED-GLLVAIKRA--KKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           ++IGEG  G V  A +   G LVA+K+   +K+Q   L     +EV ++    H N+V++
Sbjct: 157 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEM 213
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                 G+E  ++ EF+  G L    D      ++  Q   + + V   L+ LH      
Sbjct: 214 YNSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG--- 267
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK------GTVGYLDPEY 442
           +IHRD+KS +ILLT   R K++DFGF            +S +V       GT  ++ PE 
Sbjct: 268 VIHRDIKSDSILLTHDGRVKLSDFGFC---------AQVSKEVPRRKXLVGTPYWMAPEL 318
Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +       + D++S G++++E++ G  P
Sbjct: 319 ISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN 324
           NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL++ H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH-- 120
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM- 443
              +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE + 
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV--TLWYRAPEILL 176
Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGR 468
             K Y  +T  D++S G +  E++T R
Sbjct: 177 GCKYY--STAVDIWSLGCIFAEMVTRR 201

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 272 LRIGEGGFGTVYKA-QLEDGLLVAIKRA--KKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           ++IGEG  G V  A +   G  VA+K+   +K+Q   L     +EV ++    H N+V +
Sbjct: 51  IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL---LFNEVVIMRDYHHDNVVDM 107
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                 G+E  ++ EF+  G L    D      ++  Q   + + V   L+YLH    + 
Sbjct: 108 YSSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEEQIATVCLSVLRALSYLH---NQG 161
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           +IHRD+KS +ILLT   R K++DFGF       S        + GT  ++ PE +     
Sbjct: 162 VIHRDIKSDSILLTSDGRIKLSDFGFC---AQVSKEVPKRKXLVGTPYWMAPEVISRLPY 218
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP 477
            T+ D++S G++++E++ G  P     PP
Sbjct: 219 GTEVDIWSLGIMVIEMIDGEPPY-FNEPP 246

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 121/288 (42%), Gaps = 40/288 (13%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLV 326
           +G G FG V +A      +      VA+K  K+    +      SE+++L  I H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 327 KLLGFVDK-GNERLIITEFVPNGTLREHLDGQ------------YGKTLDFNQRLEIAID 373
            LLG   K G   ++I EF   G L  +L  +            Y   L     +  +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
           VA G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR    D D        + 
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR-KGDARL 212
Query: 434 TVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF-KRYNE 492
            + ++ PE +     T +SDV+SFGVLL EI +      L   P   V +   F +R  E
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCRRLKE 266
Query: 493 GNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
           G  +   D +  E         M+   + C     + RP    + E L
Sbjct: 267 GTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 272 LRIGEGGFGTVYKAQLED-GLLVAIKRA--KKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           ++IGEG  G V  A +   G LVA+K+   +K+Q   L     +EV ++    H N+V++
Sbjct: 80  IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEM 136
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                 G+E  ++ EF+  G L    D      ++  Q   + + V   L+ LH    + 
Sbjct: 137 YNSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQG 190
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           +IHRD+KS +ILLT   R K++DFGF      +  R      + GT  ++ PE +     
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVGTPYWMAPELISRLPY 247
Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
             + D++S G++++E++ G  P
Sbjct: 248 GPEVDIWSLGIMVIEMVDGEPP 269

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 121/289 (41%), Gaps = 41/289 (14%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLV 326
           +G G FG V +A      +      VA+K  K+    +      SE+++L  I H  N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 327 KLLGFVDK-GNERLIITEFVPNGTLREHLDGQ-------------YGKTLDFNQRLEIAI 372
            LLG   K G   ++I EF   G L  +L  +             Y   L     +  + 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 373 DVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK 432
            VA G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR    D D        +
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR-KGDAR 211
Query: 433 GTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF-KRYN 491
             + ++ PE +     T +SDV+SFGVLL EI +      L   P   V +   F +R  
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCRRLK 265
Query: 492 EGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
           EG  +   D +  E         M+   + C     + RP    + E L
Sbjct: 266 EGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 122 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 175
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 176 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 203

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 120 H---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 173
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 174 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 201

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 122 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 175
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 176 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 203

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 121/286 (42%), Gaps = 38/286 (13%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLV 326
           +G G FG V +A      +      VA+K  K+    +      SE+++L  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 327 KLLGFVDK-GNERLIITEFVPNGTLREHLDGQ----------YGKTLDFNQRLEIAIDVA 375
            LLG   K G   ++I EF   G L  +L  +          Y   L     +  +  VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
            G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR    D D        +  +
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDARLPL 210
Query: 436 GYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF-KRYNEGN 494
            ++ PE +     T +SDV+SFGVLL EI +      L   P   V +   F +R  EG 
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCRRLKEGT 264
Query: 495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            +   D +  E         M+   + C     + RP    + E L
Sbjct: 265 RMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 14/207 (6%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN 324
           NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM- 443
              +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE + 
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV--TLWYRAPEILL 175
Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGR 468
             K Y  +T  D++S G +  E++T R
Sbjct: 176 GCKYY--STAVDIWSLGCIFAEMVTRR 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 173
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 174 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 201

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 121/290 (41%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLV 326
           +G G FG V +A      +      VA+K  K+    +      SE+++L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 327 KLLGFVDK-GNERLIITEFVPNGTLREHLDGQ--------------YGKTLDFNQRLEIA 371
            LLG   K G   ++I EF   G L  +L  +              Y   L     +  +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV 431
             VA G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR    D D        
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR-KGDA 201
Query: 432 KGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF-KRY 490
           +  + ++ PE +     T +SDV+SFGVLL EI +      L   P   V +   F +R 
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCRRL 255
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG  +   D +  E         M+   + C     + RP    + E L
Sbjct: 256 KEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 176
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 177 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 204

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 176
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 177 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 122 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 175
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 176 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 203

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 14/207 (6%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN 324
           NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM- 443
              +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE + 
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV--TLWYRAPEILL 176
Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGR 468
             K Y  +T  D++S G +  E++T R
Sbjct: 177 GCKYY--STAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 14/207 (6%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN 324
           NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM- 443
              +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE + 
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV--TLWYRAPEILL 175
Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGR 468
             K Y  +T  D++S G +  E++T R
Sbjct: 176 GCKYY--STAVDIWSLGCIFAEMVTRR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 173
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 174 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 14/207 (6%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN 324
           NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM- 443
              +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE + 
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPEILL 175
Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGR 468
             K Y  +T  D++S G +  E++T R
Sbjct: 176 GCKYY--STAVDIWSLGCIFAEMVTRR 200

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 122 H---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 175
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 176 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 14/207 (6%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN 324
           NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM- 443
              +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE + 
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPEILL 175
Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGR 468
             K Y  +T  D++S G +  E++T R
Sbjct: 176 GCKYY--STAVDIWSLGCIFAEMVTRR 200

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 173
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 174 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 201

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 10/204 (4%)
Query: 268 FSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
           F+   +IG+G FG V+K        +VAIK    E+ E+   +   E+ +LS+ D   + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           K  G   K  +  II E++  G+    LD      LD  Q   I  ++  GL YLH  +E
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILREILKGLDYLH--SE 138
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K+I HRD+K++N+LL+E    K+ADFG A  G +   +   +  V GT  ++ PE +K  
Sbjct: 139 KKI-HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFV-GTPFWMAPEVIKQS 194
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
              +K+D++S G+  +E+  G  P
Sbjct: 195 AYDSKADIWSLGITAIELARGEPP 218

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 174
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 175 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 173
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 174 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV--TLWYRAPE 174
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 175 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 202

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IG+G  GTVY A  +  G  VAI++   +Q +  +    +E+ ++ +  + N+V  L  
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
              G+E  ++ E++  G+L    D      +D  Q   +  +    L +LH     Q+IH
Sbjct: 87  YLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIH 140
Query: 392 RDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           R++KS NILL      K+ DFGF A++ P  S R   ST V GT  ++ PE +       
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMV-GTPYWMAPEVVTRKAYGP 196
Query: 451 KSDVYSFGVLLLEILTGRRP 470
           K D++S G++ +E++ G  P
Sbjct: 197 KVDIWSLGIMAIEMIEGEPP 216

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 14/207 (6%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN 324
           NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM- 443
              +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE + 
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV--TLWYRAPEILL 176
Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGR 468
             K Y  +T  D++S G +  E++T R
Sbjct: 177 GCKYY--STAVDIWSLGCIFAEMVTRR 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 121 H---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 174
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 175 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 176
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 177 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 204

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 14/207 (6%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN 324
           NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + H  
Sbjct: 71  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 127
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM- 443
              +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE + 
Sbjct: 128 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV--TLWYRAPEILL 183
Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGR 468
             K Y  +T  D++S G +  E++T R
Sbjct: 184 GCKYY--STAVDIWSLGCIFAEMVTRR 208

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 121/286 (42%), Gaps = 38/286 (13%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLV 326
           +G G FG V +A      +      VA+K  K+    +      SE+++L  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 327 KLLGFVDK-GNERLIITEFVPNGTLREHLDGQ----------YGKTLDFNQRLEIAIDVA 375
            LLG   K G   ++I EF   G L  +L  +          Y   L     +  +  VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
            G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR    D D        +  +
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVR-KGDARLPL 210
Query: 436 GYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF-KRYNEGN 494
            ++ PE +     T +SDV+SFGVLL EI +      L   P   V +   F +R  EG 
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFXRRLKEGT 264
Query: 495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            +   D +  E         M+   + C     + RP    + E L
Sbjct: 265 RMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 121/290 (41%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLV 326
           +G G FG V +A      +      VA+K  K+    +      SE+++L  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 327 KLLGFVDK-GNERLIITEFVPNGTLREHLDGQ--------------YGKTLDFNQRLEIA 371
            LLG   K G   ++I EF   G L  +L  +              Y   L     +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV 431
             VA G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR    D D        
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR-KGDA 210
Query: 432 KGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF-KRY 490
           +  + ++ PE +     T +SDV+SFGVLL EI +      L   P   V +   F +R 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCRRL 264
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG  +   D +  E         M+   + C     + RP    + E L
Sbjct: 265 KEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 14/207 (6%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN 324
           NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + H  
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 121
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM- 443
              +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE + 
Sbjct: 122 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPEILL 177
Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGR 468
             K Y  +T  D++S G +  E++T R
Sbjct: 178 GCKYY--STAVDIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 124 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 177
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 178 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 205

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 14/207 (6%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN 324
           NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++H N
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + H  
Sbjct: 68  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 124
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM- 443
              +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE + 
Sbjct: 125 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV--TLWYRAPEILL 180
Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGR 468
             K Y  +T  D++S G +  E++T R
Sbjct: 181 GCKYY--STAVDIWSLGCIFAEMVTRR 205

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 10/204 (4%)
Query: 268 FSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
           F+   +IG+G FG V+K        +VAIK    E+ E+   +   E+ +LS+ D   + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           K  G   K  +  II E++  G+    LD      LD  Q   I  ++  GL YLH  +E
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILREILKGLDYLH--SE 123
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K+I HRD+K++N+LL+E    K+ADFG A  G +   +   +  V GT  ++ PE +K  
Sbjct: 124 KKI-HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFV-GTPFWMAPEVIKQS 179
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
              +K+D++S G+  +E+  G  P
Sbjct: 180 AYDSKADIWSLGITAIELARGEPP 203

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 13/210 (6%)
Query: 267 NFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQT--EFSSEVELLSKIDHR 323
           NF    +IG G F  VY+A  L DG+ VA+K+ +     + +   +   E++LL +++H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLR---EHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
           N++K      + NE  I+ E    G L    +H   Q  + +      +  + +   L +
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEH 151
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
           +H    ++++HRD+K +N+ +T +   K+ D G  R     S +T  +  + GT  Y+ P
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYYMSP 205
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           E +       KSD++S G LL E+   + P
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI+ + +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 87  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 138
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 139 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 196
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI+ + +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 85  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 136
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 194
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI+ + +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 84  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 135
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 136 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 193
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 121 H---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 174
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 175 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 202

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 90  LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 141
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 142 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH-AEGGKVPIKWMALESIL 199
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 14/207 (6%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN 324
           NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + H  
Sbjct: 71  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 127
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM- 443
              +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE + 
Sbjct: 128 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV--TLWYRAPEILL 183
Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGR 468
             K Y  +T  D++S G +  E++T R
Sbjct: 184 GXKYY--STAVDIWSLGCIFAEMVTRR 208

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 123 H---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 176
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 177 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 204

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 83  LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 134
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH-AEGGKVPIKWMALESIL 192
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI+ + +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 86  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 137
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 138 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 195
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 85  LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 136
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH-AEGGKVPIKWMALESIL 194
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 14/207 (6%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN 324
           NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM- 443
              +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE + 
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV--TLWYRAPEILL 176
Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGR 468
             K Y  +T  D++S G +  E++T R
Sbjct: 177 GXKYY--STAVDIWSLGCIFAEMVTRR 201

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI+ + +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 83  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 134
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 192
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 121/290 (41%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLV 326
           +G G FG V +A      +      VA+K  K+    +      SE+++L  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 327 KLLGFVDK-GNERLIITEFVPNGTLREHLDGQ--------------YGKTLDFNQRLEIA 371
            LLG   K G   ++I EF   G L  +L  +              Y   L     +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV 431
             VA G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR    D D        
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVR-KGDA 210
Query: 432 KGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF-KRY 490
           +  + ++ PE +     T +SDV+SFGVLL EI +      L   P   V +   F +R 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCRRL 264
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG  +   D +  E         M+   + C     + RP    + E L
Sbjct: 265 KEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI+ + +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 84  LGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 135
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 136 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 193
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ EF+ +  L+  +D      +           +  GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 176
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 177 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 204

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 121/290 (41%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLV 326
           +G G FG V +A      +      VA+K  K+    +      SE+++L  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 327 KLLGFVDK-GNERLIITEFVPNGTLREHLDGQ--------------YGKTLDFNQRLEIA 371
            LLG   K G   ++I EF   G L  +L  +              Y   L     +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV 431
             VA G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR    D D        
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDA 210
Query: 432 KGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF-KRY 490
           +  + ++ PE +     T +SDV+SFGVLL EI +      L   P   V +   F +R 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCRRL 264
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG  +   D +  E         M+   + C     + RP    + E L
Sbjct: 265 KEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 121/290 (41%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLV 326
           +G G FG V +A      +      VA+K  K+    +      SE+++L  I H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 327 KLLGFVDK-GNERLIITEFVPNGTLREHLDGQ--------------YGKTLDFNQRLEIA 371
            LLG   K G   ++I EF   G L  +L  +              Y   L     +  +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV 431
             VA G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR    D D        
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDA 212
Query: 432 KGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF-KRY 490
           +  + ++ PE +     T +SDV+SFGVLL EI +      L   P   V +   F +R 
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCRRL 266
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG  +   D +  E         M+   + C     + RP    + E L
Sbjct: 267 KEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 123/273 (45%), Gaps = 32/273 (11%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G+G +G VY  + L + + +AIK    E+          E+ L   + H+N+V+ LG  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIP-ERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI-DVAHGLTYLHLYAEKQIIH 391
            +     I  E VP G+L   L  ++G   D  Q +      +  GL YLH   + QI+H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145
Query: 392 RDVKSSNILL-TESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEYMK--TYQ 447
           RD+K  N+L+ T S   K++DFG + RL  ++      +    GT+ Y+ PE +      
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINP----CTETFTGTLQYMAPEIIDKGPRG 201
Query: 448 LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI 507
               +D++S G  ++E+ TG+ P      P+  +     FK          V P I E +
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK----------VHPEIPESM 251
Query: 508 SMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
           S E   K F   ++C  P     PD ++    L
Sbjct: 252 SAE--AKAF--ILKCFEP----DPDKRACANDL 276

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 123/273 (45%), Gaps = 32/273 (11%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G+G +G VY  + L + + +AIK    E+          E+ L   + H+N+V+ LG  
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIP-ERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI-DVAHGLTYLHLYAEKQIIH 391
            +     I  E VP G+L   L  ++G   D  Q +      +  GL YLH   + QI+H
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 131
Query: 392 RDVKSSNILL-TESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEYMK--TYQ 447
           RD+K  N+L+ T S   K++DFG + RL  ++      +    GT+ Y+ PE +      
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINP----CTETFTGTLQYMAPEIIDKGPRG 187
Query: 448 LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI 507
               +D++S G  ++E+ TG+ P      P+  +     FK          V P I E +
Sbjct: 188 YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK----------VHPEIPESM 237
Query: 508 SMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
           S E   K F   ++C  P     PD ++    L
Sbjct: 238 SAE--AKAF--ILKCFEP----DPDKRACANDL 262

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 273 RIGEGGFGTVYKAQLEDG-LLVAIKRAKKEQF------------ENLQTEFSSEVELLSK 319
           ++G G +G V   + ++G    AIK  KK QF            E    E  +E+ LL  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 320 IDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLT 379
           +DH N++KL    +      ++TEF   G L E +  ++    D      I   +  G+ 
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGIC 160
Query: 380 YLHLYAEKQIIHRDVKSSNILLTES---MRAKVADFGFARLGPMD---SDRTHISTKVKG 433
           YLH +    I+HRD+K  NILL      +  K+ DFG +     D    DR        G
Sbjct: 161 YLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL-------G 210
Query: 434 TVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           T  Y+ PE +K  +   K DV+S GV++  +L G  P
Sbjct: 211 TAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 121/290 (41%), Gaps = 42/290 (14%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR-NLV 326
           +G G FG V +A      +      VA+K  K+    +      SE+++L  I H  N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 327 KLLGFVDK-GNERLIITEFVPNGTLREHLDGQ--------------YGKTLDFNQRLEIA 371
            LLG   K G   ++I EF   G L  +L  +              Y   L     +  +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV 431
             VA G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR    D D        
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDA 247
Query: 432 KGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF-KRY 490
           +  + ++ PE +     T +SDV+SFGVLL EI +      L   P   V +   F +R 
Sbjct: 248 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCRRL 301
Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG  +   D +  E         M+   + C     + RP    + E L
Sbjct: 302 KEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +  G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 83  LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 134
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 192
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +  G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 90  LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 141
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 142 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 199
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 14/210 (6%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKID 321
           +  NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N+VKLL  +   N+  ++ E V +  L++ +D      +           +  GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV--TLWYRAPE 176
Query: 442 YM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +   K Y  +T  D++S G +  E++T R
Sbjct: 177 ILLGCKYY--STAVDIWSLGCIFAEMVTRR 204

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 28/221 (12%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLV 326
           +G G FG V +A      + +  + VA+K  K       +    SE+++LS + +H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI---------------- 370
            LLG    G   L+ITE+   G L   L  +    +       I                
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
           +  VA G+ +L   A K  IHRD+ + NILLT     K+ DFG AR    DS+   +   
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV-VKGN 206
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
            +  V ++ PE +     T +SDV+S+G+ L E+ + G  P
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 28/221 (12%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLV 326
           +G G FG V +A      + +  + VA+K  K       +    SE+++LS + +H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI---------------- 370
            LLG    G   L+ITE+   G L   L  +    +       I                
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
           +  VA G+ +L   A K  IHRD+ + NILLT     K+ DFG AR    DS+   +   
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYV-VKGN 229
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
            +  V ++ PE +     T +SDV+S+G+ L E+ + G  P
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 123/288 (42%), Gaps = 41/288 (14%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +GE  FG VYK  L      E    VAIK  K +    L+ EF  E  L +++ H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL--------------DGQYGKTLDFNQRLEIAID 373
           LLG V K     +I  +  +G L E L              D      L+    + +   
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
           +A G+ YL   +   ++H+D+ + N+L+ + +  K++D G  R     +D   +      
Sbjct: 154 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-EVYAADYYKLLGNSLL 209
Query: 434 TVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNE 492
            + ++ PE +   + +  SD++S+GV+L E+ + G +P                +  Y+ 
Sbjct: 210 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP----------------YCGYSN 253
Query: 493 GNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            ++++M+          +    ++ L I+C     + RP  K +  +L
Sbjct: 254 QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI+ + +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 85  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 136
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH-AEGGKVPIKWMALESIL 194
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI+ + +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 87  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 138
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 139 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH-AEGGKVPIKWMALESIL 196
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 99  FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 151
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   ++ V GT  Y+ PE +    
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPELLTEKS 210
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
            +  SD+++ G ++ +++ G  P
Sbjct: 211 ASKSSDLWALGCIIYQLVAGLPP 233

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAI   ++        E   E  +++ +D+ ++ +L
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI T+ +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 117 LGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 168
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 169 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 226
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 227 HRIYTHQSDVWSYGVTVWELMTFGSKP 253

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 28/221 (12%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLV 326
           +G G FG V +A      + +  + VA+K  K       +    SE+++LS + +H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI---------------- 370
            LLG    G   L+ITE+   G L   L  +    +       I                
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
           +  VA G+ +L   A K  IHRD+ + NILLT     K+ DFG AR    DS+   +   
Sbjct: 167 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV-VKGN 222
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
            +  V ++ PE +     T +SDV+S+G+ L E+ + G  P
Sbjct: 223 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 263

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFS-SEVELLSKIDHRNLVKLLG 330
           +IGEG +G V+K +  D G +VAIK+  + + + +  + +  E+ +L ++ H NLV LL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +     ++ E+  +  L E LD +Y + +  +    I       + + H   +   I
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHE-LD-RYQRGVPEHLVKSITWQTLQAVNFCH---KHNCI 124
Query: 391 HRDVKSSNILLTESMRAKVADFGFARL--GPMDSDRTHISTKVKGTVGYLDPEYM-KTYQ 447
           HRDVK  NIL+T+    K+ DFGFARL  GP D     ++T+      Y  PE +    Q
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPELLVGDTQ 179
Query: 448 LTTKSDVYSFGVLLLEILTG 467
                DV++ G +  E+L+G
Sbjct: 180 YGPPVDVWAIGCVFAELLSG 199

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +G G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI+ + +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 85  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 136
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH-AEGGKVPIKWMALESIL 194
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 123/288 (42%), Gaps = 41/288 (14%)
Query: 274 IGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +GE  FG VYK  L      E    VAIK  K +    L+ EF  E  L +++ H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL--------------DGQYGKTLDFNQRLEIAID 373
           LLG V K     +I  +  +G L E L              D      L+    + +   
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
           +A G+ YL   +   ++H+D+ + N+L+ + +  K++D G  R     +D   +      
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-EVYAADYYKLLGNSLL 192
Query: 434 TVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNE 492
            + ++ PE +   + +  SD++S+GV+L E+ + G +P                +  Y+ 
Sbjct: 193 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP----------------YCGYSN 236
Query: 493 GNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            ++++M+          +    ++ L I+C     + RP  K +  +L
Sbjct: 237 QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 107/207 (51%), Gaps = 14/207 (6%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN 324
           NF    +IGEG +G VYKA+ +  G +VA+ + + + + E + +    E+ LL +++H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM- 443
              +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE + 
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV--TLWYRAPEILL 176
Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGR 468
             K Y  +T  D++S G +  E++T R
Sbjct: 177 GCKYY--STAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 107/207 (51%), Gaps = 14/207 (6%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN 324
           NF    +IGEG +G VYKA+ +  G +VA+ + + + + E + +    E+ LL +++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKLL  +   N+  ++ EF+ +  L++ +D      +           +  GL + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM- 443
              +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE + 
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV--TLWYRAPEILL 175
Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGR 468
             K Y  +T  D++S G +  E++T R
Sbjct: 176 GCKYY--STAVDIWSLGCIFAEMVTRR 200

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFSSEVEL-LSKIDHRNLVKLLG 330
           +G G FG V+  +   +G   A+K  KKE    L Q E +++  L LS + H  ++++ G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE--IAIDVAHGLTYLHLYAEKQ 388
                 +  +I +++  G L   L     K+  F   +    A +V   L YLH    K 
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLH---SKD 126
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           II+RD+K  NILL ++   K+ DFGFA+  P       ++  + GT  Y+ PE + T   
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVP------DVTYXLCGTPDYIAPEVVSTKPY 180
Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
               D +SFG+L+ E+L G  P
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTP 202

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 28/221 (12%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLV 326
           +G G FG V +A      + +  + VA+K  K       +    SE+++LS + +H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI---------------- 370
            LLG    G   L+ITE+   G L   L  +    +       I                
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
           +  VA G+ +L   A K  IHRD+ + NILLT     K+ DFG AR    DS+   +   
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV-VKGN 229
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
            +  V ++ PE +     T +SDV+S+G+ L E+ + G  P
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 26/206 (12%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++GEG +G VYKA+   G +VA+KR + + + E + +    E+ LL ++ H N+V L+  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFN----QRLEIAI---DVAHGLTYLHLY 384
           +   +ER +   F       E ++    K LD N    Q  +I I    +  G+ + H  
Sbjct: 88  IH--SERCLTLVF-------EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH-- 136
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE-Y 442
            + +I+HRD+K  N+L+      K+ADFG AR  G      TH       T+ Y  P+  
Sbjct: 137 -QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPDVL 191
Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGR 468
           M + + +T  D++S G +  E++TG+
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 28/221 (12%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLV 326
           +G G FG V +A      + +  + VA+K  K       +    SE+++LS + +H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI---------------- 370
            LLG    G   L+ITE+   G L   L  +    +       I                
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
           +  VA G+ +L   A K  IHRD+ + NILLT     K+ DFG AR    DS+   +   
Sbjct: 169 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV-VKGN 224
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
            +  V ++ PE +     T +SDV+S+G+ L E+ + G  P
Sbjct: 225 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 265

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 293 VAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL-GFVDKGNERLIITEFVPNGTLR 351
           VAIKR   E+ +    E   E++ +S+  H N+V     FV K +E  ++ + +  G++ 
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-DELWLVMKLLSGGSVL 96
Query: 352 EHLDGQYGK------TLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM 405
           + +     K       LD +    I  +V  GL YLH   +   IHRDVK+ NILL E  
Sbjct: 97  DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDG 153
Query: 406 RAKVADFGFARLGPMDSD--RTHISTKVKGTVGYLDPEYMKTYQ-LTTKSDVYSFGVLLL 462
             ++ADFG +       D  R  +     GT  ++ PE M+  +    K+D++SFG+  +
Sbjct: 154 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 213
Query: 463 EILTGRRPVELKRPPEERVTL 483
           E+ TG  P   K PP + + L
Sbjct: 214 ELATGAAPYH-KYPPMKVLML 233

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 14/207 (6%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN 324
           NF    +IGEG +G VYKA+ +  G +VA+K+ + + + E + +    E+ LL +++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKLL  +   N+  ++ E V +  L+  +D      +           +  GL + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM- 443
              +++HRD+K  N+L+      K+ADFG AR   +   RT+    V  T+ Y  PE + 
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV--TLWYRAPEILL 175
Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGR 468
             K Y  +T  D++S G +  E++T R
Sbjct: 176 GCKYY--STAVDIWSLGCIFAEMVTRR 200

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 26/206 (12%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++GEG +G VYKA+   G +VA+KR + + + E + +    E+ LL ++ H N+V L+  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFN----QRLEIAI---DVAHGLTYLHLY 384
           +   +ER +   F       E ++    K LD N    Q  +I I    +  G+ + H  
Sbjct: 88  IH--SERCLTLVF-------EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH-- 136
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE-Y 442
            + +I+HRD+K  N+L+      K+ADFG AR  G      TH       T+ Y  P+  
Sbjct: 137 -QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPDVL 191
Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGR 468
           M + + +T  D++S G +  E++TG+
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 15/195 (7%)
Query: 293 VAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL-GFVDKGNERLIITEFVPNGTLR 351
           VAIKR   E+ +    E   E++ +S+  H N+V     FV K +E  ++ + +  G++ 
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-DELWLVMKLLSGGSVL 101
Query: 352 EHLDGQYGK------TLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM 405
           + +     K       LD +    I  +V  GL YLH   +   IHRDVK+ NILL E  
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDG 158
Query: 406 RAKVADFGFARLGPMDSD--RTHISTKVKGTVGYLDPEYMKTYQ-LTTKSDVYSFGVLLL 462
             ++ADFG +       D  R  +     GT  ++ PE M+  +    K+D++SFG+  +
Sbjct: 159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 218
Query: 463 EILTGRRPVELKRPP 477
           E+ TG  P   K PP
Sbjct: 219 ELATGAAPYH-KYPP 232

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 127
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMXGTLPYVAPELLKRREFHA 186
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 99
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 152
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   ++ V GT  Y+ PE +    
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPELLTEKS 211
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPP 234

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 126
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 20/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +  G FGTVYK   + +G    + VAIK  ++        E   E  +++ +D+ ++ +L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 329 LGFVDKGNERLIITEFVPNGTL----REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LG       +LI+ + +P G L    REH D    + L     L   + +A G+ YL   
Sbjct: 90  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 141
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +++++HRD+ + N+L+      K+ DFG A+L   +    H +   K  + ++  E + 
Sbjct: 142 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-AEGGKVPIKWMALESIL 199
Query: 445 TYQLTTKSDVYSFGVLLLEILT-GRRP 470
               T +SDV+S+GV + E++T G +P
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 95
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 148
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   ++ V GT  Y+ PE +    
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPELLTEKS 207
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPP 230

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 26/205 (12%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IGEG +G VYKAQ   G   A+K+ + E + E + +    E+ +L ++ H N+VKL   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR-LE------IAIDVAHGLTYLHLY 384
           +    +RL++        + EHLD    K LD  +  LE        + + +G+ Y H  
Sbjct: 69  IHT-KKRLVL--------VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-- 117
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE-Y 442
            +++++HRD+K  N+L+      K+ADFG AR  G      TH       T+ Y  P+  
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAPDVL 172
Query: 443 MKTYQLTTKSDVYSFGVLLLEILTG 467
           M + + +T  D++S G +  E++ G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH-RNLVKLLG- 330
           +G G +G VYK + ++ G L AIK       E  + E   E+ +L K  H RN+    G 
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 331 FVDKG-----NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           F+ K      ++  ++ EF   G++ + +    G TL       I  ++  GL++LH   
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 146
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM-- 443
           + ++IHRD+K  N+LLTE+   K+ DFG +    +D      +T + GT  ++ PE +  
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI-GTPYWMAPEVIAC 203
Query: 444 -----KTYQLTTKSDVYSFGVLLLEILTGRRPV 471
                 TY    KSD++S G+  +E+  G  P+
Sbjct: 204 DENPDATYDF--KSDLWSLGITAIEMAEGAPPL 234

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 26/205 (12%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IGEG +G VYKAQ   G   A+K+ + E + E + +    E+ +L ++ H N+VKL   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR-LE------IAIDVAHGLTYLHLY 384
           +    +RL++        + EHLD    K LD  +  LE        + + +G+ Y H  
Sbjct: 69  IHT-KKRLVL--------VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-- 117
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE-Y 442
            +++++HRD+K  N+L+      K+ADFG AR  G      TH       T+ Y  P+  
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAPDVL 172
Query: 443 MKTYQLTTKSDVYSFGVLLLEILTG 467
           M + + +T  D++S G +  E++ G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ + + ++H N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 127
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 149
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV-GTAQYVSPELLTEKS 208
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 126
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 26/205 (12%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IGEG +G VYKAQ   G   A+K+ + E + E + +    E+ +L ++ H N+VKL   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR-LE------IAIDVAHGLTYLHLY 384
           +    +RL++        + EHLD    K LD  +  LE        + + +G+ Y H  
Sbjct: 69  IHT-KKRLVL--------VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-- 117
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE-Y 442
            +++++HRD+K  N+L+      K+ADFG AR  G      TH       T+ Y  P+  
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVL 172
Query: 443 MKTYQLTTKSDVYSFGVLLLEILTG 467
           M + + +T  D++S G +  E++ G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 103
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 104 FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 156
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 215
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 216 ACKSSDLWALGCIIYQLVAGLPP 238

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 101
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 102 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 154
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 213
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 214 ACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 99
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 152
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 211
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPP 234

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 126
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 76
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 77  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 129
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 130 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 188
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 189 ACKSSDLWALGCIIYQLVAGLPP 211

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 127
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 149
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 208
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 126
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 75
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 76  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 128
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 129 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 187
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 188 ACKSSDLWALGCIIYQLVAGLPP 210

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 151
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 210
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 151
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 210
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 151
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 210
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 80
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 81  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 133
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 192
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 193 ACKSSDLWALGCIIYQLVAGLPP 215

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 149
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 208
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 126
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 151
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 210
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 95
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 148
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 207
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPP 230

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 73
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 74  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 126
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 127 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 185
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 186 ACKSSDLWALGCIIYQLVAGLPP 208

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 74
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 75  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 127
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 186
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPP 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 126
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 13  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 125
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 185 EPVDVWSCGIVLTAMLAGELP 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 126
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 126
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 127
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 127
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 127
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 127
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 115/231 (49%), Gaps = 18/231 (7%)
Query: 267 NFSPSLRIGEGGFGTVYK-AQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL 325
           +F     +G G  G V+K +    GL++A K    E    ++ +   E+++L + +   +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL-EIAIDVAHGLTYLHLY 384
           V   G      E  I  E +  G+L + L  + G+  +  Q L +++I V  GLTYL   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE--QILGKVSIAVIKGLTYLR-- 121
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEYM 443
            + +I+HRDVK SNIL+      K+ DFG + +L  +DS    ++    GT  Y+ PE +
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS----MANSFVGTRSYMSPERL 175
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN 494
           +    + +SD++S G+ L+E+  GR P+    PP +   L   F    EG+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELELMFGCQVEGD 222

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 127
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 126
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 12/210 (5%)
Query: 267 NFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKE---QFENLQTEFSSEVELLSKIDH 322
           NF     +G+G FG V  A++ E G L A+K  KK+   Q ++++   + +  L    +H
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLH 382
             L +L       +    + EFV  G L  H+  Q  +  D  +    A ++   L +LH
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISALMFLH 141
Query: 383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEY 442
              +K II+RD+K  N+LL      K+ADFG  + G  +   T       GT  Y+ PE 
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT---ATFCGTPDYIAPEI 195
Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRPVE 472
           ++        D ++ GVLL E+L G  P E
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F TV  A +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 151
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 210
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 211 AXKSSDLWALGCIIYQLVAGLPP 233

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 126
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 115/231 (49%), Gaps = 18/231 (7%)
Query: 267 NFSPSLRIGEGGFGTVYK-AQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL 325
           +F     +G G  G V+K +    GL++A K    E    ++ +   E+++L + +   +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL-EIAIDVAHGLTYLHLY 384
           V   G      E  I  E +  G+L + L  + G+  +  Q L +++I V  GLTYL   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE--QILGKVSIAVIKGLTYLR-- 121
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEYM 443
            + +I+HRDVK SNIL+      K+ DFG + +L  +DS    ++    GT  Y+ PE +
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS----MANSFVGTRSYMSPERL 175
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN 494
           +    + +SD++S G+ L+E+  GR P+    PP +   L   F    EG+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELELMFGCQVEGD 222

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG +G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 126
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 115/231 (49%), Gaps = 18/231 (7%)
Query: 267 NFSPSLRIGEGGFGTVYK-AQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL 325
           +F     +G G  G V+K +    GL++A K    E    ++ +   E+++L + +   +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL-EIAIDVAHGLTYLHLY 384
           V   G      E  I  E +  G+L + L  + G+  +  Q L +++I V  GLTYL   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE--QILGKVSIAVIKGLTYLR-- 121
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEYM 443
            + +I+HRDVK SNIL+      K+ DFG + +L  +DS    ++    GT  Y+ PE +
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS----MANSFVGTRSYMSPERL 175
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN 494
           +    + +SD++S G+ L+E+  GR P+    PP +   L   F    EG+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELELMFGCQVEGD 222

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 115/231 (49%), Gaps = 18/231 (7%)
Query: 267 NFSPSLRIGEGGFGTVYK-AQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL 325
           +F     +G G  G V+K +    GL++A K    E    ++ +   E+++L + +   +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL-EIAIDVAHGLTYLHLY 384
           V   G      E  I  E +  G+L + L  + G+  +  Q L +++I V  GLTYL   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE--QILGKVSIAVIKGLTYLR-- 121
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEYM 443
            + +I+HRDVK SNIL+      K+ DFG + +L  +DS    ++    GT  Y+ PE +
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS----MANSFVGTRSYMSPERL 175
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN 494
           +    + +SD++S G+ L+E+  GR P+    PP +   L   F    EG+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELELMFGCQVEGD 222

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 10/215 (4%)
Query: 257 NMSQVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVE 315
           N    V     F+   RIG+G FG VYK        +VAIK    E+ E+   +   E+ 
Sbjct: 10  NQHSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEIT 69
Query: 316 LLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVA 375
           +LS+ D   + +  G   K  +  II E++  G+    LD      L+      I  ++ 
Sbjct: 70  VLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSA---LDLLKPGPLEETYIATILREIL 126
Query: 376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
            GL YLH  +E++I HRD+K++N+LL+E    K+ADFG A  G +   +   +  V GT 
Sbjct: 127 KGLDYLH--SERKI-HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNXFV-GTP 180
Query: 436 GYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            ++ PE +K      K+D++S G+  +E+  G  P
Sbjct: 181 FWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 113/225 (50%), Gaps = 18/225 (8%)
Query: 273 RIGEGGFGTVYK-AQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
            +G G  G V+K +    GL++A K    E    ++ +   E+++L + +   +V   G 
Sbjct: 75  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 134
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL-EIAIDVAHGLTYLHLYAEKQII 390
                E  I  E +  G+L + L  + G+  +  Q L +++I V  GLTYL    + +I+
Sbjct: 135 FYSDGEISICMEHMDGGSLDQVLK-KAGRIPE--QILGKVSIAVIKGLTYLR--EKHKIM 189
Query: 391 HRDVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           HRDVK SNIL+      K+ DFG + +L  +DS    ++    GT  Y+ PE ++    +
Sbjct: 190 HRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS----MANSFVGTRSYMSPERLQGTHYS 243
Query: 450 TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN 494
            +SD++S G+ L+E+  GR P+    PP +   L   F    EG+
Sbjct: 244 VQSDIWSMGLSLVEMAVGRYPI----PPPDAKELELMFGCQVEGD 284

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 273 RIGEGGFGTVYK--AQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           ++GEG + TVYK  ++L D L VA+K  + E  E        EV LL  + H N+V L  
Sbjct: 9   KLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            +       ++ E++ +  L+++LD   G  ++ +        +  GL Y H    ++++
Sbjct: 68  IIHTEKSLTLVFEYL-DKDLKQYLD-DCGNIINMHNVKLFLFQLLRGLAYCH---RQKVL 122
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE-YMKTYQLT 449
           HRD+K  N+L+ E    K+ADFG AR   + + +T+ +  V  T+ Y  P+  + +   +
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYDNEVV--TLWYRPPDILLGSTDYS 179
Query: 450 TKSDVYSFGVLLLEILTGR 468
           T+ D++  G +  E+ TGR
Sbjct: 180 TQIDMWGVGCIFYEMATGR 198

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFS-SEVELLSKIDHRNLVKLLGF 331
           +GEG +G V K + +D G +VAIK+  +   + +  + +  E++LL ++ H NLV LL  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             K     ++ EFV + T+ + L+  +   LD+    +    + +G+ + H +    IIH
Sbjct: 93  CKKKKRWYLVFEFV-DHTILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIH 147
Query: 392 RDVKSSNILLTESMRAKVADFGFARL--GPMDSDRTHISTKVKGTVGYLDPEYM-KTYQL 448
           RD+K  NIL+++S   K+ DFGFAR    P +     ++T+      Y  PE +    + 
Sbjct: 148 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAPELLVGDVKY 202
Query: 449 TTKSDVYSFGVLLLEILTG 467
               DV++ G L+ E+  G
Sbjct: 203 GKAVDVWAIGCLVTEMFMG 221

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 16/218 (7%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G G  G V K Q    GL++A K    E    ++ +   E+++L + +   +V   G  
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 83
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
               E  I  E +  G+L + L  +  K +      +++I V  GL YL    + QI+HR
Sbjct: 84  YSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLR--EKHQIMHR 139
Query: 393 DVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           DVK SNIL+      K+ DFG + +L  +DS    ++    GT  Y+ PE ++    + +
Sbjct: 140 DVKPSNILVNSRGEIKLCDFGVSGQL--IDS----MANSFVGTRSYMAPERLQGTHYSVQ 193
Query: 452 SDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           SD++S G+ L+E+  GR P+    PP +   L   F R
Sbjct: 194 SDIWSMGLSLVELAVGRYPI----PPPDAKELEAIFGR 227

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 274 IGEGGFGTVYKAQL--EDG--LLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKL 328
           +GEG FG+V +  L  EDG  L VA+K  K +     + E F SE   +    H N+++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 329 LGFVDKGNER-----LIITEFVPNGTLREHLDGQYGKT----LDFNQRLEIAIDVAHGLT 379
           LG   + + +     ++I  F+  G L  +L     +T    +     L+  +D+A G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLD 439
           YL   + +  +HRD+ + N +L + M   VADFG ++      D        K  V ++ 
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-KIYSGDYYRQGRIAKMPVKWIA 217
Query: 440 PEYMKTYQLTTKSDVYSFGVLLLEILT 466
            E +     T+KSDV++FGV + EI T
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 115/231 (49%), Gaps = 18/231 (7%)
Query: 267 NFSPSLRIGEGGFGTVYK-AQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL 325
           +F     +G G  G V+K +    GL++A K    E    ++ +   E+++L + +   +
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL-EIAIDVAHGLTYLHLY 384
           V   G      E  I  E +  G+L + L  + G+  +  Q L +++I V  GLTYL   
Sbjct: 94  VGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE--QILGKVSIAVIKGLTYLR-- 148
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEYM 443
            + +I+HRDVK SNIL+      K+ DFG + +L  +DS    ++    GT  Y+ PE +
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS----MANSFVGTRSYMSPERL 202
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN 494
           +    + +SD++S G+ L+E+  GR P+    PP +   L   F    EG+
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELELMFGCQVEGD 249

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL 325
           +F P   +G GGFG V++A+ + D    AIKR +    E  + +   EV+ L+K++H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 326 VKLL-GFVDKGN-ERL----------IITEFVPNGTLREHLDGQYGKTLDFNQR---LEI 370
           V+    +++K   E+L          I  +      L++ ++G+   T++  +R   L I
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHI 123
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
            + +A  + +LH    K ++HRD+K SNI  T     KV DFG       D +   + T 
Sbjct: 124 FLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 431 VK------GTVG---YLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
           +       G VG   Y+ PE +     + K D++S G++L E+L
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 272 LRIGEGGFGTVYKA-QLEDGLLVAIKRA--KKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           ++IGEG  G V  A +   G  VA+K    +K+Q   L     +EV ++    H N+V++
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL---LFNEVVIMRDYQHFNVVEM 107
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                 G E  ++ EF+  G L + +       L+  Q   +   V   L YLH    + 
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLH---AQG 161
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           +IHRD+KS +ILLT   R K++DFGF      D  +      + GT  ++ PE +     
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKXLVGTPYWMAPEVISRSLY 218
Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
            T+ D++S G++++E++ G  P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPP 240

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGT-VYKAQLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG F T V   +L      AIK  +K     EN     + E +++S++DH   VKL  
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 331 FVDKGNERLII-TEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           F  + +E+L     +  NG L +++   G + +T     R   A ++   L YLH    K
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLH---GK 149
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            IIHRD+K  NILL E M  ++ DFG A++   +S +   +  V GT  Y+ PE +    
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPELLTEKS 208
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               SD+++ G ++ +++ G  P
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE------IAIDVAHGLTYLHLYAE 386
                R    E + +  L  HL G     L   Q L           +  GL Y+H    
Sbjct: 111 -----RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 162
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
             ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   
Sbjct: 163 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 447 QLTTKS-DVYSFGVLLLEILTGR 468
           +  TKS D++S G +L E+L+ R
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG  G V  A     E+   VA+K    ++  +       E+ +   ++H N+VK  G
Sbjct: 14  LGEGAAGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +GN + +  E+   G L + ++   G      QR      +  G+ YLH      I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---IT 126
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 451 KS-DVYSFGVLLLEILTGRRP 470
           +  DV+S G++L  +L G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 19/218 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFEN-LQTEFSSEVELLSKID 321
           AT  + P   IG G +GTVYKA+    G  VA+K  +    E  L      EV LL +++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 322 ---HRNLVKLLGF-----VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAID 373
              H N+V+L+        D+  +  ++ E V +  LR +LD      L      ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
              GL +LH      I+HRD+K  NIL+T     K+ADFG AR+             V  
Sbjct: 121 FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARI----YSYQMALAPVVV 173
Query: 434 TVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPV 471
           T+ Y  PE +      T  D++S G +  E+   R+P+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 111/220 (50%), Gaps = 20/220 (9%)
Query: 267 NFSPSLRIGEGGFGTVYK-AQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL 325
           +F     +G G  G V+K +    GL++A K    E    ++ +   E+++L + +   +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL-EIAIDVAHGLTYLHLY 384
           V   G      E  I  E +  G+L + L  + G+  +  Q L +++I V  GLTYL   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE--QILGKVSIAVIKGLTYLR-- 121
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEYM 443
            + +I+HRDVK SNIL+      K+ DFG + +L  +DS    ++    GT  Y+ PE +
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS----MANSFVGTRSYMSPERL 175
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRPV------ELKRPP 477
           +    + +SD++S G+ L+E+  GR P+      E  RPP
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPP 215

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 274 IGEGGFGTVYKAQLED------GLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLV 326
           +G G FG V  A           + VA+K  K++   + +    SE+++++++  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGK---------------------TLDFN 365
            LLG         +I E+   G L  +L  +  K                      L F 
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 366 QRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT 425
             L  A  VA G+ +L     K  +HRD+ + N+L+T     K+ DFG AR    DS+  
Sbjct: 173 DLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
            +    +  V ++ PE +     T KSDV+S+G+LL EI +
Sbjct: 230 -VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 16/213 (7%)
Query: 267 NFSPSLRIGEGGFGTVYK-AQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL 325
           +F     +G G  G V+K +    GL++A K    E    ++ +   E+++L + +   +
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL-EIAIDVAHGLTYLHLY 384
           V   G      E  I  E +  G+L + L  + G+  +  Q L +++I V  GLTYL   
Sbjct: 70  VGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE--QILGKVSIAVIKGLTYLR-- 124
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            + +I+HRDVK SNIL+      K+ DFG +  G +  +   ++ +  GT  Y+ PE ++
Sbjct: 125 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDE---MANEFVGTRSYMSPERLQ 179
Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP 477
               + +SD++S G+ L+E+  GR P    RPP
Sbjct: 180 GTHYSVQSDIWSMGLSLVEMAVGRYP----RPP 208

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 134/280 (47%), Gaps = 41/280 (14%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +G+G +G V++  L  G  VA+K   ++ EQ    +TE  + V L     H N+   LGF
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLL----RHDNI---LGF 67
Query: 332 V-------DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL- 383
           +       +   +  +IT +  +G+L + L  Q   TL+ +  L +A+  A GL +LH+ 
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQ---TLEPHLALRLAVSAACGLAHLHVE 124
Query: 384 ----YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-GTVGYL 438
                 +  I HRD KS N+L+  +++  +AD G A +    SD   I    + GT  Y+
Sbjct: 125 IFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYM 184
Query: 439 DPEYM------KTYQLTTKSDVYSFGVLLLEILTGRRP-----VELKRPP-EERVTLRWA 486
            PE +        ++    +D+++FG++L EI   RR      VE  RPP  + V    +
Sbjct: 185 APEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTIVNGIVEDYRPPFYDVVPNDPS 242
Query: 487 FKRYNEGNLLDMVDPSIKEVISME-ILTKMFGLAIQCAAP 525
           F+   +   +D   P+I   ++ + +L+ +  +  +C  P
Sbjct: 243 FEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYP 282

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 19/218 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFEN-LQTEFSSEVELLSKID 321
           AT  + P   IG G +GTVYKA+    G  VA+K  +    E  L      EV LL +++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 322 ---HRNLVKLLGF-----VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAID 373
              H N+V+L+        D+  +  ++ E V +  LR +LD      L      ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
              GL +LH      I+HRD+K  NIL+T     K+ADFG AR+             V  
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI----YSYQMALDPVVV 173
Query: 434 TVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPV 471
           T+ Y  PE +      T  D++S G +  E+   R+P+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 19/218 (8%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFEN-LQTEFSSEVELLSKID 321
           AT  + P   IG G +GTVYKA+    G  VA+K  +    E  L      EV LL +++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 322 ---HRNLVKLLGF-----VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAID 373
              H N+V+L+        D+  +  ++ E V +  LR +LD      L      ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
              GL +LH      I+HRD+K  NIL+T     K+ADFG AR+             V  
Sbjct: 121 FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARI----YSYQMALFPVVV 173
Query: 434 TVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPV 471
           T+ Y  PE +      T  D++S G +  E+   R+P+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 22/221 (9%)
Query: 264 ATRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAK----KEQFENLQTEFSSEVELLS 318
           AT  + P   IG G +GTVYKA+    G  VA+K  +          L      EV LL 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 319 KID---HRNLVKLLGF-----VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI 370
           +++   H N+V+L+        D+  +  ++ E V +  LR +LD      L      ++
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDL 125
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
                 GL +LH      I+HRD+K  NIL+T     K+ADFG AR+           T 
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARI----YSYQMALTP 178
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPV 471
           V  T+ Y  PE +      T  D++S G +  E+   R+P+
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAK-KEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +IGEG +GTV+KA+  E   +VA+KR +  +  E + +    E+ LL ++ H+N+V+L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            +    +  ++ EF  +  L+++ D   G  LD          +  GL + H    + ++
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCH---SRNVL 123
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL-T 449
           HRD+K  N+L+  +   K+ADFG AR   +   R + +  V  T+ Y  P+ +   +L +
Sbjct: 124 HRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYSAEVV--TLWYRPPDVLFGAKLYS 180
Query: 450 TKSDVYSFGVLLLEILTGRRPV 471
           T  D++S G +  E+    RP+
Sbjct: 181 TSIDMWSAGCIFAELANAARPL 202

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 274 IGEGGFGTVYKAQLEDGLL---VAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLL 329
           +G+G FG V K +  D +     A+K   K   +N  T     EVELL K+DH N++KL 
Sbjct: 30  LGKGSFGEVLKCK--DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
             ++  +   I+ E    G L + +  +  K    +    I   V  G+TY+H   +  I
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNI 142
Query: 390 IHRDVKSSNILLTESMR---AKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK-T 445
           +HRD+K  NILL    +    K+ DFG   L       T +  ++ GT  Y+ PE ++ T
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFG---LSTCFQQNTKMKDRI-GTAYYIAPEVLRGT 198
Query: 446 YQLTTKSDVYSFGVLLLEILTGRRP 470
           Y    K DV+S GV+L  +L+G  P
Sbjct: 199 YD--EKCDVWSAGVILYILLSGTPP 221

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 274 IGEGGFGTVYKAQLEDGLL---VAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLL 329
           +G+G FG V K +  D +     A+K   K   +N  T     EVELL K+DH N++KL 
Sbjct: 30  LGKGSFGEVLKCK--DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
             ++  +   I+ E    G L + +  +  K    +    I   V  G+TY+H   +  I
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNI 142
Query: 390 IHRDVKSSNILLTESMR---AKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK-T 445
           +HRD+K  NILL    +    K+ DFG   L       T +  ++ GT  Y+ PE ++ T
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFG---LSTCFQQNTKMKDRI-GTAYYIAPEVLRGT 198
Query: 446 YQLTTKSDVYSFGVLLLEILTGRRP 470
           Y    K DV+S GV+L  +L+G  P
Sbjct: 199 YD--EKCDVWSAGVILYILLSGTPP 221

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 274 IGEGGFGTVYKAQLEDGL-LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G G F  V  A+ +    LVAIK   KE  E  +    +E+ +L KI H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
           + G    +I + V  G L + +  +   T     RL     V   + YLH   +  I+HR
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLDAVKYLH---DLGIVHR 140
Query: 393 DVKSSNIL---LTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           D+K  N+L   L E  +  ++DFG +++     D   + +   GT GY+ PE +     +
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D +S GV+   +L G  P
Sbjct: 197 KAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 274 IGEGGFGTVYKAQLEDGL-LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G G F  V  A+ +    LVAIK   KE  E  +    +E+ +L KI H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
           + G    +I + V  G L + +  +   T     RL     V   + YLH   +  I+HR
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLDAVKYLH---DLGIVHR 140
Query: 393 DVKSSNIL---LTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           D+K  N+L   L E  +  ++DFG +++     D   + +   GT GY+ PE +     +
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D +S GV+   +L G  P
Sbjct: 197 KAVDCWSIGVIAYILLCGYPP 217

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 12/215 (5%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQF---ENLQTEFSSEVE 315
           Q+     +F     +G+G FG V+ A+ +      AIK  KK+     ++++     +  
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 316 LLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVA 375
           L    +H  L  +            + E++  G L  H+  Q     D ++    A ++ 
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEII 129
Query: 376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
            GL +LH    K I++RD+K  NILL +    K+ADFG  +   +   +T    +  GT 
Sbjct: 130 LGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NEFCGTP 183
Query: 436 GYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            Y+ PE +   +     D +SFGVLL E+L G+ P
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 333 DKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                   + + I + +    L + L  Q+   L  +        +  GL Y+H      
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQH---LSNDHICYFLYQILRGLKYIH---SAN 148
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   + 
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 449 TTKS-DVYSFGVLLLEILTGR 468
            TKS D++S G +L E+L+ R
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR 229

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 274 IGEGGFGTVYKAQLEDGL-LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G G F  V  A+ +    LVAIK   KE  E  +    +E+ +L KI H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
           + G    +I + V  G L + +  +   T     RL     V   + YLH   +  I+HR
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLDAVKYLH---DLGIVHR 140
Query: 393 DVKSSNIL---LTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           D+K  N+L   L E  +  ++DFG +++     D   + +   GT GY+ PE +     +
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D +S GV+   +L G  P
Sbjct: 197 KAVDCWSIGVIAYILLCGYPP 217

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 122/253 (48%), Gaps = 33/253 (13%)
Query: 277 GGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN 336
           G FG V+KAQL +   VA+K    +  ++ Q+E   E+     + H NL++ +    +G+
Sbjct: 26  GRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQSE--REIFSTPGMKHENLLQFIAAEKRGS 82
Query: 337 ----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA------- 385
               E  +IT F   G+L ++L G     + +N+   +A  ++ GL+YLH          
Sbjct: 83  NLEVELWLITAFHDKGSLTDYLKGN---IITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 386 -EKQIIHRDVKSSNILLTESMRAKVADFGFA-RLGP-MDSDRTHISTKVKGTVGYLDPEY 442
            +  I HRD KS N+LL   + A +ADFG A R  P      TH      GT  Y+ PE 
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV---GTRRYMAPEV 196
Query: 443 MK---TYQLTT--KSDVYSFGVLLLEILTGRR----PV-ELKRPPEERVTLRWAFKRYNE 492
           ++    +Q     + D+Y+ G++L E+++  +    PV E   P EE +    + +   E
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQE 256
Query: 493 GNLLDMVDPSIKE 505
             +   + P+IK+
Sbjct: 257 VVVHKKMRPTIKD 269

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 333 -----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
                ++  +  I+ + +    L + L  Q+   L  +        +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SA 147
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   +
Sbjct: 148 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 448 LTTKS-DVYSFGVLLLEILTGR 468
             TKS D++S G +L E+L+ R
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 333 -----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
                ++  +  I+ + +    L + L  Q+   L  +        +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SA 143
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   +
Sbjct: 144 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 448 LTTKS-DVYSFGVLLLEILTGR 468
             TKS D++S G +L E+L+ R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 333 DKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                   + + I + +    L + L  Q+   L  +        +  GL Y+H      
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SAN 146
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   + 
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 449 TTKS-DVYSFGVLLLEILTGR 468
            TKS D++S G +L E+L+ R
Sbjct: 207 YTKSIDIWSVGCILAEMLSNR 227

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 333 -----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
                ++  +  I+ + +    L + L  Q+   L  +        +  GL Y+H     
Sbjct: 111 RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SA 163
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   +
Sbjct: 164 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 448 LTTKS-DVYSFGVLLLEILTGR 468
             TKS D++S G +L E+L+ R
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNR 245

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 333 DKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                   + + I + +    L + L  Q+   L  +        +  GL Y+H      
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SAN 142
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   + 
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 449 TTKS-DVYSFGVLLLEILTGR 468
            TKS D++S G +L E+L+ R
Sbjct: 203 YTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 333 -----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
                ++  +  I+ + +    L + L  Q+   L  +        +  GL Y+H     
Sbjct: 96  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SA 148
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   +
Sbjct: 149 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 208
Query: 448 LTTKS-DVYSFGVLLLEILTGR 468
             TKS D++S G +L E+L+ R
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 333 -----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
                ++  +  I+ + +    L + L  Q+   L  +        +  GL Y+H     
Sbjct: 97  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SA 149
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   +
Sbjct: 150 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 209
Query: 448 LTTKS-DVYSFGVLLLEILTGR 468
             TKS D++S G +L E+L+ R
Sbjct: 210 GYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 333 -----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
                ++  +  I+ + +    L + L  Q+   L  +        +  GL Y+H     
Sbjct: 88  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SA 140
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   +
Sbjct: 141 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 200
Query: 448 LTTKS-DVYSFGVLLLEILTGR 468
             TKS D++S G +L E+L+ R
Sbjct: 201 GYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 333 -----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
                ++  +  I+ + +    L + L  Q+   L  +        +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SA 147
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   +
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 448 LTTKS-DVYSFGVLLLEILTGR 468
             TKS D++S G +L E+L+ R
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 333 -----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
                ++  +  I+ + +    L + L  Q+   L  +        +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SA 143
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   +
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 448 LTTKS-DVYSFGVLLLEILTGR 468
             TKS D++S G +L E+L+ R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 277 GGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN 336
           G FG V+KAQL +   VA+K    +  ++ Q E+  EV  L  + H N+++ +G   +G 
Sbjct: 35  GRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKRGT 91
Query: 337 ----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA------- 385
               +  +IT F   G+L + L       + +N+   IA  +A GL YLH          
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFA---RLGPMDSDRTHISTKVKGTVGYLDPEY 442
           +  I HRD+KS N+LL  ++ A +ADFG A     G    D TH      GT  Y+ PE 
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD-THGQV---GTRRYMAPEV 204
Query: 443 MK---TYQLTT--KSDVYSFGVLLLEI 464
           ++    +Q     + D+Y+ G++L E+
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 333 -----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
                ++  +  I+ + +    L + L  Q+   L  +        +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SA 147
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   +
Sbjct: 148 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 448 LTTKS-DVYSFGVLLLEILTGR 468
             TKS D++S G +L E+L+ R
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 333 DKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                   + + I + +    L + L  Q+   L  +        +  GL Y+H      
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SAN 142
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   + 
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 449 TTKS-DVYSFGVLLLEILTGR 468
            TKS D++S G +L E+L+ R
Sbjct: 203 YTKSIDIWSVGCILAEMLSNR 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 333 DKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                   + + I + +    L + L  Q+   L  +        +  GL Y+H      
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SAN 152
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   + 
Sbjct: 153 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 212
Query: 449 TTKS-DVYSFGVLLLEILTGR 468
            TKS D++S G +L E+L+ R
Sbjct: 213 YTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 333 DKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                   + + I + +    L + L  Q+   L  +        +  GL Y+H      
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SAN 144
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   + 
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 449 TTKS-DVYSFGVLLLEILTGR 468
            TKS D++S G +L E+L+ R
Sbjct: 205 YTKSIDIWSVGCILAEMLSNR 225

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 274 IGEGGFGTVYKAQLEDGLL---VAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLL 329
           +G+G FG V K +  D +     A+K   K   +N  T     EVELL K+DH N++KL 
Sbjct: 30  LGKGSFGEVLKCK--DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
             ++  +   I+ E    G L + +  +  K    +    I   V  G+TY+H +    I
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NI 142
Query: 390 IHRDVKSSNILLTESMR---AKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK-T 445
           +HRD+K  NILL    +    K+ DFG   L       T +  ++ GT  Y+ PE ++ T
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFG---LSTCFQQNTKMKDRI-GTAYYIAPEVLRGT 198
Query: 446 YQLTTKSDVYSFGVLLLEILTGRRP 470
           Y    K DV+S GV+L  +L+G  P
Sbjct: 199 YD--EKCDVWSAGVILYILLSGTPP 221

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 12/215 (5%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQF---ENLQTEFSSEVE 315
           Q+     +F     +G+G FG V+ A+ +      AIK  KK+     ++++     +  
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 316 LLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVA 375
           L    +H  L  +            + E++  G L  H+  Q     D ++    A ++ 
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEII 128
Query: 376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
            GL +LH    K I++RD+K  NILL +    K+ADFG  +   +   +T+      GT 
Sbjct: 129 LGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC---GTP 182
Query: 436 GYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            Y+ PE +   +     D +SFGVLL E+L G+ P
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 267 NFSPSLRIGEGGFGTVYK-AQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL 325
           +F     +G G  G V+K +    GL++A K    E    ++ +   E+++L + +   +
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 85
Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL-EIAIDVAHGLTYLHLY 384
           V   G      E  I  E +  G+L + L  + G+  +  Q L +++I V  GLTYL   
Sbjct: 86  VGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE--QILGKVSIAVIKGLTYLR-- 140
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            + +I+HRDVK SNIL+      K+ DFG +    +DS    ++    GT  Y+ PE ++
Sbjct: 141 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDS----MANSFVGTRSYMSPERLQ 195
Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRPV 471
               + +SD++S G+ L+E+  GR P+
Sbjct: 196 GTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 333 -----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
                ++  +  I+ + +    L + L  Q+   L  +        +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SA 143
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   +
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 448 LTTKS-DVYSFGVLLLEILTGR 468
             TKS D++S G +L E+L+ R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAK-KEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +IGEG +GTV+KA+  E   +VA+KR +  +  E + +    E+ LL ++ H+N+V+L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            +    +  ++ EF  +  L+++ D   G  LD          +  GL + H    + ++
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCH---SRNVL 123
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL-T 449
           HRD+K  N+L+  +   K+A+FG AR   +   R + +  V  T+ Y  P+ +   +L +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVV--TLWYRPPDVLFGAKLYS 180
Query: 450 TKSDVYSFGVLLLEILTGRRPV 471
           T  D++S G +  E+    RP+
Sbjct: 181 TSIDMWSAGCIFAELANAGRPL 202

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAI++    + +        E+++L +  H N++ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 333 -----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
                ++  +  I+ + +    L + L  Q+   L  +        +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SA 147
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   +
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 448 LTTKS-DVYSFGVLLLEILTGR 468
             TKS D++S G +L E+L+ R
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L    H N++ +   +
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 333 -----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
                ++  +  I+ + +    L + L  Q+   L  +        +  GL Y+H     
Sbjct: 93  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SA 145
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   +
Sbjct: 146 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 448 LTTKS-DVYSFGVLLLEILTGR 468
             TKS D++S G +L E+L+ R
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 24/238 (10%)
Query: 243 TMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGL-LVAIKRAKKE 301
           +M P  +    V+ +  ++++A         IG+G FG V   Q  D   + A+K   K+
Sbjct: 1   SMPPVFDENEDVNFDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQ 51
Query: 302 QF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYG 359
           +    N       E++++  ++H  LV L        +  ++ + +  G LR HL     
Sbjct: 52  KCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ---- 107
Query: 360 KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP 419
           + + F +   + + +   +  L     ++IIHRD+K  NILL E     + DF  A + P
Sbjct: 108 QNVHFKEET-VKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166
Query: 420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS---DVYSFGVLLLEILTGRRPVELK 474
            +   T I+T + GT  Y+ PE   + +    S   D +S GV   E+L GRRP  ++
Sbjct: 167 RE---TQITT-MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 333 -----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
                ++  +  I+ + +    L + L  Q+   L  +        +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SA 143
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   +
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 448 LTTKS-DVYSFGVLLLEILTGR 468
             TKS D++S G +L E+L+ R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 274 IGEGGFGTVYKAQLEDGL-LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G G F  V  A+ +    LVAIK   K+  E  +    +E+ +L KI H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
           + G    +I + V  G L + +  +   T     RL     V   + YLH   +  I+HR
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLDAVKYLH---DLGIVHR 140
Query: 393 DVKSSNIL---LTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           D+K  N+L   L E  +  ++DFG +++     D   + +   GT GY+ PE +     +
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D +S GV+   +L G  P
Sbjct: 197 KAVDCWSIGVIAYILLCGYPP 217

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 106/216 (49%), Gaps = 30/216 (13%)
Query: 268 FSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKR---AKKEQFENLQTEFSSEVELLSKIDHR 323
           FS    IG G FG VY A+ + +  +VAIK+   + K+  E  Q +   EV  L K+ H 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-DIIKEVRFLQKLRHP 114
Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHG----LT 379
           N ++  G   + +   ++ E+   G+  + L+  + K L   Q +EIA  V HG    L 
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYC-LGSASDLLE-VHKKPL---QEVEIAA-VTHGALQGLA 168
Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYL 438
           YLH +    +IHRDVK+ NILL+E    K+ DFG A  + P        +    GT  ++
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--------ANXFVGTPYWM 217
Query: 439 DPEY---MKTYQLTTKSDVYSFGVLLLEILTGRRPV 471
            PE    M   Q   K DV+S G+  +E+   + P+
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 111/244 (45%), Gaps = 35/244 (14%)
Query: 244 MSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQ 302
           M+PK +     H+   Q+VK          +GEG FG V  A     G  VA+K   K+ 
Sbjct: 1   MNPKSSLADGAHIGNYQIVKT---------LGEGSFGKVKLAYHTTTGQKVALKIINKKV 51
Query: 303 F--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTL-----REHLD 355
               ++Q     E+  L  + H +++KL   +   +E +++ E+  N        R+ + 
Sbjct: 52  LAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMS 111
Query: 356 GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA 415
            Q  +   F Q++  A++  H           +I+HRD+K  N+LL E +  K+ADFG +
Sbjct: 112 EQEARR--FFQQIISAVEYCH---------RHKIVHRDLKPENLLLDEHLNVKIADFGLS 160
Query: 416 RLGPMDSDRTHISTKVKGTVGYLDPEYM--KTYQLTTKSDVYSFGVLLLEILTGRRPVEL 473
            +    +D   + T   G+  Y  PE +  K Y    + DV+S GV+L  +L  R P + 
Sbjct: 161 NIM---TDGNFLKTSC-GSPNYAAPEVISGKLYA-GPEVDVWSCGVILYVMLCRRLPFDD 215
Query: 474 KRPP 477
           +  P
Sbjct: 216 ESIP 219

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 106/216 (49%), Gaps = 30/216 (13%)
Query: 268 FSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKR---AKKEQFENLQTEFSSEVELLSKIDHR 323
           FS    IG G FG VY A+ + +  +VAIK+   + K+  E  Q +   EV  L K+ H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-DIIKEVRFLQKLRHP 75
Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHG----LT 379
           N ++  G   + +   ++ E+   G+  + L+  + K L   Q +EIA  V HG    L 
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYC-LGSASDLLE-VHKKPL---QEVEIAA-VTHGALQGLA 129
Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYL 438
           YLH +    +IHRDVK+ NILL+E    K+ DFG A  + P        +    GT  ++
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--------ANXFVGTPYWM 178
Query: 439 DPEY---MKTYQLTTKSDVYSFGVLLLEILTGRRPV 471
            PE    M   Q   K DV+S G+  +E+   + P+
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 110/250 (44%), Gaps = 57/250 (22%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH---------- 322
           +G+G FG V KA+   D    AIK+ +  + E L T   SEV LL+ ++H          
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLST-ILSEVMLLASLNHQYVVRYYAAW 71
Query: 323 ---RNLVKLLGFVDKGNERLIITEFVPNGTL-----REHLDGQYGKTLD-FNQRLEIAID 373
              RN VK +  V K +   I  E+  NGTL      E+L+ Q  +    F Q LE    
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE---- 127
Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-----LGPMDSDRTHIS 428
               L+Y+H    + IIHRD+K  NI + ES   K+ DFG A+     L  +  D  ++ 
Sbjct: 128 ---ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 429 ------TKVKGTVGYLDPEYMK-TYQLTTKSDVYSFGVLLLE-------------ILTGR 468
                 T   GT  Y+  E +  T     K D+YS G++  E             IL   
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKL 241
Query: 469 RPVELKRPPE 478
           R V ++ PP+
Sbjct: 242 RSVSIEFPPD 251

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L    H N++ +   +
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 333 DKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                   + + I + +    L + L  Q+   L  +        +  GL Y+H      
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SAN 146
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T  Y  PE M   + 
Sbjct: 147 VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 449 TTKS-DVYSFGVLLLEILTGR 468
            TKS D++S G +L E+L+ R
Sbjct: 207 YTKSIDIWSVGCILAEMLSNR 227

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 109/209 (52%), Gaps = 18/209 (8%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSS--EVELLSKIDHRNLVKLLG 330
           +G+GGFG V   Q+   G + A K+ +K++ +  + E  +  E ++L K++ R +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 331 FVDKGNERLIITEFVPNGTLREHL--DGQYGKTLDFNQRLEI--AIDVAHGLTYLHLYAE 386
             +  +   ++   +  G L+ H+   GQ G    F +   +  A ++  GL  LH    
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAG----FPEARAVFYAAEICCGLEDLH---R 304
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           ++I++RD+K  NILL +    +++D G A   P   +   I  +V GTVGY+ PE +K  
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRV-GTVGYMAPEVVKNE 360
Query: 447 QLTTKSDVYSFGVLLLEILTGRRPVELKR 475
           + T   D ++ G LL E++ G+ P + ++
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLG 330
           IG+G F  V  A+ +  G  VAIK   K Q    +LQ  F  EV ++  ++H N+VKL  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            ++      +I E+   G + ++L   +G+  +   R +    +   + Y H   +K+I+
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFR-QIVSAVQYCH---QKRIV 136
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG---YLDPEYMKTYQ 447
           HRD+K+ N+LL   M  K+ADFGF       S+   +  K+    G   Y  PE  +  +
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGF-------SNEFTVGGKLDAFCGAPPYAAPELFQGKK 189
Query: 448 LT-TKSDVYSFGVLLLEILTGRRPVE 472
               + DV+S GV+L  +++G  P +
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 333 -----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
                ++  +  I+ + +    L + L  Q+   L  +        +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SA 147
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            ++HRD+K SN+LL  +   K+ DFG AR+   D D T    +   T  Y  PE M   +
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 448 LTTKS-DVYSFGVLLLEILTGR 468
             TKS D++S G +L E+L+ R
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IGEG +G V  A    + + VAIK+    + +        E+++L +  H N++ +   +
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 333 -----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
                ++  +  I+ + +    L + L  Q+   L  +        +  GL Y+H     
Sbjct: 96  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---SA 148
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            ++HRD+K SN+LL  +   K+ DFG AR+   D D T    +   T  Y  PE M   +
Sbjct: 149 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 448 LTTKS-DVYSFGVLLLEILTGR 468
             TKS D++S G +L E+L+ R
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNR 230

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 124/277 (44%), Gaps = 35/277 (12%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI--DHRNLVKLLG 330
           +IG+G +G V+  +   G  VA+K      F   +  +  E E+   +   H N++  + 
Sbjct: 44  QIGKGRYGEVWMGKWR-GEKVAVKVF----FTTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 331 FVDKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL--- 383
              KG     +  +IT++  NG+L ++L      TLD    L++A     GL +LH    
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 384 --YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-GTVGYLDP 440
               +  I HRD+KS NIL+ ++    +AD G A     D++   I    + GT  Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 441 EYMKT------YQLTTKSDVYSFGVLLLEILTGRRPV------ELKRPPEERVTLRWAFK 488
           E +        +Q    +D+YSFG++L E+   RR V      E + P  + V    +++
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 489 RYNEGNLLDMVDPSIKEVISM-EILTKMFGLAIQCAA 524
              E   +  + PS     S  E L +M  L  +C A
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA 310

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 109/209 (52%), Gaps = 18/209 (8%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSS--EVELLSKIDHRNLVKLLG 330
           +G+GGFG V   Q+   G + A K+ +K++ +  + E  +  E ++L K++ R +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 331 FVDKGNERLIITEFVPNGTLREHL--DGQYGKTLDFNQRLEI--AIDVAHGLTYLHLYAE 386
             +  +   ++   +  G L+ H+   GQ G    F +   +  A ++  GL  LH    
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAG----FPEARAVFYAAEICCGLEDLH---R 304
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           ++I++RD+K  NILL +    +++D G A   P   +   I  +V GTVGY+ PE +K  
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRV-GTVGYMAPEVVKNE 360
Query: 447 QLTTKSDVYSFGVLLLEILTGRRPVELKR 475
           + T   D ++ G LL E++ G+ P + ++
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 122/264 (46%), Gaps = 47/264 (17%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHRNLV 326
           +G+G FG V+  +   G     L A+K  KK      + ++T+   E ++L +++H  +V
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM--ERDILVEVNHPFIV 90
Query: 327 KL-LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD----FNQRLEIAIDVAHGLTYL 381
           KL   F  +G   LI+ +F+  G L   L  +   T +    +   L +A+D  H L   
Sbjct: 91  KLHYAFQTEGKLYLIL-DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG-- 147
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
                  II+RD+K  NILL E    K+ DFG ++   +D ++   S    GTV Y+ PE
Sbjct: 148 -------IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYS--FCGTVEYMAPE 197
Query: 442 YMKTYQLTTKSDVYSFGVLLLEILTGRRPVE---------------LKRP----PEERVT 482
            +     T  +D +SFGVL+ E+LTG  P +               L  P    PE +  
Sbjct: 198 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 257
Query: 483 LRWAFKRYNEGNLLDMVDPSIKEV 506
           LR  FKR N  N L      ++E+
Sbjct: 258 LRMLFKR-NPANRLGAGPDGVEEI 280

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLLG- 330
           IG G +G   K + + DG ++  K          + +   SEV LL ++ H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 331 FVDKGNERL-IITEFVPNGTL----------REHLDGQYGKTLDFNQRLEIAIDVAHGLT 379
            +D+ N  L I+ E+   G L          R++LD ++   L    +L +A+   H  +
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF--VLRVMTQLTLALKECHRRS 131
Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLD 439
                    ++HRD+K +N+ L      K+ DFG AR+   D D    + +  GT  Y+ 
Sbjct: 132 D----GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED---FAKEFVGTPYYMS 184
Query: 440 PEYMKTYQLTTKSDVYSFGVLLLEI 464
           PE M       KSD++S G LL E+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 122/264 (46%), Gaps = 47/264 (17%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHRNLV 326
           +G+G FG V+  +   G     L A+K  KK      + ++T+   E ++L +++H  +V
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM--ERDILVEVNHPFIV 89
Query: 327 KL-LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD----FNQRLEIAIDVAHGLTYL 381
           KL   F  +G   LI+ +F+  G L   L  +   T +    +   L +A+D  H L   
Sbjct: 90  KLHYAFQTEGKLYLIL-DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG-- 146
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
                  II+RD+K  NILL E    K+ DFG ++   +D ++   S    GTV Y+ PE
Sbjct: 147 -------IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYS--FCGTVEYMAPE 196
Query: 442 YMKTYQLTTKSDVYSFGVLLLEILTGRRPVE---------------LKRP----PEERVT 482
            +     T  +D +SFGVL+ E+LTG  P +               L  P    PE +  
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 256
Query: 483 LRWAFKRYNEGNLLDMVDPSIKEV 506
           LR  FKR N  N L      ++E+
Sbjct: 257 LRMLFKR-NPANRLGAGPDGVEEI 279

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 122/264 (46%), Gaps = 47/264 (17%)
Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHRNLV 326
           +G+G FG V+  +   G     L A+K  KK      + ++T+   E ++L +++H  +V
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM--ERDILVEVNHPFIV 89
Query: 327 KL-LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD----FNQRLEIAIDVAHGLTYL 381
           KL   F  +G   LI+ +F+  G L   L  +   T +    +   L +A+D  H L   
Sbjct: 90  KLHYAFQTEGKLYLIL-DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG-- 146
Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
                  II+RD+K  NILL E    K+ DFG ++   +D ++   S    GTV Y+ PE
Sbjct: 147 -------IIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYS--FCGTVEYMAPE 196
Query: 442 YMKTYQLTTKSDVYSFGVLLLEILTGRRPVE---------------LKRP----PEERVT 482
            +     T  +D +SFGVL+ E+LTG  P +               L  P    PE +  
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 256
Query: 483 LRWAFKRYNEGNLLDMVDPSIKEV 506
           LR  FKR N  N L      ++E+
Sbjct: 257 LRMLFKR-NPANRLGAGPDGVEEI 279

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 20/206 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLG 330
           IG+G F  V  A+ +  G  VAIK   K Q    +LQ  F  EV ++  ++H N+VKL  
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 78
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            ++      +I E+   G + ++L   +G+  +   R +    +   + Y H   +K+I+
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFR-QIVSAVQYCH---QKRIV 133
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK---GTVGYLDPEYMKTYQ 447
           HRD+K+ N+LL   M  K+ADFGF       S+   +  K+    G+  Y  PE  +  +
Sbjct: 134 HRDLKAENLLLDADMNIKIADFGF-------SNEFTVGGKLDTFCGSPPYAAPELFQGKK 186
Query: 448 LT-TKSDVYSFGVLLLEILTGRRPVE 472
               + DV+S GV+L  +++G  P +
Sbjct: 187 YDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 20/222 (9%)
Query: 261 VVKATRNFSPSLRIGEGGFGTVYKAQ--LEDGLLVAIKRAKKEQFEN-LQTEFSSEVELL 317
           + +A + +     IGEG +G V+KA+     G  VA+KR + +  E  +      EV +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 318 SKID---HRNLVKLLGF-----VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE 369
             ++   H N+V+L         D+  +  ++ E V +  L  +LD      +      +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +   +  GL +LH +   +++HRD+K  NIL+T S + K+ADFG AR+       T +  
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPV 471
               T+ Y  PE +      T  D++S G +  E+   R+P+
Sbjct: 182 ----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 20/222 (9%)
Query: 261 VVKATRNFSPSLRIGEGGFGTVYKAQ--LEDGLLVAIKRAKKEQFEN-LQTEFSSEVELL 317
           + +A + +     IGEG +G V+KA+     G  VA+KR + +  E  +      EV +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 318 SKID---HRNLVKLLGF-----VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE 369
             ++   H N+V+L         D+  +  ++ E V +  L  +LD      +      +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +   +  GL +LH +   +++HRD+K  NIL+T S + K+ADFG AR+       T +  
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPV 471
               T+ Y  PE +      T  D++S G +  E+   R+P+
Sbjct: 182 ----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 19/209 (9%)
Query: 274 IGEGGFGTVY----KAQLEDGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHRNLV 326
           +G+G FG V+      + + G L A+K  KK      + ++T+   E ++L+ ++H  +V
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM--ERDILADVNHPFVV 93
Query: 327 KL-LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           KL   F  +G   LI+ +F+  G L   L  +   T + + +  +A ++A GL +LH   
Sbjct: 94  KLHYAFQTEGKLYLIL-DFLRGGDLFTRLSKEVMFTEE-DVKFYLA-ELALGLDHLHSLG 150
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
              II+RD+K  NILL E    K+ DFG ++   +D ++   S    GTV Y+ PE +  
Sbjct: 151 ---IIYRDLKPENILLDEEGHIKLTDFGLSKEA-IDHEKKAYS--FCGTVEYMAPEVVNR 204
Query: 446 YQLTTKSDVYSFGVLLLEILTGRRPVELK 474
              +  +D +S+GVL+ E+LTG  P + K
Sbjct: 205 QGHSHSADWWSYGVLMFEMLTGSLPFQGK 233

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  K  F+++        E+ L
Sbjct: 31  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSKP-FQSIIHAKRTYRELRL 86
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 135 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 185
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 186 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 20/222 (9%)
Query: 261 VVKATRNFSPSLRIGEGGFGTVYKAQ--LEDGLLVAIKRAKKEQFEN-LQTEFSSEVELL 317
           + +A + +     IGEG +G V+KA+     G  VA+KR + +  E  +      EV +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 318 SKID---HRNLVKLLGF-----VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE 369
             ++   H N+V+L         D+  +  ++ E V +  L  +LD      +      +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +   +  GL +LH +   +++HRD+K  NIL+T S + K+ADFG AR+       T +  
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPV 471
               T+ Y  PE +      T  D++S G +  E+   R+P+
Sbjct: 182 ----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 24/225 (10%)
Query: 253 SVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLED-GLLVAIK-----RAKKEQFENL 306
           ++HL M+       +FS    IG GGFG VY  +  D G + A+K     R K +Q E L
Sbjct: 183 NIHLTMN-------DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL 235
Query: 307 QTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQ 366
                  + L+S  D   +V +       ++   I + +  G L  HL  Q+G   + + 
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADM 294
Query: 367 RLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH 426
           R   A ++  GL ++H    + +++RD+K +NILL E    +++D G A        + H
Sbjct: 295 RF-YAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPH 348
Query: 427 ISTKVKGTVGYLDPEYM-KTYQLTTKSDVYSFGVLLLEILTGRRP 470
            S    GT GY+ PE + K     + +D +S G +L ++L G  P
Sbjct: 349 ASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 24/225 (10%)
Query: 253 SVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLED-GLLVAIK-----RAKKEQFENL 306
           ++HL M+       +FS    IG GGFG VY  +  D G + A+K     R K +Q E L
Sbjct: 183 NIHLTMN-------DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL 235
Query: 307 QTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQ 366
                  + L+S  D   +V +       ++   I + +  G L  HL  Q+G   + + 
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADM 294
Query: 367 RLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH 426
           R   A ++  GL ++H    + +++RD+K +NILL E    +++D G A        + H
Sbjct: 295 RF-YAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPH 348
Query: 427 ISTKVKGTVGYLDPEYM-KTYQLTTKSDVYSFGVLLLEILTGRRP 470
            S    GT GY+ PE + K     + +D +S G +L ++L G  P
Sbjct: 349 ASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 26  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 81
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 180
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H + ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 181 ---HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 111/227 (48%), Gaps = 33/227 (14%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G+G +G V++   + + + V I  ++ E+    +TE  + V L     H N+   LGF+
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVML----RHENI---LGFI 68
Query: 333 -------DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL-- 383
                      +  +IT +   G+L ++L      TLD    L I + +A GL +LH+  
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 384 ---YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-GTVGYLD 439
                +  I HRD+KS NIL+ ++ +  +AD G A +    +++  +    + GT  Y+ 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 440 PEYM-KTYQLTT-----KSDVYSFGVLLLEI---LTGRRPVELKRPP 477
           PE + +T Q+       + D+++FG++L E+   +     VE  +PP
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 111/227 (48%), Gaps = 33/227 (14%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G+G +G V++   + + + V I  ++ E+    +TE  + V L     H N+   LGF+
Sbjct: 45  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVML----RHENI---LGFI 97
Query: 333 -------DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL-- 383
                      +  +IT +   G+L ++L      TLD    L I + +A GL +LH+  
Sbjct: 98  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEI 154
Query: 384 ---YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-GTVGYLD 439
                +  I HRD+KS NIL+ ++ +  +AD G A +    +++  +    + GT  Y+ 
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 440 PEYM-KTYQLTT-----KSDVYSFGVLLLEI---LTGRRPVELKRPP 477
           PE + +T Q+       + D+++FG++L E+   +     VE  +PP
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 261

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 24/225 (10%)
Query: 253 SVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLED-GLLVAIK-----RAKKEQFENL 306
           ++HL M+       +FS    IG GGFG VY  +  D G + A+K     R K +Q E L
Sbjct: 183 NIHLTMN-------DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL 235
Query: 307 QTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQ 366
                  + L+S  D   +V +       ++   I + +  G L  HL  Q+G   + + 
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADM 294
Query: 367 RLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH 426
           R   A ++  GL ++H    + +++RD+K +NILL E    +++D G A        + H
Sbjct: 295 RF-YAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPH 348
Query: 427 ISTKVKGTVGYLDPEYM-KTYQLTTKSDVYSFGVLLLEILTGRRP 470
            S    GT GY+ PE + K     + +D +S G +L ++L G  P
Sbjct: 349 ASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLLG- 330
           IG G +G   K + + DG ++  K          + +   SEV LL ++ H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 331 FVDKGNERL-IITEFVPNGTL----------REHLDGQYGKTLDFNQRLEIAIDVAHGLT 379
            +D+ N  L I+ E+   G L          R++LD ++   L    +L +A+   H  +
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF--VLRVMTQLTLALKECHRRS 131
Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLD 439
                    ++HRD+K +N+ L      K+ DFG AR+  ++ D +   T V GT  Y+ 
Sbjct: 132 D----GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFV-GTPYYMS 184
Query: 440 PEYMKTYQLTTKSDVYSFGVLLLEI 464
           PE M       KSD++S G LL E+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 111/227 (48%), Gaps = 33/227 (14%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G+G +G V++   + + + V I  ++ E+    +TE  + V L     H N+   LGF+
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVML----RHENI---LGFI 68
Query: 333 -------DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL-- 383
                      +  +IT +   G+L ++L      TLD    L I + +A GL +LH+  
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 384 ---YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-GTVGYLD 439
                +  I HRD+KS NIL+ ++ +  +AD G A +    +++  +    + GT  Y+ 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 440 PEYM-KTYQLTT-----KSDVYSFGVLLLEI---LTGRRPVELKRPP 477
           PE + +T Q+       + D+++FG++L E+   +     VE  +PP
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 26  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 81
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 180
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H + ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 181 ---HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 24/225 (10%)
Query: 253 SVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLED-GLLVAIK-----RAKKEQFENL 306
           ++HL M+       +FS    IG GGFG VY  +  D G + A+K     R K +Q E L
Sbjct: 182 NIHLTMN-------DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL 234
Query: 307 QTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQ 366
                  + L+S  D   +V +       ++   I + +  G L  HL  Q+G   + + 
Sbjct: 235 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADM 293
Query: 367 RLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH 426
           R   A ++  GL ++H    + +++RD+K +NILL E    +++D G A        + H
Sbjct: 294 RF-YAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPH 347
Query: 427 ISTKVKGTVGYLDPEYM-KTYQLTTKSDVYSFGVLLLEILTGRRP 470
            S    GT GY+ PE + K     + +D +S G +L ++L G  P
Sbjct: 348 ASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 26  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 81
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 180
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H + ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 181 ---HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   IG G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 24  EVPERYQNLSP---IGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 79
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR------ 178
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 179 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 110/243 (45%), Gaps = 35/243 (14%)
Query: 245 SPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF 303
           +PK +     H+   Q+VK          +GEG FG V  A     G  VA+K   K+  
Sbjct: 1   NPKSSLADGAHIGNYQIVKT---------LGEGSFGKVKLAYHTTTGQKVALKIINKKVL 51
Query: 304 --ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTL-----REHLDG 356
              ++Q     E+  L  + H +++KL   +   +E +++ E+  N        R+ +  
Sbjct: 52  AKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE 111
Query: 357 QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR 416
           Q  +   F Q++  A++  H           +I+HRD+K  N+LL E +  K+ADFG + 
Sbjct: 112 QEARR--FFQQIISAVEYCH---------RHKIVHRDLKPENLLLDEHLNVKIADFGLSN 160
Query: 417 LGPMDSDRTHISTKVKGTVGYLDPEYM--KTYQLTTKSDVYSFGVLLLEILTGRRPVELK 474
           +    +D   + T   G+  Y  PE +  K Y    + DV+S GV+L  +L  R P + +
Sbjct: 161 IM---TDGNFLKTSC-GSPNYAAPEVISGKLYA-GPEVDVWSCGVILYVMLCRRLPFDDE 215
Query: 475 RPP 477
             P
Sbjct: 216 SIP 218

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G G FG V+K +    GL +A K  K    ++ + E  +E+ +++++DH NL++L    
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD-KEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 333 DKGNERLIITEFVPNGTLREH-LDGQYGKT-LDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           +  N+ +++ E+V  G L +  +D  Y  T LD    +     +  G+ ++H   +  I+
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELD---TILFMKQICEGIRHMH---QMYIL 209
Query: 391 HRDVKSSNILLT--ESMRAKVADFGFARLGPMDSDRTHISTKVK---GTVGYLDPEYMKT 445
           H D+K  NIL    ++ + K+ DFG AR       R     K+K   GT  +L PE +  
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLAR-------RYKPREKLKVNFGTPEFLAPEVVNY 262
Query: 446 YQLTTKSDVYSFGVLLLEILTGRRP 470
             ++  +D++S GV+   +L+G  P
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLLG- 330
           IG G +G   K + + DG ++  K          + +   SEV LL ++ H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 331 FVDKGNERL-IITEFVPNGTL----------REHLDGQYGKTLDFNQRLEIAIDVAHGLT 379
            +D+ N  L I+ E+   G L          R++LD ++   L    +L +A+   H  +
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF--VLRVMTQLTLALKECHRRS 131
Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLD 439
                    ++HRD+K +N+ L      K+ DFG AR+   D   T  +    GT  Y+ 
Sbjct: 132 D----GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD---TSFAKAFVGTPYYMS 184
Query: 440 PEYMKTYQLTTKSDVYSFGVLLLEI 464
           PE M       KSD++S G LL E+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 267 NFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHR 323
           N+     IG+G F  V  A+ +  G  VA+K   K Q    +LQ  F  EV ++  ++H 
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 74
Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
           N+VKL   ++      ++ E+   G + ++L   +G+  +   R +    +   + Y H 
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFR-QIVSAVQYCH- 131
Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK---GTVGYLDP 440
             +K I+HRD+K+ N+LL   M  K+ADFGF       S+   +  K+    G+  Y  P
Sbjct: 132 --QKYIVHRDLKAENLLLDGDMNIKIADFGF-------SNEFTVGNKLDTFCGSPPYAAP 182
Query: 441 EYMKTYQLT-TKSDVYSFGVLLLEILTGRRPVE 472
           E  +  +    + DV+S GV+L  +++G  P +
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 31  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 86
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 135 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 185
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 186 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 31  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 86
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 135 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 185
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 186 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 21  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 76
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 175
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 176 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 21  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 76
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 175
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 176 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 16  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 71
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 72  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 119
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 120 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 170
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 171 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 15  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 70
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 169
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 170 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 26  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 81
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 180
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 181 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 16  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 71
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 72  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 119
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 120 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 170
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 171 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 17  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 72
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 73  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 120
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 121 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 171
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 172 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 24  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 79
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 178
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 179 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 18  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 73
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 74  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 121
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 122 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 172
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 173 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 21  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 76
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 175
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 176 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 38  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 93
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 94  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 142 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 192
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 193 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 24  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 79
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 178
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 179 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 42  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 97
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 98  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 145
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 146 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 196
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 197 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 24  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 79
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR------ 178
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 179 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 30  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 85
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 86  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 134 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 184
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 185 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 25  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 80
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 179
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 180 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 42  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 97
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 98  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 145
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 146 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 196
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 197 ---HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 39  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 94
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 143 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 193
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 194 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 30  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 85
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 86  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 134 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR------ 184
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 185 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 25  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 80
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 179
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 180 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 274 IGEGGFGTVYKAQ----LEDGLLVAIKRAKKEQF-ENLQTEFSSEVE--LLSKIDHRNLV 326
           +G+GG+G V++ +       G + A+K  KK     N +    ++ E  +L ++ H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            L+     G +  +I E++  G L   L+ + G  ++      +A +++  L +LH   +
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLA-EISMALGHLH---Q 139
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K II+RD+K  NI+L      K+ DFG  +    D   TH      GT+ Y+ PE +   
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIEYMAPEILMRS 196
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
                 D +S G L+ ++LTG  P
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 21  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 76
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR------ 175
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 176 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 274 IGEGGFGTVYKAQ----LEDGLLVAIKRAKKEQF-ENLQTEFSSEVE--LLSKIDHRNLV 326
           +G+GG+G V++ +       G + A+K  KK     N +    ++ E  +L ++ H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            L+     G +  +I E++  G L   L+ + G  ++      +A +++  L +LH   +
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLA-EISMALGHLH---Q 139
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K II+RD+K  NI+L      K+ DFG  +    D   TH      GT+ Y+ PE +   
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC---GTIEYMAPEILMRS 196
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
                 D +S G L+ ++LTG  P
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 25  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 80
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR------ 179
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 180 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 113/217 (52%), Gaps = 17/217 (7%)
Query: 262 VKATRNFSPSLRIGEGGFGTVYKAQLEDGL-LVAIKRAKKE---QFENLQTEFSSEVELL 317
           VK T +F+  + +G+G FG V  A  +    L AIK  KK+   Q ++++     E  +L
Sbjct: 16  VKLT-DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMV-EKRVL 73
Query: 318 SKIDHRNLVKLLGFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAH 376
           + +D    +  L    +  +RL  + E+V  G L  H+  Q GK  +  Q +  A +++ 
Sbjct: 74  ALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGKFKE-PQAVFYAAEISI 131
Query: 377 GLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG 436
           GL +LH   ++ II+RD+K  N++L      K+ADFG  +   MD   T    +  GT  
Sbjct: 132 GLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTR---EFCGTPD 185
Query: 437 YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           Y+ PE +  YQ   KS D +++GVLL E+L G+ P +
Sbjct: 186 YIAPEII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 109/250 (43%), Gaps = 57/250 (22%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH---------- 322
           +G+G FG V KA+   D    AIK+ +  + E L T   SEV LL+ ++H          
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLST-ILSEVMLLASLNHQYVVRYYAAW 71
Query: 323 ---RNLVKLLGFVDKGNERLIITEFVPNGTL-----REHLDGQYGKTLD-FNQRLEIAID 373
              RN VK +  V K +   I  E+  N TL      E+L+ Q  +    F Q LE    
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE---- 127
Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-----LGPMDSDRTHIS 428
               L+Y+H    + IIHRD+K  NI + ES   K+ DFG A+     L  +  D  ++ 
Sbjct: 128 ---ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 429 ------TKVKGTVGYLDPEYMK-TYQLTTKSDVYSFGVLLLE-------------ILTGR 468
                 T   GT  Y+  E +  T     K D+YS G++  E             IL   
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKL 241
Query: 469 RPVELKRPPE 478
           R V ++ PP+
Sbjct: 242 RSVSIEFPPD 251

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 115
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + ++I ++      Y  PE
Sbjct: 175 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 226
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G G F  V  A+ +  G L A+K   K+  +  ++   +E+ +L KI H N+V L    
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIY 89
Query: 333 DKGNERLIITEFVPNGTLREHL--DGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           +  N   ++ + V  G L + +   G Y +  D +  +   +D  +   YLH      I+
Sbjct: 90  ESPNHLYLVMQLVSGGELFDRIVEKGFYTEK-DASTLIRQVLDAVY---YLHRMG---IV 142
Query: 391 HRDVKSSNILL---TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
           HRD+K  N+L     E  +  ++DFG +++      +  + +   GT GY+ PE +    
Sbjct: 143 HRDLKPENLLYYSQDEESKIMISDFGLSKM----EGKGDVMSTACGTPGYVAPEVLAQKP 198
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
            +   D +S GV+   +L G  P
Sbjct: 199 YSKAVDCWSIGVIAYILLCGYPP 221

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 117
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 118 FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 176
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + ++I ++      Y  PE
Sbjct: 177 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 228
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 229 LIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 6/220 (2%)
Query: 252 GSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEF 310
           G V +   Q       ++    IGEG +G V  A        VAIK+    + +      
Sbjct: 29  GEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRT 88
Query: 311 SSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQY-GKTLDFNQRLE 369
             E+++L +  H N++ +   +       +   ++    +   L      + L  +    
Sbjct: 89  LREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY 148
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
               +  GL Y+H      ++HRD+K SN+L+  +   K+ DFG AR+   + D T   T
Sbjct: 149 FLYQILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLT 205
Query: 430 KVKGTVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
           +   T  Y  PE M   +  TKS D++S G +L E+L+ R
Sbjct: 206 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 119
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 120 FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 178
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + ++I ++      Y  PE
Sbjct: 179 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 230
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 109
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 110 FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 168
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + ++I ++      Y  PE
Sbjct: 169 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 220
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 221 LIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLLG 330
           IG+G F  V  A+ +  G  VA+K   K Q  +  LQ  F  EV ++  ++H N+VKL  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            ++      ++ E+   G + ++L   +G+  +   R +    +   + Y H   +K I+
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFR-QIVSAVQYCH---QKFIV 135
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG---YLDPEYMKTYQ 447
           HRD+K+ N+LL   M  K+ADFGF       S+      K+    G   Y  PE  +  +
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGF-------SNEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 448 LT-TKSDVYSFGVLLLEILTGRRPVE 472
               + DV+S GV+L  +++G  P +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLLG 330
           IG+G F  V  A+ +  G  VA+K   K Q  +  LQ  F  EV ++  ++H N+VKL  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            ++      ++ E+   G + ++L   +G+  +   R +    +   + Y H   +K I+
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFR-QIVSAVQYCH---QKFIV 135
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK---GTVGYLDPEYMKTYQ 447
           HRD+K+ N+LL   M  K+ADFGF       S+      K+    G+  Y  PE  +  +
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGF-------SNEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 448 LT-TKSDVYSFGVLLLEILTGRRPVE 472
               + DV+S GV+L  +++G  P +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 160
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 161 FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 219
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + ++I ++      Y  PE
Sbjct: 220 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 271
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +  +Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG  R      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 86
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 87  FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 145
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + ++I ++      Y  PE
Sbjct: 146 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 197
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 198 LIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 94
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 95  FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 153
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + ++I ++      Y  PE
Sbjct: 154 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 205
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 206 LIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLLG 330
           IG+G F  V  A+ +  G  VA+K   K Q  +  LQ  F  EV ++  ++H N+VKL  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            ++      ++ E+   G + ++L   +G+  +   R +    +   + Y H   +K I+
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFR-QIVSAVQYCH---QKFIV 135
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK---GTVGYLDPEYMKTYQ 447
           HRD+K+ N+LL   M  K+ADFGF       S+      K+    G+  Y  PE  +  +
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGF-------SNEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 448 LT-TKSDVYSFGVLLLEILTGRRPVE 472
               + DV+S GV+L  +++G  P +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 81
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + ++I ++      Y  PE
Sbjct: 141 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 192
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ D+G AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 99/230 (43%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYM-KTYQLTTKSDVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M          D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 35/233 (15%)
Query: 255 HLNMSQVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFS 311
           H+   Q+VK          +GEG FG V  A     G  VA+K   K+     ++Q    
Sbjct: 6   HIGNYQIVKT---------LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE 56
Query: 312 SEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTL-----REHLDGQYGKTLDFNQ 366
            E+  L  + H +++KL   +   +E +++ E+  N        R+ +  Q  +   F Q
Sbjct: 57  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARR--FFQ 114
Query: 367 RLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH 426
           ++  A++  H           +I+HRD+K  N+LL E +  K+ADFG + +    +D   
Sbjct: 115 QIISAVEYCH---------RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNF 162
Query: 427 ISTKVKGTVGYLDPEYM--KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP 477
           + T   G+  Y  PE +  K Y    + DV+S GV+L  +L  R P + +  P
Sbjct: 163 LKTSC-GSPNYAAPEVISGKLYA-GPEVDVWSCGVILYVMLCRRLPFDDESIP 213

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 35/233 (15%)
Query: 255 HLNMSQVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQF--ENLQTEFS 311
           H+   Q+VK          +GEG FG V  A     G  VA+K   K+     ++Q    
Sbjct: 2   HIGNYQIVKT---------LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE 52
Query: 312 SEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTL-----REHLDGQYGKTLDFNQ 366
            E+  L  + H +++KL   +   +E +++ E+  N        R+ +  Q  +   F Q
Sbjct: 53  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARR--FFQ 110
Query: 367 RLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH 426
           ++  A++  H           +I+HRD+K  N+LL E +  K+ADFG + +    +D   
Sbjct: 111 QIISAVEYCH---------RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNF 158
Query: 427 ISTKVKGTVGYLDPEYM--KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP 477
           + T   G+  Y  PE +  K Y    + DV+S GV+L  +L  R P + +  P
Sbjct: 159 LKTSC-GSPNYAAPEVISGKLYA-GPEVDVWSCGVILYVMLCRRLPFDDESIP 209

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 126/265 (47%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           IG G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    KVADFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIKVADFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + + F+N       E++++ K+DH N+V+L  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNIVRLRYF 81
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + ++I ++      Y  PE
Sbjct: 141 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 192
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 115
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + + I ++      Y  PE
Sbjct: 175 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPE 226
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 272 LRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           LR+G G FG V++ +  + G   A+K+ + E F       + E+   + +    +V L G
Sbjct: 99  LRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR------AEELMACAGLTSPRIVPLYG 152
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            V +G    I  E +  G+L + +  Q    L  ++ L        GL YLH    ++I+
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQ--GCLPEDRALYYLGQALEGLEYLH---SRRIL 207
Query: 391 HRDVKSSNILLT-ESMRAKVADFGFAR-LGPMDSDRTHISTK-VKGTVGYLDPEYMKTYQ 447
           H DVK+ N+LL+ +   A + DFG A  L P    ++ ++   + GT  ++ PE +    
Sbjct: 208 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS 267
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
              K DV+S   ++L +L G  P
Sbjct: 268 CDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLLG 330
           IG+G F  V  A+ +  G  VA++   K Q  +  LQ  F  EV ++  ++H N+VKL  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            ++      ++ E+   G + ++L   +G+  +   R +    +   + Y H   +K I+
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFR-QIVSAVQYCH---QKFIV 135
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK---GTVGYLDPEYMKTYQ 447
           HRD+K+ N+LL   M  K+ADFGF       S+      K+    G+  Y  PE  +  +
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGF-------SNEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 448 LT-TKSDVYSFGVLLLEILTGRRPVE 472
               + DV+S GV+L  +++G  P +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + + F+N       E++++ K+DH N+V+L  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNIVRLRYF 81
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + ++I ++      Y  PE
Sbjct: 141 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 192
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQT--EFSSEVELLSKIDHRNLVKLLG 330
           +G G FG V   + E  G  VA+K   +++  +L    +   E++ L    H +++KL  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            +   ++  ++ E+V  G L +++  + G+ LD  +   +   +  G+ Y H +    ++
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYI-CKNGR-LDEKESRRLFQQILSGVDYCHRH---MVV 138
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM--KTYQL 448
           HRD+K  N+LL   M AK+ADFG   L  M SD   +     G+  Y  PE +  + Y  
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFG---LSNMMSDGEFLRXSC-GSPNYAAPEVISGRLYA- 193
Query: 449 TTKSDVYSFGVLLLEILTGRRPVE 472
             + D++S GV+L  +L G  P +
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFD 217

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 93
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + + I ++      Y  PE
Sbjct: 153 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPE 204
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 81
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + + I ++      Y  PE
Sbjct: 141 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPE 192
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 81
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 82  FYSSGEKKDVVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + + I ++      Y  PE
Sbjct: 141 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPE 192
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLLG 330
           IG+G F  V  A+ +  G  VA++   K Q  +  LQ  F  EV ++  ++H N+VKL  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            ++      ++ E+   G + ++L   +G+  +   R +    +   + Y H   +K I+
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFR-QIVSAVQYCH---QKFIV 135
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK---GTVGYLDPEYMKTYQ 447
           HRD+K+ N+LL   M  K+ADFGF       S+      K+    G+  Y  PE  +  +
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGF-------SNEFTFGNKLDEFCGSPPYAAPELFQGKK 188
Query: 448 LT-TKSDVYSFGVLLLEILTGRRPVE 472
               + DV+S GV+L  +++G  P +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + G  VA+K+  +  F+++        E+ L
Sbjct: 39  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRL 94
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 143 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 193
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 194 ---HTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 81
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + + I ++      Y  PE
Sbjct: 141 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPE 192
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 93
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + + I ++      Y  PE
Sbjct: 153 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPE 204
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 109/252 (43%), Gaps = 54/252 (21%)
Query: 242 FTMS----PKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIK 296
           FTMS    P   R   ++  + +V +  +  SP   +G G +G+V  +  ++ GL +A+K
Sbjct: 27  FTMSHKERPTFYR-QELNKTIWEVPERYQTLSP---VGSGAYGSVCSSYDVKSGLKIAVK 82
Query: 297 RAKKEQFENL--QTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE-- 352
           +  +  F+++        E+ LL  + H N++ LL              F P  +L E  
Sbjct: 83  KLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPATSLEEFN 129
Query: 353 ------HLDGQYGKTLDFNQRLE------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNIL 400
                 HL G     +   Q+L       +   +  GL Y+H      IIHRD+K SN+ 
Sbjct: 130 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLA 186
Query: 401 LTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG---YLDPEYMKTY-QLTTKSDVYS 456
           + E    K+ DFG AR         H   ++ G V    Y  PE M  +       D++S
Sbjct: 187 VNEDCELKILDFGLAR---------HTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWS 237
Query: 457 FGVLLLEILTGR 468
            G ++ E+LTGR
Sbjct: 238 VGCIMAELLTGR 249

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 15/209 (7%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQT--EFSSEVELLSKIDHRNLVKLLG 330
           +G G FG V   + +  G  VA+K   +++  +L    +   E++ L    H +++KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            +    +  ++ E+V  G L +++  ++G+  +   R  +   +   + Y H      ++
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEAR-RLFQQILSAVDYCH---RHMVV 133
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM--KTYQL 448
           HRD+K  N+LL   M AK+ADFG +    M SD   + T   G+  Y  PE +  + Y  
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSN---MMSDGEFLRTSC-GSPNYAAPEVISGRLYA- 188
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP 477
             + D++S GV+L  +L G  P + +  P
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVP 217

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 19/205 (9%)
Query: 272 LRIGEGGFGTVYKAQLED---GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           LR+G G FG V++  +ED   G   A+K+ + E F       + E+   + +    +V L
Sbjct: 80  LRLGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFR------AEELMACAGLTSPRIVPL 131
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
            G V +G    I  E +  G+L + +  Q    L  ++ L        GL YLH    ++
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLVKEQ--GCLPEDRALYYLGQALEGLEYLH---SRR 186
Query: 389 IIHRDVKSSNILLT-ESMRAKVADFGFARLGPMDSDRTHISTK--VKGTVGYLDPEYMKT 445
           I+H DVK+ N+LL+ +   A + DFG A     D     + T   + GT  ++ PE +  
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG 246
Query: 446 YQLTTKSDVYSFGVLLLEILTGRRP 470
                K DV+S   ++L +L G  P
Sbjct: 247 RSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 85
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 86  FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 144
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + + I ++      Y  PE
Sbjct: 145 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPE 196
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 197 LIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 100
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 101 FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 159
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + + I ++      Y  PE
Sbjct: 160 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPE 211
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 212 LIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 82
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 83  FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 141
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + + I ++      Y  PE
Sbjct: 142 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPE 193
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 194 LIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + ++F+N       E++++ K+DH N+V+L  F
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYF 89
Query: 332 VDKGNERL------IITEFVPNGTLR--EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
                E+       ++ ++VP    R   H   +  +TL           +   L Y+H 
Sbjct: 90  FYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS 148
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
           +    I HRD+K  N+LL  ++   K+ DFG A+ L   + + + I ++      Y  PE
Sbjct: 149 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPE 200
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      T+  DV+S G +L E+L G+
Sbjct: 201 LIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + G  VA+K+  +  F+++        E+ L
Sbjct: 38  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRL 93
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 94  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 142 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 192
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 193 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + G  VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + G  VA+K+  +  F+++        E+ L
Sbjct: 15  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRL 70
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 169
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 170 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + G  VA+K+  +  F+++        E+ L
Sbjct: 39  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRL 94
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 143 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 193
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 194 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYK-AQLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+GGF   Y+   ++   + A K   K      + + + S+E+ +   +D+ ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F +  +   ++ E     +L E L  +     +   R  +   +  G+ YLH     ++I
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-QGVQYLH---NNRVI 164
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+ L + M  K+ DFG A     D +R      + GT  Y+ PE +     + 
Sbjct: 165 HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKTLCGTPNYIAPEVLCKKGHSF 221
Query: 451 KSDVYSFGVLLLEILTGRRPVE 472
           + D++S G +L  +L G+ P E
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFE 243

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYK-AQLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+GGF   Y+   ++   + A K   K      + + + S+E+ +   +D+ ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F +  +   ++ E     +L E L  +     +   R  +   +  G+ YLH     ++I
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-QGVQYLH---NNRVI 164
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+ L + M  K+ DFG A     D +R      + GT  Y+ PE +     + 
Sbjct: 165 HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIAPEVLCKKGHSF 221
Query: 451 KSDVYSFGVLLLEILTGRRPVE 472
           + D++S G +L  +L G+ P E
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFE 243

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + G  VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYK-AQLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+GGF   Y+   ++   + A K   K      + + + S+E+ +   +D+ ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F +  +   ++ E     +L E L  +     +   R  +   +  G+ YLH     ++I
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-QGVQYLH---NNRVI 164
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+ L + M  K+ DFG A     D +R      + GT  Y+ PE +     + 
Sbjct: 165 HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGTPNYIAPEVLCKKGHSF 221
Query: 451 KSDVYSFGVLLLEILTGRRPVE 472
           + D++S G +L  +L G+ P E
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFE 243

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + G  VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIK----RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG+G FG V++ +   G  VA+K    R ++  F        +E+     + H N++  +
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE------AEIYQTVMLRHENILGFI 64
Query: 330 GFVDKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL-- 383
              +K N    +  +++++  +G+L ++L+ +Y  T+     +++A+  A GL +LH+  
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RY--TVTVEGMIKLALSTASGLAHLHMEI 121
Query: 384 ---YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-GTVGYLD 439
                +  I HRD+KS NIL+ ++    +AD G A      +D   I+   + GT  Y+ 
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 181
Query: 440 PEY------MKTYQLTTKSDVYSFGVLLLEI 464
           PE       MK ++   ++D+Y+ G++  EI
Sbjct: 182 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + G  VA+K+  +  F+++        E+ L
Sbjct: 15  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRL 70
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 169
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 170 ---HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLLG 330
           IG+G F  V  A+ +  G  VA+K   K Q  +  LQ  F  EV ++  ++H N+VKL  
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 73
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            ++      ++ E+   G + ++L   +G   +   R +    +   + Y H   +K I+
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYLVA-HGWMKEKEARAKFR-QIVSAVQYCH---QKFIV 128
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK---GTVGYLDPEYMKTYQ 447
           HRD+K+ N+LL   M  K+ADFGF       S+      K+    G+  Y  PE  +  +
Sbjct: 129 HRDLKAENLLLDADMNIKIADFGF-------SNEFTFGNKLDTFCGSPPYAAPELFQGKK 181
Query: 448 LT-TKSDVYSFGVLLLEILTGRRPVE 472
               + DV+S GV+L  +++G  P +
Sbjct: 182 YDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 126/265 (47%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           IG G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E++P G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYMPGGDMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    KVADFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIKVADFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           R+G G FG V++ +  + G   A+K+ + E F         E+   + +    +V L G 
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGA 134
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           V +G    I  E +  G+L + L  Q G  L  ++ L        GL YLH    ++I+H
Sbjct: 135 VREGPWVNIFMELLEGGSLGQ-LIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILH 189
Query: 392 RDVKSSNILLT-ESMRAKVADFGFAR-LGPMDSDRTHISTK-VKGTVGYLDPEYMKTYQL 448
            DVK+ N+LL+ +  RA + DFG A  L P    ++ ++   + GT  ++ PE +     
Sbjct: 190 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 249
Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
             K D++S   ++L +L G  P
Sbjct: 250 DAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIK----RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG+G FG V++ +   G  VA+K    R ++  F        +E+     + H N++  +
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE------AEIYQTVMLRHENILGFI 69
Query: 330 GFVDKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL-- 383
              +K N    +  +++++  +G+L ++L+ +Y  T+     +++A+  A GL +LH+  
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RY--TVTVEGMIKLALSTASGLAHLHMEI 126
Query: 384 ---YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-GTVGYLD 439
                +  I HRD+KS NIL+ ++    +AD G A      +D   I+   + GT  Y+ 
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 186
Query: 440 PEY------MKTYQLTTKSDVYSFGVLLLEI 464
           PE       MK ++   ++D+Y+ G++  EI
Sbjct: 187 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 126/265 (47%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           IG G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E++P G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYMPGGDMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    KVADFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIKVADFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           R+G G FG V++ +  + G   A+K+ + E F         E+   + +    +V L G 
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGA 118
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           V +G    I  E +  G+L + L  Q G  L  ++ L        GL YLH    ++I+H
Sbjct: 119 VREGPWVNIFMELLEGGSLGQ-LIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILH 173
Query: 392 RDVKSSNILLT-ESMRAKVADFGFARLGPMDSDRTHISTK--VKGTVGYLDPEYMKTYQL 448
            DVK+ N+LL+ +  RA + DFG A     D     + T   + GT  ++ PE +     
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
             K D++S   ++L +L G  P
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHP 255

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + G  VA+K+  +  F+++        E+ L
Sbjct: 25  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRL 80
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 179
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 180 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIK----RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG+G FG V++ +   G  VA+K    R ++  F        +E+     + H N++  +
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE------AEIYQTVMLRHENILGFI 66
Query: 330 GFVDKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL-- 383
              +K N    +  +++++  +G+L ++L+ +Y  T+     +++A+  A GL +LH+  
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RY--TVTVEGMIKLALSTASGLAHLHMEI 123
Query: 384 ---YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-GTVGYLD 439
                +  I HRD+KS NIL+ ++    +AD G A      +D   I+   + GT  Y+ 
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 183
Query: 440 PEY------MKTYQLTTKSDVYSFGVLLLEI 464
           PE       MK ++   ++D+Y+ G++  EI
Sbjct: 184 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 91/202 (45%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+GGF   ++    D   V   +   +      + + + S E+ +   + H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F +  +   ++ E     +L E L  +     +   R  +   +  G  YLH     ++I
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLH---RNRVI 163
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+ L E +  K+ DFG A     D +R  +   + GT  Y+ PE +     + 
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKKGHSF 220
Query: 451 KSDVYSFGVLLLEILTGRRPVE 472
           + DV+S G ++  +L G+ P E
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFE 242

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+  FG AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 91/202 (45%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+GGF   ++    D   V   +   +      + + + S E+ +   + H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F +  +   ++ E     +L E L  +     +   R  +   +  G  YLH     ++I
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLH---RNRVI 161
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+ L E +  K+ DFG A     D +R  +   + GT  Y+ PE +     + 
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKKGHSF 218
Query: 451 KSDVYSFGVLLLEILTGRRPVE 472
           + DV+S G ++  +L G+ P E
Sbjct: 219 EVDVWSIGCIMYTLLVGKPPFE 240

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +G G F  V+   Q   G L A+K  KK   F +  +   +E+ +L KI H N+V L   
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKHENIVTLEDI 74
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
            +      ++ + V  G L + +  + G   + +  L I   V   + YLH   E  I+H
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRI-LERGVYTEKDASLVIQ-QVLSAVKYLH---ENGIVH 129
Query: 392 RDVKSSNILL---TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           RD+K  N+L     E+ +  + DFG +++     ++  I +   GT GY+ PE +     
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKM-----EQNGIMSTACGTPGYVAPEVLAQKPY 184
Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
           +   D +S GV+   +L G  P
Sbjct: 185 SKAVDCWSIGVITYILLCGYPP 206

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYK-AQLEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+GGF   Y+   ++   + A K   K      + + + S+E+ +   +D+ ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F +  +   ++ E     +L E L  +     +   R  +   +  G+ YLH     ++I
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-QGVQYLH---NNRVI 148
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+ L + M  K+ DFG A     D +R      + GT  Y+ PE +     + 
Sbjct: 149 HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIAPEVLCKKGHSF 205
Query: 451 KSDVYSFGVLLLEILTGRRPVE 472
           + D++S G +L  +L G+ P E
Sbjct: 206 EVDIWSLGCILYTLLVGKPPFE 227

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIK----RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG+G FG V++ +   G  VA+K    R ++  F        +E+     + H N++  +
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE------AEIYQTVMLRHENILGFI 63
Query: 330 GFVDKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL-- 383
              +K N    +  +++++  +G+L ++L+ +Y  T+     +++A+  A GL +LH+  
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RY--TVTVEGMIKLALSTASGLAHLHMEI 120
Query: 384 ---YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-GTVGYLD 439
                +  I HRD+KS NIL+ ++    +AD G A      +D   I+   + GT  Y+ 
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 440 PEY------MKTYQLTTKSDVYSFGVLLLEI 464
           PE       MK ++   ++D+Y+ G++  EI
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ D G AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 91/202 (45%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+GGF   ++    D   V   +   +      + + + S E+ +   + H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F +  +   ++ E     +L E L  +     +   R  +   +  G  YLH     ++I
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLH---RNRVI 137
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+ L E +  K+ DFG A     D +R  +   + GT  Y+ PE +     + 
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKKGHSF 194
Query: 451 KSDVYSFGVLLLEILTGRRPVE 472
           + DV+S G ++  +L G+ P E
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFE 216

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIK----RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG+G FG V++ +   G  VA+K    R ++  F        +E+     + H N++  +
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE------AEIYQTVMLRHENILGFI 89
Query: 330 GFVDKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL-- 383
              +K N    +  +++++  +G+L ++L+ +Y  T+     +++A+  A GL +LH+  
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RY--TVTVEGMIKLALSTASGLAHLHMEI 146
Query: 384 ---YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-GTVGYLD 439
                +  I HRD+KS NIL+ ++    +AD G A      +D   I+   + GT  Y+ 
Sbjct: 147 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 206
Query: 440 PEY------MKTYQLTTKSDVYSFGVLLLEI 464
           PE       MK ++   ++D+Y+ G++  EI
Sbjct: 207 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           R+G G FG V++ +  + G   A+K+ + E F         E+   + +    +V L G 
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGA 132
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           V +G    I  E +  G+L + L  Q G  L  ++ L        GL YLH    ++I+H
Sbjct: 133 VREGPWVNIFMELLEGGSLGQ-LIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILH 187
Query: 392 RDVKSSNILLT-ESMRAKVADFGFAR-LGPMDSDRTHISTK-VKGTVGYLDPEYMKTYQL 448
            DVK+ N+LL+ +  RA + DFG A  L P    ++ ++   + GT  ++ PE +     
Sbjct: 188 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 247
Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
             K D++S   ++L +L G  P
Sbjct: 248 DAKVDIWSSCCMMLHMLNGCHP 269

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIK----RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG+G FG V++ +   G  VA+K    R ++  F        +E+     + H N++  +
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE------AEIYQTVMLRHENILGFI 102
Query: 330 GFVDKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL-- 383
              +K N    +  +++++  +G+L ++L+ +Y  T+     +++A+  A GL +LH+  
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RY--TVTVEGMIKLALSTASGLAHLHMEI 159
Query: 384 ---YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-GTVGYLD 439
                +  I HRD+KS NIL+ ++    +AD G A      +D   I+   + GT  Y+ 
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 440 PEY------MKTYQLTTKSDVYSFGVLLLEI 464
           PE       MK ++   ++D+Y+ G++  EI
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + G  VA+K+  +  F+++        E+ L
Sbjct: 15  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRL 70
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTL---DFNQRLEIA-- 371
           L  + H N++ LL              F P  +L E  D      L   D N  ++ A  
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKL 118
Query: 372 ---------IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                      +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 169
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 170 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 107/250 (42%), Gaps = 57/250 (22%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH---------- 322
           +G+G FG V KA+   D    AIK+ +  + E L T   SEV LL+ ++H          
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLST-ILSEVXLLASLNHQYVVRYYAAW 71
Query: 323 ---RNLVKLLGFVDKGNERLIITEFVPNGTL-----REHLDGQYGKTLD-FNQRLEIAID 373
              RN VK    V K +   I  E+  N TL      E+L+ Q  +    F Q LE    
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE---- 127
Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-----LGPMDSDRTHIS 428
               L+Y+H    + IIHR++K  NI + ES   K+ DFG A+     L  +  D  ++ 
Sbjct: 128 ---ALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 429 ------TKVKGTVGYLDPEYMK-TYQLTTKSDVYSFGVLLLE-------------ILTGR 468
                 T   GT  Y+  E +  T     K D YS G++  E             IL   
Sbjct: 182 GSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNILKKL 241
Query: 469 RPVELKRPPE 478
           R V ++ PP+
Sbjct: 242 RSVSIEFPPD 251

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ D G AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 252 GSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKE-QFENLQTE 309
           GS+ ++ +    +   +    ++GEG +G VYKA        VAIKR + E + E +   
Sbjct: 20  GSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGT 79
Query: 310 FSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL- 368
              EV LL ++ HRN+++L   +   +   +I E+  N  L++++D    K  D + R+ 
Sbjct: 80  AIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYMD----KNPDVSMRVI 134
Query: 369 -EIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL-----TESMRAKVADFGFAR-LGPMD 421
                 + +G+ + H    ++ +HRD+K  N+LL     +E+   K+ DFG AR  G   
Sbjct: 135 KSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191
Query: 422 SDRTHISTKVKGTVGYLDPE-YMKTYQLTTKSDVYSFGVLLLEIL 465
              TH       T+ Y  PE  + +   +T  D++S   +  E+L
Sbjct: 192 RQFTHEII----TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N +P   +G G +G+V  A   + G  VA+K+  +  F+++        E+ L
Sbjct: 29  EVPERYQNLAP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRL 84
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 85  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 132
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      
Sbjct: 133 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 183
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 184 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G FG VY+A+L D G LVAIK+  + + F+N       E++++ K+DH N+V+L  F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNIVRLRYF 81
Query: 332 VDKGNERL------IITEFVPNGTLREHLDGQYGK-TLDFNQRLEIAIDVAHGLTYLHLY 384
                E+       ++ ++VP    R        K TL           +   L Y+H +
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 385 AEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEY 442
               I HRD+K  N+LL  ++   K+ DFG A+ L   + + + I ++      Y  PE 
Sbjct: 142 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPEL 193
Query: 443 M-KTYQLTTKSDVYSFGVLLLEILTGR 468
           +      T+  DV+S G +L E+L G+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFS--SEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K   K Q +    + S   EV+LL ++DH N++KL  
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 99
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F +      ++ E    G L + +  +  K         I   V  G+TY+H   + +I+
Sbjct: 100 FFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMH---KNKIV 154
Query: 391 HRDVKSSNILL---TESMRAKVADFGFARLGPMDSDRTHI--STKVK---GTVGYLDPEY 442
           HRD+K  N+LL   ++    ++ DFG +         TH   S K+K   GT  Y+ PE 
Sbjct: 155 HRDLKPENLLLESKSKDANIRIIDFGLS---------THFEASKKMKDKIGTAYYIAPEV 205
Query: 443 MK-TYQLTTKSDVYSFGVLLLEILTGRRP 470
           +  TY    K DV+S GV+L  +L+G  P
Sbjct: 206 LHGTYD--EKCDVWSTGVILYILLSGCPP 232

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + GL VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ D G AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 39/220 (17%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKR---AKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           IG G +G VYK  L D   VA+K    A ++ F N +  +      +  ++H N+ + + 
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYR-----VPLMEHDNIARFIV 74
Query: 331 -----FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL-- 383
                  D   E L++ E+ PNG+L ++L      T D+     +A  V  GL YLH   
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTEL 131
Query: 384 ----YAEKQIIHRDVKSSNILLTESMRAKVADFGFA-RLG------PMDSDRTHISTKVK 432
               + +  I HRD+ S N+L+       ++DFG + RL       P + D   IS    
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE--V 189
Query: 433 GTVGYLDPEYMK-------TYQLTTKSDVYSFGVLLLEIL 465
           GT+ Y+ PE ++             + D+Y+ G++  EI 
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 94/191 (49%), Gaps = 18/191 (9%)
Query: 293 VAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEFVPNGTLR 351
           V  +R   EQ E ++     E  +L ++  H +++ L+   +  +   ++ + +  G L 
Sbjct: 129 VTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF 188
Query: 352 EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVAD 411
           ++L  +    L   +   I   +   +++LH      I+HRD+K  NILL ++M+ +++D
Sbjct: 189 DYLTEKVA--LSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSD 243
Query: 412 FGFA-RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT------KSDVYSFGVLLLEI 464
           FGF+  L P +  R     ++ GT GYL PE +K     T      + D+++ GV+L  +
Sbjct: 244 FGFSCHLEPGEKLR-----ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL 298
Query: 465 LTGRRPVELKR 475
           L G  P   +R
Sbjct: 299 LAGSPPFWHRR 309

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 274 IGEGGFGTVYK-AQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G G FG V++  +   G   A K        + +T    E++ +S + H  LV L    
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET-VRKEIQTMSVLRHPTLVNLHDAF 223
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
           +  NE ++I EF+  G L E +  ++ K +  ++ +E    V  GL ++H   E   +H 
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH---ENNYVHL 279
Query: 393 DVKSSNILLT--ESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           D+K  NI+ T   S   K+ DFG  A L P  S +        GT  +  PE  +   + 
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-----TTGTAEFAAPEVAEGKPVG 334
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
             +D++S GVL   +L+G  P
Sbjct: 335 YYTDMWSVGVLSYILLSGLSP 355

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+GGF   ++    D   V   +   +      + + + S E+ +   + H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F +  +   ++ E     +L E L  +     +   R  +   +  G  YLH     ++I
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLH---RNRVI 143
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+ L E +  K+ DFG A     D +R      + GT  Y+ PE +     + 
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIAPEVLSKKGHSF 200
Query: 451 KSDVYSFGVLLLEILTGRRPVE 472
           + DV+S G ++  +L G+ P E
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPFE 222

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+GGF   ++    D   V   +   +      + + + S E+ +   + H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F +  +   ++ E     +L E L  +     +   R  +   +  G  YLH     ++I
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLH---RNRVI 139
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+ L E +  K+ DFG A     D +R      + GT  Y+ PE +     + 
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIAPEVLSKKGHSF 196
Query: 451 KSDVYSFGVLLLEILTGRRPVE 472
           + DV+S G ++  +L G+ P E
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFE 218

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 32/212 (15%)
Query: 274 IGEGGFGTV-----YKAQLEDGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLV 326
           +GEG FG V     YK Q +    VA+K   ++  +  ++      E+  L  + H +++
Sbjct: 17  LGEGSFGKVKLATHYKTQQK----VALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLD----FNQRLEIAIDVAHGLTYLH 382
           KL   +    + +++ E+   G L +++  +   T D    F Q++  AI+  H      
Sbjct: 73  KLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH------ 125
Query: 383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEY 442
                +I+HRD+K  N+LL +++  K+ADFG + +    +D   + T   G+  Y  PE 
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM---TDGNFLKTSC-GSPNYAAPEV 178
Query: 443 M--KTYQLTTKSDVYSFGVLLLEILTGRRPVE 472
           +  K Y    + DV+S G++L  +L GR P +
Sbjct: 179 INGKLYA-GPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 109/241 (45%), Gaps = 39/241 (16%)
Query: 252 GSVHLNMSQVVKATRN-FSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFE----- 304
           G +  +MS   KA R+ +  S  +G G  G V  A + +    VAIK   K +F      
Sbjct: 1   GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAR 60
Query: 305 --NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTL 362
             +      +E+E+L K++H  ++K+  F D   +  I+ E +  G L + + G      
Sbjct: 61  EADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVG------ 113
Query: 363 DFNQRLEIAI------DVAHGLTYLHLYAEKQIIHRDVKSSNILLT---ESMRAKVADFG 413
             N+RL+ A        +   + YLH   E  IIHRD+K  N+LL+   E    K+ DFG
Sbjct: 114 --NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 168
Query: 414 FAR-LGPMDSDRTHISTKVKGTVGYLDPEYM---KTYQLTTKSDVYSFGVLLLEILTGRR 469
            ++ LG     RT     + GT  YL PE +    T       D +S GV+L   L+G  
Sbjct: 169 HSKILGETSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 223
Query: 470 P 470
           P
Sbjct: 224 P 224

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFS--SEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K   K Q +    + S   EV+LL ++DH N++KL  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F +      ++ E    G L + +  +  K         I   V  G+TY+H   + +I+
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMH---KNKIV 148
Query: 391 HRDVKSSNILL---TESMRAKVADFGFARLGPMDSDRTHI--STKVK---GTVGYLDPEY 442
           HRD+K  N+LL   ++    ++ DFG +         TH   S K+K   GT  Y+ PE 
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLS---------THFEASKKMKDKIGTAYYIAPEV 199
Query: 443 MK-TYQLTTKSDVYSFGVLLLEILTGRRP 470
           +  TY    K DV+S GV+L  +L+G  P
Sbjct: 200 LHGTYD--EKCDVWSTGVILYILLSGCPP 226

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 11/202 (5%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+GGF   ++    D   V   +   +      + + + S E+ +   + H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F +  +   ++ E     +L E L  +     +   R  +   +  G  YLH     ++I
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLH---RNRVI 139
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+ L E +  K+ DFG A     D +R      + GT  Y+ PE +     + 
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIAPEVLSKKGHSF 196
Query: 451 KSDVYSFGVLLLEILTGRRPVE 472
           + DV+S G ++  +L G+ P E
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFE 218

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 274 IGEGGFGTVYK-AQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G G FG V++  +   G   A K        + +T    E++ +S + H  LV L    
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET-VRKEIQTMSVLRHPTLVNLHDAF 117
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
           +  NE ++I EF+  G L E +  ++ K +  ++ +E    V  GL ++H   E   +H 
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH---ENNYVHL 173
Query: 393 DVKSSNILLT--ESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           D+K  NI+ T   S   K+ DFG  A L P  S +        GT  +  PE  +   + 
Sbjct: 174 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-----TTGTAEFAAPEVAEGKPVG 228
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
             +D++S GVL   +L+G  P
Sbjct: 229 YYTDMWSVGVLSYILLSGLSP 249

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 15/209 (7%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQT--EFSSEVELLSKIDHRNLVKLLG 330
           +G G FG V   + +  G  VA+K   +++  +L    +   E++ L    H +++KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            +    +  ++ E+V  G L +++  ++G+  +   R  +   +   + Y H      ++
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEAR-RLFQQILSAVDYCH---RHMVV 133
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM--KTYQL 448
           HRD+K  N+LL   M AK+ADFG +    M SD   +     G+  Y  PE +  + Y  
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSN---MMSDGEFLRDSC-GSPNYAAPEVISGRLYA- 188
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP 477
             + D++S GV+L  +L G  P + +  P
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVP 217

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFS--SEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K   K Q +    + S   EV+LL ++DH N++KL  
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 117
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F +      ++ E    G L + +  +  K         I   V  G+TY+H   + +I+
Sbjct: 118 FFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMH---KNKIV 172
Query: 391 HRDVKSSNILL---TESMRAKVADFGFARLGPMDSDRTHI--STKVK---GTVGYLDPEY 442
           HRD+K  N+LL   ++    ++ DFG +         TH   S K+K   GT  Y+ PE 
Sbjct: 173 HRDLKPENLLLESKSKDANIRIIDFGLS---------THFEASKKMKDKIGTAYYIAPEV 223
Query: 443 MK-TYQLTTKSDVYSFGVLLLEILTGRRP 470
           +  TY    K DV+S GV+L  +L+G  P
Sbjct: 224 LHGTYD--EKCDVWSTGVILYILLSGCPP 250

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 312 SEVELLSKIDHRNLVKLLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLE 369
            E+ +L K+DH N+VKL+  +D  NE    ++ E V  G + E       K L  +Q   
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME---VPTLKPLSEDQARF 141
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
              D+  G+ YLH    ++IIHRD+K SN+L+ E    K+ADFG +           +S 
Sbjct: 142 YFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSN--EFKGSDALLSN 196
Query: 430 KVKGTVGYLDPEYM-KTYQLTTKS--DVYSFGVLLLEILTGRRP 470
            V GT  ++ PE + +T ++ +    DV++ GV L   + G+ P
Sbjct: 197 TV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 18/220 (8%)
Query: 258 MSQVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIK--RAKKEQFENLQTEFSSEV 314
           M+   K + N+     +G+G F  V +      GL  A K    KK    + Q +   E 
Sbjct: 21  MNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREA 79
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDG-QYGKTLDFNQRLEIAID 373
            +  K+ H N+V+L   + + +   ++ + V  G L E +   ++    D +  ++    
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---Q 136
Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRA---KVADFGFARLGPMDSDRTHISTK 430
           +   + Y H      I+HR++K  N+LL    +    K+ADFG A +   DS+  H    
Sbjct: 137 ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWH---G 189
Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
             GT GYL PE +K    +   D+++ GV+L  +L G  P
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFS--SEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K   K Q +    + S   EV+LL ++DH N++KL  
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 116
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F +      ++ E    G L + +  +  K         I   V  G+TY+H   + +I+
Sbjct: 117 FFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMH---KNKIV 171
Query: 391 HRDVKSSNILL---TESMRAKVADFGFARLGPMDSDRTHI--STKVK---GTVGYLDPEY 442
           HRD+K  N+LL   ++    ++ DFG +         TH   S K+K   GT  Y+ PE 
Sbjct: 172 HRDLKPENLLLESKSKDANIRIIDFGLS---------THFEASKKMKDKIGTAYYIAPEV 222
Query: 443 MK-TYQLTTKSDVYSFGVLLLEILTGRRP 470
           +  TY    K DV+S GV+L  +L+G  P
Sbjct: 223 LHGTYD--EKCDVWSTGVILYILLSGCPP 249

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 31/204 (15%)
Query: 273 RIGEGGFGTVYKAQL-EDGLLVAIKRA------KKEQFENLQTEFSSEVELLSKI-DHRN 324
           R+G G +G V+K +  EDG L A+KR+       K++   L     +EV    K+  H  
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL-----AEVGSHEKVGQHPC 118
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
            V+L    ++G    + TE     +L++H +  +G +L   Q      D    L +LH  
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLH-- 174
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
             + ++H DVK +NI L    R K+ DFG             + T   G V   DP YM 
Sbjct: 175 -SQGLVHLDVKPANIFLGPRGRCKLGDFGLL---------VELGTAGAGEVQEGDPRYMA 224
Query: 445 TYQLT----TKSDVYSFGVLLLEI 464
              L     T +DV+S G+ +LE+
Sbjct: 225 PELLQGSYGTAADVFSLGLTILEV 248

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 262 VKATRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVEL-LSK 319
           VKA  +  P + +G G +G V K + +  G ++A+KR +       Q     ++++ +  
Sbjct: 48  VKAD-DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT 106
Query: 320 IDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL------EIAID 373
           +D    V   G + +  +  I  E      +   LD  Y + +D  Q +      +IA+ 
Sbjct: 107 VDCPFTVTFYGALFREGDVWICMEL-----MDTSLDKFYKQVIDKGQTIPEDILGKIAVS 161
Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
           +   L +LH  ++  +IHRDVK SN+L+    + K+ DFG +    +DS    I     G
Sbjct: 162 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDSVAKTIDA---G 215
Query: 434 TVGYLDPEYM------KTYQLTTKSDVYSFGVLLLEILTGRRP 470
              Y+ PE +      K Y  + KSD++S G+ ++E+   R P
Sbjct: 216 CKPYMAPERINPELNQKGY--SVKSDIWSLGITMIELAILRFP 256

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 263 KATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSK 319
           K + N+     +G+G F  V +      GL  A K    KK    + Q +   E  +  K
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRK 61
Query: 320 IDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDG-QYGKTLDFNQRLEIAIDVAHGL 378
           + H N+V+L   + + +   ++ + V  G L E +   ++    D +  ++    +   +
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESI 118
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRA---KVADFGFARLGPMDSDRTHISTKVKGTV 435
            Y H      I+HR++K  N+LL    +    K+ADFG A +   DS+  H      GT 
Sbjct: 119 AYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWH---GFAGTP 171
Query: 436 GYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           GYL PE +K    +   D+++ GV+L  +L G  P
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 110 SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLH---SLDL 163
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 272
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 273 LLQVD-LTKRFGNLKNGVNDIKNHK 296

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 263 KATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSK 319
           K + N+     +G+G F  V +      GL  A K    KK    + Q +   E  +  K
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRK 61
Query: 320 IDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDG-QYGKTLDFNQRLEIAIDVAHGL 378
           + H N+V+L   + + +   ++ + V  G L E +   ++    D +  ++    +   +
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESI 118
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRA---KVADFGFARLGPMDSDRTHISTKVKGTV 435
            Y H      I+HR++K  N+LL    +    K+ADFG A +   DS+  H      GT 
Sbjct: 119 AYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWH---GFAGTP 171
Query: 436 GYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           GYL PE +K    +   D+++ GV+L  +L G  P
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 12/204 (5%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFS---SEVELLSKI-DHRNLVKLL 329
           IG G +  V   +L+    +   R  K++  N   +     +E  +  +  +H  LV L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
                 +    + E+V  G L  H+  Q  + L        + +++  L YLH   E+ I
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGI 174
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           I+RD+K  N+LL      K+ D+G  + G    D T   +   GT  Y+ PE ++     
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGEDYG 231
Query: 450 TKSDVYSFGVLLLEILTGRRPVEL 473
              D ++ GVL+ E++ GR P ++
Sbjct: 232 FSVDWWALGVLMFEMMAGRSPFDI 255

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 106/235 (45%), Gaps = 39/235 (16%)
Query: 258 MSQVVKATRN-FSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFE-------NLQT 308
           MS   KA R+ +  S  +G G  G V  A + +    VAIK   K +F        +   
Sbjct: 1   MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 309 EFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL 368
              +E+E+L K++H  ++K+  F D   +  I+ E +  G L + + G        N+RL
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVG--------NKRL 111
Query: 369 EIAI------DVAHGLTYLHLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFAR-LG 418
           + A        +   + YLH   E  IIHRD+K  N+LL+   E    K+ DFG ++ LG
Sbjct: 112 KEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 419 PMDSDRTHISTKVKGTVGYLDPEYM---KTYQLTTKSDVYSFGVLLLEILTGRRP 470
                RT     + GT  YL PE +    T       D +S GV+L   L+G  P
Sbjct: 169 ETSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE---FSSEVELLSKIDHRNLVKL 328
           + IG G F TVYK  L+    V +   + +  +  ++E   F  E E L  + H N+V+ 
Sbjct: 32  IEIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 329 LGFVD---KGNERLI-ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
               +   KG + ++ +TE   +GTL+ +L  +  K             +  GL +LH  
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYL--KRFKVXKIKVLRSWCRQILKGLQFLHTR 148
Query: 385 AEKQIIHRDVKSSNILLT-ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE-Y 442
               IIHRD+K  NI +T  +   K+ D G A L      R   +  V GT  +  PE Y
Sbjct: 149 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-----KRASFAKAVIGTPEFXAPEXY 202
Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            + Y  +   DVY+FG   LE  T   P
Sbjct: 203 EEKYDESV--DVYAFGXCXLEXATSEYP 228

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLLG 330
           IG+G F  V  A+ +  G  VA+K   K Q  +  LQ  F  EV +   ++H N+VKL  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIVKLFE 80
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            ++      ++ E+   G + ++L   +G+  +   R +    +   + Y H   +K I+
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVA-HGRXKEKEARAKFR-QIVSAVQYCH---QKFIV 135
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG---YLDPEYMKTYQ 447
           HRD+K+ N+LL      K+ADFGF       S+      K+    G   Y  PE  +  +
Sbjct: 136 HRDLKAENLLLDADXNIKIADFGF-------SNEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 448 LT-TKSDVYSFGVLLLEILTGRRPVE 472
               + DV+S GV+L  +++G  P +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 263 KATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSK 319
           K + N+     +G+G F  V +      GL  A K    KK    + Q +   E  +  K
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRK 60
Query: 320 IDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDG-QYGKTLDFNQRLEIAIDVAHGL 378
           + H N+V+L   + + +   ++ + V  G L E +   ++    D +  ++    +   +
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESI 117
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRA---KVADFGFARLGPMDSDRTHISTKVKGTV 435
            Y H      I+HR++K  N+LL    +    K+ADFG A +   DS+  H      GT 
Sbjct: 118 AYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWH---GFAGTP 170
Query: 436 GYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           GYL PE +K    +   D+++ GV+L  +L G  P
Sbjct: 171 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 106/235 (45%), Gaps = 39/235 (16%)
Query: 258 MSQVVKATRN-FSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFE-------NLQT 308
           MS   KA R+ +  S  +G G  G V  A + +    VAIK   K +F        +   
Sbjct: 1   MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 309 EFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL 368
              +E+E+L K++H  ++K+  F D   +  I+ E +  G L + + G        N+RL
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVG--------NKRL 111
Query: 369 EIAI------DVAHGLTYLHLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFAR-LG 418
           + A        +   + YLH   E  IIHRD+K  N+LL+   E    K+ DFG ++ LG
Sbjct: 112 KEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 419 PMDSDRTHISTKVKGTVGYLDPEYM---KTYQLTTKSDVYSFGVLLLEILTGRRP 470
                RT     + GT  YL PE +    T       D +S GV+L   L+G  P
Sbjct: 169 ETSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 106/235 (45%), Gaps = 39/235 (16%)
Query: 258 MSQVVKATRN-FSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFE-------NLQT 308
           MS   KA R+ +  S  +G G  G V  A + +    VAIK   K +F        +   
Sbjct: 1   MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 309 EFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL 368
              +E+E+L K++H  ++K+  F D   +  I+ E +  G L + + G        N+RL
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVG--------NKRL 111
Query: 369 EIAI------DVAHGLTYLHLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFAR-LG 418
           + A        +   + YLH   E  IIHRD+K  N+LL+   E    K+ DFG ++ LG
Sbjct: 112 KEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 419 PMDSDRTHISTKVKGTVGYLDPEYM---KTYQLTTKSDVYSFGVLLLEILTGRRP 470
                RT     + GT  YL PE +    T       D +S GV+L   L+G  P
Sbjct: 169 ETSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 87/178 (48%), Gaps = 23/178 (12%)
Query: 309 EFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL 368
           +F +E+++++ I +   +   G +   +E  II E++ N ++ +    +Y   LD N   
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKF--DEYFFVLDKNYTC 146
Query: 369 EIAIDVAHGL------TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
            I I V   +      ++ +++ EK I HRDVK SNIL+ ++ R K++DFG         
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFG--------E 198
Query: 423 DRTHISTKVKGTVG---YLDPEYM---KTYQLTTKSDVYSFGVLLLEILTGRRPVELK 474
               +  K+KG+ G   ++ PE+     +Y    K D++S G+ L  +     P  LK
Sbjct: 199 SEYMVDKKIKGSRGTYEFMPPEFFSNESSYN-GAKVDIWSLGICLYVMFYNVVPFSLK 255

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKE------QFENLQTEFSSEVELLSKIDHRNLV 326
           IG G +  V   +L+    + A+K  KKE        + +QTE     E  S  +H  LV
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE-KHVFEQAS--NHPFLV 84
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            L       +    + E+V  G L  H+  Q  + L        + +++  L YLH   E
Sbjct: 85  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---E 139
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + II+RD+K  N+LL      K+ D+G  + G    D T   +   GT  Y+ PE ++  
Sbjct: 140 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPEILRGE 196
Query: 447 QLTTKSDVYSFGVLLLEILTGRRPVEL 473
                 D ++ GVL+ E++ GR P ++
Sbjct: 197 DYGFSVDWWALGVLMFEMMAGRSPFDI 223

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKE------QFENLQTEFSSEVELLSKIDHRNLV 326
           IG G +  V   +L+    + A+K  KKE        + +QTE     E  S  +H  LV
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE-KHVFEQAS--NHPFLV 69
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            L       +    + E+V  G L  H+  Q  + L        + +++  L YLH   E
Sbjct: 70  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---E 124
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + II+RD+K  N+LL      K+ D+G  + G    D T   +   GT  Y+ PE ++  
Sbjct: 125 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPEILRGE 181
Query: 447 QLTTKSDVYSFGVLLLEILTGRRPVEL 473
                 D ++ GVL+ E++ GR P ++
Sbjct: 182 DYGFSVDWWALGVLMFEMMAGRSPFDI 208

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKE------QFENLQTEFSSEVELLSKIDHRNLV 326
           IG G +  V   +L+    + A+K  KKE        + +QTE     E  S  +H  LV
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE-KHVFEQAS--NHPFLV 73
Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            L       +    + E+V  G L  H+  Q  + L        + +++  L YLH   E
Sbjct: 74  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---E 128
Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + II+RD+K  N+LL      K+ D+G  + G    D T   +   GT  Y+ PE ++  
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPEILRGE 185
Query: 447 QLTTKSDVYSFGVLLLEILTGRRPVEL 473
                 D ++ GVL+ E++ GR P ++
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDI 212

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 24/264 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 110 SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 163
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           I+RD+K  N+L+ +    +V DFGFA+       RT     + GT  YL PE + +    
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWT---LCGTPEYLAPEIILSKGYN 217
Query: 450 TKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKEV 506
              D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ +
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRNL 273
Query: 507 ISMEILTKMFGLAIQCAAPIRNDR 530
           + ++ LTK FG        I+N +
Sbjct: 274 LQVD-LTKRFGNLKNGVNDIKNHK 296

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 110 SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 163
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 272
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 273 LLQVD-LTKRFGNLKNGVNDIKNHK 296

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 62/115 (53%), Gaps = 4/115 (3%)
Query: 352 EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVAD 411
           E  DG Y + +     +  +  VA G+ +L   + ++ IHRD+ + NILL+E+   K+ D
Sbjct: 186 EDSDGFYKEPITMEDLISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICD 242
Query: 412 FGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT 466
           FG AR    + D        +  + ++ PE +     +TKSDV+S+GVLL EI +
Sbjct: 243 FGLARDIYKNPDYVR-KGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKDGVNDIKNHK 295

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G+G    V++ + +  G L AIK      F         E E+L K++H+N+VKL    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 333 DKGNER--LIITEFVPNG---TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           ++   R  ++I EF P G   T+ E     YG  L  ++ L +  DV  G+ +L    E 
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG--LPESEFLIVLRDVVGGMNHLR---EN 131
Query: 388 QIIHRDVKSSNIL--LTESMRA--KVADFGFARLGPMDSDRTHISTKVKGTVGYLDP--- 440
            I+HR++K  NI+  + E  ++  K+ DFG AR   ++ D   +S  + GT  YL P   
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR--ELEDDEQFVS--LYGTEEYLHPDMY 187
Query: 441 -------EYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
                  ++ K Y  T   D++S GV      TG  P
Sbjct: 188 ERAVLRKDHQKKYGATV--DLWSIGVTFYHAATGSLP 222

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGF 331
           +GEG +  V  A  L++G   A+K  +K+   +    F  EVE L +   ++N+++L+ F
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFR-EVETLYQCQGNKNILELIEF 79
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHLYAEKQI 389
            +      ++ E +  G++  H+  Q      FN+R    +  DVA  L +LH    K I
Sbjct: 80  FEDDTRFYLVFEKLQGGSILAHIQKQK----HFNEREASRVVRDVAAALDFLHT---KGI 132
Query: 390 IHRDVKSSNILLTESMR---AKVADFGFARLGPMDSDRTHIS----TKVKGTVGYLDPEY 442
            HRD+K  NIL     +    K+ DF       +++  T I+    T   G+  Y+ PE 
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEV 192
Query: 443 MKTY--QLT---TKSDVYSFGVLLLEILTGRRP 470
           ++ +  Q T    + D++S GV+L  +L+G  P
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 274 IGEGGFGTVYKAQLEDGL----LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           +GEG +G V +    + L    +  +K+ K  +  N +     E++LL ++ H+N+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 330 GFV--DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
             +  ++  +  ++ E+   G ++E LD    K     Q       +  GL YLH    +
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQ 128
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
            I+H+D+K  N+LLT     K++  G A  L P  +D T  ++  +G+  +  PE     
Sbjct: 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS--QGSPAFQPPEIANGL 186
Query: 447 QLTT--KSDVYSFGVLLLEILTGRRPVE 472
              +  K D++S GV L  I TG  P E
Sbjct: 187 DTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 49/230 (21%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENL--QTEFSSEVEL 316
           +V +  +N SP   +G G +G+V  A   + G  VA+K+  +  F+++        E+ L
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLRE--------HLDGQYGKTLDFNQRL 368
           L  + H N++ LL              F P  +L E        HL G     +   Q+L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 369 E------IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
                  +   +  GL Y+H      IIHRD+K SN+ + E    K+ DF  AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLAR------ 173
Query: 423 DRTHISTKVKGTVG---YLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              H   ++ G V    Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+ P G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYAPGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+++ +    KV DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLMIDQQGYIKVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 95  SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 148
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 149 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWTLCGTPEYLAPEIILSKGY 201
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 202 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 257
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 258 LLQVD-LTKRFGNLKDGVNDIKNHK 281

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 13/203 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVE--LLSKIDHRNLVKLLG 330
           +G GGFG V+  Q++  G L A K+  K++ +  +    + VE  +L+K+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI--AIDVAHGLTYLHLYAEKQ 388
             +   +  ++   +  G +R H+         F +   I     +  GL +LH   ++ 
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRN 309
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK-VKGTVGYLDPEYMKTYQ 447
           II+RD+K  N+LL +    +++D G A    ++       TK   GT G++ PE +   +
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLA----VELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
                D ++ GV L E++  R P
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGP 388

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 107/227 (47%), Gaps = 30/227 (13%)
Query: 259 SQVVKATRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVEL- 316
           S  VKA  +  P + +G G +G V K + +  G ++A+KR +       Q     ++++ 
Sbjct: 1   SMEVKAD-DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS 59
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL------EI 370
           +  +D    V   G + +  +  I  E      +   LD  Y + +D  Q +      +I
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVWICMEL-----MDTSLDKFYKQVIDKGQTIPEDILGKI 114
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
           A+ +   L +LH  ++  +IHRDVK SN+L+    + K+ DFG +  G +  D   ++  
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDD---VAKD 167
Query: 431 VK-GTVGYLDPEYM------KTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +  G   Y+ PE +      K Y  + KSD++S G+ ++E+   R P
Sbjct: 168 IDAGCKPYMAPERINPELNQKGY--SVKSDIWSLGITMIELAILRFP 212

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK + ++ +      +   EV +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +  E    + +G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 388 QIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           QI H D+K  NI+L +      R K+ DFG A      ++  +I     GT  ++ PE +
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPAFVAPEIV 189
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 274 IGEGGFGTVYKAQLEDGL---LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           IG+G FG VY  +    +   L+ I+R  ++Q +     F  EV    +  H N+V  +G
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLK----AFKREVMAYRQTRHENVVLFMG 96
Query: 331 FVDKGNERLIITEFVPNGTLREHL-DGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
                    IIT      TL   + D +    LD N+  +IA ++  G+ YLH    K I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 390 IHRDVKSSNILLTESMRAKVADFG-FARLGPMDSDRTHISTKVK-GTVGYLDPEYMKTYQ 447
           +H+D+KS N+   ++ +  + DFG F+  G + + R     +++ G + +L PE ++   
Sbjct: 152 LHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 448 LTTK---------SDVYSFGVLLLEILTGRRPVELKRPPEERVTLR 484
             T+         SDV++ G +  E+     P   K  P E +  +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWP--FKTQPAEAIIWQ 254

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 13/203 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVE--LLSKIDHRNLVKLLG 330
           +G GGFG V+  Q++  G L A K+  K++ +  +    + VE  +L+K+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI--AIDVAHGLTYLHLYAEKQ 388
             +   +  ++   +  G +R H+         F +   I     +  GL +LH   ++ 
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRN 309
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK-VKGTVGYLDPEYMKTYQ 447
           II+RD+K  N+LL +    +++D G A    ++       TK   GT G++ PE +   +
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLA----VELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
                D ++ GV L E++  R P
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGP 388

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 16/212 (7%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE---QFENLQTEFSSEVELLSKIDH 322
           +F+  + +G+G FG V  ++ +    L A+K  KK+   Q ++++     +  L      
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLH 382
             L +L       +    + E+V  G L  H+  Q G+  +    +  A ++A GL +L 
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKE-PHAVFYAAEIAIGLFFLQ 459
Query: 383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK-VKGTVGYLDPE 441
               K II+RD+K  N++L      K+ADFG  +    D     ++TK   GT  Y+ PE
Sbjct: 460 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFCGTPDYIAPE 512
Query: 442 YMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
            +  YQ   KS D ++FGVLL E+L G+ P E
Sbjct: 513 II-AYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 13/203 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVE--LLSKIDHRNLVKLLG 330
           +G GGFG V+  Q++  G L A K+  K++ +  +    + VE  +L+K+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI--AIDVAHGLTYLHLYAEKQ 388
             +   +  ++   +  G +R H+         F +   I     +  GL +LH   ++ 
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRN 309
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK-VKGTVGYLDPEYMKTYQ 447
           II+RD+K  N+LL +    +++D G A    ++       TK   GT G++ PE +   +
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLA----VELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
                D ++ GV L E++  R P
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 13/203 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVE--LLSKIDHRNLVKLLG 330
           +G GGFG V+  Q++  G L A K+  K++ +  +    + VE  +L+K+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI--AIDVAHGLTYLHLYAEKQ 388
             +   +  ++   +  G +R H+         F +   I     +  GL +LH   ++ 
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRN 309
Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK-VKGTVGYLDPEYMKTYQ 447
           II+RD+K  N+LL +    +++D G A    ++       TK   GT G++ PE +   +
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLA----VELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
                D ++ GV L E++  R P
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGP 388

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +GEG F    K    +     A+K   K    N Q E ++ ++L     H N+VKL    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITA-LKLCE--GHPNIVKLHEVF 75
Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
                  ++ E +  G L E +  +  K     +   I   +   ++++H   +  ++HR
Sbjct: 76  HDQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMH---DVGVVHR 130
Query: 393 DVKSSNILLTE---SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           D+K  N+L T+   ++  K+ DFGFARL P D+           T+ Y  PE +      
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC---FTLHYAAPELLNQNGYD 187
Query: 450 TKSDVYSFGVLLLEILTGRRPVE 472
              D++S GV+L  +L+G+ P +
Sbjct: 188 ESCDLWSLGVILYTMLSGQVPFQ 210

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G GG G V+ A   D    VAIK+      ++++     E++++ ++DH N+VK+   +
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEIL 77
Query: 333 DKGNERLI-----ITEFVPNGTLREHLDGQYGKTLDFNQRLE-----IAIDVAHGLTYLH 382
                +L      +TE      ++E+++      L+    LE         +  GL Y+H
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIH 137
Query: 383 LYAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDP 440
                 ++HRD+K +N+ + TE +  K+ DFG AR + P  S + H+S  +  T  Y  P
Sbjct: 138 ---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSP 193
Query: 441 EYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
             + +    TK+ D+++ G +  E+LTG+
Sbjct: 194 RLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 102 SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLH---SLDL 155
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 156 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 209 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 264
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 265 LLQVD-LTKRFGNLKNGVNDIKNHK 288

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 104/230 (45%), Gaps = 39/230 (16%)
Query: 263 KATRN-FSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFE-------NLQTEFSSE 313
           KA R+ +  S  +G G  G V  A + +    VAIK   K +F        +      +E
Sbjct: 5   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 64
Query: 314 VELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI- 372
           +E+L K++H  ++K+  F D   +  I+ E +  G L + + G        N+RL+ A  
Sbjct: 65  IEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVG--------NKRLKEATC 115
Query: 373 -----DVAHGLTYLHLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFAR-LGPMDSD 423
                 +   + YLH   E  IIHRD+K  N+LL+   E    K+ DFG ++ LG     
Sbjct: 116 KLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 172
Query: 424 RTHISTKVKGTVGYLDPEYM---KTYQLTTKSDVYSFGVLLLEILTGRRP 470
           RT     + GT  YL PE +    T       D +S GV+L   L+G  P
Sbjct: 173 RT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 158
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 159 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 204
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 158
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 159 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 204
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 157
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 158 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 203
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+ P G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYAPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+++ +    KV DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLMIDQQGYIKVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 273 RIGEGGFGTVY--KAQLEDGLLVAIKRAKKEQFENLQTE--FSSEVELLSKIDHRNLVKL 328
           ++G G +G V   K +L  G   AIK  KK              EV +L ++DH N++KL
Sbjct: 28  KLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 329 LGFV-DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
             F  DK N  L++  +       E +  Q    +D      I   V  G TYLH   + 
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IMKQVLSGTTYLH---KH 140
Query: 388 QIIHRDVKSSNILLTESMR---AKVADFGFARLGPMDSDRTHISTKVK---GTVGYLDPE 441
            I+HRD+K  N+LL    R    K+ DFG        S    +  K+K   GT  Y+ PE
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGL-------SAHFEVGGKMKERLGTAYYIAPE 193
Query: 442 YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            ++  +   K DV+S GV+L  +L G  P
Sbjct: 194 VLRK-KYDEKCDVWSCGVILYILLCGYPP 221

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 145
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 146 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 191
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 16/212 (7%)
Query: 267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKE---QFENLQTEFSSEVELLSKIDH 322
           +F+  + +G+G FG V  ++ +    L A+K  KK+   Q ++++     +  L      
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLH 382
             L +L       +    + E+V  G L  H+  Q G+  +    +  A ++A GL +L 
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKE-PHAVFYAAEIAIGLFFLQ 138
Query: 383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK-VKGTVGYLDPE 441
               K II+RD+K  N++L      K+ADFG  +    D     ++TK   GT  Y+ PE
Sbjct: 139 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFCGTPDYIAPE 191
Query: 442 YMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
            +  YQ   KS D ++FGVLL E+L G+ P E
Sbjct: 192 II-AYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 157
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 158 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 203
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 158
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 159 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 204
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 157
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 158 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 203
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 158
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 159 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 204
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 172
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 173 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 218
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 157
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 158 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 203
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 144
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 145 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 190
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 144
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 145 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 190
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 145
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLT-ESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+       K+ DFG   L      +  + T   G
Sbjct: 146 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 191
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 164
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLT-ESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+       K+ DFG   L      +  + T   G
Sbjct: 165 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 210
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 17/163 (10%)
Query: 313 EVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI 372
           EV +L  +DH N++KL  F +      ++ E    G L + +  +    + FN+     I
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR----MKFNEVDAAVI 141
Query: 373 --DVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR---AKVADFGFARLGPMDSDRTHI 427
              V  G+TYLH +    I+HRD+K  N+LL    +    K+ DFG   L  +  ++  +
Sbjct: 142 IKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFG---LSAVFENQKKM 195
Query: 428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
             ++ GT  Y+ PE ++  +   K DV+S GV+L  +L G  P
Sbjct: 196 KERL-GTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPP 236

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 172
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 173 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 218
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFS--SEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K   K Q +    + S   EV+LL ++DH N+ KL  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYE 93
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F +      ++ E    G L + +  +  K         I   V  G+TY H   + +I+
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYXH---KNKIV 148
Query: 391 HRDVKSSNILL---TESMRAKVADFGFARLGPMDSDRTHISTKVK-----GTVGYLDPEY 442
           HRD+K  N+LL   ++    ++ DFG +         TH     K     GT  Y+ PE 
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLS---------THFEASKKXKDKIGTAYYIAPEV 199
Query: 443 MK-TYQLTTKSDVYSFGVLLLEILTGRRP 470
           +  TY    K DV+S GV+L  +L+G  P
Sbjct: 200 LHGTYD--EKCDVWSTGVILYILLSGCPP 226

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 30/172 (17%)
Query: 312 SEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIA 371
           +E+E+L K++H  ++K+  F D   +  I+ E +  G L + + G        N+RL+ A
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVG--------NKRLKEA 239
Query: 372 I------DVAHGLTYLHLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFAR-LGPMD 421
                   +   + YLH   E  IIHRD+K  N+LL+   E    K+ DFG ++ LG   
Sbjct: 240 TCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 296
Query: 422 SDRTHISTKVKGTVGYLDPEYM---KTYQLTTKSDVYSFGVLLLEILTGRRP 470
             RT     + GT  YL PE +    T       D +S GV+L   L+G  P
Sbjct: 297 LMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 108/239 (45%), Gaps = 43/239 (17%)
Query: 255 HLNMSQVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----T 308
           H+   + +++     P L  G GGFG+VY   ++ D L VAIK  +K++  +       T
Sbjct: 22  HMKEKEPLESQYQVGPLL--GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 79
Query: 309 EFSSEVELLSKIDH--RNLVKLLGFVDKGNERLIITE-----------FVPNGTLREHLD 355
               EV LL K+      +++LL + ++ +  ++I E               G L+E L 
Sbjct: 80  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 139
Query: 356 GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGF 414
             +     F Q LE A+   H            ++HRD+K  NIL+  +    K+ DFG 
Sbjct: 140 RSF-----FWQVLE-AVRHCHNCG---------VLHRDIKDENILIDLNRGELKLIDFGS 184
Query: 415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
             L      +  + T   GT  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 185 GALL-----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 238

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 124 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 177
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 178 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 223
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 224 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 263

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 145
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLT-ESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+       K+ DFG   L      +  + T   G
Sbjct: 146 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 191
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 130
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLT-ESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+       K+ DFG   L      +  + T   G
Sbjct: 131 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 176
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 30/172 (17%)
Query: 312 SEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIA 371
           +E+E+L K++H  ++K+  F D   +  I+ E +  G L + + G        N+RL+ A
Sbjct: 203 TEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVG--------NKRLKEA 253
Query: 372 I------DVAHGLTYLHLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFAR-LGPMD 421
                   +   + YLH   E  IIHRD+K  N+LL+   E    K+ DFG ++ LG   
Sbjct: 254 TCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 310
Query: 422 SDRTHISTKVKGTVGYLDPEYM---KTYQLTTKSDVYSFGVLLLEILTGRRP 470
             RT     + GT  YL PE +    T       D +S GV+L   L+G  P
Sbjct: 311 LMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G+G    V++ + +  G L AIK      F         E E+L K++H+N+VKL    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 333 DKGNER--LIITEFVPNG---TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           ++   R  ++I EF P G   T+ E     YG  L  ++ L +  DV  G+ +L    E 
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG--LPESEFLIVLRDVVGGMNHLR---EN 131
Query: 388 QIIHRDVKSSNIL--LTESMRA--KVADFGFARLGPMDSDRTHISTKVKGTVGYLDP--- 440
            I+HR++K  NI+  + E  ++  K+ DFG AR   ++ D   +   + GT  YL P   
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR--ELEDDEQFVX--LYGTEEYLHPDMY 187
Query: 441 -------EYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
                  ++ K Y  T   D++S GV      TG  P
Sbjct: 188 ERAVLRKDHQKKYGATV--DLWSIGVTFYHAATGSLP 222

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 130
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 131 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 176
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 130
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 131 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 176
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 129
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 130 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 175
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 176 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 102 SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 155
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 156 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 209 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 264
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 265 LLQVD-LTKRFGNLKNGVNDIKNHK 288

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 93/193 (48%), Gaps = 13/193 (6%)
Query: 277 GGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN 336
           G +G +++ ++   LL  + +A +    N    F     ++SK+ H++LV   G    G+
Sbjct: 33  GDYGQLHETEV---LLKVLDKAHR----NYSESFFEAASMMSKLSHKHLVLNYGVCFCGD 85
Query: 337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKS 396
           E +++ EFV  G+L  +L  +    ++   +LE+A  +A     +H   E  +IH +V +
Sbjct: 86  ENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAWA---MHFLEENTLIHGNVCA 141
Query: 397 SNILLTESMRAKVADFGFARLG-PMDSDRTHISTKVKGTVGYLDPEYMKTYQ-LTTKSDV 454
            NILL      K  +  F +L  P  S        ++  + ++ PE ++  + L   +D 
Sbjct: 142 KNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDK 201
Query: 455 YSFGVLLLEILTG 467
           +SFG  L EI +G
Sbjct: 202 WSFGTTLWEICSG 214

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 76  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 129
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 130 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 175
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 176 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK + ++ +      +   EV +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +  E    + +G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 388 QIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           QI H D+K  NI+L +      R K+ DFG A      ++  +I     GT  ++ PE +
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIV 189
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 130 SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 183
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 184 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 292
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 293 LLQVD-LTKRFGNLKNGVNDIKNHK 316

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK + ++ +      +   EV +L +I H N++ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +  E    + +G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 388 QIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           QI H D+K  NI+L +      R K+ DFG A      ++  +I     GT  ++ PE +
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIV 189
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 113/247 (45%), Gaps = 21/247 (8%)
Query: 274 IGEGGFGTVYKAQLEDGLLV--AIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           IG G +G V K  ++ G  +  A K+  K   E++   F  E+E++  +DH N+++L   
Sbjct: 17  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHPNIIRLYET 74
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
            +   +  ++ E    G L E +   + +    +    I  DV   + Y H   +  + H
Sbjct: 75  FEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVAYCH---KLNVAH 129
Query: 392 RDVKSSNIL-LTESMRA--KVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
           RD+K  N L LT+S  +  K+ DFG  AR  P    RT +     GT  Y+ P+ ++   
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-----GTPYYVSPQVLEGL- 183
Query: 448 LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI 507
              + D +S GV++  +L G  P       E  + +R     + E + L+ V P  + +I
Sbjct: 184 YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLN-VSPQAESLI 242
Query: 508 SMEILTK 514
              +LTK
Sbjct: 243 R-RLLTK 248

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 274 IGEGGFGTVYKAQL-EDGLLVAIKRAKK--EQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G G  G V+K +  + G ++A+K+ ++   + EN +     +V L S  D   +V+  G
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFG 91
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
                 +  I  E +  GT  E L  +    +      ++ + +   L YL    +  +I
Sbjct: 92  TFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK--EKHGVI 147
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT- 449
           HRDVK SNILL E  + K+ DFG +  G +  D+     +  G   Y+ PE +     T 
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGIS--GRLVDDKA--KDRSAGCAAYMAPERIDPPDPTK 203
Query: 450 ----TKSDVYSFGVLLLEILTGRRP 470
                ++DV+S G+ L+E+ TG+ P
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFP 228

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK + ++ +      +   EV +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +  E    + +G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 388 QIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           QI H D+K  NI+L +      R K+ DFG A      ++  +I     GT  ++ PE +
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIV 189
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK + ++ +      +   EV +L +I H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +  E    + +G+ YLH     
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SL 132
Query: 388 QIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           QI H D+K  NI+L +      R K+ DFG A      ++  +I     GT  ++ PE +
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIV 188
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 13/193 (6%)
Query: 277 GGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN 336
           G +G +++ ++   LL  + +A +    N    F     ++SK+ H++LV   G    G+
Sbjct: 33  GDYGQLHETEV---LLKVLDKAHR----NYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85
Query: 337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKS 396
           E +++ EFV  G+L  +L  +    ++   +LE+A  +A     +H   E  +IH +V +
Sbjct: 86  ENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAA---MHFLEENTLIHGNVCA 141
Query: 397 SNILLTESMRAKVADFGFARLGPMDSDRTHISTKV-KGTVGYLDPEYMKTYQ-LTTKSDV 454
            NILL      K  +  F +L       T +   + +  + ++ PE ++  + L   +D 
Sbjct: 142 KNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDK 201
Query: 455 YSFGVLLLEILTG 467
           +SFG  L EI +G
Sbjct: 202 WSFGTTLWEICSG 214

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 125
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 126 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 171
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 112/248 (45%), Gaps = 23/248 (9%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKE---QFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           IG G +G V K  ++ G    I+RA K+    F      F  E+E++  +DH N+++L  
Sbjct: 34  IGRGSWGEV-KIAVQKG--TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 90
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
             +   +  ++ E    G L E +   + +    +    I  DV   + Y H   +  + 
Sbjct: 91  TFEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVAYCH---KLNVA 145
Query: 391 HRDVKSSNIL-LTESMRA--KVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           HRD+K  N L LT+S  +  K+ DFG  AR  P    RT +     GT  Y+ P+ ++  
Sbjct: 146 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-----GTPYYVSPQVLEGL 200
Query: 447 QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEV 506
               + D +S GV++  +L G  P       E  + +R     + E + L+ V P  + +
Sbjct: 201 -YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLN-VSPQAESL 258
Query: 507 ISMEILTK 514
           I   +LTK
Sbjct: 259 IR-RLLTK 265

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 125
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 126 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 171
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 110 SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 163
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 272
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 273 LLQVD-LTKRFGNLKNGVNDIKNHK 296

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 134/294 (45%), Gaps = 38/294 (12%)
Query: 245 SPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF 303
           SP  N   + HL+  + +K          +G G FG V   +  E G   A+K   K++ 
Sbjct: 33  SPAQN---TAHLDQFERIKT---------LGTGSFGRVMLVKHKETGNHYAMKILDKQKV 80
Query: 304 ENL-QTEFS-SEVELLSKIDHRNLVKL-LGFVDKGNERLIITEFVPNGTLREHLDGQYGK 360
             L Q E + +E  +L  ++   LVKL   F D  N  +++ E+VP G +  HL  + G+
Sbjct: 81  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM-EYVPGGEMFSHLR-RIGR 138
Query: 361 TLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM 420
             + + R   A  +     YLH      +I+RD+K  N+L+ +    +V DFGFA+    
Sbjct: 139 FSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---- 190
Query: 421 DSDRTHIST-KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP-- 477
              R    T  + GT  YL PE + +       D ++ GVL+ E+  G  P    +P   
Sbjct: 191 ---RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 478 -EERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDR 530
            E+ V+ +  F  +   +L D+    ++ ++ ++ LTK FG        I+N +
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDL----LRNLLQVD-LTKRFGNLKNGVNDIKNHK 296

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 79/184 (42%), Gaps = 20/184 (10%)
Query: 358 YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL 417
           Y   L     +  +  VA G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR 
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 418 GPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP 477
              D D        +  + ++ PE +     T +SDV+SFGVLL EI +      L   P
Sbjct: 243 IYKDPDYVR-KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP 295
Query: 478 EERVTLRWAF-KRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
              V +   F +R  EG  +   D +  E         M+   + C     + RP    +
Sbjct: 296 YPGVKIDEEFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSEL 346
Query: 537 GEQL 540
            E L
Sbjct: 347 VEHL 350

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 75  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 128
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 129 CHNCG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 174
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 175 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 214

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK + ++ +      +   EV +L +I H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +  E    + +G+ YLH     
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SL 132
Query: 388 QIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           QI H D+K  NI+L +      R K+ DFG A      ++  +I     GT  ++ PE +
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIV 188
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 79/184 (42%), Gaps = 20/184 (10%)
Query: 358 YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL 417
           Y   L     +  +  VA G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR 
Sbjct: 184 YKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD 240
Query: 418 GPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP 477
              D D        +  + ++ PE +     T +SDV+SFGVLL EI +      L   P
Sbjct: 241 IYKDPDYVR-KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP 293
Query: 478 EERVTLRWAF-KRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
              V +   F +R  EG  +   D +  E         M+   + C     + RP    +
Sbjct: 294 YPGVKIDEEFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSEL 344
Query: 537 GEQL 540
            E L
Sbjct: 345 VEHL 348

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK + ++ +      +   EV +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +  E    + +G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL--- 133
Query: 388 QIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           QI H D+K  NI+L +      R K+ DFG A      ++  +I     GT  ++ PE +
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIV 189
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   L KL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+ P G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 110 SFKDNSNLYMVM-EYAPGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLH---SLDL 163
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+++ +    KV DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 164 IYRDLKPENLMIDQQGYIKVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 272
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 273 LLQVD-LTKRFGNLKNGVNDIKNHK 296

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK + ++ +      +   EV +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +  E    + +G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 388 QIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           QI H D+K  NI+L +      R K+ DFG A      ++  +I     GT  ++ PE +
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIV 189
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 120/252 (47%), Gaps = 26/252 (10%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 110 SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 163
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 272
Query: 506 VISMEILTKMFG 517
           ++ ++ LTK FG
Sbjct: 273 LLQVD-LTKRFG 283

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK + ++ +      +   EV +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +  E    + +G+ YLH     
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL--- 133
Query: 388 QIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           QI H D+K  NI+L +      R K+ DFG A      ++  +I     GT  ++ PE +
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIV 189
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK + ++ +      +   EV +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +  E    + +G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 388 QIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           QI H D+K  NI+L +      R K+ DFG A      ++  +I     GT  ++ PE +
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIV 189
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+ P G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYAPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+++ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLMIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK + ++ +      +   EV +L +I H N++ 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +  E    + +G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 388 QIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           QI H D+K  NI+L +      R K+ DFG A      ++  +I     GT  ++ PE +
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIV 189
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDH--RNL 325
           +G GGFG+VY   ++ D L VAIK  +K++  +       T    EV LL K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 326 VKLLGFVDKGNERLIITE-----------FVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           ++LL + ++ +  ++I E               G L+E L   +     F Q LE A+  
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQVLE-AVRH 125
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDSDRTHISTKVKG 433
            H            ++HRD+K  NIL+  +    K+ DFG   L      +  + T   G
Sbjct: 126 CHNXG---------VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDG 171
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVE 472
           T  Y  PE+++ ++   +S  V+S G+LL +++ G  P E
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 79/184 (42%), Gaps = 20/184 (10%)
Query: 358 YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL 417
           Y   L     +  +  VA G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR 
Sbjct: 193 YKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD 249
Query: 418 GPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP 477
              D D        +  + ++ PE +     T +SDV+SFGVLL EI +      L   P
Sbjct: 250 IYKDPDYVR-KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP 302
Query: 478 EERVTLRWAF-KRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
              V +   F +R  EG  +   D +  E         M+   + C     + RP    +
Sbjct: 303 YPGVKIDEEFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSEL 353
Query: 537 GEQL 540
            E L
Sbjct: 354 VEHL 357

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 30/213 (14%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKK--EQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           IG G +G V  A+    G  VAIK+     +   N +     E+++L    H N++ +  
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNIIAI-- 119
Query: 331 FVDKGNERLIITEFVPNGTLR------EHLDGQYGKTLDFNQRLEIA------IDVAHGL 378
                  + I+   VP G  +      + ++    + +  +Q L +         +  GL
Sbjct: 120 -------KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGL 172
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGY 437
            Y+H     Q+IHRD+K SN+L+ E+   K+ DFG AR L    ++  +  T+   T  Y
Sbjct: 173 KYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 229
Query: 438 LDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRR 469
             PE M + ++ T   D++S G +  E+L  R+
Sbjct: 230 RAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK + ++ +      +   EV +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +  E    + +G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL--- 133
Query: 388 QIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           QI H D+K  NI+L +      R K+ DFG A      ++  +I     GT  ++ PE +
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIV 189
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKDGVNDIKNHK 295

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+VP G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKDGVNDIKNHK 295

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 79/184 (42%), Gaps = 20/184 (10%)
Query: 358 YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL 417
           Y   L     +  +  VA G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR 
Sbjct: 191 YKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD 247
Query: 418 GPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP 477
              D D        +  + ++ PE +     T +SDV+SFGVLL EI +      L   P
Sbjct: 248 IYKDPDYVR-KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP 300
Query: 478 EERVTLRWAF-KRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
              V +   F +R  EG  +   D +  E         M+   + C     + RP    +
Sbjct: 301 YPGVKIDEEFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSEL 351
Query: 537 GEQL 540
            E L
Sbjct: 352 VEHL 355

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK + ++ +      +   EV +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +  E    + +G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 388 QIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           QI H D+K  NI+L +      R K+ DFG A      ++  +I     GT  ++ PE +
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIV 189
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK + ++ +      +   EV +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +  E    + +G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 388 QIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           QI H D+K  NI+L +      R K+ DFG A      ++  +I     GT  ++ PE +
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIV 189
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 18/200 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAK----KEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +GEG F TVYKA+ ++   +VAIK+ K     E  + +      E++LL ++ H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 329 L-GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L  F  K N  L+  +F+   T  E +       L  +      +    GL YLH   + 
Sbjct: 78  LDAFGHKSNISLVF-DFM--ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 131
Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
            I+HRD+K +N+LL E+   K+ADFG A+  G    +R +    V  T  Y  PE +   
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYXHQVV--TRWYRAPELLFGA 187
Query: 447 QL-TTKSDVYSFGVLLLEIL 465
           ++     D+++ G +L E+L
Sbjct: 188 RMYGVGVDMWAVGCILAELL 207

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   L KL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+ P G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 110 SFKDNSNLYMVM-EYAPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 163
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+++ +    KV DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 164 IYRDLKPENLMIDQQGYIKVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 272
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 273 LLQVD-LTKRFGNLKNGVNDIKNHK 296

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   L KL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+ P G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 110 SFKDNSNLYMVM-EYAPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 163
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+++ +    KV DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 164 IYRDLKPENLMIDQQGYIKVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 272
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 273 LLQVD-LTKRFGNLKNGVNDIKNHK 296

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 273 RIGEGGFGTVY--KAQLEDGLLVAIKRAKKEQFENLQTEFS--SEVELLSKIDHRNLVKL 328
           ++G G +G V   K +L  G   AIK  KK          +   EV +L ++DH N++KL
Sbjct: 11  KLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 329 LGFV-DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
             F  DK N  L++  +       E +  Q    +D      I   V  G TYLH +   
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVD---AAVIMKQVLSGTTYLHKH--- 123
Query: 388 QIIHRDVKSSNILLTESMR---AKVADFGFARLGPMDSDRTHISTKVK---GTVGYLDPE 441
            I+HRD+K  N+LL    R    K+ DFG        S    +  K+K   GT  Y+ PE
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGL-------SAHFEVGGKMKERLGTAYYIAPE 176
Query: 442 YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            ++  +   K DV+S GV+L  +L G  P
Sbjct: 177 VLRK-KYDEKCDVWSCGVILYILLCGYPP 204

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 133/294 (45%), Gaps = 38/294 (12%)
Query: 245 SPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF 303
           SP  N   + HL+  + +K          +G G FG V   +  E G   A+K   K++ 
Sbjct: 33  SPAQN---TAHLDQFERIKT---------LGTGSFGRVMLVKHKETGNHYAMKILDKQKV 80
Query: 304 ENL-QTEFS-SEVELLSKIDHRNLVKL-LGFVDKGNERLIITEFVPNGTLREHLDGQYGK 360
             L Q E + +E  +L  ++   LVKL   F D  N  +++ E+ P G +  HL  + G+
Sbjct: 81  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM-EYAPGGEMFSHLR-RIGR 138
Query: 361 TLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM 420
             + + R   A  +     YLH      +I+RD+K  N+++ +    KV DFGFA+    
Sbjct: 139 FSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK---- 190
Query: 421 DSDRTHIST-KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP-- 477
              R    T  + GT  YL PE + +       D ++ GVL+ E+  G  P    +P   
Sbjct: 191 ---RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 247
Query: 478 -EERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDR 530
            E+ V+ +  F  +   +L D+    ++ ++ ++ LTK FG        I+N +
Sbjct: 248 YEKIVSGKVRFPSHFSSDLKDL----LRNLLQVD-LTKRFGNLKNGVNDIKNHK 296

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 30/222 (13%)
Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++GEGGF  V   + L DG   A+KR    + ++ + E   E ++    +H N+++L+ +
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD-REEAQREADMHRLFNHPNILRLVAY 94
Query: 332 V--DKG--NERLIITEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
              ++G  +E  ++  F   GTL   ++     G  L  +Q L + + +  GL  +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIS-----------TKVKGT 434
            K   HRD+K +NILL +  +  + D     LG M+    H+               + T
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMD-----LGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 435 VGYLDPEYMKTYQ---LTTKSDVYSFGVLLLEILTGRRPVEL 473
           + Y  PE         +  ++DV+S G +L  ++ G  P ++
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 99/229 (43%), Gaps = 36/229 (15%)
Query: 274 IGEGGFGTVYKAQLEDGL---LVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKL 328
           IG G FG      + D L   LVA+K  ++     EN+Q E  +   L     H N+V+ 
Sbjct: 28  IGSGNFGVA--RLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL----RHPNIVRF 81
Query: 329 LGFVDKGNERLIITEFVPNGTLREHL--DGQYGKT---LDFNQRLEIAIDVAHGLTYLHL 383
              +       II E+   G L E +   G++ +      F Q L        G++Y H 
Sbjct: 82  KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-------GVSYCH- 133
Query: 384 YAEKQIIHRDVKSSNILL--TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
               QI HRD+K  N LL  + + R K+ DFG+++   + S          GT  Y+ PE
Sbjct: 134 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPE 187
Query: 442 YMKTYQLTTK-SDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
            +   +   K +DV+S GV L  +L G  P E    PEE    R   +R
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE---DPEEPRDYRKTIQR 233

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +   ++   LVKL  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEF 109
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+ P G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 110 SFKDNSNLYMVL-EYAPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 163
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    KVADFGFA+       R    T  + GT  YL PE + +   
Sbjct: 164 IYRDLKPENLLIDQQGYIKVADFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 272
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 273 LLQVD-LTKRFGNLKNGVNDIKNHK 296

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSS--EVELLSKIDHRNLVKLLG 330
           IG G +G V  A+    G  VAIK+     F+ +     +  E+++L    H N++ +  
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPN-AFDVVTNAKRTLRELKILKHFKHDNIIAI-- 118
Query: 331 FVDKGNERLIITEFVPNGTLR------EHLDGQYGKTLDFNQRLEIA------IDVAHGL 378
                  + I+   VP G  +      + ++    + +  +Q L +         +  GL
Sbjct: 119 -------KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGL 171
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGY 437
            Y+H     Q+IHRD+K SN+L+ E+   K+ DFG AR L    ++  +  T+   T  Y
Sbjct: 172 KYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 228
Query: 438 LDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRR 469
             PE M + ++ T   D++S G +  E+L  R+
Sbjct: 229 RAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKDGVNDIKNHK 295

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRA-KKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IG G FG V++A+L +   VAIK+  + ++F+N       E++++  + H N+V L  F 
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN------RELQIMRIVKHPNVVDLKAFF 101
Query: 333 ----DKGNERL--IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI---DVAHGLTYLHL 383
               DK +E    ++ E+VP    R      Y K       L I +    +   L Y+H 
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRA--SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 384 YAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
                I HRD+K  N+LL   S   K+ DFG A+ L   + + + I ++      Y  PE
Sbjct: 160 IG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-----YRAPE 211
Query: 442 YM-KTYQLTTKSDVYSFGVLLLEILTGR 468
            +      TT  D++S G ++ E++ G+
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 40/221 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF- 331
           +GEG +G V  A     G +VAIK+ +             E+++L    H N++ +    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 332 ----VDKGNERLIITEFVPNGTLR---------EHLDGQYGKTLDFNQRLEIAIDVAHGL 378
                +  NE  II E +     R         +H+     +TL        A+ V HG 
Sbjct: 79  RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR-------AVKVLHG- 130
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTV-- 435
                     +IHRD+K SN+L+  +   KV DFG AR +    +D +  + +  G V  
Sbjct: 131 --------SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 436 ----GYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPV 471
                Y  PE M T    +++ DV+S G +L E+   RRP+
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 17/167 (10%)
Query: 311 SSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE 369
           + E+E+L +   H N++ L    D G    ++TE +  G L + +  Q  K     +   
Sbjct: 63  TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASA 120
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT------ESMRAKVADFGFARLGPMDSD 423
           +   +   + YLH    + ++HRD+K SNIL        ES+R  + DFGFA+   + ++
Sbjct: 121 VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIR--ICDFGFAK--QLRAE 173
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
              + T    T  ++ PE ++        D++S GVLL  +LTG  P
Sbjct: 174 NGLLMTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF- 331
           +GEG +G V  A     G +VAIK+ +             E+++L    H N++ +    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 332 ----VDKGNERLIITEFVPNGTLR---------EHLDGQYGKTLDFNQRLEIAIDVAHGL 378
                +  NE  II E +     R         +H+     +TL        A+ V HG 
Sbjct: 79  RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR-------AVKVLHG- 130
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIS---------T 429
                     +IHRD+K SN+L+  +   KV DFG AR+  +D      S         T
Sbjct: 131 --------SNVIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMT 180
Query: 430 KVKGTVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPV 471
           +   T  Y  PE M T    +++ DV+S G +L E+   RRP+
Sbjct: 181 EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 130 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLH---SLDL 183
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 184 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 292
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 293 LLQVD-LTKRFGNLKNGVNDIKNHK 316

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 95
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 96  SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 149
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ E    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 150 IYRDLKPENLLIDEQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 202
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 203 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 258
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 259 LLQVD-LTKRFGNLKNGVNDIKNHK 282

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 130 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 183
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R   +T  + GT  YL PE + +   
Sbjct: 184 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGATWTLCGTPEYLAPEIILSKGY 236
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 292
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 293 LLQVD-LTKRFGNLKNGVNDIKNHK 316

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 26/224 (11%)
Query: 274 IGEGGFGTV-YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IG G FG        +   LVA+K    E+ E +      E+     + H N+V+    +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 333 DKGNERLIITEFVPNGTLREHL--DGQYGKTLD--FNQRLEIAIDVAHGLTYLHLYAEKQ 388
                  I+ E+   G L E +   G++ +     F Q+L   +  AH +         Q
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAM---------Q 135
Query: 389 IIHRDVKSSNILL--TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + HRD+K  N LL  + + R K+ADFG+++   + S          GT  Y+ PE +   
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQ----PKSAVGTPAYIAPEVLLKK 191
Query: 447 QLTTK-SDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           +   K +DV+S GV L  +L G  P E    PEE    R    R
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFE---DPEEPKNFRKTIHR 232

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF- 331
           +GEG +G V  A     G +VAIK+ +             E+++L    H N++ +    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 332 ----VDKGNERLIITEFVPNGTLR---------EHLDGQYGKTLDFNQRLEIAIDVAHGL 378
                +  NE  II E +     R         +H+     +TL        A+ V HG 
Sbjct: 79  RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR-------AVKVLHG- 130
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIS---------T 429
                     +IHRD+K SN+L+  +   KV DFG AR+  +D      S         T
Sbjct: 131 --------SNVIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMT 180
Query: 430 KVKGTVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPV 471
           +   T  Y  PE M T    +++ DV+S G +L E+   RRP+
Sbjct: 181 EYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLXGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLAGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 312 SEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL--DGQYGKTLDFNQRLE 369
           +E+ +L ++ H N++KL    +   E  ++ E V  G L + +   G Y +        +
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE----RDAAD 152
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL-TESMRA--KVADFGFARLGPMDSDRTH 426
               +   + YLH   E  I+HRD+K  N+L  T +  A  K+ADFG +++     +   
Sbjct: 153 AVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI----VEHQV 205
Query: 427 ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +   V GT GY  PE ++      + D++S G++   +L G  P
Sbjct: 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K  Q   G   A K  KK +  + +      E   EV +L +I H N++ 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +   T D  +  +    +  G+ YLH    K
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED--EATQFLKQILDGVHYLH---SK 134
Query: 388 QIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           +I H D+K  NI+L +    + R K+ DFG A      ++  +I     GT  ++ PE +
Sbjct: 135 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----GTPEFVAPEIV 190
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 41/224 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A LE    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRP-FQN-QTHAKRAYREL 74
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  +L E  D     + +D N    I ++
Sbjct: 75  VLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQME 122
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLAR----TAG 177
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG 467
            + + T    T  Y  PE +         D++S GV++ E++ G
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLPNGVNDIKNHK 295

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKAFGNLKNGVNDIKNHK 295

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 274 IGEGGFGTVYK-AQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGF 331
           IG G +G+V K      G ++A+KR +    E  Q +   +++++ +  D   +V+  G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI--AIDVAHGLTYLHLYAEKQI 389
           + +  +  I  E +   T  +         LD     EI   I +A      HL    +I
Sbjct: 90  LFREGDCWICMELM--STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ-- 447
           IHRD+K SNILL  S   K+ DFG +  G +    +   T+  G   Y+ PE +      
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGIS--GQLVD--SIAKTRDAGCRPYMAPERIDPSASR 203
Query: 448 --LTTKSDVYSFGVLLLEILTGRRP 470
                +SDV+S G+ L E+ TGR P
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFP 228

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFAEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 47/229 (20%)
Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKE-QFENLQTEFSSEVELL 317
           +V    R+  P   +G G +G V  A     G  VAIK+  +  Q E        E+ LL
Sbjct: 22  EVRAVYRDLQP---VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 78
Query: 318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLD---------GQYGKTLDFNQ-- 366
             + H N++ LL              F P+ TL +  D            GK +   +  
Sbjct: 79  KHMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG 126
Query: 367 --RLEIAI-DVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
             R++  +  +  GL Y+H      IIHRD+K  N+ + E    K+ DFG AR       
Sbjct: 127 EDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR------- 176
Query: 424 RTHISTKVKGTV---GYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
                +++ G V    Y  PE +  +   T++ D++S G ++ E++TG+
Sbjct: 177 --QADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 35/218 (16%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIK---RAKKEQFENLQTEFSS--EVELLSKID----HR 323
           +G+GGFGTV+   +L D L VAIK   R +   +  L    +   EV LL K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 324 NLVKLLGFVDKGNERLIITE-FVPNGTLREHLDGQ----YGKTLDFNQRLEIAIDVAHGL 378
            +++LL + +     +++ E  +P   L +++  +     G +  F  ++  AI   H  
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH-- 156
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMR---AKVADFGFARLGPMDSDRTHISTKVKGTV 435
                   + ++HRD+K  NIL+   +R   AK+ DFG    G +  D  +  T   GT 
Sbjct: 157 -------SRGVVHRDIKDENILI--DLRRGCAKLIDFGS---GALLHDEPY--TDFDGTR 202
Query: 436 GYLDPEYMKTYQL-TTKSDVYSFGVLLLEILTGRRPVE 472
            Y  PE++  +Q     + V+S G+LL +++ G  P E
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L + E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+ P G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYAPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+++ +    KV DFG A+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLMIDQQGYIKVTDFGLAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K  Q   G   A K  KK +  + +      E   EV +L +I H N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +   T D  +  +    +  G+ YLH    K
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED--EATQFLKQILDGVHYLH---SK 127
Query: 388 QIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           +I H D+K  NI+L +    + R K+ DFG A      ++  +I     GT  ++ PE +
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----GTPEFVAPEIV 183
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K  Q   G   A K  KK +  + +      E   EV +L +I H N++ 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +   T D  +  +    +  G+ YLH    K
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED--EATQFLKQILDGVHYLH---SK 148
Query: 388 QIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           +I H D+K  NI+L +    + R K+ DFG A      ++  +I     GT  ++ PE +
Sbjct: 149 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----GTPEFVAPEIV 204
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 205 NYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 29/208 (13%)
Query: 274 IGEGGFGT----VYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKL 328
           IG G +      ++KA   +  +  I ++K++  E        E+E+L +   H N++ L
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTE--------EIEILLRYGQHPNIITL 81
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
               D G    ++TE    G L + +  Q  K     +   +   +   + YLH    + 
Sbjct: 82  KDVYDDGKYVYVVTELXKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLH---AQG 136
Query: 389 IIHRDVKSSNILLT------ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEY 442
           ++HRD+K SNIL        ES+R  + DFGFA+   + ++   + T    T  ++ PE 
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIR--ICDFGFAK--QLRAENGLLXTPCY-TANFVAPEV 191
Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           ++        D++S GVLL   LTG  P
Sbjct: 192 LERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 19/216 (8%)
Query: 265 TRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQ-FENLQTE------FSSEVEL 316
           ++ +S    +G G FG V+ A   E    V +K  KKE+  E+   E       + E+ +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 317 LSKIDHRNLVKLLG-FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVA 375
           LS+++H N++K+L  F ++G  +L++ +      L   +D      LD      I   + 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLV 140
Query: 376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
             + YL L   K IIHRD+K  NI++ E    K+ DFG A       +R  +     GT+
Sbjct: 141 SAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAY----LERGKLFYTFCGTI 193
Query: 436 GYLDPEY-MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            Y  PE  M       + +++S GV L  ++    P
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 41/224 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A LE    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVVAAYDAILERN--VAIKKLSRP-FQN-QTHAKRAYREL 74
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  +L E  D     + +D N    I ++
Sbjct: 75  VLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQME 122
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLAR----TAG 177
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG 467
            + + T    T  Y  PE +         D++S GV++ E++ G
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 103
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 104 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLH---SLDL 157
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 158 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 210
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 211 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 266
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 267 LLQVD-LTKRFGNLKNGVNDIKNHK 290

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 87/178 (48%), Gaps = 18/178 (10%)
Query: 301 EQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYG 359
           E+ + L+     EV++L K+  H N+++L    +      ++ + +  G L ++L  +  
Sbjct: 61  EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV- 119
Query: 360 KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA-RLG 418
            TL   +  +I   +   +  LH   +  I+HRD+K  NILL + M  K+ DFGF+ +L 
Sbjct: 120 -TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQ------LTTKSDVYSFGVLLLEILTGRRP 470
           P +  R+     V GT  YL PE ++            + D++S GV++  +L G  P
Sbjct: 176 PGEKLRS-----VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 269 SPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLV 326
           SP+  +G G +G+V  A     G  VAIK+  +  Q E        E+ LL  + H N++
Sbjct: 46  SPT-HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVI 104
Query: 327 KLLG-FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
            LL  F    + R     ++    ++  L    G      +   +   +  GL Y+H   
Sbjct: 105 GLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH--- 161
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV---GYLDPEY 442
              ++HRD+K  N+ + E    K+ DFG AR         H   ++ G V    Y  PE 
Sbjct: 162 SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---------HADAEMTGYVVTRWYRAPEV 212
Query: 443 MKTYQLTTKS-DVYSFGVLLLEILTGR 468
           + ++    ++ D++S G ++ E+LTG+
Sbjct: 213 ILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 110 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 163
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 272
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 273 LLQVD-LTKRFGNLKNGVNDIKNHK 296

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 87/178 (48%), Gaps = 18/178 (10%)
Query: 301 EQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYG 359
           E+ + L+     EV++L K+  H N+++L    +      ++ + +  G L ++L  +  
Sbjct: 61  EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV- 119
Query: 360 KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA-RLG 418
            TL   +  +I   +   +  LH   +  I+HRD+K  NILL + M  K+ DFGF+ +L 
Sbjct: 120 -TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQ------LTTKSDVYSFGVLLLEILTGRRP 470
           P +  R     +V GT  YL PE ++            + D++S GV++  +L G  P
Sbjct: 176 PGEKLR-----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 87/178 (48%), Gaps = 18/178 (10%)
Query: 301 EQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYG 359
           E+ + L+     EV++L K+  H N+++L    +      ++ + +  G L ++L  +  
Sbjct: 48  EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV- 106
Query: 360 KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA-RLG 418
            TL   +  +I   +   +  LH   +  I+HRD+K  NILL + M  K+ DFGF+ +L 
Sbjct: 107 -TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 162
Query: 419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQ------LTTKSDVYSFGVLLLEILTGRRP 470
           P +  R     +V GT  YL PE ++            + D++S GV++  +L G  P
Sbjct: 163 PGEKLR-----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 269 SPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLV 326
           SP+  +G G +G+V  A     G  VAIK+  +  Q E        E+ LL  + H N++
Sbjct: 28  SPT-HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVI 86
Query: 327 KLLG-FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
            LL  F    + R     ++    ++  L    G      +   +   +  GL Y+H   
Sbjct: 87  GLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH--- 143
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV---GYLDPEY 442
              ++HRD+K  N+ + E    K+ DFG AR         H   ++ G V    Y  PE 
Sbjct: 144 SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---------HADAEMTGYVVTRWYRAPEV 194
Query: 443 MKTYQLTTKS-DVYSFGVLLLEILTGR 468
           + ++    ++ D++S G ++ E+LTG+
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGF 331
           +GEG    V     L      A+K  +K Q  ++++    EVE+L +   HRN+++L+ F
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEK-QPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI---DVAHGLTYLHLYAEKQ 388
            ++ +   ++ E +  G++  H+     K   FN+ LE ++   DVA  L +LH    K 
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIH----KRRHFNE-LEASVVVQDVASALDFLH---NKG 131
Query: 389 IIHRDVKSSNILLTESMR---AKVADFGFARLGPMDSDRTHISTK----VKGTVGYLDPE 441
           I HRD+K  NIL     +    K+ DFG      ++ D + IST       G+  Y+ PE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 442 YMKTYQ-----LTTKSDVYSFGVLLLEILTGRRP 470
            ++ +         + D++S GV+L  +L+G  P
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 274 IGEGGFGTVYKAQLEDGLLV-AIKRAKK-EQFENLQTE-FSSEVELLSKIDHRNLVKL-L 329
           IG G FG V   +L++   V A+K   K E  +  +T  F  E ++L   D + +  L  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 330 GFVDKGNERLIITEFVPNG--TLREHLDGQYGKTLD--FNQRLEIAIDVAHGLTYLHLYA 385
            F D  N  L++  +V     TL    + +  + +   +   + IAID  H L Y     
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY----- 196
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
               +HRD+K  NIL+  +   ++ADFG + L  M+ D T  S+   GT  Y+ PE ++ 
Sbjct: 197 ----VHRDIKPDNILMDMNGHIRLADFG-SCLKLME-DGTVQSSVAVGTPDYISPEILQA 250
Query: 446 YQ-----LTTKSDVYSFGVLLLEILTGRRP 470
            +        + D +S GV + E+L G  P
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 26/224 (11%)
Query: 274 IGEGGFGTV-YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IG G FG        +   LVA+K    E+ E +      E+     + H N+V+    +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVI 83
Query: 333 DKGNERLIITEFVPNGTLREHL--DGQYGKTLD--FNQRLEIAIDVAHGLTYLHLYAEKQ 388
                  I+ E+   G L E +   G++ +     F Q+L        G++Y H     Q
Sbjct: 84  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYCHAM---Q 134
Query: 389 IIHRDVKSSNILL--TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + HRD+K  N LL  + + R K+ DFG+++   + S          GT  Y+ PE +   
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKK 190
Query: 447 QLTTK-SDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           +   K +DV+S GV L  +L G  P E    PEE    R    R
Sbjct: 191 EYDGKVADVWSCGVTLYVMLVGAYPFE---DPEEPKNFRKTIHR 231

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 26/224 (11%)
Query: 274 IGEGGFGTV-YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IG G FG        +   LVA+K    E+ E +      E+     + H N+V+    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYI--ERGEKIAANVKREIINHRSLRHPNIVRFKEVI 84
Query: 333 DKGNERLIITEFVPNGTLREHL--DGQYGKTLD--FNQRLEIAIDVAHGLTYLHLYAEKQ 388
                  I+ E+   G L E +   G++ +     F Q+L        G++Y H     Q
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYCHAM---Q 135
Query: 389 IIHRDVKSSNILL--TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + HRD+K  N LL  + + R K+ DFG+++   + S          GT  Y+ PE +   
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKK 191
Query: 447 QLTTK-SDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           +   K +DV+S GV L  +L G  P E    PEE    R    R
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFE---DPEEPKNFRKTIHR 232

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 102/237 (43%), Gaps = 51/237 (21%)
Query: 266 RNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN---LQTEFSSEVELLSKID 321
           R +    ++G+G +G V+K+     G +VA+K+   + F+N    Q  F  E+ +L+++ 
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQNSTDAQRTFR-EIMILTELS 66
Query: 322 -HRNLVKLLGFVDKGNERLIITEF---------VPNGTLREHLDGQYGKTLDFNQRLEIA 371
            H N+V LL  +   N+R +   F         V    + E +  QY           + 
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY-----------VV 115
Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR--------------- 416
             +   + YLH      ++HRD+K SNILL      KVADFG +R               
Sbjct: 116 YQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 417 ----LGPMDSDRTHISTKVKGTVGYLDPE-YMKTYQLTTKSDVYSFGVLLLEILTGR 468
                   D D+  I T    T  Y  PE  + + + T   D++S G +L EIL G+
Sbjct: 173 INENTENFDDDQP-ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQT-EFSSEVELLSKIDHRNLVKLLGF 331
           ++ E   G ++K + + G  + +K  K   +   ++ +F+ E   L    H N++ +LG 
Sbjct: 17  KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 332 VD--KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
                     +IT ++P G+L   L       +D +Q ++ A+D+A G+ +LH   E  I
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLI 134
Query: 390 IHRDVKSSNILLTESMRAKV--ADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
               + S ++++ E M A++  AD  F+   P    R +          ++ PE ++   
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFSFQSP---GRMYAP-------AWVAPEALQKKP 184
Query: 448 LTTK---SDVYSFGVLLLEILTGRRP 470
             T    +D++SF VLL E++T   P
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVP 210

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 122/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P     P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+++ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLIIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIIISKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   + +E G   A+K   K++   L + E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+ P G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYAPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+++ +    +V DFG A+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLMIDQQGYIQVTDFGLAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 41/224 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A LE    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRP-FQN-QTHAKRAYREL 74
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  +L E  D     + +D N    I ++
Sbjct: 75  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQME 122
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 177
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG 467
            + + T    T  Y  PE +         D++S G ++ E++ G
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 41/224 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A LE    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRP-FQN-QTHAKRAYREL 74
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  +L E  D     + +D N    I ++
Sbjct: 75  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 177
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG 467
            + + T    T  Y  PE +         D++S G ++ E++ G
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 12/201 (5%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTE---FSSEVELLSKIDHRNLVKLL 329
           IG+G FG V  A+ + + +  A+K  +K+     + E    S    LL  + H  LV L 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
                 ++   + +++  G L  HL  +    L+   R   A ++A  L YLH      I
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERC-FLEPRARF-YAAEIASALGYLH---SLNI 160
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           ++RD+K  NILL       + DFG  +    + +    ++   GT  YL PE +      
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D +  G +L E+L G  P
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPP 238

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 311 SSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE 369
           S E+E+L +   H N++ L    D G    ++TE +  G L + +  Q  K     +   
Sbjct: 68  SEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQ--KFFSEREASF 125
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR----AKVADFGFARLGPMDSDRT 425
           +   +   + YLH    + ++HRD+K SNIL  +        ++ DFGFA+   + ++  
Sbjct: 126 VLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAK--QLRAENG 180
Query: 426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVE--LKRPPEERVTL 483
            + T    T  ++ PE +K        D++S G+LL  +L G  P        PEE +T 
Sbjct: 181 LLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTR 239
Query: 484 RWAFKRYNEGNLLDMVDPSIKEVIS 508
             + K    G   + V  + K+++S
Sbjct: 240 IGSGKFTLSGGNWNTVSETAKDLVS 264

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ ++  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 41/224 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A LE    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRP-FQN-QTHAKRAYREL 74
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  +L E  D     + +D N    I ++
Sbjct: 75  VLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQME 122
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLAR----TAG 177
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG 467
            + + T    T  Y  PE +         D++S G ++ E++ G
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 41/224 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A LE    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRP-FQN-QTHAKRAYREL 74
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  +L E  D     + +D N    I ++
Sbjct: 75  VLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQME 122
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLAR----TAG 177
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG 467
            + + T    T  Y  PE +         D++S G ++ E++ G
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 41/224 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A LE    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRP-FQN-QTHAKRAYREL 74
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  +L E  D     + +D N    I ++
Sbjct: 75  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQME 122
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLAR----TAG 177
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG 467
            + + T    T  Y  PE +         D++S G ++ E++ G
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 41/224 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A LE    VAIK+  +  F+N QT       E+
Sbjct: 23  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRP-FQN-QTHAKRAYREL 75
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  +L E  D     + +D N    I ++
Sbjct: 76  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 123
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 178
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG 467
            + + T    T  Y  PE +         D++S G ++ E++ G
Sbjct: 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 52/109 (47%), Gaps = 16/109 (14%)
Query: 368 LEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR----------- 416
           L I I +A  + +LH    K ++HRD+K SNI  T     KV DFG              
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 417 LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
           L PM +  TH      GT  Y+ PE +     + K D++S G++L E+L
Sbjct: 224 LTPMPAYATHXGQ--VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 41/224 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A LE    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRP-FQN-QTHAKRAYREL 74
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  +L E  D     + +D N    I ++
Sbjct: 75  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 177
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG 467
            + + T    T  Y  PE +         D++S G ++ E++ G
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A L+    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRP-FQN-QTHAKRAYREL 74
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQY-GKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  TL E  D     + +D N    I ++
Sbjct: 75  VLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQME 122
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDXTLKILDFGLAR----TAG 177
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
            + + T    T  Y  PE +         D++S G ++ E++
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 41/224 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A LE    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRP-FQN-QTHAKRAYREL 74
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  +L E  D     + +D N    I ++
Sbjct: 75  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 177
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG 467
            + + T    T  Y  PE +         D++S G ++ E++ G
Sbjct: 178 TSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 10/200 (5%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K  KKE    ++      +E  +L    H  L  L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
                +    + E+   G L  HL  +  +    ++      ++   L YLH  +EK ++
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLH--SEKNVV 271
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           +RD+K  N++L +    K+ DFG  + G  D           GT  YL PE ++      
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---GTPEYLAPEVLEDNDYGR 328
Query: 451 KSDVYSFGVLLLEILTGRRP 470
             D +  GV++ E++ GR P
Sbjct: 329 AVDWWGLGVVMYEMMCGRLP 348

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 311 SSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE 369
           S E+E+L +   H N++ L    D G    ++TE +  G L + +  Q  K     +   
Sbjct: 68  SEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQ--KFFSEREASF 125
Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR----AKVADFGFARLGPMDSDRT 425
           +   +   + YLH    + ++HRD+K SNIL  +        ++ DFGFA+   + ++  
Sbjct: 126 VLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAK--QLRAENG 180
Query: 426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVE--LKRPPEERVTL 483
            + T    T  ++ PE +K        D++S G+LL  +L G  P        PEE +T 
Sbjct: 181 LLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTR 239
Query: 484 RWAFKRYNEGNLLDMVDPSIKEVIS 508
             + K    G   + V  + K+++S
Sbjct: 240 IGSGKFTLSGGNWNTVSETAKDLVS 264

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A L+    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRP-FQN-QTHAKRAYREL 74
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQY-GKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  TL E  D     + +D N    I ++
Sbjct: 75  VLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQME 122
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG-IIHRDLKPSNIVVKSDXTLKILDFGLAR----TAG 177
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
            + + T    T  Y  PE +         D++S G ++ E++
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 10/200 (5%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K  KKE    ++      +E  +L    H  L  L  
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
                +    + E+   G L  HL  +  +    ++      ++   L YLH  +EK ++
Sbjct: 77  SFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLH--SEKNVV 132
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           +RD+K  N++L +    K+ DFG  + G  D           GT  YL PE ++      
Sbjct: 133 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKXFCGTPEYLAPEVLEDNDYGR 189
Query: 451 KSDVYSFGVLLLEILTGRRP 470
             D +  GV++ E++ GR P
Sbjct: 190 AVDWWGLGVVMYEMMCGRLP 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 10/200 (5%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K  KKE    ++      +E  +L    H  L  L  
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 77
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
                +    + E+   G L  HL  +  +    ++      ++   L YLH  +EK ++
Sbjct: 78  SFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLH--SEKNVV 133
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           +RD+K  N++L +    K+ DFG  + G  D           GT  YL PE ++      
Sbjct: 134 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKXFCGTPEYLAPEVLEDNDYGR 190
Query: 451 KSDVYSFGVLLLEILTGRRP 470
             D +  GV++ E++ GR P
Sbjct: 191 AVDWWGLGVVMYEMMCGRLP 210

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 10/200 (5%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K  KKE    ++      +E  +L    H  L  L  
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
                +    + E+   G L  HL  +  +    ++      ++   L YLH  +EK ++
Sbjct: 76  SFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLH--SEKNVV 131
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           +RD+K  N++L +    K+ DFG  + G  D           GT  YL PE ++      
Sbjct: 132 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKXFCGTPEYLAPEVLEDNDYGR 188
Query: 451 KSDVYSFGVLLLEILTGRRP 470
             D +  GV++ E++ GR P
Sbjct: 189 AVDWWGLGVVMYEMMCGRLP 208

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 10/200 (5%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K  KKE    ++      +E  +L    H  L  L  
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 218
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
                +    + E+   G L  HL  +  +    ++      ++   L YLH  +EK ++
Sbjct: 219 SFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLH--SEKNVV 274
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           +RD+K  N++L +    K+ DFG  + G  D           GT  YL PE ++      
Sbjct: 275 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---GTPEYLAPEVLEDNDYGR 331
Query: 451 KSDVYSFGVLLLEILTGRRP 470
             D +  GV++ E++ GR P
Sbjct: 332 AVDWWGLGVVMYEMMCGRLP 351

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 122/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT  YL P  + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPAIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 46/216 (21%)
Query: 274 IGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENL--QTEFSSEVELLSKIDHRNLVKL 328
           +G G +G+V   Y A+L     VA+K+  +  F++L        E+ LL  + H N++ L
Sbjct: 28  VGSGAYGSVCSAYDARLRQK--VAVKKLSRP-FQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTL---DFNQRLE-----------IAIDV 374
           L              F P  ++ +  +     TL   D N  ++           +   +
Sbjct: 85  LDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL 132
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT-HISTKVKG 433
             GL Y+H      IIHRD+K SN+ + E    ++ DFG AR    D + T +++T+   
Sbjct: 133 LRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQA--DEEMTGYVATR--- 184
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              Y  PE M  +    ++ D++S G ++ E+L G+
Sbjct: 185 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A L+    VAIK+  +  F+N QT       E+
Sbjct: 60  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRP-FQN-QTHAKRAYREL 112
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  TL E  D     + +D N    I ++
Sbjct: 113 VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 160
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 161 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART----AG 215
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
            + + T    T  Y  PE +         D++S G ++ E++
Sbjct: 216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 267 NFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSK-IDHRN 324
           +  P   +G G +G V K + +  G + A+KR +       Q     ++++  + +D   
Sbjct: 35  DLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPF 94
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL------EIAIDVAHGL 378
            V   G + +  +  I  E          LD  Y + +D  Q +      +IA+ +   L
Sbjct: 95  TVTFYGALFREGDVWICXELXDTS-----LDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 149
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-GTVGY 437
            +LH  ++  +IHRDVK SN+L+    + K  DFG +  G +  D   ++  +  G   Y
Sbjct: 150 EHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGIS--GYLVDD---VAKDIDAGCKPY 202
Query: 438 LDPEYM------KTYQLTTKSDVYSFGVLLLEILTGRRP 470
             PE +      K Y  + KSD++S G+  +E+   R P
Sbjct: 203 XAPERINPELNQKGY--SVKSDIWSLGITXIELAILRFP 239

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A L+    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRP-FQN-QTHAKRAYREL 74
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQY-GKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  TL E  D     + +D N    I ++
Sbjct: 75  VLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 122
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDXTLKILDFGLAR----TAG 177
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
            + + T    T  Y  PE +         D++S G ++ E++
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A L+    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRP-FQN-QTHAKRAYREL 74
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  TL E  D     + +D N    I ++
Sbjct: 75  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQME 122
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG-IIHRDLKPSNIVVKSDXTLKILDFGLAR----TAG 177
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
            + + T    T  Y  PE +         D++S G ++ E++
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A L+    VAIK+  +  F+N QT       E+
Sbjct: 15  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRP-FQN-QTHAKRAYREL 67
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  TL E  D     + +D N    I ++
Sbjct: 68  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQME 115
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 116 LDHERMSYLLYQMLXGIKHLHSAG-IIHRDLKPSNIVVKSDXTLKILDFGLAR----TAG 170
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
            + + T    T  Y  PE +         D++S G ++ E++
Sbjct: 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 41/217 (18%)
Query: 274 IGEGGFGTV----YKAQLEDGLLVAIKRAKKEQFENLQTE----FSSEVELLSKIDHRNL 325
           IG G FG V    +KA  +   + A+K   K  FE ++      F  E ++++  +   +
Sbjct: 83  IGRGAFGEVQLVRHKASQK---VYAMKLLSK--FEMIKRSDSAFFWEERDIMAFANSPWV 137
Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDG-----QYGKTLDFNQRLEIAIDVAHGLTY 380
           V+L           ++ E++P G L   +       ++ K   +   + +A+D  H +  
Sbjct: 138 VQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF--YTAEVVLALDAIHSMG- 194
Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT---HISTKVKGTVGY 437
                   +IHRDVK  N+LL +    K+ADFG      M  D T   H  T V GT  Y
Sbjct: 195 --------LIHRDVKPDNMLLDKHGHLKLADFGTC----MKMDETGMVHCDTAV-GTPDY 241
Query: 438 LDPEYMKTY----QLTTKSDVYSFGVLLLEILTGRRP 470
           + PE +K+         + D +S GV L E+L G  P
Sbjct: 242 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 45/242 (18%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTE----FSSEVELLSKIDHRNLVKL 328
           IG+G +G V  A + +   + AIK   K +   +  +      +EV L+ K+ H N+ +L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 329 LGFVDKGNERLIITEFVPNGTLREHL----DGQYGK------------------------ 360
               +      ++ E    G L + L    D   GK                        
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 361 ------TLDFNQRLEIAIDVAHGL-TYLHLYAEKQIIHRDVKSSNILLT--ESMRAKVAD 411
                 +LDF QR ++  ++   + + LH    + I HRD+K  N L +  +S   K+ D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 412 FGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT--TKSDVYSFGVLLLEILTGR 468
           FG ++    +++   +  T   GT  ++ PE + T   +   K D +S GVLL  +L G 
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 469 RP 470
            P
Sbjct: 274 VP 275

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A L+    VAIK+  +  F+N QT       E+
Sbjct: 15  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRP-FQN-QTHAKRAYREL 67
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  TL E  D     + +D N    I ++
Sbjct: 68  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 115
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 170
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
            + + T    T  Y  PE +         D++S G ++ E++
Sbjct: 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 37/222 (16%)
Query: 261 VVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSS---EVEL 316
           V+K  +   P   IG G  G V  A     G+ VA+K+  +  F+N QT       E+ L
Sbjct: 22  VLKRYQQLKP---IGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQN-QTHAKRAYRELVL 76
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAIDVA 375
           L  ++H+N++ LL              F P  TL E  D     + +D N    I +++ 
Sbjct: 77  LKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELD 124
Query: 376 HG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT 425
           H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR    +    
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---- 179
Query: 426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG 467
            + T    T  Y  PE +         D++S G ++ E++ G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A L+    VAIK+  +  F+N QT       E+
Sbjct: 16  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRP-FQN-QTHAKRAYREL 68
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  TL E  D     + +D N    I ++
Sbjct: 69  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 116
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 171
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
            + + T    T  Y  PE +         D++S G ++ E++
Sbjct: 172 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A L+    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRP-FQN-QTHAKRAYREL 74
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  TL E  D     + +D N    I ++
Sbjct: 75  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 122
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 177
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
            + + T    T  Y  PE +         D++S G ++ E++
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A L+    VAIK+  +  F+N QT       E+
Sbjct: 21  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRP-FQN-QTHAKRAYREL 73
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  TL E  D     + +D N    I ++
Sbjct: 74  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 121
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 122 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 176
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
            + + T    T  Y  PE +         D++S G ++ E++
Sbjct: 177 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A L+    VAIK+  +  F+N QT       E+
Sbjct: 23  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRP-FQN-QTHAKRAYREL 75
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  TL E  D     + +D N    I ++
Sbjct: 76  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 123
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 178
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
            + + T    T  Y  PE +         D++S G ++ E++
Sbjct: 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A L+    VAIK+  +  F+N QT       E+
Sbjct: 16  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRP-FQN-QTHAKRAYREL 68
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  TL E  D     + +D N    I ++
Sbjct: 69  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 116
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 171
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
            + + T    T  Y  PE +         D++S G ++ E++
Sbjct: 172 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A L+    VAIK+  +  F+N QT       E+
Sbjct: 60  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRP-FQN-QTHAKRAYREL 112
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  TL E  D     + +D N    I ++
Sbjct: 113 VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 160
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 161 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 215
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
            + + T    T  Y  PE +         D++S G ++ E++
Sbjct: 216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 275 GEGGFGTVYKAQLED-GLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKL---- 328
           G+G FGTV   + +  G+ VAIK+  ++ +F N + +   ++ +L    H N+V+L    
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLH---HPNIVQLQSYF 88
Query: 329 --LGFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRL--EIAIDVAHGLTYLHL 383
             LG  D+ +  L ++ E+VP+ TL       Y + +     L       +   +  LHL
Sbjct: 89  YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL 147
Query: 384 YAEKQIIHRDVKSSNILLTES-MRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPE 441
                + HRD+K  N+L+ E+    K+ DFG A +L P + +  +I ++      Y  PE
Sbjct: 148 -PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPE 201
Query: 442 YMKTYQ-LTTKSDVYSFGVLLLEILTG 467
            +   Q  TT  D++S G +  E++ G
Sbjct: 202 LIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A L+    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRP-FQN-QTHAKRAYREL 74
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  TL E  D     + +D N    I ++
Sbjct: 75  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 122
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 177
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
            + + T    T  Y  PE +         D++S G ++ E++
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A L+    VAIK+  +  F+N QT       E+
Sbjct: 23  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRP-FQN-QTHAKRAYREL 75
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  TL E  D     + +D N    I ++
Sbjct: 76  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 123
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 178
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
            + + T    T  Y  PE +         D++S G ++ E++
Sbjct: 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 100/224 (44%), Gaps = 41/224 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A LE    VAIK+  +  F+N QT       E+
Sbjct: 24  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRP-FQN-QTHAKRAYREL 76
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  +L E  D     + +D N    I ++
Sbjct: 77  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 124
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 125 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 179
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG 467
            + +      T  Y  PE +         D++S G ++ E++ G
Sbjct: 180 TSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 120/289 (41%), Gaps = 35/289 (12%)
Query: 259 SQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLS 318
           S V+    +F P   +G G  GT+    + D   VA+KR   E F    +    EV+LL 
Sbjct: 17  SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLR 72
Query: 319 KID-HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHG 377
           + D H N+++          + I  E     TL+E+++ +    L   + + +      G
Sbjct: 73  ESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGL-EPITLLQQTTSG 130
Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTE-----SMRAKVADFGFARLGPMDSDRTHISTKVK 432
           L +LH      I+HRD+K  NIL++       ++A ++DFG  +   +        + V 
Sbjct: 131 LAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 433 GTVGYLDPEYMK---TYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFK 488
           GT G++ PE +        T   D++S G +   +++ G  P       +  + L     
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL----- 242
Query: 489 RYNEGNLLDMVDPSIKE-VISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
                  LD + P   E VI+ E++ KM  +  Q        RP  K V
Sbjct: 243 ---GACSLDCLHPEKHEDVIARELIEKMIAMDPQ-------KRPSAKHV 281

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFEN-----LQTEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK Q         + E   EV +L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +       +  G+ YLH    K
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---K 134
Query: 388 QIIHRDVKSSNILLTESM----RAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           +I H D+K  NI+L +        K+ DFG A       +  +I     GT  ++ PE +
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----GTPEFVAPEIV 190
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 46/216 (21%)
Query: 274 IGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENL--QTEFSSEVELLSKIDHRNLVKL 328
           +G G +G+V   Y A+L     VA+K+  +  F++L        E+ LL  + H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRP-FQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTL---DFNQRLE-----------IAIDV 374
           L              F P  ++ +  +     TL   D N  ++           +   +
Sbjct: 93  LDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL 140
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT-HISTKVKG 433
             GL Y+H      IIHRD+K SN+ + E    ++ DFG AR    D + T +++T+   
Sbjct: 141 LRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQA--DEEMTGYVATR--- 192
Query: 434 TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              Y  PE M  +    ++ D++S G ++ E+L G+
Sbjct: 193 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 38/212 (17%)
Query: 274 IGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENL--QTEFSSEVELLSKIDHRNLVKL 328
           +G G +G+V   Y A+L     VA+K+  +  F++L        E+ LL  + H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRP-FQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 329 LGF------VDKGNERLIITEF----VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGL 378
           L        ++  +E  ++T      + N    + L  ++ + L +         +  GL
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQ--------LLRGL 144
Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT-HISTKVKGTVGY 437
            Y+H      IIHRD+K SN+ + E    ++ DFG AR    D + T +++T+      Y
Sbjct: 145 KYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQA--DEEMTGYVATR-----WY 194
Query: 438 LDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
             PE M  +    ++ D++S G ++ E+L G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGF 331
           +GEG    V     L      A+K  +K Q  ++++    EVE+L +   HRN+++L+ F
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEK-QPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI---DVAHGLTYLHLYAEKQ 388
            ++ +   ++ E +  G++  H+     K   FN+ LE ++   DVA  L +LH    K 
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIH----KRRHFNE-LEASVVVQDVASALDFLH---NKG 131
Query: 389 IIHRDVKSSNILLTESMR---AKVADFGFARLGPMDSDRTHISTK----VKGTVGYLDPE 441
           I HRD+K  NIL     +    K+ DF       ++ D + IST       G+  Y+ PE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 442 YMKTYQ-----LTTKSDVYSFGVLLLEILTGRRP 470
            ++ +         + D++S GV+L  +L+G  P
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 122/265 (46%), Gaps = 26/265 (9%)
Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKL-L 329
           +G G FG V   +  E G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  +++ E+V  G +  HL  + G+  + + R   A  +     YLH      +
Sbjct: 109 SFKDNSNLYMVM-EYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLH---SLDL 162
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST-KVKGTVGYLDPEYMKTYQL 448
           I+RD+K  N+L+ +    +V DFGFA+       R    T  + GT   L PE + +   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEALAPEIILSKGY 215
Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPP---EERVTLRWAFKRYNEGNLLDMVDPSIKE 505
               D ++ GVL+ E+  G  P    +P    E+ V+ +  F  +   +L D+    ++ 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----LRN 271
Query: 506 VISMEILTKMFGLAIQCAAPIRNDR 530
           ++ ++ LTK FG        I+N +
Sbjct: 272 LLQVD-LTKRFGNLKNGVNDIKNHK 295

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 37/222 (16%)
Query: 261 VVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSS---EVEL 316
           V+K  +   P   IG G  G V  A     G+ VA+K+  +  F+N QT       E+ L
Sbjct: 20  VLKRYQQLKP---IGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQN-QTHAKRAYRELVL 74
Query: 317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAIDVA 375
           L  ++H+N++ LL              F P  TL E  D     + +D N    I +++ 
Sbjct: 75  LKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELD 122
Query: 376 HG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT 425
           H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     +   
Sbjct: 123 HERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TASTN 177
Query: 426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG 467
            + T    T  Y  PE +         D++S G ++ E++ G
Sbjct: 178 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK Q    +      E   EV +L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +       +  G+ YLH    K
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---K 134
Query: 388 QIIHRDVKSSNILLTESM----RAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           +I H D+K  NI+L +        K+ DFG A       +  +I     GT  ++ PE +
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----GTPEFVAPEIV 190
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK Q    +      E   EV +L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +       +  G+ YLH    K
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---K 134
Query: 388 QIIHRDVKSSNILLTESM----RAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           +I H D+K  NI+L +        K+ DFG A       +  +I     GT  ++ PE +
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----GTPEFVAPEIV 190
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK Q    +      E   EV +L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +       +  G+ YLH    K
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---K 134
Query: 388 QIIHRDVKSSNILLTESM----RAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           +I H D+K  NI+L +        K+ DFG A       +  +I     GT  ++ PE +
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----GTPEFVAPEIV 190
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 24/210 (11%)
Query: 274 IGEGGFGTVYKAQLEDG-LLVAIKRAKK-EQFENLQTE-FSSEVELLSKIDHRNLVKLLG 330
           IG G FG V   ++++   + A+K   K E  +  +T  F  E ++L   D + +  L  
Sbjct: 98  IGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHY 157
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI-----AIDVAHGLTYLHLYA 385
                N   ++ ++   G L   L     K  +   R  I     AID  H L Y     
Sbjct: 158 AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY----- 212
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
               +HRD+K  N+LL  +   ++ADFG      M+ D T  S+   GT  Y+ PE ++ 
Sbjct: 213 ----VHRDIKPDNVLLDVNGHIRLADFGSCL--KMNDDGTVQSSVAVGTPDYISPEILQA 266
Query: 446 YQ-----LTTKSDVYSFGVLLLEILTGRRP 470
            +        + D +S GV + E+L G  P
Sbjct: 267 MEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 24/210 (11%)
Query: 274 IGEGGFGTVYKAQLEDG-LLVAIKRAKK-EQFENLQTE-FSSEVELLSKIDHRNLVKLLG 330
           IG G FG V   ++++   + A+K   K E  +  +T  F  E ++L   D + +  L  
Sbjct: 82  IGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHY 141
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEI-----AIDVAHGLTYLHLYA 385
                N   ++ ++   G L   L     K  +   R  I     AID  H L Y     
Sbjct: 142 AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY----- 196
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
               +HRD+K  N+LL  +   ++ADFG      M+ D T  S+   GT  Y+ PE ++ 
Sbjct: 197 ----VHRDIKPDNVLLDVNGHIRLADFGSCL--KMNDDGTVQSSVAVGTPDYISPEILQA 250
Query: 446 YQ-----LTTKSDVYSFGVLLLEILTGRRP 470
            +        + D +S GV + E+L G  P
Sbjct: 251 MEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK Q    +      E   EV +L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +       +  G+ YLH    K
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---K 134
Query: 388 QIIHRDVKSSNILLTESM----RAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           +I H D+K  NI+L +        K+ DFG A       +  +I     GT  ++ PE +
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----GTPEFVAPEIV 190
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 26/224 (11%)
Query: 274 IGEGGFGTV-YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IG G FG        +   LVA+K    E+ E +      E+     + H N+V+    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 333 DKGNERLIITEFVPNGTLREHL--DGQYGKTLD--FNQRLEIAIDVAHGLTYLHLYAEKQ 388
                  I+ E+   G L E +   G++ +     F Q+L        G++Y H     Q
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYCHAM---Q 135
Query: 389 IIHRDVKSSNILL--TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + HRD+K  N LL  + + R K+  FG+++   + S          GT  Y+ PE +   
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKK 191
Query: 447 QLTTK-SDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           +   K +DV+S GV L  +L G  P E    PEE    R    R
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFE---DPEEPKNFRKTIHR 232

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 71/150 (47%), Gaps = 12/150 (8%)
Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           ++ L    +  +E ++I E+   G +      +  + +  N  + +   +  G+ YLH  
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH-- 148
Query: 385 AEKQIIHRDVKSSNILLTESM---RAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDP 440
            +  I+H D+K  NILL+        K+ DFG +R +G     R     ++ GT  YL P
Sbjct: 149 -QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR-----EIMGTPEYLAP 202
Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           E +    +TT +D+++ G++   +LT   P
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQ-----TEFSSEVELLSKIDHRNLVK 327
           +G G F  V K + +  GL  A K  KK Q    +      E   EV +L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L    +   + ++I E V  G L + L  +  ++L   +       +  G+ YLH    K
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---K 134
Query: 388 QIIHRDVKSSNILLTESM----RAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
           +I H D+K  NI+L +        K+ DFG A       +  +I     GT  ++ PE +
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----GTPEFVAPEIV 190
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               L  ++D++S GV+   +L+G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 26/224 (11%)
Query: 274 IGEGGFGTV-YKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IG G FG        +   LVA+K    E+ E +      E+     + H N+V+    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 333 DKGNERLIITEFVPNGTLREHL--DGQYGKTLD--FNQRLEIAIDVAHGLTYLHLYAEKQ 388
                  I+ E+   G L E +   G++ +     F Q+L        G++Y H     Q
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYCHAM---Q 135
Query: 389 IIHRDVKSSNILL--TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + HRD+K  N LL  + + R K+  FG+++   + S          GT  Y+ PE +   
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ----PKDTVGTPAYIAPEVLLKK 191
Query: 447 QLTTK-SDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
           +   K +DV+S GV L  +L G  P E    PEE    R    R
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFE---DPEEPKNFRKTIHR 232

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 101/225 (44%), Gaps = 41/225 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A LE    VAIK+  +  F+N QT       E+
Sbjct: 27  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRP-FQN-QTHAKRAYREL 79
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  +L E  D     + +D N    I ++
Sbjct: 80  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 127
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 128 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 182
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGR 468
            + + T    T  Y  PE +         D++S G ++ E++  +
Sbjct: 183 TSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 101/225 (44%), Gaps = 41/225 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A LE    VAIK+  +  F+N QT       E+
Sbjct: 16  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRP-FQN-QTHAKRAYREL 68
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  +L E  D     + +D N    I ++
Sbjct: 69  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 116
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 171
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGR 468
            + + T    T  Y  PE +         D++S G ++ E++  +
Sbjct: 172 TSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +IG+G FG V+KA+  + G  VA+K+   E + E        E+++L  + H N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 331 FVDKGN---ERLIITEFVPNGTLREHLDGQYGKTL---DFNQRLEIAIDVAHGLTYLHLY 384
                     R   + ++        L G     L     ++   +   + +GL Y+H  
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-- 142
Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM--DSDRTHISTKVKGTVGYLDPE- 441
              +I+HRD+K++N+L+T     K+ADFG AR   +  +S       +V  T+ Y  PE 
Sbjct: 143 -RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPPEL 200
Query: 442 YMKTYQLTTKSDVYSFGVLLLEILTGRRPV 471
            +         D++  G ++ E+ T R P+
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
           +G G FG V++   +    V + +     +   +    +E+ +++++ H  L+ L    +
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 334 KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
              E ++I EF+  G L + +  +  K  +  + +        GL ++H   E  I+H D
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSE-AEVINYMRQACEGLKHMH---EHSIVHLD 174
Query: 394 VKSSNILLTESMRA---KVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +K  NI + E+ +A   K+ DFG A +L P       I      T  +  PE +    + 
Sbjct: 175 IKPENI-MCETKKASSVKIIDFGLATKLNP-----DEIVKVTTATAEFAAPEIVDREPVG 228
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
             +D+++ GVL   +L+G  P
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSP 249

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 30/217 (13%)
Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +IG+G FG V+KA+  + G  VA+K+   E + E        E+++L  + H N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 331 FVD---------KGNERLIITEFVPNGTLREH-LDGQYGKTL---DFNQRLEIAIDVAHG 377
                       KG+  L+  +F       EH L G     L     ++   +   + +G
Sbjct: 85  ICRTKASPYNRCKGSIYLVF-DFC------EHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM--DSDRTHISTKVKGTV 435
           L Y+H     +I+HRD+K++N+L+T     K+ADFG AR   +  +S       +V  T+
Sbjct: 138 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 193
Query: 436 GYLDPE-YMKTYQLTTKSDVYSFGVLLLEILTGRRPV 471
            Y  PE  +         D++  G ++ E+ T R P+
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 30/217 (13%)
Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +IG+G FG V+KA+  + G  VA+K+   E + E        E+++L  + H N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 331 FVD---------KGNERLIITEFVPNGTLREH-LDGQYGKTL---DFNQRLEIAIDVAHG 377
                       KG+  L+  +F       EH L G     L     ++   +   + +G
Sbjct: 85  ICRTKASPYNRCKGSIYLVF-DFC------EHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM--DSDRTHISTKVKGTV 435
           L Y+H     +I+HRD+K++N+L+T     K+ADFG AR   +  +S       +V  T+
Sbjct: 138 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 193
Query: 436 GYLDPE-YMKTYQLTTKSDVYSFGVLLLEILTGRRPV 471
            Y  PE  +         D++  G ++ E+ T R P+
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 30/217 (13%)
Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +IG+G FG V+KA+  + G  VA+K+   E + E        E+++L  + H N+V L+ 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 331 FVD---------KGNERLIITEFVPNGTLREH-LDGQYGKTL---DFNQRLEIAIDVAHG 377
                       KG+  L+  +F       EH L G     L     ++   +   + +G
Sbjct: 84  ICRTKASPYNRCKGSIYLVF-DFC------EHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM--DSDRTHISTKVKGTV 435
           L Y+H     +I+HRD+K++N+L+T     K+ADFG AR   +  +S       +V  T+
Sbjct: 137 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 192
Query: 436 GYLDPE-YMKTYQLTTKSDVYSFGVLLLEILTGRRPV 471
            Y  PE  +         D++  G ++ E+ T R P+
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           IG+G F  V +  +L  G   A K    KK    + Q +   E  +   + H N+V+L  
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQ-KLEREARICRLLKHSNIVRLHD 70
Query: 331 FVDKGNERLIITEFVPNGTLREHLDG-QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            + +     ++ + V  G L E +   +Y    D +  ++  ++       LH + +  +
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-----LHCH-QMGV 124
Query: 390 IHRDVKSSNILLTESMRA---KVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           +HRD+K  N+LL    +    K+ADFG A     D           GT GYL PE ++  
Sbjct: 125 VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWF---GFAGTPGYLSPEVLRKE 181
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
                 D+++ GV+L  +L G  P
Sbjct: 182 AYGKPVDIWACGVILYILLVGYPP 205

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K  +KE    ++      +E  +L    H  L  L  
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-K 74
Query: 331 FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           +  + ++RL  + E+   G L  HL  +  +     +      ++   L YLH    + +
Sbjct: 75  YAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDV 129
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           ++RD+K  N++L +    K+ DFG  + G   SD   + T   GT  YL PE ++     
Sbjct: 130 VYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKTFC-GTPEYLAPEVLEDNDYG 186
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D +  GV++ E++ GR P
Sbjct: 187 RAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K  +KE    ++      +E  +L    H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-K 71
Query: 331 FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           +  + ++RL  + E+   G L  HL  +  +     +      ++   L YLH    + +
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDV 126
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           ++RD+K  N++L +    K+ DFG  + G   SD   + T   GT  YL PE ++     
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKT-FCGTPEYLAPEVLEDNDYG 183
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D +  GV++ E++ GR P
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 11/200 (5%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K  +KE    ++      +E  +L    H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
                +    + E+   G L  HL  +  +     +      ++   L YLH    + ++
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDVV 127
Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           +RD+K  N++L +    K+ DFG  + G   SD   + T   GT  YL PE ++      
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKT-FCGTPEYLAPEVLEDNDYGR 184
Query: 451 KSDVYSFGVLLLEILTGRRP 470
             D +  GV++ E++ GR P
Sbjct: 185 AVDWWGLGVVMYEMMCGRLP 204

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 33/212 (15%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSS----------EVELLSKIDHR 323
           I  G +G V      +G+ VAIKR      +       S          E+ LL+   H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKT----LDFNQRLEIAID-----V 374
           N++ L         R I   F      + +L  +  +T    +  +QR+ I+       +
Sbjct: 90  NILGL---------RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT 434
            H L  LH+  E  ++HRD+   NILL ++    + DF  AR    D+++TH  T     
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH---- 196
Query: 435 VGYLDPEYMKTYQLTTK-SDVYSFGVLLLEIL 465
             Y  PE +  ++  TK  D++S G ++ E+ 
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 33/212 (15%)
Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSS----------EVELLSKIDHR 323
           I  G +G V      +G+ VAIKR      +       S          E+ LL+   H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKT----LDFNQRLEIAID-----V 374
           N++ L         R I   F      + +L  +  +T    +  +QR+ I+       +
Sbjct: 90  NILGL---------RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT 434
            H L  LH+  E  ++HRD+   NILL ++    + DF  AR    D+++TH  T     
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH---- 196
Query: 435 VGYLDPEYMKTYQLTTK-SDVYSFGVLLLEIL 465
             Y  PE +  ++  TK  D++S G ++ E+ 
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K  +KE    ++      +E  +L    H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-K 71
Query: 331 FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           +  + ++RL  + E+   G L  HL  +  +     +      ++   L YLH    + +
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDV 126
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           ++RD+K  N++L +    K+ DFG  + G  D           GT  YL PE ++     
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D +  GV++ E++ GR P
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLP 204

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 62/135 (45%), Gaps = 11/135 (8%)
Query: 339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSN 398
           LII E +  G L   +  +  +     +  EI  D+   + +LH +    I HRDVK  N
Sbjct: 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPEN 158
Query: 399 ILLTESMR---AKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVY 455
           +L T   +    K+ DFGFA+    ++ +T   T       Y+ PE +   +     D++
Sbjct: 159 LLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-----YVAPEVLGPEKYDKSCDMW 213
Query: 456 SFGVLLLEILTGRRP 470
           S GV++  +L G  P
Sbjct: 214 SLGVIMYILLCGFPP 228

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 41/225 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A LE    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRP-FQN-QTHAKRAYREL 74
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  +L E  D     + +D N    I ++
Sbjct: 75  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 177
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGR 468
            + +      T  Y  PE +         D++S G ++ E++  +
Sbjct: 178 TSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 45/231 (19%)
Query: 273 RIGEGGFGTVY--KAQLEDGL--LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           +IGEG F +VY   AQL+ G    +A+K              ++E++ L+    ++ V  
Sbjct: 28  KIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP---IRIAAELQCLTVAGGQDNVMG 84
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           + +  + N+ ++I   +P       LD     +L F +  E  +++   L  +H +    
Sbjct: 85  VKYCFRKNDHVVIA--MPYLEHESFLD--ILNSLSFQEVREYMLNLFKALKRIHQFG--- 137
Query: 389 IIHRDVKSSNILLTESMRA-KVADFGFARLGPMD-------------------------- 421
           I+HRDVK SN L    ++   + DFG A+ G  D                          
Sbjct: 138 IVHRDVKPSNFLYNRRLKKYALVDFGLAQ-GTHDTKIELLKFVQSEAQQERCSQNKCSIC 196
Query: 422 -SDRTHISTKVKGTVGYLDPEYM-KTYQLTTKSDVYSFGVLLLEILTGRRP 470
            S R  ++ +  GT G+  PE + K    TT  D++S GV+ L +L+GR P
Sbjct: 197 LSRRQQVAPRA-GTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 274 IGEGGFGTVYKAQLEDGLLV-AIKRAKKEQFENLQTE----FSSEVELLSKIDHRNLVKL 328
           IG G FG V   + +    V A+K   K  FE ++      F  E ++++  +   +V+L
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSK--FEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 329 LGFVDKGNERLIITEFVPNG---TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
                      ++ E++P G    L  + D        +   + +A+D  H + +     
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF----- 189
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
               IHRDVK  N+LL +S   K+ADFG      M+ +         GT  Y+ PE +K+
Sbjct: 190 ----IHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 446 Y----QLTTKSDVYSFGVLLLEILTGRRP 470
                    + D +S GV L E+L G  P
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 62/135 (45%), Gaps = 11/135 (8%)
Query: 339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSN 398
           LII E +  G L   +  +  +     +  EI  D+   + +LH +    I HRDVK  N
Sbjct: 83  LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPEN 139
Query: 399 ILLTESMR---AKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVY 455
           +L T   +    K+ DFGFA+    ++ +T   T       Y+ PE +   +     D++
Sbjct: 140 LLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-----YVAPEVLGPEKYDKSCDMW 194
Query: 456 SFGVLLLEILTGRRP 470
           S GV++  +L G  P
Sbjct: 195 SLGVIMYILLCGFPP 209

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K  +KE    ++      +E  +L    H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-K 71
Query: 331 FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           +  + ++RL  + E+   G L  HL  +  +     +      ++   L YLH    + +
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDV 126
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           ++RD+K  N++L +    K+ DFG  + G  D           GT  YL PE ++     
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D +  GV++ E++ GR P
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLP 204

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K  +KE    ++      +E  +L    H  L  L  
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-K 76
Query: 331 FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           +  + ++RL  + E+   G L  HL  +  +     +      ++   L YLH    + +
Sbjct: 77  YAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDV 131
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           ++RD+K  N++L +    K+ DFG  + G  D           GT  YL PE ++     
Sbjct: 132 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKXFCGTPEYLAPEVLEDNDYG 188
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D +  GV++ E++ GR P
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLP 209

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 274 IGEGGFGTVYKAQLEDGLLV-AIKRAKKEQFENLQTE----FSSEVELLSKIDHRNLVKL 328
           IG G FG V   + +    V A+K   K  FE ++      F  E ++++  +   +V+L
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSK--FEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 329 LGFVDKGNERLIITEFVPNG---TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
                      ++ E++P G    L  + D        +   + +A+D  H + +     
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF----- 194
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
               IHRDVK  N+LL +S   K+ADFG      M+ +         GT  Y+ PE +K+
Sbjct: 195 ----IHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 446 Y----QLTTKSDVYSFGVLLLEILTGRRP 470
                    + D +S GV L E+L G  P
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/223 (21%), Positives = 93/223 (41%), Gaps = 23/223 (10%)
Query: 258 MSQVVKATRNFSPSLRIGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFS 311
           M+   + T ++     +G+G F  V +       Q     ++  K+      + L+    
Sbjct: 23  MATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLE---- 78
Query: 312 SEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDG-QYGKTLDFNQRLEI 370
            E  +   + H N+V+L   + +     ++ + V  G L E +   +Y    D +  +  
Sbjct: 79  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH- 137
Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRA---KVADFGFARLGPMDSDRTHI 427
              +   + ++H   +  I+HRD+K  N+LL    +    K+ADFG A +      +   
Sbjct: 138 --QILESVNHIH---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWF 191
Query: 428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
                GT GYL PE ++        D+++ GV+L  +L G  P
Sbjct: 192 G--FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 274 IGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG V   + +  G   A+K  +KE    ++      +E  +L    H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-K 71
Query: 331 FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           +  + ++RL  + E+   G L  HL  +  +     +      ++   L YLH    + +
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDV 126
Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           ++RD+K  N++L +    K+ DFG  + G  D           GT  YL PE ++     
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D +  GV++ E++ GR P
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLP 204

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 274 IGEGGFGTVYKAQLEDGLLV-AIKRAKKEQFENLQTE----FSSEVELLSKIDHRNLVKL 328
           IG G FG V   + +    V A+K   K  FE ++      F  E ++++  +   +V+L
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSK--FEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 329 LGFVDKGNERLIITEFVPNG---TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
                      ++ E++P G    L  + D        +   + +A+D  H + +     
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF----- 194
Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
               IHRDVK  N+LL +S   K+ADFG      M+ +         GT  Y+ PE +K+
Sbjct: 195 ----IHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 446 Y----QLTTKSDVYSFGVLLLEILTGRRP 470
                    + D +S GV L E+L G  P
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 109/237 (45%), Gaps = 24/237 (10%)
Query: 251 IGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE- 309
           +G+ +L    +    R +S   +IG GG   V++   E   + AIK    E+ +N   + 
Sbjct: 13  LGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS 72
Query: 310 FSSEVELLSKIDHRN--LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR 367
           + +E+  L+K+   +  +++L  + +  ++ + +     N  L   L  +  K++D  +R
Sbjct: 73  YRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECGNIDLNSWLKKK--KSIDPWER 129
Query: 368 LEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI 427
                ++   +  +H +    I+H D+K +N L+ + M  K+ DFG A    M  D T +
Sbjct: 130 KSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA--NQMQPDTTSV 183
Query: 428 STKVK-GTVGYLDPEYMKTYQLTTKS-----------DVYSFGVLLLEILTGRRPVE 472
               + GTV Y+ PE +K    + ++           DV+S G +L  +  G+ P +
Sbjct: 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 73/166 (43%), Gaps = 13/166 (7%)
Query: 309 EFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDG-QYGKTLDFNQR 367
           +   E  +   + H N+V+L   + +     +I + V  G L E +   +Y    D +  
Sbjct: 67  KLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC 126
Query: 368 LEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRA---KVADFGFARLGPMDSDR 424
           ++  ++       LH + +  ++HRD+K  N+LL   ++    K+ADFG A         
Sbjct: 127 IQQILEAV-----LHCH-QMGVVHRDLKPENLLLASKLKGAAVKLADFGLA---IEVEGE 177
Query: 425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
                   GT GYL PE ++        D+++ GV+L  +L G  P
Sbjct: 178 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 103/222 (46%), Gaps = 24/222 (10%)
Query: 266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRN 324
           R +S   +IG GG   V++   E   + AIK    E+ +N   + + +E+  L+K+   +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 325 --LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLH 382
             +++L  + +  ++ + +     N  L   L  +  K++D  +R     ++   +  +H
Sbjct: 69  DKIIRLYDY-EITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH 125
Query: 383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-GTVGYLDPE 441
            +    I+H D+K +N L+ + M  K+ DFG A    M  D T +    + GTV Y+ PE
Sbjct: 126 QHG---IVHSDLKPANFLIVDGM-LKLIDFGIA--NQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 442 YMKTYQLTTKS-----------DVYSFGVLLLEILTGRRPVE 472
            +K    + ++           DV+S G +L  +  G+ P +
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 17/204 (8%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G F  V +  ++  G   A K    KK    + Q +   E  +   + H N+V+L  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ-KLEREARICRLLKHPNIVRLHD 70
Query: 331 FVDKGNERLIITEFVPNGTLREHLDG-QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            + +     ++ + V  G L E +   +Y    D +  ++    +   + + HL     I
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ---QILESVNHCHLNG---I 124
Query: 390 IHRDVKSSNILLTESMRA---KVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           +HRD+K  N+LL    +    K+ADFG A     D           GT GYL PE ++  
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF---GFAGTPGYLSPEVLRKD 181
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
                 D+++ GV+L  +L G  P
Sbjct: 182 PYGKPVDMWACGVILYILLVGYPP 205

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFEN---LQTE-FSSEVELLSKIDHRNLVKL 328
           IG+G F  V +    E G   A+K     +F +   L TE    E  +   + H ++V+L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL--EIAIDVAHGLTYLHLYAE 386
           L          ++ EF+    L   +  +      +++ +       +   L Y H   +
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 148
Query: 387 KQIIHRDVKSSNILLT---ESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEY 442
             IIHRDVK  N+LL     S   K+ DFG A +LG    +   ++    GT  ++ PE 
Sbjct: 149 NNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG----ESGLVAGGRVGTPHFMAPEV 204
Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +K        DV+  GV+L  +L+G  P
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 103/222 (46%), Gaps = 24/222 (10%)
Query: 266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRN 324
           R +S   +IG GG   V++   E   + AIK    E+ +N   + + +E+  L+K+   +
Sbjct: 12  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 71
Query: 325 --LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLH 382
             +++L  + +  ++ + +     N  L   L  +  K++D  +R     ++   +  +H
Sbjct: 72  DKIIRLYDY-EITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH 128
Query: 383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-GTVGYLDPE 441
            +    I+H D+K +N L+ + M  K+ DFG A    M  D T +    + GTV Y+ PE
Sbjct: 129 QHG---IVHSDLKPANFLIVDGM-LKLIDFGIA--NQMQPDTTSVVKDSQVGTVNYMPPE 182
Query: 442 YMKTYQLTTKS-----------DVYSFGVLLLEILTGRRPVE 472
            +K    + ++           DV+S G +L  +  G+ P +
Sbjct: 183 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 224

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 274 IGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G+G F  V +       Q    +++  K+      + L+     E  +   + H N+V+
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE----REARICRLLKHPNIVR 74
Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDG-QYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           L   + +     +I + V  G L E +   +Y    D +  ++  ++       LH + +
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-----LHCH-Q 128
Query: 387 KQIIHRDVKSSNILLTESMRA---KVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
             ++HR++K  N+LL   ++    K+ADFG A    ++ ++        GT GYL PE +
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQ-QAWFGFAGTPGYLSPEVL 185
Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +        D+++ GV+L  +L G  P
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 22/221 (9%)
Query: 266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKID-HR 323
           R +S   +IG GG   V++   E   + AIK    E+ +N   + + +E+  L+K+  H 
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
           + +  L   +  ++ + +     N  L   L  +  K++D  +R     ++   +  +H 
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-GTVGYLDPEY 442
           +    I+H D+K +N L+ + M  K+ DFG A    M  D T +    + GTV Y+ PE 
Sbjct: 174 HG---IVHSDLKPANFLIVDGM-LKLIDFGIA--NQMQPDTTSVVKDSQVGTVNYMPPEA 227
Query: 443 MKTYQLTTKS-----------DVYSFGVLLLEILTGRRPVE 472
           +K    + ++           DV+S G +L  +  G+ P +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 103/222 (46%), Gaps = 24/222 (10%)
Query: 266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRN 324
           R +S   +IG GG   V++   E   + AIK    E+ +N   + + +E+  L+K+   +
Sbjct: 8   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 67
Query: 325 --LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLH 382
             +++L  + +  ++ + +     N  L   L  +  K++D  +R     ++   +  +H
Sbjct: 68  DKIIRLYDY-EITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH 124
Query: 383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-GTVGYLDPE 441
            +    I+H D+K +N L+ + M  K+ DFG A    M  D T +    + GTV Y+ PE
Sbjct: 125 QHG---IVHSDLKPANFLIVDGM-LKLIDFGIA--NQMQPDTTSVVKDSQVGTVNYMPPE 178
Query: 442 YMKTYQLTTKS-----------DVYSFGVLLLEILTGRRPVE 472
            +K    + ++           DV+S G +L  +  G+ P +
Sbjct: 179 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 220

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 17/204 (8%)
Query: 274 IGEGGFGTVYKA-QLEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G F  V +  ++  G   A K    KK    + Q +   E  +   + H N+V+L  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ-KLEREARICRLLKHPNIVRLHD 70
Query: 331 FVDKGNERLIITEFVPNGTLREHLDG-QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            + +     ++ + V  G L E +   +Y    D +  ++    +   + + HL     I
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ---QILESVNHCHLNG---I 124
Query: 390 IHRDVKSSNILLTESMRA---KVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           +HRD+K  N+LL    +    K+ADFG A     D           GT GYL PE ++  
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF---GFAGTPGYLSPEVLRKD 181
Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
                 D+++ GV+L  +L G  P
Sbjct: 182 PYGKPVDMWACGVILYILLVGYPP 205

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 22/221 (9%)
Query: 266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKID-HR 323
           R +S   +IG GG   V++   E   + AIK    E+ +N   + + +E+  L+K+  H 
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
           + +  L   +  ++ + +     N  L   L  +  K++D  +R     ++   +  +H 
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-GTVGYLDPEY 442
           +    I+H D+K +N L+ + M  K+ DFG A    M  D T +    + GTV Y+ PE 
Sbjct: 174 HG---IVHSDLKPANFLIVDGM-LKLIDFGIA--NQMQPDTTSVVKDSQVGTVNYMPPEA 227
Query: 443 MKTYQLTTKS-----------DVYSFGVLLLEILTGRRPVE 472
           +K    + ++           DV+S G +L  +  G+ P +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 41/225 (18%)
Query: 261 VVKATRNFSPSLRIGEGGFGTV---YKAQLEDGLLVAIKRAKKEQFENLQTEFSS---EV 314
           V+K  +N  P   IG G  G V   Y A LE    VAIK+  +  F+N QT       E+
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRP-FQN-QTHAKRAYREL 74
Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAID 373
            L+  ++H+N++ LL              F P  +L E  D     + +D N    I ++
Sbjct: 75  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 374 VAHG-LTYL---------HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD 423
           + H  ++YL         HL++   IIHRD+K SNI++      K+ DFG AR     + 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAG 177
Query: 424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGR 468
            + +      T  Y  PE +         D++S G ++ E++  +
Sbjct: 178 TSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	554
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-133
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-119
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-114
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-75
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-67
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-64
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-63
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-62
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-62
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-62
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-61
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-61
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-58
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-54
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-54
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-52
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-50
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-50
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-48
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-48
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-47
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-47
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-47
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-47
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-46
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-46
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-46
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-46
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-46
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-46
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-46
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-46
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-46
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-46
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-46
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-46
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-45
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-45
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-45
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-45
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-45
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-45
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-45
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-45
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-45
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-44
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-44
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-44
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-44
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-44
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-44
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-44
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-44
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-44
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-44
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-44
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-44
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-44
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-44
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-44
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-44
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-44
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-43
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-43
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-43
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-43
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-43
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-43
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-43
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-43
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-43
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-43
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-42
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-42
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-42
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-41
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-41
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-41
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-41
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-40
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-39
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-39
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-38
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-38
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-38
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-38
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-37
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-37
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-35
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-35
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-34
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-33
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-33
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-32
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-32
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-32
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-32
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-32
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-31
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-31
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-30
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-28
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-25
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-24
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-22
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-22
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-22
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-21
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-21
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-21
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-12
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-20
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-19
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-17
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-17
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-17
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-16
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-16
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-07

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  390 bits (1004), Expect = e-133
 Identities = 129/327 (39%), Positives = 177/327 (54%), Gaps = 21/327 (6%)

Query: 216 NSGSEKVSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIG 275
           +  S+  +  +    S   VP    R  +                + +AT NF     IG
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLV--------------DLEEATNNFDHKFLIG 48

Query: 276 EGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG 335
            G FG VYK  L DG  VA+KR   E  + ++ EF +E+E LS   H +LV L+GF D+ 
Sbjct: 49  HGVFGKVYKGVLRDGAKVALKRRTPESSQGIE-EFETEIETLSFCRHPHLVSLIGFCDER 107

Query: 336 NERLIITEFVPNGTLREHL--DGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRD 393
           NE ++I +++ NG L+ HL        ++ + QRLEI I  A GL YLH    + IIHRD
Sbjct: 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRD 164

Query: 394 VKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSD 453
           VKS NILL E+   K+ DFG ++ G  + D+TH+ST VKGT+GY+DPEY    +LT KSD
Sbjct: 165 VKSINILLDENFVPKITDFGISKKGT-ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSD 223

Query: 454 VYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILT 513
           VYSFGV+L E+L  R  +    P E      WA + +N G L  +VDP++ + I  E L 
Sbjct: 224 VYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLR 283

Query: 514 KMFGLAIQCAAPIRNDRPDMKSVGEQL 540
           K    A++C A    DRP M  V  +L
Sbjct: 284 KFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  354 bits (912), Expect = e-119
 Identities = 109/278 (39%), Positives = 166/278 (59%), Gaps = 6/278 (2%)

Query: 263 KATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH 322
            A+ NFS    +G GGFG VYK +L DG LVA+KR K+E+ +  + +F +EVE++S   H
Sbjct: 27  VASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH 86

Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYG--KTLDFNQRLEIAIDVAHGLTY 380
           RNL++L GF     ERL++  ++ NG++   L  +      LD+ +R  IA+  A GL Y
Sbjct: 87  RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAY 146

Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
           LH + + +IIHRDVK++NILL E   A V DFG A+L  MD   TH++T V+GT+G++ P
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL--MDYKDTHVTTAVRGTIGHIAP 204

Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVT--LRWAFKRYNEGNLLDM 498
           EY+ T + + K+DV+ +GV+LLE++TG+R  +L R   +     L W      E  L  +
Sbjct: 205 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEAL 264

Query: 499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
           VD  ++     E + ++  +A+ C      +RP M  V
Sbjct: 265 VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  341 bits (876), Expect = e-114
 Identities = 96/289 (33%), Positives = 158/289 (54%), Gaps = 20/289 (6%)

Query: 259 SQVVKATRNFSPSL------RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFEN-LQ--TE 309
            ++   T NF          ++GEGGFG VYK  + +   VA+K+          +   +
Sbjct: 18  YELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQ 76

Query: 310 FSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHL-DGQYGKTLDFNQRL 368
           F  E+++++K  H NLV+LLGF   G++  ++  ++PNG+L + L        L ++ R 
Sbjct: 77  FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136

Query: 369 EIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIS 428
           +IA   A+G+ +LH   E   IHRD+KS+NILL E+  AK++DFG AR       +T ++
Sbjct: 137 KIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF-AQTVMT 192

Query: 429 TKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFK 488
           +++ GT  Y+ PE +   ++T KSD+YSFGV+LLEI+TG   V+  R P+  +      +
Sbjct: 193 SRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD--IKEE 249

Query: 489 RYNE-GNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
             +E   + D +D  + +      +  M+ +A QC    +N RPD+K V
Sbjct: 250 IEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  241 bits (618), Expect = 1e-75
 Identities = 72/311 (23%), Positives = 123/311 (39%), Gaps = 31/311 (9%)

Query: 253 SVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSS 312
            V L    +   +           G FG V+KAQL     VA+K    +  ++ Q E+  
Sbjct: 11  GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEY-- 67

Query: 313 EVELLSKIDHRNLVKLLGFVDKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRL 368
           EV  L  + H N+++ +G   +G     +  +IT F   G+L + L       + +N+  
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELC 124

Query: 369 EIAIDVAHGLTYLHLYAEKQ-------IIHRDVKSSNILLTESMRAKVADFGFARLGPMD 421
            IA  +A GL YLH             I HRD+KS N+LL  ++ A +ADFG A     +
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK--FE 182

Query: 422 SDRTHISTK-VKGTVGYLDPEYM-----KTYQLTTKSDVYSFGVLLLEILTGRRPVELKR 475
           + ++   T    GT  Y+ PE +            + D+Y+ G++L E+ +     +   
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242

Query: 476 PP-----EERVTLRWAFKRYNEGNLLDMVDPSI-KEVISMEILTKMFGLAIQCAAPIRND 529
                  EE +    + +   E  +     P +         +  +     +C       
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302

Query: 530 RPDMKSVGEQL 540
           R     VGE++
Sbjct: 303 RLSAGCVGERI 313

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  218 bits (558), Expect = 5e-67
 Identities = 80/281 (28%), Positives = 132/281 (46%), Gaps = 28/281 (9%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IG G FGTV++A+   G  VA+K   ++ F      EF  EV ++ ++ H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 332 VDKGNERLIITEFVPNGTLREHL-DGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           V +     I+TE++  G+L   L      + LD  +RL +A DVA G+ YLH      I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP-IV 161

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HR++KS N+L+ +    KV DFG +RL    +     S    GT  ++ PE ++      
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218

Query: 451 KSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM---VDPSIKEVI 507
           KSDVYSFGV+L E+ T ++P     P       +       +   L++   ++P +  +I
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNP------AQVVAAVGFKCKRLEIPRNLNPQVAAII 272

Query: 508 SMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL 548
                         C       RP   ++ + L  +   ++
Sbjct: 273 E------------GCWTNEPWKRPSFATIMDLLRPLIKSAV 301

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  210 bits (536), Expect = 8e-64
 Identities = 69/274 (25%), Positives = 117/274 (42%), Gaps = 36/274 (13%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
            +G G FG V KA+      VAIK+ + E        F  E+  LS+++H N+VKL G  
Sbjct: 15  VVGRGAFGVVCKAKW-RAKDVAIKQIESESERK---AFIVELRQLSRVNHPNIVKLYGAC 70

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGK-TLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
                  ++ E+   G+L   L G            +   +  + G+ YLH    K +IH
Sbjct: 71  LN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128

Query: 392 RDVKSSNILLTESMR-AKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           RD+K  N+LL       K+ DFG A       D     T  KG+  ++ PE  +    + 
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC------DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182

Query: 451 KSDVYSFGVLLLEILTGRRP-VELKRPPEERVTLRWAFKRYNEGNLLDM---VDPSIKEV 506
           K DV+S+G++L E++T R+P  E+  P              + G    +   +   I+ +
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFR------IMWAVHNGTRPPLIKNLPKPIESL 236

Query: 507 ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
           ++            +C +   + RP M+ + + +
Sbjct: 237 MT------------RCWSKDPSQRPSMEEIVKIM 258

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  207 bits (530), Expect = 4e-63
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 25/273 (9%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           RIG G FGTVYK +      VA+K              F +EV +L K  H N++  +G+
Sbjct: 31  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
                   I+T++    +L  HL        +  + ++IA   A G+ YLH    K IIH
Sbjct: 89  STAPQ-LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH---AKSIIH 143

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL--- 448
           RD+KS+NI L E    K+ DFG A         +H   ++ G++ ++ PE ++       
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKS-RWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202

Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPPEERV-TLRWAFKRYNEGNLLDMVDPSIKEVI 507
           + +SDVY+FG++L E++TG+ P       ++ +  +       +   +       +K ++
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLM 262

Query: 508 SMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
           +            +C    R++RP    +  ++
Sbjct: 263 A------------ECLKKKRDERPSFPRILAEI 283

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  206 bits (526), Expect = 1e-62
 Identities = 78/287 (27%), Positives = 131/287 (45%), Gaps = 47/287 (16%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFEN------LQTEFSSEVELLSKIDHRNL 325
           +IG+GGFG V+K + ++D  +VAIK       E          EF  EV ++S ++H N+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85

Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           VKL G +       ++ EFVP G L   L  +    + ++ +L + +D+A G+ Y+    
Sbjct: 86  VKLYGLMHNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQN 142

Query: 386 EKQIIHRDVKSSNILLTES-----MRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
              I+HRD++S NI L        + AKVADFG ++         H  + + G   ++ P
Sbjct: 143 PP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVSGLLGNFQWMAP 195

Query: 441 EYM----KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL 496
           E +    ++Y  T K+D YSF ++L  ILTG  P +     +    +++      EG   
Sbjct: 196 ETIGAEEESY--TEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEGLRP 249

Query: 497 DM---VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            +     P ++ VI              C +     RP    + ++L
Sbjct: 250 TIPEDCPPRLRNVIE------------LCWSGDPKKRPHFSYIVKEL 284

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  205 bits (523), Expect = 2e-62
 Identities = 69/209 (33%), Positives = 101/209 (48%), Gaps = 20/209 (9%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQ---TEFSSEVELLSKIDHRNLVKLL 329
            IG GGFG VY+A    G  VA+K A+ +  E++         E +L + + H N++ L 
Sbjct: 14  IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G   K     ++ EF   G L   L G   K +  +  +  A+ +A G+ YLH  A   I
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 390 IHRDVKSSNILLTESMR--------AKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           IHRD+KSSNIL+ + +          K+ DFG AR                G   ++ PE
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTK---MSAAGAYAWMAPE 184

Query: 442 YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            ++    +  SDV+S+GVLL E+LTG  P
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  204 bits (521), Expect = 4e-62
 Identities = 45/204 (22%), Positives = 88/204 (43%), Gaps = 16/204 (7%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++ E   G ++K +   G  + +K  K   +      +F+ E   L    H N++ +LG 
Sbjct: 17  KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 332 VDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
                     +IT ++P G+L   L       +D +Q ++ A+D+A G+ +LH   E  I
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLI 134

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK---TY 446
               + S ++++ E M A+++              +  S        ++ PE ++     
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVK--------FSFQSPGRMYAPAWVAPEALQKKPED 186

Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
                +D++SF VLL E++T   P
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVP 210

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  204 bits (520), Expect = 2e-61
 Identities = 71/280 (25%), Positives = 111/280 (39%), Gaps = 31/280 (11%)

Query: 273 RIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
            +G+G FG   K    E G ++ +K   +   E  Q  F  EV+++  ++H N++K +G 
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           + K      ITE++  GTLR  +         ++QR+  A D+A G+ YLH      IIH
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLH---SMNIIH 131

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK-----------GTVGYLDP 440
           RD+ S N L+ E+    VADFG ARL   +  +      +K           G   ++ P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191

Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD 500
           E +       K DV+SFG++L EI+          P      L                 
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-----NVRGFLDRY--- 243

Query: 501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
                          F + ++C       RP    +   L
Sbjct: 244 ------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  203 bits (519), Expect = 3e-61
 Identities = 62/281 (22%), Positives = 109/281 (38%), Gaps = 36/281 (12%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGF 331
            IG+G FG VY  +      VAI+    E+  E+    F  EV    +  H N+V  +G 
Sbjct: 40  LIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
                   IIT      TL   +       LD N+  +IA ++  G+ YLH    K I+H
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153

Query: 392 RDVKSSNILLTESMRAKVADFGFARL--GPMDSDRTHISTKVKGTVGYLDPEYMKTYQL- 448
           +D+KS N+   ++ +  + DFG   +        R        G + +L PE ++     
Sbjct: 154 KDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 449 --------TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD 500
                   +  SDV++ G +  E+     P                FK      ++  + 
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWP----------------FKTQPAEAIIWQMG 256

Query: 501 PSIK-EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
             +K  +  + +  ++  + + C A  + +RP    + + L
Sbjct: 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  196 bits (500), Expect = 3e-58
 Identities = 63/315 (20%), Positives = 114/315 (36%), Gaps = 44/315 (13%)

Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR 323
              N      IG G +G VYK  L D   VA+K       +N   E    +  +  ++H 
Sbjct: 11  DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINE--KNIYRVPLMEHD 67

Query: 324 NLVKLLGFVDKGN-----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGL 378
           N+ + +   ++       E L++ E+ PNG+L ++L      T D+     +A  V  GL
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGL 124

Query: 379 TYLH------LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL-----GPMDSDRTHI 427
            YLH       + +  I HRD+ S N+L+       ++DFG +            +  + 
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184

Query: 428 STKVKGTVGYLDPEYMK-------TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEER 480
           +    GT+ Y+ PE ++             + D+Y+ G++  EI      +       E 
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE- 243

Query: 481 VTLRWAFKRYNEGNLLDMVD--------PSIKE--VISMEILTKMFGLAIQC--AAPIRN 528
             + +  +  N     DM          P   E    +   +  +      C        
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA--E 301

Query: 529 DRPDMKSVGEQLWAI 543
            R   +   E++  +
Sbjct: 302 ARLTAQXAEERMAEL 316

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  185 bits (471), Expect = 2e-54
 Identities = 64/289 (22%), Positives = 121/289 (41%), Gaps = 27/289 (9%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
            +G+G +G V++     G  VA+K       ++   E   E+     + H N++  +   
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRET--ELYNTVMLRHENILGFIASD 71

Query: 333 DKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                   +  +IT +   G+L ++L      TLD    L I + +A GL +LH+     
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 389 -----IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI-STKVKGTVGYLDPE- 441
                I HRD+KS NIL+ ++ +  +AD G A +    +++  + +    GT  Y+ PE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188

Query: 442 -----YMKTYQLTTKSDVYSFGVLLLEILTGRRPV----ELKRPPEERVTLRWAFKRYNE 492
                 +  +    + D+++FG++L E+           + K P  + V    +F+   +
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248

Query: 493 GNLLDMVDPSI-KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
              +D   P+I     S   LT +  L  +C     + R     + + L
Sbjct: 249 VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  185 bits (471), Expect = 5e-54
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 27/289 (9%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +IG+G +G V+  +   G  VA+K     +  +   E  +E+     + H N++  +   
Sbjct: 44  QIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIAAD 100

Query: 333 DKGNER----LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
            KG        +IT++  NG+L ++L      TLD    L++A     GL +LH      
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157

Query: 389 -----IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI-STKVKGTVGYLDPE- 441
                I HRD+KS NIL+ ++    +AD G A     D++   I      GT  Y+ PE 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217

Query: 442 -----YMKTYQLTTKSDVYSFGVLLLEILTGRRPV----ELKRPPEERVTLRWAFKRYNE 492
                    +Q    +D+YSFG++L E+           E + P  + V    +++   E
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277

Query: 493 GNLLDMVDPSI-KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
              +  + PS      S E L +M  L  +C A     R     V + L
Sbjct: 278 IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  174 bits (443), Expect = 5e-50
 Identities = 64/289 (22%), Positives = 123/289 (42%), Gaps = 27/289 (9%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
            IG+G FG V++ +   G  VA+K     +  +   E  +E+     + H N++  +   
Sbjct: 49  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 105

Query: 333 DKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           +K N    +  +++++  +G+L ++L+     T+     +++A+  A GL +LH+     
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGT 162

Query: 389 -----IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI-STKVKGTVGYLDPE- 441
                I HRD+KS NIL+ ++    +AD G A      +D   I      GT  Y+ PE 
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222

Query: 442 -----YMKTYQLTTKSDVYSFGVLLLEILTGRRPV----ELKRPPEERVTLRWAFKRYNE 492
                 MK ++   ++D+Y+ G++  EI           + + P  + V    + +   +
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282

Query: 493 GNLLDMVDPSI-KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
                 + P+I     S E L  M  +  +C       R     + + L
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  175 bits (445), Expect = 8e-50
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 13/203 (6%)

Query: 273 RIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IG G FG V+  +L  D  LVA+K  ++    +L+ +F  E  +L +  H N+V+L+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     I+ E V  G     L  + G  L     L++  D A G+ YL     K  IH
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE---SKCCIH 236

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK---VKGTVGYLDPEYMKTYQL 448
           RD+ + N L+TE    K++DFG +R             +   VK T     PE +   + 
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA----PEALNYGRY 292

Query: 449 TTKSDVYSFGVLLLEILT-GRRP 470
           +++SDV+SFG+LL E  + G  P
Sbjct: 293 SSESDVWSFGILLWETFSLGASP 315

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  168 bits (428), Expect = 3e-48
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 28/283 (9%)

Query: 273 RIGEGGFGTVYKAQLE-----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
            +GEG FG V   + +      G  VA+K  K E   N   +   E+E+L  + H N+VK
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87

Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G   +       +I EF+P+G+L+E+L  +    ++  Q+L+ A+ +  G+ YL    
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL---G 143

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            +Q +HRD+ + N+L+    + K+ DFG  +    D +   +       V +  PE +  
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203

Query: 446 YQLTTKSDVYSFGVLLLEILT-GRRP-------VELKRPPEERVTLRWAFKRYNEGNLLD 497
            +    SDV+SFGV L E+LT            +++  P   ++T+        EG  L 
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP 263

Query: 498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
              P        E+   M     +C     ++R   +++ E  
Sbjct: 264 C--P---PNCPDEVYQLM----RKCWEFQPSNRTSFQNLIEGF 297

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  168 bits (427), Expect = 9e-48
 Identities = 71/296 (23%), Positives = 132/296 (44%), Gaps = 41/296 (13%)

Query: 273 RIGEGGFGTVYKAQL-----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   +        G LVA+K   +    + Q +F  E+++L  +    +VK
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G       +   ++ E++P+G LR+ L  ++   LD ++ L  +  +  G+ YL    
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLG--- 144

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            ++ +HRD+ + NIL+      K+ADFG A+L P+D D   +    +  + +  PE +  
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204

Query: 446 YQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK 504
              + +SDV+SFGV+L E+ T   +                    +      +   P++ 
Sbjct: 205 NIFSRQSDVWSFGVVLYELFTYCDKS-------------CSPSAEFLRMMGCERDVPALS 251

Query: 505 EVISMEILTK-------------MFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS 547
            ++  E+L +             +  L   C AP   DRP   ++G QL  + + S
Sbjct: 252 RLL--ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  167 bits (425), Expect = 1e-47
 Identities = 71/283 (25%), Positives = 122/283 (43%), Gaps = 30/283 (10%)

Query: 273 RIGEGGFGTVYKAQLED-----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
            +GEG FG V     +      G +VA+K  K +     ++ +  E+++L  + H +++K
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G  +        ++ E+VP G+LR++L      ++   Q L  A  +  G+ YLH   
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH--- 151

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            +  IHRD+ + N+LL      K+ DFG A+  P   +   +       V +  PE +K 
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211

Query: 446 YQLTTKSDVYSFGVLLLEILT-GRRP-------VELKRPPEERVTLRWAFKRYNEGNLLD 497
           Y+    SDV+SFGV L E+LT            +EL    + ++T+    +    G  L 
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP 271

Query: 498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
              P   +    E+   M      C     + RP  +++   L
Sbjct: 272 R--P---DKCPAEVYHLM----KNCWETEASFRPTFENLIPIL 305

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  165 bits (421), Expect = 3e-47
 Identities = 71/202 (35%), Positives = 106/202 (52%), Gaps = 13/202 (6%)

Query: 273 RIGEGGFGTVYKAQLEDG-LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + +     L +A  ++  + YL    +K  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 134

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK--VKGTVGYLDPEYMKTYQLT 449
           RD+ + N L+ E+   KVADFG +RL   D+   H   K  +K T     PE +   + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 190

Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
            KSDV++FGVLL EI T G  P
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSP 212

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  166 bits (422), Expect = 4e-47
 Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 9/203 (4%)

Query: 273 RIGEGGFGTVYKAQL----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
            IG G  G V   +L    +  + VAIK  K    E  + +F SE  ++ + DH N+++L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
            G V +G   +I+TE++ NG+L   L    G+     Q + +   V  G+ YL   ++  
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYL---SDLG 171

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            +HRD+ + N+L+  ++  KV+DFG +R+   D D  + +T  K  + +  PE +     
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231

Query: 449 TTKSDVYSFGVLLLEILT-GRRP 470
           ++ SDV+SFGV++ E+L  G RP
Sbjct: 232 SSASDVWSFGVVMWEVLAYGERP 254

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  163 bits (416), Expect = 9e-47
 Identities = 67/202 (33%), Positives = 109/202 (53%), Gaps = 19/202 (9%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
            IG+G FG V       G  VA+K  K +        F +E  +++++ H NLV+LLG +
Sbjct: 28  TIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 333 DKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
            +    L I+TE++  G+L ++L  +    L  +  L+ ++DV   + YL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVH 140

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK--VKGTVGYLDPEYMKTYQLT 449
           RD+ + N+L++E   AKV+DFG  +    ++  T  + K  VK T     PE ++  + +
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTA----PEALREKKFS 192

Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           TKSDV+SFG+LL EI + GR P
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVP 214

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  165 bits (419), Expect = 1e-46
 Identities = 52/204 (25%), Positives = 104/204 (50%), Gaps = 12/204 (5%)

Query: 273 RIGEGGFGTVYKAQLEDG-----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
            +G G FGTVYK           + VAIK  ++        E   E  +++ +D+ ++ +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           LLG     +   +IT+ +P G L +++  ++   +     L   + +A G+ YL    ++
Sbjct: 82  LLGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL---EDR 136

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
           +++HRD+ + N+L+      K+ DFG A+L   + ++ + +   K  + ++  E +    
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMALESILHRI 195

Query: 448 LTTKSDVYSFGVLLLEILT-GRRP 470
            T +SDV+S+GV + E++T G +P
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  169 bits (429), Expect = 2e-46
 Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 9/200 (4%)

Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + +     L +A  ++  + YL    +K  IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 341

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           R++ + N L+ E+   KVADFG +RL  M  D        K  + +  PE +   + + K
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399

Query: 452 SDVYSFGVLLLEILT-GRRP 470
           SDV++FGVLL EI T G  P
Sbjct: 400 SDVWAFGVLLWEIATYGMSP 419

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  164 bits (418), Expect = 2e-46
 Identities = 77/222 (34%), Positives = 112/222 (50%), Gaps = 36/222 (16%)

Query: 273 RIGEGGFGTVYKAQLEDG---LLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKL 328
            IGEG FG V KA+++     +  AIKR K+   ++   +F+ E+E+L K+  H N++ L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91

Query: 329 LGFVDKGNERLIITEFVPNGTLREHL--------------DGQYGKTLDFNQRLEIAIDV 374
           LG  +      +  E+ P+G L + L                    TL   Q L  A DV
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151

Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT 434
           A G+ YL   ++KQ IHRD+ + NIL+ E+  AK+ADFG +R      +       VK T
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQE-----VYVKKT 199

Query: 435 VGYL-----DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
           +G L       E +     TT SDV+S+GVLL EI++ G  P
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  167 bits (426), Expect = 2e-46
 Identities = 67/202 (33%), Positives = 109/202 (53%), Gaps = 19/202 (9%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
            IG+G FG V       G  VA+K  K +        F +E  +++++ H NLV+LLG +
Sbjct: 200 TIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 333 DKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
            +    L I+TE++  G+L ++L  +    L  +  L+ ++DV   + YL        +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVH 312

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK--VKGTVGYLDPEYMKTYQLT 449
           RD+ + N+L++E   AKV+DFG  +    ++  T  + K  VK T     PE ++  + +
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTA----PEALREKKFS 364

Query: 450 TKSDVYSFGVLLLEILT-GRRP 470
           TKSDV+SFG+LL EI + GR P
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP 386

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  163 bits (414), Expect = 2e-46
 Identities = 53/203 (26%), Positives = 103/203 (50%), Gaps = 9/203 (4%)

Query: 272 LRIGEGGFGTVYKAQLEDG---LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           + +G G FG+V +         + VAIK  K+   +    E   E +++ ++D+  +V+L
Sbjct: 16  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           +G   +    +++ E    G L + L G+  + +  +   E+   V+ G+ YL    EK 
Sbjct: 76  IGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            +HRD+ + N+LL     AK++DFG ++    D       +  K  + +  PE +   + 
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190

Query: 449 TTKSDVYSFGVLLLEILT-GRRP 470
           +++SDV+S+GV + E L+ G++P
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  163 bits (414), Expect = 2e-46
 Identities = 72/289 (24%), Positives = 136/289 (47%), Gaps = 26/289 (8%)

Query: 273 RIGEGGFGTVYKAQLE-----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   + +      G +VA+K+ +    E+L+ +F  E+E+L  + H N+VK
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVK 75

Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G       R   +I E++P G+LR++L  ++ + +D  + L+    +  G+ YL    
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLG--- 131

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K+ IHRD+ + NIL+    R K+ DFG  ++ P D +   +    +  + +  PE +  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191

Query: 446 YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD----- 500
            + +  SDV+SFGV+L E+ T     +       R+       +    +L++++      
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 251

Query: 501 --PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS 547
             P   +    EI   M     +C     N RP  + +  ++  IR + 
Sbjct: 252 PRP---DGCPDEIYMIM----TECWNNNVNQRPSFRDLALRVDQIRDNM 293

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  162 bits (412), Expect = 3e-46
 Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 13/201 (6%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
            IG G FG V+     +   VAIK  ++      + +F  E E++ K+ H  LV+L G  
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     ++TEF+ +G L ++L  Q G        L + +DV  G+ YL    E  +IHR
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYL---EEACVIHR 128

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK--VKGTVGYLDPEYMKTYQLTT 450
           D+ + N L+ E+   KV+DFG  R    D   +   TK  VK       PE     + ++
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS----PEVFSFSRYSS 184

Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFGVL+ E+ + G+ P
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIP 205

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  162 bits (413), Expect = 3e-46
 Identities = 59/203 (29%), Positives = 105/203 (51%), Gaps = 11/203 (5%)

Query: 273 RIGEGGFGTVYKAQLEDG---LLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKL 328
            +G G FGTV K   +       VA+K  K E  +  L+ E  +E  ++ ++D+  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           +G  +     +++ E    G L ++L  Q  + +     +E+   V+ G+ YL    E  
Sbjct: 84  IGICEA-ESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL---EESN 137

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            +HRD+ + N+LL     AK++DFG ++    D +     T  K  V +  PE +  Y+ 
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197

Query: 449 TTKSDVYSFGVLLLEILT-GRRP 470
           ++KSDV+SFGVL+ E  + G++P
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKP 220

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  162 bits (412), Expect = 4e-46
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 13/201 (6%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
            +G G FG V   +      VAIK  K+      + EF  E +++  + H  LV+L G  
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            K     IITE++ NG L  +L           Q LE+  DV   + YL     KQ +HR
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHR 144

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK--VKGTVGYLDPEYMKTYQLTT 450
           D+ + N L+ +    KV+DFG +R    D   + + +K  V+ +     PE +   + ++
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP----PEVLMYSKFSS 200

Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSD+++FGVL+ EI + G+ P
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMP 221

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  161 bits (410), Expect = 5e-46
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 13/201 (6%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
            +G G FG V   + +    VA+K  K+      + EF  E + + K+ H  LVK  G  
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            K     I+TE++ NG L  +L   +GK L+ +Q LE+  DV  G+ +L      Q IHR
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK--VKGTVGYLDPEYMKTYQLTT 450
           D+ + N L+   +  KV+DFG  R    D   + + TK  VK +     PE    ++ ++
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA----PEVFHYFKYSS 184

Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV++FG+L+ E+ + G+ P
Sbjct: 185 KSDVWAFGILMWEVFSLGKMP 205

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  162 bits (413), Expect = 7e-46
 Identities = 69/284 (24%), Positives = 130/284 (45%), Gaps = 30/284 (10%)

Query: 273 RIGEGGFGTVYKAQLE-----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G+G FG+V   + +      G +VA+K+ +    E+L+ +F  E+E+L  + H N+VK
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVK 106

Query: 328 LLGFVDKGNER--LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
             G       R   +I E++P G+LR++L  ++ + +D  + L+    +  G+ YL    
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---G 162

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            K+ IHRD+ + NIL+    R K+ DFG  ++ P D +   +    +  + +  PE +  
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 222

Query: 446 YQLTTKSDVYSFGVLLLEILT---------GRRPVELKRPPEERVTLRWAFKRYNEGNLL 496
            + +  SDV+SFGV+L E+ T               +    + ++ +    +       L
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 282

Query: 497 DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
               P   +    EI   M     +C     N RP  + +  ++
Sbjct: 283 PR--P---DGCPDEIYMIM----TECWNNNVNQRPSFRDLALRV 317

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  161 bits (410), Expect = 9e-46
 Identities = 71/254 (27%), Positives = 117/254 (46%), Gaps = 38/254 (14%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG- 330
            IG GGFG V+KA+   DG    IKR K    +  +     EV+ L+K+DH N+V   G 
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER-----EVKALAKLDHVNIVHYNGC 72

Query: 331 FVDKGNERL---------------IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVA 375
           +     +                 I  EF   GTL + ++ + G+ LD    LE+   + 
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132

Query: 376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
            G+ Y+H    K++I+RD+K SNI L ++ + K+ DFG      + +D     T+ KGT+
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--LKNDGKR--TRSKGTL 185

Query: 436 GYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL 495
            Y+ PE + +     + D+Y+ G++L E+L       +     E       F    +G +
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLH------VCDTAFETSKF---FTDLRDGII 236

Query: 496 LDMVDPSIKEVISM 509
            D+ D   K ++  
Sbjct: 237 SDIFDKKEKTLLQK 250

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  161 bits (409), Expect = 1e-45
 Identities = 70/201 (34%), Positives = 109/201 (54%), Gaps = 13/201 (6%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G FG V+         VA+K  K+         F +E  L+ ++ H+ LV+L   V
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++ NG+L + L    G  L  N+ L++A  +A G+ ++    E+  IHR
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHR 133

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK--VKGTVGYLDPEYMKTYQLTT 450
           D++++NIL+++++  K+ADFG ARL   +        K  +K T     PE +     T 
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGTFTI 189

Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFG+LL EI+T GR P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  163 bits (415), Expect = 1e-45
 Identities = 60/203 (29%), Positives = 107/203 (52%), Gaps = 9/203 (4%)

Query: 273 RIGEGGFGTVYKAQL----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
            +G G FG V   +L    +  + VAIK  K    E  + +F  E  ++ + DH N+++L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
            G V K    +I+TE++ NG+L   L     +     Q + +   +A G+ YL   ++  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL---SDMG 167

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            +HRD+ + NIL+  ++  KV+DFG  R+   D +  + +   K  + +  PE +   + 
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227

Query: 449 TTKSDVYSFGVLLLEILT-GRRP 470
           T+ SDV+S+G++L E+++ G RP
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP 250

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  162 bits (412), Expect = 2e-45
 Identities = 66/204 (32%), Positives = 111/204 (54%), Gaps = 10/204 (4%)

Query: 273 RIGEGGFGTVYKAQL-----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
            IG G FG VYK  L     +  + VAIK  K    E  + +F  E  ++ +  H N+++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L G + K    +IITE++ NG L + L  + G+     Q + +   +A G+ YL   A  
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYL---ANM 166

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
             +HRD+ + NIL+  ++  KV+DFG +R+   D + T+ ++  K  + +  PE +   +
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226

Query: 448 LTTKSDVYSFGVLLLEILT-GRRP 470
            T+ SDV+SFG+++ E++T G RP
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERP 250

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  161 bits (409), Expect = 3e-45
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 20/246 (8%)

Query: 230 PSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQ-LE 288
              M+ PP P           +G   L   ++ K         +IG G F  VY+A  L 
Sbjct: 5   SQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEK---------KIGRGQFSEVYRAACLL 55

Query: 289 DGLLVAIKRAKKEQFENLQ--TEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVP 346
           DG+ VA+K+ +     + +   +   E++LL +++H N++K      + NE  I+ E   
Sbjct: 56  DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115

Query: 347 NGTLREHL--DGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES 404
            G L   +    +  + +      +  + +   L ++H    ++++HRD+K +N+ +T +
Sbjct: 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITAT 172

Query: 405 MRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEI 464
              K+ D G  R     S  T   + V GT  Y+ PE +       KSD++S G LL E+
Sbjct: 173 GVVKLGDLGLGRF--FSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 229

Query: 465 LTGRRP 470
              + P
Sbjct: 230 AALQSP 235

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  160 bits (408), Expect = 4e-45
 Identities = 67/232 (28%), Positives = 106/232 (45%), Gaps = 43/232 (18%)

Query: 273 RIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
            +GEG FG V KA             VA+K  K+    +   +  SE  +L +++H +++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHL----------------------DGQYGKTLDF 364
           KL G   +    L+I E+   G+LR  L                      D    + L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 365 NQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR 424
              +  A  ++ G+ YL   AE +++HRD+ + NIL+ E  + K++DFG +R      D 
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR------DV 200

Query: 425 THISTKVKGTVGYL-----DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
               + VK + G +       E +  +  TT+SDV+SFGVLL EI+T G  P
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  160 bits (408), Expect = 4e-45
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 19/213 (8%)

Query: 273 RIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
            +G+G FG VY+         E    VAIK   +      + EF +E  ++ + +  ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHL--------DGQYGKTLDFNQRLEIAIDVAHGL 378
           +LLG V +G   L+I E +  G L+ +L        +         ++ +++A ++A G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YL      + +HRD+ + N ++ E    K+ DFG  R    ++D      K    V ++
Sbjct: 152 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWM 207

Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
            PE +K    TT SDV+SFGV+L EI T   +P
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  161 bits (409), Expect = 5e-45
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 8/199 (4%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFS-SEVELLSKIDHRNLVKLLGF 331
           IGEG FG     +  EDG    IK     +  + + E S  EV +L+ + H N+V+    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
            ++     I+ ++   G L + ++ Q G     +Q L+  + +   L ++H   +++I+H
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILH 148

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+KS NI LT+    ++ DFG AR+  ++S        + GT  YL PE  +      K
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACI-GTPYYLSPEICENKPYNNK 205

Query: 452 SDVYSFGVLLLEILTGRRP 470
           SD+++ G +L E+ T +  
Sbjct: 206 SDIWALGCVLYELCTLKHA 224

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  164 bits (416), Expect = 5e-45
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 13/201 (6%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           ++G G FG V+ A       VA+K  K          F +E  ++  + H  LVKL   V
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            K     IITEF+  G+L + L    G      + ++ +  +A G+ ++    ++  IHR
Sbjct: 253 TK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHR 308

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK--VKGTVGYLDPEYMKTYQLTT 450
           D++++NIL++ S+  K+ADFG AR+   +        K  +K T     PE +     T 
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGSFTI 364

Query: 451 KSDVYSFGVLLLEILT-GRRP 470
           KSDV+SFG+LL+EI+T GR P
Sbjct: 365 KSDVWSFGILLMEIVTYGRIP 385

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  164 bits (416), Expect = 6e-45
 Identities = 67/199 (33%), Positives = 106/199 (53%), Gaps = 9/199 (4%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           ++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L   V
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     I+TE++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +HR
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHR 304

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T KS
Sbjct: 305 DLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362

Query: 453 DVYSFGVLLLEILT-GRRP 470
           DV+SFG+LL E+ T GR P
Sbjct: 363 DVWSFGILLTELTTKGRVP 381

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  159 bits (404), Expect = 1e-44
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 13/206 (6%)

Query: 273 RIGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
            IG+G FG VY  +  D     +  AIK   +         F  E  L+  ++H N++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 329 LGFVDKGNER-LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           +G +        ++  ++ +G L + +     +       +   + VA G+ YL   AE+
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYL---AEQ 143

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT--VGYLDPEYMKT 445
           + +HRD+ + N +L ES   KVADFG AR   +D +   +         V +   E ++T
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARD-ILDREYYSVQQHRHARLPVKWTALESLQT 202

Query: 446 YQLTTKSDVYSFGVLLLEILT-GRRP 470
           Y+ TTKSDV+SFGVLL E+LT G  P
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAPP 228

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  158 bits (403), Expect = 1e-44
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 11/204 (5%)

Query: 274 IGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY   L D     +  A+K   +       ++F +E  ++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92

Query: 330 GFV-DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           G         L++  ++ +G LR  +  +          +   + VA G+ YL   A K+
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYL---ASKK 148

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            +HRD+ + N +L E    KVADFG AR +   +    H  T  K  V ++  E ++T +
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 208

Query: 448 LTTKSDVYSFGVLLLEILT-GRRP 470
            TTKSDV+SFGVLL E++T G  P
Sbjct: 209 FTTKSDVWSFGVLLWELMTRGAPP 232

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  159 bits (405), Expect = 1e-44
 Identities = 71/227 (31%), Positives = 109/227 (48%), Gaps = 38/227 (16%)

Query: 273 RIGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHR 323
            +GEG FG V  A+         ++ + VA+K  K +  E   ++  SE+E++  I  H+
Sbjct: 42  PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101

Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHL--------------DGQYGKTLDFNQRLE 369
           N++ LLG   +     +I E+   G LRE+L              +    + + F   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161

Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
               +A G+ YL   A ++ IHRD+ + N+L+TE+   K+ADFG AR      D  +I  
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDY 212

Query: 430 KVKGTVGYL-----DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
             K T G L      PE +     T +SDV+SFGVL+ EI T G  P
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  158 bits (403), Expect = 2e-44
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 19/213 (8%)

Query: 273 RIGEGGFGTVYKAQLEDG----LLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVK 327
            +GEG FG+V +  L+      L VA+K  K +   +    EF SE   +    H N+++
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100

Query: 328 LLGFVDKGN-----ERLIITEFVPNGTLREHL----DGQYGKTLDFNQRLEIAIDVAHGL 378
           LLG   + +     + ++I  F+  G L  +L         K +     L+  +D+A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YL   + +  +HRD+ + N +L + M   VADFG ++      D        K  V ++
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK-IYSGDYYRQGRIAKMPVKWI 216

Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
             E +     T+KSDV++FGV + EI T G  P
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  158 bits (403), Expect = 2e-44
 Identities = 68/226 (30%), Positives = 96/226 (42%), Gaps = 37/226 (16%)

Query: 273 RIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNL 325
            +G G FG V +A             VA+K  K+    +      SE+++L  I  H N+
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93

Query: 326 VKLLGFV-DKGNERLIITEFVPNGTLREHL--------------DGQYGKTLDFNQRLEI 370
           V LLG     G   ++I EF   G L  +L              +  Y   L     +  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153

Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
           +  VA G+ +L   A ++ IHRD+ + NILL+E    K+ DFG AR      D       
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR------DIYKDPDY 204

Query: 431 VKGTVGYL-----DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
           V+     L      PE +     T +SDV+SFGVLL EI + G  P
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  159 bits (405), Expect = 3e-44
 Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 21/292 (7%)

Query: 195 TAHTVLARDPNSMDSASSLDVNSGSEKVSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSV 254
             H    R  +          + G + +   +++  S  +   S + +        I   
Sbjct: 10  HHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLS 69

Query: 255 HLNMSQVVKATRNFSPSLR---------IGEGGFGTVYKAQLEDG----LLVAIKRAKKE 301
            LN  ++V+A ++               IG G FG VY   L D     +  A+K   + 
Sbjct: 70  ALN-PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 128

Query: 302 QFENLQTEFSSEVELLSKIDHRNLVKLLGFV-DKGNERLIITEFVPNGTLREHLDGQYGK 360
                 ++F +E  ++    H N++ LLG         L++  ++ +G LR  +      
Sbjct: 129 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETH 187

Query: 361 TLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGP 419
                  +   + VA G+ +L   A K+ +HRD+ + N +L E    KVADFG AR +  
Sbjct: 188 NPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244

Query: 420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
            + D  H  T  K  V ++  E ++T + TTKSDV+SFGVLL E++T G  P
Sbjct: 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  159 bits (405), Expect = 3e-44
 Identities = 71/227 (31%), Positives = 109/227 (48%), Gaps = 38/227 (16%)

Query: 273 RIGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHR 323
            +GEG FG V  A+         ++ + VA+K  K +  E   ++  SE+E++  I  H+
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHL--------------DGQYGKTLDFNQRLE 369
           N++ LLG   +     +I E+   G LRE+L              +    + + F   + 
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207

Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
               +A G+ YL   A ++ IHRD+ + N+L+TE+   K+ADFG AR      D  +I  
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDY 258

Query: 430 KVKGTVGYL-----DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
             K T G L      PE +     T +SDV+SFGVL+ EI T G  P
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  157 bits (399), Expect = 4e-44
 Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 33/223 (14%)

Query: 273 RIGEGGFGTVYKAQLEDGL------LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
            +GE  FG VYK  L           VAIK  K +    L+ EF  E  L +++ H N+V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHL--------------DGQYGKTLDFNQRLEIAI 372
            LLG V K     +I  +  +G L E L              D      L+    + +  
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135

Query: 373 DVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD--RTHISTK 430
            +A G+ YL   +   ++H+D+ + N+L+ + +  K++D G  R     +D  +   ++ 
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE-VYAADYYKLLGNSL 191

Query: 431 --VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
             ++       PE +   + +  SD++S+GV+L E+ + G +P
Sbjct: 192 LPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  158 bits (402), Expect = 4e-44
 Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 19/213 (8%)

Query: 273 RIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
            +G G FG VY+ Q+         L VA+K   +   E  + +F  E  ++SK +H+N+V
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHL-----DGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           + +G   +   R I+ E +  G L+  L           +L     L +A D+A G  YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 382 HLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
               E   IHRD+ + N LLT       AK+ DFG AR     +            V ++
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-DIYRASYYRKGGCAMLPVKWM 212

Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
            PE       T+K+D +SFGVLL EI + G  P
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  163 bits (414), Expect = 4e-44
 Identities = 67/199 (33%), Positives = 106/199 (53%), Gaps = 9/199 (4%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           ++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L   V
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     I+TE++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +HR
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHR 387

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T KS
Sbjct: 388 DLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445

Query: 453 DVYSFGVLLLEILT-GRRP 470
           DV+SFG+LL E+ T GR P
Sbjct: 446 DVWSFGILLTELTTKGRVP 464

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  157 bits (399), Expect = 4e-44
 Identities = 67/219 (30%), Positives = 112/219 (51%), Gaps = 26/219 (11%)

Query: 273 RIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
            +GEG FG V+ A+       +D +LVA+K A K+     + +F  E ELL+ + H ++V
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVK-ALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHL--------------DGQYGKTLDFNQRLEIAI 372
           K  G    G+  +++ E++ +G L + L                Q    L  +Q L IA 
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 373 DVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK 432
            +A G+ YL   A +  +HRD+ + N L+  ++  K+ DFG +R     +D   +     
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD-VYSTDYYRVGGHTM 196

Query: 433 GTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
             + ++ PE +   + TT+SDV+SFGV+L EI T G++P
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  158 bits (401), Expect = 4e-44
 Identities = 52/204 (25%), Positives = 104/204 (50%), Gaps = 12/204 (5%)

Query: 273 RIGEGGFGTVYKAQLEDG-----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
            +G G FGTVYK           + VAIK  ++        E   E  +++ +D+ ++ +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           LLG     +   +IT+ +P G L +++  ++   +     L   + +A G+ YL    ++
Sbjct: 82  LLGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL---EDR 136

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
           +++HRD+ + N+L+      K+ DFG A+L   + ++ + +   K  + ++  E +    
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMALESILHRI 195

Query: 448 LTTKSDVYSFGVLLLEILT-GRRP 470
            T +SDV+S+GV + E++T G +P
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  157 bits (398), Expect = 5e-44
 Identities = 68/270 (25%), Positives = 113/270 (41%), Gaps = 38/270 (14%)

Query: 273 RIGEGGFGTVYKA-QLEDGLLVAIKRAK-KEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            IG G F TVYK    E  + VA    + ++  ++ +  F  E E+L  + H N+V+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 331 F---VDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
                 KG + + ++TE + +GTL+ +L  +  K +           +  GL +LH    
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLH-TRT 149

Query: 387 KQIIHRDVKSSNILLT-ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
             IIHRD+K  NI +T  +   K+ D G A L      +      V GT  ++ PE  + 
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-----VIGTPEFMAPEMYEE 204

Query: 446 YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN----LLDMVDP 501
            +     DVY+FG+ +LE+ T       + P  E       ++R   G        +  P
Sbjct: 205 -KYDESVDVYAFGMCMLEMATS------EYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257

Query: 502 SIKEVISMEILTKMFGLAIQCAAPIRNDRP 531
            +KE+I              C    +++R 
Sbjct: 258 EVKEIIE------------GCIRQNKDERY 275

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  157 bits (400), Expect = 7e-44
 Identities = 69/223 (30%), Positives = 97/223 (43%), Gaps = 34/223 (15%)

Query: 273 RIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNL 325
            +G G FG V +A        +  L VA+K  K     + +    SE++++S +  H N+
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHL------------DGQYGKTLDFNQRLEIAID 373
           V LLG    G   L+ITE+   G L   L                  T      L  +  
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172

Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
           VA G+ +L   A K  IHRDV + N+LLT    AK+ DFG AR      D  + S  +  
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR------DIMNDSNYIVK 223

Query: 434 TVGYL-----DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
               L      PE +     T +SDV+S+G+LL EI + G  P
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  156 bits (396), Expect = 7e-44
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 12/203 (5%)

Query: 273 RIGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
            IGEG FG V++          L VAIK  K    ++++ +F  E   + + DH ++VKL
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           +G + + N   II E    G LR  L  +    LD    +  A  ++  L YL     K+
Sbjct: 82  IGVITE-NPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYL---ESKR 136

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            +HRD+ + N+L++ +   K+ DFG +R   M+    + ++K K  + ++ PE +   + 
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRF 194

Query: 449 TTKSDVYSFGVLLLEILT-GRRP 470
           T+ SDV+ FGV + EIL  G +P
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  157 bits (399), Expect = 7e-44
 Identities = 68/227 (29%), Positives = 96/227 (42%), Gaps = 38/227 (16%)

Query: 273 RIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNL 325
            +G G FG V +A        +  + VA+K  K       +    SE+++LS + +H N+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHL----------------DGQYGKTLDFNQRLE 369
           V LLG    G   L+ITE+   G L   L                       LD    L 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
            +  VA G+ +L   A K  IHRD+ + NILLT     K+ DFG AR      D  + S 
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR------DIKNDSN 200

Query: 430 KVKGTVGYL-----DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
            V      L      PE +     T +SDV+S+G+ L E+ + G  P
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  157 bits (399), Expect = 8e-44
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 20/214 (9%)

Query: 273 RIGEGGFGTVYKAQLEDG----LLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVK 327
            +G+G FG+V +AQL+      + VA+K  K +    +   EF  E   + + DH ++ K
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89

Query: 328 LLGFVDKGNER------LIITEFVPNGTLREHL----DGQYGKTLDFNQRLEIAIDVAHG 377
           L+G   +   +      ++I  F+ +G L   L     G+    L     +   +D+A G
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY 437
           + YL   + +  IHRD+ + N +L E M   VADFG +R      D        K  V +
Sbjct: 150 MEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK-IYSGDYYRQGCASKLPVKW 205

Query: 438 LDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
           L  E +     T  SDV++FGV + EI+T G+ P
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  157 bits (399), Expect = 1e-43
 Identities = 68/218 (31%), Positives = 112/218 (51%), Gaps = 25/218 (11%)

Query: 273 RIGEGGFGTVYKAQLEDGL------LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
            +GEG FG V+ A+  + L      LVA+K A KE  E+ + +F  E ELL+ + H+++V
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVK-ALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHL-------------DGQYGKTLDFNQRLEIAID 373
           +  G   +G   L++ E++ +G L   L             +      L   Q L +A  
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKG 433
           VA G+ YL   A    +HRD+ + N L+ + +  K+ DFG +R     +D   +  +   
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD-IYSTDYYRVGGRTML 222

Query: 434 TVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
            + ++ PE +   + TT+SDV+SFGV+L EI T G++P
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  155 bits (395), Expect = 1e-43
 Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 11/206 (5%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLG 330
            IG G +G   K +   DG ++  K        E  +    SEV LL ++ H N+V+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 331 -FVDKGNERL-IITEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLH--LY 384
             +D+ N  L I+ E+   G L   +    +  + LD    L +   +   L   H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
               ++HRD+K +N+ L      K+ DFG AR+  ++ D +   T V GT  Y+ PE M 
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFV-GTPYYMSPEQMN 189

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRP 470
                 KSD++S G LL E+     P
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPP 215

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  157 bits (398), Expect = 1e-43
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 12/204 (5%)

Query: 273 RIGEGGFGTVYKAQLEDG-----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
            +G G FGTV+K           + V IK  + +         +  +  +  +DH ++V+
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           LLG    G+   ++T+++P G+L +H+  Q+   L     L   + +A G+ YL    E 
Sbjct: 80  LLGLC-PGSSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYL---EEH 134

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            ++HR++ + N+LL    + +VADFG A L P D D+  + ++ K  + ++  E +   +
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-DKQLLYSEAKTPIKWMALESIHFGK 193

Query: 448 LTTKSDVYSFGVLLLEILT-GRRP 470
            T +SDV+S+GV + E++T G  P
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAEP 217

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  155 bits (395), Expect = 1e-43
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 12/205 (5%)

Query: 273 RIGEGGFGTVYKAQL----EDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLV 326
           ++G+G FG V + +        + VA+K  K +         +F  EV  +  +DHRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           +L G V       ++TE  P G+L + L  ++            A+ VA G+ YL     
Sbjct: 85  RLYGVV-LTPPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYL---ES 139

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K+ IHRD+ + N+LL      K+ DFG  R  P + D   +    K    +  PE +KT 
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199

Query: 447 QLTTKSDVYSFGVLLLEILT-GRRP 470
             +  SD + FGV L E+ T G+ P
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP 224

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  157 bits (400), Expect = 1e-43
 Identities = 69/218 (31%), Positives = 97/218 (44%), Gaps = 29/218 (13%)

Query: 273 RIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
            +G G FG VY+ Q+         L VA+K   +   E  + +F  E  ++SK +H+N+V
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHL-----DGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           + +G   +   R I+ E +  G L+  L           +L     L +A D+A G  YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 382 HLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
               E   IHRD+ + N LLT       AK+ DFG AR      D        KG    L
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRAGYYRKGGCAML 248

Query: 439 -----DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
                 PE       T+K+D +SFGVLL EI + G  P
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  157 bits (398), Expect = 2e-43
 Identities = 68/232 (29%), Positives = 110/232 (47%), Gaps = 43/232 (18%)

Query: 273 RIGEGGFGTVYKAQLEDGL------LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
            IGEG FG V++A+    L      +VA+K  K+E   ++Q +F  E  L+++ D+ N+V
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHL----------------------DGQYGKTLDF 364
           KLLG    G    ++ E++  G L E L                             L  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173

Query: 365 NQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR 424
            ++L IA  VA G+ YL   +E++ +HRD+ + N L+ E+M  K+ADFG +R      + 
Sbjct: 174 AEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR------NI 224

Query: 425 THISTKVKGTVGYL-----DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
                        +      PE +   + TT+SDV+++GV+L EI + G +P
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  154 bits (392), Expect = 3e-43
 Identities = 56/203 (27%), Positives = 104/203 (51%), Gaps = 12/203 (5%)

Query: 273 RIGEGGFGTVYKAQL----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
            +GEG FG VY+        + + VA+K  KK+   + + +F SE  ++  +DH ++VKL
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           +G +++     II E  P G L  +L+     +L     +  ++ +   + YL       
Sbjct: 79  IGIIEE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYL---ESIN 133

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            +HRD+   NIL+      K+ DFG +R   ++ +  + ++  +  + ++ PE +   + 
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKASVTRLPIKWMSPESINFRRF 191

Query: 449 TTKSDVYSFGVLLLEILT-GRRP 470
           TT SDV+ F V + EIL+ G++P
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP 214

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  161 bits (409), Expect = 5e-43
 Identities = 61/277 (22%), Positives = 119/277 (42%), Gaps = 15/277 (5%)

Query: 204 PNSMDSASSLDVNSGSEKVSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVK 263
           P      S+L           +D   P P R+        M    +   S   +  ++  
Sbjct: 268 PTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKD 327

Query: 264 ATRNFSPS------LRIGEGGFGTVYKAQLEDG---LLVAIKRAKKEQFENLQTEFSSEV 314
                         + +G G FG+V +         + VAIK  K+   +    E   E 
Sbjct: 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 387

Query: 315 ELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           +++ ++D+  +V+L+G   +    +++ E    G L + L G+  + +  +   E+   V
Sbjct: 388 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQV 445

Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT 434
           + G+ YL    EK  +HR++ + N+LL     AK++DFG ++    D       +  K  
Sbjct: 446 SMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502

Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
           + +  PE +   + +++SDV+S+GV + E L+ G++P
Sbjct: 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  156 bits (397), Expect = 6e-43
 Identities = 76/227 (33%), Positives = 104/227 (45%), Gaps = 38/227 (16%)

Query: 273 RIGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHR 323
            +GEG FG V  A+              VA+K  K +  E   ++  SE+E++  I  H+
Sbjct: 76  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135

Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHL--------------DGQYGKTLDFNQRLE 369
           N++ LLG   +     +I E+   G LRE+L                   + L     + 
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195

Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
            A  VA G+ YL   A K+ IHRD+ + N+L+TE    K+ADFG AR      D  HI  
Sbjct: 196 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 246

Query: 430 KVKGTVGYL-----DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
             K T G L      PE +     T +SDV+SFGVLL EI T G  P
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  155 bits (393), Expect = 8e-43
 Identities = 63/232 (27%), Positives = 96/232 (41%), Gaps = 43/232 (18%)

Query: 273 RIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNL 325
            +G G FG V  A           + VA+K  K++   + +    SE+++++++  H N+
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111

Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHL---------------------DGQYGKTLDF 364
           V LLG         +I E+   G L  +L                     + +    L F
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171

Query: 365 NQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR 424
              L  A  VA G+ +L     K  +HRD+ + N+L+T     K+ DFG AR      D 
Sbjct: 172 EDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR------DI 222

Query: 425 THISTKVKGTVGYL-----DPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
              S  V      L      PE +     T KSDV+S+G+LL EI + G  P
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  153 bits (388), Expect = 4e-42
 Identities = 64/266 (24%), Positives = 110/266 (41%), Gaps = 18/266 (6%)

Query: 209 SASSLDVNSGSEKVSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNF 268
           S SS   +S +              R+ P            ++  V     +        
Sbjct: 4   SVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYRE---EVHWM 60

Query: 269 SPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +   R+G G FG V++ +  + G   A+K+ + E F         E+   + +    +V 
Sbjct: 61  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVP 114

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L G V +G    I  E +  G+L + +  Q G  L  ++ L        GL YLH    +
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIK-QMGC-LPEDRALYYLGQALEGLEYLH---TR 169

Query: 388 QIIHRDVKSSNILLTES-MRAKVADFGFA-RLGPMDSDRTHISTK-VKGTVGYLDPEYMK 444
           +I+H DVK+ N+LL+    RA + DFG A  L P    ++ ++   + GT  ++ PE + 
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRP 470
                 K D++S   ++L +L G  P
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHP 255

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  152 bits (385), Expect = 6e-42
 Identities = 61/299 (20%), Positives = 124/299 (41%), Gaps = 40/299 (13%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKR---AKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           ++GEGGF  V   + L DG   A+KR    +++  E  Q E     ++    +H N+++L
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE----ADMHRLFNHPNILRL 91

Query: 329 LGF----VDKGNERLIITEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLH 382
           + +        +E  ++  F   GTL   ++     G  L  +Q L + + +  GL  +H
Sbjct: 92  VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151

Query: 383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK------GTVG 436
               K   HRD+K +NILL +  +  + D G      +  + +  +  ++       T+ 
Sbjct: 152 ---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208

Query: 437 YLDPEYMKTYQ---LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG 493
           Y  PE         +  ++DV+S G +L  ++ G  P ++     + V L    +     
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQ 268

Query: 494 NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKSVK 552
           +       ++ ++++  ++T           P  + RP +  +  QL A++  +     
Sbjct: 269 S--PRHSSALWQLLNS-MMTV---------DP--HQRPHIPLLLSQLEALQPPAPGQHT 313

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  150 bits (382), Expect = 8e-42
 Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 34/218 (15%)

Query: 273 RIGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRN 324
            +G+G F  ++K                V +K   K    N    F     ++SK+ H++
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKH 73

Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LV   G    G+E +++ EFV  G+L  +L  +    ++   +LE+A  +A  + +L   
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL--- 129

Query: 385 AEKQIIHRDVKSSNILLT--------ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG 436
            E  +IH +V + NILL              K++D G +    +  D      ++     
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-VLPKDILQE--RIPWVP- 185

Query: 437 YLDPE---YMKTYQLTTKSDVYSFGVLLLEILT-GRRP 470
              PE     K       +D +SFG  L EI + G +P
Sbjct: 186 ---PECIENPKNL--NLATDKWSFGTTLWEICSGGDKP 218

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  150 bits (380), Expect = 2e-41
 Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)

Query: 273 RIGEGGFGTVYKAQLEDGLL---VAIK--RAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           ++G GG  TVY A  ED +L   VAIK       + E     F  EV   S++ H+N+V 
Sbjct: 18  KLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           ++   ++ +   ++ E++   TL E+++  +G  L  +  +     +  G+ + H   + 
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGP-LSVDTAINFTNQILDGIKHAH---DM 130

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
           +I+HRD+K  NIL+  +   K+ DFG A+    ++  T  +  V GTV Y  PE  K   
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNH-VLGTVQYFSPEQAKGEA 188

Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
               +D+YS G++L E+L G  P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  150 bits (381), Expect = 2e-41
 Identities = 65/271 (23%), Positives = 108/271 (39%), Gaps = 32/271 (11%)

Query: 209 SASSLDVNSGSEKVSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNF 268
            +S +D+ + +       ++ P  +      S    SP  +                  F
Sbjct: 7   HSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQS-------F 59

Query: 269 SPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAK------KEQFENLQTEFSSEVELLSKI- 320
               R+G G +G V+K +  EDG L A+KR+       K++   L      EV    K+ 
Sbjct: 60  QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA-----EVGSHEKVG 114

Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
            H   V+L    ++G    + TE     +L++H +  +G +L   Q      D    L +
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCE-AWGASLPEAQVWGYLRDTLLALAH 172

Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLD 439
           LH    + ++H DVK +NI L    R K+ DFG    LG   +          G   Y+ 
Sbjct: 173 LH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-----GDPRYMA 224

Query: 440 PEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           PE ++     T +DV+S G+ +LE+      
Sbjct: 225 PELLQG-SYGTAADVFSLGLTILEVACNMEL 254

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  156 bits (395), Expect = 5e-41
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 12/203 (5%)

Query: 273 RIGEGGFGTVYKAQLEDG----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
            IGEG FG V++          + VAIK  K    ++++ +F  E   + + DH ++VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           +G + + N   II E    G LR  L      +LD    +  A  ++  L YL     K+
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYL---ESKR 511

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            +HRD+ + N+L++ +   K+ DFG +R   M+    + ++K K  + ++ PE +   + 
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRF 569

Query: 449 TTKSDVYSFGVLLLEILT-GRRP 470
           T+ SDV+ FGV + EIL  G +P
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKP 592

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  148 bits (377), Expect = 8e-41
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 16/207 (7%)

Query: 273 RIGEGGFGTVYKAQLEDGLL---VAIK--RAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
            +G GG   V+ A+  D      VA+K  RA   +  +    F  E +  + ++H  +V 
Sbjct: 19  ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 328 LL--GFVDKGNERL--IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
           +   G  +     L  I+ E+V   TLR+ +    G  +   + +E+  D    L + H 
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGP-MTPKRAIEVIADACQALNFSH- 133

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
             +  IIHRDVK +NI+++ +   KV DFG AR      +    +  V GT  YL PE  
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191

Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +   +  +SDVYS G +L E+LTG  P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  147 bits (373), Expect = 2e-40
 Identities = 62/279 (22%), Positives = 110/279 (39%), Gaps = 38/279 (13%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG- 330
            +G GGFG V++A+   D    AIKR +    E  + +   EV+ L+K++H  +V+    
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 331 FVDKGNERL-----------IITEFVPNGTLREHLDGQYGKT-LDFNQRLEIAIDVAHGL 378
           +++K                I  +      L++ ++G+      + +  L I + +A  +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIS---------T 429
            +LH    K ++HRD+K SNI  T     KV DFG       D +   +          T
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188

Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-----GRRPVELKRPPEERVTLR 484
              GT  Y+ PE +     + K D++S G++L E+L        R   L      +    
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPL 248

Query: 485 WAFKRYNEGNLLDM---VD----PSIKEVISMEILTKMF 516
           +  K   E  ++           P    +I   +   + 
Sbjct: 249 FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  143 bits (364), Expect = 3e-39
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 16/204 (7%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G+G +G VY    L + + +AIK   +      Q     E+ L   + H+N+V+ LG  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGSF 88

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI---DVAHGLTYLHLYAEKQI 389
            +     I  E VP G+L   L  ++G  L  N++  I      +  GL YLH   + QI
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGP-LKDNEQT-IGFYTKQILEGLKYLH---DNQI 143

Query: 390 IHRDVKSSNILL-TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE--YMKTY 446
           +HRD+K  N+L+ T S   K++DFG ++   +        T   GT+ Y+ PE       
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTET-FTGTLQYMAPEIIDKGPR 200

Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
                +D++S G  ++E+ TG+ P
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPP 224

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  143 bits (362), Expect = 7e-39
 Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 32/221 (14%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG- 330
            +G+G FG V KA+   D    AIK+ +    E   +   SEV LL+ ++H+ +V+    
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAA 70

Query: 331 FVDKGNERL------------IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGL 378
           ++++ N               I  E+  NGTL + +          ++   +   +   L
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWRLFRQILEAL 129

Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIS---------- 428
           +Y+H    + IIHRD+K  NI + ES   K+ DFG A+      D   +           
Sbjct: 130 SYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186

Query: 429 -TKVKGTVGYLDPEYMK-TYQLTTKSDVYSFGVLLLEILTG 467
            T   GT  Y+  E +  T     K D+YS G++  E++  
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  143 bits (362), Expect = 9e-39
 Identities = 52/203 (25%), Positives = 80/203 (39%), Gaps = 14/203 (6%)

Query: 273 RIGEGGFGTVYKAQLEDGLL---VAIK--RAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
            +G GG G VY+A  ED +    VA+K            +T    E     ++   ++V 
Sbjct: 41  LVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           +  F +   +  +    +    L   L  Q    L   + + I   +   L   H     
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAH---AA 153

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
              HRDVK  NIL++    A + DFG A     D   T +     GT+ Y+ PE      
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGN-TVGTLYYMAPERFSESH 211

Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
            T ++D+Y+   +L E LTG  P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  144 bits (364), Expect = 1e-38
 Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 22/211 (10%)

Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNL--VKLLG 330
           IG GG   V++   E   + AIK    E+ +N   + + +E+  L+K+   +   ++L  
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           +        ++ E   N  L   L  +  K++D  +R     ++   +  +H   +  I+
Sbjct: 77  YEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 130

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE--------- 441
           H D+K +N L+ + M  K+ DFG A     D+      +   GTV Y+ PE         
Sbjct: 131 HSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEAIKDMSSSR 188

Query: 442 --YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
                  +++ KSDV+S G +L  +  G+ P
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  149 bits (377), Expect = 2e-38
 Identities = 50/222 (22%), Positives = 96/222 (43%), Gaps = 26/222 (11%)

Query: 273 RIGEGGFGTVYKA--QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            I  GG G +Y A  +  +G  V +K          Q    +E + L+++ H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 331 FVDKGNERL-----IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           FV+  +        I+ E+V   +L+     +    L   + +   +++   L+YLH   
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLH--- 199

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
              +++ D+K  NI+LTE  + K+ D G      ++S        + GT G+  PE ++T
Sbjct: 200 SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINSFGY-----LYGTPGFQAPEIVRT 251

Query: 446 YQLTTKSDVYSFGVLLLEILTGRRP---VELKRPPEERVTLR 484
              T  +D+Y+ G  L  +           +   PE+   L+
Sbjct: 252 -GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK 292

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  142 bits (360), Expect = 2e-38
 Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 22/211 (10%)

Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNL--VKLLG 330
           IG GG   V++   E   + AIK    E+ +N   + + +E+  L+K+   +   ++L  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           +        ++ E   N  L   L  +  K++D  +R     ++   +  +H   +  I+
Sbjct: 96  YEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 149

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE--------- 441
           H D+K +N L+ + M  K+ DFG A     D+      +   GTV Y+ PE         
Sbjct: 150 HSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEAIKDMSSSR 207

Query: 442 --YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
                  +++ KSDV+S G +L  +  G+ P
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  143 bits (363), Expect = 3e-38
 Identities = 62/282 (21%), Positives = 112/282 (39%), Gaps = 33/282 (11%)

Query: 205 NSMDSASSLDVNSGSEKVSGADKVPPSPMRVPPSPS--RFTMSPKLNRIGSVHLNMSQVV 262
           +    +S L       K + A K     M  P   +      S   N   SV   +  ++
Sbjct: 2   HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61

Query: 263 KATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKID 321
           K         +IG GG   V++   E   + AIK    E+ +N   + + +E+  L+K+ 
Sbjct: 62  K---------QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 112

Query: 322 HRNL--VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLT 379
             +   ++L  +        ++ E   N  L   L  +  K++D  +R     ++   + 
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERKSYWKNMLEAVH 169

Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLD 439
            +H   +  I+H D+K +N L+ + M  K+ DFG A     D+      +   G V Y+ 
Sbjct: 170 TIH---QHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDS-QVGAVNYMP 224

Query: 440 PE-----------YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           PE                +++ KSDV+S G +L  +  G+ P
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  140 bits (355), Expect = 1e-37
 Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 25/215 (11%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
            +G+G    V++ +  + G L AIK      F         E E+L K++H+N+VKL   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 332 VDKGNERLI--ITEFVPNGTLREHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHLYAEK 387
            ++   R    I EF P G+L   L+ +        +   L +  DV  G+ +L    E 
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131

Query: 388 QIIHRDVKSSNILLT----ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
            I+HR++K  NI+           K+ DFG AR   ++ D     +   GT  YL P+  
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDD-EQFVSLY-GTEEYLHPDMY 187

Query: 444 KTYQLTT--------KSDVYSFGVLLLEILTGRRP 470
           +   L            D++S GV      TG  P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  139 bits (353), Expect = 9e-37
 Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 25/214 (11%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G+G    V++ +  + G L AIK      F         E E+L K++H+N+VKL    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76

Query: 333 DKGNERLI--ITEFVPNGTLREHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHLYAEKQ 388
           ++   R    I EF P G+L   L+ +        +   L +  DV  G+ +L    E  
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 389 IIHRDVKSSNILLT----ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
           I+HR++K  NI+           K+ DFG AR   ++ D     +   GT  YL P+  +
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDD-EQFVSLY-GTEEYLHPDMYE 188

Query: 445 TYQLTT--------KSDVYSFGVLLLEILTGRRP 470
              L            D++S GV      TG  P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  133 bits (337), Expect = 2e-35
 Identities = 46/224 (20%), Positives = 91/224 (40%), Gaps = 37/224 (16%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS--EVELLSKI-DHRNLVKL 328
           +IG G FG+V+K     DG + AIKR+KK        E ++  EV   + +  H ++V+ 
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKP-LAGSVDEQNALREVYAHAVLGQHSHVVRY 76

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
                + +  LI  E+   G+L + +    +        +  ++ + V  GL Y+H    
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133

Query: 387 KQIIHRDVKSSNILLTES-------------------MRAKVADFGFARLGPMDSDRTHI 427
             ++H D+K SNI ++ +                   +  K+ D G      + S +   
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR--ISSPQV-- 189

Query: 428 STKVKGTVGYLDPEYMK-TYQLTTKSDVYSFGVLLLEILTGRRP 470
               +G   +L  E ++  Y    K+D+++  + ++        
Sbjct: 190 ---EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  139 bits (352), Expect = 3e-35
 Identities = 65/220 (29%), Positives = 109/220 (49%), Gaps = 20/220 (9%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           R+G GGFG V +    + G  VAIK+ ++E     +  +  E++++ K++H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 332 VD------KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHL 383
            D        +  L+  E+   G LR++L+ Q+       +     +  D++  L YLH 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDISSALRYLH- 138

Query: 384 YAEKQIIHRDVKSSNILL---TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
             E +IIHRD+K  NI+L    + +  K+ D G+A+   +D     + T+  GT+ YL P
Sbjct: 139 --ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQG--ELCTEFVGTLQYLAP 192

Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEER 480
           E ++  + T   D +SFG L  E +TG RP      P + 
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 232

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  136 bits (344), Expect = 3e-35
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 18/213 (8%)

Query: 267 NFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNL 325
           +F P   +G G  GT+    + D   VA+KR   E F         EV+LL + D H N+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD----REVQLLRESDEHPNV 80

Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           ++          + I  E     TL+E+++ Q        + + +      GL +LH   
Sbjct: 81  IRYFCTEKDRQFQYIAIELCA-ATLQEYVE-QKDFAHLGLEPITLLQQTTSGLAHLH--- 135

Query: 386 EKQIIHRDVKSSNILLTES-----MRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
              I+HRD+K  NIL++       ++A ++DFG  +   +        + V GT G++ P
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 441 EYMK---TYQLTTKSDVYSFGVLLLEILTGRRP 470
           E +        T   D++S G +   +++    
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  128 bits (325), Expect = 8e-34
 Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 15/201 (7%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTE--FSSEVELLSKIDHRNLVKLLG 330
           +G+G FG VY A+  +   ++A+K   K Q E    E     EVE+ S + H N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 331 -FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D     LI+ E+ P GT+   L  Q     D  +      ++A+ L+Y H    K++
Sbjct: 77  YFHDATRVYLIL-EYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH---SKRV 130

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           IHRD+K  N+LL  +   K+ADFG++   P           + GT+ YL PE ++     
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLPPEMIEGRMHD 185

Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            K D++S GVL  E L G+ P
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPP 206

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  127 bits (322), Expect = 2e-33
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 28/209 (13%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G F  VY+A+ +  GL VAIK   K+      +     +EV++  ++ H ++++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLD-------FNQRLEIAIDVAHGLTYLHL 383
           + +  N   ++ E   NG +  +L  +  K           +Q       +  G+ YLH 
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQ-------IITGMLYLH- 129

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
                I+HRD+  SN+LLT +M  K+ADFG A    M  ++ +      GT  Y+ PE  
Sbjct: 130 --SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYISPEIA 184

Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGRRP 470
               +    +SDV+S G +   +L GR P
Sbjct: 185 TRSAH--GLESDVWSLGCMFYTLLIGRPP 211

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  129 bits (325), Expect = 2e-33
 Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 24/219 (10%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGF 331
           + EGGF  VY+AQ +  G   A+KR    + E  +     EV  + K+  H N+V+    
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR-AIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 332 -------VDKGNERLIITEFVPNGTLREHLDGQYGKT-LDFNQRLEIAIDVAHGLTYLHL 383
                   D G    ++   +  G L E L     +  L  +  L+I       + ++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK---------GT 434
             +  IIHRD+K  N+LL+     K+ DFG A       D +  + +            T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 435 VGYLDPEYMKTYQ---LTTKSDVYSFGVLLLEILTGRRP 470
             Y  PE +  Y    +  K D+++ G +L  +   + P
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  125 bits (317), Expect = 1e-32
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 23/213 (10%)

Query: 273 RIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG- 330
            IG G    V  A        VAIKR   E+ +    E   E++ +S+  H N+V     
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE---IAI---DVAHGLTYLHLY 384
           FV   +E  ++ + +  G++ + +     K    +  L+   IA    +V  GL YLH  
Sbjct: 82  FV-VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-- 138

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT-VG---YLDP 440
            +   IHRDVK+ NILL E    ++ADFG +    + +       KV+ T VG   ++ P
Sbjct: 139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVS--AFLATGGDITRNKVRKTFVGTPCWMAP 195

Query: 441 EYM---KTYQLTTKSDVYSFGVLLLEILTGRRP 470
           E M   + Y    K+D++SFG+  +E+ TG  P
Sbjct: 196 EVMEQVRGY--DFKADIWSFGITAIELATGAAP 226

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  127 bits (321), Expect = 2e-32
 Identities = 48/215 (22%), Positives = 85/215 (39%), Gaps = 27/215 (12%)

Query: 273 RIGEG--GFGTVYKAQ-LEDGLLVAIKR-----AKKEQFENLQTEFSSEVELLSKIDHRN 324
            IG+G     TV  A+    G  V ++R        E    LQ E    + +    +H N
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE----LHVSKLFNHPN 87

Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI---DVAHGLTYL 381
           +V         NE  ++T F+  G+ ++ +   +   ++      IA     V   L Y+
Sbjct: 88  IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA---IAYILQGVLKALDYI 144

Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVG---Y 437
           H       +HR VK+S+IL++   +  ++       +      +  +    K +V    +
Sbjct: 145 H---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 438 LDPEYMKTYQL--TTKSDVYSFGVLLLEILTGRRP 470
           L PE ++        KSD+YS G+   E+  G  P
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  124 bits (313), Expect = 5e-32
 Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 16/202 (7%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IG+G FG V+K        +VAIK    E+ E+   +   E+ +LS+ D   + K  G 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI---DVAHGLTYLHLYAEKQ 388
             K  +  II E++  G+  + L+      LD  Q   IA    ++  GL YLH    ++
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQ---IATILREILKGLDYLH---SEK 139

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            IHRD+K++N+LL+E    K+ADFG A  G +   +   +T V GT  ++ PE +K    
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 196

Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
            +K+D++S G+  +E+  G  P
Sbjct: 197 DSKADIWSLGITAIELARGEPP 218

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  125 bits (316), Expect = 5e-32
 Identities = 59/247 (23%), Positives = 103/247 (41%), Gaps = 10/247 (4%)

Query: 273 RIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
            +G G  G V+K      GL++A K    E    ++ +   E+++L + +   +V   G 
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
                E  I  E +  G+L + L  +    +      +++I V  GLTYL    + +I+H
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMH 155

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RDVK SNIL+      K+ DFG +  G +     +  + V GT  Y+ PE ++    + +
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMAN--SFV-GTRSYMSPERLQGTHYSVQ 210

Query: 452 SDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEI 511
           SD++S G+ L+E+  GR P+      E  +      +            P          
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270

Query: 512 LTKMFGL 518
                 +
Sbjct: 271 SRPPMAI 277

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  123 bits (311), Expect = 8e-32
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 17/210 (8%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G+G FG VY A+  ++  ++A+K   K Q E   ++ +   E+E+ S + H N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 331 -FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
            F D+  +R+ ++ EF P G L + L  Q     D  +      ++A  L Y H   E++
Sbjct: 82  YFHDR--KRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCH---ERK 134

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           +IHRD+K  N+L+      K+ADFG++   P  S R        GT+ YL PE ++    
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAP--SLRRRTMC---GTLDYLPPEMIEGKTH 189

Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPPE 478
             K D++  GVL  E L G  P +     E
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  125 bits (314), Expect = 9e-32
 Identities = 40/246 (16%), Positives = 78/246 (31%), Gaps = 27/246 (10%)

Query: 274 IGEGGFGTVYKAQ------LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +GEG F  VY+A        ++     +K  K              +E L        +K
Sbjct: 73  LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ-LMERLKPSMQHMFMK 131

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLD---GQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
                   N  +++ E    GTL   ++       K +     +  A+ + + +  +H  
Sbjct: 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH-- 189

Query: 385 AEKQIIHRDVKSSNILLTESMRA-----------KVADFGFARLGPMDSDRTHISTKVKG 433
            + +IIH D+K  N +L                  + D G +    +    T  + K   
Sbjct: 190 -DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC-E 247

Query: 434 TVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG 493
           T G+   E +       + D +     +  +L G          E +      F+R    
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--PEGLFRRLPHL 305

Query: 494 NLLDMV 499
           ++ +  
Sbjct: 306 DMWNEF 311

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  122 bits (308), Expect = 2e-31
 Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 22/208 (10%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
            +G+G FG VYKA+  E G L A K  + +  E L+ ++  E+E+L+  DH  +VKLLG 
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIVKLLGA 84

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI---DVAHGLTYLHLYAEKQ 388
                +  I+ EF P G +   +  +  + L   Q   I +    +   L +LH    K+
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIML-ELDRGLTEPQ---IQVVCRQMLEALNFLH---SKR 137

Query: 389 IIHRDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPE-----Y 442
           IIHRD+K+ N+L+T     ++ADFG  A+       R    + + GT  ++ PE      
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD---SFI-GTPYWMAPEVVMCET 193

Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           MK      K+D++S G+ L+E+     P
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  122 bits (307), Expect = 3e-31
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 13/200 (6%)

Query: 273 RIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IG+G  GTVY A  +  G  VAI++   +Q    +    +E+ ++ +  + N+V  L  
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNIVNYLDS 85

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
              G+E  ++ E++  G+L + +       +D  Q   +  +    L +LH     Q+IH
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIH 139

Query: 392 RDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           RD+KS NILL      K+ DFGF A++ P  S R+   T V GT  ++ PE +       
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---TMV-GTPYWMAPEVVTRKAYGP 195

Query: 451 KSDVYSFGVLLLEILTGRRP 470
           K D++S G++ +E++ G  P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  124 bits (314), Expect = 3e-31
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 36/225 (16%)

Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFV 332
           +G G  GTV       G  VA+KR   +  +        E++LL++ D H N+++     
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL----MEIKLLTESDDHPNVIRYYCSE 78

Query: 333 DKGNERLIITEFVPNGTLREHLD--GQYGKTLDFNQRLEIAI---DVAHGLTYLHLYAEK 387
                  I  E   N  L++ ++      + L   +          +A G+ +LH     
Sbjct: 79  TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SL 134

Query: 388 QIIHRDVKSSNILLT-------------ESMRAKVADFGFAR-LGPMDSDRTHISTKVKG 433
           +IIHRD+K  NIL++             E++R  ++DFG  + L    S          G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194

Query: 434 TVGYLDPEYMK-------TYQLTTKSDVYSFGVLLLEILT-GRRP 470
           T G+  PE ++         +LT   D++S G +   IL+ G+ P
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  122 bits (308), Expect = 5e-31
 Identities = 56/256 (21%), Positives = 100/256 (39%), Gaps = 32/256 (12%)

Query: 230 PSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATR---NFSPSLRIGEGGFGTVYKAQ 286
           P+P     +      +P           + +V+   R    +     +G+GGF   ++  
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEIS 61

Query: 287 -LEDGLLVAIKRAKKEQFENLQTE--FSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE 343
             +   + A K   K            S E+ +   + H+++V   GF +  +   ++ E
Sbjct: 62  DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121

Query: 344 FVPNGTLREHLDGQYGKTLD-------FNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKS 396
                +L E    +  K L          Q       +  G  YLH     ++IHRD+K 
Sbjct: 122 LCRRRSLLELH--KRRKALTEPEARYYLRQ-------IVLGCQYLH---RNRVIHRDLKL 169

Query: 397 SNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM--KTYQLTTKSDV 454
            N+ L E +  K+ DFG A     D +R  +     GT  Y+ PE +  K +  + + DV
Sbjct: 170 GNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGH--SFEVDV 224

Query: 455 YSFGVLLLEILTGRRP 470
           +S G ++  +L G+ P
Sbjct: 225 WSIGCIMYTLLVGKPP 240

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  123 bits (310), Expect = 6e-31
 Identities = 30/256 (11%), Positives = 69/256 (26%), Gaps = 47/256 (18%)

Query: 273 RIGEGGFGTVYKA-QLEDGLLVAIK------RAKKEQFENLQTEFS-------------- 311
            +G+       +A   E G    +       R      + ++ E                
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 312 -SEVELLSKID---HRNLVKLLGFVDKGNERLIITEFV----PNGTLREHLD-----GQY 358
              +  +   D        K++       +  +++ F         L+   +        
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 359 GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG 418
            K+L  + RL++ + V   L  LH      ++H  ++  +I+L +     +  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 259

Query: 419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQ-----LTTKSDVYSFGVLLLEILTGRRPVEL 473
              +       +            +   Q     +T   D ++ G+ +  I     P   
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319

Query: 474 KRPPEERVTLRWAFKR 489
                      W F+ 
Sbjct: 320 DAALG---GSEWIFRS 332

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  120 bits (304), Expect = 1e-30
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 13/200 (6%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IGEG  G V  A+    G  VA+K     + +  +    +EV ++    H N+V++   
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE-LLFNEVVIMRDYQHFNVVEMYKS 110

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
              G E  ++ EF+  G L + +       L+  Q   +   V   L YLH    + +IH
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLH---AQGVIH 164

Query: 392 RDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           RD+KS +ILLT   R K++DFGF A++      R    + V GT  ++ PE +      T
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK---SLV-GTPYWMAPEVISRSLYAT 220

Query: 451 KSDVYSFGVLLLEILTGRRP 470
           + D++S G++++E++ G  P
Sbjct: 221 EVDIWSLGIMVIEMVDGEPP 240

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  120 bits (303), Expect = 1e-30
 Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 29/209 (13%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTE--FSSEVELLSKIDHRNLVKLLG 330
           +G+GGF   ++    +   + A K   K            S E+ +   + H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLD-------FNQRLEIAIDVAHGLTYLHL 383
           F +  +   ++ E     +L E    +  K L          Q       +  G  YLH 
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQ-------IVLGCQYLH- 132

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
               ++IHRD+K  N+ L E +  K+ DFG A     D +R  +     GT  Y+ PE +
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVL 187

Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGRRP 470
             K +  + + DV+S G ++  +L G+ P
Sbjct: 188 SKKGH--SFEVDVWSIGCIMYTLLVGKPP 214

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  121 bits (305), Expect = 1e-30
 Identities = 48/221 (21%), Positives = 94/221 (42%), Gaps = 32/221 (14%)

Query: 274 IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSS----------------EVELL 317
           + +G F  +   + +D    A+K+ +K   E  +    S                E++++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 318 SKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE------IA 371
           + I +   +   G +   +E  II E++ N ++ +  +  +    ++   +       I 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV 431
             V +  +Y+H   EK I HRDVK SNIL+ ++ R K++DFG +     D          
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV-DKKI----KGS 210

Query: 432 KGTVGYLDPE--YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +GT  ++ PE    ++     K D++S G+ L  +     P
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  120 bits (302), Expect = 2e-30
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 21/212 (9%)

Query: 265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAK-KEQFENLQTEFSSEVELLSKIDH 322
              F    ++GEG +G+VYKA   E G +VAIK+   +   + +  E    + ++ + D 
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKE----ISIMQQCDS 83

Query: 323 RNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI---DVAHGLT 379
            ++VK  G   K  +  I+ E+   G++ + +     KTL  ++   IA        GL 
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDE---IATILQSTLKGLE 139

Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYL 438
           YLH     + IHRD+K+ NILL     AK+ADFG   +L    + R    T + GT  ++
Sbjct: 140 YLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN---TVI-GTPFWM 192

Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            PE ++       +D++S G+  +E+  G+ P
Sbjct: 193 APEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  120 bits (303), Expect = 3e-30
 Identities = 30/326 (9%), Positives = 81/326 (24%), Gaps = 46/326 (14%)

Query: 225 ADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYK 284
                   ++ P +      +    +     ++ S + +  R       +  G    V+ 
Sbjct: 22  IGYCREEALKEPAAMVEAVTATVWPQNAETTVD-SLLSQGERKLKLVEPLRVGDRSVVFL 80

Query: 285 A-QLEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF---------- 331
              +E     A+K      E   +            +++   +  +              
Sbjct: 81  VRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140

Query: 332 ----------VDKGNERLIITEFV-----PNGTLREHLD-----GQYGKTLDFNQRLEIA 371
                     +  G +   +  ++      +  L            +           + 
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200

Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV 431
             +      L     K ++H      N+ +    R  + D            R   S+  
Sbjct: 201 AQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK---VGTRGPASS-- 252

Query: 432 KGTVGYLDPEYM--KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
              V Y   E++   T   T   + +  G+ +  +     P  L  P  +    R + + 
Sbjct: 253 -VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311

Query: 490 YNEGNLLDMVDPSIKEVISMEILTKM 515
               +L       + + +   ++ + 
Sbjct: 312 PGTDSLAFGSCTPLPDFV-KTLIGRF 336

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  118 bits (298), Expect = 4e-30
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 29/213 (13%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVE-LLSKIDHRNLVKLLG 330
            +G G +G V K + +  G ++A+KR +       Q     +++  +  +D    V   G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE------IAIDVAHGLTYLHLY 384
            + +  +  I  E +        LD  Y + +D  Q +       IA+ +   L +LH  
Sbjct: 74  ALFREGDVWICMELMDTS-----LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH-- 126

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPE-- 441
           ++  +IHRDVK SN+L+    + K+ DFG    L               G   Y+ PE  
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-----VDDVAKDIDAGCKPYMAPERI 181

Query: 442 ----YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
                 K Y  + KSD++S G+ ++E+   R P
Sbjct: 182 NPELNQKGY--SVKSDIWSLGITMIELAILRFP 212

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  118 bits (298), Expect = 8e-30
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 15/205 (7%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVE-LLSKIDHRNLVKLLG 330
            +G G  G V+K +  + G ++A+K+ ++   +        +++ +L   D   +V+  G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
                 +  I  E +  GT  E L  +    +      ++ + +   L YL    +  +I
Sbjct: 92  TFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK--EKHGVI 147

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL-- 448
           HRDVK SNILL E  + K+ DFG +  G +  D+     +  G   Y+ PE +       
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGIS--GRLVDDKAK--DRSAGCAAYMAPERIDPPDPTK 203

Query: 449 ---TTKSDVYSFGVLLLEILTGRRP 470
                ++DV+S G+ L+E+ TG+ P
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFP 228

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  115 bits (291), Expect = 3e-29
 Identities = 30/203 (14%), Positives = 58/203 (28%), Gaps = 44/203 (21%)

Query: 273 RIGEGGFGTVYKAQLEDGLL---VAIK--RAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
             G       ++A   D  L   VA+     +    +++  E  S    LS+ID   + +
Sbjct: 38  FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           +L  V      L++ E++  G+L+E  D            +     +A      H     
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH---RA 148

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            +       S + ++      +A                           +         
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA-----------------------TMPDA------ 179

Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
              + D+   G  L  +L  R P
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWP 201

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  117 bits (295), Expect = 4e-29
 Identities = 41/319 (12%), Positives = 87/319 (27%), Gaps = 57/319 (17%)

Query: 197 HTVLARDPNSMDSASSLDVNSGSEKVSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHL 256
           H    R+         + +     ++  A+    S      + S    S  L   G    
Sbjct: 6   HHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLV--STSLWNTGQPFR 63

Query: 257 NMSQVVKATRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIK------RAKKEQFENLQTE 309
             S++ +  R       +G+       +A   E G    +       R      + ++ E
Sbjct: 64  VESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEE 123

Query: 310 ---------------------FSSEVELLSKIDHRNLVKLLG-FVDKGNERLIITEFVPN 347
                                F    +L+     + ++++     D              
Sbjct: 124 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 183

Query: 348 GTLREHLD-----GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT 402
             L+   +         K+L  + RL++ + V   L  LH      ++H  ++  +I+L 
Sbjct: 184 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLD 240

Query: 403 ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL-----------TTK 451
           +     +  F           R         + G+  PE                  T  
Sbjct: 241 QRGGVFLTGFEHLV-------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFS 293

Query: 452 SDVYSFGVLLLEILTGRRP 470
            D ++ G+++  I     P
Sbjct: 294 FDAWALGLVIYWIWCADLP 312

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  116 bits (292), Expect = 6e-29
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 22/210 (10%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVE-LLSKIDHRNLVKLLG 330
            IG G +G+V K      G ++A+KR +    E  Q +   +++ ++   D   +V+  G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQY---GKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
            + +  +  I  E + + +  +     Y      +      +I +     L +L      
Sbjct: 89  ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK--ENL 145

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGF-ARLGPMDSDRTHISTKVKGTVGYLDPE----- 441
           +IIHRD+K SNILL  S   K+ DFG   +L    +          G   Y+ PE     
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA-----GCRPYMAPERIDPS 200

Query: 442 -YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
              + Y    +SDV+S G+ L E+ TGR P
Sbjct: 201 ASRQGY--DVRSDVWSLGITLYELATGRFP 228

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  114 bits (288), Expect = 2e-28
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 27/214 (12%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLG 330
            +G G +G VYK + ++ G L AIK        + + E   E+ +L K   HRN+    G
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYG 88

Query: 331 -----FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI---DVAHGLTYL 381
                     +++L ++ EF   G++ + +    G TL       IA    ++  GL++L
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW---IAYICREILRGLSHL 145

Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H   + ++IHRD+K  N+LLTE+   K+ DFG +    +D      +T + GT  ++ PE
Sbjct: 146 H---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI-GTPYWMAPE 199

Query: 442 YMKTYQLT-----TKSDVYSFGVLLLEILTGRRP 470
            +   +        KSD++S G+  +E+  G  P
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  114 bits (286), Expect = 6e-28
 Identities = 67/261 (25%), Positives = 106/261 (40%), Gaps = 34/261 (13%)

Query: 219 SEKVSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGG 278
           +E +     + P P        +    P +  +     +  ++      FS    IG G 
Sbjct: 17  TENLYFQGAMDPMPAGGRAGSLK---DPDVAELFFKD-DPEKL------FSDLREIGHGS 66

Query: 279 FGTVYKAQ-LEDGLLVAIKRAK--KEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG 335
           FG VY A+ + +  +VAIK+     +Q      +   EV  L K+ H N ++  G   + 
Sbjct: 67  FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 126

Query: 336 NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI---DVAHGLTYLHLYAEKQIIHR 392
           +   ++ E+         L   + K L   +   IA        GL YLH      +IHR
Sbjct: 127 HTAWLVMEYCLGSASD--LLEVHKKPLQEVE---IAAVTHGALQGLAYLH---SHNMIHR 178

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE---YMKTYQLT 449
           DVK+ NILL+E    K+ DFG A    M    + +     GT  ++ PE    M   Q  
Sbjct: 179 DVKAGNILLSEPGLVKLGDFGSA--SIMAPANSFV-----GTPYWMAPEVILAMDEGQYD 231

Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            K DV+S G+  +E+   + P
Sbjct: 232 GKVDVWSLGITCIELAERKPP 252

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  108 bits (272), Expect = 3e-26
 Identities = 67/231 (29%), Positives = 109/231 (47%), Gaps = 18/231 (7%)

Query: 250 RIGSVHLNMSQVVKATRNFSPS----LR-IGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF 303
           R G+  L  +Q     R   P      + +GEG F TV  A+        AIK  +K   
Sbjct: 9   RPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI 68

Query: 304 ENL-QTEF-SSEVELLSKIDHRNLVKLLG-FVDKGNERL-IITEFVPNGTLREHLDGQYG 359
               +  + + E +++S++DH   VKL   F D   E+L     +  NG L +++  + G
Sbjct: 69  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIR-KIG 125

Query: 360 KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP 419
              +   R   A ++   L YLH    K IIHRD+K  NILL E M  ++ DFG A++  
Sbjct: 126 SFDETCTRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 181

Query: 420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            +S +   ++ V GT  Y+ PE +        SD+++ G ++ +++ G  P
Sbjct: 182 PESKQARANSFV-GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  110 bits (277), Expect = 4e-26
 Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 21/205 (10%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLLGF 331
           +G G +G V         +  AIK  +K             EV +L  +DH N++KL  F
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHLYAEKQI 389
            +      ++ E    G L + +  +      FN+     I   V  G+TYLH   +  I
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMK----FNEVDAAVIIKQVLSGVTYLH---KHNI 157

Query: 390 IHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE-YMKT 445
           +HRD+K  N+LL    +    K+ DFG + +     +      +  GT  Y+ PE   K 
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAV----FENQKKMKERLGTAYYIAPEVLRKK 213

Query: 446 YQLTTKSDVYSFGVLLLEILTGRRP 470
           Y    K DV+S GV+L  +L G  P
Sbjct: 214 Y--DEKCDVWSIGVILFILLAGYPP 236

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  107 bits (268), Expect = 9e-26
 Identities = 50/241 (20%), Positives = 86/241 (35%), Gaps = 37/241 (15%)

Query: 303 FENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKT- 361
             +     S ++  +     +N V  L          I  +      L++ ++ +     
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160

Query: 362 LDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD 421
            +    L I I +A  + +LH    K ++HRD+K SNI  T     KV DFG       D
Sbjct: 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217

Query: 422 SDRTHIS---------TKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVE 472
            +   +          T   GT  Y+ PE +     + K D++S G++L E+L       
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS----- 272

Query: 473 LKRPPEERVTL-----------RWAFKRYNEGNLL-DMVD------PSIKEVISMEILTK 514
                 ERV +            +  K   E  ++ DM+       P   ++I   I   
Sbjct: 273 -FSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

Query: 515 M 515
           +
Sbjct: 332 L 332

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  105 bits (265), Expect = 1e-25
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 14/203 (6%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G G FG V+   +   GL   IK   K++ +    +  +E+E+L  +DH N++K+    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHLYAEKQII 390
           +  +   I+ E    G L E +     +    ++    E+   + + L Y H    + ++
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146

Query: 391 HRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
           H+D+K  NIL          K+ DFG A L    SD    +    GT  Y+ PE  K   
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEH-STNAA-GTALYMAPEVFK-RD 201

Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
           +T K D++S GV++  +LTG  P
Sbjct: 202 VTFKCDIWSAGVVMYFLLTGCLP 224

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  109 bits (273), Expect = 2e-25
 Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 21/205 (10%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLLGF 331
           +G+G FG V K          A+K   K   +N  T     EVELL K+DH N++KL   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHLYAEKQI 389
           ++  +   I+ E    G L + +  +      F++     I   V  G+TY+H   +  I
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMH---KHNI 142

Query: 390 IHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE-YMKT 445
           +HRD+K  NILL    +    K+ DFG +        +        GT  Y+ PE    T
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTC----FQQNTKMKDRIGTAYYIAPEVLRGT 198

Query: 446 YQLTTKSDVYSFGVLLLEILTGRRP 470
           Y    K DV+S GV+L  +L+G  P
Sbjct: 199 Y--DEKCDVWSAGVILYILLSGTPP 221

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  107 bits (270), Expect = 3e-25
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 22/206 (10%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTE--FSSEVELLSKIDHRNLVKLLG 330
           +G+G FG V        G   A+K   K Q +    +     EV+LL ++DH N++KL  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL--EIAIDVAHGLTYLHLYAEKQ 388
           F +      ++ E    G L + +  +      F++     I   V  G+TY+H   + +
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYMH---KNK 146

Query: 389 IIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE-YMK 444
           I+HRD+K  N+LL    +    ++ DFG +       + +       GT  Y+ PE    
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTH----FEASKKMKDKIGTAYYIAPEVLHG 202

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRP 470
           TY    K DV+S GV+L  +L+G  P
Sbjct: 203 TY--DEKCDVWSTGVILYILLSGCPP 226

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  107 bits (268), Expect = 8e-25
 Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 32/216 (14%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSS------------EVELLSKI 320
           +G G +G V    +       AIK  KK QF+  +    +            E+ LL  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103

Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--LEIAIDVAHGL 378
           DH N++KL    +      ++TEF   G L E +     K   F++     I   +  G+
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII-NRHK---FDECDAANIMKQILSGI 159

Query: 379 TYLHLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
            YLH   +  I+HRD+K  NILL      +  K+ DFG +        + +      GT 
Sbjct: 160 CYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF----FSKDYKLRDRLGTA 212

Query: 436 GYLDPE-YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            Y+ PE   K Y    K DV+S GV++  +L G  P
Sbjct: 213 YYIAPEVLKKKY--NEKCDVWSCGVIMYILLCGYPP 246

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  103 bits (260), Expect = 1e-24
 Identities = 62/277 (22%), Positives = 103/277 (37%), Gaps = 52/277 (18%)

Query: 216 NSGSEKVSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIG 275
            S       +  + P    + P            +      +  QV            +G
Sbjct: 2   GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPL---------LG 52

Query: 276 EGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS-----EVELLSKIDHR--NLVK 327
            GGFG+VY    + D L VAIK  +K++  +     +      EV LL K+      +++
Sbjct: 53  SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112

Query: 328 LLGFVDKGNERLIITEFVP-----------NGTLREHLDGQYGKTLDFNQRLEIAIDVAH 376
           LL + ++ +  ++I E               G L+E L   +     F Q       V  
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQ-------VLE 160

Query: 377 GLTYLHLYAEKQIIHRDVKSSNILL-TESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
            + + H      ++HRD+K  NIL+       K+ DFG   L       T  +    GT 
Sbjct: 161 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFD-GTR 212

Query: 436 GYLDPEYM--KTYQLTTKSDVYSFGVLLLEILTGRRP 470
            Y  PE++    Y     + V+S G+LL +++ G  P
Sbjct: 213 VYSPPEWIRYHRYH-GRSAAVWSLGILLYDMVCGDIP 248

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  104 bits (260), Expect = 2e-24
 Identities = 61/279 (21%), Positives = 117/279 (41%), Gaps = 18/279 (6%)

Query: 201 ARDPNSMDSASSLDVNSGSEKVSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQ 260
                SM ++   D  SG  +            R+P    R +             +   
Sbjct: 18  NLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRI 77

Query: 261 VVKATRNFS------PSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSE 313
           V       +       +  +G G FG V+K  +   GL +A K  K    ++ + E  +E
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNE 136

Query: 314 VELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAID 373
           + +++++DH NL++L    +  N+ +++ E+V  G L + +  +    L     +     
Sbjct: 137 ISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQ 195

Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLT--ESMRAKVADFGFARLGPMDSDRTHISTKV 431
           +  G+ ++H   +  I+H D+K  NIL    ++ + K+ DFG AR       R  +    
Sbjct: 196 ICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLAR---RYKPREKLKVNF 249

Query: 432 KGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            GT  +L PE +    ++  +D++S GV+   +L+G  P
Sbjct: 250 -GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  102 bits (255), Expect = 4e-24
 Identities = 62/264 (23%), Positives = 100/264 (37%), Gaps = 54/264 (20%)

Query: 231 SPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQ-LED 289
            P++ PP+P      P   +         ++            +G+GGFGTV+    L D
Sbjct: 5   KPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPL---------LGKGGFGTVFAGHRLTD 55

Query: 290 GLLVAIKRAKKEQFENLQTEFSS-----EVELLSKID----HRNLVKLLGFVDKGNERLI 340
            L VAIK   + +         S     EV LL K+     H  +++LL + +     ++
Sbjct: 56  RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115

Query: 341 ITEF-----------VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           + E               G L E     +     F Q       V   + + H    + +
Sbjct: 116 VLERPLPAQDLFDYITEKGPLGEGPSRCF-----FGQ-------VVAAIQHCH---SRGV 160

Query: 390 IHRDVKSSNILL-TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM--KTY 446
           +HRD+K  NIL+      AK+ DFG   L          +    GT  Y  PE++    Y
Sbjct: 161 VHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYTDFD-GTRVYSPPEWISRHQY 215

Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
                + V+S G+LL +++ G  P
Sbjct: 216 H-ALPATVWSLGILLYDMVCGDIP 238

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  101 bits (254), Expect = 4e-24
 Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 29/209 (13%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLLGF 331
           +G+G FG V K          A+K   K   +N  T     EVELL K+DH N++KL   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 332 VDKGNERLIITEFVPNGTL------REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           ++  +   I+ E    G L      R+                 I   V  G+TY+H   
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--------RIIKQVFSGITYMH--- 138

Query: 386 EKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE- 441
           +  I+HRD+K  NILL    +    K+ DFG +       +   +  ++ GT  Y+ PE 
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTK-MKDRI-GTAYYIAPEV 194

Query: 442 YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
              TY    K DV+S GV+L  +L+G  P
Sbjct: 195 LRGTY--DEKCDVWSAGVILYILLSGTPP 221

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  102 bits (255), Expect = 6e-24
 Identities = 53/247 (21%), Positives = 89/247 (36%), Gaps = 55/247 (22%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTE----FSSEVELLSKIDHRNLVKL 328
           IG+G +G V  A + +   + AIK   K +   +  +      +EV L+ K+ H N+ +L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 329 LGFVDKGNERLIITEFVPNGTL------REHLDGQYGKTLDFNQRL-------------- 368
               +      ++ E    G L                      ++              
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 369 ------------------EIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT--ESMRAK 408
                              I   +   L YLH    + I HRD+K  N L +  +S   K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210

Query: 409 VADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE----YMKTYQLTTKSDVYSFGVLLLE 463
           + DFG ++    +++   +  T   GT  ++ PE      ++Y    K D +S GVLL  
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY--GPKCDAWSAGVLLHL 268

Query: 464 ILTGRRP 470
           +L G  P
Sbjct: 269 LLMGAVP 275

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  100 bits (252), Expect = 1e-23
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 19/203 (9%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G G F  V+   Q   G L A+K  KK           +E+ +L KI H N+V L    
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS-SLENEIAVLKKIKHENIVTLEDIY 75

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL--EIAIDVAHGLTYLHLYAEKQII 390
           +      ++ + V  G L + +  + G    + ++    +   V   + YLH   E  I+
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRIL-ERGV---YTEKDASLVIQQVLSAVKYLH---ENGIV 128

Query: 391 HRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
           HRD+K  N+L     E+ +  + DFG +++     ++  I +   GT GY+ PE +    
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKM-----EQNGIMSTACGTPGYVAPEVLAQKP 183

Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
            +   D +S GV+   +L G  P
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPP 206

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  102 bits (256), Expect = 1e-23
 Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 40/219 (18%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTE-------FSSEVELLSKIDHRNL 325
           +G G  G V  A + +    VAI+   K +F               +E+E+L K++H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 326 VKLLGFVDKGNERLIITEFVPNGTL------REHLDGQYGKTLDFNQRLEIAIDVAHGLT 379
           +K+  F D   +  I+ E +  G L       + L     K   F Q       +   + 
Sbjct: 203 IKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLY-FYQ-------MLLAVQ 253

Query: 380 YLHLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG 436
           YLH   E  IIHRD+K  N+LL+   E    K+ DFG ++   +  + + + T   GT  
Sbjct: 254 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMRTLC-GTPT 306

Query: 437 YLDPE-----YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           YL PE         Y      D +S GV+L   L+G  P
Sbjct: 307 YLAPEVLVSVGTAGY--NRAVDCWSLGVILFICLSGYPP 343

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  100 bits (251), Expect = 1e-23
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 31/214 (14%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIK---RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           +GEG +G V +    E     A+K   + K  +  N +     E++LL ++ H+N+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 330 GFVDKGNERLI--ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAH--------GLT 379
             +    ++ +  + E+   G ++E LD          +R  +    AH        GL 
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCG-MQEMLD--SVP----EKRFPV--CQAHGYFCQLIDGLE 123

Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLD 439
           YLH    + I+H+D+K  N+LLT     K++  G A      +      T  +G+  +  
Sbjct: 124 YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQP 179

Query: 440 PE---YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           PE    + T+    K D++S GV L  I TG  P
Sbjct: 180 PEIANGLDTFS-GFKVDIWSAGVTLYNITTGLYP 212

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 26/208 (12%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +GEG +G V  A        VA+K    ++  +       E+ +   ++H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAH--------GLTYLHLY 384
            +GN + +  E+   G L + ++         +  +      A         G+ YLH  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEP--------DIGMPE--PDAQRFFHQLMAGVVYLH-- 122

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM- 443
               I HRD+K  N+LL E    K++DFG A +   ++    ++    GT+ Y+ PE + 
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180

Query: 444 -KTYQLTTKSDVYSFGVLLLEILTGRRP 470
            + +      DV+S G++L  +L G  P
Sbjct: 181 RREFH-AEPVDVWSCGIVLTAMLAGELP 207

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  101 bits (254), Expect = 2e-23
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 33/212 (15%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKE------QFENLQTEFSSEVELLSKIDHRNLV 326
           IG+G FG V   Q  D   + A+K   K+      +  N+  E    ++++  ++H  LV
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKE----LQIMQGLEHPFLV 78

Query: 327 KLLG-FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQ---RLEIAIDVAHGLTYL 381
            L   F D+  E + ++ + +  G LR HL  Q      F +   +L I  ++   L YL
Sbjct: 79  NLWYSFQDE--EDMFMVVDLLLGGDLRYHL-QQNVH---FKEETVKLFIC-ELVMALDYL 131

Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
                ++IIHRD+K  NILL E     + DF  A + P     T I+T   GT  Y+ PE
Sbjct: 132 Q---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMA-GTKPYMAPE 184

Query: 442 YMKTYQLT--TKS-DVYSFGVLLLEILTGRRP 470
              + +    + + D +S GV   E+L GRRP
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  100 bits (252), Expect = 2e-23
 Identities = 49/207 (23%), Positives = 82/207 (39%), Gaps = 16/207 (7%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQT----EFSSEVELLSKIDHRNLVKL 328
           IG+G F  V +    E G   A+K     +F +       +   E  +   + H ++V+L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRL--EIAIDVAHGLTYLHLYAE 386
           L          ++ EF+    L   +  +      +++ +       +   L Y H   +
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 148

Query: 387 KQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
             IIHRDVK   +LL     S   K+  FG A    +         +V GT  ++ PE +
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRV-GTPHFMAPEVV 205

Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
           K        DV+  GV+L  +L+G  P
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLP 232

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  102 bits (256), Expect = 3e-23
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 15/204 (7%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVE--LLSKIDHRNLVKLL- 329
           +G GGFG V+  Q++  G L A K+  K++ +  +    + VE  +L+K+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252

Query: 330 GFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEI--AIDVAHGLTYLHLYAE 386
            F  K    L ++   +  G +R H+         F +   I     +  GL +LH   +
Sbjct: 253 AFETK--TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---Q 307

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           + II+RD+K  N+LL +    +++D G A        +T       GT G++ PE +   
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--GYA-GTPGFMAPELLLGE 364

Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
           +     D ++ GV L E++  R P
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGP 388

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 98.4 bits (246), Expect = 3e-23
 Identities = 50/208 (24%), Positives = 82/208 (39%), Gaps = 29/208 (13%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           IG G +G V  A Q    +  A K+  K   E++   F  E+E++  +DH N+++L    
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHPNIIRLYETF 75

Query: 333 DKGNERLIITEFVPNGTL------REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           +   +  ++ E    G L      +          +     L         + Y H   +
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-MKDVLS-------AVAYCH---K 124

Query: 387 KQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE-Y 442
             + HRD+K  N L          K+ DFG A        +  + TKV GT  Y+ P+  
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKM-MRTKV-GTPYYVSPQVL 180

Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
              Y    + D +S GV++  +L G  P
Sbjct: 181 EGLY--GPECDEWSAGVMMYVLLCGYPP 206

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 98.9 bits (247), Expect = 5e-23
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 26/208 (12%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +GEG +G V  A        VA+K    ++  +       E+ +   ++H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAH--------GLTYLHLY 384
            +GN + +  E+   G L + ++         +  +      A         G+ YLH  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEP--------DIGMPE--PDAQRFFHQLMAGVVYLH-- 122

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM- 443
               I HRD+K  N+LL E    K++DFG A +   ++    ++    GT+ Y+ PE + 
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180

Query: 444 -KTYQLTTKSDVYSFGVLLLEILTGRRP 470
            + +      DV+S G++L  +L G  P
Sbjct: 181 RREFH-AEPVDVWSCGIVLTAMLAGELP 207

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  100 bits (251), Expect = 6e-23
 Identities = 69/271 (25%), Positives = 121/271 (44%), Gaps = 42/271 (15%)

Query: 217 SGSEKVSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGE 276
           + S   S      PS             S     + +      +      +++ +  IG 
Sbjct: 7   TTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQ--EVSYTDTKVIGN 64

Query: 277 GGFGTVYKAQL-EDGLLVAIKRAKKEQ-FENLQTEFSSEVELLSKIDHRNLVKLLGFV-- 332
           G FG VY+A+L + G LVAIK+  +++ F+N       E++++ K+DH N+V+L  F   
Sbjct: 65  GSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYS 118

Query: 333 --DKGNERLI--ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI------DVAHGLTYLH 382
             +K +E  +  + ++VP  T+       Y +     Q L +         +   L Y+H
Sbjct: 119 SGEKKDEVYLNLVLDYVPE-TVYRVAR-HYSRA---KQTLPVIYVKLYMYQLFRSLAYIH 173

Query: 383 LYAEKQIIHRDVKSSNILL-TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDP 440
                 I HRD+K  N+LL  ++   K+ DFG A+ L   + + ++I ++      Y  P
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 225

Query: 441 EYM---KTYQLTTKSDVYSFGVLLLEILTGR 468
           E +     Y  T+  DV+S G +L E+L G+
Sbjct: 226 ELIFGATDY--TSSIDVWSAGCVLAELLLGQ 254

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 99.1 bits (247), Expect = 1e-22
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 40/222 (18%)

Query: 272 LRIGEGGFGTVYKAQ---LEDGLLVAIKRAKKEQFENLQTEFSS--EVELLSKIDHRNLV 326
            ++G G +G VYKA+    +D    A+K+ +           S+  E+ LL ++ H N++
Sbjct: 27  CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVI 81

Query: 327 KLLG-FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAH-------- 376
            L   F+   + ++ ++ ++  +  L   +            +  + +            
Sbjct: 82  SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQI 137

Query: 377 --GLTYLHLYAEKQIIHRDVKSSNILLT----ESMRAKVADFGFARL-GPMDSDRTHIST 429
             G+ YLH      ++HRD+K +NIL+     E  R K+AD GFARL          +  
Sbjct: 138 LDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194

Query: 430 KVKGTVGYLDPEYM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            V  T  Y  PE +   + Y  T   D+++ G +  E+LT  
Sbjct: 195 VVV-TFWYRAPELLLGARHY--TKAIDIWAIGCIFAELLTSE 233

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 14/201 (6%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLLGF 331
           IG+G F  V  A+ +  G  VAIK   K Q      +    EV ++  ++H N+VKL   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           ++      +I E+   G + ++L   +G+ +   +       +   + Y H   +K+I+H
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLV-AHGR-MKEKEARSKFRQIVSAVQYCH---QKRIVH 137

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM--KTYQLT 449
           RD+K+ N+LL   M  K+ADFGF+      +    +     G   Y  PE    K Y   
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSN---EFTVGGKLDAFC-GAPPYAAPELFQGKKYD-G 192

Query: 450 TKSDVYSFGVLLLEILTGRRP 470
            + DV+S GV+L  +++G  P
Sbjct: 193 PEVDVWSLGVILYTLVSGSLP 213

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 97.6 bits (244), Expect = 1e-22
 Identities = 44/147 (29%), Positives = 76/147 (51%), Gaps = 9/147 (6%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS--EVELLSKIDHRNLVKLL 329
           +IGEG +G V+K +  + G +VAIK+  +   ++   +  +  E+ +L ++ H NLV LL
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLES-EDDPVIKKIALREIRMLKQLKHPNLVNLL 68

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
               +     ++ E+  + T+   LD +Y + +  +    I       + + H   +   
Sbjct: 69  EVFRRKRRLHLVFEYCDH-TVLHELD-RYQRGVPEHLVKSITWQTLQAVNFCH---KHNC 123

Query: 390 IHRDVKSSNILLTESMRAKVADFGFAR 416
           IHRDVK  NIL+T+    K+ DFGFAR
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFAR 150

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =   99 bits (249), Expect = 2e-22
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 22/205 (10%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVA---IKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           +G G FG V++  +   G   A   +    +   E ++     E++ +S + H  LV L 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR----KEIQTMSVLRHPTLVNLH 220

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHLYAEK 387
              +  NE ++I EF+  G L E +  ++ K    ++   +E    V  GL ++H   E 
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMH---EN 274

Query: 388 QIIHRDVKSSNILLT--ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
             +H D+K  NI+ T   S   K+ DFG          +  +     GT  +  PE  + 
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTT-GTAEFAAPEVAEG 330

Query: 446 YQLTTKSDVYSFGVLLLEILTGRRP 470
             +   +D++S GVL   +L+G  P
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSP 355

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 49/148 (33%), Positives = 83/148 (56%), Gaps = 11/148 (7%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS--EVELLSKIDHRNLVKLL 329
            +GEG +G V K +  + G +VAIK+  +   ++   +  +  E++LL ++ H NLV LL
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 330 GFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
             V K  +R  ++ EFV + T+ + L+  +   LD+    +    + +G+ + H      
Sbjct: 91  E-VCKKKKRWYLVFEFVDH-TILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCH---SHN 144

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFAR 416
           IIHRD+K  NIL+++S   K+ DFGFAR
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFAR 172

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 41/218 (18%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF-------ENLQTEFSSEVELLSKIDHRNL 325
           +G G FG V+ A   E    V +K  KKE+        +    + + E+ +LS+++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 326 VKLLGFVDKGNERLIITEF-----------VPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           +K+L   +      ++ E              +  L E L         F Q       +
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI-----FRQ-------L 139

Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT 434
              + YL     K IIHRD+K  NI++ E    K+ DFG A             T   GT
Sbjct: 140 VSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFC-GT 192

Query: 435 VGYLDPEYM--KTYQLTTKSDVYSFGVLLLEILTGRRP 470
           + Y  PE +    Y+   + +++S GV L  ++    P
Sbjct: 193 IEYCAPEVLMGNPYR-GPELEMWSLGVTLYTLVFEENP 229

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 96.6 bits (241), Expect = 3e-22
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 42/229 (18%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS-------------------- 312
           IG+G +G V  A    D    A+K   K++                              
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 313 -----EVELLSKIDHRNLVKLLGFVDKGNERLI--ITEFVPNGTLREHLDGQYGKTLDFN 365
                E+ +L K+DH N+VKL+  +D  NE  +  + E V  G +   ++    K L  +
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSED 137

Query: 366 QRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT 425
           Q      D+  G+ YLH    ++IIHRD+K SN+L+ E    K+ADFG +          
Sbjct: 138 QARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE--FKGSDA 192

Query: 426 HISTKVKGTVGYLDPE----YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            +S  V GT  ++ PE      K +      DV++ GV L   + G+ P
Sbjct: 193 LLSNTV-GTPAFMAPESLSETRKIFS-GKALDVWAMGVTLYCFVFGQCP 239

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 97.8 bits (244), Expect = 3e-22
 Identities = 63/252 (25%), Positives = 115/252 (45%), Gaps = 40/252 (15%)

Query: 236 PPSPSRFTMSPKLNRIGSVHLNMSQVVKATRN-FSPSLRIGEGGFGTVYKAQLEDGLLVA 294
           P +  +       N++  V  +  +  +     ++    IG G FG V++A+L +   VA
Sbjct: 9   PLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVA 68

Query: 295 IKRAKKEQ-FENLQTEFSSEVELLSKIDHRNLVKLLGFV----DKGNERLI--ITEFVPN 347
           IK+  +++ F+N       E++++  + H N+V L  F     DK +E  +  + E+VP 
Sbjct: 69  IKKVLQDKRFKN------RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE 122

Query: 348 GTLREHLDGQYGKTLDFNQRLEIAI------DVAHGLTYLHLYAEKQIIHRDVKSSNILL 401
            T+       Y K     Q + + +       +   L Y+H      I HRD+K  N+LL
Sbjct: 123 -TVYRASR-HYAKL---KQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLL 174

Query: 402 -TESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYM---KTYQLTTKSDVYS 456
              S   K+ DFG A+ L   + + ++I ++      Y  PE +     Y  TT  D++S
Sbjct: 175 DPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATNY--TTNIDIWS 227

Query: 457 FGVLLLEILTGR 468
            G ++ E++ G+
Sbjct: 228 TGCVMAELMQGQ 239

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 95.7 bits (239), Expect = 4e-22
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 25/208 (12%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTE-FSS----EVELLSKIDHRNLV 326
           +IGEG +GTV+KA+  E   +VA+KR + +  +    E   S    E+ LL ++ H+N+V
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD----EGVPSSALREICLLKELKHKNIV 64

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           +L   +    +  ++ EF     L+++ D      LD          +  GL + H    
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQ-DLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCH---S 119

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARL-GPMDSDRTHISTKVKGTVGYLDPEYM-- 443
           + ++HRD+K  N+L+  +   K+A+FG AR  G      +    +V  T+ Y  P+ +  
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRPPDVLFG 175

Query: 444 -KTYQLTTKSDVYSFGVLLLEILTGRRP 470
            K Y  +T  D++S G +  E+    RP
Sbjct: 176 AKLY--STSIDMWSAGCIFAELANAGRP 201

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 97.5 bits (243), Expect = 4e-22
 Identities = 43/203 (21%), Positives = 86/203 (42%), Gaps = 18/203 (8%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           +G G FG V++  +   G +   K        +      +E+ +++++ H  L+ L    
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAF 117

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI---DVAHGLTYLHLYAEKQI 389
           +   E ++I EF+  G L + +     +    ++  E+         GL ++H   E  I
Sbjct: 118 EDKYEMVLILEFLSGGELFDRI---AAEDYKMSEA-EVINYMRQACEGLKHMH---EHSI 170

Query: 390 IHRDVKSSNILLT--ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
           +H D+K  NI+    ++   K+ DFG A      +    +      T  +  PE +    
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTT-ATAEFAAPEIVDREP 226

Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
           +   +D+++ GVL   +L+G  P
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSP 249

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 98.1 bits (245), Expect = 4e-22
 Identities = 44/210 (20%), Positives = 86/210 (40%), Gaps = 29/210 (13%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLLGF 331
           +G+G F  V +  ++  G   A      ++      +    E  +   + H N+V+L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 332 VDKGNERLIITEFVPNGTL------REHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHL 383
           + +     +I + V  G L      RE+          +++         +   + + H 
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAREY----------YSEADASHCIQQILEAVLHCH- 127

Query: 384 YAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
             +  ++HR++K  N+LL    +    K+ADFG A    ++ ++        GT GYL P
Sbjct: 128 --QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFA-GTPGYLSP 182

Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           E ++        D+++ GV+L  +L G  P
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 95.3 bits (238), Expect = 5e-22
 Identities = 55/215 (25%), Positives = 87/215 (40%), Gaps = 35/215 (16%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQT-----EFSSEVELLSKIDHRNLVK 327
           +G G F  V K  Q   G   A K  KK +  + +      E   EV +L +I H N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 328 LLGFVDKGNERLIITEFVPNGTL------REHLDGQYGKTLDFNQR--LEIAIDVAHGLT 379
           L    +   + ++I E V  G L      +E             +    +    +  G+ 
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKES----------LTEDEATQFLKQILDGVH 122

Query: 380 YLHLYAEKQIIHRDVKSSNILLT----ESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
           YLH    K+I H D+K  NI+L      + R K+ DFG A                 GT 
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH---KIEAGNEFKNIF-GTP 175

Query: 436 GYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            ++ PE +    L  ++D++S GV+   +L+G  P
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 95.8 bits (239), Expect = 6e-22
 Identities = 46/204 (22%), Positives = 83/204 (40%), Gaps = 21/204 (10%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G G FG V++  +         K  + K      ++ E    + +L+   HRN++ L  
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKE----ISILNIARHRNILHLHE 68

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHLYAEKQ 388
             +   E ++I EF+    + E +        + N+R  +     V   L +LH      
Sbjct: 69  SFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLH---SHN 122

Query: 389 IIHRDVKSSNILLT--ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           I H D++  NI+     S   K+ +FG AR         +          Y  PE  +  
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLF-TAPEYYAPEVHQHD 178

Query: 447 QLTTKSDVYSFGVLLLEILTGRRP 470
            ++T +D++S G L+  +L+G  P
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINP 202

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 95.3 bits (238), Expect = 7e-22
 Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 25/211 (11%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS----EVELL---SKIDHRN 324
            IG G +GTVYKA+    G  VA+K  +                 EV LL      +H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 325 LVKLLG-FVDKGNERL----IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLT 379
           +V+L+        +R     ++ E V    LR +LD      L      ++      GL 
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134

Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLD 439
           +LH      I+HRD+K  NIL+T     K+ADFG AR+       T     V  T+ Y  
Sbjct: 135 FLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP---VVV-TLWYRA 187

Query: 440 PEYM--KTYQLTTKSDVYSFGVLLLEILTGR 468
           PE +   TY   T  D++S G +  E+   +
Sbjct: 188 PEVLLQSTY--ATPVDMWSVGCIFAEMFRRK 216

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 94.9 bits (237), Expect = 7e-22
 Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 26/208 (12%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLLGF 331
           +G+G F  V +      GL  A K    ++      +    E  +  K+ H N+V+L   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 332 VDKGNERLIITEFVPNGTL------REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           + + +   ++ + V  G L      RE             Q LE        + Y H   
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-IQQILE-------SIAYCH--- 122

Query: 386 EKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEY 442
              I+HR++K  N+LL    +    K+ADFG A    ++           GT GYL PE 
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEA-WHGFA-GTPGYLSPEV 178

Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +K    +   D+++ GV+L  +L G  P
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPP 206

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 95.4 bits (238), Expect = 8e-22
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 33/210 (15%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGF 331
           +GEG F    K    +     A+K   K    N Q     E+  L   + H N+VKL   
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ----KEITALKLCEGHPNIVKLHEV 74

Query: 332 VDKGNERLIITEFVPNGTL------REHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHL 383
                   ++ E +  G L      ++H          F++     I   +   ++++H 
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKH----------FSETEASYIMRKLVSAVSHMH- 123

Query: 384 YAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
             +  ++HRD+K  N+L T   +++  K+ DFGFARL     D   + T    T+ Y  P
Sbjct: 124 --DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPC-FTLHYAAP 178

Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           E +         D++S GV+L  +L+G+ P
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 95.0 bits (237), Expect = 8e-22
 Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 37/219 (16%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKK--------EQFENLQTEFSSEVELLSKID-HR 323
           +G G    V +          A+K            E+ + L+     EV++L K+  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTL------REHLDGQYGKTLDFNQRLEIAIDVAHG 377
           N+++L    +      ++ + +  G L      +  L  +  + +     LE        
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MRALLE-------V 136

Query: 378 LTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY 437
           +  LH   +  I+HRD+K  NILL + M  K+ DFGF+    +D     +     GT  Y
Sbjct: 137 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEK-LREVC-GTPSY 189

Query: 438 LDPEYMKTYQLTTKS------DVYSFGVLLLEILTGRRP 470
           L PE ++              D++S GV++  +L G  P
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 95.8 bits (239), Expect = 9e-22
 Identities = 58/245 (23%), Positives = 94/245 (38%), Gaps = 28/245 (11%)

Query: 237 PSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAI 295
           P  +  T   ++ R     +N S       +    L  G+G F  V +      GL  A 
Sbjct: 2   PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEEL--GKGAFSVVRRCVHKTTGLEFAA 59

Query: 296 KRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTL---- 350
           K    ++      +    E  +  K+ H N+V+L   + + +   ++ + V  G L    
Sbjct: 60  KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 119

Query: 351 --REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT---ESM 405
             RE             Q LE        + Y H      I+HR++K  N+LL    +  
Sbjct: 120 VAREFYSEADASHC-IQQILE-------SIAYCH---SNGIVHRNLKPENLLLASKAKGA 168

Query: 406 RAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEIL 465
             K+ADFG A    ++           GT GYL PE +K    +   D+++ GV+L  +L
Sbjct: 169 AVKLADFGLAIE--VNDSEA-WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224

Query: 466 TGRRP 470
            G  P
Sbjct: 225 VGYPP 229

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 95.9 bits (239), Expect = 9e-22
 Identities = 60/307 (19%), Positives = 121/307 (39%), Gaps = 42/307 (13%)

Query: 189 YKKRKATAHTVLARDPNSMDSASSLDVNSGSEKVSGADKVPPSPMRVPPSPSRFTMSPKL 248
           + K +  A   +   PN         + S  +  S +  +     ++  +  + T +   
Sbjct: 15  FNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYF 74

Query: 249 NRIG--SVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKA-QLEDGLLVAIK-------RA 298
             +G      + +   +  + + P   IG G    V +      G   A+K       R 
Sbjct: 75  QSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERL 134

Query: 299 KKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEFVPNGTL------R 351
             EQ E ++     E  +L ++  H +++ L+   +  +   ++ + +  G L      +
Sbjct: 135 SPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK 194

Query: 352 EHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVAD 411
             L  +  +++     LE        +++LH      I+HRD+K  NILL ++M+ +++D
Sbjct: 195 VALSEKETRSI-MRSLLE-------AVSFLH---ANNIVHRDLKPENILLDDNMQIRLSD 243

Query: 412 FGFARLGPMDSDRTHISTKVKGTVGYLDPE--------YMKTYQLTTKSDVYSFGVLLLE 463
           FGF+    ++     +     GT GYL PE            Y    + D+++ GV+L  
Sbjct: 244 FGFSCH--LEPGEK-LRELC-GTPGYLAPEILKCSMDETHPGY--GKEVDLWACGVILFT 297

Query: 464 ILTGRRP 470
           +L G  P
Sbjct: 298 LLAGSPP 304

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 23/209 (11%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIK-----RAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G F  V K  +   GL  A K     +++  +    + E   EV +L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHL--DGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           L    +   + ++I E V  G L + L       +     +       +  G+ YLH   
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILDGVNYLH--- 132

Query: 386 EKQIIHRDVKSSNILLT----ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
            K+I H D+K  NI+L          K+ DFG A       D         GT  ++ PE
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIF-GTPEFVAPE 188

Query: 442 YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            +    L  ++D++S GV+   +L+G  P
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASP 217

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 31/213 (14%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIK-----RAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G F  V K  +   GL  A K     +++  +    + E   EV +L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 328 LLGFVDKGNERLIITEFVPNGTL------REHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           L    +   + ++I E V  G L      +E L  +   +    Q L+       G+ YL
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNYL 131

Query: 382 HLYAEKQIIHRDVKSSNILLT----ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY 437
           H    K+I H D+K  NI+L          K+ DFG A       D         GT  +
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIF-GTPEF 184

Query: 438 LDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           + PE +    L  ++D++S GV+   +L+G  P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 94.5 bits (236), Expect = 1e-21
 Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 24/205 (11%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE---FSS--EVELLSKIDHRNLVK 327
           ++GEG +G VYKA+   G +VA+KR + +  +    E    ++  E+ LL ++ H N+V 
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAED----EGIPSTAIREISLLKELHHPNIVS 83

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L+  +       ++ EF+    L++ LD +    L  +Q       +  G+ + H   + 
Sbjct: 84  LIDVIHSERCLTLVFEFMEKD-LKKVLD-ENKTGLQDSQIKIYLYQLLRGVAHCH---QH 138

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARL-GPMDSDRTHISTKVKGTVGYLDPEYM--- 443
           +I+HRD+K  N+L+      K+ADFG AR  G      TH   +V  T+ Y  P+ +   
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRAPDVLMGS 194

Query: 444 KTYQLTTKSDVYSFGVLLLEILTGR 468
           K Y  +T  D++S G +  E++TG+
Sbjct: 195 KKY--STSVDIWSIGCIFAEMITGK 217

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 10/149 (6%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS----EVELLSKIDHRNLVK 327
            +GEG F TVYKA+      +VAIK+ K       +   +     E++LL ++ H N++ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           LL      +   ++ +F+    L   +       L  +      +    GL YLH   + 
Sbjct: 77  LLDAFGHKSNISLVFDFMETD-LEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLH---QH 131

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFAR 416
            I+HRD+K +N+LL E+   K+ADFG A+
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAK 160

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 47/203 (23%), Positives = 87/203 (42%), Gaps = 13/203 (6%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKR-AKKEQFENLQTEFSSEVELLSKIDHR-NLVKLLG 330
           +G G F  V +      G   A K   K+ + ++ + E   E+ +L        ++ L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
             +  +E ++I E+   G +      +  + +  N  + +   +  G+ YLH   +  I+
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIV 153

Query: 391 HRDVKSSNILL---TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
           H D+K  NILL         K+ DFG +R          +   + GT  YL PE +    
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSR---KIGHACELREIM-GTPEYLAPEILNYDP 209

Query: 448 LTTKSDVYSFGVLLLEILTGRRP 470
           +TT +D+++ G++   +LT   P
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSP 232

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 55/215 (25%), Positives = 86/215 (40%), Gaps = 35/215 (16%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIK-----RAKKEQFENLQTEFSSEVELLSKIDHRNLVK 327
           +G G F  V K  +   GL  A K     R K  +    + +   EV +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 328 LLGFVDKGNERLIITEFVPNGTL------REHLDGQYGKTLDFNQR--LEIAIDVAHGLT 379
           L    +   + ++I E V  G L      +E             +    E    + +G+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKES----------LTEEEATEFLKQILNGVY 128

Query: 380 YLHLYAEKQIIHRDVKSSNILLT----ESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
           YLH     QI H D+K  NI+L        R K+ DFG A                 GT 
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIF-GTP 181

Query: 436 GYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            ++ PE +    L  ++D++S GV+   +L+G  P
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 93.0 bits (232), Expect = 4e-21
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 24/205 (11%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE-FSS----EVELLSKIDHRNLVK 327
           +IGEG +G VYKAQ   G   A+K+ + E+ +    E   S    E+ +L ++ H N+VK
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKED----EGIPSTTIREISILKELKHSNIVK 64

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L   +      +++ E +    L++ LD      L+        + + +G+ Y H   ++
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQD-LKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCH---DR 119

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARL-GPMDSDRTHISTKVKGTVGYLDPEYM--- 443
           +++HRD+K  N+L+      K+ADFG AR  G      TH   ++  T+ Y  P+ +   
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRAPDVLMGS 175

Query: 444 KTYQLTTKSDVYSFGVLLLEILTGR 468
           K Y  +T  D++S G +  E++ G 
Sbjct: 176 KKY--STTIDIWSVGCIFAEMVNGT 198

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 93.5 bits (233), Expect = 5e-21
 Identities = 56/268 (20%), Positives = 103/268 (38%), Gaps = 37/268 (13%)

Query: 216 NSGSEKVSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIG 275
           +  S    G + +    M    + S    +  L     +  +    +         L  G
Sbjct: 6   HHSSGVDLGTENLYFQSMS-SVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL--G 62

Query: 276 EGGFGTVYKA-QLEDGLLVAIKR-AKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD 333
            G    VY+  Q       A+K   K    + ++TE    + +L ++ H N++KL    +
Sbjct: 63  RGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTE----IGVLLRLSHPNIIKLKEIFE 118

Query: 334 KGNERLIITEFVPNGTL------REHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHLYA 385
              E  ++ E V  G L      + +          +++R   +    +   + YLH   
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGY----------YSERDAADAVKQILEAVAYLH--- 165

Query: 386 EKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEY 442
           E  I+HRD+K  N+L          K+ADFG ++   +   +  + T   GT GY  PE 
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKTVC-GTPGYCAPEI 221

Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           ++      + D++S G++   +L G  P
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCGFEP 249

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 93.1 bits (232), Expect = 5e-21
 Identities = 61/219 (27%), Positives = 92/219 (42%), Gaps = 40/219 (18%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTE-------FSSEVELLSKIDHRNL 325
           +G G  G V  A + +    VAIK   K +F               +E+E+L K++H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 326 VKLLGFVDKGNERLIITEFVPNGTL------REHLDGQYGKTLDFNQRLEIAIDVAHGLT 379
           +K+  F D   +  I+ E +  G L       + L     K   F Q       +   + 
Sbjct: 78  IKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLY-FYQ-------MLLAVQ 128

Query: 380 YLHLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG 436
           YLH   E  IIHRD+K  N+LL+   E    K+ DFG ++   +  + + + T   GT  
Sbjct: 129 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMRTLC-GTPT 181

Query: 437 YLDPE-----YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           YL PE         Y      D +S GV+L   L+G  P
Sbjct: 182 YLAPEVLVSVGTAGY--NRAVDCWSLGVILFICLSGYPP 218

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 93.5 bits (232), Expect = 6e-21
 Identities = 42/126 (33%), Positives = 58/126 (46%), Gaps = 15/126 (11%)

Query: 351 REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVA 410
            E  +  Y   L     +  +  VA G+ +L   A ++ IHRD+ + NILL+E    K+ 
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 235

Query: 411 DFGFARLGPMDSDRTHISTKVKGTVGYLD-----PEYMKTYQLTTKSDVYSFGVLLLEIL 465
           DFG AR      D       V+     L      PE +     T +SDV+SFGVLL EI 
Sbjct: 236 DFGLAR------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289

Query: 466 T-GRRP 470
           + G  P
Sbjct: 290 SLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 35/144 (24%), Positives = 53/144 (36%), Gaps = 17/144 (11%)

Query: 273 RIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNL 325
            +G G FG V +A             VA+K  K+    +      SE+++L  I  H N+
Sbjct: 29  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88

Query: 326 VKLLGFV-DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           V LLG     G   ++I EF   G L  +L          ++R E       G  +    
Sbjct: 89  VNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGARFRQGK 139

Query: 385 AEKQIIHRDVKSSNILLTESMRAK 408
                I  D+K     +T S  + 
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSA 163

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 92.3 bits (230), Expect = 8e-21
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 36/219 (16%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGF 331
           +GEG    V     L      A+K  +K+     ++    EVE+L +   HRN+++L+ F
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHI-RSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 332 VDKGNERLIITEFVPNGTL------REHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHL 383
            ++ +   ++ E +  G++      R H          FN+     +  DVA  L +LH 
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRH----------FNELEASVVVQDVASALDFLH- 128

Query: 384 YAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVK----GTVG 436
              K I HRD+K  NIL     +    K+ DF       ++ D + IST       G+  
Sbjct: 129 --NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186

Query: 437 YLDPEYMKTYQLTTKS-----DVYSFGVLLLEILTGRRP 470
           Y+ PE ++ +           D++S GV+L  +L+G  P
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 38/227 (16%)

Query: 263 KATRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQT---EFSSEVELLS 318
           K    F      G+G FGTV   +    G+ VAIK+      ++ +    E    ++ L+
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----IQDPRFRNRELQ-IMQDLA 74

Query: 319 KIDHRNLVKLLGFVDKGNER-------LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIA 371
            + H N+V+L  +     ER        ++ E+VP+ TL       Y +           
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCR-NYYRR---QVAPPPI 129

Query: 372 I------DVAHGLTYLHLYAEKQIIHRDVKSSNILL-TESMRAKVADFGFARLGPMDSDR 424
           +       +   +  LHL +   + HRD+K  N+L+       K+ DFG A+   +    
Sbjct: 130 LIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAK--KLSPSE 186

Query: 425 THISTKVKGTVGYLDPEYM---KTYQLTTKSDVYSFGVLLLEILTGR 468
            +++     +  Y  PE +   + Y  TT  D++S G +  E++ G 
Sbjct: 187 PNVAYIC--SRYYRAPELIFGNQHY--TTAVDIWSVGCIFAEMMLGE 229

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 31/210 (14%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G G FG V   +    G  VA+K   +++    ++  +   E++ L    H +++KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAH--------GLTYLH 382
            +    +  ++ E+V  G L +++          + R+E     A          + Y H
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICK--------HGRVEE--MEARRLFQQILSAVDYCH 128

Query: 383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEY 442
                 ++HRD+K  N+LL   M AK+ADFG + +   D +    S    G+  Y  PE 
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTSC---GSPNYAAPEV 181

Query: 443 M--KTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +  + Y    + D++S GV+L  +L G  P
Sbjct: 182 ISGRLYA-GPEVDIWSCGVILYALLCGTLP 210

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 93.7 bits (233), Expect = 2e-20
 Identities = 62/239 (25%), Positives = 114/239 (47%), Gaps = 34/239 (14%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVE--LLSKIDHRNLVKLL- 329
           +G+GGFG V   Q+   G + A K+ +K++ +  + E  +  E  +L K++ R +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251

Query: 330 GFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEI--AIDVAHGLTYLHLYAE 386
            +  K  + L ++   +  G L+ H+   +     F +   +  A ++  GL  LH    
Sbjct: 252 AYETK--DALCLVLTLMNGGDLKFHI--YHMGQAGFPEARAVFYAAEICCGLEDLH---R 304

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           ++I++RD+K  NILL +    +++D G A   P +        +V GTVGY+ PE +K  
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIK--GRV-GTVGYMAPEVVKNE 360

Query: 447 QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE 505
           + T   D ++ G LL E++ G+ P                F++  +    + V+  +KE
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSP----------------FQQRKKKIKREEVERLVKE 403

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 91.1 bits (227), Expect = 4e-20
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 41/220 (18%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS----EVELLSKIDHRNLVK 327
           +IG+G FG V+KA+  + G  VA+K+      EN +  F      E+++L  + H N+V 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVN 80

Query: 328 LLG-FVDKGNERL-------IITEFVPN--GTLREHLDGQYG----KTLDFNQRLEIAID 373
           L+     K +          ++ +F  +    L  ++  ++     K +     L     
Sbjct: 81  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-MQMLLN---- 135

Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL--GPMDSDRTHISTKV 431
              GL Y+H     +I+HRD+K++N+L+T     K+ADFG AR      +S     + +V
Sbjct: 136 ---GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189

Query: 432 KGTVGYLDPEYM---KTYQLTTKSDVYSFGVLLLEILTGR 468
             T+ Y  PE +   + Y      D++  G ++ E+ T  
Sbjct: 190 V-TLWYRPPELLLGERDY--GPPIDLWGAGCIMAEMWTRS 226

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 90.3 bits (225), Expect = 4e-20
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 33/212 (15%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS----EVELLSKIDHRNLVK 327
           ++G G + TVYK      G+ VA+K  K +  E       S    E+ L+ ++ H N+V+
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG----TPSTAIREISLMKELKHENIVR 67

Query: 328 LLGFVDKGNERLIITEFVPN---GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           L   +   N+  ++ EF+ N     +     G   + L+ N        +  GL + H  
Sbjct: 68  LYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH-- 125

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFAR-----LGPMDSDRTHISTKVKGTVGYLD 439
            E +I+HRD+K  N+L+ +  + K+ DFG AR     +       +    +V  T+ Y  
Sbjct: 126 -ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF----SS---EVV-TLWYRA 176

Query: 440 PEYM---KTYQLTTKSDVYSFGVLLLEILTGR 468
           P+ +   +TY  +T  D++S G +L E++TG+
Sbjct: 177 PDVLMGSRTY--STSIDIWSCGCILAEMITGK 206

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 90.9 bits (226), Expect = 6e-20
 Identities = 61/275 (22%), Positives = 101/275 (36%), Gaps = 30/275 (10%)

Query: 211 SSLDVNSGSEKVSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFS- 269
           S+    S           P  P    P P      P   +    H+     +K       
Sbjct: 3   SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDD 62

Query: 270 ---PSLRIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRN 324
               S  +G G  G V +          A+K  +         +   EVEL  +     +
Sbjct: 63  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPH 116

Query: 325 LVKLLG-FVDKGNER---LIITEFVPNGTLREHLDGQYGKTLDFNQR--LEIAIDVAHGL 378
           +V+++  + +    R   LI+ E +  G L   +  +  +   F +R   EI   +   +
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAI 174

Query: 379 TYLHLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTV 435
            YLH      I HRDVK  N+L T    +   K+ DFGFA+     +    ++T    T 
Sbjct: 175 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPC-YTP 227

Query: 436 GYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
            Y+ PE +   +     D++S GV++  +L G  P
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 90.0 bits (224), Expect = 7e-20
 Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 35/211 (16%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSK-IDHRNLVKLLGF 331
           IG G +    +       +  A+K   K + +  +     E+E+L +   H N++ L   
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----EIEILLRYGQHPNIITLKDV 84

Query: 332 VDKGNERLIITEFVPNGTL------REHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHL 383
            D G    ++TE +  G L      ++           F++R    +   +   + YLH 
Sbjct: 85  YDDGKYVYVVTELMKGGELLDKILRQKF----------FSEREASAVLFTITKTVEYLH- 133

Query: 384 YAEKQIIHRDVKSSNILLT----ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLD 439
              + ++HRD+K SNIL           ++ DFGFA+   + ++   + T    T  ++ 
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAENGLLMTPC-YTANFVA 188

Query: 440 PEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           PE ++        D++S GVLL  +LTG  P
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 91.6 bits (227), Expect = 1e-19
 Identities = 93/434 (21%), Positives = 147/434 (33%), Gaps = 30/434 (6%)

Query: 51  WGIFASGFAIQSKVCGADHIAYSNSNEVELFYING---NLVDKFSFCKVIQFHYANHCIF 107
           +G+   G   +   C  +       N   L   +                +         
Sbjct: 124 YGLIHQGM--KCDTCMMNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDREVLIVVVRDA 181

Query: 108 EGYSGSDYCRLDLSLAKLSFSPGRKNLQKEVKEEPKTHDAGQNFHPREEKNYSGSLSTTK 167
           +     D   L     KL   P  K+  K+  +  K+    +       +          
Sbjct: 182 KNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRL 241

Query: 168 KVGIAATGLFVMSCALLCPCFYKKRKATAHTVLARDPNSMDSASSLDVNSGSEKVSGADK 227
            V I    L   +  +    F       A         S +     +V    E   G ++
Sbjct: 242 SVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEE 301

Query: 228 VPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKAT-RNFSPSLRIGEGGFGTVYKAQ 286
           +     R            K     S   N     +    +F+  + +G+G FG V  ++
Sbjct: 302 LRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSE 361

Query: 287 LED-GLLVAIKRAKKE------QFENLQTEFSSEVELLSKIDHRNLVKLLG-FVDKGNER 338
            +    L A+K  KK+        E    E    V L        L +L   F     +R
Sbjct: 362 RKGTDELYAVKILKKDVVIQDDDVECTMVE--KRV-LALPGKPPFLTQLHSCFQTM--DR 416

Query: 339 L-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSS 397
           L  + E+V  G L  H+  Q G+  + +     A ++A GL +L     K II+RD+K  
Sbjct: 417 LYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAA-EIAIGLFFLQ---SKGIIYRDLKLD 471

Query: 398 NILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS-DVYS 456
           N++L      K+ADFG  +    D   T   T   GT  Y+ PE +  YQ   KS D ++
Sbjct: 472 NVMLDSEGHIKIADFGMCKENIWDGVTT--KTFC-GTPDYIAPE-IIAYQPYGKSVDWWA 527

Query: 457 FGVLLLEILTGRRP 470
           FGVLL E+L G+ P
Sbjct: 528 FGVLLYEMLAGQAP 541

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 91.1 bits (226), Expect = 2e-19
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 21/206 (10%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVE--LLSKI---DHRNLVK 327
           IG GGFG VY  +  D G + A+K   K++ +  Q E  +  E  +LS +   D   +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 328 LLG-FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           +   F     ++L  I + +  G L  HL  Q+G   + + R   A ++  GL ++H   
Sbjct: 257 MSYAFHTP--DKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAA-EIILGLEHMH--- 309

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            + +++RD+K +NILL E    +++D G A        + H    V GT GY+ PE ++ 
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPH--ASV-GTHGYMAPEVLQK 364

Query: 446 YQLTTKS-DVYSFGVLLLEILTGRRP 470
                 S D +S G +L ++L G  P
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSP 390

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 34/211 (16%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +GEG FG V  A   +    VA+K   ++     ++      E+  L  + H +++KL  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 331 FVDKGNERLIITEF---------VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
            +    + +++ E+         V    + E    ++     F Q       +   + Y 
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRF-----FQQ-------IICAIEYC 124

Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +I+HRD+K  N+LL +++  K+ADFG + +   D +    S    G+  Y  PE
Sbjct: 125 H---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI-MTDGNFLKTSC---GSPNYAAPE 177

Query: 442 YM--KTYQLTTKSDVYSFGVLLLEILTGRRP 470
            +  K Y    + DV+S G++L  +L GR P
Sbjct: 178 VINGKLYA-GPEVDVWSCGIVLYVMLVGRLP 207

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 27/208 (12%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLG- 330
           +G G  G V +      G   A+K            +   EV+   +     ++V +L  
Sbjct: 37  LGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDV 90

Query: 331 FVDKGNER---LIITEFVPNGTLREHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHLYA 385
           + +  + +   LII E +  G L   +  +  +   F +R   EI  D+   + +LH   
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQA--FTEREAAEIMRDIGTAIQFLH--- 145

Query: 386 EKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEY 442
              I HRDVK  N+L T   +    K+ DFGFA+    ++    + T    T  Y+ PE 
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPC-YTPYYVAPEV 200

Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +   +     D++S GV++  +L G  P
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 64/243 (26%), Positives = 113/243 (46%), Gaps = 35/243 (14%)

Query: 243 TMSPKLNRIGSVHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKE 301
           T+  +    GS+ ++ +    +   +    ++GEG +G VYKA        VAIKR + E
Sbjct: 11  TLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE 70

Query: 302 QFENLQTE-FSS----EVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDG 356
             E    E        EV LL ++ HRN+++L   +   +   +I E+  N  L++++D 
Sbjct: 71  HEE----EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD- 124

Query: 357 QYGKTLDFNQRL--EIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRA-----KV 409
              K  D + R+       + +G+ + H    ++ +HRD+K  N+LL+ S  +     K+
Sbjct: 125 ---KNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKI 178

Query: 410 ADFGFARL-GPMDSDRTHISTKVKGTVGYLDPEYM---KTYQLTTKSDVYSFGVLLLEIL 465
            DFG AR  G      TH   ++  T+ Y  PE +   + Y  +T  D++S   +  E+L
Sbjct: 179 GDFGLARAFGIPIRQFTH---EII-TLWYRPPEILLGSRHY--STSVDIWSIACIWAEML 232

Query: 466 TGR 468
              
Sbjct: 233 MKT 235

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 89.0 bits (221), Expect = 4e-19
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 24/211 (11%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQ-FENLQTE-FSSEVELLSKIDHRNLVKLL- 329
           IG G F  V   +++  G + A+K   K    +  +   F  E ++L   D R + +L  
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128

Query: 330 GFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQ-RLEIAIDVAHGLTYLHLYAEK 387
            F D+    L ++ E+   G L   L  ++G+ +     R  +A ++   +  +H     
Sbjct: 129 AFQDE--NYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLA-EIVMAIDSVH---RL 181

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
             +HRD+K  NILL      ++ADFG   +L    + R+     V GT  YL PE ++  
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL--VAV-GTPDYLSPEILQAV 238

Query: 447 QLTTKSDVY-------SFGVLLLEILTGRRP 470
                +  Y       + GV   E+  G+ P
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 86.9 bits (216), Expect = 7e-19
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 29/212 (13%)

Query: 273 RIGEGGFGTVYKAQ--LEDGLLVAIKRAKKEQFENLQTEFSS----EVELL---SKIDHR 323
            IGEG +G V+KA+     G  VA+KR + +  E            EV +L      +H 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE---GMPLSTIREVAVLRHLETFEHP 74

Query: 324 NLVKLL----GFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGL 378
           N+V+L             +L ++ E V    L  +LD      +      ++   +  GL
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133

Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            +LH     +++HRD+K  NIL+T S + K+ADFG AR+       T     V  T+ Y 
Sbjct: 134 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVV-TLWYR 186

Query: 439 DPEYM--KTYQLTTKSDVYSFGVLLLEILTGR 468
            PE +   +Y   T  D++S G +  E+   +
Sbjct: 187 APEVLLQSSY--ATPVDLWSVGCIFAEMFRRK 216

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 88.3 bits (219), Expect = 7e-19
 Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 16/206 (7%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQ-FENLQTE-FSSEVELLSKIDHRNLVKLLG 330
           IG G FG V   +L++   + A+K   K +  +  +T  F  E ++L   D + +  L  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141

Query: 331 -FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
            F D  N  L+  ++   G L   L     +  +   R  +A ++   +  +H   +   
Sbjct: 142 AFQDDNNLYLV-MDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVH---QLHY 196

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           +HRD+K  NIL+  +   ++ADFG       D      S  V GT  Y+ PE ++  +  
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS-SVAV-GTPDYISPEILQAMEGG 254

Query: 450 TKS-----DVYSFGVLLLEILTGRRP 470
                   D +S GV + E+L G  P
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETP 280

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 88.3 bits (219), Expect = 8e-19
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 25/207 (12%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G G FG V   +    G  VA+K   +++    ++  +   E++ L    H +++KL  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGK-----TLDFNQRLEIAIDVAHGLTYLHLYA 385
            +   ++  ++ E+V  G L +++  + G+     +    Q++   +D      Y H   
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGVD------YCH--- 133

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM-- 443
              ++HRD+K  N+LL   M AK+ADFG + +   D +    S    G+  Y  PE +  
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTSC---GSPNYAAPEVISG 189

Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
           + Y    + D++S GV+L  +L G  P
Sbjct: 190 RLYA-GPEVDIWSSGVILYALLCGTLP 215

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 86.5 bits (215), Expect = 8e-19
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 24/205 (11%)

Query: 273 RIGEGGFGTVYKA-QLEDGLLVAIKRAKKEQFENLQTEFSS----EVELLSKIDHRNLVK 327
           ++GEG + TVYK        LVA+K  + E  E            EV LL  + H N+V 
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVT 64

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           L   +       ++ E++    L+++LD   G  ++ +        +  GL Y H    +
Sbjct: 65  LHDIIHTEKSLTLVFEYLDK-DLKQYLD-DCGNIINMHNVKLFLFQLLRGLAYCH---RQ 119

Query: 388 QIIHRDVKSSNILLTESMRAKVADFGFARL-GPMDSDRTHISTKVKGTVGYLDPEYM--- 443
           +++HRD+K  N+L+ E    K+ADFG AR          +   +V  T+ Y  P+ +   
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYRPPDILLGS 175

Query: 444 KTYQLTTKSDVYSFGVLLLEILTGR 468
             Y  +T+ D++  G +  E+ TGR
Sbjct: 176 TDY--STQIDMWGVGCIFYEMATGR 198

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 87.0 bits (216), Expect = 8e-19
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 18/202 (8%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKLLG 330
           +G G FG V   + ++ G   A+K   K++   L Q E + +E  +L  ++   LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 331 -FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
            F D  N  L ++ E+V  G +  HL  +             A  +     YLH      
Sbjct: 109 SFKD--NSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLH---SLD 161

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           +I+RD+K  N+L+ +    +V DFGFA+       RT   T + GT   L PE + +   
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTW--T-LCGTPEALAPEIILSKGY 215

Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
               D ++ GVL+ E+  G  P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP 237

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 87.9 bits (218), Expect = 9e-19
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 22/206 (10%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKE------QFENLQTEFSSEVELLSKIDHRNLV 326
           +G+G FG V   + +  G   A+K  KKE      +  +  TE      +L    H  L 
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR----VLQNSRHPFLT 211

Query: 327 KLLG-FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
            L   F     +RL  + E+   G L  HL  +     +   R   A ++   L YLH  
Sbjct: 212 ALKYSFQTH--DRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGA-EIVSALDYLH-- 265

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
           +EK +++RD+K  N++L +    K+ DFG  + G  D           GT  YL PE ++
Sbjct: 266 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK---TFCGTPEYLAPEVLE 322

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRP 470
                   D +  GV++ E++ GR P
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 60/209 (28%), Positives = 88/209 (42%), Gaps = 31/209 (14%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           IG G FG     +      LVA+K  ++     EN+Q E    +     + H N+V+   
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRFKE 83

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGK-----TLDFNQRLEIAIDVAHGLTYLHLYA 385
            +       II E+   G L E +    G+        F Q+L   +       Y H   
Sbjct: 84  VILTPTHLAIIMEYASGGELYERIC-NAGRFSEDEARFFFQQLLSGVS------YCH--- 133

Query: 386 EKQIIHRDVKSSNILLTES--MRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
             QI HRD+K  N LL  S   R K+ DFG+++   + S      + V GT  Y+ PE +
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTV-GTPAYIAPEVL 189

Query: 444 --KTYQLTTKSDVYSFGVLLLEILTGRRP 470
             + Y     +DV+S GV L  +L G  P
Sbjct: 190 LRQEYD-GKIADVWSCGVTLYVMLVGAYP 217

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 86.0 bits (214), Expect = 1e-18
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 36/211 (17%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENL-QTEFS-SEVELLSKIDHRNLVKLLG 330
           +G G FG V+  +    G   A+K  KKE    L Q E +  E  +LS + H  ++++ G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73

Query: 331 -FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRL------EIAIDVAHGLTYLH 382
            F D   +++ +I +++  G L   L  +  +   F   +      E+ +     L YLH
Sbjct: 74  TFQD--AQQIFMIMDYIEGGELFSLLR-KSQR---FPNPVAKFYAAEVCL----ALEYLH 123

Query: 383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE- 441
               K II+RD+K  NILL ++   K+ DFGFA+      D T+  T + GT  Y+ PE 
Sbjct: 124 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTY--T-LCGTPDYIAPEV 174

Query: 442 -YMKTYQLTTKS-DVYSFGVLLLEILTGRRP 470
              K Y    KS D +SFG+L+ E+L G  P
Sbjct: 175 VSTKPY---NKSIDWWSFGILIYEMLAGYTP 202

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 45/211 (21%), Positives = 87/211 (41%), Gaps = 36/211 (17%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLG 330
           ++G G +  V++A  + +   V +K  K  +    + +   E+++L  +    N++ L  
Sbjct: 43  KLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLAD 98

Query: 331 FV-DKGNERLI-ITEFVPNGTLREHLDGQYGKTLD-------FNQRLEIAIDVAHGLTYL 381
            V D  +     + E V N   +     Q  +TL          + L+        L Y 
Sbjct: 99  IVKDPVSRTPALVFEHVNNTDFK-----QLYQTLTDYDIRFYMYEILK-------ALDYC 146

Query: 382 HLYAEKQIIHRDVKSSNILLTESMRA-KVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
           H      I+HRDVK  N+++    R  ++ D+G A       +      +V  +  +  P
Sbjct: 147 H---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV---RV-ASRYFKGP 199

Query: 441 EYMKTYQLTTKS-DVYSFGVLLLEILTGRRP 470
           E +  YQ+   S D++S G +L  ++  + P
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 27/210 (12%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKEQ-FENLQTE-FSSEVELLSKIDHRNLVKLLG 330
           IG G FG V   + +    + A+K   K +  +   +  F  E ++++  +   +V+L  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136

Query: 331 -FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQ---RLEIAIDVAHGLTYLHLYA 385
            F D  +  L ++ E++P G L   +        D  +   R   A +V   L  +H   
Sbjct: 137 AFQD--DRYLYMVMEYMPGGDLVNLM-----SNYDVPEKWARFYTA-EVVLALDAIH--- 185

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFA-RLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
               IHRDVK  N+LL +S   K+ADFG   ++      R    T V GT  Y+ PE +K
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD--TAV-GTPDYISPEVLK 242

Query: 445 TYQLT---TKS-DVYSFGVLLLEILTGRRP 470
           +        +  D +S GV L E+L G  P
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 31/210 (14%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKE------QFENLQTEFSSEVELLSKIDHRNLV 326
           +G+G FG V   + +  G   A+K  +KE      +  +  TE      +L    H  L 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR----VLQNTRHPFLT 68

Query: 327 KLLG-FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQ---RLEIAIDVAHGLTYL 381
            L   F     +RL  + E+   G L  HL  +      F +   R   A ++   L YL
Sbjct: 69  ALKYAFQTH--DRLCFVMEYANGGELFFHLS-RERV---FTEERARFYGA-EIVSALEYL 121

Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H    + +++RD+K  N++L +    K+ DFG  + G  D       T   GT  YL PE
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFC-GTPEYLAPE 175

Query: 442 YMKTYQLTTKS-DVYSFGVLLLEILTGRRP 470
            +       ++ D +  GV++ E++ GR P
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 68/255 (26%), Positives = 108/255 (42%), Gaps = 41/255 (16%)

Query: 236 PPSPSRFTMSPKLNRIGSVHLNMSQVVKATRNFSPS----LR-IGEGGFGTVYKAQL-ED 289
           P  P     +P      S  +N+     +  +  PS    L+ IG+G FG V  A+   +
Sbjct: 5   PQEPELMNANPAPPPAPSQQINLGP--SSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE 62

Query: 290 GLLVAIKRAKKE------QFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL-IIT 342
            +  A+K  +K+      + +++ +E    V LL  + H  LV L  F  +  ++L  + 
Sbjct: 63  EVFYAVKVLQKKAILKKKEEKHIMSE--RNV-LLKNVKHPFLVGLH-FSFQTADKLYFVL 118

Query: 343 EFVPNGTLREHLDGQYGKTLDFNQRL------EIAIDVAHGLTYLHLYAEKQIIHRDVKS 396
           +++  G L  HL  +      F +        EIA      L YLH      I++RD+K 
Sbjct: 119 DYINGGELFYHLQ-RERC---FLEPRARFYAAEIAS----ALGYLH---SLNIVYRDLKP 167

Query: 397 SNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS-DVY 455
            NILL       + DFG  +     +  T  ST   GT  YL PE +   Q   ++ D +
Sbjct: 168 ENILLDSQGHIVLTDFGLCKENIEHNSTT--STFC-GTPEYLAPE-VLHKQPYDRTVDWW 223

Query: 456 SFGVLLLEILTGRRP 470
             G +L E+L G  P
Sbjct: 224 CLGAVLYEMLYGLPP 238

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 49/232 (21%), Positives = 90/232 (38%), Gaps = 49/232 (21%)

Query: 265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTE-FSS---------EV 314
              ++    I  G +G V      +G+ VAIKR      +       S          E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 315 ELLSKIDHRNLVKLLGFV-----DKGNERLIITEFV----------PNGTL-REHLDGQY 358
            LL+   H N++ L            ++  ++TE +              +  +H+  QY
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHI--QY 138

Query: 359 GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG 418
                          +  GL  LH   E  ++HRD+   NILL ++    + DF  AR  
Sbjct: 139 -----------FMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLARED 184

Query: 419 PMDSDRT-HISTKVKGTVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
             D+++T +++ +      Y  PE +  ++  TK  D++S G ++ E+   +
Sbjct: 185 TADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 65/207 (31%), Positives = 94/207 (45%), Gaps = 24/207 (11%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKE------QFENLQTEFSSEVELLSKIDHRNLV 326
           +G+G FG V+ A+ +      AIK  KK+        E    E    V L    +H  L 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE--KRV-LSLAWEHPFLT 81

Query: 327 KLLG-FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
            +   F  K  E L  + E++  G L  H+     K          A ++  GL +LH  
Sbjct: 82  HMFCTFQTK--ENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAA-EIILGLQFLH-- 135

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
             K I++RD+K  NILL +    K+ADFG  +   +   +T  +T   GT  Y+ PE + 
Sbjct: 136 -SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFC-GTPDYIAPE-IL 190

Query: 445 TYQLTTKS-DVYSFGVLLLEILTGRRP 470
             Q    S D +SFGVLL E+L G+ P
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 81.7 bits (202), Expect = 5e-17
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 28/216 (12%)

Query: 265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS--EVELLSKID 321
            + +     IG G  G V  A        VAIK+  +  F+N      +  E+ L+  ++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82

Query: 322 HRNLVKLL------GFVDKGNERLIITEFVP---NGTLREHLDGQYGKTLDFNQRLEIAI 372
           H+N++ LL        +++  +  I+ E +       ++  LD +    L + Q L    
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY-QML---- 137

Query: 373 DVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK 432
               G+ +LH      IIHRD+K SNI++      K+ DFG AR     +  + + T   
Sbjct: 138 ---CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYV 187

Query: 433 GTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGR 468
            T  Y  PE +         D++S G ++ E++ G 
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 80.3 bits (199), Expect = 9e-17
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 29/210 (13%)

Query: 274 IGEGGFGTVY----KAQLEDGLLVAIKRAKKEQ-FENLQTEFSSEVELLSKIDHRNLVKL 328
           +G+G FG V+     +  +   L A+K  KK       +     E ++L +++H  +VKL
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 329 L-GFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRL------EIAIDVAHGLTY 380
              F  +   +L +I +F+  G L   L  +      F +        E+A+     L +
Sbjct: 92  HYAFQTE--GKLYLILDFLRGGDLFTRLS-KEVM---FTEEDVKFYLAELAL----ALDH 141

Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
           LH      II+RD+K  NILL E    K+ DFG ++       + +  +   GTV Y+ P
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--SFC-GTVEYMAP 195

Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           E +     T  +D +SFGVL+ E+LTG  P
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 66/207 (31%), Positives = 97/207 (46%), Gaps = 24/207 (11%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKE------QFENLQTEFSSEVELLSKIDHRNLV 326
           +G+G FG V  ++ +    L A+K  KK+        E    E    V L        L 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE--KRV-LALPGKPPFLT 84

Query: 327 KLLG-FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +L   F  +  +RL  + E+V  G L  H+  Q G+  + +     A ++A GL +L   
Sbjct: 85  QLHSCF--QTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAA-EIAIGLFFLQ-- 138

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
             K II+RD+K  N++L      K+ADFG  +    D   T   T   GT  Y+ PE + 
Sbjct: 139 -SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK--TFC-GTPDYIAPE-II 193

Query: 445 TYQLTTKS-DVYSFGVLLLEILTGRRP 470
            YQ   KS D ++FGVLL E+L G+ P
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 66/207 (31%), Positives = 100/207 (48%), Gaps = 24/207 (11%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKE------QFENLQTEFSSEVELLSKIDHRNLV 326
           +G+G FG V  A++++ G L A+K  KK+        E   TE    + L    +H  L 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE--KRI-LSLARNHPFLT 87

Query: 327 KLLG-FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +L   F  +  +RL  + EFV  G L  H+  Q  +  D  +    A ++   L +LH  
Sbjct: 88  QLFCCF--QTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISALMFLH-- 141

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +K II+RD+K  N+LL      K+ADFG  + G  +   T  +T   GT  Y+ PE + 
Sbjct: 142 -DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFC-GTPDYIAPE-IL 196

Query: 445 TYQLTTKS-DVYSFGVLLLEILTGRRP 470
              L   + D ++ GVLL E+L G  P
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 48/258 (18%), Positives = 101/258 (39%), Gaps = 78/258 (30%)

Query: 265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDH 322
           ++ +S    +G G FG V +   +E G   A+K+  ++ +++N       E++++  +DH
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR------ELDIMKVLDH 59

Query: 323 RNLVKLLGFVDKGNERL--------------------------------------IITEF 344
            N++KL+ +     +                                        +I E+
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAH----------GLTYLHLYAEKQIIHRDV 394
           VP+ TL + L   + ++    + + +                 + ++H      I HRD+
Sbjct: 120 VPD-TLHKVLK-SFIRS---GRSIPMN----LISIYIYQLFRAVGFIH---SLGICHRDI 167

Query: 395 KSSNILL-TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM---KTYQLTT 450
           K  N+L+ ++    K+ DFG A+   +      ++     +  Y  PE M     Y  T 
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAK--KLIPSEPSVAYIC--SRFYRAPELMLGATEY--TP 221

Query: 451 KSDVYSFGVLLLEILTGR 468
             D++S G +  E++ G+
Sbjct: 222 SIDLWSIGCVFGELILGK 239

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 30/219 (13%)

Query: 265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS----EVELLSK 319
              ++    IGEG +G V  A    + + VAIK  K   FE+    +      E+++L +
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK--KISPFEHQT--YCQRTLREIKILLR 81

Query: 320 IDHRNLVKLLGFV-----DKGNERLIITEFVP---NGTLR-EHLDGQYGKTLDFNQRLEI 370
             H N++ +   +     ++  +  I+ + +       L+ +HL   +     + Q L  
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QIL-- 138

Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
                 GL Y+H      ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+
Sbjct: 139 -----RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190

Query: 431 VKGTVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
              T  Y  PE M   +  TKS D++S G +L E+L+ R
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 79.5 bits (196), Expect = 6e-16
 Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 32/218 (14%)

Query: 265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS----EVELLSK 319
            + +     IG G  G V  A        VAIK+  +  F+N     +     E+ L+  
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQT--HAKRAYRELVLMKC 117

Query: 320 IDHRNLVKLL------GFVDKGNERLIITEFVP---NGTLREHLDGQYGKTLDFNQRLEI 370
           ++H+N++ LL        +++  +  ++ E +       ++  LD +    L + Q L  
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY-QML-- 174

Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
                 G+ +LH      IIHRD+K SNI++      K+ DFG AR     +  + + T 
Sbjct: 175 -----CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTP 222

Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGR 468
              T  Y  PE +         D++S G ++ E++  +
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 78.0 bits (193), Expect = 7e-16
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 24/207 (11%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKE------QFENLQTEFSSEVELLSKIDHRNLV 326
           IG G +  V   +L+    + A+K  KKE        + +QTE    V      +H  LV
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE--KHV-FEQASNHPFLV 73

Query: 327 KLLG-FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
            L   F  +   RL  + E+V  G L  H+  +  K  + + R   A +++  L YLH  
Sbjct: 74  GLHSCF--QTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSA-EISLALNYLH-- 127

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            E+ II+RD+K  N+LL      K+ D+G  + G    D T       GT  Y+ PE + 
Sbjct: 128 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST---FCGTPNYIAPE-IL 182

Query: 445 TYQLTTKS-DVYSFGVLLLEILTGRRP 470
             +    S D ++ GVL+ E++ GR P
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSP 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 24/207 (11%)

Query: 274 IGEGGFGTVYKAQLED-GLLVAIKRAKKE------QFENLQTEFSSEVELLSKIDHRNLV 326
           IG G +  V   +L+    + A++  KKE        + +QTE    V      +H  LV
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE--KHV-FEQASNHPFLV 116

Query: 327 KLLG-FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
            L   F  +   RL  + E+V  G L  H+  +  K  + + R   A +++  L YLH  
Sbjct: 117 GLHSCF--QTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSA-EISLALNYLH-- 170

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            E+ II+RD+K  N+LL      K+ D+G  + G    D T       GT  Y+ PE + 
Sbjct: 171 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST---FCGTPNYIAPE-IL 225

Query: 445 TYQLTTKS-DVYSFGVLLLEILTGRRP 470
             +    S D ++ GVL+ E++ GR P
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 77.2 bits (191), Expect = 1e-15
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 41/217 (18%)

Query: 274 IGEGGFGTVYKAQL----EDGLLVAIKRAKKE-------QFENLQTEFSSEVELLSKIDH 322
           +G+GG+G V++ +       G + A+K  KK           + + E +    +L ++ H
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN----ILEEVKH 80

Query: 323 RNLVKLL-GFVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRL------EIAIDV 374
             +V L+  F      +L +I E++  G L   L+ + G    F +        EI++  
Sbjct: 81  PFIVDLIYAFQTG--GKLYLILEYLSGGELFMQLE-REGI---FMEDTACFYLAEISM-- 132

Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT 434
              L +LH   +K II+RD+K  NI+L      K+ DFG  +    D   TH  T   GT
Sbjct: 133 --ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH--TFC-GT 184

Query: 435 VGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRP 470
           + Y+ PE +       ++ D +S G L+ ++LTG  P
Sbjct: 185 IEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 54/234 (23%), Positives = 95/234 (40%), Gaps = 51/234 (21%)

Query: 265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS----EVELLSK 319
              +     +G GG G V+ A   +    VAIK   K    + Q         E++++ +
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQ--SVKHALREIKIIRR 64

Query: 320 IDHRNLVKLL--------------GFVDKGNERLIITEFVP--------NGTL-REHLDG 356
           +DH N+VK+               G + + N   I+ E++          G L  EH   
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA-- 122

Query: 357 QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL-TESMRAKVADFGFA 415
           +                +  GL Y+H      ++HRD+K +N+ + TE +  K+ DFG A
Sbjct: 123 RL-----------FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLA 168

Query: 416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
           R+           ++   T  Y  P  + +    TK+ D+++ G +  E+LTG+
Sbjct: 169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 33/218 (15%)

Query: 265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS--EVELLSKID 321
            + +     +G G +G+V  A     G  VAIK+  +  F++      +  E+ LL  + 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQ 81

Query: 322 HRNLVKLL------GFVDKGNERLIITEFVP---NGTLREHLDGQYGKTLDFNQRLEIAI 372
           H N++ LL        +    +  ++  F+       +      +  + L + Q L    
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY-QML---- 136

Query: 373 DVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTH-ISTKV 431
               GL Y+H      ++HRD+K  N+ + E    K+ DFG AR    D++ T  + T+ 
Sbjct: 137 ---KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRW 188

Query: 432 KGTVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
                Y  PE + ++    ++ D++S G ++ E+LTG+
Sbjct: 189 -----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 63/232 (27%), Positives = 95/232 (40%), Gaps = 49/232 (21%)

Query: 265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS----EVELLSK 319
           + +F     +GEG +G V  A     G +VAIK  K E F+     F+     E+++L  
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK--KIEPFDKPL--FALRTLREIKILKH 65

Query: 320 IDHRNLVKLL-----GFVDKGNERLIITEFVP--------NGTL-REHLDGQYGKTLDFN 365
             H N++ +         +  NE  II E +            L  +H+  QY     F 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI--QY-----FI 118

Query: 366 -QRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR 424
            Q L         +  LH      +IHRD+K SN+L+  +   KV DFG AR+    +  
Sbjct: 119 YQTL-------RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168

Query: 425 THISTKVKG-------TVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
               T  +        T  Y  PE M T    +++ DV+S G +L E+   R
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 50/231 (21%), Positives = 89/231 (38%), Gaps = 48/231 (20%)

Query: 205 NSMDSASSLDVNSGSEKVSGADKVPPSPMRVPPSPSRFTMSPKLNRIGSVHLNMSQVVKA 264
           +   +A+    +     VSG+ +      +   S    +M                  + 
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRP-----------HSDWQI 51

Query: 265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL---QTEFSSEVELLSKI 320
              +     IG G +G V +A    +  +VAIK+  +  FE+L   +     E+ +L+++
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILR-EIAILNRL 109

Query: 321 DHRNLVKLL-----GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVA 375
           +H ++VK+L       V+K +E  ++ E           D  + K       L       
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEI---------ADSDFKKLFRTPVYLTEL---- 156

Query: 376 H----------GLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR 416
           H          G+ Y+H      I+HRD+K +N L+ +    KV DFG AR
Sbjct: 157 HIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 48/210 (22%), Positives = 76/210 (36%), Gaps = 51/210 (24%)

Query: 274 IGEGGFGTVYKA-QLEDGLLVAIKR-AKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLG 330
           +G G  G V +          A+K      +          EVEL  +     ++V+++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-------EVELHWRASQCPHIVRIVD 78

Query: 331 -FVDKGNER---LIITEFVPNGTLREHLDGQYGKTLDFNQR--LEIAIDVAHGLTYLHLY 384
            + +    R   LI+ E +  G L   +  +  +   F +R   EI   +   + YLH  
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLH-- 134

Query: 385 AEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
               I HRDVK  N+L T    +   K+ DFGFA                         E
Sbjct: 135 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------------------------KE 169

Query: 442 YMKT-YQLTTKSDVYSFGVLLLEILTGRRP 470
                Y      D++S GV++  +L G  P
Sbjct: 170 TTGEKY--DKSCDMWSLGVIMYILLCGYPP 197

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 73.2 bits (180), Expect = 4e-14
 Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 37/219 (16%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSKI---------- 320
           +G G F TV+ A+ + +   VA+K  R  K   E  + E    ++LL ++          
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----IKLLQRVNDADNTKEDS 82

Query: 321 -DHRNLVKLLG-FVDKGNERL---IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVA 375
               +++KLL  F  KG   +   ++ E V    L   +     + +      +I+  + 
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQLL 141

Query: 376 HGLTYLHLYAEKQIIHRDVKSSNILLTESMRA------KVADFGFARLGPMDSDRTHIST 429
            GL Y+H      IIH D+K  N+L+            K+AD G A          H + 
Sbjct: 142 LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-----WYDEHYTN 194

Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGR 468
            ++ T  Y  PE +        +D++S   L+ E++TG 
Sbjct: 195 SIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 43/220 (19%)

Query: 274 IGEGGFGTVYKAQL----EDGLLVAIKRAKK-------EQFENLQTEFSSEVELLSKIDH 322
           +G G +G V+  +     + G L A+K  KK       +  E+ +TE      +L  I  
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ----VLEHIRQ 117

Query: 323 RN-LVKLLG-FVDKGNERL-IITEFVPNGTLREHLDGQYGKTLDFNQRL------EIAID 373
              LV L   F  +   +L +I +++  G L  HL  Q  +   F +        EI + 
Sbjct: 118 SPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLS-QRER---FTEHEVQIYVGEIVL- 170

Query: 374 VAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG-PMDSDRTHISTKVK 432
               L +LH   +  II+RD+K  NILL  +    + DFG ++     +++R +      
Sbjct: 171 ---ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY--DFC- 221

Query: 433 GTVGYLDPEYMKTYQL-TTKS-DVYSFGVLLLEILTGRRP 470
           GT+ Y+ P+ ++       K+ D +S GVL+ E+LTG  P
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 44/224 (19%)

Query: 265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS--EVELLSKID 321
              +     +G G +G V  A     G  VAIK+  +  F++      +  E+ LL  + 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMR 82

Query: 322 HRNLVKLL------GFVDKGNERLIITEF--------VPNGTLR-EHLDGQYGKTLDFNQ 366
           H N++ LL        +D   +  ++  F        + +  L  + +  Q+        
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI--QF-------- 132

Query: 367 RLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT- 425
              +   +  GL Y+H      IIHRD+K  N+ + E    K+ DFG AR    DS+ T 
Sbjct: 133 ---LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTG 184

Query: 426 HISTKVKGTVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
           ++ T+      Y  PE +  +   T++ D++S G ++ E++TG+
Sbjct: 185 YVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 34/219 (15%)

Query: 265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS--EVELLSKID 321
              +     +G G +G+V  A   + GL VA+K+  +  F+++     +  E+ LL  + 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMK 86

Query: 322 HRNLVKLL------GFVDKGNERLIITEFVP---NGTLR-EHLDGQYGKTLDFNQRLEIA 371
           H N++ LL        +++ N+  ++T  +    N  ++ + L   + + L + Q L   
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY-QIL--- 142

Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT-HISTK 430
                GL Y+H      IIHRD+K SN+ + E    K+ DFG AR      + T +++T+
Sbjct: 143 ----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATR 193

Query: 431 VKGTVGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
                 Y  PE M  +    ++ D++S G ++ E+LTGR
Sbjct: 194 W-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 55/248 (22%), Positives = 91/248 (36%), Gaps = 63/248 (25%)

Query: 265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS----EVELLSK 319
             N+     IG G +G VY A        VAIK+  +  FE+L          E+ +L++
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLI--DCKRILREITILNR 81

Query: 320 IDHRNLVKLLGFV-----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQ--RLEIAI 372
           +    +++L   +      K +E  I+ E   +               D  +  +  I +
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS---------------DLKKLFKTPIFL 126

Query: 373 DVAH----------GLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS 422
              H          G  ++H   E  IIHRD+K +N LL +    KV DFG AR    + 
Sbjct: 127 TEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183

Query: 423 DRTHISTKVKGTVGYLD-------------------PEYMKTYQLTTKS-DVYSFGVLLL 462
           D   ++   +                          PE +   +  TKS D++S G +  
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA 243

Query: 463 EILTGRRP 470
           E+L   + 
Sbjct: 244 ELLNMLQS 251

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 37/212 (17%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSKI------DHRN 324
           IG+G FG V KA   +    VA+K  R +K        E    + +L  +      +  N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMN 160

Query: 325 LVKLLGFVDKGNERLIITEFV-PNGTLREHL-DGQY-GKTLDFNQRLEIAIDVAHGLTYL 381
           ++ +L      N   +  E +  N  L E +   ++ G +L   ++   A  +   L  L
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMN--LYELIKKNKFQGFSLPLVRK--FAHSILQCLDAL 216

Query: 382 HLYAEKQIIHRDVKSSNILLTESMRA--KVADFGFARLGPMDSDRTH---ISTKVKGTVG 436
           H   + +IIH D+K  NILL +  R+  KV DFG +        +     I ++      
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF----- 264

Query: 437 YLDPEYMKTYQLTTKSDVYSFGVLLLEILTGR 468
           Y  PE +   +     D++S G +L E+LTG 
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 56/240 (23%), Positives = 96/240 (40%), Gaps = 55/240 (22%)

Query: 265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS----EVELLSK 319
            R +    ++G+G +G V+K+     G +VA+K+     F+N     +     E+ +L++
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-AFQNST--DAQRTFREIMILTE 64

Query: 320 I-DHRNLVKLLGFV--DKGNERLIITEFVP---NGTLR------EHLDGQYGKTLDFNQR 367
           +  H N+V LL  +  D   +  ++ +++    +  +R       H   QY         
Sbjct: 65  LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHK--QY--------- 113

Query: 368 LEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI 427
             +   +   + YLH      ++HRD+K SNILL      KVADFG +R        T+ 
Sbjct: 114 --VVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168

Query: 428 STKVKGTVGYLD------------------PEYMKTYQLTTKS-DVYSFGVLLLEILTGR 468
                                         PE +      TK  D++S G +L EIL G+
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 68.3 bits (166), Expect = 4e-12
 Identities = 87/506 (17%), Positives = 156/506 (30%), Gaps = 149/506 (29%)

Query: 100 HYANHCIFEGYSGSDYCRLD-LSLAKLSFSPGRKNLQ-KEVKEEPKTHDAGQNFHPREEK 157
           H+ +H  FE      Y   D LS+ + +F     N   K+V++ PK              
Sbjct: 2   HHHHHMDFE-TGEHQYQYKDILSVFEDAF---VDNFDCKDVQDMPK-------------- 43

Query: 158 NYSGSLSTTKKVGIAATGLFVMSCALLCPCFYKKRKATAHTVLARDPNSMDSASSLDVNS 217
                LS  +   I  +   V     L      K++      +            L +N 
Sbjct: 44  ---SILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVE---------EVLRINY 91

Query: 218 G--SEKVSGADKVPPSPM--------RVPPSPSRFTMSPKLN--RIGSVHLNMSQVVKAT 265
                 +    + P            R+      F    K N  R+        ++ +A 
Sbjct: 92  KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVF---AKYNVSRLQPYL----KLRQAL 144

Query: 266 RNFSPSLRI---GEGGFG-TVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID 321
               P+  +   G  G G T         + + +  + K     +Q +   ++  L+   
Sbjct: 145 LELRPAKNVLIDGVLGSGKTW--------VALDVCLSYK-----VQCKMDFKIFWLN--- 188

Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI-DVAHGLTY 380
                  L   +     L + +      L   +D  +    D +  +++ I  +   L  
Sbjct: 189 -------LKNCNSPETVLEMLQ-----KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236

Query: 381 L---HLYAEKQIIHRDVKSSN----------ILLTESMRAKVADFGFARLGPMDSDRTHI 427
           L     Y    ++  +V+++           ILLT +   +V DF    L    +  THI
Sbjct: 237 LLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLT-TRFKQVTDF----LSA--ATTTHI 289

Query: 428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPE--------- 478
           S     ++     E         KS       LLL+ L   RP +L  P E         
Sbjct: 290 SL-DHHSMTLTPDE--------VKS-------LLLKYL-DCRPQDL--PREVLTTNPRRL 330

Query: 479 ----ERV---TLRWA-FKRYNEGNLLDMVDPSIKEVISMEILTKMF-GLAIQCAAPIRND 529
               E +      W  +K  N   L  +++ S+  V+      KMF  L++         
Sbjct: 331 SIIAESIRDGLATWDNWKHVNCDKLTTIIESSL-NVLEPAEYRKMFDRLSV-----FPPS 384

Query: 530 RPDMKSVGEQLWA--IRADSLKSVKK 553
                 +   +W   I++D +  V K
Sbjct: 385 AHIPTILLSLIWFDVIKSDVMVVVNK 410

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.5 bits (99), Expect = 3e-04
 Identities = 79/574 (13%), Positives = 146/574 (25%), Gaps = 179/574 (31%)

Query: 59  AIQSKVCGADHIAYSNSNEVELFYI-------NGNLVDKFSFCKVIQFHYANHCIFEGYS 111
            +  +    DHI  S         +          +V KF   +V++ +Y    +     
Sbjct: 45  ILSKEEI--DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKF-VEEVLRINYK--FLMSPIK 99

Query: 112 GSDYCRLDLSLAKLSFSPGRKNLQKEVKEEPKTHDAGQNFHPREE-----KNYSGSLSTT 166
                R   S+    +   R  L  + +   K +        R +     +     L   
Sbjct: 100 --TEQR-QPSMMTRMYIEQRDRLYNDNQVFAKYN------VSRLQPYLKLRQALLELRPA 150

Query: 167 KKV---GIAATG---LFVMSC---ALLCPCFYK------KRKATAHTVLARDPNSMDSAS 211
           K V   G+  +G   + +  C    + C   +K      K   +  TVL           
Sbjct: 151 KNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQK------ 204

Query: 212 SLDVNSGSEKVSGADKVPPSPMR---VPPSPSRFTMSPKLNRIGSV--HLNMSQVVKA-- 264
            L         S +D      +R   +     R   S        V  ++  ++   A  
Sbjct: 205 -LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFN 263

Query: 265 --------TRNFSPSLRIGEGGFGTVYKAQLEDG-------------------------- 290
                   TR    +  +       +                                  
Sbjct: 264 LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVL 323

Query: 291 ----LLVAI------------KRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG-F-- 331
                 ++I               K    + L T   S + +L   ++R +   L  F  
Sbjct: 324 TTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPP 383

Query: 332 ---------------VDKGNERLIITEFV---------PNGT---------LREHLDG-- 356
                          V K +  +++ +              T         L+  L+   
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEY 443

Query: 357 --------QYG--KTLDFNQRLEIAID--VAHGLTYLHLYAEKQIIHRDVKSSNILLTES 404
                    Y   KT D +  +   +D      + + HL   +    R      + L   
Sbjct: 444 ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-HLKNIEH-PERMTLFRMVFL--- 498

Query: 405 MRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP-EYMKTYQ--LTTKSDVYSFGVLL 461
                 DF F     ++    H ST    +   L+  + +K Y+  +      Y    L+
Sbjct: 499 ------DFRF-----LEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYE--RLV 545

Query: 462 LEILTGRRPVE--LKRPPEERVTLRWAFKRYNEG 493
             IL     +E  L       + LR A    +E 
Sbjct: 546 NAILDFLPKIEENLICSKYTDL-LRIALMAEDEA 578

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 56/210 (26%), Positives = 83/210 (39%), Gaps = 31/210 (14%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSKI------DHRN 324
           IG+G FG V KA    +   VAIK  + KK      Q E    V LL  +          
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----VRLLELMNKHDTEMKYY 117

Query: 325 LVKLLGFVDKGNERLIITEFV-PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
           +V L       N   ++ E +  N  L + L     + +  N   + A  +   L +L  
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSYN--LYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175

Query: 384 YAEKQIIHRDVKSSNILLTESMRA--KVADFGFARLGPMDSDRTH---ISTKVKGTVGYL 438
             E  IIH D+K  NILL    R+  K+ DFG +        +     I ++      Y 
Sbjct: 176 -PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRF-----YR 225

Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILTGR 468
            PE +         D++S G +L+E+ TG 
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 55/268 (20%), Positives = 84/268 (31%), Gaps = 91/268 (33%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-----DHRN--- 324
           +G G F TV+ +  ++    VA+K  K  +          E+ LL  +     +  N   
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD--EIRLLKSVRNSDPNDPNREM 102

Query: 325 LVKLLG-FVDKGNERLIITEFVPNGT------------LREHLDGQYGKTLDFNQRLEIA 371
           +V+LL  F   G           NGT            L + +     + L      +I 
Sbjct: 103 VVQLLDDFKISG----------VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152

Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLT----------------------------- 402
             V  GL YLH   + +IIH D+K  NILL+                             
Sbjct: 153 QQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210

Query: 403 --------------------ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEY 442
                               E ++ K+AD G A         T        T  Y   E 
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQ----TRQYRSLEV 264

Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +      T +D++S   +  E+ TG   
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYL 292

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 62.2 bits (150), Expect = 1e-10
 Identities = 34/199 (17%), Positives = 56/199 (28%), Gaps = 52/199 (26%)

Query: 264 ATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQT-------EFSSEVEL 316
            T       +IGEG FG V++    D   VAIK    E  + +         E   E+ +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 317 LSKI---------DHRNLVKLLGF------------------------------VDKGNE 337
             ++              + L                                   K ++
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSS 397
             I+ EF   G   E +     K         I   +   L      A  +  HRD+   
Sbjct: 137 LFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWG 191

Query: 398 NILLTESMRAKVADFGFAR 416
           N+LL ++   K+      +
Sbjct: 192 NVLLKKTSLKKLHYTLNGK 210

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 54/230 (23%), Positives = 84/230 (36%), Gaps = 46/230 (20%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFEN--LQTEFSSEVELLSKIDHRNLVKLL 329
           +IG GGFG +Y A         A    K E  EN  L +E      +  K   +  ++  
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQY--------GKTLD--FNQR--------LEIA 371
                G     I  F  +G   E     Y        G  L     Q         L++ 
Sbjct: 104 QLDYLG-----IPLFYGSGL-TEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157

Query: 372 IDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKV--ADFGFARLGPMDSDRTHIST 429
           I +   L Y+H   E + +H D+K++N+LL      +V  AD+G +     + +      
Sbjct: 158 IRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214

Query: 430 KVK----GTVGYLDPEYM-----KTYQLTTKSDVYSFGVLLLEILTGRRP 470
             +    GT+     E+      K   L+ +SDV   G  +L  L G+ P
Sbjct: 215 NPRKGHNGTI-----EFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 44/209 (21%), Positives = 79/209 (37%), Gaps = 19/209 (9%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH-RNLVKLLG 330
           RIGEG FG +++   L +   VAIK    E   +   +   E      +     +  +  
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 73

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F  +G   +++ + +  G   E L    G+          A  +   +  +H   EK ++
Sbjct: 74  FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 128

Query: 391 HRDVKSSNILLTESMRAK-----VADFGFARLGPMDSDRTHISTKVK----GTVGYLDPE 441
           +RD+K  N L+            V DFG  +       + HI  + K    GT  Y+   
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 188

Query: 442 YMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
                + + + D+ + G + +  L G  P
Sbjct: 189 THLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 50/223 (22%), Positives = 83/223 (37%), Gaps = 39/223 (17%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSKI-----DHRNL 325
           +G+G FG V   Q +++    A+K  R  K+   + + E     ++L KI     ++ N+
Sbjct: 43  MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNNNI 98

Query: 326 VKLLGFVDKGNERLIITEFV-PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           VK  G     +   +I E + P+  L E +                 I++   L YL   
Sbjct: 99  VKYHGKFMYYDHMCLIFEPLGPS--LYEIITRNNYNGFHIEDIKLYCIEILKALNYLR-- 154

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI-STKVK----GTVGYLD 439
            +  + H D+K  NILL +    K                    ST +K    G   +  
Sbjct: 155 -KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213

Query: 440 PEYMKTYQLT---------------TKSDVYSFGVLLLEILTG 467
            +Y  +   T                 SD++SFG +L E+ TG
Sbjct: 214 -DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 23/210 (10%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS---EVELLSKIDH-RNLVK 327
           +IG G FG +Y    +  G  VAIK       E ++T+      E ++   +     +  
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIK------LECVKTKHPQLHIESKIYKMMQGGVGIPT 69

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           +     +G+  +++ E +  G   E L     +       L +A  +   + Y+H    K
Sbjct: 70  IRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SK 124

Query: 388 QIIHRDVKSSNILL---TESMRAKVADFGFARLGPMDSDRTHISTKVK----GTVGYLDP 440
             IHRDVK  N L+    +     + DFG A+         HI  +      GT  Y   
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184

Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
                 + + + D+ S G +L+    G  P
Sbjct: 185 NTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 46/228 (20%), Positives = 81/228 (35%), Gaps = 39/228 (17%)

Query: 273 RIGEGGFGTVYKAQ---------LEDGLLVAIK------RAKKEQFENLQTEFSSEVEL- 316
                  G +Y+A                 ++K      R   EQ    +     +V   
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 317 --LSKIDHRNLVKLLGF-VDKGNER-LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI 372
             L       +   +GF V +   R L++     +  L+  LD      L     L++A 
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRS--LQSALDVSPKHVLSERSVLQVAC 166

Query: 373 DVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKV--ADFGFARLGPMDSDRTHIS-- 428
            +   L +LH   E + +H +V + NI +    +++V  A +GFA          H++  
Sbjct: 167 RLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF--RYCPSGKHVAYV 221

Query: 429 -TKVKGTVGYLDPEYM-----KTYQLTTKSDVYSFGVLLLEILTGRRP 470
                   G  D E++     K    + +SD+ S G  +L+ L G  P
Sbjct: 222 EGSRSPHEG--DLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 49/210 (23%), Positives = 87/210 (41%), Gaps = 23/210 (10%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS---EVELLSKIDHRNLV-K 327
           +IG G FG +Y    ++    VAIK       EN++T+      E ++   +     +  
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKIYRILQGGTGIPN 67

Query: 328 LLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
           +  F  +G+  +++ + +  G   E L     + L     L +A  + + + ++H    K
Sbjct: 68  VRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SK 122

Query: 388 QIIHRDVKSSNILLTESMRAK---VADFGFARLGPMDSDRTHISTKVK----GTVGYLDP 440
             +HRD+K  N L+    RA    + DFG A+     S   HI  +      GT  Y   
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV 182

Query: 441 EYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
                 + + + D+ S G +L+  L G  P
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 56.7 bits (137), Expect = 7e-09
 Identities = 45/234 (19%), Positives = 83/234 (35%), Gaps = 51/234 (21%)

Query: 273 RIGEGGFGTVYKAQ------LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
            IG+GGFG +Y A       +       +K    +    L TE             +  +
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFTELKFYQRAAKPEQIQKWI 100

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQY--------GKTL----DFNQR------- 367
           +       G     + ++  +G L +     Y        G  L    + N +       
Sbjct: 101 RTRKLKYLG-----VPKYWGSG-LHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154

Query: 368 LEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKV--ADFGFARLGPMDSDRT 425
           L++++ +   L Y+H   E + +H D+K+SN+LL      +V   D+G A     +    
Sbjct: 155 LQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211

Query: 426 HISTKVK----GTVGYLDPEYM-----KTYQLTTKSDVYSFGVLLLEILTGRRP 470
             +   K    GT+     E+           + + D+   G  +++ LTG  P
Sbjct: 212 AYAADPKRCHDGTI-----EFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 47/224 (20%), Positives = 79/224 (35%), Gaps = 45/224 (20%)

Query: 274 IGEGGFGTVYKA--QLEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSKI------DHR 323
           +GEG FG V +          VA+K  R   +  E  + E    + +L KI      +  
Sbjct: 27  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKENKF 82

Query: 324 NLVKLLGFVDKGNERLIITEFV-PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLH 382
             V +  + +      I  E +  N    E L     +         +A  + H L +LH
Sbjct: 83  LCVLMSDWFNFHGHMCIAFELLGKN--TFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 140

Query: 383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK----GTVGYL 438
              E Q+ H D+K  NIL   S    + +   +       +++  +T ++    G+  + 
Sbjct: 141 ---ENQLTHTDLKPENILFVNSEFETLYNEHKSC-----EEKSVKNTSIRVADFGSATFD 192

Query: 439 DPEYMKTYQLT---------------TKSDVYSFGVLLLEILTG 467
             E+  T   T                  DV+S G +L E   G
Sbjct: 193 H-EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 48/213 (22%), Positives = 83/213 (38%), Gaps = 27/213 (12%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSS---EVELLSKIDH-RNLVK 327
           +IG G FG +   + L     VAIK       E +++       E     ++     + +
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLEYRFYKQLGSGDGIPQ 69

Query: 328 LLGFVDKGNERLIITEFV-PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           +  F   G    ++ E + P+  L E L     +T      L IAI +   + Y+H    
Sbjct: 70  VYYFGPCGKYNAMVLELLGPS--L-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---S 123

Query: 387 KQIIHRDVKSSNILL--TESMRAKVA---DFGFARLGPMDSDRTHISTKVK----GTVGY 437
           K +I+RDVK  N L+    +   +V    DF  A+       + HI  +      GT  Y
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183

Query: 438 LDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +        + + + D+ + G + +  L G  P
Sbjct: 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 45/224 (20%), Positives = 84/224 (37%), Gaps = 45/224 (20%)

Query: 274 IGEGGFGTVYKAQ--LEDGLLVAIK--RAKKEQFENLQTEFSSEVELLSKI------DHR 323
           +GEG FG V +       G  VA+K  +      E  ++E    +++L  +         
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE----IQVLEHLNTTDPNSTF 77

Query: 324 NLVKLLGFVDKGNERLIITEFV-PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLH 382
             V++L + +      I+ E +  +    + +          +   ++A  +   + +LH
Sbjct: 78  RCVQMLEWFEHHGHICIVFELLGLS--TYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH 135

Query: 383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK----GTVGYL 438
                ++ H D+K  NIL  +S   +  +    R      +RT I+  +K    G+  Y 
Sbjct: 136 ---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR-----DERTLINPDIKVVDFGSATYD 187

Query: 439 DPEYMKTYQLT---------------TKSDVYSFGVLLLEILTG 467
           D E+  T   T                  DV+S G +L+E   G
Sbjct: 188 D-EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	554
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.69
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.14
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.01
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.78
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.59
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.5
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.48
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.47
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.27
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.01
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.94
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.81
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.75
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.51
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.49
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.31
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.29
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.26
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	97.09
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.08
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.05
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	97.0
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.0
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.87
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.79
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	96.22
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.13
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	95.81
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	95.63
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	95.54
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	95.49
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	95.48
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	95.33
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	95.33
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	95.32
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	95.16
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	95.1
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	95.07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	95.02
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	94.98
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	94.76
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	94.7
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	94.67
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	94.57
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	94.41
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	94.4
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	94.21
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	93.86
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	93.72
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	93.69
3e6j_A	229	Variable lymphocyte receptor diversity region; var	93.64
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	93.56
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	93.54
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	93.26
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	93.22
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	93.18
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	92.77
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	92.69
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	92.63
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	92.62
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	92.58
3e6j_A	229	Variable lymphocyte receptor diversity region; var	92.53
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	92.51
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	92.5
3m19_A	251	Variable lymphocyte receptor A diversity region; a	92.22
3m19_A	251	Variable lymphocyte receptor A diversity region; a	91.99
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	91.9
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	91.88
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	91.84
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	91.8
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	91.77
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	91.69
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	91.61
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	91.44
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	91.28
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	91.24
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	91.24
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	91.09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	91.01
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	91.01
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	90.93
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	90.59
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	90.55
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	90.44
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	90.43
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	90.43
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	90.39
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	90.21
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	90.11
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	90.1
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	89.83
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	89.73
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	89.72
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	89.61
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	89.61
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	89.47
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	89.41
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	89.34
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	89.06
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	89.04
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	88.96
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	88.95
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	88.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	88.84
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	88.82
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	88.81
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	88.81
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	88.74
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	88.65
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	88.63
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	88.48
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	88.31
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	88.26
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	88.21
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.15
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	88.12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	88.09
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	88.03
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	87.83
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	87.79
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	87.73
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	87.69
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	87.69
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	87.65
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	87.59
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	87.48
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	87.31
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	87.24
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	87.16
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	87.13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	86.73
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	86.56
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	86.52
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	86.44
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	86.32
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	86.26
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	85.67
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	85.62
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	85.53
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	85.2
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	85.09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	85.04
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	85.0
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	84.96
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	84.77
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	84.64
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	84.61
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	84.44
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	84.2
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	84.08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	84.01
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	82.74
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.31
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	82.11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	81.89
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	81.7
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	81.64
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	81.49
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.8

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-55  Score=451.45  Aligned_cols=260  Identities=29%  Similarity=0.481  Sum_probs=208.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      ++|...++||+|+||+||+|++.      +++.||||+++... ....++|.+|+++|++++|||||+++|+|.+++..+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            45677889999999999999864      47899999997654 445678999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhccc-------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc
Q 042763          340 IITEFVPNGTLREHLDGQY-------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR  406 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~  406 (554)
                      +|||||++|+|.++++...             ...++|.+++.|+.||+.||+|||   +++|+||||||+|||+++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCc
Confidence            9999999999999997642             246899999999999999999999   899999999999999999999


Q ss_pred             EEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHH
Q 042763          407 AKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRW  485 (554)
Q Consensus       407 vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~  485 (554)
                      +||+|||+|+..... ..........||+.|||||++.+..|+.++|||||||+||||+| |+.||......+...   .
T Consensus       197 ~Ki~DFGla~~~~~~-~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~---~  272 (329)
T 4aoj_A          197 VKIGDFGMSRDIYST-DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID---C  272 (329)
T ss_dssp             EEECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH---H
T ss_pred             EEEcccccceeccCC-CcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH---H
Confidence            999999999864322 22233345679999999999999999999999999999999999 899998755433221   1


Q ss_pred             HHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          486 AFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      ...    +...+         .+..++..+.+|+.+||+.||++||||.||+++|+.+...
T Consensus       273 i~~----g~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          273 ITQ----GRELE---------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHH----TCCCC---------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHc----CCCCC---------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            111    11000         1223456789999999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.5e-56  Score=449.02  Aligned_cols=260  Identities=28%  Similarity=0.473  Sum_probs=213.6

Q ss_pred             cCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      ++|...++||+|+||+||+|++.      ++..||||+++... ....++|.+|+++|++++|||||+++|+|.+++..+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            56778889999999999999764      47899999997654 445678999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcc-----------cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEE
Q 042763          340 IITEFVPNGTLREHLDGQ-----------YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAK  408 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vk  408 (554)
                      +|||||++|+|.++|+..           ....+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEE
Confidence            999999999999999753           2357999999999999999999999   89999999999999999999999


Q ss_pred             EEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHH
Q 042763          409 VADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAF  487 (554)
Q Consensus       409 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~  487 (554)
                      |+|||+|+..... ..........||+.|||||++.+..|+.++|||||||++|||+| |+.||......+..   ....
T Consensus       169 i~DFGla~~~~~~-~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~---~~i~  244 (299)
T 4asz_A          169 IGDFGMSRDVYST-DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI---ECIT  244 (299)
T ss_dssp             ECCCSCHHHHTGG-GCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HHHH
T ss_pred             ECCcccceecCCC-CceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHH
Confidence            9999999864321 12222334569999999999999999999999999999999999 89999875543221   1111


Q ss_pred             HhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          488 KRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                          .+....         .+..++..+.+|+.+||+.||++|||++||.+.|+++...
T Consensus       245 ----~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          245 ----QGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             ----HTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----cCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                111111         1233456789999999999999999999999999887653

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.6e-56  Score=449.41  Aligned_cols=257  Identities=25%  Similarity=0.409  Sum_probs=211.9

Q ss_pred             CCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      +++..++||+|+||+||+|.+.      +++.||||+++........++|.+|+.++++++|||||+++|+|.+++..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3455778999999999999863      4689999999876555556789999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhccc--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc
Q 042763          341 ITEFVPNGTLREHLDGQY--------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR  406 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~  406 (554)
                      |||||++|+|.++|..+.              ...+++.+++.|+.|||.||+|||   +++||||||||+|||+++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence            999999999999996532              236899999999999999999999   899999999999999999999


Q ss_pred             EEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHH
Q 042763          407 AKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRW  485 (554)
Q Consensus       407 vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~  485 (554)
                      +||+|||+|+..... +.........||+.|||||++.+..|+.++|||||||+||||+| |+.||......+.   +..
T Consensus       184 ~Ki~DFGlar~~~~~-~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~---~~~  259 (308)
T 4gt4_A          184 VKISDLGLFREVYAA-DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---VEM  259 (308)
T ss_dssp             EEECCSCCBCGGGGG-GCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH---HHH
T ss_pred             EEECCcccceeccCC-CceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH---HHH
Confidence            999999999864321 12223345679999999999999999999999999999999999 8999987553322   222


Q ss_pred             HHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          486 AFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      +    ..+....         .+.+++..+.+|+.+||+.||++||||.||+++|++.
T Consensus       260 i----~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          260 I----RNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             H----HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             H----HcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1    1111111         2234556789999999999999999999999999865

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.3e-56  Score=454.16  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=210.2

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ++|++.++||+|+||+||+|... +|+.||||++..... ....+.+.+|+++|++|+|||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999765 699999999976543 3345789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      ||++|+|.+++..+....+++.+++.++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+...   .
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~---~  177 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN---S  177 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCC---H
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeec---C
Confidence            999999999998776667899999999999999999999   8999999999999999999999999999998642   1


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      ........+||+.|||||++.+..|+.++|||||||++|||+||+.||......+...   ...    .+....      
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~---~i~----~~~~~~------  244 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL---KII----SGSFPP------  244 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHH----HTCCCC------
T ss_pred             CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HHH----cCCCCC------
Confidence            1223345679999999999999999999999999999999999999998755332221   111    111110      


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                         .+..++..+.+|+.+||+.||++|||+.|+++|.|--
T Consensus       245 ---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~  281 (350)
T 4b9d_A          245 ---VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA  281 (350)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred             ---CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhh
Confidence               1223445688999999999999999999999998753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6e-55  Score=440.53  Aligned_cols=263  Identities=30%  Similarity=0.497  Sum_probs=208.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .+++...++||+|+||+||+|++.+  .||||+++.... ....+.|.+|+++|++++|||||+++|++.+ +..++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            3567788899999999999998763  589999875432 3445789999999999999999999998865 56899999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      ||++|+|.+++... ...+++.+++.|+.||+.||+|||   +++||||||||+|||+++++.+||+|||+|+...... 
T Consensus       112 y~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~-  186 (307)
T 3omv_A          112 WCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS-  186 (307)
T ss_dssp             CCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCC-
Confidence            99999999999754 346999999999999999999999   8899999999999999999999999999998643222 


Q ss_pred             CccccccccCCCCCcChhcccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          424 RTHISTKVKGTVGYLDPEYMKT---YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      ........+||+.|||||++.+   ..|+.++|||||||+||||+||+.||...........  ........        
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~--~~~~~~~~--------  256 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF--MVGRGYAS--------  256 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH--HHHTTCCC--------
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH--HHhcCCCC--------
Confidence            2223345689999999999964   3699999999999999999999999987654432211  11111111        


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      |.+. ....+++..+.+|+.+||+.||++||||.||+++|+.++..
T Consensus       257 p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          257 PDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             CCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             CCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence            1111 12234556789999999999999999999999999988754

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.2e-55  Score=448.22  Aligned_cols=256  Identities=23%  Similarity=0.384  Sum_probs=213.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ..|+..++||+|+||+||+|... +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            56999999999999999999775 699999999976543 2345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      |++|+|.+++...   .+++.++..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.....   
T Consensus       153 ~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~---  223 (346)
T 4fih_A          153 LEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE---  223 (346)
T ss_dssp             CTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS---
T ss_pred             CCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCC---
Confidence            9999999999753   6999999999999999999999   899999999999999999999999999999875322   


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      .......+||+.|||||++.+..|+.++|||||||++|||++|+.||......+...   ......         .+.+.
T Consensus       224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~---~i~~~~---------~~~~~  291 (346)
T 4fih_A          224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIRDNL---------PPRLK  291 (346)
T ss_dssp             SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHSS---------CCCCS
T ss_pred             CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HHHcCC---------CCCCC
Confidence            223445789999999999999999999999999999999999999998654332221   111110         01110


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                        ....++..+.+++.+||+.||++|||+.|+++|.|--+.
T Consensus       292 --~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          292 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             --CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence              112344568899999999999999999999999886543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-54  Score=438.15  Aligned_cols=260  Identities=23%  Similarity=0.300  Sum_probs=214.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|++.++||+|+||+||+|... +|+.||||++.+...  ....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999765 699999999987643  234567999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      |||++|+|.+++.+.  ..+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+......
T Consensus       112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            999999999999765  57999999999999999999999   8999999999999999999999999999998754322


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                       ........+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....   +.    .... .     
T Consensus       187 -~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~---i~----~~~~-~-----  252 (311)
T 4aw0_A          187 -KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK---II----KLEY-D-----  252 (311)
T ss_dssp             -TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HH----HTCC-C-----
T ss_pred             -CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH----cCCC-C-----
Confidence             22234557899999999999999999999999999999999999999986543322211   11    1111 0     


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                          ++..++.++.+++.+||+.||++|||+.|++.+-|=.+--|.
T Consensus       253 ----~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F  294 (311)
T 4aw0_A          253 ----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF  294 (311)
T ss_dssp             ----CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGG
T ss_pred             ----CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCc
Confidence                112234567899999999999999999997655544333333

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.7e-54  Score=441.56  Aligned_cols=258  Identities=22%  Similarity=0.281  Sum_probs=211.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .+.|...++||+|+||+||+|... +|+.||||+++....      ..+|+.+|++++|||||++++++.+++..|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356778889999999999999765 699999999976532      2469999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC-cEEEEeecCcccCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPMDS  422 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~~~~~  422 (554)
                      ||++|+|.++++..  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.+| .+||+|||+|+......
T Consensus       131 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          131 LLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             ccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            99999999999765  57999999999999999999999   99999999999999999987 69999999998754322


Q ss_pred             CCc--cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          423 DRT--HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       423 ~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      ...  ......+||+.|||||++.+..|+.++|||||||++|||+||+.||...........+..     ..        
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-----~~--------  272 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-----EP--------  272 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH-----SC--------
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc-----CC--------
Confidence            111  122346799999999999999999999999999999999999999987655433222211     00        


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                      +.. ..++..++..+.+++.+||+.||++|||+.|++++++....+.
T Consensus       273 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          273 PPI-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             CGG-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CCc-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence            000 1123345667899999999999999999999999998876543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.4e-54  Score=429.40  Aligned_cols=248  Identities=25%  Similarity=0.435  Sum_probs=202.0

Q ss_pred             CcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc----CCceEEEE
Q 042763          269 SPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK----GNERLIIT  342 (554)
Q Consensus       269 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~~lv~  342 (554)
                      +..++||+|+||+||+|... ++..||+|++..... ....+.|.+|+++|++++|||||++++++.+    ++..++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999765 589999999976543 3345779999999999999999999999865    34579999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eEeCCCCCCCeEEC-CCCcEEEEeecCcccCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ--IIHRDVKSSNILLT-ESMRAKVADFGFARLGP  419 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NILl~-~~~~vkl~DfGla~~~~  419 (554)
                      |||++|+|.+++.+.  ..+++.+++.++.||+.||+|||   +++  |+||||||+|||++ .++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            999999999999765  57999999999999999999999   777  99999999999998 48999999999998632


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      .     ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.........      ......+.    .
T Consensus       184 ~-----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~------~~~i~~~~----~  247 (290)
T 3fpq_A          184 A-----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGV----K  247 (290)
T ss_dssp             T-----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTC----C
T ss_pred             C-----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH------HHHHHcCC----C
Confidence            1     22345689999999999875 6999999999999999999999999765443221      11111111    1


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .+....    ..+..+.+++.+||+.||++|||+.|+++|.|
T Consensus       248 ~~~~~~----~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~  285 (290)
T 3fpq_A          248 PASFDK----VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             CGGGGG----CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCCCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            111111    22345789999999999999999999999877

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.5e-54  Score=451.22  Aligned_cols=256  Identities=23%  Similarity=0.384  Sum_probs=213.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +.|+..++||+|+||+||+|... +|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            56999999999999999999765 699999999976543 2345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      |++|+|.+++...   .+++.++..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.....   
T Consensus       230 ~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~---  300 (423)
T 4fie_A          230 LEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE---  300 (423)
T ss_dssp             CTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS---
T ss_pred             CCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCC---
Confidence            9999999999754   6999999999999999999999   899999999999999999999999999999875322   


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      .......+||+.|||||++.+..|+.++|||||||++|||++|+.||......+...   ......         .+.+.
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~---~i~~~~---------~~~~~  368 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIRDNL---------PPRLK  368 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHSC---------CCCCS
T ss_pred             CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HHHcCC---------CCCCc
Confidence            223345789999999999999999999999999999999999999998654433221   111110         01110


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                        ....++..+.+|+.+||+.||++|||+.|+++|.|--+.
T Consensus       369 --~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          369 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             --CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence              111234568899999999999999999999999886543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.1e-54  Score=426.45  Aligned_cols=250  Identities=23%  Similarity=0.371  Sum_probs=196.6

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|++.+.||+|+||+||+|... +|+.||||++.+...  ......+.+|+++|++++|||||++++++.+++..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999765 699999999976543  233567999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||| +|+|.+++..+  ..+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+....  
T Consensus        93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--  164 (275)
T ss_dssp             ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCC--
Confidence            999 78999999765  57999999999999999999999   89999999999999999999999999999986422  


Q ss_pred             CCccccccccCCCCCcChhccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQL-TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                        .......+||+.|||||++.+..| +.++|||||||++|||+||+.||.........   ...    ..+...     
T Consensus       165 --~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~---~~i----~~~~~~-----  230 (275)
T 3hyh_A          165 --GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF---KNI----SNGVYT-----  230 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HHTCCC-----
T ss_pred             --CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH---HHH----HcCCCC-----
Confidence              222345689999999999998876 57999999999999999999999865432211   111    111110     


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                           ++..++..+.+++.+||+.||++|||+.|+++|.|-
T Consensus       231 -----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~  266 (275)
T 3hyh_A          231 -----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF  266 (275)
T ss_dssp             -----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred             -----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence                 112234567899999999999999999999999884

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.4e-53  Score=439.38  Aligned_cols=269  Identities=28%  Similarity=0.387  Sum_probs=219.0

Q ss_pred             HHHHHhhcCCCcceeeeccCceEEEEEEEcC------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCC-CCceeeeeE
Q 042763          259 SQVVKATRNFSPSLRIGEGGFGTVYKAQLED------GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH-RNLVKLLGF  331 (554)
Q Consensus       259 ~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~  331 (554)
                      ++.....++|+..++||+|+||+||+|.+..      ++.||||++.........++|.+|+++|++++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            3444456789999999999999999997642      368999999876655566789999999999965 999999999


Q ss_pred             EEc-CCceEEEEEeCCCCCHHHHHhccc--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCC
Q 042763          332 VDK-GNERLIITEFVPNGTLREHLDGQY--------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKS  396 (554)
Q Consensus       332 ~~~-~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp  396 (554)
                      |.+ ++..++|||||++|+|.++|+...              ...+++.+++.++.|||.||+|||   +++||||||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~  213 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA  213 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCc
Confidence            966 456899999999999999997542              235899999999999999999999   89999999999


Q ss_pred             CCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 042763          397 SNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKR  475 (554)
Q Consensus       397 ~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~  475 (554)
                      +|||+++++.+||+|||+|+...... .........||+.|||||++.+..|+.++|||||||+||||+| |+.||....
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~-~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCC-CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999998654332 2223345679999999999999999999999999999999998 999998765


Q ss_pred             ChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          476 PPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       476 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      .......  ..    ..+....         .+..++.++.+++.+||+.||++|||+.||+++|.++...
T Consensus       293 ~~~~~~~--~i----~~g~~~~---------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          293 IDEEFCR--RL----KEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CSHHHHH--HH----HHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHH--HH----HcCCCCC---------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            4433211  11    1111000         1223445688999999999999999999999999988654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5e-53  Score=427.92  Aligned_cols=273  Identities=22%  Similarity=0.307  Sum_probs=203.5

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC----ceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN----ERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----~~~lv  341 (554)
                      ++|...++||+|+||+||+|++. |+.||||+++.....  ...+..|+..+.+++|||||++++++.+++    ..++|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            45677889999999999999885 899999999765422  223345666677899999999999997654    57999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhc-----cCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY-----AEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ||||++|+|.++++..   .+++.++++++.|++.||+|||..     ...+|+||||||+|||++.++.+||+|||+|+
T Consensus        80 ~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999999999999764   689999999999999999999932     12399999999999999999999999999998


Q ss_pred             cCCCCCCCc-cccccccCCCCCcChhccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhh--------HH
Q 042763          417 LGPMDSDRT-HISTKVKGTVGYLDPEYMKTY------QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEE--------RV  481 (554)
Q Consensus       417 ~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~------~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~--------~~  481 (554)
                      ......... ......+||+.|||||++.+.      .++.++|||||||+||||+||..||........        ..
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            643322221 122345799999999999764      467899999999999999999887643221100        00


Q ss_pred             HHHHHHHhhccCCccccCChhhh-hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          482 TLRWAFKRYNEGNLLDMVDPSIK-EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                      .............    .+|.+. .....+++..+.+|+.+||+.||++||||.||++.|++|..+..
T Consensus       237 ~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~  300 (303)
T 3hmm_A          237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             CHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             hHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence            0111111111111    122211 11234567789999999999999999999999999999987643

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.2e-54  Score=433.43  Aligned_cols=259  Identities=25%  Similarity=0.320  Sum_probs=206.6

Q ss_pred             cCCCcceeeeccCceEEEEEEEc----CCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      ++|++.+.||+|+||+||+|+..    +++.||||++++.... .....+.+|+++|++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999753    4789999999765422 223468899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      |||||++|+|.+++.+.  ..+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus       104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            99999999999999765  57999999999999999999999   89999999999999999999999999999986322


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                         ........+||+.|||||++.+..|+.++|||||||++|||+||+.||...+..+....+   .    .....    
T Consensus       179 ---~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i---~----~~~~~----  244 (304)
T 3ubd_A          179 ---HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI---L----KAKLG----  244 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H----HCCCC----
T ss_pred             ---CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH---H----cCCCC----
Confidence               122334568999999999999999999999999999999999999999875543322211   1    11110    


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHHhhhhhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPD-----MKSVGEQLWAIRADSLK  549 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~i~~~~~~  549 (554)
                            .+..++..+.+++.+||+.||++|||     ++|+++|.|--.-+|.+
T Consensus       245 ------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~  292 (304)
T 3ubd_A          245 ------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNK  292 (304)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             ------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHH
Confidence                  11223456889999999999999998     58999988753334433

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.6e-51  Score=415.35  Aligned_cols=255  Identities=26%  Similarity=0.407  Sum_probs=193.0

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC--------
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN--------  336 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--------  336 (554)
                      ++|++.+.||+|+||+||+|... +|+.||||+++....+...+.+.+|+++|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45888999999999999999765 689999999976554555678999999999999999999999986544        


Q ss_pred             ----ceEEEEEeCCCCCHHHHHhcccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEe
Q 042763          337 ----ERLIITEFVPNGTLREHLDGQYG-KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVAD  411 (554)
Q Consensus       337 ----~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~D  411 (554)
                          ..|+|||||++|+|.+++..+.. ...++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999976532 23456678899999999999999   89999999999999999999999999


Q ss_pred             ecCcccCCCCCCCc---------cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHH
Q 042763          412 FGFARLGPMDSDRT---------HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVT  482 (554)
Q Consensus       412 fGla~~~~~~~~~~---------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~  482 (554)
                      ||+|+.........         ...+..+||+.|||||++.+..|+.++|||||||++|||++   ||....  +....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~  236 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRT  236 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHH
Confidence            99998754322111         12234579999999999999999999999999999999996   775311  11111


Q ss_pred             HHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          483 LRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       483 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      +.    ......    ..+.     .......+.+++.+||+.||++|||+.|+++|.|
T Consensus       237 ~~----~~~~~~----~p~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~  282 (299)
T 4g31_A          237 LT----DVRNLK----FPPL-----FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV  282 (299)
T ss_dssp             HH----HHHTTC----CCHH-----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HH----HHhcCC----CCCC-----CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence            11    111111    1111     1223345678999999999999999999999765

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.1e-51  Score=425.72  Aligned_cols=271  Identities=20%  Similarity=0.256  Sum_probs=209.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc------CC
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK------GN  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~------~~  336 (554)
                      .++|++.++||+|+||+||+|... +|+.||||+++.... ....+.+.+|+++|++++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            367999999999999999999765 699999999976533 2344678899999999999999999998753      36


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ..|+|||||+ |+|.+++...  ..+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceee
Confidence            7899999995 7899999764  57999999999999999999999   8999999999999999999999999999998


Q ss_pred             cCCCCC-CCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          417 LGPMDS-DRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       417 ~~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      ...... .........+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+.+..+....+...........
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            653322 122334457899999999998775 579999999999999999999999987655443333222111110000


Q ss_pred             ccccCC---------------hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          495 LLDMVD---------------PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       495 ~~~~~d---------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ......               ..+.. ........+.+|+.+||+.||++|||+.|+++|.|-
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f  348 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWET-VYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL  348 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHH-hCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhh
Confidence            000000               00000 111234568899999999999999999999999774

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.9e-49  Score=405.74  Aligned_cols=266  Identities=21%  Similarity=0.302  Sum_probs=203.0

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEEc----CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCc
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNE  337 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~  337 (554)
                      ...++|++.++||+|+||+||+|+.+    +++.||||++.+...   ...+.+|+++|+.+ +||||+++++++.+.+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            34678999999999999999999653    468999999876532   34678999999998 69999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC-CcEEEEeecCcc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES-MRAKVADFGFAR  416 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkl~DfGla~  416 (554)
                      .++|||||++|+|.+++.     .+++.++..++.||+.||+|||   +++|+||||||+|||++.+ +.+||+|||+|+
T Consensus        95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            999999999999999984     4899999999999999999999   8999999999999999876 899999999998


Q ss_pred             cCCCCCCC-------------------------ccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCC
Q 042763          417 LGPMDSDR-------------------------THISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRP  470 (554)
Q Consensus       417 ~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P  470 (554)
                      ........                         .......+||+.|||||++.+. .|+.++||||+||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            64322110                         1112345799999999999775 589999999999999999999999


Q ss_pred             CCCCCChhhHHHHHHHHHh------------hcc-----CCcc--------------ccCChhhhh---------hccHH
Q 042763          471 VELKRPPEERVTLRWAFKR------------YNE-----GNLL--------------DMVDPSIKE---------VISME  510 (554)
Q Consensus       471 ~~~~~~~~~~~~~~~~~~~------------~~~-----~~~~--------------~~~d~~l~~---------~~~~~  510 (554)
                      |.......+.  +......            ...     ....              ....+....         .....
T Consensus       247 f~~~~~~~~~--l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  324 (361)
T 4f9c_A          247 FYKASDDLTA--LAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE  324 (361)
T ss_dssp             SSCCSSHHHH--HHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred             CCCCCCHHHH--HHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence            9765543221  1111100            000     0000              000000000         00112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          511 ILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       511 ~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .+.++.+|+.+||+.||++|||++|+++|.|
T Consensus       325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~  355 (361)
T 4f9c_A          325 VPDEAYDLLDKLLDLNPASRITAEEALLHPF  355 (361)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence            3456789999999999999999999999876

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.3e-48  Score=394.00  Aligned_cols=282  Identities=44%  Similarity=0.665  Sum_probs=243.5

Q ss_pred             HHHHHhhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCce
Q 042763          259 SQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       259 ~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  338 (554)
                      .++...+++|...+.||+|+||+||+|...+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..
T Consensus        32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            34556778999999999999999999998889999999987654 33456799999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHhcccC--CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          339 LIITEFVPNGTLREHLDGQYG--KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ++||||+++|+|.+++.....  ..+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            999999999999999976432  35899999999999999999999   8999999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL  496 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  496 (554)
                      ...... .........||+.|+|||++.+..++.++||||||+++|||++|+.||....+.+......|.........+.
T Consensus       188 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          188 KGTELD-QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             ECSSSS-CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             cccccc-ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            643221 2222344568999999999998899999999999999999999999998776665555566666666666677


Q ss_pred             ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          497 DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       497 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      ..+++.+......+.+..+.+++.+||+.||++|||+.||+++|+.+..
T Consensus       267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            7777777777788899999999999999999999999999999998865

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.8e-48  Score=422.56  Aligned_cols=261  Identities=23%  Similarity=0.303  Sum_probs=210.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHH---HHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEF---SSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~---~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      ++|++.++||+|+||+||+|+.. +|+.||||++.+....  .....+   ..++.+++.++|||||++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999765 6999999999765432  122233   34467777889999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +|||||+||+|.+++...  ..+++..+..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+...
T Consensus       269 lVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            999999999999999765  57999999999999999999999   9999999999999999999999999999998643


Q ss_pred             CCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ..     .....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||......+..........  ....    
T Consensus       344 ~~-----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~--~~~~----  412 (689)
T 3v5w_A          344 KK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVE----  412 (689)
T ss_dssp             SC-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--CCCC----
T ss_pred             CC-----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--CCCC----
Confidence            22     2334689999999999964 5799999999999999999999999986544332222221111  1111    


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHHhhhhhhhh
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPD-----MKSVGEQLWAIRADSLKS  550 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~i~~~~~~~  550 (554)
                              ++..++..+.+|+.+||+.||++|++     +.||++|.|--.-+|.+-
T Consensus       413 --------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l  461 (689)
T 3v5w_A          413 --------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV  461 (689)
T ss_dssp             --------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred             --------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence                    12234456889999999999999998     799999987655454443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.8e-48  Score=422.34  Aligned_cols=254  Identities=23%  Similarity=0.324  Sum_probs=211.1

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|++.+.||+|+||+||+|..+ +|+.||+|++.... ....+.+.+|+++|+.++|||||++++++.+++..++||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            57999999999999999999765 69999999987654 23356789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC--CcEEEEeecCcccCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES--MRAKVADFGFARLGPMDS  422 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~--~~vkl~DfGla~~~~~~~  422 (554)
                      |++|+|.+++..+ ...+++.++..++.||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+|+....  
T Consensus       236 ~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~--  309 (573)
T 3uto_A          236 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--  309 (573)
T ss_dssp             CCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--
T ss_pred             cCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccC--
Confidence            9999999999654 246899999999999999999999   8999999999999999854  8999999999987432  


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                        .......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+....+.       ....  ..++.
T Consensus       310 --~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~-------~~~~--~~~~~  378 (573)
T 3uto_A          310 --KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK-------SCDW--NMDDS  378 (573)
T ss_dssp             --TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-------TTCC--CCCSG
T ss_pred             --CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-------hCCC--CCCcc
Confidence              222345679999999999999999999999999999999999999998765433222111       1110  01111


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .    ...++..+.+|+.+||+.||++|||+.|+++|.|
T Consensus       379 ~----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw  413 (573)
T 3uto_A          379 A----FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW  413 (573)
T ss_dssp             G----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             c----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence            1    1123456789999999999999999999999977

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.9e-47  Score=390.44  Aligned_cols=289  Identities=37%  Similarity=0.624  Sum_probs=240.6

Q ss_pred             cccChHHHHHhhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEE
Q 042763          254 VHLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD  333 (554)
Q Consensus       254 ~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~  333 (554)
                      ..++..++....++|...+.||+|+||+||+|...+|+.||||++...........+.+|++++++++||||+++++++.
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   97 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM   97 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence            45677899999999999999999999999999888899999999987654433446899999999999999999999999


Q ss_pred             cCCceEEEEEeCCCCCHHHHHhcccC--CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEe
Q 042763          334 KGNERLIITEFVPNGTLREHLDGQYG--KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVAD  411 (554)
Q Consensus       334 ~~~~~~lv~E~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~D  411 (554)
                      +++..++||||+++|+|.+++.....  ..+++..++.++.|++.||+|||.....+|+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D  177 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD  177 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence            99999999999999999999986532  3589999999999999999999932222999999999999999999999999


Q ss_pred             ecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--ChhhHHHHHHHHHh
Q 042763          412 FGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKR--PPEERVTLRWAFKR  489 (554)
Q Consensus       412 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~--~~~~~~~~~~~~~~  489 (554)
                      ||+++.....  .........||+.|+|||++.+..++.++||||||+++|||++|+.||....  .........|....
T Consensus       178 fg~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          178 FGLAKLMDYK--DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CSSCEECCSS--SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             CccccccCcc--cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            9999875322  2223344569999999999998899999999999999999999999996211  11222334455555


Q ss_pred             hccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          490 YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      ..........+..+......+.+..+.+++.+||+.||++|||+.||+++|+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            5566666777777777778888999999999999999999999999999998643

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.3e-45  Score=372.64  Aligned_cols=256  Identities=23%  Similarity=0.357  Sum_probs=212.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|+..++||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+.++++++||||+++++++..++..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            46899999999999999999975 46899999998765433 34678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++|+|.+++...   .+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++....... 
T Consensus        98 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  170 (297)
T 3fxz_A           98 YLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (297)
T ss_dssp             CCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             CCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-
Confidence            99999999999765   6899999999999999999999   8899999999999999999999999999998643222 


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                        .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............   .. ....   ..    
T Consensus       171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~-~~~~---~~----  237 (297)
T 3fxz_A          171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TN-GTPE---LQ----  237 (297)
T ss_dssp             --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HH-CSCC---CS----
T ss_pred             --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hC-CCCC---CC----
Confidence              22344579999999999999999999999999999999999999998654432221111   10 1100   00    


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                         .+..++..+.+++.+||+.||++|||+.|++++.|--.
T Consensus       238 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  275 (297)
T 3fxz_A          238 ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI  275 (297)
T ss_dssp             ---CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             ---CccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence               11233456889999999999999999999999877543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=376.71  Aligned_cols=263  Identities=28%  Similarity=0.432  Sum_probs=215.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc----CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      .++|.+.+.||+|+||+||+|...    .+..||||+++........+.+.+|++++++++||||+++++++.+++..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            467888999999999999999874    3557999999876555556789999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||||+++|+|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       128 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             EeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            99999999999999654 346899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ............+|+.|+|||++.+..++.++||||||+++|||++ |..||...........+   .    ......  
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---~----~~~~~~--  274 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV---E----EGYRLP--  274 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH---H----TTCCCC--
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH---H----cCCCCC--
Confidence            4333333334457889999999998899999999999999999999 99999765433222111   1    110000  


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                             .+..++..+.+++.+||+.||++|||+.+|++.|+++....
T Consensus       275 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          275 -------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             -------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence                   12234456889999999999999999999999999987654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.1e-45  Score=380.59  Aligned_cols=263  Identities=30%  Similarity=0.448  Sum_probs=216.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc--------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcC
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE--------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKG  335 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~  335 (554)
                      .++|...+.||+|+||+||+|...        ++..||||+++........+.+.+|+++++++ +||||+++++++.++
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467888999999999999999752        35689999998765555567899999999999 899999999999999


Q ss_pred             CceEEEEEeCCCCCHHHHHhccc--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE
Q 042763          336 NERLIITEFVPNGTLREHLDGQY--------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL  401 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl  401 (554)
                      +..++||||+++|+|.+++....              ...+++.+++.++.||+.||+|||   +++|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999997653              235789999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhH
Q 042763          402 TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEER  480 (554)
Q Consensus       402 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~  480 (554)
                      +.++.+||+|||+++...... .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+..
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~  315 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  315 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCC-TTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             CCCCCEEEccccCCcccCccc-ceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            999999999999998643222 1122334457889999999999999999999999999999999 99999865543322


Q ss_pred             HHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          481 VTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                      ..+       ..+....         .+..++..+.+++.+||+.||++||++.|++++|.++....
T Consensus       316 ~~~-------~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          316 KLL-------KEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             HHH-------HTTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHH-------hcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            111       1111000         12234457899999999999999999999999999987643

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.5e-45  Score=370.30  Aligned_cols=265  Identities=27%  Similarity=0.415  Sum_probs=214.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|...++||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            467888999999999999999775 58999999886543 3445789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++|+|.+++... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus        88 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           88 YIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999999764 357899999999999999999999   89999999999999999999999999999987533221


Q ss_pred             Cc-----------cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhcc
Q 042763          424 RT-----------HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE  492 (554)
Q Consensus       424 ~~-----------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  492 (554)
                      ..           .......||+.|+|||++.+..++.++||||||+++|||++|..|+...........          
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~----------  233 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG----------  233 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS----------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh----------
Confidence            11           111245799999999999999999999999999999999999999875433211100          


Q ss_pred             CCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          493 GNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       493 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                          ...........+..++..+.+++.+||+.||++|||+.++++.|++++....
T Consensus       234 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          234 ----LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             ----BCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ----hhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence                0000111111223344568899999999999999999999999999987643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-45  Score=377.27  Aligned_cols=253  Identities=25%  Similarity=0.375  Sum_probs=211.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .++|...+.||+|+||.||+|.. .+|+.||||++..... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46799999999999999999977 5799999999976543 334567889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++...  ..+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....  
T Consensus        94 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--  166 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--  166 (328)
T ss_dssp             CCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS--
T ss_pred             ECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC--
Confidence            999999999999765  56899999999999999999999   89999999999999999999999999999976432  


Q ss_pred             CCccccccccCCCCCcChhccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLT-TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s-~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                        .......+||+.|+|||++.+..++ .++|||||||++|||++|+.||...........+.       .+...     
T Consensus       167 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-------~~~~~-----  232 (328)
T 3fe3_A          167 --GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL-------RGKYR-----  232 (328)
T ss_dssp             --SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCCCC-----
T ss_pred             --CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCCC-----
Confidence              1233456799999999999888775 89999999999999999999998755332221111       11110     


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                           .+...+..+.+++.+||+.||++|||+.|+++|.|--
T Consensus       233 -----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~  269 (328)
T 3fe3_A          233 -----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN  269 (328)
T ss_dssp             -----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTT
T ss_pred             -----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhc
Confidence                 1112345678999999999999999999999997743

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.8e-45  Score=370.04  Aligned_cols=263  Identities=30%  Similarity=0.468  Sum_probs=206.0

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ..++|++.++||+|+||+||+|+. +|+.||||++..... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            346788899999999999999987 488999999876543 334567899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          343 EFVPNGTLREHLDGQY-GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ--IIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      ||+++|+|.+++.... ...+++.+++.++.|++.||+|||   +.+  |+||||||+|||++.++.+||+|||+++...
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            9999999999997642 124899999999999999999999   888  9999999999999999999999999997532


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      .   .........||+.|+|||++.+..++.++||||||+++|||++|+.||...........+   ........     
T Consensus       191 ~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~~~~-----  259 (309)
T 3p86_A          191 S---TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV---GFKCKRLE-----  259 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH---HHSCCCCC-----
T ss_pred             c---cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcCCCCC-----
Confidence            2   112233457999999999999999999999999999999999999999865443222111   11111111     


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                             .+..+...+.+++.+||+.||++|||+.+|++.|+.+.....
T Consensus       260 -------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          260 -------IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             -------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             -------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence                   122334568899999999999999999999999998876543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.1e-45  Score=381.01  Aligned_cols=263  Identities=27%  Similarity=0.456  Sum_probs=204.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc----CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      ..+|.+.+.||+|+||.||+|...    ++..||||+++........+++.+|+.++++++||||+++++++.+++..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            467999999999999999999765    5778999999876545556789999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||||+++|+|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       124 v~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            99999999999999754 346899999999999999999999   88999999999999999999999999999987543


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ............+++.|+|||++.+..++.++||||||+++|||++ |+.||......+..   .........       
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~---~~i~~~~~~-------  269 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI---KAVDEGYRL-------  269 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH---HHHHTTEEC-------
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCCC-------
Confidence            3222222223346788999999999999999999999999999998 99999765432221   111111000       


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                            ..+..++..+.+++.+||+.||++||++.+|++.|+++..+.
T Consensus       270 ------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          270 ------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             ------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             ------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence                  011234466899999999999999999999999999997654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.7e-44  Score=360.80  Aligned_cols=285  Identities=35%  Similarity=0.618  Sum_probs=230.0

Q ss_pred             ccccChHHHHHhhcCCCcc------eeeeccCceEEEEEEEcCCcEEEEEEcchhh---hhhHHHHHHHHHHHHHhCCCC
Q 042763          253 SVHLNMSQVVKATRNFSPS------LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQ---FENLQTEFSSEVELLSKIDHR  323 (554)
Q Consensus       253 ~~~~~~~~l~~~~~~f~~~------~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~---~~~~~~~~~~Ei~~l~~l~Hp  323 (554)
                      ...++..++..++++|...      ++||+|+||+||+|.. +++.||||++....   .....+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            3467888999999999887      8999999999999987 48899999986532   234457899999999999999


Q ss_pred             CceeeeeEEEcCCceEEEEEeCCCCCHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC
Q 042763          324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQY-GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT  402 (554)
Q Consensus       324 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~  402 (554)
                      ||+++++++.+++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence            99999999999999999999999999999997543 356899999999999999999999   88999999999999999


Q ss_pred             CCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHH
Q 042763          403 ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVT  482 (554)
Q Consensus       403 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~  482 (554)
                      .++.+||+|||+++...... .........||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFA-QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCS-SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             CCCcEEEeeccccccccccc-ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            99999999999998643222 1222334579999999998876 589999999999999999999999987554432222


Q ss_pred             HHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          483 LRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       483 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      +..... .....+.+.+++.+. ......+..+.+++.+||+.+|++|||+.+|+++|+++++
T Consensus       246 ~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          246 IKEEIE-DEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHH-TTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHhh-hhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            211111 112222233333332 2355677889999999999999999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-44  Score=367.72  Aligned_cols=270  Identities=22%  Similarity=0.311  Sum_probs=210.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|+..++||+|+||+||+|...+|+.||+|++..... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            467999999999999999999988899999999876543 2344678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |++ ++|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       100 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--  172 (311)
T 3niz_A          100 FME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP--  172 (311)
T ss_dssp             CCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC--
T ss_pred             CCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC--
Confidence            996 5888888754 346899999999999999999999   889999999999999999999999999999864322  


Q ss_pred             CccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc----
Q 042763          424 RTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM----  498 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  498 (554)
                       ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...............    
T Consensus       173 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          173 -VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             -CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             -cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence             122334568999999999876 56899999999999999999999999876655443333222211111111110    


Q ss_pred             ---------CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          499 ---------VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       499 ---------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                               ................+.+++.+||+.||++|||+.|+++|.|-
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  304 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF  304 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence                     01111111112334578899999999999999999999998663

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-44  Score=364.33  Aligned_cols=272  Identities=23%  Similarity=0.309  Sum_probs=216.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC--ceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN--ERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--~~~lv  341 (554)
                      .++|.+.++||+|+||+||+|... +|+.||||++.........+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            367889999999999999999776 489999999987665555677889999999999999999999987655  77999


Q ss_pred             EEeCCCCCHHHHHhcccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE----CCCCcEEEEeecCcc
Q 042763          342 TEFVPNGTLREHLDGQYG-KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL----TESMRAKVADFGFAR  416 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl----~~~~~vkl~DfGla~  416 (554)
                      |||+++++|.+++..... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999986532 34899999999999999999999   8899999999999999    788889999999998


Q ss_pred             cCCCCCCCccccccccCCCCCcChhccc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH-HH
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMK--------TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRW-AF  487 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~-~~  487 (554)
                      ......    ......||+.|+|||++.        +..++.++|||||||++|||++|+.||.............. ..
T Consensus       165 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          165 ELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             ECCTTC----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             ecCCCC----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            753322    223456999999999986        56889999999999999999999999976554433322222 21


Q ss_pred             HhhccCCccccC-----------ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          488 KRYNEGNLLDMV-----------DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       488 ~~~~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      ............           +......+.......+.+++.+||+.||++|||+.|+++++.+.
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            111111110000           00111234567788899999999999999999999999998754

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.1e-45  Score=373.09  Aligned_cols=270  Identities=24%  Similarity=0.296  Sum_probs=210.8

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC----ceE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN----ERL  339 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----~~~  339 (554)
                      ..++|+..++||+|+||+||+|+.. ++.||||++.....  ......+|+.++++++||||+++++++..+.    ..+
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK--QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch--HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            4578999999999999999999876 89999999976542  2345567999999999999999999997754    369


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCC----------CeEeCCCCCCCeEECCCCcEEE
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK----------QIIHRDVKSSNILLTESMRAKV  409 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~----------~ivH~Dlkp~NILl~~~~~vkl  409 (554)
                      +||||+++|+|.+++...   .+++.+++.++.|++.||+|||   +.          +|+||||||+|||++.++.+||
T Consensus        99 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence            999999999999999764   5899999999999999999999   77          9999999999999999999999


Q ss_pred             EeecCcccCCCCCCCccccccccCCCCCcChhcccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHH--
Q 042763          410 ADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-----YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVT--  482 (554)
Q Consensus       410 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~--  482 (554)
                      +|||+++....... ........||+.|+|||++.+     ..++.++|||||||++|||+||+.||...........  
T Consensus       173 ~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          173 ADFGLALKFEAGKS-AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             CCCTTCEEECTTSC-CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             ccCCcccccccccC-ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            99999976433221 122334579999999999986     3566789999999999999999999976433211000  


Q ss_pred             -------HHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          483 -------LRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       483 -------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                             ....................   ......+..+.+++.+||+.||++|||+.||++.|++|+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKKKRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhccCCchhhhhhhhhcccCCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                   00011111111111111111   11234567799999999999999999999999999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.5e-45  Score=373.26  Aligned_cols=260  Identities=22%  Similarity=0.300  Sum_probs=215.0

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|+..+.||+|+||+||+|... +|+.||+|++++...  ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57888999999999999999775 689999999977542  234567889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        85 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  158 (337)
T 1o6l_A           85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-  158 (337)
T ss_dssp             ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence            999999999999765  57899999999999999999999   899999999999999999999999999999853221 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                        .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........   ...  ....        
T Consensus       159 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---i~~--~~~~--------  223 (337)
T 1o6l_A          159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL---ILM--EEIR--------  223 (337)
T ss_dssp             --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHH--CCCC--------
T ss_pred             --CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH---HHc--CCCC--------
Confidence              1223456799999999999999999999999999999999999999986543222111   110  1101        


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHhhhhhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAIRADSLKS  550 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i~~~~~~~  550 (554)
                          ++..++..+.+++.+||+.||++||     ++.||++|.|-..-+|.+.
T Consensus       224 ----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~  272 (337)
T 1o6l_A          224 ----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV  272 (337)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHH
Confidence                1123345688999999999999999     9999999987655554443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.3e-45  Score=377.18  Aligned_cols=271  Identities=27%  Similarity=0.361  Sum_probs=218.8

Q ss_pred             hHHHHHhhcCCCcceeeeccCceEEEEEEE------cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeee
Q 042763          258 MSQVVKATRNFSPSLRIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLG  330 (554)
Q Consensus       258 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~  330 (554)
                      ..+.....++|...++||+|+||.||+|.+      .+++.||||+++........+.+.+|+++++++ +||||+++++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            345555678899999999999999999963      246899999998765555567899999999999 7999999999


Q ss_pred             EEEcCCc-eEEEEEeCCCCCHHHHHhcccC--------------------------------------------------
Q 042763          331 FVDKGNE-RLIITEFVPNGTLREHLDGQYG--------------------------------------------------  359 (554)
Q Consensus       331 ~~~~~~~-~~lv~E~~~~g~L~~~l~~~~~--------------------------------------------------  359 (554)
                      ++.+.+. .++||||+++|+|.+++.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            9977554 8999999999999999976532                                                  


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          360 --------------KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       360 --------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                                    ..+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~  249 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DY  249 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT-TC
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc-cc
Confidence                          12889999999999999999999   8899999999999999999999999999998643322 22


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      .......||+.|+|||++.+..++.++||||||+++|||++ |..||.............   .......          
T Consensus       250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~~~~~~~----------  316 (359)
T 3vhe_A          250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL---KEGTRMR----------  316 (359)
T ss_dssp             EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH---HHTCCCC----------
T ss_pred             hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH---HcCCCCC----------
Confidence            23344568999999999999999999999999999999998 999998766543322111   1111100          


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                        .+..+...+.+++.+||+.||++|||+.||+++|.++....
T Consensus       317 --~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          317 --APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence              11123456889999999999999999999999999987653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.4e-44  Score=369.10  Aligned_cols=266  Identities=24%  Similarity=0.373  Sum_probs=216.1

Q ss_pred             cChHHHHHhhcC----------CCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCC
Q 042763          256 LNMSQVVKATRN----------FSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRN  324 (554)
Q Consensus       256 ~~~~~l~~~~~~----------f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn  324 (554)
                      ++.+++..+++.          |...++||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++|||
T Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCTT
T ss_pred             CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCC
Confidence            455566665543          667789999999999999876 69999999987654 233567889999999999999


Q ss_pred             ceeeeeEEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC
Q 042763          325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES  404 (554)
Q Consensus       325 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~  404 (554)
                      |+++++++..++..++||||+++++|.+++...   .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.+
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence            999999999999999999999999999998753   6899999999999999999999   8899999999999999999


Q ss_pred             CcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHH
Q 042763          405 MRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR  484 (554)
Q Consensus       405 ~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~  484 (554)
                      +.+||+|||+++......   .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........   .
T Consensus       178 ~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~---~  251 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDV---PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---K  251 (321)
T ss_dssp             CCEEECCCTTCEECCSSS---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H
T ss_pred             CcEEEeeeeeeeecccCc---cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence            999999999998643221   1223457999999999999999999999999999999999999999865432221   1


Q ss_pred             HHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       485 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      ..... ..        +.+.  ....++..+.+++.+||+.||++|||+.|++++.|-...
T Consensus       252 ~~~~~-~~--------~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          252 RLRDS-PP--------PKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             HHHHS-SC--------CCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             HHhcC-CC--------CCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence            11111 10        0000  011234568899999999999999999999999886543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-44  Score=359.91  Aligned_cols=258  Identities=29%  Similarity=0.421  Sum_probs=213.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .++|+..+.||+|+||+||+|...++..||+|++......  .+++.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            4678889999999999999999888999999999865432  35789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  .
T Consensus        87 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  160 (269)
T 4hcu_A           87 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--Q  160 (269)
T ss_dssp             CTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH--H
T ss_pred             CCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc--c
Confidence            9999999999754 346899999999999999999999   899999999999999999999999999999863221  1


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+   .    ...  ...    
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~---~----~~~--~~~----  227 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---S----TGF--RLY----  227 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---H----TTC--CCC----
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---h----cCc--cCC----
Confidence            122233457788999999999999999999999999999999 99999865433221111   1    110  000    


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                         .+...+..+.+++.+||+.||++||++.|++++|+++..+
T Consensus       228 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          228 ---KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ---CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence               1112245688999999999999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6e-46  Score=373.90  Aligned_cols=269  Identities=24%  Similarity=0.431  Sum_probs=207.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-----cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEc--CCc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDK--GNE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~  337 (554)
                      .++|++.++||+|+||+||+|.+     .+++.||||++.... ....+.+.+|++++++++||||+++++++..  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            46788999999999999999974     358999999987654 3345679999999999999999999999854  356


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             eEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            899999999999999997652 35899999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCh---------hhHHHHHHHHH
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP---------EERVTLRWAFK  488 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~---------~~~~~~~~~~~  488 (554)
                      ...............+++.|+|||.+.+..++.++||||||+++|||++|..|+......         ...........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            544333333334455788899999999999999999999999999999999998642110         00000001111


Q ss_pred             hhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          489 RYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       489 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                      .......         ...+..++..+.+++.+||+.||++|||+.||++.|++++.+.
T Consensus       244 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          244 LLKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHhccCc---------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            1111100         0112234567899999999999999999999999999998753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.3e-44  Score=358.88  Aligned_cols=258  Identities=28%  Similarity=0.482  Sum_probs=213.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .++|+..+.||+|+||+||+|+..++..||+|++......  .+++.+|++++++++||||+++++++.+++..++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            4678889999999999999999988889999999765432  35789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  .
T Consensus        85 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~--~  158 (268)
T 3sxs_A           85 ISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--Q  158 (268)
T ss_dssp             CTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT--C
T ss_pred             cCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchh--h
Confidence            9999999999764 346899999999999999999999   889999999999999999999999999999864322  2


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.............       ...  ....   
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~~~--~~~~---  226 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-------QGH--RLYR---  226 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-------TTC--CCCC---
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-------cCC--CCCC---
Confidence            222334457788999999999899999999999999999999 999997655432221111       100  0001   


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                          +...+..+.+++.+||+.||++|||+.|++++|+.++.+
T Consensus       227 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          227 ----PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ----CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ----CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                111234688999999999999999999999999998764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.1e-45  Score=380.77  Aligned_cols=261  Identities=29%  Similarity=0.457  Sum_probs=213.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|...++||+|+||.||+|... +++.||||+++........+.+.+|++++++++||||+++++++..++..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467888899999999999999886 6899999999865444445678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++|+|.+++... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...... 
T Consensus       193 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~-  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV-  267 (377)
T ss_dssp             CCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE-
T ss_pred             cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc-
Confidence            99999999999754 346899999999999999999999   8999999999999999999999999999998632211 


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                      .........+++.|+|||++.+..++.++||||||+++|||++ |..||..........   ..    ..+....     
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~---~~----~~~~~~~-----  335 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE---FV----EKGGRLP-----  335 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH---HH----HTTCCCC-----
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HH----HcCCCCC-----
Confidence            0111112235778999999998899999999999999999998 999998654332211   11    1111000     


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                          .+..++..+.+++.+||+.||++|||+.+|++.|++++..
T Consensus       336 ----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          336 ----CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                1122345688999999999999999999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.2e-45  Score=372.14  Aligned_cols=259  Identities=23%  Similarity=0.393  Sum_probs=208.3

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|++.++||+|+||+||+|... +++.||||++.........+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            367999999999999999999766 6899999998765544445678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++|+|.+++...  ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        86 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-  159 (323)
T 3tki_A           86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-  159 (323)
T ss_dssp             CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT-
T ss_pred             cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCC-
Confidence            99999999999654  56899999999999999999999   8999999999999999999999999999998643221 


Q ss_pred             CccccccccCCCCCcChhccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQL-TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                      .........||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......... ..+..    ...   ...+ 
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~----~~~---~~~~-  230 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWKE----KKT---YLNP-  230 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH-HHHHT----TCT---TSTT-
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH-HHHhc----ccc---cCCc-
Confidence            2222345679999999999988775 779999999999999999999998655432211 11110    000   0000 


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                           ...+...+.+++.+||+.||++|||+.|++++.|--
T Consensus       231 -----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~  266 (323)
T 3tki_A          231 -----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN  266 (323)
T ss_dssp             -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred             -----cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhc
Confidence                 112345678999999999999999999999988753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.4e-44  Score=369.65  Aligned_cols=257  Identities=23%  Similarity=0.326  Sum_probs=211.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhh-----HHHHHHHHHHHHHhCCCCCceeeeeEEEcCCce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFEN-----LQTEFSSEVELLSKIDHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  338 (554)
                      .++|.+.+.||+|+||+||+|... +|+.||+|++.......     ..+.+.+|+.++++++||||+++++++.+++..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467899999999999999999776 58999999987654321     346789999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC----cEEEEeecC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM----RAKVADFGF  414 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~----~vkl~DfGl  414 (554)
                      ++||||+++|+|.+++...  ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++    .+||+|||+
T Consensus        91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            9999999999999999754  57899999999999999999999   89999999999999998877    799999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      ++.....    .......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+       ....
T Consensus       166 a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i-------~~~~  234 (361)
T 2yab_A          166 AHEIEDG----VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-------TAVS  234 (361)
T ss_dssp             CEECCTT----CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-------HTTC
T ss_pred             ceEcCCC----CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhcC
Confidence            9864322    1223457999999999999999999999999999999999999999865433221111       1111


Q ss_pred             ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       495 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      .  ..++...    ..++..+.+++.+||+.||++|||+.|+++|.|--
T Consensus       235 ~--~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  277 (361)
T 2yab_A          235 Y--DFDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (361)
T ss_dssp             C--CCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred             C--CCCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence            0  1111111    12345688999999999999999999999988743

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.4e-44  Score=360.75  Aligned_cols=264  Identities=23%  Similarity=0.401  Sum_probs=211.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....  ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467999999999999999999765 689999998854332  33456799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++++|.+++...  ..+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        90 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            9999999999999765  47899999999999999999999   889999999999999999999999999999864321


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                        .........||+.|+|||.+.+..++.++||||||+++|||++|+.||.........      .......      .+
T Consensus       165 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~------~~  230 (294)
T 4eqm_A          165 --SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQDS------VP  230 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSSC------CC
T ss_pred             --cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhcc------CC
Confidence              112233456999999999999999999999999999999999999999865432221      1111110      11


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHhhhhh
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRP-DMKSVGEQLWAIRADS  547 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~l~~i~~~~  547 (554)
                      ........+++..+.+++.+||+.||++|| ++.++.+.|.++..+.
T Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            111123334556789999999999999999 9999999998876544

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-44  Score=367.16  Aligned_cols=257  Identities=20%  Similarity=0.266  Sum_probs=211.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|.+.+.||+|+||+||+|... +++.||+|.+....  .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            467899999999999999999765 58999999987543  234568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC--CCcEEEEeecCcccCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE--SMRAKVADFGFARLGPMD  421 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~--~~~vkl~DfGla~~~~~~  421 (554)
                      |+++|+|.+++... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.  ++.+||+|||+++.....
T Consensus        82 ~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             eCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            99999999999754 246899999999999999999999   889999999999999987  789999999999874322


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                          .......||+.|+|||++.+..++.++||||||+++|||++|..||...........+.   .    ...  ..+.
T Consensus       158 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~----~~~--~~~~  224 (321)
T 1tki_A          158 ----DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM---N----AEY--TFDE  224 (321)
T ss_dssp             ----CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---H----TCC--CCCH
T ss_pred             ----CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH---c----CCC--CCCh
Confidence                22334569999999999999889999999999999999999999998654332211111   1    100  0111


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      ...    ..++..+.+++.+||+.||++|||+.|+++|.|--.
T Consensus       225 ~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  263 (321)
T 1tki_A          225 EAF----KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             hhh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence            111    123456889999999999999999999999998543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=373.21  Aligned_cols=259  Identities=25%  Similarity=0.349  Sum_probs=209.8

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~l  340 (554)
                      .++|+..++||+|+||+||+|+.. +|+.||||++++...  ....+.+.+|..+++.+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999765 589999999987532  23456788999999988 79999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||||+++|+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       102 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            99999999999999765  57999999999999999999999   88999999999999999999999999999985321


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                         ........+||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.       .....    
T Consensus       177 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~-------~~~~~----  242 (353)
T 3txo_A          177 ---NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL-------NDEVV----  242 (353)
T ss_dssp             ------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCCCC----
T ss_pred             ---CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH-------cCCCC----
Confidence               2223345679999999999999899999999999999999999999998755432221111       11110    


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHHHhhhhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDM------KSVGEQLWAIRADSL  548 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~l~~i~~~~~  548 (554)
                            ++......+.+++.+||+.||++||++      .|+++|.|--.-+|.
T Consensus       243 ------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          243 ------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             ------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence                  112234567899999999999999999      899998775444443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.2e-44  Score=363.07  Aligned_cols=263  Identities=28%  Similarity=0.433  Sum_probs=216.4

Q ss_pred             hhcCCCcceeeeccCceEEEEEEE------cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE  337 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  337 (554)
                      ..++|...+.||+|+||.||+|..      .++..||||++.........+.+.+|++++++++||||+++++++.+++.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            356788899999999999999975      24589999999876555556789999999999999999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHhcccC----------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCC
Q 042763          338 RLIITEFVPNGTLREHLDGQYG----------------------KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVK  395 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk  395 (554)
                      .++||||+++++|.+++.....                      ..+++.+++.++.||+.||+|||   +++|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence            9999999999999999976432                      34889999999999999999999   8899999999


Q ss_pred             CCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 042763          396 SSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELK  474 (554)
Q Consensus       396 p~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~  474 (554)
                      |+|||++.++.+||+|||+++...... .........+|+.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEED-SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTS-CEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             hheEEEcCCCCEEEccccccccccccc-cceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999998643222 1122234457889999999999899999999999999999999 99999876


Q ss_pred             CChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          475 RPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       475 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      ........+.       ......         .+..++..+.+++.+||+.||++||++.+|+++|+++..+
T Consensus       257 ~~~~~~~~~~-------~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          257 PPERLFNLLK-------TGHRME---------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             CGGGHHHHHH-------TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHhh-------cCCcCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            5433221111       111000         1123445688999999999999999999999999998664

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.4e-44  Score=358.70  Aligned_cols=259  Identities=27%  Similarity=0.426  Sum_probs=211.4

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ..++|+..+.||+|+||+||+|...++..||||++......  .+++.+|++++++++||||+++++++.+++..++|||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            34678889999999999999999998889999999865432  3678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++++|.+++... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....  
T Consensus       100 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--  173 (283)
T 3gen_A          100 YMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--  173 (283)
T ss_dssp             CCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH--
T ss_pred             ccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccc--
Confidence            99999999999763 246899999999999999999999   899999999999999999999999999999864221  


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                      .........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+.   .. ..     ..   
T Consensus       174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~---~~-~~-----~~---  241 (283)
T 3gen_A          174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA---QG-LR-----LY---  241 (283)
T ss_dssp             HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---TT-CC-----CC---
T ss_pred             ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh---cc-cC-----CC---
Confidence            1112223457788999999999899999999999999999998 999998655432221111   10 00     00   


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                          .+......+.+++.+||+.+|++|||+.+++++|+++..+
T Consensus       242 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          242 ----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             ----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                1112235688999999999999999999999999998865

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-44  Score=369.59  Aligned_cols=266  Identities=30%  Similarity=0.453  Sum_probs=215.9

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN  336 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  336 (554)
                      ...++|...+.||+|+||.||+|...      +++.||||+++........+.+.+|++++++++||||+++++++.+++
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            34678999999999999999999775      348999999987655556678999999999999999999999999999


Q ss_pred             ceEEEEEeCCCCCHHHHHhccc----------------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCC
Q 042763          337 ERLIITEFVPNGTLREHLDGQY----------------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDV  394 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl  394 (554)
                      ..++||||+++|+|.+++....                      ...+++.+++.++.||+.||.|||   +++|+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence            9999999999999999997642                      156899999999999999999999   889999999


Q ss_pred             CCCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 042763          395 KSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVEL  473 (554)
Q Consensus       395 kp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~  473 (554)
                      ||+|||++.++.+||+|||+++...... .........+|+.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCc-cccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            9999999999999999999997532211 1112234568899999999999899999999999999999999 9999986


Q ss_pred             CCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          474 KRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       474 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                      ....+..   ..    ........         .+..++..+.+++.+||+.||++||++.+|+++|+++.....
T Consensus       280 ~~~~~~~---~~----~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          280 MAHEEVI---YY----VRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             SCHHHHH---HH----HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             CChHHHH---HH----HhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            5432211   11    11111111         112334568899999999999999999999999999987654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-44  Score=373.20  Aligned_cols=263  Identities=31%  Similarity=0.430  Sum_probs=216.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc--------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcC
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE--------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKG  335 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~  335 (554)
                      .++|.+.++||+|+||+||+|...        .+..||||++...........+.+|+++++++ +||||+++++++.++
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            467888999999999999999752        24689999998765555667899999999999 899999999999999


Q ss_pred             CceEEEEEeCCCCCHHHHHhcccC--------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE
Q 042763          336 NERLIITEFVPNGTLREHLDGQYG--------------KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL  401 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl  401 (554)
                      +..++||||+++|+|.+++.....              ..+++.+++.++.||+.||+|||   +.+|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            999999999999999999986532              35899999999999999999999   8899999999999999


Q ss_pred             CCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhH
Q 042763          402 TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEER  480 (554)
Q Consensus       402 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~  480 (554)
                      +.++.+||+|||+++...... .........+|+.|+|||++.+..++.++||||||+++|||++ |..||......+..
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~  303 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHID-YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  303 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCC-TTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             cCCCcEEEcccCccccccccc-ccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999999998643221 1122334467889999999999999999999999999999999 99999865432211


Q ss_pred             HHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          481 VTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                         ...    .......         .+..+...+.+++.+||+.||++|||+.||+++|+++....
T Consensus       304 ---~~~----~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          304 ---KLL----KEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             ---HHH----HTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             ---HHH----HcCCCCC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence               111    1111000         11223456889999999999999999999999999987643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=377.03  Aligned_cols=264  Identities=30%  Similarity=0.419  Sum_probs=213.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  338 (554)
                      .++|...++||+|+||+||+|...      +++.||||+++..........+.+|+.++++++||||+++++++.++...
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            367888999999999999999743      46789999997655455566799999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHhcccC-----CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC---cEEEE
Q 042763          339 LIITEFVPNGTLREHLDGQYG-----KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM---RAKVA  410 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~---~vkl~  410 (554)
                      ++||||+++|+|.+++.....     ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999976532     35899999999999999999999   89999999999999999555   59999


Q ss_pred             eecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHh
Q 042763          411 DFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKR  489 (554)
Q Consensus       411 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~  489 (554)
                      |||+++...... .........||+.|+|||++.+..++.++|||||||++|||++ |..||......+..   ...   
T Consensus       227 DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~---~~i---  299 (367)
T 3l9p_A          227 DFGMARDIYRAG-YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---EFV---  299 (367)
T ss_dssp             CCHHHHHHHHHS-SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHH---
T ss_pred             CCcccccccccc-ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH---
Confidence            999997432111 1112233458999999999999999999999999999999998 99999865433221   111   


Q ss_pred             hccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          490 YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                       .......         .+..++..+.+++.+||+.||++|||+.+|+++|+.+..+..
T Consensus       300 -~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          300 -TSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             -HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             -HcCCCCC---------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence             1111000         112234568899999999999999999999999999987653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.2e-44  Score=366.45  Aligned_cols=257  Identities=23%  Similarity=0.337  Sum_probs=210.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-----hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-----NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  338 (554)
                      .++|...+.||+|+||+||+|... +|+.||+|++......     ...+.+.+|+.++++++||||+++++++.+++..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356888999999999999999775 5899999998765322     1356799999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC----cEEEEeecC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM----RAKVADFGF  414 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~----~vkl~DfGl  414 (554)
                      ++||||+++++|.+++...  ..+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++    .+||+|||+
T Consensus        90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            9999999999999999754  57899999999999999999999   89999999999999999887    899999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      ++......    ......||+.|+|||++.+..++.++||||||+++|||++|..||......+....+.   . . .. 
T Consensus       165 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~---~-~-~~-  234 (326)
T 2y0a_A          165 AHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS---A-V-NY-  234 (326)
T ss_dssp             CEECCTTS----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH---H-T-CC-
T ss_pred             CeECCCCC----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH---h-c-CC-
Confidence            98753221    2234569999999999999999999999999999999999999998654332211111   0 0 00 


Q ss_pred             ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       495 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                         .......    ...+..+.+++.+||+.||++|||+.|+++|.|--
T Consensus       235 ---~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  276 (326)
T 2y0a_A          235 ---EFEDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK  276 (326)
T ss_dssp             ---CCCHHHH----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred             ---CcCcccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence               0111111    12345688999999999999999999999987753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.3e-44  Score=365.61  Aligned_cols=271  Identities=22%  Similarity=0.334  Sum_probs=197.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|+..++||+|+||+||+|... +|+.||+|+++........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467889999999999999999765 5899999998765444444678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhccc----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          344 FVPNGTLREHLDGQY----GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      |++ |+|.+++....    ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            996 69999987543    245889999999999999999999   8899999999999999999999999999998643


Q ss_pred             CCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc---
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL---  495 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---  495 (554)
                      ...   .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+............   
T Consensus       160 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          160 IPV---NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             SCC---CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             CCc---ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            221   12234568999999999976 46899999999999999999999999876543332222211110000000   


Q ss_pred             ----------cccCCh----hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          496 ----------LDMVDP----SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       496 ----------~~~~d~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                                ......    .+...........+.+++.+||+.||++|||+.|++++.|-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f  297 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF  297 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhh
Confidence                      000000    00111111234578999999999999999999999998764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.1e-44  Score=371.95  Aligned_cols=257  Identities=21%  Similarity=0.314  Sum_probs=210.3

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .++|...+.||+|+||.||+|... +|+.||+|++..... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            467999999999999999999765 589999999976543 234467899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC---CcEEEEeecCcccCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES---MRAKVADFGFARLGP  419 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~---~~vkl~DfGla~~~~  419 (554)
                      ||+++|+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.+   +.+||+|||+++...
T Consensus       108 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          108 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             CCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            999999999999754  57899999999999999999999   8899999999999999865   459999999998643


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ..    .......||+.|+|||++.+..++.++|||||||++|||++|..||..........   ...    .+.. ...
T Consensus       183 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---~i~----~~~~-~~~  250 (362)
T 2bdw_A          183 DS----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA---QIK----AGAY-DYP  250 (362)
T ss_dssp             TC----CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHH----HTCC-CCC
T ss_pred             CC----cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHH----hCCC-CCC
Confidence            21    12234679999999999999999999999999999999999999998654322211   111    1110 000


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      .+. .    ..++..+.+++.+||+.||++||++.|++++.|--
T Consensus       251 ~~~-~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  289 (362)
T 2bdw_A          251 SPE-W----DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC  289 (362)
T ss_dssp             TTG-G----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred             ccc-c----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence            111 1    12345688999999999999999999999998854

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.4e-44  Score=361.57  Aligned_cols=267  Identities=27%  Similarity=0.409  Sum_probs=218.8

Q ss_pred             hhcCCCcceeeeccCceEEEEEEE------cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCC
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGN  336 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~  336 (554)
                      ..++|...+.||+|+||+||+|..      .+++.||||++.........+.+.+|+.+++++ +||||+++++++.+++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            346788899999999999999975      346899999998765445567899999999999 9999999999999999


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccC----------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeE
Q 042763          337 ERLIITEFVPNGTLREHLDGQYG----------------KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNIL  400 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIL  400 (554)
                      ..++||||+++|+|.+++.....                ..+++.+++.++.|++.||+|||   +++|+||||||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEE
Confidence            99999999999999999976532                24899999999999999999999   889999999999999


Q ss_pred             ECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhh
Q 042763          401 LTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEE  479 (554)
Q Consensus       401 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~  479 (554)
                      ++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++||||||+++|||++ |..||........
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EcCCCCEEEcccccccccccccc-ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            99999999999999986543221 122334457889999999999999999999999999999999 9999987654332


Q ss_pred             HHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 042763          480 RVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK  549 (554)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~  549 (554)
                      .....  .... .    ..        .+..++..+.+++.+||+.||++|||+.|++++|+++..+...
T Consensus       257 ~~~~~--~~~~-~----~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  311 (313)
T 1t46_A          257 FYKMI--KEGF-R----ML--------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN  311 (313)
T ss_dssp             HHHHH--HHTC-C----CC--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred             HHHHh--ccCC-C----CC--------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence            21111  1110 0    00        1122345688999999999999999999999999998876543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.1e-44  Score=373.70  Aligned_cols=267  Identities=22%  Similarity=0.338  Sum_probs=211.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~l  340 (554)
                      .++|+..++||+|+||+||+|+.. +++.||+|++++....  ...+.+.+|..++.++ +||||+++++++.+++..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            367889999999999999999876 5889999999876432  2234578899999887 89999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||||+++|+|.+++...  ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       131 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            99999999999999765  57999999999999999999999   89999999999999999999999999999985322


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHH--HHHHHHHhhccCCcccc
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERV--TLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  498 (554)
                         ........+||+.|+|||++.+..++.++|||||||++|||++|+.||......+...  ..............   
T Consensus       206 ---~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---  279 (396)
T 4dc2_A          206 ---PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---  279 (396)
T ss_dssp             ---TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---
T ss_pred             ---CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---
Confidence               2223445689999999999999999999999999999999999999997543221110  01111111111111   


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHHHhhhhhhh
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDM------KSVGEQLWAIRADSLK  549 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~l~~i~~~~~~  549 (554)
                             .++..+...+.+++.+||+.||++||++      .||++|.|--.-+|.+
T Consensus       280 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~  329 (396)
T 4dc2_A          280 -------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM  329 (396)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHH
T ss_pred             -------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHH
Confidence                   0122344568899999999999999994      7999987754444433

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3e-44  Score=360.54  Aligned_cols=269  Identities=23%  Similarity=0.335  Sum_probs=206.2

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|...++||+|+||+||+|...+|+.||+|++..... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46888999999999999999888899999999865432 22346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      ++ ++|.+++... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....   
T Consensus        82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  153 (288)
T 1ob3_A           82 LD-QDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP---  153 (288)
T ss_dssp             CS-EEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             cC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc---
Confidence            96 5999998754 356899999999999999999999   889999999999999999999999999999764221   


Q ss_pred             ccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc-----cc
Q 042763          425 THISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL-----DM  498 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~  498 (554)
                      ........||+.|+|||++.+. .++.++||||||+++|||++|+.||......+....+.............     ..
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence            1122344689999999998764 58999999999999999999999998755433322221111110000000     00


Q ss_pred             CChh-------hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          499 VDPS-------IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       499 ~d~~-------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .++.       ........+...+.+++.+||+.||++|||+.|+++|.|-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  284 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence            0110       0011112345678899999999999999999999998763

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.4e-44  Score=372.71  Aligned_cols=275  Identities=21%  Similarity=0.260  Sum_probs=213.5

Q ss_pred             ccChHHHHHhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-----CCCceee
Q 042763          255 HLNMSQVVKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-----HRNLVKL  328 (554)
Q Consensus       255 ~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-----HpnIv~l  328 (554)
                      .+++.+.....++|.+.++||+|+||+||+|... +++.||||++....  .....+..|+++++.++     ||||+++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            3444444455689999999999999999999774 68999999997532  33456788999999986     9999999


Q ss_pred             eeEEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC-----
Q 042763          329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE-----  403 (554)
Q Consensus       329 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~-----  403 (554)
                      ++++...+..++||||+ +++|.+++.......+++.+++.++.||+.||+|||   +++|+||||||+|||++.     
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCE
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccc
Confidence            99999999999999999 999999998776667999999999999999999999   899999999999999975     


Q ss_pred             --------------------CCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHH
Q 042763          404 --------------------SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLE  463 (554)
Q Consensus       404 --------------------~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~e  463 (554)
                                          ++.+||+|||+++.....      .....||+.|+|||++.+..++.++|||||||++||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                789999999999863321      234568999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCChhhHHHHHHHHHhhc--------cCCccccC--------Chhh----------hhhc---cHHHHHH
Q 042763          464 ILTGRRPVELKRPPEERVTLRWAFKRYN--------EGNLLDMV--------DPSI----------KEVI---SMEILTK  514 (554)
Q Consensus       464 lltg~~P~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~--------d~~l----------~~~~---~~~~~~~  514 (554)
                      |++|+.||......+....+........        ........        .+..          ....   .......
T Consensus       252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (360)
T 3llt_A          252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL  331 (360)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred             HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence            9999999987554333222221100000        00000000        0000          0000   0001256


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          515 MFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       515 l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      +.+++.+||+.||++|||+.|+++|.|
T Consensus       332 l~~li~~~L~~dP~~Rpta~elL~hp~  358 (360)
T 3llt_A          332 FCDFLYSILQIDPTLRPSPAELLKHKF  358 (360)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhcCcc
Confidence            789999999999999999999998866

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.5e-44  Score=371.75  Aligned_cols=259  Identities=24%  Similarity=0.351  Sum_probs=212.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|.+.+.||+|+||.||+|... +++.||+|++.....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            57888999999999999999765 588999999976542  233467889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++...  ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        95 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-  168 (384)
T ss_dssp             CCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence            999999999999764  57999999999999999999999   899999999999999999999999999999864322 


Q ss_pred             CCccccccccCCCCCcChhcccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKT---YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                         ......+||+.|+|||++.+   ..++.++|||||||++|||++|+.||...................  ..     
T Consensus       169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~-----  238 (384)
T 4fr4_A          169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VT-----  238 (384)
T ss_dssp             ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--CC-----
T ss_pred             ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--cC-----
Confidence               22345679999999999964   458999999999999999999999998655443332222211110  00     


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHHhhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPD-MKSVGEQLWAIRADS  547 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~l~~i~~~~  547 (554)
                             ++..++..+.+++.+||+.||++||+ +.+|.+|.|--.-+|
T Consensus       239 -------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w  280 (384)
T 4fr4_A          239 -------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW  280 (384)
T ss_dssp             -------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred             -------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence                   12233466899999999999999999 888888766544343

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-44  Score=363.62  Aligned_cols=256  Identities=25%  Similarity=0.353  Sum_probs=213.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|+..+.||+|+||+||+|... +|+.||+|++.+....  ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57888999999999999999775 6899999999875432  33567889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++...  ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....  
T Consensus        86 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--  158 (318)
T ss_dssp             CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred             eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence            999999999999764  57899999999999999999999   89999999999999999999999999999986432  


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                          .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..........   ...    .....      
T Consensus       159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~i~----~~~~~------  221 (318)
T 1fot_A          159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE---KIL----NAELR------  221 (318)
T ss_dssp             ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHH----HCCCC------
T ss_pred             ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH---HHH----hCCCC------
Confidence                1234579999999999999999999999999999999999999998654322211   111    11100      


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHhhhhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAIRADSLK  549 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i~~~~~~  549 (554)
                          ++......+.+++.+||+.||++||     ++.+|++|.|--.-+|.+
T Consensus       222 ----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~  269 (318)
T 1fot_A          222 ----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK  269 (318)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred             ----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHH
Confidence                1122345688999999999999999     999999998765444433

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=355.41  Aligned_cols=264  Identities=25%  Similarity=0.421  Sum_probs=215.6

Q ss_pred             cCCCcce-eeeccCceEEEEEEEc---CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          266 RNFSPSL-RIGEGGFGTVYKAQLE---DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       266 ~~f~~~~-~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ++|.+.. .||+|+||.||+|...   ++..||||+++........+.+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4555555 8999999999999753   57889999998765455567899999999999999999999999 45678999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++++|.+++... ...+++.+++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            9999999999999754 356899999999999999999999   889999999999999999999999999999875433


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      ...........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....   ..    .....    
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---i~----~~~~~----  232 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---IE----QGKRM----  232 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH---HH----TTCCC----
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH---Hh----cCCcC----
Confidence            322222334457899999999998889999999999999999999 9999987654332211   11    11100    


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKS  550 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~~  550 (554)
                           ..+..++..+.+++.+||+.||++||++.+++++|+++..+....
T Consensus       233 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          233 -----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             -----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             -----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence                 012234567899999999999999999999999999998876544

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.3e-44  Score=355.86  Aligned_cols=260  Identities=28%  Similarity=0.433  Sum_probs=203.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC----CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      .++|+..+.||+|+||+||+|....    +..||+|++.........+.+.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4678889999999999999997642    56799999887655556678999999999999999999999984 467899


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||||+++++|.+++... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            99999999999999754 346899999999999999999999   88999999999999999999999999999986432


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ..  ........+|+.|+|||++.+..++.++||||||+++|||++ |..||......+....+.       ......  
T Consensus       169 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-------~~~~~~--  237 (281)
T 1mp8_A          169 ST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NGERLP--  237 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTCCCC--
T ss_pred             cc--ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-------cCCCCC--
Confidence            21  112233457889999999999899999999999999999997 999998755433221111       111000  


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                             .+..++..+.+++.+||+.||++|||+.|++++|+++..+.
T Consensus       238 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          238 -------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                   12234466889999999999999999999999999997764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.6e-44  Score=370.76  Aligned_cols=260  Identities=23%  Similarity=0.350  Sum_probs=213.2

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~  339 (554)
                      ..++|...+.||+|+||+||+|+.+ +|+.||||++++...  ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            4578999999999999999999875 589999999987542  23346688899999876 9999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +||||+++|+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        95 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            999999999999999765  47899999999999999999999   8899999999999999999999999999998532


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ..   .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.     .....     
T Consensus       170 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~-----~~~~~-----  236 (345)
T 1xjd_A          170 LG---DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-----MDNPF-----  236 (345)
T ss_dssp             CT---TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HCCCC-----
T ss_pred             cC---CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-----hCCCC-----
Confidence            21   122345679999999999999999999999999999999999999998654332221111     01111     


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHHHhhhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMK-SVGEQLWAIRADSL  548 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~l~~i~~~~~  548 (554)
                             ++..+...+.+++.+||+.||++||++. +|++|.|--.-+|.
T Consensus       237 -------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          237 -------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             -------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             -------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence                   1122345688999999999999999998 89888765444443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.4e-43  Score=378.56  Aligned_cols=255  Identities=29%  Similarity=0.452  Sum_probs=212.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC-ceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN-ERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-~~~lv~E  343 (554)
                      .++|...++||+|+||.||+|... |+.||||+++...   ..+.+.+|+++|++++||||+++++++.+.. ..++|||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            467888999999999999999886 7899999997653   3467999999999999999999999987655 7899999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      ||++|+|.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....  
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            999999999998765556899999999999999999999   899999999999999999999999999999853221  


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                          .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+....+.       .+...      
T Consensus       343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~~~------  405 (450)
T 1k9a_A          343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKM------  405 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-------TTCCC------
T ss_pred             ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCC------
Confidence                122357889999999999999999999999999999998 999998765443322111       11000      


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                         ..+..++..+.+++.+||+.||++|||+.+|++.|++++...+
T Consensus       406 ---~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l  448 (450)
T 1k9a_A          406 ---DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL  448 (450)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             ---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence               0122345678999999999999999999999999999987643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.5e-44  Score=378.94  Aligned_cols=259  Identities=19%  Similarity=0.285  Sum_probs=210.0

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ..++|+..++||+|+||+||+|... +|+.||+|++..... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            3567999999999999999999664 689999999876543 23456789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC---CCCcEEEEeecCcccC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLG  418 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~---~~~~vkl~DfGla~~~  418 (554)
                      ||||++|+|.+++...  ..+++.++..++.||+.||+|||   +++|+||||||+|||++   .++.+||+|||+++..
T Consensus        89 ~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           89 FDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             ECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            9999999999999765  57899999999999999999999   88999999999999998   5688999999999864


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ...   ........||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+.       .+.. ..
T Consensus       164 ~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~-------~~~~-~~  232 (444)
T 3soa_A          164 EGE---QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK-------AGAY-DF  232 (444)
T ss_dssp             CTT---CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-------HTCC-CC
T ss_pred             cCC---CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-------hCCC-CC
Confidence            322   122334679999999999999999999999999999999999999998654332221111       1110 00


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      ..+.     ...++..+.+++.+||+.||++|||+.|+++|.|--
T Consensus       233 ~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~  272 (444)
T 3soa_A          233 PSPE-----WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS  272 (444)
T ss_dssp             CTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred             Cccc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence            0111     012345688999999999999999999999998743

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.5e-44  Score=370.81  Aligned_cols=260  Identities=20%  Similarity=0.271  Sum_probs=209.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhh----HHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFEN----LQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      .++|+..+.||+|+||+||+|... +|+.||||++.......    ..+.+.+|+.++++++||||+++++++.+++..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            457889999999999999999765 68999999997654321    3567899999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc---EEEEeecC
Q 042763          340 IITEFVPNGTLREHLDGQY--GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR---AKVADFGF  414 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~---vkl~DfGl  414 (554)
                      +|||||++++|.+++....  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999998886542  345899999999999999999999   899999999999999987655   99999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      ++.....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....    .......    ...
T Consensus       180 a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i~----~~~  248 (351)
T 3c0i_A          180 AIQLGES---GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGII----KGK  248 (351)
T ss_dssp             CEECCTT---SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHHH----HTC
T ss_pred             eeEecCC---CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHHH----cCC
Confidence            9875322   1223345799999999999999999999999999999999999999986321    1111111    111


Q ss_pred             ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       495 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      .  ..++....    .++..+.+++.+||+.||++|||+.|+++|.|--.
T Consensus       249 ~--~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          249 Y--KMNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             C--CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             C--CCCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            0  01111111    23456889999999999999999999999987543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.3e-44  Score=367.79  Aligned_cols=251  Identities=21%  Similarity=0.368  Sum_probs=208.1

Q ss_pred             cCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|.+.+.||+|+||+||+|.. .+|+.||||++......  .....+.+|+++++.++||||+++++++.+++..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            6789999999999999999976 46899999999765432  22357899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+ +|+|.+++...  ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.....  
T Consensus        89 E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~--  160 (336)
T 3h4j_B           89 EYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--  160 (336)
T ss_dssp             CCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT--
T ss_pred             ECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccC--
Confidence            999 78999998765  57899999999999999999999   88999999999999999999999999999986432  


Q ss_pred             CCccccccccCCCCCcChhccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQL-TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                        .......+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.........                ..+..
T Consensus       161 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~  222 (336)
T 3h4j_B          161 --GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNS  222 (336)
T ss_dssp             --SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCS
T ss_pred             --CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHc
Confidence              122344579999999999988776 78999999999999999999999764432110                00000


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      .. ...+...+..+.+++.+||+.||.+|||+.|++++.|--
T Consensus       223 ~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  263 (336)
T 3h4j_B          223 CV-YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN  263 (336)
T ss_dssp             SC-CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred             CC-CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence            00 011223445688999999999999999999999999853

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.4e-43  Score=365.58  Aligned_cols=264  Identities=23%  Similarity=0.354  Sum_probs=211.2

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ++|+..+.||+|+||+||+|+.. +++.||+|++.+...  ....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57888999999999999999876 589999999986543  23446688999999988 899999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++|+|.+++...  ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            9999999999999765  47899999999999999999999   889999999999999999999999999999853221


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhH--HHHHHHHHhhccCCccccC
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEER--VTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  499 (554)
                         .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ................   
T Consensus       164 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---  237 (345)
T 3a8x_A          164 ---GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---  237 (345)
T ss_dssp             ---TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC---
T ss_pred             ---CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC---
Confidence               12234567999999999999999999999999999999999999999753322110  0011111111111110   


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHHHhhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDM------KSVGEQLWAIRADS  547 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~l~~i~~~~  547 (554)
                             ++......+.+++.+||+.||++||++      .|+++|.|--.-+|
T Consensus       238 -------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          238 -------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             -------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred             -------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence                   122334568899999999999999995      89998877544333

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-43  Score=372.03  Aligned_cols=276  Identities=19%  Similarity=0.248  Sum_probs=212.0

Q ss_pred             hhcCCCcceeeecc--CceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          264 ATRNFSPSLRIGEG--GFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       264 ~~~~f~~~~~LG~G--~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      ..++|++.++||+|  +||+||+|... +|+.||||++..... ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            45789999999999  99999999876 699999999976543 334567889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +|||||++|+|.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||.+....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            9999999999999998776677999999999999999999999   8999999999999999999999999999886532


Q ss_pred             CCCC----CccccccccCCCCCcChhcccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH-HHHhhcc
Q 042763          420 MDSD----RTHISTKVKGTVGYLDPEYMKT--YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRW-AFKRYNE  492 (554)
Q Consensus       420 ~~~~----~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~-~~~~~~~  492 (554)
                      ....    .........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.............. .......
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            1111    1111223468999999999987  6799999999999999999999999987554332211100 0000000


Q ss_pred             -------------------CCccccC---Ch------hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          493 -------------------GNLLDMV---DP------SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       493 -------------------~~~~~~~---d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                                         ....+..   .+      .........+...+.+++.+||+.||++|||+.|+++|.|-
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f  337 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  337 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence                               0000000   00      00001122345678999999999999999999999988653

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.7e-44  Score=359.33  Aligned_cols=266  Identities=27%  Similarity=0.423  Sum_probs=209.1

Q ss_pred             cCCCcceeeeccCceEEEEEEE-----cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC--Cce
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQL-----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG--NER  338 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~  338 (554)
                      ++|+..++||+|+||.||+|.+     .+++.||||++.........+.+.+|++++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4578889999999999999983     368999999998765555567899999999999999999999999876  668


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ++||||+++++|.+++... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            9999999999999999654 346899999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------hhhHHHHHHHHHhh
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRP--------PEERVTLRWAFKRY  490 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~--------~~~~~~~~~~~~~~  490 (554)
                      ..............||..|+|||++.+..++.++||||||+++|||++|..|+.....        ..............
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence            5443333334456688899999999998999999999999999999999998642210        00000011111111


Q ss_pred             ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      ......         ..+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       257 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          257 KEGKRL---------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hccCCC---------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            111000         012234567899999999999999999999999998874

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.3e-44  Score=368.70  Aligned_cols=267  Identities=25%  Similarity=0.398  Sum_probs=213.2

Q ss_pred             CCCcceeeeccCceEEEEEEEc-----CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC--CceE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG--NERL  339 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-----~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~  339 (554)
                      .|+..++||+|+||+||++.+.     +++.||||++.........+.+.+|++++++++||||+++++++.+.  ...+
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            3488899999999999988653     58899999998765555567899999999999999999999999874  5679


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +||||+++|+|.+++...   .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       112 lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            999999999999999765   5899999999999999999999   8899999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChh--------hHHHHHHHHHhhc
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPE--------ERVTLRWAFKRYN  491 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~--------~~~~~~~~~~~~~  491 (554)
                      .............+|+.|+|||++.+..++.++||||||+++|||++|+.||.......        .............
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            43333333445568889999999999899999999999999999999999987422110        0000001111111


Q ss_pred             cCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          492 EGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       492 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                      ....         ...+..++..+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus       266 ~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          266 RGER---------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             cccC---------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            1100         01122345678999999999999999999999999999987664

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.3e-43  Score=356.50  Aligned_cols=266  Identities=21%  Similarity=0.322  Sum_probs=206.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ++|+..++||+|+||+||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            47888999999999999999775 589999999875543 3345678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |++ +++.+++... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....  
T Consensus        82 ~~~-~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--  154 (292)
T 3o0g_A           82 FCD-QDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--  154 (292)
T ss_dssp             CCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--
T ss_pred             cCC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--
Confidence            996 5666666543 357899999999999999999999   889999999999999999999999999999864322  


Q ss_pred             CccccccccCCCCCcChhccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc----
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQ-LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM----  498 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  498 (554)
                       ........||+.|+|||++.+.. ++.++|||||||++|||++|..||.........  +...............    
T Consensus       155 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~--~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             -CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGG
T ss_pred             -cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHHhCCCChhhhhhhc
Confidence             22233456899999999997765 899999999999999999998886544433222  2222221111110000    


Q ss_pred             --CC---------hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          499 --VD---------PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       499 --~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                        .+         ..............+.+++.+||+.||++|||+.|+++|.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  285 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY  285 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence              00         00000111234567889999999999999999999999876

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.5e-44  Score=362.87  Aligned_cols=256  Identities=25%  Similarity=0.372  Sum_probs=201.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC-------
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN-------  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-------  336 (554)
                      .++|+..+.||+|+||.||+|... +|+.||||+++........+.+.+|++++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            357888999999999999999876 799999999976554555678999999999999999999999986543       


Q ss_pred             --------------------------------------------------ceEEEEEeCCCCCHHHHHhcccC-CCCCHH
Q 042763          337 --------------------------------------------------ERLIITEFVPNGTLREHLDGQYG-KTLDFN  365 (554)
Q Consensus       337 --------------------------------------------------~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~  365 (554)
                                                                        ..++|||||++++|.+++..... ....+.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              27999999999999999976532 245666


Q ss_pred             HHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc---------cccccccCCCC
Q 042763          366 QRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT---------HISTKVKGTVG  436 (554)
Q Consensus       366 ~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~---------~~~~~~~gt~~  436 (554)
                      .++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.........         .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            78999999999999999   8999999999999999999999999999998754332111         12234569999


Q ss_pred             CcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHH
Q 042763          437 YLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMF  516 (554)
Q Consensus       437 y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  516 (554)
                      |+|||++.+..++.++||||||+++|||++|..|+.     ........    .....     .+.    ........+.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~----~~~~~-----~~~----~~~~~~~~~~  303 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITD----VRNLK-----FPL----LFTQKYPQEH  303 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHH----HHTTC-----CCH----HHHHHCHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHH----hhccC-----CCc----ccccCChhHH
Confidence            999999999999999999999999999999877642     11111111    11111     111    1123445678


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          517 GLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       517 ~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      +++.+||+.||++|||+.|++++.|
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~~~~  328 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIENAI  328 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHHSTT
T ss_pred             HHHHHHccCCCCcCCCHHHHhhchh
Confidence            9999999999999999999998765

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.4e-43  Score=355.25  Aligned_cols=266  Identities=24%  Similarity=0.339  Sum_probs=204.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHh--CCCCCceeeeeEEEc----CCce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSK--IDHRNLVKLLGFVDK----GNER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~~~~~~----~~~~  338 (554)
                      .++|+..+.||+|+||+||+|.. +|+.||||++....    ...+.+|.+++..  ++||||+++++++..    ....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            46899999999999999999987 58999999987653    2455667777766  799999999998644    2457


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhcc-----CCCeEeCCCCCCCeEECCCCcEEEEeec
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA-----EKQIIHRDVKSSNILLTESMRAKVADFG  413 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~Dlkp~NILl~~~~~vkl~DfG  413 (554)
                      ++||||+++|+|.++++..   .+++..++.++.|++.||+|||...     +++|+||||||+|||++.++.+||+|||
T Consensus        82 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence            9999999999999999643   7899999999999999999999321     5789999999999999999999999999


Q ss_pred             CcccCCCCCCCcc-ccccccCCCCCcChhccccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCCCC
Q 042763          414 FARLGPMDSDRTH-ISTKVKGTVGYLDPEYMKTY------QLTTKSDVYSFGVLLLEILTG----------RRPVELKRP  476 (554)
Q Consensus       414 la~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~------~~s~ksDVwSlGvil~elltg----------~~P~~~~~~  476 (554)
                      +++.......... ......||+.|+|||++.+.      .++.++||||||+++|||++|          +.||.....
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~  238 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP  238 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence            9976432222111 12234799999999999876      455799999999999999999          888865433


Q ss_pred             hhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          477 PEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      .........  .............   ........+..+.+++.+||+.||++|||+.||++.|.+|
T Consensus       239 ~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          239 NDPSFEDMR--KVVCVDQQRPNIP---NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SSCCHHHHH--HHHTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcchhhhh--HHHhccCCCCCCC---hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            322111111  1111111111111   1123345778899999999999999999999999999876

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.1e-43  Score=353.12  Aligned_cols=267  Identities=16%  Similarity=0.249  Sum_probs=216.3

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .++|...+.||+|+||+||+|.. .+|+.||||++.....   .+.+.+|+.+++++ +|+|++++++++.++...++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            46799999999999999999976 5699999999865432   24578899999999 7999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc-----EEEEeecCccc
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR-----AKVADFGFARL  417 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~-----vkl~DfGla~~  417 (554)
                      ||+ +++|.+++... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.     +||+|||+++.
T Consensus        86 e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           86 DLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             Eec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            999 99999999754 346899999999999999999999   899999999999999987776     99999999987


Q ss_pred             CCCCCCCc----cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC
Q 042763          418 GPMDSDRT----HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG  493 (554)
Q Consensus       418 ~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  493 (554)
                      ........    .......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            54332211    12345679999999999999999999999999999999999999998765443333332221111111


Q ss_pred             CccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          494 NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       494 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                      ..     +.    ....++..+.+++.+||+.||++||++.+|++.|+++..+..
T Consensus       241 ~~-----~~----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          241 PL-----RE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             CH-----HH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cH-----HH----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            00     00    112345678999999999999999999999999999876543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.1e-43  Score=377.06  Aligned_cols=272  Identities=20%  Similarity=0.236  Sum_probs=217.5

Q ss_pred             hHHHHHhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEc
Q 042763          258 MSQVVKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDK  334 (554)
Q Consensus       258 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  334 (554)
                      ..++....++|+..++||+|+||+||+|+.. +++.||+|++.+....  .....+.+|+.++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            3445556789999999999999999999876 4889999999765332  222348899999999999999999999999


Q ss_pred             CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecC
Q 042763          335 GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGF  414 (554)
Q Consensus       335 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl  414 (554)
                      ++..++|||||++|+|.+++... ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence            99999999999999999999763 357899999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHh
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMK-----TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR  489 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~  489 (554)
                      ++.....  ........+||+.|+|||++.     ...++.++|||||||++|||++|+.||......+....+......
T Consensus       222 a~~~~~~--~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  299 (437)
T 4aw2_A          222 CLKLMED--GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER  299 (437)
T ss_dssp             CEECCTT--SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred             hhhcccC--CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence            9764322  222334467999999999987     457899999999999999999999999876544333222211111


Q ss_pred             hccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHHHhhhhh
Q 042763          490 YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRND--RPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~~i~~~~  547 (554)
                      ..-...            ...+...+.+++.+||+.+|++  ||++.|+++|.|--.-+|
T Consensus       300 ~~~p~~------------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w  347 (437)
T 4aw2_A          300 FQFPTQ------------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW  347 (437)
T ss_dssp             CCCCSS------------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred             ccCCcc------------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence            110000            0113456789999999988888  999999999987644443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.9e-43  Score=360.49  Aligned_cols=265  Identities=18%  Similarity=0.235  Sum_probs=214.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .++|...+.||+|+||+||+|.. .+|+.||||++.....   .+.+.+|+++++++ +||||+++++++..++..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            46799999999999999999976 4689999999875532   24588999999999 9999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc-----EEEEeecCccc
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR-----AKVADFGFARL  417 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~-----vkl~DfGla~~  417 (554)
                      ||+ +++|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.     +||+|||+++.
T Consensus        85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           85 ELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            999 99999999764 457999999999999999999999   889999999999999999887     99999999986


Q ss_pred             CCCCCCCcc----ccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC
Q 042763          418 GPMDSDRTH----ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG  493 (554)
Q Consensus       418 ~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  493 (554)
                      .........    ......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            533222111    1235679999999999999999999999999999999999999998765444333322221111000


Q ss_pred             CccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          494 NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       494 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                            ..   .......+ .+.+++.+||+.||.+||++.+|.+.|.++....
T Consensus       240 ------~~---~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          240 ------PI---EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             ------CH---HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ------CH---HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence                  00   00111123 7899999999999999999999999999887654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.4e-44  Score=361.01  Aligned_cols=272  Identities=25%  Similarity=0.316  Sum_probs=208.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh----hhHHHHHHHHHHHHHhC---CCCCceeeeeEEEcCC
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF----ENLQTEFSSEVELLSKI---DHRNLVKLLGFVDKGN  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~----~~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~~~  336 (554)
                      .++|++.++||+|+||+||+|.. .+|+.||||++.....    ......+.+|+++++++   +||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            57899999999999999999976 4689999999874321    11124566777777766   4999999999997755


Q ss_pred             -----ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEe
Q 042763          337 -----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVAD  411 (554)
Q Consensus       337 -----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~D  411 (554)
                           ..++||||++ ++|.+++.......+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEee
Confidence                 4799999995 69999998776666999999999999999999999   88999999999999999999999999


Q ss_pred             ecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhc
Q 042763          412 FGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN  491 (554)
Q Consensus       412 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~  491 (554)
                      ||+++.....    .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+........
T Consensus       164 fg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          164 FGLARIYSYQ----MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             CSCTTTSTTC----CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             CccccccCCC----cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999864322    223445799999999999999999999999999999999999999987654433322222111111


Q ss_pred             cCCccccC----------ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          492 EGNLLDMV----------DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       492 ~~~~~~~~----------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      ........          .+........++...+.+++.+||+.||++|||+.|+++|.|--+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~  302 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK  302 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence            11111000          000001112234567899999999999999999999999987543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.3e-44  Score=378.10  Aligned_cols=268  Identities=21%  Similarity=0.252  Sum_probs=215.9

Q ss_pred             HHHHHhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcC
Q 042763          259 SQVVKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKG  335 (554)
Q Consensus       259 ~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  335 (554)
                      .++....++|...++||+|+||+||+|+.. +++.||+|++.+....  ...+.+.+|+.+++.++||||+++++++.++
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344455688999999999999999999876 5899999999764321  2234588999999999999999999999999


Q ss_pred             CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCc
Q 042763          336 NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA  415 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla  415 (554)
                      +..++|||||++|+|.+++...   .+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEecccee
Confidence            9999999999999999999754   6899999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhc
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ----LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN  491 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~  491 (554)
                      +.....  ........+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...........+........
T Consensus       216 ~~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~  293 (410)
T 3v8s_A          216 MKMNKE--GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT  293 (410)
T ss_dssp             EECCTT--SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred             EeeccC--CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc
Confidence            864322  222334567999999999998765    88999999999999999999999987654333222211110000


Q ss_pred             cCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHHHhhhhh
Q 042763          492 EGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRND--RPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       492 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~~i~~~~  547 (554)
                      -        +.     ...++..+.+++.+||+.+|.+  ||++.||++|.|--.-+|
T Consensus       294 ~--------p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w  338 (410)
T 3v8s_A          294 F--------PD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  338 (410)
T ss_dssp             C--------CT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred             C--------CC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence            0        00     0123456889999999999998  999999999988654433

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.8e-44  Score=360.70  Aligned_cols=254  Identities=26%  Similarity=0.351  Sum_probs=200.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-------------------------hHHHHHHHHHHHHH
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-------------------------NLQTEFSSEVELLS  318 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-------------------------~~~~~~~~Ei~~l~  318 (554)
                      .++|...+.||+|+||+||+|... +++.||||++......                         ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            367899999999999999999765 6899999998654321                         11356889999999


Q ss_pred             hCCCCCceeeeeEEEc--CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCC
Q 042763          319 KIDHRNLVKLLGFVDK--GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKS  396 (554)
Q Consensus       319 ~l~HpnIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp  396 (554)
                      +++||||+++++++.+  ++..++||||+++++|.+++..   ..+++.+++.++.|++.||+|||   +++|+||||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp  165 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKP  165 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCH
Confidence            9999999999999986  5678999999999999887643   47899999999999999999999   88999999999


Q ss_pred             CCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCC---CCchhhHHHHHHHHHHHHhCCCCCCC
Q 042763          397 SNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ---LTTKSDVYSFGVLLLEILTGRRPVEL  473 (554)
Q Consensus       397 ~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~ksDVwSlGvil~elltg~~P~~~  473 (554)
                      +|||++.++.+||+|||+++.....   ........||+.|+|||++.+..   ++.++||||||+++|||++|+.||..
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGS---DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSS---SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHEEECCCCCEEEecCCCccccccc---cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999864322   12233457999999999998765   47899999999999999999999986


Q ss_pred             CCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          474 KRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       474 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .......   ...    ...... .  +     ....++..+.+++.+||+.||++|||+.|+++|.|-
T Consensus       243 ~~~~~~~---~~~----~~~~~~-~--~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~  296 (298)
T 2zv2_A          243 ERIMCLH---SKI----KSQALE-F--P-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV  296 (298)
T ss_dssp             SSHHHHH---HHH----HHCCCC-C--C-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred             ccHHHHH---HHH----hcccCC-C--C-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence            4422111   111    111100 0  0     011234568899999999999999999999999874

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-44  Score=366.14  Aligned_cols=267  Identities=27%  Similarity=0.368  Sum_probs=211.2

Q ss_pred             hhcCCCcceeeeccCceEEEEEEE------cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCC
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGN  336 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~  336 (554)
                      ..++|...+.||+|+||+||+|..      .++..||||++.........+.+.+|+.+++++ +||||+++++++..++
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            457889999999999999999975      246789999998654444557899999999999 8999999999999999


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccC---------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCC
Q 042763          337 ERLIITEFVPNGTLREHLDGQYG---------------------KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVK  395 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk  395 (554)
                      ..++||||+++|+|.+++.....                     ..+++.+++.++.||+.||+|||   +++|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence            99999999999999999976532                     24789999999999999999999   8999999999


Q ss_pred             CCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 042763          396 SSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELK  474 (554)
Q Consensus       396 p~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~  474 (554)
                      |+|||++.++.+||+|||+++...... .........||+.|+|||++.+..++.++||||||+++|||+| |..||...
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCc-cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            999999999999999999997643222 1222334557889999999999999999999999999999998 99999876


Q ss_pred             CChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 042763          475 RPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK  549 (554)
Q Consensus       475 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~  549 (554)
                      .........  ..    .....         ..+..++..+.+++.+||+.||++|||+.+|+++|+.+......
T Consensus       279 ~~~~~~~~~--~~----~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  338 (344)
T 1rjb_A          279 PVDANFYKL--IQ----NGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE  338 (344)
T ss_dssp             CCSHHHHHH--HH----TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             CcHHHHHHH--Hh----cCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence            544322111  11    11000         01122345688999999999999999999999999998776443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.9e-43  Score=351.35  Aligned_cols=253  Identities=29%  Similarity=0.476  Sum_probs=208.3

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      +.++|++.+.||+|+||+||+|... ++..||||++......  .....+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3467889999999999999999765 5789999998765432  235678999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||||+++++|.+++...  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus        87 v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             EECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            99999999999999765  56899999999999999999999   89999999999999999999999999999865322


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      .     ......||+.|+|||.+.+..++.++||||||+++|+|++|..||......+....+..     ....      
T Consensus       162 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~------  225 (279)
T 3fdn_A          162 S-----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-----VEFT------  225 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-----TCCC------
T ss_pred             c-----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh-----CCCC------
Confidence            1     22345689999999999999999999999999999999999999986543322211111     0000      


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                            .+......+.+++.+||+.||++|||+.|+++|.|--
T Consensus       226 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~  262 (279)
T 3fdn_A          226 ------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  262 (279)
T ss_dssp             ------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred             ------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence                  1122345678999999999999999999999998853

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.1e-44  Score=384.11  Aligned_cols=259  Identities=27%  Similarity=0.463  Sum_probs=213.9

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ..++|...++||+|+||+||+|...++..||||+++....  ..+.+.+|+++|++++||||+++++++. .+..++|||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            3467888999999999999999998889999999986542  3568999999999999999999999986 567899999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      ||++|+|.+++.......+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....  
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~--  337 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN--  337 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH--
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC--
Confidence            999999999998665457899999999999999999999   889999999999999999999999999999864321  


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                      .........+|+.|+|||++.+..++.++||||||+++|||+| |+.||......+....+   ......      .   
T Consensus       338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~~~~~~------~---  405 (454)
T 1qcf_A          338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---ERGYRM------P---  405 (454)
T ss_dssp             HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---HHTCCC------C---
T ss_pred             ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCCCC------C---
Confidence            1111223446788999999998899999999999999999999 99999865543322111   111110      0   


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                          .+..++..+.+++.+||+.||++|||+.+|++.|+++...
T Consensus       406 ----~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          406 ----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             ----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                1123456789999999999999999999999999988654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.1e-43  Score=367.20  Aligned_cols=260  Identities=23%  Similarity=0.303  Sum_probs=212.9

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcC-CcEEEEEEcchhhh--hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQF--ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~  339 (554)
                      ..++|...+.||+|+||+||+|+... |+.||||++++...  ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            34689999999999999999998764 88999999987643  23456788999999988 7999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +||||+++|+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        98 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            999999999999999765  46899999999999999999999   8899999999999999999999999999998532


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ..   .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+...   ...    .....   
T Consensus       173 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~---~i~----~~~~~---  239 (353)
T 2i0e_A          173 WD---GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ---SIM----EHNVA---  239 (353)
T ss_dssp             CT---TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHH----HCCCC---
T ss_pred             cC---CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHH---HHH----hCCCC---
Confidence            21   122345679999999999999999999999999999999999999998654332211   111    11110   


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHHhhhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPD-----MKSVGEQLWAIRADSL  548 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~i~~~~~  548 (554)
                             ++...+..+.+++.+||+.||++||+     +.+|++|.|--.-+|.
T Consensus       240 -------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          240 -------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             -------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             -------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence                   11233456889999999999999994     6999998775443443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=9.9e-44  Score=367.29  Aligned_cols=257  Identities=21%  Similarity=0.293  Sum_probs=215.2

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|+..+.||+|+||.||+|... +|+.||||++.+...  ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            67889999999999999999875 689999999976543  233567889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++..... 
T Consensus       121 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            999999999999765  46899999999999999999999   899999999999999999999999999999864321 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                           ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+       ..+...      
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i-------~~~~~~------  256 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-------VSGKVR------  256 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCCCC------
T ss_pred             -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHH-------HcCCCC------
Confidence                 23457999999999999999999999999999999999999999865432221111       111110      


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHHhhhhhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPD-----MKSVGEQLWAIRADSLKS  550 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~i~~~~~~~  550 (554)
                          ++..+...+.+++.+||+.||++||+     +.+|++|.|--.-+|.+.
T Consensus       257 ----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~  305 (350)
T 1rdq_E          257 ----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI  305 (350)
T ss_dssp             ----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHH
Confidence                11223456889999999999999999     999999988665555443

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9e-44  Score=363.99  Aligned_cols=261  Identities=23%  Similarity=0.393  Sum_probs=204.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCc----EEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGL----LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      .++|+..++||+|+||+||+|.+. +++    .||+|.+.........+++.+|+.++++++||||+++++++.++ ..+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence            467888999999999999999764 344    46888887655445567899999999999999999999999875 478


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +|+||+++|+|.+++... ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            999999999999999764 356899999999999999999999   8899999999999999999999999999998643


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      .... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+.    ......    
T Consensus       169 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~----~~~~~~----  239 (327)
T 3poz_A          169 AEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----KGERLP----  239 (327)
T ss_dssp             TTCC--------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----TTCCCC----
T ss_pred             CCcc-cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH----cCCCCC----
Confidence            3222 222233457889999999999999999999999999999999 999998755433222111    110000    


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                              .+..+...+.+++.+||+.+|++||++.||+++|..+..+.
T Consensus       240 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          240 --------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             --------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             --------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence                    11223456889999999999999999999999999987654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.2e-43  Score=351.46  Aligned_cols=254  Identities=21%  Similarity=0.298  Sum_probs=208.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC--CceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG--NERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~lv  341 (554)
                      .++|...+.||+|+||+||+|... ++.||||++..... ....+.+.+|+.++++++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            357888999999999999999986 88999999876542 33456799999999999999999999999877  778999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ--IIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      |||+++|+|.+++.......+++.+++.++.|++.||+|||   +.+  ++||||||+|||++.++.++|+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            99999999999998765557999999999999999999999   788  9999999999999999999999999875421


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTT---KSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL  496 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~---ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  496 (554)
                              .....||+.|+|||++.+..++.   ++||||||+++|||++|+.||..........   ........    
T Consensus       165 --------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~~----  229 (271)
T 3kmu_A          165 --------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM---KVALEGLR----  229 (271)
T ss_dssp             --------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH---HHHHSCCC----
T ss_pred             --------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH---HHHhcCCC----
Confidence                    12346899999999998765444   8999999999999999999998654332211   11111001    


Q ss_pred             ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          497 DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       497 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                          +.    .+..++..+.+++.+||+.||++|||+.|+++.|.+++.
T Consensus       230 ----~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          230 ----PT----IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ----CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                01    122334568899999999999999999999999999875

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.3e-43  Score=362.95  Aligned_cols=257  Identities=23%  Similarity=0.333  Sum_probs=202.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEE----cCCcEEEEEEcchhhh---hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL----EDGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  337 (554)
                      .++|+..+.||+|+||.||+|..    .+|+.||+|+++....   ......+.+|++++++++||||+++++++.+++.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            36788899999999999999976    4689999999976532   2234567899999999999999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .++||||+++++|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            99999999999999999765  46899999999999999999999   88999999999999999999999999999975


Q ss_pred             CCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                      ....   ........||+.|+|||++.+..++.++||||||+++|||++|+.||..........   .....  ...   
T Consensus       171 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~--~~~---  239 (327)
T 3a62_A          171 SIHD---GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID---KILKC--KLN---  239 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHT--CCC---
T ss_pred             cccC---CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHH---HHHhC--CCC---
Confidence            3221   122334579999999999999999999999999999999999999998654332211   11110  000   


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHhhhh
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAIRAD  546 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i~~~  546 (554)
                               .+......+.+++.+||+.||++||     ++.|+++|.|--.-+
T Consensus       240 ---------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~  284 (327)
T 3a62_A          240 ---------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN  284 (327)
T ss_dssp             ---------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred             ---------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence                     1122345688999999999999999     899999998754333

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.4e-43  Score=372.89  Aligned_cols=256  Identities=21%  Similarity=0.277  Sum_probs=196.1

Q ss_pred             cCCCcc-eeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHH-hCCCCCceeeeeEEEc----CCce
Q 042763          266 RNFSPS-LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLS-KIDHRNLVKLLGFVDK----GNER  338 (554)
Q Consensus       266 ~~f~~~-~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~-~l~HpnIv~l~~~~~~----~~~~  338 (554)
                      ++|... ++||+|+||+||+|... +|+.||||++...      ..+.+|++++. ..+||||+++++++..    ....
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            456655 68999999999999765 6899999998643      35667888874 4589999999999865    5678


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC---CCcEEEEeecCc
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE---SMRAKVADFGFA  415 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~DfGla  415 (554)
                      ++|||||++|+|.+++.......+++.+++.++.||+.||+|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999998765567999999999999999999999   889999999999999997   789999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHH-HHHHHHHhhccCC
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERV-TLRWAFKRYNEGN  494 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~-~~~~~~~~~~~~~  494 (554)
                      +....    .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ......    .+.
T Consensus       212 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~  283 (400)
T 1nxk_A          212 KETTS----HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQ  283 (400)
T ss_dssp             EECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTC
T ss_pred             cccCC----CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCc
Confidence            86432    122345678999999999999999999999999999999999999997654322110 011110    000


Q ss_pred             ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       495 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      . ....+.     ...+...+.+++.+||+.||++|||+.|+++|.|-..
T Consensus       284 ~-~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          284 Y-EFPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             C-CCCTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             c-cCCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence            0 000000     0123456889999999999999999999999998654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.4e-44  Score=362.80  Aligned_cols=260  Identities=25%  Similarity=0.363  Sum_probs=201.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc----
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE----  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~----  337 (554)
                      .++|++.+.||+|+||+||+|.. .+++.||||++.....  ......+.+|++++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999976 5689999999976532  2345678999999999999999999999876544    


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .++||||+++++|.+++...  ..+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            39999999999999999765  47899999999999999999999   88999999999999999999999999999986


Q ss_pred             CCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                      ...............||+.|+|||++.+..++.++||||||+++|||++|+.||..........  .    .....    
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~--~----~~~~~----  235 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY--Q----HVRED----  235 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--H----HHHCC----
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--H----HhcCC----
Confidence            5433323233344569999999999999999999999999999999999999998654332211  1    11110    


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ...+.   .....++..+.+++.+||+.||++||++.+++.+.|.
T Consensus       236 ~~~~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  277 (311)
T 3ork_A          236 PIPPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  277 (311)
T ss_dssp             CCCHH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CCCcc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence            01111   0112245668899999999999999988888776654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.9e-44  Score=356.02  Aligned_cols=263  Identities=29%  Similarity=0.395  Sum_probs=219.4

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcC-CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ..++|...+.||+|+||+||+|.... +..||+|++....  ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            45778899999999999999998764 8899999987653  23567899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++++|.+++.......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++...... 
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-  164 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-  164 (288)
T ss_dssp             ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS-
T ss_pred             EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCC-
Confidence            9999999999998766677999999999999999999999   889999999999999999999999999999864322 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                       .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.    .....        
T Consensus       165 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~----~~~~~--------  231 (288)
T 3kfa_A          165 -TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----KDYRM--------  231 (288)
T ss_dssp             -SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH----TTCCC--------
T ss_pred             -ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh----ccCCC--------
Confidence             2223334457889999999999999999999999999999999 999998765433222111    10000        


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK  549 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~  549 (554)
                          ..+..++..+.+++.+||+.||++|||+.++++.|+++..+...
T Consensus       232 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~  275 (288)
T 3kfa_A          232 ----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI  275 (288)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccc
Confidence                01123345688999999999999999999999999998876543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.8e-43  Score=349.89  Aligned_cols=259  Identities=29%  Similarity=0.417  Sum_probs=213.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .++|...+.||+|+||.||+|...++..||+|++......  .+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            4678889999999999999999888899999999876432  36789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++++|.+++... ...+++..++.++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++.....  .
T Consensus        85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~--~  158 (267)
T 3t9t_A           85 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--Q  158 (267)
T ss_dssp             CTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH--H
T ss_pred             CCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc--c
Confidence            9999999999764 346899999999999999999999   899999999999999999999999999999864211  1


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      ........+++.|+|||++.+..++.++||||||+++|||++ |+.||..........   ..    .....  ..    
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---~i----~~~~~--~~----  225 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE---DI----STGFR--LY----  225 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---HH----HTTCC--CC----
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH---HH----hcCCc--CC----
Confidence            112233457788999999998899999999999999999999 899998654322211   11    11100  00    


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                         .+...+..+.+++.+||+.||++||++.+++++|.++....
T Consensus       226 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (267)
T 3t9t_A          226 ---KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG  266 (267)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ---CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence               11123456889999999999999999999999999998753

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.9e-43  Score=358.65  Aligned_cols=273  Identities=27%  Similarity=0.355  Sum_probs=219.4

Q ss_pred             ChHHHHHhhcCCCcceeeeccCceEEEEEEE------cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeee
Q 042763          257 NMSQVVKATRNFSPSLRIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLL  329 (554)
Q Consensus       257 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~  329 (554)
                      .........++|...+.||+|+||+||+|..      .+++.||||++.........+.+.+|+.+++++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3344455668899999999999999999974      346899999998765555567899999999999 799999999


Q ss_pred             eEEEcCC-ceEEEEEeCCCCCHHHHHhcccC--------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCC
Q 042763          330 GFVDKGN-ERLIITEFVPNGTLREHLDGQYG--------------KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDV  394 (554)
Q Consensus       330 ~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl  394 (554)
                      +++...+ ..++||||+++++|.+++.....              ..+++.+++.++.|++.||.|||   +++|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccC
Confidence            9987654 48999999999999999976532              12789999999999999999999   889999999


Q ss_pred             CCCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 042763          395 KSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVEL  473 (554)
Q Consensus       395 kp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~  473 (554)
                      ||+||+++.++.+||+|||+++...... .........||+.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ccceEEECCCCCEEECCCccccccccCc-cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999999999999998643322 2222334567899999999999999999999999999999998 9999987


Q ss_pred             CCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          474 KRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       474 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                      .........  .... .....            .+......+.+++.+||+.||++|||+.||+++|+++.....
T Consensus       254 ~~~~~~~~~--~~~~-~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          254 VKIDEEFCR--RLKE-GTRMR------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             CCCSHHHHH--HHHH-TCCCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             cchhHHHHH--Hhcc-CccCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            654432211  1111 00000            111234568899999999999999999999999999987653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.2e-43  Score=366.32  Aligned_cols=258  Identities=22%  Similarity=0.317  Sum_probs=200.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|...++||+|+||+||++... +++.||||++......  .+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            467999999999999999999776 6899999999765322  3568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc--EEEEeecCcccCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR--AKVADFGFARLGPMD  421 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~--vkl~DfGla~~~~~~  421 (554)
                      |+++|+|.+++...  ..+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.  +||+|||+++.... 
T Consensus        97 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-  170 (361)
T 3uc3_A           97 YASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-  170 (361)
T ss_dssp             CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc-
Confidence            99999999999765  46899999999999999999999   899999999999999987765  99999999974221 


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTK-SDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k-sDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                         ........||+.|+|||++.+..++.+ +|||||||++|||++|+.||................   ......  ..
T Consensus       171 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~---~~~~~~--~~  242 (361)
T 3uc3_A          171 ---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI---LSVKYS--IP  242 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHH---HTTCCC--CC
T ss_pred             ---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHH---hcCCCC--CC
Confidence               122234569999999999988887765 899999999999999999998655433322221111   111000  00


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      .      ...+...+.+++.+||+.||++|||+.|+++|.|-.+
T Consensus       243 ~------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          243 D------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             T------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             C------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence            0      0012356789999999999999999999999998754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=356.72  Aligned_cols=270  Identities=24%  Similarity=0.334  Sum_probs=206.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ++|+..++||+|+||+||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57889999999999999999875 589999998865443 2345678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++++|.+++...  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus        83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  155 (311)
T 4agu_A           83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--  155 (311)
T ss_dssp             CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--
Confidence            99999999988654  56899999999999999999999   889999999999999999999999999999864322  


Q ss_pred             CccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHh--------hccCC
Q 042763          424 RTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR--------YNEGN  494 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~--------~~~~~  494 (554)
                       ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+......        .....
T Consensus       156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          156 -SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             -ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence             122234568999999999876 67899999999999999999999999876554433322221110        00000


Q ss_pred             c---cccCChh---hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          495 L---LDMVDPS---IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       495 ~---~~~~d~~---l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      .   ....++.   ........++..+.+++.+||+.||++|||++|+++|.|--
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  289 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE  289 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence            0   0000100   00001123456689999999999999999999999987643

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-43  Score=360.40  Aligned_cols=263  Identities=29%  Similarity=0.464  Sum_probs=207.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC-----CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED-----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~-----g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      .++|...+.||+|+||+||+|....     +..||||++...........+.+|++++++++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3567778899999999999997652     34699999987654555678999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +||||+++|+|.+++... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       123 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          123 IITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            999999999999999754 356899999999999999999999   8899999999999999999999999999998754


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      .............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+..   ...    ....... 
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~---~~~----~~~~~~~-  270 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM---KAI----NDGFRLP-  270 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHH----HTTCCCC-
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH---HHH----HCCCcCC-
Confidence            33222222233456889999999999999999999999999999999 99999765432211   111    1110000 


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                              .+..++..+.+++.+||+.+|++||++.+|+++|+++....
T Consensus       271 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          271 --------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             --------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             --------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                    11233456889999999999999999999999999887654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=373.07  Aligned_cols=267  Identities=21%  Similarity=0.255  Sum_probs=213.9

Q ss_pred             hHHHHHhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc
Q 042763          258 MSQVVKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK  334 (554)
Q Consensus       258 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  334 (554)
                      +.+.....++|+..++||+|+||+||+|+.+ +|+.||||++.+...  ....+.+.+|..++.+++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444556789999999999999999999875 699999999976532  2223458899999999999999999999999


Q ss_pred             CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecC
Q 042763          335 GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGF  414 (554)
Q Consensus       335 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl  414 (554)
                      .+..++||||+++|+|.+++... +..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechh
Confidence            99999999999999999999754 347899999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhccc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMK-------TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF  487 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~  487 (554)
                      ++.....  ........+||+.|+|||++.       +..|+.++|||||||++|||++|+.||......+....+....
T Consensus       209 a~~~~~~--~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  286 (412)
T 2vd5_A          209 CLKLRAD--GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK  286 (412)
T ss_dssp             CEECCTT--SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred             heeccCC--CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence            9864322  122233467999999999997       3568999999999999999999999998765433322221111


Q ss_pred             HhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHHHHHh
Q 042763          488 KRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDR---PDMKSVGEQLWAI  543 (554)
Q Consensus       488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~l~~i  543 (554)
                      ....        .+.    ....++..+.+++.+||+ +|++|   |++.||++|.|--
T Consensus       287 ~~~~--------~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~  332 (412)
T 2vd5_A          287 EHLS--------LPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF  332 (412)
T ss_dssp             HHCC--------CC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGT
T ss_pred             cCcC--------CCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcC
Confidence            1110        011    112234568899999999 99998   6999999998753

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-43  Score=383.87  Aligned_cols=259  Identities=29%  Similarity=0.417  Sum_probs=215.8

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC-CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ..+|...++||+|+||.||+|.+.. +..||||+++....  ..+++.+|+.+|++++||||+++++++.+++..++|||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            4568888999999999999998774 88999999976532  24679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      ||++|+|.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....  
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--  371 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD--  371 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC--
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCC--
Confidence            999999999998765667999999999999999999999   899999999999999999999999999999864322  


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                      .........+++.|+|||++.+..++.++||||||+++|||++ |..||...........   ......    .      
T Consensus       372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~---~~~~~~----~------  438 (495)
T 1opk_A          372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKDYR----M------  438 (495)
T ss_dssp             CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---HHTTCC----C------
T ss_pred             ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcCCC----C------
Confidence            2222233456789999999999899999999999999999999 9999987654332211   111000    0      


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                         ..+..++..+.+++.+||+.||++|||+.+|++.|+.+..+
T Consensus       439 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          439 ---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             ---CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence               01223456788999999999999999999999999987544

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.1e-43  Score=368.04  Aligned_cols=275  Identities=23%  Similarity=0.287  Sum_probs=217.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC--ceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN--ERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--~~~lv  341 (554)
                      .++|...++||+|+||+||+|... +|+.||||++.........+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            367889999999999999999776 489999999987655555677889999999999999999999998755  67999


Q ss_pred             EEeCCCCCHHHHHhcccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE----CCCCcEEEEeecCcc
Q 042763          342 TEFVPNGTLREHLDGQYG-KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL----TESMRAKVADFGFAR  416 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl----~~~~~vkl~DfGla~  416 (554)
                      |||+++|+|.+++..... ..+++.+++.++.||+.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999976532 34899999999999999999999   8899999999999999    788889999999998


Q ss_pred             cCCCCCCCccccccccCCCCCcChhcccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHH-HHH
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKT--------YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR-WAF  487 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~-~~~  487 (554)
                      ....    ........||+.|+|||++.+        ..++.++|||||||++|||++|+.||............. ...
T Consensus       165 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          165 ELED----DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             ECCC----GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             EccC----CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            6432    122334569999999999865        567889999999999999999999997544332222221 111


Q ss_pred             HhhccCCccccC-----------ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          488 KRYNEGNLLDMV-----------DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       488 ~~~~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      ............           +......+.......+.+++.+||+.||++||++.|+++.++++...
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            111111100000           00111124467788899999999999999999999999999888654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.1e-43  Score=360.86  Aligned_cols=263  Identities=29%  Similarity=0.436  Sum_probs=214.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc--------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcC
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE--------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKG  335 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~  335 (554)
                      .++|...+.||+|+||+||+|...        ++..||||++.........+.+.+|+++++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            467888999999999999999763        46789999998765555567899999999999 899999999999999


Q ss_pred             CceEEEEEeCCCCCHHHHHhcccC--------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE
Q 042763          336 NERLIITEFVPNGTLREHLDGQYG--------------KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL  401 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl  401 (554)
                      +..++||||+++|+|.+++.....              ..+++.+++.++.||+.||+|||   +.+|+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            999999999999999999976532              24889999999999999999999   8899999999999999


Q ss_pred             CCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhH
Q 042763          402 TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEER  480 (554)
Q Consensus       402 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~  480 (554)
                      +.++.+||+|||+++...... .........+|+.|+|||++.+..++.++||||||+++|||++ |..||......+..
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  269 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  269 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTS-SEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             cCCCCEEEccccccccccccc-cccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence            999999999999998643221 1122233457889999999998889999999999999999999 99999865432221


Q ss_pred             HHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          481 VTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                      .   ....    .....         .+..++..+.+++.+||+.||++|||+.||+++|.++....
T Consensus       270 ~---~~~~----~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          270 K---LLKE----GHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             H---HHHH----TCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             H---HHhc----CCCCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            1   1111    11000         11233456889999999999999999999999999987643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.7e-44  Score=364.96  Aligned_cols=271  Identities=22%  Similarity=0.319  Sum_probs=204.1

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|...++||+|+||+||+|... +++.||||++...........+.+|++++++++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            47888999999999999999776 68999999997654333333466899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      ++ |+|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus        82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~---  153 (324)
T 3mtl_A           82 LD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---  153 (324)
T ss_dssp             CS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC---
Confidence            96 6999998754 356899999999999999999999   899999999999999999999999999999853321   


Q ss_pred             ccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh-
Q 042763          425 THISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS-  502 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-  502 (554)
                      ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+................... 
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence            222234568999999999876 568999999999999999999999998765444333222221111111111110000 


Q ss_pred             h------------hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          503 I------------KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       503 l------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      .            .......+...+.+++.+||+.||++|||+.|+++|.|-..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  287 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS  287 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence            0            00011223467889999999999999999999999987543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.1e-43  Score=349.07  Aligned_cols=262  Identities=21%  Similarity=0.333  Sum_probs=212.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .++|+..+.||+|+||.||+|... +|+.||+|++..... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999765 589999999876543 334467889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc---EEEEeecCcccCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR---AKVADFGFARLGP  419 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~---vkl~DfGla~~~~  419 (554)
                      ||+++++|.+++...  ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||++....
T Consensus        85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            999999999998765  57899999999999999999999   889999999999999986655   9999999997643


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ..    .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.   .    ... ...
T Consensus       160 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---~----~~~-~~~  227 (284)
T 3kk8_A          160 DS----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK---A----GAY-DYP  227 (284)
T ss_dssp             SS----CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H----TCC-CCC
T ss_pred             cC----ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH---h----ccc-cCC
Confidence            21    22234569999999999999999999999999999999999999997654332221111   1    000 000


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                      .+.     ...++..+.+++.+||+.||++|||+.|++++.|--..+..
T Consensus       228 ~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (284)
T 3kk8_A          228 SPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV  271 (284)
T ss_dssp             TTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred             chh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence            111     01234568899999999999999999999999886554443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.8e-43  Score=349.61  Aligned_cols=252  Identities=31%  Similarity=0.458  Sum_probs=196.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhh---hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFE---NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .++|+..+.||+|+||.||+|... |..||||++......   ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357888999999999999999876 899999998765332   2346789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCC---eEeCCCCCCCeEECC--------CCcEEEE
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ---IIHRDVKSSNILLTE--------SMRAKVA  410 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~---ivH~Dlkp~NILl~~--------~~~vkl~  410 (554)
                      |||+++++|.+++..   ..+++.+++.++.|++.||+|||   +++   |+||||||+|||++.        ++.+||+
T Consensus        85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            999999999999964   37899999999999999999999   666   999999999999986        7789999


Q ss_pred             eecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhh
Q 042763          411 DFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY  490 (554)
Q Consensus       411 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  490 (554)
                      |||+++......     .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...........   .   .
T Consensus       159 Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~---~  227 (271)
T 3dtc_A          159 DFGLAREWHRTT-----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG---V---A  227 (271)
T ss_dssp             CCCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH---H---H
T ss_pred             cCCccccccccc-----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh---h---h
Confidence            999997543211     2234689999999999999999999999999999999999999986543222111   1   1


Q ss_pred             ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      ... ...    .    .+..++..+.+++.+||+.||++|||+.|++++|.+|
T Consensus       228 ~~~-~~~----~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          228 MNK-LAL----P----IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             TSC-CCC----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             cCC-CCC----C----CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            111 000    0    1223345688999999999999999999999999764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=366.82  Aligned_cols=253  Identities=23%  Similarity=0.320  Sum_probs=200.8

Q ss_pred             CcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          269 SPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       269 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      ...+.||+|+||.||+|... +|+.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            34567999999999999764 689999999987543 3356799999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE--CCCCcEEEEeecCcccCCCCCCCc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL--TESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl--~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ++|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||+  +.++.+||+|||+++.....    
T Consensus       171 ~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~----  242 (373)
T 2x4f_A          171 GELFDRIIDE-SYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR----  242 (373)
T ss_dssp             CEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT----
T ss_pred             CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc----
Confidence            9999988654 246899999999999999999999   8899999999999999  67789999999999874322    


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE  505 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  505 (554)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...   .......     ......   
T Consensus       243 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~i~~~~~-----~~~~~~---  311 (373)
T 2x4f_A          243 EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN---NILACRW-----DLEDEE---  311 (373)
T ss_dssp             CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHHTCC-----CSCSGG---
T ss_pred             cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhccC-----CCChhh---
Confidence            12233469999999999999899999999999999999999999998654332211   1111100     000111   


Q ss_pred             hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          506 VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       506 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                        ...+...+.+++.+||+.||++|||+.|++++.|--
T Consensus       312 --~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~  347 (373)
T 2x4f_A          312 --FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS  347 (373)
T ss_dssp             --GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             --hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence              112345688999999999999999999999988743

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.6e-43  Score=359.28  Aligned_cols=266  Identities=28%  Similarity=0.414  Sum_probs=198.9

Q ss_pred             HHhhcCCCcceeeeccCceEEEEEEEcC-C---cEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC
Q 042763          262 VKATRNFSPSLRIGEGGFGTVYKAQLED-G---LLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN  336 (554)
Q Consensus       262 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~-g---~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  336 (554)
                      ....++|...+.||+|+||+||+|.... +   ..||||++..... ....+.+.+|++++++++||||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            3445789999999999999999997654 3   2799999976532 334578999999999999999999999998776


Q ss_pred             ce------EEEEEeCCCCCHHHHHhcccC----CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc
Q 042763          337 ER------LIITEFVPNGTLREHLDGQYG----KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR  406 (554)
Q Consensus       337 ~~------~lv~E~~~~g~L~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~  406 (554)
                      ..      ++||||+++|+|.+++.....    ..+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCC
Confidence            55      999999999999999965432    25899999999999999999999   889999999999999999999


Q ss_pred             EEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHH
Q 042763          407 AKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRW  485 (554)
Q Consensus       407 vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~  485 (554)
                      +||+|||+++...... .........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....+. 
T Consensus       176 ~kl~Dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-  253 (323)
T 3qup_A          176 VCVADFGLSRKIYSGD-YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-  253 (323)
T ss_dssp             EEECCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-
T ss_pred             EEEeeccccccccccc-cccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh-
Confidence            9999999998643221 1122233457889999999999999999999999999999999 999998765443222111 


Q ss_pred             HHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          486 AFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                            ......         .+..++..+.+++.+||+.||++|||+.++++.++++....
T Consensus       254 ------~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          254 ------GGNRLK---------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             ------TTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ------cCCCCC---------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                  110000         11233456889999999999999999999999999887643

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=8.1e-43  Score=349.43  Aligned_cols=254  Identities=29%  Similarity=0.476  Sum_probs=204.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhh------HHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFEN------LQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~------~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  337 (554)
                      .++|+..+.||+|+||+||+|... +++.||||++.......      ..+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367888999999999999999774 68999999986543221      1167899999999999999999999987654 


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eEeCCCCCCCeEECCCCc-----EEEE
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ--IIHRDVKSSNILLTESMR-----AKVA  410 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NILl~~~~~-----vkl~  410 (554)
                       ++||||+++|+|.+++... ...+++..++.++.|++.||+|||   +++  |+||||||+|||++.++.     +||+
T Consensus        97 -~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             -eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence             7999999999999988654 357899999999999999999999   888  999999999999988776     9999


Q ss_pred             eecCcccCCCCCCCccccccccCCCCCcChhccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH
Q 042763          411 DFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK--TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFK  488 (554)
Q Consensus       411 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~  488 (554)
                      |||+++....      ......||+.|+|||++.  ...++.++||||||+++|||++|+.||........... .....
T Consensus       172 Dfg~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~  244 (287)
T 4f0f_A          172 DFGLSQQSVH------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-NMIRE  244 (287)
T ss_dssp             CCTTCBCCSS------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH-HHHHH
T ss_pred             CCCccccccc------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH-HHHhc
Confidence            9999975221      233457999999999984  45678999999999999999999999986654432211 11111


Q ss_pred             hhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          489 RYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       489 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      ....        +.    .+..++..+.+++.+||+.||++|||+.||++.|.++
T Consensus       245 ~~~~--------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          245 EGLR--------PT----IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             SCCC--------CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             cCCC--------CC----CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            1111        11    1223345689999999999999999999999999764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.4e-43  Score=349.88  Aligned_cols=261  Identities=30%  Similarity=0.464  Sum_probs=213.5

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ..++|...+.||+|+||+||+|...++..||||++.....  ..+.+.+|++++++++||||+++++++.. +..++|||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   87 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence            3467888999999999999999988888999999976542  24678999999999999999999999864 56899999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++++|.+++.......+++.+++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....  
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--  162 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN--  162 (279)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS--
T ss_pred             cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc--
Confidence            999999999997654447899999999999999999999   899999999999999999999999999999874322  


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                      .........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+..   ....    .... .     
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~~----~~~~-~-----  229 (279)
T 1qpc_A          163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---QNLE----RGYR-M-----  229 (279)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHH----TTCC-C-----
T ss_pred             ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH---HHHh----cccC-C-----
Confidence            1122233457889999999998889999999999999999999 99999865433221   1111    1100 0     


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                         ..+..++..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus       230 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          230 ---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             ---CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence               0112334568899999999999999999999999999876543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1e-43  Score=361.89  Aligned_cols=271  Identities=27%  Similarity=0.398  Sum_probs=218.9

Q ss_pred             HHHhhcCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEc
Q 042763          261 VVKATRNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDK  334 (554)
Q Consensus       261 l~~~~~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  334 (554)
                      .....++|...+.||+|+||.||+|...      +++.||||++...........+.+|++++++++||||+++++++.+
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            3345678999999999999999999654      3688999999866545556679999999999999999999999999


Q ss_pred             CCceEEEEEeCCCCCHHHHHhccc--------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc
Q 042763          335 GNERLIITEFVPNGTLREHLDGQY--------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR  406 (554)
Q Consensus       335 ~~~~~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~  406 (554)
                      ++..++||||+++|+|.+++....        ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCC
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCe
Confidence            999999999999999999997532        145689999999999999999999   889999999999999999999


Q ss_pred             EEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHH
Q 042763          407 AKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRW  485 (554)
Q Consensus       407 vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~  485 (554)
                      +||+|||+++...... .........+|+.|+|||++.+..++.++||||||+++|||++ |..||.........   ..
T Consensus       177 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~  252 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL---RF  252 (322)
T ss_dssp             EEECCTTCCCGGGGGG-CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH---HH
T ss_pred             EEECcCcccccccccc-ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH---HH
Confidence            9999999997532211 1122233457889999999999899999999999999999999 89999765432211   11


Q ss_pred             HHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhhhh
Q 042763          486 AFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKSV  551 (554)
Q Consensus       486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~~~  551 (554)
                      .    .......         .+..++..+.+++.+||+.||++|||+.|++++|+++......++
T Consensus       253 ~----~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~  305 (322)
T 1p4o_A          253 V----MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  305 (322)
T ss_dssp             H----HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             H----HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence            1    1111111         112344568899999999999999999999999999877665543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-43  Score=368.60  Aligned_cols=256  Identities=19%  Similarity=0.285  Sum_probs=208.8

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|.+.+.||+|+||+||+|... +|+.||+|++..... .....+.+|++++++++||||+++++++.++...++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            367999999999999999999765 689999999876532 234578999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC--CCcEEEEeecCcccCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE--SMRAKVADFGFARLGPMD  421 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~--~~~vkl~DfGla~~~~~~  421 (554)
                      |+++|+|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.  ++.+||+|||+++.....
T Consensus       129 ~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          129 FLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             cCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            99999999999754 346899999999999999999999   899999999999999974  578999999999874322


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                          .......||+.|+|||++.+..++.++|||||||++|||++|..||.........   ......    ..  ..++
T Consensus       205 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~i~~~----~~--~~~~  271 (387)
T 1kob_A          205 ----EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVKRC----DW--EFDE  271 (387)
T ss_dssp             ----SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHHC----CC--CCCS
T ss_pred             ----cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH---HHHHhC----CC--CCCc
Confidence                1223346999999999999999999999999999999999999999865432221   111110    00  0111


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ..    ...++..+.+++.+||+.||++|||+.|++++.|-
T Consensus       272 ~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  308 (387)
T 1kob_A          272 DA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL  308 (387)
T ss_dssp             ST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred             cc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccc
Confidence            11    11234568899999999999999999999998763

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.8e-43  Score=361.63  Aligned_cols=254  Identities=23%  Similarity=0.352  Sum_probs=185.2

Q ss_pred             ceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEEEEEeCCCC
Q 042763          271 SLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLIITEFVPNG  348 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~~g  348 (554)
                      .++||+|+||+||+|... +|+.||||++....    ...+.+|+.+++++. ||||+++++++.++...++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhh----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            468999999999999775 58999999997643    356778999999997 999999999999999999999999999


Q ss_pred             CHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC---cEEEEeecCcccCCCCCCCc
Q 042763          349 TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM---RAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       349 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~---~vkl~DfGla~~~~~~~~~~  425 (554)
                      +|.+++...  ..+++.+++.++.|++.||+|||   +++|+||||||+|||++.++   .+||+|||+++.....   .
T Consensus        92 ~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~---~  163 (325)
T 3kn6_A           92 ELFERIKKK--KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD---N  163 (325)
T ss_dssp             BHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC---C
Confidence            999999765  57999999999999999999999   89999999999999997765   8999999999864322   2


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE  505 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  505 (554)
                      .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....................+...  .....  
T Consensus       164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~--  239 (325)
T 3kn6_A          164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS--FEGEA--  239 (325)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--CCSHH--
T ss_pred             CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--CCccc--
Confidence            22334568999999999999999999999999999999999999998654321111111222222222211  11111  


Q ss_pred             hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          506 VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       506 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                        ...++..+.+++.+||+.||++|||+.|++++.|-
T Consensus       240 --~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~  274 (325)
T 3kn6_A          240 --WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL  274 (325)
T ss_dssp             --HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGG
T ss_pred             --ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhh
Confidence              12245678999999999999999999999988774

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=364.92  Aligned_cols=258  Identities=21%  Similarity=0.308  Sum_probs=202.5

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCC--CCceeeeeEEEcCCceEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDH--RNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~~~~l  340 (554)
                      ..++|++.+.||+|+||+||+|...+++.||||++..... ....+.+.+|++++++++|  |||+++++++.+++..++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            3567999999999999999999888899999999875433 3345678999999999976  999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      |||+ .+++|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++ ++.+||+|||+++....
T Consensus        87 v~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           87 VMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             EEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            9995 589999999765  57899999999999999999999   88999999999999997 67899999999986432


Q ss_pred             CCCCccccccccCCCCCcChhcccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHh
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKT-----------YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR  489 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~  489 (554)
                      .. .........||+.|+|||++.+           ..++.++|||||||++|||++|+.||........  ....   .
T Consensus       160 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~---~  233 (343)
T 3dbq_A          160 DT-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--KLHA---I  233 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHH---H
T ss_pred             cc-ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH--HHHH---H
Confidence            21 1122334579999999999865           6789999999999999999999999975433211  1111   1


Q ss_pred             hccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          490 YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      .......         ..+......+.+++.+||+.||++|||+.|++++.|--
T Consensus       234 ~~~~~~~---------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~  278 (343)
T 3dbq_A          234 IDPNHEI---------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  278 (343)
T ss_dssp             HCTTSCC---------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             hcCCccc---------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence            1111100         01111234678999999999999999999999998853

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.2e-43  Score=374.02  Aligned_cols=252  Identities=23%  Similarity=0.390  Sum_probs=211.2

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|...+.||+|+||.||+|... +|+.||||++......  .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            67888999999999999999776 6999999999765432  33567899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++|+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-  169 (476)
T 2y94_A           96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  169 (476)
T ss_dssp             ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence            999999999999754  57899999999999999999999   899999999999999999999999999999874321 


Q ss_pred             CCccccccccCCCCCcChhccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQL-TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                         ......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...........+       ..+...     
T Consensus       170 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i-------~~~~~~-----  234 (476)
T 2y94_A          170 ---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI-------CDGIFY-----  234 (476)
T ss_dssp             ---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH-------HTTCCC-----
T ss_pred             ---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH-------hcCCcC-----
Confidence               22334579999999999988766 68999999999999999999999876543322111       111100     


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                           .+..+...+.+++.+||+.||++|||+.|+++|.|--
T Consensus       235 -----~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~  271 (476)
T 2y94_A          235 -----TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK  271 (476)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred             -----CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence                 1112334678999999999999999999999998753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-43  Score=354.24  Aligned_cols=254  Identities=28%  Similarity=0.416  Sum_probs=203.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|...++||+|+||+||+|... ++..||+|++.........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            57888999999999999999765 58999999998765544567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE---CCCCcEEEEeecCcccCC
Q 042763          345 VPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL---TESMRAKVADFGFARLGP  419 (554)
Q Consensus       345 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl---~~~~~vkl~DfGla~~~~  419 (554)
                      +++|+|.+++...  ....+++..++.++.|++.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999998653  2467999999999999999999999   8999999999999999   556889999999997643


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ..    .......||+.|+|||++. ..++.++||||||+++|||++|+.||......+......     ..........
T Consensus       179 ~~----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~-----~~~~~~~~~~  248 (285)
T 3is5_A          179 SD----EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT-----YKEPNYAVEC  248 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HCCCCCCC--
T ss_pred             Cc----ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc-----cCCccccccc
Confidence            22    2233456999999999986 478999999999999999999999998654332211111     1111110000


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                               ......+.+++.+||+.||++|||+.|++++.|
T Consensus       249 ---------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  281 (285)
T 3is5_A          249 ---------RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEW  281 (285)
T ss_dssp             ---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred             ---------CcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence                     012356789999999999999999999998866

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.9e-43  Score=377.72  Aligned_cols=258  Identities=29%  Similarity=0.445  Sum_probs=208.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .++|...++||+|+||.||+|.+.++..||||+++....  ..+++.+|+++|++++||||+++++++.+ +..++||||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            466888899999999999999998888899999986542  24679999999999999999999999876 678999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++|+|.+++.......+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....  .
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~  334 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--E  334 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCC--c
Confidence            99999999998655567899999999999999999999   899999999999999999999999999999864322  1


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      ........+++.|+|||++.+..++.++||||||+++|||++ |+.||......+...   ..    ..+...       
T Consensus       335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~---~i----~~~~~~-------  400 (452)
T 1fmk_A          335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD---QV----ERGYRM-------  400 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HH----HTTCCC-------
T ss_pred             eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH---HH----HcCCCC-------
Confidence            112223457889999999999999999999999999999999 999998654332211   11    111000       


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                        ..+..++..+.+++.+||+.||++|||+.+|++.|.++...
T Consensus       401 --~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          401 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             --CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence              01223456788999999999999999999999999988654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-42  Score=351.37  Aligned_cols=268  Identities=26%  Similarity=0.342  Sum_probs=206.3

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC--CCCCceeeeeEEEcC----Cc
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI--DHRNLVKLLGFVDKG----NE  337 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l--~HpnIv~l~~~~~~~----~~  337 (554)
                      ..++|+..++||+|+||.||+|+.. |+.||||++....    ...+..|.+++..+  +||||+++++++...    ..
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            4578999999999999999999876 8999999986543    23445556666554  899999999999877    67


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCC--------CeEeCCCCCCCeEECCCCcEEE
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK--------QIIHRDVKSSNILLTESMRAKV  409 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~--------~ivH~Dlkp~NILl~~~~~vkl  409 (554)
                      .++||||+++|+|.+++...   .+++.+++.++.|++.||+|||   +.        +|+||||||+|||++.++.+||
T Consensus       110 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             eEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence            89999999999999999754   6899999999999999999999   77        9999999999999999999999


Q ss_pred             EeecCcccCCCCCCCcc-ccccccCCCCCcChhccccCCCCch------hhHHHHHHHHHHHHhC----------CCCCC
Q 042763          410 ADFGFARLGPMDSDRTH-ISTKVKGTVGYLDPEYMKTYQLTTK------SDVYSFGVLLLEILTG----------RRPVE  472 (554)
Q Consensus       410 ~DfGla~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~k------sDVwSlGvil~elltg----------~~P~~  472 (554)
                      +|||+++.......... ......||+.|+|||++.+..++.+      +|||||||++|||++|          ..||.
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            99999976533222211 1224579999999999987766554      9999999999999999          66776


Q ss_pred             CCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          473 LKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                      ............  ...............   .....+++..+.+++.+||+.||++|||+.||+++|+++..+.
T Consensus       264 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          264 DLVPSDPSYEDM--REIVCIKKLRPSFPN---RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             TTSCSSCCHHHH--HHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             hhcCCCCchhhh--HHHHhhhccCccccc---cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            543322211111  111111111111111   1123367888999999999999999999999999999998765

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.6e-43  Score=368.70  Aligned_cols=259  Identities=22%  Similarity=0.302  Sum_probs=201.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHH-HHhCCCCCceeeeeEEEcCCceEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVEL-LSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~-l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      .++|+..+.||+|+||+||+|+.. +++.||||++.+....  .....+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            367899999999999999999876 5889999999876532  233456677776 567899999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||||+++|+|.+++...  ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       117 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            99999999999999765  57899999999999999999999   89999999999999999999999999999985321


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                         ........+||+.|+|||++.+..++.++|||||||++|||++|..||......+....+   ..    ....    
T Consensus       192 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i---~~----~~~~----  257 (373)
T 2r5t_A          192 ---HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI---LN----KPLQ----  257 (373)
T ss_dssp             ---CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH---HH----SCCC----
T ss_pred             ---CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---Hh----cccC----
Confidence               112234567999999999999999999999999999999999999999865433222111   11    1100    


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHHHHhhhhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDM----KSVGEQLWAIRADSL  548 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~l~~i~~~~~  548 (554)
                            ++..+...+.+++.+||+.||++||++    .++.+|.|--.-+|.
T Consensus       258 ------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~  303 (373)
T 2r5t_A          258 ------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD  303 (373)
T ss_dssp             ------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred             ------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence                  112234568899999999999999997    466666554333333

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-43  Score=371.09  Aligned_cols=268  Identities=22%  Similarity=0.298  Sum_probs=197.3

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCC--ce
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGN--ER  338 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~--~~  338 (554)
                      ..++|+..++||+|+||+||+|... +|+.||||++..... ......+.+|+.+++++. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            3578999999999999999999764 689999999865422 334467889999999997 999999999997544  68


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ++|||||+ ++|.+++...   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            99999996 7999999764   6899999999999999999999   899999999999999999999999999999864


Q ss_pred             CCCC------------------CCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhh
Q 042763          419 PMDS------------------DRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEE  479 (554)
Q Consensus       419 ~~~~------------------~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~  479 (554)
                      ....                  .........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            3211                  01112334579999999999976 6799999999999999999999999987654433


Q ss_pred             HHHHHHHHHhhccCCcc---ccCCh-------------------------hhhh-----hccHHHHHHHHHHHHHccCCC
Q 042763          480 RVTLRWAFKRYNEGNLL---DMVDP-------------------------SIKE-----VISMEILTKMFGLAIQCAAPI  526 (554)
Q Consensus       480 ~~~~~~~~~~~~~~~~~---~~~d~-------------------------~l~~-----~~~~~~~~~l~~li~~cl~~d  526 (554)
                      ...+.   .........   ....+                         ....     .....+...+.+++.+||+.|
T Consensus       240 ~~~i~---~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d  316 (388)
T 3oz6_A          240 LERII---GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN  316 (388)
T ss_dssp             HHHHH---HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred             HHHHH---HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence            22222   111111000   00000                         0000     000023457899999999999


Q ss_pred             CCCCCCHHHHHHHHH
Q 042763          527 RNDRPDMKSVGEQLW  541 (554)
Q Consensus       527 P~~RPs~~evl~~l~  541 (554)
                      |++|||+.|+++|.|
T Consensus       317 P~~R~t~~e~l~Hp~  331 (388)
T 3oz6_A          317 PNKRISANDALKHPF  331 (388)
T ss_dssp             GGGSCCHHHHTTSTT
T ss_pred             cccCCCHHHHhCCHH
Confidence            999999999999976

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.5e-43  Score=359.86  Aligned_cols=268  Identities=28%  Similarity=0.400  Sum_probs=217.4

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcC------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCC
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLED------GLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGN  336 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~  336 (554)
                      ..++|...+.||+|+||+||+|....      +..||+|++.........+.+.+|+.+++++ +||||+++++++.+++
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            35788899999999999999997642      2489999998765455567899999999999 8999999999999999


Q ss_pred             ceEEEEEeCCCCCHHHHHhccc------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC
Q 042763          337 ERLIITEFVPNGTLREHLDGQY------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES  404 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~  404 (554)
                      ..++||||+++|+|.+++....            ...+++..++.++.|++.||+|||   +++|+||||||+|||++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCC
Confidence            9999999999999999997542            346799999999999999999999   8899999999999999999


Q ss_pred             CcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHH
Q 042763          405 MRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTL  483 (554)
Q Consensus       405 ~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~  483 (554)
                      +.+||+|||+++...... .........+|+.|+|||++.+..++.++||||||+++|||++ |..||............
T Consensus       201 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  279 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDS-NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL  279 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCT-TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred             CeEEECcccccccccccc-ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence            999999999998543221 1122233457889999999999899999999999999999999 99999876544332211


Q ss_pred             HHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhhh
Q 042763          484 RWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKS  550 (554)
Q Consensus       484 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~~  550 (554)
                      .  ...... .            .+...+..+.+++.+||+.||++|||+.||+++|+++..+..+.
T Consensus       280 ~--~~~~~~-~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~  331 (333)
T 2i1m_A          280 V--KDGYQM-A------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE  331 (333)
T ss_dssp             H--HHTCCC-C------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred             H--hcCCCC-C------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhcc
Confidence            1  111100 0            11122456889999999999999999999999999998876543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.1e-43  Score=381.41  Aligned_cols=264  Identities=23%  Similarity=0.344  Sum_probs=217.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .++|...+.||+|+||.||+|... +|+.||||++.+...  ......+.+|+++|++++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467899999999999999999775 699999999977543  23346788999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++|+|.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999998765556999999999999999999999   889999999999999999999999999999875322


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                          ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....... ...       
T Consensus       340 ----~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~~~-------  407 (576)
T 2acx_A          340 ----QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEE-------  407 (576)
T ss_dssp             ----CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-CCC-------
T ss_pred             ----ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-ccc-------
Confidence                12234579999999999999899999999999999999999999998755432222222111111 101       


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHhhhhhh
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAIRADSL  548 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i~~~~~  548 (554)
                           ++..++..+.+++.+||+.||++||     ++.||++|.|--.-+|.
T Consensus       408 -----~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          408 -----YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             -----CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence                 1223345688999999999999999     89999999876544443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.1e-43  Score=361.89  Aligned_cols=267  Identities=22%  Similarity=0.289  Sum_probs=207.7

Q ss_pred             HHHHhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh----hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc
Q 042763          260 QVVKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF----ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK  334 (554)
Q Consensus       260 ~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  334 (554)
                      ++....++|...+.||+|+||+||+|... +++.||+|++.....    ....+.+.+|++++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            34556788999999999999999999764 688999999976542    2345789999999999999999999999999


Q ss_pred             CCceEEEEEeCCCCCHHHHHhccc--------------------------------------CCCCCHHHHHHHHHHHHH
Q 042763          335 GNERLIITEFVPNGTLREHLDGQY--------------------------------------GKTLDFNQRLEIAIDVAH  376 (554)
Q Consensus       335 ~~~~~lv~E~~~~g~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~qi~~  376 (554)
                      ++..++||||+++|+|.+++....                                      ...+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            999999999999999999985211                                      112356778899999999


Q ss_pred             HHHHhhhccCCCeEeCCCCCCCeEECCCC--cEEEEeecCcccCCCCC-CCccccccccCCCCCcChhcccc--CCCCch
Q 042763          377 GLTYLHLYAEKQIIHRDVKSSNILLTESM--RAKVADFGFARLGPMDS-DRTHISTKVKGTVGYLDPEYMKT--YQLTTK  451 (554)
Q Consensus       377 ~L~~LH~~~~~~ivH~Dlkp~NILl~~~~--~vkl~DfGla~~~~~~~-~~~~~~~~~~gt~~y~aPE~l~~--~~~s~k  451 (554)
                      ||+|||   +.+|+||||||+|||++.++  .+||+|||+++...... ..........||+.|+|||++.+  ..++.+
T Consensus       180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999   88999999999999998776  89999999998542211 11122344569999999999975  678999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCC
Q 042763          452 SDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRP  531 (554)
Q Consensus       452 sDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP  531 (554)
                      +||||||+++|||++|+.||......+....   ....    .. ....+..     ..+...+.+++.+||+.||++||
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~---~~~~----~~-~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp  323 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQ---VLNK----KL-CFENPNY-----NVLSPLARDLLSNLLNRNVDERF  323 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHC----CC-CTTSGGG-----GGSCHHHHHHHHHHSCSCTTTSC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHHHHH---HHhc----cc-ccCCccc-----ccCCHHHHHHHHHHcCCChhHCC
Confidence            9999999999999999999986554332211   1110    00 0111111     12345688999999999999999


Q ss_pred             CHHHHHHHHHH
Q 042763          532 DMKSVGEQLWA  542 (554)
Q Consensus       532 s~~evl~~l~~  542 (554)
                      ++.|++++.|-
T Consensus       324 s~~~~l~hp~~  334 (345)
T 3hko_A          324 DAMRALQHPWI  334 (345)
T ss_dssp             CHHHHHHSHHH
T ss_pred             CHHHHhcChhh
Confidence            99999998774

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.7e-43  Score=361.47  Aligned_cols=255  Identities=22%  Similarity=0.333  Sum_probs=195.0

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ..++|...+.||+|+||+||+|... +++.||||++....   ..+.+.+|++++++++||||+++++++.+++..++||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            3567999999999999999999876 58899999997653   2356889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC---CCcEEEEeecCcccCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE---SMRAKVADFGFARLGP  419 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~DfGla~~~~  419 (554)
                      ||+++|+|.+++...  ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++...
T Consensus       128 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          128 ELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             EeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            999999999999764  56899999999999999999999   889999999999999975   8899999999998643


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      .    ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ...    ...... ...
T Consensus       203 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~----i~~~~~-~~~  271 (349)
T 2w4o_A          203 H----QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM--FRR----ILNCEY-YFI  271 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH--HHH----HHTTCC-CCC
T ss_pred             c----ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH--HHH----HHhCCC-ccC
Confidence            2    12223457999999999999999999999999999999999999999765543211  111    111111 001


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .+     ...+++..+.+++.+||+.||++|||+.|++++.|-
T Consensus       272 ~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  309 (349)
T 2w4o_A          272 SP-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV  309 (349)
T ss_dssp             TT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred             Cc-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence            11     112334568899999999999999999999998764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.4e-43  Score=352.41  Aligned_cols=265  Identities=26%  Similarity=0.432  Sum_probs=211.4

Q ss_pred             hhcCCCcce-eeeccCceEEEEEEEc---CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCce
Q 042763          264 ATRNFSPSL-RIGEGGFGTVYKAQLE---DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       264 ~~~~f~~~~-~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  338 (554)
                      ..++|.+.+ .||+|+||+||+|...   +++.||||++..... ....+++.+|++++++++||||+++++++ ..+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            346777777 8999999999999543   468899999976543 23357899999999999999999999999 55778


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ++||||+++++|.+++...  ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            9999999999999999764  56899999999999999999999   889999999999999999999999999999875


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                      ..............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.........   ...    .......
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~----~~~~~~~  240 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT---AML----EKGERMG  240 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHH----HTTCCCC
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHH----HcCCCCC
Confidence            443332222333457789999999998889999999999999999999 99999865432211   111    1111000


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhhh
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKS  550 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~~  550 (554)
                               .+..++..+.+++.+||+.||++||++.+|++.|.++-.+.-..
T Consensus       241 ---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  284 (291)
T 1xbb_A          241 ---------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE  284 (291)
T ss_dssp             ---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence                     12234566899999999999999999999999999987766554

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.3e-44  Score=366.00  Aligned_cols=269  Identities=27%  Similarity=0.446  Sum_probs=211.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-----cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEE--cCCc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD--KGNE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~--~~~~  337 (554)
                      .++|+..+.||+|+||.||+|.+     .+++.||||++.... ....+.+.+|++++++++||||+++++++.  +...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            46788999999999999999984     358899999997654 334567999999999999999999999886  4556


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .++||||+++++|.+++.... ..+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            899999999999999997642 36899999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhH--------HHHHHHHHh
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEER--------VTLRWAFKR  489 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~--------~~~~~~~~~  489 (554)
                      ...............||+.|+|||++.+..++.++||||||+++|+|++|+.||.........        .........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            654433333344456888999999999989999999999999999999999998642211000        000000000


Q ss_pred             hccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          490 YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                      .....         ....+..++..+.+++.+||+.||++|||+.|++++|+.+....
T Consensus       257 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          257 LEEGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             hhccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            00100         00112334567899999999999999999999999999886644

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.1e-43  Score=351.24  Aligned_cols=256  Identities=30%  Similarity=0.448  Sum_probs=207.7

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEc--------
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDK--------  334 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--------  334 (554)
                      ...+|+..+.||+|+||.||+|... +|+.||+|++....     +.+.+|++++++++||||+++++++..        
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            3467899999999999999999876 69999999987653     356789999999999999999998854        


Q ss_pred             --------CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc
Q 042763          335 --------GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR  406 (554)
Q Consensus       335 --------~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~  406 (554)
                              ....++||||+++++|.+++.......+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCC
Confidence                    345799999999999999998766678999999999999999999999   889999999999999999999


Q ss_pred             EEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH
Q 042763          407 AKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWA  486 (554)
Q Consensus       407 vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~  486 (554)
                      +||+|||+++......    ......||+.|+|||++.+..++.++||||||+++|||++|..|+..     ....    
T Consensus       161 ~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~~~----  227 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----TSKF----  227 (284)
T ss_dssp             EEECCCTTCEESSCCS----CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----HHHH----
T ss_pred             EEECcchhheeccccc----cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----HHHH----
Confidence            9999999998653322    22344699999999999999999999999999999999999988641     1111    


Q ss_pred             HHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhhhhc
Q 042763          487 FKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKSVK  552 (554)
Q Consensus       487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~~~~  552 (554)
                      .........            +...+..+.+++.+||+.||++|||+.|++++|+.++....+..|
T Consensus       228 ~~~~~~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~~  281 (284)
T 2a19_B          228 FTDLRDGII------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER  281 (284)
T ss_dssp             HHHHHTTCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-------
T ss_pred             HHHhhcccc------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcccc
Confidence            111111111            112234578999999999999999999999999999987766554

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.4e-43  Score=378.04  Aligned_cols=258  Identities=21%  Similarity=0.274  Sum_probs=203.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .++|+..++||+|+||.||+|... +|+.||||++.....  ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            357889999999999999999765 689999999986532  23345678999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE-KQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      |||+++|+|.+++...  ..+++..++.++.||+.||+|||   + ++|+||||||+|||++.++.+||+|||+++....
T Consensus       227 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             ECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            9999999999999765  57899999999999999999999   6 8999999999999999999999999999985322


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                         ........+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.   .  ....      
T Consensus       302 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~---~--~~~~------  367 (446)
T 4ejn_A          302 ---DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---M--EEIR------  367 (446)
T ss_dssp             --------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H--CCCC------
T ss_pred             ---CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH---h--CCCC------
Confidence               1222345679999999999999999999999999999999999999998654332221111   0  1111      


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHhhhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAIRADS  547 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i~~~~  547 (554)
                            ++..+...+.+++.+||+.||++||     ++.|+++|.|--.-++
T Consensus       368 ------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~  413 (446)
T 4ejn_A          368 ------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW  413 (446)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             ------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence                  1122345688999999999999999     9999999877544443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.7e-43  Score=387.31  Aligned_cols=260  Identities=25%  Similarity=0.441  Sum_probs=207.2

Q ss_pred             CCCcce-eeeccCceEEEEEEEc---CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          267 NFSPSL-RIGEGGFGTVYKAQLE---DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       267 ~f~~~~-~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++.... +||+|+||.||+|.+.   ++..||||+++........+++.+|+++|++++||||+++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999764   4678999999876444456789999999999999999999999976 5689999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      |||++|+|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus       415 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             ECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             EeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            999999999999754 456899999999999999999999   8899999999999999999999999999998754332


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                      ..........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+       ..+....    
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-------~~~~~~~----  559 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQGKRME----  559 (613)
T ss_dssp             -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH-------HTTCCCC----
T ss_pred             ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HcCCCCC----
Confidence            22222223346789999999999999999999999999999998 99999876654322211       1111100    


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                           .+..++..+.+++.+||+.+|++||++.+|++.|..+..+.
T Consensus       560 -----~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          560 -----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             -----CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence                 12234567899999999999999999999999999876554

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.2e-43  Score=362.62  Aligned_cols=261  Identities=25%  Similarity=0.410  Sum_probs=207.3

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCc----EEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGL----LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      .++|+..++||+|+||+||+|... +++    .||+|.+...........+.+|+.++++++||||+++++++. ++..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            357888999999999999999764 344    378887765443333456788999999999999999999986 46789


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +||||+++|+|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        91 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            999999999999999764 346899999999999999999999   8899999999999999999999999999998754


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ... .........||+.|+|||++.+..++.++||||||+++|||++ |+.||...........+.    ......    
T Consensus       167 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~----~~~~~~----  237 (325)
T 3kex_A          167 PDD-KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE----KGERLA----  237 (325)
T ss_dssp             CCT-TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH----TTCBCC----
T ss_pred             ccc-ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH----cCCCCC----
Confidence            332 2222344568889999999999999999999999999999999 999998765543322211    111100    


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                              .+..+...+.+++.+||+.||++||++.|++++|.++..+.
T Consensus       238 --------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          238 --------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             --------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             --------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                    01112334778999999999999999999999999987654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=358.19  Aligned_cols=248  Identities=23%  Similarity=0.334  Sum_probs=197.5

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|+..++||+|+||+||+|... +|+.||||++..... ......+..|+..+.++ +||||+++++++.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999876 699999998765322 22334455666655555 8999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+ +++|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       137 e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-  210 (311)
T ss_dssp             ECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             ecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence            999 78999998765 356999999999999999999999   889999999999999999999999999999864321 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                         .......||+.|+|||++.+ .++.++|||||||++|||++|..|+....   .       .......    ...+.
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~-------~~~~~~~----~~~~~  272 (311)
T 3p1a_A          211 ---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---G-------WQQLRQG----YLPPE  272 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---H-------HHHHTTT----CCCHH
T ss_pred             ---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---H-------HHHHhcc----CCCcc
Confidence               22334569999999999886 79999999999999999999977765321   1       1111111    11122


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ..    ..+...+.+++.+||+.||++|||+.|++++.|
T Consensus       273 ~~----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~  307 (311)
T 3p1a_A          273 FT----AGLSSELRSVLVMMLEPDPKLRATAEALLALPV  307 (311)
T ss_dssp             HH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             cc----cCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence            11    223467899999999999999999999999876

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.9e-43  Score=363.26  Aligned_cols=272  Identities=22%  Similarity=0.304  Sum_probs=211.7

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC-----Cc
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG-----NE  337 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~  337 (554)
                      ..++|+..+.||+|+||.||+|... +++.||||++.........+.+.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            4578999999999999999999765 68899999998655455567899999999999999999999998654     36


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .++||||++ |+|.+++...   .+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            899999995 6999998754   6899999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL  496 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  496 (554)
                      ...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.............
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            5433322223345679999999998754 458999999999999999999999998766544433322111100000000


Q ss_pred             ccCChh--------------hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          497 DMVDPS--------------IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       497 ~~~d~~--------------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ...+..              ............+.+++.+||+.||++|||+.|+++|.|-
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~  317 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL  317 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence            000000              0000112234568999999999999999999999998774

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7.6e-43  Score=348.69  Aligned_cols=261  Identities=25%  Similarity=0.385  Sum_probs=209.9

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcC----CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLED----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      ..++|...+.||+|+||+||+|...+    +..||+|++.........+.+.+|+.++++++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            34678889999999999999997543    346999999876545556789999999999999999999999875 4568


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +||||+++++|.+++... ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++...
T Consensus        89 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            999999999999999764 346899999999999999999999   8999999999999999999999999999998643


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ..  .........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+.   . .....    
T Consensus       165 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~---~-~~~~~----  234 (281)
T 3cc6_A          165 DE--DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE---K-GDRLP----  234 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH---H-TCCCC----
T ss_pred             cc--cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh---c-CCCCC----
Confidence            22  1112233457889999999998899999999999999999998 999997655433222111   1 00000    


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                              .+..++..+.+++.+||+.||++||++.|++++|+++....
T Consensus       235 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          235 --------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence                    11123456889999999999999999999999999987654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=352.10  Aligned_cols=257  Identities=27%  Similarity=0.432  Sum_probs=201.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .++|+..+.||+|+||+||+|... ++.||||++....   ..+.+.+|++++++++||||+++++++.  +..++||||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~   80 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES---ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY   80 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT---HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh---HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence            356888899999999999999876 7899999997542   3467899999999999999999999887  357999999


Q ss_pred             CCCCCHHHHHhcccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc-EEEEeecCcccCCCCC
Q 042763          345 VPNGTLREHLDGQYG-KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR-AKVADFGFARLGPMDS  422 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~-vkl~DfGla~~~~~~~  422 (554)
                      +++|+|.+++..... ..+++..++.++.|+++||+|||....++|+||||||+|||++.++. +||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            999999999976532 24788999999999999999999322289999999999999998886 799999999753211 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                           .....||+.|+|||++.+..++.++||||||+++|||++|+.||........  ...+.........        
T Consensus       160 -----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~--------  224 (307)
T 2eva_A          160 -----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNGTRPP--------  224 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHHTTCCCC--------
T ss_pred             -----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHhcCCCCC--------
Confidence                 2234599999999999999999999999999999999999999986443322  1122111111111        


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                          ....++..+.+++.+||+.||++|||+.+++++|..+....
T Consensus       225 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          225 ----LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             ----CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             ----cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence                11123456889999999999999999999999999987643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.4e-43  Score=362.11  Aligned_cols=257  Identities=22%  Similarity=0.351  Sum_probs=206.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .++|+..+.||+|+||+||+|... +|+.||||++.....     ...+|++++.++ +||||+++++++.+++..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467899999999999999999775 589999999976542     245688888887 7999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC----CcEEEEeecCcccC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES----MRAKVADFGFARLG  418 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~----~~vkl~DfGla~~~  418 (554)
                      ||+++|+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||+..+    +.+||+|||+++..
T Consensus        96 E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           96 ELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            999999999999765  57899999999999999999999   8899999999999998543    35999999999864


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ....   ......+||+.|+|||++.+..++.++|||||||++|||++|..||...............    ..+...  
T Consensus       171 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i----~~~~~~--  241 (342)
T 2qr7_A          171 RAEN---GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI----GSGKFS--  241 (342)
T ss_dssp             BCTT---CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH----HHCCCC--
T ss_pred             cCCC---CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH----ccCCcc--
Confidence            3221   2233457899999999999888999999999999999999999999864332222222211    111110  


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      ....    ....++..+.+++.+||+.||++||++.++++|.|-..
T Consensus       242 ~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          242 LSGG----YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             CCST----TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             cCcc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            0000    11233456889999999999999999999999999754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.2e-42  Score=346.33  Aligned_cols=254  Identities=22%  Similarity=0.339  Sum_probs=207.8

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|...++||+|+||+||+|... ++..||+|++...... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            467899999999999999999776 4789999998765433 35678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE---CCCCcEEEEeecCcccCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL---TESMRAKVADFGFARLGPM  420 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl---~~~~~vkl~DfGla~~~~~  420 (554)
                      |+++++|.+++...  ..+++.+++.++.|++.||+|||   +++|+||||||+|||+   +.++.+||+|||++.....
T Consensus        87 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           87 LCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             ccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            99999999998765  56899999999999999999999   8999999999999999   7889999999999986432


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      .    .......||+.|+|||++.+ .++.++||||||+++|||++|+.||......+....+.       ....  ...
T Consensus       162 ~----~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~~~~--~~~  227 (277)
T 3f3z_A          162 G----KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR-------EGTF--TFP  227 (277)
T ss_dssp             T----SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCCC--CCC
T ss_pred             c----cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------hCCC--CCC
Confidence            2    22334569999999999876 49999999999999999999999998654332211111       1100  000


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ....    ..++..+.+++.+||+.||++|||+.+++++.|-
T Consensus       228 ~~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  265 (277)
T 3f3z_A          228 EKDW----LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF  265 (277)
T ss_dssp             HHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred             chhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence            1100    1234568899999999999999999999998774

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.4e-43  Score=367.79  Aligned_cols=256  Identities=21%  Similarity=0.318  Sum_probs=202.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCC--CCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKID--HRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .++|.+.+.||+|+||+||+|...+++.||||++..... ....+.+.+|++++++++  ||||+++++++..++..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            456999999999999999999888899999999875432 344577999999999996  59999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      || +.+++|.+++...  ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++ ++.+||+|||+++.....
T Consensus       135 ~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             Ee-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            99 5589999999765  47889999999999999999999   89999999999999995 579999999999864322


Q ss_pred             CCCccccccccCCCCCcChhcccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKT-----------YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY  490 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  490 (554)
                      . .........||+.|+|||++.+           ..++.++|||||||++|||++|+.||........  .+...   .
T Consensus       208 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--~~~~~---~  281 (390)
T 2zmd_A          208 T-TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--KLHAI---I  281 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHH---H
T ss_pred             C-ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH--HHHHH---h
Confidence            1 1122344579999999999865           3689999999999999999999999976443211  11111   1


Q ss_pred             ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .......         .+......+.+++.+||+.||++|||+.|++++.|-
T Consensus       282 ~~~~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~  324 (390)
T 2zmd_A          282 DPNHEIE---------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  324 (390)
T ss_dssp             CTTSCCC---------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             CccccCC---------CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence            1110000         111123467899999999999999999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.9e-43  Score=358.49  Aligned_cols=274  Identities=22%  Similarity=0.286  Sum_probs=201.3

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHH--HHhCCCCCceeeeeEEEc-----CCc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVEL--LSKIDHRNLVKLLGFVDK-----GNE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~--l~~l~HpnIv~l~~~~~~-----~~~  337 (554)
                      .++|+..+.||+|+||+||+|+. +++.||||++.....    ..+..|.++  +..++||||+++++.+..     ...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR----QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch----hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            36788899999999999999976 589999999976542    233344444  455899999999985532     235


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCC---------CeEeCCCCCCCeEECCCCcEE
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK---------QIIHRDVKSSNILLTESMRAK  408 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~---------~ivH~Dlkp~NILl~~~~~vk  408 (554)
                      .++||||+++|+|.+++...   ..++..++.++.||+.||+|||   +.         +|+||||||+|||++.++.+|
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             EEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEE
Confidence            68999999999999999765   4589999999999999999999   77         999999999999999999999


Q ss_pred             EEeecCcccCCCCCC-----CccccccccCCCCCcChhcccc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 042763          409 VADFGFARLGPMDSD-----RTHISTKVKGTVGYLDPEYMKT-------YQLTTKSDVYSFGVLLLEILTGRRPVELKRP  476 (554)
Q Consensus       409 l~DfGla~~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwSlGvil~elltg~~P~~~~~~  476 (554)
                      |+|||+++.......     .........||+.|+|||++.+       ..++.++|||||||++|||++|..||.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999986542211     1122234569999999999976       4567899999999999999999777643322


Q ss_pred             hhhHHH-----------HHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          477 PEERVT-----------LRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       477 ~~~~~~-----------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      ......           ................+.....  ....++..+.+++.+||+.||++|||+.|+++.|.++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            111000           0000000111111111111111  123466789999999999999999999999999999998


Q ss_pred             hhhhhh
Q 042763          546 DSLKSV  551 (554)
Q Consensus       546 ~~~~~~  551 (554)
                      .+.+..
T Consensus       319 ~~~~~~  324 (336)
T 3g2f_A          319 IWERNK  324 (336)
T ss_dssp             CCCC--
T ss_pred             HHHhcc
Confidence            877654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9.9e-43  Score=350.70  Aligned_cols=265  Identities=27%  Similarity=0.408  Sum_probs=208.8

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC----CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEE-EcCCceE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV-DKGNERL  339 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-~~~~~~~  339 (554)
                      ..+|...++||+|+||+||+|...+    +..||+|.+.........+.+.+|+.++++++||||+++++++ ..++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3568888999999999999997542    3468999988755455567899999999999999999999986 4556789


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +||||+++|+|.+++... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       104 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            999999999999999754 356899999999999999999999   8899999999999999999999999999998643


Q ss_pred             CCCC-CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          420 MDSD-RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       420 ~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                      .... .........+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......+......   . ...     
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~---~-~~~-----  250 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---Q-GRR-----  250 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH---T-TCC-----
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh---c-CCC-----
Confidence            2211 1122234567889999999999999999999999999999999 555665544332211111   0 000     


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK  549 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~  549 (554)
                      ..       .+..++..+.+++.+||+.||++|||+.|+++.|.++..+...
T Consensus       251 ~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          251 LL-------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             CC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             CC-------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            00       1112345688999999999999999999999999999876543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.3e-42  Score=352.35  Aligned_cols=256  Identities=23%  Similarity=0.319  Sum_probs=210.3

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhh-----HHHHHHHHHHHHHhCCCCCceeeeeEEEcCCce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFEN-----LQTEFSSEVELLSKIDHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  338 (554)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.......     ..+.+.+|+.++++++||||+++++++.+++..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            457889999999999999999775 58999999987654321     356799999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC----cEEEEeecC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM----RAKVADFGF  414 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~----~vkl~DfGl  414 (554)
                      ++||||+++++|.+++...  ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++    .+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            9999999999999999754  57899999999999999999999   88999999999999999888    799999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      ++......    ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....   .    ....
T Consensus       166 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---i----~~~~  234 (321)
T 2a2a_A          166 AHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN---I----TSVS  234 (321)
T ss_dssp             CEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH---H----HTTC
T ss_pred             ceecCccc----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHH---H----Hhcc
Confidence            98643321    22345699999999999999999999999999999999999999986543222111   1    1100


Q ss_pred             ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       495 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                        ...++...    ...+..+.+++.+||+.||++|||+.|++++.|-
T Consensus       235 --~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~  276 (321)
T 2a2a_A          235 --YDFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI  276 (321)
T ss_dssp             --CCCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred             --cccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence              01111111    1234568899999999999999999999998774

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1e-42  Score=349.58  Aligned_cols=262  Identities=28%  Similarity=0.475  Sum_probs=199.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|...++||+|+||+||+|...+  .||||+++.... ....+.+.+|++++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            4678899999999999999998653  599999875432 33457799999999999999999999965 4567899999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++++|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       100 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  174 (289)
T 3og7_A          100 WCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS-  174 (289)
T ss_dssp             CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             ecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccc-
Confidence            99999999999654 356899999999999999999999   8899999999999999999999999999997543211 


Q ss_pred             CccccccccCCCCCcChhccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          424 RTHISTKVKGTVGYLDPEYMK---TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      .........||+.|+|||++.   +..++.++||||||+++|||++|+.||...........  ............    
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~----  248 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE--MVGRGSLSPDLS----  248 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHH--HHHHTSCCCCTT----
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHH--HhcccccCcchh----
Confidence            122233456999999999986   56789999999999999999999999987655433221  111111111110    


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                           .....++..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus       249 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          249 -----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             -----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                 0122345678999999999999999999999999998864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.6e-43  Score=360.87  Aligned_cols=269  Identities=22%  Similarity=0.306  Sum_probs=201.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .++|...++||+|+||+||+|... +++.||||++...... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            467999999999999999999754 6899999999755432 23456789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE-----CCCCcEEEEeecCccc
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL-----TESMRAKVADFGFARL  417 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl-----~~~~~vkl~DfGla~~  417 (554)
                      ||++ |+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||+     +.++.+||+|||+++.
T Consensus       113 e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          113 EYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             ECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             ecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            9996 6999999765  46899999999999999999999   8899999999999999     4556699999999976


Q ss_pred             CCCCCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC--
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN--  494 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--  494 (554)
                      ....   ........||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+...........  
T Consensus       187 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  263 (329)
T 3gbz_A          187 FGIP---IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP  263 (329)
T ss_dssp             HC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             cCCc---ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence            4321   1223345689999999999874 589999999999999999999999987654333222221111110000  


Q ss_pred             -----------ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          495 -----------LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       495 -----------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                                 ........+.......+...+.+++.+||+.||++|||+.|+++|.|-
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  322 (329)
T 3gbz_A          264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF  322 (329)
T ss_dssp             TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence                       001111122222222244678999999999999999999999998774

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.6e-43  Score=374.01  Aligned_cols=266  Identities=19%  Similarity=0.235  Sum_probs=201.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC------C
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG------N  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------~  336 (554)
                      .++|+..++||+|+||+||+|... +|+.||||++..... ....+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999999655 689999999976532 33456788999999999999999999999654      3


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ..++||||++ ++|.+.+..    .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       141 ~~~lv~E~~~-~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCS-EEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            5699999996 457777643    4899999999999999999999   8899999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHh-------
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR-------  489 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~-------  489 (554)
                      ....    ........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+......       
T Consensus       213 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          213 TAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             --------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             ecCC----CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            6432    22234567999999999999999999999999999999999999999876543332222111000       


Q ss_pred             --------h-c-cCCccc-----cCChhhh---hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          490 --------Y-N-EGNLLD-----MVDPSIK---EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       490 --------~-~-~~~~~~-----~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                              + . ......     .....+.   ..........+.+|+.+||+.||++|||+.|+++|.|-
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~  359 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI  359 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence                    0 0 000000     0000000   00111235678999999999999999999999999874

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.7e-43  Score=347.57  Aligned_cols=258  Identities=23%  Similarity=0.398  Sum_probs=210.8

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|+..+.||+|+||.||+|... +++.||||++.........+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467889999999999999999775 6899999999766555556789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++++|.+++...  ..+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....... 
T Consensus        86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-  159 (276)
T 2yex_A           86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-  159 (276)
T ss_dssp             CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT-
T ss_pred             ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc-
Confidence            99999999998654  56899999999999999999999   8999999999999999999999999999997643211 


Q ss_pred             CccccccccCCCCCcChhccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQL-TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                      .........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......... ..+..    ....   ..+ 
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~----~~~~---~~~-  230 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWKE----KKTY---LNP-  230 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH-HHHHT----TCTT---STT-
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH-HHhhh----cccc---cCc-
Confidence            1122334578999999999988765 789999999999999999999998755432211 11110    0000   000 


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                           ...+...+.+++.+||+.||++|||+.|++++.|-
T Consensus       231 -----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  265 (276)
T 2yex_A          231 -----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY  265 (276)
T ss_dssp             -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             -----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccc
Confidence                 11234567899999999999999999999998763

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.3e-43  Score=357.62  Aligned_cols=275  Identities=23%  Similarity=0.317  Sum_probs=210.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .++|+..+.||+|+||.||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            367889999999999999999776 489999998865443 233466889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++++|.+++...  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       104 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  177 (331)
T 4aaa_A          104 EFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-  177 (331)
T ss_dssp             ECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC-
Confidence            999999998887543  46899999999999999999999   889999999999999999999999999999764321 


Q ss_pred             CCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH-----------h-
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFK-----------R-  489 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~-----------~-  489 (554)
                        ........||+.|+|||++.+. .++.++||||||+++|||++|+.||......+....+.....           . 
T Consensus       178 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          178 --GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             --ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence              1223345689999999999875 789999999999999999999999987654333222211100           0 


Q ss_pred             --hccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          490 --YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       490 --~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                        .....................++..+.+++.+||+.||++|||+.|++++.|--....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  315 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGF  315 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGH
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCCh
Confidence              0000111111111111111234567899999999999999999999999988654433

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.6e-42  Score=345.43  Aligned_cols=251  Identities=26%  Similarity=0.436  Sum_probs=209.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|...+.||+|+||.||+|... +++.||||++......  .....+.+|++++++++||||+++++++.+++..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57888999999999999999776 5889999999765432  23467899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++++|.+++...  ..+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++...... 
T Consensus        94 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            999999999999765  46899999999999999999999   899999999999999999999999999998764321 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                          ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+....       ......      .
T Consensus       168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------~~~~~~------~  230 (284)
T 2vgo_A          168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR-------IVNVDL------K  230 (284)
T ss_dssp             ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------HHTTCC------C
T ss_pred             ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH-------Hhcccc------C
Confidence                12345689999999999999999999999999999999999999986543222111       111110      0


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                          .+..++..+.+++.+||+.||++||++.+++++.|--
T Consensus       231 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~  267 (284)
T 2vgo_A          231 ----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK  267 (284)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred             ----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence                1122345688999999999999999999999988753

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.5e-42  Score=348.86  Aligned_cols=264  Identities=23%  Similarity=0.368  Sum_probs=202.9

Q ss_pred             cCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .+|.+.+.||+|+||.||+|.. .+|+.||||++.....  ......+.+|+.++++++||||+++++++..++..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            5788999999999999999976 4689999999875322  334567899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          343 EFVPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       343 E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||+++++|.+++...  ....+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            999999999999752  2456899999999999999999999   88999999999999999999999999999976432


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      .   ........|++.|+|||++.+..++.++||||||+++|||++|+.||......... ...    ........... 
T Consensus       189 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~----~~~~~~~~~~~-  259 (310)
T 2wqm_A          189 K---TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCK----KIEQCDYPPLP-  259 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH-HHH----HHHTTCSCCCC-
T ss_pred             C---CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH-HHH----HhhcccCCCCc-
Confidence            1   11223456899999999999999999999999999999999999999764432211 111    11111111110 


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                             ...++..+.+++.+||+.||++|||+.+|+++++++++..-
T Consensus       260 -------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          260 -------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             -------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             -------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence                   11234568899999999999999999999999999988653

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.6e-43  Score=357.91  Aligned_cols=253  Identities=23%  Similarity=0.369  Sum_probs=210.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .++|...+.||+|+||.||++... +++.||+|++.....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467889999999999999999776 488999999876532  23456789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++++|.+++...  ..+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            9999999999998765  57899999999999999999999   889999999999999999999999999999865322


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                      .   .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+.     .....       
T Consensus       195 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-----~~~~~-------  259 (335)
T 2owb_A          195 G---ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-----KNEYS-------  259 (335)
T ss_dssp             T---CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----HTCCC-------
T ss_pred             c---ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh-----cCCCC-------
Confidence            2   12234569999999999999999999999999999999999999998654332211111     01111       


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                           .+..+...+.+++.+||+.||++|||+.|++++.|-
T Consensus       260 -----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~  295 (335)
T 2owb_A          260 -----IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF  295 (335)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             -----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence                 111223457899999999999999999999998774

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.5e-42  Score=360.21  Aligned_cols=273  Identities=18%  Similarity=0.244  Sum_probs=207.9

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcC------CcEEEEEEcchhhhhh----------HHHHHHHHHHHHHhCCCCCcee
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLED------GLLVAIKRAKKEQFEN----------LQTEFSSEVELLSKIDHRNLVK  327 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~~~----------~~~~~~~Ei~~l~~l~HpnIv~  327 (554)
                      ..++|.+.++||+|+||+||+|.+.+      ++.||||++.......          ....+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35689999999999999999997764      4789999986553211          0123445667788889999999


Q ss_pred             eeeEEEcC----CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC-
Q 042763          328 LLGFVDKG----NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT-  402 (554)
Q Consensus       328 l~~~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~-  402 (554)
                      +++++...    ...++||||+ +++|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+|||++ 
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEES
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEec
Confidence            99998764    4479999999 99999999764 457999999999999999999999   88999999999999999 


Q ss_pred             -CCCcEEEEeecCcccCCCCCCC----ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCh
Q 042763          403 -ESMRAKVADFGFARLGPMDSDR----THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP  477 (554)
Q Consensus       403 -~~~~vkl~DfGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~  477 (554)
                       .++.+||+|||+++........    ........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             8899999999999865322111    11123455999999999999999999999999999999999999999864333


Q ss_pred             hhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          478 EERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                      ........  .... ..+.+..++.+.   ...++..+.+++.+||+.+|++||++.+|++.|.++..+.
T Consensus       268 ~~~~~~~~--~~~~-~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          268 PKYVRDSK--IRYR-ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             HHHHHHHH--HHHH-HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHH--HHhh-hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            22211111  1110 011111111110   1223567899999999999999999999999999887654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.9e-42  Score=351.37  Aligned_cols=269  Identities=27%  Similarity=0.381  Sum_probs=204.9

Q ss_pred             hHHHHHhhcCCCcceeeeccCceEEEEEEEc----CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEE
Q 042763          258 MSQVVKATRNFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFV  332 (554)
Q Consensus       258 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~  332 (554)
                      +.++....++|...+.||+|+||.||+|...    ++..||||++..... ....+.+.+|+.++++++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            3444556688999999999999999999654    345899999976532 33456789999999999999999999999


Q ss_pred             EcCCc-----eEEEEEeCCCCCHHHHHhcc----cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC
Q 042763          333 DKGNE-----RLIITEFVPNGTLREHLDGQ----YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE  403 (554)
Q Consensus       333 ~~~~~-----~~lv~E~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~  403 (554)
                      .+.+.     .++||||+++++|.+++...    ....+++.+++.++.|++.||.|||   +++|+||||||+|||++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~  182 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRD  182 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcC
Confidence            76553     49999999999999998532    2357899999999999999999999   899999999999999999


Q ss_pred             CCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 042763          404 SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVT  482 (554)
Q Consensus       404 ~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~  482 (554)
                      ++.+||+|||+++...... .........+++.|+|||.+.+..++.++||||||+++|||++ |..||...........
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  261 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGD-YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY  261 (313)
T ss_dssp             TSCEEECSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             CCcEEEeecCcceeccccc-ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence            9999999999998643221 1122233457889999999999999999999999999999999 8899976554332211


Q ss_pred             HHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          483 LRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       483 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                         ..    ......         .+..++..+.+++.+||+.||++|||+.+++++|.++..+
T Consensus       262 ---~~----~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          262 ---LL----HGHRLK---------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             ---HH----TTCCCC---------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HH----cCCCCC---------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence               11    110000         1123445689999999999999999999999999998754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1e-42  Score=355.76  Aligned_cols=259  Identities=33%  Similarity=0.481  Sum_probs=207.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEE--EEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLV--AIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~v--AvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ++|...+.||+|+||.||+|... +|..+  |+|++.........+.+.+|+++++++ +||||+++++++.+++..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57888999999999999999764 56644  999887654444556789999999999 899999999999999999999


Q ss_pred             EEeCCCCCHHHHHhccc--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcE
Q 042763          342 TEFVPNGTLREHLDGQY--------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRA  407 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v  407 (554)
                      |||+++++|.+++....              ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999997642              347899999999999999999999   8999999999999999999999


Q ss_pred             EEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHH
Q 042763          408 KVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWA  486 (554)
Q Consensus       408 kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~  486 (554)
                      ||+|||+++...    .........+++.|+|||++.+..++.++||||||+++|||++ |+.||......+..      
T Consensus       182 kL~Dfg~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~------  251 (327)
T 1fvr_A          182 KIADFGLSRGQE----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------  251 (327)
T ss_dssp             EECCTTCEESSC----EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------
T ss_pred             EEcccCcCcccc----ccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH------
Confidence            999999997422    1112233457889999999998889999999999999999998 99999765432211      


Q ss_pred             HHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          487 FKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                       ..........         .+..++..+.+++.+||+.||++|||+.|++++|+++..+.
T Consensus       252 -~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          252 -EKLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             -HHGGGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             -HHhhcCCCCC---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence             1111111000         11233456889999999999999999999999999987754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-43  Score=364.27  Aligned_cols=264  Identities=28%  Similarity=0.424  Sum_probs=201.5

Q ss_pred             CCCcceeeeccCceEEEEEEEc--CC--cEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEc-CCceEEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE--DG--LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDK-GNERLII  341 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~--~g--~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~lv  341 (554)
                      .|...+.||+|+||+||+|...  ++  ..||||.++........+.+.+|+.++++++||||+++++++.+ ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4666789999999999999764  22  46899998765444556789999999999999999999998754 5678999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++|+|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       170 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            9999999999999754 346789999999999999999999   889999999999999999999999999999864322


Q ss_pred             CC-CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          422 SD-RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       422 ~~-~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      .. .........+|+.|+|||++.+..++.++||||||+++|||++ |.+||......+....+.       .+..  ..
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-------~~~~--~~  316 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------QGRR--LL  316 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-------TTCC--CC
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-------cCCC--CC
Confidence            11 1112233457889999999999999999999999999999999 677777654433221111       1100  00


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKS  550 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~~  550 (554)
                             .+..++..+.+++.+||+.||++|||+.|++++|+++......+
T Consensus       317 -------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~  360 (373)
T 3c1x_A          317 -------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  360 (373)
T ss_dssp             -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence                   11223456889999999999999999999999999998766543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.8e-42  Score=374.42  Aligned_cols=264  Identities=20%  Similarity=0.290  Sum_probs=214.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .++|...+.||+|+||+||+|... +|+.||+|++.+....  .....+.+|++++++++||||+++++++.+.+..++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367889999999999999999875 6999999999776432  3346788999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          342 TEFVPNGTLREHLDGQY--GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      |||+++|+|.+++....  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999997643  346899999999999999999999   8999999999999999999999999999998643


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ...   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...   ......    
T Consensus       341 ~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~---i~~~~~----  410 (543)
T 3c4z_A          341 AGQ---TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---VLEQAV----  410 (543)
T ss_dssp             TTC---CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH---HHHCCC----
T ss_pred             CCC---cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH---Hhhccc----
Confidence            221   1223457999999999999999999999999999999999999999875432221111111   111110    


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHHhhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDM-----KSVGEQLWAIRADS  547 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~l~~i~~~~  547 (554)
                            .++..++..+.+++.+||+.||++||++     .+|++|.|--.-+|
T Consensus       411 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          411 ------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             ------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence                  0122344568899999999999999964     88988876544333

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.1e-42  Score=351.43  Aligned_cols=257  Identities=27%  Similarity=0.383  Sum_probs=213.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .+.|...+.||+|+||.||+|... +++.||||++.........+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356888999999999999999764 6899999999776555556789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++++|.+++..   ..+++.+++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++......  
T Consensus       101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--  172 (303)
T 3a7i_A          101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--  172 (303)
T ss_dssp             CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--
T ss_pred             eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcc--
Confidence            9999999999965   36899999999999999999999   889999999999999999999999999999764322  


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                       ........||+.|+|||++.+..++.++||||||+++|||++|+.||..........   .. ......        . 
T Consensus       173 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~-~~~~~~--------~-  238 (303)
T 3a7i_A          173 -QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF---LI-PKNNPP--------T-  238 (303)
T ss_dssp             -BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HH-HHSCCC--------C-
T ss_pred             -ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH---Hh-hcCCCC--------C-
Confidence             112234568999999999999999999999999999999999999997654322111   11 111111        1 


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                         ....++..+.+++.+||+.||++|||+.+++++.|-.+..
T Consensus       239 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          239 ---LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             ---CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             ---CccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence               1112345688999999999999999999999998875543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.3e-43  Score=350.37  Aligned_cols=253  Identities=23%  Similarity=0.374  Sum_probs=203.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC-C-------cEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED-G-------LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~-g-------~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  336 (554)
                      .++|...+.||+|+||+||+|.... +       ..||+|++.... ....+.+.+|++++++++||||+++++++.+++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            3578889999999999999996542 3       579999987654 344578999999999999999999999999999


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc--------EE
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR--------AK  408 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~--------vk  408 (554)
                      ..++||||+++|+|.+++... ...+++..++.++.|++.||.|||   +++|+||||||+|||++.++.        +|
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999999765 234899999999999999999999   899999999999999998887        99


Q ss_pred             EEeecCcccCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 042763          409 VADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF  487 (554)
Q Consensus       409 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~  487 (554)
                      |+|||++.....       .....||+.|+|||++.+ ..++.++||||||+++|||++|..|+...........  .. 
T Consensus       162 l~Dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~--~~-  231 (289)
T 4fvq_A          162 LSDPGISITVLP-------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ--FY-  231 (289)
T ss_dssp             ECCCCSCTTTSC-------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH--HH-
T ss_pred             eccCcccccccC-------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH--Hh-
Confidence            999999875311       123458899999999987 6799999999999999999996655544333222111  11 


Q ss_pred             HhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          488 KRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      .  ......            ......+.+++.+||+.||++|||+.+++++|.++...
T Consensus       232 ~--~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          232 E--DRHQLP------------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             H--TTCCCC------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             h--ccCCCC------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            1  111111            11123478999999999999999999999999988653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.2e-42  Score=346.44  Aligned_cols=253  Identities=22%  Similarity=0.367  Sum_probs=210.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .++|...+.||+|+||+||+|... +++.||+|++.....  ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467888999999999999999776 588999999876532  23456789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++++|.+++...  ..+++.+++.++.|++.||+|||   +++++||||||+|||++.++.+||+|||+++.....
T Consensus        94 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           94 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            9999999999998765  47899999999999999999999   889999999999999999999999999999864322


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                      .   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+       ..... .    
T Consensus       169 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~~~~~-~----  233 (294)
T 2rku_A          169 G---ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-------KKNEY-S----  233 (294)
T ss_dssp             T---CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------HTTCC-C----
T ss_pred             c---cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------hhccC-C----
Confidence            2   1223456999999999999989999999999999999999999999865433221111       11110 0    


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                           .+......+.+++.+||+.||++|||+.|++++.|-
T Consensus       234 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~  269 (294)
T 2rku_A          234 -----IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF  269 (294)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             -----CccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence                 111233567899999999999999999999998875

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=346.69  Aligned_cols=258  Identities=26%  Similarity=0.405  Sum_probs=190.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .++|...+.||+|+||.||+|.. .+|+.||||++......  ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46789999999999999999976 46899999999765432  2346789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++++|.+++... ...+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999999999754 356899999999999999999999   889999999999999999999999999999864322


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                      .   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........       .....      +.
T Consensus       166 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~------~~  229 (278)
T 3cok_A          166 H---EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-------KVVLA------DY  229 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSS------CC
T ss_pred             C---CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-------HHhhc------cc
Confidence            1   11223568999999999999899999999999999999999999998654332110       00000      00


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      .    .+..++..+.+++.+||+.||++|||+.+++++.|-....
T Consensus       230 ~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          230 E----MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             C----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             C----CccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            0    1122345688999999999999999999999988754433

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.2e-42  Score=341.63  Aligned_cols=254  Identities=24%  Similarity=0.351  Sum_probs=205.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-----hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-----NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      ++|...+.||+|+||+||+|... +|+.||+|++......     ...+.+.+|++++++++||||+++++++.+++..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            56888999999999999999876 6899999998765322     13567999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC----cEEEEeecCc
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM----RAKVADFGFA  415 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~----~vkl~DfGla  415 (554)
                      +||||+++++|.+++...  ..+++.+++.++.|++.||+|||   +++++||||||+||+++.++    .+||+|||++
T Consensus        85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            999999999999999764  57899999999999999999999   88999999999999999877    8999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      .......    ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+       .... 
T Consensus       160 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~-  227 (283)
T 3bhy_A          160 HKIEAGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI-------SAVN-  227 (283)
T ss_dssp             EECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------HTTC-
T ss_pred             eeccCCC----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh-------Hhcc-
Confidence            8643221    223456899999999999989999999999999999999999999865432211111       0100 


Q ss_pred             cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          496 LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       496 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                       ...++...    ...+..+.+++.+||+.||++||++.|++++.|
T Consensus       228 -~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  268 (283)
T 3bhy_A          228 -YDFDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW  268 (283)
T ss_dssp             -CCCCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHH
T ss_pred             -cCCcchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHH
Confidence             01111111    123456889999999999999999999999765

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-42  Score=372.37  Aligned_cols=271  Identities=21%  Similarity=0.226  Sum_probs=191.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc-----CCc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK-----GNE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~~~  337 (554)
                      .++|.+.++||+|+||+||+|... +|+.||||++..... ....+.+.+|+++|++++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            368999999999999999999765 689999999865432 2334678999999999999999999999843     357


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .++||||+ +++|.+++...  ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence            89999998 68999999754  57999999999999999999999   88999999999999999999999999999987


Q ss_pred             CCCCCCCc------------------------cccccccCCCCCcChhcc-ccCCCCchhhHHHHHHHHHHHHh------
Q 042763          418 GPMDSDRT------------------------HISTKVKGTVGYLDPEYM-KTYQLTTKSDVYSFGVLLLEILT------  466 (554)
Q Consensus       418 ~~~~~~~~------------------------~~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwSlGvil~ellt------  466 (554)
                      ........                        ...+..+||+.|+|||++ .+..|+.++|||||||++|||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            54221110                        123445789999999976 56679999999999999999999      


Q ss_pred             -----CCCCCCCCCCh-----------------hhHHHHHHHHHhhccCCcc------------------ccCChhhhhh
Q 042763          467 -----GRRPVELKRPP-----------------EERVTLRWAFKRYNEGNLL------------------DMVDPSIKEV  506 (554)
Q Consensus       467 -----g~~P~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~------------------~~~d~~l~~~  506 (554)
                           |+++|.+....                 .....+.............                  ......+...
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 66666543310                 0111111121111111100                  0000001111


Q ss_pred             ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          507 ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       507 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                       .......+.+|+.+||+.||++|||+.|+++|.|-
T Consensus       366 -~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f  400 (458)
T 3rp9_A          366 -FPASSADAIHLLKRMLVFNPNKRITINECLAHPFF  400 (458)
T ss_dssp             -STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             -CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhh
Confidence             11235678899999999999999999999999774

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-43  Score=362.62  Aligned_cols=264  Identities=23%  Similarity=0.319  Sum_probs=210.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEE----cCCcEEEEEEcchhhh---hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCC
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL----EDGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGN  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~~~~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~  336 (554)
                      .++|...++||+|+||+||+|..    .+|+.||||+++....   ....+.+.+|+++++++ +||||+++++++..++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36789999999999999999987    3689999999875432   12235677899999999 6999999999999999


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ..++||||+++|+|.+++...  ..+++.+++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            999999999999999999765  46899999999999999999999   8899999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccCCCCCcChhcccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKT--YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      ....  ..........||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+....... ...
T Consensus       208 ~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~  284 (355)
T 1vzo_A          208 EFVA--DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPP  284 (355)
T ss_dssp             ECCG--GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CCC
T ss_pred             eccc--CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-CCC
Confidence            6432  12222334579999999999985  357899999999999999999999998654332222221111110 000


Q ss_pred             ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHHhhhhhh
Q 042763          495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLWAIRADSL  548 (554)
Q Consensus       495 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~i~~~~~  548 (554)
                                  .+.++...+.+++.+||+.||++||     ++.|+++++|--..++.
T Consensus       285 ------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~  331 (355)
T 1vzo_A          285 ------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD  331 (355)
T ss_dssp             ------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             ------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence                        1223345688999999999999999     99999999887655444

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.8e-43  Score=348.07  Aligned_cols=255  Identities=29%  Similarity=0.448  Sum_probs=204.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC-CceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG-NERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-~~~~lv~E  343 (554)
                      .++|+..+.||+|+||+||+|+.. |+.||||++....   ..+.+.+|++++++++||||+++++++.+. +..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            467888999999999999999875 8899999997643   346789999999999999999999987544 47899999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+++++|.+++.......+++..++.++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++.....  
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            999999999998664445889999999999999999999   889999999999999999999999999999753221  


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                          .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+...       ........      
T Consensus       171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~-------~~~~~~~~------  233 (278)
T 1byg_A          171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-------RVEKGYKM------  233 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH-------HHTTTCCC------
T ss_pred             ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHhcCCCC------
Confidence                122357889999999999899999999999999999998 999998654332211       11111100      


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                         ..+..++..+.+++.+||+.||++||++.|+++.|++++....
T Consensus       234 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~  276 (278)
T 1byg_A          234 ---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL  276 (278)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             ---CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhhc
Confidence               0122344668899999999999999999999999999987653

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.9e-43  Score=356.23  Aligned_cols=264  Identities=30%  Similarity=0.428  Sum_probs=209.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEE------cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  338 (554)
                      .++|...+.||+|+||.||+|..      .++..||||++...........+.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46899999999999999999973      247799999997654455567899999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHhcccC-----CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC---CCcEEEE
Q 042763          339 LIITEFVPNGTLREHLDGQYG-----KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE---SMRAKVA  410 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~  410 (554)
                      ++||||+++++|.+++.....     ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999986532     35889999999999999999999   889999999999999994   4469999


Q ss_pred             eecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHh
Q 042763          411 DFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKR  489 (554)
Q Consensus       411 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~  489 (554)
                      |||+++...... .........||+.|+|||++.+..++.++||||||+++|||++ |..||........   .....  
T Consensus       186 Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~~--  259 (327)
T 2yfx_A          186 DFGMARDIYRAS-YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEFVT--  259 (327)
T ss_dssp             CCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHHH--
T ss_pred             cccccccccccc-ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---HHHHh--
Confidence            999987532211 1112233457899999999999899999999999999999998 9999976543221   11111  


Q ss_pred             hccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          490 YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                        ......         .+..++..+.+++.+||+.||++||++.+|++++|.+..+..
T Consensus       260 --~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  307 (327)
T 2yfx_A          260 --SGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  307 (327)
T ss_dssp             --TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             --cCCCCC---------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence              111000         112234568899999999999999999999999999987653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.2e-43  Score=357.74  Aligned_cols=263  Identities=20%  Similarity=0.299  Sum_probs=209.9

Q ss_pred             HHHHhhcCCCcc-eeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcC
Q 042763          260 QVVKATRNFSPS-LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKG  335 (554)
Q Consensus       260 ~l~~~~~~f~~~-~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~  335 (554)
                      ......++|... ++||+|+||+||+|... +|+.||+|++..... ......+.+|+.+++++ +||||+++++++.++
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~  101 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT  101 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence            334445667766 78999999999999766 589999999876543 23356789999999999 469999999999999


Q ss_pred             CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC---CCcEEEEee
Q 042763          336 NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE---SMRAKVADF  412 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~Df  412 (554)
                      +..++||||+++|+|.+++.......+++.+++.++.|++.||+|||   +++|+||||||+|||++.   ++.+||+||
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            99999999999999999997766678999999999999999999999   889999999999999998   789999999


Q ss_pred             cCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhcc
Q 042763          413 GFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE  492 (554)
Q Consensus       413 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  492 (554)
                      |+++.....    .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+..    ...
T Consensus       179 g~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~----~~~  250 (327)
T 3lm5_A          179 GMSRKIGHA----CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ----VNV  250 (327)
T ss_dssp             GGCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----TCC
T ss_pred             ccccccCCc----cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh----ccc
Confidence            999864322    122345799999999999999999999999999999999999999987554332221111    000


Q ss_pred             CCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          493 GNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       493 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                       ..    ...    ....+...+.+++.+||+.||++|||+.|++++.|-
T Consensus       251 -~~----~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~  291 (327)
T 3lm5_A          251 -DY----SEE----TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL  291 (327)
T ss_dssp             -CC----CTT----TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred             -cc----Cch----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence             00    000    111234568899999999999999999999998774

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.5e-42  Score=345.76  Aligned_cols=269  Identities=18%  Similarity=0.262  Sum_probs=208.9

Q ss_pred             hhcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEE-EcCCceEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV-DKGNERLII  341 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-~~~~~~~lv  341 (554)
                      ..++|+..+.||+|+||+||+|.. .+++.||||++.....   ...+.+|+++++.++|++++..+.++ ..++..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            457899999999999999999976 5689999998765432   23578899999999988877766655 667788999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE---CCCCcEEEEeecCcccC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL---TESMRAKVADFGFARLG  418 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl---~~~~~vkl~DfGla~~~  418 (554)
                      |||+ +++|.+++... ...+++.+++.++.|++.||.|||   +++|+||||||+|||+   +.++.+||+|||+++..
T Consensus        84 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            9999 99999999743 346899999999999999999999   8899999999999999   78999999999999875


Q ss_pred             CCCCCCc----cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          419 PMDSDRT----HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       419 ~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      .......    .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            4332211    122345799999999999999999999999999999999999999987554332222221111100000


Q ss_pred             ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 042763          495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK  549 (554)
Q Consensus       495 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~  549 (554)
                               .......++..+.+++.+||+.||++|||+.+|++.|.++..+...
T Consensus       239 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          239 ---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             ---------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             ---------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence                     0001112346789999999999999999999999999999876653

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-42  Score=346.67  Aligned_cols=264  Identities=26%  Similarity=0.357  Sum_probs=208.8

Q ss_pred             CCCcceeeeccCceEEEEEEEcC----CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCce-EEE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLED----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNER-LII  341 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~-~lv  341 (554)
                      .|...++||+|+||+||+|...+    +..||+|++.........+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45567899999999999997542    3379999987655455567899999999999999999999999776655 999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+.+|+|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            9999999999999763 356899999999999999999999   889999999999999999999999999999754321


Q ss_pred             CC-CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          422 SD-RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       422 ~~-~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      .. .........+|+.|+|||.+.+..++.++||||||+++|||++|..|+..........  .... ......      
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~--~~~~-~~~~~~------  248 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT--HFLA-QGRRLP------  248 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH--HHHH-TTCCCC------
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH--HHhh-cCCCCC------
Confidence            11 1112233568899999999999999999999999999999999666654433322211  1111 111000      


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK  549 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~  549 (554)
                            .+..++..+.+++.+||+.||++|||+.++++.|.++......
T Consensus       249 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          249 ------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             ------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence                  1112345688999999999999999999999999999876543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-42  Score=356.07  Aligned_cols=272  Identities=22%  Similarity=0.249  Sum_probs=203.5

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhh----HHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFEN----LQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE  337 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  337 (554)
                      ...++|...+.||+|+||+||+|... +|+.||||++.......    ..+.+.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999775 58999999997643221    22468899999999999999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .++||||+++ +|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             eEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            9999999964 898888754 356889999999999999999999   88999999999999999999999999999986


Q ss_pred             CCCCCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL  496 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  496 (554)
                      ....   ........||+.|+|||++.+. .++.++|||||||++|||++|..||......+....+.............
T Consensus       162 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          162 FGSP---NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             TTSC---CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             ccCC---cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence            4322   1223345789999999998654 58999999999999999999999998765433322221111111111111


Q ss_pred             ccC---C--------hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          497 DMV---D--------PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       497 ~~~---d--------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      +..   +        ..............+.+++.+||+.||++|||+.|++++.|-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f  295 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF  295 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence            000   0        000000112344678999999999999999999999999874

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5e-42  Score=344.83  Aligned_cols=268  Identities=18%  Similarity=0.261  Sum_probs=211.8

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEE-EcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV-DKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-~~~~~~~lv~  342 (554)
                      .++|...+.||+|+||+||+|.. .+|+.||||++.....   .+.+.+|+.+++.++|++++..+.++ ..++..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            57899999999999999999976 5799999999865432   24688999999999988877666655 6667789999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC---CCCcEEEEeecCcccCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGP  419 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~---~~~~vkl~DfGla~~~~  419 (554)
                      ||+ +++|.+++... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++   .++.+||+|||+++...
T Consensus        85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             Eec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            999 99999999743 357899999999999999999999   89999999999999994   88999999999998754


Q ss_pred             CCCCCc----cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          420 MDSDRT----HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       420 ~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      ......    .......||+.|+|||++.+..++.++||||||+++|||++|+.||....................... 
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-  238 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-
Confidence            332211    112445799999999999999999999999999999999999999987544322222221111100000 


Q ss_pred             cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 042763          496 LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK  549 (554)
Q Consensus       496 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~  549 (554)
                              .......++..+.+++.+||+.||++|||+.+|++.|+++..+...
T Consensus       239 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          239 --------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             --------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             --------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence                    0001123346789999999999999999999999999999877654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.6e-42  Score=374.02  Aligned_cols=257  Identities=26%  Similarity=0.396  Sum_probs=207.1

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh------------hHHHHHHHHHHHHHhCCCCCceeeee
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE------------NLQTEFSSEVELLSKIDHRNLVKLLG  330 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~------------~~~~~~~~Ei~~l~~l~HpnIv~l~~  330 (554)
                      ..++|.+.++||+|+||+||+|... +++.||||++......            ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999775 5889999998765322            23567899999999999999999999


Q ss_pred             EEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC---cE
Q 042763          331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM---RA  407 (554)
Q Consensus       331 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~---~v  407 (554)
                      ++.++...++|||||++|+|.+++...  ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++   .+
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccE
Confidence            999999999999999999999999765  57899999999999999999999   88999999999999998776   69


Q ss_pred             EEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 042763          408 KVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF  487 (554)
Q Consensus       408 kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~  487 (554)
                      ||+|||+++.....    .......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+.   
T Consensus       189 kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---  260 (504)
T 3q5i_A          189 KIVDFGLSSFFSKD----YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE---  260 (504)
T ss_dssp             EECCCTTCEECCTT----SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---
T ss_pred             EEEECCCCEEcCCC----CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---
Confidence            99999999874322    22334569999999999875 69999999999999999999999998755432222111   


Q ss_pred             HhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          488 KRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                          .+..  ..+....    ..++..+.+++.+||+.||++|||+.|+++|.|--
T Consensus       261 ----~~~~--~~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  306 (504)
T 3q5i_A          261 ----KGKY--YFDFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK  306 (504)
T ss_dssp             ----HCCC--CCCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             ----cCCC--CCCcccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhh
Confidence                1111  0011111    12345689999999999999999999999998853

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=355.89  Aligned_cols=262  Identities=23%  Similarity=0.397  Sum_probs=205.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCc----EEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGL----LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      .++|+..++||+|+||+||+|... +++    .||+|.+.........+.+.+|+.++++++||||+++++++..+. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            467999999999999999999764 444    357777765544455678999999999999999999999998754 78


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +|+||+++|+|.+++... ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            999999999999999764 346899999999999999999999   8899999999999999999999999999998643


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ... .........+|+.|+|||.+.+..++.++||||||+++|||++ |..||...........+.    ....   .. 
T Consensus       169 ~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~----~~~~---~~-  239 (327)
T 3lzb_A          169 AEE-KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----KGER---LP-  239 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----TTCC---CC-
T ss_pred             Ccc-ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH----cCCC---CC-
Confidence            222 1122233457889999999999999999999999999999999 999998765443222111    1000   00 


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                              .+..++..+.+++.+||+.||++||++.|+++.|.++..+..
T Consensus       240 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  281 (327)
T 3lzb_A          240 --------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ  281 (327)
T ss_dssp             --------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred             --------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence                    112234468899999999999999999999999999986543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-42  Score=352.31  Aligned_cols=269  Identities=25%  Similarity=0.443  Sum_probs=211.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-----cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC--c
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN--E  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--~  337 (554)
                      .++|+..+.||+|+||.||+|..     .+|+.||||++.... ....+.+.+|++++++++||||+++++++...+  .
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            46688899999999999999984     368999999987653 344567999999999999999999999986544  6


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .++||||+++++|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            79999999999999999765 346899999999999999999999   88999999999999999999999999999987


Q ss_pred             CCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCh---------hhHHHHHHHHH
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP---------EERVTLRWAFK  488 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~---------~~~~~~~~~~~  488 (554)
                      ...............++..|+|||.+.+..++.++||||||+++|||++|..|+......         ...........
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            544332222233445788899999999888999999999999999999999988632100         00000000111


Q ss_pred             hhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          489 RYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       489 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                      ........         ..+..++..+.+++.+||+.||++|||+.||++.|++++.+.
T Consensus       275 ~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          275 LLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             HHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HhhcCCCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            11110000         012234567899999999999999999999999999998753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.8e-42  Score=357.66  Aligned_cols=253  Identities=26%  Similarity=0.369  Sum_probs=206.2

Q ss_pred             cCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      +.|...+.||+|+||+||+|.. .+|+.||||++.....  ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588899999999999999976 5789999999865422  334467899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+. |+|.+++... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....  
T Consensus       134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  206 (348)
T ss_dssp             ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence            9996 7888888643 357899999999999999999999   88999999999999999999999999999986421  


Q ss_pred             CCccccccccCCCCCcChhccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          423 DRTHISTKVKGTVGYLDPEYMK---TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                           .....||+.|+|||++.   ...++.++|||||||++|||++|+.||..........   .... ...   ... 
T Consensus       207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~---~~~~-~~~---~~~-  273 (348)
T 1u5q_A          207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQ-NES---PAL-  273 (348)
T ss_dssp             -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHH-SCC---CCC-
T ss_pred             -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHh-cCC---CCC-
Confidence                 12356999999999984   5679999999999999999999999997654322211   1111 000   000 


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                             .....+..+.+++.+||+.||++|||+.+++++.|-.+.
T Consensus       274 -------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          274 -------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             -------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             -------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence                   011234567899999999999999999999999886553

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.1e-42  Score=358.22  Aligned_cols=271  Identities=24%  Similarity=0.373  Sum_probs=210.8

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|...++||+|+||+||+|... +++.||+|++.........+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            367999999999999999999776 6899999999876445556789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK-QIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||   +. +|+||||||+|||++.++.+||+|||++.....  
T Consensus       112 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--  184 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--  184 (360)
T ss_dssp             CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred             CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc--
Confidence            99999999999765  46899999999999999999999   64 899999999999999999999999999864211  


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHh-------------
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR-------------  489 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~-------------  489 (554)
                         .......||+.|+|||++.+..++.++||||||+++|||++|+.||..................             
T Consensus       185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence               1223456999999999999999999999999999999999999999865433221111000000             


Q ss_pred             ----------hccCCccccCChhhh----hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          490 ----------YNEGNLLDMVDPSIK----EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       490 ----------~~~~~~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                                .......+..+....    ......++..+.+++.+||+.||++|||+.|+++|.|--..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                      000000000000000    00011234568999999999999999999999999885443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6e-43  Score=381.48  Aligned_cols=259  Identities=29%  Similarity=0.448  Sum_probs=212.9

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ..++|...++||+|+||.||+|.+.++..||||+++....  ..++|.+|+++|++++||||+++++++.+ +..++|||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            3466888899999999999999998888899999986542  24679999999999999999999999876 67899999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      ||++|+|.+++.......+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....  
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--  416 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--  416 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH--
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC--
Confidence            999999999998655567899999999999999999999   899999999999999999999999999999864321  


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                      .........++..|+|||++.+..++.++||||||+++|||++ |+.||......+..   ...    ..+....     
T Consensus       417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~---~~i----~~~~~~~-----  484 (535)
T 2h8h_A          417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQV----ERGYRMP-----  484 (535)
T ss_dssp             HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH---HHH----HTTCCCC-----
T ss_pred             ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HcCCCCC-----
Confidence            1111223457788999999999999999999999999999999 99999865433221   111    1110000     


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                          .+..++..+.+++.+||+.||++|||+.+|+++|+++...
T Consensus       485 ----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          485 ----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             ----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                1223456788999999999999999999999999987543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=359.30  Aligned_cols=267  Identities=19%  Similarity=0.237  Sum_probs=209.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC---------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCcee--------
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED---------GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK--------  327 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~---------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~--------  327 (554)
                      .++|...+.||+|+||+||+|....         ++.||||++...      +.+.+|++++++++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            4679999999999999999997763         789999998754      36789999999999999887        


Q ss_pred             -------eeeEEEc-CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCe
Q 042763          328 -------LLGFVDK-GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNI  399 (554)
Q Consensus       328 -------l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI  399 (554)
                             +++++.. +...++||||+ +++|.+++.......+++.+++.++.||+.||+|||   +++|+||||||+||
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NI  190 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHE
Confidence                   5677765 67889999999 999999998765568999999999999999999999   88999999999999


Q ss_pred             EECCCC--cEEEEeecCcccCCCCCCC----ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 042763          400 LLTESM--RAKVADFGFARLGPMDSDR----THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVEL  473 (554)
Q Consensus       400 Ll~~~~--~vkl~DfGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~  473 (554)
                      |++.++  .+||+|||+++........    ........||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  8999999999864322111    1112345799999999999999999999999999999999999999987


Q ss_pred             CCChhhH-HHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          474 KRPPEER-VTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       474 ~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                      ....... ........ ....   ...+....   ...++..+.+++.+||+.||++||++.+|++.|+++..+..
T Consensus       271 ~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFV-DKPG---PFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             GTTCHHHHHHHHHHHH-HSCC---CEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CCcCHHHHHHHHHhcc-CChh---hhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            5532221 11111111 1111   11111100   01224568899999999999999999999999999887654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.8e-42  Score=350.34  Aligned_cols=265  Identities=22%  Similarity=0.324  Sum_probs=200.7

Q ss_pred             cCCCcc-eeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPS-LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~-~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      +.|.+. +.||+|+||+||+|... +++.||||++.... ......+.+|++++.++ +||||+++++++.+++..++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            456664 67999999999999754 68999999997653 23356789999999985 7999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc---EEEEeecCcccCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR---AKVADFGFARLGP  419 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~---vkl~DfGla~~~~  419 (554)
                      ||+++++|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.   +||+|||+++...
T Consensus        91 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           91 EKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             EcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            999999999999765  57899999999999999999999   889999999999999998776   9999999997643


Q ss_pred             CCCCC----ccccccccCCCCCcChhcccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHH--------H
Q 042763          420 MDSDR----THISTKVKGTVGYLDPEYMKT-----YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERV--------T  482 (554)
Q Consensus       420 ~~~~~----~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~--------~  482 (554)
                      .....    ........||+.|+|||++.+     ..++.++||||||+++|||++|+.||......+...        .
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            22111    111223469999999999875     468899999999999999999999998654322000        0


Q ss_pred             HHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          483 LRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       483 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ............. . ......    ..++..+.+++.+||+.||++|||+.|+++|.|-
T Consensus       246 ~~~~~~~i~~~~~-~-~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~  299 (316)
T 2ac3_A          246 QNMLFESIQEGKY-E-FPDKDW----AHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV  299 (316)
T ss_dssp             HHHHHHHHHHCCC-C-CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred             HHHHHHHHhccCc-c-cCchhc----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence            0000111111110 0 001100    1234568999999999999999999999998774

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.9e-42  Score=344.43  Aligned_cols=252  Identities=25%  Similarity=0.423  Sum_probs=203.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc----CCce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK----GNER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~  338 (554)
                      .+.|...+.||+|+||+||+|... ++..||+|++..... ....+.+.+|+.++++++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            345777889999999999999765 588999999876543 3345678999999999999999999998865    3557


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eEeCCCCCCCeEEC-CCCcEEEEeecCc
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ--IIHRDVKSSNILLT-ESMRAKVADFGFA  415 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NILl~-~~~~vkl~DfGla  415 (554)
                      ++||||+++++|.+++...  ..+++..++.++.|++.||.|||   +.+  |+||||||+|||++ .++.+||+|||++
T Consensus       105 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            9999999999999999765  57899999999999999999999   777  99999999999998 8899999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      ......     ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||..........  .    .......
T Consensus       180 ~~~~~~-----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~----~~~~~~~  247 (290)
T 1t4h_A          180 TLKRAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY--R----RVTSGVK  247 (290)
T ss_dssp             GGCCTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH--H----HHTTTCC
T ss_pred             cccccc-----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH--H----HHhccCC
Confidence            753221     2234569999999998875 59999999999999999999999998655433221  1    1111110


Q ss_pred             cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          496 LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       496 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                          ....    +......+.+++.+||+.||++|||+.|++++.|
T Consensus       248 ----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~  285 (290)
T 1t4h_A          248 ----PASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             ----CGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             ----cccc----CCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence                1111    1112346889999999999999999999999876

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.1e-42  Score=343.03  Aligned_cols=252  Identities=21%  Similarity=0.355  Sum_probs=201.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.....  ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367889999999999999999876 689999999976543  23356789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++++|.+++...  ..+++.+++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||++......
T Consensus        90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             EeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            9999999999999765  46899999999999999999999   889999999999999999999999999999864321


Q ss_pred             CCCccccccccCCCCCcChhccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQL-TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                          .......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||..........   ...    .... .   
T Consensus       165 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~----~~~~-~---  229 (276)
T 2h6d_A          165 ----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK---KIR----GGVF-Y---  229 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHH----HCCC-C---
T ss_pred             ----cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH---Hhh----cCcc-c---
Confidence                12234468999999999988765 689999999999999999999997644322111   111    1100 0   


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                            .+..+...+.+++.+||+.||++|||+.|++++.|-
T Consensus       230 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~  265 (276)
T 2h6d_A          230 ------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF  265 (276)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred             ------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence                  111233568899999999999999999999999774

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.9e-42  Score=367.44  Aligned_cols=268  Identities=21%  Similarity=0.219  Sum_probs=208.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC------CCCCceeeeeEEEcCCc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI------DHRNLVKLLGFVDKGNE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l------~HpnIv~l~~~~~~~~~  337 (554)
                      ..+|++.++||+|+||+||+|... +++.||||++....  .....+.+|+++++.+      +|+||+++++++...+.
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            467999999999999999999665 58999999997643  3345677888888876      57799999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc--EEEEeecCc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR--AKVADFGFA  415 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~--vkl~DfGla  415 (554)
                      .++||||+ .++|.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.  +||+|||++
T Consensus       174 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          174 ICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999999 479999998776667999999999999999999999   889999999999999999987  999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHh------
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR------  489 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~------  489 (554)
                      +....      ......||+.|+|||++.+..++.++|||||||++|||++|..||......+....+......      
T Consensus       250 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          250 CYEHQ------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             EETTC------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             eecCC------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            76322      122457899999999999999999999999999999999999999876544332222111100      


Q ss_pred             ---------hccCCcc------ccC---------------------ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCH
Q 042763          490 ---------YNEGNLL------DMV---------------------DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDM  533 (554)
Q Consensus       490 ---------~~~~~~~------~~~---------------------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  533 (554)
                               .......      ...                     ...............+.+++.+||+.||++|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence                     0000000      000                     0000111111124568999999999999999999


Q ss_pred             HHHHHHHHHhh
Q 042763          534 KSVGEQLWAIR  544 (554)
Q Consensus       534 ~evl~~l~~i~  544 (554)
                      .|+++|.|--+
T Consensus       404 ~e~L~Hpw~~~  414 (429)
T 3kvw_A          404 GQALRHPWLRR  414 (429)
T ss_dssp             HHHHTSTTTC-
T ss_pred             HHHhCChhhcc
Confidence            99999987543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-42  Score=361.79  Aligned_cols=266  Identities=21%  Similarity=0.296  Sum_probs=203.9

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEc-------
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDK-------  334 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-------  334 (554)
                      ...++|...++||+|+||+||+|.. .+|+.||||++.....     ...+|+++++.++||||+++++++..       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            3457899999999999999999976 4699999999865432     23479999999999999999999843       


Q ss_pred             -------------------------------CCceEEEEEeCCCCCHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHh
Q 042763          335 -------------------------------GNERLIITEFVPNGTLREHLDG--QYGKTLDFNQRLEIAIDVAHGLTYL  381 (554)
Q Consensus       335 -------------------------------~~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~L  381 (554)
                                                     ....++||||++ |+|.+.+..  .....+++..++.++.||+.||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           234789999996 688887764  2346799999999999999999999


Q ss_pred             hhccCCCeEeCCCCCCCeEEC-CCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHH
Q 042763          382 HLYAEKQIIHRDVKSSNILLT-ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGV  459 (554)
Q Consensus       382 H~~~~~~ivH~Dlkp~NILl~-~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGv  459 (554)
                      |   +.+|+||||||+|||++ .++.+||+|||+++.....    .......||+.|+|||++.+. .++.++|||||||
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS----EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC  230 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT----SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC----CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence            9   89999999999999997 6899999999999864322    122345689999999998765 5899999999999


Q ss_pred             HHHHHHhCCCCCCCCCChhhHHHHHHHHH------------hhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCC
Q 042763          460 LLLEILTGRRPVELKRPPEERVTLRWAFK------------RYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIR  527 (554)
Q Consensus       460 il~elltg~~P~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP  527 (554)
                      ++|||++|+.||......+....+.....            .+.+...............+...+..+.+++.+||+.||
T Consensus       231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            99999999999987654433222211100            001111111112223333444456678999999999999


Q ss_pred             CCCCCHHHHHHHHH
Q 042763          528 NDRPDMKSVGEQLW  541 (554)
Q Consensus       528 ~~RPs~~evl~~l~  541 (554)
                      ++|||+.|+++|.|
T Consensus       311 ~~R~t~~e~l~hp~  324 (383)
T 3eb0_A          311 DLRINPYEAMAHPF  324 (383)
T ss_dssp             GGSCCHHHHHTSGG
T ss_pred             hhCCCHHHHhcCHH
Confidence            99999999998865

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.6e-42  Score=359.19  Aligned_cols=274  Identities=18%  Similarity=0.223  Sum_probs=205.8

Q ss_pred             hHHHHHhhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh----------hhHHHHHHHHHHHHHhCCCCCcee
Q 042763          258 MSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF----------ENLQTEFSSEVELLSKIDHRNLVK  327 (554)
Q Consensus       258 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~----------~~~~~~~~~Ei~~l~~l~HpnIv~  327 (554)
                      ..++....++|...+.||+|+||.||+|...+|+.||||++.....          ....+.+.+|++++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            4567777899999999999999999999888899999998854321          123467999999999999999999


Q ss_pred             eeeEEEc-----CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC
Q 042763          328 LLGFVDK-----GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT  402 (554)
Q Consensus       328 l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~  402 (554)
                      +++++..     ....++||||++ |+|.+++... ...+++.+++.++.||+.||.|||   +.+|+||||||+|||++
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLA  168 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEC
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEc
Confidence            9999844     335799999996 7898888754 346899999999999999999999   88999999999999999


Q ss_pred             CCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHH
Q 042763          403 ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERV  481 (554)
Q Consensus       403 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~  481 (554)
                      .++.+||+|||+++....    ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+...
T Consensus       169 ~~~~~kl~Dfg~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  244 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTA----DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN  244 (362)
T ss_dssp             TTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             CCCCEEEEecCccccccc----ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999975322    122334568999999999877 679999999999999999999999998765433322


Q ss_pred             HHHHHHHh----------------hccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          482 TLRWAFKR----------------YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       482 ~~~~~~~~----------------~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .+......                ............. ...........+.+++.+||+.||++|||+.|+++|.|
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  319 (362)
T 3pg1_A          245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARA-WTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY  319 (362)
T ss_dssp             HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCC-HHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhh-HHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence            22111000                0000011111111 11112233466899999999999999999999999876

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.4e-42  Score=350.46  Aligned_cols=263  Identities=21%  Similarity=0.274  Sum_probs=203.3

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .++|...+.||+|+||.||+|... +++.||+|++.....  ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999875 689999999976543  23457799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++++|.+++...  ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus       113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            9999999999999765  46899999999999999999999   889999999999999999999999999999764321


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                        .........|++.|+|||++.+..++.++||||||+++|||++|+.||......    .+....   ....    ..+
T Consensus       188 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~---~~~~----~~~  254 (309)
T 2h34_A          188 --KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VMGAHI---NQAI----PRP  254 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HHHHHH---HSCC----CCG
T ss_pred             --ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HHHHHh---ccCC----CCc
Confidence              112223456899999999999989999999999999999999999999864321    111111   1100    000


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHhhhhhh
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRP-DMKSVGEQLWAIRADSL  548 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~l~~i~~~~~  548 (554)
                         ......++..+.+++.+||+.||++|| ++.++++.|+++.....
T Consensus       255 ---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          255 ---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             ---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             ---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence               012223445688999999999999999 99999999988765543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.6e-42  Score=348.95  Aligned_cols=254  Identities=23%  Similarity=0.362  Sum_probs=206.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|...+.||+|+||+||+|... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            467889999999999999999775 689999999976532 224568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE---CCCCcEEEEeecCcccCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL---TESMRAKVADFGFARLGPM  420 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl---~~~~~vkl~DfGla~~~~~  420 (554)
                      |+++++|.+++...  ..+++.+++.++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++....
T Consensus        87 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           87 LVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             cCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            99999999999765  46899999999999999999999   8899999999999999   7889999999999975321


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                           .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........   ....    .... .. .
T Consensus       162 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~----~~~~-~~-~  227 (304)
T 2jam_A          162 -----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF---EKIK----EGYY-EF-E  227 (304)
T ss_dssp             -----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHH----HCCC-CC-C
T ss_pred             -----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHH----cCCC-CC-C
Confidence                 1223346899999999999999999999999999999999999999865432211   1111    1110 00 0


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ..    ....++..+.+++.+||+.||++|||+.|++++.|-
T Consensus       228 ~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  265 (304)
T 2jam_A          228 SP----FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI  265 (304)
T ss_dssp             TT----TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred             cc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence            01    112234568899999999999999999999998874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-42  Score=360.17  Aligned_cols=263  Identities=21%  Similarity=0.276  Sum_probs=200.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC------
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN------  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------  336 (554)
                      .++|...+.||+|+||.||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            468999999999999999999764 699999999865432 334567899999999999999999999997653      


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ..++||||+ +++|.+++...   .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            459999999 89999999763   6899999999999999999999   8999999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC-
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN-  494 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-  494 (554)
                      ....      ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+........... 
T Consensus       177 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          177 QADS------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             ECCS------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccc------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            6432      1234578999999999877 6799999999999999999999999987654333222211110000000 


Q ss_pred             --------------ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          495 --------------LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       495 --------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                                    +.......... ........+.+++.+||+.||++|||+.|+++|.|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~  310 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY  310 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence                          00000001111 11233567899999999999999999999999866

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.8e-42  Score=381.88  Aligned_cols=254  Identities=27%  Similarity=0.457  Sum_probs=203.3

Q ss_pred             eeeeccCceEEEEEEEc---CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLE---DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      ++||+|+||+||+|.+.   .++.||||+++.... ....+++.+|+++|++++||||+++++++.. +..++|||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653   468899999987543 2345789999999999999999999999975 568999999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...........
T Consensus       454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            9999999754  57899999999999999999999   889999999999999999999999999999875443333333


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhh
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEV  506 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  506 (554)
                      .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+       ..+....         
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-------~~~~~~~---------  592 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGERMG---------  592 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTTCCCC---------
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcCCCCC---------
Confidence            344557889999999999999999999999999999998 99999875543221111       1111110         


Q ss_pred             ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          507 ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       507 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                      .+..++..+.+++.+||+.||++||++.+|++.|+++..+.
T Consensus       593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            12234567899999999999999999999999999876653

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.7e-41  Score=346.83  Aligned_cols=273  Identities=23%  Similarity=0.342  Sum_probs=213.0

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHh--CCCCCceeeeeEEEcCC----
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSK--IDHRNLVKLLGFVDKGN----  336 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~~~~~~~~----  336 (554)
                      ...++|...+.||+|+||+||+|... |+.||||++....    ...+.+|++++..  ++||||+++++++....    
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             cccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            34578999999999999999999875 8999999997543    3567788898887  78999999999998776    


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhcc-----CCCeEeCCCCCCCeEECCCCcEEEEe
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA-----EKQIIHRDVKSSNILLTESMRAKVAD  411 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~Dlkp~NILl~~~~~vkl~D  411 (554)
                      ..++||||+++|+|.+++...   .+++.+++.++.|++.||+|||...     +.+|+||||||+|||++.++.+||+|
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  190 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  190 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred             eeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence            789999999999999999764   6899999999999999999999321     46899999999999999999999999


Q ss_pred             ecCcccCCCCCCCc-cccccccCCCCCcChhccccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCC
Q 042763          412 FGFARLGPMDSDRT-HISTKVKGTVGYLDPEYMKTY------QLTTKSDVYSFGVLLLEILTG----------RRPVELK  474 (554)
Q Consensus       412 fGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~------~~s~ksDVwSlGvil~elltg----------~~P~~~~  474 (554)
                      ||+++......... .......||+.|+|||++.+.      .++.++||||||+++|||++|          ..||...
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            99997643222111 122345799999999999775      234789999999999999999          7788764


Q ss_pred             CChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          475 RPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       475 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                      ........  ..............+...   ....++...+.+++.+||+.||++|||+.||+++|+++..+..
T Consensus       271 ~~~~~~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~  339 (342)
T 1b6c_B          271 VPSDPSVE--EMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  339 (342)
T ss_dssp             SCSSCCHH--HHHHHHTTSCCCCCCCGG---GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred             CcCcccHH--HHHHHHHHHHhCCCCccc---ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence            43221111  111111111111111111   1234677889999999999999999999999999999988654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.2e-42  Score=371.61  Aligned_cols=257  Identities=26%  Similarity=0.371  Sum_probs=208.3

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .++|.+.++||+|+||+||+|... +++.||||++..... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            467889999999999999999775 689999999976543 233567899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC---CCCcEEEEeecCcccCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGP  419 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~---~~~~vkl~DfGla~~~~  419 (554)
                      |||++|+|.+++...  ..+++.+++.++.||+.||.|||   +++|+||||||+|||++   .++.+||+|||+++...
T Consensus       101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            999999999998765  57899999999999999999999   89999999999999995   56679999999998643


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ..    .......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+.       .+... ..
T Consensus       176 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-------~~~~~-~~  242 (486)
T 3mwu_A          176 QN----TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE-------TGKYA-FD  242 (486)
T ss_dssp             CC--------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HTCCC-SC
T ss_pred             CC----CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCCC-CC
Confidence            22    22334579999999999976 59999999999999999999999998654332221111       11110 00


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      .+..     ..++..+.+++.+||+.||++|||+.|+++|.|--.
T Consensus       243 ~~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~  282 (486)
T 3mwu_A          243 LPQW-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (486)
T ss_dssp             SGGG-----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred             Cccc-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence            0111     123456889999999999999999999999988543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.8e-42  Score=356.08  Aligned_cols=273  Identities=20%  Similarity=0.278  Sum_probs=207.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc--------
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK--------  334 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--------  334 (554)
                      .++|+..++||+|+||+||+|.. .+|+.||||++..... ......+.+|++++++++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            36788999999999999999977 4689999999865543 2234567899999999999999999999876        


Q ss_pred             CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecC
Q 042763          335 GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGF  414 (554)
Q Consensus       335 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl  414 (554)
                      ++..++||||++ ++|.+.+... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           96 KGSIYLVFDFCE-HDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -CEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence            446899999996 5888877654 246899999999999999999999   88999999999999999999999999999


Q ss_pred             cccCCCCCC-CccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhcc
Q 042763          415 ARLGPMDSD-RTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE  492 (554)
Q Consensus       415 a~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  492 (554)
                      ++....... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.........
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            986542221 2222344578999999998876 46899999999999999999999999876544433333222211111


Q ss_pred             CCccccC--------------Chhhhhhcc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          493 GNLLDMV--------------DPSIKEVIS-MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       493 ~~~~~~~--------------d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .......              ...+..... ......+.+++.+||+.||++|||+.|+++|.|-
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  315 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF  315 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence            1100000              000000000 0113457899999999999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7e-43  Score=348.24  Aligned_cols=258  Identities=24%  Similarity=0.371  Sum_probs=206.8

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEE--cCCceEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVD--KGNERLI  340 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~--~~~~~~l  340 (554)
                      .++|+..+.||+|+||+||+|... +|+.||+|++..... ....+.+.+|++++++++||||+++++++.  .+...++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467888999999999999999775 689999999976542 334567999999999999999999999874  4567899


Q ss_pred             EEEeCCCCCHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHhhhccCCC-----eEeCCCCCCCeEECCCCcEEEEeec
Q 042763          341 ITEFVPNGTLREHLDGQY--GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ-----IIHRDVKSSNILLTESMRAKVADFG  413 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-----ivH~Dlkp~NILl~~~~~vkl~DfG  413 (554)
                      ||||+++++|.+++....  ...+++.+++.++.|++.||+|||   +.+     |+||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999997542  345899999999999999999999   666     9999999999999999999999999


Q ss_pred             CcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC
Q 042763          414 FARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG  493 (554)
Q Consensus       414 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  493 (554)
                      +++.....   ........||+.|+|||++.+..++.++||||||+++|||++|+.||.........   ...    ..+
T Consensus       162 ~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~i----~~~  231 (279)
T 2w5a_A          162 LARILNHD---TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA---GKI----REG  231 (279)
T ss_dssp             HHHHC------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HHT
T ss_pred             hheeeccc---cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHH---HHH----hhc
Confidence            99864321   11223356899999999999989999999999999999999999999865432211   111    111


Q ss_pred             CccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          494 NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       494 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      ....         .+..++..+.+++.+||+.||++||++.||++++|.-.
T Consensus       232 ~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          232 KFRR---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             CCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             cccc---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence            1111         11233456889999999999999999999999887544

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.6e-42  Score=344.85  Aligned_cols=259  Identities=22%  Similarity=0.337  Sum_probs=193.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHH-HHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQ-TEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~-~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .++|+..++||+|+||+||+|... +|+.||||++......... +.+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            467889999999999999999764 6899999999765433333 33445555678889999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          343 EFVPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYAEK-QIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       343 E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      ||++ |+|.+++...  ....+++..++.++.|++.||+|||   ++ +|+||||||+|||++.++.+||+|||+++...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9996 6988887642  3457999999999999999999999   76 99999999999999999999999999997643


Q ss_pred             CCCCCccccccccCCCCCcChhcc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYM----KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      ..    .......||+.|+|||++    .+..++.++||||||+++|||++|+.||.........  ..........   
T Consensus       162 ~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~---  232 (290)
T 3fme_A          162 DD----VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--LKQVVEEPSP---  232 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH--HHHHHHSCCC---
T ss_pred             cc----ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH--HHHHhccCCC---
Confidence            22    122334699999999996    5667899999999999999999999999864433221  1111111100   


Q ss_pred             cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          496 LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       496 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                       ..        ....++..+.+++.+||+.||++|||+.|+++|.|--..
T Consensus       233 -~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          233 -QL--------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             -CC--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             -Cc--------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence             00        011234568899999999999999999999998876543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.8e-42  Score=347.16  Aligned_cols=265  Identities=28%  Similarity=0.455  Sum_probs=201.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc--CCc--EEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE--DGL--LVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~--~g~--~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  338 (554)
                      .++|+..+.||+|+||+||+|.+.  ++.  .||||+++....  ....+.+.+|++++++++||||+++++++.++. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            467889999999999999999753  233  689999876532  234578999999999999999999999998754 8


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ++||||+++++|.+++... ...+++.+++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            8999999999999999764 246899999999999999999999   889999999999999999999999999999875


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                      ..............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........   ....   .......
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~---~~~~~~~  245 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---HKID---KEGERLP  245 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHH---TSCCCCC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH---HHHH---ccCCCCC
Confidence            443333333344567889999999998889999999999999999999 99999865432211   1111   1110000


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK  549 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~  549 (554)
                               ....++..+.+++.+||+.||++|||+.+++++|.++.....+
T Consensus       246 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  288 (291)
T 1u46_A          246 ---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR  288 (291)
T ss_dssp             ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             ---------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchh
Confidence                     1123446689999999999999999999999999998876554

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.6e-42  Score=364.26  Aligned_cols=271  Identities=23%  Similarity=0.255  Sum_probs=201.6

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC-----Cc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG-----NE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~  337 (554)
                      .++|.+.+.||+|+||+||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            578999999999999999999765 589999999975432 23446789999999999999999999998766     57


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .++||||++ ++|.+++...  ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            899999995 6999999754  56899999999999999999999   88999999999999999999999999999987


Q ss_pred             CCCCCCCc-------------------cccccccCCCCCcChhcc-ccCCCCchhhHHHHHHHHHHHHhCCCCCC-----
Q 042763          418 GPMDSDRT-------------------HISTKVKGTVGYLDPEYM-KTYQLTTKSDVYSFGVLLLEILTGRRPVE-----  472 (554)
Q Consensus       418 ~~~~~~~~-------------------~~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwSlGvil~elltg~~P~~-----  472 (554)
                      ........                   ...+..+||+.|+|||++ ....++.++|||||||++|||++|..||.     
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            54322110                   123456799999999986 56679999999999999999998554443     


Q ss_pred             ------CCCCh--------------hhHHHHHHHHHhhccCCcc---ccCChh---------------hhhhccHHHHHH
Q 042763          473 ------LKRPP--------------EERVTLRWAFKRYNEGNLL---DMVDPS---------------IKEVISMEILTK  514 (554)
Q Consensus       473 ------~~~~~--------------~~~~~~~~~~~~~~~~~~~---~~~d~~---------------l~~~~~~~~~~~  514 (554)
                            +....              .....+.............   ....+.               +... .......
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~  337 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK-YPSISDD  337 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH-STTSCHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHH-CCCCCHH
Confidence                  22110              0111122222211111100   000000               0000 0124567


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          515 MFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       515 l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      +.+|+.+||+.||++|||+.|+++|.|-
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f  365 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDHPYL  365 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTCGGG
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcChhh
Confidence            8899999999999999999999998763

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.7e-43  Score=358.94  Aligned_cols=246  Identities=24%  Similarity=0.364  Sum_probs=204.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-------hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-------NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-------~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  336 (554)
                      .++|...+.||+|+||+||+|... +++.||||++......       .....+.+|++++++++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            468999999999999999999754 6899999998765321       12345778999999999999999999999999


Q ss_pred             ceEEEEEeCCCC-CHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCc
Q 042763          337 ERLIITEFVPNG-TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA  415 (554)
Q Consensus       337 ~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla  415 (554)
                      ..++||||+.+| +|.+++...  ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            999999999777 999999765  56899999999999999999999   889999999999999999999999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL-TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      +.....    .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......             ....
T Consensus       178 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------~~~~  240 (335)
T 3dls_A          178 AYLERG----KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------VEAA  240 (335)
T ss_dssp             EECCTT----CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------TTTC
T ss_pred             eECCCC----CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------Hhhc
Confidence            864322    12234569999999999988877 88999999999999999999999742110             0000


Q ss_pred             ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       495 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                          ..      .+..++..+.+++.+||+.||++|||+.+++++.|-
T Consensus       241 ----~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~  278 (335)
T 3dls_A          241 ----IH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV  278 (335)
T ss_dssp             ----CC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred             ----cC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence                00      011134568899999999999999999999999874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.2e-43  Score=351.94  Aligned_cols=268  Identities=24%  Similarity=0.349  Sum_probs=191.7

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ..++|...+.||+|+||+||+|... +++.||||++.........+++.+|+.++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            3578999999999999999999754 689999999876654445567889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcc------cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          343 EFVPNGTLREHLDGQ------YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       343 E~~~~g~L~~~l~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ||+++++|.+++...      ....+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            999999999998642      2356899999999999999999999   8899999999999999999999999999997


Q ss_pred             cCCCCCC--CccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC
Q 042763          417 LGPMDSD--RTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG  493 (554)
Q Consensus       417 ~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  493 (554)
                      .......  .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||..........   ..... ...
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~-~~~  245 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM---LTLQN-DPP  245 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---HHHTS-SCC
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH---HHhcc-CCC
Confidence            6533221  1112234569999999999876 578999999999999999999999998755433211   11111 111


Q ss_pred             Cccc-cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          494 NLLD-MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       494 ~~~~-~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .... ..++.    ....+...+.+++.+||+.||++||++.+++++.|-
T Consensus       246 ~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  291 (303)
T 2vwi_A          246 SLETGVQDKE----MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF  291 (303)
T ss_dssp             CTTC-----C----CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC
T ss_pred             ccccccccch----hhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence            1100 11111    111234568899999999999999999999998664

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.5e-42  Score=353.13  Aligned_cols=271  Identities=23%  Similarity=0.293  Sum_probs=207.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC-----Cce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG-----NER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~~  338 (554)
                      .++|...+.||+|+||+||+|... +|+.||||++...........+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468899999999999999999775 68999999997654445566788999999999999999999987654     678


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ++||||++ ++|.+++...   .+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus        90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            99999995 7999998763   6899999999999999999999   889999999999999999999999999999875


Q ss_pred             CCCCCCcc-------ccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhh
Q 042763          419 PMDSDRTH-------ISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY  490 (554)
Q Consensus       419 ~~~~~~~~-------~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  490 (554)
                      ........       ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+.......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            43221111       1223568999999998764 679999999999999999999999998765433222221111111


Q ss_pred             ccCCccc-cCChhhh--------------hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          491 NEGNLLD-MVDPSIK--------------EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       491 ~~~~~~~-~~d~~l~--------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ....... ...+...              ......++..+.+++.+||+.||++|||+.|++++.|-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  309 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL  309 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence            0000000 0011000              00112345678999999999999999999999998764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=351.94  Aligned_cols=266  Identities=22%  Similarity=0.364  Sum_probs=205.8

Q ss_pred             hhcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEE----cCCce
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD----KGNER  338 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~----~~~~~  338 (554)
                      ..++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.    .....
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            457899999999999999999976 568999999886543 334567899999999999999999999986    33477


Q ss_pred             EEEEEeCCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          339 LIITEFVPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ++||||+++|+|.+++...  ....+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            9999999999999999763  2457899999999999999999999   8899999999999999999999999999987


Q ss_pred             cCCCCCCCcc------ccccccCCCCCcChhccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 042763          417 LGPMDSDRTH------ISTKVKGTVGYLDPEYMKTYQ---LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF  487 (554)
Q Consensus       417 ~~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~---~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~  487 (554)
                      ..........      ......||+.|+|||++.+..   ++.++||||||+++|||++|+.||.........  .....
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~  260 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--VALAV  260 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC--HHHHH
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch--hhHHh
Confidence            5321111100      012235799999999987654   789999999999999999999999531100000  00000


Q ss_pred             HhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          488 KRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       488 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                      ..  ....     +     ....++..+.+++.+||+.||++|||+.+|+++|++++...
T Consensus       261 ~~--~~~~-----~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          261 QN--QLSI-----P-----QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             HC--C--C-----C-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             hc--cCCC-----C-----ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence            00  0000     0     11223456899999999999999999999999999987643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9e-42  Score=348.78  Aligned_cols=259  Identities=17%  Similarity=0.254  Sum_probs=202.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEc--CCceEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDK--GNERLI  340 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~--~~~~~l  340 (554)
                      .++|+..++||+|+||+||+|.. .+++.||||++....    .+.+.+|++++++++ ||||+++++++.+  ....++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            46799999999999999999976 468999999987543    357889999999997 9999999999987  667899


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC-cEEEEeecCcccCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGP  419 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~~  419 (554)
                      ||||+++++|.+++.     .+++.+++.++.|++.||+|||   +++|+||||||+|||++.++ .+||+|||+++...
T Consensus       111 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            999999999999984     4789999999999999999999   89999999999999999776 89999999998643


Q ss_pred             CCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc---
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL---  495 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---  495 (554)
                      ...    ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........  ...........   
T Consensus       183 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~--~~~~~~~~~~~~~~  256 (330)
T 3nsz_A          183 PGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV--RIAKVLGTEDLYDY  256 (330)
T ss_dssp             TTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH--HHHHHHCHHHHHHH
T ss_pred             CCC----ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH--HHHHhcCCchhhhH
Confidence            222    2234568999999999877 6799999999999999999999999965543322111  10000000000   


Q ss_pred             ----cccCChhh----------------hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          496 ----LDMVDPSI----------------KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       496 ----~~~~d~~l----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                          ....++..                .......+...+.+++.+||+.||++|||+.|+++|.|
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~  322 (330)
T 3nsz_A          257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  322 (330)
T ss_dssp             HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence                00000000                00011124567899999999999999999999999876

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=356.05  Aligned_cols=268  Identities=18%  Similarity=0.223  Sum_probs=202.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc----CCcEEEEEEcchhhhhh----------HHHHHHHHHHHHHhCCCCCceeeee
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFEN----------LQTEFSSEVELLSKIDHRNLVKLLG  330 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~~~----------~~~~~~~Ei~~l~~l~HpnIv~l~~  330 (554)
                      .++|...+.||+|+||+||+|...    ++..||||+........          ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467889999999999999999875    57889999887543110          1134678899999999999999999


Q ss_pred             EEEc----CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC-
Q 042763          331 FVDK----GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM-  405 (554)
Q Consensus       331 ~~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-  405 (554)
                      ++..    ....++||||+ +++|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++ 
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSST
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCC
Confidence            9977    67889999999 99999999765  37899999999999999999999   88999999999999999887 


Q ss_pred             -cEEEEeecCcccCCCCCC----CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhH
Q 042763          406 -RAKVADFGFARLGPMDSD----RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEER  480 (554)
Q Consensus       406 -~vkl~DfGla~~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~  480 (554)
                       .+||+|||+++.......    .........||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             999999999986532211    111124457999999999999999999999999999999999999999653322221


Q ss_pred             HHHHHHHHhhccCCccccCChhhhhhcc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          481 VTLRWAFKRYNEGNLLDMVDPSIKEVIS-MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      ....  .....     ......+....+ ..++..+.+++.+||+.||++||++.+|++.|+++..
T Consensus       270 ~~~~--~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          270 VQTA--KTNLL-----DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHH--HHHHH-----HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHH--HHhhc-----ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            1111  11100     111111111111 1345678999999999999999999999999987653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.7e-42  Score=358.68  Aligned_cols=265  Identities=23%  Similarity=0.261  Sum_probs=208.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC--------CCCceeeeeEEE--
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKID--------HRNLVKLLGFVD--  333 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~--------HpnIv~l~~~~~--  333 (554)
                      .++|.+.++||+|+||+||+|... +++.||||++....  ...+.+.+|++++++++        |+||+++++++.  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            368999999999999999999754 68999999997542  34567889999999985        788999999987  


Q ss_pred             --cCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeEeCCCCCCCeEECCCC-----
Q 042763          334 --KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK-QIIHRDVKSSNILLTESM-----  405 (554)
Q Consensus       334 --~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dlkp~NILl~~~~-----  405 (554)
                        .+...++||||+ +++|.+++.......+++.+++.++.||+.||+|||   ++ +|+||||||+|||++.++     
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhh
Confidence              556789999999 778888877665567999999999999999999999   77 999999999999999775     


Q ss_pred             --------------------------------------------cEEEEeecCcccCCCCCCCccccccccCCCCCcChh
Q 042763          406 --------------------------------------------RAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE  441 (554)
Q Consensus       406 --------------------------------------------~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE  441 (554)
                                                                  .+||+|||+++.....      .....||+.|+|||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE  263 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCCh
Confidence                                                        7999999999864321      23346899999999


Q ss_pred             ccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChh---hHHHHHHHHHhhccC-------------------CccccC
Q 042763          442 YMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPE---ERVTLRWAFKRYNEG-------------------NLLDMV  499 (554)
Q Consensus       442 ~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~---~~~~~~~~~~~~~~~-------------------~~~~~~  499 (554)
                      ++.+..++.++|||||||++|||++|+.||.......   ....+..........                   ......
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            9999999999999999999999999999998655332   111121111111100                   000000


Q ss_pred             C---hh----h--hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          500 D---PS----I--KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       500 d---~~----l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      +   ..    +  ......+....+.+|+.+||+.||++|||+.|+++|.|
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  394 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW  394 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence            0   00    0  01134567788999999999999999999999999876

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.2e-42  Score=343.15  Aligned_cols=250  Identities=21%  Similarity=0.330  Sum_probs=202.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .++|+..+.||+|+||+||+|... +++.||||++..... ......+.+|+..+.++ +||||+++++++.+++..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467899999999999999999776 699999999876432 23456788999999999 999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC---------------
Q 042763          342 TEFVPNGTLREHLDGQY--GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES---------------  404 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~---------------  404 (554)
                      |||+++++|.+++....  ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999997643  256899999999999999999999   8899999999999999844               


Q ss_pred             ----CcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhh
Q 042763          405 ----MRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEE  479 (554)
Q Consensus       405 ----~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~  479 (554)
                          ..+||+|||++......       ....||+.|+|||++.+. .++.++||||||+++|||++|.+|+....   .
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~  236 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---Q  236 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---H
T ss_pred             cCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---H
Confidence                47999999999864321       123589999999999775 56789999999999999999998765321   1


Q ss_pred             HHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          480 RVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                         ...    ........         .+..++..+.+++.+||+.||++|||+.|++++.|-.
T Consensus       237 ---~~~----~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  284 (289)
T 1x8b_A          237 ---WHE----IRQGRLPR---------IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL  284 (289)
T ss_dssp             ---HHH----HHTTCCCC---------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred             ---HHH----HHcCCCCC---------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence               111    11111111         1122345688999999999999999999999987643

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.2e-41  Score=352.42  Aligned_cols=263  Identities=19%  Similarity=0.243  Sum_probs=198.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC------
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN------  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------  336 (554)
                      .++|...+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999765 689999999875432 334567889999999999999999999997654      


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ..++||||++ ++|.+++..    .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            6799999995 688888853    4889999999999999999999   8899999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhcc----
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE----  492 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----  492 (554)
                      ....    ........||+.|+|||++.+..++.++|||||||++|||++|+.||...........+   ......    
T Consensus       176 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~  248 (371)
T 2xrw_A          176 TAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV---IEQLGTPCPE  248 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HC-CCCCCHH
T ss_pred             cccc----ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCHH
Confidence            6322    12233457999999999999999999999999999999999999999875533221111   110000    


Q ss_pred             ----------------CCcc-----ccCChhhh---hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          493 ----------------GNLL-----DMVDPSIK---EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       493 ----------------~~~~-----~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                                      ....     ........   ..........+.+++.+||+.||++|||+.|+++|.|-
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  322 (371)
T 2xrw_A          249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  322 (371)
T ss_dssp             HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred             HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence                            0000     00000000   00112346678999999999999999999999999884

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.7e-42  Score=369.43  Aligned_cols=256  Identities=24%  Similarity=0.377  Sum_probs=203.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .++|...++||+|+||+||+|... ++..||+|++..... ......+.+|+.++++++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            357889999999999999999775 688999999876542 223467899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC---CCcEEEEeecCcccCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE---SMRAKVADFGFARLGP  419 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~DfGla~~~~  419 (554)
                      |||++|+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.   ++.+||+|||+++...
T Consensus       116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            999999999998765  56899999999999999999999   889999999999999976   4559999999998643


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ..    .......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+.       .... ...
T Consensus       191 ~~----~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-------~~~~-~~~  257 (494)
T 3lij_A          191 NQ----KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE-------KGKY-TFD  257 (494)
T ss_dssp             TT----BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HTCC-CCC
T ss_pred             CC----ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCC-CCC
Confidence            22    22334579999999999874 79999999999999999999999998755432221111       1110 001


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      .+..     ..++..+.+++.+||+.||++|||+.|+++|.|--
T Consensus       258 ~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  296 (494)
T 3lij_A          258 SPEW-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK  296 (494)
T ss_dssp             SGGG-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred             chhc-----ccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccc
Confidence            1111     12345688999999999999999999999998753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.8e-42  Score=373.36  Aligned_cols=257  Identities=24%  Similarity=0.366  Sum_probs=210.3

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .++|...++||+|+||+||+|... +|+.||||++.....  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            357888999999999999999776 689999999866532  23456799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE---CCCCcEEEEeecCcccC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL---TESMRAKVADFGFARLG  418 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl---~~~~~vkl~DfGla~~~  418 (554)
                      |||+.+|+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||+   +.++.+||+|||+++..
T Consensus       105 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          105 GEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             ECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            9999999999999765  57899999999999999999999   8899999999999999   56789999999999864


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ...    .......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+...   ...    .+... .
T Consensus       180 ~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~----~~~~~-~  246 (484)
T 3nyv_A          180 EAS----KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK---KVE----KGKYT-F  246 (484)
T ss_dssp             CCC----CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHH----HCCCC-C
T ss_pred             ccc----cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHH----cCCCC-C
Confidence            322    12234569999999999876 79999999999999999999999998754332221   111    11110 0


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      ..+..     ..++..+.+++.+||+.||++|||+.|+++|.|--.
T Consensus       247 ~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          247 ELPQW-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             CSGGG-----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred             CCccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence            01111     123456889999999999999999999999988543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9.4e-42  Score=348.87  Aligned_cols=265  Identities=19%  Similarity=0.277  Sum_probs=208.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEE--cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCC------CceeeeeEEEcCC
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL--EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR------NLVKLLGFVDKGN  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~--~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hp------nIv~l~~~~~~~~  336 (554)
                      .++|++.+.||+|+||+||+|..  .+++.||||+++...  ...+.+.+|+++++.++|+      +++++++++.+.+
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            46899999999999999999976  368999999997542  3356788999999988655      4999999999999


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC-------------
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE-------------  403 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~-------------  403 (554)
                      ..++||||+ +++|.+++.......+++.+++.++.|++.||+|||   +++|+||||||+|||++.             
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999999 899999998775567899999999999999999999   889999999999999987             


Q ss_pred             ------CCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCh
Q 042763          404 ------SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP  477 (554)
Q Consensus       404 ------~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~  477 (554)
                            ++.+||+|||+++.....      .....||+.|+|||++.+..++.++||||||+++|||++|..||......
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                  678999999999863221      23456899999999999999999999999999999999999999876544


Q ss_pred             hhHHHHHHHHHhhc--------cCCc-------ccc-----------CChhh-hhhccHHHHHHHHHHHHHccCCCCCCC
Q 042763          478 EERVTLRWAFKRYN--------EGNL-------LDM-----------VDPSI-KEVISMEILTKMFGLAIQCAAPIRNDR  530 (554)
Q Consensus       478 ~~~~~~~~~~~~~~--------~~~~-------~~~-----------~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~R  530 (554)
                      +....+........        ....       +..           ..+.. ...........+.+++.+||+.||++|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            33222222111000        0000       000           00000 001123456789999999999999999


Q ss_pred             CCHHHHHHHHH
Q 042763          531 PDMKSVGEQLW  541 (554)
Q Consensus       531 Ps~~evl~~l~  541 (554)
                      ||+.|++++.|
T Consensus       321 pt~~ell~hp~  331 (339)
T 1z57_A          321 ITLREALKHPF  331 (339)
T ss_dssp             CCHHHHTTSGG
T ss_pred             cCHHHHhcCHH
Confidence            99999998754

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.1e-41  Score=353.95  Aligned_cols=258  Identities=21%  Similarity=0.342  Sum_probs=208.6

Q ss_pred             HHhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhh-------hhhHHHHHHHHHHHHHhC-CCCCceeeeeEE
Q 042763          262 VKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQ-------FENLQTEFSSEVELLSKI-DHRNLVKLLGFV  332 (554)
Q Consensus       262 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-------~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~  332 (554)
                      ....++|.+.+.||+|+||.||+|... +|+.||||++....       .....+.+.+|+.+++++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            334577999999999999999999875 69999999986543       123346788999999999 799999999999


Q ss_pred             EcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEee
Q 042763          333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADF  412 (554)
Q Consensus       333 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df  412 (554)
                      ......++||||+++++|.+++...  ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+||
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~Df  244 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDF  244 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEec
Confidence            9999999999999999999999765  57899999999999999999999   889999999999999999999999999


Q ss_pred             cCcccCCCCCCCccccccccCCCCCcChhcccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH
Q 042763          413 GFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT------YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWA  486 (554)
Q Consensus       413 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~  486 (554)
                      |++......    .......||+.|+|||++.+      ..++.++|||||||++|||++|+.||........   ....
T Consensus       245 G~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~i  317 (365)
T 2y7j_A          245 GFSCHLEPG----EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM---LRMI  317 (365)
T ss_dssp             TTCEECCTT----CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH
T ss_pred             CcccccCCC----cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH---HHHH
Confidence            999864322    12234679999999999863      3588999999999999999999999976443221   1111


Q ss_pred             HHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          487 FKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ..    ... . ......    ...+..+.+++.+||+.||++|||+.|++++.|
T Consensus       318 ~~----~~~-~-~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~  362 (365)
T 2y7j_A          318 ME----GQY-Q-FSSPEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQHPF  362 (365)
T ss_dssp             HH----TCC-C-CCHHHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             Hh----CCC-C-CCCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence            11    100 0 000000    122456889999999999999999999999876

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=342.41  Aligned_cols=258  Identities=22%  Similarity=0.329  Sum_probs=206.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh---hhHHHHHHHHHHHHHhCCCCCceeeeeEE--EcCCce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHRNLVKLLGFV--DKGNER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~--~~~~~~  338 (554)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.....   ......+.+|++++++++||||+++++++  .+.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999775 588999999976543   23457799999999999999999999998  445678


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ++||||++++ |.+++.......+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999766 888887766678999999999999999999999   889999999999999999999999999999864


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQ--LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL  496 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  496 (554)
                      .... .........||+.|+|||++.+..  ++.++||||||+++|||++|+.||...........+       ..... 
T Consensus       160 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i-------~~~~~-  230 (305)
T 2wtk_C          160 HPFA-ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI-------GKGSY-  230 (305)
T ss_dssp             CTTC-SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-------HHCCC-
T ss_pred             Cccc-cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH-------hcCCC-
Confidence            3222 122233456999999999997644  478999999999999999999999865432221111       11110 


Q ss_pred             ccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          497 DMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       497 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                               ..+..+...+.+++.+||+.||++|||+.|++++.|--.
T Consensus       231 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  269 (305)
T 2wtk_C          231 ---------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK  269 (305)
T ss_dssp             ---------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred             ---------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence                     011223456789999999999999999999999987543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=352.41  Aligned_cols=261  Identities=25%  Similarity=0.374  Sum_probs=204.3

Q ss_pred             HHHHhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEc---
Q 042763          260 QVVKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDK---  334 (554)
Q Consensus       260 ~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~---  334 (554)
                      ++....++|+..+.||+|+||.||+|... +|+.||||++.....  ..+.+.+|+.+++++ +||||+++++++..   
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence            44456788999999999999999999774 689999999875432  236788999999999 79999999999976   


Q ss_pred             ---CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEe
Q 042763          335 ---GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVAD  411 (554)
Q Consensus       335 ---~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~D  411 (554)
                         .+..++||||+++++|.+++.......+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEee
Confidence               467899999999999999998765567899999999999999999999   88999999999999999999999999


Q ss_pred             ecCcccCCCCCCCccccccccCCCCCcChhccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH
Q 042763          412 FGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK-----TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWA  486 (554)
Q Consensus       412 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~  486 (554)
                      ||++......   ........||+.|+|||++.     +..++.++||||||+++|+|++|+.||..........   ..
T Consensus       173 fg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~  246 (326)
T 2x7f_A          173 FGVSAQLDRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---LI  246 (326)
T ss_dssp             CTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HH
T ss_pred             CcCceecCcC---ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH---Hh
Confidence            9999764321   11223456899999999987     5678999999999999999999999997654322211   11


Q ss_pred             HHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          487 FKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                       .....   ...        ....++..+.+++.+||+.||++||++.+++++.|--
T Consensus       247 -~~~~~---~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~  291 (326)
T 2x7f_A          247 -PRNPA---PRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR  291 (326)
T ss_dssp             -HHSCC---CCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred             -hcCcc---ccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence             11111   000        0112345688999999999999999999999987643

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.9e-42  Score=342.84  Aligned_cols=257  Identities=23%  Similarity=0.377  Sum_probs=202.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|.....||+|+||+||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            34555668999999999999764 68899999987653 33456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC-CCcEEEEeecCcccCCCCC
Q 042763          345 VPNGTLREHLDGQYG-KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE-SMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~~~~~~~  422 (554)
                      +++++|.+++..... ..+++..++.++.|++.||+|||   +.+++||||||+||+++. ++.+||+|||+++..... 
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-  176 (295)
T 2clq_A          101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-  176 (295)
T ss_dssp             CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC-
Confidence            999999999976532 35678889999999999999999   889999999999999987 899999999999864321 


Q ss_pred             CCccccccccCCCCCcChhccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQ--LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                        ........||+.|+|||++.+..  ++.++||||||+++|||++|+.||........... . .......        
T Consensus       177 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~-~~~~~~~--------  244 (295)
T 2clq_A          177 --NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-K-VGMFKVH--------  244 (295)
T ss_dssp             ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH-H-HHHHCCC--------
T ss_pred             --CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH-h-hcccccc--------
Confidence              11223456899999999997643  88999999999999999999999975443322111 1 0000000        


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      +.    .+..++..+.+++.+||+.||++||++.+++++.|--
T Consensus       245 ~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~  283 (295)
T 2clq_A          245 PE----IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK  283 (295)
T ss_dssp             CC----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGC
T ss_pred             cc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence            11    1223345688999999999999999999999887643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.7e-42  Score=364.21  Aligned_cols=258  Identities=26%  Similarity=0.370  Sum_probs=198.1

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-------hHHHHHHHHHHHHHhCCCCCceeeeeEEEcC
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-------NLQTEFSSEVELLSKIDHRNLVKLLGFVDKG  335 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-------~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  335 (554)
                      ..++|...++||+|+||+||+|... +++.||||++......       .....+.+|++++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            3578999999999999999999765 5899999998765321       122358899999999999999999999865 


Q ss_pred             CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC---cEEEEee
Q 042763          336 NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM---RAKVADF  412 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~---~vkl~Df  412 (554)
                      +..++||||+++|+|.+++...  ..+++.+++.++.|++.||+|||   +++|+||||||+|||++.++   .+||+||
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence            5579999999999999998654  57899999999999999999999   88999999999999997544   5999999


Q ss_pred             cCcccCCCCCCCccccccccCCCCCcChhcccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHh
Q 042763          413 GFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT---YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR  489 (554)
Q Consensus       413 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~  489 (554)
                      |+++....    ........||+.|+|||++.+   ..++.++|||||||++|||++|+.||...........  ..   
T Consensus       287 G~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~--~i---  357 (419)
T 3i6u_A          287 GHSKILGE----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD--QI---  357 (419)
T ss_dssp             STTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHH--HH---
T ss_pred             ccceecCC----CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHH--HH---
Confidence            99986432    222344679999999999853   5788999999999999999999999976543322111  10   


Q ss_pred             hccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          490 YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                       .....  ...+...    ..++..+.+++.+||+.||++|||+.|+++|.|--
T Consensus       358 -~~~~~--~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  404 (419)
T 3i6u_A          358 -TSGKY--NFIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ  404 (419)
T ss_dssp             -HTTCC--CCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             -hcCCC--CCCchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccC
Confidence             11110  0011111    12345688999999999999999999999998853

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.6e-43  Score=366.70  Aligned_cols=245  Identities=16%  Similarity=0.149  Sum_probs=191.8

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh--hhHHHHHHHHHH---HHHhCCCCCceeee-------eE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF--ENLQTEFSSEVE---LLSKIDHRNLVKLL-------GF  331 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~~Ei~---~l~~l~HpnIv~l~-------~~  331 (554)
                      .++|...+.||+|+||+||+|.. .+|+.||||++.....  ....+.+.+|++   ++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999986 4699999999875321  334577899994   55556899999998       66


Q ss_pred             EEcCCc-----------------eEEEEEeCCCCCHHHHHhcccC-----CCCCHHHHHHHHHHHHHHHHHhhhccCCCe
Q 042763          332 VDKGNE-----------------RLIITEFVPNGTLREHLDGQYG-----KTLDFNQRLEIAIDVAHGLTYLHLYAEKQI  389 (554)
Q Consensus       332 ~~~~~~-----------------~~lv~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i  389 (554)
                      +...+.                 .++||||+ +|+|.+++.....     ..+++..++.++.||+.||+|||   +++|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            665532                 78999999 6899999976421     12335888899999999999999   8899


Q ss_pred             EeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccC-----------CCCchhhHHHHH
Q 042763          390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY-----------QLTTKSDVYSFG  458 (554)
Q Consensus       390 vH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~s~ksDVwSlG  458 (554)
                      +||||||+|||++.++.+||+|||+++...      .......| +.|+|||++.+.           .++.++||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETT------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecC------CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            999999999999999999999999998522      12334567 999999999887           899999999999


Q ss_pred             HHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 042763          459 VLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGE  538 (554)
Q Consensus       459 vil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  538 (554)
                      |++|||++|+.||..........               ....      ....++..+.+++.+||+.||++|||+.|+++
T Consensus       301 ~il~elltg~~Pf~~~~~~~~~~---------------~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGGSE---------------WIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHHSSCCC------CCSG---------------GGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHHCCCCCcccccccchh---------------hhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999999997543211100               0000      00123456889999999999999999999998


Q ss_pred             HHH
Q 042763          539 QLW  541 (554)
Q Consensus       539 ~l~  541 (554)
                      +.|
T Consensus       360 hp~  362 (377)
T 3byv_A          360 TPE  362 (377)
T ss_dssp             SHH
T ss_pred             ChH
Confidence            755

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.8e-42  Score=382.30  Aligned_cols=261  Identities=24%  Similarity=0.304  Sum_probs=214.4

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~  339 (554)
                      ..++|...++||+|+||+||+|... +++.||||++++...  ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3468999999999999999999765 588999999986532  23346788999999988 7999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +||||+++|+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       419 lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            999999999999999865  57999999999999999999999   8999999999999999999999999999998632


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ..   .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......+...   .    ......    
T Consensus       494 ~~---~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~---~----i~~~~~----  559 (674)
T 3pfq_A          494 WD---GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ---S----IMEHNV----  559 (674)
T ss_dssp             CT---TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---H----HHSSCC----
T ss_pred             cC---CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH---H----HHhCCC----
Confidence            22   122345689999999999999999999999999999999999999998754332211   1    111111    


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHHhhhhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDM-----KSVGEQLWAIRADSLK  549 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~l~~i~~~~~~  549 (554)
                            .++..+...+.+|+.+||+.||++||++     .||++|.|--.-+|.+
T Consensus       560 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~  608 (674)
T 3pfq_A          560 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  608 (674)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred             ------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence                  0122345668999999999999999998     8998887654444433

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.7e-42  Score=348.49  Aligned_cols=272  Identities=24%  Similarity=0.321  Sum_probs=208.9

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEE--cCCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhC---CCCCceeeeeEEE---
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQL--EDGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKI---DHRNLVKLLGFVD---  333 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~--~~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~---  333 (554)
                      ...++|...+.||+|+||+||+|..  .+|+.||+|++...... .....+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            4567899999999999999999987  36889999998754322 1123466777777666   8999999999986   


Q ss_pred             --cCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEe
Q 042763          334 --KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVAD  411 (554)
Q Consensus       334 --~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~D  411 (554)
                        .....++||||++ |+|.+++.......+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence              5567899999996 79999998776667999999999999999999999   88999999999999999999999999


Q ss_pred             ecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhc
Q 042763          412 FGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN  491 (554)
Q Consensus       412 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~  491 (554)
                      ||+++...    .........||+.|+|||++.+..++.++||||||+++|||++|+.||...........+........
T Consensus       164 fg~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (326)
T 1blx_A          164 FGLARIYS----FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  239 (326)
T ss_dssp             CCSCCCCC----GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             Cccccccc----CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99997632    12223446789999999999998999999999999999999999999987654333222211111000


Q ss_pred             cCCccccC----------ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          492 EGNLLDMV----------DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       492 ~~~~~~~~----------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ........          ...........++..+.+++.+||+.||++|||+.|++++.|-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  300 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  300 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccc
Confidence            00000000          0000111223445678999999999999999999999988663

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.2e-42  Score=355.94  Aligned_cols=263  Identities=21%  Similarity=0.321  Sum_probs=210.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhH----------------HHHHHHHHHHHHhCCCCCceee
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENL----------------QTEFSSEVELLSKIDHRNLVKL  328 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~----------------~~~~~~Ei~~l~~l~HpnIv~l  328 (554)
                      .++|...+.||+|+||.||+|.. +|+.||||++........                .+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999988 899999999986643211                1689999999999999999999


Q ss_pred             eeEEEcCCceEEEEEeCCCCCHHHH------HhcccCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCeEeCCCCCCCeEE
Q 042763          329 LGFVDKGNERLIITEFVPNGTLREH------LDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE-KQIIHRDVKSSNILL  401 (554)
Q Consensus       329 ~~~~~~~~~~~lv~E~~~~g~L~~~------l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-~~ivH~Dlkp~NILl  401 (554)
                      ++++.+++..++||||+++++|.++      +.......+++..++.++.|++.||.|||   + ++|+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999999      66544578999999999999999999999   6 999999999999999


Q ss_pred             CCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCChhh
Q 042763          402 TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY-QLTT-KSDVYSFGVLLLEILTGRRPVELKRPPEE  479 (554)
Q Consensus       402 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~-ksDVwSlGvil~elltg~~P~~~~~~~~~  479 (554)
                      +.++.+||+|||++......     ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||........
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             cCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            99999999999999864321     23445799999999999887 6766 99999999999999999999987655222


Q ss_pred             HHHHHHHHHhhccCCccc------cC---ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          480 RVTLRWAFKRYNEGNLLD------MV---DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~------~~---d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .  ...    ........      ..   .+.........++..+.+++.+||+.||++|||+.|++++.|-
T Consensus       261 ~--~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f  326 (348)
T 2pml_X          261 L--FNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL  326 (348)
T ss_dssp             H--HHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred             H--HHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence            1  111    11111100      00   0000011113345678999999999999999999999998653

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=362.12  Aligned_cols=270  Identities=21%  Similarity=0.270  Sum_probs=188.7

Q ss_pred             CCCc-ceeeeccCceEEEEEEEc---CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEE--cCCceEE
Q 042763          267 NFSP-SLRIGEGGFGTVYKAQLE---DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD--KGNERLI  340 (554)
Q Consensus       267 ~f~~-~~~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~--~~~~~~l  340 (554)
                      .|.. .++||+|+||+||+|...   +++.||||++.....   ...+.+|+++|++++||||+++++++.  .+...++
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            3544 457999999999999865   478999999976532   246789999999999999999999994  4678899


Q ss_pred             EEEeCCCCCHHHHHhccc-------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE----CCCCcEEE
Q 042763          341 ITEFVPNGTLREHLDGQY-------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL----TESMRAKV  409 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl----~~~~~vkl  409 (554)
                      ||||++ ++|.+++....       ...+++..++.++.||+.||+|||   +.+|+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999995 68888875321       225899999999999999999999   8899999999999999    77899999


Q ss_pred             EeecCcccCCCCCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChh------hHHH
Q 042763          410 ADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPE------ERVT  482 (554)
Q Consensus       410 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~------~~~~  482 (554)
                      +|||+++................||+.|+|||++.+. .++.++|||||||++|||++|+.||.......      ....
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            9999998754332222334456799999999999874 58999999999999999999999997654321      1112


Q ss_pred             HHHHHHhhccCCc--cccCCh-----hh--------hhh---------ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 042763          483 LRWAFKRYNEGNL--LDMVDP-----SI--------KEV---------ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGE  538 (554)
Q Consensus       483 ~~~~~~~~~~~~~--~~~~d~-----~l--------~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  538 (554)
                      +............  +..+..     .+        ...         ........+.+|+.+||+.||++|||+.|+++
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            2222222111110  000000     00        000         00001346789999999999999999999999


Q ss_pred             HHHHh
Q 042763          539 QLWAI  543 (554)
Q Consensus       539 ~l~~i  543 (554)
                      |.|-.
T Consensus       334 hp~f~  338 (405)
T 3rgf_A          334 DPYFL  338 (405)
T ss_dssp             SGGGT
T ss_pred             Chhhc
Confidence            98864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=351.01  Aligned_cols=256  Identities=17%  Similarity=0.174  Sum_probs=206.7

Q ss_pred             HhhcCCCcceeeeccCceEEEEEE------EcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC---CCCceeeeeEEE
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQ------LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID---HRNLVKLLGFVD  333 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~------~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~  333 (554)
                      ...++|.+.++||+|+||+||+|.      ..+++.||||++....    ..++.+|++++++++   |+||+++++++.
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            345789999999999999999993      4568999999997653    346778888888887   999999999999


Q ss_pred             cCCceEEEEEeCCCCCHHHHHhcc---cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC-------
Q 042763          334 KGNERLIITEFVPNGTLREHLDGQ---YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE-------  403 (554)
Q Consensus       334 ~~~~~~lv~E~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~-------  403 (554)
                      .++..++|||||++|+|.+++...   ....+++.+++.++.||+.||+|||   +++|+||||||+|||++.       
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC--
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccc
Confidence            999999999999999999999753   2457999999999999999999999   899999999999999998       


Q ss_pred             ----CCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhh
Q 042763          404 ----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEE  479 (554)
Q Consensus       404 ----~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~  479 (554)
                          ++.+||+|||+|+..... .........+||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  293 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLF-PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC  293 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGS-CTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred             cccccCCEEEeeCchhhhhhcc-CCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence                899999999999753222 122334456799999999999999999999999999999999999999864322110


Q ss_pred             HHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHHhhhhh
Q 042763          480 RVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDR-PDMKSVGEQLWAIRADS  547 (554)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~l~~i~~~~  547 (554)
                                        .........   .....+.+++..|++.+|.+| |++.++.+.|.++....
T Consensus       294 ------------------~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          294 ------------------KPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             ------------------EECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ------------------eechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                              000111111   123457789999999999988 67888888887766553

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.9e-42  Score=362.76  Aligned_cols=263  Identities=23%  Similarity=0.297  Sum_probs=199.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC----C--ce
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG----N--ER  338 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~----~--~~  338 (554)
                      .+|...+.||+|+||+||+|... +|+.||||++....     ....+|++++++++||||+++++++...    +  ..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            46888999999999999999875 58999999986543     2234799999999999999999988432    1  35


Q ss_pred             EEEEEeCCCCCHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC-CcEEEEeecCc
Q 042763          339 LIITEFVPNGTLREHLDG--QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES-MRAKVADFGFA  415 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkl~DfGla  415 (554)
                      ++||||++ ++|.+.+..  .....+++..++.++.||+.||+|||   +++|+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            78999996 477766643  22457899999999999999999999   8999999999999999965 67899999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH-------
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF-------  487 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~-------  487 (554)
                      +......    ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+....       
T Consensus       205 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          205 KQLVRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             EECCTTC----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             hhcccCC----CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            8643221    12345789999999998764 79999999999999999999999998765433322221110       


Q ss_pred             -HhhccCCccc-----cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          488 -KRYNEGNLLD-----MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       488 -~~~~~~~~~~-----~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                       ... .....+     .........+.......+.+|+.+||+.||++||++.|+++|.|-
T Consensus       281 ~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f  340 (420)
T 1j1b_A          281 IREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  340 (420)
T ss_dssp             HHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence             000 111111     111112222333445678999999999999999999999998764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.7e-42  Score=349.89  Aligned_cols=261  Identities=25%  Similarity=0.313  Sum_probs=190.1

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEE--------
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVD--------  333 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~--------  333 (554)
                      ...+|...++||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++++. ||||+++++++.        
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            3468899999999999999999865 68999999986553 333567899999999996 999999999984        


Q ss_pred             cCCceEEEEEeCCCCCHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eEeCCCCCCCeEECCCCcEEEE
Q 042763          334 KGNERLIITEFVPNGTLREHLDGQ-YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ--IIHRDVKSSNILLTESMRAKVA  410 (554)
Q Consensus       334 ~~~~~~lv~E~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NILl~~~~~vkl~  410 (554)
                      .....++||||+ +|+|.+++... ....+++.+++.++.||+.||+|||   +.+  |+||||||+|||++.++.+||+
T Consensus       105 ~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          105 GQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             SSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             CCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEe
Confidence            334479999999 58999998753 2346999999999999999999999   888  9999999999999999999999


Q ss_pred             eecCcccCCCCCCCc---------cccccccCCCCCcChhcc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChh
Q 042763          411 DFGFARLGPMDSDRT---------HISTKVKGTVGYLDPEYM---KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPE  478 (554)
Q Consensus       411 DfGla~~~~~~~~~~---------~~~~~~~gt~~y~aPE~l---~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~  478 (554)
                      |||+++.........         .......||+.|+|||++   .+..++.++||||||+++|||++|+.||.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            999998754322211         111134589999999998   56678999999999999999999999997533211


Q ss_pred             hHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          479 ERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                      .      .......         .    ........+.+++.+||+.||++|||+.|++++|+++.....
T Consensus       261 ~------~~~~~~~---------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          261 I------VNGKYSI---------P----PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             -----------CCC---------C----TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             h------hcCcccC---------C----cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence            0      0000000         0    001112347789999999999999999999999999987543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=348.68  Aligned_cols=270  Identities=21%  Similarity=0.281  Sum_probs=198.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEE----------
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVD----------  333 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~----------  333 (554)
                      .++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            468999999999999999999876 48999999987553 334567899999999999999999999873          


Q ss_pred             ----cCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC-CCCcEE
Q 042763          334 ----KGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT-ESMRAK  408 (554)
Q Consensus       334 ----~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~-~~~~vk  408 (554)
                          +....++||||++ |+|.+++..   ..+++..++.++.|++.||+|||   +++|+||||||+|||++ +++.+|
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEE
Confidence                3467799999996 799999965   36899999999999999999999   88999999999999997 577999


Q ss_pred             EEeecCcccCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 042763          409 VADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF  487 (554)
Q Consensus       409 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~  487 (554)
                      |+|||+++................+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999999865322222222334467999999998865 679999999999999999999999998765433222111100


Q ss_pred             HhhccC---CccccCChhh----------hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          488 KRYNEG---NLLDMVDPSI----------KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       488 ~~~~~~---~~~~~~d~~l----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ......   .....+....          .......++..+.+++.+||+.||++|||+.|++++.|-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  309 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM  309 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence            000000   0000000000          000112345678999999999999999999999998874

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.2e-42  Score=359.07  Aligned_cols=264  Identities=21%  Similarity=0.275  Sum_probs=201.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc------e
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE------R  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~------~  338 (554)
                      ..+|...++||+|+||+||+|....+..||+|++.....     ...+|+++++.++||||+++++++...+.      .
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            357889999999999999999987777799998865431     22469999999999999999999855433      7


Q ss_pred             EEEEEeCCCCCHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC-CCCcEEEEeecCc
Q 042763          339 LIITEFVPNGTLREHLDG--QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT-ESMRAKVADFGFA  415 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~-~~~~vkl~DfGla  415 (554)
                      ++||||++++ +.+.+..  .....+++..++.++.||+.||+|||   +++|+||||||+|||++ .++.+||+|||++
T Consensus       114 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          114 NLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            8999999754 4443331  22457899999999999999999999   89999999999999999 7999999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH-------
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF-------  487 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~-------  487 (554)
                      +......    ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+....       
T Consensus       190 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          190 KILIAGE----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ  265 (394)
T ss_dssp             EECCTTC----CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccccCCC----CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            8643221    22345689999999998764 58999999999999999999999998765433322221110       


Q ss_pred             -----HhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          488 -----KRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       488 -----~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                           ..+.+..............+.......+.+++.+||+.||++|||+.|+++|.|
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  324 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF  324 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence                 011111111111222222333345567999999999999999999999999866

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.9e-42  Score=358.00  Aligned_cols=260  Identities=11%  Similarity=0.014  Sum_probs=187.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhC--CCCCceeee-------eEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKI--DHRNLVKLL-------GFV  332 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l--~HpnIv~l~-------~~~  332 (554)
                      ..+|...++||+|+||+||+|... +|+.||||++.....  ....+.+.+|+.+++.|  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345888999999999999999865 689999999987542  23446677885544444  699987754       444


Q ss_pred             EcC-----------------CceEEEEEeCCCCCHHHHHhcccCCCCCHHHH------HHHHHHHHHHHHHhhhccCCCe
Q 042763          333 DKG-----------------NERLIITEFVPNGTLREHLDGQYGKTLDFNQR------LEIAIDVAHGLTYLHLYAEKQI  389 (554)
Q Consensus       333 ~~~-----------------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~------~~i~~qi~~~L~~LH~~~~~~i  389 (554)
                      ...                 ...++|||||+ |+|.+++.... ..+.+..+      +.++.||+.||+|||   +++|
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~i  215 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQ---SKGL  215 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCC
Confidence            433                 23799999998 99999998642 24456666      788899999999999   8999


Q ss_pred             EeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhcccc--CCCCchhhHHHHHHHHHHHHhC
Q 042763          390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT--YQLTTKSDVYSFGVLLLEILTG  467 (554)
Q Consensus       390 vH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvil~elltg  467 (554)
                      +||||||+|||++.++.+||+|||+++....      ......+|+.|+|||++.+  ..++.++|||||||++|||++|
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTC------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCC------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            9999999999999999999999999986421      1113457799999999987  6799999999999999999999


Q ss_pred             CCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          468 RRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       468 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      +.||.........        ......................++..+.+++.+||+.||++|||+.++++|.|--
T Consensus       290 ~~Pf~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  357 (371)
T 3q60_A          290 FLPFGLVTPGIKG--------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL  357 (371)
T ss_dssp             SCSTTBCCTTCTT--------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred             CCCCCCcCccccc--------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence            9999866432111        0000000000011111001123456789999999999999999999999987643

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=343.97  Aligned_cols=256  Identities=25%  Similarity=0.360  Sum_probs=204.5

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ..++|+..+.||+|+||.||+|... +|+.||||++....   ..+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            3567999999999999999999776 58999999987643   2357889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++++|.+++... ...+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++...... 
T Consensus       104 e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (314)
T 3com_A          104 EYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-  178 (314)
T ss_dssp             ECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT-
T ss_pred             ecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh-
Confidence            999999999999743 357899999999999999999999   899999999999999999999999999999764321 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                        ........||+.|+|||++.+..++.++||||||+++|+|++|+.||..........    .........   ..   
T Consensus       179 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~---~~---  246 (314)
T 3com_A          179 --MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF----MIPTNPPPT---FR---  246 (314)
T ss_dssp             --BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSCCCC---CS---
T ss_pred             --ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH----HHhcCCCcc---cC---
Confidence              122234568999999999999999999999999999999999999998654322211    111111100   00   


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                          .+..++..+.+++.+||+.||++|||+.+++++.|--
T Consensus       247 ----~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~  283 (314)
T 3com_A          247 ----KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR  283 (314)
T ss_dssp             ----SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             ----CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence                1112345688999999999999999999999987754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.3e-41  Score=340.47  Aligned_cols=256  Identities=23%  Similarity=0.311  Sum_probs=207.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhh--------hhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQ--------FENLQTEFSSEVELLSKID-HRNLVKLLGFVDK  334 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--------~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~  334 (554)
                      .++|...+.||+|+||.||+|... +|+.||||++....        .....+.+.+|+++++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468999999999999999999775 58999999986542        1234567889999999995 9999999999999


Q ss_pred             CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecC
Q 042763          335 GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGF  414 (554)
Q Consensus       335 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl  414 (554)
                      ++..++||||+++++|.+++...  ..+++.+++.++.|++.||+|||   +++++||||||+||+++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            99999999999999999999765  57899999999999999999999   88999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMK------TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFK  488 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~  488 (554)
                      +......    .......|++.|+|||++.      ...++.++||||||+++|||++|+.||.........   .....
T Consensus       171 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~  243 (298)
T 1phk_A          171 SCQLDPG----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML---RMIMS  243 (298)
T ss_dssp             CEECCTT----CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHH
T ss_pred             hhhcCCC----cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH---HHHhc
Confidence            9864322    1223456899999999885      456889999999999999999999999765432211   11111


Q ss_pred             hhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          489 RYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       489 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                          ... ....+.     ...++..+.+++.+||+.||++|||+.|++++.|-
T Consensus       244 ----~~~-~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (298)
T 1phk_A          244 ----GNY-QFGSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF  287 (298)
T ss_dssp             ----TCC-CCCTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred             ----CCc-ccCccc-----ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHh
Confidence                110 000111     11234568899999999999999999999998763

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.3e-42  Score=358.25  Aligned_cols=261  Identities=22%  Similarity=0.308  Sum_probs=189.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC------C
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG------N  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------~  336 (554)
                      .++|...+.||+|+||.||+|.. .+|+.||||++..... ....+.+.+|++++++++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            47899999999999999999975 4689999999865432 23456788999999999999999999998654      5


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ..++||||+ +++|.+++..   ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            679999999 7899999865   36899999999999999999999   8999999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC-
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN-  494 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-  494 (554)
                      ....      ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+.   ....... 
T Consensus       181 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~---~~~g~p~~  251 (367)
T 2fst_X          181 HTAD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA  251 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCSCCH
T ss_pred             cccc------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHhCCCCH
Confidence            6321      1234579999999999877 679999999999999999999999998765433322221   1111110 


Q ss_pred             --ccccCCh---------------hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          495 --LLDMVDP---------------SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       495 --~~~~~d~---------------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                        +......               ..... .......+.+|+.+||+.||++|||+.|+++|.|-
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~  315 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF  315 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHH-TTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHH-CCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhh
Confidence              0000000               00000 01234568899999999999999999999998763

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4e-42  Score=346.74  Aligned_cols=256  Identities=25%  Similarity=0.365  Sum_probs=201.9

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            3468999999999999999999876 58999999987654 233567899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+++++|.+++... ...+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++....   
T Consensus        96 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~---  168 (302)
T 2j7t_A           96 EFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL---  168 (302)
T ss_dssp             ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH---
T ss_pred             EeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccc---
Confidence            999999999998753 356899999999999999999999   8899999999999999999999999999875311   


Q ss_pred             CCccccccccCCCCCcChhcc-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          423 DRTHISTKVKGTVGYLDPEYM-----KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l-----~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                      ..........||+.|+|||++     .+..++.++||||||+++|||++|+.||..........   .... ...   ..
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~-~~~---~~  241 (302)
T 2j7t_A          169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL---KIAK-SDP---PT  241 (302)
T ss_dssp             HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHH-SCC---CC
T ss_pred             ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH---HHhc-cCC---cc
Confidence            011112234689999999998     36678999999999999999999999998654322211   1111 110   00


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ..       .+..++..+.+++.+||+.||++|||+.+++++.|
T Consensus       242 ~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  278 (302)
T 2j7t_A          242 LL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF  278 (302)
T ss_dssp             CS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred             cC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence            00       11223456889999999999999999999998765

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.1e-41  Score=352.62  Aligned_cols=262  Identities=20%  Similarity=0.291  Sum_probs=203.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCce----
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNER----  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~----  338 (554)
                      .++|...+.||+|+||+||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            478999999999999999999765 689999999976432 33457789999999999999999999999877655    


Q ss_pred             --EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          339 --LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       339 --~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                        ++||||++ ++|.+++..    .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence              99999995 788888743    4899999999999999999999   8899999999999999999999999999997


Q ss_pred             cCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      ....      ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+........ ...
T Consensus       193 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~  265 (371)
T 4exu_A          193 HADA------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG-TEF  265 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-HHH
T ss_pred             cccc------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc-HHH
Confidence            5322      1234568999999999887 6899999999999999999999999987654333222211110000 000


Q ss_pred             cccC-C---------------hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          496 LDMV-D---------------PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       496 ~~~~-d---------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ...+ +               ..... ....+...+.+++.+||+.||++|||+.|++++.|-
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  327 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF  327 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHH-hccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence            0000 0               00000 112235678999999999999999999999999774

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7.7e-41  Score=359.35  Aligned_cols=266  Identities=17%  Similarity=0.282  Sum_probs=212.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCC-CCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH-RNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~~lv~  342 (554)
                      .++|.+.++||+|+||.||+|.. .+++.||||++......   ..+.+|+++++.++| +++..+..++..++..++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            46899999999999999999976 46899999987655322   357899999999987 55666666777888889999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE---CCCCcEEEEeecCcccCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL---TESMRAKVADFGFARLGP  419 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl---~~~~~vkl~DfGla~~~~  419 (554)
                      ||+ +++|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+|||+   +.++.+||+|||+++...
T Consensus        83 e~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            999 99999999743 357999999999999999999999   8899999999999999   588999999999998754


Q ss_pred             CCCCCc----cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          420 MDSDRT----HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       420 ~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      ......    .......||+.|+|||++.+..++.++|||||||+||||++|+.||...........+............
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            332221    1223567999999999999999999999999999999999999999876654443333322221111100


Q ss_pred             cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          496 LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       496 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                           ..    ....++..+.+++.+||+.+|++||++.+|++.|+++....
T Consensus       238 -----~~----l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          238 -----EA----LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             -----HH----HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -----HH----HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence                 00    11123467899999999999999999999999999886643

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.4e-41  Score=344.86  Aligned_cols=256  Identities=27%  Similarity=0.375  Sum_probs=200.8

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-------hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-------ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-------~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  336 (554)
                      .++|.+.+.||+|+||.||+|... +++.||||++.....       ......+.+|++++++++||||+++++++..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            467899999999999999999765 589999999875432       122345889999999999999999999987654


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc---EEEEeec
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR---AKVADFG  413 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~---vkl~DfG  413 (554)
                       .++||||+++++|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.   +||+|||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             -eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence             89999999999999999754  57899999999999999999999   889999999999999987664   9999999


Q ss_pred             CcccCCCCCCCccccccccCCCCCcChhccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhh
Q 042763          414 FARLGPMDSDRTHISTKVKGTVGYLDPEYMK---TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY  490 (554)
Q Consensus       414 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  490 (554)
                      +++....    ........||+.|+|||++.   ...++.++||||||+++|||++|..||..........  ....   
T Consensus       163 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~---  233 (322)
T 2ycf_A          163 HSKILGE----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK--DQIT---  233 (322)
T ss_dssp             TCEECCC----CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH--HHHH---
T ss_pred             cceeccc----ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHH--HHHH---
Confidence            9986432    12223456999999999974   4678999999999999999999999997654432211  1110   


Q ss_pred             ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                       ....  ...+...    ..++..+.+++.+||+.||++||++.+++++.|-
T Consensus       234 -~~~~--~~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~  278 (322)
T 2ycf_A          234 -SGKY--NFIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL  278 (322)
T ss_dssp             -HTCC--CCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             -hCcc--ccCchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCc
Confidence             0000  0111111    1234568899999999999999999999988664

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.5e-41  Score=344.64  Aligned_cols=267  Identities=21%  Similarity=0.264  Sum_probs=208.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CC-cEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCC------ceeeeeEEEcCC
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DG-LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRN------LVKLLGFVDKGN  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g-~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn------Iv~l~~~~~~~~  336 (554)
                      .++|.+.+.||+|+||+||+|... ++ +.||+|+++...  ...+.+.+|++++++++|++      ++.+++++...+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            468999999999999999999764 34 789999997542  33467888999999987665      899999999999


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE---------------
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL---------------  401 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl---------------  401 (554)
                      ..++||||+ +++|.+++.......+++.+++.++.||+.||+|||   +++|+||||||+|||+               
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccc
Confidence            999999999 788888887765567999999999999999999999   8999999999999999               


Q ss_pred             ----CCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCh
Q 042763          402 ----TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPP  477 (554)
Q Consensus       402 ----~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~  477 (554)
                          +.++.+||+|||+++.....      .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                56789999999999863221      23456999999999999999999999999999999999999999876544


Q ss_pred             hhHHHHHHHHHhh--------ccCCc-------cccCChh------------hhhhccHHHHHHHHHHHHHccCCCCCCC
Q 042763          478 EERVTLRWAFKRY--------NEGNL-------LDMVDPS------------IKEVISMEILTKMFGLAIQCAAPIRNDR  530 (554)
Q Consensus       478 ~~~~~~~~~~~~~--------~~~~~-------~~~~d~~------------l~~~~~~~~~~~l~~li~~cl~~dP~~R  530 (554)
                      +....+.......        .....       +......            ............+.+++.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            3322222211100        00000       0000000            0001122345678999999999999999


Q ss_pred             CCHHHHHHHHHHh
Q 042763          531 PDMKSVGEQLWAI  543 (554)
Q Consensus       531 Ps~~evl~~l~~i  543 (554)
                      ||+.|+++|.|--
T Consensus       326 pt~~e~l~hp~f~  338 (355)
T 2eu9_A          326 ITLAEALLHPFFA  338 (355)
T ss_dssp             CCHHHHTTSGGGG
T ss_pred             cCHHHHhcChhhc
Confidence            9999999887643

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.8e-40  Score=345.44  Aligned_cols=269  Identities=21%  Similarity=0.215  Sum_probs=207.5

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CC-----CceeeeeEEEcCC
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HR-----NLVKLLGFVDKGN  336 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-Hp-----nIv~l~~~~~~~~  336 (554)
                      ..++|.+.++||+|+||+||+|... +++.||||+++...  ....++.+|+.+++.++ |+     +|+++++++...+
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            3578999999999999999999765 68899999997543  33466788888888875 55     4999999999999


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC--CCCcEEEEeecC
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT--ESMRAKVADFGF  414 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~--~~~~vkl~DfGl  414 (554)
                      ..++||||++ ++|.+++.......+++..++.++.|++.||.|||.. ..+|+||||||+|||++  .++.+||+|||+
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            9999999995 6999999877656799999999999999999999932 46899999999999995  578899999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhc---
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYN---  491 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~---  491 (554)
                      ++.....      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+........   
T Consensus       208 a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  281 (382)
T 2vx3_A          208 SCQLGQR------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI  281 (382)
T ss_dssp             CEETTCC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ceecccc------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9864321      2345789999999999999999999999999999999999999987654433222221110000   


Q ss_pred             ---------------cCCcc---------ccCCh---hhhh-----------------hccHHHHHHHHHHHHHccCCCC
Q 042763          492 ---------------EGNLL---------DMVDP---SIKE-----------------VISMEILTKMFGLAIQCAAPIR  527 (554)
Q Consensus       492 ---------------~~~~~---------~~~d~---~l~~-----------------~~~~~~~~~l~~li~~cl~~dP  527 (554)
                                     ...+.         ....+   .+..                 .........+.+|+.+||+.||
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence                           00000         00000   0000                 0112334578999999999999


Q ss_pred             CCCCCHHHHHHHHHH
Q 042763          528 NDRPDMKSVGEQLWA  542 (554)
Q Consensus       528 ~~RPs~~evl~~l~~  542 (554)
                      ++|||+.|+++|.|-
T Consensus       362 ~~Rpta~e~L~hp~f  376 (382)
T 2vx3_A          362 KTRIQPYYALQHSFF  376 (382)
T ss_dssp             TTSCCHHHHTTSGGG
T ss_pred             hhCCCHHHHhcCccc
Confidence            999999999998774

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=9.7e-42  Score=346.24  Aligned_cols=262  Identities=21%  Similarity=0.314  Sum_probs=203.6

Q ss_pred             HHHHhhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCC--CCCceeeeeEEEcCC
Q 042763          260 QVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKID--HRNLVKLLGFVDKGN  336 (554)
Q Consensus       260 ~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~~  336 (554)
                      .+....++|.+.+.||+|+||.||+|...+++.||||++..... ....+.+.+|++++++++  ||||+++++++.+++
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            34445678999999999999999999888899999999865432 334577899999999997  599999999999999


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ..++||| +.+++|.+++...  ..+++.+++.++.|++.||.|||   +.+|+||||||+|||+++ +.+||+|||+++
T Consensus       102 ~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~  174 (313)
T 3cek_A          102 YIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIAN  174 (313)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred             EEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccc
Confidence            9999999 5589999999765  57899999999999999999999   889999999999999964 899999999998


Q ss_pred             cCCCCCCCccccccccCCCCCcChhcccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKT-----------YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRW  485 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~  485 (554)
                      ....... ........||+.|+|||++.+           ..++.++||||||+++|||++|+.||.........  ...
T Consensus       175 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~  251 (313)
T 3cek_A          175 QMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--LHA  251 (313)
T ss_dssp             C---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--HHH
T ss_pred             cccCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH--HHH
Confidence            6432211 112234568999999999875           47889999999999999999999999765432211  111


Q ss_pred             HHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          486 AFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       486 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                         .........         .+......+.+++.+||+.||++||++.|++++.|--
T Consensus       252 ---~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~  297 (313)
T 3cek_A          252 ---IIDPNHEIE---------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  297 (313)
T ss_dssp             ---HHCTTSCCC---------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             ---HHhcccccC---------CcccchHHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence               111111000         1111235688999999999999999999999998753

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.9e-41  Score=373.65  Aligned_cols=261  Identities=27%  Similarity=0.416  Sum_probs=210.1

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc----CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      ..++|...+.||+|+||+||+|.+.    .+..||||++.........+.+.+|+.++++++||||+++++++. ++..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            3467888999999999999999764    256899999877655556678999999999999999999999985 46789


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +||||+++|+|.+++... ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       467 lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            999999999999999754 346899999999999999999999   8899999999999999999999999999998643


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ..  .........+|+.|+|||++.+..++.++||||||+++|||++ |..||......+..   .....    ..... 
T Consensus       543 ~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~---~~i~~----~~~~~-  612 (656)
T 2j0j_A          543 DS--TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIEN----GERLP-  612 (656)
T ss_dssp             C------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHH----TCCCC-
T ss_pred             CC--cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHc----CCCCC-
Confidence            22  1122233457889999999999999999999999999999997 99999865433221   11111    11000 


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                              .+..++..+.+++.+||+.||++|||+.+|++.|.++..+.
T Consensus       613 --------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          613 --------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence                    12234466889999999999999999999999999987653

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.5e-41  Score=343.49  Aligned_cols=263  Identities=23%  Similarity=0.348  Sum_probs=186.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHH-HHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVE-LLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .++|...+.||+|+||.||+|... +|+.||||++...........+..|+. +++.++||||+++++++.+++..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            367888999999999999999775 689999999976544444455666666 677789999999999999999999999


Q ss_pred             EeCCCCCHHHHHhc---ccCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          343 EFVPNGTLREHLDG---QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK-QIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       343 E~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ||++ ++|.+++..   .....+++..++.++.|++.||.|||   +. +|+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            9996 588887763   22467899999999999999999999   77 9999999999999999999999999999764


Q ss_pred             CCCCCCccccccccCCCCCcChhcc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYM----KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      ...    .......||+.|+|||++    .+..++.++||||||+++|||++|+.||.........      ....... 
T Consensus       177 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~-  245 (327)
T 3aln_A          177 VDS----IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------LTQVVKG-  245 (327)
T ss_dssp             ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCS-
T ss_pred             ccc----cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH------HHHHhcC-
Confidence            321    122234699999999998    4567899999999999999999999999754321110      0001111 


Q ss_pred             ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       495 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                          ..+.+.......+...+.+++.+||+.||++|||+.+|+++.|-...+
T Consensus       246 ----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          246 ----DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             ----CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ----CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence                011111111123445789999999999999999999999998865543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.4e-41  Score=347.87  Aligned_cols=275  Identities=20%  Similarity=0.247  Sum_probs=195.5

Q ss_pred             HHHHhhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc-
Q 042763          260 QVVKATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE-  337 (554)
Q Consensus       260 ~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~-  337 (554)
                      ......++|.+.+.||+|+||+||+|... +|+.||||++.....  ....+.+|++.++.++||||+++++++...+. 
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            45566789999999999999999999875 689999998865432  22456678888899999999999999865433 


Q ss_pred             ------eEEEEEeCCCCCHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC-CCcEE
Q 042763          338 ------RLIITEFVPNGTLREHLDG--QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE-SMRAK  408 (554)
Q Consensus       338 ------~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~vk  408 (554)
                            .++||||+++ +|.+.+..  .....+++..++.++.|++.||.|||.. +++|+||||||+|||++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEE
Confidence                  7899999965 66555443  2345788999999999999999999943 679999999999999996 89999


Q ss_pred             EEeecCcccCCCCCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 042763          409 VADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF  487 (554)
Q Consensus       409 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~  487 (554)
                      |+|||+++.....    .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+....
T Consensus       173 l~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          173 LCDFGSAKKLSPS----EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             ECCCTTCBCCCTT----SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EeeCCCceecCCC----CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            9999999864322    122345689999999998664 48999999999999999999999998765443332222111


Q ss_pred             --------HhhccC-CccccCC------hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          488 --------KRYNEG-NLLDMVD------PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       488 --------~~~~~~-~~~~~~d------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                              ...... ......+      ..............+.+++.+||+.||++|||+.|+++|.|-
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  318 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF  318 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence                    000000 0000000      000001112245679999999999999999999999998764

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1e-40  Score=334.44  Aligned_cols=256  Identities=27%  Similarity=0.370  Sum_probs=206.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .++|.+.+.||+|+||+||+|... +++.||||++..... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            468999999999999999999875 689999999876543 234567899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC---CcEEEEeecCcccCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES---MRAKVADFGFARLGP  419 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~---~~vkl~DfGla~~~~  419 (554)
                      ||+++++|.+++...  ..+++.+++.++.|++.||+|||   +++++||||||+||+++.+   +.+||+|||++....
T Consensus       101 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A          101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            999999999998765  46899999999999999999999   8899999999999999754   469999999998643


Q ss_pred             CCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ...    ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||........   ....    ..+.... .
T Consensus       176 ~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~----~~~~~~~-~  242 (287)
T 2wei_A          176 QNT----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LKRV----ETGKYAF-D  242 (287)
T ss_dssp             CCS----SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHCCCCC-C
T ss_pred             CCC----ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHH----HcCCCCC-C
Confidence            221    1223358899999999876 589999999999999999999999986543221   1111    1111100 0


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      .+.     ...++..+.+++.+||+.||++|||+.|++++.|--
T Consensus       243 ~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~  281 (287)
T 2wei_A          243 LPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ  281 (287)
T ss_dssp             SGG-----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred             chh-----hhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHh
Confidence            010     012345688999999999999999999999987743

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.4e-41  Score=345.81  Aligned_cols=263  Identities=19%  Similarity=0.268  Sum_probs=202.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc-----
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE-----  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~-----  337 (554)
                      .++|...+.||+|+||+||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467899999999999999999765 689999999876432 3345678999999999999999999999977654     


Q ss_pred             -eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          338 -RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       338 -~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                       .++||||++ ++|.+++..    .+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence             499999996 688887743    4899999999999999999999   8899999999999999999999999999997


Q ss_pred             cCCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      ....      ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+............
T Consensus       175 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          175 HADA------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             C--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             CCCC------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            5321      1234568999999999877 67899999999999999999999999876543322221111000000000


Q ss_pred             cccC---------------ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          496 LDMV---------------DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       496 ~~~~---------------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ....               .+... .........+.+++.+||+.||++|||+.|+++|.|-
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f  309 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF  309 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence            0000               00000 0112345678999999999999999999999998774

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.1e-40  Score=346.51  Aligned_cols=267  Identities=20%  Similarity=0.286  Sum_probs=205.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-----------CCCceeeeeEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-----------HRNLVKLLGFV  332 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-----------HpnIv~l~~~~  332 (554)
                      .++|...+.||+|+||+||+|.. .+++.||||++....  ...+.+.+|++++++++           ||||+++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            46799999999999999999976 468999999997543  23467889999999886           89999999998


Q ss_pred             EcCC----ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeEeCCCCCCCeEEC-----
Q 042763          333 DKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK-QIIHRDVKSSNILLT-----  402 (554)
Q Consensus       333 ~~~~----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dlkp~NILl~-----  402 (554)
                      ...+    ..++||||+ +++|.+++.......+++..++.++.||+.||+|||   ++ +|+||||||+|||++     
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETT
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCC
Confidence            7644    789999999 999999998766667999999999999999999999   77 999999999999994     


Q ss_pred             -CCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChh---
Q 042763          403 -ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPE---  478 (554)
Q Consensus       403 -~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~---  478 (554)
                       ..+.+||+|||+++.....      .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......   
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             cCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence             4458999999999864321      233468999999999999999999999999999999999999998654221   


Q ss_pred             hHHHHHHHHHhhcc------------------CCccccCC--------hhh--hhhccHHHHHHHHHHHHHccCCCCCCC
Q 042763          479 ERVTLRWAFKRYNE------------------GNLLDMVD--------PSI--KEVISMEILTKMFGLAIQCAAPIRNDR  530 (554)
Q Consensus       479 ~~~~~~~~~~~~~~------------------~~~~~~~d--------~~l--~~~~~~~~~~~l~~li~~cl~~dP~~R  530 (554)
                      ....+.........                  ......+.        ..+  ....+......+.+++.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence            11111111111110                  00000000        000  112345678889999999999999999


Q ss_pred             CCHHHHHHHHHHh
Q 042763          531 PDMKSVGEQLWAI  543 (554)
Q Consensus       531 Ps~~evl~~l~~i  543 (554)
                      ||+.|+++|.|--
T Consensus       326 pt~~ell~hp~f~  338 (373)
T 1q8y_A          326 ADAGGLVNHPWLK  338 (373)
T ss_dssp             BCHHHHHTCGGGT
T ss_pred             CCHHHHhhChhhh
Confidence            9999999988754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=7.2e-41  Score=343.88  Aligned_cols=258  Identities=21%  Similarity=0.271  Sum_probs=177.9

Q ss_pred             hcCCCcce-eeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEc----CCce
Q 042763          265 TRNFSPSL-RIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDK----GNER  338 (554)
Q Consensus       265 ~~~f~~~~-~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~  338 (554)
                      .++|.+.+ .||+|+||+||+|... +|+.||||++....  .   ........++.++||||+++++++..    +...
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            46777754 6999999999999776 68999999986542  1   11222334567799999999999865    4457


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC---CCcEEEEeecCc
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE---SMRAKVADFGFA  415 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~DfGla  415 (554)
                      ++||||+++|+|.+++.......+++.+++.++.|++.||.|||   +++|+||||||+|||++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999998776668999999999999999999999   889999999999999986   455999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      +.....     ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..............   .......
T Consensus       179 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~  250 (336)
T 3fhr_A          179 KETTQN-----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR---RIRLGQY  250 (336)
T ss_dssp             EEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             eecccc-----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH---hhhcccc
Confidence            864321     22345689999999999888899999999999999999999999975443221110000   0000000


Q ss_pred             cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          496 LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       496 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                       ....+     ....++..+.+++.+||+.||++|||+.|++++.|--.
T Consensus       251 -~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          251 -GFPNP-----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             -CCCTT-----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             -ccCch-----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence             00000     01133456889999999999999999999999988543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.8e-41  Score=336.56  Aligned_cols=258  Identities=25%  Similarity=0.384  Sum_probs=196.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEc---------
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDK---------  334 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~---------  334 (554)
                      .++|+..+.||+|+||+||+|... +|+.||||++...  ....+.+.+|+.++++++||||+++++++.+         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            467889999999999999999865 6899999999654  2345678999999999999999999998754         


Q ss_pred             ----CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEE
Q 042763          335 ----GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVA  410 (554)
Q Consensus       335 ----~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~  410 (554)
                          ....++||||+++|+|.+++... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEe
Confidence                35679999999999999999754 346788999999999999999999   8899999999999999999999999


Q ss_pred             eecCcccCCCCCC-----------CccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChh
Q 042763          411 DFGFARLGPMDSD-----------RTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPE  478 (554)
Q Consensus       411 DfGla~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~  478 (554)
                      |||+++.......           .........||+.|+|||++.+. .++.++||||||+++|||++   ||....  .
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~  233 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--E  233 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--H
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--h
Confidence            9999986432111           01122345689999999999764 68999999999999999998   544211  1


Q ss_pred             hHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          479 ERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      ......    .......  ...+.    .....+..+.+++.+||+.||++|||+.+++++.|--
T Consensus       234 ~~~~~~----~~~~~~~--~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (303)
T 1zy4_A          234 RVNILK----KLRSVSI--EFPPD----FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP  288 (303)
T ss_dssp             HHHHHH----HHHSTTC--CCCTT----CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred             HHHHHH----hcccccc--ccCcc----ccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence            111111    1111100  01111    2233445688999999999999999999999987753

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.7e-40  Score=353.10  Aligned_cols=257  Identities=23%  Similarity=0.273  Sum_probs=192.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +.|...+.||+|+||+||.+...+|+.||||++....    .+.+.+|+++++++ +||||+++++++.+++..++||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            3455567899999999988777789999999987643    34578899999876 899999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCC-----CCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC-------------Cc
Q 042763          345 VPNGTLREHLDGQYGKT-----LDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES-------------MR  406 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-------------~~  406 (554)
                      |+ |+|.+++.......     ..+..++.++.||+.||+|||   +++|+||||||+|||++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceE
Confidence            95 79999997653211     134456789999999999999   8899999999999999754             48


Q ss_pred             EEEEeecCcccCCCCCCCc-cccccccCCCCCcChhcccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCh
Q 042763          407 AKVADFGFARLGPMDSDRT-HISTKVKGTVGYLDPEYMKT-------YQLTTKSDVYSFGVLLLEILT-GRRPVELKRPP  477 (554)
Q Consensus       407 vkl~DfGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~  477 (554)
                      +||+|||+++......... .......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            9999999998754322111 11234579999999999975       578999999999999999999 99999765433


Q ss_pred             hhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          478 EERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .. .   ........        +.........++..+.+++.+||+.||++|||+.||++|.|-
T Consensus       247 ~~-~---i~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f  299 (434)
T 2rio_A          247 ES-N---IIRGIFSL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF  299 (434)
T ss_dssp             HH-H---HHHTCCCC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             HH-H---HhcCCCCc--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence            21 1   11111110        011112234567789999999999999999999999998653

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=345.10  Aligned_cols=264  Identities=23%  Similarity=0.358  Sum_probs=201.8

Q ss_pred             HhhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          263 KATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       263 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ...++|...+.||+|+||.||+|...+  .||+|++..... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            345788999999999999999998764  489999875432 22235678899999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++++|.+++... ...+++.+++.++.|++.||+|||   +++++||||||+|||++ ++.+||+|||+++.....
T Consensus       108 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             CBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             eecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            9999999999999764 346899999999999999999999   88999999999999998 679999999998764321


Q ss_pred             CC--CccccccccCCCCCcChhcccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhh
Q 042763          422 SD--RTHISTKVKGTVGYLDPEYMKT---------YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY  490 (554)
Q Consensus       422 ~~--~~~~~~~~~gt~~y~aPE~l~~---------~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  490 (554)
                      ..  .........||+.|+|||++.+         ..++.++||||||+++|||++|+.||.........    +.....
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~  258 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII----WQMGTG  258 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH----HHHHTT
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHhccC
Confidence            11  1122233458999999999864         45789999999999999999999999865432211    111111


Q ss_pred             ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                      ..   .....        ..++..+.+++.+||+.||++|||+.+|++.|++++....
T Consensus       259 ~~---~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          259 MK---PNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             CC---CCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             CC---CCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence            11   11100        1123457899999999999999999999999999887643

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=337.65  Aligned_cols=247  Identities=26%  Similarity=0.404  Sum_probs=195.3

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhh-----HHHHHHHHHHHHHhC----CCCCceeeeeEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFEN-----LQTEFSSEVELLSKI----DHRNLVKLLGFVD  333 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~-----~~~~~~~Ei~~l~~l----~HpnIv~l~~~~~  333 (554)
                      ..++|...+.||+|+||.||+|... +++.||||++.......     ....+.+|+.++.++    +||||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            4578999999999999999999764 68999999997654321     223466799999988    8999999999999


Q ss_pred             cCCceEEEEEe-CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC-CCCcEEEEe
Q 042763          334 KGNERLIITEF-VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT-ESMRAKVAD  411 (554)
Q Consensus       334 ~~~~~~lv~E~-~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~-~~~~vkl~D  411 (554)
                      ..+..++|||| +.+++|.+++...  ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++ .++.+||+|
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~d  183 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLID  183 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             cCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEE
Confidence            98999999999 7899999999765  46899999999999999999999   88999999999999999 889999999


Q ss_pred             ecCcccCCCCCCCccccccccCCCCCcChhccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhh
Q 042763          412 FGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT-TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY  490 (554)
Q Consensus       412 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~  490 (554)
                      ||+++.....     ......||+.|+|||++.+..+. .++||||||+++|||++|+.||....     . .   ..  
T Consensus       184 fg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~-~---~~--  247 (312)
T 2iwi_A          184 FGSGALLHDE-----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----E-I---LE--  247 (312)
T ss_dssp             CSSCEECCSS-----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-H---HH--
T ss_pred             cchhhhcccC-----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----H-H---hh--
Confidence            9999864322     12345699999999999877765 58999999999999999999997421     0 0   00  


Q ss_pred             ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       491 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      ....            .+..+...+.+++.+||+.||++|||+.|++++.|--
T Consensus       248 ~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~  288 (312)
T 2iwi_A          248 AELH------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ  288 (312)
T ss_dssp             TCCC------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred             hccC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence            0000            1122345688999999999999999999999987643

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.1e-40  Score=334.34  Aligned_cols=258  Identities=22%  Similarity=0.325  Sum_probs=186.7

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHH-HHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQ-TEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~-~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ..++|+..+.||+|+||.||+|... +|+.||||++......... +.+..+..+++.++||||+++++++.+++..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3467888999999999999999875 6899999999765433333 3444555678888999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK-QIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      |||+ ++.+..+.. .....+++..++.++.|++.||.|||   ++ +++||||||+|||++.++.+||+|||++.....
T Consensus       103 ~e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          103 MELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             ECCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             Eecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            9999 555555544 33467899999999999999999999   64 999999999999999999999999999975432


Q ss_pred             CCCCccccccccCCCCCcChhccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMK-----TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      .    .......||+.|+|||++.     ...++.++||||||+++|||++|+.||.........  ....... .....
T Consensus       178 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~-~~~~~  250 (318)
T 2dyl_A          178 D----KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV--LTKVLQE-EPPLL  250 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--HHHHHHS-CCCCC
T ss_pred             C----ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH--HHHHhcc-CCCCC
Confidence            1    1223456999999999984     457899999999999999999999999864433221  1111111 00000


Q ss_pred             cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          496 LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       496 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                      .          ....++..+.+++.+||+.||++||++.+++++.|--
T Consensus       251 ~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (318)
T 2dyl_A          251 P----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK  288 (318)
T ss_dssp             C----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             C----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence            0          0012345688999999999999999999999988754

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=352.32  Aligned_cols=255  Identities=24%  Similarity=0.332  Sum_probs=192.5

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ...+|...++||+|+||+||.....+|+.||||++......    .+.+|+++++++ +||||+++++++.+....++||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            34568888999999999977666667999999999765432    356799999999 7999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC-----CCcEEEEeecCccc
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE-----SMRAKVADFGFARL  417 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~-----~~~vkl~DfGla~~  417 (554)
                      |||+ |+|.+++.... ......+++.++.||+.||+|||   +++|+||||||+|||++.     ...+||+|||+++.
T Consensus        98 E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             ECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             ECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            9995 79999997653 23455677899999999999999   889999999999999953     33588999999987


Q ss_pred             CCCCCCCccccccccCCCCCcChhccc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccC
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMK---TYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEG  493 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~  493 (554)
                      ...............||+.|+|||++.   ...++.++|||||||++|||++ |..||..........       .....
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-------~~~~~  245 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-------LLGAC  245 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-------HTTCC
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-------HhccC
Confidence            543332223344567999999999997   4567889999999999999999 999996543322110       11111


Q ss_pred             CccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          494 NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       494 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .. ....+      .......+.+++.+||+.||++|||+.||++|.|
T Consensus       246 ~~-~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~  286 (432)
T 3p23_A          246 SL-DCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF  286 (432)
T ss_dssp             CC-TTSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTT
T ss_pred             Cc-cccCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcc
Confidence            11 11111      1233456789999999999999999999998765

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.4e-40  Score=339.18  Aligned_cols=246  Identities=25%  Similarity=0.408  Sum_probs=202.2

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhh-----HHHHHHHHHHHHHhCC--CCCceeeeeEEEcC
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFEN-----LQTEFSSEVELLSKID--HRNLVKLLGFVDKG  335 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~-----~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~  335 (554)
                      ..++|...+.||+|+||+||+|... +++.||||++.......     ..+.+.+|+.++++++  ||||+++++++.++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            3577999999999999999999754 68999999997654321     2245678999999996  59999999999999


Q ss_pred             CceEEEEEeCCC-CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC-CCCcEEEEeec
Q 042763          336 NERLIITEFVPN-GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT-ESMRAKVADFG  413 (554)
Q Consensus       336 ~~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~-~~~~vkl~DfG  413 (554)
                      +..++||||+.+ ++|.+++...  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++ .++.+||+|||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             CcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            999999999976 8999999765  57899999999999999999999   89999999999999999 78999999999


Q ss_pred             CcccCCCCCCCccccccccCCCCCcChhccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhcc
Q 042763          414 FARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL-TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE  492 (554)
Q Consensus       414 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  492 (554)
                      +++.....     ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....     ...    .  ..
T Consensus       196 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~----~--~~  259 (320)
T 3a99_A          196 SGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII----R--GQ  259 (320)
T ss_dssp             TCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH----H--CC
T ss_pred             cccccccc-----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hhh----c--cc
Confidence            99864321     2234569999999999987776 688999999999999999999997421     000    0  00


Q ss_pred             CCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          493 GNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       493 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ..            ....++..+.+++.+||+.||++|||+.||+++.|-
T Consensus       260 ~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~  297 (320)
T 3a99_A          260 VF------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM  297 (320)
T ss_dssp             CC------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             cc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence            00            111234568899999999999999999999998663

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.5e-38  Score=319.20  Aligned_cols=236  Identities=15%  Similarity=0.106  Sum_probs=188.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .++|++.+.||+|+||.||+|... +|+.||||++.....  ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367999999999999999999776 489999999986543  33457799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||+++++|.+++...    ....++.+++.|++.||+|||   +++|+||||||+|||++.++.+||+++|        
T Consensus       110 ~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence            9999999999999543    355678899999999999999   8999999999999999999999997443        


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                                     |++       .++.++||||||+++|||+||+.||..........        .........  +
T Consensus       175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--------~~~~~~~~~--~  222 (286)
T 3uqc_A          175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--------PAERDTAGQ--P  222 (286)
T ss_dssp             ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--------ECCBCTTSC--B
T ss_pred             ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--------HHHHHhccC--C
Confidence                           333       37899999999999999999999998654322100        000000000  0


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                      .........++..+.+++.+||+.||++| |+.|+++.|.++.....
T Consensus       223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            00011223445678999999999999999 99999999999887654

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=9.9e-40  Score=359.28  Aligned_cols=269  Identities=25%  Similarity=0.328  Sum_probs=202.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEc------CCce
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDK------GNER  338 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~------~~~~  338 (554)
                      ++|.+.++||+|+||+||+|... +|+.||||++.........+.+.+|++++++++||||+++++++..      ++..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            67999999999999999999764 6899999998765445556789999999999999999999998755      6778


Q ss_pred             EEEEEeCCCCCHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCc---EEEEeecC
Q 042763          339 LIITEFVPNGTLREHLDGQY-GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMR---AKVADFGF  414 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~---vkl~DfGl  414 (554)
                      ++||||+++|+|.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            99999999999999998643 236899999999999999999999   889999999999999997765   99999999


Q ss_pred             cccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHH--HHHHH-hhc
Q 042763          415 ARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTL--RWAFK-RYN  491 (554)
Q Consensus       415 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~--~~~~~-~~~  491 (554)
                      +......    .......||+.|+|||++.+..++.++||||||+++|||++|..||............  ..... ...
T Consensus       171 a~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          171 AKELDQG----ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCBTTSC----CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccccc----cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            9864322    2223457999999999999999999999999999999999999999754322110000  00000 000


Q ss_pred             cCCcccc--CCh--hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          492 EGNLLDM--VDP--SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       492 ~~~~~~~--~d~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .......  ...  .........++..+.+++.+||+.||++|||+.|++++.|
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~  300 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC  300 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTT
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHH
Confidence            0000000  000  0011233456788999999999999999999999655443

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.9e-38  Score=355.89  Aligned_cols=243  Identities=21%  Similarity=0.301  Sum_probs=195.8

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc--CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCc-----
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE--DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNE-----  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~-----  337 (554)
                      .++|.+.++||+|+||+||+|...  +|+.||||++...........+.+|++++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            368999999999999999999875  5899999998765444556778999999999999999999999987665     


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .++||||+++++|.+++..    .+++.+++.++.||+.||.|||   +++|+||||||+|||++.+ .+||+|||+++.
T Consensus       159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence            6999999999999988754    6899999999999999999999   8899999999999999986 899999999986


Q ss_pred             CCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                      ....       ....||+.|+|||++.+. ++.++|||||||++|+|++|..||......                .+. 
T Consensus       231 ~~~~-------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------~~~-  285 (681)
T 2pzi_A          231 INSF-------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------------GLP-  285 (681)
T ss_dssp             TTCC-------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------------SCC-
T ss_pred             cccC-------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc----------------ccc-
Confidence            4321       345699999999999775 489999999999999999999887642111                000 


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHHhhhh
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPD-MKSVGEQLWAIRAD  546 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~l~~i~~~  546 (554)
                        ..    .........+.+++.+||+.||++||+ +.++...+..+..+
T Consensus       286 --~~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          286 --ED----DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             --TT----CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             --cc----ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence              00    011123457889999999999999995 55555555555433

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.2e-38  Score=317.59  Aligned_cols=237  Identities=20%  Similarity=0.266  Sum_probs=184.5

Q ss_pred             cCCCcc-eeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHH-HhCCCCCceeeeeEEEc----CCce
Q 042763          266 RNFSPS-LRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELL-SKIDHRNLVKLLGFVDK----GNER  338 (554)
Q Consensus       266 ~~f~~~-~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l-~~l~HpnIv~l~~~~~~----~~~~  338 (554)
                      ++|... +.||+|+||.||+|... +++.||+|++...      ..+.+|++++ +.++||||+++++++..    ....
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            456666 67999999999999764 6899999998653      3566888887 56699999999999876    6678


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC---CCcEEEEeecCc
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE---SMRAKVADFGFA  415 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~DfGla  415 (554)
                      ++||||+++|+|.+++.......+++.+++.++.|++.||+|||   +++|+||||||+|||++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999998876667999999999999999999999   899999999999999998   789999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      ....                         +..++.++||||||+++|||++|+.||.........       ..... ..
T Consensus       168 ~~~~-------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------~~~~~-~~  214 (299)
T 3m2w_A          168 KETT-------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGMKT-RI  214 (299)
T ss_dssp             EECT-------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------CCSCC-SS
T ss_pred             cccc-------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------HHHHH-HH
Confidence            7522                         134788999999999999999999999754322110       00000 00


Q ss_pred             cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          496 LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       496 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      .. ............++..+.+++.+||+.||++|||+.|+++|.|-...
T Consensus       215 ~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          215 RM-GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             CT-TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             hh-ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            00 00000000001245678999999999999999999999999886543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=7.2e-39  Score=338.34  Aligned_cols=246  Identities=15%  Similarity=0.121  Sum_probs=184.0

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHHHHHHHHHhCCC-CCcee------------
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFSSEVELLSKIDH-RNLVK------------  327 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~~Ei~~l~~l~H-pnIv~------------  327 (554)
                      ..++|...+.||+|+||+||+|.+. +|+.||||++......  ...+.+.+|+.+++.++| +|...            
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            3456777889999999999999754 6999999998743222  224678999999999987 32111            


Q ss_pred             ---------eeeEEEc-----CCceEEEEEeCCCCCHHHHHh-----cccCCCCCHHHHHHHHHHHHHHHHHhhhccCCC
Q 042763          328 ---------LLGFVDK-----GNERLIITEFVPNGTLREHLD-----GQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ  388 (554)
Q Consensus       328 ---------l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~-----~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~  388 (554)
                               +..++..     ....+++|+++ +++|.+++.     ......+++..++.++.||+.||+|||   +++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence                     1111111     22457777766 799999985     222346788899999999999999999   899


Q ss_pred             eEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhcc----------ccCCCCchhhHHHHH
Q 042763          389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM----------KTYQLTTKSDVYSFG  458 (554)
Q Consensus       389 ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~s~ksDVwSlG  458 (554)
                      |+||||||+|||++.++.+||+|||+++....      ......| +.|+|||++          .+..++.++||||||
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG  304 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG  304 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTE------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCC------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence            99999999999999999999999999986321      1344567 999999999          555688999999999


Q ss_pred             HHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 042763          459 VLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGE  538 (554)
Q Consensus       459 vil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  538 (554)
                      |++|||++|+.||..........               ..    ...  ...++..+.+++.+||+.||++||++.++++
T Consensus       305 vil~elltg~~Pf~~~~~~~~~~---------------~~----~~~--~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          305 LAIYWIWCADLPNTDDAALGGSE---------------WI----FRS--CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHHHSSCCCCTTGGGSCSG---------------GG----GSS--CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHCCCCCCCcchhhhHH---------------HH----Hhh--cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99999999999997543221100               00    000  0123466899999999999999999999988


Q ss_pred             HHH
Q 042763          539 QLW  541 (554)
Q Consensus       539 ~l~  541 (554)
                      +.|
T Consensus       364 ~~~  366 (413)
T 3dzo_A          364 TPE  366 (413)
T ss_dssp             SHH
T ss_pred             CHH
Confidence            743

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.1e-38  Score=321.22  Aligned_cols=247  Identities=17%  Similarity=0.166  Sum_probs=187.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-------hhHHHHHHHHHHHHHhCC---------CCCceee
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-------ENLQTEFSSEVELLSKID---------HRNLVKL  328 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-------~~~~~~~~~Ei~~l~~l~---------HpnIv~l  328 (554)
                      .++|+..++||+|+||+||+|.. +|+.||||++.....       ....+.+.+|+.++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46788899999999999999987 689999999976532       223467889999998885         6666666


Q ss_pred             eeEE-----------------Ec-------------CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHH
Q 042763          329 LGFV-----------------DK-------------GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGL  378 (554)
Q Consensus       329 ~~~~-----------------~~-------------~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L  378 (554)
                      .+.+                 .+             .+..++|||||++|++.+.+.+   ..+++.+++.++.||+.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence            6653                 22             6789999999999977776643   4689999999999999999


Q ss_pred             HHhhhccCCCeEeCCCCCCCeEECCCC--------------------cEEEEeecCcccCCCCCCCccccccccCCCCCc
Q 042763          379 TYLHLYAEKQIIHRDVKSSNILLTESM--------------------RAKVADFGFARLGPMDSDRTHISTKVKGTVGYL  438 (554)
Q Consensus       379 ~~LH~~~~~~ivH~Dlkp~NILl~~~~--------------------~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~  438 (554)
                      +|||.  +++|+||||||+|||++.++                    .+||+|||+|+....        ....||+.|+
T Consensus       175 ~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~y~  244 (336)
T 2vuw_A          175 AVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDVSM  244 (336)
T ss_dssp             HHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCCCTT
T ss_pred             HHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEeeccc
Confidence            99992  46899999999999999887                    899999999986421        1347999999


Q ss_pred             ChhccccCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCChhhHHHHHHHHHhhc-cCCccccCChhhhhhccHHHHHHHH
Q 042763          439 DPEYMKTYQLTTKSDVYSFGVL-LLEILTGRRPVELKRPPEERVTLRWAFKRYN-EGNLLDMVDPSIKEVISMEILTKMF  516 (554)
Q Consensus       439 aPE~l~~~~~s~ksDVwSlGvi-l~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~  516 (554)
                      |||++.+.. +.++|||||+++ .+++++|..||..     . ........... ..........    .....++..+.
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----~-~~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~~~  313 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----V-LWLHYLTDKMLKQMTFKTKCNT----PAMKQIKRKIQ  313 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----H-HHHHHHHHHHHHTCCCSSCCCS----HHHHHHHHHHH
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----h-hhhhHHHHhhhhhhccCcccch----hhhhhcCHHHH
Confidence            999998766 899999998777 7788899998742     1 00011111111 1011111111    12345778899


Q ss_pred             HHHHHccCCCCCCCCCHHHHH-HHHH
Q 042763          517 GLAIQCAAPIRNDRPDMKSVG-EQLW  541 (554)
Q Consensus       517 ~li~~cl~~dP~~RPs~~evl-~~l~  541 (554)
                      +++.+||+.|     |+.|++ +|.|
T Consensus       314 dli~~~L~~d-----sa~e~l~~Hp~  334 (336)
T 2vuw_A          314 EFHRTMLNFS-----SATDLLCQHSL  334 (336)
T ss_dssp             HHHHHGGGSS-----SHHHHHHHCGG
T ss_pred             HHHHHHhccC-----CHHHHHhcCCC
Confidence            9999999976     999999 8765

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=3.1e-31  Score=290.29  Aligned_cols=186  Identities=16%  Similarity=0.126  Sum_probs=131.0

Q ss_pred             eeeccCceEEEEEE-EcCCcEEEEEEcchhh---------hhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEE
Q 042763          273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQ---------FENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       273 ~LG~G~fG~Vy~a~-~~~g~~vAvK~~~~~~---------~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ..+.|++|.+..++ .--|+.||||++....         .+...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35677777777663 3358899999986531         233456799999999999 699999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      |||++|++|.+++...  ..++..   +|+.||+.||+|+|   +++||||||||+|||++.+|.+||+|||+|+.....
T Consensus       321 MEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999999765  455543   58899999999999   999999999999999999999999999999864332


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP  470 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P  470 (554)
                      .   ......+||+.|||||++.+ .+..++|+|++|+++++|.++..+
T Consensus       393 ~---~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 C---SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             C---ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            2   22344679999999999976 467789999999998877665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=7.3e-28  Score=262.06  Aligned_cols=189  Identities=17%  Similarity=0.254  Sum_probs=146.5

Q ss_pred             CCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-------hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          268 FSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-------ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-------~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      +...++||+|+||+||+|... +..+++|+......       ....+.+.+|++++++++||||+++..++...+..++
T Consensus       338 ~~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          338 KIPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ----------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            345668999999999999554 78889987543221       1124568999999999999999976666667778899


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ||||+++++|.+++..          ++.++.|++.||+|||   +++|+||||||+|||++.  .+||+|||+++....
T Consensus       417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            9999999999999865          5689999999999999   899999999999999999  999999999997532


Q ss_pred             CCCCc----cccccccCCCCCcChhcccc--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 042763          421 DSDRT----HISTKVKGTVGYLDPEYMKT--YQLTTKSDVYSFGVLLLEILTGRRPVE  472 (554)
Q Consensus       421 ~~~~~----~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvil~elltg~~P~~  472 (554)
                      .....    .......||+.|||||++..  ..|+...|+|+..+-..+.+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            11110    01235679999999999987  568889999999999999888887764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=1.2e-24  Score=217.58  Aligned_cols=155  Identities=14%  Similarity=0.117  Sum_probs=125.4

Q ss_pred             hHHHHHhhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhh-----------------hHHHHHHHHHHHHHhC
Q 042763          258 MSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFE-----------------NLQTEFSSEVELLSKI  320 (554)
Q Consensus       258 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~-----------------~~~~~~~~Ei~~l~~l  320 (554)
                      +..+......|...+.||+|+||.||+|...+|+.||||+++.....                 .....+.+|+++++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            34555666778888999999999999998877999999998643211                 1346789999999999


Q ss_pred             CCCCceeeeeEEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeE
Q 042763          321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNIL  400 (554)
Q Consensus       321 ~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIL  400 (554)
                      +  | +++.+++.. +..++||||+++++|.+ +.        ..+...++.|++.||.|||   +.+|+||||||+|||
T Consensus       162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NIL  225 (282)
T 1zar_A          162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVL  225 (282)
T ss_dssp             T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEE
T ss_pred             c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEE
Confidence            9  5 666665544 56699999999999988 42        1345579999999999999   899999999999999


Q ss_pred             ECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhcccc
Q 042763          401 LTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT  445 (554)
Q Consensus       401 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~  445 (554)
                      ++ ++.+||+|||+|+.                +..|+|||++..
T Consensus       226 l~-~~~vkl~DFG~a~~----------------~~~~~a~e~l~r  253 (282)
T 1zar_A          226 VS-EEGIWIIDFPQSVE----------------VGEEGWREILER  253 (282)
T ss_dssp             EE-TTEEEECCCTTCEE----------------TTSTTHHHHHHH
T ss_pred             EE-CCcEEEEECCCCeE----------------CCCCCHHHHHHH
Confidence            99 99999999999973                345789998754

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=2.7e-19  Score=176.17  Aligned_cols=144  Identities=21%  Similarity=0.183  Sum_probs=109.9

Q ss_pred             HHHhhcCCCcceeeeccCceEEEEEEE-cCCcE--EEEEEcchhhhh-----------------------hHHHHHHHHH
Q 042763          261 VVKATRNFSPSLRIGEGGFGTVYKAQL-EDGLL--VAIKRAKKEQFE-----------------------NLQTEFSSEV  314 (554)
Q Consensus       261 l~~~~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~--vAvK~~~~~~~~-----------------------~~~~~~~~Ei  314 (554)
                      +.....-|...+.||+|+||.||+|.. .+|+.  ||||+++.....                       .....+.+|+
T Consensus        42 ~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~  121 (258)
T 1zth_A           42 LSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEF  121 (258)
T ss_dssp             HHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHH
T ss_pred             HHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHH
Confidence            333334467788999999999999987 67988  999986543110                       1123678999


Q ss_pred             HHHHhCCCCCc--eeeeeEEEcCCceEEEEEeCCC-C----CHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCC
Q 042763          315 ELLSKIDHRNL--VKLLGFVDKGNERLIITEFVPN-G----TLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK  387 (554)
Q Consensus       315 ~~l~~l~HpnI--v~l~~~~~~~~~~~lv~E~~~~-g----~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~  387 (554)
                      ..+.+++|+++  +.++++    +..++||||+.+ |    +|.++...     .++.++..++.|++.||.|||.  +.
T Consensus       122 ~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~--~~  190 (258)
T 1zth_A          122 RNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ--EA  190 (258)
T ss_dssp             HHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH--TS
T ss_pred             HHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH--HC
Confidence            99999988764  334432    356899999942 4    67766532     2355778999999999999993  57


Q ss_pred             CeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          388 QIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       388 ~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      +|+||||||+|||++.  .++|+|||+|..
T Consensus       191 givHrDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          191 ELVHADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             CEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             CEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence            9999999999999998  999999999975

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.69  E-value=5e-18  Score=174.80  Aligned_cols=147  Identities=15%  Similarity=0.152  Sum_probs=104.7

Q ss_pred             hHHHHHhhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhh-------------hHHHH--------HHHHHHH
Q 042763          258 MSQVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFE-------------NLQTE--------FSSEVEL  316 (554)
Q Consensus       258 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~-------------~~~~~--------~~~Ei~~  316 (554)
                      +..+.....-|.+...||+|+||.||+|...+|+.||||+++.....             .....        ..+|...
T Consensus        87 L~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n  166 (397)
T 4gyi_A           87 LHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF  166 (397)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence            34455555568999999999999999999889999999987542110             00111        2346666


Q ss_pred             HHhCCCCCceeeeeEEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCC
Q 042763          317 LSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKS  396 (554)
Q Consensus       317 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp  396 (554)
                      |.++.+.++....-+..  ...++||||+++++|.++..        ......++.|++.+|.+||   ..+||||||||
T Consensus       167 L~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp  233 (397)
T 4gyi_A          167 MKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLA---KHGLIHGDFNE  233 (397)
T ss_dssp             HHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHH---HTTEECSCCST
T ss_pred             HHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCH
Confidence            66664444321111111  23379999999988865532        2345678899999999999   88999999999


Q ss_pred             CCeEECCCC----------cEEEEeecCccc
Q 042763          397 SNILLTESM----------RAKVADFGFARL  417 (554)
Q Consensus       397 ~NILl~~~~----------~vkl~DfGla~~  417 (554)
                      .|||+++++          .+.|+||+-+-.
T Consensus       234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          234 FNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             HHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            999998877          389999998753

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.31  E-value=5.9e-12  Score=123.45  Aligned_cols=145  Identities=15%  Similarity=0.104  Sum_probs=113.7

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEEEE
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      .-..|.....++.|+.+.||++... +..+++|+...... .....+.+|+++++.+. +..+.++++++.+.+..++||
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            3456877888899999999999865 67899999876321 11235889999999884 677889999998888999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhcc-------------------------------------
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA-------------------------------------  385 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------------------------  385 (554)
                      ||++|.+|.+.+.       +..+...++.+++++|..||...                                     
T Consensus        90 e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           90 SEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             ECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            9999999987632       12234578889999999999610                                     


Q ss_pred             -------------------CCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          386 -------------------EKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       386 -------------------~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                                         ...++|+|++|.|||++++..+.|+||+.+..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                               14599999999999998766667999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.23  E-value=9.5e-12  Score=121.28  Aligned_cols=129  Identities=17%  Similarity=0.169  Sum_probs=97.4

Q ss_pred             eccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCC--ceeeeeEEEcCCceEEEEEeCCCCCHHH
Q 042763          275 GEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRN--LVKLLGFVDKGNERLIITEFVPNGTLRE  352 (554)
Q Consensus       275 G~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~~~~~~~~~lv~E~~~~g~L~~  352 (554)
                      +.|..+.||++...+|..+++|+.....    ...+.+|+++++.+.+.+  +.+++++...++..++||||++|.+|. 
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence            4566799999987778889999876542    235778899999885444  556888888878889999999998884 


Q ss_pred             HHhcccCCCCCHHHHHHHHHHHHHHHHHhhhcc-----------------------------------------------
Q 042763          353 HLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA-----------------------------------------------  385 (554)
Q Consensus       353 ~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----------------------------------------------  385 (554)
                       ...     .   ....++.+++..|..||...                                               
T Consensus       104 -~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (264)
T 1nd4_A          104 -SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL  174 (264)
T ss_dssp             -TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred             -cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence             211     1   12356778888888888421                                               


Q ss_pred             --------CCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          386 --------EKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       386 --------~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                              ...++|+|++|.|||+++++.+.|+||+.+..
T Consensus       175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                    11299999999999998876677999998864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.14  E-value=8.1e-11  Score=120.98  Aligned_cols=144  Identities=14%  Similarity=0.211  Sum_probs=107.5

Q ss_pred             CcceeeeccCceEEEEEEEcCCcEEEEEEcc--hhhhhhHHHHHHHHHHHHHhCC--CCCceeeeeEEEcC---CceEEE
Q 042763          269 SPSLRIGEGGFGTVYKAQLEDGLLVAIKRAK--KEQFENLQTEFSSEVELLSKID--HRNLVKLLGFVDKG---NERLII  341 (554)
Q Consensus       269 ~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~--~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~---~~~~lv  341 (554)
                      ...+.|+.|.++.||++...+ ..+++|+..  ..........+.+|+.+++.+.  +..+.++++++.+.   +..++|
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            346679999999999998764 678889876  4332222356888999999987  45578889888766   447999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhcc------------------------------------
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA------------------------------------  385 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------------  385 (554)
                      |||++|..+.+..    ...++..++..++.++++.|..||...                                    
T Consensus       120 me~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          120 MEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            9999988775421    124677888899999999999999621                                    


Q ss_pred             -------------------CCCeEeCCCCCCCeEECCCCc--EEEEeecCccc
Q 042763          386 -------------------EKQIIHRDVKSSNILLTESMR--AKVADFGFARL  417 (554)
Q Consensus       386 -------------------~~~ivH~Dlkp~NILl~~~~~--vkl~DfGla~~  417 (554)
                                         ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               256999999999999997753  68999999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.01  E-value=2.4e-10  Score=114.69  Aligned_cols=183  Identities=20%  Similarity=0.179  Sum_probs=121.7

Q ss_pred             ceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCC--ceeeeeEEEcCC---ceEEEEEe
Q 042763          271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRN--LVKLLGFVDKGN---ERLIITEF  344 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-Hpn--Iv~l~~~~~~~~---~~~lv~E~  344 (554)
                      .+.++.|....||++.    ..+++|+....   .....+.+|.++++.+. +..  +.+++.....++   ..|+|||+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568999999999864    45888886543   23457889999998873 333  344555443333   34889999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhcc---------------------------------------
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA---------------------------------------  385 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------------  385 (554)
                      ++|.+|.+...    ..++..++..++.+++..|..||...                                       
T Consensus        98 i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           98 IKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             cCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            99988865332    24667777788888888888888510                                       


Q ss_pred             ----------------CCCeEeCCCCCCCeEECC--CCcEEEEeecCcccCCCCCCCccccccccCCCCC---cChhccc
Q 042763          386 ----------------EKQIIHRDVKSSNILLTE--SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY---LDPEYMK  444 (554)
Q Consensus       386 ----------------~~~ivH~Dlkp~NILl~~--~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y---~aPE~l~  444 (554)
                                      ...++|+|++|.||++++  +..+.|+||+.+......   ....    ....+   ..|+...
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~---~Dl~----~~~~~~~~~~~~~~~  246 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD---NDFI----SLMEDDEEYGMEFVS  246 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT---HHHH----TTCCTTTSCCHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH---HHHH----HHHhhccccCHHHHH
Confidence                            134899999999999998  556889999998753211   0000    00111   2333221


Q ss_pred             ----cC-C---------CCchhhHHHHHHHHHHHHhCCCCC
Q 042763          445 ----TY-Q---------LTTKSDVYSFGVLLLEILTGRRPV  471 (554)
Q Consensus       445 ----~~-~---------~s~ksDVwSlGvil~elltg~~P~  471 (554)
                          .. .         .....+.|+++.++|.+.+|..+|
T Consensus       247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                11 1         122368999999999999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.50  E-value=8.1e-07  Score=86.90  Aligned_cols=135  Identities=19%  Similarity=0.239  Sum_probs=98.0

Q ss_pred             eeeccCce-EEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEEEEEeCCCCC
Q 042763          273 RIGEGGFG-TVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLIITEFVPNGT  349 (554)
Q Consensus       273 ~LG~G~fG-~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~~g~  349 (554)
                      .+..|..| .||+.... ++..+++|+.....    ..++.+|...|+.+. +--+.++++++.+++..++|||++++.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHH----HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCC----HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            35556655 69988655 46778999876543    346788999998884 3346788899998899999999999988


Q ss_pred             HHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhcc--------------------------------------------
Q 042763          350 LREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA--------------------------------------------  385 (554)
Q Consensus       350 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--------------------------------------------  385 (554)
                      +.+.....      ......++.+++..|..||...                                            
T Consensus       107 ~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          107 AFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             ccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            87765321      2233456666677777777410                                            


Q ss_pred             -----------CCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          386 -----------EKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       386 -----------~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                                 ...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       11279999999999999887778999998864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.47  E-value=1e-06  Score=88.18  Aligned_cols=137  Identities=18%  Similarity=0.168  Sum_probs=94.5

Q ss_pred             cceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCC---CceeeeeEEE-cCCceEEEEEeC
Q 042763          270 PSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR---NLVKLLGFVD-KGNERLIITEFV  345 (554)
Q Consensus       270 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hp---nIv~l~~~~~-~~~~~~lv~E~~  345 (554)
                      ..+.++.|....||+.    |..+++|+....   .....+.+|.++|+.+.+.   .+.+.+.++. ..+..++||||+
T Consensus        23 ~v~~l~~G~~n~v~~v----g~~~VlR~~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i   95 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV----NGDWVFRFPKSQ---QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV   95 (306)
T ss_dssp             CEEEEEECSSEEEEEE----TTTEEEEEESSH---HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred             eeeecCCCcceeEEEE----CCEEEEEecCCc---hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence            3456899999999988    456888875332   2346788999999999653   3566676664 455678999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhc-----------------------------------------
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY-----------------------------------------  384 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----------------------------------------  384 (554)
                      +|..+.+..-    ..++..+...++.+++..|..||..                                         
T Consensus        96 ~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           96 QGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             CCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            9988866321    1234444445555555555555531                                         


Q ss_pred             ----------------cCCCeEeCCCCCCCeEECC---CCc-EEEEeecCccc
Q 042763          385 ----------------AEKQIIHRDVKSSNILLTE---SMR-AKVADFGFARL  417 (554)
Q Consensus       385 ----------------~~~~ivH~Dlkp~NILl~~---~~~-vkl~DfGla~~  417 (554)
                                      ....++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            1335799999999999997   455 48999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.27  E-value=9.1e-07  Score=90.35  Aligned_cols=81  Identities=6%  Similarity=0.007  Sum_probs=55.6

Q ss_pred             ceee-eccCceEEEEEEEc-------CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCC-C--CCceeeeeEEEcC--
Q 042763          271 SLRI-GEGGFGTVYKAQLE-------DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKID-H--RNLVKLLGFVDKG--  335 (554)
Q Consensus       271 ~~~L-G~G~fG~Vy~a~~~-------~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~-H--pnIv~l~~~~~~~--  335 (554)
                      .+.| +.|....+|+....       ++..+++|+......  ......+.+|+.+++.+. +  -.+.++++++.++  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3467 88999999998764       267789998765430  000135678888888774 3  3467788877655  


Q ss_pred             -CceEEEEEeCCCCCHH
Q 042763          336 -NERLIITEFVPNGTLR  351 (554)
Q Consensus       336 -~~~~lv~E~~~~g~L~  351 (554)
                       +..++||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999886654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.01  E-value=4.3e-05  Score=76.97  Aligned_cols=140  Identities=14%  Similarity=0.149  Sum_probs=79.9

Q ss_pred             eeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-----CCCceeee-e--EEEcCCceEEEEE
Q 042763          272 LRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-----HRNLVKLL-G--FVDKGNERLIITE  343 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-----HpnIv~l~-~--~~~~~~~~~lv~E  343 (554)
                      +.|+.|..+.||++...+| .+++|+.....     ..+..|..+++.|.     .|.++... |  +...++..+++||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~-----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE-----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSCH-----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCCH-----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            4566678999999987655 48999887532     23334555555442     34443311 1  1234567799999


Q ss_pred             eCCCCCHH--------------HHHhcccC----C--------CCCHHHH------------------------------
Q 042763          344 FVPNGTLR--------------EHLDGQYG----K--------TLDFNQR------------------------------  367 (554)
Q Consensus       344 ~~~~g~L~--------------~~l~~~~~----~--------~l~~~~~------------------------------  367 (554)
                      |++|..+.              ..++....    .        ...|...                              
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99886542              01111100    0        0122211                              


Q ss_pred             -HHHHHHHHHHHHHhhh----------ccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          368 -LEIAIDVAHGLTYLHL----------YAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       368 -~~i~~qi~~~L~~LH~----------~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                       ..+..++..++++|+.          .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             0111223345666652          1267899999999999998888999999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.94  E-value=2e-05  Score=81.72  Aligned_cols=76  Identities=13%  Similarity=0.084  Sum_probs=49.0

Q ss_pred             ceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh------hhHHHHHHHHHHHHHhCCC--CC-ceeeeeEEEcCCceEE
Q 042763          271 SLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF------ENLQTEFSSEVELLSKIDH--RN-LVKLLGFVDKGNERLI  340 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~------~~~~~~~~~Ei~~l~~l~H--pn-Iv~l~~~~~~~~~~~l  340 (554)
                      .+.||.|.++.||++... +++.++||.......      ......+..|.++++.+..  |. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            557999999999999654 467899997653211      0112456778888887732  33 3455543  3445689


Q ss_pred             EEEeCCCC
Q 042763          341 ITEFVPNG  348 (554)
Q Consensus       341 v~E~~~~g  348 (554)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.81  E-value=0.00012  Score=73.37  Aligned_cols=77  Identities=13%  Similarity=0.194  Sum_probs=60.8

Q ss_pred             CcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC---CCCceeeeeEEEcCCceEEEEEeC
Q 042763          269 SPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID---HRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       269 ~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      ...+.|+.|....+|+.... +..+++|+.....    ...+..|.+.|+.|.   ...+.+++++....+..++||||+
T Consensus        39 ~~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~~----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLINDE-VQTVFVKINERSY----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             CEEEEECCSSSSEEEEEESS-SCEEEEEEEEGGG----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eeeEEeCCccceeeeEEEEC-CCeEEEEeCCccc----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            34567999999999999864 6778899876542    456788989888873   356888888888778899999999


Q ss_pred             CCCCH
Q 042763          346 PNGTL  350 (554)
Q Consensus       346 ~~g~L  350 (554)
                      ++..+
T Consensus       114 ~G~~~  118 (312)
T 3jr1_A          114 NKSKN  118 (312)
T ss_dssp             CCCCC
T ss_pred             cCCCC
Confidence            98764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.75  E-value=9e-05  Score=73.09  Aligned_cols=80  Identities=19%  Similarity=0.263  Sum_probs=57.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCC---CceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR---NLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hp---nIv~l~~~~~~~~~~~lv~  342 (554)
                      ........+|.|..+.||+.+..||+.|++|+...... .....|..|.+.|+.|.--   -+.+++++.    ..++||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~   89 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM   89 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence            45566778999999999999999999999998765432 1224578899999888421   244555542    347899


Q ss_pred             EeCCCCCH
Q 042763          343 EFVPNGTL  350 (554)
Q Consensus       343 E~~~~g~L  350 (554)
                      ||++++..
T Consensus        90 e~l~~~~~   97 (288)
T 3f7w_A           90 EWVDERPP   97 (288)
T ss_dssp             ECCCCCCC
T ss_pred             EeecccCC
Confidence            99987653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.51  E-value=0.00034  Score=72.96  Aligned_cols=78  Identities=17%  Similarity=0.253  Sum_probs=47.4

Q ss_pred             CCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccc-cCCCCCcChhccccCC---CCchhhHHHHHHHH
Q 042763          386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKV-KGTVGYLDPEYMKTYQ---LTTKSDVYSFGVLL  461 (554)
Q Consensus       386 ~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~---~s~ksDVwSlGvil  461 (554)
                      ...++|+|+++.|||++.++ ++++||+.+.......   ...... .-...|.+|+......   -....++......+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~---Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF---DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH---HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH---HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            67899999999999999876 9999999987522110   000000 0112355555443111   12234556777777


Q ss_pred             HHHHhC
Q 042763          462 LEILTG  467 (554)
Q Consensus       462 ~elltg  467 (554)
                      |+.+++
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            777765

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.49  E-value=0.00032  Score=70.61  Aligned_cols=140  Identities=16%  Similarity=0.161  Sum_probs=74.0

Q ss_pred             eeeeccCceE-EEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCC--CCceeeeeEEEcCCceEEEEEeCCCC
Q 042763          272 LRIGEGGFGT-VYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH--RNLVKLLGFVDKGNERLIITEFVPNG  348 (554)
Q Consensus       272 ~~LG~G~fG~-Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~~~~lv~E~~~~g  348 (554)
                      +.|+.|.... +|+....+|..+++|.......    ..+..|+.+++.+..  -.+.+++.+....+  +++||++.+.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            3466665554 6677654467777886654321    234456676666632  23556666533322  7899999776


Q ss_pred             CHHHHHhccc---------------------C---CCCCHHHHH-------HH-------------HHHHHHHHHHhh--
Q 042763          349 TLREHLDGQY---------------------G---KTLDFNQRL-------EI-------------AIDVAHGLTYLH--  382 (554)
Q Consensus       349 ~L~~~l~~~~---------------------~---~~l~~~~~~-------~i-------------~~qi~~~L~~LH--  382 (554)
                      .+.+++....                     .   ..++.....       .+             ...+...++.+.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            7665443210                     0   011111000       00             001111222221  


Q ss_pred             -hccCCCeEeCCCCCCCeEECCC----CcEEEEeecCccc
Q 042763          383 -LYAEKQIIHRDVKSSNILLTES----MRAKVADFGFARL  417 (554)
Q Consensus       383 -~~~~~~ivH~Dlkp~NILl~~~----~~vkl~DfGla~~  417 (554)
                       ......++|||+.+.|||++.+    +.+.|+||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             1124679999999999999875    6899999999876

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.31  E-value=0.00054  Score=67.88  Aligned_cols=73  Identities=14%  Similarity=0.120  Sum_probs=44.4

Q ss_pred             CcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCc-eeeeeEEEcCCceEEEEEeC-C
Q 042763          269 SPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL-VKLLGFVDKGNERLIITEFV-P  346 (554)
Q Consensus       269 ~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lv~E~~-~  346 (554)
                      .-.+.|+.|....+|++     ..+++|+.......  .....+|+.+++.+...++ .+++++.  .+.-++++||+ +
T Consensus        21 ~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~   91 (301)
T 3dxq_A           21 TGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG   91 (301)
T ss_dssp             CSCEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred             cceeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence            33678999999999998     45788877653211  1123457777776642222 4555543  33457899999 5


Q ss_pred             CCCH
Q 042763          347 NGTL  350 (554)
Q Consensus       347 ~g~L  350 (554)
                      +.++
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            5444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.29  E-value=0.0019  Score=64.48  Aligned_cols=142  Identities=14%  Similarity=0.131  Sum_probs=81.5

Q ss_pred             ceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCC--CceeeeeE-----EEcCCceEEEEE
Q 042763          271 SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHR--NLVKLLGF-----VDKGNERLIITE  343 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hp--nIv~l~~~-----~~~~~~~~lv~E  343 (554)
                      ...|+ |....||++...+|+.+++|+......  ....+..|..+++.+...  .+++++..     ...++..+++||
T Consensus        31 ~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           31 LTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             CEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             EEeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence            34577 888999999877787899999874321  124566777877776421  23444432     222455688999


Q ss_pred             eCCCCCHH-----HH---------Hhcc----c---CCCCCHHHH----HHH---------------HHHHHHHHHHhhh
Q 042763          344 FVPNGTLR-----EH---------LDGQ----Y---GKTLDFNQR----LEI---------------AIDVAHGLTYLHL  383 (554)
Q Consensus       344 ~~~~g~L~-----~~---------l~~~----~---~~~l~~~~~----~~i---------------~~qi~~~L~~LH~  383 (554)
                      |++|..+.     .+         ++..    .   ....++...    ..+               ...+...++.+..
T Consensus       108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~  187 (328)
T 1zyl_A          108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA  187 (328)
T ss_dssp             CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence            99875431     11         1110    0   011121110    000               1111112222221


Q ss_pred             c----cCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          384 Y----AEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       384 ~----~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .    ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1    245689999999999999 4 899999998864

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.26  E-value=0.0037  Score=62.18  Aligned_cols=157  Identities=13%  Similarity=0.164  Sum_probs=85.5

Q ss_pred             ChHHHHHhhcCCCc-----ceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCC--ceeee
Q 042763          257 NMSQVVKATRNFSP-----SLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRN--LVKLL  329 (554)
Q Consensus       257 ~~~~l~~~~~~f~~-----~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~  329 (554)
                      +.+++......|..     .+.|+.|....+|+....+| .+++|+......   .+.+..|+.++..|...+  +.+++
T Consensus         8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCccc
Confidence            34455444445544     34567788899999987766 578898875311   134556777777663212  23333


Q ss_pred             eE------EEcCCceEEEEEeCCCCCHHH----H----------Hhcc---cCCC----C---CHHHHHH----------
Q 042763          330 GF------VDKGNERLIITEFVPNGTLRE----H----------LDGQ---YGKT----L---DFNQRLE----------  369 (554)
Q Consensus       330 ~~------~~~~~~~~lv~E~~~~g~L~~----~----------l~~~---~~~~----l---~~~~~~~----------  369 (554)
                      ..      ....+..+++|+|++|..+..    .          ++..   ....    .   .|...+.          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      122356789999998765311    0          1111   0000    0   1221100          


Q ss_pred             --HHHHHHHHHHHhhhc----cCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          370 --IAIDVAHGLTYLHLY----AEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       370 --i~~qi~~~L~~LH~~----~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                        +...+...++.++..    ....++|+|+.+.|||++.+..+.|+||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              001133445555421    135799999999999999876668999998753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.21  E-value=0.00057  Score=71.55  Aligned_cols=72  Identities=18%  Similarity=0.289  Sum_probs=48.9

Q ss_pred             ceeeeccCceEEEEEEEcC--------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCc-eeeeeEEEcCCceEEE
Q 042763          271 SLRIGEGGFGTVYKAQLED--------GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL-VKLLGFVDKGNERLII  341 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~--------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lv  341 (554)
                      .+.|+.|....||++...+        +..+++|+......   ...+.+|..+++.|...++ .++++.+.+    .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence            4568889999999998753        47889998843211   1345578888888753333 567766543    389


Q ss_pred             EEeCCCCC
Q 042763          342 TEFVPNGT  349 (554)
Q Consensus       342 ~E~~~~g~  349 (554)
                      |||++|.+
T Consensus       151 ~e~l~G~~  158 (429)
T 1nw1_A          151 EEYIPSRP  158 (429)
T ss_dssp             ECCCCEEE
T ss_pred             EEEeCCcc
Confidence            99997633

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=97.09  E-value=0.00013  Score=82.39  Aligned_cols=67  Identities=9%  Similarity=0.024  Sum_probs=51.9

Q ss_pred             EeeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccC
Q 042763           25 IFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANH  104 (554)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~  104 (554)
                      +..+++|+|+|+|.+...+.-+..                  ...|++|+|+      ++|.+|+.++.|++|+.|++++
T Consensus       634 L~~LdLs~N~l~g~ip~~l~~l~~------------------L~~L~Ls~N~------l~g~ip~~l~~L~~L~~LdLs~  689 (768)
T 3rgz_A          634 MMFLDMSYNMLSGYIPKEIGSMPY------------------LFILNLGHND------ISGSIPDEVGDLRGLNILDLSS  689 (768)
T ss_dssp             CCEEECCSSCCBSCCCGGGGGCTT------------------CCEEECCSSC------CCSCCCGGGGGCTTCCEEECCS
T ss_pred             ccEEECcCCcccccCCHHHhcccc------------------CCEEeCcCCc------cCCCCChHHhCCCCCCEEECCC
Confidence            456789999999988765433222                  4778888888      8888888888888888888888


Q ss_pred             ceeecccCCCc
Q 042763          105 CIFEGYSGSDY  115 (554)
Q Consensus       105 n~~~g~~~~~~  115 (554)
                      |+++|.+|...
T Consensus       690 N~l~g~ip~~l  700 (768)
T 3rgz_A          690 NKLDGRIPQAM  700 (768)
T ss_dssp             SCCEECCCGGG
T ss_pred             CcccCcCChHH
Confidence            88888888554

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.08  E-value=0.00098  Score=68.45  Aligned_cols=141  Identities=15%  Similarity=0.221  Sum_probs=82.5

Q ss_pred             ceeeeccCceEEEEEEEcC--------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEEE
Q 042763          271 SLRIGEGGFGTVYKAQLED--------GLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~--------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .+.|..|-...+|++...+        +..+++|+.....  .....+.+|..+++.|. +.-..++++++.+    .+|
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v  128 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL  128 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence            3467788899999998652        4789999864321  12345668889888874 3223567766643    299


Q ss_pred             EEeCCCCCHHHH--------------H---hcc---cCCCCC--HHHHHHHHHHHHH-------------------HHHH
Q 042763          342 TEFVPNGTLREH--------------L---DGQ---YGKTLD--FNQRLEIAIDVAH-------------------GLTY  380 (554)
Q Consensus       342 ~E~~~~g~L~~~--------------l---~~~---~~~~l~--~~~~~~i~~qi~~-------------------~L~~  380 (554)
                      |||++|..|..-              |   +..   ..+...  +.++.++..++..                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            999987554310              0   111   011122  3444455544322                   2233


Q ss_pred             hhh-----ccCCCeEeCCCCCCCeEECCC----CcEEEEeecCccc
Q 042763          381 LHL-----YAEKQIIHRDVKSSNILLTES----MRAKVADFGFARL  417 (554)
Q Consensus       381 LH~-----~~~~~ivH~Dlkp~NILl~~~----~~vkl~DfGla~~  417 (554)
                      |..     .....++|+|+.+.|||++.+    +.+.++||..+..
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            321     113469999999999999876    7899999998864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.05  E-value=0.0031  Score=58.82  Aligned_cols=101  Identities=15%  Similarity=0.084  Sum_probs=66.1

Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      -+|.+.|... +.+++++++|.++.|.+.+|.-+-.  ...-..+=+.|..|++..+|.|-+.+ +.+.           
T Consensus        33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence            3788888754 5789999999999999999877621  11111333456899999999988764 1110           


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCC
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGR  468 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~  468 (554)
                          .....+.+||... ...+.+.=|||||+++|.-+-=.
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence                0122456788663 35678899999999999988633

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=97.00  E-value=0.00016  Score=81.61  Aligned_cols=66  Identities=14%  Similarity=0.079  Sum_probs=57.8

Q ss_pred             EeeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccC
Q 042763           25 IFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANH  104 (554)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~  104 (554)
                      ...+++|+|+|+|.+-..+.-+..                  ...||+|+|+      ++|.+|..++.|+.|+.|++++
T Consensus       658 L~~L~Ls~N~l~g~ip~~l~~L~~------------------L~~LdLs~N~------l~g~ip~~l~~l~~L~~L~ls~  713 (768)
T 3rgz_A          658 LFILNLGHNDISGSIPDEVGDLRG------------------LNILDLSSNK------LDGRIPQAMSALTMLTEIDLSN  713 (768)
T ss_dssp             CCEEECCSSCCCSCCCGGGGGCTT------------------CCEEECCSSC------CEECCCGGGGGCCCCSEEECCS
T ss_pred             CCEEeCcCCccCCCCChHHhCCCC------------------CCEEECCCCc------ccCcCChHHhCCCCCCEEECcC
Confidence            346899999999999876554433                  5899999999      9999999999999999999999


Q ss_pred             ceeecccCCC
Q 042763          105 CIFEGYSGSD  114 (554)
Q Consensus       105 n~~~g~~~~~  114 (554)
                      |+++|.||..
T Consensus       714 N~l~g~iP~~  723 (768)
T 3rgz_A          714 NNLSGPIPEM  723 (768)
T ss_dssp             SEEEEECCSS
T ss_pred             CcccccCCCc
Confidence            9999999953

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.00  E-value=0.0018  Score=68.21  Aligned_cols=74  Identities=18%  Similarity=0.134  Sum_probs=47.7

Q ss_pred             ceeeeccCceEEEEEEEcC-CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCc-eeeeeEEEcCCceEEEEEeCCCC
Q 042763          271 SLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL-VKLLGFVDKGNERLIITEFVPNG  348 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~~~~~~~~lv~E~~~~g  348 (554)
                      .+.|+.|-...+|++...+ +..+++|+..... ... -+-.+|..+++.|...++ .++++.+.  +  .+||||++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            4568889999999998775 4788898875432 111 112578888888865444 56777663  2  3599999874


Q ss_pred             CH
Q 042763          349 TL  350 (554)
Q Consensus       349 ~L  350 (554)
                      +|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            43

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.87  E-value=0.0014  Score=66.92  Aligned_cols=73  Identities=18%  Similarity=0.166  Sum_probs=43.8

Q ss_pred             ceeeeccCceEEEEEEEcC---------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCC-ceeeeeEEEcCCceEE
Q 042763          271 SLRIGEGGFGTVYKAQLED---------GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRN-LVKLLGFVDKGNERLI  340 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~---------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~~~~~~~~~~~l  340 (554)
                      .+.|+.|....+|++...+         +..+++|+..... ... .+...|.++++.+...+ ..++++..  .  -++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence            3467889899999998654         2678889876532 111 12356778887774333 34666544  2  268


Q ss_pred             EEEeCCCCC
Q 042763          341 ITEFVPNGT  349 (554)
Q Consensus       341 v~E~~~~g~  349 (554)
                      ||||++|..
T Consensus       112 v~e~i~G~~  120 (369)
T 3c5i_A          112 IEEWLYGDP  120 (369)
T ss_dssp             EEECCCSEE
T ss_pred             EEEEecCCc
Confidence            999998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.79  E-value=0.0025  Score=64.30  Aligned_cols=32  Identities=19%  Similarity=0.335  Sum_probs=28.5

Q ss_pred             CCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          386 EKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       386 ~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      ...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            35699999999999999888899999988765

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=96.22  E-value=0.0007  Score=67.50  Aligned_cols=44  Identities=14%  Similarity=0.100  Sum_probs=38.9

Q ss_pred             cCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCCC
Q 042763           65 CGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSD  114 (554)
Q Consensus        65 ~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~~  114 (554)
                      ....+|++++|+      ++|.+|..+..+++|+.|++++|+++|.+|..
T Consensus       244 ~~L~~L~Ls~N~------l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~  287 (313)
T 1ogq_A          244 KNLNGLDLRNNR------IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG  287 (313)
T ss_dssp             TTCCEEECCSSC------CEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred             CCCCEEECcCCc------ccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence            357889999999      99999999999999999999999999988864

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=95.81  E-value=0.0023  Score=58.86  Aligned_cols=64  Identities=9%  Similarity=-0.069  Sum_probs=48.3

Q ss_pred             EEeeecCCCcccccCCch--hHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhh
Q 042763           24 SIFLPRESSLDISSNFAP--SSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHY  101 (554)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~  101 (554)
                      .+..+++++|+|.+-...  +..+..                   ..+|++++|+      ++|..|..|..+++|+.|+
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~-------------------L~~L~Ls~N~------l~~~~~~~~~~l~~L~~L~   84 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPH-------------------LVKLELKRNQ------LTGIEPNAFEGASHIQELQ   84 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTT-------------------CCEEECCSSC------CCCBCTTTTTTCTTCCEEE
T ss_pred             CCCEEECCCCcCCccCCccccccCCC-------------------CCEEECCCCC------CCCcCHhHcCCcccCCEEE
Confidence            445677888888764432  222222                   5889999999      9998899999999999999


Q ss_pred             ccCceeecccC
Q 042763          102 ANHCIFEGYSG  112 (554)
Q Consensus       102 ~~~n~~~g~~~  112 (554)
                      +++|++++..+
T Consensus        85 Ls~N~l~~~~~   95 (192)
T 1w8a_A           85 LGENKIKEISN   95 (192)
T ss_dssp             CCSCCCCEECS
T ss_pred             CCCCcCCccCH
Confidence            99999987555

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=95.63  E-value=0.0019  Score=64.89  Aligned_cols=43  Identities=9%  Similarity=-0.062  Sum_probs=32.0

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCCCc
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDY  115 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~~~  115 (554)
                      ..+|++++|+      +.|.+|+.++.+++|+.|++++|++.+.+|...
T Consensus       231 L~~L~Ls~n~------~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~  273 (328)
T 4fcg_A          231 LEELDLRGCT------ALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDI  273 (328)
T ss_dssp             CCEEECTTCT------TCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTG
T ss_pred             CCEEECcCCc------chhhhHHHhcCCCCCCEEECCCCCchhhcchhh
Confidence            4777777777      777777777777777777777777777777543

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=95.54  E-value=0.0047  Score=67.90  Aligned_cols=28  Identities=11%  Similarity=0.025  Sum_probs=24.8

Q ss_pred             EEcCccccchhhhhhhhhhhccCceeecc
Q 042763           82 YINGNLVDKFSFCKVIQFHYANHCIFEGY  110 (554)
Q Consensus        82 ~~~G~~p~~~~~~~~l~~l~~~~n~~~g~  110 (554)
                      .++| +|+.++.|++|+.|++++|+++|.
T Consensus       194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~  221 (636)
T 4eco_A          194 NITF-VSKAVMRLTKLRQFYMGNSPFVAE  221 (636)
T ss_dssp             EEEE-ECGGGGGCTTCCEEEEESCCCCGG
T ss_pred             CCcc-CCHHHhcccCCCEEECcCCccccc
Confidence            4888 999999999999999999999985

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=95.49  E-value=0.0024  Score=64.33  Aligned_cols=37  Identities=14%  Similarity=0.110  Sum_probs=29.6

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      +.+|+|++|+      |+|..|..|..|++|+.|++++|+|++
T Consensus        58 L~~L~l~~N~------l~~~~~~~~~~l~~L~~L~l~~N~l~~   94 (347)
T 2ifg_A           58 LRNLTIVKSG------LRFVAPDAFHFTPRLSRLNLSFNALES   94 (347)
T ss_dssp             CSEEECCSSC------CCEECTTGGGSCSCCCEEECCSSCCSC
T ss_pred             CCEEECCCCc------cceeCHHHhcCCcCCCEEeCCCCccce
Confidence            4778888888      888777788888888888888888874

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=95.48  E-value=0.0036  Score=62.29  Aligned_cols=68  Identities=13%  Similarity=0.077  Sum_probs=48.7

Q ss_pred             EEeeecCCCccccc--CCchhHHHHHHHhhhhhhccceeeccccCCCceeec-cCCcceeEEEcCccccchhhhhhhhhh
Q 042763           24 SIFLPRESSLDISS--NFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYS-NSNEVELFYINGNLVDKFSFCKVIQFH  100 (554)
Q Consensus        24 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s-~n~~~~~~~~~G~~p~~~~~~~~l~~l  100 (554)
                      .+..+++++|+|.|  .+.+.+.-+.                  ...+|+++ +|+      ++|.+|+.|+.|++|+.|
T Consensus        51 ~l~~L~L~~~~l~~~~~~~~~l~~l~------------------~L~~L~L~~~n~------l~~~~p~~l~~l~~L~~L  106 (313)
T 1ogq_A           51 RVNNLDLSGLNLPKPYPIPSSLANLP------------------YLNFLYIGGINN------LVGPIPPAIAKLTQLHYL  106 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCT------------------TCSEEEEEEETT------EESCCCGGGGGCTTCSEE
T ss_pred             eEEEEECCCCCccCCcccChhHhCCC------------------CCCeeeCCCCCc------ccccCChhHhcCCCCCEE
Confidence            46778899999998  5544322211                  25778888 488      888888888888888888


Q ss_pred             hccCceeecccCCCc
Q 042763          101 YANHCIFEGYSGSDY  115 (554)
Q Consensus       101 ~~~~n~~~g~~~~~~  115 (554)
                      ++++|+++|.+|...
T Consensus       107 ~Ls~n~l~~~~p~~~  121 (313)
T 1ogq_A          107 YITHTNVSGAIPDFL  121 (313)
T ss_dssp             EEEEECCEEECCGGG
T ss_pred             ECcCCeeCCcCCHHH
Confidence            888888887776443

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=95.33  E-value=0.0063  Score=54.67  Aligned_cols=36  Identities=6%  Similarity=-0.099  Sum_probs=22.6

Q ss_pred             CceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           68 DHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        68 ~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      .+|++++|+      +++..|..|..+++|+.|++++|++++
T Consensus        33 ~~L~L~~N~------i~~~~~~~~~~l~~L~~L~Ls~N~l~~   68 (170)
T 3g39_A           33 QVLYLYDNQ------ITKLEPGVFDRLTQLTRLDLDNNQLTV   68 (170)
T ss_dssp             SEEECCSSC------CCCCCTTTTTTCTTCSEEECCSSCCCC
T ss_pred             cEEEcCCCc------CCccChhhhcCcccCCEEECCCCCcCc
Confidence            556666666      666666666666666666666666663

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=95.33  E-value=0.0052  Score=61.61  Aligned_cols=43  Identities=9%  Similarity=0.018  Sum_probs=35.8

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCCCc
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDY  115 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~~~  115 (554)
                      ...+|++++|+      ++| +|+.++.|++|+.|++++|++.+.+|...
T Consensus       207 ~L~~L~L~~N~------l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~  249 (328)
T 4fcg_A          207 NLKSLKIRNSP------LSA-LGPAIHHLPKLEELDLRGCTALRNYPPIF  249 (328)
T ss_dssp             TCCEEEEESSC------CCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCT
T ss_pred             CCCEEEccCCC------CCc-CchhhccCCCCCEEECcCCcchhhhHHHh
Confidence            36889999999      885 77789999999999999999988887543

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=95.32  E-value=0.0052  Score=69.93  Aligned_cols=57  Identities=4%  Similarity=-0.037  Sum_probs=35.5

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCCCcc-ccccccccccCCCCC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDYC-RLDLSLAKLSFSPGR  131 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~~~~-~~~~~~~~~~~~~~~  131 (554)
                      ...|++++|+      +++-.|..+.  ++|+.|++++|+++|..|..+. ...+.+.+++|..+.
T Consensus       506 L~~L~Ls~N~------l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c  563 (844)
T 3j0a_A          506 LRGLSLNSNR------LTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICEC  563 (844)
T ss_dssp             CSEEEEESCC------CSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSS
T ss_pred             hheeECCCCC------CCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccc
Confidence            5677777777      7765555555  6777777777777776664332 223556666666544

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=95.16  E-value=0.0066  Score=55.65  Aligned_cols=41  Identities=7%  Similarity=0.032  Sum_probs=30.3

Q ss_pred             CCceeeccCCcceeEEEcCcccc-chhhhhhhhhhhccCceeecccCC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVD-KFSFCKVIQFHYANHCIFEGYSGS  113 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~-~~~~~~~l~~l~~~~n~~~g~~~~  113 (554)
                      ..+|++++|+      +++..|+ .|+.+++|+.|++++|++++-.|.
T Consensus        31 l~~L~l~~n~------i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~   72 (192)
T 1w8a_A           31 TTELLLNDNE------LGRISSDGLFGRLPHLVKLELKRNQLTGIEPN   72 (192)
T ss_dssp             CSEEECCSCC------CCSBCCSCSGGGCTTCCEEECCSSCCCCBCTT
T ss_pred             CCEEECCCCc------CCccCCccccccCCCCCEEECCCCCCCCcCHh
Confidence            5778888888      7766654 478888888888888888765553

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=95.10  E-value=0.0063  Score=57.15  Aligned_cols=41  Identities=5%  Similarity=0.010  Sum_probs=33.3

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGS  113 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~  113 (554)
                      ..+|++++|+      +++..|..|..|++|+.|++++|++++-.+.
T Consensus        83 L~~L~Ls~N~------l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  123 (220)
T 2v70_A           83 VNEILLTSNR------LENVQHKMFKGLESLKTLMLRSNRITCVGND  123 (220)
T ss_dssp             CCEEECCSSC------CCCCCGGGGTTCSSCCEEECTTSCCCCBCTT
T ss_pred             CCEEECCCCc------cCccCHhHhcCCcCCCEEECCCCcCCeECHh
Confidence            5788888888      8887778888888888888888888865553

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.09  E-value=0.023  Score=59.08  Aligned_cols=140  Identities=11%  Similarity=0.124  Sum_probs=82.8

Q ss_pred             ceeeeccCceEEEEEEEcC--------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEEE
Q 042763          271 SLRIGEGGFGTVYKAQLED--------GLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~--------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv  341 (554)
                      .+.|..|-...+|+....+        +..+++|+..... +. .-+..+|..+++.+. +.-..++++.+.    -++|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-ch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence            4567889999999998763        5788999865432 11 112346777777774 222445565332    2789


Q ss_pred             EEeCCCCCHHH-------H-------H---hcc-------c---CC-CCCHHHHHHHHHHH-------------------
Q 042763          342 TEFVPNGTLRE-------H-------L---DGQ-------Y---GK-TLDFNQRLEIAIDV-------------------  374 (554)
Q Consensus       342 ~E~~~~g~L~~-------~-------l---~~~-------~---~~-~l~~~~~~~i~~qi-------------------  374 (554)
                      |||++|..|..       .       +   +..       .   .+ +.-+.++.++..++                   
T Consensus       149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  228 (424)
T 3mes_A          149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI  228 (424)
T ss_dssp             EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred             EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence            99998865321       0       0   100       0   11 11234433333222                   


Q ss_pred             HHHHHHhhh---------------------ccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          375 AHGLTYLHL---------------------YAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       375 ~~~L~~LH~---------------------~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      ...+.+|..                     .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus       229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            222333321                     11345899999999999 7888999999998864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=95.07  E-value=0.0053  Score=69.88  Aligned_cols=26  Identities=15%  Similarity=0.094  Sum_probs=21.7

Q ss_pred             EcCccccchhhhhhhhhhhccCceeec
Q 042763           83 INGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        83 ~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ++| ||+.++.|++|+.|++++|+++|
T Consensus       437 L~~-IP~~l~~L~~L~~L~Ls~N~Lsg  462 (876)
T 4ecn_A          437 ITF-ISKAIQRLTKLQIIYFANSPFTY  462 (876)
T ss_dssp             EEE-ECGGGGGCTTCCEEEEESCCCCG
T ss_pred             ccc-hhHHHhcCCCCCEEECcCCcCCC
Confidence            666 88888888888888888888887

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=95.02  E-value=0.0081  Score=54.22  Aligned_cols=37  Identities=16%  Similarity=0.105  Sum_probs=29.6

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ..+|++++|+      +++..|..|+.+++|+.|++++|++++
T Consensus        35 L~~L~Ls~N~------l~~~~~~~~~~l~~L~~L~Ls~N~l~~   71 (174)
T 2r9u_A           35 KQRLWLNNNQ------ITKLEPGVFDHLVNLQQLYFNSNKLTA   71 (174)
T ss_dssp             CSEEECCSSC------CCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CcEEEeCCCC------ccccCHHHhcCCcCCCEEECCCCCCCc
Confidence            4778888888      888777888888888888888888875

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=94.98  E-value=0.0028  Score=55.33  Aligned_cols=38  Identities=11%  Similarity=0.131  Sum_probs=28.3

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ...+|++++|.      +++.+|..+..|++|+.|++++|.+++
T Consensus        65 ~L~~L~Ls~n~------i~~~~~~~~~~l~~L~~L~ls~N~i~~  102 (149)
T 2je0_A           65 KLKKLELSDNR------VSGGLEVLAEKCPNLTHLNLSGNKIKD  102 (149)
T ss_dssp             TCCEEECCSSC------CCSCTHHHHHHCTTCCEEECTTSCCCS
T ss_pred             CCCEEECCCCc------ccchHHHHhhhCCCCCEEECCCCcCCC
Confidence            45777777777      777777777777777777777777765

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=94.76  E-value=0.0055  Score=53.39  Aligned_cols=40  Identities=10%  Similarity=0.151  Sum_probs=35.2

Q ss_pred             CCCceeeccCCcceeEEEcCc-cccchhhhhhhhhhhccCceeeccc
Q 042763           66 GADHIAYSNSNEVELFYINGN-LVDKFSFCKVIQFHYANHCIFEGYS  111 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~-~p~~~~~~~~l~~l~~~~n~~~g~~  111 (554)
                      ...+|++++|.      +++. .|..+..|++|+.|++++|.+++..
T Consensus        89 ~L~~L~ls~N~------i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~  129 (149)
T 2je0_A           89 NLTHLNLSGNK------IKDLSTIEPLKKLENLKSLDLFNCEVTNLN  129 (149)
T ss_dssp             TCCEEECTTSC------CCSHHHHGGGGGCTTCCEEECTTCGGGGST
T ss_pred             CCCEEECCCCc------CCChHHHHHHhhCCCCCEEeCcCCcccchH
Confidence            36999999999      9984 5699999999999999999998643

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=94.70  E-value=0.014  Score=65.08  Aligned_cols=64  Identities=11%  Similarity=0.041  Sum_probs=48.0

Q ss_pred             EeeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccC
Q 042763           25 IFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANH  104 (554)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~  104 (554)
                      +..++||+|+|. ++.+-..-                  ...+.+|+|++|.      |+ .+|+.|+.|++|+.|++++
T Consensus       226 L~~L~Ls~n~l~-~l~~~~~~------------------l~~L~~L~Ls~N~------l~-~lp~~~~~l~~L~~L~Ls~  279 (727)
T 4b8c_D          226 WHALDLSNLQIF-NISANIFK------------------YDFLTRLYLNGNS------LT-ELPAEIKNLSNLRVLDLSH  279 (727)
T ss_dssp             CCEEECTTSCCS-CCCGGGGG------------------CCSCSCCBCTTSC------CS-CCCGGGGGGTTCCEEECTT
T ss_pred             CcEEECCCCCCC-CCChhhcC------------------CCCCCEEEeeCCc------Cc-ccChhhhCCCCCCEEeCcC
Confidence            345788888887 44432211                  1236899999999      88 8999999999999999999


Q ss_pred             ceeecccCCCc
Q 042763          105 CIFEGYSGSDY  115 (554)
Q Consensus       105 n~~~g~~~~~~  115 (554)
                      |+++ .+|...
T Consensus       280 N~l~-~lp~~~  289 (727)
T 4b8c_D          280 NRLT-SLPAEL  289 (727)
T ss_dssp             SCCS-SCCSSG
T ss_pred             CcCC-ccChhh
Confidence            9998 777554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=94.67  E-value=0.012  Score=63.86  Aligned_cols=59  Identities=14%  Similarity=0.195  Sum_probs=43.0

Q ss_pred             eeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCc
Q 042763           26 FLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHC  105 (554)
Q Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n  105 (554)
                      ..+++|+|+|++ +..+..+..                   ..+|++++|+      ++ .+|+.++.|++|+.|++++|
T Consensus       444 ~~L~Ls~n~l~~-lp~~~~l~~-------------------L~~L~Ls~N~------l~-~lp~~~~~l~~L~~L~Ls~N  496 (567)
T 1dce_A          444 RVLHLAHKDLTV-LCHLEQLLL-------------------VTHLDLSHNR------LR-ALPPALAALRCLEVLQASDN  496 (567)
T ss_dssp             SEEECTTSCCSS-CCCGGGGTT-------------------CCEEECCSSC------CC-CCCGGGGGCTTCCEEECCSS
T ss_pred             eEEEecCCCCCC-CcCcccccc-------------------CcEeecCccc------cc-ccchhhhcCCCCCEEECCCC
Confidence            347788888876 433333333                   4788888888      77 78888888888888888888


Q ss_pred             eeecccC
Q 042763          106 IFEGYSG  112 (554)
Q Consensus       106 ~~~g~~~  112 (554)
                      ++++ +|
T Consensus       497 ~l~~-lp  502 (567)
T 1dce_A          497 ALEN-VD  502 (567)
T ss_dssp             CCCC-CG
T ss_pred             CCCC-Cc
Confidence            8886 44

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=94.57  E-value=0.0074  Score=65.41  Aligned_cols=62  Identities=8%  Similarity=-0.038  Sum_probs=44.4

Q ss_pred             EeeecCCCcccccCCch-hHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhcc
Q 042763           25 IFLPRESSLDISSNFAP-SSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYAN  103 (554)
Q Consensus        25 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~  103 (554)
                      +..+++|+|+|+ .+.. +..+.                   .+.+|++++|+      ++| +| .++.|++|+.|+++
T Consensus       465 L~~L~Ls~N~l~-~lp~~~~~l~-------------------~L~~L~Ls~N~------l~~-lp-~l~~l~~L~~L~Ls  516 (567)
T 1dce_A          465 VTHLDLSHNRLR-ALPPALAALR-------------------CLEVLQASDNA------LEN-VD-GVANLPRLQELLLC  516 (567)
T ss_dssp             CCEEECCSSCCC-CCCGGGGGCT-------------------TCCEEECCSSC------CCC-CG-GGTTCSSCCEEECC
T ss_pred             CcEeecCccccc-ccchhhhcCC-------------------CCCEEECCCCC------CCC-Cc-ccCCCCCCcEEECC
Confidence            445678888877 4532 22222                   25888999888      887 67 88889999999999


Q ss_pred             Cceeeccc-CCC
Q 042763          104 HCIFEGYS-GSD  114 (554)
Q Consensus       104 ~n~~~g~~-~~~  114 (554)
                      +|++++.. |..
T Consensus       517 ~N~l~~~~~p~~  528 (567)
T 1dce_A          517 NNRLQQSAAIQP  528 (567)
T ss_dssp             SSCCCSSSTTGG
T ss_pred             CCCCCCCCCcHH
Confidence            99888765 543

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=94.41  E-value=0.011  Score=64.18  Aligned_cols=40  Identities=13%  Similarity=0.084  Sum_probs=30.4

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++|+|+      +++..|..|++|++|+.|++++|++++-.+
T Consensus       496 L~~L~Ls~N~------L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~  535 (635)
T 4g8a_A          496 LTFLDLSQCQ------LEQLSPTAFNSLSSLQVLNMSHNNFFSLDT  535 (635)
T ss_dssp             CCEEECTTSC------CCEECTTTTTTCTTCCEEECTTSCCCBCCC
T ss_pred             cCEEECCCCc------cCCcChHHHcCCCCCCEEECCCCcCCCCCh
Confidence            4778888888      787777788888888888888888776443

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=94.40  E-value=0.014  Score=53.62  Aligned_cols=40  Identities=15%  Similarity=-0.020  Sum_probs=34.8

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|+      +++..|..|..|++|+.|++++|++++-.+
T Consensus        56 L~~L~Ls~N~------i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~   95 (193)
T 2wfh_A           56 LTLIDLSNNR------ISTLSNQSFSNMTQLLTLILSYNRLRCIPP   95 (193)
T ss_dssp             CCEEECCSSC------CCCCCTTTTTTCTTCCEEECCSSCCCBCCT
T ss_pred             CCEEECCCCc------CCEeCHhHccCCCCCCEEECCCCccCEeCH
Confidence            5889999999      998888889999999999999999986444

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=94.21  E-value=0.0046  Score=55.13  Aligned_cols=38  Identities=11%  Similarity=-0.022  Sum_probs=22.9

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ...+|++++|.      +++.+|..+..|++|+.|++++|++++
T Consensus        72 ~L~~L~Ls~N~------l~~~~~~~~~~l~~L~~L~Ls~N~l~~  109 (168)
T 2ell_A           72 KLKKLELSENR------IFGGLDMLAEKLPNLTHLNLSGNKLKD  109 (168)
T ss_dssp             SCCEEEEESCC------CCSCCCHHHHHCTTCCEEECBSSSCCS
T ss_pred             CCCEEECcCCc------CchHHHHHHhhCCCCCEEeccCCccCc
Confidence            34566666666      666556555566666666666666654

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=93.86  E-value=0.016  Score=54.26  Aligned_cols=62  Identities=15%  Similarity=-0.029  Sum_probs=47.5

Q ss_pred             eeecCCCcccccCCch--hHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhcc
Q 042763           26 FLPRESSLDISSNFAP--SSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYAN  103 (554)
Q Consensus        26 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~  103 (554)
                      ..+++|+|+|++-..+  +..+..                   ..+|++++|+      +++..|..|..+++|+.|+++
T Consensus        35 ~~L~L~~N~l~~~~~~~~~~~l~~-------------------L~~L~L~~N~------i~~i~~~~~~~l~~L~~L~Ls   89 (220)
T 2v70_A           35 AELRLNNNEFTVLEATGIFKKLPQ-------------------LRKINFSNNK------ITDIEEGAFEGASGVNEILLT   89 (220)
T ss_dssp             SEEECCSSCCCEECCCCCGGGCTT-------------------CCEEECCSSC------CCEECTTTTTTCTTCCEEECC
T ss_pred             CEEEcCCCcCCccCchhhhccCCC-------------------CCEEECCCCc------CCEECHHHhCCCCCCCEEECC
Confidence            3567888888775332  222222                   5899999999      998888899999999999999


Q ss_pred             CceeecccC
Q 042763          104 HCIFEGYSG  112 (554)
Q Consensus       104 ~n~~~g~~~  112 (554)
                      +|++++-.+
T Consensus        90 ~N~l~~~~~   98 (220)
T 2v70_A           90 SNRLENVQH   98 (220)
T ss_dssp             SSCCCCCCG
T ss_pred             CCccCccCH
Confidence            999986544

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=93.72  E-value=0.023  Score=51.00  Aligned_cols=40  Identities=10%  Similarity=0.130  Sum_probs=33.2

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|+      +++-.+..|..+++|+.|++++|++++..+
T Consensus        54 L~~L~l~~n~------l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~   93 (177)
T 2o6r_A           54 LTKLSLSQNQ------IQSLPDGVFDKLTKLTILYLHENKLQSLPN   93 (177)
T ss_dssp             CSEEECCSSC------CCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             ccEEECCCCc------ceEeChhHccCCCccCEEECCCCCccccCH
Confidence            5889999999      887666778999999999999999986444

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=93.69  E-value=0.015  Score=51.70  Aligned_cols=62  Identities=3%  Similarity=-0.113  Sum_probs=38.6

Q ss_pred             EeeecCCCcccc-cCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhcc
Q 042763           25 IFLPRESSLDIS-SNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYAN  103 (554)
Q Consensus        25 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~  103 (554)
                      +..+++++|+|. |.+...+.-+.                  ...+|++++|+      +++.  +.++.|++|+.|+++
T Consensus        26 L~~L~l~~n~l~~~~i~~~~~~l~------------------~L~~L~l~~n~------l~~~--~~~~~l~~L~~L~Ls   79 (168)
T 2ell_A           26 VRELVLDNCKSNDGKIEGLTAEFV------------------NLEFLSLINVG------LISV--SNLPKLPKLKKLELS   79 (168)
T ss_dssp             CSEEECCSCBCBTTBCSSCCGGGG------------------GCCEEEEESSC------CCCC--SSCCCCSSCCEEEEE
T ss_pred             CCEEECCCCCCChhhHHHHHHhCC------------------CCCEEeCcCCC------CCCh--hhhccCCCCCEEECc
Confidence            344566777776 55554421111                  14677777777      6665  667777777777777


Q ss_pred             CceeecccC
Q 042763          104 HCIFEGYSG  112 (554)
Q Consensus       104 ~n~~~g~~~  112 (554)
                      +|++++.+|
T Consensus        80 ~N~l~~~~~   88 (168)
T 2ell_A           80 ENRIFGGLD   88 (168)
T ss_dssp             SCCCCSCCC
T ss_pred             CCcCchHHH
Confidence            777776544

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=93.64  E-value=0.027  Score=53.02  Aligned_cols=41  Identities=2%  Similarity=-0.128  Sum_probs=34.2

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCCC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSD  114 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~~  114 (554)
                      ..+|++++|+      +++..+..|..+++|+.|++++|+++ .+|..
T Consensus        90 L~~L~Ls~N~------l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~  130 (229)
T 3e6j_A           90 LTVLDLGTNQ------LTVLPSAVFDRLVHLKELFMCCNKLT-ELPRG  130 (229)
T ss_dssp             CCEEECCSSC------CCCCCTTTTTTCTTCCEEECCSSCCC-SCCTT
T ss_pred             cCEEECCCCc------CCccChhHhCcchhhCeEeccCCccc-ccCcc
Confidence            5889999999      88777777899999999999999988 66643

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=93.56  E-value=0.022  Score=53.34  Aligned_cols=40  Identities=10%  Similarity=-0.038  Sum_probs=29.9

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|+      +++-.+..|..+++|+.|++++|++++-.+
T Consensus        82 L~~L~Ls~N~------l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~  121 (220)
T 2v9t_B           82 LNSLVLYGNK------ITELPKSLFEGLFSLQLLLLNANKINCLRV  121 (220)
T ss_dssp             CCEEECCSSC------CCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CCEEECCCCc------CCccCHhHccCCCCCCEEECCCCCCCEeCH
Confidence            5788888888      775544567888888888888888876544

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=93.54  E-value=0.018  Score=51.58  Aligned_cols=80  Identities=8%  Similarity=-0.061  Sum_probs=54.5

Q ss_pred             EeeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccC
Q 042763           25 IFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANH  104 (554)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~  104 (554)
                      +..+++|+|+|++-....+.-+                  -...+|++++|+      +++-.|..|..+++|+.|++++
T Consensus        32 l~~L~L~~N~i~~~~~~~~~~l------------------~~L~~L~Ls~N~------l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           32 TQVLYLYDNQITKLEPGVFDRL------------------TQLTRLDLDNNQ------LTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             CSEEECCSSCCCCCCTTTTTTC------------------TTCSEEECCSSC------CCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEcCCCcCCccChhhhcCc------------------ccCCEEECCCCC------cCccChhhccCCCCCCEEECCC
Confidence            3457888998887543322211                  125899999999      9987778899999999999999


Q ss_pred             ceeecccCCCc----cccccccccccCC
Q 042763          105 CIFEGYSGSDY----CRLDLSLAKLSFS  128 (554)
Q Consensus       105 n~~~g~~~~~~----~~~~~~~~~~~~~  128 (554)
                      |++++-.+..+    .++.+.+.++.|.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence            99996433211    1223445555554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=93.26  E-value=0.017  Score=54.12  Aligned_cols=40  Identities=15%  Similarity=-0.002  Sum_probs=35.3

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGS  113 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~  113 (554)
                      ..+|++++|+      +++..|+.|..|++|+.|++++|+++ .++.
T Consensus        58 L~~L~Ls~N~------i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~   97 (220)
T 2v9t_B           58 LRRIDLSNNQ------ISELAPDAFQGLRSLNSLVLYGNKIT-ELPK   97 (220)
T ss_dssp             CCEEECCSSC------CCEECTTTTTTCSSCCEEECCSSCCC-CCCT
T ss_pred             CCEEECCCCc------CCCcCHHHhhCCcCCCEEECCCCcCC-ccCH
Confidence            6899999999      99888999999999999999999998 4443

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=93.22  E-value=0.033  Score=51.02  Aligned_cols=36  Identities=6%  Similarity=0.023  Sum_probs=20.6

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ..+|++++|+      ++ .+|..|..+++|+.|++++|++++
T Consensus        33 l~~L~L~~n~------i~-~ip~~~~~l~~L~~L~Ls~N~i~~   68 (193)
T 2wfh_A           33 VTELYLDGNQ------FT-LVPKELSNYKHLTLIDLSNNRIST   68 (193)
T ss_dssp             CCEEECCSSC------CC-SCCGGGGGCTTCCEEECCSSCCCC
T ss_pred             CCEEECCCCc------Cc-hhHHHhhcccCCCEEECCCCcCCE
Confidence            3555566555      54 455556666666666666666554

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=93.18  E-value=0.028  Score=62.81  Aligned_cols=41  Identities=15%  Similarity=0.058  Sum_probs=34.5

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCCCc
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDY  115 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~~~  115 (554)
                      ...|+|++|.      +. .+|+.+..|++|+.|++++|.++ .+|...
T Consensus       226 L~~L~Ls~n~------l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~  266 (727)
T 4b8c_D          226 WHALDLSNLQ------IF-NISANIFKYDFLTRLYLNGNSLT-ELPAEI  266 (727)
T ss_dssp             CCEEECTTSC------CS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGG
T ss_pred             CcEEECCCCC------CC-CCChhhcCCCCCCEEEeeCCcCc-ccChhh
Confidence            5789999999      77 78888889999999999999998 777544

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.12  E-value=0.044  Score=56.49  Aligned_cols=29  Identities=31%  Similarity=0.587  Sum_probs=25.1

Q ss_pred             eEeCCCCCCCeEE------CCCCcEEEEeecCccc
Q 042763          389 IIHRDVKSSNILL------TESMRAKVADFGFARL  417 (554)
Q Consensus       389 ivH~Dlkp~NILl------~~~~~vkl~DfGla~~  417 (554)
                      ++|+|+.+.|||+      +++..++++||-+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4567899999998864

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=92.77  E-value=0.011  Score=64.87  Aligned_cols=44  Identities=11%  Similarity=0.011  Sum_probs=40.2

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCce-eec-ccCCCc
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCI-FEG-YSGSDY  115 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~-~~g-~~~~~~  115 (554)
                      ...+|++++|+      ++|.+|+.++.|++|+.|++++|+ ++| .+|...
T Consensus       250 ~L~~L~L~~n~------l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~  295 (636)
T 4eco_A          250 DLTDVEVYNCP------NLTKLPTFLKALPEMQLINVACNRGISGEQLKDDW  295 (636)
T ss_dssp             TCCEEEEECCT------TCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHH
T ss_pred             CCCEEEecCCc------CCccChHHHhcCCCCCEEECcCCCCCccccchHHH
Confidence            47999999999      999999999999999999999998 999 888544

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=92.69  E-value=0.019  Score=52.74  Aligned_cols=64  Identities=11%  Similarity=0.194  Sum_probs=32.7

Q ss_pred             EeeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccC
Q 042763           25 IFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANH  104 (554)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~  104 (554)
                      +...+++.+++.|.+.++..+-..     |.       ......+|++++|+      +++ +| .+..|++|+.|++++
T Consensus        20 l~~l~l~~~~l~~~~~~l~~l~~~-----~~-------~l~~L~~L~ls~n~------l~~-l~-~~~~l~~L~~L~l~~   79 (198)
T 1ds9_A           20 VVATEAEKVELHGMIPPIEKMDAT-----LS-------TLKACKHLALSTNN------IEK-IS-SLSGMENLRILSLGR   79 (198)
T ss_dssp             CCCTTCSEEECCBCCTTCCCCHHH-----HH-------HTTTCSEEECSEEE------ESC-CC-CHHHHTTCCEEEEEE
T ss_pred             ccCcchheeEeccccCcHhhhhHH-----Hh-------cCCCCCEEECCCCC------Ccc-cc-ccccCCCCCEEECCC
Confidence            345677777777776652111100     00       00113556666655      555 44 555566666666666


Q ss_pred             ceee
Q 042763          105 CIFE  108 (554)
Q Consensus       105 n~~~  108 (554)
                      |+++
T Consensus        80 n~l~   83 (198)
T 1ds9_A           80 NLIK   83 (198)
T ss_dssp             EEEC
T ss_pred             CCcc
Confidence            6555

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=92.63  E-value=0.022  Score=52.23  Aligned_cols=59  Identities=7%  Similarity=-0.042  Sum_probs=44.9

Q ss_pred             EEeeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhcc
Q 042763           24 SIFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYAN  103 (554)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~  103 (554)
                      ++..+++|+|+|.+ +..+..+..                   ..+|++++|+      ++ .+|..+..+++|+.|+++
T Consensus        49 ~L~~L~ls~n~l~~-l~~~~~l~~-------------------L~~L~l~~n~------l~-~l~~~~~~~~~L~~L~L~  101 (198)
T 1ds9_A           49 ACKHLALSTNNIEK-ISSLSGMEN-------------------LRILSLGRNL------IK-KIENLDAVADTLEELWIS  101 (198)
T ss_dssp             TCSEEECSEEEESC-CCCHHHHTT-------------------CCEEEEEEEE------EC-SCSSHHHHHHHCSEEEEE
T ss_pred             CCCEEECCCCCCcc-ccccccCCC-------------------CCEEECCCCC------cc-cccchhhcCCcCCEEECc
Confidence            34566778888877 543333333                   4899999998      87 688888889999999999


Q ss_pred             Cceeec
Q 042763          104 HCIFEG  109 (554)
Q Consensus       104 ~n~~~g  109 (554)
                      +|++++
T Consensus       102 ~N~l~~  107 (198)
T 1ds9_A          102 YNQIAS  107 (198)
T ss_dssp             EEECCC
T ss_pred             CCcCCc
Confidence            999886

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=92.62  E-value=0.024  Score=50.88  Aligned_cols=37  Identities=3%  Similarity=-0.064  Sum_probs=33.1

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ..+|++++|+      +++..+..|+.+++|+.|++++|++++
T Consensus        78 L~~L~l~~N~------l~~~~~~~~~~l~~L~~L~l~~N~l~~  114 (177)
T 2o6r_A           78 LTILYLHENK------LQSLPNGVFDKLTQLKELALDTNQLKS  114 (177)
T ss_dssp             CCEEECCSSC------CCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             cCEEECCCCC------ccccCHHHhhCCcccCEEECcCCcceE
Confidence            5899999999      998777888999999999999999984

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=92.58  E-value=0.029  Score=50.51  Aligned_cols=62  Identities=6%  Similarity=-0.085  Sum_probs=47.1

Q ss_pred             EeeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccC
Q 042763           25 IFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANH  104 (554)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~  104 (554)
                      +-.+++|+|+|++-....+.-+                  -...+|+|++|+      +++-.+..|..+++|+.|++++
T Consensus        35 L~~L~Ls~N~l~~~~~~~~~~l------------------~~L~~L~Ls~N~------l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           35 KQRLWLNNNQITKLEPGVFDHL------------------VNLQQLYFNSNK------LTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             CSEEECCSSCCCCCCTTTTTTC------------------TTCCEEECCSSC------CCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCccccCHHHhcCC------------------cCCCEEECCCCC------CCccChhHhCCcchhhEEECCC
Confidence            3457888998887543322211                  125999999999      9986667789999999999999


Q ss_pred             ceeecc
Q 042763          105 CIFEGY  110 (554)
Q Consensus       105 n~~~g~  110 (554)
                      |++++-
T Consensus        91 N~l~~l   96 (174)
T 2r9u_A           91 NHLKSI   96 (174)
T ss_dssp             SCCCCC
T ss_pred             Ccccee
Confidence            999953

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=92.53  E-value=0.044  Score=51.59  Aligned_cols=38  Identities=5%  Similarity=-0.022  Sum_probs=28.5

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecc
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGY  110 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~  110 (554)
                      ..+|++++|+      +++-.+..|..+++|+.|++++|++++-
T Consensus        66 L~~L~L~~N~------l~~i~~~~~~~l~~L~~L~Ls~N~l~~l  103 (229)
T 3e6j_A           66 LKELYLGSNQ------LGALPVGVFDSLTQLTVLDLGTNQLTVL  103 (229)
T ss_dssp             CCEEECCSSC------CCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CcEEECCCCC------CCCcChhhcccCCCcCEEECCCCcCCcc
Confidence            5788888888      7554456678888888888888888753

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=92.51  E-value=0.032  Score=53.97  Aligned_cols=40  Identities=5%  Similarity=-0.043  Sum_probs=34.1

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|+      +++..|..++.|++|+.|++++|++++..+
T Consensus       159 L~~L~l~~n~------l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  198 (272)
T 3rfs_A          159 LTELDLSYNQ------LQSLPEGVFDKLTQLKDLRLYQNQLKSVPD  198 (272)
T ss_dssp             CCEEECCSSC------CCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CCEEECCCCC------cCccCHHHhcCCccCCEEECCCCcCCccCH
Confidence            5889999999      888777788999999999999999987554

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=92.50  E-value=0.054  Score=52.31  Aligned_cols=64  Identities=3%  Similarity=-0.179  Sum_probs=47.9

Q ss_pred             EeeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccC
Q 042763           25 IFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANH  104 (554)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~  104 (554)
                      +-.+++++|+|.+-....+.-                  .....+|++++|+      +++..|..|+.|++|+.|++++
T Consensus       111 L~~L~L~~n~l~~~~~~~~~~------------------l~~L~~L~L~~n~------l~~~~~~~~~~l~~L~~L~l~~  166 (272)
T 3rfs_A          111 LKELVLVENQLQSLPDGVFDK------------------LTNLTYLNLAHNQ------LQSLPKGVFDKLTNLTELDLSY  166 (272)
T ss_dssp             CCEEECTTSCCCCCCTTTTTT------------------CTTCCEEECCSSC------CCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEECCCCcCCccCHHHhcc------------------CCCCCEEECCCCc------cCccCHHHhccCccCCEEECCC
Confidence            445677888887543322111                  1236999999999      9988888899999999999999


Q ss_pred             ceeecccC
Q 042763          105 CIFEGYSG  112 (554)
Q Consensus       105 n~~~g~~~  112 (554)
                      |++++..+
T Consensus       167 n~l~~~~~  174 (272)
T 3rfs_A          167 NQLQSLPE  174 (272)
T ss_dssp             SCCCCCCT
T ss_pred             CCcCccCH
Confidence            99996544

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=92.22  E-value=0.047  Score=51.98  Aligned_cols=37  Identities=3%  Similarity=-0.098  Sum_probs=24.1

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ..+|++++|+      +++..|..|..+++|+.|++++|++++
T Consensus        61 L~~L~L~~n~------l~~~~~~~~~~l~~L~~L~L~~n~l~~   97 (251)
T 3m19_A           61 LTWLNLDYNQ------LQTLSAGVFDDLTELGTLGLANNQLAS   97 (251)
T ss_dssp             CCEEECTTSC------CCCCCTTTTTTCTTCCEEECTTSCCCC
T ss_pred             CCEEECCCCc------CCccCHhHhccCCcCCEEECCCCcccc
Confidence            4666666666      666666666666666666666666663

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=91.99  E-value=0.055  Score=51.54  Aligned_cols=39  Identities=8%  Similarity=0.121  Sum_probs=31.8

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecc
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGY  110 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~  110 (554)
                      ...+|++++|+      +++..|..|..+++|+.|++++|++++-
T Consensus        84 ~L~~L~L~~n~------l~~~~~~~~~~l~~L~~L~L~~N~l~~~  122 (251)
T 3m19_A           84 ELGTLGLANNQ------LASLPLGVFDHLTQLDKLYLGGNQLKSL  122 (251)
T ss_dssp             TCCEEECTTSC------CCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             cCCEEECCCCc------ccccChhHhcccCCCCEEEcCCCcCCCc
Confidence            46888888888      8877777888888888888888888843

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=91.90  E-value=0.056  Score=52.37  Aligned_cols=38  Identities=5%  Similarity=-0.011  Sum_probs=35.4

Q ss_pred             CCceeeccCCcceeEEEcC--ccccchhhhhhhhhhhccCceeecc
Q 042763           67 ADHIAYSNSNEVELFYING--NLVDKFSFCKVIQFHYANHCIFEGY  110 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G--~~p~~~~~~~~l~~l~~~~n~~~g~  110 (554)
                      ...|+||+|.      ++|  .+|+.+..|++|+.|++++|++++.
T Consensus       172 L~~L~Ls~N~------l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~  211 (267)
T 3rw6_A          172 LLSLNLSNNR------LYRLDDMSSIVQKAPNLKILNLSGNELKSE  211 (267)
T ss_dssp             CCEEECTTSC------CCCCGGGTTHHHHSTTCCEEECTTSCCCSG
T ss_pred             CCEEECCCCC------CCCCccchhHHhhCCCCCEEECCCCccCCc
Confidence            6899999999      999  7889999999999999999999975

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=91.88  E-value=0.096  Score=35.20  Aligned_cols=30  Identities=17%  Similarity=0.211  Sum_probs=14.9

Q ss_pred             CcceehhHHHHHHHHHHHHHHHHhhccccc
Q 042763          165 TTKKVGIAATGLFVMSCALLCPCFYKKRKA  194 (554)
Q Consensus       165 ~~~~i~i~~~~~~~l~~~~l~~~~~r~rk~  194 (554)
                      .+.+++++++.+++++++++.++|.|||+.
T Consensus        11 ~~~Ia~~vVGvll~vi~~l~~~~~~RRR~~   40 (44)
T 2jwa_A           11 LTSIISAVVGILLVVVLGVVFGILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred             ccchHHHHHHHHHHHHHHHHHHhheehhhh
Confidence            344555555533333444444555565554

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=91.84  E-value=0.024  Score=56.05  Aligned_cols=36  Identities=3%  Similarity=-0.156  Sum_probs=20.7

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhh-----hhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFC-----KVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~-----~~l~~l~~~~n~~~g  109 (554)
                      ..+|++++|+      ++|. |..++.+     ++|+.|++++|++++
T Consensus       123 L~~L~Ls~N~------l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~  163 (312)
T 1wwl_A          123 LNILNLRNVS------WATR-DAWLAELQQWLKPGLKVLSIAQAHSLN  163 (312)
T ss_dssp             CSEEEEESCB------CSSS-SSHHHHHHTTCCTTCCEEEEESCSCCC
T ss_pred             ccEEEccCCC------Ccch-hHHHHHHHHhhcCCCcEEEeeCCCCcc
Confidence            3555666665      5555 5555555     556666666665554

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=91.80  E-value=0.12  Score=33.69  Aligned_cols=23  Identities=17%  Similarity=0.069  Sum_probs=14.8

Q ss_pred             CCCCCcceehhHHHHHHHHHHHH
Q 042763          161 GSLSTTKKVGIAATGLFVMSCAL  183 (554)
Q Consensus       161 ~~~~~~~~i~i~~~~~~~l~~~~  183 (554)
                      ++.+.+.++||++++++.+++++
T Consensus         6 ~~ls~GaIAGiVvG~v~gv~li~   28 (38)
T 2k1k_A            6 RGLTGGEIVAVIFGLLLGAALLL   28 (38)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCceeeeehHHHHHHHHHH
Confidence            34567778888877766444433

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=91.77  E-value=0.035  Score=58.76  Aligned_cols=29  Identities=14%  Similarity=-0.026  Sum_probs=25.1

Q ss_pred             HHHHHHHHHHHHhCCCCCceeeeeEEEcC
Q 042763          307 QTEFSSEVELLSKIDHRNLVKLLGFVDKG  335 (554)
Q Consensus       307 ~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  335 (554)
                      .++|..|++.+.+++|+|+|+++|||...
T Consensus       323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~  351 (487)
T 3oja_A          323 SETERLECERENQARQREIDALKEQYRTV  351 (487)
T ss_dssp             --CHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHHhcccccchhhHHHHhcCh
Confidence            46799999999999999999999998764

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=91.69  E-value=0.046  Score=53.89  Aligned_cols=44  Identities=7%  Similarity=0.065  Sum_probs=38.5

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhh---hhhhhhhccCceeecccCCCcc
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFC---KVIQFHYANHCIFEGYSGSDYC  116 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~---~~l~~l~~~~n~~~g~~~~~~~  116 (554)
                      ...+|++|+|+      +++.+|+.+..|   ++|+.|++++|+++ .+|...+
T Consensus       225 ~L~~L~Ls~N~------l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~  271 (310)
T 4glp_A          225 QPHSLDLSHNS------LRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP  271 (310)
T ss_dssp             CCSSEECTTSC------CCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC
T ss_pred             CCCEEECCCCC------CCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc
Confidence            46999999999      999999888888   69999999999999 7776554

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=91.61  E-value=0.039  Score=58.92  Aligned_cols=38  Identities=13%  Similarity=0.151  Sum_probs=23.5

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|+      ++ .+|+ ...+++|+.|++++|++++..+
T Consensus       453 L~~L~Ls~N~------l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~  490 (549)
T 2z81_A          453 LQELYISRNK------LK-TLPD-ASLFPVLLVMKISRNQLKSVPD  490 (549)
T ss_dssp             CCEEECCSSC------CS-SCCC-GGGCTTCCEEECCSSCCCCCCT
T ss_pred             hcEEECCCCc------cC-cCCC-cccCccCCEEecCCCccCCcCH
Confidence            4666666666      65 5555 4566666666666666665444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=91.44  E-value=0.077  Score=56.13  Aligned_cols=45  Identities=11%  Similarity=-0.011  Sum_probs=37.2

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCCCcc
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDYC  116 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~~~~  116 (554)
                      ...+|++++|.      ++|..|..++.|++|+.|++++|.+++..|...+
T Consensus       121 ~L~~L~L~~N~------l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~  165 (487)
T 3oja_A          121 GKKNIYLANNK------ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA  165 (487)
T ss_dssp             SCEEEECCSSC------CCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGG
T ss_pred             CCCEEECCCCC------CCCCCchhhcCCCCCCEEECCCCCCCCcChHHHh
Confidence            46888888888      8888888889999999999999999886665543

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=91.28  E-value=0.021  Score=59.42  Aligned_cols=38  Identities=8%  Similarity=0.042  Sum_probs=24.7

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecc
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGY  110 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~  110 (554)
                      ..+|++++|+      +++..|..|+.|++|+.|++++|++++.
T Consensus        81 L~~L~Ls~n~------l~~~~~~~~~~l~~L~~L~L~~n~l~~~  118 (455)
T 3v47_A           81 LIILKLDYNQ------FLQLETGAFNGLANLEVLTLTQCNLDGA  118 (455)
T ss_dssp             CCEEECTTCT------TCEECTTTTTTCTTCCEEECTTSCCBTH
T ss_pred             CCEEeCCCCc------cCccChhhccCcccCCEEeCCCCCCCcc
Confidence            4666666666      6666666666666666666666666653

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=91.24  E-value=0.02  Score=52.47  Aligned_cols=40  Identities=5%  Similarity=0.076  Sum_probs=34.3

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|.      +++..|..++.|++|+.|++++|++++..+
T Consensus        90 L~~L~l~~n~------l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~  129 (197)
T 4ezg_A           90 LERLRIMGKD------VTSDKIPNLSGLTSLTLLDISHSAHDDSIL  129 (197)
T ss_dssp             CCEEEEECTT------CBGGGSCCCTTCTTCCEEECCSSBCBGGGH
T ss_pred             CCEEEeECCc------cCcccChhhcCCCCCCEEEecCCccCcHhH
Confidence            5889999999      888888889999999999999999887444

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=91.24  E-value=0.044  Score=54.77  Aligned_cols=40  Identities=3%  Similarity=0.023  Sum_probs=25.3

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|.      +++..|..+..|++|+.|++++|.+++..|
T Consensus       289 L~~L~L~~n~------l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~  328 (347)
T 4fmz_A          289 LNSLFLNNNQ------LGNEDMEVIGGLTNLTTLFLSQNHITDIRP  328 (347)
T ss_dssp             CSEEECCSSC------CCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred             CCEEECcCCc------CCCcChhHhhccccCCEEEccCCccccccC
Confidence            4566666666      666666666666666666666666665444

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=91.09  E-value=0.056  Score=49.75  Aligned_cols=40  Identities=8%  Similarity=-0.006  Sum_probs=32.5

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|+      +++..+..|..+++|+.|++++|++++-.+
T Consensus        78 L~~L~Ls~n~------l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  117 (208)
T 2o6s_A           78 LTYLNLSTNQ------LQSLPNGVFDKLTQLKELALNTNQLQSLPD  117 (208)
T ss_dssp             CCEEECCSSC------CCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             cCEEECCCCc------CCccCHhHhcCccCCCEEEcCCCcCcccCH
Confidence            5889999998      887666778899999999999998885433

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=91.01  E-value=0.021  Score=51.26  Aligned_cols=58  Identities=16%  Similarity=0.063  Sum_probs=35.9

Q ss_pred             EeeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccC
Q 042763           25 IFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANH  104 (554)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~  104 (554)
                      +..+++++|+|.+ +..+..+.                  -...+|++++|+      +++-  +.++.|++|+.|++++
T Consensus        21 L~~L~l~~n~l~~-i~~~~~~~------------------~~L~~L~Ls~N~------l~~~--~~l~~l~~L~~L~Ls~   73 (176)
T 1a9n_A           21 DRELDLRGYKIPV-IENLGATL------------------DQFDAIDFSDNE------IRKL--DGFPLLRRLKTLLVNN   73 (176)
T ss_dssp             CEEEECTTSCCCS-CCCGGGGT------------------TCCSEEECCSSC------CCEE--CCCCCCSSCCEEECCS
T ss_pred             ceEEEeeCCCCch-hHHhhhcC------------------CCCCEEECCCCC------CCcc--cccccCCCCCEEECCC
Confidence            3456778887773 43332222                  024777777777      6653  5677777777777777


Q ss_pred             ceeec
Q 042763          105 CIFEG  109 (554)
Q Consensus       105 n~~~g  109 (554)
                      |++++
T Consensus        74 N~l~~   78 (176)
T 1a9n_A           74 NRICR   78 (176)
T ss_dssp             SCCCE
T ss_pred             Ccccc
Confidence            77764

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=91.01  E-value=0.13  Score=50.54  Aligned_cols=41  Identities=7%  Similarity=-0.001  Sum_probs=32.7

Q ss_pred             CCCceeeccCCcceeEEEcC--cccc-chhhhhhhhhhhccCceeecccC
Q 042763           66 GADHIAYSNSNEVELFYING--NLVD-KFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G--~~p~-~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ...+|++++|+      +++  .++. .++.+++|+.|++++|++++.+|
T Consensus       198 ~L~~L~Ls~N~------l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p  241 (310)
T 4glp_A          198 AIQNLALRNTG------METPTGVCAALAAAGVQPHSLDLSHNSLRATVN  241 (310)
T ss_dssp             CCCSCBCCSSC------CCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCC
T ss_pred             CCCEEECCCCC------CCchHHHHHHHHhcCCCCCEEECCCCCCCccch
Confidence            47899999999      762  2222 36888999999999999998766

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=90.93  E-value=0.055  Score=58.58  Aligned_cols=43  Identities=14%  Similarity=0.096  Sum_probs=33.6

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCCCc
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDY  115 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~~~  115 (554)
                      ..+|++++|+      +++..|..|..|++|+.|++++|++++..|...
T Consensus       475 L~~L~Ls~n~------l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  517 (606)
T 3vq2_A          475 LTFLDLSKCQ------LEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHY  517 (606)
T ss_dssp             CCEEECTTSC------CCEECTTTTTTCTTCCEEECCSSCCSCEEGGGT
T ss_pred             CCEEECCCCc------CCccChhhhcccccCCEEECCCCcCCCcCHHHc
Confidence            5788888888      888888888888888888888888887655433

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=90.59  E-value=0.068  Score=49.15  Aligned_cols=39  Identities=5%  Similarity=-0.021  Sum_probs=32.7

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeeccc
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYS  111 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~  111 (554)
                      ..+|++++|+      +++..+..|..+++|+.|++++|++++..
T Consensus       102 L~~L~L~~N~------l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  140 (208)
T 2o6s_A          102 LKELALNTNQ------LQSLPDGVFDKLTQLKDLRLYQNQLKSVP  140 (208)
T ss_dssp             CCEEECCSSC------CCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCEEEcCCCc------CcccCHhHhccCCcCCEEECCCCccceeC
Confidence            5889999999      88777777899999999999999988533

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=90.55  E-value=0.076  Score=60.36  Aligned_cols=42  Identities=5%  Similarity=-0.109  Sum_probs=32.3

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccC------ceeecccCCCc
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANH------CIFEGYSGSDY  115 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~------n~~~g~~~~~~  115 (554)
                      ..+|++++|+      ++| +|..+..|++|+.|++++      |++.+.+|...
T Consensus       755 L~~L~Ls~N~------L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l  802 (876)
T 4ecn_A          755 LSNMDVSYNC------FSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI  802 (876)
T ss_dssp             CCEEECCSSC------CSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTG
T ss_pred             cCEEEeCCCC------CCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHH
Confidence            5778888888      887 788888888888888865      66777777544

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=90.44  E-value=0.076  Score=47.49  Aligned_cols=60  Identities=7%  Similarity=-0.216  Sum_probs=43.5

Q ss_pred             EEeeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhcc
Q 042763           24 SIFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYAN  103 (554)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~  103 (554)
                      .+..+++|+|+|++- ..+.                   ......+|++++|.      +++..|..|..|++|+.|+++
T Consensus        43 ~L~~L~Ls~N~l~~~-~~l~-------------------~l~~L~~L~Ls~N~------l~~~~~~~~~~l~~L~~L~L~   96 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL-DGFP-------------------LLRRLKTLLVNNNR------ICRIGEGLDQALPDLTELILT   96 (176)
T ss_dssp             CCSEEECCSSCCCEE-CCCC-------------------CCSSCCEEECCSSC------CCEECSCHHHHCTTCCEEECC
T ss_pred             CCCEEECCCCCCCcc-cccc-------------------cCCCCCEEECCCCc------ccccCcchhhcCCCCCEEECC
Confidence            455677888887762 2221                   12346899999999      886544556999999999999


Q ss_pred             Cceeec
Q 042763          104 HCIFEG  109 (554)
Q Consensus       104 ~n~~~g  109 (554)
                      +|+++.
T Consensus        97 ~N~i~~  102 (176)
T 1a9n_A           97 NNSLVE  102 (176)
T ss_dssp             SCCCCC
T ss_pred             CCcCCc
Confidence            999963

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=90.43  E-value=0.068  Score=55.75  Aligned_cols=41  Identities=7%  Similarity=0.024  Sum_probs=32.6

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ...+|++++|+      +++..|..|..|++|+.|++++|++++..+
T Consensus       219 ~L~~L~Ls~N~------l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  259 (452)
T 3zyi_A          219 GLEELEMSGNH------FPEIRPGSFHGLSSLKKLWVMNSQVSLIER  259 (452)
T ss_dssp             TCCEEECTTSC------CSEECGGGGTTCTTCCEEECTTSCCCEECT
T ss_pred             cccEEECcCCc------CcccCcccccCccCCCEEEeCCCcCceECH
Confidence            35788888888      888888888888888888888888876444

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=90.43  E-value=0.047  Score=59.33  Aligned_cols=37  Identities=8%  Similarity=0.085  Sum_probs=27.2

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ..+|++++|.      ++|.+|..|+.|++|+.|++++|++++
T Consensus       256 L~~L~Ls~N~------l~~~~~~~~~~l~~L~~L~Ls~N~l~~  292 (597)
T 3oja_B          256 LVEVDLSYNE------LEKIMYHPFVKMQRLERLYISNNRLVA  292 (597)
T ss_dssp             CSEEECCSSC------CCEEESGGGTTCSSCCEEECTTSCCCE
T ss_pred             CCEEECCCCc------cCCCCHHHhcCccCCCEEECCCCCCCC
Confidence            4677777777      777777777777777777777777765

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=90.39  E-value=0.3  Score=32.88  Aligned_cols=32  Identities=13%  Similarity=0.123  Sum_probs=16.8

Q ss_pred             CCCcceehhHHHHHHHHHHHHHH-HHhhccccc
Q 042763          163 LSTTKKVGIAATGLFVMSCALLC-PCFYKKRKA  194 (554)
Q Consensus       163 ~~~~~~i~i~~~~~~~l~~~~l~-~~~~r~rk~  194 (554)
                      ++++.|++.+++++++++++++. +++.|||+.
T Consensus         8 s~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B            8 PKIPSIATGMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             SCSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCcceEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            34555666666666655544433 445555443

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=90.21  E-value=0.049  Score=58.97  Aligned_cols=14  Identities=14%  Similarity=-0.282  Sum_probs=9.6

Q ss_pred             EEeeecCCCccccc
Q 042763           24 SIFLPRESSLDISS   37 (554)
Q Consensus        24 ~~~~~~~~~~~~~~   37 (554)
                      ++..++||.|+|++
T Consensus        53 ~~~~LdLs~N~i~~   66 (635)
T 4g8a_A           53 STKNLDLSFNPLRH   66 (635)
T ss_dssp             TCCEEECTTSCCCE
T ss_pred             CCCEEEeeCCCCCC
Confidence            35567788887764

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=90.11  E-value=0.043  Score=58.25  Aligned_cols=27  Identities=7%  Similarity=-0.102  Sum_probs=11.3

Q ss_pred             ccccchhhhhhhhhhhccCceeecccC
Q 042763           86 NLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        86 ~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      .+|..+..|++|+.|++++|.+++.+|
T Consensus       365 ~~~~~~~~l~~L~~L~Ls~N~l~~~l~  391 (520)
T 2z7x_B          365 KIAEMTTQMKSLQQLDISQNSVSYDEK  391 (520)
T ss_dssp             HHHHHHTTCTTCCEEECCSSCCBCCGG
T ss_pred             cchHHHhhCCCCCEEECCCCcCCcccc
Confidence            333444444444444444444443333

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=90.10  E-value=0.036  Score=54.80  Aligned_cols=41  Identities=7%  Similarity=0.151  Sum_probs=36.1

Q ss_pred             ccCCCceeeccCCcceeEEEcCccccch--hhhhhhhhhhccCceeecc
Q 042763           64 VCGADHIAYSNSNEVELFYINGNLVDKF--SFCKVIQFHYANHCIFEGY  110 (554)
Q Consensus        64 ~~~~~~l~~s~n~~~~~~~~~G~~p~~~--~~~~~l~~l~~~~n~~~g~  110 (554)
                      .-...+|++++|+      ++|.+|..+  ..+++|+.|++++|++++.
T Consensus        94 l~~L~~L~L~~n~------l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~  136 (312)
T 1wwl_A           94 ISGLQELTLENLE------VTGTAPPPLLEATGPDLNILNLRNVSWATR  136 (312)
T ss_dssp             TSCCCEEEEEEEB------CBSCCCCCSSSCCSCCCSEEEEESCBCSSS
T ss_pred             cCCccEEEccCCc------ccchhHHHHHHhcCCCccEEEccCCCCcch
Confidence            3467899999999      999999876  8999999999999999876

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=89.83  E-value=0.093  Score=51.36  Aligned_cols=40  Identities=13%  Similarity=0.096  Sum_probs=34.5

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeeccc
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYS  111 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~  111 (554)
                      ...+|++++|+      +++..|..+..+++|+.|++++|++++..
T Consensus       176 ~L~~L~Ls~n~------l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  215 (306)
T 2z66_A          176 NLTFLDLSQCQ------LEQLSPTAFNSLSSLQVLNMSHNNFFSLD  215 (306)
T ss_dssp             TCCEEECTTSC------CCEECTTTTTTCTTCCEEECTTSCCSBCC
T ss_pred             CCCEEECCCCC------cCCcCHHHhcCCCCCCEEECCCCccCccC
Confidence            46889999999      88888899999999999999999988643

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=89.73  E-value=0.09  Score=52.13  Aligned_cols=35  Identities=11%  Similarity=0.088  Sum_probs=19.1

Q ss_pred             CceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceee
Q 042763           68 DHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFE  108 (554)
Q Consensus        68 ~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~  108 (554)
                      .+|++++|+      +++..|..|+.|++|+.|++++|+++
T Consensus        79 ~~L~L~~n~------l~~~~~~~~~~l~~L~~L~Ls~n~l~  113 (330)
T 1xku_A           79 HTLILINNK------ISKISPGAFAPLVKLERLYLSKNQLK  113 (330)
T ss_dssp             CEEECCSSC------CCCBCTTTTTTCTTCCEEECCSSCCS
T ss_pred             CEEECCCCc------CCeeCHHHhcCCCCCCEEECCCCcCC
Confidence            555555555      55555555555555555555555554

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=89.72  E-value=0.058  Score=54.53  Aligned_cols=37  Identities=8%  Similarity=0.046  Sum_probs=21.0

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      +.+|++++|+      +++-.|..|..|++|+.|++++|++++
T Consensus        66 L~~L~L~~N~------i~~i~~~~~~~l~~L~~L~Ls~N~l~~  102 (361)
T 2xot_A           66 LHSLLLSHNH------LNFISSEAFVPVPNLRYLDLSSNHLHT  102 (361)
T ss_dssp             CCEEECCSSC------CCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             cCEEECCCCc------CCccChhhccCCCCCCEEECCCCcCCc
Confidence            3555666555      555445555556666666666665553

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=89.61  E-value=0.25  Score=33.20  Aligned_cols=32  Identities=16%  Similarity=0.247  Sum_probs=16.8

Q ss_pred             CCCcceehhHHHHHHHHHHHHHH-HHhhccccc
Q 042763          163 LSTTKKVGIAATGLFVMSCALLC-PCFYKKRKA  194 (554)
Q Consensus       163 ~~~~~~i~i~~~~~~~l~~~~l~-~~~~r~rk~  194 (554)
                      +.++.|++.+++++++++++++. ++++|||+.
T Consensus         7 s~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~   39 (44)
T 2l2t_A            7 ARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSI   39 (44)
T ss_dssp             CSSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             CCcceEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence            34555666666666655544433 445555543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=89.61  E-value=0.057  Score=49.32  Aligned_cols=41  Identities=5%  Similarity=-0.149  Sum_probs=32.4

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCCC
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSD  114 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~~  114 (554)
                      ...+|++++|.      ++  .++.+..|++|+.|++++|++++..+..
T Consensus        67 ~L~~L~l~~n~------~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~  107 (197)
T 4ezg_A           67 NIKDLTINNIH------AT--NYNPISGLSNLERLRIMGKDVTSDKIPN  107 (197)
T ss_dssp             TCSEEEEESCC------CS--CCGGGTTCTTCCEEEEECTTCBGGGSCC
T ss_pred             CCCEEEccCCC------CC--cchhhhcCCCCCEEEeECCccCcccChh
Confidence            35899999887      43  4568899999999999999998755533

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=89.47  E-value=0.11  Score=56.49  Aligned_cols=36  Identities=6%  Similarity=-0.062  Sum_probs=23.8

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceee
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFE  108 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~  108 (554)
                      ..+|++++|.      ++|..|..|+.|++|+.|++++|.++
T Consensus       101 L~~L~L~~n~------l~~~~~~~~~~l~~L~~L~L~~n~l~  136 (597)
T 3oja_B          101 IQKLYMGFNA------IRYLPPHVFQNVPLLTVLVLERNDLS  136 (597)
T ss_dssp             CCEEECCSSC------CCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCEEECCCCc------CCCCCHHHHcCCCCCCEEEeeCCCCC
Confidence            4666666666      66666666666666666666666666

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=89.41  E-value=0.14  Score=50.88  Aligned_cols=43  Identities=7%  Similarity=-0.014  Sum_probs=34.1

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCCCc
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDY  115 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~~~  115 (554)
                      ...+|++++|+      +++..|..+..+++|+.|++++|+++ .+|...
T Consensus       218 ~L~~L~L~~N~------l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l  260 (332)
T 2ft3_A          218 KLYRLGLGHNQ------IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL  260 (332)
T ss_dssp             TCSCCBCCSSC------CCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTG
T ss_pred             CCCEEECCCCc------CCcCChhHhhCCCCCCEEECCCCcCe-ecChhh
Confidence            36788888888      88877778888888888888888888 566443

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=89.34  E-value=0.081  Score=54.93  Aligned_cols=41  Identities=10%  Similarity=0.026  Sum_probs=30.2

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ...+|++++|+      +++..|..|..|++|+.|++++|++++-.+
T Consensus       208 ~L~~L~Ls~N~------l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  248 (440)
T 3zyj_A          208 KLDELDLSGNH------LSAIRPGSFQGLMHLQKLWMIQSQIQVIER  248 (440)
T ss_dssp             SCCEEECTTSC------CCEECTTTTTTCTTCCEEECTTCCCCEECT
T ss_pred             ccCEEECCCCc------cCccChhhhccCccCCEEECCCCceeEECh
Confidence            35778888887      777777777778888888888777775433

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=89.06  E-value=0.12  Score=55.68  Aligned_cols=33  Identities=12%  Similarity=0.245  Sum_probs=15.7

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ..+|++++|+      ++| +|+   .+++|+.|++++|++++
T Consensus       122 L~~L~Ls~N~------l~~-lp~---~l~~L~~L~Ls~N~l~~  154 (571)
T 3cvr_A          122 LKHLDVDNNQ------LTM-LPE---LPALLEYINADNNQLTM  154 (571)
T ss_dssp             CCEEECCSSC------CSC-CCC---CCTTCCEEECCSSCCSC
T ss_pred             CCEEECCCCc------CCC-CCC---cCccccEEeCCCCccCc
Confidence            3444555544      444 444   34445555555555443

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=89.04  E-value=0.1  Score=50.55  Aligned_cols=74  Identities=8%  Similarity=-0.077  Sum_probs=43.1

Q ss_pred             cccccCCchhHHHHHHHhhhhhhccceeeccccCCC-----------ceeeccCCcceeEEEcCccccchhhhhhhhhhh
Q 042763           33 LDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGAD-----------HIAYSNSNEVELFYINGNLVDKFSFCKVIQFHY  101 (554)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~  101 (554)
                      ..+.|.++|-..   -++..+.......+++.=.++           .++++.|.   .-.+.+.++.....|++|+.|+
T Consensus       103 ~~~~~~l~~~~~---~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~---~~~~~~~l~i~~~~l~~L~~L~  176 (267)
T 3rw6_A          103 HTILNELKPEQV---EQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR---RSCMAATLRIIEENIPELLSLN  176 (267)
T ss_dssp             HHHHTSCCHHHH---HHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS---HHHHHHHHHHHHHHCTTCCEEE
T ss_pred             ccccccCCHHHH---HHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCH---HHHHHHHHHHHHhhCCCCCEEE
Confidence            455666765432   123334444444444332222           25666663   1115555665567789999999


Q ss_pred             ccCceeec--ccC
Q 042763          102 ANHCIFEG--YSG  112 (554)
Q Consensus       102 ~~~n~~~g--~~~  112 (554)
                      +++|++++  .++
T Consensus       177 Ls~N~l~~l~~l~  189 (267)
T 3rw6_A          177 LSNNRLYRLDDMS  189 (267)
T ss_dssp             CTTSCCCCCGGGT
T ss_pred             CCCCCCCCCccch
Confidence            99999998  444

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=88.96  E-value=0.095  Score=52.92  Aligned_cols=41  Identities=7%  Similarity=-0.094  Sum_probs=34.1

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      .+.+|+|++|+      +++-.+..|..|++|+.|++++|++++-.+
T Consensus        89 ~L~~L~Ls~N~------l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~  129 (361)
T 2xot_A           89 NLRYLDLSSNH------LHTLDEFLFSDLQALEVLLLYNNHIVVVDR  129 (361)
T ss_dssp             TCCEEECCSSC------CCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             CCCEEECCCCc------CCcCCHHHhCCCcCCCEEECCCCcccEECH
Confidence            46889999999      887777789999999999999999885433

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=88.95  E-value=0.087  Score=50.77  Aligned_cols=38  Identities=11%  Similarity=0.088  Sum_probs=25.0

Q ss_pred             CCCceeeccCCcceeEEEcC-ccccchhhhhhhhhhhccCceeec
Q 042763           66 GADHIAYSNSNEVELFYING-NLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G-~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ...+|++++|+      +++ .+|..++.+++|+.|++++|++++
T Consensus       125 ~L~~L~l~~n~------l~~~~l~~~~~~l~~L~~L~Ls~N~l~~  163 (276)
T 2z62_A          125 TLKELNVAHNL------IQSFKLPEYFSNLTNLEHLDLSSNKIQS  163 (276)
T ss_dssp             TCCEEECCSSC------CCCCCCCGGGGGCTTCCEEECCSSCCCE
T ss_pred             CCCEEECcCCc------cceecCchhhccCCCCCEEECCCCCCCc
Confidence            35666666666      655 356667777777777777776664

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=88.92  E-value=0.11  Score=56.60  Aligned_cols=38  Identities=8%  Similarity=-0.016  Sum_probs=21.5

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      +..|+|++|.      +++.  +.+..|++|+.|++++|.+++..+
T Consensus       133 L~~L~Ls~N~------l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~  170 (605)
T 1m9s_A          133 LESLYLGNNK------ITDI--TVLSRLTKLDTLSLEDNQISDIVP  170 (605)
T ss_dssp             CSEEECCSSC------CCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred             cCEEECCCCc------cCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence            3556666665      5543  455566666666666666655433

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=88.84  E-value=0.14  Score=49.93  Aligned_cols=37  Identities=8%  Similarity=-0.053  Sum_probs=29.4

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ..+|++++|+      +++-.|..|..|++|+.|++++|++++
T Consensus       102 L~~L~l~~N~------l~~l~~~~~~~l~~L~~L~L~~N~l~~  138 (290)
T 1p9a_G          102 LTVLDVSFNR------LTSLPLGALRGLGELQELYLKGNELKT  138 (290)
T ss_dssp             CCEEECCSSC------CCCCCSSTTTTCTTCCEEECTTSCCCC
T ss_pred             CCEEECCCCc------CcccCHHHHcCCCCCCEEECCCCCCCc
Confidence            5778888888      877667778888888888888888874

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=88.82  E-value=0.1  Score=54.30  Aligned_cols=36  Identities=8%  Similarity=-0.032  Sum_probs=22.7

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceee
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFE  108 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~  108 (554)
                      ..+|++++|+      +++..|..|..|++|+.|++++|+++
T Consensus       101 L~~L~Ls~n~------i~~~~~~~~~~l~~L~~L~L~~n~l~  136 (452)
T 3zyi_A          101 LEVLQLGRNS------IRQIEVGAFNGLASLNTLELFDNWLT  136 (452)
T ss_dssp             CCEEECCSSC------CCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             CCEEECCCCc------cCCcChhhccCcccCCEEECCCCcCC
Confidence            4566666666      66655566666666666666666665

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=88.81  E-value=0.13  Score=50.19  Aligned_cols=36  Identities=6%  Similarity=-0.047  Sum_probs=21.0

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ..+|++++|+      ++ .+|..+..+++|+.|++++|++++
T Consensus        79 L~~L~Ls~N~------l~-~l~~~~~~l~~L~~L~l~~N~l~~  114 (290)
T 1p9a_G           79 LGTLDLSHNQ------LQ-SLPLLGQTLPALTVLDVSFNRLTS  114 (290)
T ss_dssp             CCEEECCSSC------CS-SCCCCTTTCTTCCEEECCSSCCCC
T ss_pred             CCEEECCCCc------CC-cCchhhccCCCCCEEECCCCcCcc
Confidence            4556666665      54 455555666666666666666553

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=88.81  E-value=0.065  Score=56.83  Aligned_cols=41  Identities=12%  Similarity=0.112  Sum_probs=33.7

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCCC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSD  114 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~~  114 (554)
                      ..+|++++|+      +++..|+.|..|++|+.|++++|+++ .+|..
T Consensus        47 L~~L~Ls~n~------l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~   87 (520)
T 2z7x_B           47 LRILIISHNR------IQYLDISVFKFNQELEYLDLSHNKLV-KISCH   87 (520)
T ss_dssp             CCEEECCSSC------CCEEEGGGGTTCTTCCEEECCSSCCC-EEECC
T ss_pred             ccEEecCCCc------cCCcChHHhhcccCCCEEecCCCcee-ecCcc
Confidence            5888888888      88888888888888888888888888 46544

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=88.74  E-value=0.093  Score=54.45  Aligned_cols=38  Identities=8%  Similarity=-0.071  Sum_probs=35.2

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ...+|++++|+      +++..|..|..|++|+.|++++|++++
T Consensus       348 ~L~~L~Ls~N~------l~~~~~~~~~~l~~L~~L~L~~N~l~~  385 (455)
T 3v47_A          348 KLEVLDLSYNH------IRALGDQSFLGLPNLKELALDTNQLKS  385 (455)
T ss_dssp             TCCEEECCSSC------CCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred             cCCEEECCCCc------ccccChhhccccccccEEECCCCcccc
Confidence            36899999999      999999999999999999999999996

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=88.65  E-value=0.11  Score=50.86  Aligned_cols=37  Identities=8%  Similarity=-0.021  Sum_probs=25.0

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ..+|++++|.      +++..|..+..+++|+.|++++|.+++
T Consensus       128 L~~L~l~~n~------l~~~~~~~~~~l~~L~~L~l~~n~l~~  164 (306)
T 2z66_A          128 LIYLDISHTH------TRVAFNGIFNGLSSLEVLKMAGNSFQE  164 (306)
T ss_dssp             CCEEECTTSC------CEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred             CCEEECCCCc------CCccchhhcccCcCCCEEECCCCcccc
Confidence            4666777666      666666666666777777777776665

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=88.63  E-value=0.069  Score=58.39  Aligned_cols=41  Identities=5%  Similarity=-0.056  Sum_probs=29.3

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCC
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGS  113 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~  113 (554)
                      ...+|++++|+      ++ .+|+.+..|++|+.|++++|.+++.++.
T Consensus       262 ~L~~L~Ls~N~------L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~  302 (622)
T 3g06_A          262 GLLSLSVYRNQ------LT-RLPESLIHLSSETTVNLEGNPLSERTLQ  302 (622)
T ss_dssp             TCCEEECCSSC------CC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred             cCcEEeCCCCC------CC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence            46677777777      66 6777777777777777777777765553

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=88.48  E-value=0.13  Score=51.48  Aligned_cols=43  Identities=2%  Similarity=-0.139  Sum_probs=37.6

Q ss_pred             CCCceeecc-CCcceeEEEcCccccchhhhhhhhhhhccCceeecccCCC
Q 042763           66 GADHIAYSN-SNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSD  114 (554)
Q Consensus        66 ~~~~l~~s~-n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~~  114 (554)
                      .+.+|+|++ |+      |++-.|..|+.|++|+.|++++|++++..+..
T Consensus        32 ~L~~L~l~~~n~------l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~   75 (347)
T 2ifg_A           32 NLTELYIENQQH------LQHLELRDLRGLGELRNLTIVKSGLRFVAPDA   75 (347)
T ss_dssp             CCSEEECCSCSS------CCEECGGGSCSCCCCSEEECCSSCCCEECTTG
T ss_pred             CeeEEEccCCCC------CCCcChhHhccccCCCEEECCCCccceeCHHH
Confidence            368999996 99      99888899999999999999999999866643

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=88.31  E-value=0.15  Score=55.58  Aligned_cols=37  Identities=5%  Similarity=0.142  Sum_probs=31.1

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecc
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGY  110 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~  110 (554)
                      .+.+|+|++|+      +++  ++.+..|++|+.|++++|++++.
T Consensus       110 ~L~~L~Ls~N~------l~~--l~~l~~l~~L~~L~Ls~N~l~~l  146 (605)
T 1m9s_A          110 KLKSLSLEHNG------ISD--INGLVHLPQLESLYLGNNKITDI  146 (605)
T ss_dssp             TCCEEECTTSC------CCC--CGGGGGCTTCSEEECCSSCCCCC
T ss_pred             CCCEEEecCCC------CCC--CccccCCCccCEEECCCCccCCc
Confidence            35899999999      876  35689999999999999999864

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=88.26  E-value=0.09  Score=55.06  Aligned_cols=12  Identities=8%  Similarity=-0.241  Sum_probs=6.7

Q ss_pred             eeecCCCccccc
Q 042763           26 FLPRESSLDISS   37 (554)
Q Consensus        26 ~~~~~~~~~~~~   37 (554)
                      ..+++|+|+|++
T Consensus       320 ~~L~Ls~N~l~~  331 (454)
T 1jl5_A          320 EELNVSNNKLIE  331 (454)
T ss_dssp             CEEECCSSCCSC
T ss_pred             CEEECCCCcccc
Confidence            345556666655

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=88.21  E-value=0.084  Score=56.73  Aligned_cols=26  Identities=12%  Similarity=0.013  Sum_probs=12.2

Q ss_pred             EcCccccchhhhhhhhhhhccCceee
Q 042763           83 INGNLVDKFSFCKVIQFHYANHCIFE  108 (554)
Q Consensus        83 ~~G~~p~~~~~~~~l~~l~~~~n~~~  108 (554)
                      ++|.+|..++.+++|+.|++++|+++
T Consensus       365 l~~~~~~~~~~l~~L~~L~L~~N~l~  390 (562)
T 3a79_B          365 FTDSVFQGCSTLKRLQTLILQRNGLK  390 (562)
T ss_dssp             CCTTTTTTCCSCSSCCEEECCSSCCC
T ss_pred             cccchhhhhcccCCCCEEECCCCCcC
Confidence            44444444444444444444444444

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.15  E-value=1.7  Score=40.20  Aligned_cols=116  Identities=8%  Similarity=0.093  Sum_probs=79.3

Q ss_pred             CCCCceeeeeEEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeE
Q 042763          321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNIL  400 (554)
Q Consensus       321 ~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIL  400 (554)
                      .||++++. .+-.+++...+.++.-  .+...|-.-   +.++...+++++.+|+....+++     .-+|--|.|+|++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcC--cccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEE
Confidence            68888876 4556666655555543  333333321   35788999999999998776655     4578899999999


Q ss_pred             ECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 042763          401 LTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVE  472 (554)
Q Consensus       401 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~  472 (554)
                      ++.++.+++.=.|+-...                    +|.     .++...=.-.+=+++..+++++..|+
T Consensus       112 f~~~~~p~i~~RGik~~l--------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVV--------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECTTSCEEESCCEETTTB--------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EcCCCCEEEEEccCccCC--------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999877764321                    111     12222223457789999999998875

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=88.12  E-value=0.1  Score=56.44  Aligned_cols=37  Identities=8%  Similarity=-0.025  Sum_probs=27.8

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCC
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGS  113 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~  113 (554)
                      ...+|++++|+      +++ +|.   .+++|+.|++++|++++ +|.
T Consensus       141 ~L~~L~Ls~N~------l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~  177 (571)
T 3cvr_A          141 LLEYINADNNQ------LTM-LPE---LPTSLEVLSVRNNQLTF-LPE  177 (571)
T ss_dssp             TCCEEECCSSC------CSC-CCC---CCTTCCEEECCSSCCSC-CCC
T ss_pred             cccEEeCCCCc------cCc-CCC---cCCCcCEEECCCCCCCC-cch
Confidence            46788888888      777 776   56778888888888876 554

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=88.09  E-value=0.11  Score=49.87  Aligned_cols=37  Identities=8%  Similarity=0.112  Sum_probs=28.7

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecc
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGY  110 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~  110 (554)
                      ...+|++++|+      +++ + +.+..|++|+.|++++|++++-
T Consensus       107 ~L~~L~L~~N~------l~~-~-~~l~~l~~L~~L~Ls~N~i~~~  143 (263)
T 1xeu_A          107 CLSRLFLDNNE------LRD-T-DSLIHLKNLEILSIRNNKLKSI  143 (263)
T ss_dssp             SCCEEECCSSC------CSB-S-GGGTTCTTCCEEECTTSCCCBC
T ss_pred             cccEEEccCCc------cCC-C-hhhcCcccccEEECCCCcCCCC
Confidence            46888888888      776 2 4588888888888888888763

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=88.03  E-value=0.083  Score=51.18  Aligned_cols=40  Identities=8%  Similarity=-0.031  Sum_probs=30.1

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|+      +++..+..|..+++|+.|++++|.+++..+
T Consensus       155 L~~L~l~~n~------l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  194 (285)
T 1ozn_A          155 LTHLFLHGNR------ISSVPERAFRGLHSLDRLLLHQNRVAHVHP  194 (285)
T ss_dssp             CCEEECCSSC------CCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             ccEEECCCCc------ccccCHHHhcCccccCEEECCCCcccccCH
Confidence            5778888887      776555668888888888888888876555

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=87.83  E-value=0.11  Score=55.42  Aligned_cols=41  Identities=7%  Similarity=0.033  Sum_probs=34.6

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ...+|++++|+      +++..|..|..|++|+.|++++|++++..+
T Consensus       471 ~L~~L~l~~n~------l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  511 (570)
T 2z63_A          471 NLTFLDLSQCQ------LEQLSPTAFNSLSSLQVLNMASNQLKSVPD  511 (570)
T ss_dssp             TCCEEECTTSC------CCEECTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CCCEEECCCCc------cccCChhhhhcccCCCEEeCCCCcCCCCCH
Confidence            36888999998      888888889999999999999998887554

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=87.79  E-value=0.17  Score=48.53  Aligned_cols=36  Identities=8%  Similarity=0.006  Sum_probs=30.0

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ...+|++++|+      +++..|  +..|++|+.|++++|++++
T Consensus        64 ~L~~L~L~~N~------i~~~~~--l~~l~~L~~L~L~~N~l~~   99 (263)
T 1xeu_A           64 NLKELHLSHNQ------ISDLSP--LKDLTKLEELSVNRNRLKN   99 (263)
T ss_dssp             TCCEEECCSSC------CCCCGG--GTTCSSCCEEECCSSCCSC
T ss_pred             CCCEEECCCCc------cCCChh--hccCCCCCEEECCCCccCC
Confidence            35889999998      887544  8899999999999999886

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=87.73  E-value=0.19  Score=49.85  Aligned_cols=41  Identities=5%  Similarity=-0.028  Sum_probs=36.8

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ...+|++++|.      +++..|..+..|++|+.|++++|++++..+
T Consensus       194 ~L~~L~l~~n~------i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  234 (332)
T 2ft3_A          194 TLNELHLDHNK------IQAIELEDLLRYSKLYRLGLGHNQIRMIEN  234 (332)
T ss_dssp             SCSCCBCCSSC------CCCCCTTSSTTCTTCSCCBCCSSCCCCCCT
T ss_pred             CCCEEECCCCc------CCccCHHHhcCCCCCCEEECCCCcCCcCCh
Confidence            47899999999      999888999999999999999999987554

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=87.69  E-value=0.22  Score=47.87  Aligned_cols=39  Identities=3%  Similarity=-0.083  Sum_probs=31.9

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecc
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGY  110 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~  110 (554)
                      ...+|++++|+      +++..+..|+.|++|+.|++++|.+++-
T Consensus       134 ~L~~L~Ls~n~------l~~~~~~~~~~l~~L~~L~L~~n~l~~~  172 (270)
T 2o6q_A          134 KLTYLSLGYNE------LQSLPKGVFDKLTSLKELRLYNNQLKRV  172 (270)
T ss_dssp             TCCEEECCSSC------CCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCEEECCCCc------CCccCHhHccCCcccceeEecCCcCcEe
Confidence            36889999888      8876667788899999999999988853

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=87.69  E-value=0.11  Score=55.58  Aligned_cols=40  Identities=18%  Similarity=0.278  Sum_probs=19.8

Q ss_pred             CCceeeccCCcceeEEEc-CccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYIN-GNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~-G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|.      ++ |.+|..+..|++|+.|++++|++++..|
T Consensus       447 L~~L~l~~n~------l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~  487 (570)
T 2z63_A          447 LEVLKMAGNS------FQENFLPDIFTELRNLTFLDLSQCQLEQLSP  487 (570)
T ss_dssp             CCEEECTTCE------EGGGEECSCCTTCTTCCEEECTTSCCCEECT
T ss_pred             CcEEECcCCc------CccccchhhhhcccCCCEEECCCCccccCCh
Confidence            3445555554      44 3455555555555555555555554333

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=87.65  E-value=0.093  Score=56.76  Aligned_cols=38  Identities=11%  Similarity=0.017  Sum_probs=25.2

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ...+|++++|.      +++..|..|+.|++|+.|++++|.+++
T Consensus        81 ~L~~L~Ls~n~------l~~~~p~~~~~l~~L~~L~L~~n~l~~  118 (606)
T 3vq2_A           81 HLSNLILTGNP------IQSFSPGSFSGLTSLENLVAVETKLAS  118 (606)
T ss_dssp             TCCEEECTTCC------CCCCCTTSSTTCTTCCEEECTTSCCCC
T ss_pred             hcCEeECCCCc------ccccChhhcCCcccCCEEEccCCcccc
Confidence            35666666666      666666666666667777776666654

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=87.59  E-value=0.12  Score=55.75  Aligned_cols=41  Identities=12%  Similarity=0.045  Sum_probs=27.8

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ...+|++++|+      +++..|..|+.|++|+.|++++|++++..+
T Consensus       477 ~L~~L~Ls~n~------l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  517 (606)
T 3t6q_A          477 RLEILVLSFCD------LSSIDQHAFTSLKMMNHVDLSHNRLTSSSI  517 (606)
T ss_dssp             TCCEEECTTSC------CCEECTTTTTTCTTCCEEECCSSCCCGGGG
T ss_pred             CccEEECCCCc------cCccChhhhccccCCCEEECCCCccCcCCh
Confidence            35666777776      666666777777777777777777766544

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=87.48  E-value=0.12  Score=53.71  Aligned_cols=38  Identities=3%  Similarity=-0.073  Sum_probs=22.7

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|+      ++ .+| .+..+++|+.|++++|++++-.+
T Consensus       187 L~~L~L~~n~------l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~  224 (440)
T 3zyj_A          187 LRYLNLAMCN------LR-EIP-NLTPLIKLDELDLSGNHLSAIRP  224 (440)
T ss_dssp             CCEEECTTSC------CS-SCC-CCTTCSSCCEEECTTSCCCEECT
T ss_pred             cCeecCCCCc------Cc-ccc-ccCCCcccCEEECCCCccCccCh
Confidence            4666666666      55 344 36666666666666666665433

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=87.31  E-value=0.043  Score=62.33  Aligned_cols=37  Identities=5%  Similarity=-0.004  Sum_probs=18.0

Q ss_pred             CCceeeccCCcceeEEEcCccccc--hhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDK--FSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~--~~~~~~l~~l~~~~n~~~g  109 (554)
                      ..+|++++|.      ++|.+|+.  |+.|++|+.|++++|++++
T Consensus        99 L~~L~Ls~n~------l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~  137 (844)
T 3j0a_A           99 LFELRLYFCG------LSDAVLKDGYFRNLKALTRLDLSKNQIRS  137 (844)
T ss_dssp             CCCEECTTCC------CSSCCSTTCCCSSCSSCCEEEEESCCCCC
T ss_pred             cCEeeCcCCC------CCcccccCccccccCCCCEEECCCCcccc
Confidence            3444555554      44444433  4455555555555555444

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=87.24  E-value=0.16  Score=53.23  Aligned_cols=61  Identities=5%  Similarity=-0.158  Sum_probs=39.9

Q ss_pred             EeeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccC
Q 042763           25 IFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANH  104 (554)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~  104 (554)
                      +..+++|+|+|.+-....+.-+                  -...+|++++|+      +++..|..|..|++|+.|++++
T Consensus        34 l~~L~L~~n~l~~~~~~~~~~l------------------~~L~~L~L~~n~------i~~~~~~~~~~l~~L~~L~L~~   89 (477)
T 2id5_A           34 TRLLDLGKNRIKTLNQDEFASF------------------PHLEELELNENI------VSAVEPGAFNNLFNLRTLGLRS   89 (477)
T ss_dssp             CSEEECCSSCCCEECTTTTTTC------------------TTCCEEECTTSC------CCEECTTTTTTCTTCCEEECCS
T ss_pred             CcEEECCCCccceECHhHccCC------------------CCCCEEECCCCc------cCEeChhhhhCCccCCEEECCC
Confidence            3456778888776432211111                  124777888777      7777777778888888888888


Q ss_pred             ceeec
Q 042763          105 CIFEG  109 (554)
Q Consensus       105 n~~~g  109 (554)
                      |++++
T Consensus        90 n~l~~   94 (477)
T 2id5_A           90 NRLKL   94 (477)
T ss_dssp             SCCCS
T ss_pred             CcCCc
Confidence            77764

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=87.16  E-value=0.16  Score=50.32  Aligned_cols=41  Identities=7%  Similarity=-0.080  Sum_probs=33.5

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCC
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGS  113 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~  113 (554)
                      ...+|++++|.      +++..|..+..+++|+.|++++|+++ .+|.
T Consensus       217 ~L~~L~Ls~n~------l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~  257 (330)
T 1xku_A          217 NLAKLGLSFNS------ISAVDNGSLANTPHLRELHLNNNKLV-KVPG  257 (330)
T ss_dssp             TCCEEECCSSC------CCEECTTTGGGSTTCCEEECCSSCCS-SCCT
T ss_pred             CCCEEECCCCc------CceeChhhccCCCCCCEEECCCCcCc-cCCh
Confidence            36888899888      88877788888889999999999888 5554

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=87.13  E-value=0.13  Score=55.19  Aligned_cols=36  Identities=14%  Similarity=0.182  Sum_probs=19.0

Q ss_pred             CceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           68 DHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        68 ~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      .+|++++|+      +++..|..|..+++|+.|++++|++++
T Consensus        55 ~~L~Ls~N~------i~~~~~~~~~~l~~L~~L~Ls~N~l~~   90 (562)
T 3a79_B           55 KALSLSQNS------ISELRMPDISFLSELRVLRLSHNRIRS   90 (562)
T ss_dssp             CEEECCSSC------CCCCCGGGTTTCTTCCEEECCSCCCCE
T ss_pred             CEEECCCCC------ccccChhhhccCCCccEEECCCCCCCc
Confidence            455555555      555444555555555555555555554

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=86.73  E-value=0.12  Score=56.00  Aligned_cols=37  Identities=8%  Similarity=-0.097  Sum_probs=20.5

Q ss_pred             CceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecc
Q 042763           68 DHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGY  110 (554)
Q Consensus        68 ~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~  110 (554)
                      .+|++++|+      +++..|..|..|++|+.|++++|++++.
T Consensus        60 ~~L~Ls~n~------i~~~~~~~~~~l~~L~~L~Ls~n~l~~~   96 (606)
T 3t6q_A           60 TFLDLTRCQ------IYWIHEDTFQSQHRLDTLVLTANPLIFM   96 (606)
T ss_dssp             SEEECTTCC------CCEECTTTTTTCTTCCEEECTTCCCSEE
T ss_pred             eEEECCCCc------cceeChhhccCccccCeeeCCCCccccc
Confidence            555555555      5555555555555555555555555543

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=86.56  E-value=0.18  Score=49.14  Aligned_cols=35  Identities=6%  Similarity=0.111  Sum_probs=23.6

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ..+|++++|+      +++-  +.+..|++|+.|++++|++++
T Consensus       114 L~~L~L~~n~------i~~~--~~l~~l~~L~~L~l~~n~l~~  148 (291)
T 1h6t_A          114 LKSLSLEHNG------ISDI--NGLVHLPQLESLYLGNNKITD  148 (291)
T ss_dssp             CCEEECTTSC------CCCC--GGGGGCTTCCEEECCSSCCCC
T ss_pred             CCEEECCCCc------CCCC--hhhcCCCCCCEEEccCCcCCc
Confidence            4677777777      6652  456677777777777777665

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=86.52  E-value=0.12  Score=52.61  Aligned_cols=37  Identities=8%  Similarity=0.085  Sum_probs=28.5

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ..+|++++|.      +++..|..|..+++|+.|++++|++++
T Consensus       250 L~~L~Ls~n~------l~~~~~~~~~~l~~L~~L~L~~n~l~~  286 (390)
T 3o6n_A          250 LVEVDLSYNE------LEKIMYHPFVKMQRLERLYISNNRLVA  286 (390)
T ss_dssp             CSEEECCSSC------CCEEESGGGTTCSSCCEEECCSSCCCE
T ss_pred             ccEEECCCCc------CCCcChhHccccccCCEEECCCCcCcc
Confidence            5777788777      777777777778888888888887765

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=86.44  E-value=0.17  Score=49.00  Aligned_cols=38  Identities=8%  Similarity=0.103  Sum_probs=31.8

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecc
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGY  110 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~  110 (554)
                      ..+|++++|+      +++..|..|..|++|+.|++++|.+++.
T Consensus       107 L~~L~l~~n~------l~~~~~~~~~~l~~L~~L~l~~n~l~~~  144 (285)
T 1ozn_A          107 LHTLHLDRCG------LQELGPGLFRGLAALQYLYLQDNALQAL  144 (285)
T ss_dssp             CCEEECTTSC------CCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCEEECCCCc------CCEECHhHhhCCcCCCEEECCCCccccc
Confidence            5788888888      8887788888888888888888888753

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=86.32  E-value=0.18  Score=49.24  Aligned_cols=60  Identities=10%  Similarity=-0.051  Sum_probs=41.4

Q ss_pred             EeeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccC
Q 042763           25 IFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANH  104 (554)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~  104 (554)
                      +..+++++|+|.+ +..+..+.                   ...+|++++|+      +++-  +.+..|++|+.|++++
T Consensus       114 L~~L~L~~n~i~~-~~~l~~l~-------------------~L~~L~l~~n~------l~~~--~~l~~l~~L~~L~L~~  165 (291)
T 1h6t_A          114 LKSLSLEHNGISD-INGLVHLP-------------------QLESLYLGNNK------ITDI--TVLSRLTKLDTLSLED  165 (291)
T ss_dssp             CCEEECTTSCCCC-CGGGGGCT-------------------TCCEEECCSSC------CCCC--GGGGGCTTCSEEECCS
T ss_pred             CCEEECCCCcCCC-ChhhcCCC-------------------CCCEEEccCCc------CCcc--hhhccCCCCCEEEccC
Confidence            3456778887776 33222222                   35788888888      7764  6788888888888888


Q ss_pred             ceeecccC
Q 042763          105 CIFEGYSG  112 (554)
Q Consensus       105 n~~~g~~~  112 (554)
                      |++++..+
T Consensus       166 N~l~~~~~  173 (291)
T 1h6t_A          166 NQISDIVP  173 (291)
T ss_dssp             SCCCCCGG
T ss_pred             Cccccchh
Confidence            88886544

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=86.26  E-value=0.1  Score=50.23  Aligned_cols=39  Identities=5%  Similarity=-0.053  Sum_probs=27.6

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeeccc
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYS  111 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~  111 (554)
                      ..+|++++|+      +++..+..|..+++|+.|++++|++++..
T Consensus        54 L~~L~l~~n~------l~~~~~~~~~~l~~L~~L~L~~n~l~~~~   92 (276)
T 2z62_A           54 LQVLDLSRCE------IQTIEDGAYQSLSHLSTLILTGNPIQSLA   92 (276)
T ss_dssp             CSEEECTTCC------CCEECTTTTTTCTTCCEEECTTCCCCEEC
T ss_pred             CcEEECCCCc------CCccCHHHccCCcCCCEEECCCCccCccC
Confidence            4677777777      66666667777777777777777776543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=85.67  E-value=0.24  Score=50.30  Aligned_cols=36  Identities=6%  Similarity=-0.062  Sum_probs=24.2

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceee
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFE  108 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~  108 (554)
                      ..+|++++|+      +++..|..|+.+++|+.|++++|.++
T Consensus        95 L~~L~L~~n~------l~~~~~~~~~~l~~L~~L~L~~n~l~  130 (390)
T 3o6n_A           95 IQKLYMGFNA------IRYLPPHVFQNVPLLTVLVLERNDLS  130 (390)
T ss_dssp             CCEEECCSSC------CCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             cCEEECCCCC------CCcCCHHHhcCCCCCCEEECCCCccC
Confidence            4666666666      66666666666677777777776666

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=85.62  E-value=0.098  Score=55.78  Aligned_cols=37  Identities=8%  Similarity=0.140  Sum_probs=21.4

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ..+|++++|+      +++..|..|+.|++|+.|++++|.+++
T Consensus        76 L~~L~Ls~n~------l~~~~~~~~~~l~~L~~L~Ls~n~l~~  112 (549)
T 2z81_A           76 LEHLDLSDNH------LSSLSSSWFGPLSSLKYLNLMGNPYQT  112 (549)
T ss_dssp             CCEEECTTSC------CCSCCHHHHTTCTTCCEEECTTCCCSS
T ss_pred             CCEEECCCCc------cCccCHHHhccCCCCcEEECCCCcccc
Confidence            4555666655      555555555666666666666665553

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=85.53  E-value=0.26  Score=51.50  Aligned_cols=12  Identities=8%  Similarity=-0.130  Sum_probs=7.7

Q ss_pred             eeecCCCccccc
Q 042763           26 FLPRESSLDISS   37 (554)
Q Consensus        26 ~~~~~~~~~~~~   37 (554)
                      ..+++|+|+|.|
T Consensus        45 ~~L~Ls~n~l~~   56 (457)
T 3bz5_A           45 TSLDCHNSSITD   56 (457)
T ss_dssp             CEEECCSSCCCC
T ss_pred             CEEEccCCCccc
Confidence            345667777765

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=85.20  E-value=0.044  Score=54.40  Aligned_cols=37  Identities=24%  Similarity=0.222  Sum_probs=20.7

Q ss_pred             CCceeeccCCcceeEEEcCc-cccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGN-LVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~-~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ..+|++++|+      +++. +|..+..|++|+.|++++|++++
T Consensus        95 L~~L~L~~~~------l~~~~~~~~~~~~~~L~~L~L~~~~l~~  132 (336)
T 2ast_B           95 VQHMDLSNSV------IEVSTLHGILSQCSKLQNLSLEGLRLSD  132 (336)
T ss_dssp             CCEEECTTCE------ECHHHHHHHHTTBCCCSEEECTTCBCCH
T ss_pred             CCEEEccCCC------cCHHHHHHHHhhCCCCCEEeCcCcccCH
Confidence            4555555555      5554 55555555555555555555544

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=85.09  E-value=0.32  Score=46.59  Aligned_cols=39  Identities=3%  Similarity=0.012  Sum_probs=35.3

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecc
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGY  110 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~  110 (554)
                      ...+|++++|+      +++..|..|+.+++|+.|++++|++++-
T Consensus       110 ~L~~L~l~~n~------l~~~~~~~~~~l~~L~~L~Ls~n~l~~~  148 (270)
T 2o6q_A          110 NLAELRLDRNQ------LKSLPPRVFDSLTKLTYLSLGYNELQSL  148 (270)
T ss_dssp             SCCEEECCSSC------CCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCCEEECCCCc------cCeeCHHHhCcCcCCCEEECCCCcCCcc
Confidence            36899999999      9998889999999999999999999853

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=85.04  E-value=0.17  Score=49.94  Aligned_cols=42  Identities=5%  Similarity=-0.028  Sum_probs=34.7

Q ss_pred             cCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCCC
Q 042763           65 CGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSD  114 (554)
Q Consensus        65 ~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~~  114 (554)
                      ....+|++++|+      +++ +|+.+..+++|+.|++++|++++ +|..
T Consensus       191 ~~L~~L~Ls~N~------l~~-l~~~~~~l~~L~~L~L~~N~l~~-l~~~  232 (317)
T 3o53_A          191 AKLKTLDLSSNK------LAF-MGPEFQSAAGVTWISLRNNKLVL-IEKA  232 (317)
T ss_dssp             TTCCEEECCSSC------CCE-ECGGGGGGTTCSEEECTTSCCCE-ECTT
T ss_pred             ccCCEEECCCCc------CCc-chhhhcccCcccEEECcCCcccc-hhhH
Confidence            346899999999      885 66679999999999999999984 5543

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=85.00  E-value=0.13  Score=51.48  Aligned_cols=37  Identities=14%  Similarity=0.046  Sum_probs=20.7

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ..+|++++|+      +++..+..|..|++|+.|++++|++++
T Consensus        54 L~~L~l~~n~------i~~~~~~~~~~l~~L~~L~L~~n~l~~   90 (353)
T 2z80_A           54 VKSLDLSNNR------ITYISNSDLQRCVNLQALVLTSNGINT   90 (353)
T ss_dssp             CCEEECTTSC------CCEECTTTTTTCTTCCEEECTTSCCCE
T ss_pred             CcEEECCCCc------CcccCHHHhccCCCCCEEECCCCccCc
Confidence            3555666555      554444455556666666666665554

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=84.96  E-value=0.1  Score=49.04  Aligned_cols=34  Identities=6%  Similarity=0.028  Sum_probs=16.5

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhh---hhhccCc-eee
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQ---FHYANHC-IFE  108 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~---~l~~~~n-~~~  108 (554)
                      ..+|++++|.      +++ +|+ |..+++|+   .|++++| +++
T Consensus       107 L~~L~l~~n~------l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~  144 (239)
T 2xwt_C          107 LKFLGIFNTG------LKM-FPD-LTKVYSTDIFFILEITDNPYMT  144 (239)
T ss_dssp             CCEEEEEEEC------CCS-CCC-CTTCCBCCSEEEEEEESCTTCC
T ss_pred             CCEEeCCCCC------Ccc-ccc-cccccccccccEEECCCCcchh
Confidence            3555555555      444 443 44444444   5555555 443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=84.77  E-value=0.2  Score=52.36  Aligned_cols=40  Identities=8%  Similarity=-0.220  Sum_probs=24.6

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|.      +++..+..|..|++|+.|++++|++++..+
T Consensus       250 L~~L~Ls~n~------l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  289 (477)
T 2id5_A          250 LRFLNLSYNP------ISTIEGSMLHELLRLQEIQLVGGQLAVVEP  289 (477)
T ss_dssp             CCEEECCSSC------CCEECTTSCTTCTTCCEEECCSSCCSEECT
T ss_pred             cCeeECCCCc------CCccChhhccccccCCEEECCCCccceECH
Confidence            4566666666      665555566666666666666666665433

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=84.64  E-value=0.27  Score=53.86  Aligned_cols=15  Identities=7%  Similarity=-0.139  Sum_probs=9.5

Q ss_pred             EeeecCCCcccccCC
Q 042763           25 IFLPRESSLDISSNF   39 (554)
Q Consensus        25 ~~~~~~~~~~~~~~~   39 (554)
                      +..+++|.|+|.+-.
T Consensus        27 l~~L~Ls~n~l~~~~   41 (680)
T 1ziw_A           27 ITVLNLTHNQLRRLP   41 (680)
T ss_dssp             CSEEECCSSCCCCCC
T ss_pred             CcEEECCCCCCCCcC
Confidence            455677777776643

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=84.61  E-value=0.15  Score=50.39  Aligned_cols=40  Identities=3%  Similarity=0.000  Sum_probs=28.8

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|+      +++..|..|..+++|+.|++++|++++..+
T Consensus        36 L~~L~L~~n~------l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~   75 (317)
T 3o53_A           36 VKELDLSGNP------LSQISAADLAPFTKLELLNLSSNVLYETLD   75 (317)
T ss_dssp             CSEEECTTSC------CCCCCHHHHTTCTTCCEEECTTSCCEEEEE
T ss_pred             CCEEECcCCc------cCcCCHHHhhCCCcCCEEECCCCcCCcchh
Confidence            5677777777      777666777777777777777777766444

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=84.44  E-value=0.23  Score=48.90  Aligned_cols=36  Identities=8%  Similarity=0.132  Sum_probs=24.7

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecc
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGY  110 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~  110 (554)
                      ..+|++++|+      +++ +|. +..|++|+.|++++|++++.
T Consensus       109 L~~L~l~~n~------l~~-~~~-l~~l~~L~~L~l~~n~l~~~  144 (308)
T 1h6u_A          109 IKTLDLTSTQ------ITD-VTP-LAGLSNLQVLYLDLNQITNI  144 (308)
T ss_dssp             CCEEECTTSC------CCC-CGG-GTTCTTCCEEECCSSCCCCC
T ss_pred             CCEEECCCCC------CCC-chh-hcCCCCCCEEECCCCccCcC
Confidence            4777777777      665 333 77777777777777777653

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=84.20  E-value=0.16  Score=53.22  Aligned_cols=43  Identities=12%  Similarity=-0.020  Sum_probs=19.5

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCCCcc
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDYC  116 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~~~~  116 (554)
                      ...|++++|+      + |.+|+.++.|++|+.|++++|.++|.+|...+
T Consensus        13 L~~L~l~~n~------l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~   55 (454)
T 1jl5_A           13 LQEPLRHSSN------L-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNG   55 (454)
T ss_dssp             ----------------------------CCHHHHHHHHHHHHHTSCTTSC
T ss_pred             chhhhcccCc------h-hhCChhHhcccchhhhhccCCcccccCCcccc
Confidence            4788999999      8 99999999999999999999999998886554

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=84.08  E-value=0.27  Score=48.30  Aligned_cols=37  Identities=11%  Similarity=0.106  Sum_probs=26.8

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeeccc
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYS  111 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~  111 (554)
                      ..+|++++|+      +++ +++ +..|++|+.|++++|++++-.
T Consensus       153 L~~L~l~~n~------l~~-~~~-l~~l~~L~~L~l~~n~l~~~~  189 (308)
T 1h6u_A          153 LQYLSIGNAQ------VSD-LTP-LANLSKLTTLKADDNKISDIS  189 (308)
T ss_dssp             CCEEECCSSC------CCC-CGG-GTTCTTCCEEECCSSCCCCCG
T ss_pred             ccEEEccCCc------CCC-Chh-hcCCCCCCEEECCCCccCcCh
Confidence            5778888887      775 333 778888888888888877533

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=84.01  E-value=0.39  Score=50.07  Aligned_cols=38  Identities=8%  Similarity=0.010  Sum_probs=27.1

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|+      +++..|  ++.|++|+.|++++|++++..+
T Consensus       289 L~~L~L~~n~------l~~~~~--~~~l~~L~~L~L~~n~l~~~~~  326 (466)
T 1o6v_A          289 LTNLELNENQ------LEDISP--ISNLKNLTYLTLYFNNISDISP  326 (466)
T ss_dssp             CSEEECCSSC------CSCCGG--GGGCTTCSEEECCSSCCSCCGG
T ss_pred             cCeEEcCCCc------ccCchh--hcCCCCCCEEECcCCcCCCchh
Confidence            4777777777      776444  6777777777777777776554

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=82.74  E-value=0.37  Score=52.84  Aligned_cols=40  Identities=10%  Similarity=-0.066  Sum_probs=23.8

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|+      +++-.|..|+.|++|+.|++++|.+++..+
T Consensus        99 L~~L~L~~n~------l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~  138 (680)
T 1ziw_A           99 LTELHLMSNS------IQKIKNNPFVKQKNLITLDLSHNGLSSTKL  138 (680)
T ss_dssp             CSEEECCSSC------CCCCCSCTTTTCTTCCEEECCSSCCSCCCC
T ss_pred             CCEEECCCCc------cCccChhHccccCCCCEEECCCCcccccCc
Confidence            4566666666      555555566666666666666666655433

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.31  E-value=2.8  Score=38.88  Aligned_cols=114  Identities=10%  Similarity=0.113  Sum_probs=77.2

Q ss_pred             CCCCceeeeeEEEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHH-HhhhccCCCeEeCCCCCCCe
Q 042763          321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLT-YLHLYAEKQIIHRDVKSSNI  399 (554)
Q Consensus       321 ~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~-~LH~~~~~~ivH~Dlkp~NI  399 (554)
                      .||++  -..+-.+++...+.++.-+++.=...+     +.++..++++++.+|+.... +++     .-+|--|.|+|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence            68888  333446667777767654333322333     25788999999999888666 444     568889999999


Q ss_pred             EECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhH-HHHHHHHHHHHhCCCCCC
Q 042763          400 LLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDV-YSFGVLLLEILTGRRPVE  472 (554)
Q Consensus       400 Ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDV-wSlGvil~elltg~~P~~  472 (554)
                      +++.++.+++.-.|+-..                    ++|.     ..+ ..|. -.+=+++..++.++..|+
T Consensus       116 ~f~~~~~p~i~hRGi~~~--------------------lpP~-----e~~-ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKES--------------------LPPD-----EWD-DERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EECTTCCEEESCCEETTT--------------------BSSC-----SCC-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EEeCCCcEEEEEcCCccc--------------------CCCC-----CCC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999987776432                    2222     112 2343 347788889999988764

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=82.11  E-value=0.34  Score=48.08  Aligned_cols=35  Identities=6%  Similarity=-0.017  Sum_probs=29.6

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceee
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFE  108 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~  108 (554)
                      ...+|++++|.      +++..|  +..|++|+.|++++|.++
T Consensus       312 ~L~~L~L~~n~------l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          312 NLTTLFLSQNH------ITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             TCSEEECCSSS------CCCCGG--GGGCTTCSEESSSCC---
T ss_pred             cCCEEEccCCc------cccccC--hhhhhccceeehhhhccc
Confidence            47899999999      998777  999999999999999876

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=81.89  E-value=0.35  Score=50.42  Aligned_cols=36  Identities=11%  Similarity=-0.064  Sum_probs=27.8

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecc
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGY  110 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~  110 (554)
                      ..+|++++|+      ++|..|  +..|++|+.|++++|.+++.
T Consensus       311 L~~L~L~~n~------l~~~~~--~~~l~~L~~L~l~~n~l~~~  346 (466)
T 1o6v_A          311 LTYLTLYFNN------ISDISP--VSSLTKLQRLFFYNNKVSDV  346 (466)
T ss_dssp             CSEEECCSSC------CSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred             CCEEECcCCc------CCCchh--hccCccCCEeECCCCccCCc
Confidence            5788888888      777666  67788888888888887764

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=81.70  E-value=0.081  Score=52.46  Aligned_cols=38  Identities=8%  Similarity=0.145  Sum_probs=34.3

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCc-eeec
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHC-IFEG  109 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n-~~~g  109 (554)
                      ...+|++++|+      +++.+|..++.|++|+.|++++| .+++
T Consensus       119 ~L~~L~L~~~~------l~~~~~~~l~~~~~L~~L~L~~~~~l~~  157 (336)
T 2ast_B          119 KLQNLSLEGLR------LSDPIVNTLAKNSNLVRLNLSGCSGFSE  157 (336)
T ss_dssp             CCSEEECTTCB------CCHHHHHHHTTCTTCSEEECTTCBSCCH
T ss_pred             CCCEEeCcCcc------cCHHHHHHHhcCCCCCEEECCCCCCCCH
Confidence            57899999999      99999999999999999999999 6775

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=81.64  E-value=0.23  Score=49.73  Aligned_cols=61  Identities=11%  Similarity=-0.023  Sum_probs=44.9

Q ss_pred             EEeeecCCCcccccCCc-hhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhc
Q 042763           24 SIFLPRESSLDISSNFA-PSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYA  102 (554)
Q Consensus        24 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~  102 (554)
                      ++..+++|+|+|.+-.. .+..+.                   ...+|++++|+      +++..|..|..|++|+.|++
T Consensus        53 ~L~~L~l~~n~i~~~~~~~~~~l~-------------------~L~~L~L~~n~------l~~~~~~~~~~l~~L~~L~L  107 (353)
T 2z80_A           53 AVKSLDLSNNRITYISNSDLQRCV-------------------NLQALVLTSNG------INTIEEDSFSSLGSLEHLDL  107 (353)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCT-------------------TCCEEECTTSC------CCEECTTTTTTCTTCCEEEC
T ss_pred             cCcEEECCCCcCcccCHHHhccCC-------------------CCCEEECCCCc------cCccCHhhcCCCCCCCEEEC
Confidence            34566788888775322 122222                   25889999999      88888888999999999999


Q ss_pred             cCceeec
Q 042763          103 NHCIFEG  109 (554)
Q Consensus       103 ~~n~~~g  109 (554)
                      ++|++++
T Consensus       108 s~n~l~~  114 (353)
T 2z80_A          108 SYNYLSN  114 (353)
T ss_dssp             CSSCCSS
T ss_pred             CCCcCCc
Confidence            9999885

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=81.49  E-value=0.88  Score=30.05  Aligned_cols=27  Identities=15%  Similarity=0.146  Sum_probs=11.2

Q ss_pred             CcceehhHHHHHHHHH-HHHHHHHhhcc
Q 042763          165 TTKKVGIAATGLFVMS-CALLCPCFYKK  191 (554)
Q Consensus       165 ~~~~i~i~~~~~~~l~-~~~l~~~~~r~  191 (554)
                      ...+++.+++++++++ +++++++++||
T Consensus        12 ~~~I~~~vv~Gv~ll~~iv~~~~~~~rR   39 (41)
T 2k9y_A           12 NLAVIGGVAVGVVLLLVLAGVGFFIHRR   39 (41)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred             eEEEEeehhHHHHHHHHHHHHheeEeee
Confidence            3344444444444444 33333344443

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.80  E-value=0.17  Score=53.10  Aligned_cols=61  Identities=11%  Similarity=0.091  Sum_probs=17.4

Q ss_pred             cceeeeccCceEEEEEEEcC-CcEEEE------EEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEE
Q 042763          270 PSLRIGEGGFGTVYKAQLED-GLLVAI------KRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVD  333 (554)
Q Consensus       270 ~~~~LG~G~fG~Vy~a~~~~-g~~vAv------K~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~  333 (554)
                      ..++||   ||.||+|.+.. ..+|||      |..+..... .....+.+|..+++.++|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345676   99999998764 357888      766543322 22356888999999999999999988754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	554
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-69
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-66
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-62
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-62
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-62
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-61
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-61
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-58
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-58
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-57
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-55
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-55
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-54
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-53
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-44
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-43
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-43
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-41
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-23

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (568), Expect = 2e-69
 Identities = 75/277 (27%), Positives = 125/277 (45%), Gaps = 23/277 (8%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           RIG G FGTVYK +      VA+K              F +EV +L K  H N++  +G+
Sbjct: 15  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
                   I+T++    +L  HL     K  +  + ++IA   A G+ YLH    K IIH
Sbjct: 73  STAPQ-LAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSIIH 127

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ---L 448
           RD+KS+NI L E +  K+ DFG A +    S  +H   ++ G++ ++ PE ++       
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPY 186

Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS 508
           + +SDVY+FG++L E++TG+ P       +              G     + P + + + 
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRG----YLSPDLSK-VR 235

Query: 509 MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA 545
                 M  L  +C    R++RP    +   +  +  
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 1e-66
 Identities = 73/268 (27%), Positives = 125/268 (46%), Gaps = 23/268 (8%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           R+G G FG V+         VA+K  K+         F +E  L+ ++ H+ LV+L   V
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     IITE++ NG+L + L    G  L  N+ L++A  +A G+ ++    E+  IHR
Sbjct: 78  TQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL+++++  K+ADFG ARL  ++ +        K  + +  PE +     T KS
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191

Query: 453 DVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEIL 512
           DV+SFG+LL EI+T  R                 +       ++  ++   + V      
Sbjct: 192 DVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMVRPDNCP 236

Query: 513 TKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            +++ L   C      DRP    +   L
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 6e-63
 Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 29/273 (10%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG-F 331
            IG+G FG V       G  VA+K  K +        F +E  +++++ H NLV+LLG  
Sbjct: 14  TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVI 69

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           V++     I+TE++  G+L ++L  +    L  +  L+ ++DV   + YL        +H
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N+L++E   AKV+DFG  +      D           V +  PE ++  + +TK
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK------LPVKWTAPEALREKKFSTK 180

Query: 452 SDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEI 511
           SDV+SFG+LL EI +        R P  R+ L+    R  +G  +D  D     V     
Sbjct: 181 SDVWSFGILLWEIYSFG------RVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE--- 231

Query: 512 LTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR 544
                 +   C       RP    + EQL  I+
Sbjct: 232 ------VMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (521), Expect = 2e-62
 Identities = 64/296 (21%), Positives = 125/296 (42%), Gaps = 27/296 (9%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
            IG+G FG V++ +   G  VA+K     +  +   E  +E+     + H N++  +   
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 66

Query: 333 DKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA--- 385
           +K N    +  +++++  +G+L ++L+     T+     +++A+  A GL +LH+     
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 386 --EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI-STKVKGTVGYLDPEY 442
             +  I HRD+KS NIL+ ++    +AD G A      +D   I      GT  Y+ PE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 443 ------MKTYQLTTKSDVYSFGVLLLEILTGRRP----VELKRPPEERVTLRWAFKRYNE 492
                 MK ++   ++D+Y+ G++  EI           + + P  + V    + +   +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 493 GNLLDMVDPSIKEVI-SMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS 547
                 + P+I     S E L  M  +  +C       R     + + L  +    
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 3e-62
 Identities = 75/268 (27%), Positives = 122/268 (45%), Gaps = 23/268 (8%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
           ++G+G FG V+         VAIK  K          F  E +++ K+ H  LV+L   V
Sbjct: 24  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVV 81

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     I+TE++  G+L + L G+ GK L   Q +++A  +A G+ Y+        +HR
Sbjct: 82  SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 137

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D++++NIL+ E++  KVADFG ARL  ++ +        K  + +  PE     + T KS
Sbjct: 138 DLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 195

Query: 453 DVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEIL 512
           DV+SFG+LL E+ T  R                 +       +LD V+   +     E  
Sbjct: 196 DVWSFGILLTELTTKGRVP---------------YPGMVNREVLDQVERGYRMPCPPECP 240

Query: 513 TKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
             +  L  QC      +RP  + +   L
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 3e-62
 Identities = 62/233 (26%), Positives = 105/233 (45%), Gaps = 14/233 (6%)

Query: 267 NFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL 325
           +F     +G G  G V+K      GL++A K    E    ++ +   E+++L + +   +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           V   G      E  I  E +  G+L + L       +      +++I V  GLTYL    
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLR--E 122

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
           + +I+HRDVK SNIL+      K+ DFG +         + +     GT  Y+ PE ++ 
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQG 177

Query: 446 YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM 498
              + +SD++S G+ L+E+  GR P+    PP +   L   F    EG+  + 
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELELMFGCQVEGDAAET 226

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 4e-62
 Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 23/272 (8%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFV 332
            IG G FG V+     +   VAIK  ++      + +F  E E++ K+ H  LV+L G  
Sbjct: 12  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 333 DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR 392
            +     ++ EF+ +G L ++L  Q G        L + +DV  G+ YL    E  +IHR
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAYLE---EACVIHR 125

Query: 393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKS 452
           D+ + N L+ E+   KV+DFG  R   +  D+   ST  K  V +  PE     + ++KS
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183

Query: 453 DVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEIL 512
           DV+SFGVL+ E+ +  +     R   E               +++ +    +        
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSE---------------VVEDISTGFRLYKPRLAS 228

Query: 513 TKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR 544
           T ++ +   C      DRP    +  QL  I 
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (518), Expect = 8e-62
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 36/305 (11%)

Query: 263 KATRNFSPSL---------RIGEGGFGTVYKAQL----EDGLLVAIKRAKKEQFENLQTE 309
           +A R F+  +          IG G FG V    L    +  + VAIK  K    E  + +
Sbjct: 14  EAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD 73

Query: 310 FSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLE 369
           F SE  ++ + DH N++ L G V K    +IITEF+ NG+L   L    G+     Q + 
Sbjct: 74  FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-TVIQLVG 132

Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
           +   +A G+ YL    +   +HRD+ + NIL+  ++  KV+DFG +R    D+     ++
Sbjct: 133 MLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 189

Query: 430 KV--KGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF 487
            +  K  + +  PE ++  + T+ SDV+S+G+++ E+++                    +
Sbjct: 190 ALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER---------------PY 234

Query: 488 KRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA-- 545
                 ++++ ++   +    M+  + +  L + C    RN RP    +   L  +    
Sbjct: 235 WDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294

Query: 546 DSLKS 550
           +SLK+
Sbjct: 295 NSLKA 299

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (516), Expect = 1e-61
 Identities = 62/281 (22%), Positives = 124/281 (44%), Gaps = 23/281 (8%)

Query: 274 IGEGGFGTVYKAQL---EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +G G FG+V +      +  + VAIK  K+   +    E   E +++ ++D+  +V+L+G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
                   +++ E    G L + L G+  + +  +   E+   V+ G+ YL    EK  +
Sbjct: 77  VCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLE---EKNFV 131

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+ + N+LL     AK++DFG ++    D       +  K  + +  PE +   + ++
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191

Query: 451 KSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISME 510
           +SDV+S+GV + E L+  +                 +K+     ++  ++   +     E
Sbjct: 192 RSDVWSYGVTMWEALSYGQK---------------PYKKMKGPEVMAFIEQGKRMECPPE 236

Query: 511 ILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKSV 551
              +++ L   C      DRPD  +V +++ A        V
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 1e-61
 Identities = 68/275 (24%), Positives = 119/275 (43%), Gaps = 23/275 (8%)

Query: 266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL 325
           ++ +    +G G FG V   +      VAIK  K+      + EF  E +++  + H  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKL 61

Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
           V+L G   K     IITE++ NG L  +L     +     Q LE+  DV   + YL    
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE--- 117

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
            KQ +HRD+ + N L+ +    KV+DFG +R   +  D    S   K  V +  PE +  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 446 YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE 505
            + ++KSD+++FGVL+ EI +  +                 ++R+      + +   ++ 
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRL 220

Query: 506 VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
                   K++ +   C     ++RP  K +   +
Sbjct: 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 1e-61
 Identities = 75/285 (26%), Positives = 135/285 (47%), Gaps = 26/285 (9%)

Query: 274 IGEGGFGTVYKAQLEDG-----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
           IG G FG VYK  L+       + VAIK  K    E  + +F  E  ++ +  H N+++L
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
            G + K    +IITE++ NG L + L  + G+     Q + +   +A G+ YL       
Sbjct: 75  EGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLA---NMN 130

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            +HRD+ + NIL+  ++  KV+DFG +R+   D + T+ ++  K  + +  PE +   + 
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 190

Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS 508
           T+ SDV+SFG+++ E++T       +    E               ++  ++   +    
Sbjct: 191 TSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------VMKAINDGFRLPTP 235

Query: 509 MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA--DSLKSV 551
           M+  + ++ L +QC    R  RP    +   L  +    DSLK++
Sbjct: 236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 280

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  201 bits (512), Expect = 4e-61
 Identities = 74/276 (26%), Positives = 124/276 (44%), Gaps = 23/276 (8%)

Query: 273 RIGEGGFGTVYKAQLED-GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G +G VY+   +   L VA+K  K++  E    EF  E  ++ +I H NLV+LLG 
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +     IITEF+  G L ++L     + +     L +A  ++  + YL    +K  IH
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 138

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+ + N L+ E+   KVADFG +RL  M  D        K  + +  PE +   + + K
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196

Query: 452 SDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEI 511
           SDV++FGVLL EI T                    +   +   + ++++   +       
Sbjct: 197 SDVWAFGVLLWEIATYGMSP---------------YPGIDLSQVYELLEKDYRMERPEGC 241

Query: 512 LTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS 547
             K++ L   C     +DRP    + +    +  +S
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (509), Expect = 1e-60
 Identities = 80/296 (27%), Positives = 131/296 (44%), Gaps = 47/296 (15%)

Query: 273 RIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
            IGEG FG V++A+       E   +VA+K  K+E   ++Q +F  E  L+++ D+ N+V
Sbjct: 20  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKT----------------------LDF 364
           KLLG    G    ++ E++  G L E L      T                      L  
Sbjct: 80  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139

Query: 365 NQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR 424
            ++L IA  VA G+ YL    E++ +HRD+ + N L+ E+M  K+ADFG +R     +D 
Sbjct: 140 AEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY-SADY 195

Query: 425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR 484
                     + ++ PE +   + TT+SDV+++GV+L EI +          P   +   
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG------LQPYYGMAHE 249

Query: 485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
                  +GN+L   +    E+ +         L   C + +  DRP   S+   L
Sbjct: 250 EVIYYVRDGNILACPENCPLELYN---------LMRLCWSKLPADRPSFCSIHRIL 296

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 2e-59
 Identities = 64/272 (23%), Positives = 120/272 (44%), Gaps = 25/272 (9%)

Query: 273 RIGEGGFGTVYKAQLED---GLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKL 328
            +G G FGTV K   +       VA+K  K E     L+ E  +E  ++ ++D+  +V++
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           +G  +  +  +++ E    G L ++L     + +     +E+   V+ G+ YL    E  
Sbjct: 74  IGICEAES-WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESN 127

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            +HRD+ + N+LL     AK++DFG ++    D +     T  K  V +  PE +  Y+ 
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187

Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS 508
           ++KSDV+SFGVL+ E  +  +                 ++      +  M++   +    
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQK---------------PYRGMKGSEVTAMLEKGERMGCP 232

Query: 509 MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
                +M+ L   C      +RP   +V  +L
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 3e-59
 Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 25/282 (8%)

Query: 274 IGEGGFGTVYKAQLED----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLL 329
           IG G FG VY   L D     +  A+K   +       ++F +E  ++    H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94

Query: 330 GF-VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           G  +      L++  ++ +G LR  +  +          +   + VA G+ +L     K+
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA---SKK 150

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
            +HRD+ + N +L E    KVADFG AR +   + D  H  T  K  V ++  E ++T +
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210

Query: 448 LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVI 507
            TTKSDV+SFGVLL E++T         PP   V          +G    ++ P      
Sbjct: 211 FTTKSDVWSFGVLLWELMTRG------APPYPDVNTFDITVYLLQGR--RLLQPE----- 257

Query: 508 SMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK 549
                  ++ + ++C  P    RP    +  ++ AI +  + 
Sbjct: 258 --YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 5e-58
 Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 41/298 (13%)

Query: 273 RIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNL 325
            +G G FG V +A        +  + VA+K  K       +    SE+++LS + +H N+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGK----------------TLDFNQRLE 369
           V LLG    G   L+ITE+   G L   L  +                    LD    L 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
            +  VA G+ +L     K  IHRD+ + NILLT     K+ DFG AR    +     +  
Sbjct: 150 FSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIK-NDSNYVVKG 205

Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
             +  V ++ PE +     T +SDV+S+G+ L E+ +         P + +         
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--------- 256

Query: 490 YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS 547
                   M+    + +       +M+ +   C       RP  K + + +    ++S
Sbjct: 257 -----FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 5e-58
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 31/278 (11%)

Query: 273 RIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLL 329
            +G+G FG VY A+  +   ++A+K   K Q     ++ +   EVE+ S + H N+++L 
Sbjct: 13  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G+        +I E+ P GT+   L  Q     D  +      ++A+ L+Y H    K++
Sbjct: 73  GYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH---SKRV 127

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           IHRD+K  N+LL  +   K+ADFG++   P     T     + GT+ YL PE ++     
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDYLPPEMIEGRMHD 182

Query: 450 TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISM 509
            K D++S GVL  E L G+ P E     E   T +   +   E    D V    +++IS 
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKRISR--VEFTFPDFVTEGARDLIS- 236

Query: 510 EILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS 547
                      +      + RP ++ V E  W I A+S
Sbjct: 237 -----------RLLKHNPSQRPMLREVLEHPW-ITANS 262

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 5e-57
 Identities = 73/287 (25%), Positives = 119/287 (41%), Gaps = 29/287 (10%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
            +G+G FG VYKAQ  E  +L A K    +  E L+ ++  E+++L+  DH N+VKLL  
Sbjct: 19  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDA 77

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
               N   I+ EF   G +   +  +  + L  +Q   +       L YLH   + +IIH
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLH---DNKIIH 133

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL--- 448
           RD+K+ NIL T     K+ADFG +        R        GT  ++ PE +        
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR---DSFIGTPYWMAPEVVMCETSKDR 190

Query: 449 --TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEV 506
               K+DV+S G+ L+E+     P         RV L+ A               + K+ 
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPP--HHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248

Query: 507 ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKSVKK 553
           +             +C     + R     + +  + +  DS K +++
Sbjct: 249 LK------------KCLEKNVDARWTTSQLLQHPF-VTVDSNKPIRE 282

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 3e-56
 Identities = 64/284 (22%), Positives = 117/284 (41%), Gaps = 27/284 (9%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
            +GEG +G V  A        VA+K    ++  +       E+ +   ++H N+VK  G 
Sbjct: 12  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
             +GN + +  E+   G L + ++   G  +           +  G+ YLH      I H
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH---GIGITH 126

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL-TT 450
           RD+K  N+LL E    K++DFG A +   + +R  +  K+ GT+ Y+ PE +K  +    
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYN-NRERLLNKMCGTLPYVAPELLKRREFHAE 185

Query: 451 KSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISME 510
             DV+S G++L  +L G  P +  +P +         ++    N    +D +   ++   
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH-- 241

Query: 511 ILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKSVKKG 554
                     +      + R  +  + +  W       K +KKG
Sbjct: 242 ----------KILVENPSARITIPDIKKDRW-YN----KPLKKG 270

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 7e-56
 Identities = 67/271 (24%), Positives = 111/271 (40%), Gaps = 30/271 (11%)

Query: 273 RIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLG 330
            IG G F TVYK    E  + VA    +  +  ++ +  F  E E+L  + H N+V+   
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 331 F----VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
                V      +++TE + +GTL+ +L     K +           +  GL +LH    
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLH-TRT 132

Query: 387 KQIIHRDVKSSNILLT-ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
             IIHRD+K  NI +T  +   K+ D G A L      R   +  V GT  ++ PE  + 
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-----KRASFAKAVIGTPEFMAPEMYEE 187

Query: 446 YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE 505
            +     DVY+FG+ +LE+ T   P    +   +    R         +   +  P +KE
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVKPASFDKVAIPEVKE 244

Query: 506 VISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
           +I              C    +++R  +K +
Sbjct: 245 IIE------------GCIRQNKDERYSIKDL 263

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 9e-56
 Identities = 62/272 (22%), Positives = 103/272 (37%), Gaps = 27/272 (9%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLG 330
            IG G +G   K +   DG ++  K        E  +    SEV LL ++ H N+V+   
Sbjct: 11  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70

Query: 331 -FVDKGNERL-IITEFVPNGTLREHLD--GQYGKTLDFNQRLEIAIDVAHGLTYLHL--Y 384
             +D+ N  L I+ E+   G L   +    +  + LD    L +   +   L   H    
Sbjct: 71  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
               ++HRD+K +N+ L      K+ DFG AR+   D+          GT  Y+ PE M 
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KAFVGTPYYMSPEQMN 187

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK 504
                 KSD++S G LL E+     P                F  +++  L   +     
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPP----------------FTAFSQKELAGKIREGKF 231

Query: 505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSV 536
             I      ++  +  +        RP ++ +
Sbjct: 232 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-55
 Identities = 79/292 (27%), Positives = 128/292 (43%), Gaps = 40/292 (13%)

Query: 273 RIGEGGFGTVYKAQLEDG---LLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKL 328
            IGEG FG V KA+++     +  AIKR K+   ++   +F+ E+E+L K+  H N++ L
Sbjct: 17  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQY--------------GKTLDFNQRLEIAIDV 374
           LG  +      +  E+ P+G L + L                    TL   Q L  A DV
Sbjct: 77  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136

Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT 434
           A G+ YL    +KQ IHRD+ + NIL+ E+  AK+ADFG +R   +   +T      +  
Sbjct: 137 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM----GRLP 189

Query: 435 VGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN 494
           V ++  E +     TT SDV+S+GVLL EI++                    +       
Sbjct: 190 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYCGMTCAE 234

Query: 495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD 546
           L + +    +    +    +++ L  QC      +RP    +   L  +  +
Sbjct: 235 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-55
 Identities = 73/274 (26%), Positives = 119/274 (43%), Gaps = 25/274 (9%)

Query: 273 RIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQFENLQT--EFSSEVELLSKIDHRNLV 326
           ++G+G FG V + + +      + VA+K  K +     +   +F  EV  +  +DHRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
           +L G V     + ++TE  P G+L + L    G           A+ VA G+ YL     
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLE---S 129

Query: 387 KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTY 446
           K+ IHRD+ + N+LL      K+ DFG  R  P + D   +    K    +  PE +KT 
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189

Query: 447 QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEV 506
             +  SD + FGV L E+ T  +      P       +   K   EG  L   +   +++
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244

Query: 507 ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            +         + +QC A    DRP   ++ + L
Sbjct: 245 YN---------VMVQCWAHKPEDRPTFVALRDFL 269

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 4e-55
 Identities = 57/294 (19%), Positives = 126/294 (42%), Gaps = 27/294 (9%)

Query: 258 MSQVVKATRNFSPSLRIGEGGFGTVYKAQL-----EDGLLVAIKRAKKEQFENLQTEFSS 312
           + +++K T  F     +G G FGTVYK        +  + VAIK  ++        E   
Sbjct: 2   LLRILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60

Query: 313 EVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAI 372
           E  +++ +D+ ++ +LLG       +LI  + +P G L ++   ++   +     L   +
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDY-VREHKDNIGSQYLLNWCV 118

Query: 373 DVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVK 432
            +A G+ YL    +++++HRD+ + N+L+      K+ DFG A+L     ++ + +   K
Sbjct: 119 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEGGK 174

Query: 433 GTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE 492
             + ++  E +     T +SDV+S+GV + E++T                    +     
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPA 219

Query: 493 GNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD 546
             +  +++   +          ++ + ++C     + RP  + +  +   +  D
Sbjct: 220 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 4e-55
 Identities = 69/298 (23%), Positives = 114/298 (38%), Gaps = 46/298 (15%)

Query: 273 RIGEGGFGTVYKAQLED------GLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNL 325
            +G G FG V  A           + VA+K  K++   + +    SE+++++++  H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 326 VKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGK---------------------TLDF 364
           V LLG         +I E+   G L  +L  +  K                      L F
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 365 NQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR 424
              L  A  VA G+ +L     K  +HRD+ + N+L+T     K+ DFG AR    DS+ 
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLR 484
                  +  V ++ PE +     T KSDV+S+G+LL EI +         P +      
Sbjct: 221 VVRGN-ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA----- 274

Query: 485 WAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA 542
                    N   ++    K         +++ +   C A     RP   ++   L  
Sbjct: 275 ---------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 4e-55
 Identities = 74/281 (26%), Positives = 124/281 (44%), Gaps = 32/281 (11%)

Query: 273 RIGEGGFGTVYKAQL----EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKL 328
            IGEG FG V++          L VAIK  K    ++++ +F  E   + + DH ++VKL
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           +G + +     II E    G LR  L  +    LD    +  A  ++  L YL     K+
Sbjct: 74  IGVITENP-VWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE---SKR 128

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
            +HRD+ + N+L++ +   K+ DFG +R   M+    + ++K K  + ++ PE +   + 
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRF 186

Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM---VDPSIKE 505
           T+ SDV+ FGV + EIL           P + V       R   G  L M     P++  
Sbjct: 187 TSASDVWMFGVCMWEILMH------GVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240

Query: 506 VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD 546
           +++            +C A   + RP    +  QL  I  +
Sbjct: 241 LMT------------KCWAYDPSRRPRFTELKAQLSTILEE 269

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 4e-54
 Identities = 71/282 (25%), Positives = 119/282 (42%), Gaps = 33/282 (11%)

Query: 273 RIGEGGFGTVYKAQL------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
            +G+G FG VY+         E    VAIK   +      + EF +E  ++ + +  ++V
Sbjct: 27  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGK--------TLDFNQRLEIAIDVAHGL 378
           +LLG V +G   L+I E +  G L+ +L                  ++ +++A ++A G+
Sbjct: 87  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146

Query: 379 TYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYL 438
            YL+     + +HRD+ + N ++ E    K+ DFG  R    ++D      K    V ++
Sbjct: 147 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYYRKGGKGLLPVRWM 202

Query: 439 DPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM 498
            PE +K    TT SDV+SFGV+L EI T          P + ++     +   EG LLD 
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLA------EQPYQGLSNEQVLRFVMEGGLLDK 256

Query: 499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            D     +           L   C       RP    +   +
Sbjct: 257 PDNCPDMLFE---------LMRMCWQYNPKMRPSFLEIISSI 289

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 8e-54
 Identities = 63/281 (22%), Positives = 117/281 (41%), Gaps = 25/281 (8%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IG+G  GTVY A  +  G  VAI++   +Q    +    +E+ ++ +  + N+V  L  
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNIVNYLDS 85

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
              G+E  ++ E++  G+L + +       +D  Q   +  +    L +LH     Q+IH
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLH---SNQVIH 139

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+KS NILL      K+ DFGF      +  +    + + GT  ++ PE +       K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAYGPK 196

Query: 452 SDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEI 511
            D++S G++ +E++ G  P         R     A     E    + +    ++ ++   
Sbjct: 197 VDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN--- 251

Query: 512 LTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKSVK 552
                    +C       R   K + +  +   A  L S+ 
Sbjct: 252 ---------RCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  180 bits (458), Expect = 5e-53
 Identities = 67/288 (23%), Positives = 112/288 (38%), Gaps = 35/288 (12%)

Query: 265 TRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQ--TEFSSEVELLSKID 321
            + FS    IG G FG VY A+ + +  +VAIK+      ++ +   +   EV  L K+ 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 322 HRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           H N ++  G   + +   ++ E+             + K L   +   +      GL YL
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H      +IHRDVK+ NILL+E    K+ DFG A +          +    GT  ++ PE
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-------MAPANSFVGTPYWMAPE 181

Query: 442 Y---MKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM 498
               M   Q   K DV+S G+  +E+   + P                    N  + L  
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP----------------LFNMNAMSALYH 225

Query: 499 VDPSIKEVISMEILTKMF-GLAIQCAAPIRNDRPDMKSVGEQLWAIRA 545
           +  +    +     ++ F      C   I  DRP  + + +  + +R 
Sbjct: 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-51
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 9/211 (4%)

Query: 263 KATRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSK 319
           K   +F     +GEG F TV  A+ L      AIK  +K     EN     + E +++S+
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 320 IDHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLT 379
           +DH   VKL        +      +  NG L +++  +   + D         ++   L 
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALE 122

Query: 380 YLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLD 439
           YLH    K IIHRD+K  NILL E M  ++ DFG A++   +S +   ++   GT  Y+ 
Sbjct: 123 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVS 178

Query: 440 PEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
           PE +        SD+++ G ++ +++ G  P
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 2e-50
 Identities = 85/298 (28%), Positives = 127/298 (42%), Gaps = 42/298 (14%)

Query: 273 RIGEGGFGTVYKAQL--------EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHR 323
            +GEG FG V  A+              VA+K  K +  E   ++  SE+E++  I  H+
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYG--------------KTLDFNQRLE 369
           N++ LLG   +     +I E+   G LRE+L  +                + L     + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 370 IAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHIST 429
            A  VA G+ YL     K+ IHRD+ + N+L+TE    K+ADFG AR      D    +T
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTT 195

Query: 430 KVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR 489
             +  V ++ PE +     T +SDV+SFGVLL EI T          P   V +   FK 
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG------GSPYPGVPVEELFKL 249

Query: 490 YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS 547
             EG+ +D       E+           +   C   + + RP  K + E L  I A +
Sbjct: 250 LKEGHRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 5e-50
 Identities = 72/290 (24%), Positives = 110/290 (37%), Gaps = 40/290 (13%)

Query: 273 RIGEGGFGTVYKA------QLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLV 326
            +G G FG V +A      +      VA+K  K+    +      SE+++L  I H   V
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 327 KLLG--FVDKGNERLIITEFVPNGTLREHLDGQ--------------YGKTLDFNQRLEI 370
             L       G   ++I EF   G L  +L  +              Y   L     +  
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 371 AIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTK 430
           +  VA G+ +L     ++ IHRD+ + NILL+E    K+ DFG AR    D D       
Sbjct: 140 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGD 195

Query: 431 VKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRY 490
            +  + ++ PE +     T +SDV+SFGVLL EI +         P           +R 
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRL 250

Query: 491 NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            EG  +   D +  E+             + C     + RP    + E L
Sbjct: 251 KEGTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHL 291

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  172 bits (436), Expect = 2e-49
 Identities = 61/272 (22%), Positives = 108/272 (39%), Gaps = 25/272 (9%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
            +G G FG V++      G   A K        + +     E++ +S + H  LV L   
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDA 91

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
            +  NE ++I EF+  G L E +  ++ K +  ++ +E    V  GL ++H   E   +H
Sbjct: 92  FEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH---ENNYVH 147

Query: 392 RDVKSSNILLT--ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
            D+K  NI+ T   S   K+ DFG      +D  ++   T   GT  +  PE  +   + 
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVT--TGTAEFAAPEVAEGKPVG 203

Query: 450 TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISM 509
             +D++S GVL   +L+G  P   +   E    ++      ++ +    +    K+ I  
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD-SAFSGISEDGKDFIR- 261

Query: 510 EILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW 541
                      +      N R  +    E  W
Sbjct: 262 -----------KLLLADPNTRMTIHQALEHPW 282

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  169 bits (430), Expect = 2e-49
 Identities = 64/280 (22%), Positives = 107/280 (38%), Gaps = 26/280 (9%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLL 329
            +G GG   V+ A+ L     VA+K  + +     +    F  E +  + ++H  +V + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 330 GFV----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
                    G    I+ E+V   TLR+ +       +   + +E+  D    L + H   
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSH--- 128

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
           +  IIHRDVK +NI+++ +   KV DFG AR      +    +  V GT  YL PE  + 
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188

Query: 446 YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE 505
             +  +SDVYS G +L E+LTG  P      P                   + +   +  
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDPIPPSARHEGLSADLDA 247

Query: 506 VISMEILTKMFGLAIQCAAPIRNDRP-DMKSVGEQLWAIR 544
           V+             +  A    +R      +   L  + 
Sbjct: 248 VVL------------KALAKNPENRYQTAAEMRADLVRVH 275

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  165 bits (419), Expect = 7e-47
 Identities = 53/272 (19%), Positives = 102/272 (37%), Gaps = 25/272 (9%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
            +G G FG V++      G +   K        +  T   +E+ +++++ H  L+ L   
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT-VKNEISIMNQLHHPKLINLHDA 94

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
            +   E ++I EF+  G L + +  +    +   + +        GL ++H   E  I+H
Sbjct: 95  FEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVH 150

Query: 392 RDVKSSNILL--TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
            D+K  NI+    ++   K+ DFG A       +   I      T  +  PE +    + 
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLAT----KLNPDEIVKVTTATAEFAAPEIVDREPVG 206

Query: 450 TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISM 509
             +D+++ GVL   +L+G  P   +   E    ++     ++E +    V P  K+ I  
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE-DAFSSVSPEAKDFIK- 264

Query: 510 EILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW 541
                               R  +    E  W
Sbjct: 265 -----------NLLQKEPRKRLTVHDALEHPW 285

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 2e-46
 Identities = 46/201 (22%), Positives = 83/201 (41%), Gaps = 13/201 (6%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
            +G G FG V++            K  K +  +  Q     E+ +L+   HRN++ L   
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHES 69

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
            +   E ++I EF+    + E ++      L+  + +     V   L +LH      I H
Sbjct: 70  FESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH---SHNIGH 125

Query: 392 RDVKSSNILLT--ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
            D++  NI+     S   K+ +FG AR      +       +     Y  PE  +   ++
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL----LFTAPEYYAPEVHQHDVVS 181

Query: 450 TKSDVYSFGVLLLEILTGRRP 470
           T +D++S G L+  +L+G  P
Sbjct: 182 TATDMWSLGTLVYVLLSGINP 202

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  162 bits (410), Expect = 4e-46
 Identities = 60/268 (22%), Positives = 102/268 (38%), Gaps = 26/268 (9%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
            +G G F  V  A+      LVAIK   K+  E  +    +E+ +L KI H N+V L   
Sbjct: 16  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
            + G    +I + V  G L + +  +            +   V   + YLH   +  I+H
Sbjct: 76  YESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLH---DLGIVH 130

Query: 392 RDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           RD+K  N+L     E  +  ++DFG +++     D   + +   GT GY+ PE +     
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQKPY 186

Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS 508
           +   D +S GV+   +L G  P   +   +    +  A   ++     D +  S K+ I 
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS-PYWDDISDSAKDFIR 245

Query: 509 MEILTKMFGLAIQCAAPIRNDRPDMKSV 536
                                R   +  
Sbjct: 246 ------------HLMEKDPEKRFTCEQA 261

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  159 bits (404), Expect = 1e-44
 Identities = 61/249 (24%), Positives = 106/249 (42%), Gaps = 19/249 (7%)

Query: 267 NFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIK-----RAKKEQFENLQTEFSSEVELLSKI 320
           +FS    IG GGFG VY  +  + G + A+K     R K +Q E L       + L+S  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 321 DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTY 380
           D   +V +       ++   I + +  G L  HL      +         A ++  GL +
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA--DMRFYAAEIILGLEH 122

Query: 381 LHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDP 440
           +H    + +++RD+K +NILL E    +++D G A        + H      GT GY+ P
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD--FSKKKPHA---SVGTHGYMAP 174

Query: 441 EYMKTYQ-LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV 499
           E ++      + +D +S G +L ++L G  P    +  ++    R       E  L D  
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--LPDSF 232

Query: 500 DPSIKEVIS 508
            P ++ ++ 
Sbjct: 233 SPELRSLLE 241

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 3e-44
 Identities = 59/240 (24%), Positives = 103/240 (42%), Gaps = 17/240 (7%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHRNLVKL 328
            +G+G FG V+ A+  +     AIK  KK+     ++++     +  L    +H  L  +
Sbjct: 9   MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                       + E++  G L  H+  Q     D ++    A ++  GL +LH    K 
Sbjct: 69  FCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLH---SKG 123

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           I++RD+K  NILL +    K+ADFG  +   +   +T       GT  Y+ PE +   + 
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NTFCGTPDYIAPEILLGQKY 180

Query: 449 TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVIS 508
               D +SFGVLL E+L G+ P   +   E      +   R +       ++   K+++ 
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-----LFHSIRMDNPFYPRWLEKEAKDLLV 235

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  157 bits (397), Expect = 3e-44
 Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 14/201 (6%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQ--TEFSSEVELLSKIDHRNLVKLL 329
            +G G FG V+  +   +G   A+K  KKE    L+     + E  +LS + H  ++++ 
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
           G      +  +I +++  G L      +  +          A +V   L YLH    K I
Sbjct: 71  GTFQDAQQIFMIMDYIEGGELFSL--LRKSQRFPNPVAKFYAAEVCLALEYLH---SKDI 125

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           I+RD+K  NILL ++   K+ DFGFA+  P       ++  + GT  Y+ PE + T    
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVP------DVTYTLCGTPDYIAPEVVSTKPYN 179

Query: 450 TKSDVYSFGVLLLEILTGRRP 470
              D +SFG+L+ E+L G  P
Sbjct: 180 KSIDWWSFGILIYEMLAGYTP 200

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  154 bits (390), Expect = 1e-43
 Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 25/220 (11%)

Query: 267 NFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKK--------EQFENLQTEFSSEVELL 317
           N+ P   +G G    V +          A+K            E+ + L+     EV++L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 318 SKI-DHRNLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAH 376
            K+  H N+++L    +      ++ + +  G L ++L  +   TL   +  +I   +  
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLE 121

Query: 377 GLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG 436
            +  LH   +  I+HRD+K  NILL + M  K+ DFGF+       D      +V GT  
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ----LDPGEKLREVCGTPS 174

Query: 437 YLDPEYMKTYQL------TTKSDVYSFGVLLLEILTGRRP 470
           YL PE ++            + D++S GV++  +L G  P
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 2e-43
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 8/206 (3%)

Query: 267 NFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRN 324
           NF    +IGEG +G VYKA+    G +VA+K+ + + + E + +    E+ LL +++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +VKLL  +   N+  ++ EF+    L++ +D      +           +  GL + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
              +++HRD+K  N+L+      K+ADFG AR           + +V           + 
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRP 470
               +T  D++S G +  E++T R  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRAL 202

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 5e-43
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 12/225 (5%)

Query: 260 QVVKATRNFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLS 318
           QV      ++    IGEG +G V  A    + + VAIK+    + +        E+++L 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 319 KIDHRNLVKLLGFVDKGN----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDV 374
           +  H N++ +   +        + + +   +    L + L  Q+   L  +        +
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQI 118

Query: 375 AHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGT 434
             GL Y+H      ++HRD+K SN+LL  +   K+ DFG AR+   D D T   T+   T
Sbjct: 119 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175

Query: 435 VGYLDPEYMKTYQLTTKS-DVYSFGVLLLEILTGRRPVELKRPPE 478
             Y  PE M   +  TKS D++S G +L E+L+ R     K   +
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (385), Expect = 8e-43
 Identities = 52/277 (18%), Positives = 97/277 (35%), Gaps = 26/277 (9%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IG G FG +Y    +  G  VAIK    +       +   E ++   +     +  + +
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVK---TKHPQLHIESKIYKMMQGGVGIPTIRW 70

Query: 332 V-DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
              +G+  +++ E +              +       L +A  +   + Y+H    K  I
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIH---SKNFI 125

Query: 391 HRDVKSSNILLTES---MRAKVADFGFARLGPMDSDRTHI----STKVKGTVGYLDPEYM 443
           HRDVK  N L+          + DFG A+         HI    +  + GT  Y      
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI 503
              + + + D+ S G +L+    G     L     +  T R  ++R +E   +      +
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGS----LPWQGLKAATKRQKYERISEKK-MSTPIEVL 240

Query: 504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
            +    E  T        C +   +D+PD   + +  
Sbjct: 241 CKGYPSEFAT----YLNFCRSLRFDDKPDYSYLRQLF 273

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 3e-41
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 19/218 (8%)

Query: 273 RIGEGGFGTVYKAQ--LEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKI---DHRNLV 326
            IGEG +G V+KA+     G  VA+KR + +   E +      EV +L  +   +H N+V
Sbjct: 14  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73

Query: 327 KLLGFV-----DKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYL 381
           +L         D+  +  ++ E V       +LD      +      ++   +  GL +L
Sbjct: 74  RLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 382 HLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPE 441
           H     +++HRD+K  NIL+T S + K+ADFG AR+           T V  T+ Y  PE
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI----YSFQMALTSVVVTLWYRAPE 185

Query: 442 YMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEE 479
            +      T  D++S G +  E+   +         ++
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 223

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 4e-41
 Identities = 66/279 (23%), Positives = 113/279 (40%), Gaps = 42/279 (15%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENL-----QTEFSSEVELLSKID--HRN 324
            +G GGFG+VY    + D L VAIK  +K++  +       T    EV LL K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           +++LL + ++ +  ++I E             + G  L           V   + + H  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 127

Query: 385 AEKQIIHRDVKSSNILLTES-MRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
               ++HRD+K  NIL+  +    K+ DFG   L      +  + T   GT  Y  PE++
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFDGTRVYSPPEWI 181

Query: 444 KTYQLTTKS-DVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS 502
           + ++   +S  V+S G+LL +++ G  P E     EE +  +  F+          V   
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE---HDEEIIRGQVFFR--------QRVSSE 230

Query: 503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW 541
            + +I              C A   +DRP  + +    W
Sbjct: 231 CQHLIR------------WCLALRPSDRPTFEEIQNHPW 257

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 1e-40
 Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 14/203 (6%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF----ENLQTEFSSEVELLSKIDHRNLVKL 328
           +GEG F TVYKA+      +VAIK+ K        + +      E++LL ++ H N++ L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 329 LGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
           L      +   ++ +F+         D     T          +    GL YLH   +  
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS--HIKAYMLMTLQGLEYLH---QHW 120

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           I+HRD+K +N+LL E+   K+ADFG A+            T    T  Y  PE +   ++
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK---SFGSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 449 -TTKSDVYSFGVLLLEILTGRRP 470
                D+++ G +L E+L     
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPF 200

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-40
 Identities = 62/291 (21%), Positives = 115/291 (39%), Gaps = 32/291 (10%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFEN-----LQTEFSSEVELLSKIDHRNLV 326
            +G G F  V K +    GL  A K  KK + ++      + +   EV +L +I H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 327 KLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE 386
            L    +   + ++I E V  G L + L  +  ++L   +  E    + +G+ YLH    
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---S 131

Query: 387 KQIIHRDVKSSNILLTE----SMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEY 442
            QI H D+K  NI+L +      R K+ DFG A      ++  +    + GT  ++ PE 
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPEI 187

Query: 443 MKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS 502
           +    L  ++D++S GV+   +L+G  P       E    +      + +          
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED-EYFSNTSAL 246

Query: 503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKSVKK 553
            K+ I             +        R  ++   +  W    D+ +++  
Sbjct: 247 AKDFIR------------RLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSS 285

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  146 bits (368), Expect = 2e-40
 Identities = 46/279 (16%), Positives = 93/279 (33%), Gaps = 28/279 (10%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRN-LVKLLG 330
           RIGEG FG +++   L +   VAIK   +        +   E      +     +  +  
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYY 68

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
           F  +G   +++ + +  G   E L    G+          A  +   +  +H   EK ++
Sbjct: 69  FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 123

Query: 391 HRDVKSSNILLTESMR-----AKVADFGFARLGPMDSDRTHI----STKVKGTVGYLDPE 441
           +RD+K  N L+            V DFG  +       + HI       + GT  Y+   
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 442 YMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP 501
                + + + D+ + G + +  L G  P        +  T +  ++R     + +    
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLP----WQGLKAATNKQKYER-----IGEKKQS 234

Query: 502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQL 540
           +    +      + +           +  PD   +    
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  145 bits (367), Expect = 2e-40
 Identities = 47/199 (23%), Positives = 91/199 (45%), Gaps = 8/199 (4%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           +IGEG +G VYKAQ   G   A+K+ + E+  E + +    E+ +L ++ H N+VKL   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIH 391
           +      +++ E +     +          L+        + + +G+ Y H   +++++H
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123

Query: 392 RDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTK 451
           RD+K  N+L+      K+ADFG AR           + ++           M + + +T 
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181

Query: 452 SDVYSFGVLLLEILTGRRP 470
            D++S G +  E++ G   
Sbjct: 182 IDIWSVGCIFAEMVNGTPL 200

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 3e-39
 Identities = 50/207 (24%), Positives = 85/207 (41%), Gaps = 11/207 (5%)

Query: 267 NFSPSLRIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHR 323
           +F     +G+G FG V   +    G   A+K  +KE    ++      +E  +L    H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
            L  L       +    + E+   G L  HL  +   T +  +      ++   L YLH 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE--RARFYGAEIVSALEYLH- 122

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
              + +++RD+K  N++L +    K+ DFG  + G  D           GT  YL PE +
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLAPEVL 177

Query: 444 KTYQLTTKSDVYSFGVLLLEILTGRRP 470
           +        D +  GV++ E++ GR P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 4e-39
 Identities = 48/206 (23%), Positives = 80/206 (38%), Gaps = 22/206 (10%)

Query: 274 IGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLG- 330
           +G G  G V +          A+K  +         +   EVEL  +     ++V+++  
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVDV 73

Query: 331 ---FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEK 387
                      LI+ E +  G L   +  +  +     +  EI   +   + YLH     
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 388 QIIHRDVKSSNILLT---ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            I HRDVK  N+L T    +   K+ DFGFA+     +  T        T  Y+ PE + 
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT----PCYTPYYVAPEVLG 186

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRP 470
             +     D++S GV++  +L G  P
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPP 212

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 9e-39
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)

Query: 267 NFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL 325
           +++ +  IG G FG VY+A+L + G LVAIK+  +++        + E++++ K+DH N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 75

Query: 326 VKLLGFVDKGNER------LIITEFVPNGTLREHLDGQYGK-TLDFNQRLEIAIDVAHGL 378
           V+L  F     E+       ++ ++VP    R        K TL           +   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 379 TYLHLYAEKQIIHRDVKSSNILLT-ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGY 437
            Y+H      I HRD+K  N+LL  ++   K+ DFG A+            + +      
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYR 189

Query: 438 LDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRP 470
                      T+  DV+S G +L E+L G+  
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-38
 Identities = 56/291 (19%), Positives = 111/291 (38%), Gaps = 32/291 (10%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +IG+G FG V+KA+  + G  VA+K+   E + E        E+++L  + H N+V L+ 
Sbjct: 17  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76

Query: 331 FVDKGNER--------LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLH 382
                            ++ +F  +       +         ++   +   + +GL Y+H
Sbjct: 77  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIH 134

Query: 383 LYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR-LGPMDSDRTHISTKVKGTVGYLDPE 441
                +I+HRD+K++N+L+T     K+ADFG AR      + + +  T    T+ Y  PE
Sbjct: 135 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 442 YMKTYQL-TTKSDVYSFGVLLLEILTGRRPVE--------------LKRPPEERVTLRWA 486
            +   +      D++  G ++ E+ T    ++                    E       
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 487 FKRYNEGNLLDMVDPSIKEVISMEILTKMF-GLAIQCAAPIRNDRPDMKSV 536
           ++ Y +  L+      +K+ +   +       L  +        R D    
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-37
 Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 9/200 (4%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLG 330
           +IGEG +GTV+KA+  E   +VA+KR + +   E + +    E+ LL ++ H+N+V+L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQII 390
            +    +  ++ EF                 LD          +  GL + H    + ++
Sbjct: 69  VLHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVL 123

Query: 391 HRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTT 450
           HRD+K  N+L+  +   K+A+FG AR           S +V                 +T
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 451 KSDVYSFGVLLLEILTGRRP 470
             D++S G +  E+    RP
Sbjct: 182 SIDMWSAGCIFAELANAGRP 201

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (344), Expect = 2e-36
 Identities = 59/262 (22%), Positives = 100/262 (38%), Gaps = 22/262 (8%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQT--EFSSEVELLSKIDHRNLVKLL 329
            +G G FG V   +  E G   A+K   K++   L+      +E  +L  ++   LVKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 330 GFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQI 389
                 +   ++ E+V  G +  HL                A  +     YLH      +
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH---SLDL 162

Query: 390 IHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLT 449
           I+RD+K  N+L+ +    +V DFGFA+           +  + GT   L PE + +    
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEALAPEIILSKGYN 216

Query: 450 TKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISM 509
              D ++ GVL+ E+  G  P    +P +             +          +K+++  
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKIVS--GKVRFPSHFSSDLKDLLRN 271

Query: 510 EI---LTKMFGLAIQCAAPIRN 528
            +   LTK FG        I+N
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKN 293

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-34
 Identities = 50/202 (24%), Positives = 81/202 (40%), Gaps = 12/202 (5%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            +G G +G V  A     G  VAIK+  +  Q E        E+ LL  + H N++ LL 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 331 FVDKGNERLIITEFVPNGTLREHLDGQYGK--TLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
                      T+F           G+  K   L  ++   +   +  GL Y+H      
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAG 141

Query: 389 IIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL 448
           IIHRD+K  N+ + E    K+ DFG AR        + ++  V           +   + 
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILNWMRY 196

Query: 449 TTKSDVYSFGVLLLEILTGRRP 470
           T   D++S G ++ E++TG+  
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTL 218

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  128 bits (321), Expect = 2e-33
 Identities = 41/204 (20%), Positives = 83/204 (40%), Gaps = 22/204 (10%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLG 330
           ++G G +  V++A  + +   V +K  K  + +    +   E+++L  +    N++ L  
Sbjct: 42  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKILENLRGGPNIITLAD 97

Query: 331 FVDKGNERLI--ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ 388
            V     R    + E V N   ++       +TL          ++   L Y H      
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH---SMG 149

Query: 389 IIHRDVKSSNILLT-ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQ 447
           I+HRDVK  N+++  E  + ++ D+G A       +          +  +  PE +  YQ
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR----VASRYFKGPELLVDYQ 205

Query: 448 L-TTKSDVYSFGVLLLEILTGRRP 470
           +     D++S G +L  ++  + P
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEP 229

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 2e-33
 Identities = 57/246 (23%), Positives = 99/246 (40%), Gaps = 18/246 (7%)

Query: 273 RIGEGGFGTVYKAQL----EDGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDHR-N 324
            +G G +G V+  +     + G L A+K  KK              +E ++L  I     
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90

Query: 325 LVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
           LV L        +  +I +++  G L  HL  +   T       E+ I V   +  L   
Sbjct: 91  LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH-----EVQIYVGEIVLALEHL 145

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
            +  II+RD+K  NILL  +    + DFG ++     +D T  +    GT+ Y+ P+ ++
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSK--EFVADETERAYDFCGTIEYMAPDIVR 203

Query: 445 T--YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS 502
                     D +S GVL+ E+LTG  P  +      +  +     + +E      +   
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSAL 262

Query: 503 IKEVIS 508
            K++I 
Sbjct: 263 AKDLIQ 268

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 1e-30
 Identities = 47/214 (21%), Positives = 87/214 (40%), Gaps = 20/214 (9%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKE-QFENLQTEFSSEVELLSKIDHRNLVKLLG 330
            IG G  G V  A        VAIK+  +  Q +        E+ L+  ++H+N++ LL 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 331 F------VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY 384
                  +++  +  ++ E +     +          LD  +   +   +  G+ +LH  
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH-- 136

Query: 385 AEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMK 444
               IIHRD+K SNI++      K+ DFG AR     +  + + T    T  Y  PE + 
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRYYRAPEVIL 191

Query: 445 TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPE 478
                   D++S G ++ E++  +     +   +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 1e-29
 Identities = 46/205 (22%), Positives = 81/205 (39%), Gaps = 18/205 (8%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTE-FSSEVELLSKIDHRNLVKLLG 330
            +G G +G+V  A   + GL VA+K+  +     +  +    E+ LL  + H N++ LL 
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84

Query: 331 FVDKGN-----ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA 385
                        + +   +      +  +    + L  +    +   +  GL Y+H   
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGA---DLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 138

Query: 386 EKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKT 445
              IIHRD+K SN+ + E    K+ DFG AR          ++  V           +  
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNW 193

Query: 446 YQLTTKSDVYSFGVLLLEILTGRRP 470
                  D++S G ++ E+LTGR  
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTL 218

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (268), Expect = 4e-26
 Identities = 46/216 (21%), Positives = 82/216 (37%), Gaps = 21/216 (9%)

Query: 273 RIGEGGFGTVYKAQ-LEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGF 331
           ++G G F TV+ A+ + +   VA+K  + ++          E++LL +++  +  K    
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 332 VDKGNERLI--ITEFVPNGTLREHLDGQYG------------KTLDFNQRLEIAIDVAHG 377
                 +L+       PNG     +    G            + +      +I+  +  G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 378 LTYLHLYAEKQIIHRDVKSSNILLT-ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVG 436
           L Y+H      IIH D+K  N+L+        +     A LG       H  T    T  
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TNSIQTRE 194

Query: 437 YLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVE 472
           Y  PE +        +D++S   L+ E++TG    E
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 95.6 bits (237), Expect = 2e-23
 Identities = 37/200 (18%), Positives = 73/200 (36%), Gaps = 24/200 (12%)

Query: 273 RIGEGGFGTVYKAQLEDGLLVAIK---------RAKKEQFENLQTEFSSEVELLSKIDHR 323
            +GEG    V+    E      +K         +  KE+ +     FS      ++ + R
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 324 NLVKLLGFVDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL 383
            L KL G         +   +  N  L E +D +    +      E+   +   +   + 
Sbjct: 67  ALQKLQGL----AVPKVY-AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120

Query: 384 YAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYM 443
              + I+H D+   N+L++E     + DF  +     +  R  +   V+  + Y    + 
Sbjct: 121 --HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITY----FS 173

Query: 444 KTYQLTTKSDVYSFGVLLLE 463
           +TY   T+ D+ S    +L+
Sbjct: 174 RTY--RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	554
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.48
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.11
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.77
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	97.26
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.13
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.69
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	96.57
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.47
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	96.38
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	94.48
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	94.14
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	92.81
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	91.45
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	90.6
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	90.34
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	89.77
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	88.16
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	87.22
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	86.53
d2ifga3	156	High affinity nerve growth factor receptor, N-term	86.53
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	86.52
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	86.5
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	84.49
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	82.97
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	82.93
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	82.42
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	82.29
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	81.82
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	81.23

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=428.99  Aligned_cols=257  Identities=23%  Similarity=0.391  Sum_probs=208.1

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|++.++||+|+||+||+|... +|+.||||++.........+.+.+|+++|++++||||+++++++.+++..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57889999999999999999775 68999999997665444556799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      |++|+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...... .
T Consensus        85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~-~  158 (271)
T d1nvra_          85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-R  158 (271)
T ss_dssp             CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT-E
T ss_pred             cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCC-c
Confidence            9999999999654  57999999999999999999999   8999999999999999999999999999998753221 2


Q ss_pred             ccccccccCCCCCcChhccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQL-TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      .......+||+.|||||++.+..+ +.++|||||||++|||++|+.||............ .    .......     . 
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~----~~~~~~~-----~-  227 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-W----KEKKTYL-----N-  227 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-H----HTTCTTS-----T-
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-H----hcCCCCC-----C-
Confidence            223445689999999999988876 57899999999999999999999865543222111 1    0110000     0 


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                         ....++..+.+++.+||+.||++|||++|+++|.|-
T Consensus       228 ---~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf  263 (271)
T d1nvra_         228 ---PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY  263 (271)
T ss_dssp             ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             ---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence               011234567899999999999999999999998773

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=421.04  Aligned_cols=251  Identities=28%  Similarity=0.479  Sum_probs=212.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|++.+.||+|+||+||+|..+ +|+.||+|++.+...  ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46888999999999999999775 689999999976543  234567899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      |||++|+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+..... 
T Consensus        86 Ey~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  159 (263)
T ss_dssp             ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred             eecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence            999999999999765  57999999999999999999999   899999999999999999999999999999864322 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                          ......||+.|||||++.+..|+.++|||||||++|||++|+.||......+....       ......      .
T Consensus       160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~-------i~~~~~------~  222 (263)
T d2j4za1         160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-------ISRVEF------T  222 (263)
T ss_dssp             ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------HHTTCC------C
T ss_pred             ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHH-------HHcCCC------C
Confidence                22345799999999999999999999999999999999999999986543322111       111111      0


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                          .+..++..+.+++.+||+.||++|||++|+++|.|--
T Consensus       223 ----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~  259 (263)
T d2j4za1         223 ----FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  259 (263)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred             ----CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence                1222345688999999999999999999999998753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=421.67  Aligned_cols=258  Identities=28%  Similarity=0.397  Sum_probs=202.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .++|+..++||+|+||+||+|.+.++..||||+++....  ..++|.+|++++++++||||++++|++.+++..++||||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC--cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            357888999999999999999998899999999976543  246799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      |++|+|.+++... ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....  .
T Consensus        82 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~--~  155 (263)
T d1sm2a_          82 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--Q  155 (263)
T ss_dssp             CTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             cCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCC--C
Confidence            9999999998754 356899999999999999999999   899999999999999999999999999999864322  1


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      ........||+.|+|||++.+..|+.++|||||||++|||+|+..|+........  ......... .     ...    
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~--~~~~i~~~~-~-----~~~----  223 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGF-R-----LYK----  223 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH--HHHHHHHTC-C-----CCC----
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH--HHHHHHhcC-C-----CCC----
Confidence            2223345689999999999999999999999999999999995444433332222  111111110 0     111    


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                         +..++..+.+++.+||+.||++||||+||+++|++|+.
T Consensus       224 ---p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         224 ---PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence               11234568899999999999999999999999999865

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-53  Score=420.75  Aligned_cols=263  Identities=28%  Similarity=0.482  Sum_probs=209.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|...++||+|+||+||+|++++  .||||+++.... ....+.|.+|+++|++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            4678889999999999999998653  599999875432 3456789999999999999999999998754 56899999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      ||++|+|.+++... ...+++.+++.++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        84 y~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~-  158 (276)
T d1uwha_          84 WCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-  158 (276)
T ss_dssp             CCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             cCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccC-
Confidence            99999999999754 246899999999999999999999   8899999999999999999999999999998643222 


Q ss_pred             CccccccccCCCCCcChhcccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          424 RTHISTKVKGTVGYLDPEYMKT---YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      .........||+.|||||++.+   ..|+.++|||||||++|||+||+.||............  .......        
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~--~~~~~~~--------  228 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM--VGRGYLS--------  228 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHHTSCC--------
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH--HhcCCCC--------
Confidence            2223345679999999999864   35899999999999999999999999876554332211  1111111        


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      +.+. .....++..+.+++.+||+.||++|||++||+++|+.++.+
T Consensus       229 p~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         229 PDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             CCGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             Ccch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            1111 12334556789999999999999999999999999998764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-53  Score=423.92  Aligned_cols=253  Identities=23%  Similarity=0.362  Sum_probs=211.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|+..++||+|+||+||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            47999999999999999999764 6999999998765433 346799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      |++|+|.+++.+.   .+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....   
T Consensus        99 ~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~---  169 (293)
T d1yhwa1          99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---  169 (293)
T ss_dssp             CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST---
T ss_pred             cCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccc---
Confidence            9999999988654   6899999999999999999999   899999999999999999999999999999874322   


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      .......+||+.|||||++.+..|+.++|||||||++|||++|+.||..........   ..... .....      .  
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~~~~~-~~~~~------~--  237 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---LIATN-GTPEL------Q--  237 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHH-CSCCC------S--
T ss_pred             cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH---HHHhC-CCCCC------C--
Confidence            223345679999999999999999999999999999999999999998654332211   11111 11010      0  


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                        .+..++..+.+++.+||+.||++|||+.|+++|.|-
T Consensus       238 --~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~  273 (293)
T d1yhwa1         238 --NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL  273 (293)
T ss_dssp             --SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred             --CcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence              112344568899999999999999999999998774

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.9e-53  Score=422.84  Aligned_cols=262  Identities=28%  Similarity=0.439  Sum_probs=204.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEcC-C---cEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLED-G---LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~-g---~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ++|+..++||+|+||+||+|.++. +   ..||||++.........++|.+|+++|++++|||||+++|++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            456777899999999999997752 3   368999987765566667899999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      ||||++|+|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus       106 ~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             EECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            9999999999988754 346899999999999999999999   899999999999999999999999999999875432


Q ss_pred             CCCcc--ccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          422 SDRTH--ISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       422 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      .....  ......||+.|||||.+.+..++.++|||||||++|||+| |+.||......+..   ....    .+...  
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~---~~i~----~~~~~--  252 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI---NAIE----QDYRL--  252 (299)
T ss_dssp             --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHH----TTCCC--
T ss_pred             CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHH---HHHH----cCCCC--
Confidence            22211  1223458999999999999999999999999999999998 89999865543221   1111    11000  


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                             ..+.+++..+.+++.+||+.||++||||.||++.|+++..+.
T Consensus       253 -------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         253 -------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             -------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence                   012234567899999999999999999999999999886654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-53  Score=424.95  Aligned_cols=260  Identities=27%  Similarity=0.374  Sum_probs=216.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|+..++||+|+||+||+|.+. +|+.||||+++....  ..++|.+|+++|++++|||||++++++.+++..++|||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            356788889999999999999876 589999999976543  24679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      ||++|+|.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~--  168 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--  168 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS--
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCC--
Confidence            999999999998776778999999999999999999999   889999999999999999999999999999874332  


Q ss_pred             CccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      .........||+.|||||++.+..|+.++|||||||++|||++|..||..........  ...    ..+..     +  
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~--~~i----~~~~~-----~--  235 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELL----EKDYR-----M--  235 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--HHH----HTTCC-----C--
T ss_pred             CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH--HHH----hcCCC-----C--
Confidence            2233344568999999999999999999999999999999999877765544332211  111    11100     0  


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                        ..+..++..+.+++.+||+.||++||||.||++.|+.+..+
T Consensus       236 --~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         236 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             --CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence              01223446789999999999999999999999999987654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-53  Score=418.26  Aligned_cols=257  Identities=29%  Similarity=0.441  Sum_probs=210.8

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .++|+..++||+|+||+||+|.+++++.||||+++....  ..+.|.+|++++++++|||||+++|++.+ +..++||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC--CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            457888899999999999999998889999999976543  24679999999999999999999998865 567999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      |++|+|.+++.......+++.+++.++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+....  ..
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~--~~  163 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED--NE  163 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS--SC
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccC--Cc
Confidence            99999999987765567999999999999999999999   89999999999999999999999999999987532  22


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      ........||+.|||||++.+..++.++|||||||++|||+||..|+.......+  ......    .+..     +.  
T Consensus       164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~~~~i~----~~~~-----~~--  230 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLE----RGYR-----MV--  230 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHH----TTCC-----CC--
T ss_pred             cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--HHHHHH----hcCC-----CC--
Confidence            2333456799999999999998999999999999999999997666544333222  111111    1100     00  


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                        .+..++..+.+++.+||+.||++||||.||++.|+++-
T Consensus       231 --~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         231 --RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence              11234456899999999999999999999999988754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=420.92  Aligned_cols=257  Identities=24%  Similarity=0.360  Sum_probs=198.2

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc--CCceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK--GNERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~lv  341 (554)
                      ++|++.+.||+|+||+||+|... +|+.||||++..... +...+.+.+|++++++++|||||++++++.+  ++..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57899999999999999999765 689999999876543 3345678999999999999999999999854  4568999


Q ss_pred             EEeCCCCCHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHhhhcc--CCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          342 TEFVPNGTLREHLDGQ--YGKTLDFNQRLEIAIDVAHGLTYLHLYA--EKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      ||||++|+|.+++...  ....+++.+++.++.||+.||+|||+..  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998653  3467999999999999999999999421  23599999999999999999999999999987


Q ss_pred             CCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                      ....   ........||+.|||||++.+..|+.++|||||||++|||+||+.||......+..   ..    ..++....
T Consensus       164 ~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~---~~----i~~~~~~~  233 (269)
T d2java1         164 LNHD---TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA---GK----IREGKFRR  233 (269)
T ss_dssp             C--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HH----HHHTCCCC
T ss_pred             cccC---CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHH---HH----HHcCCCCC
Confidence            5322   22234567999999999999999999999999999999999999999865432221   11    11111111


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                               .+..++..+.+++.+||+.||++|||+.|+++|.|
T Consensus       234 ---------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~  268 (269)
T d2java1         234 ---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  268 (269)
T ss_dssp             ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence                     12233456889999999999999999999998865

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=416.73  Aligned_cols=263  Identities=25%  Similarity=0.437  Sum_probs=215.0

Q ss_pred             cCCCcce-eeeccCceEEEEEEEc---CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEE
Q 042763          266 RNFSPSL-RIGEGGFGTVYKAQLE---DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       266 ~~f~~~~-~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ++|.... +||+|+||+||+|.++   ++..||||+++........++|.+|+++|++++|||||+++|++.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4555555 4999999999999664   3568999999876555556789999999999999999999999875 568999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      ||||++|+|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        87 mE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            9999999999998644 357899999999999999999999   899999999999999999999999999999976544


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      ...........||+.|||||++.+..++.++|||||||++|||+| |+.||......+....+       ..+...+   
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i-------~~~~~~~---  232 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQGKRME---  232 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-------HTTCCCC---
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcCCCCC---
Confidence            333333445678999999999999999999999999999999998 99999876544322111       1111111   


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLK  549 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~  549 (554)
                            .+..++..+.+|+.+||+.||++|||+.+|.+.|+.+..+...
T Consensus       233 ------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~  275 (285)
T d1u59a_         233 ------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  275 (285)
T ss_dssp             ------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             ------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence                  2233456788999999999999999999999999877654433

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=417.74  Aligned_cols=262  Identities=27%  Similarity=0.431  Sum_probs=206.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCC-----cEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDG-----LLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g-----~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      ..|+..++||+|+||+||+|.+++.     ..||||++.....+....+|.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577888999999999999977642     47999999776555556789999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      |||||.++++.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        87 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          87 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            99999999999988654 357899999999999999999999   89999999999999999999999999999987544


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                      ............||+.|||||++.+..++.++|||||||++|||++|..|+.......+.  .....    .+..     
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~--~~~i~----~~~~-----  231 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--MKAIN----DGFR-----  231 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHH----TTCC-----
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH--HHHHh----ccCC-----
Confidence            333333344456899999999999999999999999999999999977666544433221  12211    1110     


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      +    ..+.+++..+.+|+.+||+.||++||||.||++.|+++...
T Consensus       232 ~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         232 L----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             C----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             C----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            0    11223456789999999999999999999999999988764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-53  Score=420.74  Aligned_cols=255  Identities=25%  Similarity=0.357  Sum_probs=209.6

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      +.|++.++||+|+||+||+|... +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            46888999999999999999765 68999999987654 33346789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      |++|+|.+++.+. ...+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+....   .
T Consensus        91 ~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~---~  163 (288)
T d2jfla1          91 CAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR---T  163 (288)
T ss_dssp             CTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH---H
T ss_pred             CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCC---C
Confidence            9999999998654 357999999999999999999999   89999999999999999999999999999975321   1


Q ss_pred             ccccccccCCCCCcChhccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          425 THISTKVKGTVGYLDPEYMK-----TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      ........||+.|||||++.     +..|+.++|||||||++|||+||+.||......+....+.   .    .......
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~---~----~~~~~~~  236 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA---K----SEPPTLA  236 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH---H----SCCCCCS
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH---c----CCCCCCC
Confidence            12234567999999999984     4568999999999999999999999998765443322111   1    1100000


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                             .+..++..+.+++.+||+.||++|||+.|+++|.|-
T Consensus       237 -------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~  272 (288)
T d2jfla1         237 -------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV  272 (288)
T ss_dssp             -------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred             -------ccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence                   112344568899999999999999999999998764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-52  Score=408.05  Aligned_cols=255  Identities=28%  Similarity=0.439  Sum_probs=213.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .++|+..++||+|+||+||+|++++++.||||+++.....  .++|.+|++++++++||||++++|++.+++..++||||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            3688999999999999999999988999999999875432  46799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++|+|.+++.... ..+++..+++++.|+++||+|||   +++|+||||||+|||++.++.+||+|||+++.....  .
T Consensus        81 ~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~--~  154 (258)
T d1k2pa_          81 MANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--E  154 (258)
T ss_dssp             CTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS--S
T ss_pred             cCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCC--C
Confidence            99999999976543 46889999999999999999999   889999999999999999999999999999865332  2


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                      ........||+.|+|||++.+..++.++||||||+++|||+| |+.||......+....   .    ..+.  ....   
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~---i----~~~~--~~~~---  222 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---I----AQGL--RLYR---  222 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH---H----HTTC--CCCC---
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH---H----HhCC--CCCC---
Confidence            222334568999999999999999999999999999999998 8999987654332211   1    1111  0111   


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                          +..++..+.+++.+||+.||++|||+.||+++|.+|
T Consensus       223 ----p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         223 ----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             ----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ----cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                112335688999999999999999999999998654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-52  Score=412.69  Aligned_cols=252  Identities=27%  Similarity=0.449  Sum_probs=202.9

Q ss_pred             eeeeccCceEEEEEEEcC---CcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeCCC
Q 042763          272 LRIGEGGFGTVYKAQLED---GLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFVPN  347 (554)
Q Consensus       272 ~~LG~G~fG~Vy~a~~~~---g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  347 (554)
                      ++||+|+||+||+|.+++   ++.||||+++.... ....++|.+|+++|++++|||||+++|++.+ +..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999997643   56899999976543 3345789999999999999999999999965 467899999999


Q ss_pred             CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCccc
Q 042763          348 GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRTHI  427 (554)
Q Consensus       348 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~  427 (554)
                      |+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...........
T Consensus        92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            9999999765  57999999999999999999999   889999999999999999999999999999876544333333


Q ss_pred             cccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhhh
Q 042763          428 STKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEV  506 (554)
Q Consensus       428 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  506 (554)
                      .....||+.|||||.+.+..++.++|||||||++|||+| |+.||......+..   ..    ...+....         
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~---~~----i~~~~~~~---------  230 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT---AM----LEKGERMG---------  230 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HH----HHTTCCCC---------
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH---HH----HHcCCCCC---------
Confidence            445679999999999999999999999999999999998 89999865433211   11    11111111         


Q ss_pred             ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          507 ISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       507 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      .+..++..+.+|+.+||+.||++|||+++|.+.|+..-.
T Consensus       231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            122345678899999999999999999999888776543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-52  Score=410.85  Aligned_cols=249  Identities=25%  Similarity=0.436  Sum_probs=201.6

Q ss_pred             CCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc----CCceEEE
Q 042763          268 FSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK----GNERLII  341 (554)
Q Consensus       268 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~~lv  341 (554)
                      |+..++||+|+||+||+|... +++.||+|++..... ....+.+.+|+++|++++|||||++++++.+    +...++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            355678999999999999765 588999999876543 3445679999999999999999999999864    3457999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eEeCCCCCCCeEEC-CCCcEEEEeecCcccC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQ--IIHRDVKSSNILLT-ESMRAKVADFGFARLG  418 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NILl~-~~~~vkl~DfGla~~~  418 (554)
                      ||||++|+|.+++...  ..+++.+++.++.||+.||+|||   +++  |+||||||+|||++ +++.+||+|||+|+..
T Consensus        91 mE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            9999999999999765  57899999999999999999999   777  99999999999996 5789999999999863


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ..     .......||+.|||||++.+ .|+.++|||||||++|||++|+.||.........      ......+.    
T Consensus       166 ~~-----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~------~~~i~~~~----  229 (270)
T d1t4ha_         166 RA-----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGV----  229 (270)
T ss_dssp             CT-----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTC----
T ss_pred             cC-----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH------HHHHHcCC----
Confidence            22     12335679999999999876 6999999999999999999999999765443321      11111111    


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ..+....    ....++.+++.+||+.||++|||+.|+++|.|
T Consensus       230 ~~~~~~~----~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~  268 (270)
T d1t4ha_         230 KPASFDK----VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF  268 (270)
T ss_dssp             CCGGGGG----CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCcccCc----cCCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence            1111111    22345789999999999999999999999865

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=426.42  Aligned_cols=271  Identities=24%  Similarity=0.349  Sum_probs=212.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|++.++||+|+||+||+|... +|+.||+|+++........+.+.+|+.+|++++|||||+++++|.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            467999999999999999999765 6899999999765545556789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAE-KQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~-~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||++|+|.+++.+.  ..+++.++..++.|++.||+|||   + ++|+||||||+|||++.++.+||+|||+|+....  
T Consensus        85 y~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--  157 (322)
T ss_dssp             CCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred             cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC--
Confidence            99999999999765  57899999999999999999999   5 4899999999999999999999999999986321  


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH-hhc----------
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFK-RYN----------  491 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~-~~~----------  491 (554)
                         ......+||+.|||||++.+..|+.++||||+||++|||++|+.||................. ...          
T Consensus       158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             ---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence               223346899999999999999999999999999999999999999987654322111000000 000          


Q ss_pred             ----cCCccccCChhhhh------------hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          492 ----EGNLLDMVDPSIKE------------VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       492 ----~~~~~~~~d~~l~~------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                          .............+            ......+.++.+++.+||+.||++|||++|+++|.|--+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                00000000000000            0001123568899999999999999999999999775443

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=416.62  Aligned_cols=255  Identities=24%  Similarity=0.293  Sum_probs=209.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|++.+.||+|+||+||+|... +|+.||||++.+...  ....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56899999999999999999775 689999999976543  334567999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      |||++|+|.+++...  ..+++.+++.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+......
T Consensus        88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            999999999998765  57999999999999999999999   8999999999999999999999999999998754322


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                      . .......+||+.|||||++.+..|+.++|||||||++|||++|+.||..........   .    ...... .     
T Consensus       163 ~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~---~----i~~~~~-~-----  228 (288)
T d1uu3a_         163 K-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ---K----IIKLEY-D-----  228 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---H----HHTTCC-C-----
T ss_pred             c-ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH---H----HHcCCC-C-----
Confidence            2 222344679999999999999999999999999999999999999998654322211   1    111111 0     


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                          ++..++..+.+++.+||+.||++|||++|++++.|-.
T Consensus       229 ----~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~  265 (288)
T d1uu3a_         229 ----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK  265 (288)
T ss_dssp             ----CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHH
T ss_pred             ----CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHH
Confidence                1122345688999999999999999999987766533

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-52  Score=422.42  Aligned_cols=256  Identities=22%  Similarity=0.336  Sum_probs=195.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .+.|+..+.||+|+||+||+|... +|+.||||++...........+.+|+++|++++||||+++++++.+++..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356899999999999999999775 6899999999876655555678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC---CCCcEEEEeecCcccCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT---ESMRAKVADFGFARLGPM  420 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~---~~~~vkl~DfGla~~~~~  420 (554)
                      ||++|+|.+++...  ..+++.++..++.||+.||+|||   +++|+||||||+|||+.   +++.+||+|||+|+....
T Consensus        88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            99999999999764  57999999999999999999999   89999999999999995   578999999999986322


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVD  500 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  500 (554)
                          .......+||+.|||||++.+..|+.++|||||||++|||++|+.||......+..   ....    .....  .+
T Consensus       163 ----~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~i~----~~~~~--~~  229 (307)
T d1a06a_         163 ----GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF---EQIL----KAEYE--FD  229 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHH----TTCCC--CC
T ss_pred             ----CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH---HHHh----ccCCC--CC
Confidence                22234467999999999999999999999999999999999999999865433221   1111    11100  01


Q ss_pred             hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          501 PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       501 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ..    ....++..+.+++.+||+.||++|||+.|+++|.|-
T Consensus       230 ~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  267 (307)
T d1a06a_         230 SP----YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI  267 (307)
T ss_dssp             TT----TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred             Cc----cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence            11    112344568899999999999999999999998653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=419.60  Aligned_cols=258  Identities=27%  Similarity=0.376  Sum_probs=207.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED------GLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~  337 (554)
                      .++|+..++||+|+||+||+|....      ...||||++...........+.+|+.+|+++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3578889999999999999997653      2379999987665555557899999999998 89999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHhcccC---------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCC
Q 042763          338 RLIITEFVPNGTLREHLDGQYG---------------------KTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKS  396 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp  396 (554)
                      .++|||||++|+|.+++..+..                     ..+++.+++.++.||+.||+|||   +++|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence            9999999999999999976532                     35889999999999999999999   89999999999


Q ss_pred             CCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 042763          397 SNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKR  475 (554)
Q Consensus       397 ~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~  475 (554)
                      +|||++.++.+||+|||+|+...... .........||+.|||||++.+..|+.++|||||||++|||+| |+.||....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hccccccCCeEEEeeccccccccCCC-ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999998643322 2222334568999999999999999999999999999999998 899998765


Q ss_pred             ChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          476 PPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       476 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .......+.      ..+.     .+    ..+..++..+.+|+.+||+.||++|||++||+++|.
T Consensus       272 ~~~~~~~~~------~~~~-----~~----~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         272 VDANFYKLI------QNGF-----KM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CSHHHHHHH------HTTC-----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHH------hcCC-----CC----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            543322111      1110     00    012234567899999999999999999999999984

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.5e-51  Score=418.10  Aligned_cols=255  Identities=24%  Similarity=0.318  Sum_probs=210.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|++.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            57999999999999999999765 699999999976543 3356789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC--CCcEEEEeecCcccCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE--SMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~--~~~vkl~DfGla~~~~~~~  422 (554)
                      |++|+|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.  ++.+||+|||+|+..... 
T Consensus       105 ~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-  179 (350)
T d1koaa2         105 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  179 (350)
T ss_dssp             CCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred             CCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence            9999999999654 246999999999999999999999   899999999999999964  678999999999874322 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                         .......||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+....+.   ..  ...    .+..
T Consensus       180 ---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~---~~--~~~----~~~~  247 (350)
T d1koaa2         180 ---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK---SC--DWN----MDDS  247 (350)
T ss_dssp             ---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HT--CCC----SCCG
T ss_pred             ---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH---hC--CCC----CCcc
Confidence               22344679999999999999999999999999999999999999998654332221111   11  000    1111


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      .    ...++..+.+++.+||+.||++|||++|+++|.|-
T Consensus       248 ~----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~  283 (350)
T d1koaa2         248 A----FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL  283 (350)
T ss_dssp             G----GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTT
T ss_pred             c----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            1    12234568899999999999999999999998663

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-51  Score=413.86  Aligned_cols=251  Identities=25%  Similarity=0.333  Sum_probs=206.2

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      +.|+..++||+|+||+||+|... +|+.||||++.....  ....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35889999999999999999764 689999999876532  334467999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      |||++|+|..++..+  ..+++.+++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+....  
T Consensus        95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (309)
T ss_dssp             ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence            999999997776544  57999999999999999999999   89999999999999999999999999999986321  


Q ss_pred             CCccccccccCCCCCcChhcccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKT---YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                           .....||+.|||||++.+   ..|+.++|||||||++|||++|+.||.........   .....    ...... 
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~---~~i~~----~~~~~~-  234 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQ----NESPAL-  234 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHH----SCCCCC-
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHh----CCCCCC-
Confidence                 234579999999999864   46899999999999999999999999865432221   11111    111111 


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                             .+..++..+.+++.+||+.||++|||+.|+++|.|-.
T Consensus       235 -------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~  271 (309)
T d1u5ra_         235 -------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (309)
T ss_dssp             -------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             -------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhc
Confidence                   1112345688999999999999999999999987643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=409.32  Aligned_cols=255  Identities=24%  Similarity=0.344  Sum_probs=210.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh-----hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE-----NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      ++|++.+.||+|+||+||+|... +|+.||||++.+....     ...+.+.+|+++|++++|||||++++++.+++..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            67999999999999999999874 6999999998754322     23578999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC----cEEEEeecCc
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM----RAKVADFGFA  415 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~----~vkl~DfGla  415 (554)
                      +|||||++|+|.+++...  ..+++.+++.++.|++.||+|||   +++|+||||||+|||++.++    .+||+|||+|
T Consensus        90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence            999999999999999765  57999999999999999999999   89999999999999998776    4999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      +.....    .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+...   ..    .....
T Consensus       165 ~~~~~~----~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~---~i----~~~~~  233 (293)
T d1jksa_         165 HKIDFG----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---NV----SAVNY  233 (293)
T ss_dssp             EECTTS----CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HH----HTTCC
T ss_pred             hhcCCC----ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH---HH----HhcCC
Confidence            874322    22344579999999999999999999999999999999999999998654332211   11    11100


Q ss_pred             cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          496 LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       496 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                        ...+.    ....++..+.+++.+||+.||++|||++|+++|.|-
T Consensus       234 --~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  274 (293)
T d1jksa_         234 --EFEDE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI  274 (293)
T ss_dssp             --CCCHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred             --CCCch----hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence              01111    112234568899999999999999999999998764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=412.11  Aligned_cols=253  Identities=22%  Similarity=0.309  Sum_probs=213.0

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||++++...  ....+.+.+|+.+|++++||||+++++++.+++..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            56899999999999999999764 699999999987643  234567899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      |||++|+|.+++...  ..+++..++.++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+..... 
T Consensus        85 ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-  158 (337)
T d1o6la_          85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-  158 (337)
T ss_dssp             ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred             eccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence            999999999999875  57899999999999999999999   899999999999999999999999999999864322 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                        .......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+......   ....  ....        
T Consensus       159 --~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~---~i~~--~~~~--------  223 (337)
T d1o6la_         159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---LILM--EEIR--------  223 (337)
T ss_dssp             --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHH--CCCC--------
T ss_pred             --CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHH---HHhc--CCCC--------
Confidence              223345689999999999999999999999999999999999999998765432211   1111  1111        


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHHh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPD-----MKSVGEQLWAI  543 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~i  543 (554)
                          ++..++..+.+++.+||+.||++||+     +.|+++|.|--
T Consensus       224 ----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~  265 (337)
T d1o6la_         224 ----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  265 (337)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             ----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccc
Confidence                12223456789999999999999995     89999987643

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-51  Score=406.40  Aligned_cols=258  Identities=29%  Similarity=0.438  Sum_probs=207.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEeC
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEFV  345 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  345 (554)
                      ++|++.+.||+|+||+||+|.++++..||||+++....  ..+.|.+|+.++++++|||||+++|++.+ +..++|||||
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            57888999999999999999998888999999976543  24679999999999999999999999854 5689999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCCc
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDRT  425 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~  425 (554)
                      ++|+|..++.......+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~--~~  168 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--EY  168 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCC--Cc
Confidence            9999999998766667999999999999999999999   889999999999999999999999999999864322  22


Q ss_pred             cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhhh
Q 042763          426 HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKE  505 (554)
Q Consensus       426 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  505 (554)
                      .......||+.|+|||++....++.++|||||||++|||++|..|+.......+.  +........    ..        
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~--~~~i~~~~~----~~--------  234 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQVERGYR----MP--------  234 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHHHTTCC----CC--------
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH--HHHHHhcCC----CC--------
Confidence            2233456999999999999999999999999999999999977776654443322  222211110    00        


Q ss_pred             hccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          506 VISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       506 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                       .+..++..+.+++.+||+.||++||+|.+|+++|...-.+
T Consensus       235 -~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         235 -CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence             1223445788999999999999999999999988875543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.5e-51  Score=416.66  Aligned_cols=254  Identities=19%  Similarity=0.292  Sum_probs=210.0

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|++.++||+|+||+||+|... +|+.||||+++.... .....+.+|+++|++++|||||++++++.+++..++||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            56899999999999999999764 699999999876543 2346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC--CCCcEEEEeecCcccCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT--ESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~--~~~~vkl~DfGla~~~~~~~  422 (554)
                      |++|+|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+|||++  .++.+||+|||+|+..... 
T Consensus       108 ~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-  182 (352)
T d1koba_         108 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-  182 (352)
T ss_dssp             CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred             CCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence            9999999987654 346999999999999999999999   89999999999999998  6789999999999875322 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                         .......||+.|||||++.+..|+.++|||||||++|||+||+.||.+....+...   .....  ....    ...
T Consensus       183 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~---~i~~~--~~~~----~~~  250 (352)
T d1koba_         183 ---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ---NVKRC--DWEF----DED  250 (352)
T ss_dssp             ---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH---HHHHC--CCCC----CSS
T ss_pred             ---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhC--CCCC----Ccc
Confidence               23344679999999999999999999999999999999999999998654432211   11111  0000    011


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                          ....++..+.+|+.+||+.||++|||+.|+++|.|
T Consensus       251 ----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~  285 (352)
T d1koba_         251 ----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW  285 (352)
T ss_dssp             ----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred             ----cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence                11233456889999999999999999999999865

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=400.63  Aligned_cols=259  Identities=28%  Similarity=0.428  Sum_probs=204.5

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC----CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      .++|+..+.||+|+||+||+|.+..    +..||||+++....+...+.+.+|++++++++||||+++++++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3578889999999999999997642    45799999977665666778999999999999999999999986 467899


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      |||||++|+|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+|+....
T Consensus        85 v~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            99999999999987654 357899999999999999999999   89999999999999999999999999999986432


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      .  .........||+.|+|||++.+..++.++|||||||++|||+| |.+||......+....   .    ..+....  
T Consensus       161 ~--~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~---i----~~~~~~~--  229 (273)
T d1mp8a_         161 S--TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---I----ENGERLP--  229 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---H----HTTCCCC--
T ss_pred             C--cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH---H----HcCCCCC--
Confidence            2  2223345568999999999999999999999999999999998 8999987655432211   1    1111111  


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                             .+..++..+.+++.+||+.||++|||+.||+++|.+|..+
T Consensus       230 -------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         230 -------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                   1223456789999999999999999999999999998765

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.6e-50  Score=400.71  Aligned_cols=263  Identities=24%  Similarity=0.362  Sum_probs=206.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC----c
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN----E  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----~  337 (554)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++....  ......+.+|++++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            36799999999999999999976 4699999999976543  234567999999999999999999999987654    3


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .|+|||||++++|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.++++|||.++.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhh
Confidence            78999999999999998765  57999999999999999999999   89999999999999999999999999999886


Q ss_pred             CCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                      ...............||+.|||||++.+..++.++|||||||++|||+||+.||......+...      ........  
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~~~~~~~~--  232 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVREDPI--  232 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCCCC--
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH------HHHhcCCC--
Confidence            5444444444556789999999999999999999999999999999999999998654332211      11111110  


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHhhh
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRP-DMKSVGEQLWAIRA  545 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~l~~i~~  545 (554)
                        .+   ......++..+.+++.+||+.||++|| |+++++..|.++++
T Consensus       233 --~~---~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         233 --PP---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             --CG---GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             --CC---chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence              01   011223456788999999999999999 89999999988763

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-50  Score=408.05  Aligned_cols=264  Identities=30%  Similarity=0.453  Sum_probs=214.8

Q ss_pred             HHHhhcCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEc
Q 042763          261 VVKATRNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDK  334 (554)
Q Consensus       261 l~~~~~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  334 (554)
                      +....++|+..++||+|+||+||+|+.+      +++.||||+++........++|.+|++++++++||||+++++++.+
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3334578999999999999999999864      3578999999876656667789999999999999999999999999


Q ss_pred             CCceEEEEEeCCCCCHHHHHhccc----------------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeC
Q 042763          335 GNERLIITEFVPNGTLREHLDGQY----------------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHR  392 (554)
Q Consensus       335 ~~~~~lv~E~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~  392 (554)
                      .+..+++|||+++|+|.+++....                      ...+++.+++.++.|++.||+|||   +++|+||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEee
Confidence            999999999999999999996431                      235789999999999999999999   8999999


Q ss_pred             CCCCCCeEECCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCC-CCC
Q 042763          393 DVKSSNILLTESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGR-RPV  471 (554)
Q Consensus       393 Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~-~P~  471 (554)
                      ||||+|||++.++.+||+|||+|+..... ..........||+.|+|||.+.+..|+.++|||||||++|||++|. +||
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSA-DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGG-GCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCC-ccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            99999999999999999999999864322 2222334567899999999999999999999999999999999986 566


Q ss_pred             CCCCChhhHHHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          472 ELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                      ......+..   ..    +.++....         .+..++.++.+|+.+||+.+|++||||.||+++|++|.
T Consensus       244 ~~~~~~e~~---~~----v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         244 YGMAHEEVI---YY----VRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTSCHHHHH---HH----HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCHHHHH---HH----HHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            654433221   11    11221111         12234456899999999999999999999999999875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-51  Score=400.27  Aligned_cols=253  Identities=28%  Similarity=0.450  Sum_probs=203.2

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEc-CCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDK-GNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~lv~E~  344 (554)
                      ++|+..++||+|+||.||+|.++ |..||||+++...   ..+.+.+|++++++++||||++++|++.+ .+..++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            45777889999999999999986 7899999997643   34679999999999999999999999854 4568999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +++|+|.+++..+....+++..+++++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....    
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----  155 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----  155 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC----
Confidence            99999999998765556899999999999999999999   89999999999999999999999999999986322    


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSI  503 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  503 (554)
                        ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||......+..   .+.    ..+...+      
T Consensus       156 --~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~---~~i----~~~~~~~------  220 (262)
T d1byga_         156 --TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRV----EKGYKMD------  220 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---HHH----TTTCCCC------
T ss_pred             --CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH---HHH----HcCCCCC------
Confidence              1223468899999999999999999999999999999998 68877765433221   111    1111111      


Q ss_pred             hhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 042763          504 KEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADS  547 (554)
Q Consensus       504 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~  547 (554)
                         .+..++..+.+++.+||+.||.+||||.+|+++|++|+...
T Consensus       221 ---~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~  261 (262)
T d1byga_         221 ---APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  261 (262)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ---CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence               22233456889999999999999999999999999998753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.2e-50  Score=406.15  Aligned_cols=248  Identities=26%  Similarity=0.367  Sum_probs=210.0

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|++.++||+|+||+||+|+.+ +|+.||||++++...  ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46889999999999999999874 699999999976543  234577999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      |||++|+|..++...  ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+..... 
T Consensus        84 E~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          84 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            999999999998765  57889999999999999999999   999999999999999999999999999999875321 


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                           ....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+.   .  ....        
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~---~--~~~~--------  219 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL---N--AELR--------  219 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---H--CCCC--------
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH---c--CCCC--------
Confidence                 234679999999999999999999999999999999999999998755433222111   1  1111        


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLW  541 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~  541 (554)
                          .+..++..+.+++.+||+.||.+||     |++++++|.|
T Consensus       220 ----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~  259 (316)
T d1fota_         220 ----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW  259 (316)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             ----CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence                1122345688999999999999996     9999999866

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-50  Score=406.39  Aligned_cols=261  Identities=23%  Similarity=0.393  Sum_probs=207.1

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCc----EEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGL----LVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  340 (554)
                      .+|+..++||+|+||+||+|.+. +|+    .||+|+++........++|.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999764 343    68999887665555677899999999999999999999999874 5678


Q ss_pred             EEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCC
Q 042763          341 ITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPM  420 (554)
Q Consensus       341 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~  420 (554)
                      ++||+.+|+|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus        88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            89999999999988754 457899999999999999999999   88999999999999999999999999999987543


Q ss_pred             CCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccccC
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLDMV  499 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  499 (554)
                      .. .........||+.|||||++.+..|+.++|||||||++|||+| |..||......+....+.   ... ..      
T Consensus       164 ~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~---~~~-~~------  232 (317)
T d1xkka_         164 EE-KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGE-RL------  232 (317)
T ss_dssp             TC-C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH---HTC-CC------
T ss_pred             cc-ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---cCC-CC------
Confidence            22 2222334568999999999999999999999999999999999 788887655433222111   100 00      


Q ss_pred             ChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          500 DPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       500 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                            ..+..++..+.+++.+||+.||++|||+.||+++++.+..+..
T Consensus       233 ------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~  275 (317)
T d1xkka_         233 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  275 (317)
T ss_dssp             ------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHH
T ss_pred             ------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhChH
Confidence                  0122344568899999999999999999999999999876543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=400.29  Aligned_cols=262  Identities=27%  Similarity=0.358  Sum_probs=201.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcC-C
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKG-N  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~-~  336 (554)
                      .++|+..++||+|+||+||+|...      +++.||||+++........+.+.+|+.++.++ +|+||+.+++++.+. .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            467899999999999999999754      24689999998766555567788888888877 689999999987654 4


Q ss_pred             ceEEEEEeCCCCCHHHHHhccc--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEEC
Q 042763          337 ERLIITEFVPNGTLREHLDGQY--------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLT  402 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~  402 (554)
                      ..++|||||++|+|.+++..+.              ...+++.+++.++.||+.||+|||   +++|+||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeEC
Confidence            6899999999999999997542              235889999999999999999999   89999999999999999


Q ss_pred             CCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCChhhHH
Q 042763          403 ESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTG-RRPVELKRPPEERV  481 (554)
Q Consensus       403 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg-~~P~~~~~~~~~~~  481 (554)
                      .++.+||+|||+|+...... .........||+.|||||++.+..++.++|||||||++|||+|| ..||..........
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~  247 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  247 (299)
T ss_dssp             GGGCEEECC------CCSCT-TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             CCCcEEEccCcchhhccccc-cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999998644322 22233456799999999999999999999999999999999996 55777655443321


Q ss_pred             HHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          482 TLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                      ..  . ......   .         .+..++..+.+++.+||+.||++|||+.||+++|++|..
T Consensus       248 ~~--~-~~~~~~---~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         248 RR--L-KEGTRM---R---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             HH--H-HHTCCC---C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH--H-hcCCCC---C---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11  1 111111   1         122234568899999999999999999999999998854

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.5e-49  Score=394.61  Aligned_cols=254  Identities=22%  Similarity=0.296  Sum_probs=208.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--------hhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcC
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--------ENLQTEFSSEVELLSKID-HRNLVKLLGFVDKG  335 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--------~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~  335 (554)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++....        +...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            67899999999999999999764 699999999865432        233456889999999997 99999999999999


Q ss_pred             CceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCc
Q 042763          336 NERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFA  415 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla  415 (554)
                      +..++|||||++|+|.+++..+  ..+++.+++.++.||++||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhe
Confidence            9999999999999999999765  57999999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhcccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHh
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKT------YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKR  489 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~  489 (554)
                      +.....    .......||+.|+|||++.+      ..++.++||||+||++|||++|+.||...........   ..  
T Consensus       158 ~~~~~~----~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~---i~--  228 (277)
T d1phka_         158 CQLDPG----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM---IM--  228 (277)
T ss_dssp             EECCTT----CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HH--
T ss_pred             eEccCC----CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH---HH--
Confidence            875322    22344679999999998853      3578999999999999999999999987653322111   11  


Q ss_pred             hccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          490 YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                        .+... ...+     ....++..+.+++.+||+.||++|||+.||++|.|
T Consensus       229 --~~~~~-~~~~-----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~  272 (277)
T d1phka_         229 --SGNYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF  272 (277)
T ss_dssp             --HTCCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             --hCCCC-CCCc-----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence              11110 0111     11134456889999999999999999999998865

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-50  Score=397.46  Aligned_cols=259  Identities=29%  Similarity=0.469  Sum_probs=201.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC--C--cEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED--G--LLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~--g--~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  338 (554)
                      .++|+..+.||+|+||+||+|++..  +  ..||||++.+...  +...++|.+|+++|++++||||++++|++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            3568889999999999999997642  2  4789999876533  3445789999999999999999999999976 467


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccC
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLG  418 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~  418 (554)
                      ++|||||++|++.+++..+ ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus        86 ~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             heeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence            8999999999999988765 346999999999999999999999   899999999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHhhccCCccc
Q 042763          419 PMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEERVTLRWAFKRYNEGNLLD  497 (554)
Q Consensus       419 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (554)
                      ..............||..|+|||++.+..++.++||||||+++|||+| |+.||......+.   ..+..   ..+...+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~---~~~i~---~~~~~~~  235 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LHKID---KEGERLP  235 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHH---TSCCCCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH---HHHHH---hCCCCCC
Confidence            555444444555678899999999999999999999999999999998 8999986543322   12211   1111000


Q ss_pred             cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 042763          498 MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAI  543 (554)
Q Consensus       498 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i  543 (554)
                               .+..++..+.+|+.+||+.||++||||.||.+.|.+.
T Consensus       236 ---------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         236 ---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                     1123345688999999999999999999999998875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-49  Score=407.52  Aligned_cols=254  Identities=22%  Similarity=0.293  Sum_probs=212.5

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~  342 (554)
                      ++|++.++||+|+||+||+|..+ +|+.||||++.+...  ....+.+.+|+++|++++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999775 699999999976543  233567899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDS  422 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~  422 (554)
                      ||+.+|+|.+++...  ..+++.+++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+....  
T Consensus       121 e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--  193 (350)
T ss_dssp             ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred             ccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence            999999999999765  47999999999999999999999   89999999999999999999999999999987432  


Q ss_pred             CCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChh
Q 042763          423 DRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPS  502 (554)
Q Consensus       423 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  502 (554)
                          ......||+.|||||++.+..|+.++|||||||++|||+||+.||.........   ....    .....      
T Consensus       194 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i~----~~~~~------  256 (350)
T d1rdqe_         194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY---EKIV----SGKVR------  256 (350)
T ss_dssp             ----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HCCCC------
T ss_pred             ----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH---HHHh----cCCCC------
Confidence                123457999999999999999999999999999999999999999865432221   1111    11100      


Q ss_pred             hhhhccHHHHHHHHHHHHHccCCCCCCC-----CCHHHHHHHHHHhhhhh
Q 042763          503 IKEVISMEILTKMFGLAIQCAAPIRNDR-----PDMKSVGEQLWAIRADS  547 (554)
Q Consensus       503 l~~~~~~~~~~~l~~li~~cl~~dP~~R-----Ps~~evl~~l~~i~~~~  547 (554)
                          .+..++..+.+++.+||+.||.+|     ||+.++++|.|--..+|
T Consensus       257 ----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         257 ----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             ----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             ----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence                112334568899999999999999     49999999877543333

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-49  Score=396.47  Aligned_cols=261  Identities=26%  Similarity=0.416  Sum_probs=208.8

Q ss_pred             ceeeeccCceEEEEEEEcC----CcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEc-CCceEEEEEeC
Q 042763          271 SLRIGEGGFGTVYKAQLED----GLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDK-GNERLIITEFV  345 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~lv~E~~  345 (554)
                      .++||+|+||+||+|.+.+    ...||||+++........++|.+|+++|++++||||++++|++.+ ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4679999999999998753    236899999765445556789999999999999999999999865 56789999999


Q ss_pred             CCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC-C
Q 042763          346 PNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD-R  424 (554)
Q Consensus       346 ~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~-~  424 (554)
                      ++|+|.+++... ...+++..++.++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+++....... .
T Consensus       112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            999999998754 346778899999999999999999   89999999999999999999999999999987543322 2


Q ss_pred             ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCChhhh
Q 042763          425 THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDPSIK  504 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  504 (554)
                      ........||+.|+|||.+.+..++.++||||||+++|||+||+.||.......+.  ..+..    .+.  ...     
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~--~~~i~----~g~--~~~-----  254 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL----QGR--RLL-----  254 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C--HHHHH----TTC--CCC-----
T ss_pred             ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH--HHHHH----cCC--CCC-----
Confidence            22233457899999999999999999999999999999999988888654322211  11111    111  001     


Q ss_pred             hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhhh
Q 042763          505 EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKS  550 (554)
Q Consensus       505 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~~  550 (554)
                        .+..++..+.+++.+||+.||++||+|.||+++|++|...+..+
T Consensus       255 --~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~  298 (311)
T d1r0pa_         255 --QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  298 (311)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             --CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence              11223456889999999999999999999999999998876554

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=403.50  Aligned_cols=251  Identities=24%  Similarity=0.377  Sum_probs=207.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh--hhHHHHHHHHHHHHH-hCCCCCceeeeeEEEcCCceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF--ENLQTEFSSEVELLS-KIDHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~~Ei~~l~-~l~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ++|.+.++||+|+||+||+|... +|+.||||++++...  +...+.+..|+.++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57889999999999999999775 699999999976542  233456677777665 68999999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMD  421 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~  421 (554)
                      ||||++|+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            9999999999999765  57899999999999999999999   889999999999999999999999999999864322


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                         ........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+.     .....       
T Consensus       157 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-----~~~~~-------  221 (320)
T d1xjda_         157 ---DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-----MDNPF-------  221 (320)
T ss_dssp             ---TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HCCCC-------
T ss_pred             ---cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH-----cCCCC-------
Confidence               223345679999999999999999999999999999999999999998755432221111     11111       


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHH
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMK-SVGEQLW  541 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~l~  541 (554)
                           ++..++..+.+|+.+||+.||++||++. |+++|.|
T Consensus       222 -----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpf  257 (320)
T d1xjda_         222 -----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL  257 (320)
T ss_dssp             -----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred             -----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCch
Confidence                 1122345688999999999999999995 8888755

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=404.17  Aligned_cols=257  Identities=21%  Similarity=0.290  Sum_probs=203.9

Q ss_pred             cCCCcce-eeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHh-CCCCCceeeeeEEEc----CCce
Q 042763          266 RNFSPSL-RIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSK-IDHRNLVKLLGFVDK----GNER  338 (554)
Q Consensus       266 ~~f~~~~-~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~-l~HpnIv~l~~~~~~----~~~~  338 (554)
                      ++|.+.. .||+|+||+||+|.. .+|+.||||+++..      ..+.+|++++.+ .+|||||++++++.+    +...
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            5787765 599999999999976 46899999998654      356789988765 489999999999865    4568


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC---CCcEEEEeecCc
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE---SMRAKVADFGFA  415 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~DfGla  415 (554)
                      |+|||||++|+|.+++..+....+++.+++.++.||+.||+|||   +++|+||||||+|||++.   ++.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999998765568999999999999999999999   899999999999999985   567999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      +.....    .......||+.|||||++.+..|+.++|||||||++|||+||+.||...........+   .........
T Consensus       162 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~~~~~  234 (335)
T d2ozaa1         162 KETTSH----NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQY  234 (335)
T ss_dssp             EECCCC----CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS
T ss_pred             eeccCC----CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHhcCCC
Confidence            874332    2234467999999999999999999999999999999999999999765443221111   111111110


Q ss_pred             cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 042763          496 LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIR  544 (554)
Q Consensus       496 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~  544 (554)
                       ....+     ....++..+.+++.+||+.||++|||+.|+++|.|-.+
T Consensus       235 -~~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         235 -EFPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             -SCCTT-----HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             -CCCCc-----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence             01011     11234567899999999999999999999999987543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=400.96  Aligned_cols=258  Identities=33%  Similarity=0.458  Sum_probs=205.6

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCc--EEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGL--LVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~--~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ++|+..++||+|+||+||+|.++ +|.  .||||+++........+++.+|+++|+++ +|||||+++|++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            57788889999999999999775 344  57888886655455567899999999999 799999999999999999999


Q ss_pred             EEeCCCCCHHHHHhcc--------------cCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcE
Q 042763          342 TEFVPNGTLREHLDGQ--------------YGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRA  407 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v  407 (554)
                      |||+++|+|.++++..              ....+++.+++.++.||+.||.|||   +++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999999654              2457899999999999999999999   8999999999999999999999


Q ss_pred             EEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCChhhHHHHHHH
Q 042763          408 KVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRR-PVELKRPPEERVTLRWA  486 (554)
Q Consensus       408 kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~-P~~~~~~~~~~~~~~~~  486 (554)
                      ||+|||+++....    ........||..|+|||.+.+..++.++|||||||++|||++|.. ||......+.   ..  
T Consensus       167 kl~DfG~a~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~---~~--  237 (309)
T d1fvra_         167 KIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YE--  237 (309)
T ss_dssp             EECCTTCEESSCE----ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH--
T ss_pred             EEccccccccccc----cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH---HH--
Confidence            9999999986322    122234468999999999999999999999999999999999765 5654432221   11  


Q ss_pred             HHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          487 FKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       487 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                        ....+..     +.    .+..++..+.+|+.+||+.||++||||.||+++|.++..+
T Consensus       238 --~i~~~~~-----~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         238 --KLPQGYR-----LE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             --HGGGTCC-----CC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             --HHHhcCC-----CC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence              1111110     11    1223446789999999999999999999999999998754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=400.03  Aligned_cols=255  Identities=20%  Similarity=0.270  Sum_probs=209.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      .++|++.+.||+|+||+||+|... +|+.||||+++....+  ...+.+|+++|++++||||+++++++.+++..|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH--HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc--HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            367899999999999999999765 6899999999876433  3568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCC--CcEEEEeecCcccCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTES--MRAKVADFGFARLGPMD  421 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~--~~vkl~DfGla~~~~~~  421 (554)
                      ||++|+|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.+  ..+||+|||+++.... 
T Consensus        82 ~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-  156 (321)
T d1tkia_          82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-  156 (321)
T ss_dssp             CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred             cCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcccc-
Confidence            99999999999754 246899999999999999999999   8999999999999999854  5899999999986432 


Q ss_pred             CCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccccCCh
Q 042763          422 SDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDMVDP  501 (554)
Q Consensus       422 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  501 (554)
                         ........+|+.|+|||.+.+..|+.++|||||||++|||++|+.||......+....+.       ....  ..+.
T Consensus       157 ---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~-------~~~~--~~~~  224 (321)
T d1tkia_         157 ---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM-------NAEY--TFDE  224 (321)
T ss_dssp             ---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-------HTCC--CCCH
T ss_pred             ---CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCC--CCCh
Confidence               222344578999999999999999999999999999999999999998755432221111       1110  0111


Q ss_pred             hhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          502 SIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       502 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                      ...    ..++..+.+++.+||+.||++|||+.|+++|.|-
T Consensus       225 ~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~  261 (321)
T d1tkia_         225 EAF----KEISIEAMDFVDRLLVKERKSRMTASEALQHPWL  261 (321)
T ss_dssp             HHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             hhc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence            111    1234568899999999999999999999999874

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=397.05  Aligned_cols=263  Identities=23%  Similarity=0.241  Sum_probs=200.3

Q ss_pred             cceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhh----HHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          270 PSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFEN----LQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       270 ~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      .+++||+|+||+||+|... +|+.||||+++......    ..+.+.+|++++++++|||||++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3568999999999999765 68999999997654322    234688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      |.++++..+...  ...+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+......  
T Consensus        82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--  154 (299)
T d1ua2a_          82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--  154 (299)
T ss_dssp             CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--
T ss_pred             hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc--
Confidence            988777666543  357899999999999999999999   8999999999999999999999999999998643222  


Q ss_pred             ccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc-----
Q 042763          425 THISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM-----  498 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  498 (554)
                       ......+||+.|+|||++.+ ..|+.++|||||||++|||+||..||......+....+...............     
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence             22334579999999998865 46899999999999999999999999876544332222211111111100000     


Q ss_pred             -------CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          499 -------VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       499 -------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                             ....+.. ........+.+++.+||+.||++|||++|+++|.|
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~  282 (299)
T d1ua2a_         234 YVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  282 (299)
T ss_dssp             CCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             hhhhccCCCCChHH-hcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence                   0000111 11123467899999999999999999999999876

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-49  Score=394.57  Aligned_cols=273  Identities=22%  Similarity=0.303  Sum_probs=204.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC----ceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN----ERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----~~~lv  341 (554)
                      ++|...++||+|+||+||+|++. |+.||||+++.....  ......|+..+.+++||||+++++++.+.+    ..++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            45677789999999999999874 899999999765322  122334555666789999999999997644    57999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhc-----cCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLY-----AEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      ||||++|+|.+++++.   .+++.+++.++.|++.||+|||..     .+++|+||||||+|||++.++.+||+|||+++
T Consensus        80 ~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            9999999999999765   689999999999999999999942     24699999999999999999999999999998


Q ss_pred             cCCCCCCCc-cccccccCCCCCcChhccccCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCChhh--------HH
Q 042763          417 LGPMDSDRT-HISTKVKGTVGYLDPEYMKTYQ------LTTKSDVYSFGVLLLEILTGRRPVELKRPPEE--------RV  481 (554)
Q Consensus       417 ~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~------~s~ksDVwSlGvil~elltg~~P~~~~~~~~~--------~~  481 (554)
                      ......... .......||+.|||||++.+..      ++.++|||||||+||||+||..||........        ..
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            754332221 1233567999999999987642      67799999999999999999988753221100        00


Q ss_pred             HHHHHHHhhccCCccccCChhhh-hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 042763          482 TLRWAFKRYNEGNLLDMVDPSIK-EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSL  548 (554)
Q Consensus       482 ~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~  548 (554)
                      .............    .+|.+. .....+....+.+|+.+||+.||++|||+.||+++|.+++.+..
T Consensus       237 ~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~  300 (303)
T d1vjya_         237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             CHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             hHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence            0111111111211    122211 11233566789999999999999999999999999999987653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.7e-49  Score=406.74  Aligned_cols=253  Identities=23%  Similarity=0.311  Sum_probs=205.4

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhh--hHHHHHH---HHHHHHHhCCCCCceeeeeEEEcCCceE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFE--NLQTEFS---SEVELLSKIDHRNLVKLLGFVDKGNERL  339 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~---~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  339 (554)
                      ++|++.++||+|+||+||+|... +|+.||||++.+....  .....+.   +|+++++.++|||||++++++.+++..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57899999999999999999765 6999999999765432  1223333   4467777888999999999999999999


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      +|||||++|+|.+++...  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus        84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            999999999999999765  57889999999999999999999   8999999999999999999999999999998643


Q ss_pred             CCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      ..     ......||+.|||||++.. ..|+.++|||||||++|||+||+.||.............    .......   
T Consensus       159 ~~-----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----~~~~~~~---  226 (364)
T d1omwa3         159 KK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLTMAV---  226 (364)
T ss_dssp             SS-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH----HSSSCCC---
T ss_pred             CC-----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hcccCCC---
Confidence            22     2234579999999999864 568999999999999999999999998765543322111    1111110   


Q ss_pred             CChhhhhhccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHH
Q 042763          499 VDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPD-----MKSVGEQLWA  542 (554)
Q Consensus       499 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~  542 (554)
                         .    .+..++..+.+++.+||+.||++|||     ++|+++|.|-
T Consensus       227 ---~----~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f  268 (364)
T d1omwa3         227 ---E----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF  268 (364)
T ss_dssp             ---C----CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred             ---C----CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccc
Confidence               0    11123456889999999999999999     7999998764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-49  Score=395.82  Aligned_cols=263  Identities=27%  Similarity=0.402  Sum_probs=215.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcCCc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKGNE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~  337 (554)
                      .++|+..++||+|+||.||+|++.      +++.||||+++.........++.+|+.+++++ +|||||++++++.+++.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            357788899999999999999752      46799999998766555667899999999999 69999999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHhccc----------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE
Q 042763          338 RLIITEFVPNGTLREHLDGQY----------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL  401 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl  401 (554)
                      .++|||||++|+|.+++....                ...+++.+++.++.||+.||+|||   +++++||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence            999999999999999997543                235889999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhH
Q 042763          402 TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEER  480 (554)
Q Consensus       402 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~  480 (554)
                      +.++.+|++|||+++...... .........||+.|+|||++.+..++.++|||||||++|||+| |.+||......+..
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             cccCcccccccchheeccCCC-cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999999998754322 2334455679999999999999999999999999999999999 55555554443332


Q ss_pred             HHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          481 VTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      ..+.  .... .        +    ..+...+..+.+|+.+||+.||++||||.||+++|+++..+
T Consensus       258 ~~~i--~~~~-~--------~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         258 YKMI--KEGF-R--------M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHH--HHTC-C--------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHH--hcCC-C--------C----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            2111  1100 0        0    01122345689999999999999999999999999887655

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-49  Score=395.84  Aligned_cols=261  Identities=31%  Similarity=0.447  Sum_probs=209.1

Q ss_pred             hcCCCcceeeeccCceEEEEEEEcC--------CcEEEEEEcchhhhhhHHHHHHHHHHHHHhC-CCCCceeeeeEEEcC
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLED--------GLLVAIKRAKKEQFENLQTEFSSEVELLSKI-DHRNLVKLLGFVDKG  335 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~~--------g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~  335 (554)
                      .++|...+.||+|+||.||+|+...        +..||||+++.........++.+|+..+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3578888999999999999997532        3579999998776666667899999999888 899999999999999


Q ss_pred             CceEEEEEeCCCCCHHHHHhccc--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEE
Q 042763          336 NERLIITEFVPNGTLREHLDGQY--------------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILL  401 (554)
Q Consensus       336 ~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl  401 (554)
                      +..++|||||++|+|.+++..+.              ...+++.+++.++.||+.||+|||   +++|+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence            99999999999999999997553              246899999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCChhhH
Q 042763          402 TESMRAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILT-GRRPVELKRPPEER  480 (554)
Q Consensus       402 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~ellt-g~~P~~~~~~~~~~  480 (554)
                      +.++.+||+|||+++...... .........||+.|+|||.+.+..|+.++||||||+++|||++ |..||........ 
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~-  246 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHID-YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-  246 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCC-TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred             cCCCCeEeccchhhccccccc-cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH-
Confidence            999999999999998643222 2223445678999999999999999999999999999999998 6888875443221 


Q ss_pred             HHHHHHHHhhccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          481 VTLRWAFKRYNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                        ...    ...+....         .+..++..+.+|+.+||+.||++|||+.||++.|++|-+
T Consensus       247 --~~~----i~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         247 --FKL----LKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             --HHH----HHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHH----HHcCCCCC---------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence              111    11111111         112234568999999999999999999999999998854

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-49  Score=393.48  Aligned_cols=268  Identities=24%  Similarity=0.334  Sum_probs=206.2

Q ss_pred             cCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhh-hHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFE-NLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ++|++.++||+|+||+||+|.. .+|+.||||+++..... ...+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5789999999999999999976 46999999999765432 234678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      |+. +++.+++.......+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+....   
T Consensus        82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~---  154 (298)
T d1gz8a_          82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---  154 (298)
T ss_dssp             CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC---
T ss_pred             ecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccC---
Confidence            995 56666666665678999999999999999999999   89999999999999999999999999999986432   


Q ss_pred             CccccccccCCCCCcChhccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCccc-----
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQ-LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLD-----  497 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  497 (554)
                      .........||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+..+.............+.....     
T Consensus       155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence            222334457999999999877655 57899999999999999999999986553332222111111101100000     


Q ss_pred             --------cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          498 --------MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       498 --------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                              ........ ........+.+++.+||+.||++|||+.|+++|.|
T Consensus       235 ~~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~f  285 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSK-VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF  285 (298)
T ss_dssp             TCCTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             ccccccccccccchhh-hccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHh
Confidence                    00000000 11123467899999999999999999999999855

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=394.29  Aligned_cols=267  Identities=27%  Similarity=0.407  Sum_probs=216.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc------CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCce
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE------DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNER  338 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  338 (554)
                      .++|...++||+|+||+||+|.+.      +++.||||+++..........|.+|++++++++||||+++++++..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            467888899999999999999763      35789999998765555567799999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHHhccc--------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEE
Q 042763          339 LIITEFVPNGTLREHLDGQY--------GKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVA  410 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~  410 (554)
                      ++|||||++|+|.+++....        ...+++.+++.++.|+++||.|||   +++|+||||||+|||++.++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence            99999999999999986432        235789999999999999999999   8899999999999999999999999


Q ss_pred             eecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCChhhHHHHHHHHHh
Q 042763          411 DFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGR-RPVELKRPPEERVTLRWAFKR  489 (554)
Q Consensus       411 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~-~P~~~~~~~~~~~~~~~~~~~  489 (554)
                      |||+|+..... ..........||+.|+|||.+.+..++.++||||||+++|||+||. .||......+..   ...   
T Consensus       176 DFGla~~~~~~-~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~---~~i---  248 (308)
T d1p4oa_         176 DFGMTRDIYET-DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL---RFV---  248 (308)
T ss_dssp             CTTCCCGGGGG-GCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH---HHH---
T ss_pred             ecccceeccCC-cceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH---HHH---
Confidence            99999864322 2223334456899999999999999999999999999999999985 666654332221   111   


Q ss_pred             hccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhhhhhhh
Q 042763          490 YNEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRADSLKSV  551 (554)
Q Consensus       490 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~~~~~~  551 (554)
                       ..+....         .+..++..+.+++.+||+.+|++||||.+|+++|++......+++
T Consensus       249 -~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~  300 (308)
T d1p4oa_         249 -MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  300 (308)
T ss_dssp             -HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             -HhCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence             1111111         112334579999999999999999999999999988776655543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.3e-48  Score=390.14  Aligned_cols=268  Identities=22%  Similarity=0.318  Sum_probs=206.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEEe
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITEF  344 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  344 (554)
                      ++|+..++||+|+||+||+|+.++|+.||||+++.... +...+.+.+|+.+|++++||||+++++++..++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57889999999999999999988999999999876543 33356799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCCC
Q 042763          345 VPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSDR  424 (554)
Q Consensus       345 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~  424 (554)
                      +.++.+..+....  ..+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||++......   
T Consensus        82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~---  153 (286)
T d1ob3a_          82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP---  153 (286)
T ss_dssp             CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccC---
Confidence            9777666665433  67999999999999999999999   889999999999999999999999999999864322   


Q ss_pred             ccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcc---c---
Q 042763          425 THISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLL---D---  497 (554)
Q Consensus       425 ~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~---  497 (554)
                      ........|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.............   .   
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence            1223344689999999998754 57999999999999999999999998765433322222111111000000   0   


Q ss_pred             ------cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          498 ------MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       498 ------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                            ...+.............+.+++.+||+.||++|||++|+++|.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~  283 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY  283 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence                  00011111112234467889999999999999999999998865

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-48  Score=388.00  Aligned_cols=270  Identities=23%  Similarity=0.287  Sum_probs=203.9

Q ss_pred             hhcCCCcceeeeccCceEEEEEEEc-C-CcEEEEEEcchhhhh-hHHHHHHHHHHHHHhC---CCCCceeeeeEEEc---
Q 042763          264 ATRNFSPSLRIGEGGFGTVYKAQLE-D-GLLVAIKRAKKEQFE-NLQTEFSSEVELLSKI---DHRNLVKLLGFVDK---  334 (554)
Q Consensus       264 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~-g~~vAvK~~~~~~~~-~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~---  334 (554)
                      ..++|++.++||+|+||+||+|... + ++.||||+++..... .....+.+|+++|+.|   +||||+++++++..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            3478999999999999999999763 4 678999998754322 2223466777777665   79999999999853   


Q ss_pred             --CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEee
Q 042763          335 --GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADF  412 (554)
Q Consensus       335 --~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df  412 (554)
                        ....+++|||++++++.... ......+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             ccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecch
Confidence              34679999999776665443 344567899999999999999999999   899999999999999999999999999


Q ss_pred             cCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhcc
Q 042763          413 GFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE  492 (554)
Q Consensus       413 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  492 (554)
                      |+++...    .........||+.|||||++.+..|+.++||||+||++|||++|+.||......+....+.........
T Consensus       161 g~~~~~~----~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  236 (305)
T d1blxa_         161 GLARIYS----FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  236 (305)
T ss_dssp             CSCCCCC----GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             hhhhhhc----ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence            9997532    223345567999999999999999999999999999999999999999876544333332222111110


Q ss_pred             CCccc----------cCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          493 GNLLD----------MVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       493 ~~~~~----------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .....          .................+.+|+.+||+.||++|||+.|+++|.|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf  295 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  295 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence            00000          00000011122234466889999999999999999999999866

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=385.36  Aligned_cols=243  Identities=25%  Similarity=0.408  Sum_probs=199.8

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhh-----HHHHHHHHHHHHHhCC--CCCceeeeeEEEcCCc
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFEN-----LQTEFSSEVELLSKID--HRNLVKLLGFVDKGNE  337 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~-----~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~~~  337 (554)
                      ++|++.++||+|+||+||+|... +|+.||||++.+.....     ....+.+|+.++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999764 68999999987654321     1234678999999986  8999999999999999


Q ss_pred             eEEEEEeCCC-CCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC-CCcEEEEeecCc
Q 042763          338 RLIITEFVPN-GTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE-SMRAKVADFGFA  415 (554)
Q Consensus       338 ~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla  415 (554)
                      .++||||+.+ +++.+++..+  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++. ++.+||+|||+|
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence            9999999976 6888888655  57899999999999999999999   899999999999999985 579999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCcChhccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCC
Q 042763          416 RLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQL-TTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGN  494 (554)
Q Consensus       416 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  494 (554)
                      +....     .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....     . +.   .  ....
T Consensus       159 ~~~~~-----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~-i~---~--~~~~  222 (273)
T d1xwsa_         159 ALLKD-----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E-II---R--GQVF  222 (273)
T ss_dssp             EECCS-----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-HH---H--CCCC
T ss_pred             eeccc-----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H-Hh---h--cccC
Confidence            86432     12345679999999999988765 567899999999999999999997421     0 10   0  0000


Q ss_pred             ccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          495 LLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       495 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                                  .+..++.++.+++.+||+.||++|||++|+++|.|
T Consensus       223 ------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~  257 (273)
T d1xwsa_         223 ------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW  257 (273)
T ss_dssp             ------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             ------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence                        11123456889999999999999999999999876

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=391.19  Aligned_cols=270  Identities=22%  Similarity=0.304  Sum_probs=205.2

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC----ceE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN----ERL  339 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----~~~  339 (554)
                      +.+|+..++||+|+||+||+|.. .+|+.||||++++.......+.+.+|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999965 4799999999986655555678999999999999999999999986543    235


Q ss_pred             EEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCC
Q 042763          340 IITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGP  419 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~  419 (554)
                      ++++|+.+|+|.+++..+   .+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            555667799999999754   6899999999999999999999   8999999999999999999999999999998754


Q ss_pred             CCCCCccccccccCCCCCcChhccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCcccc
Q 042763          420 MDSDRTHISTKVKGTVGYLDPEYMK-TYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNLLDM  498 (554)
Q Consensus       420 ~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (554)
                      .............||+.|+|||++. +..++.++||||+||++|||++|+.||......+....................
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            4333333345567999999999984 456789999999999999999999999876543332222111100000000000


Q ss_pred             CC---------------hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          499 VD---------------PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       499 ~d---------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ..               ..... .......++.+++.+||+.||++|||+.|+++|.|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf  297 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY  297 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             hhhhhhcccccCCccCCCCHHH-hCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            00               00000 11123356889999999999999999999999865

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=379.77  Aligned_cols=272  Identities=19%  Similarity=0.264  Sum_probs=202.9

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc--------
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK--------  334 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--------  334 (554)
                      -++|++.++||+|+||+||+|... +|+.||||++..... +.....+.+|+++|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            368999999999999999999764 799999999865533 3344678899999999999999999998754        


Q ss_pred             CCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecC
Q 042763          335 GNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGF  414 (554)
Q Consensus       335 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl  414 (554)
                      ++..++||||++++.+..+...  ...+++.+++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecce
Confidence            3467999999977766554433  357889999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCCCC-CccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhcc
Q 042763          415 ARLGPMDSD-RTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNE  492 (554)
Q Consensus       415 a~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  492 (554)
                      ++....... ........+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...........+.........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            976543221 11223345799999999998765 6899999999999999999999999875544333333322211111


Q ss_pred             CCccccC--------------Chhhhhhcc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          493 GNLLDMV--------------DPSIKEVIS-MEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       493 ~~~~~~~--------------d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .......              ......... ......+.+|+.+||+.||++|||++|+++|.|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf  307 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF  307 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence            1111110              001111000 111345678999999999999999999999987

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-46  Score=383.09  Aligned_cols=263  Identities=23%  Similarity=0.291  Sum_probs=197.6

Q ss_pred             CCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC------CceE
Q 042763          267 NFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG------NERL  339 (554)
Q Consensus       267 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~------~~~~  339 (554)
                      +|...++||+|+||+||+|+.. +|+.||||++....     ....+|+++|++++||||+++++++...      ...+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            5777889999999999999875 69999999997653     2234799999999999999999998543      3468


Q ss_pred             EEEEeCCCCCHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC-cEEEEeecCccc
Q 042763          340 IITEFVPNGTLREHLDG-QYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARL  417 (554)
Q Consensus       340 lv~E~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~  417 (554)
                      +|||||+++.+..+... .....+++.+++.++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+++.
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            99999976544433322 23457999999999999999999999   99999999999999999775 899999999986


Q ss_pred             CCCCCCCccccccccCCCCCcChhcccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH--------H
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKT-YQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAF--------K  488 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~--------~  488 (554)
                      ....    .......||+.|+|||.+.+ ..|+.++||||+||++|||++|+.||......+....+....        .
T Consensus       173 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         173 LVRG----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             CCTT----SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccCC----cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            4322    22334579999999998765 578999999999999999999999998765433322221110        0


Q ss_pred             hh----ccCCccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          489 RY----NEGNLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       489 ~~----~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ..    .......................++.+|+.+||+.||++|||+.|+++|.|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  305 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF  305 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            00    011111111111111222334567899999999999999999999999855

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=368.83  Aligned_cols=268  Identities=20%  Similarity=0.293  Sum_probs=208.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCCceEEEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGNERLIITE  343 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  343 (554)
                      ++|++.++||+|+||+||+|+.. +|+.||||+++.... +.....+.+|+.+|++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57899999999999999999764 689999999865543 3456789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcccCCCCCC
Q 042763          344 FVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARLGPMDSD  423 (554)
Q Consensus       344 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~  423 (554)
                      ++.+++|..++...  +.+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||.++...... 
T Consensus        82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-  155 (292)
T d1unla_          82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-  155 (292)
T ss_dssp             CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-
T ss_pred             eccccccccccccc--cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCC-
Confidence            99999888887644  67899999999999999999999   8999999999999999999999999999998754322 


Q ss_pred             CccccccccCCCCCcChhccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHH-HHHHHHhhccCCc---ccc
Q 042763          424 RTHISTKVKGTVGYLDPEYMKTYQ-LTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVT-LRWAFKRYNEGNL---LDM  498 (554)
Q Consensus       424 ~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~  498 (554)
                        .......+++.|+|||++.... ++.++|||||||++|||++|+.||.......+... +............   ...
T Consensus       156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             --ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence              2223345788999999987654 69999999999999999999999865544333221 1111111000000   000


Q ss_pred             CC---------hhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          499 VD---------PSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       499 ~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      .+         ..............+.+++.+||+.||++|||++|+++|.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~  285 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY  285 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence            00         00001112233456889999999999999999999999865

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-46  Score=381.55  Aligned_cols=263  Identities=21%  Similarity=0.286  Sum_probs=198.7

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcCC------
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKGN------  336 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------  336 (554)
                      .++|++.++||+|+||+||+|... +|+.||||+++.... +...+.+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999764 699999999976432 344567899999999999999999999997654      


Q ss_pred             ceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCcc
Q 042763          337 ERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFAR  416 (554)
Q Consensus       337 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~  416 (554)
                      +.++||||| +.+|..+++..   .+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+|++|||+|+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccccee
Confidence            569999999 67888877543   6999999999999999999999   8999999999999999999999999999998


Q ss_pred             cCCCCCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC--
Q 042763          417 LGPMDSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG--  493 (554)
Q Consensus       417 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--  493 (554)
                      ....      ..+...||+.|+|||++.+. .++.++||||+||++|||++|+.||......................  
T Consensus       170 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         170 QADS------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             ECCS------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccCC------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            6432      12345799999999998764 57899999999999999999999998765433222211111000000  


Q ss_pred             -------------CccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          494 -------------NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       494 -------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                                   ...+.....+.. ........+.+|+.+||+.||++|||+.|+++|.|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~  303 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY  303 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             hhhcchhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence                         000000001111 11223456789999999999999999999999854

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.1e-45  Score=364.14  Aligned_cols=265  Identities=16%  Similarity=0.256  Sum_probs=212.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCC-CCceeeeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH-RNLVKLLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~~lv~  342 (554)
                      .++|++.++||+|+||+||+|+.. +|+.||||++.....   ...+.+|++.++.++| +|++.+++++.++...++||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            468999999999999999999765 689999998865432   2357788999999975 89999999999999999999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC-----CCcEEEEeecCccc
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE-----SMRAKVADFGFARL  417 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~-----~~~vkl~DfGla~~  417 (554)
                      ||+ +++|.+++... ...+++.++..++.|++.||+|||   +++|+||||||+|||++.     ++.+||+|||+|+.
T Consensus        81 e~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          81 DLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             Eec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            999 79999988654 457899999999999999999999   999999999999999974     57899999999987


Q ss_pred             CCCCCCCc----cccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC
Q 042763          418 GPMDSDRT----HISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG  493 (554)
Q Consensus       418 ~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  493 (554)
                      ........    .......||+.|||||++.+..++.++|||||||++|||+||+.||......................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            54322211    22334679999999999999999999999999999999999999998766554433333222111111


Q ss_pred             CccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhhh
Q 042763          494 NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRAD  546 (554)
Q Consensus       494 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~~  546 (554)
                      ..     +.    ....++.++.+++..|++.+|++||+++.+.+.+.++-..
T Consensus       236 ~~-----~~----l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~  279 (293)
T d1csna_         236 PL-----RE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  279 (293)
T ss_dssp             CH-----HH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             Ch-----HH----hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence            00     01    1122345688999999999999999999999888876543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.6e-45  Score=366.01  Aligned_cols=264  Identities=17%  Similarity=0.237  Sum_probs=201.4

Q ss_pred             hcCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCcee-eeeEEEcCCceEEEE
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNLVK-LLGFVDKGNERLIIT  342 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~-l~~~~~~~~~~~lv~  342 (554)
                      .++|++.++||+|+||+||+|... +|+.||||++.....   ..++..|++++++++|+|++. +.+++.+++..++||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            357999999999999999999764 689999998876432   245788999999998776555 555567788889999


Q ss_pred             EeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECC---CCcEEEEeecCcccCC
Q 042763          343 EFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTE---SMRAKVADFGFARLGP  419 (554)
Q Consensus       343 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~DfGla~~~~  419 (554)
                      ||+ +++|.+.+... ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.   +..+||+|||+|+...
T Consensus        83 e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          83 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            999 66777766543 357899999999999999999999   899999999999999864   5579999999998754


Q ss_pred             CCCCC----ccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          420 MDSDR----THISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       420 ~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      .....    ........||+.|||||++.+..++.++|||||||++|||+||+.||....................... 
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-  236 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-  236 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-
Confidence            32221    1223456799999999999999999999999999999999999999987655433332222111100000 


Q ss_pred             cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhh
Q 042763          496 LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWAIRA  545 (554)
Q Consensus       496 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~i~~  545 (554)
                          .+.    ....++..+.+++.+||+.+|++||++.++.+.|+.+..
T Consensus       237 ----~~~----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         237 ----IEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             ----HHH----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             ----hhH----hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence                001    112344668999999999999999999999888877643

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.4e-45  Score=370.42  Aligned_cols=260  Identities=17%  Similarity=0.281  Sum_probs=199.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEc--CCceEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDK--GNERLII  341 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~--~~~~~lv  341 (554)
                      ++|++.++||+|+||+||+|+.. +|+.||||+++...    .+.+.+|+++|++++ ||||+++++++..  ....++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            57999999999999999999764 69999999987643    356889999999995 9999999999874  3568999


Q ss_pred             EEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC-cEEEEeecCcccCCC
Q 042763          342 TEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM-RAKVADFGFARLGPM  420 (554)
Q Consensus       342 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~~~  420 (554)
                      ||||++++|..+.     +.+++.+++.++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|+....
T Consensus       111 ~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         111 FEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             EeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccC
Confidence            9999999997764     36899999999999999999999   89999999999999998654 699999999987432


Q ss_pred             CCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHH-HHHH---------HHh
Q 042763          421 DSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVT-LRWA---------FKR  489 (554)
Q Consensus       421 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~-~~~~---------~~~  489 (554)
                      .    .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........... +...         ...
T Consensus       183 ~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         183 G----QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             T----CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             C----CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            2    123445789999999998765 579999999999999999999999986654322111 1000         000


Q ss_pred             hccC---CccccCC----hh----hhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 042763          490 YNEG---NLLDMVD----PS----IKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLW  541 (554)
Q Consensus       490 ~~~~---~~~~~~d----~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~  541 (554)
                      ....   .......    ..    ........+..++.+|+.+||+.||++|||++|+++|.|
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  321 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  321 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            0000   0000000    00    000011223456889999999999999999999998765

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=373.98  Aligned_cols=256  Identities=23%  Similarity=0.328  Sum_probs=207.7

Q ss_pred             cCCCcceeeeccCceEEEEEEEc----CCcEEEEEEcchhhh---hhHHHHHHHHHHHHHhCCC-CCceeeeeEEEcCCc
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE----DGLLVAIKRAKKEQF---ENLQTEFSSEVELLSKIDH-RNLVKLLGFVDKGNE  337 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~---~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~  337 (554)
                      ++|++.++||+|+||+||+|...    +|+.||||++++...   ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999652    488999999875432   2234568899999999976 899999999999999


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .+++|||+.+|+|.+++...  ..+.+..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            99999999999999999766  46788999999999999999999   89999999999999999999999999999986


Q ss_pred             CCCCCCCccccccccCCCCCcChhccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccCCc
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKTY--QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEGNL  495 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  495 (554)
                      ...  ..........|++.|+|||.+.+.  .++.++|||||||+||||++|+.||...........+......... . 
T Consensus       179 ~~~--~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~-~-  254 (322)
T d1vzoa_         179 FVA--DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-P-  254 (322)
T ss_dssp             CCG--GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC-C-
T ss_pred             hcc--cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC-C-
Confidence            432  222333456799999999998754  4788999999999999999999999876654443333222111111 0 


Q ss_pred             cccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHH
Q 042763          496 LDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRP-----DMKSVGEQLW  541 (554)
Q Consensus       496 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~  541 (554)
                                 .+..++..+.+++.+||+.||++||     |++|+++|.|
T Consensus       255 -----------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf  294 (322)
T d1vzoa_         255 -----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  294 (322)
T ss_dssp             -----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             -----------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence                       1223456788999999999999999     5899999876

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=371.27  Aligned_cols=265  Identities=19%  Similarity=0.226  Sum_probs=195.9

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEc------CCc
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDK------GNE  337 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~------~~~  337 (554)
                      ++|++.++||+|+||+||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999765 699999999976543 2334678999999999999999999999853      367


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .|+|||||.+ ++.+.+.    ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+|++|||+++.
T Consensus        97 ~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhc
Confidence            8999999965 5555553    35899999999999999999999   89999999999999999999999999999886


Q ss_pred             CCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH---------
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFK---------  488 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~---------  488 (554)
                      ..    .........+|+.|+|||++.+..+++++||||+||++|||++|+.||.+.+.......+.....         
T Consensus       169 ~~----~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         169 AG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cc----cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            32    22334456799999999999999999999999999999999999999986653322221110000         


Q ss_pred             ------h--hccCCcc-----ccCChhhh---hhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          489 ------R--YNEGNLL-----DMVDPSIK---EVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       489 ------~--~~~~~~~-----~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                            .  .......     ........   ..........+.+|+.+||+.||++|||++|+++|.|-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~  314 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI  314 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence                  0  0000000     00000000   01123456788999999999999999999999999764

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-45  Score=373.97  Aligned_cols=265  Identities=22%  Similarity=0.286  Sum_probs=201.0

Q ss_pred             hcCCCcceeeeccCceEEEEEEE-cCCcEEEEEEcchhhh-hhHHHHHHHHHHHHHhCCCCCceeeeeEEEcC-----Cc
Q 042763          265 TRNFSPSLRIGEGGFGTVYKAQL-EDGLLVAIKRAKKEQF-ENLQTEFSSEVELLSKIDHRNLVKLLGFVDKG-----NE  337 (554)
Q Consensus       265 ~~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~  337 (554)
                      +++|++.++||+|+||+||+|.. .+|+.||||+++.... ....+.+.+|+++|++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            57899999999999999999976 4799999999976543 23346788999999999999999999998533     33


Q ss_pred             eEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          338 RLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       338 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .+++|+|+.+|+|.+++..+   .+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+|++|||++..
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcc
Confidence            46667778899999999654   6999999999999999999999   89999999999999999999999999999975


Q ss_pred             CCCCCCCccccccccCCCCCcChhccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHhhccC---
Q 042763          418 GPMDSDRTHISTKVKGTVGYLDPEYMKTY-QLTTKSDVYSFGVLLLEILTGRRPVELKRPPEERVTLRWAFKRYNEG---  493 (554)
Q Consensus       418 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---  493 (554)
                      ..      .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+..........   
T Consensus       171 ~~------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         171 TD------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CT------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             cC------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            32      223445789999999987665 56899999999999999999999998765443332222111100000   


Q ss_pred             ------------CccccCChhhhhhccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 042763          494 ------------NLLDMVDPSIKEVISMEILTKMFGLAIQCAAPIRNDRPDMKSVGEQLWA  542 (554)
Q Consensus       494 ------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~  542 (554)
                                  .........+.. ........+.+|+.+||+.||++|||+.|+++|.|-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f  304 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF  304 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             hccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhh
Confidence                        000000001110 011234567899999999999999999999998764

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-39  Score=333.05  Aligned_cols=267  Identities=21%  Similarity=0.262  Sum_probs=194.3

Q ss_pred             cCCCcceeeeccCceEEEEEEEc-CCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-----------CCCceeeeeEEE
Q 042763          266 RNFSPSLRIGEGGFGTVYKAQLE-DGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-----------HRNLVKLLGFVD  333 (554)
Q Consensus       266 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-----------HpnIv~l~~~~~  333 (554)
                      .+|++.++||+|+||+||+|+.. +|+.||||+++....  ..+.+.+|+.++++++           |+||+++++++.
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            35999999999999999999764 799999999986532  2356788998888775           578999998875


Q ss_pred             c--CCceEEEEEeCCCCC-HHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCC-----
Q 042763          334 K--GNERLIITEFVPNGT-LREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESM-----  405 (554)
Q Consensus       334 ~--~~~~~lv~E~~~~g~-L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-----  405 (554)
                      .  ....+++|+++..+. ............+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++     
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccc
Confidence            4  345667777665554 3444444445688999999999999999999993  48999999999999998665     


Q ss_pred             -cEEEEeecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCChhh---HH
Q 042763          406 -RAKVADFGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLLEILTGRRPVELKRPPEE---RV  481 (554)
Q Consensus       406 -~vkl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~elltg~~P~~~~~~~~~---~~  481 (554)
                       .++++|||.+.....      ......||+.|+|||++.+..++.++||||+||+++||++|+.||........   ..
T Consensus       169 ~~~kl~dfg~s~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             EEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             ceeeEeeccccccccc------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence             399999999976322      22345799999999999999999999999999999999999999975432211   11


Q ss_pred             HHHHHHHhhcc------------------CCccccC----C-h-----hhhhhccHHHHHHHHHHHHHccCCCCCCCCCH
Q 042763          482 TLRWAFKRYNE------------------GNLLDMV----D-P-----SIKEVISMEILTKMFGLAIQCAAPIRNDRPDM  533 (554)
Q Consensus       482 ~~~~~~~~~~~------------------~~~~~~~----d-~-----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  533 (554)
                      .+.........                  .......    . +     .............+.+|+.+||+.||++|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            11111110000                  0000000    0 0     00112345667889999999999999999999


Q ss_pred             HHHHHHHHH
Q 042763          534 KSVGEQLWA  542 (554)
Q Consensus       534 ~evl~~l~~  542 (554)
                      +|+++|.|-
T Consensus       323 ~e~L~Hp~f  331 (362)
T d1q8ya_         323 GGLVNHPWL  331 (362)
T ss_dssp             HHHHTCGGG
T ss_pred             HHHhcCccc
Confidence            999998763

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=1e-24  Score=202.87  Aligned_cols=171  Identities=17%  Similarity=0.156  Sum_probs=121.3

Q ss_pred             CcceeeeccCceEEEEEEEcCCcEEEEEEcchhhh-----------------hhHHHHHHHHHHHHHhCCCCCceeeeeE
Q 042763          269 SPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQF-----------------ENLQTEFSSEVELLSKIDHRNLVKLLGF  331 (554)
Q Consensus       269 ~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-----------------~~~~~~~~~Ei~~l~~l~HpnIv~l~~~  331 (554)
                      .+.++||+|+||+||+|...+|+.||||+++....                 .........|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            34678999999999999988899999998653211                 0112345678899999999999988865


Q ss_pred             EEcCCceEEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEeCCCCCCCeEECCCCcEEEEe
Q 042763          332 VDKGNERLIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYAEKQIIHRDVKSSNILLTESMRAKVAD  411 (554)
Q Consensus       332 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~D  411 (554)
                      .    ..+++|||+++..+.         .++......++.|++.+|+|||   +++|+||||||+|||++++ .++|+|
T Consensus        83 ~----~~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          83 E----GNAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             E----TTEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECC
T ss_pred             c----CCEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEE
Confidence            3    237999999876543         2455567789999999999999   8999999999999999965 489999


Q ss_pred             ecCcccCCCCCCCccccccccCCCCCcChhccccCCCCchhhHHHHHHHHH
Q 042763          412 FGFARLGPMDSDRTHISTKVKGTVGYLDPEYMKTYQLTTKSDVYSFGVLLL  462 (554)
Q Consensus       412 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvil~  462 (554)
                      ||+|..................     -.|.+ .+.|+.++|+||+.--+.
T Consensus       146 FG~a~~~~~~~~~~~l~rd~~~-----~~~~f-~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         146 FPQSVEVGEEGWREILERDVRN-----IITYF-SRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CTTCEETTSTTHHHHHHHHHHH-----HHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred             CCCcccCCCCCcHHHHHHHHHH-----HHHHH-cCCCCCcccHHHHHHHHh
Confidence            9999753211110000000000     01111 246788999999865443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.48  E-value=2.9e-07  Score=87.30  Aligned_cols=149  Identities=15%  Similarity=0.112  Sum_probs=100.4

Q ss_pred             HHHHhhcCCCcceeeeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCce
Q 042763          260 QVVKATRNFSPSLRIGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNER  338 (554)
Q Consensus       260 ~l~~~~~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~  338 (554)
                      ++......|...+..+-++.+.||+.... +..+++|+....... ....+.+|...+..+. +--+.+++.+...++..
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            45555567766665544556789998754 566788887655322 1234677888887774 33367788888888889


Q ss_pred             EEEEEeCCCCCHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhhcc---------------------------------
Q 042763          339 LIITEFVPNGTLREHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHLYA---------------------------------  385 (554)
Q Consensus       339 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------  385 (554)
                      ++||+++++.++.+.....       .....++.+++..+..||...                                 
T Consensus        86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            9999999998886543211       112234555555555565310                                 


Q ss_pred             -----------------------CCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          386 -----------------------EKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       386 -----------------------~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                                             ...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                   11279999999999999876677999998864

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.11  E-value=1.7e-06  Score=81.28  Aligned_cols=130  Identities=18%  Similarity=0.182  Sum_probs=85.3

Q ss_pred             eeccC-ceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCC--CCceeeeeEEEcCCceEEEEEeCCCCCH
Q 042763          274 IGEGG-FGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH--RNLVKLLGFVDKGNERLIITEFVPNGTL  350 (554)
Q Consensus       274 LG~G~-fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~~~~lv~E~~~~g~L  350 (554)
                      +..|. -+.||+....++..+++|.......    ..+..|...++.+..  -.+.+++++..+++..++||+|++|.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            44554 3689999888888889998765532    246677787777642  3366788888888889999999987665


Q ss_pred             HHHHhcccCCCCCHHHHHHHHHHHHHHHHHhhh-----------------------------------------------
Q 042763          351 REHLDGQYGKTLDFNQRLEIAIDVAHGLTYLHL-----------------------------------------------  383 (554)
Q Consensus       351 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-----------------------------------------------  383 (554)
                      .+..       ..   ....+.++...|.-||.                                               
T Consensus        94 ~~~~-------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          94 LSSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             TTSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             cccc-------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            3311       00   00111222222222221                                               


Q ss_pred             ----c----cCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          384 ----Y----AEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       384 ----~----~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                          .    ....++|+|+.|.|||++++..+-|+||+.+..
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                0    112389999999999999877678999998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.77  E-value=2.8e-05  Score=78.02  Aligned_cols=77  Identities=14%  Similarity=0.136  Sum_probs=48.2

Q ss_pred             ceeeeccCceEEEEEEEcC-CcEEEEEEcchhh------hhhHHHHHHHHHHHHHhCC-C--CCceeeeeEEEcCCceEE
Q 042763          271 SLRIGEGGFGTVYKAQLED-GLLVAIKRAKKEQ------FENLQTEFSSEVELLSKID-H--RNLVKLLGFVDKGNERLI  340 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~------~~~~~~~~~~Ei~~l~~l~-H--pnIv~l~~~~~~~~~~~l  340 (554)
                      .+.||.|....||++...+ ++.++||...+..      ......+...|.+.|+.+. +  ..+.+++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4468999999999997654 6789999654321      1111234556888887662 2  235555544  3456689


Q ss_pred             EEEeCCCCC
Q 042763          341 ITEFVPNGT  349 (554)
Q Consensus       341 v~E~~~~g~  349 (554)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=97.26  E-value=1.6e-05  Score=77.02  Aligned_cols=42  Identities=14%  Similarity=0.126  Sum_probs=39.7

Q ss_pred             CCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCC
Q 042763           66 GADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGS  113 (554)
Q Consensus        66 ~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~  113 (554)
                      ...+|++++|+      ++|.+|+.++.|++|+.|++++|+++|.+|.
T Consensus       245 ~L~~L~Ls~N~------l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~  286 (313)
T d1ogqa_         245 NLNGLDLRNNR------IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ  286 (313)
T ss_dssp             TCCEEECCSSC------CEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred             ccccccCccCe------ecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence            46899999999      9999999999999999999999999999985

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.13  E-value=0.00075  Score=65.36  Aligned_cols=137  Identities=15%  Similarity=0.125  Sum_probs=78.7

Q ss_pred             cCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCCCCc-----eeee--eEEEcCCceEEEEEeCCCCC
Q 042763          277 GGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDHRNL-----VKLL--GFVDKGNERLIITEFVPNGT  349 (554)
Q Consensus       277 G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-----v~l~--~~~~~~~~~~lv~E~~~~g~  349 (554)
                      +.--.||+++.++|..|++|+.++....  .+++..|...+..|...++     +..-  ..+..++..+.++++++|..
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s--~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             cccceeEEEEcCCCCEEEEEEeCCCCCC--HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            3456899999999999999998775322  3567778888877742221     1111  12345567788999986543


Q ss_pred             H-----HHHH---------hc----cc---CCCCCH-------------------HHHHHHHHHHHHHHHHhhh----cc
Q 042763          350 L-----REHL---------DG----QY---GKTLDF-------------------NQRLEIAIDVAHGLTYLHL----YA  385 (554)
Q Consensus       350 L-----~~~l---------~~----~~---~~~l~~-------------------~~~~~i~~qi~~~L~~LH~----~~  385 (554)
                      +     ..+.         +.    ..   ....++                   .....+...+...++.+..    ..
T Consensus       111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~  190 (325)
T d1zyla1         111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF  190 (325)
T ss_dssp             CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred             CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence            2     1111         00    00   011111                   1111122222222333321    12


Q ss_pred             CCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          386 EKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       386 ~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      ..+++|+|+.+.|||++++  ..++||+-+..
T Consensus       191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            4578999999999999754  45899998875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.69  E-value=0.0058  Score=58.28  Aligned_cols=158  Identities=12%  Similarity=0.044  Sum_probs=84.3

Q ss_pred             cChHHHHHhhcCCCccee-----eeccCceEEEEEEEcCCcEEEEEEcchhhhhhHHHHHHHHHHHHHhCCC-----CCc
Q 042763          256 LNMSQVVKATRNFSPSLR-----IGEGGFGTVYKAQLEDGLLVAIKRAKKEQFENLQTEFSSEVELLSKIDH-----RNL  325 (554)
Q Consensus       256 ~~~~~l~~~~~~f~~~~~-----LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~H-----pnI  325 (554)
                      ++.+++.....+|...+.     |..|---+.|+.+..+|+ +++|+......   .+++..|++++..|..     |..
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC---HHHHHHHHHHHHhhhhcccccccc
Confidence            455677777777766433     456777889999887665 88998765422   2345556677776632     222


Q ss_pred             eeee-e--EEEcCCceEEEEEeCCCCCHHHH--------------Hhc----ccC-C--------------------CCC
Q 042763          326 VKLL-G--FVDKGNERLIITEFVPNGTLREH--------------LDG----QYG-K--------------------TLD  363 (554)
Q Consensus       326 v~l~-~--~~~~~~~~~lv~E~~~~g~L~~~--------------l~~----~~~-~--------------------~l~  363 (554)
                      +... |  +.........++.+..+......              ++.    ... .                    ...
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            2211 1  12233455667777655432110              000    000 0                    000


Q ss_pred             HHHHHHHHHHHHHHHHHhhh-ccCCCeEeCCCCCCCeEECCCCcEEEEeecCccc
Q 042763          364 FNQRLEIAIDVAHGLTYLHL-YAEKQIIHRDVKSSNILLTESMRAKVADFGFARL  417 (554)
Q Consensus       364 ~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~  417 (554)
                      .......+..+...+...+. ....+++|+|+.++||+++.+...-|.||+.+..
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            11111222222333333321 1256799999999999999887778999998863

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=96.57  E-value=0.00021  Score=68.68  Aligned_cols=65  Identities=12%  Similarity=0.200  Sum_probs=53.2

Q ss_pred             EEeeecCCCcccccCCc---hhHHHHHHHhhhhhhccceeeccccCCCceeecc-CCcceeEEEcCccccchhhhhhhhh
Q 042763           24 SIFLPRESSLDISSNFA---PSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSN-SNEVELFYINGNLVDKFSFCKVIQF   99 (554)
Q Consensus        24 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~-n~~~~~~~~~G~~p~~~~~~~~l~~   99 (554)
                      -++.++|++++++|-+.   .+.-|..                   +.+|++++ |+      ++|.+|+.++.|++|+.
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~-------------------L~~L~Ls~~N~------l~g~iP~~i~~L~~L~~  105 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPY-------------------LNFLYIGGINN------LVGPIPPAIAKLTQLHY  105 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTT-------------------CSEEEEEEETT------EESCCCGGGGGCTTCSE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCcc-------------------ccccccccccc------cccccccccccccccch
Confidence            36788999999999643   2333333                   59999995 99      99999999999999999


Q ss_pred             hhccCceeecccCC
Q 042763          100 HYANHCIFEGYSGS  113 (554)
Q Consensus       100 l~~~~n~~~g~~~~  113 (554)
                      |++++|++++..+.
T Consensus       106 L~Ls~N~l~~~~~~  119 (313)
T d1ogqa_         106 LYITHTNVSGAIPD  119 (313)
T ss_dssp             EEEEEECCEEECCG
T ss_pred             hhhccccccccccc
Confidence            99999999986664

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.47  E-value=0.0041  Score=61.60  Aligned_cols=73  Identities=18%  Similarity=0.241  Sum_probs=48.2

Q ss_pred             ceeeeccCceEEEEEEEcCC--------cEEEEEEcchhhhhhHHHHHHHHHHHHHhCC-CCCceeeeeEEEcCCceEEE
Q 042763          271 SLRIGEGGFGTVYKAQLEDG--------LLVAIKRAKKEQFENLQTEFSSEVELLSKID-HRNLVKLLGFVDKGNERLII  341 (554)
Q Consensus       271 ~~~LG~G~fG~Vy~a~~~~g--------~~vAvK~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv  341 (554)
                      ++.|+.|-.-.+|++...++        +.|.+++.-..  .. .....+|..+++.+. +.-..++++++.+    .+|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            35688899999999987543        45666665422  11 234557888888874 4334567777643    689


Q ss_pred             EEeCCCCCH
Q 042763          342 TEFVPNGTL  350 (554)
Q Consensus       342 ~E~~~~g~L  350 (554)
                      |||+++..+
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999976543

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=96.38  E-value=0.00067  Score=55.84  Aligned_cols=55  Identities=15%  Similarity=0.225  Sum_probs=47.3

Q ss_pred             ecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCcee
Q 042763           28 PRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIF  107 (554)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~  107 (554)
                      +++|.|+|+ .+.++..+..+                   .+|++++|.      ++ .+|+.++.|++|+.|++++|.+
T Consensus         3 L~Ls~n~l~-~l~~l~~l~~L-------------------~~L~ls~N~------l~-~lp~~~~~l~~L~~L~l~~N~i   55 (124)
T d1dcea3           3 LHLAHKDLT-VLCHLEQLLLV-------------------THLDLSHNR------LR-ALPPALAALRCLEVLQASDNAL   55 (124)
T ss_dssp             EECTTSCCS-SCCCGGGGTTC-------------------CEEECCSSC------CC-CCCGGGGGCTTCCEEECCSSCC
T ss_pred             EEcCCCCCC-CCcccccCCCC-------------------CEEECCCCc------cC-cchhhhhhhhcccccccccccc
Confidence            578999997 66666666655                   999999999      87 5898999999999999999999


Q ss_pred             ec
Q 042763          108 EG  109 (554)
Q Consensus       108 ~g  109 (554)
                      ++
T Consensus        56 ~~   57 (124)
T d1dcea3          56 EN   57 (124)
T ss_dssp             CC
T ss_pred             cc
Confidence            85

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=94.48  E-value=0.0045  Score=54.60  Aligned_cols=60  Identities=10%  Similarity=-0.023  Sum_probs=43.8

Q ss_pred             EeeecCCCcccccCCchhHH--HHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhc
Q 042763           25 IFLPRESSLDISSNFAPSSF--LLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYA  102 (554)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~  102 (554)
                      +..+++|+|+|++.+.+...  +..                   ..+|++++|+      +++..+..|..+++|++|++
T Consensus        31 l~~L~Ls~N~i~~~~~~~~f~~l~~-------------------L~~L~L~~N~------i~~~~~~~~~~~~~L~~L~L   85 (192)
T d1w8aa_          31 TTELLLNDNELGRISSDGLFGRLPH-------------------LVKLELKRNQ------LTGIEPNAFEGASHIQELQL   85 (192)
T ss_dssp             CSEEECCSCCCCSBCCSCSGGGCTT-------------------CCEEECCSSC------CCCBCTTTTTTCTTCCEEEC
T ss_pred             CCEEEeCCCCCcccccccccCCCce-------------------Eeeeeccccc------cccccccccccccccceeee
Confidence            44578999999876644332  222                   4778888888      88777888888888888888


Q ss_pred             cCceeec
Q 042763          103 NHCIFEG  109 (554)
Q Consensus       103 ~~n~~~g  109 (554)
                      ++|++++
T Consensus        86 s~N~l~~   92 (192)
T d1w8aa_          86 GENKIKE   92 (192)
T ss_dssp             CSCCCCE
T ss_pred             ccccccc
Confidence            8888773

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=94.14  E-value=0.0072  Score=53.17  Aligned_cols=40  Identities=5%  Similarity=-0.012  Sum_probs=30.4

Q ss_pred             CCceeeccCCcceeEEEcCccc-cchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLV-DKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p-~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|+|++|+      +++.++ ..|+.+++|+.|++++|++++-.+
T Consensus        31 l~~L~Ls~N~------i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~   71 (192)
T d1w8aa_          31 TTELLLNDNE------LGRISSDGLFGRLPHLVKLELKRNQLTGIEP   71 (192)
T ss_dssp             CSEEECCSCC------CCSBCCSCSGGGCTTCCEEECCSSCCCCBCT
T ss_pred             CCEEEeCCCC------CcccccccccCCCceEeeeeccccccccccc
Confidence            4778888888      887654 677888888888888888875443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.81  E-value=0.018  Score=53.18  Aligned_cols=43  Identities=5%  Similarity=0.006  Sum_probs=35.5

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCCCcc
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDYC  116 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~~~~  116 (554)
                      ..+|++++|+      +++..|..|..+++|+.|++++|+++ ++|.+..
T Consensus       150 l~~l~l~~N~------l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~  192 (266)
T d1p9ag_         150 LEKLSLANNN------LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF  192 (266)
T ss_dssp             CCEEECTTSC------CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTT
T ss_pred             chhccccccc------ccccCccccccccccceeecccCCCc-ccChhHC
Confidence            5778888888      88877788888999999999999988 7775543

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=91.45  E-value=0.025  Score=54.66  Aligned_cols=38  Identities=11%  Similarity=0.218  Sum_probs=23.7

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ...|++++|+      +++ +| .++.|++|+.|++++|++++-.|
T Consensus       331 L~~L~L~~n~------l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~  368 (384)
T d2omza2         331 LQRLFFANNK------VSD-VS-SLANLTNINWLSAGHNQISDLTP  368 (384)
T ss_dssp             CCEEECCSSC------CCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred             CCEEECCCCC------CCC-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence            3667777666      654 33 46667777777777777665433

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.60  E-value=0.011  Score=50.57  Aligned_cols=35  Identities=23%  Similarity=0.344  Sum_probs=29.3

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      .++|++|+|+      ++ .+ +.|+.|++|+.|++++|+++.
T Consensus        43 L~~L~Ls~N~------i~-~l-~~~~~l~~L~~L~ls~N~i~~   77 (162)
T d1a9na_          43 FDAIDFSDNE------IR-KL-DGFPLLRRLKTLLVNNNRICR   77 (162)
T ss_dssp             CSEEECCSSC------CC-EE-CCCCCCSSCCEEECCSSCCCE
T ss_pred             CCEEECCCCC------CC-cc-CCcccCcchhhhhcccccccC
Confidence            5899999998      65 34 358889999999999999985

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.34  E-value=0.027  Score=47.99  Aligned_cols=36  Identities=6%  Similarity=-0.208  Sum_probs=18.1

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceee
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFE  108 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~  108 (554)
                      ..+|++++|.      ++..-+..+..|++|+.|++++|+++
T Consensus        65 L~~L~ls~N~------i~~l~~~~~~~l~~L~~L~L~~N~i~  100 (162)
T d1a9na_          65 LKTLLVNNNR------ICRIGEGLDQALPDLTELILTNNSLV  100 (162)
T ss_dssp             CCEEECCSSC------CCEECSCHHHHCTTCCEEECCSCCCC
T ss_pred             hhhhhccccc------ccCCCccccccccccccceecccccc
Confidence            4455555555      44433333445555555555555554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=89.77  E-value=0.026  Score=49.83  Aligned_cols=34  Identities=18%  Similarity=0.284  Sum_probs=18.7

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceee
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFE  108 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~  108 (554)
                      ..+|++++|+      ++ .++ .+..|++|+.|++++|.++
T Consensus        50 L~~L~Ls~n~------I~-~i~-~l~~l~~L~~L~Ls~N~i~   83 (198)
T d1m9la_          50 CKHLALSTNN------IE-KIS-SLSGMENLRILSLGRNLIK   83 (198)
T ss_dssp             CCEEECSEEE------ES-CCC-CHHHHTTCCEEECCEEEEC
T ss_pred             cceeECcccC------CC-Ccc-cccCCccccChhhcccccc
Confidence            3556666555      54 333 3555666666666666554

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.16  E-value=0.043  Score=50.94  Aligned_cols=40  Identities=8%  Similarity=-0.031  Sum_probs=29.1

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|+      +++-.|..|..+++|+.+++++|++++-.|
T Consensus       155 L~~L~l~~N~------l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~  194 (284)
T d1ozna_         155 LTHLFLHGNR------ISSVPERAFRGLHSLDRLLLHQNRVAHVHP  194 (284)
T ss_dssp             CCEEECCSSC------CCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             hhhcccccCc------ccccchhhhccccccchhhhhhccccccCh
Confidence            5677777777      776666777777777777777777775444

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=87.22  E-value=0.063  Score=49.33  Aligned_cols=37  Identities=8%  Similarity=0.162  Sum_probs=33.3

Q ss_pred             cCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceee
Q 042763           65 CGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFE  108 (554)
Q Consensus        65 ~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~  108 (554)
                      -...+|+|++|+      |+ .+|+.+..+++|+.|++++|.+.
T Consensus       172 ~~L~~L~Ls~N~------L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         172 ENLDTLLLQENS------LY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             TTCCEEECCSSC------CC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             cccceeecccCC------Cc-ccChhHCCCCCCCEEEecCCCCC
Confidence            346899999999      99 89999999999999999999765

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=86.53  E-value=0.03  Score=52.56  Aligned_cols=39  Identities=8%  Similarity=-0.091  Sum_probs=28.0

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|+      +++..|..+.+|++|++|++++|+++ .+|
T Consensus       197 l~~L~~s~n~------l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp  235 (305)
T d1xkua_         197 LAKLGLSFNS------ISAVDNGSLANTPHLRELHLNNNKLV-KVP  235 (305)
T ss_dssp             CCEEECCSSC------CCEECTTTGGGSTTCCEEECCSSCCS-SCC
T ss_pred             cccccccccc------ccccccccccccccceeeeccccccc-ccc
Confidence            4567777777      77766777777777777777777776 444

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=86.53  E-value=0.11  Score=43.52  Aligned_cols=42  Identities=12%  Similarity=0.029  Sum_probs=32.0

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccCCCc
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSGSDY  115 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~~~~  115 (554)
                      ...|++++|+      |++--|..|..+++|+.|++++|+++ +++.+.
T Consensus        58 L~~L~Ls~N~------l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~   99 (156)
T d2ifga3          58 LRNLTIVKSG------LRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKT   99 (156)
T ss_dssp             CSEEECCSSC------CCEECTTGGGSCSCCCEEECCSSCCS-CCCSTT
T ss_pred             cCcceeeccc------cCCcccccccccccccceeccCCCCc-ccChhh
Confidence            5788888888      77766777888888888888888887 555443

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=86.52  E-value=0.074  Score=46.54  Aligned_cols=56  Identities=14%  Similarity=0.084  Sum_probs=38.6

Q ss_pred             eeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCc
Q 042763           26 FLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHC  105 (554)
Q Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n  105 (554)
                      ..+++++|+|.. ++.+..+.-                   ..+|++++|+      +++-.|  ++.|++|+.|++++|
T Consensus        43 ~~L~l~~~~i~~-l~~l~~l~n-------------------L~~L~Ls~N~------l~~~~~--l~~l~~L~~L~l~~n   94 (199)
T d2omxa2          43 TTLQADRLGIKS-IDGVEYLNN-------------------LTQINFSNNQ------LTDITP--LKNLTKLVDILMNNN   94 (199)
T ss_dssp             CEEECTTSCCCC-CTTGGGCTT-------------------CCEEECCSSC------CCCCGG--GTTCTTCCEEECCSS
T ss_pred             CEEECCCCCCCC-ccccccCCC-------------------cCcCcccccc------ccCccc--ccCCccccccccccc
Confidence            346677777663 444443333                   4888888888      876433  888888888888888


Q ss_pred             eeec
Q 042763          106 IFEG  109 (554)
Q Consensus       106 ~~~g  109 (554)
                      .+..
T Consensus        95 ~~~~   98 (199)
T d2omxa2          95 QIAD   98 (199)
T ss_dssp             CCCC
T ss_pred             cccc
Confidence            7764

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=86.50  E-value=0.071  Score=51.20  Aligned_cols=59  Identities=14%  Similarity=0.116  Sum_probs=45.5

Q ss_pred             EeeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccC
Q 042763           25 IFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANH  104 (554)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~  104 (554)
                      +..+++++|+|+. ++.+..|--                   ..+|++++|+      +++- | .++.|++|+.|++++
T Consensus        46 l~~L~l~~~~I~~-l~gl~~L~n-------------------L~~L~Ls~N~------l~~l-~-~l~~L~~L~~L~L~~   97 (384)
T d2omza2          46 VTTLQADRLGIKS-IDGVEYLNN-------------------LTQINFSNNQ------LTDI-T-PLKNLTKLVDILMNN   97 (384)
T ss_dssp             CCEEECCSSCCCC-CTTGGGCTT-------------------CCEEECCSSC------CCCC-G-GGTTCTTCCEEECCS
T ss_pred             CCEEECCCCCCCC-ccccccCCC-------------------CCEEeCcCCc------CCCC-c-cccCCcccccccccc
Confidence            5667888888874 555544443                   4999999999      8874 3 399999999999999


Q ss_pred             ceeeccc
Q 042763          105 CIFEGYS  111 (554)
Q Consensus       105 n~~~g~~  111 (554)
                      |++++-.
T Consensus        98 n~i~~i~  104 (384)
T d2omza2          98 NQIADIT  104 (384)
T ss_dssp             SCCCCCG
T ss_pred             ccccccc
Confidence            9998643

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=84.49  E-value=0.17  Score=40.62  Aligned_cols=57  Identities=9%  Similarity=0.007  Sum_probs=43.3

Q ss_pred             EeeecCCCcccccCCch-hHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhcc
Q 042763           25 IFLPRESSLDISSNFAP-SSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYAN  103 (554)
Q Consensus        25 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~  103 (554)
                      +..+++|+|.|+. +.+ +..+-.                   ...|++++|.      +++ +| .+..|++|+.|+++
T Consensus        22 L~~L~ls~N~l~~-lp~~~~~l~~-------------------L~~L~l~~N~------i~~-l~-~~~~l~~L~~L~l~   73 (124)
T d1dcea3          22 VTHLDLSHNRLRA-LPPALAALRC-------------------LEVLQASDNA------LEN-VD-GVANLPRLQELLLC   73 (124)
T ss_dssp             CCEEECCSSCCCC-CCGGGGGCTT-------------------CCEEECCSSC------CCC-CG-GGTTCSSCCEEECC
T ss_pred             CCEEECCCCccCc-chhhhhhhhc-------------------cccccccccc------ccc-cC-ccccccccCeEECC
Confidence            4557888888874 543 222222                   5899999999      885 44 59999999999999


Q ss_pred             Cceeec
Q 042763          104 HCIFEG  109 (554)
Q Consensus       104 ~n~~~g  109 (554)
                      +|+++.
T Consensus        74 ~N~i~~   79 (124)
T d1dcea3          74 NNRLQQ   79 (124)
T ss_dssp             SSCCCS
T ss_pred             CCccCC
Confidence            999985

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=82.97  E-value=0.081  Score=48.98  Aligned_cols=56  Identities=9%  Similarity=-0.028  Sum_probs=40.4

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC----CCccccccccccccCC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG----SDYCRLDLSLAKLSFS  128 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~----~~~~~~~~~~~~~~~~  128 (554)
                      ..++++++|+      +++-.|..|..+++|+.|++++|++++..+    ...-++.+.+.++.|.
T Consensus       179 L~~l~l~~N~------l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~  238 (284)
T d1ozna_         179 LDRLLLHQNR------VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV  238 (284)
T ss_dssp             CCEEECCSSC------CCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred             cchhhhhhcc------ccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence            5788999999      888888999999999999999999886443    1112233455555554

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=82.93  E-value=0.12  Score=45.43  Aligned_cols=57  Identities=11%  Similarity=0.124  Sum_probs=43.8

Q ss_pred             EeeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccC
Q 042763           25 IFLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANH  104 (554)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~  104 (554)
                      +..+++++|+|.+ +.++..+..|                   .+|++++|.      +++ ++ .++.|++|+.|++++
T Consensus        48 L~~L~l~~~~i~~-l~~l~~l~~L-------------------~~L~L~~n~------i~~-l~-~~~~l~~L~~L~l~~   99 (210)
T d1h6ta2          48 IDQIIANNSDIKS-VQGIQYLPNV-------------------TKLFLNGNK------LTD-IK-PLANLKNLGWLFLDE   99 (210)
T ss_dssp             CCEEECTTSCCCC-CTTGGGCTTC-------------------CEEECCSSC------CCC-CG-GGTTCTTCCEEECCS
T ss_pred             ccEEECcCCCCCC-chhHhhCCCC-------------------CEEeCCCcc------ccC-cc-ccccCcccccccccc
Confidence            4556888998874 5555554444                   899999999      887 44 478899999999999


Q ss_pred             ceeec
Q 042763          105 CIFEG  109 (554)
Q Consensus       105 n~~~g  109 (554)
                      |++++
T Consensus       100 n~i~~  104 (210)
T d1h6ta2         100 NKVKD  104 (210)
T ss_dssp             SCCCC
T ss_pred             ccccc
Confidence            99885

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=82.42  E-value=0.26  Score=41.35  Aligned_cols=39  Identities=5%  Similarity=-0.065  Sum_probs=33.8

Q ss_pred             cCCCceeeccCCcceeEEEcCc--cccchhhhhhhhhhhccCceeec
Q 042763           65 CGADHIAYSNSNEVELFYINGN--LVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        65 ~~~~~l~~s~n~~~~~~~~~G~--~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      -...+|++|+|+      ++..  ++..+..|++|+.|++++|.++.
T Consensus        65 ~~L~~L~Ls~N~------i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~  105 (162)
T d1koha1          65 PELLSLNLSNNR------LYRLDDMSSIVQKAPNLKILNLSGNELKS  105 (162)
T ss_dssp             TTCCCCCCCSSC------CCCCSGGGTHHHHSTTCCCCCCTTSCCCC
T ss_pred             CCCCEeeCCCcc------ccCCchhHHHHhhCCcccccccccCcccc
Confidence            357999999999      8863  56778999999999999999984

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=82.29  E-value=0.17  Score=44.89  Aligned_cols=35  Identities=3%  Similarity=-0.031  Sum_probs=20.8

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeec
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEG  109 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g  109 (554)
                      ...|++++|.      +++ +| .+..|++|+.|++++|++++
T Consensus       175 L~~L~Ls~n~------l~~-l~-~l~~l~~L~~L~Ls~N~lt~  209 (227)
T d1h6ua2         175 LTTLKADDNK------ISD-IS-PLASLPNLIEVHLKNNQISD  209 (227)
T ss_dssp             CCEEECCSSC------CCC-CG-GGGGCTTCCEEECTTSCCCB
T ss_pred             ceecccCCCc------cCC-Ch-hhcCCCCCCEEECcCCcCCC
Confidence            4666666666      554 32 35666666666666666653

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=81.82  E-value=0.14  Score=45.16  Aligned_cols=38  Identities=16%  Similarity=0.192  Sum_probs=29.3

Q ss_pred             CCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCceeecccC
Q 042763           67 ADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHCIFEGYSG  112 (554)
Q Consensus        67 ~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n~~~g~~~  112 (554)
                      ..+|++++|.      ++. ++ .+..|++|+.|++++|++++-.+
T Consensus        48 L~~L~l~~~~------i~~-l~-~l~~l~~L~~L~L~~n~i~~l~~   85 (210)
T d1h6ta2          48 IDQIIANNSD------IKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP   85 (210)
T ss_dssp             CCEEECTTSC------CCC-CT-TGGGCTTCCEEECCSSCCCCCGG
T ss_pred             ccEEECcCCC------CCC-ch-hHhhCCCCCEEeCCCccccCccc
Confidence            3788999888      764 33 47889999999999999986333

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=81.23  E-value=0.14  Score=44.74  Aligned_cols=57  Identities=9%  Similarity=-0.009  Sum_probs=41.6

Q ss_pred             eeecCCCcccccCCchhHHHHHHHhhhhhhccceeeccccCCCceeeccCCcceeEEEcCccccchhhhhhhhhhhccCc
Q 042763           26 FLPRESSLDISSNFAPSSFLLFLQFWGIFASGFAIQSKVCGADHIAYSNSNEVELFYINGNLVDKFSFCKVIQFHYANHC  105 (554)
Q Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~s~n~~~~~~~~~G~~p~~~~~~~~l~~l~~~~n  105 (554)
                      -.+++|+|+|+ .+.++..+..|                   .+|++++|.      ++ .+|..+..++.|+.|++++|
T Consensus        51 ~~L~Ls~n~I~-~i~~l~~l~~L-------------------~~L~Ls~N~------i~-~i~~~~~~~~~L~~L~l~~N  103 (198)
T d1m9la_          51 KHLALSTNNIE-KISSLSGMENL-------------------RILSLGRNL------IK-KIENLDAVADTLEELWISYN  103 (198)
T ss_dssp             CEEECSEEEES-CCCCHHHHTTC-------------------CEEECCEEE------EC-SCSSHHHHHHHCCEEECSEE
T ss_pred             ceeECcccCCC-CcccccCCccc-------------------cChhhcccc------cc-cccccccccccccccccccc
Confidence            35678888887 57776666555                   788888887      65 56766667777888888888


Q ss_pred             eeec
Q 042763          106 IFEG  109 (554)
Q Consensus       106 ~~~g  109 (554)
                      +++.
T Consensus       104 ~i~~  107 (198)
T d1m9la_         104 QIAS  107 (198)
T ss_dssp             ECCC
T ss_pred             cccc
Confidence            7764